Citrus Sinensis ID: 043157

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680----
Protein Sequence
IILLLWTVESASEPLSCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSPNIAVNISVTSLSSINNAKGINLTGTPFSFSQRINKFLAIGCDNYANNQQNDSISSNSILTDAGGECISICTCNPSENSDCCDMVCNIPHNSSTKVLDANTSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVCYEDYNSHTKVCNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRDSFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASNSNSM
Secondary Structure (PSIPRED)
cEEEcccccccccccccccccccEEEccccccccccccccccEEEEcccccccccccccccEEEEEEEEcccEEEEEEEEcccccccccccccccccccccEEcccccEEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEEEEcccccccccEEEEEccccccccccccccccccccccccEEEEEEEcccccHHccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHcccccccEEEEEcHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEcccccHHHHHHHHHHHHHHHHcccccEEcEEcEEcccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEcccccccccccccccEEEEEEccccccccHHHHcccccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccccccHHHHccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHcccccccccccccEEEcccccccccccccccEEEEEcccccccccccccccEEEEEEEccccEEEEEEccccccccccccccccccccccEEEcccccEEEEEEcccEEEEEcccccEEccEEEEcccccEEcccccccccccccccccccccccccEEEEEEEccccccccccccEEEEEEEcccEEcccccccccccccccccEEEEEEEcccccHHccccccccccccccEEcccccccEEEEcccccccccccccccccccccccccHHcccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHcccccccEEEEEcHHHHHHHHcccccccEEccccccEEEEEEEccccEEEEEEcEEEcHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEccccccEEEEEEEcccccccHHHHHHccccHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHcccHHHHHHHHHHccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHccccccccc
Coil and Loop (DISEMBL)
IILLLWTVesaseplscpdrcgsvlieypfgigagcyfdesfevvcdnssgppKAILQKIGQEISSYIsysgspniaVNISVTSLssinnakginltgtpfsFSQRINKFLAIgcdnyannqqndsissnsiltdaggecisictcnpsensdccdmvcniphnsstkvldantsyvysqsipqgctslslvdpdwifsnylktpsglkdkkkipavlewgkykgvcyedynshtkvcnkddrcliqlssgdlicnttsghncskcpdgynyyrpayyrplqerrcspkrsrdsffskktriifGNISSFIIYRYAISILRLsssgvgctsggLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELAstegtiektKLFTSKELERAtdnfnlnrilgqggqgtvykgmlpdgkivavkkskvideskVEEFINEMVILSQINHRNVVKLLGccletevpllvyefipngtlfqyihdqnedfpiTWEMRLRIAIEVSGALSylhsaasipiyhrdikstnillddkyrakvsdfgasrsmavdqthmttqvhgtfgyldpeyfrssqftdksdvySFGVVLAELltgekpirfttleEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLnlngkkrptmREVTSELAGIkawngasnsnsm
Flexible Loop (DISEMBL)
IILLLWTVesaseplscpdRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSPNIAVNISVTSLSSINNAKGINLTGTPFSFSQRINKFLAIGCDNYANNQQNDSISSNSILTDAGGECISICTCNPSENSDCCDMVCNIPHNSSTKVLDANTSYVYSQSIPQGCTSLSLVDPDWIFSNylktpsglkdkkkipaVLEWGKYKGVCYEDYNSHTKVCNKDDRCLIQLSSGDLIcnttsghncskcpdgyNYYRPAYYrplqerrcspkrsrdsffskktriifgnisSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKrkffkrngglllqqelastegtiektKLFTSKEleratdnfnlnrilgqggqGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASrsmavdqthMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELltgekpirfttleeDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRClnlngkkrptmreVTSElagikawngasnsnsm
Low Complexity Region (SEG)
IILLLWTVESASEPLSCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSPNIAVNISVTSLSSINNAKGINLTGTPFSFSQRINKFLAIGCDNYAnnqqndsissnsiLTDAGGECISICTCNPSENSDCCDMVCNIPHNSSTKVLDANTSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVCYEDYNSHTKVCNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRDSFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASNSNSM
Disordered region (IsUnstruct)
*ILLLWTVESASEPLSCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSPNIAVNISVTSLSSINNAKGINLTGTPFSFSQRINKFLAIGCDNYANNQ*******NSILTDAGGECISICTCNPSENSDCCDMVCNIPHNSSTKVLDANTSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVCYEDYNSHTKVCNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQ************FFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNG****************************
Disordered Region (DISOPRED)
IILLLW***************GSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSPNIAVNISVTSLSSINNAKGINLTGTPFSFSQRINKFLAIGCDNYANNQQNDSISSNSILTDAGGECISICTCNPSENSDCCDMVCNIPHNSSTKVLDANTSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVCYEDYNSHTKVCNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRDSFFSKKTRIIFGNISSFI*******ILRLSSSGVGCTSGGLGMFLLIGAWWLFKFV************************************LFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID**KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL***************
Disordered Region (DISEMBL)
IILLLWTVESASEPLSCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSPNIAVNISVTSLSSINNAKGINLTGTPFSFSQRINKFLAIGCDNYANNQQNDSISSNSILTDAGGECISICTCNPSENSDCCDMVCNIPHNSSTKVLDANTSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVCYEDYNSHTKVCNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQE**********SFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN********
Disordered Region (DISPRO)
IILLLWTVESASEPLSCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSPNIAVNISVTSLSSINNAKGINLTGTPFSFSQRINKFLAIGCDNYANNQQNDSISSNSILTDAGGECISICTCNPSENSDCCDMVCNIPHNSSTKVLDANTSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVCYEDYNSHTKVCNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRDSFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK*W*********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
IILLLWTVESASEPLSCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSPNIAVNISVTSLSSINNAKGINLTGTPFSFSQRINKFLAIGCDNYANNQQNDSISSNSILTDAGGECISICTCNPSENSDCCDMVCNIPHNSSTKVLDANTSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVCYEDYNSHTKVCNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRDSFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASNSNSM
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	684	2.2.26 [Sep-21-2011]
Q8VYA3	769	Wall-associated receptor	yes	no	0.929	0.827	0.433	1e-145
Q9SA25	720	Wall-associated receptor	no	no	0.916	0.870	0.433	1e-142
Q9LN59	788	Putative wall-associated	no	no	0.934	0.810	0.453	1e-141
Q9C9L5	792	Wall-associated receptor	no	no	0.505	0.436	0.661	1e-138
Q9M092	786	Wall-associated receptor	no	no	0.922	0.802	0.442	1e-136
Q7X8C5	748	Wall-associated receptor	no	no	0.480	0.439	0.639	1e-135
Q9S9M5	730	Wall-associated receptor	no	no	0.459	0.430	0.65	1e-134
Q9S9M2	761	Wall-associated receptor	no	no	0.480	0.432	0.634	1e-132
Q8RY17	751	Wall-associated receptor	no	no	0.466	0.424	0.654	1e-132
Q9LMT9	764	Putative wall-associated	no	no	0.497	0.445	0.648	1e-132

>sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1

 Score =  514 bits (1325), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 308/711 (43%), Positives = 431/711 (60%), Gaps = 75/711 (10%)

Query: 16  SCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYS---- 71
           SCP  CG + I YPFGIG GCY ++ +E++C N+S P    L  I +E+ S IS+S    
Sbjct: 26  SCPKTCGGIDIPYPFGIGTGCYLEKWYEIICVNNSVP---FLSIINREVVS-ISFSDMYR 81

Query: 72  -------GSPNIAVNISVTSLSSINNAKG--INLTGTPFSFSQRINKFLAIGCDNYAN-- 120
                  GS  I   I+    SS     G  +N+TG PF      N  +A+GC+N A+  
Sbjct: 82  RFFNVGYGSIRIRNPIASKGCSSGGQEFGSLLNMTGYPFYLGDN-NMLIAVGCNNTASLT 140

Query: 121 NQQNDSISSNSILTDAG----GECISICTCNPS-ENSDCCDMVCNIPHNSSTKV--LDAN 173
           N +   +   S  +        + + +  CN    +S+ C  +  +   S   +    A+
Sbjct: 141 NVEPSIVGCESTCSTNQDIPINDYLGVLYCNARYGDSEYCKNISIMNDTSCNGIGCCKAS 200

Query: 174 TSYVYSQSI----------PQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEW--- 220
               Y Q I           +GC    + D ++  SN    P  L         L W   
Sbjct: 201 LPARYQQIIGVEIDDSNTESKGCKVAFITDEEYFLSNG-SDPERLHANGYDTVDLRWFIH 259

Query: 221 -------GKYKGVCYEDYNSHTKVCNKDDR-----CLIQLSSGDLICNTTSGHNCSKCPD 268
                  G       ++Y     +  +D+R     CL   +S      TT+G+    C  
Sbjct: 260 TANHSFIGSLGCKSIDEYT----ILRRDNREYGIGCLCDYNS------TTTGYATCSCAS 309

Query: 269 GY--NYYRPAYYRPLQERRCSPKRSRDSFFSKKTRIIFGNISSFIIYRYAISILRLSSSG 326
           G+  N Y P   + + E       +      K   ++ G    +  +R  +         
Sbjct: 310 GFEGNPYIPGECKDINECVRGIDGNPVCTAGKCVNLLGGYTCEYTNHRPLV--------- 360

Query: 327 VGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKL 386
           +G ++    +  + G +WL+KF++R+R +  K+KFFKRNGGLLLQQ+L +TEG ++ T++
Sbjct: 361 IGLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRV 420

Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVI 446
           F S+ELE+AT+NF+L RILG+GGQGTVYKGML DG+IVAVKKSKV+DE K+EEFINE+VI
Sbjct: 421 FNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVI 480

Query: 447 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPIT-WEMRLRIAIEV 505
           LSQINHRN+VKLLGCCLET+VP+LVYEFIPNG LF+++HD ++D+ +T WE+RLRIA+++
Sbjct: 481 LSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDI 540

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
           +GALSYLHSAAS PIYHRDIKSTNI+LD+K+RAKVSDFG SR++ VD TH+TT V GT G
Sbjct: 541 AGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVG 600

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
           Y+DPEYF+SSQFTDKSDVYSFGVVLAEL+TGEK + F   +E ++LA YF  AMKE RL 
Sbjct: 601 YMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLS 660

Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN 676
           +I+DAR+      +++   AK+A++CLN+ G+KRP+MR+V+ EL  I++++
Sbjct: 661 DIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYS 711

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1

 Score =  506 bits (1304), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 312/720 (43%), Positives = 423/720 (58%), Gaps = 93/720 (12%)

Query: 1   IILLLWTVESASE---PLS---CPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGP-P 53
           ++LLL   E A+    PL+   C D CG+V + YPFGIG GCY ++ FE+VC +SS   P
Sbjct: 11  VMLLLRICEYAAASTFPLALRNCSDHCGNVSVPYPFGIGKGCYKNKWFEIVCKSSSDQQP 70

Query: 54  KAILQKIGQEISSY-------------------ISYSGSPNIAVNISVTSLSSINNAKGI 94
             +L +I + ++S+                   + +SG PN              ++  +
Sbjct: 71  ILLLPRIRRAVTSFNLGDPFSISVYNKFYIQSPLKHSGCPN----------RDGYSSSSL 120

Query: 95  NLTGTPFSFSQRINKFLAIGCDNYANNQQNDSISSNSIL---TDAGGECISICTCNPS-E 150
           NL G+PF  S+  NKF A+GC    NN+   +++   I+   T  G E  S    N S  
Sbjct: 121 NLKGSPFFISEN-NKFTAVGC----NNKAFMNVTGLQIVGCETTCGNEIRSYKGANTSCV 175

Query: 151 NSDCCDMVCNIPHNSSTKVLDANTSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKD 210
              CC M   IP     +V DA    +      QGC    L    +  S  L TP     
Sbjct: 176 GYKCCQMT--IPPLLQLQVFDATVEKLEPNK--QGCQVAFLTQ--FTLSGSLFTP----- 224

Query: 211 KKKIPAVLEWGKYKGVCYEDYNSHTKVCNKDDRCLIQLSSGDLICNTTS----GHNCSKC 266
               P ++E+ +Y  +  E               L  ++S  ++C   +     + CS C
Sbjct: 225 ----PELMEYSEYTTIELEWRLD-----------LSYMTSKRVLCKGNTFFEDSYQCS-C 268

Query: 267 PDGY--NYYRPAYYRPLQERRCSPKRSRDSFFSK-KTRIIFGNISSFIIYRYAISILRLS 323
            +GY  N Y P   + + E        RD   +K   R     + S+   +   +IL  +
Sbjct: 269 HNGYEGNPYIPGGCQDIDE-------CRDPHLNKCGKRKCVNVLGSYRCEKTWPAILSGT 321

Query: 324 SSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEK 383
            S             + G W L K  ++R+  K KRKFF+RNGGLLLQQ+ +   G++ +
Sbjct: 322 LSSGLLLL-------IFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNR 374

Query: 384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINE 443
           TK+F+S +LE ATD FN +RILGQGGQGTVYKGML DG IVAVKKSK + E  +EEFINE
Sbjct: 375 TKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINE 434

Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
           +++LSQINHRNVVK+LGCCLETEVP+LVYEFIPN  LF ++H+ +EDFP++WE+RL IA 
Sbjct: 435 IILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIAC 494

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           EV+ ALSYLHSA SIPIYHRD+KSTNILLD+K+RAKVSDFG SRS+A+D TH+TT V GT
Sbjct: 495 EVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGT 554

Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER 623
            GY+DPEY +S+ FT KSDVYSFGV+L ELLTGEKP+     +E + L AYFL AM+ +R
Sbjct: 555 IGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDR 614

Query: 624 LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASNSNS 683
           L EILDAR+ +E   +E++  AK+A+RCL+LN + RPTMR+V  EL  +++    + S +
Sbjct: 615 LHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQA 674

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2

 Score =  503 bits (1294), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 320/705 (45%), Positives = 427/705 (60%), Gaps = 66/705 (9%)

Query: 21  CGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSP------ 74
           CG++ I YPFGI  GCY +E +++ C N++ P    L K+G  + + IS  G        
Sbjct: 38  CGNINIPYPFGIEKGCYLNEWYKIECKNATYP---FLFKMGMAVVN-ISLPGDDGYNNPV 93

Query: 75  ---NIAVNISVTSLSSINNAKG----INLTGTPFSFSQRINKFLAIGCDNYAN------- 120
              +I V I +TS+    + K     +N T +PF F    N  +A+GC++ A+       
Sbjct: 94  SYGSIRVKIPITSIGCSRDGKESGSVLNFTDSPFYFGIG-NSLVAVGCNSKASLTNINPS 152

Query: 121 --------NQQNDSISSNSILTDAGGEC--------ISICTCNPSENSDCCD----MVCN 160
                       +++ S SI       C         S+CT N  E+   CD     +  
Sbjct: 153 KVGCELNCTASKETLPSKSIPFFDKTGCSNNKLPYYSSLCTKNNGEDERSCDGNGCCIAG 212

Query: 161 IPHNSSTKVLDANT-SYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLE 219
           +  + + +V+  N  S+ +  S    C    L D    FSN    P  L  K+     L 
Sbjct: 213 LLDSEAPQVIGINIESFDHGNSTKLECRVAFLTDDVSPFSN-ASEPKRLFAKRYATVSLG 271

Query: 220 WG-KYKGVCYEDYNSHTKVCNKDDRCL-IQLSSGDLICN--TTSG---HNCSKCPDGY-- 270
           W  + K + + +  S       D+    I+L +   ICN  T SG    NC  C  GY  
Sbjct: 272 WVIQTKNLSFVNSLSCKNTKEYDNSTYNIKLVTS-CICNNVTISGTDYANCG-CSQGYEG 329

Query: 271 NYYRPAYYRPLQERRCSPKRSRDSFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCT 330
           N Y P   + + E   +    R +     T +      + I  +  ++++     GVG  
Sbjct: 330 NPYLPGGCKDINECLRNSYGQRQNCRESDTCVNLPGTFNCIGNKTRVTMI-----GVGSA 384

Query: 331 SGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSK 390
            G L   L++G WWL KF+K+RR  K KRKFFKRNGGLLLQQ+L + +G +EKT++F+S+
Sbjct: 385 FGIL--VLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSR 442

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           ELE+ATDNF+ +RILGQGGQGTVYKGML DG+ VAVKKSKV+DE K+EEFINE+VILSQI
Sbjct: 443 ELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQI 502

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NHR+VVKLLGCCLETEVP LVYEFIPNG LFQ+IH++++D+  TW MRLRIA++++GALS
Sbjct: 503 NHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALS 562

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YLHSAAS PIYHRDIKSTNILLD+KYR KVSDFG SRS+ +D TH TT + GT GY+DPE
Sbjct: 563 YLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPE 622

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKP-IRFTTLEEDKSLAAYFLFAMKEERLFEILD 629
           Y+ SSQ+TDKSDVYSFGVVL EL+TGEKP I  +  +E + LA +F  AMKE R FEI+D
Sbjct: 623 YYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMD 682

Query: 630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
           AR+      ++++  A +A+RCLN  GKKRP MR+V ++L  I A
Sbjct: 683 ARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILA 727

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1

 Score =  493 bits (1270), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 231/349 (66%), Positives = 295/349 (84%), Gaps = 3/349 (0%)

Query: 326 GVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTK 385
           G+G + G L    ++G + L+KF+K++R++  K+KFFKRNGGLLLQQ+L ST G +EKT 
Sbjct: 376 GLGASFGSL--IFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTI 433

Query: 386 LFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMV 445
           +F+S+ELE+AT+NF+ NRILGQGGQGTVYKGML DG+IVAVKKSKV+DE K+EEFINE+V
Sbjct: 434 VFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVV 493

Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIE 504
           ILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG LF+++HD+ +E+   TW +RLRIAI+
Sbjct: 494 ILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAID 553

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           ++GALSYLHS+AS PIYHRD+KSTNI+LD+KYRAKVSDFG SR++ VD TH+TT V GT 
Sbjct: 554 IAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTV 613

Query: 565 GYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
           GY+DPEYF+SSQFTDKSDVYSFGVVL EL+TGEK I F   +E+++LA YF+ AMKE +L
Sbjct: 614 GYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKL 673

Query: 625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           F+I+DAR+       ++   AKVA++CLNL G+KRP+MREV+ EL  I+
Sbjct: 674 FDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2

 Score =  485 bits (1248), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 310/701 (44%), Positives = 419/701 (59%), Gaps = 70/701 (9%)

Query: 20  RCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSP---NI 76
           +CG + I YPFGIG GCY ++S+E+ C N+SG     L  I +E+ S I   G     ++
Sbjct: 41  KCGGIAIPYPFGIGKGCYLEKSYEIECLNTSGKLVPFLSVISKEVVS-IHLPGRQSFGSV 99

Query: 77  AVNISVTSLSSINNAKG----INLTGTPFSFSQRINKFLAIGCDNYA------------- 119
            V   +TS    ++ K     +NLT +PF F   IN  + +GC +               
Sbjct: 100 RVRSPITSAGCSSDGKDSAPVMNLTDSPF-FVSDINNLVGVGCSSKVSLEHIKQNMVGCE 158

Query: 120 -NNQQNDSISSNSI-LTDAGGECIS-----ICTCNPSENSDCCDMVC---NIPHNSSTKV 169
            N    ++  SNSI   D  G   S     +CT N  E+  C    C   ++P     +V
Sbjct: 159 LNCSTTNASDSNSIPFFDKTGCSFSYTFAQVCTGNKPEDMGCDGRGCCQASLPREPQ-QV 217

Query: 170 LDANTSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEW-GKYKGVCY 228
           +         +S   G   ++ +  ++   + L  P  L  K+     L W  + +   +
Sbjct: 218 IGIRIESNDGKSTTSGDCRVAFLTDEFFSLSKLTKPEQLHAKRYATLSLGWIMQTRNTSF 277

Query: 229 EDYNSHTKVCNKD-DRCLIQLSSGDLICNTTSG-------HNCSKCPDGY--NYYRPAYY 278
              NS      KD D       S   IC+ T          NC +C  GY  N Y     
Sbjct: 278 --VNSLACKIRKDTDTAYSNDQSIKCICDYTMSIISDIRYANC-ECNLGYKGNPYDSDGC 334

Query: 279 RPLQERRCSPKRSRDS----FFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGL 334
           R + E + +PK  +++     F    R +     + +I             G G    G 
Sbjct: 335 RDIDECKENPKYCKETDTCVNFEGGYRCVGDKTKAIMI-------------GAGT---GF 378

Query: 335 GMFLLIGA-WWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELE 393
           G+ +L+G  WWL KF+ +RR  K K+KFFKRNGGLLLQQEL + +G +EK ++FTSKELE
Sbjct: 379 GVLVLVGGVWWLRKFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELE 438

Query: 394 RATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHR 453
           +AT+NF+ NR+LG GGQGTVYKGML DG+ VAVKKSKVIDE K++EFINE+VILSQINHR
Sbjct: 439 KATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHR 498

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYL 512
           +VVKLLGCCLETEVP+LVYEFI NG LF++IH++  +D+ + W MRLRIA++++GALSYL
Sbjct: 499 HVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYL 558

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HSAAS PIYHRDIKSTNILLD+KYRAKV+DFG SRS+ +DQTH TT + GT GY+DPEY+
Sbjct: 559 HSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYY 618

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKP-IRFTTLEEDKSLAAYFLFAMKEERLFEILDAR 631
           RSSQ+T+KSDVYSFGV+LAEL+TG+KP I     +E  +LA +F  AMKE RL +I+DAR
Sbjct: 619 RSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDAR 678

Query: 632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
           +  +S  ++++  A +A +CL+  G+ RP MREV +EL  I
Sbjct: 679 IRDDSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERI 719

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1

 Score =  483 bits (1242), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 222/347 (63%), Positives = 288/347 (82%)

Query: 328 GCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLF 387
           G   G   +    G + L+KFV++RR++   RKFF+RNGG+LL+Q+LA  EG +E +++F
Sbjct: 345 GVLIGSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIF 404

Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
           +S ELE+ATDNFN NR+LGQGGQGTVYKGML DG+IVAVK+SK +DE +VEEFINE+V+L
Sbjct: 405 SSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVL 464

Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           +QINHRN+VKLLGCCLETEVP+LVYEF+PNG L + +HD+++D+ +TWE+RL IAIE++G
Sbjct: 465 AQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAG 524

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           ALSYLHSAAS PIYHRDIK+TNILLD++ RAKVSDFG SRS+ +DQTH+TTQV GTFGY+
Sbjct: 525 ALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYV 584

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
           DPEYF+SS+FT+KSDVYSFGVVL ELLTGEKP      EE++ LAA+F+ A+KE R+ +I
Sbjct: 585 DPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDI 644

Query: 628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
           +D R+  E   D++++ A +A+RCLN  GKKRP MREV+ EL  I++
Sbjct: 645 VDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRS 691

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1

 Score =  478 bits (1231), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 221/340 (65%), Positives = 288/340 (84%)

Query: 335 GMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELER 394
           G+   +G +WLFK +K+RR I   +KFFKRNGGLLL+Q+L + +G +E +K+F+SKEL +
Sbjct: 365 GLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRK 424

Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN 454
           ATDNF+++R+LGQGGQGTVYKGML DG IVAVK+SKV+DE K+EEFINE+V+LSQINHRN
Sbjct: 425 ATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRN 484

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           +VKLLGCCLETEVP+LVYE+IPNG LF+ +HD+++D+ +TWE+RLRIAIE++GAL+Y+HS
Sbjct: 485 IVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHS 544

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           AAS PI+HRDIK+TNILLD+KYRAKVSDFG SRS+ +DQTH+TT V GTFGY+DPEYF S
Sbjct: 545 AASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLS 604

Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK 634
           SQ+T KSDVYSFGVVL EL+TGEKP+     EE + LA +FL AMKE R+ +I+D R+  
Sbjct: 605 SQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKD 664

Query: 635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
           ES  ++++  AK+A++CLN  GK RP M+EV++EL  I++
Sbjct: 665 ESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRS 704

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2

 Score =  474 bits (1219), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 220/347 (63%), Positives = 280/347 (80%)

Query: 328 GCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLF 387
           G   G   +    G + L+KF+K++R     R FF+RNGG+LL+Q+LA  EG +E +K+F
Sbjct: 353 GVLIGSALLLFAFGIFGLYKFIKKQRRSSRMRVFFRRNGGMLLKQQLARKEGNVEMSKIF 412

Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
           +S ELE+ATDNFN NR+LGQGGQGTVYKGML DG+IVAVK+SK +DE KVEEFINE+V+L
Sbjct: 413 SSNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVL 472

Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           +QINHRN+VKLLGCCLETEVP+LVYEF+PNG L + + D+ +D+ +TWE+RL IAIE++G
Sbjct: 473 AQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRDECDDYIMTWEVRLHIAIEIAG 532

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           ALSYLHSAAS PIYHRDIK+TNILLD+KY+ KVSDFG SRS+ +DQTH+TTQV GTFGY+
Sbjct: 533 ALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYV 592

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
           DPEYF+SS+FTDKSDVYSFGVVL EL+TG+ P      EE++  AA+F+ A+KE R  +I
Sbjct: 593 DPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKENRFLDI 652

Query: 628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
           +D R+  E   D+++  AK+AKRCLN  GKKRP MREV+ EL  I++
Sbjct: 653 VDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRS 699

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1

 Score =  472 bits (1214), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 222/339 (65%), Positives = 289/339 (85%)

Query: 336 MFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERA 395
           +FL++G W L KFVK+RR+I  KR FFKRNGGLLL+Q+L +  G ++ +K+F+SKELE+A
Sbjct: 358 LFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKA 417

Query: 396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
           TDNFN+NR+LGQGGQGTVYKGML DG+IVAVK+SKV+DE KVEEFINE+ +LSQINHRN+
Sbjct: 418 TDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNI 477

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           VKL+GCCLETEVP+LVYE IPNG LF+ +H  ++D+ +TW++RLRI++E++GAL+YLHSA
Sbjct: 478 VKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSA 537

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
           AS P+YHRD+K+TNILLD+KYRAKVSDFG SRS+ VDQTH+TT V GTFGYLDPEYF++S
Sbjct: 538 ASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTS 597

Query: 576 QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE 635
           QFTDKSDVYSFGVVL EL+TGEKP      EE++ L ++F  AMK+ R+ +I+D+R+ + 
Sbjct: 598 QFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEG 657

Query: 636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
              ++++  AK+A+RCL+L GKKRP MREV+ EL  I++
Sbjct: 658 CTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRS 696

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1

 Score =  471 bits (1213), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 223/344 (64%), Positives = 277/344 (80%), Gaps = 4/344 (1%)

Query: 333 GLGMFLLI---GAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTS 389
           G G F+LI   G WW  K +++RR    KRKFFKRNGGLLLQQ+L +T+G +EKTKLF+S
Sbjct: 385 GAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSS 444

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQ 449
           +ELE+ATDNFN NR++GQGGQGTVYKGML DG+ VAVKKS V+DE K++EFINE++ILSQ
Sbjct: 445 RELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQ 504

Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           INHR+VVKLLGCCLETEVP+LVYEFIPNG LFQ++H++ +D+   W +R+RIA+++SGA 
Sbjct: 505 INHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAF 564

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           SYLH+AA  PIYHRDIKSTNILLD+KYRAKVSDFG SRS+++D TH TT + GT GY+DP
Sbjct: 565 SYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDP 624

Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKP-IRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           EY+ SS FT+KSDVYSFGVVL EL+TGEKP I  +  +E   LA YF  AM+E RLFEI+
Sbjct: 625 EYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEII 684

Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
           DAR+  +   +++I  A +A RCL   GK RP MREV++ L  I
Sbjct: 685 DARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	684
255545828	694	kinase, putative [Ricinus communis] gi|2	0.935	0.922	0.520	0.0
255545824	727	kinase, putative [Ricinus communis] gi|2	0.931	0.876	0.489	1e-174
359475622	867	PREDICTED: wall-associated receptor kina	0.875	0.690	0.509	1e-172
255541802	743	kinase, putative [Ricinus communis] gi|2	0.880	0.810	0.491	1e-172
359475620	822	PREDICTED: wall-associated receptor kina	0.938	0.781	0.506	1e-171
147765961	679	hypothetical protein VITISV_007744 [Viti	0.858	0.864	0.497	1e-169
224143699	635	predicted protein [Populus trichocarpa]	0.912	0.982	0.495	1e-165
224075944	702	predicted protein [Populus trichocarpa]	0.918	0.894	0.469	1e-160
224053054	722	predicted protein [Populus trichocarpa]	0.915	0.867	0.500	1e-159
224103351	685	predicted protein [Populus trichocarpa]	0.875	0.874	0.468	1e-159

>gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis]

 Score =  654 bits (1687), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/707 (52%), Positives = 475/707 (67%), Gaps = 67/707 (9%)

Query: 1   IILLLWTVESAS-EPLSCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQK 59
           + L+LW  ++ S EP  C   CG+V IE+PFGIG GCY DESFEV C++SS PPK  L  
Sbjct: 17  LFLILWLAQARSVEP--CESYCGNVPIEFPFGIGKGCYMDESFEVTCNSSSEPPKPFLTS 74

Query: 60  IGQEISSYISYSGSPN-IAVN---ISVTSLSSINNAKGINLTGTPFSFSQRINKFLAIGC 115
           I  E+   +S    PN + VN   I        + A  ++L+GTPF+FS   N+F A GC
Sbjct: 75  INMELLEVLS----PNQVQVNNPVIYSNCSHKTSTASRVSLSGTPFTFSNASNRFTAKGC 130

Query: 116 DNYANNQQNDSISSNSILTDAGGECISICTCNPSENSDCCDMVC---NIPHNSSTKVLDA 172
           +NYA   Q+        + D  G C+SIC  + + +S C  + C    IP     K  +A
Sbjct: 131 NNYAILMQD--------IGDTVGGCLSICR-DEANSSGCYGINCWQTTIP--PYMKSFEA 179

Query: 173 NTSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKD---KKKIPAVLEWGKYKGVC-- 227
           N +  +S +    C S  +VD  W F+    +   L D   K  +PAVL+W  Y+G C  
Sbjct: 180 NMTNPFSDNT-NNCKSAFMVDQSW-FAFQSSSSRSLDDLNYKDHVPAVLDWANYQGYCDI 237

Query: 228 YEDYN----SHTKVC----NKDDRCLIQLSSGDLICNTTSGHNCSK-C---PDGYNYYRP 275
            E YN    + +  C    N+   C+ Q    +   + +S +NC   C   P GYN   P
Sbjct: 238 SEYYNITCTTDSSYCWKELNRSQVCICQCEDPNKCPDQSSNYNCRLFCMYRPGGYNCPCP 297

Query: 276 -AYYRPLQERRCSPKRSRDSFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGL 334
             + +     RC P    +S F  K+R                   +  S  +GC SG  
Sbjct: 298 RGHGKYENSNRCYP----NSVFWGKSRT------------------KTKSIIIGCGSGIG 335

Query: 335 GMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELER 394
            + LLIG W L+K +KRRR +KLK+ FFKRNGGLLL+Q+L+STE  +E+TK+FTSKELE+
Sbjct: 336 FLLLLIGIWSLYKIIKRRRAMKLKQNFFKRNGGLLLEQQLSSTENYVEQTKVFTSKELEK 395

Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN 454
           ATD+++ NRILGQGGQGTVYKGML DG++VA+KKSKV+DE K+++FINE+VILSQINHRN
Sbjct: 396 ATDDYHTNRILGQGGQGTVYKGMLIDGRVVAIKKSKVVDEDKLDQFINEVVILSQINHRN 455

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           VVKL+GCCLETEVPLLVYEFIPNGTL+QYIH+ NE+FP+TWEMRLRIA EV+GAL+YLH+
Sbjct: 456 VVKLIGCCLETEVPLLVYEFIPNGTLYQYIHNPNEEFPVTWEMRLRIATEVAGALAYLHA 515

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           AAS+PIYHRDIKS+NILLD+KYRAKV+DFG S+S+++DQTH+TT+V GTFGYLDPEYF+S
Sbjct: 516 AASMPIYHRDIKSSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGYLDPEYFQS 575

Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK 634
           SQFT+KSDVYSFGVVL ELLTG+KPI      E++SLA YFL  M+E RLFEILDARV+K
Sbjct: 576 SQFTEKSDVYSFGVVLVELLTGQKPISSYRSVEERSLATYFLMTMEESRLFEILDARVLK 635

Query: 635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASNS 681
           E G +EII  AK+A++CLNLNGKKRP M+ V  EL GI++  G +++
Sbjct: 636 EGGREEIIAMAKLAEKCLNLNGKKRPKMKTVAIELEGIRSSQGHNHT 682

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis]

 Score =  617 bits (1590), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 347/709 (48%), Positives = 449/709 (63%), Gaps = 72/709 (10%)

Query: 1   IILLLWT----VESASEPLSCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAI 56
           I++ LW     + +A+ P+ C + CG +   +PFGIG GCY  E FE+VC++S  PPK  
Sbjct: 13  ILIQLWLNQALLATAAGPV-CQESCGDITFPFPFGIGKGCYMSEMFEIVCNDSFTPPKPF 71

Query: 57  LQKIGQEISSYISYSGSPNIAVNISVTSLSSINNAKG---INLTGTPFSFSQRINKFLAI 113
           L  I  E+    S  GS  I VN  V S +  N +     ++L GT F FS   N+F  I
Sbjct: 72  LTSINMELLHDPSI-GSERITVNSPVISSNCSNKSSTSTEVSLLGTSFLFSNESNRFTTI 130

Query: 114 GCDNYANNQQNDSISSNSILTDAG---GECISICTCNPSENS---DCCDMVCNIPHNSST 167
           GCD+YA            +LT +G   G C+SIC  N S      +CC     IP    +
Sbjct: 131 GCDSYA------------MLTQSGNTVGGCLSICRDNSSSGCYGLNCCQTT--IPPYVQS 176

Query: 168 KVLDANTSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVC 227
             ++    +         C S  +V  +W+ S        ++    +PAVL+W   +G C
Sbjct: 177 FEVNITNPFNSDGDGRDRCKSAFMVSQNWLASKSTNLDE-VRQMDHVPAVLDWANDQGYC 235

Query: 228 YEDYNSHTKVCNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNYY----RPAYYR---- 279
             D + +  +      C  QL+     C      +  KC +  NYY    +  Y R    
Sbjct: 236 --DISKNPNITCTSRYCWAQLTENQF-CICRQCEDVGKCTNPKNYYYCQLKCMYNRGGYN 292

Query: 280 ---PLQERR----CSPKRSRDSFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSG 332
              P++  +    C P    DS F+ K+RI    I         + I+ +  S       
Sbjct: 293 CPCPVEHHKEYSICYP----DSAFAGKSRIKTILIGCGSGLGLLLLIIGIWLS------- 341

Query: 333 GLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKEL 392
                        +K +KRRR  KLK+KFFKRNGGLLL+Q+L+STE  +E+TK+FTSKEL
Sbjct: 342 -------------YKIIKRRRATKLKQKFFKRNGGLLLEQQLSSTESHVEQTKVFTSKEL 388

Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           E+ATDN++ +RILGQGGQGTVYKGML DG++VA+KKSK++DE K+++FINE+VILSQINH
Sbjct: 389 EKATDNYHTSRILGQGGQGTVYKGMLTDGRVVAIKKSKLVDEDKLDQFINEVVILSQINH 448

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
           RNVVKL GCCLETEVPLLVYEFIPNGTLFQYI + N++FPITWEMRLRIA EV+GAL+YL
Sbjct: 449 RNVVKLTGCCLETEVPLLVYEFIPNGTLFQYIQNPNKEFPITWEMRLRIATEVAGALAYL 508

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HSAAS+PIYHRDIKS+NILLD+KYRAKV+DFG S+S+A++QTH+TT V GTFGYLDPEYF
Sbjct: 509 HSAASMPIYHRDIKSSNILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYF 568

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV 632
           +SSQFT+KSDVYSFGVVL ELLTG+KPI      E++SLA YFL  M+E RLFEILDARV
Sbjct: 569 QSSQFTEKSDVYSFGVVLVELLTGQKPISSLRSVEERSLATYFLMTMEENRLFEILDARV 628

Query: 633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASNS 681
           +KE G +EII  AK+A++CLNLNGKKRP M+ V  EL GI++  G S++
Sbjct: 629 LKEGGREEIIAMAKMAEKCLNLNGKKRPKMKTVAIELEGIRSSQGVSST 677

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera]

 Score =  612 bits (1579), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 345/677 (50%), Positives = 435/677 (64%), Gaps = 78/677 (11%)

Query: 17  CPDRCGSVLIEYPFGIG-AGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSPN 75
           C +RCG V I YPFGIG AGCYFDE FEV C+NS+ PPK  L+ +  E+ + +S  G+  
Sbjct: 37  CQERCGDVDIPYPFGIGSAGCYFDEWFEVTCNNSTDPPKPFLKGVNLEVLN-VSLDGT-- 93

Query: 76  IAVNISVTSLSSINNAKGINLT----GTPFSFSQRINKFLAIGCDNYANNQQNDSISSNS 131
           I VN  V  LS   + K  N T    G PFSFS    +F A+GC       Q+D++    
Sbjct: 94  IRVNNPVL-LSQNCSGKPSNDTQWWEGGPFSFSNTYTRFTAVGCSALVYIMQDDTVI--- 149

Query: 132 ILTDAGGECISICTCNPSENS-------DCCDMVCNIPHNSSTKVLDANTSYVYSQSIPQ 184
                 G C++ C  + +          +CC     +P    +   +  T    S    +
Sbjct: 150 ------GGCMTFCKKDATAAKKASCYGLECCQT--QVPPGLLSFTANLGTFSDGSADEQE 201

Query: 185 GCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVCY---EDYNSHTKVCNKD 241
            C    +VD +W  SN +  P  +KD + +PAVL+W  Y   C     + N+ T  C ++
Sbjct: 202 QCKFAFMVDQEWFISN-VPDPHTVKDMEYVPAVLDWRIYNATCAASTSNLNTSTSFCGEN 260

Query: 242 DRCLIQLSSGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRDSFFSKKTR 301
             C     +  LIC+      C    +G N Y P        + C   +S          
Sbjct: 261 TLCSTDTQTSSLICS------CFPVYEG-NPYLP--------QGCQGTQS---------- 295

Query: 302 IIFGNISSFIIYRYAISILRLSSSGVGCTSGGLGMFLLI-GAWWLFKFVKRRREIKLKRK 360
                     I   A+            T G LG  LL+  AWWL+  +KRR++IK K K
Sbjct: 296 ----------IEDCAV-----------ITIGALGTLLLVLCAWWLYIVLKRRKKIKYKEK 334

Query: 361 FFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPD 420
            F RNGGLLL+Q+L+STEG I+KTKLFTSKELE+ATD +N NR++GQGG+GTVYKGML D
Sbjct: 335 CFNRNGGLLLEQQLSSTEGNIDKTKLFTSKELEKATDRYNENRVIGQGGEGTVYKGMLMD 394

Query: 421 GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 480
           G+IVAVKK K++ +SK+E+FINE+VIL QINHRNVVKLLGCCLETEVPLLVYEFIPNGTL
Sbjct: 395 GRIVAVKKLKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 454

Query: 481 FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 540
            ++IH QNE+FPITWE+RLRIA EV+GALSYLHSAAS+PIYHRDIKSTNILLDDKYRAKV
Sbjct: 455 SEHIHGQNEEFPITWEIRLRIATEVAGALSYLHSAASVPIYHRDIKSTNILLDDKYRAKV 514

Query: 541 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           +DFG S+ +A+DQTH+TTQV GTFGYLDPEYF+SSQFT+KSDVYSFG+VL ELLTG+KPI
Sbjct: 515 ADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPI 574

Query: 601 RFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRP 660
             T  EE KSLA+YF+ +M E+RL ++LDA+V+KES  +EI   A +A+RC+NLNGKKRP
Sbjct: 575 LSTASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRP 634

Query: 661 TMREVTSELAGIKAWNG 677
           TM EV  EL  I+   G
Sbjct: 635 TMMEVAMELERIRKCQG 651

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis]

 Score =  610 bits (1574), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 363/739 (49%), Positives = 452/739 (61%), Gaps = 137/739 (18%)

Query: 1   IILLLWTVESASEPLS-----CPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKA 55
           II+  W + S+    S     C DRCG+V I YPFGIG GCY D  F V C+ +S P + 
Sbjct: 11  IIIFPWLINSSMAAASVAKPGCSDRCGNVTIPYPFGIGEGCYMDSGFAVTCNKTSLPYRP 70

Query: 56  ILQKIGQEISSYISYSGSPNIAVNISVTSLSSINNAKGINLTGTP----------FSFSQ 105
            L  I  E+           + V++  T +   N     N    P               
Sbjct: 71  YLTSINLEL-----------LRVSLESTLVRVNNPVLNSNCQDRPPVSDLSFSGSPFSFS 119

Query: 106 RINKFLAIGCDNYANNQQNDSISSNSILTDAGGECISICTCNPSENS----DCCDMVCNI 161
             N+F A+GC+N A   + D +          G C+SIC    +E+S    +CC    +I
Sbjct: 120 DNNRFTALGCNNLALIYRQDMVI---------GGCLSICNVTVTESSCYGINCCQT--SI 168

Query: 162 PH-----NSSTKVLDANTSYVYSQSIP-QGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIP 215
           P      N+S + +D          +P + C    +VD +W  SN     S L   K++P
Sbjct: 169 PPYLKFINASLRSIDP---------VPDEQCRVAFMVDREWFSSNASDNISALLGAKQVP 219

Query: 216 AVLEWGKYKGVCYEDYNSH--TKVCNKDDRCLIQ------------------LSSGD--- 252
           AVLEWG   G C +   +   T +C  +  C ++                  LS  D   
Sbjct: 220 AVLEWGISNGTCADSPGAENSTDICGSNASCSVKVGINYQCSCNQGYEGNPYLSCQDINE 279

Query: 253 ----------LIC-NTTSGHNCSKCPDGY-----NYYRPAYYRPLQERRCSPKRSRDSFF 296
                     +IC NT   + CS CPDGY     N Y    Y    ER            
Sbjct: 280 CEDSQKNKCSMICVNTPGSYKCS-CPDGYISMGNNCYLTDGY---TER------------ 323

Query: 297 SKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGLGM-FLLIGAWWLFKFVKRRREI 355
                           +R  I+I+          S GLG+ FLLIG WWL+K  KRR++ 
Sbjct: 324 ----------------FRPVIAIV---------LSAGLGIPFLLIGTWWLYKVQKRRKDA 358

Query: 356 KLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYK 415
           KL+++FFKRNGGLLLQQ+L+S+E +IEKT +FT+KELE+ATD++N NRILGQGGQGTVYK
Sbjct: 359 KLRQRFFKRNGGLLLQQQLSSSESSIEKTNMFTAKELEKATDHYNENRILGQGGQGTVYK 418

Query: 416 GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI 475
           GML DGK+VA+KKSK+ DESK E+FINE+VILSQINHRNVVKLLGCCLETEVPLLVYEFI
Sbjct: 419 GMLTDGKVVAIKKSKIADESKTEQFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 478

Query: 476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK 535
           PNGTL+Q++HD +E+FPITWEMRLRIAIE   ALSYLHSAAS+PIYHRDIKSTNILLDDK
Sbjct: 479 PNGTLYQHLHDPSEEFPITWEMRLRIAIETGSALSYLHSAASVPIYHRDIKSTNILLDDK 538

Query: 536 YRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
           YRAKVSDFG S+S+AVDQTH+TT+V GTFGYLDPEYF+SSQFT+KSDVYSFGVVL ELLT
Sbjct: 539 YRAKVSDFGTSKSIAVDQTHVTTRVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 598

Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G+KPI      E++SLA YFL +M++ RLFEILDARV+KE G +EI+  AK+A+RCLNLN
Sbjct: 599 GQKPISSARAVEERSLAMYFLLSMEQNRLFEILDARVLKEGGKEEILAVAKLARRCLNLN 658

Query: 656 GKKRPTMREVTSELAGIKA 674
           GKKRPTMR V +E+  I+A
Sbjct: 659 GKKRPTMRTVVTEVERIRA 677

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera]

 Score =  607 bits (1565), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 355/701 (50%), Positives = 442/701 (63%), Gaps = 59/701 (8%)

Query: 1   IILLLWT---VESASEPLSCPDRCGSVLIEYPFGIG-AGCYFDESFEVVCDNSSGP--PK 54
           I LLLW    + +      C + CG V I YPFGIG AGCYFDE FEV C+NS  P  PK
Sbjct: 134 ISLLLWLSRGLAATQGKSGCLETCGDVDIPYPFGIGSAGCYFDEWFEVTCNNSIHPHIPK 193

Query: 55  AILQKIGQEISSYISYSGSPNIAVNISVT-----SLSSINNAKGINLTGTPFSFSQRINK 109
             L+ +  E+ + +S + S  I VN  V      S    N+A+  +  G PFSFS    +
Sbjct: 194 PFLKILNLEVLN-VSLNRS-TIRVNNPVLGYMNCSGKPSNDAQ--SWEGGPFSFSDTYTR 249

Query: 110 FLAIGCDNYANNQQNDSISSNSILTDAGGECISICT--CNPSENSDCCDM-VCNIPHNSS 166
           F A+GC   A   QNDS+          G C+S C      ++N  C  +  C       
Sbjct: 250 FTAVGCSTLAYITQNDSVI---------GGCMSYCKQGTTAAKNGSCYGLKCCQTQFPPG 300

Query: 167 TKVLDANTSYVYSQSIPQG-CTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKG 225
            +          S S  Q  C    +VD +W F +  + P  +KD    PAVL+W  Y  
Sbjct: 301 LQYFTTMLGDFPSNSDDQDECKYAFMVDQEW-FISMEQDPDKVKDVGHAPAVLDWRIYNA 359

Query: 226 VC-------YEDYNSHTKVCNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNYYRPAYY 278
            C           N+ T  C  +  C     +  L C         +CP GY        
Sbjct: 360 TCKSVGWNNTSTSNTSTSFCGANAICSADTQTPSLTC---------RCPRGYE------G 404

Query: 279 RPLQERRCSPKRSRDSFFSKKTRII--FGNISSFIIYRYAISI----LRLSSSGVGCTSG 332
            P     C     +   +   T  I    N S + + +  +      + L    VG  +G
Sbjct: 405 NPYLTEGCEGTNYK--LYENGTVCINRNANFSCYPVDKLIVDPRPRRMVLPGICVGILAG 462

Query: 333 GLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKEL 392
              + L+I AWWL+K +KRR++IK K K FKRNGGLLL+Q+L+S+EG ++KTKLFTSKEL
Sbjct: 463 VGTLLLVICAWWLYKVLKRRQKIKYKEKCFKRNGGLLLEQQLSSSEGNVDKTKLFTSKEL 522

Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           E+ATD +N NR++GQGGQGTVYKGML DG+IVAVKK K++ + KVE+FINE+VILSQINH
Sbjct: 523 EKATDRYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDGKVEQFINEVVILSQINH 582

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
           RNVVKLLGCCLET VPLLVYEFIPNGTL ++IHDQNE+FPITWEMRLRIAIEV+GALSYL
Sbjct: 583 RNVVKLLGCCLETAVPLLVYEFIPNGTLSEHIHDQNEEFPITWEMRLRIAIEVAGALSYL 642

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HSAASIPIYHRDIKSTNILLDDKYRAKV+DFG S+S+A+DQTH+TTQV GTFGYLDPEYF
Sbjct: 643 HSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTQVQGTFGYLDPEYF 702

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV 632
           +SSQFT+KSDVYSFG+VL ELLTG+KPI  T  EE KSLA+YF+ +M E+RL ++LDA+V
Sbjct: 703 QSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLLDAQV 762

Query: 633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +KE   +EI   A +A+RC+NLNGKKRPTM EV  EL  +K
Sbjct: 763 VKEGKKEEINAIAFLARRCINLNGKKRPTMMEVAMELEILK 803

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera]

 Score =  602 bits (1553), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 339/681 (49%), Positives = 428/681 (62%), Gaps = 94/681 (13%)

Query: 17  CPDRCGSVLIEYPFGIGA-GCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSPN 75
           C + CG V I YPFGIG+ GCYFDE FEV C+NS+ PPK  L+ +  E+ + +S  G+  
Sbjct: 30  CQEWCGDVDIPYPFGIGSSGCYFDEWFEVTCNNSTDPPKPFLKGVNLEVLN-VSLHGT-- 86

Query: 76  IAVNISVTSLSSINNAKGINLT----GTPFSFSQRINKFLAIGCDNYANNQQNDSISSNS 131
           + VN  V  LS   + K  N T    G PFSFS    +F A+GC   A   Q+D++    
Sbjct: 87  VRVNNPVL-LSQNCSGKPSNDTQWWEGGPFSFSNTYTRFTAVGCSAMAYFMQDDTVI--- 142

Query: 132 ILTDAGGECISIC---TCNPSENSDCCDMVC---NIPHNSSTKVLDANTSYVYSQSIPQG 185
                 G C+++C       ++N+ C  + C    +P    +   + +T    S    + 
Sbjct: 143 ------GGCMTLCKKDVATAAKNASCYGLECCQTQVPPGLLSFTANLDTFPEGSADEQEP 196

Query: 186 CTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVC---YEDYNSHTKVCNKDD 242
           C    +VD +W  SN +  P  +KD + +PAVL+W  Y   C     + N+ T  C ++ 
Sbjct: 197 CKYAFMVDQEWFISN-VPDPHTVKDMEYVPAVLDWRIYNATCDASTSNLNTSTSFCGENT 255

Query: 243 RCLIQLSSGDLICNTTSGHNCSKCPDGY--NYYRPAYYRPLQERRCSPKRSRDSFFSKKT 300
            C     +  L C+         CP  Y  N Y P                         
Sbjct: 256 FCSTDTQTSSLTCS---------CPLLYEGNPYLPQ------------------------ 282

Query: 301 RIIFGNISSFIIYRYAISILRLSSSGVGC---TSGGLGMFLLI-GAWWLFKFVKRRREIK 356
                                      GC   T G LG  LL+  AWWL+  +KRR++IK
Sbjct: 283 ---------------------------GCQVITIGSLGTLLLVLCAWWLYIXLKRRKKIK 315

Query: 357 LKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKG 416
            K K F RNGGLLL+Q+L+S+EG I+KTKLFTSKELE+ATD +N NR++GQG QGT YKG
Sbjct: 316 YKEKCFNRNGGLLLEQQLSSSEGNIDKTKLFTSKELEKATDRYNENRVIGQGXQGTXYKG 375

Query: 417 MLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 476
           ML DG+IVAVKK K++ +SK+E+FINE+VIL QINHRNVVKLLGCCLETEVPLLVYEFIP
Sbjct: 376 MLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIP 435

Query: 477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY 536
           NGTL ++IH QNE+FPITWEMRLRIA EV GALSYLHS ASIPIYHRDIKSTNILLBDKY
Sbjct: 436 NGTLSEHIHGQNEEFPITWEMRLRIATEVXGALSYLHSXASIPIYHRDIKSTNILLBDKY 495

Query: 537 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTG 596
           RAKV+DFG S+ +A+DQTH+TTQV GTFGYLDPEYF+SSQFT+KSDVYSFG+VL ELLTG
Sbjct: 496 RAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTG 555

Query: 597 EKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNG 656
           +KPI     EE KSLA+YF+ +M E+RL ++LDA+V+KES  +EI   A +A+RC+NLNG
Sbjct: 556 KKPILSIASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAIAFLARRCINLNG 615

Query: 657 KKRPTMREVTSELAGIKAWNG 677
           KKRPTM EV  EL  I+   G
Sbjct: 616 KKRPTMMEVAMELERIRKCQG 636

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224143699|ref|XP_002336072.1| predicted protein [Populus trichocarpa] gi|222869913|gb|EEF07044.1| predicted protein [Populus trichocarpa]

 Score =  589 bits (1519), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 334/674 (49%), Positives = 438/674 (64%), Gaps = 50/674 (7%)

Query: 2   ILLLWTVESASEPLS---CPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQ 58
           ++L++ V +A+ P++   CPDRCG + I YPFGI   CY +E F + C+ S  P +A + 
Sbjct: 9   LMLMFQVAAAAAPIARSGCPDRCGDISIPYPFGIRKDCYMNEWFAIECNASVNPARAFIS 68

Query: 59  KIGQEISSYISYSGSPNIAVNISVTSLSSINNAKGINLTGTPFSFSQRINKFLAIGCDNY 118
           +I  E+ +  +   +  +   I  ++ +   +   +NLTGTPF FS+  N F+A+GC+  
Sbjct: 69  RINMEVLNISAERATATVKSPIISSNCTGREDGVPLNLTGTPFVFSRYDNVFIAVGCNTQ 128

Query: 119 ANNQQNDSISSNSILTDAGGECISICTCNPSENSDCCDMVCNIPHNSSTKVLDANTSYVY 178
           A       I+ N I       C+S C+   S+N       C     SS +V +       
Sbjct: 129 A---LMTGITPNLI------GCVSTCSDVKSKN------FCEALLPSSLQVFNPRIEATD 173

Query: 179 SQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVCYEDYNSHTKVC 238
                +GC    LV+  W  SN +  P  L+ +  +PA L W                  
Sbjct: 174 DNQDREGCKLAFLVNHTWFESN-VSDPFSLQSRDYVPAELGWAMS--------------V 218

Query: 239 NKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRDSFFSK 298
           N DD    +        N + G  C +C  GY      Y   +    C  K S+ S    
Sbjct: 219 NDDDPVYCRGYY-----NRSFGSEC-ECDGGYEGI--PYLGCIDVDEC--KESKHS---- 264

Query: 299 KTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLK 358
             R +   +++   +   I+ L ++   +G     L + LL+G WWL+K VK+ ++I+LK
Sbjct: 265 -CRGLLKCVNTRGYFNCEINKLYIALIVIGAVV--LALSLLMGIWWLYKLVKKWKKIELK 321

Query: 359 RKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGML 418
           +KFFKRNGGLLLQQEL + EG ++KTK+++SKELE ATD FN+NRILGQGGQGTVYKGML
Sbjct: 322 KKFFKRNGGLLLQQELRAAEGWVQKTKIYSSKELEVATDRFNVNRILGQGGQGTVYKGML 381

Query: 419 PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 478
            DG+IVAVKKS V+DE K+EEFINE+V+LSQINHRNVVKLLGCCLETEVPLLVYEFIPNG
Sbjct: 382 ADGRIVAVKKSMVVDEGKLEEFINEVVVLSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 441

Query: 479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 538
            L++YIHD NEDF ++WEMRLRIAIEV+GALSYLHSA SIPIYHRDIKSTNILLD+KYRA
Sbjct: 442 NLYKYIHDPNEDFLLSWEMRLRIAIEVAGALSYLHSATSIPIYHRDIKSTNILLDEKYRA 501

Query: 539 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEK 598
           KVSDFG+SRS+++DQTH+TT V GTFGYLDPEYF+SSQFT+KSDVYSFGVVL EL++G+K
Sbjct: 502 KVSDFGSSRSISIDQTHLTTLVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELISGQK 561

Query: 599 PIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKK 658
           PI   +  E +SLA +F+  M++ RL ++LDARV +    +E+I+ A +AKRCLNLNGK 
Sbjct: 562 PIFSVSQTETRSLATHFIMLMEDNRLSDVLDARVKEGCQNEEVISVANLAKRCLNLNGKN 621

Query: 659 RPTMREVTSELAGI 672
           RPTMREVTSEL  I
Sbjct: 622 RPTMREVTSELERI 635

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224075944|ref|XP_002304840.1| predicted protein [Populus trichocarpa] gi|222842272|gb|EEE79819.1| predicted protein [Populus trichocarpa]

 Score =  570 bits (1470), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 328/698 (46%), Positives = 435/698 (62%), Gaps = 70/698 (10%)

Query: 1   IILLLWTVESASEPLS---CPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAIL 57
           +++L++ +  A+ P++   CPDRCG++ I YPFG    CY DE F + C+ ++ PP+A +
Sbjct: 3   LLMLMFQLAKAAAPVAKFGCPDRCGAISIPYPFGTRKECYMDERFAIECNETANPPRAFI 62

Query: 58  QKIGQEISSYISYSGSPNIAVNISVTSLSSINNAKG--INLTGTPFSFSQRINKFLAIGC 115
            +I  E+ +    + +    V   V S + I    G  +NLTGTPF FS + N F+A+GC
Sbjct: 63  SRIKMEVLNISVKTATA--TVKSPVISFNCIGRVDGAPLNLTGTPFVFSSKRNLFVAVGC 120

Query: 116 DNYA--NNQQNDSISSNSILTDAGGECISICTCNPSENSDCCDMVCNIPHNSS-TKVLDA 172
           D  A     + D +   S   +              EN  C    C++    S  +V + 
Sbjct: 121 DTRAFMTGTEPDLVVWESTWGNLES------NVRLQENKMCSGQNCSLARIPSLLQVFNP 174

Query: 173 NTSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEW------GKYKGV 226
                 +  + +GC    LV+P W  SN +  P  ++ +  +P  L W            
Sbjct: 175 RLVSTNANQVGEGCKLAFLVNPTWFESN-ISDPFAMQYRDYVPMDLGWMMNLNDNDISTH 233

Query: 227 CYEDYNSHTK---VCNK--DDRCLIQLSSGDLI-CNTTSGHNCS---KCPDGYNYYRPAY 277
           C E YN  +K   VC    +    ++L   D+  C T   + C    KC +    YR A 
Sbjct: 234 CEESYNQSSKSECVCEDGFEGNPYLELGCTDVDECKTPEKNTCRGMLKCMNTRGGYRCAI 293

Query: 278 YRPLQERRCSPKRSR--DSFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGLG 335
            +       + +     D+FF+  T I                             G +G
Sbjct: 294 NKIYIIIIGTQQTENLSDAFFAPNTVI-----------------------------GLVG 324

Query: 336 -MFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELER 394
            +FLLIGA W++        I+LK+KFFKRNGGLLLQQ+L+S++G+++KTK+F+S ELE+
Sbjct: 325 VLFLLIGARWIYNC------IRLKKKFFKRNGGLLLQQQLSSSDGSVQKTKIFSSNELEK 378

Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN 454
           ATD FN +RILG GGQGTVYKGML DG IVAVKKSK++DE K+EEFINE+VILSQI+HRN
Sbjct: 379 ATDYFNESRILGHGGQGTVYKGMLADGTIVAVKKSKIVDEDKLEEFINEVVILSQISHRN 438

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           VV+LLGCCLET+VPLLVYEFIPNGTLFQY+H+QNEDF ++WE+RLRIA E +GA+SYLHS
Sbjct: 439 VVRLLGCCLETDVPLLVYEFIPNGTLFQYLHEQNEDFTLSWELRLRIASEAAGAISYLHS 498

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
            ASIPIYHRDIKSTNILLD+KYRAKVSDFG SRS+++DQTH+TT+V GTFGYLDPEYFR+
Sbjct: 499 TASIPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDQTHLTTKVQGTFGYLDPEYFRT 558

Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK 634
           SQ T+KSDVYSFGVVL ELL+G+KPI  T   E  SLA +F+  M++ RLF+I+DA+V  
Sbjct: 559 SQLTEKSDVYSFGVVLVELLSGKKPIFLTHSLETMSLAEHFIELMEDSRLFDIIDAQVKG 618

Query: 635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
           +   +E I  A +AKRCLNLNG+ RPTMREV  EL GI
Sbjct: 619 DCTEEEAIVIANLAKRCLNLNGRNRPTMREVAMELEGI 656

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224053054|ref|XP_002297684.1| predicted protein [Populus trichocarpa] gi|222844942|gb|EEE82489.1| predicted protein [Populus trichocarpa]

 Score =  570 bits (1469), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 338/675 (50%), Positives = 439/675 (65%), Gaps = 49/675 (7%)

Query: 16  SCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSG--PPKAILQKIGQEISSYISYSGS 73
           +C + CG++ I +PFGIG GCY ++ F V C+ ++   P +A L +I  E+   IS   S
Sbjct: 31  NCTETCGNITIPFPFGIGTGCYMNDWFSVHCNETTADSPSRAFLSRINMEVFK-ISLESS 89

Query: 74  PNIAVNISVTSLSSINNAKG----INLTGTPFSFSQRINKFLAIGCDNYANNQQNDSISS 129
               V ++   +SS  + +G    IN+TG+PFSFS   N F A+GC+N A          
Sbjct: 90  ---VVRVNSPIISSGCSGRGANLAINMTGSPFSFSSS-NIFTAMGCNNRA--------LL 137

Query: 130 NSILTDAGGECISIC--TCNPSENSDCC-DMVCNIPHNSSTKVLDANTSYVYSQSIPQG- 185
           N I  +  G C S C  +    ENS C  +  C     SS +V++A+          QG 
Sbjct: 138 NGIEPEIVG-CTSTCGASTEGKENSYCSGNNCCQTTIPSSLQVVNASLGTPEHPINDQGR 196

Query: 186 --CTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVCYEDYNSHTKVCNKDDR 243
             C    +V   W F N + +P  ++D + +P +L+W      C    N  +    +   
Sbjct: 197 NQCKVAFIVQEKW-FRNNISSPEVVQDMQYVPVILDWNSDAMYCDPPMNLTS---GRSGL 252

Query: 244 CLIQLSSGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRDSFFSKKTRII 303
             + L S   IC+   G+      DG N Y P     + E +  P+ +  S  +K   + 
Sbjct: 253 RTVTLYSNSTICSCNWGY------DG-NPYLPDGCTDIDECKI-PRGNSCSGMTKCVNVP 304

Query: 304 FGNISSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFK 363
            G    F        I  LS++       GL + LL+G W L+K VK+R+ I+LK+KFFK
Sbjct: 305 GG----FKCELDKAKITFLSAAT------GL-LLLLVGIWRLYKLVKKRKNIELKKKFFK 353

Query: 364 RNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKI 423
           RNGGLLLQQ+L+S++G+I+KTK+FTSKELE+ATD FN NRILGQGGQGTVYKGM  DG I
Sbjct: 354 RNGGLLLQQQLSSSDGSIQKTKIFTSKELEKATDRFNDNRILGQGGQGTVYKGMQADGMI 413

Query: 424 VAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 483
           VAVKKS ++DE K+EEFINE+VILSQ+NHRNVVKLLGCCLETEVPLLVYEFIPNG LF+Y
Sbjct: 414 VAVKKSILVDEEKLEEFINEVVILSQVNHRNVVKLLGCCLETEVPLLVYEFIPNGNLFEY 473

Query: 484 IHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 543
           IHDQ E+F  +WEMRLRIA EV+ ALSYLHSAASIP+YHRDIKSTNI+LD+K+RAKVSDF
Sbjct: 474 IHDQKEEFEFSWEMRLRIATEVARALSYLHSAASIPVYHRDIKSTNIMLDEKFRAKVSDF 533

Query: 544 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFT 603
           G SRS+A+DQTH+TT V GTFGYLDPEYF+SSQFT KSDVYSFGVVLAELL+G+KPI + 
Sbjct: 534 GTSRSIAIDQTHLTTHVQGTFGYLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQKPISYE 593

Query: 604 TLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMR 663
             EE  SLA +F+  ++E ++F+ILD R+M +   +E+I  A +A+RCLNL G+KRPTMR
Sbjct: 594 RSEERGSLATHFILLVEENKIFDILDERLMGQDREEEVIAVANLARRCLNLIGRKRPTMR 653

Query: 664 EVTSELAGIKAWNGA 678
           EV  EL  I+   GA
Sbjct: 654 EVAIELEQIRLSKGA 668

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224103351|ref|XP_002334062.1| predicted protein [Populus trichocarpa] gi|222869636|gb|EEF06767.1| predicted protein [Populus trichocarpa]

 Score =  567 bits (1461), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 330/704 (46%), Positives = 439/704 (62%), Gaps = 105/704 (14%)

Query: 16  SCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPK--AILQKIGQEISSYISYSGS 73
           +C D CG++ I +PFGIG GCY +  F V C+ ++   +  A L  I  E+   IS   S
Sbjct: 5   NCKDTCGNISIPFPFGIGTGCYLNYWFSVHCNKTTADSRSRAFLSSINMEVLE-ISLRRS 63

Query: 74  PNIAVNISVTSLSSINNAKG----INLTGTPFSFSQRINKFLAIGCDNYA--NNQQNDSI 127
               V ++   +SS  + +G    I++TG+PF+FS   N F+A+GC+N A  +  + + +
Sbjct: 64  ---VVRVNSPIISSGCSGRGANISIDMTGSPFAFSSS-NIFIAMGCNNRALLSRIEPEIV 119

Query: 128 SSNSILTDAGGECISICTCNPSENSDCCDMVCNIPHNSSTKVLDANTSYVYSQSIPQG-- 185
              +  +   G+  S C+ N     +CC     IP N   +V +A+          QG  
Sbjct: 120 GCTTTGSSTEGKENSYCSGN-----NCCQTT--IPSN--LQVFNASLGTTEHPINDQGRN 170

Query: 186 -CTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGV------------------ 226
            C    +V+ +W F N + +P  ++D + +P +L W  Y G                   
Sbjct: 171 QCKVAFIVEEEW-FRNNISSPEVVQDMQYVPVILRWLMYYGTDIPEGVTLWGLSTVTLYS 229

Query: 227 ------CYEDYNSHTKV---CNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNYYRPAY 277
                 C   Y+ H  +   C   D+C I         N  SG   +KC +      P +
Sbjct: 230 NSITCWCSPGYDGHPYLPDGCTDIDQCKIPG------VNWCSGM--TKCVN-----VPGW 276

Query: 278 YRPLQERRCSPKRSRDSFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGLGMF 337
           Y+      C   +++ +F S  T +                                 + 
Sbjct: 277 YK------CELDKAKITFLSAATGL---------------------------------LL 297

Query: 338 LLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATD 397
           LL+G W L+K VK+R+ I+LK+KFFKRNGGLLLQQ+L+S++G+I+KTK+FTSKELE+ATD
Sbjct: 298 LLVGIWRLYKLVKKRKNIELKKKFFKRNGGLLLQQQLSSSDGSIQKTKIFTSKELEKATD 357

Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVK 457
            FN NRILGQGGQGTVYKGM  DG IVAVKKS ++DE K+EEFINE+VILSQ+NHRNVVK
Sbjct: 358 RFNDNRILGQGGQGTVYKGMQADGMIVAVKKSILVDEEKLEEFINEVVILSQVNHRNVVK 417

Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           LLGCCLETEVPLLVYEFIPNG LF+YIHDQ E+F  +WEMRLRIA EV+ ALSYLHSAAS
Sbjct: 418 LLGCCLETEVPLLVYEFIPNGNLFEYIHDQKEEFEFSWEMRLRIATEVARALSYLHSAAS 477

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 577
           IP+YHRDIKSTNI+LD+K+RAKVSDFG SRS+A+DQTH+TT V GTFGYLDPEYF+SSQF
Sbjct: 478 IPVYHRDIKSTNIMLDEKFRAKVSDFGTSRSIAIDQTHLTTHVQGTFGYLDPEYFQSSQF 537

Query: 578 TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG 637
           T KSDVYSFGVVLAELL+G+KPI +   E+ +SLA +F+  M+E ++F+ILD R+M +  
Sbjct: 538 TGKSDVYSFGVVLAELLSGQKPISYERPEDRRSLATHFILLMEENKIFDILDERLMGQDR 597

Query: 638 GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASNS 681
            +E+I  A +A+RCLNLNG+KRPTMREV  EL  I+   GA ++
Sbjct: 598 EEEVIAVANLARRCLNLNGRKRPTMREVAIELEQIRVSKGAPHA 641

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	684
TAIR|locus:2205040	792	AT1G69730 [Arabidopsis thalian	0.505	0.436	0.661	9e-145
TAIR|locus:2016377	788	AT1G19390 [Arabidopsis thalian	0.764	0.663	0.510	3e-142
TAIR|locus:2019843	769	WAKL10 "WALL ASSOCIATED KINASE	0.602	0.535	0.556	1.7e-141
TAIR|locus:2032875	720	AT1G16260 [Arabidopsis thalian	0.622	0.591	0.544	7.2e-139
TAIR|locus:2019893	751	RFO1 "RESISTANCE TO FUSARIUM O	0.495	0.451	0.654	1.5e-136
TAIR|locus:2126316	786	AT4G31100 [Arabidopsis thalian	0.748	0.651	0.491	1.5e-136
TAIR|locus:2200552	730	WAKL1 "wall associated kinase-	0.507	0.475	0.642	3.6e-135
TAIR|locus:2030988	764	AT1G17910 [Arabidopsis thalian	0.497	0.445	0.648	1.2e-134
TAIR|locus:2200562	748	WAKL2 "wall associated kinase-	0.507	0.463	0.639	5.2e-134
TAIR|locus:2126271	793	AT4G31110 [Arabidopsis thalian	0.624	0.538	0.547	1.6e-128

TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)]

 Score = 1236 (440.2 bits), Expect = 9.0e-145, Sum P(3) = 9.0e-145
 Identities = 231/349 (66%), Positives = 295/349 (84%)

Query:   326 GVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTK 385
             G+G + G L    ++G + L+KF+K++R++  K+KFFKRNGGLLLQQ+L ST G +EKT 
Sbjct:   376 GLGASFGSL--IFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTI 433

Query:   386 LFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMV 445
             +F+S+ELE+AT+NF+ NRILGQGGQGTVYKGML DG+IVAVKKSKV+DE K+EEFINE+V
Sbjct:   434 VFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVV 493

Query:   446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIE 504
             ILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG LF+++HD+ +E+   TW +RLRIAI+
Sbjct:   494 ILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAID 553

Query:   505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
             ++GALSYLHS+AS PIYHRD+KSTNI+LD+KYRAKVSDFG SR++ VD TH+TT V GT 
Sbjct:   554 IAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTV 613

Query:   565 GYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
             GY+DPEYF+SSQFTDKSDVYSFGVVL EL+TGEK I F   +E+++LA YF+ AMKE +L
Sbjct:   614 GYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKL 673

Query:   625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
             F+I+DAR+       ++   AKVA++CLNL G+KRP+MREV+ EL  I+
Sbjct:   674 FDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)]

 Score = 1267 (451.1 bits), Expect = 3.0e-142, Sum P(2) = 3.0e-142
 Identities = 280/548 (51%), Positives = 361/548 (65%)

Query:   142 SICTCNPSENSDCCD----MVCNIPHNSSTKVLDANT-SYVYSQSIPQGCTSLSLVDPDW 196
             S+CT N  E+   CD     +  +  + + +V+  N  S+ +  S    C    L D   
Sbjct:   190 SLCTKNNGEDERSCDGNGCCIAGLLDSEAPQVIGINIESFDHGNSTKLECRVAFLTDDVS 249

Query:   197 IFSNYLKTPSGLKDKKKIPAVLEWG-KYKGVCYEDYNSHTKVCNKDDRCL-IQLSSGDLI 254
              FSN    P  L  K+     L W  + K + + +  S       D+    I+L +   I
Sbjct:   250 PFSN-ASEPKRLFAKRYATVSLGWVIQTKNLSFVNSLSCKNTKEYDNSTYNIKLVTS-CI 307

Query:   255 CN--TTSGH---NCSKCPDGY--NYYRPAYYRPLQERRCSPKRSRDSFFSKKTRIIFGNI 307
             CN  T SG    NC  C  GY  N Y P   + + E   +    R +     T +   N+
Sbjct:   308 CNNVTISGTDYANCG-CSQGYEGNPYLPGGCKDINECLRNSYGQRQNCRESDTCV---NL 363

Query:   308 SSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGG 367
                  +    +  R++  GVG   G L   L++G WWL KF+K+RR  K KRKFFKRNGG
Sbjct:   364 PG--TFNCIGNKTRVTMIGVGSAFGIL--VLVVGIWWLRKFLKKRRMSKRKRKFFKRNGG 419

Query:   368 LLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVK 427
             LLLQQ+L + +G +EKT++F+S+ELE+ATDNF+ +RILGQGGQGTVYKGML DG+ VAVK
Sbjct:   420 LLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVK 479

Query:   428 KSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ 487
             KSKV+DE K+EEFINE+VILSQINHR+VVKLLGCCLETEVP LVYEFIPNG LFQ+IH++
Sbjct:   480 KSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEE 539

Query:   488 NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 547
             ++D+  TW MRLRIA++++GALSYLHSAAS PIYHRDIKSTNILLD+KYR KVSDFG SR
Sbjct:   540 SDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSR 599

Query:   548 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP-IRFTTLE 606
             S+ +D TH TT + GT GY+DPEY+ SSQ+TDKSDVYSFGVVL EL+TGEKP I  +  +
Sbjct:   600 SVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQ 659

Query:   607 EDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVT 666
             E + LA +F  AMKE R FEI+DAR+      ++++  A +A+RCLN  GKKRP MR+V 
Sbjct:   660 EIRGLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVF 719

Query:   667 SELAGIKA 674
             ++L  I A
Sbjct:   720 TDLEKILA 727

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1236 (440.2 bits), Expect = 1.7e-141, Sum P(2) = 1.7e-141
 Identities = 236/424 (55%), Positives = 321/424 (75%)

Query:   256 NTTSGHNCSKCPDGY--NYYRPAYYRPLQERRCSPKRSRDSFFSKKTRIIFGNISSFIIY 313
             +TT+G+    C  G+  N Y P   + + E       +      K   ++ G    +  +
Sbjct:   297 STTTGYATCSCASGFEGNPYIPGECKDINECVRGIDGNPVCTAGKCVNLLGGYTCEYTNH 356

Query:   314 RYAISILRLSSSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQE 373
             R  +         +G ++    +  + G +WL+KF++R+R +  K+KFFKRNGGLLLQQ+
Sbjct:   357 RPLV---------IGLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQ 407

Query:   374 LASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID 433
             L +TEG ++ T++F S+ELE+AT+NF+L RILG+GGQGTVYKGML DG+IVAVKKSKV+D
Sbjct:   408 LTTTEGNVDSTRVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVD 467

Query:   434 ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPI 493
             E K+EEFINE+VILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG LF+++HD ++D+ +
Sbjct:   468 EDKLEEFINEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTM 527

Query:   494 T-WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 552
             T WE+RLRIA++++GALSYLHSAAS PIYHRDIKSTNI+LD+K+RAKVSDFG SR++ VD
Sbjct:   528 TTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVD 587

Query:   553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLA 612
              TH+TT V GT GY+DPEYF+SSQFTDKSDVYSFGVVLAEL+TGEK + F   +E ++LA
Sbjct:   588 HTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLA 647

Query:   613 AYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              YF  AMKE RL +I+DAR+      +++   AK+A++CLN+ G+KRP+MR+V+ EL  I
Sbjct:   648 TYFTLAMKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKI 707

Query:   673 KAWN 676
             ++++
Sbjct:   708 RSYS 711

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006182 "cGMP biosynthetic process" evidence=IDA

GO:0006952 "defense response" evidence=IEP

GO:0009617 "response to bacterium" evidence=IEP

GO:0009620 "response to fungus" evidence=IEP

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0009723 "response to ethylene stimulus" evidence=RCA

TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)]

 Score = 1167 (415.9 bits), Expect = 7.2e-139, Sum P(2) = 7.2e-139
 Identities = 243/446 (54%), Positives = 318/446 (71%)

Query:   230 DYNSHTKVCNKDDRCLIQLSSGDLIC--NT--TSGHNCSKCPDGY--NYYRPAYYRPLQE 283
             +Y+ +T +  +    L  ++S  ++C  NT     + CS C +GY  N Y P   + + E
Sbjct:   229 EYSEYTTIELEWRLDLSYMTSKRVLCKGNTFFEDSYQCS-CHNGYEGNPYIPGGCQDIDE 287

Query:   284 RRCSPKRSRDSFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGAW 343
              R  P  ++     +K   + G+      YR   +   + S   G  S GL + L+ G W
Sbjct:   288 CR-DPHLNKCG--KRKCVNVLGS------YRCEKTWPAILS---GTLSSGL-LLLIFGMW 334

Query:   344 WLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNR 403
              L K  ++R+  K KRKFF+RNGGLLLQQ+ +   G++ +TK+F+S +LE ATD FN +R
Sbjct:   335 LLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASR 394

Query:   404 ILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
             ILGQGGQGTVYKGML DG IVAVKKSK + E  +EEFINE+++LSQINHRNVVK+LGCCL
Sbjct:   395 ILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCL 454

Query:   464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHR 523
             ETEVP+LVYEFIPN  LF ++H+ +EDFP++WE+RL IA EV+ ALSYLHSA SIPIYHR
Sbjct:   455 ETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHR 514

Query:   524 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 583
             D+KSTNILLD+K+RAKVSDFG SRS+A+D TH+TT V GT GY+DPEY +S+ FT KSDV
Sbjct:   515 DVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDV 574

Query:   584 YSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIIT 643
             YSFGV+L ELLTGEKP+     +E + L AYFL AM+ +RL EILDAR+ +E   +E++ 
Sbjct:   575 YSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLA 634

Query:   644 FAKVAKRCLNLNGKKRPTMREVTSEL 669
              AK+A+RCL+LN + RPTMR+V  EL
Sbjct:   635 VAKLARRCLSLNSEHRPTMRDVFIEL 660

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1218 (433.8 bits), Expect = 1.5e-136, Sum P(2) = 1.5e-136
 Identities = 222/339 (65%), Positives = 289/339 (85%)

Query:   336 MFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERA 395
             +FL++G W L KFVK+RR+I  KR FFKRNGGLLL+Q+L +  G ++ +K+F+SKELE+A
Sbjct:   358 LFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKA 417

Query:   396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
             TDNFN+NR+LGQGGQGTVYKGML DG+IVAVK+SKV+DE KVEEFINE+ +LSQINHRN+
Sbjct:   418 TDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNI 477

Query:   456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
             VKL+GCCLETEVP+LVYE IPNG LF+ +H  ++D+ +TW++RLRI++E++GAL+YLHSA
Sbjct:   478 VKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSA 537

Query:   516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
             AS P+YHRD+K+TNILLD+KYRAKVSDFG SRS+ VDQTH+TT V GTFGYLDPEYF++S
Sbjct:   538 ASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTS 597

Query:   576 QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE 635
             QFTDKSDVYSFGVVL EL+TGEKP      EE++ L ++F  AMK+ R+ +I+D+R+ + 
Sbjct:   598 QFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEG 657

Query:   636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
                ++++  AK+A+RCL+L GKKRP MREV+ EL  I++
Sbjct:   658 CTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRS 696

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009620 "response to fungus" evidence=IMP

TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)]

 Score = 1189 (423.6 bits), Expect = 1.5e-136, Sum P(2) = 1.5e-136
 Identities = 270/549 (49%), Positives = 352/549 (64%)

Query:   143 ICTCNPSENSDCCDMVC---NIPHNSSTKVLDANTSYVYSQSIPQG-CTSLSLVDPDWIF 198
             +CT N  E+  C    C   ++P     +V+         +S   G C    L D  +  
Sbjct:   189 VCTGNKPEDMGCDGRGCCQASLPREPQ-QVIGIRIESNDGKSTTSGDCRVAFLTDEFFSL 247

Query:   199 SNYLKTPSGLKDKKKIPAVLEW-GKYKGVCYEDYNSHTKVCNKD-DRCLIQLSSGDLICN 256
             S   K P  L  K+     L W  + +   +   NS      KD D       S   IC+
Sbjct:   248 SKLTK-PEQLHAKRYATLSLGWIMQTRNTSF--VNSLACKIRKDTDTAYSNDQSIKCICD 304

Query:   257 TTSG-------HNCSKCPDGY--NYYRPAYYRPLQERRCSPKRSRDSFFSKKTRIIF-GN 306
              T          NC +C  GY  N Y     R + E + +PK  +++     T + F G 
Sbjct:   305 YTMSIISDIRYANC-ECNLGYKGNPYDSDGCRDIDECKENPKYCKET----DTCVNFEGG 359

Query:   307 ISSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGA-WWLFKFVKRRREIKLKRKFFKRN 365
                   YR      +    G G    G G+ +L+G  WWL KF+ +RR  K K+KFFKRN
Sbjct:   360 ------YRCVGDKTKAIMIGAGT---GFGVLVLVGGVWWLRKFLVKRRMAKRKKKFFKRN 410

Query:   366 GGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVA 425
             GGLLLQQEL + +G +EK ++FTSKELE+AT+NF+ NR+LG GGQGTVYKGML DG+ VA
Sbjct:   411 GGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLGHGGQGTVYKGMLVDGRTVA 470

Query:   426 VKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 485
             VKKSKVIDE K++EFINE+VILSQINHR+VVKLLGCCLETEVP+LVYEFI NG LF++IH
Sbjct:   471 VKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIH 530

Query:   486 DQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
             ++  +D+ + W MRLRIA++++GALSYLHSAAS PIYHRDIKSTNILLD+KYRAKV+DFG
Sbjct:   531 EEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFG 590

Query:   545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP-IRFT 603
              SRS+ +DQTH TT + GT GY+DPEY+RSSQ+T+KSDVYSFGV+LAEL+TG+KP I   
Sbjct:   591 TSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQ 650

Query:   604 TLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMR 663
               +E  +LA +F  AMKE RL +I+DAR+  +S  ++++  A +A +CL+  G+ RP MR
Sbjct:   651 NTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQVMAVANLAMKCLSSRGRNRPNMR 710

Query:   664 EVTSELAGI 672
             EV +EL  I
Sbjct:   711 EVFTELERI 719

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1228 (437.3 bits), Expect = 3.6e-135, Sum P(2) = 3.6e-135
 Identities = 223/347 (64%), Positives = 290/347 (83%)

Query:   328 GCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLF 387
             G   G  G+   +G +WLFK +K+RR I   +KFFKRNGGLLL+Q+L + +G +E +K+F
Sbjct:   358 GILIGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIF 417

Query:   388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
             +SKEL +ATDNF+++R+LGQGGQGTVYKGML DG IVAVK+SKV+DE K+EEFINE+V+L
Sbjct:   418 SSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLL 477

Query:   448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
             SQINHRN+VKLLGCCLETEVP+LVYE+IPNG LF+ +HD+++D+ +TWE+RLRIAIE++G
Sbjct:   478 SQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAG 537

Query:   508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
             AL+Y+HSAAS PI+HRDIK+TNILLD+KYRAKVSDFG SRS+ +DQTH+TT V GTFGY+
Sbjct:   538 ALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYM 597

Query:   568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
             DPEYF SSQ+T KSDVYSFGVVL EL+TGEKP+     EE + LA +FL AMKE R+ +I
Sbjct:   598 DPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDI 657

Query:   628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
             +D R+  ES  ++++  AK+A++CLN  GK RP M+EV++EL  I++
Sbjct:   658 IDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRS 704

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)]

 Score = 1180 (420.4 bits), Expect = 1.2e-134, Sum P(3) = 1.2e-134
 Identities = 223/344 (64%), Positives = 277/344 (80%)

Query:   333 GLGMFLLI---GAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTS 389
             G G F+LI   G WW  K +++RR    KRKFFKRNGGLLLQQ+L +T+G +EKTKLF+S
Sbjct:   385 GAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSS 444

Query:   390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQ 449
             +ELE+ATDNFN NR++GQGGQGTVYKGML DG+ VAVKKS V+DE K++EFINE++ILSQ
Sbjct:   445 RELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQ 504

Query:   450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
             INHR+VVKLLGCCLETEVP+LVYEFIPNG LFQ++H++ +D+   W +R+RIA+++SGA 
Sbjct:   505 INHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAF 564

Query:   510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
             SYLH+AA  PIYHRDIKSTNILLD+KYRAKVSDFG SRS+++D TH TT + GT GY+DP
Sbjct:   565 SYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDP 624

Query:   570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKP-IRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
             EY+ SS FT+KSDVYSFGVVL EL+TGEKP I  +  +E   LA YF  AM+E RLFEI+
Sbjct:   625 EYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEII 684

Query:   629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
             DAR+  +   +++I  A +A RCL   GK RP MREV++ L  I
Sbjct:   685 DARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1201 (427.8 bits), Expect = 5.2e-134, Sum P(2) = 5.2e-134
 Identities = 222/347 (63%), Positives = 288/347 (82%)

Query:   328 GCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLF 387
             G   G   +    G + L+KFV++RR++   RKFF+RNGG+LL+Q+LA  EG +E +++F
Sbjct:   345 GVLIGSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIF 404

Query:   388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
             +S ELE+ATDNFN NR+LGQGGQGTVYKGML DG+IVAVK+SK +DE +VEEFINE+V+L
Sbjct:   405 SSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVL 464

Query:   448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
             +QINHRN+VKLLGCCLETEVP+LVYEF+PNG L + +HD+++D+ +TWE+RL IAIE++G
Sbjct:   465 AQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAG 524

Query:   508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
             ALSYLHSAAS PIYHRDIK+TNILLD++ RAKVSDFG SRS+ +DQTH+TTQV GTFGY+
Sbjct:   525 ALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYV 584

Query:   568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
             DPEYF+SS+FT+KSDVYSFGVVL ELLTGEKP      EE++ LAA+F+ A+KE R+ +I
Sbjct:   585 DPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDI 644

Query:   628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
             +D R+  E   D++++ A +A+RCLN  GKKRP MREV+ EL  I++
Sbjct:   645 VDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRS 691

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1176 (419.0 bits), Expect = 1.6e-128, Sum P(2) = 1.6e-128
 Identities = 246/449 (54%), Positives = 319/449 (71%)

Query:   229 EDYNSHTKVCNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGY--NYYRPAYYRPLQERRC 286
             +D   +    N + +C    + G +  + TS  NC  C  GY  N Y     + + E  C
Sbjct:   297 KDREDYRNTTNLERKC----TCGRITISETSYANCG-CTYGYTGNPYVLNGCKDIDE--C 349

Query:   287 SPKRSRDSFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCTSGGLGMFLLIGA-WWL 345
               K      +  KT     N      YR      +    G G    G G+ +L+G  WWL
Sbjct:   350 KVKFE----YCGKTETCV-NFEGG--YRCVRDKTKAIMIGAGT---GFGVLVLVGGLWWL 399

Query:   346 FKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRIL 405
              KF+ +RR  K K+KFFKRNGGLLL QEL + EG +EKT++F S+ELE+AT+NF+ NR+L
Sbjct:   400 RKFLIKRRITKRKKKFFKRNGGLLLLQELNTREGYVEKTRVFNSRELEKATENFSENRVL 459

Query:   406 GQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLET 465
             G GGQGTVYKGML DG+ VAVKKSKVIDE K++EFINE+VILSQINHR+VVKLLGCCLET
Sbjct:   460 GHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLET 519

Query:   466 EVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
             EVP+LVYEFI NG LF++IH++ ++D+ + W MRLRIA++++GALSYLHS+AS PIYHRD
Sbjct:   520 EVPMLVYEFIINGNLFKHIHEEESDDYTMLWGMRLRIAVDIAGALSYLHSSASSPIYHRD 579

Query:   525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
             IKSTNILLD+KYRAKV+DFG SRS+ +DQTH TT + GT GY+DPEY++SSQ+T+KSDVY
Sbjct:   580 IKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYQSSQYTEKSDVY 639

Query:   585 SFGVVLAELLTGEKP-IRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIIT 643
             SFGV+LAEL+TG+KP I     +E  +LA +F  AMKE+RL +I+DAR+  +   ++++ 
Sbjct:   640 SFGVILAELITGDKPVIMVQNTQEIVALAEHFRVAMKEKRLTDIIDARIRNDCKPEQVMA 699

Query:   644 FAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              AKVA +CL+  GKKRP MREV +EL  I
Sbjct:   700 VAKVAMKCLSSKGKKRPNMREVFTELERI 728

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8VYA3	WAKLJ_ARATH	2, ., 7, ., 1, 1, ., -	0.4331	0.9298	0.8270	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	684
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-55
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-54
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-38
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-36
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-31
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-30
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-29
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-29
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-29
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-28
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-28
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-28
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-28
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-27
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-26
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-26
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-26
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-26
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-26
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-25
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-25
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-25
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-25
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-24
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-24
pfam13947	106	pfam13947, GUB_WAK_bind, Wall-associated receptor	1e-24
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-24
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-24
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-24
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-24
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-24
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-23
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-22
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-22
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-21
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-21
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-21
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-20
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-20
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-19
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-19
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-18
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-18
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-18
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-17
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-17
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-17
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-16
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-13
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-12
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-12
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	8e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-11
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-10
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.002

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  188 bits (479), Expect = 5e-55
 Identities = 88/271 (32%), Positives = 129/271 (47%), Gaps = 21/271 (7%)

Query: 399 FNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNV 455
           + L R LG G  GTVYK      GKIVAVK  K       K +    E+ IL +++H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           V+L+    + +   LV E+   G LF Y+       P++ +   +IA+++   L YLHS 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHSN 117

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRS 574
               I HRD+K  NILLD+    K++DFG ++ +    + +TT V GT  Y+ PE     
Sbjct: 118 G---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173

Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK 634
           + +  K DV+S GV+L ELLTG+ P        +  L    L         E       +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP-----FSGENILDQLQLIRRILGPPLEF-----DE 223

Query: 635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                       + K+CLN +  KRPT  E+
Sbjct: 224 PKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  185 bits (472), Expect = 7e-54
 Identities = 87/276 (31%), Positives = 134/276 (48%), Gaps = 27/276 (9%)

Query: 401 LNRILGQGGQGTVYKGML----PDGKI-VAVKKSKVI-DESKVEEFINEMVILSQINHRN 454
           L + LG+G  G VYKG L       ++ VAVK  K    E ++EEF+ E  I+ +++H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           +VKLLG C E E  ++V E++P G L  Y+   N    ++    L  A++++  + YL  
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE- 120

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
             S    HRD+ + N L+ +    K+SDFG SR +  D  +          ++ PE  + 
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM 633
            +FT KSDV+SFGV+L E+ T GE+P          S A    +  K  RL         
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP------YPGMSNAEVLEYLKKGYRLP-------K 225

Query: 634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
             +   E+    K+  +C   + + RPT  E+   L
Sbjct: 226 PPNCPPEL---YKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  184 bits (470), Expect = 1e-53
 Identities = 84/276 (30%), Positives = 128/276 (46%), Gaps = 28/276 (10%)

Query: 401 LNRILGQGGQGTVYKGML----PDGKI-VAVKKSKVI-DESKVEEFINEMVILSQINHRN 454
           L + LG+G  G VYKG L       K+ VAVK  K    E ++EEF+ E  I+ +++H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           VVKLLG C E E   +V E++  G L  Y+        ++    L  A++++  + YL  
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP--KLSLSDLLSFALQIARGMEYLE- 119

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
             S    HRD+ + N L+ +    K+SDFG SR +  D  +          ++ PE  + 
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM 633
            +FT KSDV+SFGV+L E+ T GE+P          S      +     RL         
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP------YPGMSNEEVLEYLKNGYRLP-------Q 224

Query: 634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
             +   E+     +  +C   + + RPT  E+   L
Sbjct: 225 PPNCPPEL---YDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  179 bits (457), Expect = 2e-52
 Identities = 73/193 (37%), Positives = 108/193 (55%), Gaps = 10/193 (5%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           LG+GG GTVY       GK VA+K   K    S +EE + E+ IL ++NH N+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
            +     LV E+   G+L   + +      ++ +  LRI +++   L YLH   S  I H
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 523 RDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ-FTDK 580
           RD+K  NILLD D  + K++DFG S+ +  D++ + T V GT  Y+ PE       +++K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEK 174

Query: 581 SDVYSFGVVLAEL 593
           SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  176 bits (449), Expect = 1e-50
 Identities = 77/269 (28%), Positives = 120/269 (44%), Gaps = 23/269 (8%)

Query: 399 FNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-SKVIDESKVEEFINEMVILSQINHRNVV 456
           + +   LG+G  G VY       GK+VA+K   K   +   E  + E+ IL ++ H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +L     + +   LV E+   G LF  +  +     ++ +       ++  AL YLHS  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG---RLSEDEARFYLRQILSALEYLHSK- 116

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
              I HRD+K  NILLD+    K++DFG +R +      +TT V GT  Y+ PE      
Sbjct: 117 --GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGKG 172

Query: 577 FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES 636
           +    D++S GV+L ELLTG+ P        D  L   F    K +  F   +  +  E 
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP-----FPGDDQLLELFKKIGKPKPPFPPPEWDISPE- 226

Query: 637 GGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                     + ++ L  + +KR T  E 
Sbjct: 227 -------AKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  174 bits (444), Expect = 6e-50
 Identities = 85/286 (29%), Positives = 129/286 (45%), Gaps = 42/286 (14%)

Query: 403 RILGQGGQGTVYKGMLPDGK----IVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVK 457
           + LG+G  G VYKG L         VAVK  K    E + ++F+ E  ++ ++ H NVV+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP------ITWEMRLRIAIEVSGALSY 511
           LLG C E E   LV E++  G L  Y+      FP      ++ +  L  AI+++  + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLD 568
           L    S    HRD+ + N L+ +    K+SDFG SR +  D  +      G      ++ 
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFE- 626
           PE  +   FT KSDV+SFGV+L E+ T G  P              Y    +  E + E 
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--------------Y--PGLSNEEVLEY 219

Query: 627 ILDARVMK--ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
           +     +   E   DE+    ++   C  L+ + RPT  E+   L 
Sbjct: 220 LRKGYRLPKPEYCPDEL---YELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  169 bits (432), Expect = 3e-48
 Identities = 85/280 (30%), Positives = 135/280 (48%), Gaps = 31/280 (11%)

Query: 399 FNLNRILGQGGQGTVYKGML-----PDGKIVAVKKSKVI-DESKVEEFINEMVILSQINH 452
             L + LG+G  G VYKG L          VAVK  K    E + EEF+ E  I+ +++H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
            N+V+LLG C + E   +V E++P G L  ++    E   +T +  L++A++++  + YL
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE--KLTLKDLLQMALQIAKGMEYL 118

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPE 570
               S    HRD+ + N L+ +    K+SDFG SR +  D  +   +  G     ++ PE
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-RKRGGGKLPIKWMAPE 174

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD 629
             +  +FT KSDV+SFGV+L E+ T GE+P          S            RL     
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY------PGMSNEEVLELLEDGYRL----- 223

Query: 630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                E+  DE+    ++  +C   + + RPT  E+  +L
Sbjct: 224 --PRPENCPDEL---YELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  155 bits (394), Expect = 6e-43
 Identities = 77/274 (28%), Positives = 132/274 (48%), Gaps = 38/274 (13%)

Query: 403 RILGQGGQGTVYKGMLPD-GKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLL 459
            +LG+G  G+VY  +  D G+++AVK  ++    E ++E    E+ ILS + H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 460 GCCL-ETEVPLLVY-EFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSYLHSAA 516
           G    E +  L ++ E++  G+L   +  +    P   E  +R    ++   L+YLHS  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLP---EPVIRKYTRQILEGLAYLHSNG 121

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSS 575
              I HRDIK  NIL+D     K++DFG ++ +  ++    T  V GT  ++ PE  R  
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 576 QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE 635
           ++   +D++S G  + E+ TG+ P  ++  E    +AA +               ++   
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP--WS--ELGNPMAALY---------------KIGSS 219

Query: 636 SGGDEI-ITFAKVAK----RCLNLNGKKRPTMRE 664
               EI    ++ AK    +CL  + KKRPT  E
Sbjct: 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  142 bits (360), Expect = 3e-38
 Identities = 84/261 (32%), Positives = 119/261 (45%), Gaps = 28/261 (10%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +G+GG G VYK      GK VA+K  K+  + K E+ INE+ IL +  H N+VK  G  L
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA---IEVSGALSYLHSAASIPI 520
           + +   +V EF   G+L   +   N+    +      IA    E+   L YLHS     I
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHSNG---I 119

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRDIK+ NILL      K+ DFG S  ++  +   T    GT  ++ PE      +  K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYDYK 177

Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE 640
           +D++S G+   EL  G+ P       E   + A F  A        + +     E   DE
Sbjct: 178 ADIWSLGITAIELAEGKPPYS-----ELPPMKALFKIATNG--PPGLRN----PEKWSDE 226

Query: 641 IITFAKVAKRCLNLNGKKRPT 661
              F    K+CL  N +KRPT
Sbjct: 227 ---FKDFLKKCLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  137 bits (348), Expect = 1e-36
 Identities = 78/267 (29%), Positives = 127/267 (47%), Gaps = 24/267 (8%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLL 459
           + +G+G  G VY      DGK+  +K+  +  + E + E+ +NE+ IL ++NH N++K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 460 GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-PITWEMRLRIAIEVSGALSYLHSAASI 518
               E     +V E+   G L Q I  Q ++  P   E  L   +++  AL YLHS    
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123

Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT 578
            I HRDIK  NI L      K+ DFG S+ ++       T V GT  YL PE  ++  + 
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181

Query: 579 DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGG 638
            KSD++S G VL EL T + P  F    E ++L    L  +K +  +  + ++   E   
Sbjct: 182 YKSDIWSLGCVLYELCTLKHP--F----EGENLLELALKILKGQ--YPPIPSQYSSE--- 230

Query: 639 DEIITFAKVAKRCLNLNGKKRPTMREV 665
                   +    L  + ++RP++ ++
Sbjct: 231 -----LRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  127 bits (320), Expect = 5e-32
 Identities = 79/280 (28%), Positives = 120/280 (42%), Gaps = 22/280 (7%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH-R 453
           ++ + R LG+G  G VY     D K+VA+K   K       +VE F+ E+ IL+ +NH  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKL     +     LV E++  G+L   +       P++    L I  ++  AL YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 514 SAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQ-----VHGTFGYL 567
           S   I   HRDIK  NILLD D    K+ DFG ++ +    +  +         GT GY+
Sbjct: 119 SKGII---HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 568 DPEYFRSSQF---TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
            PE          +  SD++S G+ L ELLTG  P          S        +  E  
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ----TLKIILELP 231

Query: 625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
              L + +   +        + + K+ L  + K R +   
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  124 bits (314), Expect = 9e-32
 Identities = 81/266 (30%), Positives = 122/266 (45%), Gaps = 29/266 (10%)

Query: 400 NLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           NL +I G+G  G VYK      GK VA+KK ++  ++K E  INE++I+    H N+V  
Sbjct: 23  NLEKI-GEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDY 80

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               L  +   +V E++  G+L   I  QN    +       +  EV   L YLHS   I
Sbjct: 81  YDSYLVGDELWVVMEYMDGGSL-TDIITQN-FVRMNEPQIAYVCREVLQGLEYLHSQNVI 138

Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT 578
              HRDIKS NILL      K++DFG +  +  +++   + V GT  ++ PE  +   + 
Sbjct: 139 ---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYG 194

Query: 579 DKSDVYSFGVVLAELLTGEKP-IRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG 637
            K D++S G++  E+  GE P +R   L       A FL   K            +K   
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFLITTK--------GIPPLKNPE 240

Query: 638 G--DEIITFAKVAKRCLNLNGKKRPT 661
               E   F     +CL  + +KRP+
Sbjct: 241 KWSPEFKDF---LNKCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  123 bits (310), Expect = 2e-31
 Identities = 77/278 (27%), Positives = 118/278 (42%), Gaps = 36/278 (12%)

Query: 397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFI-NEMVILSQINHRN 454
            +    ++LGQG  G VYK    P GKI A+KK  V  + +  + +  E+  L       
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRL-RIAIEVSGALSYLH 513
           VVK  G   +     +V E++  G+L   +  +    P   E  L  IA ++   L YLH
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIP---EPVLAYIARQILKGLDYLH 116

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           +   I   HRDIK +N+L++ K   K++DFG S+ +        T V GT  Y+ PE  +
Sbjct: 117 TKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173

Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM 633
              ++  +D++S G+ L E   G+ P               FL    +   FE++ A   
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFP---------------FLPP-GQPSFFELMQAICD 217

Query: 634 KES-------GGDEIITFAKVAKRCLNLNGKKRPTMRE 664
                        E   F      CL  + KKRP+  E
Sbjct: 218 GPPPSLPAEEFSPEFRDF---ISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 7e-31
 Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 12/206 (5%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRN 454
           N+ L  ++G+G  G VYKG+ L  G  VA+K+  +  I E  ++  + E+ +L  + H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSGALSYLH 513
           +VK +G    ++   ++ E+  NG+L Q I  +   FP   E  + + + +V   L+YLH
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFP---ESLVAVYVYQVLQGLAYLH 116

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
               I   HRDIK+ NIL       K++DFG +  +  D +     V GT  ++ PE   
Sbjct: 117 EQGVI---HRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIE 172

Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKP 599
            S  +  SD++S G  + ELLTG  P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 3e-30
 Identities = 75/200 (37%), Positives = 104/200 (52%), Gaps = 13/200 (6%)

Query: 405 LGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
           LG+G  G V      D GK+ A+K   K K+I   +VE  + E  ILS+INH  +VKL  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 461 CCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIP 519
              +TE  L LV E+ P G LF ++  +   F      R   A E+  AL YLHS     
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLS-KEGRFSEER-ARFYAA-EIVLALEYLHSLG--- 113

Query: 520 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 579
           I +RD+K  NILLD     K++DFG ++ ++ + +   T   GT  YL PE      +  
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGK 172

Query: 580 KSDVYSFGVVLAELLTGEKP 599
             D +S GV+L E+LTG+ P
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  119 bits (302), Expect = 3e-30
 Identities = 73/230 (31%), Positives = 109/230 (47%), Gaps = 32/230 (13%)

Query: 397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVK---KSKVIDESKVEEFINEMVILSQIN- 451
           D+F   +I+G+G   TV         K  A+K   K ++I E KV+    E  +L+++N 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALS 510
           H  ++KL     + E    V E+ PNG L QYI    + D   T   R   A E+  AL 
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT---RFYAA-EILLALE 116

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR---------SMAVDQTHMTTQVH 561
           YLHS     I HRD+K  NILLD     K++DFG ++         S   D T++ +Q+ 
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 562 ----------GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                     GT  Y+ PE          SD+++ G ++ ++LTG+ P R
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  118 bits (299), Expect = 4e-30
 Identities = 81/280 (28%), Positives = 138/280 (49%), Gaps = 39/280 (13%)

Query: 405 LGQGGQGTVYKG--MLPDGKI--VAVK--KSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           LG G  G+V KG  ++  GK   VAVK  K + I   K +EF+ E  +++Q++H  +V+L
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVRL 61

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
           +G C   E  +LV E  P G L +Y+     + P++ +++  +A +V+  ++YL S   +
Sbjct: 62  IGVCKG-EPLMLVMELAPLGPLLKYLKK-RREIPVS-DLKE-LAHQVAMGMAYLESKHFV 117

Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQ 576
              HRD+ + N+LL ++++AK+SDFG SR++     +      G +   +  PE     +
Sbjct: 118 ---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 577 FTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA--RVM 633
           F+ KSDV+S+GV L E  + G KP                   MK   +  +L++  R+ 
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYG----------------EMKGAEVIAMLESGERLP 218

Query: 634 KESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
           +      EI +   +   C     + RPT  E+ S     
Sbjct: 219 RPEECPQEIYS---IMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  117 bits (296), Expect = 9e-30
 Identities = 69/266 (25%), Positives = 126/266 (47%), Gaps = 24/266 (9%)

Query: 398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRN 454
           +F +   +G+G  G V+K +   D ++ A+K+  +  ++  + EE I+E  +L++++   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           +++     L+     +V E+  NG L + +  Q    P+  +   R  I++   L++LHS
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHS 119

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
                I HRDIKS N+ LD     K+ D G ++ ++ D T+    + GT  YL PE    
Sbjct: 120 KK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCED 175

Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK 634
             + +KSDV++ GVVL E  TG+ P       +  +  A  L  ++           V  
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPF------DANNQGALILKIIRG----------VFP 219

Query: 635 ESGGDEIITFAKVAKRCLNLNGKKRP 660
                     A++  +CL  + ++RP
Sbjct: 220 PVSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 2e-29
 Identities = 80/270 (29%), Positives = 129/270 (47%), Gaps = 29/270 (10%)

Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESK-VEEFINEMVILSQINHRNVVKLLGCCL 463
           +G+G  G V  G    G+ VAVK  K  D+S   + F+ E  +++ + H N+V+LLG  L
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLK--DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHR 523
           +     +V E++  G+L  Y+  +     IT   +L  A++V   + YL         HR
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHR 126

Query: 524 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 583
           D+ + N+L+ +   AKVSDFG ++  +  Q      V  T     PE  R  +F+ KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDV 182

Query: 584 YSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEII 642
           +SFG++L E+ + G  P     L++   +  +     + E            E    E+ 
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEKGYRME----------APEGCPPEVY 229

Query: 643 TFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              KV K C  L+  KRPT +++  +LA I
Sbjct: 230 ---KVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  117 bits (294), Expect = 2e-29
 Identities = 70/202 (34%), Positives = 115/202 (56%), Gaps = 14/202 (6%)

Query: 403 RILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRNVVK 457
           R++G+G  G VY G L   DG+ +  AVK  +++ D  +VE+F+ E +I+   +H NV+ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 458 LLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           LLG CL +E  PL+V  ++ +G L  +I  ++E    T +  +   ++V+  + YL   A
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYL---A 115

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFGYLDPEYFR 573
           S    HRD+ + N +LD+ +  KV+DFG +R +        H  T       ++  E  +
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175

Query: 574 SSQFTDKSDVYSFGVVLAELLT 595
           + +FT KSDV+SFGV+L EL+T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  117 bits (295), Expect = 3e-29
 Identities = 71/229 (31%), Positives = 113/229 (49%), Gaps = 35/229 (15%)

Query: 397 DNFNLNRILGQGGQGTVYKG----MLPDGK--IVAVKKSK-VIDESKVEEFINEMVILSQ 449
           D   L R LG+G  G V+ G    + P+    +VAVK  K        ++F  E  +L+ 
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64

Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI--HD---------QNEDFPITWEMR 498
             H N+VK  G C E + P++V+E++ +G L +++  H           +    +T    
Sbjct: 65  FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
           L+IA++++  + YL   AS    HRD+ + N L+      K+ DFG SR +       TT
Sbjct: 125 LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTT 175

Query: 559 ---QVHGT----FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
              +V G       ++ PE     +FT +SDV+SFGVVL E+ T G++P
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  115 bits (289), Expect = 1e-28
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 20/219 (9%)

Query: 398 NFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKVIDESKVE--EFINEMVILSQINHRN 454
           +F + + LG+G  G+VYK   L D +  A+K+  +   S+ E  + +NE+ IL+ +NH N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 455 VVK-----LLGCCLETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGA 508
           ++      L G  L      +V E+ P G L + I   + +   I  +   RI I++   
Sbjct: 61  IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           L  LH      I HRD+KS NILL      K+ D G S+ +   +    TQ+ GT  Y+ 
Sbjct: 116 LQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMA 169

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           PE ++   ++ KSD++S G +L E+ T   P    ++++
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD 208

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  114 bits (288), Expect = 1e-28
 Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 17/205 (8%)

Query: 405 LGQGGQGTVYKG--MLPDGKI--VAVK--KSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           LG G  G V +G      GK+  VAVK  KS  + +  +++F+ E  I+  ++H N+++L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI-MDDFLKEAAIMHSLDHENLIRL 61

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNED-FPITWEMRLRIAIEVSGALSYLHSAAS 517
            G  L T   ++V E  P G+L   +       F I+       A++++  + YL S   
Sbjct: 62  YGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLESKRF 118

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT--FGYLDPEYFRSS 575
           I   HRD+ + NILL    + K+ DFG  R++  ++ H   + H    F +  PE  R+ 
Sbjct: 119 I---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 576 QFTDKSDVYSFGVVLAELLT-GEKP 599
            F+  SDV+ FGV L E+ T GE+P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  113 bits (286), Expect = 3e-28
 Identities = 80/277 (28%), Positives = 123/277 (44%), Gaps = 38/277 (13%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDE--SKVEEFINEMVILSQINHRNVVKLLGC 461
           +G G  G VY  + L  G+++AVK+ ++ D     ++E  +EM +L  + H N+VK  G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 462 CLETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEMRLRI-AIEVSGALSYLHSAASIP 519
            +  E   +  E+   GTL + + H +  D     E  +R+  +++   L+YLHS     
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILD-----EHVIRVYTLQLLEGLAYLHSHG--- 119

Query: 520 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG---YLDPEYFRSSQ 576
           I HRDIK  NI LD     K+ DFG +  +  + T M  +V    G   Y+ PE     +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 577 FTDK---SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF-EILDARV 632
                  +D++S G V+ E+ TG++P      E D      F      +    + L    
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWS----ELDNEFQIMFHVGAGHKPPIPDSLQLS- 234

Query: 633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                  E   F     RCL  + KKRPT     SEL
Sbjct: 235 ------PEGKDF---LDRCLESDPKKRPT----ASEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  113 bits (284), Expect = 5e-28
 Identities = 75/209 (35%), Positives = 111/209 (53%), Gaps = 14/209 (6%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQ 449
           E+ER TD   +   LG G  G VY+G+       VAVK  K  D  +VEEF+ E  ++ +
Sbjct: 2   EMER-TD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 58

Query: 450 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           I H N+V+LLG C   E P  ++ EF+  G L  Y+ + N    +   + L +A ++S A
Sbjct: 59  IKHPNLVQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSA 116

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GY 566
           + YL     I   HRD+ + N L+ + +  KV+DFG SR M  D    T      F   +
Sbjct: 117 MEYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKW 171

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
             PE    ++F+ KSDV++FGV+L E+ T
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 1e-27
 Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 30/223 (13%)

Query: 399 FNLNRILGQGGQGTVYKGML--PDGKI--VAVKKSKV--IDESKVEEFINEMVILSQINH 452
             L +ILG+G  G+V +G L   DG    VAVK  K+     S++EEF++E   +   +H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 453 RNVVKLLGCCLETE------VPLLVYEFIPNGTLFQY-----IHDQNEDFPITWEMRLRI 501
            NV+KL+G C E         P+++  F+ +G L  +     +    E  P+  +  L+ 
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKF 118

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD----QTHMT 557
            ++++  + YL +   I   HRD+ + N +L +     V+DFG S+ +       Q  + 
Sbjct: 119 MVDIALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                   ++  E      +T KSDV++FGV + E+ T G+ P
Sbjct: 176 KM---PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 3e-27
 Identities = 82/285 (28%), Positives = 138/285 (48%), Gaps = 48/285 (16%)

Query: 403 RILGQGGQGTVYKGM-LPDG---KI-VAVKKSKVIDESK----VEEFINEMVILSQINHR 453
           ++LG G  GTVYKG+ +P+G   KI VA+K   V+ E       +E ++E  +++ ++H 
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIK---VLREETSPKANKEILDEAYVMASVDHP 69

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +VV+LLG CL +    L+ + +P G L  Y+   ++D  I  +  L   ++++  +SYL 
Sbjct: 70  HVVRLLGICL-SSQVQLITQLMPLGCLLDYVR-NHKD-NIGSQYLLNWCVQIAKGMSYLE 126

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----YLD 568
                 + HRD+ + N+L+      K++DFG ++ + VD+       H   G     ++ 
Sbjct: 127 EKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE----YHAEGGKVPIKWMA 179

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLF-- 625
            E      +T KSDV+S+GV + EL+T G KP       E   L        K ERL   
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE------KGERLPQP 233

Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
            I    V              V  +C  ++ + RPT +E+ +E +
Sbjct: 234 PICTIDVY------------MVLVKCWMIDAESRPTFKELINEFS 266

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  110 bits (278), Expect = 7e-27
 Identities = 87/293 (29%), Positives = 124/293 (42%), Gaps = 55/293 (18%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN-----EMVILSQINHRNVVKL 458
           LG+G    VYK      G+IVA+KK K+ +  + ++ IN     E+ +L ++ H N++ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF------PITWEMRLRIAIEVSGALSYL 512
           L          LV+EF+    L + I D++              M LR        L YL
Sbjct: 68  LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYML-MTLR-------GLEYL 118

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-Y 571
           HS     I HRD+K  N+L+      K++DFG +RS       MT QV  T  Y  PE  
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELL 174

Query: 572 FRSSQFTDKSDVYSFGVVLAEL------LTGEKPIR-----FTTL----EED----KSLA 612
           F +  +    D++S G + AEL      L G+  I      F  L    EE+     SL 
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234

Query: 613 AYFLF-AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
            Y  F       L +I  A        D+ +      +R L LN  KR T R+
Sbjct: 235 DYVEFKPFPPTPLKQIFPAA------SDDALDL---LQRLLTLNPNKRITARQ 278

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (273), Expect = 1e-26
 Identities = 60/200 (30%), Positives = 106/200 (53%), Gaps = 15/200 (7%)

Query: 403 RILGQGGQGTVYKGMLPDGKIVAVK--KSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
             +G+G  G VYKG+L     VAVK  +S +  + K  +F+ E  IL Q +H N+VKL+G
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIG 59

Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
            C++ +   +V E +P G+L  ++  +     +  +  L+++++ +  + YL S   I  
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKNCI-- 115

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT----FGYLDPEYFRSSQ 576
            HRD+ + N L+ +    K+SDFG SR    ++  + T   G       +  PE     +
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSRE---EEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 577 FTDKSDVYSFGVVLAELLTG 596
           +T +SDV+S+G++L E  + 
Sbjct: 172 YTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  109 bits (274), Expect = 1e-26
 Identities = 73/216 (33%), Positives = 113/216 (52%), Gaps = 16/216 (7%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKG--MLPDG-KI-VAVKKSKV-IDESKVEEFINEMV 445
           E++R  ++  L R +G+G  G VY+G  M P+  KI VAVK  K     S  E+F+ E  
Sbjct: 2   EIQR--EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59

Query: 446 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
           I+ Q +H ++VKL+G    TE P+ +V E  P G L  Y+  Q   + +     +  + +
Sbjct: 60  IMRQFDHPHIVKLIGVI--TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQ 115

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           +S AL+YL S       HRDI + N+L+      K+ DFG SR +  +  +  ++     
Sbjct: 116 LSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI 172

Query: 565 GYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 2e-26
 Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 29/270 (10%)

Query: 405 LGQGGQGTVYKGMLPDGKIVAVK--KSKVIDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           LG G  G V+ G       VA+K  +   + E   ++FI E  ++ +++H N+V+L G C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
            +     +V E++ NG L  Y+ ++        E  L +  +V  A+ YL S   I   H
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGT--EWLLDMCSDVCEAMEYLESNGFI---H 123

Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 582
           RD+ + N L+ +    KVSDFG +R +  DQ   +        +  PE F  S+F+ KSD
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 583 VYSFGVVLAELLTGEK-PI-RFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE 640
           V+SFGV++ E+ +  K P  RF+  E  +S++A +       RL+         +    E
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-------RLYR-------PKLAPTE 229

Query: 641 IITFAKVAKRCLNLNGKKRPTMREVTSELA 670
           + T   +   C +   + RP  +++ S+L 
Sbjct: 230 VYT---IMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  107 bits (270), Expect = 3e-26
 Identities = 72/226 (31%), Positives = 108/226 (47%), Gaps = 14/226 (6%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIV-AVK---KSKVIDESKVEEFINEMVILSQINHR 453
           +F L R++G+G  G V      D K + A+K   K K +++  V   +NE  IL ++NH 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSGALSYL 512
            +V L     + E   LV + +  G L +Y   Q   F    E +++  I E+  AL YL
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFS---EEQVKFWICEIVLALEYL 116

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HS     I HRDIK  NILLD++    ++DF  +  +  D   +TT   GT GY+ PE  
Sbjct: 117 HSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVL 171

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA 618
               ++   D +S GV   E L G++P R  +      + A    A
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA 217

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  107 bits (268), Expect = 7e-26
 Identities = 61/208 (29%), Positives = 109/208 (52%), Gaps = 17/208 (8%)

Query: 404 ILGQGGQGTVYKGMLPDGKIVAVKK------SKVIDESKVEEFINEMVILSQINHRNVVK 457
           +LG+G  GTVY G+   G+++AVK+      + +  E + E+   E+ +L  + H N+V+
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
            LG CL+     +  EF+P G++   +   N   P+   +  +   ++   ++YLH+   
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA-----VDQTHMTTQVHGTFGYLDPEYF 572
           +   HRDIK  N++L      K+ DFG +R +A        ++M   +HGT  ++ PE  
Sbjct: 124 V---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S +  KSD++S G  + E+ TG+ P+
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  106 bits (267), Expect = 8e-26
 Identities = 65/198 (32%), Positives = 105/198 (53%), Gaps = 12/198 (6%)

Query: 403 RILGQG--GQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKL 458
           R+LG+G  G+ T+Y+    D  +V  K+  +  + E +  + +NE+VILS + H N++  
Sbjct: 6   RVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
               ++    L+  E+   GTL+  I   + + F    EM L    ++  A+SY+H A  
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE--EEMVLWYLFQIVSAVSYIHKAG- 121

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 577
             I HRDIK+ NI L      K+ DFG S+ +  + +   T V GT  Y+ PE  +  ++
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178

Query: 578 TDKSDVYSFGVVLAELLT 595
             KSD+++ G VL ELLT
Sbjct: 179 NFKSDIWALGCVLYELLT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  106 bits (267), Expect = 1e-25
 Identities = 72/273 (26%), Positives = 114/273 (41%), Gaps = 33/273 (12%)

Query: 404 ILGQGGQGTVYKGM-LPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLG 460
            +G+G  GTV K     DGKI+  K+     + E + ++ ++E+ IL ++ H N+V+   
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 461 CCL--ETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALSYLH--SA 515
             +    +   +V E+   G L Q I   + E   I  E   RI  ++  AL   H  S 
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
               + HRD+K  NI LD     K+ DFG ++ +  D +   T V GT  Y+ PE     
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHM 185

Query: 576 QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF----AMKEERLFEILDAR 631
            + +KSD++S G ++ EL     P       +  S      F          L E++   
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVI--- 242

Query: 632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
                            K  LN++  KRP+  E
Sbjct: 243 -----------------KSMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  106 bits (266), Expect = 2e-25
 Identities = 65/223 (29%), Positives = 123/223 (55%), Gaps = 21/223 (9%)

Query: 385 KLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKS-KVIDESKVE---- 438
           ++    EL+R        ++LG G  GTVYKG+ +P+G+ V +  + K+++E+       
Sbjct: 2   RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 54

Query: 439 EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR 498
           EF++E +I++ ++H ++V+LLG CL   +  LV + +P+G L  Y+H+  ++  I  ++ 
Sbjct: 55  EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLL 111

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
           L   ++++  + YL       + HRD+ + N+L+      K++DFG +R +  D+     
Sbjct: 112 LNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168

Query: 559 QVHGT-FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                   ++  E     +FT +SDV+S+GV + EL+T G KP
Sbjct: 169 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  105 bits (263), Expect = 2e-25
 Identities = 65/196 (33%), Positives = 108/196 (55%), Gaps = 7/196 (3%)

Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           +G G  G V+ G   + + VA+K  +    S+ E+FI E  ++ +++H  +V+L G C E
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                LV+EF+ +G L  Y+  Q   F  + E  L + ++V   ++YL S+  I   HRD
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKF--SQETLLGMCLDVCEGMAYLESSNVI---HRD 125

Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L+ +    KVSDFG +R +  DQ   +T       +  PE F  S+++ KSDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185

Query: 585 SFGVVLAELLT-GEKP 599
           SFGV++ E+ + G+ P
Sbjct: 186 SFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  106 bits (265), Expect = 2e-25
 Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 47/301 (15%)

Query: 398 NFNLNRILGQGGQGTVYKGM------LPDGKIVAVKKSKV-IDESKVEEFINEMVILSQI 450
           N  L + LG+G  G V K              VAVK  K     S++ + ++E  +L Q+
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH---------------------DQNE 489
           NH +V+KL G C +    LL+ E+   G+L  ++                      D  +
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           +  +T    +  A ++S  + YL   A + + HRD+ + N+L+ +  + K+SDFG SR +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 550 AVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED 608
             + +++  ++      ++  E      +T +SDV+SFGV+L E++T             
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------------- 224

Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
             L       +  ERLF +L      E   +       +   C      KRPT  +++ E
Sbjct: 225 --LGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282

Query: 669 L 669
           L
Sbjct: 283 L 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 3e-25
 Identities = 60/207 (28%), Positives = 112/207 (54%), Gaps = 14/207 (6%)

Query: 401 LNRILGQGGQGTVYKGML--PDGK--IVAVK--KSKVIDESKVEEFINEMVILSQINHRN 454
           + +++G G  G V +G L  P  K   VA+K  K+   D+ +++ F+ E  I+ Q +H N
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPN 66

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           +++L G   ++   +++ E++ NG+L +++ + +  F  T    + +   ++  + YL  
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYLSE 124

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFR 573
              +   HRD+ + NIL++     KVSDFG SR +   + T+ T        +  PE   
Sbjct: 125 MNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181

Query: 574 SSQFTDKSDVYSFGVVLAELLT-GEKP 599
             +FT  SDV+SFG+V+ E+++ GE+P
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  105 bits (263), Expect = 5e-25
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 17/210 (8%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKV-EEFINEMVILSQI 450
            +    + LG+G  G V            G+ VAVK      E +   +F  E+ IL  +
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63

Query: 451 NHRNVVKLLGCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +H N+VK  G C +       L+ E++P+G+L  Y+    +   I  +  L  + ++   
Sbjct: 64  DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKG 121

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFG 565
           + YL S   I   HRD+ + NIL++ +   K+SDFG ++ +  D+ +   +  G    F 
Sbjct: 122 MDYLGSQRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
           Y  PE  R+S+F+  SDV+SFGV L EL T
Sbjct: 179 Y-APECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  104 bits (263), Expect = 6e-25
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 16/203 (7%)

Query: 404 ILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF----INEMVILSQINHRNVVKL 458
            LG+G  G VYK      G+IVA+KK ++ +E   E      + E+ +L ++ H N+VKL
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKL 63

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
           L          LV+E+     L +Y+  +         +   I  ++   L+Y HS    
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP--NLIKSIMYQLLRGLAYCHSHR-- 118

Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT 578
            I HRD+K  NIL++     K++DFG +R+  +     T +V  T  Y  PE    S+  
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHY 176

Query: 579 DKS-DVYSFGVVLAELLTGEKPI 600
             + D++S G + AE++TG KP+
Sbjct: 177 STAVDIWSVGCIFAEMITG-KPL 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  104 bits (260), Expect = 7e-25
 Identities = 59/203 (29%), Positives = 106/203 (52%), Gaps = 5/203 (2%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           ER  + F L R LG G  G V++G+  +   VA+K  K  D  K ++F  E+  L ++ H
Sbjct: 2   ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
           ++++ L   C   E   ++ E +  G+L  ++    E   +     + +A +V+  ++YL
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYL 120

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
               SI   HRD+ + NIL+ +    KV+DFG +R +  +  ++++     + +  PE  
Sbjct: 121 EEQNSI---HRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAA 176

Query: 573 RSSQFTDKSDVYSFGVVLAELLT 595
               F+ KSDV+SFG++L E+ T
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 9e-25
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 25/211 (11%)

Query: 400 NLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN--EMVILSQINHRNVV 456
            L +I G+G  G VYK      G+IVA+KK K+  ES+        E+ +L ++NH N++
Sbjct: 3   KLGKI-GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP------ITWEMRLRIAIEVSGALS 510
           KLL          LV+EF+ +  L++ I D+    P        +++ L+        L+
Sbjct: 62  KLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQL-LQ-------GLA 112

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           + HS     I HRD+K  N+L++ +   K++DFG +RS        T  V  T  Y  PE
Sbjct: 113 FCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPE 168

Query: 571 -YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
                  ++   D++S G + AELL+  +P+
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSR-RPL 198

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  104 bits (260), Expect = 1e-24
 Identities = 66/217 (30%), Positives = 112/217 (51%), Gaps = 25/217 (11%)

Query: 405 LGQGGQGTVYKG--MLPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQINHRNVVK 457
           LG+G  G VYKG    P+ +     VA+K  K   E KV +EF  E  ++S + H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYI--HDQNEDFPITWEMR-----------LRIAIE 504
           LLG C + +   +++E++ +G L +++  +  + D                   L IAI+
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGT 563
           ++  + YL   +S    HRD+ + N L+ +    K+SDFG SR + + D   + ++    
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
             ++ PE     +FT +SD++SFGVVL E+ + G +P
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  103 bits (259), Expect = 1e-24
 Identities = 72/281 (25%), Positives = 130/281 (46%), Gaps = 32/281 (11%)

Query: 404 ILGQGGQGTVYKGMLP------DGKIVAVKK-SKVIDESKVEEFINEMVILSQINHRNVV 456
            LG+G  G V+              +V VK   K  DE+   EF  E+ +  +++H+NVV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYI------HDQNEDFPITWEMRLRIAIEVSGALS 510
           +LLG C E E   ++ E+   G L Q++       ++ +  P++ + ++ +  +++  + 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           +L +A  +   HRD+ + N L+  +   KVS    S+ +   + +          +L PE
Sbjct: 132 HLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD 629
             +   F+ KSDV+SFGV++ E+ T GE P  F  L +++ L       ++  +L     
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELP--FYGLSDEEVLNR-----LQAGKL----- 236

Query: 630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
             +    G        K+  RC  +N K RP+  E+ S L 
Sbjct: 237 -ELPVPEGCPS--RLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding

 Score = 98.5 bits (246), Expect = 1e-24
 Identities = 41/106 (38%), Positives = 60/106 (56%), Gaps = 6/106 (5%)

Query: 16  SCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYSGSPN 75
            CPDRCG+V I YPFGIG GC  D  FE+ C+N++ PP+ +L     E+ S IS + +  
Sbjct: 3   GCPDRCGNVSIPYPFGIGPGCARDPGFELTCNNTTSPPRLLLGNGNYEVLS-ISLA-NGT 60

Query: 76  IAVNISVTSLSSINNAKGIN----LTGTPFSFSQRINKFLAIGCDN 117
           + V   ++S    ++ K  +      G PF FS   NKF+ +GC+ 
Sbjct: 61  VRVLDPISSNCYNSSGKRTDNGSLSLGGPFFFSSSRNKFVVVGCNT 106

This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  103 bits (257), Expect = 1e-24
 Identities = 74/272 (27%), Positives = 134/272 (49%), Gaps = 29/272 (10%)

Query: 404 ILGQGGQGTVYKGMLPDGKIVAVK--KSKVIDESKVEEFINEMVILSQINHRNVVKLLGC 461
           +LG+G  G V+KG L D   VAVK  K  +  E K++ F++E  IL Q +H N+VKL+G 
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
           C + +   +V E +P G    ++  + ++     +  ++ A++ +  ++YL S   I   
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI--- 115

Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSM--AVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 579
           HRD+ + N L+ +    K+SDFG SR     +  +    Q+     +  PE     +++ 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSS 173

Query: 580 KSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGG 638
           +SDV+S+G++L E  + G  P    T ++ +          + E+ + +       +   
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQARE---------QVEKGYRM----SCPQKCP 220

Query: 639 DEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
           D++    KV +RC +   + RP   E+  ELA
Sbjct: 221 DDV---YKVMQRCWDYKPENRPKFSELQKELA 249

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 2e-24
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           E   ++  L R LG G  G V+ G       VAVK  K    S  E F+ E  I+ ++ H
Sbjct: 2   EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRH 60

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             +V+L   C E E   +V E++  G+L  ++    E   +     + +A +++  ++YL
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS-GEGKKLRLPQLVDMAAQIAEGMAYL 119

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPE 570
            S   I   HRD+ + NIL+ +    K++DFG +R +  D    T +    F   +  PE
Sbjct: 120 ESRNYI---HRDLAARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKFPIKWTAPE 174

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT 595
                +FT KSDV+SFG++L E++T
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 23/212 (10%)

Query: 404 ILGQGGQGTVYKGM-LPDGKIVAVK---------KSKVIDESKVEEFINEMVILSQINHR 453
           ++G G  G+VY GM    G+++AVK          SK    S ++    E+ +L ++ H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSGALSYL 512
           N+V+ LG  L+ +   +  E++P G++   + +    F    E  +R  + ++   L+YL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFE---ETLVRNFVRQILKGLNYL 122

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-----GTFGYL 567
           H+     I HRDIK  NIL+D+K   K+SDFG S+ +  +     T        G+  ++
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            PE  + + +T K+D++S G ++ E+LTG+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 7/205 (3%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E++R   +  L R LG G  G V++G+  +   VAVK  K       ++F+ E  I+ ++
Sbjct: 2   EIDR--TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKL 58

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H  +++L   C   E   +V E +  G+L +Y+        +     + +A +V+  ++
Sbjct: 59  RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMA 117

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL +   I   HRD+ + N+L+ +    KV+DFG +R +  D             +  PE
Sbjct: 118 YLEAQNYI---HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT 595
               ++F+ KSDV+SFG++L E++T
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  101 bits (254), Expect = 3e-24
 Identities = 78/279 (27%), Positives = 140/279 (50%), Gaps = 33/279 (11%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPD--GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
              L + +G+G  G V   ML D  G  VAVK  K  +++  + F+ E  +++Q+ H N+
Sbjct: 7   ELKLLQTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNL 61

Query: 456 VKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           V+LLG  +E +  L +V E++  G+L  Y+  +     +  +  L+ +++V  A+ YL +
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEA 120

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
              +   HRD+ + N+L+ +   AKVSDFG ++  +  Q      V  T     PE  R 
Sbjct: 121 NNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALRE 173

Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM 633
            +F+ KSDV+SFG++L E+ + G  P     L++            + E+ ++ +DA   
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGYK-MDA--- 220

Query: 634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              G   ++    V K+C +L+   RP+  ++  +L  I
Sbjct: 221 -PDGCPPVVY--DVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 3e-24
 Identities = 84/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKVIDESKVE--EFI 441
           EL R  +   L R LGQG  G VY+G+        P+ + VA+K +   + S  E  EF+
Sbjct: 2   ELPR--EKITLIRELGQGSFGMVYEGLAKGVVKGEPETR-VAIK-TVNENASMRERIEFL 57

Query: 442 NEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI--HDQNEDF-----PIT 494
           NE  ++ + N  +VV+LLG     +  L+V E +  G L  Y+       +      P T
Sbjct: 58  NEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPT 117

Query: 495 WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQ 553
            +  +++A E++  ++YL   A+    HRD+ + N ++ +    K+ DFG +R +   D 
Sbjct: 118 LQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY 174

Query: 554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLA 612
                +      ++ PE  +   FT KSDV+SFGVVL E+ T  E+P         + L+
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--------QGLS 226

Query: 613 AYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
                   EE L  ++D   +            ++ + C   N K RPT  E+ S L 
Sbjct: 227 -------NEEVLKFVIDGGHLDLPENCPDK-LLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  102 bits (255), Expect = 4e-24
 Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 23/215 (10%)

Query: 405 LGQGGQGTVY----KGMLPDGK--IVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           LG+G  G V+      +LP+    +VAVK  K   ES  ++F  E  +L+ + H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF------------PITWEMRLRIAIEVS 506
            G C E    L+V+E++ +G L +++     D              +T    L IA +++
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFG 565
             + YL   AS+   HRD+ + N L+      K+ DFG SR + + D   +  +      
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           ++ PE     +FT +SD++SFGVVL E+ T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  101 bits (254), Expect = 4e-24
 Identities = 66/205 (32%), Positives = 113/205 (55%), Gaps = 15/205 (7%)

Query: 405 LGQGGQGTVYKG---MLPDGKIVAVK--KSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG G  GTV KG   M    K VAVK  K+   D +  +E + E  ++ Q+++  +V+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 460 GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIP 519
           G C E E  +LV E    G L +++  +N+   +T +    +  +VS  + YL     + 
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQ-KNKH--VTEKNITELVHQVSMGMKYLEETNFV- 117

Query: 520 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQF 577
             HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   + HG +   +  PE     +F
Sbjct: 118 --HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 578 TDKSDVYSFGVVLAELLT-GEKPIR 601
           + KSDV+SFGV++ E  + G+KP +
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  101 bits (253), Expect = 7e-24
 Identities = 76/277 (27%), Positives = 127/277 (45%), Gaps = 22/277 (7%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV---IDESKVEEFINEMVILSQIN 451
             NF + + +G+G    VYK + L DG++VA+KK ++   +D    ++ + E+ +L Q++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALS 510
           H NV+K L   +E     +V E    G L + I H + +   I      +  +++  AL 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           ++HS     I HRDIK  N+ +      K+ D G  R  +   T   + V GT  Y+ PE
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
               + +  KSD++S G +L E+   + P        DK +  Y L    E+  +  L A
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDK-MNLYSLCKKIEKCDYPPLPA 230

Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
               E           +  RC+N + +KRP +  V  
Sbjct: 231 DHYSEE-------LRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  101 bits (253), Expect = 7e-24
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 25/217 (11%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESK----VEEFINEMVILSQIN 451
           D++ L  ++G G    VY  + LP+ + VA+K+   ID  K    V+E   E+  +SQ N
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKR---IDLEKCQTSVDELRKEVQAMSQCN 57

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTL-----FQYIHDQNEDFPITWEMRLRIAIEVS 506
           H NVVK     +  +   LV  ++  G+L       Y     ++  I   ++     EV 
Sbjct: 58  HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK-----EVL 112

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD---QTHMTTQVHGT 563
             L YLHS   I   HRDIK+ NILL +    K++DFG S S+A        +     GT
Sbjct: 113 KGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169

Query: 564 FGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKP 599
             ++ PE       +  K+D++SFG+   EL TG  P
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  101 bits (252), Expect = 8e-24
 Identities = 64/206 (31%), Positives = 113/206 (54%), Gaps = 15/206 (7%)

Query: 403 RILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVK 457
           +++G G  G V++G+L  P  K   VA+K  K    E + ++F++E  I+ Q +H N+++
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-PITWEMRLRIAIEVSGALSYLHSAA 516
           L G   + +  +++ E++ NG L +Y+ D + +F        LR    ++  + YL   +
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---S 124

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD--QTHMTTQVHGTFGYLDPEYFRS 574
            +   HRD+ + NIL++     KVSDFG SR +  D   T+ T+       +  PE    
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKP 599
            +FT  SDV+SFG+V+ E+++ GE+P
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  101 bits (253), Expect = 1e-23
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +GQG  GTVY  + +  G+ VA+K+  +  + K E  INE++++ +  H N+V  L   L
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 464 ETEVPLLVYEFIPNGTLFQYIHD-QNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
             +   +V E++  G+L   + +   ++  I    R     E   AL +LHS   I   H
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQVI---H 138

Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 582
           RDIKS NILL      K++DFG    +  +Q+  +T V GT  ++ PE      +  K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197

Query: 583 VYSFGVVLAELLTGEKP 599
           ++S G++  E++ GE P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 65/210 (30%), Positives = 115/210 (54%), Gaps = 17/210 (8%)

Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
           L  I+G+G  G V +G    G+ VAVK  K   +   + F+ E  ++++++H+N+V+LLG
Sbjct: 10  LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
             L   +  +V E +  G L  ++  +     ++    L+ +++V+  + YL S     +
Sbjct: 67  VILHNGL-YIVMELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---L 121

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASR--SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT 578
            HRD+ + NIL+ +   AKVSDFG +R  SM VD + +  +      +  PE  +  +F+
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFS 175

Query: 579 DKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
            KSDV+S+GV+L E+ + G  P    +L+E
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =   99 bits (250), Expect = 3e-23
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 20/210 (9%)

Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D+F   + LG G  G V   ML      GK  A+K   K+K++   +VE  +NE  IL  
Sbjct: 1   DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57

Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           I H  +V L G   +     LV E++P G LF +   ++  FP         A +V  AL
Sbjct: 58  IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFY--AAQVVLAL 114

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            YLHS     I +RD+K  N+LLD     K++DFG ++ +   +T+      GT  YL P
Sbjct: 115 EYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLC---GTPEYLAP 167

Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           E   S  +    D ++ G+++ E+L G  P
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 79/271 (29%), Positives = 130/271 (47%), Gaps = 33/271 (12%)

Query: 405 LGQGGQGTVYKGML--PDGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGC 461
           LG G  G V K +L  P GKI+AVK  ++ I+E+  ++ + E+ IL + N   +V   G 
Sbjct: 9   LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 462 CL-ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRL-RIAIEVSGALSYLHSAASIP 519
                ++ + + E++  G+L + + +     P   E  L +IA+ V   L+YLH    I 
Sbjct: 68  FYNNGDISICM-EYMDGGSLDKILKEVQGRIP---ERILGKIAVAVLKGLTYLHEKHKI- 122

Query: 520 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 579
             HRD+K +NIL++ + + K+ DFG S  + V+    T    GT  Y+ PE  + + ++ 
Sbjct: 123 -IHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFV--GTSSYMAPERIQGNDYSV 178

Query: 580 KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES--- 636
           KSD++S G+ L EL TG  P      E D               +FE+L   V +     
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPP---ENDPPDG-----------IFELLQYIVNEPPPRL 224

Query: 637 -GGDEIITFAKVAKRCLNLNGKKRPTMREVT 666
             G     F      CL  + ++RP+ +E+ 
Sbjct: 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 84/294 (28%), Positives = 139/294 (47%), Gaps = 46/294 (15%)

Query: 405 LGQGGQGTVYK---GMLPD--GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V       L D  G++VAVKK +      + +F  E+ IL  + H N+VK  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 460 GCCLETEVP--LLVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           G C         LV E++P G+L  Y+  H +  D        L  A ++   + YL S 
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL----LLYASQICKGMEYLGSK 127

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLDPEYF 572
             +   HRD+ + NIL++ + R K+ DFG ++ +  D+ +   +  G    F Y  PE  
Sbjct: 128 RYV---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESL 183

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER-----LFEI 627
             S+F+  SDV+SFGVVL EL        FT  ++  S  A F+  M  ++     ++ +
Sbjct: 184 TESKFSVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235

Query: 628 LDARVMKESG--------GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           ++  ++K +G          EI     + K C N +  +RP+  E+  ++  I+
Sbjct: 236 IE--LLKNNGRLPAPPGCPAEI---YAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 97.6 bits (243), Expect = 1e-22
 Identities = 75/220 (34%), Positives = 111/220 (50%), Gaps = 30/220 (13%)

Query: 403 RILGQGGQGTVYKGMLPD------GKI-VAVK--KSKVIDESKVEEFINEMVILSQINHR 453
             LG G  G VY+G   D      G I VAVK  +    D+ K E F+ E  ++S  NH 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHP 59

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD-QNEDFP---ITWEMRLRIAIEVSGAL 509
           N+VKLLG CL  E   ++ E +  G L  Y+ D + E F    +T +  L I ++V+   
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDK-YRA----KVSDFGASRSMAVDQTHMTTQVHG-- 562
            YL     I   HRD+ + N L+ +K Y A    K+ DFG +R +     +   +  G  
Sbjct: 120 VYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEG 173

Query: 563 --TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                ++ PE     +FT +SDV+SFGV++ E+LT G++P
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 83/284 (29%), Positives = 131/284 (46%), Gaps = 54/284 (19%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF--INEMVILSQINHRNVVKLL 459
           R++G+G  G V+      D K+V +K+  V   +K E     NE  +L  ++H N+++  
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 460 GCCLETEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
              LE +  ++V E+ P GTL +YI  + N       +  L   +++  AL ++H+    
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD--EDTILHFFVQILLALHHVHTKL-- 121

Query: 519 PIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 577
            I HRD+K+ NILLD  K   K+ DFG S+ ++      T  V GT  Y+ PE      +
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPY 178

Query: 578 TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI--LDARVMKE 635
             KSD+++ G VL EL                SL          +R FE   L A V+K 
Sbjct: 179 NQKSDIWALGCVLYELA---------------SL----------KRAFEAANLPALVLKI 213

Query: 636 SGGDEIITFAKVAKR-----------CLNLNGKKRPTMREVTSE 668
             G    TFA ++ R            LNL+  KRP + ++ ++
Sbjct: 214 MSG----TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 37/216 (17%)

Query: 399 FNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVK 457
           F++   LG+G  G+VYK +    G++VA+K   V  E  ++E I E+ IL Q +   +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 458 LLGCCLETEVPLLVYEF-----------IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVS 506
             G   +     +V E+           I N TL        E+          IA  + 
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL-------TEE---------EIAAILY 106

Query: 507 GA---LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
                L YLHS   I   HRDIK+ NILL+++ +AK++DFG S  +  D       V GT
Sbjct: 107 QTLKGLEYLHSNKKI---HRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNTVIGT 162

Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
             ++ PE  +   + +K+D++S G+   E+  G+ P
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 97.3 bits (242), Expect = 2e-22
 Identities = 81/283 (28%), Positives = 125/283 (44%), Gaps = 30/283 (10%)

Query: 403 RILGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEE-FINEMVILSQINHRNVV 456
           R+LG+G  G V    Y       G++VAVK  K     +    +  E+ IL  + H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 457 KLLGCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           K  GCC E   +   L+ E++P G+L  Y+        +     L  A ++   ++YLHS
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHS 125

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLDPEY 571
              I   HRD+ + N+LLD+    K+ DFG ++++     +   +  G    F Y   E 
Sbjct: 126 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-VEC 181

Query: 572 FRSSQFTDKSDVYSFGVVLAELLTG-----EKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
            + ++F+  SDV+SFGV L ELLT        P +F  +   K         M   RL E
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ------GQMTVVRLIE 235

Query: 627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
           +L+  +      +       + K C     K RPT R +   L
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 97.0 bits (241), Expect = 3e-22
 Identities = 78/280 (27%), Positives = 136/280 (48%), Gaps = 38/280 (13%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKKS-KVIDESKV----EEFINEMVILSQINHRNVV 456
           ++LG G  GTVYKG+ +PDG+ V +  + KV+ E+      +E ++E  +++ +    V 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +LLG CL + V L V + +P G L  Y+ +  +   I  +  L   ++++  +SYL    
Sbjct: 73  RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEE-- 127

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----YLDPEY 571
            + + HRD+ + N+L+      K++DFG +R + +D+    T+ H   G     ++  E 
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGGKVPIKWMALES 182

Query: 572 FRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
               +FT +SDV+S+GV + EL+T G KP       E   L        K ERL +    
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE------KGERLPQPPIC 236

Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
                      I    +  +C  ++ + RP  RE+  E +
Sbjct: 237 ----------TIDVYMIMVKCWMIDSECRPRFRELVDEFS 266

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 96.1 bits (239), Expect = 4e-22
 Identities = 69/206 (33%), Positives = 107/206 (51%), Gaps = 12/206 (5%)

Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           LG G  G V  G       VA+K  K    S+ +EFI E  ++ +++H  +V+L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                +V E++ NG L  Y+ +  + F       L +  +V   ++YL S   I   HRD
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRF--QPSQLLEMCKDVCEGMAYLESKQFI---HRD 125

Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSD 582
           + + N L+DD+   KVSDFG SR +  D+   T+ V   F   +  PE    S+F+ KSD
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183

Query: 583 VYSFGVVLAELLT-GEKPI-RFTTLE 606
           V++FGV++ E+ + G+ P  RF   E
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSE 209

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 95.7 bits (239), Expect = 8e-22
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 29/212 (13%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF----INEMVILSQINHRNVVK 457
             +G+G  G VYK      G++VA+KK ++  E++ E F    I E+ +L ++ H N+V+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 458 LLGCCLETEVP--LLVYEFIPNGTLFQYIHD-----QNEDFPITWEMRLRIAIEVSGALS 510
           L             +V+E++         HD      + +   T         ++   L 
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMD--------HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDP 569
           YLHS     I HRDIK +NIL+++    K++DFG +R      +   T +V  T  Y  P
Sbjct: 115 YLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170

Query: 570 E-YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           E    ++++  + D++S G +LAEL  G KPI
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLG-KPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 95.0 bits (236), Expect = 9e-22
 Identities = 61/204 (29%), Positives = 113/204 (55%), Gaps = 13/204 (6%)

Query: 405 LGQGGQGTVYKGM--LPDGKI-VAVKKSKVIDESKV-EEFINEMVILSQINHRNVVKLLG 460
           LG G  G V KG+  +   +I VA+K  K  +E  V +E + E  I+ Q+++  +V+++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
            C E E  +LV E    G L +++  + ++  IT    + +  +VS  + YL     +  
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEGKNFV-- 117

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFT 578
            HRD+ + N+LL +++ AK+SDFG S+++  D ++   +  G +   +  PE     +F+
Sbjct: 118 -HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 579 DKSDVYSFGVVLAELLT-GEKPIR 601
            +SDV+S+G+ + E  + G+KP +
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 20/205 (9%)

Query: 404 ILGQGGQGTVYKGM-LPDGKIVAVKKSKVI----DESKVEEFINEMVILSQINH---RNV 455
           ++G+G  G VY+G  +P G++VA+K   +I     +  V +   E+ +LSQ+      N+
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALK---IINLDTPDDDVSDIQREVALLSQLRQSQPPNI 64

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
            K  G  L+     ++ E+   G++   +       PI  +    I  EV  AL Y+H  
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV 120

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
               + HRDIK+ NIL+ +    K+ DFG +  +  + +  +T V GT  ++ PE     
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEG 176

Query: 576 QFTD-KSDVYSFGVVLAELLTGEKP 599
           ++ D K+D++S G+ + E+ TG  P
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 21/207 (10%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESK-----VEEFINEMVILSQINHRNVV 456
            +LG G  G+VY+G+ L DG   AVK+  + D+ +     V++   E+ +LS++ H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 457 KLLGCCLETEVPLLVY-EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE--VSGALSYLH 513
           + LG   E +  L ++ E +P G+    +    + +    E  +R+     + G L YLH
Sbjct: 66  QYLGTEREED-NLYIFLELVPGGS----LAKLLKKYGSFPEPVIRLYTRQILLG-LEYLH 119

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
              ++   HRDIK  NIL+D     K++DFG ++   V +        G+  ++ PE   
Sbjct: 120 DRNTV---HRDIKGANILVDTNGVVKLADFGMAKQ--VVEFSFAKSFKGSPYWMAPEVIA 174

Query: 574 SS-QFTDKSDVYSFGVVLAELLTGEKP 599
               +   +D++S G  + E+ TG+ P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 95.8 bits (238), Expect = 1e-21
 Identities = 61/213 (28%), Positives = 115/213 (53%), Gaps = 22/213 (10%)

Query: 399 FNLNRILGQGGQGTVYKGM-LPDG---KI-VAVKKSKVIDESKV-EEFINEMVILSQINH 452
           F   ++LG G  GTVYKG+ +P+G   KI VA+K+ +     K  +E ++E  +++ +++
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
            +V +LLG CL + V L + + +P G L  Y+ +  ++    +   L   ++++  ++YL
Sbjct: 69  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYL 125

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----YL 567
                  + HRD+ + N+L+      K++DFG ++ +  D+     + H   G     ++
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE----KEYHAEGGKVPIKWM 178

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
             E      +T +SDV+S+GV + EL+T G KP
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 21/220 (9%)

Query: 398 NFNLNRILGQGGQGTVY----KGMLP--DGKIVAVKKSKVIDESKVEEFINEMVILSQIN 451
           N  L R LG+G  G V+      + P  D  +VAVK  K   ++  ++F  E  +L+ + 
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED----------FPITWEMRLRI 501
           H ++VK  G C+E +  ++V+E++ +G L +++     D            +T    L I
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQV 560
           A +++  + YL   AS    HRD+ + N L+ +    K+ DFG SR + + D   +    
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182

Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                ++ PE     +FT +SDV+S GVVL E+ T G++P
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 53/182 (29%), Positives = 95/182 (52%), Gaps = 13/182 (7%)

Query: 424 VAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 482
           VAVK  +    ++  E+F+ E+ ILS+++  N+ +LLG C       ++ E++ NG L Q
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 483 YI--HDQNEDF------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD 534
           ++  H             +++   L +A +++  + YL    S+   HRD+ + N L+  
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165

Query: 535 KYRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAEL 593
            Y  K++DFG SR++ + D   +  +      ++  E     +FT KSDV++FGV L E+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Query: 594 LT 595
           LT
Sbjct: 226 LT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 11/200 (5%)

Query: 403 RILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLG 460
           + LG G  G V+ G       VA+K    I+E  +  E+FI E  ++ +++H  +V+L G
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
            C + +   +V EF+ NG L  Y+  +      + +M L +  +V   + YL   + I  
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGKL--SKDMLLSMCQDVCEGMEYLERNSFI-- 122

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRD+ + N L+      KVSDFG +R +  D+   ++       +  PE F  S+++ K
Sbjct: 123 -HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 581 SDVYSFGVVLAELLT-GEKP 599
           SDV+SFGV++ E+ T G+ P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 18/218 (8%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFINEMV 445
           E   D+  L R LG G  G VY+G+            VAVK   +   E    +F+ E +
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD----QNEDFPITWEMRLRI 501
           I+S+ NH+N+V+L+G   E     ++ E +  G L  ++ +          +T +  L  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSM-AVDQTHMT 557
           A +V+    YL     I   HRDI + N LL  K     AK++DFG +R +         
Sbjct: 122 ARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
            +      ++ PE F    FT K+DV+SFGV+L E+ +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 94.2 bits (234), Expect = 2e-21
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 17/208 (8%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKK------SKVIDESKVEEFINEMVILSQINHRNV 455
           + LG G   + Y+   +  G ++AVK+      +    E  VE    E+ +++++NH ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           +++LG   E     L  E++  G++   +            + +    ++   LSYLH  
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN 122

Query: 516 ASIPIYHRDIKSTNILLDDK-YRAKVSDFGASRSMAVDQT---HMTTQVHGTFGYLDPEY 571
               I HRD+K  N+L+D    R +++DFGA+  +A   T       Q+ GT  ++ PE 
Sbjct: 123 Q---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            R  Q+    DV+S G V+ E+ T + P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 19/212 (8%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESK-----VEEFINEMVILSQIN 451
           N+   ++LGQG  G VY     D G+ +AVK+     +S      V     E+ +L  + 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-PITWEMRLRIAIEVSGALS 510
           H  +V+  GC  + E   +  E++P G+    + DQ + +  +T  +  +   ++   + 
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGS----VKDQLKAYGALTETVTRKYTRQILEGVE 118

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR---SMAVDQTHMTTQVHGTFGYL 567
           YLHS     I HRDIK  NIL D     K+ DFGAS+   ++    T M + V GT  ++
Sbjct: 119 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWM 174

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            PE      +  K+DV+S G  + E+LT EKP
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT-EKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 79/271 (29%), Positives = 119/271 (43%), Gaps = 31/271 (11%)

Query: 399 FNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID----ESKVEEFINEMVILSQINHR 453
           F L   +G+G  G VYK +     ++VA+K   VID    E ++E+   E+  LSQ    
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIK---VIDLEEAEDEIEDIQQEIQFLSQCRSP 59

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
            + K  G  L+     ++ E+   G+    +     D      + LR   EV   L YLH
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFI-LR---EVLLGLEYLH 115

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
               I   HRDIK+ NILL ++   K++DFG S  +    +   T V GT  ++ PE  +
Sbjct: 116 EEGKI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIK 171

Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM 633
            S + +K+D++S G+   EL  GE P           L+      M+   LF I      
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPP-----------LSDL--HPMRV--LFLIPKNNPP 216

Query: 634 KESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
              G      F      CLN + K+RP+ +E
Sbjct: 217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 93.3 bits (232), Expect = 4e-21
 Identities = 73/280 (26%), Positives = 132/280 (47%), Gaps = 39/280 (13%)

Query: 405 LGQGGQGTVYKGMLPDG--KIVAVK----------KSKVIDESKVEEFINEMVIL-SQIN 451
           LG G  G VYK    +    ++A+K          K K   +  + + ++E+ I+  Q+ 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 452 HRNVVKLLGCCLETEVPLLVYEFI---PNGTLFQYIHDQNEDFPITWEMRL-RIAIEVSG 507
           H N+V+     LE +   +V + I   P G  F  + ++ + F    E R+  I +++  
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWNIFVQMVL 124

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           AL YLH    I   HRD+   NI+L +  +  ++DFG ++     ++ +T+ V GT  Y 
Sbjct: 125 ALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVV-GTILYS 180

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
            PE  ++  + +K+DV++FG +L ++ T + P   T +    SLA   + A+ E      
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIVEAVYEP----- 232

Query: 628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
                + E    E +T   V   CL  + + RP + +V++
Sbjct: 233 -----LPEGMYSEDVTD--VITSCLTPDAEARPDIIQVSA 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 12/204 (5%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
           DNF     +G+G  G V        G+ VAVKK  +  + + E   NE+VI+    H N+
Sbjct: 22  DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           V++    L  +   +V EF+  G L   +        +  E    + + V  ALS+LH+ 
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLKALSFLHAQ 134

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
             I   HRDIKS +ILL    R K+SDFG    ++ +     + V GT  ++ PE     
Sbjct: 135 GVI---HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRL 190

Query: 576 QFTDKSDVYSFGVVLAELLTGEKP 599
            +  + D++S G+++ E++ GE P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 92.3 bits (230), Expect = 9e-21
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 23/209 (11%)

Query: 405 LGQGGQGTVY---KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           + +G  G V+   K     G I A+K   K+ +I +++V++ + E  ILSQ     VVKL
Sbjct: 1   ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 459 LGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
                + +  L LV E++P G L   + +           R+ IA E+  AL YLHS   
Sbjct: 59  Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDV-ARIYIA-EIVLALEYLHS--- 111

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-------TTQVHGTFGYLDPE 570
             I HRD+K  NIL+D     K++DFG S+   V +            ++ GT  Y+ PE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
                  +   D +S G +L E L G  P
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 73/224 (32%), Positives = 110/224 (49%), Gaps = 19/224 (8%)

Query: 398 NFNLNRILGQGGQGTVY----KGMLPDGKIVAVK---KSKVIDESKVEEFI-NEMVILSQ 449
           NF L R+LG G  G V+     G    GK+ A+K   K+ ++ ++K  E    E  +L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 450 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +     +  L    +T+  L L+ +++  G LF +++ Q E F  + E+R+ IA E+  A
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTES-EVRVYIA-EIVLA 117

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           L +LH    + I +RDIK  NILLD +    ++DFG S+    ++        GT  Y+ 
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 569 PEYFR--SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKS 610
           PE  R  S       D +S GV+  ELLTG  P  FT   E  S
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP--FTVDGEQNS 216

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 27/227 (11%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGML-----PDGKI-VAVKKSKV-IDESKVEEFINE 443
           EL R  D   L + LG+G  G V K        P+    VAVK  K    E  + + ++E
Sbjct: 8   ELPR--DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE 65

Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-------NEDFPITW 495
           M ++  I  H+N++ LLG C +     +V E+  +G L  ++  +       + D P   
Sbjct: 66  MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125

Query: 496 EMRL------RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           E  L        A +V+  + +L S   I   HRD+ + N+L+ + +  K++DFG +R +
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCI---HRDLAARNVLVTEDHVMKIADFGLARDI 182

Query: 550 -AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
             +D    TT       ++ PE      +T +SDV+SFGV+L E+ T
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 78/269 (28%), Positives = 123/269 (45%), Gaps = 31/269 (11%)

Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID----ESKVEEFINEMVILSQINHRNVV 456
           L RI G+G  G VYKG+  D +   V   K+ID    E ++E+   E+ +LSQ +   + 
Sbjct: 9   LERI-GKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +  G  L+     ++ E++  G+      D  +  P+       I  E+   L YLHS  
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSAL----DLLKPGPLEETYIATILREILKGLDYLHSER 121

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
            I   HRDIK+ N+LL ++   K++DFG +  +   Q    T V GT  ++ PE  + S 
Sbjct: 122 KI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177

Query: 577 FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES 636
           +  K+D++S G+   EL  GE P   + L   + L   FL         E          
Sbjct: 178 YDFKADIWSLGITAIELAKGEPP--NSDLHPMRVL---FLIPKNSPPTLE---------- 222

Query: 637 GGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            G     F +  + CLN + + RPT +E+
Sbjct: 223 -GQYSKPFKEFVEACLNKDPRFRPTAKEL 250

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 13/201 (6%)

Query: 401 LNRILGQGGQGTVYK-GMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVK 457
           L RI G+G  G V+K      G+ VA+KK   + ++     + + E+  L    H  VVK
Sbjct: 5   LGRI-GEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVK 63

Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           LL         +LV E++P   L + + D  E+ P+           +   ++Y+H+   
Sbjct: 64  LLDVFPHGSGFVLVMEYMP-SDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANG- 119

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQ 576
             I HRD+K  N+L+      K++DFG +R  + ++    + QV  T  Y  PE    ++
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGAR 176

Query: 577 FTDKS-DVYSFGVVLAELLTG 596
             D   D+++ G + AELL G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 91.7 bits (227), Expect = 2e-20
 Identities = 76/270 (28%), Positives = 123/270 (45%), Gaps = 33/270 (12%)

Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID----ESKVEEFINEMVILSQINHRNVV 456
           L RI G+G  G V+KG+  D +   V   K+ID    E ++E+   E+ +LSQ +   V 
Sbjct: 9   LERI-GKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSA 515
           K  G  L+     ++ E++  G+    +     ++F I   ++     E+   L YLHS 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLHSE 120

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
             I   HRDIK+ N+LL ++   K++DFG +  +   Q    T V GT  ++ PE  + S
Sbjct: 121 KKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176

Query: 576 QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE 635
            +  K+D++S G+   EL  GE P        D          M   R+  ++       
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP------NSD----------MHPMRVLFLIPKNNPPT 220

Query: 636 SGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             G+    F +    CLN +   RPT +E+
Sbjct: 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 70/240 (29%), Positives = 107/240 (44%), Gaps = 26/240 (10%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKI-VAVKKSKVIDESKVEEFINEMVILSQ 449
           E E   D      +LG+G  G VY       ++ +A+K+    D   V+    E+ + S 
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ------NEDFPITWEMRLRIAI 503
           + HRN+V+ LG   E     +  E +P G+L   +  +      NE   I +  ++   +
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI---L 118

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA--KVSDFGASRSMAVDQTHMTTQVH 561
           E    L YLH      I HRDIK  N+L+ + Y    K+SDFG S+ +A      T    
Sbjct: 119 E---GLKYLHDNQ---IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLA-GINPCTETFT 170

Query: 562 GTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM 619
           GT  Y+ PE        +   +D++S G  + E+ TG+ P  F  L E +  AA F   M
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP--FIELGEPQ--AAMFKVGM 226

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 91.3 bits (226), Expect = 3e-20
 Identities = 76/265 (28%), Positives = 118/265 (44%), Gaps = 30/265 (11%)

Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVID----ESKVEEFINEMVILSQINHRNVVKLLG 460
           +G+G  G V+KG+  D +   V   K+ID    E ++E+   E+ +LSQ +   V K  G
Sbjct: 12  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
             L+     ++ E++  G+      D  E  P+       I  E+   L YLHS   I  
Sbjct: 70  SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI-- 123

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRDIK+ N+LL +    K++DFG +  +   Q    T V GT  ++ PE  + S +  K
Sbjct: 124 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 181

Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE 640
           +D++S G+   EL  GE P       E   +   FL         E   ++ +KE     
Sbjct: 182 ADIWSLGITAIELAKGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKE----- 231

Query: 641 IITFAKVAKRCLNLNGKKRPTMREV 665
                   + CLN     RPT +E+
Sbjct: 232 ------FVEACLNKEPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 95.3 bits (237), Expect = 4e-20
 Identities = 72/279 (25%), Positives = 126/279 (45%), Gaps = 39/279 (13%)

Query: 327 VGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKL 386
           + CT G   +  L+   + F F++ R  ++LKR          ++ E    +GT E  + 
Sbjct: 632 ITCTLGAFLVLALVA--FGFVFIRGRNNLELKR----------VENE----DGTWE-LQF 674

Query: 387 FTSKELERATDN-----FNLNRILGQGGQGTVYKGMLPDGKI-VAVKKSKVIDESKVEEF 440
           F SK  +  T N          ++ +G +G  YKG      +   VK+   ++ S     
Sbjct: 675 FDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-SIPSSE 733

Query: 441 INEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR 500
           I +M    ++ H N+VKL+G C   +   L++E+I    L + + +      ++WE R +
Sbjct: 734 IADM---GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRK 784

Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
           IAI ++ AL +LH   S  +   ++    I++D K    +        +  D     +  
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS- 842

Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
                Y+ PE   +   T+KSD+Y FG++L ELLTG+ P
Sbjct: 843 ----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 90.1 bits (223), Expect = 7e-20
 Identities = 72/293 (24%), Positives = 137/293 (46%), Gaps = 35/293 (11%)

Query: 393 ERATDNFNLNRILGQGGQGTVY----KGMLPDGKIVAVKKSKVIDESKVEE---FINEMV 445
           E A +   ++R LGQG  G VY    KG++ D     V    V + + + E   F+NE  
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-------PITWEMR 498
           ++ + N  +VV+LLG   + +  L++ E +  G L  Y+     +        P + +  
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMT 557
           +++A E++  ++YL++   +   HRD+ + N ++ + +  K+ DFG +R +   D     
Sbjct: 122 IQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFL 616
            +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P +  +            
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS------------ 226

Query: 617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
               E+ L  +++  ++ +      + F ++ + C   N K RP+  E+ S +
Sbjct: 227 ---NEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 90.6 bits (224), Expect = 7e-20
 Identities = 79/266 (29%), Positives = 130/266 (48%), Gaps = 31/266 (11%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +GQG  GTVY  M +  G+ VA+++  +  + K E  INE++++ +  + N+V  L   L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGALSYLHSAASIPIYH 522
             +   +V E++  G+L   + +   D     E ++  +  E   AL +LHS   I   H
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSNQVI---H 139

Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 582
           RDIKS NILL      K++DFG    +  +Q+  +T V GT  ++ PE      +  K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198

Query: 583 VYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK---EERLFEILDARVMKESGGD 639
           ++S G++  E++ GE P     L E+  L A +L A     E +  E L A         
Sbjct: 199 IWSLGIMAIEMIEGEPPY----LNEN-PLRALYLIATNGTPELQNPEKLSA--------- 244

Query: 640 EIITFAKVAKRCLNLNGKKRPTMREV 665
               F     RCL+++ +KR + +E+
Sbjct: 245 ---IFRDFLNRCLDMDVEKRGSAKEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 90.2 bits (223), Expect = 8e-20
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 31/266 (11%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +GQG  GTVY  + +  G+ VA+K+  +  + K E  INE++++ +  + N+V  L   L
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGALSYLHSAASIPIYH 522
             +   +V E++  G+L   + +   D     E ++  +  E   AL +LHS   I   H
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALDFLHSNQVI---H 138

Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 582
           RDIKS NILL      K++DFG    +  +Q+  +T V GT  ++ PE      +  K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197

Query: 583 VYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK---EERLFEILDARVMKESGGD 639
           ++S G++  E++ GE P     L E+  L A +L A     E +  E L A         
Sbjct: 198 IWSLGIMAIEMVEGEPPY----LNEN-PLRALYLIATNGTPELQNPERLSA--------- 243

Query: 640 EIITFAKVAKRCLNLNGKKRPTMREV 665
               F     RCL ++  +R + +E+
Sbjct: 244 ---VFRDFLNRCLEMDVDRRGSAKEL 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 89.8 bits (222), Expect = 1e-19
 Identities = 75/270 (27%), Positives = 129/270 (47%), Gaps = 39/270 (14%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +GQG  GTV+  + +  G+ VA+K+  +  + K E  INE++++ ++ + N+V  L   L
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGALSYLHSAASIPIYH 522
             +   +V E++  G+L   + +   D     E ++  +  E   AL +LH+   I   H
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTETCMD-----EAQIAAVCRECLQALEFLHANQVI---H 138

Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 582
           RDIKS N+LL      K++DFG    +  +Q+  +T V GT  ++ PE      +  K D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197

Query: 583 VYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA-------MKEERLFEILDARVMKE 635
           ++S G++  E++ GE P     L E+  L A +L A          E+L  I        
Sbjct: 198 IWSLGIMAIEMVEGEPPY----LNEN-PLRALYLIATNGTPELQNPEKLSPI-------- 244

Query: 636 SGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                   F     RCL ++ +KR + +E+
Sbjct: 245 --------FRDFLNRCLEMDVEKRGSAKEL 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 75/271 (27%), Positives = 130/271 (47%), Gaps = 28/271 (10%)

Query: 405 LGQGGQGTVYK-GMLPDGKIVAVKKSKVID-ESKVEEFI-NEMVILSQINHRNVVKLLGC 461
           LG G  G+V K   +P G ++A KK   I  +S V + I  E+ I+ +     +V   G 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
            L      +  EF+  G+L +      +  PI  E+  +IA+ V   L+YL++   I   
Sbjct: 72  FLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYNVHRI--M 126

Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSM--AVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 579
           HRDIK +NIL++ + + K+ DFG S  +  ++  T +     GT  Y+ PE  +  ++T 
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTV 181

Query: 580 KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGD 639
           KSDV+S G+ + EL  G+ P  F+ +++D       +     + L +I+     +    D
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL----DLLQQIVQEPPPRLPSSD 237

Query: 640 EIITFAKVAK----RCLNLNGKKRPTMREVT 666
               F +  +     CL  +  +RPT +++ 
Sbjct: 238 ----FPEDLRDFVDACLLKDPTERPTPQQLC 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 89.5 bits (222), Expect = 2e-19
 Identities = 78/310 (25%), Positives = 140/310 (45%), Gaps = 49/310 (15%)

Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYK----GMLPDGKI--VAVKKSK-VID 433
           I+ T+L    + E   +N +  + LG G  G V +    G+     +  VAVK  K    
Sbjct: 19  IDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH 78

Query: 434 ESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP 492
            S+ E  ++E+ I+S + NH N+V LLG C      L++ E+   G L  ++  + E F 
Sbjct: 79  SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL 138

Query: 493 ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 552
              ++ L  + +V+  +++L S   I   HRD+ + N+LL      K+ DFG +R +  D
Sbjct: 139 TLEDL-LSFSYQVAKGMAFLASKNCI---HRDLAARNVLLTHGKIVKICDFGLARDIMND 194

Query: 553 QTHMTTQVHGT----FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPI------- 600
             ++   V G       ++ PE   +  +T +SDV+S+G++L E+ + G  P        
Sbjct: 195 SNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS 251

Query: 601 RFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRP 660
           +F  L ++    A    A  E  +++I+                    K C + +  KRP
Sbjct: 252 KFYKLIKEGYRMAQPEHAPAE--IYDIM--------------------KTCWDADPLKRP 289

Query: 661 TMREVTSELA 670
           T +++   + 
Sbjct: 290 TFKQIVQLIG 299

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 11/197 (5%)

Query: 405 LGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +G+G  G V    +   GK+VAVKK  +  + + E   NE+VI+    H NVV++    L
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 464 ETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
             +   +V EF+  G L   + H +  +  I       + + V  ALS LH+   I   H
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQGVI---H 139

Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 582
           RDIKS +ILL    R K+SDFG    ++ +     + V GT  ++ PE      +  + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198

Query: 583 VYSFGVVLAELLTGEKP 599
           ++S G+++ E++ GE P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 65/245 (26%), Positives = 121/245 (49%), Gaps = 35/245 (14%)

Query: 393 ERATDNFNLNRILGQGGQGTVYK----GMLPDGK--IVAVKKSKVIDESKVE---EFINE 443
           E   +N    R +GQG  G V++    G+LP     +VAVK  K  +E+  +   +F  E
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQRE 58

Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN--------------- 488
             ++++ +H N+VKLLG C   +   L++E++  G L +++  ++               
Sbjct: 59  AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118

Query: 489 ----EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                  P++   +L IA +V+  ++YL     +   HRD+ + N L+ +    K++DFG
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFG 175

Query: 545 ASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            SR++ + D    +        ++ PE    +++T +SDV+++GVVL E+ + G +P   
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235

Query: 603 TTLEE 607
              EE
Sbjct: 236 MAHEE 240

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 15/209 (7%)

Query: 401 LNRILGQGGQGTVYKGML-PDGK---IVAVKKSKV-IDESKVEEFINEMVILSQINHRNV 455
           +  ++G G  G V +G L   GK    VA+K  K    E +  +F++E  I+ Q +H N+
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           + L G   ++   +++ EF+ NG L  ++   +  F +   + +   I  +  + YL   
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGI--AAGMKYL--- 122

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT-TQVHG---TFGYLDPEY 571
           + +   HRD+ + NIL++     KVSDFG SR +  D +  T T   G      +  PE 
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 572 FRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +FT  SDV+S+G+V+ E+++ GE+P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 71/293 (24%), Positives = 138/293 (47%), Gaps = 44/293 (15%)

Query: 405 LGQGGQGTVYKGML-----PDGKIVAVKKSKVIDESKV-EEFINEMVILSQINHRNVVKL 458
           LG+   G +YKG L        ++VA+K  K I+  +   EF  E  ++++++H N+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYI-----H-----DQNEDFPITWEMR----LRIAIE 504
           LG   + +   +++E++  G L +++     H       +ED  +   +     L IAI+
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGT 563
           ++  + YL S   +   H+D+ + NIL+ ++   K+SD G SR + + D   +  +    
Sbjct: 133 IAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEE 622
             ++ PE     +F+  SD++SFGVVL E+ + G +P              Y+ F+ +E 
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP--------------YYGFSNQE- 234

Query: 623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW 675
            + E++  R +     D       +   C      +RP  +++ + L   ++W
Sbjct: 235 -VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL---RSW 283

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 24/220 (10%)

Query: 401 LNRILGQGGQGTVY----KGMLP--DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN 454
           L R LG+G  G V+      + P  D  +VAVK  K    +  ++F  E  +L+ + H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR-------------LRI 501
           +VK  G C + +  ++V+E++ +G L +++     D  I  + +             L I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQV 560
           A +++  + YL   AS    HRD+ + N L+      K+ DFG SR + + D   +    
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                ++ PE     +FT +SDV+SFGV+L E+ T G++P
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)

Query: 405 LGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G+G  G V K      G+IVA+KK K  ++ +   +  + E+ +L Q+ H N+V L   
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
                   LV+E++   TL + +       P   +       ++  A++Y HS     I 
Sbjct: 69  FRRKGRLYLVFEYVER-TLLELLEASPGGLPP--DAVRSYIWQLLQAIAYCHSHN---II 122

Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVD-QTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
           HRDIK  NIL+ +    K+ DFG +R++     + +T  V  T  Y  PE         K
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDTNYGK 181

Query: 581 S-DVYSFGVVLAELLTGE 597
             DV++ G ++AELL GE
Sbjct: 182 PVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 87.7 bits (217), Expect = 5e-19
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 19/223 (8%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVKKSKVIDES----KVEEFINEMV 445
           E + +   L R LGQG  G VY+G   D   G+       K ++ES    +  EF+NE  
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED-------FPITWEMR 498
           ++      +VV+LLG   + +  L+V E + +G L  Y+     +        P T +  
Sbjct: 62  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMT 557
           +++A E++  ++YL++   +   HRD+ + N ++   +  K+ DFG +R +   D     
Sbjct: 122 IQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            +      ++ PE  +   FT  SD++SFGVVL E+ +  E+P
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 87.8 bits (218), Expect = 6e-19
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 23/215 (10%)

Query: 394 RATDNFN-LNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESK----VEEFINEMVIL 447
           R+   F  LNRI G+G  G VY+      G+IVA+KK + +D  +    +   + E+ +L
Sbjct: 4   RSVTEFEKLNRI-GEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISS-LREITLL 60

Query: 448 SQINHRNVVKLL----GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             + H N+V+L     G  L++    LV E+     L   + +    F  + +++  + +
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDS--IFLVMEYCEQ-DLASLLDNMPTPFSES-QVKC-LML 115

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           ++   L YLH      I HRD+K +N+LL DK   K++DFG +R+  +    MT +V  T
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-T 171

Query: 564 FGYLDPE-YFRSSQFTDKSDVYSFGVVLAELLTGE 597
             Y  PE     + +T   D+++ G +LAELL  +
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.9 bits (215), Expect = 7e-19
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 13/210 (6%)

Query: 398 NFNLNRILGQGGQGTVYKGMLP-DGK---IVAVKKSKV-IDESKVEEFINEMVILSQINH 452
              + +++G G  G V  G L   GK    VA+K  K    E +  +F++E  I+ Q +H
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
            N++ L G   +++  ++V E++ NG+L  ++   +  F +     +++   + G  S +
Sbjct: 65  PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV-----IQLVGMLRGIASGM 119

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG--YLDPE 570
              + +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                +FT  SDV+S+G+V+ E+++ GE+P
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 86.6 bits (214), Expect = 7e-19
 Identities = 73/235 (31%), Positives = 118/235 (50%), Gaps = 25/235 (10%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDES-----KVEEFINEMVILSQIN 451
           N+ L ++LGQG  G VY     D G+ +AVK+ +   ES     +V     E+ +L  + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 452 HRNVVKLLGCCLET-EVPLLVY-EFIPNGTLFQYIHDQNEDF-PITWEMRLRIAIEVSGA 508
           H  +V+  GC  +  E  L ++ E +P G+    I DQ + +  +T  +  +   ++   
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEG 118

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR---SMAVDQTHMTTQVHGTFG 565
           +SYLHS     I HRDIK  NIL D     K+ DFGAS+   ++ +  T M + V GT  
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPY 174

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
           ++ PE      +  K+D++S G  + E+LT + P       E +++AA F  A +
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP-----WAEFEAMAAIFKIATQ 224

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 86.6 bits (214), Expect = 7e-19
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 16/208 (7%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           E   ++  L + LG G  G V+ G       VAVK  K    S  E F+ E  I+ ++ H
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRH 60

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD---QNEDFPITWEMRLRIAIEVSGAL 509
             +V+L     E  +  +V E++  G+L  ++ D   +    P   +M    A +V+  +
Sbjct: 61  DKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM----AAQVAAGM 115

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYL 567
           +Y+     I   HRD++S NIL+ D    K++DFG +R   ++    T +    F   + 
Sbjct: 116 AYIERMNYI---HRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWT 170

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLT 595
            PE     +FT KSDV+SFG++L EL+T
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 86.9 bits (215), Expect = 7e-19
 Identities = 69/295 (23%), Positives = 134/295 (45%), Gaps = 41/295 (13%)

Query: 385 KLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKS-KVIDE----SKVE 438
           ++    EL +        ++LG G  GTV+KG+ +P+G  + +  + K I +       +
Sbjct: 2   RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54

Query: 439 EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR 498
           E  + M+ +  ++H  +V+LLG C    + L V +  P G+L  ++  Q+ D  +  +  
Sbjct: 55  EITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVR-QHRD-SLDPQRL 111

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMT 557
           L   ++++  + YL     +   HR++ + NILL      +++DFG A      D+ +  
Sbjct: 112 LNWCVQIAKGMYYLEEHRMV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY 168

Query: 558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFL 616
           ++      ++  E     ++T +SDV+S+GV + E+++ G +P       E   L     
Sbjct: 169 SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE--- 225

Query: 617 FAMKEERLFEILDARVMKESGGDEIITFA--KVAKRCLNLNGKKRPTMREVTSEL 669
              K ERL +             +I T     V  +C  ++   RPT +E+ +E 
Sbjct: 226 ---KGERLAQ------------PQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 86.5 bits (214), Expect = 9e-19
 Identities = 73/291 (25%), Positives = 139/291 (47%), Gaps = 36/291 (12%)

Query: 399 FNLNRILGQGGQGTVYKGMLP----DGKIVAVK--KSKVIDESKVEEFINEMVILSQINH 452
           F L R+LG+G  G+V +  L       + VAVK  K+ +   S +EEF+ E   + + +H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 453 RNVVKLLGCCLETE------VPLLVYEFIPNGTLFQYI---HDQNEDFPITWEMRLRIAI 503
            NV+KL+G  L +       +P+++  F+ +G L  ++       E F +  +  +R  I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHG 562
           +++  + YL S   I   HRD+ + N +L++     V+DFG S+ + + D          
Sbjct: 121 DIASGMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKE 621
              +L  E    + +T  SDV++FGV + E++T G+ P  +  +E     +  + + +K 
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP--YAGVEN----SEIYNYLIKG 231

Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
            RL +  D         +++    ++  +C +   K RP+ + +  +L  I
Sbjct: 232 NRLKQPPDCL-------EDVY---ELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 86.2 bits (213), Expect = 9e-19
 Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 35/274 (12%)

Query: 405 LGQGGQGTVYKGML-PDGKIVAVKKSK-VIDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           +G+G  G V+ G L  D   VAVK  +  +      +F+ E  IL Q +H N+V+L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
            + +   +V E +  G    ++  + E   +  +  +++    +  + YL S   I   H
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKHCI---H 117

Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT----QVHGTFGYLDPEYFRSSQFT 578
           RD+ + N L+ +K   K+SDFG SR    D  + +T    Q+     +  PE     +++
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQI--PVKWTAPEALNYGRYS 174

Query: 579 DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV---MKE 635
            +SDV+SFG++L E                 SL A     +  ++  E ++  V     E
Sbjct: 175 SESDVWSFGILLWEAF---------------SLGAVPYANLSNQQTREAIEQGVRLPCPE 219

Query: 636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
              D +    ++ +RC   +  +RP+   V  EL
Sbjct: 220 LCPDAVY---RLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 86.9 bits (215), Expect = 9e-19
 Identities = 57/181 (31%), Positives = 101/181 (55%), Gaps = 12/181 (6%)

Query: 421 GKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLLVYEFIPN 477
           G+ VAVK  K     + + +   E+ IL  + H N+VK  G C E       L+ EF+P+
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 478 GTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY 536
           G+L +Y+  ++N+   I  + +L+ A+++   + YL S   +   HRD+ + N+L++ ++
Sbjct: 93  GSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEH 146

Query: 537 RAKVSDFGASRSMAVDQTHMTTQ--VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL 594
           + K+ DFG ++++  D+ + T +  +     +  PE    S+F   SDV+SFGV L ELL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Query: 595 T 595
           T
Sbjct: 207 T 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 22/207 (10%)

Query: 403 RILGQGGQGTVYKGMLPDGK-------IVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
           ++LG+G  G V   +L + K       +  +KK  ++ +  VE  + E  +L+       
Sbjct: 1   KVLGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57

Query: 456 VKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSYLH 513
           +  L  C +T+  L  V E++  G L  +I      F    E R R  A E+   L +LH
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR-FD---EPRARFYAAEIVLGLQFLH 113

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHMTTQVHGTFGYLDPEYF 572
                 I +RD+K  N+LLD +   K++DFG  +  +    T  T+   GT  Y+ PE  
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEIL 168

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKP 599
               +    D ++ GV+L E+L G+ P
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 72/294 (24%), Positives = 119/294 (40%), Gaps = 60/294 (20%)

Query: 397 DNFNLNRILGQGGQGTVYKG-MLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
           +++ L + +G G  G VYK   +  G++VA+K  K+      E    E+ +L +  H N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           V   G  L  +   +V E+   G+L Q I+      P++      +  E    L+YLH  
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRG-PLSELQIAYVCRETLKGLAYLHET 120

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGAS----RSMAVDQTHMTTQVHGTFGYLDPEY 571
             I   HRDIK  NILL +    K++DFG S     ++A  ++ +     GT  ++ PE 
Sbjct: 121 GKI---HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEV 172

Query: 572 F---RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
               R   +  K D+++ G+   EL   + P                        +F++ 
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPP------------------------MFDLH 208

Query: 629 DARVM---------------KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
             R +               KE        F    K+CL  + KKRPT  ++  
Sbjct: 209 PMRALFLISKSNFPPPKLKDKEKWSPVFHDF---IKKCLTKDPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 71/210 (33%), Positives = 114/210 (54%), Gaps = 27/210 (12%)

Query: 403 RILGQGGQGTVY---KGMLPD-GKIVAVK---KS--KVIDESKVEEFINEMVILSQINHR 453
           ++LGQG  G V+   K   PD G++ A+K   K+  KV D  + +    E  IL+++NH 
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILAEVNHP 58

Query: 454 NVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVSGAL 509
            +VKL     +TE  L L+ +F+  G LF  +  +    E+     +++  +A E++ AL
Sbjct: 59  FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLA-ELALAL 111

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            +LHS   + I +RD+K  NILLD++   K++DFG S+  ++D         GT  Y+ P
Sbjct: 112 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAP 167

Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           E       T  +D +SFGV++ E+LTG  P
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 53/198 (26%), Positives = 107/198 (54%), Gaps = 16/198 (8%)

Query: 423 IVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF 481
           +VAVK  +  + ++   +F+ E+ I+S++ + N+++LLG C+  +   ++ E++ NG L 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 482 QYIHDQN--------EDFP-ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 532
           Q++  +          + P ++    L +A++++  + YL   AS+   HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162

Query: 533 DDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLA 591
            + Y  K++DFG SR++ + D   +  +      ++  E     +FT  SDV++FGV L 
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222

Query: 592 EL--LTGEKPIRFTTLEE 607
           E+  L  E+P    + E+
Sbjct: 223 EMFTLCKEQPYSLLSDEQ 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 9/196 (4%)

Query: 405 LGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +G+G  G V        G+ VAVK   +  + + E   NE+VI+    H+NVV++    L
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHR 523
             E   ++ EF+  G L   +        +  E    +   V  AL YLHS   I   HR
Sbjct: 89  VGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQGVI---HR 141

Query: 524 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 583
           DIKS +ILL    R K+SDFG    ++ D     + V GT  ++ PE    + +  + D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDI 200

Query: 584 YSFGVVLAELLTGEKP 599
           +S G+++ E++ GE P
Sbjct: 201 WSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 75/285 (26%), Positives = 137/285 (48%), Gaps = 35/285 (12%)

Query: 401 LNRILGQGGQGTVYKGML-PDGKI--VAVKKSKV--IDESKVEEFINEMVILSQINHRNV 455
           L + LG+G  G+V +G L  D  I  VAVK  K+     S++E+F++E V + + +H NV
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 456 VKLLGCCLETE------VPLLVYEFIPNGTLFQY-IHDQNEDFP--ITWEMRLRIAIEVS 506
           ++L+G CL+T        P+++  F+ +G L  + ++ +  D P  +  +M ++   +++
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT-FG 565
             + YL S + I   HRD+ + N +L++     V+DFG S+ +     +   ++      
Sbjct: 123 SGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
           ++  E      +T KSDV+SFGV + E+ T G+ P       E+  +  Y     + ++ 
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSEIYDYLRQGNRLKQP 236

Query: 625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
            + LD                 +   C  LN K RP+   +  EL
Sbjct: 237 PDCLDG-------------LYSLMSSCWLLNPKDRPSFETLRCEL 268

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 23/224 (10%)

Query: 392 LERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           L   T  F L  ++G+G  G VYK      G++VA+K   +I++ + EE   E  IL + 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59

Query: 451 -NHRNVVKLLGCCLETEVPL------LVYEFIPNGT---LFQYIHDQNEDFPITWEMRLR 500
            NH N+    G  ++   P       LV E    G+   L + +  + +   +  E    
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK--RLKEEWIAY 117

Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
           I  E    L+YLH    I   HRDIK  NILL      K+ DFG S  +        T +
Sbjct: 118 ILRETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174

Query: 561 HGTFGYLDPEYFRSSQFTD-----KSDVYSFGVVLAELLTGEKP 599
            GT  ++ PE     +  D     +SDV+S G+   EL  G+ P
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 65/198 (32%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 405 LGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +G+G  G V        GK VAVKK  +  + + E   NE+VI+   +H NVV +    L
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 464 ETEVPLLVYEFIPNGTLFQYI-HDQ-NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
             +   +V EF+  G L   + H + NE      E    + + V  ALSYLH+   I   
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTRMNE------EQIATVCLSVLRALSYLHNQGVI--- 140

Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS 581
           HRDIKS +ILL    R K+SDFG    ++ +     + V GT  ++ PE      +  + 
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199

Query: 582 DVYSFGVVLAELLTGEKP 599
           D++S G+++ E++ GE P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 89.5 bits (222), Expect = 3e-18
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 25/203 (12%)

Query: 421 GKIVAVK---KSKVIDESKVEEFINEMVILSQINHRNVVKLL--GCCLETEVPLL--VYE 473
           G  VA+K        +E +   F  E  + +++ H N+V LL  G   E    LL  V+E
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSG---EAPPGLLFAVFE 59

Query: 474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL- 532
           ++P  TL + +        +      R+ ++V  AL+  H+     I HRD+K  NI++ 
Sbjct: 60  YVPGRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVS 113

Query: 533 --DDKYRAKVSDFGAS------RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
               +  AKV DFG        R   V     TT+V GT  Y  PE  R    T  SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 585 SFGVVLAELLTGEKPIRFTTLEE 607
           ++G++  E LTG++ ++  ++ E
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAE 196

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 71/283 (25%), Positives = 131/283 (46%), Gaps = 41/283 (14%)

Query: 404 ILGQGGQGTVYKGM-LPDGKIVAVKKSKV----------IDESKVEEFINEMVILSQINH 452
           ++G+G  G VY  + +  G+++AVK+ ++            +  V+   +E+  L  ++H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 453 RNVVKLLGCCLETEVPLLVY-EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
            N+V+ LG    TE  L ++ E++P G++   +           ++      +V   L+Y
Sbjct: 68  LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAY 123

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHMTTQVHGTFGYLDPE 570
           LHS     I HRD+K+ N+L+D     K+SDFG S+ S  +        + G+  ++ PE
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 571 YFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
              S    ++ K D++S G V+ E+  G +P  ++  E   ++AA          +F++ 
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--WSDEE---AIAA----------MFKLG 225

Query: 629 DARVMKESGGDEIITFAKVA----KRCLNLNGKKRPTMREVTS 667
           + R       D  +  + VA      C  +N   RPT RE+  
Sbjct: 226 NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 86.2 bits (213), Expect = 3e-18
 Identities = 69/224 (30%), Positives = 113/224 (50%), Gaps = 21/224 (9%)

Query: 398 NFNLNRILGQGGQGTVY---KGMLPD-GKIVAVK---KSKVIDESKVEEFI-NEMVILSQ 449
           NF L ++LG G  G V+   K    D GK+ A+K   K+ ++ ++K  E    E  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 450 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSG 507
           +     +  L    +TE  L L+ +++  G +F +++ Q ++F    E  +R    E+  
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFS---EDEVRFYSGEIIL 116

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           AL +LH    + I +RDIK  NILLD +    ++DFG S+    ++   T    GT  Y+
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 568 DPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKS 610
            PE  R      K+ D +S G+++ ELLTG  P    TLE +++
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPF---TLEGERN 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 12/202 (5%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           +   L + LG G  G V+ G       VA+K  K    S  E F+ E  ++ Q+ H  +V
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLV 64

Query: 457 KLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           +L      T+ P+ ++ E++ NG+L  ++    E   +T    + +A +++  ++++   
Sbjct: 65  RLYAVV--TQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIERK 121

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFR 573
             I   HRD+++ NIL+ +    K++DFG +R   ++    T +    F   +  PE   
Sbjct: 122 NYI---HRDLRAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 574 SSQFTDKSDVYSFGVVLAELLT 595
              FT KSDV+SFG++L E++T
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 62/198 (31%), Positives = 95/198 (47%), Gaps = 15/198 (7%)

Query: 404 ILGQGGQGTVYKGM-LPDGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGC 461
           ILG G  GTVYK   L   +I+AVK   + I     ++ ++E+ IL + +   ++   G 
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
                   +  EF+  G+L  Y         I   +  RIA+ V   L+YL S   + I 
Sbjct: 68  FFVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS---LKIL 117

Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS 581
           HRD+K +N+L++ + + K+ DFG S  +    +   T V GT  Y+ PE     Q+   S
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYV-GTNAYMAPERISGEQYGIHS 174

Query: 582 DVYSFGVVLAELLTGEKP 599
           DV+S G+   EL  G  P
Sbjct: 175 DVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 77/237 (32%), Positives = 113/237 (47%), Gaps = 21/237 (8%)

Query: 398 NFNLNRILGQGGQGTVY---KGMLPD-GKIVA---VKKSKVIDESKVEEFI-NEMVILSQ 449
           NF L ++LG G  G V+   K    D GK+ A   +KK+ ++ ++K  E    E  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 450 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSG 507
           I     +  L    +T+  L L+ ++I  G LF ++  Q E F    E  ++I   E+  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFK---EQEVQIYSGEIVL 116

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           AL +LH    + I +RDIK  NILLD      ++DFG S+    D+        GT  Y+
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 568 DPEYFRSSQFT-DKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE 622
            P+  R      DK+ D +S GV++ ELLTG  P  FT   E  S A      +K E
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSE 228

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 8e-18
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 18/203 (8%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN--EMVILSQIN-HRNVVKLLG 460
           LG G  G+VY       G++VA+KK K    S  EE +N  E+  L ++N H N+VKL  
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNED-FPITWEMRLR-IAIEVSGALSYLHSAASI 518
              E +    V+E++  G L+Q + D+    F    E  +R I  ++   L+++H     
Sbjct: 66  VFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS---ESVIRSIIYQILQGLAHIHKHG-- 119

Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF-RSSQF 577
             +HRD+K  N+L+      K++DFG +R +   +   T  V  T  Y  PE   RS+ +
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYTDYV-STRWYRAPEILLRSTSY 176

Query: 578 TDKSDVYSFGVVLAELLTGEKPI 600
           +   D+++ G ++AEL T  +P+
Sbjct: 177 SSPVDIWALGCIMAELYTL-RPL 198

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 84.9 bits (210), Expect = 1e-17
 Identities = 74/229 (32%), Positives = 108/229 (47%), Gaps = 51/229 (22%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVI----DESKVEEFINEMV 445
           ELER      +NRI G G  GTVYK +  P G++ A+K   VI    +++   +   E+ 
Sbjct: 75  ELER------VNRI-GSGAGGTVYKVIHRPTGRLYALK---VIYGNHEDTVRRQICREIE 124

Query: 446 ILSQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR 500
           IL  +NH NVVK    C +      E+ +L+ EF+  G+L        E   I  E  L 
Sbjct: 125 ILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSL--------EGTHIADEQFLA 171

Query: 501 -IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 559
            +A ++   ++YLH      I HRDIK +N+L++     K++DFG SR +A       + 
Sbjct: 172 DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228

Query: 560 VHGTFGYLDPEYFRSSQFTD---------KSDVYSFGVVLAELLTGEKP 599
           V GT  Y+ PE       TD           D++S GV + E   G  P
Sbjct: 229 V-GTIAYMSPERIN----TDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)

Query: 405 LGQGGQGTVYKGML-PDGKIVAVK--KSKVIDESKVEEFI-NEMVILSQINHRNVVKLLG 460
           LG GG G V    +    +  A+K  K + I E+  +E I +E  IL + NH  +VKL  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
              + +   ++ E+   G L+  + D+   F   +  R  IA  V  A  YLH+     I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGL-FD-EYTARFYIACVVL-AFEYLHN---RGI 114

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            +RD+K  N+LLD     K+ DFG ++ +   Q   T    GT  Y+ PE   +  +   
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKGYDFS 172

Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEED 608
            D +S G++L ELLTG  P  F   +ED
Sbjct: 173 VDYWSLGILLYELLTGRPP--FGEDDED 198

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 9/207 (4%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID--ESKV-EEFINEMVILSQINHR 453
           NF + + +G+G    VY+   L DG  VA+KK ++ D  ++K   + I E+ +L Q+NH 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALSYL 512
           NV+K     +E     +V E    G L + I H + +   I  +   +  +++  AL ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HS     + HRDIK  N+ +      K+ D G  R  +   T   + V GT  Y+ PE  
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKP 599
             + +  KSD++S G +L E+   + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 71/231 (30%), Positives = 113/231 (48%), Gaps = 39/231 (16%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEF----INEMVIL 447
           +R  D F++   +G+G  G VYK    D G++VA+KK ++ +E   E F    I E+ IL
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60

Query: 448 SQINHRNVVKLLGCCLETEVPL----------LVYEFIPN-------GTLFQYIHDQNED 490
            Q+NHRN+V L     + +  L          LV+E++ +         L  +  D  + 
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120

Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 550
           F     M+     ++   L+Y H    +   HRDIK +NILL++K + K++DFG +R   
Sbjct: 121 F-----MK-----QLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYN 167

Query: 551 VDQTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPI 600
            +++   T    T  Y  PE     + +    DV+S G +L EL T +KPI
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 51/203 (25%), Positives = 98/203 (48%), Gaps = 5/203 (2%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           E   ++  L + LG G  G V+ G   +   VAVK  K    S V+ F+ E  ++  + H
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQH 60

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             +V+L     + E   ++ E++  G+L  ++    E   +     +  + +++  ++Y+
Sbjct: 61  DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYI 119

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
                I   HRD+++ N+L+ +    K++DFG +R +  ++            +  PE  
Sbjct: 120 ERKNYI---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176

Query: 573 RSSQFTDKSDVYSFGVVLAELLT 595
               FT KSDV+SFG++L E++T
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 9/207 (4%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV---IDESKVEEFINEMVILSQINHR 453
           NF + + +G+G    VY+   L D K VA+KK ++   +D    ++ + E+ +L Q+NH 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALSYL 512
           NV+K L   +E     +V E    G L Q I + + +   I      +  +++  A+ ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HS     + HRDIK  N+ +      K+ D G  R  +   T   + V GT  Y+ PE  
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKP 599
             + +  KSD++S G +L E+   + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 69/222 (31%), Positives = 98/222 (44%), Gaps = 27/222 (12%)

Query: 399 FNLNRILGQGGQGTVYKGMLPDGK-------IVAVKKSKVIDESKVEEFINEMVILSQIN 451
           F    +LG+G  G V   +L + K       I A+KK  +I   +VE  + E  I    N
Sbjct: 1   FRCLAVLGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57

Query: 452 ---HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVS 506
              H  +V L   C +TE  +  V E+   G L  +IH   + F    E R    A  V 
Sbjct: 58  SERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFS---EPRAVFYAACVV 111

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS-MAVDQTHMTTQVHGTFG 565
             L YLH      I +RD+K  N+LLD +   K++DFG  +  M       T+   GT  
Sbjct: 112 LGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPE 166

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           +L PE    + +T   D +  GV++ E+L GE P      EE
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 27/223 (12%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPDGK-------IVAVKKSKVIDESKVEEFINEMVILSQI 450
            + + + +G+G  G +Y   L   K       I  +  +K+  + K E    E+++L+++
Sbjct: 1   RYEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKM 56

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-----NEDFPITWEMRLRIAIEV 505
            H N+V       E     +V E+   G L + I+ Q     +ED  ++W       +++
Sbjct: 57  KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQI 110

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYR-AKVSDFGASRSMAVDQTHMTTQVHGTF 564
           S  L ++H      I HRDIKS NI L      AK+ DFG +R +  D   +     GT 
Sbjct: 111 SLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTP 166

Query: 565 GYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
            YL PE  ++  + +K+D++S G VL EL T + P     L +
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 77/280 (27%), Positives = 132/280 (47%), Gaps = 36/280 (12%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDES-----KVEEFINEMVILSQIN 451
           N+   ++LGQG  G VY     D G+ +A K+ +   ES     +V     E+ +L  + 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 452 HRNVVKLLGCCLE-TEVPLLVY-EFIPNGTLFQYIHDQNEDF-PITWEMRLRIAIEVSGA 508
           H  +V+  GC  +  E  L ++ E++P G+    + DQ + +  +T  +  +   ++   
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGS----VKDQLKAYGALTESVTRKYTRQILEG 118

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR---SMAVDQTHMTTQVHGTFG 565
           +SYLHS     I HRDIK  NIL D     K+ DFGAS+   ++ +  T + + V GT  
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPY 174

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
           ++ PE      +  K+DV+S G  + E+LT + P       E +++AA F  A +     
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP-----WAEYEAMAAIFKIATQPTN-- 227

Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             L + +  E   D +         C+ +  + RP+  E+
Sbjct: 228 PQLPSHI-SEHARDFL--------GCIFVEARHRPSAEEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 14/209 (6%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK---SKVIDESKVEEFINEMVILSQINH 452
           D+    + +G G  G V+           A+K     +VI   + +   NE  +L +++H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             +++L     +     ++ E++P G LF Y+ +       +    L  A E+  AL YL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYL 117

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HS     I +RD+K  NILLD +   K++DFG ++ +  D+T     + GT  YL PE  
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEYLAPEVI 170

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
           +S       D ++ G+++ E+L G  P  
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFF 199

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 72/204 (35%), Positives = 100/204 (49%), Gaps = 16/204 (7%)

Query: 403 RILGQGGQGTVYKGMLP-DGKIVAVK--KSKVIDESKVEEFI--NEMVILSQINHRNVVK 457
           +++G+G  G V       DGK  AVK  + K++   K ++ I     V+L  + H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEMRLRI-AIEVSGALSYLHSA 515
           L      TE    V +F+  G LF   H Q E  FP   E R R  A E++ AL YLHS 
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFP---EPRARFYAAEIASALGYLHS- 114

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
             I I +RD+K  NILLD +    ++DFG  +   + Q+  TT   GT  YL PE  R  
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 576 QFTDKSDVYSFGVVLAELLTGEKP 599
            + +  D +  G VL E+L G  P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 72/210 (34%), Positives = 104/210 (49%), Gaps = 16/210 (7%)

Query: 399 FNLNRILGQGGQGTVYKGML-PDGKIVAVKK--SKVIDESKVEEF-INEMVILSQINHRN 454
           F   R+LG+GG G V    +   GK+ A KK   K I + K E   +NE  IL ++N R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 455 VVKLLGCCLETEVPL-LVYEFIPNGTL-FQYIHDQNEDFPITWEMR-LRIAIEVSGALSY 511
           VV L     ET+  L LV   +  G L F   H     F    E R +  A E+   L  
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGRAVFYAAEICCGLED 117

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LH      I +RD+K  NILLDD    ++SD G +  +   QT +  +V GT GY+ PE 
Sbjct: 118 LHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEV 172

Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
            ++ ++T   D ++ G +L E++ G+ P +
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 82/282 (29%), Positives = 126/282 (44%), Gaps = 43/282 (15%)

Query: 403 RILGQGGQGTVYKG-MLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           R+LG+G  G V    +   G++ AVK   K  ++ +  VE  + E  ILS   +   +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 459 LGCCLET-EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSYLHSAA 516
           L CC +T +    V EF+  G L  +I  ++  F    E R R  A E++ AL +LH   
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEITSALMFLHDKG 116

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
              I +RD+K  N+LLD +   K++DFG  +   +     T+   GT  Y+ PE  +   
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQEML 172

Query: 577 FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE-ILDARVMKE 635
           +    D ++ GV+L E+L G  P                  A  E+ LFE IL+      
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFE----------------AENEDDLFEAILN------ 210

Query: 636 SGGDEIIT---FAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
              DE++     ++ A   L     K PTMR  +  L G +A
Sbjct: 211 ---DEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEA 249

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 80.8 bits (199), Expect = 7e-17
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 19/212 (8%)

Query: 398 NFNLNRILGQG--GQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
            +N+ R++G+G  G+  + + +  D K    +       S VE+   E V+L+++ H N+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 456 VKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQN-----EDFPITWEMRLRIAIEVSGAL 509
           V       E +  L +V E+   G L Q I  Q      ED  + W +++ + ++     
Sbjct: 61  VAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ----- 114

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            ++H      + HRDIKS NI L    + K+ DFG++R +     +  T V GT  Y+ P
Sbjct: 115 -HIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPP 169

Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
           E + +  + +KSD++S G +L EL T + P +
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 81.6 bits (201), Expect = 8e-17
 Identities = 66/240 (27%), Positives = 114/240 (47%), Gaps = 28/240 (11%)

Query: 393 ERATDNFNLNRILGQG--GQGTVYKGMLPD----GKI--VAVKKSKV-IDESKVEEFINE 443
           E   D   L + LG+G  GQ  + + +  D     ++  VAVK  K    E  + + I+E
Sbjct: 14  EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73

Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-------------DQNE 489
           M ++  I  H+N++ LLG C +     ++ E+   G L +Y+               Q  
Sbjct: 74  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133

Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           +  ++++  +  A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 190

Query: 550 A-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
             +D    TT       ++ PE      +T +SDV+SFGV+L E+ T G  P     +EE
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 80.5 bits (198), Expect = 9e-17
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 10/201 (4%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++  L   LGQG  G V+ G       VA+K  K    S  E F+ E  ++ ++ H  +V
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 64

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +L     E  +  +V E++  G+L  ++  +   + +     + +A +++  ++Y+    
Sbjct: 65  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMN 122

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRS 574
            +   HRD+++ NIL+ +    KV+DFG +R   ++    T +    F   +  PE    
Sbjct: 123 YV---HRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALY 177

Query: 575 SQFTDKSDVYSFGVVLAELLT 595
            +FT KSDV+SFG++L EL T
Sbjct: 178 GRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 80.6 bits (199), Expect = 9e-17
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 12/202 (5%)

Query: 405 LGQGGQGTVYKGMLPD-GKIVAVKK--SKVIDESKVEEF-INEMVILSQINHRNVVKLLG 460
           LG+GG G V    +   GK+ A KK   K + + K E+  +NE  IL +++ R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSYLHSAASIP 519
              ET+  L +   + NG   +Y H  N   P   E R    A ++   L +LH      
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKY-HIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--- 115

Query: 520 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 579
           I +RD+K  N+LLDD    ++SD G +  +   +        GT GY+ PE  +   +  
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDF 173

Query: 580 KSDVYSFGVVLAELLTGEKPIR 601
             D ++ G  L E++ G  P R
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFR 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 73/234 (31%), Positives = 114/234 (48%), Gaps = 23/234 (9%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESK-----VEEFINEMVILSQIN 451
           N+ L ++LG+G  G VY     D G+ +AVK+     +S+     V     E+ +L  + 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 452 HRNVVKLLGCCLE-TEVPLLVY-EFIPNGTLFQYIHDQNEDF-PITWEMRLRIAIEVSGA 508
           H  +V+  GC  +  E  L ++ E++P G+    I DQ + +  +T  +  R   ++   
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQG 118

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT--TQVHGTFGY 566
           +SYLHS     I HRDIK  NIL D     K+ DFGAS+ +       T    V GT  +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
           + PE      +  K+DV+S    + E+LT EKP       E +++AA F  A +
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT-EKP----PWAEYEAMAAIFKIATQ 224

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 68/216 (31%), Positives = 102/216 (47%), Gaps = 43/216 (19%)

Query: 401 LNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV-IDESKVEEF-INEMVILSQI---NHRN 454
           L  I G+G  GTVYK   L  G+ VA+KK +V + E  +    + E+ +L Q+    H N
Sbjct: 4   LAEI-GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 455 VVKLLGCC----LETEVPL-LVYEFIPNGTLFQYIHDQNEDFP--------ITWEMRLRI 501
           +V+LL  C     + E+ L LV+E + +  L  Y+       P        I   MR   
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL----SKCPKPGLPPETIKDLMR--- 114

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR----SMAVDQTHMT 557
             ++   + +LHS     I HRD+K  NIL+    + K++DFG +R     MA     +T
Sbjct: 115 --QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-----LT 164

Query: 558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAEL 593
           + V  T  Y  PE    S +    D++S G + AEL
Sbjct: 165 SVV-VTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 16/210 (7%)

Query: 399 FNLNRILGQGGQGTVYKGML-PDGKIVAVKK--SKVIDESKVEEF-INEMVILSQINHRN 454
           F   R+LG+GG G V    +   GK+ A KK   K I + K E   +NE  IL ++N R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 455 VVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ-NEDFPITWEMR-LRIAIEVSGALSY 511
           VV L     ET+  L LV   +  G L  +I++  N  F    E R +  A E++  L  
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAAEITCGLED 117

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LH      I +RD+K  NILLDD    ++SD G +  +   +T +  +V GT GY+ PE 
Sbjct: 118 LHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEV 172

Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
            ++ ++T   D +  G ++ E++ G+ P R
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 53/191 (27%), Positives = 100/191 (52%), Gaps = 23/191 (12%)

Query: 423 IVAVKKSKVIDESK--VEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 480
           +VAVK  +  D +K    +F+ E+ ILS++   N+++LLG C++ +   ++ E++ NG L
Sbjct: 48  LVAVKILRP-DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106

Query: 481 FQYI-HDQNED---------------FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
            Q++     +D                 I++   L +A++++  + YL   +S+   HRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163

Query: 525 IKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 583
           + + N L+ +    K++DFG SR++ A D   +  +      ++  E     +FT  SDV
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223

Query: 584 YSFGVVLAELL 594
           ++FGV L E+L
Sbjct: 224 WAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 16/212 (7%)

Query: 396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRN 454
            D + +   LG G  G VYK    +  + A  K   I  E ++E+F+ E+ ILS+  H N
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGALSYLH 513
           +V L           ++ EF   G L   I  + E   +T E ++R +  ++  AL++LH
Sbjct: 64  IVGLYEAYFYENKLWILIEFCDGGAL-DSIMLELER-GLT-EPQIRYVCRQMLEALNFLH 120

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS-RSMAVDQTHMTTQVHGTFGYLDPEY- 571
           S   I   HRD+K+ NILL      K++DFG S ++ +  Q   T    GT  ++ PE  
Sbjct: 121 SHKVI---HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVV 175

Query: 572 ----FRSSQFTDKSDVYSFGVVLAELLTGEKP 599
               F+ + +  K+D++S G+ L EL   E P
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 79.7 bits (196), Expect = 4e-16
 Identities = 64/240 (26%), Positives = 110/240 (45%), Gaps = 28/240 (11%)

Query: 393 ERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSK-VIDESKVEEFINE 443
           E + D   L + LG+G  G V         K    +   VAVK  K    E  + + ++E
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN-------------E 489
           M ++  I  H+N++ LLG C +     ++ E+   G L +Y+  +               
Sbjct: 71  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130

Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           D  +T++  +    +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 550 -AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
             +D    TT       ++ PE      +T +SDV+SFGV++ E+ T G  P     +EE
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 74/280 (26%), Positives = 115/280 (41%), Gaps = 36/280 (12%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRN 454
           +       LG+G  G+V K  L +  ++   K+   D +    ++ + E+ I        
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 455 VVKLLGCCL---ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRL-RIAIEVSGALS 510
           +VK  G  L    + + + + E+   G+L        +      E  L +IA  V   LS
Sbjct: 61  IVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS----RSMAVDQTHMTTQVHGTFGY 566
           YLHS   I   HRDIK +NILL  K + K+ DFG S     S+A   T       GT  Y
Sbjct: 120 YLHSRKII---HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-------GTSFY 169

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
           + PE  +   ++  SDV+S G+ L E+     P        +             E L  
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF-----PPEGEPP-----LGPIELLSY 219

Query: 627 ILDARV--MKESGGDEII---TFAKVAKRCLNLNGKKRPT 661
           I++     +K+  G+ I     F    K+CL  +  +RPT
Sbjct: 220 IVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 79.6 bits (196), Expect = 5e-16
 Identities = 70/243 (28%), Positives = 113/243 (46%), Gaps = 23/243 (9%)

Query: 362 FKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTV----YK-G 416
           F +N  L  +++  ST+    K K+          ++FN  R LG G  G V    YK  
Sbjct: 3   FLKNLQLHKKKDSDSTKEPKRKNKM--------KYEDFNFIRTLGTGSFGRVILATYKNE 54

Query: 417 MLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 476
             P   I   +KSK+I + +V+   +E  IL+ INH   V L G   +     LV EF+ 
Sbjct: 55  DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114

Query: 477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY 536
            G  F ++  +N+ FP   ++    A ++     YL    S+ I +RD+K  N+LLD   
Sbjct: 115 GGEFFTFLR-RNKRFPN--DVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDG 168

Query: 537 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTG 596
             K++DFG ++ +       T  + GT  Y+ PE   +      +D ++ G+ + E+L G
Sbjct: 169 FIKMTDFGFAKVVDT----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Query: 597 EKP 599
             P
Sbjct: 225 CPP 227

Length = 340

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 78.2 bits (193), Expect = 6e-16
 Identities = 59/219 (26%), Positives = 112/219 (51%), Gaps = 21/219 (9%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKI-----VAVKKSKVID---ESKVEEFINEMVILS 448
           D   L+ +L +G  G ++ G+L D K      V VK   V D   E +V   + E  +L 
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKT--VKDHASEIQVTLLLQESCLLY 63

Query: 449 QINHRNVVKLLGCCLE-TEVPLLVYEFIPNGTLFQYIHD---QNEDFPITWEMR--LRIA 502
            ++H+N++ +L  C+E  E P ++Y ++  G L  ++        + P     +  + +A
Sbjct: 64  GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVH 561
           I+++  +SYLH      + H+DI + N ++D++ + K++D   SR +     H +    +
Sbjct: 124 IQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180

Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               ++  E   + +++  SDV+SFGV+L EL+T G+ P
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 77.8 bits (191), Expect = 7e-16
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 6/199 (3%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++  L+  LGQG  G V+ G       VA+K  K       E F+ E  I+ ++ H  +V
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLV 64

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
            L     E  +  +V EF+  G+L  ++ + +  + +     + +A +++  ++Y+    
Sbjct: 65  PLYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMN 122

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
            I   HRD+++ NIL+ D    K++DFG +R +  ++            +  PE     +
Sbjct: 123 YI---HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 577 FTDKSDVYSFGVVLAELLT 595
           FT KSDV+SFG++L EL+T
Sbjct: 180 FTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 12/208 (5%)

Query: 399 FNLNRILGQGGQGTVYKGML-PDGKIVAVKK--SKVIDESKVEEF-INEMVILSQINHRN 454
           F   R+LG+GG G V    +   GK+ A K+   K I + K E   +NE  IL ++N + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR-LRIAIEVSGALSYLH 513
           VV L     ET+  L +   I NG   ++ H  N   P   E R L  A E+   L  LH
Sbjct: 62  VVNL-AYAYETKDALCLVLTIMNGGDLKF-HIYNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
              ++   +RD+K  NILLDD    ++SD G +  + + +        GT GY+ PE   
Sbjct: 120 RENTV---YRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLN 174

Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKPIR 601
           + ++T   D +  G ++ E++ G+ P R
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 78.7 bits (194), Expect = 8e-16
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)

Query: 403 RILGQGGQGTVYKGMLP-DGKIVAVK---KSKVIDESKVEEFINEM-VILSQINHRNVVK 457
           +++G+G  G V       DGK  AVK   K  ++ + + +  + E  V+L  + H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED-FPITWEMRLRI-AIEVSGALSYLHSA 515
           L       +    V +++  G LF   H Q E  FP   E R R  A E++ AL YLHS 
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELF--FHLQRERSFP---EPRARFYAAEIASALGYLHS- 114

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
             + I +RD+K  NILLD +    ++DFG  +   ++ +  T+   GT  YL PE  R  
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 576 QFTDKSDVYSFGVVLAELLTGEKP 599
            +    D +  G VL E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 68/236 (28%), Positives = 106/236 (44%), Gaps = 40/236 (16%)

Query: 397 DNFNLNRILGQGGQGTVYKG-MLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D+F + +++G+G  G V+       G++ A+K   KS +I  +++     E  IL+  + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 453 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
             +VKL     + E  L LV E++P G L   +  ++  FP     R  IA E+  AL  
Sbjct: 61  PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKD-VFPEET-ARFYIA-ELVLALDS 116

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM--AVDQTHMTTQVH-------- 561
           +H    I   HRDIK  NIL+D     K++DFG  + M  A D+ +     H        
Sbjct: 117 VHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 562 ------------------GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
                             GT  Y+ PE  R + +  + D +S GV+L E+L G  P
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 63/257 (24%), Positives = 129/257 (50%), Gaps = 20/257 (7%)

Query: 423 IVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF 481
           +VAVK  +   +++   +F+ E+ I+S++   N+++LL  C+ ++   ++ E++ NG L 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 482 QYI--HDQNEDFP------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD 533
           Q++  H+  E         I++   + +A +++  + YL   +S+   HRD+ + N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164

Query: 534 DKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAE 592
             Y  K++DFG SR++ + D   +  +      ++  E     +FT  SDV++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224

Query: 593 LLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCL 652
           +LT  K   ++ L +++ +     F   + R   +    +  +S         K+   C 
Sbjct: 225 ILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDS-------LYKLMLSCW 277

Query: 653 NLNGKKRPTMREVTSEL 669
             N K+RP+ +E+ + L
Sbjct: 278 RRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)

Query: 404 ILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFI--NEMVILSQINHRNVVKLLG 460
           ++G+G  G V K    + G+IVA+KK    ++ K+ + I   E+ +L Q+ H N+V L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP--ITWEMRLRIAIEVSGALSYLHSAASI 518
                +   LV+EF+ +  L     D  E +P  +      +   ++   + + HS    
Sbjct: 68  VFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN-- 120

Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF-RSSQF 577
            I HRDIK  NIL+      K+ DFG +R++A      T  V  T  Y  PE     +++
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKY 178

Query: 578 TDKSDVYSFGVVLAELLTGE 597
               D+++ G ++ E+LTGE
Sbjct: 179 GRAVDIWAVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 11/203 (5%)

Query: 405 LGQGGQGTVYK-GMLPDGKIVAVKKSKVIDESKVEEFINEMV---ILSQINHRNVVKLLG 460
           LG+GG G V    M   GK+ A KK       K + +   MV   IL++++ R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 461 CCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMR-LRIAIEVSGALSYLHSAASI 518
              +T+  L LV   +  G L  +I++ +E+ P   E R      ++   L +LH     
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117

Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT 578
            I +RD+K  N+LLD+    ++SD G +  +   Q+  T    GT G++ PE  +  ++ 
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175

Query: 579 DKSDVYSFGVVLAELLTGEKPIR 601
              D ++ GV L E++    P R
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFR 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 37/217 (17%)

Query: 404 ILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVV 456
           ++G+G  G V K      G+  D  I  +K+    D+ +  +F  E+ +L ++  H N++
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNII 71

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIH-----DQNEDFPI--------TWEMRLRIAI 503
            LLG C       L  E+ P+G L  ++      + +  F I        + +  L  A 
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +V+  + YL     I   HRD+ + NIL+ + Y AK++DFG SR   V        V  T
Sbjct: 132 DVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 181

Query: 564 FG-----YLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
            G     ++  E    S +T  SDV+S+GV+L E+++
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 33/222 (14%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DG-KIVAVKK--SKVIDESKVEEFINEMVILSQI-N 451
           ++     ++G+G  G V + M+  DG K+ A  K   +   E+   +F  E+ +L ++ +
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN--EDFP-----------ITWEMR 498
           H N++ LLG C       +  E+ P G L  ++      E  P           +T +  
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
           L+ A +V+  + YL     I   HRD+ + N+L+ +   +K++DFG SR   V       
Sbjct: 122 LQFASDVATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEV------- 171

Query: 559 QVHGTFG-----YLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
            V  T G     ++  E    S +T KSDV+SFGV+L E+++
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 68/238 (28%), Positives = 111/238 (46%), Gaps = 32/238 (13%)

Query: 397 DNFNLNRILGQGGQGTVYK----GMLPDGK----IVAVK--KSKVIDESKVEEFINEMVI 446
           D   L + LG+G  G V +    G+          VAVK  K    D+  + + I+EM +
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD-LADLISEMEL 70

Query: 447 LSQIN-HRNVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIH-------DQNEDFPITWEM 497
           +  I  H+N++ LLG C + E PL V  E+   G L +++        D   D     E 
Sbjct: 71  MKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129

Query: 498 RLRI------AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-A 550
           +L        A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R +  
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVTEDNVMKIADFGLARGVHD 186

Query: 551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
           +D    T+       ++ PE      +T +SDV+SFG+++ E+ T G  P     +EE
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 77.9 bits (192), Expect = 3e-15
 Identities = 68/220 (30%), Positives = 103/220 (46%), Gaps = 19/220 (8%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGKIV-AVK---KSKVIDESKVEEFINEMV 445
            +L    ++F++ +++G+G  G V        K V A+K   K ++I  S    F  E  
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 446 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
           I++  N   +V+L     + +  L +V E++P G L   +   N D P  W  R   A E
Sbjct: 96  IMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWA-RFYTA-E 150

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD-QTHMTTQVHGT 563
           V  AL  +HS   I   HRD+K  N+LLD     K++DFG    M  +      T V GT
Sbjct: 151 VVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206

Query: 564 FGYLDPEYFRS----SQFTDKSDVYSFGVVLAELLTGEKP 599
             Y+ PE  +S      +  + D +S GV L E+L G+ P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 3e-15
 Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 20/210 (9%)

Query: 405 LGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
           +GQGG G V+     D G+IVA+K   KS +   ++V   + E  IL+      +VKLL 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 461 CCLETEVPLLVYEFIPNG---TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
              + E   L  E++P G   TL   +   +ED       R  +A E+  A+  LH    
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----HARFYMA-EMFEAVDALHELGY 122

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 577
           I   HRD+K  N L+D     K++DFG S    V   +    V G+  Y+ PE  R   +
Sbjct: 123 I---HRDLKPENFLIDASGHIKLTDFGLS-KGIVTYAN---SVVGSPDYMAPEVLRGKGY 175

Query: 578 TDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
               D +S G +L E L G  P   +T  E
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 67/258 (25%), Positives = 109/258 (42%), Gaps = 51/258 (19%)

Query: 401 LNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVI----DESKVEEFIN----------EMV 445
               LG+G  G V K      GKIVA+KK K+I    D +K  + +           E+ 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR----- 500
           I+++I H N++ L+   +E +   LV + I    L + +  +         +RL      
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRK---------IRLTESQVK 122

Query: 501 -IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD------- 552
            I +++   L+ LH        HRD+   NI ++ K   K++DFG +R            
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 553 -------QTHMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTT 604
                  +  MT++V  T  Y  PE    + ++    D++S G + AELLTG KP+    
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGE 237

Query: 605 LEEDKSLAAYFLFAMKEE 622
            E D+    + L     E
Sbjct: 238 NEIDQLGRIFELLGTPNE 255

Length = 335

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 76.5 bits (188), Expect = 4e-15
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 20/215 (9%)

Query: 403 RILGQGGQGTVYKGMLPDGK-----IVAVKKSKVIDESKVEEFINEMVILSQINHRNVVK 457
           ++LG+G  G V    L  GK     + A+KK  V+ +  VE  + E  +L+       + 
Sbjct: 1   KVLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 458 LLGCCLETEVPLL-VYEFIPNGTLFQYIHDQN--EDFPITWEMRLRIAIEVSGALSYLHS 514
            L C  +T+  L  V EF+  G L  +I D+   + +  T+      A E+   L +LHS
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHS 114

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
              I   +RD+K  N++LD     K++DFG  +         +T   GT  Y+ PE  + 
Sbjct: 115 KGII---YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQG 170

Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
            ++T   D +SFGV+L E+L G+ P  F   +ED+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSP--FHGDDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGC 461
           LG G  G VYK    +   +A   +KVI+   E ++E+++ E+ IL+  NH  +VKLLG 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAA--AKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGALSYLHSAASIPI 520
                   ++ EF P G +   + + +       E +++ I  ++  AL YLHS   + I
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKI 131

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY-----FRSS 575
            HRD+K+ N+LL      K++DFG S +  V          GT  ++ PE       + +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS-AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 576 QFTDKSDVYSFGVVLAELLTGEKP 599
            +  K+D++S G+ L E+   E P
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 75.7 bits (187), Expect = 5e-15
 Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 31/219 (14%)

Query: 394 RATDNFN-LNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF----INEMVIL 447
           R+ D +  LNRI  +G  G VY+      G+IVA+KK K+  E + E F    + E+ IL
Sbjct: 2   RSVDEYEKLNRI-EEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINIL 58

Query: 448 SQINHRNVVKLLGCCLETEVPL--------LVYEFIPNGTLFQYIHDQNEDFPITWEMRL 499
            ++ H N+V +       EV +        +V E++ +  L   +    + F  + E++ 
Sbjct: 59  LKLQHPNIVTV------KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS-EVKC 110

Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 559
            + +++   +++LH      I HRD+K++N+LL+++   K+ DFG +R         T  
Sbjct: 111 -LMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL 166

Query: 560 VHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLAELLTGE 597
           V  T  Y  PE    + +++   D++S G + AELLT +
Sbjct: 167 VV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.4 bits (189), Expect = 5e-15
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 53/230 (23%)

Query: 399 FNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-----SKVIDESKVEEFINEMVILSQINH 452
           + L + +G G  G V   +    G+ VA+KK       +ID  ++   + E+ +L  + H
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRI---LREIKLLRHLRH 58

Query: 453 RNVVKLLGCCLETEVPL-----------LVYEFIPNGT-LFQYIHDQNEDFPITWEMRLR 500
            N++ LL      ++             +V E +   T L + I       P+T +    
Sbjct: 59  ENIIGLL------DILRPPSPEDFNDVYIVTELME--TDLHKVIKSPQ---PLTDDHIQY 107

Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD---QTHMT 557
              ++   L YLHSA    + HRD+K +NIL++     K+ DFG +R +  D   +  +T
Sbjct: 108 FLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 558 TQVHGTFGYLDPEYFR-------SSQFTDKSDVYSFGVVLAELLTGEKPI 600
                   Y+   ++R       SS++T   D++S G + AELLT  KP+
Sbjct: 165 -------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 26/209 (12%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF---INEMVILSQINHRNVVKL 458
           R +G G  G VY    +   ++VA+KK     +   E++   I E+  L Q+ H N ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 459 LGCCLETEVPLLVYEF-IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL---SYLHS 514
            GC L      LV E+ + + +    +H +    P+     + IA    GAL   +YLHS
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILEVHKK----PL---QEVEIAAICHGALQGLAYLHS 133

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
              I   HRDIK+ NILL +    K++DFG++  ++   + +     GT  ++ PE   +
Sbjct: 134 HERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILA 185

Query: 575 ---SQFTDKSDVYSFGVVLAELLTGEKPI 600
               Q+  K DV+S G+   EL   + P+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 69/208 (33%), Positives = 103/208 (49%), Gaps = 12/208 (5%)

Query: 399 FNLNRILGQGGQGTVYKGML-PDGKIVAVKK--SKVIDESKVEEF-INEMVILSQINHRN 454
           F   R+LG+GG G V    +   GK+ A KK   K I + K E   +NE  IL ++N R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR-LRIAIEVSGALSYLH 513
           VV L     ET+  L +   I NG   ++ H  N   P   E R +  A E+   L  L 
Sbjct: 62  VVSL-AYAYETKDALCLVLTIMNGGDLKF-HIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
                 I +RD+K  NILLDD+   ++SD G +  +   +T +  +V GT GY+ PE   
Sbjct: 120 RER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVIN 174

Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKPIR 601
           + ++T   D +  G ++ E++ G+ P R
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 76.0 bits (187), Expect = 6e-15
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 16/213 (7%)

Query: 403 RILGQGGQGTVYKGMLPDGK----IVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           ++LG+G  G V    L        I A+KK  V+++  VE  + E  +L+       +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 459 LGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSYLHSAA 516
           L C  +T+  L  V E++  G L  +I      F    E R R  A E+   L +LH   
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FD---EARARFYAAEIICGLQFLHKKG 116

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
            I   +RD+K  N+LLD     K++DFG  +     +    +   GT  Y+ PE  +  +
Sbjct: 117 II---YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-KASTFCGTPDYIAPEILKGQK 172

Query: 577 FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
           + +  D +SFGV+L E+L G+ P  F   +ED+
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP--FHGEDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 76.2 bits (187), Expect = 8e-15
 Identities = 71/225 (31%), Positives = 112/225 (49%), Gaps = 29/225 (12%)

Query: 390 KELERATDNFNLNRILGQGGQGTV----YKGMLPDGKIVAVK---KSKVIDESKVEEFIN 442
           ++L+   +++++ +++G+G  G V    +K      K+ A+K   K ++I  S    F  
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 443 EMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI 501
           E  I++  N   VV+L  C  + +  L +V E++P G L   +   N D P  W  +   
Sbjct: 93  ERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWA-KFYT 148

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT---T 558
           A EV  AL  +HS   I   HRD+K  N+LLD     K++DFG    M +D+T M    T
Sbjct: 149 A-EVVLALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDT 202

Query: 559 QVHGTFGYLDPEYFRSS----QFTDKSDVYSFGVVLAELLTGEKP 599
            V GT  Y+ PE  +S      +  + D +S GV L E+L G+ P
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.8 bits (184), Expect = 9e-15
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 12/203 (5%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESK--VEEFINEMVILSQINHRN 454
           NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 455 VVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +VKLL   + TE  L LV+EF+ +  L +++ D +    I   +      ++   L++ H
Sbjct: 61  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S   +   HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 118 SHRVL---HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 173

Query: 574 SSQF-TDKSDVYSFGVVLAELLT 595
             ++ +   D++S G + AE++T
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 9e-15
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)

Query: 405 LGQGGQGTVYKGML--PDGKIVAVKKSKVI-DESKVEEFINEM-VILSQINHRNVVKLLG 460
           +G+G  GTV K ML  P G I+AVK+ +   DE + +  + ++ V++   +   +VK  G
Sbjct: 12  IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 461 CCLETEVPLLVYEF--IPNGTLFQYIHD-QNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
                    +  E   I     ++Y+++      P   E+  +IA+    AL+YL     
Sbjct: 71  ALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP--EEILGKIAVATVKALNYLKE--E 126

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ- 576
           + I HRD+K +NILLD     K+ DFG S  + VD    T    G   Y+ PE    S  
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDA-GCRPYMAPERIDPSAR 184

Query: 577 --FTDKSDVYSFGVVLAELLTGEKP 599
             +  +SDV+S G+ L E+ TG+ P
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 10/210 (4%)

Query: 393 ERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKV-IDESKVEEFINEMVILSQI 450
           E   D+F     LG G  G V K    P G I+A K   + I  +   + I E+ +L + 
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           N   +V   G         +  E +  G+L Q + +      I  E+  +++I V   L+
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLA 117

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+K +NIL++ +   K+ DFG S  + +D   M     GT  Y+ PE
Sbjct: 118 YLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPE 172

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             + + ++ +SD++S G+ L EL  G  PI
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 67/230 (29%), Positives = 115/230 (50%), Gaps = 25/230 (10%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF----INEMVILSQINHRNVVKLL 459
           +G+G  G VYKG     G+IVA+KK ++  ES+ E      I E+ +L ++ H N+V L 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRL--ESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 460 GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIP 519
              ++     L++EF+ +  L +Y+    +   +  E+      ++   + + HS     
Sbjct: 66  DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--- 121

Query: 520 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ-FT 578
           + HRD+K  N+L+D+K   K++DFG +R+  +     T +V  T  Y  PE    S  ++
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYS 180

Query: 579 DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
              D++S G + AE+ T +KP+     E D+      LF     R+F IL
Sbjct: 181 TPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQ------LF-----RIFRIL 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 28/208 (13%)

Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEF-INEMV-------ILSQINH 452
           L + LG+G  GTVY  ++ D K VA ++ KV+ E  V E   NE V       +LS+++H
Sbjct: 4   LQQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTL---FQYIHDQNEDFP----ITWEMRLRIAIEV 505
             +VK     LE +   ++ E+     L    + +    +         W ++L + +  
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH- 120

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
                Y+H      I HRD+K+ NI L +    K+ DFG SR + +    + T   GT  
Sbjct: 121 -----YMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGSCDLATTFTGTPY 170

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAEL 593
           Y+ PE  +   +  KSD++S G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 10/210 (4%)

Query: 393 ERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKV-IDESKVEEFINEMVILSQI 450
           E   D+F     LG G  G V+K    P G I+A K   + I  +   + I E+ +L + 
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           N   +V   G         +  E +  G+L Q +        I  ++  +++I V   L+
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 117

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+K +NIL++ +   K+ DFG S  + +D   M     GT  Y+ PE
Sbjct: 118 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPE 172

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             + + ++ +SD++S G+ L E+  G  PI
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 73.7 bits (181), Expect = 4e-14
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 26/217 (11%)

Query: 403 RILGQGGQGTVYKGMLPDGK-------IVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
           ++LG+G  G V   ML + K       I  +KK  ++ +  V+  + E  IL+       
Sbjct: 1   KVLGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57

Query: 456 VKLLGCCLETEVPLL-VYEFIPNGTL-FQYIHDQNEDFPITWEMRLRI-AIEVSGALSYL 512
           +  L CC +T+  L  V E++  G L FQ    +  D     E R R  A EV+ AL +L
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSRFYAAEVTLALMFL 112

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHMTTQVHGTFGYLDPEY 571
           H    I   +RD+K  NILLD +   K++DFG  +  +    T  TT   GT  Y+ PE 
Sbjct: 113 HRHGVI---YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEI 167

Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED 608
            +  ++    D ++ GV++ E++ G+ P  F    ED
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPP--FEADNED 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 9/210 (4%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ R +    L + LG G  G V+         VAVK  K    S VE F+ E  ++  +
Sbjct: 2   EIPRES--LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTL 58

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H  +VKL    +  E   ++ EF+  G+L  ++    E         +  + +++  ++
Sbjct: 59  QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMA 116

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           ++     I   HRD+++ NIL+      K++DFG +R +  ++            +  PE
Sbjct: 117 FIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                 FT KSDV+SFG++L E++T G  P
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 39/233 (16%)

Query: 395 ATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF----INEMVILSQ 449
              ++ +   LG+G  G VYK   +  G++VA+KK  ++  ++ + F    + E+ IL +
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKK--ILMHNEKDGFPITALREIKILKK 63

Query: 450 INHRNVVKLLGCCLE-----TEVPLLVYEFIPNGTLFQYI-HD-----QNEDFPITWEMR 498
           + H NVV L+   +E           VY       +  Y+ HD     +N    +T    
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVY------MVTPYMDHDLSGLLENPSVKLTESQI 117

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM--------- 549
               +++   ++YLH      I HRDIK+ NIL+D++   K++DFG +R           
Sbjct: 118 KCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174

Query: 550 -AVDQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
                T   T +  T  Y  PE      ++T   D++  G V AE+ T  +PI
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 72.6 bits (178), Expect = 5e-14
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 17/205 (8%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           LG+G  G+VYK +  P G  +A+K+ ++ +DESK  + I E+ IL +     +V   G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
                  +  E++  G+L +          I  ++  RI   V   L +L    +I   H
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI--IH 126

Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSM--AVDQTHMTTQVHGTFGYLDPEYFRS------ 574
           RD+K TN+L++   + K+ DFG S ++  ++ +T++  Q      Y+ PE  +S      
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQ-----SYMAPERIKSGGPNQN 181

Query: 575 SQFTDKSDVYSFGVVLAELLTGEKP 599
             +T +SDV+S G+ + E+  G  P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 73.3 bits (180), Expect = 6e-14
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 26/231 (11%)

Query: 398 NFNLNRILGQGGQGTV----YKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQI 450
           +F +   LG G  G V    +KG    G+  A+K   K +++   +V+    E  IL ++
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +H  +V ++    +      + EF+  G LF ++      FP   ++      E+  A  
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-FPN--DVAKFYHAELVLAFE 132

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YLHS     I +RD+K  N+LLD+K   KV+DFG ++ +       T  + GT  YL PE
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE 185

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPI----RFTTLEEDKSLAAYFLF 617
             +S       D ++ GV+L E + G  P      F   E  K LA    F
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE--KILAGRLKF 234

Length = 329

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 73.1 bits (179), Expect = 6e-14
 Identities = 65/264 (24%), Positives = 120/264 (45%), Gaps = 38/264 (14%)

Query: 424 VAVK--KSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTL 480
           VAVK  K    D+  + + ++EM ++  I  H+N++ LLG C +     ++ E+   G L
Sbjct: 47  VAVKMLKDDATDKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105

Query: 481 FQYIHDQNE---DFP----------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKS 527
            +Y+  +     D+           +T++  +  A +V+  + YL S   I   HRD+ +
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI---HRDLAA 162

Query: 528 TNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSF 586
            N+L+ +    K++DFG +R +  +D    TT       ++ PE      +T +SDV+SF
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222

Query: 587 GVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFA 645
           GV+L E+ T G  P     +EE                LF++L      +   +      
Sbjct: 223 GVLLWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTHELY 266

Query: 646 KVAKRCLNLNGKKRPTMREVTSEL 669
            + + C +    +RPT +++  +L
Sbjct: 267 MIMRECWHAVPSQRPTFKQLVEDL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.1 bits (176), Expect = 6e-14
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 19/215 (8%)

Query: 399 FNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH-RNVV 456
           F L  ++G G  G VYKG  +  G++ A+K   V  + + EE   E+ +L + +H RN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 457 KLLGCCLETEVP------LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
              G  ++   P       LV EF   G++   I +   +  +  E    I  E+   LS
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLS 125

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           +LH    I   HRDIK  N+LL +    K+ DFG S  +        T + GT  ++ PE
Sbjct: 126 HLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 181

Query: 571 YFRSSQFTD-----KSDVYSFGVVLAELLTGEKPI 600
                +  D     KSD++S G+   E+  G  P+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 33/215 (15%)

Query: 404 ILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVE----EFINEMVILSQINHR-NVVKL 458
           ++G+G  G V K  +    +      K + E   +    +F  E+ +L ++ H  N++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQN--EDFP-----------ITWEMRLRIAIEV 505
           LG C       L  E+ P+G L  ++      E  P           ++ +  L  A +V
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
           +  + YL     I   HRD+ + NIL+ + Y AK++DFG SR   V        V  T G
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTMG 171

Query: 566 -----YLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                ++  E    S +T  SDV+S+GV+L E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (178), Expect = 7e-14
 Identities = 57/176 (32%), Positives = 81/176 (46%), Gaps = 9/176 (5%)

Query: 425 AVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 484
            ++K+ ++  S+V   + E  +L+Q+N   +V L       E   LV  FI  G LF   
Sbjct: 25  TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFH-- 82

Query: 485 HDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
           H Q E        R   A E+  AL  LH      + +RD+K  NILLD +    + DFG
Sbjct: 83  HLQREGRFDLSRARFYTA-ELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFG 138

Query: 545 ASR-SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
             + +M  D    T    GT  YL PE      +T   D ++ GV+L E+LTG  P
Sbjct: 139 LCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 71/269 (26%), Positives = 113/269 (42%), Gaps = 23/269 (8%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
           ++F L + +G G  G VYK   +  G++ A+K  K+           E++++    H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           V   G  L  +   +  EF   G+L    H      P++      ++ E    L YLHS 
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK 125

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF--- 572
             +   HRDIK  NILL D    K++DFG S  +        + + GT  ++ PE     
Sbjct: 126 GKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVE 181

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV 632
           R   +    D+++ G+   EL   + P     + +   + A FL      +  ++ D   
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPP-----MFDLHPMRALFLMTKSNFQPPKLKDK-- 234

Query: 633 MKESGGDEIITFAKVAKRCLNLNGKKRPT 661
           MK S      +F    K  L  N KKRPT
Sbjct: 235 MKWSN-----SFHHFVKMALTKNPKKRPT 258

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 21/198 (10%)

Query: 409 GQGTVYKGML----PDGKIVAVKKSKVIDESKVE--EFINEMVILSQINHRNVVKLLGCC 462
           G+G+  K +L     DGK   +K+  +   S  E  E   E+ +LS + H N+V+     
Sbjct: 9   GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68

Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQN-----EDFPITWEMRLRIAIEVSGALSYLHSAAS 517
            E     +V ++   G L++ I+ Q      ED  + W +++ +A      L ++H    
Sbjct: 69  EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK- 121

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 577
             I HRDIKS NI L      K+ DFG +R +      +     GT  YL PE   +  +
Sbjct: 122 --ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLSPEICENRPY 178

Query: 578 TDKSDVYSFGVVLAELLT 595
            +KSD+++ G VL E+ T
Sbjct: 179 NNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 73.1 bits (179), Expect = 9e-14
 Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 21/221 (9%)

Query: 390 KELERATDNFNLNRILGQGGQGTV----YKGMLPDGKIVAVK---KSKVIDESKVEEFIN 442
           ++L    +++ + +++G+G  G V    +K      K+ A+K   K ++I  S    F  
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  I++  N   VV+L     +     +V E++P G L   +   N D P  W  R   A
Sbjct: 93  ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWA-RFYTA 149

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            EV  AL  +HS   I   HRD+K  N+LLD     K++DFG    M  +         G
Sbjct: 150 -EVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205

Query: 563 TFGYLDPEYFRSS----QFTDKSDVYSFGVVLAELLTGEKP 599
           T  Y+ PE  +S      +  + D +S GV L E+L G+ P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 63/242 (26%), Positives = 104/242 (42%), Gaps = 30/242 (12%)

Query: 410 QGTVYKGMLPDGKIVAVKKSKVIDESKVEE---FINEMVILSQINHRNVVKLLGCCLETE 466
            G  ++GM      V VK+ +    +  +E   F+ E+    ++NH NV++ LG C+E+ 
Sbjct: 13  LGEAHRGM--SKARVVVKELR--ASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI 68

Query: 467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRL--RIAIEVSGALSYLHSAASIPIYHRD 524
             LLV EF P G L  Y+           +  +  R+A EV+  L +LH A  I   H D
Sbjct: 69  PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI---HSD 125

Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT-FGYLDPEYFRSSQ------- 576
           +   N  L      K+ D+G +     +  ++T   H     +L PE             
Sbjct: 126 LALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKD 185

Query: 577 FTDKSDVYSFGVVLAELLT-GEKP---------IRFTTLEEDKSLAAYFLFAMKEERLFE 626
            T KS+++S GV + EL T  ++P         ++    E+D  L    L     +R +E
Sbjct: 186 QTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE 245

Query: 627 IL 628
           ++
Sbjct: 246 VM 247

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 56/192 (29%), Positives = 89/192 (46%), Gaps = 32/192 (16%)

Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 559
           +I+I V   L+YL     I   HRD+K +NIL++ +   K+ DFG S    +D   M   
Sbjct: 103 KISIAVLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDS--MANS 157

Query: 560 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM 619
             GT  Y+ PE  + + +T +SD++S G+ L E+  G  PI     +E +++    +   
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEG 217

Query: 620 KEER-----------------LFEILDARVMKE-----SGG--DEIITFAKVAKRCLNLN 655
           + +                  +FE+LD  V +      SG   DE   F  V K CL  N
Sbjct: 218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDF--VDK-CLKKN 274

Query: 656 GKKRPTMREVTS 667
            K+R  ++E+T 
Sbjct: 275 PKERADLKELTK 286

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 66/200 (33%), Positives = 92/200 (46%), Gaps = 17/200 (8%)

Query: 409 GQGTVYKGMLP----DGKIVAVK--KSKVIDESKVEEFI--NEMVILSQINHRNVVKLLG 460
           G+G+  K +L     DG   AVK  + K I + K +  I     V+L  + H  +V L  
Sbjct: 4   GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHY 63

Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSYLHSAASIP 519
                E    V +++  G LF   H Q E      E R R  A EV+ A+ YLHS   + 
Sbjct: 64  SFQTAEKLYFVLDYVNGGELF--FHLQRER--CFLEPRARFYAAEVASAIGYLHS---LN 116

Query: 520 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 579
           I +RD+K  NILLD +    ++DFG  +   V+    T+   GT  YL PE  R   +  
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 580 KSDVYSFGVVLAELLTGEKP 599
             D +  G VL E+L G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 62/228 (27%)

Query: 405 LGQGGQGTVYKGMLPD---GKIVAVKKSKVIDESKVEEFIN---------EMVILSQI-N 451
           LG+G  G V+K +  D    ++VA+KK  + D      F N         E++ L ++ +
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALKK--IFDA-----FRNATDAQRTFREIMFLQELGD 65

Query: 452 HRNVVKLLGC--------------CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
           H N+VKLL                 +ET++    +  I    L + +H +     I +++
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYMETDL----HAVIRANIL-EDVHKRY----IMYQL 116

Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA----VDQ 553
            L+       AL Y+HS   I   HRD+K +NILL+   R K++DFG +RS++      +
Sbjct: 117 -LK-------ALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165

Query: 554 THMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             + T    T  Y  PE    S+++T   D++S G +L E+L G KP+
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 54/189 (28%), Positives = 78/189 (41%), Gaps = 18/189 (9%)

Query: 423 IVAVKKSKVIDESKVEEFINEMVIL-SQINHRNVVKLLGCCLETEVPLLVYEFIPNG--- 478
           I  +KKS +I +++V     E  I+  Q     V KL       +   LV E++  G   
Sbjct: 26  IKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCA 85

Query: 479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 538
           +L + +    ED+   +        EV   +  LH      I HRDIK  N+L+D     
Sbjct: 86  SLIKTLGGLPEDWAKQY------IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHL 136

Query: 539 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEK 598
           K++DFG SR+          +  GT  YL PE          SD +S G V+ E L G  
Sbjct: 137 KLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191

Query: 599 PIRFTTLEE 607
           P    T + 
Sbjct: 192 PFHAETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 14/211 (6%)

Query: 403 RILGQGGQGTVY----KGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           ++LG+G  G V+    KG      I A+KK  V+ +  VE  + E  +LS       +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 459 LGCCLETEVPLL-VYEFIPNGTLFQYIHDQNE-DFPITWEMRLRIAIEVSGALSYLHSAA 516
           L C  +T+  L  V E++  G L  +I   ++ D P         A E+   L +LHS  
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRA----TFYAAEIICGLQFLHSKG 116

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
              I +RD+K  NILLD     K++DFG  +   +     T    GT  Y+ PE     +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQK 172

Query: 577 FTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           +    D +SFGV+L E+L G+ P      EE
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 28/208 (13%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKK----SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G  G VY        ++VAVKK     K  +E K ++ I E+  L Q+ H N ++  
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 460 GCCLETEVPLLVYEF-IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL---SYLHSA 515
           GC L+     LV E+ + + +    +H +    P+     + IA    GAL   +YLHS 
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKK----PL---QEVEIAAITHGALQGLAYLHSH 140

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS- 574
             I   HRDIK+ NILL +  + K++DFG++   +   + +     GT  ++ PE   + 
Sbjct: 141 NMI---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192

Query: 575 --SQFTDKSDVYSFGVVLAELLTGEKPI 600
              Q+  K DV+S G+   EL   + P+
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 10/207 (4%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           LG+G   TVYKG     G+IVA+K+  +  +E      I E+ ++ ++ H N+V+L    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66

Query: 463 LETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
           + TE  L LV+E++ +  L +Y+        +          ++   +++ H      + 
Sbjct: 67  IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VL 122

Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ-FTDK 580
           HRD+K  N+L++ +   K++DFG +R+  +     + +V  T  Y  P+    S+ ++  
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTS 181

Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEE 607
            D++S G ++AE++TG      T  E+
Sbjct: 182 IDIWSVGCIMAEMITGRPLFPGTNNED 208

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 25/217 (11%)

Query: 405 LGQGGQGTVYKGML----PDGKIVAVKKSKVIDESKV---EEFINEMVILSQINHRNVVK 457
           LG+   G VYKG L    P  +  AV    + D+++    EEF +E ++ S++ H N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYI-----------HDQNEDFPITWEMR--LRIAIE 504
           LLG   + +   +++ +  +  L +++            D ++    T E    + I  +
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGT 563
           ++  + +L S     + H+D+ + N+L+ DK   K+SD G  R + A D   +       
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
             ++ PE     +F+  SD++S+GVVL E+ + G +P
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 45/227 (19%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF---------INEMVI 446
             +     +G+G  G V      P G  VA+KK        +  F         + E+ I
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--------ISPFEHQTFCQRTLREIKI 56

Query: 447 LSQINHRNVVKLLGC----CLET--EVPLLVYEFIPNGTLFQYIHDQN-EDFPI---TWE 496
           L +  H N++ +L        E+  +V  +V E +    L++ I  Q+  +  I    ++
Sbjct: 57  LRRFKHENIIGILDIIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQYFLYQ 114

Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV--DQT 554
           + LR        L Y+HSA  +   HRD+K +N+LL+     K+ DFG +R      D T
Sbjct: 115 I-LR-------GLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163

Query: 555 HMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
              T+   T  Y  PE    S  +T   D++S G +LAE+L+  +P+
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 18/204 (8%)

Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGC 461
           LG G  G VYK    +  ++A   +KVID   E ++E+++ E+ IL+  +H N+VKLL  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVS-GALSYLHSAASIPI 520
                   ++ EF   G +   + +     P+T E ++R+  + +  AL+YLH      I
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELER--PLT-EPQIRVVCKQTLEALNYLHENK---I 124

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD- 579
            HRD+K+ NIL       K++DFG S +             GT  ++ PE        D 
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS-AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183

Query: 580 ----KSDVYSFGVVLAELLTGEKP 599
               K+DV+S G+ L E+   E P
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 56/231 (24%)

Query: 403 RILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGC 461
           R LG G  G V+  +  D  K VAVKK  + D   V+  + E+ I+ +++H N+VK    
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR------------LRIAIEVSGAL 509
                    VYE      L     D  ED     E+             L   +E  G L
Sbjct: 67  ---------VYE-----VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE-QGPL 111

Query: 510 S----------------YLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVD 552
           S                Y+HSA  +   HRD+K  N+ ++ +    K+ DFG +R +   
Sbjct: 112 SEEHARLFMYQLLRGLKYIHSANVL---HRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168

Query: 553 QTH--MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPI 600
            +H    ++   T  Y  P    S + +T   D+++ G + AE+LTG KP+
Sbjct: 169 YSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPL 218

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 26/209 (12%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKK---SKVIDESKVEEFINEMVILSQINHRNVVKL 458
           R +G G  G VY    + + ++VA+KK   S      K ++ I E+  L ++ H N ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 459 LGCCLETEVPLLVYEF-IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL---SYLHS 514
            GC L      LV E+ + + +    +H +    P+     + IA    GAL   +YLHS
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKK----PL---QEVEIAAVTHGALQGLAYLHS 133

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
              I   HRD+K+ NILL +    K+ DFG++  MA     +     GT  ++ PE   +
Sbjct: 134 HNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILA 185

Query: 575 ---SQFTDKSDVYSFGVVLAELLTGEKPI 600
               Q+  K DV+S G+   EL   + P+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 17/242 (7%)

Query: 403 RILGQGGQGTVYKGMLPDGKIV----AVKKSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           R++G+G    V    L     +     VKK  V D+  ++    E  +  Q +    +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 459 LGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           L  C +T   L LV E++  G L  ++  Q +   +  E     A E+  AL++LH    
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK---LPEEHARFYAAEICIALNFLHERG- 116

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 577
             I +RD+K  N+LLD     K++D+G  +   +     T+   GT  Y+ PE  R  ++
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 578 TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE-----RLFEILDARV 632
               D ++ GV++ E++ G  P    T   D +   Y    + E+     R   +  + V
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV 233

Query: 633 MK 634
           +K
Sbjct: 234 LK 235

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 72.5 bits (178), Expect = 5e-13
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 38/235 (16%)

Query: 399 FNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVE------EFINEMVILSQIN 451
           +++ R++G+GG G VY    P   + VA+KK   I E   E       F+ E  I + + 
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKK---IREDLSENPLLKKRFLREAKIAADLI 60

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEMR------LRIAI 503
           H  +V +   C + +       +I   TL   +    Q E        +      L I  
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ---------- 553
           ++   + Y+HS     + HRD+K  NILL       + D+GA+    +++          
Sbjct: 121 KICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 554 -----THMTT--QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                + MT   ++ GT  Y+ PE       ++ +D+Y+ GV+L ++LT   P R
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232

Length = 932

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 70.1 bits (171), Expect = 5e-13
 Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 29/230 (12%)

Query: 382 EKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK---SKVIDESKV 437
           E  +LF  ++ E+    F   R +G G  G VY    +   ++VA+KK   S      K 
Sbjct: 13  EIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW 69

Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF-IPNGTLFQYIHDQNEDFPITWE 496
           ++ I E+  L +I H N ++  GC L      LV E+ + + +    +H +    P+   
Sbjct: 70  QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK----PL--- 122

Query: 497 MRLRIAIEVSGAL---SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 553
             + IA    GAL   +YLHS   I   HRDIK+ NILL +  + K++DFG S S+A   
Sbjct: 123 QEVEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFG-SASIASPA 178

Query: 554 THMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKPI 600
                   GT  ++ PE   +    Q+  K DV+S G+   EL   + P+
Sbjct: 179 NSFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 22/221 (9%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPDGK-------IVAVKKSKVIDESKVEEFINEMVILSQI 450
           +FN   +LG+G  G V   ML + K       I  +KK  VI +  VE  + E  +L+  
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ 57

Query: 451 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           +    +  L  C +T   L  V E++  G L  +I    +         +  A E+S  L
Sbjct: 58  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGL 114

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLD 568
            +LH      I +RD+K  N++LD +   K++DFG  +   VD   +TT+   GT  Y+ 
Sbjct: 115 FFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIA 169

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
           PE      +    D +++GV+L E+L G+ P  F   +ED+
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP--FDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 67/231 (29%), Positives = 98/231 (42%), Gaps = 49/231 (21%)

Query: 405 LGQGGQGTVYKGMLPD-GKIVAVKKSKV------IDESKVEEFINEMVILSQINHRNVVK 457
           +G G  GTVYK   P  G  VA+K  +V      +  S V E +  +  L   +H N+V+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPNIVR 66

Query: 458 LLGCCL------ETEVPLLVYEFI------------PNGTLFQYIHDQNEDFPITWEMRL 499
           L+  C       ET+V L V+E +            P G   + I D    F        
Sbjct: 67  LMDVCATSRTDRETKVTL-VFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF-------- 117

Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT-T 558
                + G L +LH+     I HRD+K  NIL+    + K++DFG +R   +    M  T
Sbjct: 118 -----LRG-LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALT 165

Query: 559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
            V  T  Y  PE    S +    D++S G + AE+    KP+     E D+
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 70.0 bits (171), Expect = 6e-13
 Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 28/224 (12%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPDGK-------IVAVKKSKVIDESKVEEFINEMVILSQI 450
           +FN   +LG+G  G V   ML + K       I  +KK  VI +  VE  + E  +L+  
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57

Query: 451 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVS 506
                +  L  C +T   L  V E++  G L   I       E   + +      A E++
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAEIA 111

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFG 565
             L +LHS     I +RD+K  N++LD +   K++DFG  +    D   +TT+   GT  
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPD 166

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
           Y+ PE      +    D ++FGV+L E+L G+ P  F   +ED+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--FEGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 11/200 (5%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGC 461
           +G+G  G VYK      G+IVA+KK ++   DE      I E+ +L ++NH N+V+LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
                   LV+EF+ +  L +Y+ D +    +   +      ++   ++Y HS     + 
Sbjct: 67  VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VL 121

Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTDK 580
           HRD+K  N+L+D +   K++DFG +R+  V     T +V  T  Y  PE    S Q++  
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTP 180

Query: 581 SDVYSFGVVLAELLTGEKPI 600
            D++S G + AE++   +P+
Sbjct: 181 VDIWSIGCIFAEMVNR-RPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 21/203 (10%)

Query: 403 RILGQGGQGTV-YKGMLPDGKIVAVKKSKVIDESKVEEFI--NEMVILSQINHRNVVKLL 459
           R++G+G  G V       DGK   +KK  + + S+ E      E  +LSQ+ H N+V   
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 460 GCCLETEVPLL--VYEFIPNGTLFQYIHDQN-----EDFPITWEMRLRIAIEVSGALSYL 512
               E E  LL  V  F   G L+  + +Q      E+  + W       ++++ AL YL
Sbjct: 66  ES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYL 118

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           H      I HRD+K+ N+ L      KV D G +R +  +Q  M + + GT  Y+ PE F
Sbjct: 119 HEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELF 174

Query: 573 RSSQFTDKSDVYSFGVVLAELLT 595
            +  +  KSDV++ G  + E+ T
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 71.1 bits (174), Expect = 8e-13
 Identities = 79/244 (32%), Positives = 114/244 (46%), Gaps = 46/244 (18%)

Query: 401 LNRILGQGGQGTV-YKGMLPDGKIVAVKKSKVID-ESKVEEFIN----EMVILSQINHRN 454
           ++R+LG G  GTV     + DG+  AVK   V+D E   E   N    E+  L   +  +
Sbjct: 36  ISRVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCDFFS 92

Query: 455 VVKLLGCCLE------------TEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRL 499
           +VK    C E              +  LV ++   G L Q I  +   N  F    E  L
Sbjct: 93  IVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF-REHEAGL 147

Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA------VDQ 553
            + I+V  A+ ++HS   I   HRDIKS NILL      K+ DFG S+  A      V +
Sbjct: 148 -LFIQVLLAVHHVHSKHMI---HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR 203

Query: 554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE--DKSL 611
           T       GT  Y+ PE +R   ++ K+D++S GV+L ELLT ++P     +EE   K+L
Sbjct: 204 TFC-----GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258

Query: 612 AAYF 615
           A  +
Sbjct: 259 AGRY 262

Length = 496

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 69.6 bits (171), Expect = 9e-13
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 36/212 (16%)

Query: 403 RILGQGGQGTVYKGMLPDGKI-VAVKKSKVIDESKVEEF----INEMVILSQINHRNVVK 457
             +G G  G V           VA+KK     +S           E+ +L  ++H NV+ 
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIG 78

Query: 458 LLGC-----CLE--TEVPLLVYEFIP---NGTL-FQYIHDQNEDFPITWEMRLRIAIEVS 506
           LL        LE   +V  LV   +    N  +  Q + D +  F + +++ LR      
Sbjct: 79  LLDVFTPASSLEDFQDV-YLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQI-LR------ 129

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
             L Y+HSA    I HRD+K +NI +++    K+ DFG +R    +   MT  V  T  Y
Sbjct: 130 -GLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYV-ATRWY 181

Query: 567 LDPE-YFRSSQFTDKSDVYSFGVVLAELLTGE 597
             PE       +    D++S G ++AELLTG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 71/264 (26%), Positives = 120/264 (45%), Gaps = 24/264 (9%)

Query: 403 RILGQGGQGTVYKGMLPD-GKIVA---VKKSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           R++G+G    V    L    +I A   VKK  V D+  ++    E  +  Q ++   +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 459 LGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           L  C +TE  L  V E++  G L  ++  Q +   +  E     + E+S AL+YLH    
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG- 116

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 577
             I +RD+K  N+LLD +   K++D+G  +   +     T+   GT  Y+ PE  R   +
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 578 TDKSDVYSFGVVLAELLTGEKP--IRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE 635
               D ++ GV++ E++ G  P  I  ++   D++   Y LF +  E+   I  +  +K 
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY-LFQVILEKQIRIPRSLSVKA 232

Query: 636 SGGDEIITFAKVAKRCLNLNGKKR 659
                    A V K  LN + K+R
Sbjct: 233 ---------ASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 14/203 (6%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVK--KSKVIDESKVEEFI--NEMVILSQINHRNVVK 457
           +++G+G  G V       + K  AVK  + K I + K E+ I     V+L  + H  +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSYLHSAA 516
           L       +    V ++I  G LF ++  +        E R R  A E++ AL YLHS  
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS-- 114

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
            + I +RD+K  NILLD +    ++DFG  +   ++    T+   GT  YL PE      
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 577 FTDKSDVYSFGVVLAELLTGEKP 599
           +    D +  G VL E+L G  P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 70/293 (23%), Positives = 110/293 (37%), Gaps = 79/293 (26%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
           +G G  G VYK      G ++AVK   ++   +E+K    ++  V+L   +   +VK  G
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK-RILMDLDVVLKSHDCPYIVKCYG 81

Query: 461 C----------------CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
                            CL+ ++   +   IP   L                   ++ + 
Sbjct: 82  YFITDSDVFICMELMSTCLD-KLLKRIQGPIPEDILG------------------KMTVA 122

Query: 505 VSGALSYL---HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
           +  AL YL   H      + HRD+K +NILLD     K+ DFG S  +   +    T+  
Sbjct: 123 IVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSA 175

Query: 562 GTFGYLDPEYFRSSQFTDK----SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF 617
           G   Y+ PE         K    +DV+S G+ L EL TG+ P +    E           
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----------- 224

Query: 618 AMKEERLFEILDARVMKE------SGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
                  FE+L  ++++E              F      CL  + +KRP  RE
Sbjct: 225 -------FEVL-TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRE 269

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 21/216 (9%)

Query: 399 FNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH-RNVV 456
           F L  ++G G  G VYKG  +  G++ A+K   V ++ + EE   E+ +L + +H RN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76

Query: 457 KLLGCCLETEVP------LLVYEFIPNGTLFQYIHD-QNEDFPITWEMRLRIAIEVSGAL 509
              G  ++   P       LV EF   G++   + + +       W     I  E+   L
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           ++LH+   I   HRDIK  N+LL +    K+ DFG S  +        T + GT  ++ P
Sbjct: 135 AHLHAHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190

Query: 570 EYFRSSQFTD-----KSDVYSFGVVLAELLTGEKPI 600
           E     +  D     +SD++S G+   E+  G  P+
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 37/224 (16%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-SKVIDESKV-EEFINEMVILSQINHR 453
             +     +G G  G V   +    GK VA+KK     D   + +  + E+ IL    H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 454 NVVKLLGCCLETEVPL-----LVYEFIPNGTLFQYIHDQNEDFPITWE-MR------LRI 501
           N++ +    L           +V + + +  L   IH      P+T E +R      LR 
Sbjct: 65  NIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQ---PLTEEHIRYFLYQLLR- 118

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT----HMT 557
                  L Y+HSA    + HRD+K +N+L+++    ++ DFG +R ++   T     MT
Sbjct: 119 ------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169

Query: 558 TQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             V  T  Y  PE      ++T   D++S G + AE+L G + +
Sbjct: 170 EYV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 68.6 bits (167), Expect = 2e-12
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 12/204 (5%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVE-EFINEMVILSQINHRN 454
           D++     LG+G   TVYKG    +GK+VA+K  ++ +E       I E  +L  + H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-PITWEMRLRIAIEVSGALSYLH 513
           +V L       E   LV+E++ +  L QY+        P   ++ L    ++   LSY+H
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL---FQLLRGLSYIH 120

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
                 I HRD+K  N+L+ D    K++DFG +R+ +V  +H  +    T  Y  P+   
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLL 176

Query: 574 -SSQFTDKSDVYSFGVVLAELLTG 596
            S++++   D++  G +  E++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 22/209 (10%)

Query: 405 LGQGGQGTVYKG--MLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQIN---HRNVVK 457
           +G+G  G V+K   +   G+ VA+K+ +V   +E      I E+ +L  +    H NVV+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 458 LLGCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           L   C       ET++ L V+E + +  L  Y+ D+  +  +  E    +  ++   L +
Sbjct: 69  LFDVCTVSRTDRETKLTL-VFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS     + HRD+K  NIL+    + K++DFG +R  +       T V  T  Y  PE 
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEV 180

Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
              S +    D++S G + AE+    KP+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 64/240 (26%), Positives = 100/240 (41%), Gaps = 36/240 (15%)

Query: 403 RILGQGGQGTVY------KGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++LG+G  G V        G     KI+  +K  +I + +V   + E  +L    H  + 
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKIL--RKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSYLHSA 515
            L       +    V E+   G LF ++  +     +  E R R    E+  AL YLHS 
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR 114

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
               + +RDIK  N++LD     K++DFG  +    D   M T   GT  YL PE    +
Sbjct: 115 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDN 170

Query: 576 QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE 635
            +    D +  GVV+ E++ G  P                 +    ERLFE++   +M+E
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP----------------FYNQDHERLFELI---LMEE 211

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 32/228 (14%)

Query: 409 GQGTVYKGML----PDGKIVA---VKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGC 461
           G+GT  K +L      GK  A   +KK  +I + +V   + E  +L    H  +  L   
Sbjct: 4   GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSYLHSAASIPI 520
               +    V E++  G LF ++  +     +  E R R    E+  AL YLHS     I
Sbjct: 64  FQTKDRLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK---I 116

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            +RD+K  N++LD     K++DFG  +    D   M T   GT  YL PE    + +   
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRA 175

Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
            D +  GVV+ E++ G  P                 +    E+LFE++
Sbjct: 176 VDWWGLGVVMYEMMCGRLP----------------FYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 26/227 (11%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPDGK-------IVAVKKSKVIDESKVEEFINEMVILSQI 450
           +FN   +LG+G  G V   ML + K       I  +KK  +I +  VE  + E  +L+  
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57

Query: 451 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDF--PITWEMRLRIAIEVSG 507
                +  L  C +T   L  V E++  G L  +I  Q   F  P      +  A E++ 
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPHA----VFYAAEIAI 112

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGY 566
            L +LHS     I +RD+K  N++LD +   K++DFG  +         TT+   GT  Y
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDY 167

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAA 613
           + PE      +    D ++FGV+L E+L G+ P  F   +ED+   +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP--FDGEDEDELFQS 212

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 71/237 (29%), Positives = 105/237 (44%), Gaps = 30/237 (12%)

Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKVIDE-SKVEEF 440
            + +   + L   TD + +   +G+G  G VYK     DG + AVK   ++D  S V+E 
Sbjct: 8   NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK---ILDPISDVDEE 64

Query: 441 IN-EMVILSQI-NHRNVVKLLGCCLETEVPL-----LVYEFIPNGTLFQYIHD-----QN 488
           I  E  IL  + NH NVVK  G   + +  +     LV E    G++ + +       Q 
Sbjct: 65  IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124

Query: 489 EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 548
            D  +       I+  + GAL  L    +  I HRD+K  NILL  +   K+ DFG S  
Sbjct: 125 LDEAM-------ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177

Query: 549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-----DVYSFGVVLAELLTGEKPI 600
           +   +    T V GT  ++ PE     Q  D S     DV+S G+   EL  G+ P+
Sbjct: 178 LTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 12/154 (7%)

Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP--NGTLFQYIHDQNEDFPITWEMRLR 500
           E ++L  +NH +V+++    +   +  +V   +P  +  L+ Y+       P+  +  L 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL--TKRSRPLPIDQALI 161

Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
           I  ++   L YLH+     I HRD+K+ NI ++D  +  + D GA++   V        +
Sbjct: 162 IEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGL 216

Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL 594
            GT     PE     ++  K+D++S G+VL E+L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 27/205 (13%)

Query: 405 LGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFIN-----EMVILSQINHRNVVKL 458
           +G+G  G V+K    + G+IVA+KK     ES+ +  I      E+ +L Q+ H N+V L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKK---FVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65

Query: 459 LGCCLETEVPLLVYEFIPN---GTLFQYIHDQNEDF--PITWEMRLRIAIEVSGALSYLH 513
           +          LV+E+  +     L +      E     I W+           A+++ H
Sbjct: 66  IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQ--------AVNFCH 117

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF- 572
               I   HRD+K  NIL+  + + K+ DFG +R +       T  V  T  Y  PE   
Sbjct: 118 KHNCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLV 173

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGE 597
             +Q+    DV++ G V AELLTG+
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 69/285 (24%), Positives = 127/285 (44%), Gaps = 49/285 (17%)

Query: 405 LGQGGQGTVYKGML---PDGKIVAVKKS-----KVIDESKV--EEFINEMVILSQINHRN 454
           LGQG    +YKG+L    D  IV   +      KV+         F     ++SQ++H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           +VKL G C+  E  ++V E++  G L  ++H +  +  + W  +L +A +++ AL YL  
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 515 AASIPIYHRDIKSTNILL-----DDKYR--AKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
              +   H ++   NIL+     ++ Y    K+SD G   ++   +  +         ++
Sbjct: 120 KKLV---HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPWI 171

Query: 568 DPEYFR--SSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
            PE  R   +  T  +D +SFG  L E+ + GE+P+   +  E             +ER 
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------------KERF 218

Query: 625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
           ++  D   +      E+   A +  +C   +  KRP+ R +  +L
Sbjct: 219 YQ--DQHRLPMPDCAEL---ANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 30/228 (13%)

Query: 405 LGQGGQGTVYKGMLPD-GKIVAVKKS----KVIDESK---VEEFINEMVILSQINHRNVV 456
           LGQG    ++KG+  + G    + K+    KV+D+S     E F     ++SQ++H+++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
              G C+  +  ++V E++  G+L  Y+        I+W  +L +A +++ AL +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 517 SIPIYHRDIKSTNILL----DDKYRA----KVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
              + H ++ + N+LL    D K       K+SD G   S+ V    +  +      ++ 
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI--SITVLPKEILLE---RIPWVP 172

Query: 569 PEYFRSSQ-FTDKSDVYSFGVVLAELLTG-EKPIRFTTLEEDKSLAAY 614
           PE   + Q  +  +D +SFG  L E+ +G +KP+  + L+  K L  Y
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL--SALDSQKKLQFY 218

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 67.4 bits (165), Expect = 5e-12
 Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 25/214 (11%)

Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKS--KVIDESKVEEFINEMVILSQINHRNVVKL 458
           + +         + K   P   +VAVKK       +  ++    E++   Q+ H N++  
Sbjct: 6   IGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAI---EVSGALSYLHS 514
           +   +      +V   +  G+    +     E  P      L IA    +V  AL Y+HS
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIHS 119

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG-------TFGYL 567
              I   HR +K+++ILL    +  +S    S SM +        VH           +L
Sbjct: 120 KGFI---HRSVKASHILLSGDGKVVLSGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 568 DPEYFRSS--QFTDKSDVYSFGVVLAELLTGEKP 599
            PE  + +   + +KSD+YS G+   EL  G  P
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 5e-12
 Identities = 72/253 (28%), Positives = 113/253 (44%), Gaps = 43/253 (16%)

Query: 404 ILGQGGQGT---VYKGML---PDGKIVAVKKSKVIDESKVEEF----INEMVILSQINHR 453
           I G  G+GT   VYK       DGK  A+KK K  D+ +          E+ +L ++ H 
Sbjct: 4   IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKG-DKEQYTGISQSACREIALLRELKHE 62

Query: 454 NVVKLLGCCLE-TEVPL-LVYEFIPNGTLFQYIHD--QNEDFPITWEMRLRIAIEVSGAL 509
           NVV L+   LE  +  + L++++  +  L+Q I    Q +   I   M   +  ++   +
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 510 SYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASR--------SMAVDQTHMT 557
            YLHS     + HRD+K  NIL+     ++   K+ D G +R           +D     
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD----- 173

Query: 558 TQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPIRFTTLEED-KSLAAYF 615
             V  T  Y  PE    ++ +T   D+++ G + AELLT E PI F   E   K    + 
Sbjct: 174 -PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PI-FKGREAKIKKSNPFQ 230

Query: 616 LFAMKEERLFEIL 628
              +  ER+FE+L
Sbjct: 231 RDQL--ERIFEVL 241

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 12/201 (5%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGC 461
           +G+G  G VYK       + +A+KK ++   DE      I E+ +L ++ H N+V+L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
               +   LV+E++ +  L +++ D + DF     +      ++   ++Y HS     + 
Sbjct: 70  VHSEKRLYLVFEYL-DLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VL 124

Query: 522 HRDIKSTNILLDDKYRA-KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTD 579
           HRD+K  N+L+D +  A K++DFG +R+  +     T +V  T  Y  PE    S  ++ 
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYST 183

Query: 580 KSDVYSFGVVLAELLTGEKPI 600
             D++S G + AE++  +KP+
Sbjct: 184 PVDIWSVGCIFAEMVN-QKPL 203

Length = 294

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 22/204 (10%)

Query: 403 RILGQGGQGT---VYKGM-LPDGKIVAVKKSKVIDESKVEEFIN--EMVILSQIN-HRNV 455
           +ILG+ G+GT   V K      GK  A+K  K   +S +E+  N  E+  L +++ H N+
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNI 60

Query: 456 VKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGALSYL 512
           ++L+    +  T    LV+E + +  L++ I  +    P   E R++    ++  +L ++
Sbjct: 61  LRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHM 116

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           H      I+HRDIK  NIL+ D    K++DFG+ R   +      T+   T  Y  PE  
Sbjct: 117 HRNG---IFHRDIKPENILIKD-DILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECL 170

Query: 573 RSSQF-TDKSDVYSFGVVLAELLT 595
            +  +   K D+++ G V  E+L+
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 45/219 (20%)

Query: 405 LGQGGQGTVYKGML--PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           LG+G  G V K M   P G I+AVK+ +               + SQ   R ++ L    
Sbjct: 9   LGRGAYGVVDK-MRHVPTGTIMAVKRIR-------------ATVNSQEQKRLLMDLDISM 54

Query: 463 LETEVPLLVYEFIPNGTLFQ------------------YIHDQNEDFPITWEMRLRIAIE 504
              + P  V  +   G LF+                  Y    ++   I  ++  +IA+ 
Sbjct: 55  RSVDCPYTVTFY---GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS 111

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           +  AL YLHS  S+   HRD+K +N+L++   + K+ DFG S  + VD    T    G  
Sbjct: 112 IVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDA-GCK 167

Query: 565 GYLDPEYF----RSSQFTDKSDVYSFGVVLAELLTGEKP 599
            Y+ PE          +  KSDV+S G+ + EL TG  P
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 50/215 (23%), Positives = 102/215 (47%), Gaps = 20/215 (9%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV-IDESKV-EEFINEMVILSQINHR 453
           D +     +G+G  G VYK      GK+VA+KK+++ +DE  +    + E+ +L  ++  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 454 N-VVKLLGCCLETEVPL------LVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRIAIE 504
             +V+LL      E         LV+E++ +  L +++  + +    P+  +       +
Sbjct: 61  IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +   +++ H      + HRD+K  N+L+D  K   K++D G  R+ ++     T ++  T
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-T 174

Query: 564 FGYLDPE-YFRSSQFTDKSDVYSFGVVLAELLTGE 597
             Y  PE    S+ ++   D++S G + AE+   +
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.7 bits (163), Expect = 7e-12
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 19/218 (8%)

Query: 403 RILGQGGQGTVYKGMLPDG----KIVAVK---KSKVIDESKVEEFIN-EMVILSQINHRN 454
           ++LG+GG G V++     G    KI A+K   K+ ++   K       E  IL  + H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 455 VVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +V L+    +T   L L+ E++  G LF ++  +      T    L    E+S AL +LH
Sbjct: 62  IVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS---EISLALEHLH 117

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
                 I +RD+K  NILLD +   K++DFG  +  ++ +  +T    GT  Y+ PE   
Sbjct: 118 QQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEILM 173

Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
            S      D +S G ++ ++LTG  P  FT     K++
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPP--FTAENRKKTI 209

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 15/205 (7%)

Query: 404 ILGQGGQGTVYKGMLPD-GKIVAVK--KSKVIDESKVEEF-INEMVILSQINHRNV--VK 457
           I+G+GG G VY     D GK+ A+K    K I   + E   +NE ++LS ++  +   + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
            +     T   L     + NG    Y   Q+  F    EMR   A E+   L ++H+   
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS-EKEMRF-YATEIILGLEHMHNRF- 117

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 577
             + +RD+K  NILLD+    ++SD G +   +  + H +    GT GY+ PE  +    
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTA 172

Query: 578 TDKS-DVYSFGVVLAELLTGEKPIR 601
            D S D +S G +L +LL G  P R
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFR 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 66.8 bits (163), Expect = 7e-12
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 22/238 (9%)

Query: 426 VKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI 484
           +KK  V D+  ++    E  +    ++   +  L  C +TE  L  V EF+  G L  ++
Sbjct: 28  IKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM 87

Query: 485 HDQNEDFPITWEMRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 543
             Q +  P   E   R  + E+S AL++LH      I +RD+K  N+LLD +   K++D+
Sbjct: 88  QRQRK-LP---EEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDY 140

Query: 544 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFT 603
           G  +   +     T+   GT  Y+ PE  R   +    D ++ GV++ E++ G  P    
Sbjct: 141 GMCKE-GIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199

Query: 604 TLEE--DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKR 659
            + +  D++   Y LF +  E+   I  +  +K S          V K  LN + K+R
Sbjct: 200 GMSDNPDQNTEDY-LFQVILEKQIRIPRSLSVKASS---------VLKGFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 55/272 (20%), Positives = 121/272 (44%), Gaps = 42/272 (15%)

Query: 407 QGGQGTVYKGMLPDGKIV--AVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           +  Q ++YKG+  + +++    KK     +  ++   NE+  L +I+  N++K+ G  ++
Sbjct: 30  ENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89

Query: 465 TEVPL----LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
               L    L+ E+   G L + + D+ +D  ++++ +L +AI+    L  L+   + P 
Sbjct: 90  IVDDLPRLSLILEYCTRGYLREVL-DKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP- 145

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS--SQFT 578
            ++++ S + L+ + Y+ K+   G  + ++               Y   +      S++T
Sbjct: 146 -YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN----FMVYFSYKMLNDIFSEYT 200

Query: 579 DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGG 638
            K D+YS GVVL E+ TG+ P    T +                   EI D  ++ ++  
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFENLTTK-------------------EIYDL-IINKNNS 240

Query: 639 DEIITFAK-----VAKRCLNLNGKKRPTMREV 665
            ++          + + C + +  KRP ++E+
Sbjct: 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 32/234 (13%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPD---GKIVA---VKKSKVIDESKVEEFINEMVILSQI 450
            +F++  ++G+G  G V   ++ +   G I A   +KKS ++ +  V  F  E  ILS  
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH---DQ-NEDFPITWEMRLRIAIEVS 506
           N   + +L     + +   LV E+ P G L   ++   DQ +ED    +   L +AI   
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI--- 115

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
                 HS   +   HRDIK  N+L+D     K++DFG++  +  ++   +    GT  Y
Sbjct: 116 ------HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169

Query: 567 LDPEYFRSSQFTDKS------DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY 614
           + PE   +     K       D +S GV+  E++ G  P       E  S   Y
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP-----FHEGTSAKTY 218

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 62/220 (28%), Positives = 113/220 (51%), Gaps = 18/220 (8%)

Query: 405 LGQGGQGTVYKG--MLPDGKIVAVKKSKVIDESKVE-EFINEMVILSQINHRNVVKLLGC 461
           LG+G   TVYKG   L D  +VA+K+ ++  E       I E+ +L  + H N+V L   
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 462 CLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
            + TE  L LV+E++ +  L QY+ D      +   ++L +   + G L+Y H      +
Sbjct: 73  -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFLFQLLRG-LNYCHRRK---V 125

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTD 579
            HRD+K  N+L++++   K++DFG +R+ ++     + +V  T  Y  P+    S+ ++ 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184

Query: 580 KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM 619
           + D++  G +  E+ TG      +T+EE      +F+F +
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQ----LHFIFRI 220

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 64/227 (28%), Positives = 95/227 (41%), Gaps = 42/227 (18%)

Query: 398 NFNLNRILGQGGQGTV----YKGMLPDGKIVAVKK-----SKVIDESKVEEFINEMVILS 448
            + L + LGQG  G V          +   VA+KK     SK I   +    + E+ +L 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEET-VAIKKITNVFSKKILAKRA---LRELKLLR 56

Query: 449 QI-NHRNVVKLLGCCLETEVP-------LLVYEFIPNGTLFQYIHD--QNEDFPITWEMR 498
               H+N+     C  + ++        L +YE +    L Q I       D        
Sbjct: 57  HFRGHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQS--- 109

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD----QT 554
                ++   L Y+HSA  +   HRD+K  N+L++     K+ DFG +R  + +      
Sbjct: 110 --FIYQILCGLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164

Query: 555 HMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPI 600
            MT  V  T  Y  PE   S Q +T   DV+S G +LAELL G KP+
Sbjct: 165 FMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 50/215 (23%), Positives = 96/215 (44%), Gaps = 13/215 (6%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKG--MLPDGK--IVAVKKSKV-IDESKVEEFINEMV 445
           EL+  +    + RILG G  G + +G   LP  +   VA+   +    + +   F+ E +
Sbjct: 1   ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58

Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
            L Q +H N+V+L G        ++V E++ NG L  ++            M +   +  
Sbjct: 59  TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGL-- 116

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
           +  + YL     +   H+ + +  +L++     K+S F   +    +  + T        
Sbjct: 117 ASGMKYLSEMGYV---HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  PE  +   F+  SDV+SFG+V+ E+++ GE+P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 63/222 (28%), Positives = 112/222 (50%), Gaps = 12/222 (5%)

Query: 405 LGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCC 462
           LG+G   TV+KG       +VA+K+ ++  +E      I E+ +L  + H N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI- 71

Query: 463 LETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
           + TE  L LV+E++ +  L QY+ D   +      +++    ++   LSY H      I 
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKI-FMFQLLRGLSYCHKRK---IL 125

Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTDK 580
           HRD+K  N+L+++K   K++DFG +R+ +V     + +V  T  Y  P+    S++++  
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184

Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE 622
            D++  G +L E+ TG      +T++E+  L    L    EE
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEE 226

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 71/276 (25%), Positives = 116/276 (42%), Gaps = 23/276 (8%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++ L + +G G  G VYK   L  G++ AVK  K+           E+ ++ +  H N+V
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
              G  L  E   +  E+   G+L    H      P++      +  E    L+YLHS  
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG 126

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF---R 573
            +   HRDIK  NILL D    K++DFG +  +        + + GT  ++ PE     +
Sbjct: 127 KM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEK 182

Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM 633
           +  +    D+++ G+   EL   + P     + +   + A FL +    +  ++ D    
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPP-----MFDLHPMRALFLMSKSNFQPPKLKDK--T 235

Query: 634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
           K S      TF    K  L  N KKRPT   + + L
Sbjct: 236 KWSS-----TFHNFVKISLTKNPKKRPTAERLLTHL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 34/234 (14%)

Query: 397 DNFNLNRILGQGGQGTVY----KGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           ++F   +++  G  G VY    K       +  + K  +I  +++++   E  IL+   +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 453 RNVVKLLGCCLETEVPL-LVYEFIPNG---TLFQYIHDQNEDFPITWEM-RLRIAIEVSG 507
             VV +  C  ET+  L +V E++  G   TL + I        +  +M R+  A E   
Sbjct: 61  PFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFA-ETVL 112

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-------------SMAVD-Q 553
           AL YLH+     I HRD+K  N+L+      K++DFG S+              +  D +
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
             +  QV GT  Y+ PE      +    D ++ G++L E L G  P    T EE
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 32/215 (14%)

Query: 399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKK-SKVIDE-SKVEEFINEMVILSQINHRNV 455
              +R +G G  G V+    P DGK VA+KK   V       +    E+ +L    H NV
Sbjct: 2   VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE----DF--------PITWEMRLRIAI 503
           +  L   L+           P+   F+ I+   E    D         P++ +       
Sbjct: 62  LSALDI-LQP----------PHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLY 110

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHG 562
           ++   L YLHSA    I HRDIK  N+L++     K+ DFG +R    D++ HMT +V  
Sbjct: 111 QILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT 167

Query: 563 TFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTG 596
            + Y  PE    S+ +T   D++S G + AELL  
Sbjct: 168 QY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 27/210 (12%)

Query: 404 ILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF----INEMVILSQINHRNVVKL 458
            +GQG  G V+K       +IVA+KK  V+ E++ E F    + E+ IL  + H NVV L
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNL 76

Query: 459 LGCCLETEVP--------LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +  C     P         LV+EF  +  L   + ++N  F ++ E++  + + ++G L 
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS-EIKKVMKMLLNG-LY 133

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV----DQTHMTTQVHGTFGY 566
           Y+H      I HRD+K+ NIL+      K++DFG +R+ ++         T +V  T  Y
Sbjct: 134 YIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV-VTLWY 189

Query: 567 LDPEYFRSS-QFTDKSDVYSFGVVLAELLT 595
             PE       +    D++  G ++AE+ T
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 13/207 (6%)

Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVE-EFINEMVILSQINH 452
           AT   NL + LG+G   TVYKG+   +G++VA+K   +  E  V    I E  +L  + H
Sbjct: 4   ATSYLNLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
            N+V L       E    V+E++ +  L QY+  Q+      + +RL    ++   L+Y+
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYM-IQHPGGLHPYNVRL-FMFQLLRGLAYI 119

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDPEY 571
           H      I HRD+K  N+L+      K++DFG +R+ ++  QT+ +  V  T  Y  P+ 
Sbjct: 120 HGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDV 174

Query: 572 FR-SSQFTDKSDVYSFGVVLAELLTGE 597
              ++ ++   D++  G +  E+L G+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 64/239 (26%), Positives = 101/239 (42%), Gaps = 40/239 (16%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
            +F   ++LG+G  G V+   L   GK+ A+K   K ++I  +KV+  + E  IL+ ++H
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 453 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNED-FPITWEMRLRIAIEVSGALS 510
             +  L     +TE  L LV ++ P G LF+ +  Q           R   A EV  AL 
Sbjct: 61  PFLPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-VARFYAA-EVLLALE 117

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH--------- 561
           YLH      I +RD+K  NILL +     +SDF  S+   V+   ++  +          
Sbjct: 118 YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 562 -------------------GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                              GT  Y+ PE           D ++ G++L E+L G  P +
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 65.8 bits (160), Expect = 3e-11
 Identities = 65/251 (25%), Positives = 128/251 (50%), Gaps = 27/251 (10%)

Query: 362 FKRNGGLLLQQELA--STEGTIEKTKLFTSKELERATD-NFNLNRILGQGGQGTVYKGML 418
           F+ N   L ++E +  +  G  E  +     ++ R+ + ++ L  I+G G  G VY+ + 
Sbjct: 28  FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87

Query: 419 PD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKL-----LGCCLETEVPL--- 469
            D  + VA+KK  V+ + + +    E++I+  +NH N++ L       C  + E  +   
Sbjct: 88  IDTSEKVAIKK--VLQDPQYKN--RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143

Query: 470 LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKS 527
           +V EFIP       ++    N   P+ + ++L  + ++  AL+Y+HS     I HRD+K 
Sbjct: 144 VVMEFIPQTVHKYMKHYARNNHALPL-FLVKL-YSYQLCRALAYIHSKF---ICHRDLKP 198

Query: 528 TNILLDDK-YRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYS 585
            N+L+D   +  K+ DFG+++++   Q  ++  +   F Y  PE    ++ +T   D++S
Sbjct: 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS-YICSRF-YRAPELMLGATNYTTHIDLWS 256

Query: 586 FGVVLAELLTG 596
            G ++AE++ G
Sbjct: 257 LGCIIAEMILG 267

Length = 440

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 72/295 (24%), Positives = 132/295 (44%), Gaps = 66/295 (22%)

Query: 405 LGQGGQGTVYKGML-----PDGKIVAVKKS-----KVIDESKVE---EFINEMVILSQIN 451
           LG+G +  +Y G+L      +    + +K      KV+D S  +    F     ++ Q++
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H+++V L G C+     ++V EF+  G L  ++H +++     W  + ++A +++ ALSY
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 512 LHSAASIPIYHRDIKSTNILL-----DDKYRA--KVSDFGA-----SRSMAVDQTHMTTQ 559
           L     +   H ++ + NILL     D +     K+SD G      SR   V++      
Sbjct: 121 LEDKDLV---HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER------ 171

Query: 560 VHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAEL-LTGEKPIRFTTLEEDKSLAAYFLF 617
                 ++ PE    S+  +  +D +SFG  L E+   GE P++      DK+LA     
Sbjct: 172 ----IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK------DKTLA----- 216

Query: 618 AMKEERLFE---ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
             ++ER +E   +L     KE         A +   C+N +  +RP  R +  ++
Sbjct: 217 --EKERFYEGQCMLVTPSCKE--------LADLMTHCMNYDPNQRPFFRAIMRDI 261

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 11/200 (5%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESK-VEEF-INEMVILSQINHRNVVKLLGC 461
           +G+G  GTV+K       +IVA+K+ ++ D+ + V    + E+ +L ++ H+N+V+L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
               +   LV+E+  +  L +Y    N D  I  E+      ++   L++ HS     + 
Sbjct: 68  LHSDKKLTLVFEYC-DQDLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHSHN---VL 121

Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS 581
           HRD+K  N+L++     K++DFG +R+  +     + +V  T  Y  P+    ++    S
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 180

Query: 582 -DVYSFGVVLAELLTGEKPI 600
            D++S G + AEL    +P+
Sbjct: 181 IDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 20/203 (9%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           + +G G QG V        G  VAVKK      +++  +    E+V+L  +NH+N++ LL
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q IH       +  E    +  ++   + +LH
Sbjct: 87  NVFTPQKSLEEFQDVYLVMELM-DANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH 140

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+   +   M T    T  Y  PE   
Sbjct: 141 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVIL 195

Query: 574 SSQFTDKSDVYSFGVVLAELLTG 596
              + +  D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 15/205 (7%)

Query: 404 ILGQGGQGTVYKGMLPD-GKIVAVK--KSKVIDESKVEEF-INEMVILSQINHRNV--VK 457
           I+G+GG G VY     D GK+ A+K    K I   + E   +NE ++LS ++  +   + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
            +     T   L     + NG    Y   Q+  F    EMR   A E+   L ++H+   
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-EMRF-YAAEIILGLEHMHNRF- 117

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 577
             + +RD+K  NILLD+    ++SD G +   +  + H +    GT GY+ PE  +    
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVA 172

Query: 578 TDKS-DVYSFGVVLAELLTGEKPIR 601
            D S D +S G +L +LL G  P R
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFR 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 16/199 (8%)

Query: 409 GQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQINHRNVVKLLGC 461
           G+GT  K +L      GK  A+K   K  +I + +V   + E  +L    H  +  L   
Sbjct: 4   GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSYLHSAASIPI 520
               +    V E+   G LF ++  +     +  E R R    E+  AL YLHS     +
Sbjct: 64  FQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD---V 116

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            +RD+K  N++LD     K++DFG  +    D   M T   GT  YL PE    + +   
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRA 175

Query: 581 SDVYSFGVVLAELLTGEKP 599
            D +  GVV+ E++ G  P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.5 bits (154), Expect = 8e-11
 Identities = 58/223 (26%), Positives = 111/223 (49%), Gaps = 14/223 (6%)

Query: 405 LGQGGQGTVYKG--MLPDGKIVAVKKSKVIDESKVE-EFINEMVILSQINHRNVVKLLGC 461
           LG+G   TV+KG   L +  +VA+K+ ++  E       I E+ +L  + H N+V L   
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSGALSYLHSAASIPI 520
               +   LV+E++ +  L QY+ D      +     ++I + ++   L+Y H      +
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSM---HNVKIFLYQILRGLAYCHRRK---V 125

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-SSQFTD 579
            HRD+K  N+L++++   K++DFG +R+ +V     + +V  T  Y  P+    SS+++ 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184

Query: 580 KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE 622
           + D++  G +  E+ +G      +T+E++  L    L    EE
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 12/150 (8%)

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           ++ N +KL       +  +L+ ++I +G LF  +  + E      E++  I  ++  AL+
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVKK-IIRQLVEALN 123

Query: 511 YLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            LH    I   H DIK  N+L D  K R  + D+G  + +     +      GT  Y  P
Sbjct: 124 DLHKHNII---HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175

Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           E  +   +    D ++ GV+  ELLTG+ P
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 63.5 bits (154), Expect = 2e-10
 Identities = 59/193 (30%), Positives = 98/193 (50%), Gaps = 14/193 (7%)

Query: 415 KGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF 474
           +G  P  K+VA K   + DE +     +E+  L+  +H  +VK        +  LL+ E+
Sbjct: 88  RGSDPKEKVVA-KFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146

Query: 475 IPNGTLFQYIHDQ-NEDFPIT-WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 532
              G L + I  +  E  P   +E+ L +  ++  AL  +HS     + HRD+KS NI L
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGL-LFYQIVLALDEVHSRK---MMHRDLKSANIFL 202

Query: 533 DDKYRAKVSDFGASR----SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGV 588
                 K+ DFG S+    S+++D   + +   GT  YL PE +   +++ K+D++S GV
Sbjct: 203 MPTGIIKLGDFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259

Query: 589 VLAELLTGEKPIR 601
           +L ELLT  +P +
Sbjct: 260 ILYELLTLHRPFK 272

Length = 478

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 2e-10
 Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 59/250 (23%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D+F   +++G+G  G V      D G I A+K   KS+++++ +V     E  IL++ ++
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 453 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQN---EDFPITWEMRLRIAIEVSGA 508
             VVKL     + E  L L+ E++P G +   +  ++   E+     E R  IA E   A
Sbjct: 61  PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-----ETRFYIA-ETILA 113

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT---------- 558
           +  +H    I   HRDIK  N+LLD K   K+SDFG      + ++H T           
Sbjct: 114 IDSIHKLGYI---HRDIKPDNLLLDAKGHIKLSDFGL--CTGLKKSHRTEFYRILSHALP 168

Query: 559 -----------------------------QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVV 589
                                           GT  Y+ PE F  + +  + D +S GV+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228

Query: 590 LAELLTGEKP 599
           + E+L G  P
Sbjct: 229 MYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 18/205 (8%)

Query: 405 LGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMV------ILSQINHRNVVK 457
           LG+GG G V    + + GK+ A KK   +D+ ++++   E +      IL ++N   +V 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK---LDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57

Query: 458 LLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           L     E++  L LV   +  G L  +I++  E   +  E  +  + +++  + +LHS  
Sbjct: 58  L-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS-- 113

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
            + I +RD+K  N+LLDD+   ++SD G +  +   +T   TQ  GT GY+ PE  +   
Sbjct: 114 -MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEP 170

Query: 577 FTDKSDVYSFGVVLAELLTGEKPIR 601
           ++   D ++ G  + E++ G  P +
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFK 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 63/259 (24%), Positives = 101/259 (38%), Gaps = 68/259 (26%)

Query: 397 DNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F+  +++G+G  G V        GKI A+K   KS++  + ++     E  +L++ + 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM------RLRIAIEVS 506
             VV L     + +   L+ EF+P G L   +        I ++       R  +A E  
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECV 111

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS-------------------- 546
            A+  +H    I   HRDIK  NIL+D     K+SDFG S                    
Sbjct: 112 LAIEAVHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168

Query: 547 --------RSMAVDQTHMTTQVH------------------GTFGYLDPEYFRSSQFTDK 580
                    S+AVD  ++T                      GT  Y+ PE F    +  +
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228

Query: 581 SDVYSFGVVLAELLTGEKP 599
            D +S G ++ E L G  P
Sbjct: 229 CDWWSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 21/99 (21%)

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           L Y+HSA  +   HRD+K +NIL+++    K+ DFG +R   +    MT       GY+ 
Sbjct: 121 LKYVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR---IQDPQMT-------GYVS 167

Query: 569 PEYFRSSQ-------FTDKSDVYSFGVVLAELLTGEKPI 600
             Y+R+ +       +  + D++S G + AE+L G KP+
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 20/214 (9%)

Query: 399 FNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDE--SKVEEFINEMVILSQINHRNV 455
           + +  ++G+G  G V   +    G+ VA+KK   + E  S     + E+ +L  + H ++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 456 VKLLGCCL-----ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           V++    L     E +   +V+E +    L Q I   N+D  +T E       ++  AL 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIK-ANDD--LTPEHHQFFLYQLLRALK 117

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD--QTHMTTQVHGTFGYLD 568
           Y+H+A    ++HRD+K  NIL +   + K+ DFG +R    D       T    T  Y  
Sbjct: 118 YIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 569 PEYFRS--SQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  S++T   D++S G + AE+LTG KP+
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 31/228 (13%)

Query: 409 GQGTVYKGMLPDGKIVA-------VKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGC 461
           G+GT  K +L   K          +KK  ++ + +V   + E  +L    H  +  L   
Sbjct: 4   GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 63

Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSYLHSAASIPI 520
               +    V E+   G LF ++  +     +  E R R    E+  AL YLHS  ++  
Sbjct: 64  FQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKNV-- 117

Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            +RD+K  N++LD     K++DFG  +    D   M T   GT  YL PE    + +   
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRA 176

Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
            D +  GVV+ E++ G  P                 +    E+LFE++
Sbjct: 177 VDWWGLGVVMYEMMCGRLP----------------FYNQDHEKLFELI 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.6 bits (149), Expect = 8e-10
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 14/162 (8%)

Query: 442 NEMVILSQINHRNVVKL---LGCCLETEVPLLVYEFIPNGTLFQYIHD---QNEDFPITW 495
           NE++ L ++NH N++K+   L     T +    Y+F     L+ +++D     +D P+  
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLK 267

Query: 496 EMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 555
           + R  I  ++  A+ Y+H    I   HRDIK  NI L+   +  + DFG +     ++  
Sbjct: 268 QTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323

Query: 556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGE 597
                 GT     PE      + + +D++S G++L ++L+ +
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365

Length = 501

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.8 bits (147), Expect = 8e-10
 Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 44/249 (17%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D+F   +++G+G  G V      D G I A+K   K+ ++++ +V     E  IL + + 
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             VVK+     +     L+ EF+P G +   +    +D       +  IA E   A+  +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIA-ETVLAIDAI 117

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFG---------------------------- 544
           H    I   HRDIK  N+LLD K   K+SDFG                            
Sbjct: 118 HQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 545 ------ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEK 598
                  + +   ++  +     GT  Y+ PE F  + +    D +S GV++ E+L G  
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 599 PIRFTTLEE 607
           P    T +E
Sbjct: 235 PFCSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.0 bits (145), Expect = 8e-10
 Identities = 68/236 (28%), Positives = 103/236 (43%), Gaps = 30/236 (12%)

Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFI 441
           KT +F S      +D + +   +G+G  G V+K +   +G   AVK    I +   EE  
Sbjct: 6   KTIIFDS--FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIE 62

Query: 442 NEMVILSQI-NHRNVVKLLGCCLETEVP-----LLVYEFIPNGTLFQYIH------DQNE 489
            E  IL  + +H NVVK  G   + +V       LV E    G++   +       ++ E
Sbjct: 63  AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122

Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           +  I +     I  E    L +LH   +I   HRD+K  NILL  +   K+ DFG S  +
Sbjct: 123 EPIIAY-----ILHEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQL 174

Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-----DVYSFGVVLAELLTGEKPI 600
              +    T V GT  ++ PE     Q  D +     DV+S G+   EL  G+ P+
Sbjct: 175 TSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 60.5 bits (147), Expect = 8e-10
 Identities = 37/93 (39%), Positives = 52/93 (55%), Gaps = 6/93 (6%)

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           L Y+HSA    + HRD+K +N+LL+     K+ DFG +R+ +     MT  V  T  Y  
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYV-VTRWYRA 176

Query: 569 PE-YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE     S++T   DV+S G + AELL G KP+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.9 bits (145), Expect = 8e-10
 Identities = 68/258 (26%), Positives = 107/258 (41%), Gaps = 47/258 (18%)

Query: 405 LGQGGQGTVYKGMLPDG---KIVAVKKSKVIDESKVEE---FINEMVILSQINHRNVVKL 458
           +G G  G V  G +  G     V VK+ +V   + V+E   F+ E      + H N+++ 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRV--SASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRL--RIAIEVSGALSYLHSAA 516
           LG C E    LLV EF P G L  Y+    +   +T +     R+A E++  L +LH   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT----------------QV 560
            I   H D+   N LL      K+ D+G S +   +  ++T                 +V
Sbjct: 121 FI---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR---------FTTLEEDKS 610
           HG    +D         T +S+V+S GV + EL   G +P R         +T  E+   
Sbjct: 178 HGNLLVVDQ--------TKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLK 229

Query: 611 LAAYFLFAMKEERLFEIL 628
           L    L     +R +E++
Sbjct: 230 LPKPRLKLPLSDRWYEVM 247

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 45/218 (20%)

Query: 400 NLNRILGQGGQGTV---YKGMLPDGKIVAVKKSKVIDESKVEEFIN---------EMVIL 447
           NL + +G G QG V   Y  +   G+ VA+KK           F N         E+V++
Sbjct: 20  NL-KPIGSGAQGIVCAAYDTVT--GQNVAIKKLS-------RPFQNVTHAKRAYRELVLM 69

Query: 448 SQINHRNVVKLLGC-----CLET--EVPLLVYEFIPNGTLFQYIH-DQNEDFPITWEMRL 499
             +NH+N++ LL        LE   +V  LV E + +  L Q I  D + +       R+
Sbjct: 70  KLVNHKNIIGLLNVFTPQKSLEEFQDV-YLVMELM-DANLCQVIQMDLDHE-------RM 120

Query: 500 RIAI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
              + ++   + +LHSA    I HRD+K +NI++      K+ DFG +R+ A     MT 
Sbjct: 121 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTP 176

Query: 559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTG 596
            V  T  Y  PE      + +  D++S G ++ E++ G
Sbjct: 177 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 22/224 (9%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDG-KIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F + +++G+G  G V    L +  K+ A+K   K +++  ++   F  E  +L   ++
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNG---TLFQYIHDQ-NEDFPITWEMRLRIAIEVSGA 508
           + +  L     +     LV ++   G   TL     D+  ED    +   + IAI+    
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           L Y+H         RDIK  NIL+D     +++DFG+   +  D T  ++   GT  Y+ 
Sbjct: 121 LHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 569 PEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           PE  ++      ++  + D +S GV + E+L GE P    +L E
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 70/304 (23%), Positives = 123/304 (40%), Gaps = 72/304 (23%)

Query: 405 LGQGGQGTVYKGML--------PDGKIVAVKKS--------------KVIDESKVE---E 439
           LGQG +  +Y G L         + ++                    KV+D S  +    
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 440 FINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRL 499
           F     ++SQ++H ++  + G C+     ++V EF+ +G L   +  +    P+ W++  
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKI-- 120

Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA-------KVSD----FGA-SR 547
            +A +++ ALSYL       + H ++ + NILL     A       K+SD    F A SR
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177

Query: 548 SMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAEL-LTGEKPIRFTTL 605
              V++            ++ PE     +  +  +D +SFG  L E+   GE P++  T 
Sbjct: 178 EERVER----------IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227

Query: 606 EEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            E +       F  K+ RL          E    E+   A +  +CL     +RP+ R +
Sbjct: 228 SEKER------FYEKKHRL---------PEPSCKEL---ATLISQCLTYEPTQRPSFRTI 269

Query: 666 TSEL 669
             +L
Sbjct: 270 LRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 52/161 (32%), Positives = 78/161 (48%), Gaps = 24/161 (14%)

Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT--LFQYIHDQNEDFP----ITWE 496
           E+ IL  I+HR ++ L+          +V   +P     LF Y+ D++   P    IT +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYV-DRSGPLPLEQAITIQ 191

Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 556
            RL        AL+YLH      I HRD+K+ NI LD+   A + DFGA  +  +D    
Sbjct: 192 RRLL------EALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA--ACKLDAHPD 240

Query: 557 TTQVHGTFGYLD---PEYFRSSQFTDKSDVYSFGVVLAELL 594
           T Q +G  G L+   PE      +  K+D++S G+VL E+ 
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 18/222 (8%)

Query: 397 DNFNLNRILGQG--GQGTVYKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQIN 451
           D+F + +++G+G  G+  V K M   G++ A+K   K +++  ++   F  E  +L   +
Sbjct: 1   DDFEILKVIGRGAFGEVAVVK-MKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD 59

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM-RLRIAIEVSGALS 510
            R +  L     +     LV ++   G L   +    +  P   +M R  +A E+  A+ 
Sbjct: 60  RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE--DMARFYLA-EMVLAID 116

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
            +H    +   HRDIK  N+LLD     +++DFG+   +  D T  +    GT  Y+ PE
Sbjct: 117 SVHQLGYV---HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 571 YFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
             ++      ++  + D +S GV + E+L GE P    +L E
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 17/204 (8%)

Query: 405 LGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
           +G+G  G VY+    D  +I A+K   K +++ + +V   I E  IL +        ++G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 461 CCLETEVP---LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSGALSYLHSAA 516
                +      LV +++  G LF ++  +   F    E R +  I E+  AL +LH   
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR-FS---EDRAKFYIAELVLALEHLHKY- 115

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
              I +RD+K  NILLD      + DFG S++   D    T    GT  YL PE     +
Sbjct: 116 --DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDEK 172

Query: 577 -FTDKSDVYSFGVVLAELLTGEKP 599
            +T   D +S GV++ E+  G  P
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 64/249 (25%), Positives = 103/249 (41%), Gaps = 44/249 (17%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +++G+G  G V      D G + A+K   K+ ++++ +V     E  IL + + 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             VVK+     +     L+ EF+P G +   +    +D     E +  IA E   A+  +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIA-ETVLAIDSI 117

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFG----------------ASRSMAVDQT-- 554
           H    I   HRDIK  N+LLD K   K+SDFG                 + S+  D T  
Sbjct: 118 HQLGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 555 ----------------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEK 598
                            +     GT  Y+ PE F  + +    D +S GV++ E+L G  
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 599 PIRFTTLEE 607
           P    T +E
Sbjct: 235 PFCSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 5/101 (4%)

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HS   +   HRDIK  N+LLD     +++DFG+   M  D T  ++   GT  Y+ PE 
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174

Query: 572 FRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
            ++      ++  + D +S GV + E+L GE P    +L E
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 57.8 bits (139), Expect = 7e-09
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 36/207 (17%)

Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 460 GCCLETEVPLLVYEFIPNGTL--FQYIH------DQNEDFPITWEM---RLRIAI-EVSG 507
                         F P  +L  FQ ++      D N    I  E+   R+   + ++  
Sbjct: 83  NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 130

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
            + +LHSA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y 
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYR 185

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELL 594
            PE      + +  D++S G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 9/204 (4%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGK-IVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           + F +  ++G+G  G V K    + K IVA+KK K  +E++   E  + E+ +L  +   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+V+L           LV+E++    L     +  E+ P       ++   +   +  +H
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNML-----ELLEEMP-NGVPPEKVRSYIYQLIKAIH 114

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
                 I HRDIK  N+L+      K+ DFG +R+++       T+   T  Y  PE   
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174

Query: 574 SSQFTDKSDVYSFGVVLAELLTGE 597
            + +    D++S G +L EL  G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 36/119 (30%), Positives = 64/119 (53%), Gaps = 11/119 (9%)

Query: 486 DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 545
           D  + +P+  +  LR + +V+  + +L S   I   HRD+ + N+LL D   AK+ DFG 
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGL 258

Query: 546 SRSMAVDQTHMTTQVHGT----FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +R +  D  ++   V G       ++ PE      +T +SDV+S+G++L E+ + G+ P
Sbjct: 259 ARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 22/202 (10%)

Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89

Query: 460 GC-----CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
                   LE    + +   + +  L Q I  + +   +++     +  ++   + +LHS
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           A    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE    
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG 199

Query: 575 SQFTDKSDVYSFGVVLAELLTG 596
             + +  D++S G ++ E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 48/216 (22%)

Query: 426 VKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 485
           ++K+ V+  ++      E  IL++ ++  VVKL     + +    V ++IP G +   + 
Sbjct: 34  LRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL- 92

Query: 486 DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 545
            +   F      R  IA E++ A+  +H    I   HRDIK  NIL+D     K++DFG 
Sbjct: 93  IRLGIFEEDLA-RFYIA-ELTCAIESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGL 147

Query: 546 ---------SR-----------SMAVDQT-------------------HMTTQVH---GT 563
                    S+           SM   +                    H     H   GT
Sbjct: 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGT 207

Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
             Y+ PE    + +T   D +S GV+L E+L G+ P
Sbjct: 208 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 69/283 (24%), Positives = 104/283 (36%), Gaps = 67/283 (23%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKV-IDESKVEEFINEMV 445
           E   D   L ++LG G  G V +              VAVK  K     S+ +  ++E+ 
Sbjct: 3   EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELK 62

Query: 446 ILSQI-NHRNVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFPITWE------M 497
           IL  I NH NVV LLG C +   PL+V  EF   G L  ++  + E F    E       
Sbjct: 63  ILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRG 122

Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKST----------------------------- 528
           R R  +E S     + +  +  ++ R   ST                             
Sbjct: 123 RFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQ 182

Query: 529 ---------------------NILLDDKYRAKVSDFGASRSMAVDQTHMTT-QVHGTFGY 566
                                NILL +    K+ DFG +R +  D  ++          +
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEED 608
           + PE      +T +SDV+SFGV+L E+ + G  P     + E+
Sbjct: 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 37/137 (27%), Positives = 60/137 (43%), Gaps = 37/137 (27%)

Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
             P+T E  +  + +V+  + +L S   I   HRD+ + NILL +    K+ DFG +R +
Sbjct: 167 KEPLTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDI 223

Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQ-----------------FTDKSDVYSFGVVLAE 592
                           Y DP+Y R                    +T +SDV+SFGV+L E
Sbjct: 224 ----------------YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE 267

Query: 593 LLT-GEKPIRFTTLEED 608
           + + G  P     ++E+
Sbjct: 268 IFSLGASPYPGVQIDEE 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 56.3 bits (136), Expect = 3e-08
 Identities = 67/278 (24%), Positives = 106/278 (38%), Gaps = 83/278 (29%)

Query: 397 DNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           D+F L + LG+G  G VYK  L       +GK V +KK+   +   VE ++NE V   + 
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKAT--EYGAVEIWMNERV---RR 185

Query: 451 NHRN-VVKLLGCCLET-----EVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRL---- 499
              N     +   LE      E    LV+ +    TL   +  Q+++FP   E  L    
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLM--QSKEFPYNVEPYLLGKV 243

Query: 500 ---------------RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA-KVSDF 543
                           I  ++  AL  LHS     I HRD+K  NI+  +   + K+ D 
Sbjct: 244 QDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDL 300

Query: 544 GASRSMAVDQTHMTTQVHGTFGYLDP------EYFRSSQ--------------------- 576
           GA+  + V   ++  +       LDP      +Y  S+Q                     
Sbjct: 301 GAAADLRVGINYIPKEF-----LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355

Query: 577 FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY 614
             D+ D+YS G++  ++        F  L  D +L  +
Sbjct: 356 LPDRFDIYSAGLIFLQMA-------FPNLRSDSNLIQF 386

Length = 566

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 56.7 bits (136), Expect = 4e-08
 Identities = 48/194 (24%), Positives = 88/194 (45%), Gaps = 28/194 (14%)

Query: 432 IDESKVEEFINEMVILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNE 489
           + E +  + + E+ ++ ++ H+N+V+ +   L    +   ++ EF   G L + I    +
Sbjct: 51  LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK 110

Query: 490 DF-PITWEMRLRIAIEVSGALSYLHSAASIP----IYHRDIKSTNILLDDKYR------- 537
            F  I     + I  ++  AL+Y H+    P    + HRD+K  NI L    R       
Sbjct: 111 MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170

Query: 538 ----------AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF--RSSQFTDKSDVYS 585
                     AK+ DFG S+++ ++   M     GT  Y  PE     +  + DKSD+++
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228

Query: 586 FGVVLAELLTGEKP 599
            G ++ EL +G+ P
Sbjct: 229 LGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 30/205 (14%)

Query: 405 LGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVE-EFINEMVILSQINHRNVVKLLGCC 462
           LG+G   TVYKG     G++VA+K+ ++  E       I E  +L  + H N+V L    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR---------LRIAIEVSGALSYLH 513
              +   LV+E++ +  L QY+    +D      M          LR        L+Y H
Sbjct: 73  HTKKTLTLVFEYL-DTDLKQYM----DDCGGGLSMHNVRLFLFQLLR-------GLAYCH 120

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDPEYF 572
                 + HRD+K  N+L+ ++   K++DFG +R+ +V  +T+    V  T  Y  P+  
Sbjct: 121 QRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVL 175

Query: 573 R-SSQFTDKSDVYSFGVVLAELLTG 596
             S++++   D++  G +  E+ TG
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.7 bits (129), Expect = 7e-08
 Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 17/195 (8%)

Query: 411 GTVYKGMLPDGKIVAVKKSKVIDESK-VEEFINEMVILSQINHRNVVKLLGCCLETEVPL 469
             +Y         V VK+ K    SK   EF+ +      + H N+++ LG C+E    L
Sbjct: 14  SEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71

Query: 470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRL-RIAIEVSGALSYLHSAASIPIYHRDIKST 528
           LV+E+   G L  Y+  +      +  + L R+A E++  ++++H    +   H D+   
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL---HSDLALR 128

Query: 529 NILLDDKYRAKVSDFGASRSMAVDQTHMTTQ--VHGTFGYLDPEYFRS-------SQFTD 579
           N  L      KV D+G   S    + ++ T+        +L PE           ++ T 
Sbjct: 129 NCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTK 187

Query: 580 KSDVYSFGVVLAELL 594
            S+V++ GV L EL 
Sbjct: 188 PSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.5 bits (131), Expect = 8e-08
 Identities = 48/207 (23%), Positives = 93/207 (44%), Gaps = 31/207 (14%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V   +    G+ VA+KK     +S++  +    E+ +L  + H NV+ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL-- 80

Query: 462 CLETEVPLLVYEFIPNGTL---FQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAAS 517
             +     +  +   +  L   +     Q     P++ +    +  ++   L Y+HSA  
Sbjct: 81  --DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG- 137

Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ- 576
             I HRD+K  N+ +++    K+ DFG +R    + T          GY+   ++R+ + 
Sbjct: 138 --IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----------GYVVTRWYRAPEV 185

Query: 577 ------FTDKSDVYSFGVVLAELLTGE 597
                 +    D++S G ++AE+LTG+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 34/119 (28%), Positives = 60/119 (50%), Gaps = 5/119 (4%)

Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 551
            +T E  +  + +V+  + +L S   I   HRD+ + NILL +    K+ DFG +R +  
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 231

Query: 552 DQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEED 608
           D  ++          ++ PE      +T +SDV+SFGV+L E+ + G  P     ++E+
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 56/221 (25%), Positives = 89/221 (40%), Gaps = 54/221 (24%)

Query: 426 VKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 485
           ++K  V++ ++V     E  IL++ ++  VVKL     + +    V ++IP G +   + 
Sbjct: 34  LRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL- 92

Query: 486 DQNEDFPITWEMRLRIAI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
            + E FP   E+  R  I E++ A+  +H    I   HRDIK  NIL+D     K++DFG
Sbjct: 93  IRMEVFP---EVLARFYIAELTLAIESVHKMGFI---HRDIKPDNILIDLDGHIKLTDFG 146

Query: 545 ---------------------------------------ASRSMAVDQ----THMTTQVH 561
                                                    R   ++Q     H     H
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206

Query: 562 ---GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
              GT  Y+ PE      +T   D +S GV+L E+L G+ P
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)

Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLL-- 459
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 460 ---GCCLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 135

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 136 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 182

Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 46/215 (21%)

Query: 405 LGQGGQGTVYKGMLPDGKI---VAVKKSKVIDESKVE--EFINEMVILSQINHRNVVKLL 459
           +G G  G+V      D ++   VAVKK     +S +       E+ +L  + H NV+ LL
Sbjct: 23  VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 460 -----GCCLE--TEVPL---LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
                   +E   EV L   L+   + N    Q + D++  F I   +R          L
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR---------GL 131

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            Y+HSA    I HRD+K +N+ +++    ++ DFG +R    + T          GY+  
Sbjct: 132 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT----------GYVAT 178

Query: 570 EYFRSSQ-------FTDKSDVYSFGVVLAELLTGE 597
            ++R+ +       +    D++S G ++AELL G+
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 13/170 (7%)

Query: 431 VIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP--NGTLFQYIHDQN 488
           VI   +      E  IL  INH ++++L G     +   L+   +P     L+ Y+  + 
Sbjct: 121 VIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAK- 176

Query: 489 EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 548
            +  I  ++ L I   V  A+ YLH      I HRDIK+ NI ++      + DFGA+  
Sbjct: 177 RNIAIC-DI-LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-C 230

Query: 549 MAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGE 597
             VD   +      GT     PE      +    D++S G+VL E+ T  
Sbjct: 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 51/220 (23%)

Query: 405 LGQGGQGTVYKGMLPDGKI---VAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLL 459
           +G G  GTV   +  D +    VA+KK     +S++  +    E+ +L  + H NV+ LL
Sbjct: 23  VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 460 GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITW-----------------EMRLRIA 502
                         F P+ +L     D+  DF +                   E R++  
Sbjct: 81  DV------------FTPDLSL-----DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFL 123

Query: 503 I-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
           + ++   L Y+H+A    I HRD+K  N+ +++    K+ DFG +R      + MT  V 
Sbjct: 124 VYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT---DSEMTGYVV 177

Query: 562 GTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPI 600
            T  Y  PE   +   +T   D++S G ++AE+LTG KP+
Sbjct: 178 -TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPL 215

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 22/220 (10%)

Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVE-EFINEMVILSQINHRNVVKLLGCCL 463
           +G+G  G VYK    DGK       K I+ + +      E+ +L ++ H NV+ L    L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 464 ---ETEVPLLVYEFIPNGTL----FQYIHDQNED-FPITWEMRLRIAIEVSGALSYLHSA 515
              + +V LL +++  +       F      N+    +   M   +  ++   + YLH+ 
Sbjct: 69  SHSDRKVWLL-FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 516 ASIPIYHRDIKSTNILL----DDKYRAKVSDFGASR--SMAVDQTHMTTQVHGTFGYLDP 569
               + HRD+K  NIL+     ++ R K++D G +R  +  +        V  TF Y  P
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 570 EYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPIRFTTLEED 608
           E    ++ +T   D+++ G + AELLT E PI F   +ED
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE-PI-FHCRQED 222

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 43/150 (28%), Positives = 61/150 (40%), Gaps = 24/150 (16%)

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+V L    +  +   LV +    G L+ +I        I  E   R A E+  AL  LH
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDALH 102

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-------AVDQTHMTTQVHGTFGY 566
                 I  RD+   NILLDD+   +++ F     +       AV+             Y
Sbjct: 103 REG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----------Y 148

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTG 596
             PE    S+ T+  D +S G +L ELLTG
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 25/241 (10%)

Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVE-EFINEMVILSQINHRNVVKLLGCCL 463
           +G+G  G VYK    DGK       K I+ + +      E+ +L ++ H NV+ L    L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 464 ---ETEVPLLVYEFIPNGTL----FQYIHDQNEDFPITWE--MRLRIAIEVSGALSYLHS 514
              + +V LL +++  +       F      N+  P+     M   +  ++   + YLH+
Sbjct: 69  SHADRKVWLL-FDYAEHDLWHIIKFHRASKANKK-PVQLPRGMVKSLLYQILDGIHYLHA 126

Query: 515 AASIPIYHRDIKSTNILL----DDKYRAKVSDFGASR--SMAVDQTHMTTQVHGTFGYLD 568
                + HRD+K  NIL+     ++ R K++D G +R  +  +        V  TF Y  
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 569 PEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
           PE    ++ +T   D+++ G + AELLT E PI     E+ K+   Y    +  +R+F +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPYHHDQL--DRIFNV 240

Query: 628 L 628
           +
Sbjct: 241 M 241

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 34/118 (28%), Positives = 61/118 (51%), Gaps = 11/118 (9%)

Query: 487 QNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 546
           + ++  +  E  L  + +V+  +S+L S   I   HRD+ + NILL      K+ DFG +
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLA 261

Query: 547 RSMAVDQTHMTTQVHGT----FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           R +  D  ++   V G       ++ PE   +  +T +SDV+S+G++L E+ + G  P
Sbjct: 262 RDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 30/111 (27%), Positives = 60/111 (54%), Gaps = 8/111 (7%)

Query: 488 NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 547
           NE   +++   +  + +V+  + +L S   +   HRD+ + N+L+ +    K+ DFG +R
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNVLICEGKLVKICDFGLAR 287

Query: 548 SMAVDQTHMTTQVHGTF---GYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
            +  D  +++     TF    ++ PE   ++ +T  SDV+SFG++L E+ T
Sbjct: 288 DIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.9 bits (114), Expect = 2e-05
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 20/160 (12%)

Query: 397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           + F + + + +G  G VY G    + K+ AVK   K+ +I+++ V +   E   L+    
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-----DQNEDFPITWEMRLRIAIEVSG 507
             +V L           LV E++  G +   +H     D+        EM ++   EV+ 
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVKYISEVAL 115

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 547
           AL YLH      I HRD+K  N+L+ ++   K++DFG S+
Sbjct: 116 ALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 62/255 (24%), Positives = 97/255 (38%), Gaps = 62/255 (24%)

Query: 403 RILGQGGQGTVYKGMLPDGKIV----AVKKSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           + LG G  G V      D K +     ++K  V+  ++V     E  IL++ ++  VV+L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQN---EDFPITWEMRLRIAIEVSGALSYLHSA 515
                + +    V ++IP G +   +       ED       R  IA E++ A+  +H  
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLA-----RFYIA-ELTCAVESVHKM 120

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGAS------------------RSMAVD----- 552
             I   HRDIK  NIL+D     K++DFG                    R  ++D     
Sbjct: 121 GFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 553 --------------------QTHMTTQVH---GTFGYLDPEYFRSSQFTDKSDVYSFGVV 589
                               + H     H   GT  Y+ PE    + +T   D +S GV+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237

Query: 590 LAELLTGEKPIRFTT 604
           L E+L G+ P    T
Sbjct: 238 LYEMLVGQPPFLAQT 252

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 22/200 (11%)

Query: 399 FNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           F ++R L  G +G V++   PD     V K+     S     ++E  +L +++H  V+ L
Sbjct: 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASS-----VHEARLLRRLSHPAVLAL 225

Query: 459 LGCCLETEVPLLVYEFIP--NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           L   +   +  LV   +P     L+ Y+  +    P+       +A ++  A+ Y+H   
Sbjct: 226 LDVRVVGGLTCLV---LPKYRSDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG 280

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLD---PEYF 572
              I HRDIK+ N+L++      + DFGA+      +   +T  H G  G +D   PE  
Sbjct: 281 ---IIHRDIKTENVLVNGPEDICLGDFGAA---CFARGSWSTPFHYGIAGTVDTNAPEVL 334

Query: 573 RSSQFTDKSDVYSFGVVLAE 592
               +T   D++S G+V+ E
Sbjct: 335 AGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 8/100 (8%)

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
           L    +V+  + +L S   +   HRD+ + N+LL      K+ DFG +R +  D  +++ 
Sbjct: 240 LSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296

Query: 559 QVHGTF---GYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
               TF    ++ PE    + +T  SDV+S+G++L E+ +
Sbjct: 297 G--STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.2 bits (107), Expect = 8e-05
 Identities = 35/119 (29%), Positives = 58/119 (48%), Gaps = 8/119 (6%)

Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYK----GMLPDGKI--VAVKKSKV-ID 433
           I+ T+L  +++ E   DN    + LG G  G V +    G+  +  +  VAVK  K    
Sbjct: 22  IDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH 81

Query: 434 ESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF 491
             + E  ++E+ ILS +  H+N+V LLG C      L++ E+   G L  ++  + E F
Sbjct: 82  TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 10/108 (9%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSK-VIDESKVEEFINEM 444
           E   D   L RILG G  G V +G         P  K VAVK  K     S+ +  ++E+
Sbjct: 33  EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMK-VAVKMLKPTARSSEKQALMSEL 91

Query: 445 VILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF 491
            I++ +  H N+V LLG C ++    ++ E+   G L  Y+H   ++F
Sbjct: 92  KIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 29/114 (25%), Positives = 48/114 (42%), Gaps = 22/114 (19%)

Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD----------------DKYRAKVSDF 543
           +I  +   AL Y H+   + + H D+K  NIL++                D  R ++ D 
Sbjct: 235 QIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292

Query: 544 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGE 597
           G       D+ H  T +  T  Y  PE      +   +D++S G ++ EL TG+
Sbjct: 293 GG----CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 31/103 (30%), Positives = 44/103 (42%), Gaps = 17/103 (16%)

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF---------GASRSMAVDQTHMTT 558
            L+YLH    I   HR+IK+++IL+       +S           G    +  D    +T
Sbjct: 113 GLNYLHQNGYI---HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169

Query: 559 QVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLAELLTGEKP 599
            V     +L PE  R     +  KSD+YS G+   EL TG  P
Sbjct: 170 SV---LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 33/119 (27%), Positives = 54/119 (45%), Gaps = 8/119 (6%)

Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQG-----TVYKGMLPDGKI-VAVKKSKVIDE 434
           I+ T+L    + E   +  +  + LG G  G     T Y     D  + VAVK  K    
Sbjct: 19  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH 78

Query: 435 S-KVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF 491
             + E  ++E+ +LS + NH N+V LLG C      L++ E+   G L  ++  + + F
Sbjct: 79  LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	684
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
PF13947	106	GUB_WAK_bind: Wall-associated receptor kinase gala	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
PRK10345	210	hypothetical protein; Provisional	99.77
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.72
smart00090	237	RIO RIO-like kinase.	99.7
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
PF08488	103	WAK: Wall-associated kinase; InterPro: IPR013695 T	99.31
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.27
KOG1243	690	consensus Protein kinase [General function predict	99.25
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.25
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.22
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.18
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.16
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.09
KOG3087	229	consensus Serine/threonine protein kinase [General	99.08
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.08
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.04
COG4248	637	Uncharacterized protein with protein kinase and he	99.03
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.85
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.84
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.69
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.68
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.56
PRK09902	216	hypothetical protein; Provisional	98.51
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.37
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.28
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.28
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.16
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.15
PF01636	239	APH: Phosphotransferase enzyme family This family	98.12
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.09
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.06
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.98
PLN02876	822	acyl-CoA dehydrogenase	97.93
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.89
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.73
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.69
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.67
PRK10593	297	hypothetical protein; Provisional	97.67
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.64
KOG1219	4289	consensus Uncharacterized conserved protein, conta	97.59
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.4
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.38
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.34
PRK05231	319	homoserine kinase; Provisional	97.27
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.17
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.15
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.1
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.06
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.83
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.79
PLN02236	344	choline kinase	96.67
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.53
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.29
PRK12396	409	5-methylribose kinase; Reviewed	96.05
PLN02756	418	S-methyl-5-thioribose kinase	96.03
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.84
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.84
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.77
KOG2270	520	consensus Serine/threonine protein kinase involved	95.76
PF12662	24	cEGF: Complement Clr-like EGF-like	95.67
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.67
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.24
KOG1214	1289	consensus Nidogen and related basement membrane pr	95.22
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.12
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.08
COG2334	331	Putative homoserine kinase type II (protein kinase	94.37
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.36

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-53  Score=453.67  Aligned_cols=291  Identities=46%  Similarity=0.756  Sum_probs=258.0

Q ss_pred             ccccCCHHHHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeee
Q 043157          383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCC  462 (684)
Q Consensus       383 ~~~~~~~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  462 (684)
                      ..+.|+++++..+|++|...++||+|+||+||+|.+++++.||||++.........+|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56679999999999999999999999999999999999999999988765443145599999999999999999999999


Q ss_pred             eecCc-ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEe
Q 043157          463 LETEV-PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS  541 (684)
Q Consensus       463 ~~~~~-~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~  541 (684)
                      .+.+. .+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+...++|+||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99994 99999999999999999987654 79999999999999999999999998889999999999999999999999


Q ss_pred             ccCCcccccc-CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh
Q 043157          542 DFGASRSMAV-DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK  620 (684)
Q Consensus       542 DFgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~  620 (684)
                      |||+++.... ........ .||.+|+|||++..+..+.|+|||||||+|+||+||++|...........+..|+...+.
T Consensus       220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999976554 22222211 799999999999999999999999999999999999999887665555668999888888


Q ss_pred             hhhhhhhhhhhhh-ccCCh-hHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          621 EERLFEILDARVM-KESGG-DEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       621 ~~~~~~~~d~~~~-~~~~~-~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      ..++.+++|+++. ..... +....+..++.+|++.+|++||+|.||+++|+.+...
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            8899999999986 45443 6788899999999999999999999999999776643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-47  Score=381.34  Aligned_cols=251  Identities=28%  Similarity=0.406  Sum_probs=214.0

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc-ceEEEEec
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEV-PLLVYEFI  475 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lv~E~~  475 (684)
                      .+..+.||+|..|+|||+.++ +++.+|+|.+.. .++...+++.+|+++++..+||+||+++|.|..... ..|+||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            344788999999999999976 688999999854 556678899999999999999999999999999995 99999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      ++|+|.+++...+.   +++....+|+.+|++||.|||+ ++   |+||||||+||||+..|.|||+|||.++...+.  
T Consensus       161 DgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  161 DGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             CCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            99999999997643   9999999999999999999996 66   999999999999999999999999999887654  


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                       ...+..||..|||||.+.+..|+.++||||||++++|+++|+.||..... ......         +-+..+++... .
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~---------~Ll~~Iv~~pp-P  300 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIF---------ELLCAIVDEPP-P  300 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHH---------HHHHHHhcCCC-C
Confidence             55677899999999999999999999999999999999999999985411 111111         11223333222 2


Q ss_pred             cCCh-hHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          635 ESGG-DEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       635 ~~~~-~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .++. .++.++++++..||+.||.+||+++|++++=
T Consensus       301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            3344 4899999999999999999999999999874

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-46  Score=392.35  Aligned_cols=260  Identities=34%  Similarity=0.571  Sum_probs=217.2

Q ss_pred             CCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecC-cceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETE-VPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lv~E~  474 (684)
                      .+...+.||+|+||+||+|.+.....||||++....  ....+.|.+|+.+|++++|||||+++|++.+.. ...+||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            345566799999999999999766669999887633  333679999999999999999999999999888 78999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-cEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgl~~~~~~~~  553 (684)
                      +++|+|.++++.. ....+++..+++++.|||+||.|||+.+.  ||||||||+||||+.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999999985 23459999999999999999999999984  99999999999999997 99999999998765433


Q ss_pred             ceeeecccccCCCCCccccc--cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFR--SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                       ...+...||+.|||||++.  ...|+.|+||||||++||||+||+.||.......   .            ...+....
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~------------~~~v~~~~  262 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---V------------ASAVVVGG  262 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---H------------HHHHHhcC
Confidence             2233367999999999999  5699999999999999999999999998554311   0            11122222


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .....+...+..+..|+.+||+.||++||++.|++..|+.+...-
T Consensus       263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            233444557888999999999999999999999999999888643

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=394.06  Aligned_cols=259  Identities=29%  Similarity=0.459  Sum_probs=230.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ..+++.+.||+|.||+||+|.++....||+|.++... ...+.|.+|+++|++|+|+|||++++++..++..+||||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            3456678999999999999999888899999887653 334788999999999999999999999999899999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      .|+|.++|+... ...+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+||||++...++....
T Consensus       285 ~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  285 KGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             cCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            999999999832 234899999999999999999999999   9999999999999999999999999999766677666


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....-+..|.|||.+....++.|||||||||+||||+| |+.|+...+                ..++.+.++...+..
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms----------------n~ev~~~le~GyRlp  424 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS----------------NEEVLELLERGYRLP  424 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC----------------HHHHHHHHhccCcCC
Confidence            666667889999999999999999999999999999999 888887443                444566777777777


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .|..++.++.+|+..||+.+|++|||++.+...|+.+...+
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            88899999999999999999999999999999999987654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=372.69  Aligned_cols=204  Identities=32%  Similarity=0.540  Sum_probs=185.9

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .++|.+.+.||+|+|++||+|+++ ++..||||.+...  ..+.++.+..|+.+|+.++|||||+++++++..+..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457889999999999999999965 6899999987654  6677888999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC------CcEEEeccCCc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK------YRAKVSDFGAS  546 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~------~~~kl~DFgl~  546 (684)
                      |||.+|+|.+||++++.   +++...+.++.|||.||++||+++   |+||||||+||||+..      ..+||+|||++
T Consensus        89 EyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999998764   999999999999999999999999   9999999999999764      56899999999


Q ss_pred             cccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE  607 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~  607 (684)
                      +...  ......+..|++-|||||++...+|+.|+|+||+|++|||+++|+.||...+..+
T Consensus       163 R~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  163 RFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             hhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            9875  3445667889999999999999999999999999999999999999998766544

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-45  Score=389.28  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=216.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ..|...+.||+|||+.+|.++. ..|+.||+|.+..   ....+.+.+.+||++.++|+|||||+++++|++.+..|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4699999999999999999996 8899999997654   45667788999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      |++++++|.+++++.+   +++|.+++.+..||+.||.|||+++   |+|||||..|+||+++.++||+|||||.....+
T Consensus        98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999998543   5999999999999999999999999   999999999999999999999999999877644


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                       .+...+..|||.|+|||++.....+..+||||+||+||.||+|++||+..+..+.-.               .+.... 
T Consensus       172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~---------------~Ik~~~-  234 (592)
T KOG0575|consen  172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN---------------KIKLNE-  234 (592)
T ss_pred             -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH---------------HHHhcC-
Confidence             345567789999999999999999999999999999999999999998655443211               111111 


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       -..|...+.+.++||.++|+.||.+|||+++|+++
T Consensus       235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             12334667789999999999999999999999976

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-46  Score=360.04  Aligned_cols=255  Identities=27%  Similarity=0.413  Sum_probs=209.7

Q ss_pred             CCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceee-eeeecC-cceEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLG-CCLETE-VPLLVY  472 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~-~~~~~~-~~~lv~  472 (684)
                      .|++.++||.|.||+||++. +.+|+.+|.|+++-  .+....++...|+.+|++|+|||||++++ -+.++. ..+|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            47888999999999999998 66899999998764  55677888999999999999999999998 444444 489999


Q ss_pred             EecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          473 EFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALSYLHSAA-SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       473 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~-~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      |++.+|+|..+++.- +....+++..+|+++.|++.||+.+|++- +..|+||||||.||||+.+|.|||+||||++...
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            999999999999863 33445999999999999999999999821 1239999999999999999999999999999876


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ...+ ......|||.||+||.+....|+.||||||+||++|||..-++||.+....+                +.+.+..
T Consensus       180 s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~----------------L~~KI~q  242 (375)
T KOG0591|consen  180 SKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS----------------LCKKIEQ  242 (375)
T ss_pred             chhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH----------------HHHHHHc
Confidence            5444 4555679999999999999999999999999999999999999998653221                1111111


Q ss_pred             hhhccCC-hhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          631 RVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       631 ~~~~~~~-~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .-....+ ..++.++.+||..|+..||+.||+.-.++..+
T Consensus       243 gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  243 GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            1112233 56788999999999999999999954444443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-45  Score=370.84  Aligned_cols=253  Identities=26%  Similarity=0.394  Sum_probs=208.5

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC-------hhHHHHHHHHHHHHhhcCCCcccceeeeeeecC
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID-------ESKVEEFINEMVILSQINHRNVVKLLGCCLETE  466 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  466 (684)
                      ..+.|.+.+.||+|+||.|-+|.. ++|+.||||++....       ........+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456788999999999999999984 589999999875421       112334579999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC---CcEEEecc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDF  543 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DF  543 (684)
                      ..||||||++||+|.+.+-.++.   +.+..-..++.|++.|+.|||+.+   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999999987754   778888899999999999999999   9999999999999765   78999999


Q ss_pred             CCccccccCCceeeecccccCCCCCccccccCC---CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh
Q 043157          544 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK  620 (684)
Q Consensus       544 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~  620 (684)
                      |+|+...  ......+..||+.|.|||++.+..   +..|+|+||+||+||-+|+|.+||.....+.  ++.+       
T Consensus       324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e-------  392 (475)
T KOG0615|consen  324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE-------  392 (475)
T ss_pred             chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH-------
Confidence            9999765  455677889999999999997654   3358999999999999999999998543221  1111       


Q ss_pred             hhhhhhhhhhhhh--ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          621 EERLFEILDARVM--KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       621 ~~~~~~~~d~~~~--~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                           ++...+..  ...+.+.+++..+||.+||..||++|||+.|++++=
T Consensus       393 -----QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  393 -----QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             -----HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence                 12222211  122356778899999999999999999999998763

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-45  Score=365.43  Aligned_cols=242  Identities=28%  Similarity=0.418  Sum_probs=207.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .+.|++.++||+|+||+||+++.+ +++.+|+|.++.   ....+.+..+.|..+|.+++||.||+++..|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999854 689999997754   4455678899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      +||+.||.|..+|++.+.   +++..+..++.+|+.||.|||+++   |+||||||+|||||++|+++|+||||++....
T Consensus       104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            999999999999997764   999999999999999999999999   99999999999999999999999999987554


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ... .+.+..||+.|||||++.+..|+..+|.||||+++|||++|.+||...+...-                .+.+...
T Consensus       178 ~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~----------------~~~I~~~  240 (357)
T KOG0598|consen  178 DGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM----------------YDKILKG  240 (357)
T ss_pred             CCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH----------------HHHHhcC
Confidence            333 34557899999999999999999999999999999999999999986543221                1111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCC
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRP  660 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RP  660 (684)
                      .....+.-.+.+.++|+.+.|+.||++|-
T Consensus       241 k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  241 KLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             cCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            12233344677899999999999999995

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.3e-44  Score=393.10  Aligned_cols=264  Identities=28%  Similarity=0.464  Sum_probs=225.7

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEeccccChh-HHHHHHHHHHHHhhcCCCcccceeeeeeecCc
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVIDES-KVEEFINEMVILSQINHRNVVKLLGCCLETEV  467 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  467 (684)
                      ...+..+.+.||+|+||+||+|+..      +...||||.++..... ..++|.+|+++|..++|||||+|+|.|.+++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            4456777899999999999999843      3458999999876655 78999999999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNE-----------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY  536 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~  536 (684)
                      .+||+|||..|||.++|.....           ..+|+..+.+.||.|||.||+||-+++   ++||||..+|.||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence            9999999999999999986432           234889999999999999999999999   99999999999999999


Q ss_pred             cEEEeccCCccccccCCceeee-cccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHH
Q 043157          537 RAKVSDFGASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAY  614 (684)
Q Consensus       537 ~~kl~DFgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~  614 (684)
                      .|||+||||++.....+.++.. ...-+.+||+||.+..+.++.+||||||||+|||+++ |+-||.....++       
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------  713 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------  713 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------
Confidence            9999999999987665555443 3345789999999999999999999999999999998 999988655433       


Q ss_pred             HHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          615 FLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       615 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                               +.+.+..+-.-+.+..++.++.+|+..||+.+|++||+++||-..|+..-....
T Consensus       714 ---------VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  714 ---------VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             ---------HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence                     222222222245578899999999999999999999999999999988765443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-43  Score=367.64  Aligned_cols=250  Identities=26%  Similarity=0.437  Sum_probs=215.5

Q ss_pred             cCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      ..|...++||+|+.|.||.+. ..+++.||||++........+-+++|+.+|+..+|+|||++++.+...+.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            357778899999999999998 4578899999999888888889999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++|+|.+++....    +++.++..|..++++||+|||.++   |+|||||.+|||++.++.+||+|||++........ 
T Consensus       353 ~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            9999999998654    899999999999999999999999   99999999999999999999999999988776655 


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ...+..||+.|||||+.....|+.|.||||||++++||+-|.+||-..+     .+.+..+  +..+-       .....
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----PlrAlyL--Ia~ng-------~P~lk  490 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLRALYL--IATNG-------TPKLK  490 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----hHHHHHH--HhhcC-------CCCcC
Confidence            3445569999999999999999999999999999999999999997422     1111111  11110       11112


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+...+..+++++.+||+.|+++||+++|||++
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            345678899999999999999999999999986

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-42  Score=338.72  Aligned_cols=265  Identities=23%  Similarity=0.314  Sum_probs=209.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|+..-++|+|+||+||+.+.+ +|++||||++....  +.-.+-.++|+++|++++|||+|.++.+|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45777889999999999999966 69999999986543  3345667899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |++. ++.+-|++....  ++.+.+.+++.|+++|+.|+|+++   ++||||||+||||+.++.+||+|||+|+....+ 
T Consensus        82 ~~dh-TvL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-  154 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNG--VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-  154 (396)
T ss_pred             ecch-HHHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence            9977 455555554443  899999999999999999999999   999999999999999999999999999987653 


Q ss_pred             ceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH--------Hhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF--------AMKEERL  624 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~--------~~~~~~~  624 (684)
                      ....+....|.+|.|||++.+ .+|+..+|||++||++.||++|.+-|.+....++-.++....-        ....+..
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            334556678999999999877 7899999999999999999999999987765443322221110        0011111


Q ss_pred             ------hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 ------FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ------~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                            .+.-++...+..-+..+..+.+|++.||+.||++|++.+|++.+
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence                  11111111112223445678999999999999999999999864

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=354.37  Aligned_cols=257  Identities=29%  Similarity=0.448  Sum_probs=211.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC--cceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETE--VPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lv~  472 (684)
                      ..++...+.||+|.||+||++... +|+..|||.....+....+.+.+|+.+|++++|||||+++|.....+  ...++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            345778899999999999999965 48999999887765555788999999999999999999999855554  588999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCcEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgl~~~~~~  551 (684)
                      ||+++|+|.+++.+.+.  .|++..++++..||++||+|||+++   |+||||||+||||+. ++.+||+|||+++....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999998764  4999999999999999999999999   999999999999999 79999999999987653


Q ss_pred             --CCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          552 --DQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       552 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                        ..........||+.|||||++..+ ....++|||||||++.||+||++||... .+    .         ...+..+.
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~----~---------~~~~~~ig  236 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FE----E---------AEALLLIG  236 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cc----h---------HHHHHHHh
Confidence              222334457799999999999863 3345999999999999999999999742 00    0         01112222


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      ........+...+.+..+++.+|++.||++|||++|++++.--
T Consensus       237 ~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  237 REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            2222224556678889999999999999999999999998743

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=360.69  Aligned_cols=253  Identities=29%  Similarity=0.402  Sum_probs=215.5

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc---cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcc
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV---IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  468 (684)
                      +...+|.+++.||+|+|++|++++. ++++.+|||++..   ..+..++.+..|-.+|.+| .||.|++|+..|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            3446799999999999999999994 5799999997653   4455667788899999999 899999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      |+|+||+++|+|.++|++.+.   +++...+.++.||+.||+|||+.+   ||||||||+|||||+++++||+|||.++.
T Consensus       150 YFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            999999999999999998764   999999999999999999999999   99999999999999999999999999988


Q ss_pred             cccCCce----------e--eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH
Q 043157          549 MAVDQTH----------M--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL  616 (684)
Q Consensus       549 ~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~  616 (684)
                      +......          .  ...+.||..|.+||++.....+..+|+|+||||||+|+.|++||.+...-.         
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---------  294 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---------  294 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---------
Confidence            7532221          1  145789999999999999999999999999999999999999998543111         


Q ss_pred             HHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       617 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                            ...++++  +.-+++...++.+.+|+++.|..||.+|+|.+|+.++.
T Consensus       295 ------iFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  295 ------IFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ------HHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                  0111221  12345567778999999999999999999999988764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=346.83  Aligned_cols=263  Identities=25%  Similarity=0.402  Sum_probs=212.2

Q ss_pred             HhcCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ..+.|++.+.||.|.-++||+|. .+.++.||||++...+ ...++.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            34679999999999999999998 5678999999987632 344789999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      .||.+|++.++++..-.. .+++..+..|.+++++||.|||+++   .||||||+.||||+++|.|||+|||.+..+...
T Consensus       104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            999999999999986443 3999999999999999999999999   999999999999999999999999988776543


Q ss_pred             Cce---eeecccccCCCCCcccccc--CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          553 QTH---MTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       553 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ...   ...+..||+.|||||++..  ..|+.|+||||||++..||.+|..||.....-  +.|..    .++.. ....
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~----tLqn~-pp~~  252 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLL----TLQND-PPTL  252 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHH----HhcCC-CCCc
Confidence            322   1255689999999999543  56999999999999999999999999844321  11111    11110 0000


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .-.....+........+++++..||+.||++|||+++++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            00011112223456689999999999999999999999875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-41  Score=360.46  Aligned_cols=263  Identities=27%  Similarity=0.450  Sum_probs=209.2

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe------CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecC
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETE  466 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~  466 (684)
                      ..++|++.++||+|+||.||+|.+      .+++.||+|+++.. .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            346799999999999999999974      23568999988653 234457799999999999 8999999999887654


Q ss_pred             -cceEEEEecCCCCHHHHHhhcCC--------------------------------------------------------
Q 043157          467 -VPLLVYEFIPNGTLFQYIHDQNE--------------------------------------------------------  489 (684)
Q Consensus       467 -~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------  489 (684)
                       ..+++|||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             57899999999999999975321                                                        


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce-eeecccccCC
Q 043157          490 ---DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFG  565 (684)
Q Consensus       490 ---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~  565 (684)
                         ..++++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++........ ......+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               134888899999999999999999998   999999999999999999999999999865432221 1223346778


Q ss_pred             CCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHH
Q 043157          566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITF  644 (684)
Q Consensus       566 y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  644 (684)
                      |+|||++.+..++.++||||||++||||++ |..||......+.  +.    ......         .....+...+..+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~---------~~~~~~~~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC----QRLKDG---------TRMRAPENATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----HHHhcC---------CCCCCCCCCCHHH
Confidence            999999999999999999999999999997 9999975432211  10    111111         1111233456789


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          645 AKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       645 ~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .+|+.+||+.||++|||+.|+++.|+.+...
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-41  Score=353.09  Aligned_cols=265  Identities=29%  Similarity=0.386  Sum_probs=213.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeec--CcceE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l  470 (684)
                      .+.|+..++||+|.||.||+++ ..+|++||+|++....  ++...-..+||.||++|+||||++|.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3457778899999999999999 5689999999987644  45566778999999999999999999999887  68999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      |+|||++ +|.-++....-  .+++.++..++.||+.||+|+|+++   |+|||||.+|||||.+|.+||+|||||+.+.
T Consensus       196 VFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999976 88888876433  4999999999999999999999999   9999999999999999999999999999887


Q ss_pred             cCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH-hh-hh-----
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA-MK-EE-----  622 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~-~~-~~-----  622 (684)
                      .......+...-|+.|.|||++.+ ..|+.+.|+||.||||.||++|++.|++.+..++  +...|... .. +.     
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ--l~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ--LHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH--HHHHHHHhCCCChhccccc
Confidence            766666666778999999999876 5799999999999999999999999998775443  22222211 01 11     


Q ss_pred             hhh--hhhhh-----hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          623 RLF--EILDA-----RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       623 ~~~--~~~d~-----~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ++.  ..+.+     +...+.....+....+|+..+|..||++|.|+.++++.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            111  11100     01111123456778899999999999999999998864

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=359.52  Aligned_cols=269  Identities=27%  Similarity=0.499  Sum_probs=218.4

Q ss_pred             CHHHHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec
Q 043157          388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLET  465 (684)
Q Consensus       388 ~~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  465 (684)
                      ..+++++..+.+.+.+.||+|.||+||+|.|..  .||||++..  -.+++.+.|++|+.++++-+|.||+-+.|++...
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            346677777788899999999999999999865  389998776  3456889999999999999999999999999988


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                      .. .||..+++|.+|+.+||..+.+  ++....+.||+||++||.|||.++   |||||||+.||||.+++.|||+||||
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etk--fdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETK--FDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhh--hhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence            77 9999999999999999987654  889999999999999999999999   99999999999999999999999999


Q ss_pred             cccccc-CCceeeecccccCCCCCcccccc---CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 043157          546 SRSMAV-DQTHMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE  621 (684)
Q Consensus       546 ~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~  621 (684)
                      +..-.. ..........|...|||||++..   .+|+..|||||||+++|||+||..||. ....++      ++++...
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq------IifmVGr  607 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ------IIFMVGR  607 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh------eEEEecc
Confidence            865321 12222333457889999999854   568999999999999999999999998 222111      1111221


Q ss_pred             hhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       622 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      +-+.    ++ ......+.+.++.+|+..||..++++||.+.+|+..|+.+..+.
T Consensus       608 G~l~----pd-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  608 GYLM----PD-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             cccC----cc-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            1110    11 11223567889999999999999999999999999888877643

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-41  Score=326.58  Aligned_cols=236  Identities=29%  Similarity=0.399  Sum_probs=206.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|+..+.||.|+||+|.+++.+ +|..+|+|.+..   ....+++...+|..+|+.+.||.++++.+.+.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45888999999999999999965 688999998764   45677888999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||++||.|.++|++.++   ++++.++.+|.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+++.... 
T Consensus       124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-  196 (355)
T ss_pred             eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence            99999999999998654   999999999999999999999999   99999999999999999999999999987643 


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                         .+-+..|||.|+|||+++...++.++|.|+|||++|||+.|.+||.......               ....|+..++
T Consensus       197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---------------iY~KI~~~~v  258 (355)
T KOG0616|consen  197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---------------IYEKILEGKV  258 (355)
T ss_pred             ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---------------HHHHHHhCcc
Confidence               2556789999999999999999999999999999999999999998554311               1123333322


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCC
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKR  659 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~R  659 (684)
                        ..|...+.++++|+...|+.|-.+|
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence              3456677889999999999999988

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=350.81  Aligned_cols=267  Identities=24%  Similarity=0.337  Sum_probs=209.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChh-HHHHHHHHHHHHhhcC-CCcccceeeeeeecC-cceE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDES-KVEEFINEMVILSQIN-HRNVVKLLGCCLETE-VPLL  470 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~-~~~l  470 (684)
                      ..++|.+.++||.|.||.||+|+. .+++.||||+++..-.. +.-.-++|++.|++|+ ||||+++..++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            346799999999999999999994 57999999998753322 2233468999999998 999999999999988 8999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      |||||+ -+|.++++++  +.++++..++.|+.||++||+|+|.+|   ++|||+||+|||+.....+||+|||+||...
T Consensus        88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            999995 5999999987  346999999999999999999999999   9999999999999988899999999999875


Q ss_pred             cCCceeeecccccCCCCCcccc-ccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh----
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYF-RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF----  625 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~----  625 (684)
                      ....  .+....|..|.|||++ +..-|+.+.|||++|+|++|+.+-++-|.+...-++-.-...++-......+.    
T Consensus       162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            4333  4455678899999986 45779999999999999999999999998765432221111111111111111    


Q ss_pred             --hhhhhhh-------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          626 --EILDARV-------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       626 --~~~d~~~-------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                        ..+.-+.       ...+-...+.+..+|+.+||++||++|||++|.+++-
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence              1111111       1112234678899999999999999999999999864

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=385.01  Aligned_cols=262  Identities=29%  Similarity=0.508  Sum_probs=220.9

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC--Cc----EEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD--GK----IVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~--g~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      ..+.++.+.||+|+||+||.|...+  +.    .||||.++. .+.++..+|.+|..+|+.++|||||+++|++.+...+
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4567788999999999999999643  43    489998765 5677889999999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          469 LLVYEFIPNGTLFQYIHDQNE----DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                      ++++|||++|+|..+|++.+.    ...|+....+.++.|||+|+.||++++   +|||||..+|+||++...|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999998621    235899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCceeeecc-cccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          545 ASRSMAVDQTHMTTQV-HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      +|+.....+....... .-+..|||||.+..+.++.|+|||||||+|||++| |..||...+..+-      +...+..+
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~gg  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLEGG  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHhCC
Confidence            9996655444433333 44579999999999999999999999999999999 8999875443221      11111111


Q ss_pred             hhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       623 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                                +.+.+..++..+.+|+.+||+.+|++||++..+++.+..+.+..
T Consensus       922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                      34456788999999999999999999999999999998887653

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.8e-41  Score=349.04  Aligned_cols=251  Identities=27%  Similarity=0.371  Sum_probs=207.2

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ..++|++.++||+|+||+||+++.+ +|+.+|+|+++.   ....+++.++.|..+|....+|+||+|+..|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999954 699999998875   345677889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||++||++..+|.+..   .|+++.+..++.+++.|++-||+.+   +|||||||+|+|||..|++||+||||+.-..
T Consensus       219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999999765   3999999999999999999999999   9999999999999999999999999985321


Q ss_pred             c-----------------------CCc----ee-------------------eecccccCCCCCccccccCCCCCccchh
Q 043157          551 V-----------------------DQT----HM-------------------TTQVHGTFGYLDPEYFRSSQFTDKSDVY  584 (684)
Q Consensus       551 ~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~ksDv~  584 (684)
                      .                       +..    ..                   .....|||.|||||++.+..|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                       000    00                   0123599999999999999999999999


Q ss_pred             hhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh--hccCChhHHHHHHHHHHHhhccCCCCCCC-
Q 043157          585 SFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV--MKESGGDEIITFAKVAKRCLNLNGKKRPT-  661 (684)
Q Consensus       585 SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~--~~~~~~~~~~~l~~Li~~cl~~dp~~RPt-  661 (684)
                      |||+|+||||.|.+||...+..+.-.               .++..+.  ........+.+..+||.++|. ||++|-. 
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~r---------------kI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYR---------------KIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHH---------------HHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            99999999999999999877654321               1111111  111123345788999999998 9999965 


Q ss_pred             --HHHHHH
Q 043157          662 --MREVTS  667 (684)
Q Consensus       662 --~~evl~  667 (684)
                        ++||.+
T Consensus       437 ~G~~EIK~  444 (550)
T KOG0605|consen  437 KGAEEIKK  444 (550)
T ss_pred             ccHHHHhc
Confidence              555544

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-40  Score=320.16  Aligned_cols=263  Identities=26%  Similarity=0.319  Sum_probs=212.1

Q ss_pred             cCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccccChh--HHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDES--KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|...++||+|.||.||+|. ..+|+.||||+++..+..  -.....+|++.|+.++|+||+.++++|...+..-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467778999999999999999 457999999998875332  24567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      ||+ .+|+..+++...  .++..++..++.++++||+|||++.   |+||||||+|+||+++|.+||+|||+++......
T Consensus        82 fm~-tdLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            996 599999987653  5999999999999999999999999   9999999999999999999999999999887554


Q ss_pred             ceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH--Hhhhhhhhhh---
Q 043157          554 THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF--AMKEERLFEI---  627 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~--~~~~~~~~~~---  627 (684)
                      ...... .-|..|.|||++.+ ..|+..+||||.|||+.||+-|.+-|.+.+.-++  +...|..  ...++.+.+.   
T Consensus       156 ~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  156 RIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             cccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHHHHcCCCCcccCcccccc
Confidence            443333 47889999999876 5799999999999999999999988887664443  3322221  1122222111   


Q ss_pred             hh--------hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          628 LD--------ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       628 ~d--------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .|        .......-...+.+..+|+.+||..||.+|.++.|++++
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11        111111224456778999999999999999999999976

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=358.59  Aligned_cols=264  Identities=32%  Similarity=0.484  Sum_probs=220.7

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEeCC--C--cE-EEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeee
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGMLPD--G--KI-VAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCL  463 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~--g--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  463 (684)
                      ++..-++..+.++||+|+||+||+|.+..  +  .. ||||..+.   ....++.+|++|.++|++++|||||+++|+..
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            33444566777999999999999999653  2  23 89998875   55788999999999999999999999999999


Q ss_pred             ecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEecc
Q 043157          464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF  543 (684)
Q Consensus       464 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF  543 (684)
                      .+..+++|||+++||+|.++|++...  .++..++.+++.+.|.||+|||++.   ++||||..+|+|++.+..+||+||
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF  306 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF  306 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence            99999999999999999999998765  3899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccccCCceeee-cccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhh
Q 043157          544 GASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKE  621 (684)
Q Consensus       544 gl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~  621 (684)
                      |+++...  ...... ...-+..|+|||.+....++.++|||||||++||+++ |..||......+..            
T Consensus       307 GLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~------------  372 (474)
T KOG0194|consen  307 GLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK------------  372 (474)
T ss_pred             ccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH------------
Confidence            9987643  111111 2235789999999999999999999999999999998 89999865543211            


Q ss_pred             hhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       622 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                         ..++........+...+.++..++.+||..+|++||+|.++.+.|+.+.....
T Consensus       373 ---~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  373 ---AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ---HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence               12223333344455778889999999999999999999999999998886544

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=366.63  Aligned_cols=257  Identities=25%  Similarity=0.442  Sum_probs=225.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC----CcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD----GKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ....+.++||.|.||+|++|.++-    ...||||.++. ..+.+..+|+.|..||.++.||||++|.|+.......+||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            456778999999999999999762    34799999987 4566778999999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      .|||++|+|+.+|+++..+  +++.++.-+++.||.||.||.+.+   ++||||..+|||++.+...|++||||+|...+
T Consensus       709 TEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            9999999999999987654  889999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCceeeecc--cccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          552 DQTHMTTQV--HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       552 ~~~~~~~~~--~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      +.....++.  .-+.+|.|||.+....++.+|||||||++|||.++ |.+||-.                +.+..+...+
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd----------------mSNQdVIkaI  847 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD----------------MSNQDVIKAI  847 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc----------------cchHHHHHHH
Confidence            553333333  23679999999999999999999999999999886 9999853                3344556666


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      +.......+.+++..+.+|+..||+.|-.+||.+.|++..|+++-+
T Consensus       848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            7777777789999999999999999999999999999999988765

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.2e-41  Score=348.73  Aligned_cols=247  Identities=28%  Similarity=0.450  Sum_probs=213.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+..  ..+.+++.+.+|+++++.++||||+.++++|+...+.|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            56888999999999999999965 688999997654  345667889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+.+ +|..+|...+.   ++++.+..++.+++.||.|||+.+   |+|||+||+||||+.++.+|++|||+++.+.. .
T Consensus        82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N  153 (808)
T ss_pred             hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence            9976 99999997654   999999999999999999999999   99999999999999999999999999998764 5


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      +.+.+.+.|||-|||||+..+.+|+..+|+||+||+|||+++|++||.....      .....         .|+...  
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~---------~I~~d~--  216 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVK---------SILKDP--  216 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHH---------HHhcCC--
Confidence            5567778899999999999999999999999999999999999999973221      11111         111111  


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+...+..+.+++...|..||.+|.|..+++.+
T Consensus       217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            11234677889999999999999999999998865

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.2e-39  Score=339.40  Aligned_cols=247  Identities=22%  Similarity=0.358  Sum_probs=202.4

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccCh---hHHHHHHHHHHHHhhcCCCcccceeeeeee----cCcceEEEEe
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE---SKVEEFINEMVILSQINHRNVVKLLGCCLE----TEVPLLVYEF  474 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lv~E~  474 (684)
                      ...||+|+++.||+|.+ +|+.||||+++....   ...+.+.+|+.+|++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            46899999999999998 688999998875332   225788899999999999999999999977    3467899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      +++|+|.+++.+..   .+++...++++.|++.||.|||+. +   ++||||||+|||+++++.+||+|||+++......
T Consensus       104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            99999999998653   388999999999999999999985 6   7799999999999999999999999987653321


Q ss_pred             ceeeecccccCCCCCcccccc--CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                          ....++..|+|||++.+  ..++.++||||||+++|||++|+.||...+..+.   ..            .+....
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~------------~i~~~~  238 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YD------------LIINKN  238 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HH------------HHHhcC
Confidence                12347889999999976  6899999999999999999999999975432211   11            010111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      .....+...+.++.+|+.+||+.||++|||++|+++.|++++.
T Consensus       239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            1112233567789999999999999999999999999998874

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=347.18  Aligned_cols=248  Identities=27%  Similarity=0.425  Sum_probs=215.4

Q ss_pred             CCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          398 NFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .|...+.||+|.||.||+|.. ..++.||+|.+... .+.+++++.+|+.+|.+++++||.++|+.+.....++++|||+
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            466678999999999999995 47899999998763 3456788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      .+|++.+.|+...   .+++..+.-+.++++.||.|||+++   .+|||||+.|||+..+|.+||+|||++-........
T Consensus        94 ~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             cCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999999998664   2588888889999999999999999   999999999999999999999999999877655554


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      . .++.||+.|||||+++...|+.|+||||||++.+||++|.+|+.....                .++.-++.+.....
T Consensus       168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~PP~  230 (467)
T KOG0201|consen  168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAPPR  230 (467)
T ss_pred             c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCCCc
Confidence            4 667799999999999988999999999999999999999999874332                23333344444444


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      +...++..+++++..||..||+.||++++++++
T Consensus       231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            455788889999999999999999999999876

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=355.75  Aligned_cols=253  Identities=28%  Similarity=0.511  Sum_probs=215.4

Q ss_pred             CcCceeceeCcEEEEEEEe-CCCc----EEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          400 NLNRILGQGGQGTVYKGML-PDGK----IVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       400 ~~~~~LG~G~~g~Vy~~~~-~~g~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      +..++||+|+||+||+|.+ ..|+    +||+|.+.. ...+...++++|+-+|.+|+|||+++|++++..+. +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3468999999999999985 4454    688887654 44556789999999999999999999999998776 889999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      ||+.|+|.++++.++..  +-.+..+.|..|||+||.|||.+.   ++||||..+|||+..-..+||.|||+++....+.
T Consensus       778 ~mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             hcccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            99999999999987654  888999999999999999999999   9999999999999999999999999999887655


Q ss_pred             ceee-ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          554 THMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       554 ~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .... ....-.+.|||-|.+....++.+||||||||++|||+| |..|+.....++..                +++...
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~----------------dlle~g  916 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP----------------DLLEKG  916 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh----------------HHHhcc
Confidence            4433 23344678999999999999999999999999999998 99999876655533                333333


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      .+...++.++.++..++.+||..|++.||+++|+..++.++-+
T Consensus       917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            3344567889999999999999999999999999999976653

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.1e-40  Score=336.99  Aligned_cols=255  Identities=20%  Similarity=0.366  Sum_probs=207.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC----CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP----DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|++.+.||+|+||.||+|.++    .+..||+|..+.. .......+.+|+.++++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46889999999999999999853    3568999988764 334457799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++|+|.+++.....  .+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999986533  4899999999999999999999999   99999999999999999999999998765432


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ..........++..|+|||.+....++.++||||||+++||+++ |+.||......+.   ..    .+.         .
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~----~~~---------~  223 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IK----AVE---------D  223 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH----HHH---------C
Confidence            22111222235678999999999999999999999999999875 9999975433211   00    111         1


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ......+...+..+.+++.+||+.+|++||+++|+++.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         224 GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            111122345677899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=349.98  Aligned_cols=255  Identities=26%  Similarity=0.364  Sum_probs=210.4

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc----Ch-hHHHHHHHHHHHHhhcC-CCcccceeeeeeecC
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI----DE-SKVEEFINEMVILSQIN-HRNVVKLLGCCLETE  466 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~  466 (684)
                      ...++|.+.+.||+|.||+|++|.. .+++.||+|.+...    .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999985 47899999965442    11 33456678999999998 999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CcEEEeccCC
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGA  545 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFgl  545 (684)
                      ..++||||+.+|+|.+++.+.+   ++.+..+..++.|++.|++|||+++   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            9999999999999999999843   3889999999999999999999999   9999999999999999 9999999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCC-CC-CccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ-FT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER  623 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~  623 (684)
                      +.... .......+..||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||......      ..+..      
T Consensus       168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~k------  234 (370)
T KOG0583|consen  168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRK------  234 (370)
T ss_pred             ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHH------
Confidence            98764 3344566678999999999999877 86 7999999999999999999999852211      11111      


Q ss_pred             hhhhhhhhhhccCChhH-HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          624 LFEILDARVMKESGGDE-IITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       624 ~~~~~d~~~~~~~~~~~-~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                         +....  -..+... +.++..|+.+||..||.+|+|+.|++ .-.-++
T Consensus       235 ---i~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~  279 (370)
T KOG0583|consen  235 ---IRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ  279 (370)
T ss_pred             ---HhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence               11111  1122333 77899999999999999999999999 444444

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.9e-39  Score=333.17  Aligned_cols=256  Identities=22%  Similarity=0.399  Sum_probs=211.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .++|++.++||+|++|.||+|...+++.||+|++.... ...+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35689999999999999999998888889999876533 34578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.++++.... ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            99999999986532 24889999999999999999999998   999999999999999999999999999876543332


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                      ......++..|+|||++....++.++||||||+++|+|+| |+.||........   ..    .+..         ....
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~----~~~~---------~~~~  223 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MS----ALQR---------GYRM  223 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HH----HHHc---------CCCC
Confidence            2233346778999999988889999999999999999998 9999975432221   11    0000         0111


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ......+.++.+++.+||+.+|++||+++++++.|+++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            11234566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.3e-39  Score=339.43  Aligned_cols=266  Identities=23%  Similarity=0.266  Sum_probs=204.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|++.+.||+|+||+||+++.+ +++.+|+|+++..  .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999975 6789999987643  23445778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++++|..+....   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            99987766554332   24899999999999999999999999   9999999999999999999999999998764333


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh--------
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF--------  625 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~--------  625 (684)
                      ........|++.|+|||++.+..++.++||||||+++|||++|++||......+................+.        
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            333334568999999999998889999999999999999999999998654322111110000000000000        


Q ss_pred             -hhhhhhh------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          626 -EILDARV------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       626 -~~~d~~~------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       ....+..      ........+.++.+|+++||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             0000000      000112246679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.7e-39  Score=351.84  Aligned_cols=262  Identities=25%  Similarity=0.417  Sum_probs=208.4

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEe------CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeeee
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCLE  464 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~  464 (684)
                      ....++|++.+.||+|+||+||++++      +++..||||+++.. .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            33455799999999999999999963      24568999988643 234557789999999999 89999999999999


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCC-------------------------------------------------------
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNE-------------------------------------------------------  489 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------  489 (684)
                      .+..++||||+++|+|.+++++...                                                       
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            9999999999999999999975321                                                       


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          490 -----------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       490 -----------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                                       ...+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                             124788999999999999999999998   999999999999999999999999999865433


Q ss_pred             Ccee-eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          553 QTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       553 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......  ...             +.+..
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~-------------~~~~~  332 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY-------------KMIKE  332 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH-------------HHHHh
Confidence            2211 122335667999999999999999999999999999998 888986443221  111             11111


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ......+...+.++.+|+.+||+.||++||+++|+++.|++.
T Consensus       333 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         333 GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            111112223456899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.9e-39  Score=338.99  Aligned_cols=263  Identities=24%  Similarity=0.387  Sum_probs=204.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC-----------------CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD-----------------GKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKL  458 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l  458 (684)
                      ++|.+.++||+|+||.||++.+++                 +..||+|.+... ......++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568899999999999999997532                 346999987653 34456789999999999999999999


Q ss_pred             eeeeeecCcceEEEEecCCCCHHHHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 043157          459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNE----------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYH  522 (684)
Q Consensus       459 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH  522 (684)
                      ++++.+.+..++||||+++++|.+++.....                ...+++..+++++.||+.||+|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            9999999999999999999999999975321                124788899999999999999999999   999


Q ss_pred             cCCCCCCEEECCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh--CCCC
Q 043157          523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT--GEKP  599 (684)
Q Consensus       523 ~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt--G~~P  599 (684)
                      |||||+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999765433221 2223345788999999988889999999999999999987  5566


Q ss_pred             CCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          600 IRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       600 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      |......+.   ...........      ........+...+..+.+|+.+||+.||++|||++||.+.|++
T Consensus       242 ~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDEQV---IENAGEFFRDQ------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHHHH---HHHHHHHhhhc------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            654332211   11110100000      0011111223456789999999999999999999999988863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=347.52  Aligned_cols=242  Identities=30%  Similarity=0.524  Sum_probs=204.6

Q ss_pred             CcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCC
Q 043157          400 NLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT  479 (684)
Q Consensus       400 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gs  479 (684)
                      ...+-||.|+.|-||+|+++ ++.||||+.+...+       .+|+-|++|+||||+.+.|+|......+|||||+..|-
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            34678999999999999984 57799998764333       46888999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeec
Q 043157          480 LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ  559 (684)
Q Consensus       480 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~  559 (684)
                      |..+|+...   +++......|..+||.||.|||.+.   |||||||+-||||..+..|||+|||-++......+  .-.
T Consensus       199 L~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--kMS  270 (904)
T KOG4721|consen  199 LYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--KMS  270 (904)
T ss_pred             HHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh--hhh
Confidence            999999765   4888999999999999999999999   99999999999999999999999999987654422  234


Q ss_pred             ccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChh
Q 043157          560 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGD  639 (684)
Q Consensus       560 ~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  639 (684)
                      +.||..|||||++.+.+.++|+|||||||+|||||||..||...+...       +++....+        .+....+..
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------IIwGVGsN--------sL~LpvPst  335 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------IIWGVGSN--------SLHLPVPST  335 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-------eEEeccCC--------cccccCccc
Confidence            579999999999999999999999999999999999999987332111       11112222        222334567


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          640 EIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       640 ~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ++..+.-|+++||+..|..||++++++.+|+-.
T Consensus       336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            888999999999999999999999999999743

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.5e-39  Score=331.04  Aligned_cols=255  Identities=29%  Similarity=0.475  Sum_probs=210.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      ..|.+.+.||+|++|.||++..+ .++.||+|..+.. ....+++.+|++++++++||||+++++++.+++..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            34788899999999999999965 5889999987643 344678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++..... ..+++..++.++.|+++||+|||+.+   ++||||||+|||+++++.+||+|||+++........
T Consensus        85 ~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            99999999976432 34899999999999999999999998   999999999999999999999999999876543322


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....++.                .+.+......
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----------------~~~~~~~~~~  224 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YELLEKGYRM  224 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----------------HHHHHCCCCC
Confidence            2222334678999999998999999999999999999998 9999875443221                1111111112


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ..+...+.++.+++.+||+.||++||++.|++++|+.+
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            23345667899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.5e-39  Score=330.40  Aligned_cols=251  Identities=27%  Similarity=0.423  Sum_probs=205.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      +.|++.+.||+|+||.||++.++++..+|+|...... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            3588889999999999999998888889999876432 234678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +|+|.++++....  .+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999986433  3899999999999999999999999   9999999999999999999999999987654333322


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||......+.   ...    ....         ....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~----i~~~---------~~~~  221 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEM----ISRG---------FRLY  221 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----HHCC---------CCCC
Confidence            223335668999999988889999999999999999999 8999875432211   000    0000         0111


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .+...+..+.+++.+||+.+|++||+++|+++.|
T Consensus       222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            1223456789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.6e-39  Score=336.08  Aligned_cols=252  Identities=25%  Similarity=0.321  Sum_probs=204.7

Q ss_pred             CCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .|+..+.||+|+||+||++.. .+++.||+|++....   ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999985 578999999875422   2334567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++|+|.+++..... ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999999988875432 24899999999999999999999999   9999999999999999999999999997653222


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      .  .....|+..|+|||++.+..++.++||||||+++|||++|+.||...........            +...+ ....
T Consensus       157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~------------~~~~~-~~~~  221 (285)
T cd05631         157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE------------VDRRV-KEDQ  221 (285)
T ss_pred             e--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH------------HHHHh-hccc
Confidence            2  2344689999999999999999999999999999999999999985443211100            00000 0011


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPT-----MREVTSE  668 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt-----~~evl~~  668 (684)
                      ...+...+.++.+|+.+||+.||++||+     ++|++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            2233456678999999999999999997     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.5e-39  Score=350.22  Aligned_cols=261  Identities=26%  Similarity=0.458  Sum_probs=208.4

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecC
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETE  466 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~  466 (684)
                      ..++|++.+.||+|+||.||++...      +++.||+|+++.. .....+.+.+|+.+++.+ +||||+++++++.+..
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3457999999999999999998742      3457999988753 344567789999999999 8999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCC---------------------------------------------------------
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNE---------------------------------------------------------  489 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------  489 (684)
                      ..++||||+++|+|.++++....                                                         
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            99999999999999999865321                                                         


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce-eee
Q 043157          490 ----------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTT  558 (684)
Q Consensus       490 ----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~-~~~  558 (684)
                                ..++++..+++++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++........ ...
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                      124788999999999999999999998   999999999999999999999999999765433221 122


Q ss_pred             cccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       559 ~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ...++..|+|||++....++.++||||||+++|||++ |+.||.......  ..             ............+
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~-------------~~~~~~~~~~~~~  337 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF-------------YKMVKRGYQMSRP  337 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH-------------HHHHHcccCccCC
Confidence            2335678999999998899999999999999999997 999997543211  00             1111111111112


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      ...+.++.+++.+||+.||++|||+.||++.|+++.
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            234578999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-40  Score=350.83  Aligned_cols=243  Identities=29%  Similarity=0.386  Sum_probs=207.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcce
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~  469 (684)
                      ..++|.+.++||+|.||+|+++..+ +++.+|||.++.   ....+++..+.|.+++... +||.+++++.+|...++.|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4578999999999999999999976 578999997764   4567788999999999988 5999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+.||++..+.+..    .+++..+..++.+|+.||.|||+++   ||+||||.+|||||.+|.+||+|||+++..
T Consensus       446 fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999955554433    3999999999999999999999999   999999999999999999999999999875


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      .. ....+.++.|||.|||||++.+..|+..+|.|||||+|||||.|..||.+++.++-..               .|+.
T Consensus       519 m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd---------------sI~~  582 (694)
T KOG0694|consen  519 MG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD---------------SIVN  582 (694)
T ss_pred             CC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHhc
Confidence            43 3336778999999999999999999999999999999999999999999776544211               1111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTM  662 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~  662 (684)
                      ..  ...|...+.+...+++++|..+|++|-.+
T Consensus       583 d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 DE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            11  12345667789999999999999999876

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.2e-39  Score=332.58  Aligned_cols=258  Identities=26%  Similarity=0.448  Sum_probs=215.4

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      +...+|++.++||+|+||+||+|...+++.+++|.+........+++.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34456889999999999999999988899999999887766667889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++++|.++++.... ..+++..++.++.|++.||+|||+.+   |+|+||||+|||+++++.+||+|||++.......
T Consensus        83 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          83 LMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            9999999999987532 35899999999999999999999999   9999999999999999999999999997654322


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .. .....++..|++||.+....++.++||||||+++++|++ |+.||......+.                .+.+....
T Consensus       159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~----------------~~~~~~~~  221 (261)
T cd05148         159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV----------------YDQITAGY  221 (261)
T ss_pred             cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH----------------HHHHHhCC
Confidence            21 223345678999999988899999999999999999998 8999875432111                01111111


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ....+...+..+.+++.+||+.||++|||++++++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            1122345667899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-39  Score=329.97  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=210.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .++|++.+.||+|++|.||++...+++.||+|..+... ...+++.+|+.++++++||||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45689999999999999999998788889999876533 23567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999997654 234899999999999999999999999   999999999999999999999999999876532222


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                      .......+..|+|||++....++.++||||||++++||++ |+.||........                ...++.....
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----------------~~~~~~~~~~  223 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV----------------LQQVDQGYRM  223 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH----------------HHHHHcCCCC
Confidence            1222223457999999998899999999999999999999 9999875432211                0011111111


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ..+...+..+.+++.+||+.+|++||+++++++.|+.+
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            12234567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.5e-39  Score=340.69  Aligned_cols=263  Identities=27%  Similarity=0.403  Sum_probs=208.9

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .++|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367999999999999999999965 6888999987653 34456789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+.+.  |+||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            999999999998654   38999999999999999999998642  999999999999999999999999998765322 


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh-------------
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK-------------  620 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~-------------  620 (684)
                        ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+.   ...+.....             
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL---EAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhcccccccccCCccccCcc
Confidence              22334689999999999998999999999999999999999999975443221   111100000             


Q ss_pred             -----------------hhhhhhhhhhh----hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          621 -----------------EERLFEILDAR----VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       621 -----------------~~~~~~~~d~~----~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                                       .....+..+..    .........+.++.+|+.+||+.||++|||++|++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                             00000111100    00111123567899999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.4e-39  Score=333.39  Aligned_cols=257  Identities=27%  Similarity=0.472  Sum_probs=210.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC------CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD------GKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      ++|++.+.||+|+||.||+|....      .+.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            358889999999999999998542      257999988653 3445677999999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 043157          470 LVYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY  536 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~  536 (684)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||+|||+.+   ++|+||||+|||+++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999986421             134889999999999999999999999   99999999999999999


Q ss_pred             cEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHH
Q 043157          537 RAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAY  614 (684)
Q Consensus       537 ~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~  614 (684)
                      .+||+|||+++....... .......+++.|+|||++....++.++||||||+++|||++ |..||......+       
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999976533221 22233346788999999988899999999999999999998 999987543321       


Q ss_pred             HHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          615 FLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       615 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                               +.+.+........+...+.++.+|+.+||+.||++||+++||+++|+.+
T Consensus       235 ---------~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         235 ---------VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             ---------HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence                     1111111122223456778999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.2e-39  Score=337.01  Aligned_cols=265  Identities=23%  Similarity=0.312  Sum_probs=203.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.++||+|+||+||++..+ +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46899999999999999999865 68899999876532 23345678999999999999999999999998899999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      ++ ++|.+++.....  .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LD-SDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CC-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            97 499999876543  3789999999999999999999999   99999999999999999999999999876433222


Q ss_pred             eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh-------
Q 043157          555 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE-------  626 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~-------  626 (684)
                      . .....+++.|+|||.+.+ ..++.++||||||+++|||++|++||...+..+................+..       
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         159 T-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             c-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            1 223457899999998865 5689999999999999999999999986654332211111000000111111       


Q ss_pred             --hhhhhh----hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 --ILDARV----MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 --~~d~~~----~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        ...+..    ........+.+..+|+.+||+.||.+|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              110100    001112345678899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-38  Score=333.08  Aligned_cols=260  Identities=26%  Similarity=0.425  Sum_probs=213.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC------CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ++|.+.+.||+|+||+||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57889999999999999999742      345789998877666777889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEE
Q 043157          471 VYEFIPNGTLFQYIHDQNE----------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV  540 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl  540 (684)
                      ||||+++++|.+++.....          ...+++..++.++.|++.||+|||+++   ++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            9999999999999975431          234899999999999999999999999   999999999999999999999


Q ss_pred             eccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHH
Q 043157          541 SDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFA  618 (684)
Q Consensus       541 ~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~  618 (684)
                      +|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+.       ...
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-------~~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-------IEC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHH
Confidence            999999765432221 1222335778999999998899999999999999999998 8999864432210       011


Q ss_pred             hhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          619 MKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       619 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .....         ....+...+.++.+|+.+||+.||.+|||++|+++.|+++..+
T Consensus       235 i~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 ITQGR---------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            11111         1112234556799999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=328.19  Aligned_cols=255  Identities=24%  Similarity=0.425  Sum_probs=208.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC----CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD----GKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|++.+.||+|+||+||+|.+..    ...||+|..+.. ......+|.+|+.++++++||||+++++.+.+.+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568999999999999999998742    457999987653 344567899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   |+|+||||+|||+++++.+||+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999987543  4899999999999999999999998   99999999999999999999999999987652


Q ss_pred             CCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          552 DQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       552 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ... .......++..|+|||.+....++.++||||||+++|||++ |..||......+   +.             +.+.
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~-------------~~~~  222 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VI-------------KAVE  222 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HH-------------HHHH
Confidence            222 22222335678999999998899999999999999999998 999986433221   10             1111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      .......+...+..+.+|+.+||+.+|++||+++||+++|+++
T Consensus       223 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         223 DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1011112234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-40  Score=310.63  Aligned_cols=251  Identities=26%  Similarity=0.343  Sum_probs=211.7

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++++.||+|-||.||+|..+ ++.+||+|++...   ......++.+|+++-+.|+||||++++++|.++...||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            357999999999999999999954 6789999987542   233357889999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      +||.++|+|...|+..... .+++...+.+..|+|.||.|+|..+   |+||||||+|+|++..+..||+|||.+-... 
T Consensus       101 lEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            9999999999999965433 4889999999999999999999999   9999999999999999999999999986543 


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                        .....+..||..|++||...+..++.++|+|++|++.||++.|.+||......+.               ..++..- 
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et---------------YkrI~k~-  237 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET---------------YKRIRKV-  237 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH---------------HHHHHHc-
Confidence              3345667899999999999999999999999999999999999999975442211               1111111 


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                       ....+...+.+.++||.+||..+|.+|.+..|++++--
T Consensus       238 -~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  238 -DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             -cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence             11223556778999999999999999999999998743

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=337.59  Aligned_cols=246  Identities=25%  Similarity=0.339  Sum_probs=205.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +++.||+|++...   .....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36889999999999999999965 6889999987642   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999998654   3899999999999999999999999   999999999999999999999999998765322


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                          .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+..               ..+.... 
T Consensus       155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~---------------~~i~~~~-  214 (291)
T cd05612         155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY---------------EKILAGK-  214 (291)
T ss_pred             ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHHhCC-
Confidence                12345899999999999988999999999999999999999999754322110               0111111 


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPT-----MREVTSEL  669 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt-----~~evl~~L  669 (684)
                       ...+...+..+.+|+++||+.||.+||+     ++|++++-
T Consensus       215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence             1223344668899999999999999995     88888773

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=309.88  Aligned_cols=264  Identities=25%  Similarity=0.384  Sum_probs=215.9

Q ss_pred             HhcCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc-----c
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEV-----P  468 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-----~  468 (684)
                      ..++|.+.+.||+|||+-||+++ ..+++.+|+|++.....++.+..++|++..++++|||+++++++...+..     .
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34679999999999999999999 66889999999988888889999999999999999999999999876554     8


Q ss_pred             eEEEEecCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNED-FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      ||+++|...|||.+.+...+.. ..+++.++++|+.+|.+||++||+..+ |++||||||.|||+++.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999999875433 259999999999999999999999985 69999999999999999999999999987


Q ss_pred             ccccCCceee--------ecccccCCCCCcccccc---CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH
Q 043157          548 SMAVDQTHMT--------TQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL  616 (684)
Q Consensus       548 ~~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~  616 (684)
                      .....-....        ....-|..|.|||++.-   ...++++|||||||+||+|+.|..||...-.           
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----------  246 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----------  246 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence            6532111110        11235888999999854   4578999999999999999999999973211           


Q ss_pred             HHhhhhhh-hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          617 FAMKEERL-FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       617 ~~~~~~~~-~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                         +.+.+ ..+...++........++.+.+|+++||+.||.+||++.|++.+++.+.
T Consensus       247 ---~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 ---QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ---cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence               11111 1222223322223447889999999999999999999999999998874

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.3e-40  Score=328.44  Aligned_cols=248  Identities=24%  Similarity=0.413  Sum_probs=212.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecc---ccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSK---VIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ..+|++.+.||+|.||.|-++.. ..|+.||||.++   ..+++++-.+.+|++||+.|+||||+.++.+|+..+...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            34688899999999999999984 689999999654   45677788899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||..+|.|.+|+.+.+.   |++.+.+.++.||..|+.|+|.++   ++|||||.+|||||+++++||+||||+..+..
T Consensus       132 MEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999998764   999999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCceeeecccccCCCCCccccccCCCC-CccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                        ...-+++.|++-|.+||++.+.+|. +.+|-|||||+||.|+.|..||.+.+...   +    ...+..+..++    
T Consensus       206 --~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---l----vrQIs~GaYrE----  272 (668)
T KOG0611|consen  206 --KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---L----VRQISRGAYRE----  272 (668)
T ss_pred             --ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---H----HHHhhcccccC----
Confidence              3345678899999999999998874 78999999999999999999998654221   1    11112221111    


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                             ++.+.+..-||++||..+|++|.|+.++..+-
T Consensus       273 -------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  273 -------PETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                   33455677899999999999999999999875

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5e-39  Score=341.28  Aligned_cols=242  Identities=24%  Similarity=0.301  Sum_probs=200.6

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      +.||+|+||+||++... +++.||+|+++..   .......+.+|+.++++++||||+++++.+.+.+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999864 7899999987642   3345567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeee
Q 043157          479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT  558 (684)
Q Consensus       479 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~  558 (684)
                      +|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~  153 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK  153 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence            9999998653   4899999999999999999999999   9999999999999999999999999987543222 1233


Q ss_pred             cccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCCh
Q 043157          559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGG  638 (684)
Q Consensus       559 ~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  638 (684)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||...+.+...   .   .         +...  ....+.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~---~---------~~~~--~~~~p~  216 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---E---L---------ILME--EIRFPR  216 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH---H---H---------HHcC--CCCCCC
Confidence            456899999999999999999999999999999999999999754322110   0   0         0000  012234


Q ss_pred             hHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          639 DEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       639 ~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      ..+.++.+|+.+||+.||++||     +++|++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            5667899999999999999999     79998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=343.47  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=207.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||.||++... +++.||+|+++..   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36899999999999999999975 5889999987642   2344567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++....   .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999997654   3899999999999999999999999   99999999999999999999999999876533 


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                         ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+......      .   ....+....
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~------~---~~~~~~~~~  221 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK------Y---WKETLQRPV  221 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH------h---ccccccCCC
Confidence               2334568999999999999999999999999999999999999998654433211100      0   000111110


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ........+.++.+|+.+||+.+|++||+++|++++
T Consensus       222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            111112456789999999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-39  Score=332.11  Aligned_cols=249  Identities=37%  Similarity=0.597  Sum_probs=197.8

Q ss_pred             cCceeceeCcEEEEEEEeC-----CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          401 LNRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       401 ~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.. ..+..+++.+|++.+++++||||++++|++.+.+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4688999999999999976     2568999998653 445588999999999999999999999999988889999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC-
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ-  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~-  553 (684)
                      +++|+|.++|+... ...+++..++.|+.||++||+|||+.+   ++|+||+++|||+++++.+||+|||++....... 
T Consensus        83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            99999999999872 234899999999999999999999998   9999999999999999999999999998763222 


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      ............|+|||.+....++.++||||||+++|||++ |+.||......+   +             .+.+....
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~-------------~~~~~~~~  222 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---I-------------IEKLKQGQ  222 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---H-------------HHHHHTTE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c-------------cccccccc
Confidence            223333456788999999999889999999999999999999 788876443221   1             11111111


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ....+...+..+.+++.+||+.||++|||++|+++.|
T Consensus       223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1222345677899999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-39  Score=341.56  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=218.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc-ceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEV-PLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lv~  472 (684)
                      ++|...+++|+|+||.+++.+++ +++.+++|++....  ........+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57889999999999999999865 67899999877633  3334578899999999999999999999999998 89999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      +|++||+|.+.|.+.+ ...++++.++.|+.|++.|+.|||+..   |+|||||+.|||++.+..|||+|||+++....+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999999876 345999999999999999999999888   999999999999999999999999999988765


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .. ...+..||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...++.+-   +            .++.. ..
T Consensus       160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---i------------~ki~~-~~  222 (426)
T KOG0589|consen  160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---I------------LKINR-GL  222 (426)
T ss_pred             hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---H------------HHHhh-cc
Confidence            53 45566799999999999999999999999999999999999999987655431   1            11111 11


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ....+..++.+++.|++.||+.+|+.||++.+++.+-
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            3445678899999999999999999999999999884

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.1e-38  Score=327.00  Aligned_cols=252  Identities=26%  Similarity=0.410  Sum_probs=205.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ++|++.+.||+|+||+||++...++..+|+|.++... ...+++.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            3578889999999999999998777789999877433 234679999999999999999999999998889999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.+++.....  .+++..++.++.||+.||+|||+.+   ++|+||||+|||+++++.+||+|||+++.........
T Consensus        83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999986543  4899999999999999999999999   9999999999999999999999999987654433222


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....++..|++||.+....++.++||||||+++|||++ |+.||......+.   ..            .+.. .....
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~------------~~~~-~~~~~  221 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VE------------KVSQ-GLRLY  221 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH------------HHhc-CCCCC
Confidence            222335678999999988889999999999999999998 9999874432211   00            0000 00111


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      .+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            12234678999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.7e-39  Score=341.13  Aligned_cols=245  Identities=26%  Similarity=0.334  Sum_probs=203.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +++.||+|.+...   .....+.+.+|+.++++++||||+++++.+.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56899999999999999999975 6889999987642   2345577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999998654   3889999999999999999999999   999999999999999999999999999765432


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .    ....|++.|+|||++.+..++.++||||||+++|||++|+.||........   .            ..+.... 
T Consensus       172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~------------~~i~~~~-  231 (329)
T PTZ00263        172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI---Y------------EKILAGR-  231 (329)
T ss_pred             c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH---H------------HHHhcCC-
Confidence            2    234689999999999999999999999999999999999999974432110   0            0111111 


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPT-----MREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt-----~~evl~~  668 (684)
                       ...+...+..+.+|+.+||+.||++||+     ++|++++
T Consensus       232 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        232 -LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence             1122334567899999999999999997     6887765

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=340.93  Aligned_cols=265  Identities=28%  Similarity=0.457  Sum_probs=235.1

Q ss_pred             HHHHHHhcCCCcCceeceeCcEEEEEEEeCC-CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          390 KELERATDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       390 ~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      ++++-....+....+||.|.||.||.|.|+. .-.||||.++. +...+++|+.|..+|+.++|||+|+|+|+|..+...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4555555567788999999999999999875 55799998875 345679999999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      |||.|||..|+|.+||++..+. .++.-..+.+|.||+.||+||..++   +|||||..+|.|+.++..||++||||++.
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence            9999999999999999987544 4788888999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      +..+.............|.|||.+....++.|+|||+|||+|||+.| |-.||.+.+                ..++.++
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----------------lSqVY~L  478 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQVYGL  478 (1157)
T ss_pred             hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----------------HHHHHHH
Confidence            98777776666677889999999999999999999999999999998 888887543                2345667


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      ++.....+.+..++..+.+|+++||+++|.+||++.|+-+.++.+...
T Consensus       479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            777788888899999999999999999999999999999999887654

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2e-38  Score=331.47  Aligned_cols=260  Identities=25%  Similarity=0.393  Sum_probs=213.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC------CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .+|.+.+.||+|+||.||++...      ++..+++|+.........+.+.+|++++++++||||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35788899999999999999742      356789999887666667889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc
Q 043157          471 VYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR  537 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~  537 (684)
                      ||||+++++|.+++.....             ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999976431             124899999999999999999999999   999999999999999999


Q ss_pred             EEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHH
Q 043157          538 AKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYF  615 (684)
Q Consensus       538 ~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~  615 (684)
                      +||+|||++........ .......++..|+|||++....++.++||||||+++|||+| |+.||......+.       
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-------  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence            99999999976543221 12233446788999999998999999999999999999999 9999875443221       


Q ss_pred             HHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       616 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .......         .....+...+..+.+++.+||+.+|++||++++|++.|+++.+.
T Consensus       235 ~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         235 IECITQG---------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHHhCC---------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            0111111         11122334567899999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-38  Score=330.29  Aligned_cols=272  Identities=27%  Similarity=0.407  Sum_probs=208.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-----CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeec--Ccce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~  469 (684)
                      ++|++.+.||+|+||+||++..+     +++.||+|+.........+.+.+|++++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888999999999999999742     5789999998877777788899999999999999999999987543  4678


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+++++|.+++.+...  .+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999999976533  3899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCcee--eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          550 AVDQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       550 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      .......  .....++..|+|||++.+..++.++||||||++++||++|..|+..........+............+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            4332211  11122345699999998888999999999999999999998776433211000000000000000011111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      +........+...+.++.+|+.+||+.+|++|||++||++.|+.++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            2211111223455678999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.6e-38  Score=329.77  Aligned_cols=256  Identities=27%  Similarity=0.452  Sum_probs=208.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC------CcEEEEEeccccChh-HHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD------GKIVAVKKSKVIDES-KVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      ++|.+.+.||+|+||.||+|...+      ++.||+|..+..... ..+.+.+|+++++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            458889999999999999998633      478999988764433 5678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcE
Q 043157          470 LVYEFIPNGTLFQYIHDQNE-----------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA  538 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~  538 (684)
                      +||||+++++|.++++....           ...+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            99999999999999986432           234789999999999999999999999   9999999999999999999


Q ss_pred             EEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHH
Q 043157          539 KVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFL  616 (684)
Q Consensus       539 kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~  616 (684)
                      ||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....++.   ..   
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~---  235 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IE---  235 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH---
Confidence            9999999876433222 11223345778999999999999999999999999999998 9999875443221   10   


Q ss_pred             HHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       617 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                                .+........+...+..+.+++.+||+.||++||+++||++.|++
T Consensus       236 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         236 ----------CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ----------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                      111111112233466789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.3e-38  Score=335.14  Aligned_cols=257  Identities=25%  Similarity=0.470  Sum_probs=207.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCc----EEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGK----IVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .+|++.+.||+|+||+||+|.+. +++    .||+|..+.. .....+++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            35899999999999999999854 343    4899988653 345567899999999999999999999999764 5789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ++||+++|+|.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            9999999999999987543  3889999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCcee-eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          551 VDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       551 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ...... .....++..|+|||++....++.++||||||+++|||++ |+.||......+.                ..++
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~----------------~~~~  224 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------SSIL  224 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH----------------HHHH
Confidence            433322 122234678999999999999999999999999999998 9999875432221                1111


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      ........+...+.++.+++.+||+.+|++||++.|++..|..+.+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         225 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            11111111233456789999999999999999999999999888754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-38  Score=329.41  Aligned_cols=258  Identities=26%  Similarity=0.438  Sum_probs=206.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEV  467 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  467 (684)
                      ..++|++.+.||+|+||+||+|.+.      .+..||+|+.... ......++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999998753      3567999987643 23455678999999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEE
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNE-------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV  540 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl  540 (684)
                      .++||||+++++|.+++.+...       ...+++..++.++.|+++||+|||+.+   ++|+||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999976332       124678899999999999999999998   999999999999999999999


Q ss_pred             eccCCccccccCCcee-eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHH
Q 043157          541 SDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFA  618 (684)
Q Consensus       541 ~DFgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~  618 (684)
                      +|||+++......... .....+++.|+|||++....++.++||||||+++|||++ |..||.....++..         
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---------  231 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---------  231 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---------
Confidence            9999987654322211 122345778999999998889999999999999999999 78898754332211         


Q ss_pred             hhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          619 MKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       619 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                             +.+........+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       232 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         232 -------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                   0000011112233456689999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=324.84  Aligned_cols=250  Identities=27%  Similarity=0.421  Sum_probs=204.8

Q ss_pred             CCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      +|++.+.||+|+||.||++.++++..+|+|....... ..+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            4788999999999999999987777899998754322 345788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      ++|.+++.....  .+++..++.++.|+++||+|||+.+   ++||||||+|||+++++.+||+|||+++..........
T Consensus        84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            999999986543  4899999999999999999999999   99999999999999999999999999876543322222


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES  636 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  636 (684)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+..   .             .+........
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~-------------~~~~~~~~~~  222 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---E-------------SVSAGYRLYR  222 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---H-------------HHHcCCcCCC
Confidence            22224567999999998899999999999999999999 89998754332210   0             0111111122


Q ss_pred             ChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          637 GGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       637 ~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      +...+.++.+++.+||+.+|++|||+.|+++.|
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            334677899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.5e-38  Score=324.82  Aligned_cols=255  Identities=24%  Similarity=0.401  Sum_probs=208.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .+.|++.++||+|+||.||++..++++.+|+|.+..... ..+++.+|+.++++++||||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            457899999999999999999988899999998775333 3467899999999999999999998864 55789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++..... ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            99999999976532 35899999999999999999999998   999999999999999999999999999765533322


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                      ......++..|+|||++....++.++||||||+++|||++ |+.||......+.   .             +.+......
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~-------------~~~~~~~~~  222 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---I-------------QNLERGYRM  222 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---H-------------HHHHcCCCC
Confidence            2233346778999999998889999999999999999999 9999975432211   0             011111111


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ..+...+.++.+++.+||+.+|++||+++++++.|+.+
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            22334566899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-38  Score=331.08  Aligned_cols=262  Identities=25%  Similarity=0.359  Sum_probs=198.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC--CCcEEEEEeccccC--hhHHHHHHHHHHHHhhc---CCCcccceeeeeee-----
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP--DGKIVAVKKSKVID--ESKVEEFINEMVILSQI---NHRNVVKLLGCCLE-----  464 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~-----  464 (684)
                      ++|++.+.||+|+||+||++...  +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  46889999876432  22344566787777766   69999999999852     


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                      ....++||||++ ++|.+++..... ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            345789999996 699999976532 24899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh---h
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK---E  621 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~---~  621 (684)
                      +++.....  .......|++.|+|||.+....++.++||||||+++|||++|++||......+..  ...+ ....   .
T Consensus       156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~--~~i~-~~~~~~~~  230 (290)
T cd07862         156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKIL-DVIGLPGE  230 (290)
T ss_pred             ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH--HHHH-HHhCCCCh
Confidence            99765432  2233456899999999998889999999999999999999999999865433211  1111 1110   0


Q ss_pred             hhhhh-------hhhh---hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          622 ERLFE-------ILDA---RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       622 ~~~~~-------~~d~---~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..+..       .+..   ........+.+..+.+|+.+||+.||++|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            00000       0000   00011112345678899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-38  Score=338.82  Aligned_cols=264  Identities=25%  Similarity=0.393  Sum_probs=200.1

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC-----cce
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETE-----VPL  469 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~  469 (684)
                      +|++.++||+|+||.||++... +++.||||++...  .......+.+|++++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788999999999999999964 6899999987642  2344567889999999999999999999886432     469


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||++ ++|.+++....   .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68999887653   3899999999999999999999999   999999999999999999999999999764


Q ss_pred             ccCCc--eeeecccccCCCCCcccccc--CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH--------H
Q 043157          550 AVDQT--HMTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL--------F  617 (684)
Q Consensus       550 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~--------~  617 (684)
                      .....  .......|++.|+|||++.+  ..++.++||||||+++|||++|++||................        .
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32221  12234568999999999865  678999999999999999999999997654322111110000        0


Q ss_pred             Hhhhhhhhhhhh---hhhh---ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          618 AMKEERLFEILD---ARVM---KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       618 ~~~~~~~~~~~d---~~~~---~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ........+.++   ....   .......+..+.+++.+||+.||++|||++|++++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000011111110   0000   00012345678899999999999999999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-38  Score=337.30  Aligned_cols=242  Identities=25%  Similarity=0.302  Sum_probs=200.1

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      +.||+|+||+||++... +|+.||+|.++..   .......+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999864 6899999987642   3445667889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeee
Q 043157          479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT  558 (684)
Q Consensus       479 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~  558 (684)
                      +|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~  153 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK  153 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence            9999987654   3899999999999999999999999   99999999999999999999999999875432222 223


Q ss_pred             cccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCCh
Q 043157          559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGG  638 (684)
Q Consensus       559 ~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  638 (684)
                      ...|++.|+|||++.+..++.++||||||+++|||++|+.||...+..+...               .+....  ...+.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~---------------~~~~~~--~~~p~  216 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---------------LILMEE--IRFPR  216 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH---------------HHhcCC--CCCCC
Confidence            3568999999999999999999999999999999999999997544322100               000000  11234


Q ss_pred             hHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          639 DEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       639 ~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      ..+.++.+|+.+||+.||++||     ++++++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            5567889999999999999998     88888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.7e-38  Score=323.56  Aligned_cols=253  Identities=27%  Similarity=0.417  Sum_probs=206.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ++|++.++||+|+||.||++...++..+|+|....... ..+.+.+|+.++++++|||++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46888999999999999999988888899998765333 3467899999999999999999999875 456899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.++++.... ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..........
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          84 KGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            9999999986432 34899999999999999999999999   9999999999999999999999999997654333222


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....++..|+|||++....++.++||||||+++|||++ |+.||......+.   .             +.+.......
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~-------------~~~~~~~~~~  223 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---L-------------EQVERGYRMP  223 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---H-------------HHHHcCCCCC
Confidence            223345678999999988889999999999999999999 8999864432211   0             1111111112


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      .+...+..+.+|+.+||+.+|++|||++++++.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            234556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.3e-38  Score=336.80  Aligned_cols=242  Identities=24%  Similarity=0.305  Sum_probs=200.5

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      ++||+|+||+||++... +++.||+|++...   .......+.+|+.+++.++||||+++++.+.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999864 6899999987642   3445678889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeee
Q 043157          479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT  558 (684)
Q Consensus       479 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~  558 (684)
                      +|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~  153 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK  153 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence            9999987653   3899999999999999999999999   99999999999999999999999999875432222 223


Q ss_pred             cccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCCh
Q 043157          559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGG  638 (684)
Q Consensus       559 ~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  638 (684)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+...               .+...  ....+.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~---------------~~~~~--~~~~p~  216 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---------------LILME--DIKFPR  216 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH---------------HhccC--CccCCC
Confidence            4568999999999998899999999999999999999999997543322100               00000  012234


Q ss_pred             hHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          639 DEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       639 ~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      ..+.++.+|+.+||+.||++||     +++|++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            4567889999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.6e-38  Score=343.00  Aligned_cols=264  Identities=25%  Similarity=0.410  Sum_probs=210.8

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcC-CCcccceeeeeee
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVI-DESKVEEFINEMVILSQIN-HRNVVKLLGCCLE  464 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~  464 (684)
                      +...++|.+.++||+|+||.||+|...      .+..||||+++.. .....+.+.+|+++++++. ||||+++++++.+
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            334568999999999999999999852      2347999988653 3344578999999999996 9999999999999


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCC-------------------------------------------------------
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNE-------------------------------------------------------  489 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------  489 (684)
                      ....+|||||+++|+|.++|++...                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999999875321                                                       


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 043157          490 --------------------------------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL  531 (684)
Q Consensus       490 --------------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NIL  531 (684)
                                                            ...+++..++.++.|+++||+|||+.+   |+||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence                                                  124788889999999999999999998   999999999999


Q ss_pred             ECCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhh
Q 043157          532 LDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDK  609 (684)
Q Consensus       532 l~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~  609 (684)
                      +++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||........ 
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-  348 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-  348 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-
Confidence            999999999999999865432221 1222346788999999998899999999999999999997 9999874322111 


Q ss_pred             hHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          610 SLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       610 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                       +             ...+........+...+.++.+++.+||+.||++||++.+|.+.|+++..
T Consensus       349 -~-------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 -F-------------YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -H-------------HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence             0             00111111112234556789999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.2e-38  Score=327.45  Aligned_cols=256  Identities=25%  Similarity=0.453  Sum_probs=207.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-----CCCcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-----PDGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      +.|++.+.||+|+||+||+|..     .+++.+++|.++. ........+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4578889999999999999984     2467899998874 334455788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 043157          471 VYEFIPNGTLFQYIHDQNE--------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY  536 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~  536 (684)
                      +|||+++++|.+++.....              ...+++..++.++.|++.||+|||+++   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999999964321              224788999999999999999999999   99999999999999999


Q ss_pred             cEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHH
Q 043157          537 RAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAY  614 (684)
Q Consensus       537 ~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~  614 (684)
                      .+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||......+       
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999976543221 22233345678999999988889999999999999999998 999986443211       


Q ss_pred             HHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          615 FLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       615 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                               +.+.+........+...+..+.+++.+||+.||++||++.+++++|..
T Consensus       235 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 ---------VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                     111111111122334456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.8e-38  Score=337.32  Aligned_cols=261  Identities=28%  Similarity=0.442  Sum_probs=207.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeec-C
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCLET-E  466 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~  466 (684)
                      .++|++.+.||+|+||.||+|...      +++.||+|+++.. .....+.+.+|+.+++++ +||||+++++++... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457999999999999999999632      3578999988643 234456788999999999 899999999988654 4


Q ss_pred             cceEEEEecCCCCHHHHHhhcCC---------------------------------------------------------
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNE---------------------------------------------------------  489 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------  489 (684)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999999865321                                                         


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce-eeecccccCCCC
Q 043157          490 -DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYL  567 (684)
Q Consensus       490 -~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~  567 (684)
                       ..++++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++........ ......++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             125899999999999999999999998   999999999999999999999999999875432221 222334567899


Q ss_pred             CccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHH
Q 043157          568 DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAK  646 (684)
Q Consensus       568 aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~  646 (684)
                      |||++.+..++.++||||||++||||++ |..||......+.  +.             +.+........+...+.++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC-------------RRLKEGTRMRAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH-------------HHHhccCCCCCCccCCHHHHH
Confidence            9999999999999999999999999998 9999875332211  10             111111111222345668999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          647 VAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       647 Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      ++.+||+.+|++||++.|++++|+++..
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.2e-38  Score=331.96  Aligned_cols=265  Identities=25%  Similarity=0.353  Sum_probs=201.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh-hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE-SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999975 688999998765332 234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |++ ++|.+++.....  .+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            995 688888876433  3889999999999999999999999   9999999999999999999999999987543222


Q ss_pred             ceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hhhhhh----
Q 043157          554 THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EERLFE----  626 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~~~~~----  626 (684)
                       .......+++.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..+...+.....  ...+..    
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhCCCChhhccchhhc
Confidence             12233457899999999865 458899999999999999999999997543211 111111110000  000000    


Q ss_pred             -hhhh-hhhccC---------ChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 -ILDA-RVMKES---------GGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 -~~d~-~~~~~~---------~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       ...+ ......         ....+..+.+|+.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence             0000 000000         01124578899999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.6e-38  Score=327.79  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=209.5

Q ss_pred             CCCcCceeceeCcEEEEEEEeC------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      +|++.+.||+|+||+||+|...      ....+++|..... .....+++.+|+.+++.++||||+++++.+.+.+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999853      2357888877643 34456789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 043157          471 VYEFIPNGTLFQYIHDQN---------------------EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN  529 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~N  529 (684)
                      +|||+++++|.+++....                     ...++++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999987531                     1134889999999999999999999998   9999999999


Q ss_pred             EEECCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhh
Q 043157          530 ILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE  607 (684)
Q Consensus       530 ILl~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~  607 (684)
                      ||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..||.....++
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999999999998765432221 1222345678999999988889999999999999999998 999986543221


Q ss_pred             hhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       608 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                                      +.+.+........+...+.++.+++.+||+.+|++||+++|+++.|+++-.+
T Consensus       238 ----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         238 ----------------LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             ----------------HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence                            1111111111222345567899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.8e-38  Score=323.21  Aligned_cols=260  Identities=23%  Similarity=0.361  Sum_probs=210.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||.||+|... +++.||||+...   .+......+.+|++++++++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47899999999999999999964 788999997653   33455677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      ||+++++|.+++.... ....+++..++.++.|+++||+|||+++   ++|+||||+|||++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999999986532 2234889999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||.......    .... .....        ..
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~-~~~~~--------~~  224 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLC-QKIEQ--------CD  224 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHH-HHHhc--------CC
Confidence            222 1223457889999999988889999999999999999999999986432211    1100 00000        00


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      .........+..+.+++.+||+.+|++||+++|+++.|++++
T Consensus       225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            011112345678999999999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-38  Score=338.83  Aligned_cols=245  Identities=26%  Similarity=0.340  Sum_probs=203.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC--CcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD--GKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|++.+.||+|+||+||+|.++.  +..||+|++..   ......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468999999999999999998543  36899998753   2344567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999998654   3899999999999999999999999   99999999999999999999999999976532


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .    .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+....   .            ..+....
T Consensus       184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~------------~~i~~~~  244 (340)
T PTZ00426        184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---Y------------QKILEGI  244 (340)
T ss_pred             C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---H------------HHHhcCC
Confidence            1    2334689999999999988899999999999999999999999975432210   0            0111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                        ...+...+..+.+++++||+.||++|+     +++|++++
T Consensus       245 --~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 --IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              112334556789999999999999995     89998876

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-38  Score=352.52  Aligned_cols=252  Identities=24%  Similarity=0.318  Sum_probs=208.0

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-C-CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-D-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .|.+.+.||+|++|.||++... + ++.||+|+...........+.+|+.+|+.++||||+++++++.+.+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4889999999999999999854 3 6788999877666666778889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          476 PNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       476 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      ++|+|.++|++. ....++++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999998753 23346899999999999999999999998   99999999999999999999999999986543222


Q ss_pred             -eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          555 -HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       555 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.               +..++... .
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~---------------~~~~~~~~-~  288 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI---------------MQQVLYGK-Y  288 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHHHHhCC-C
Confidence             223445699999999999999999999999999999999999999975432110               00111110 0


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+...+.++.+|+.+||+.||++||++++++.+
T Consensus       289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            11233456789999999999999999999998753

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-39  Score=341.13  Aligned_cols=249  Identities=27%  Similarity=0.411  Sum_probs=212.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .-|++++-||.|+-|.|-+|++ .+|+.+|||++...   .......+.+|+-+|+.+.|||++++++++.+..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4588999999999999999996 47999999987653   3344567789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|-|+++|-+++.   +++.+..+++.||+.|+.|+|..+   |+||||||+|+|||...++||+|||+|..-.. 
T Consensus        92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP-  164 (786)
T ss_pred             EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence            99999999999998764   899999999999999999999999   99999999999999999999999999975432 


Q ss_pred             CceeeecccccCCCCCccccccCCCC-CccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                       ...-.+.+|++.|.+||++.+.+|. .++||||-|||||.||||+.||..+..   ..|.    ...+.+         
T Consensus       165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LL----lKV~~G---------  227 (786)
T KOG0588|consen  165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLL----LKVQRG---------  227 (786)
T ss_pred             -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHH----HHHHcC---------
Confidence             3345566899999999999999885 699999999999999999999973321   1111    111111         


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                       .-+.+...+.+.++|+.+||..||++|.|++||++|--
T Consensus       228 -~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  228 -VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             -cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence             12345667788999999999999999999999999863

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-37  Score=377.72  Aligned_cols=263  Identities=24%  Similarity=0.443  Sum_probs=211.0

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ....++..++||+|+||+||+|.. .+++.||+|+++.....    ..+|++.+++++||||+++++++.+.+..++|||
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            345678889999999999999996 57899999988653322    2346889999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++|+|.++++.      ++|..+.+++.|+++||+|||+....+|+||||||+||+++.++..++. |+........ 
T Consensus       764 y~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        764 YIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             CCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            9999999999962      7899999999999999999996655559999999999999999888876 6655433211 


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                          ....+++.|+|||++.+..++.|+|||||||++|||+||+.||.... .....+..+.............+|+...
T Consensus       836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCcccc
Confidence                12257899999999999999999999999999999999999985332 2223344444444444444445555442


Q ss_pred             c--cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          634 K--ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       634 ~--~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      .  ....++..++.+++.+||+.||++||||+|++++|+++.+
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            2  2334567789999999999999999999999999998865

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.9e-38  Score=335.81  Aligned_cols=265  Identities=26%  Similarity=0.390  Sum_probs=206.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .++|++.++||+|+||+||++.+. +++.+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            467999999999999999999976 6888999987653 34456779999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+. +   |+||||||+|||+++++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            999999999998653   388999999999999999999985 5   999999999999999999999999998754322


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH--------------
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA--------------  618 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~--------------  618 (684)
                         ......|+..|+|||++.+..++.++||||||+++|||++|+.||..................              
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence               123346899999999999888999999999999999999999999754332111000000000              


Q ss_pred             -----------hhhhhhhhhhhhhhh---ccCC-hhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          619 -----------MKEERLFEILDARVM---KESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       619 -----------~~~~~~~~~~d~~~~---~~~~-~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                                 ..........+....   ...+ ...+.++.+|+.+||+.||++|||++|++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~  300 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA  300 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence                       000000011111000   0011 12456799999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=334.72  Aligned_cols=240  Identities=26%  Similarity=0.333  Sum_probs=197.5

Q ss_pred             eceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCH
Q 043157          405 LGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL  480 (684)
Q Consensus       405 LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL  480 (684)
                      ||+|+||+||++... +++.||+|+++.   ........+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999965 588999998764   2345567788999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecc
Q 043157          481 FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV  560 (684)
Q Consensus       481 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~  560 (684)
                      .+++....   .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  153 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF  153 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence            99998653   3899999999999999999999999   9999999999999999999999999987543222 223345


Q ss_pred             cccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhH
Q 043157          561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE  640 (684)
Q Consensus       561 ~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  640 (684)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||......+      .+.         .++..  ....+...
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~---------~~~~~--~~~~~~~~  216 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYR---------KILQE--PLRFPDGF  216 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHH---------HHHcC--CCCCCCcC
Confidence            68999999999999999999999999999999999999997543221      110         11111  11223455


Q ss_pred             HHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 043157          641 IITFAKVAKRCLNLNGKKRPT---MREVTSE  668 (684)
Q Consensus       641 ~~~l~~Li~~cl~~dp~~RPt---~~evl~~  668 (684)
                      +.++.+|+.+||+.||++||+   +.|++.+
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            678899999999999999985   5666554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.7e-38  Score=336.97  Aligned_cols=252  Identities=25%  Similarity=0.327  Sum_probs=202.7

Q ss_pred             CCCcCceeceeCcEEEEEEEe----CCCcEEEEEecccc----ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcc
Q 043157          398 NFNLNRILGQGGQGTVYKGML----PDGKIVAVKKSKVI----DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  468 (684)
                      +|++.+.||+|+||+||++..    .+++.||+|.+...    .....+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999875    35789999987532    233456788999999999 599999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||+++|+|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999997653   3899999999999999999999999   99999999999999999999999999986


Q ss_pred             cccCCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      .............||+.|+|||++.+. .++.++||||||+++|||+||+.||..........  . +..        .+
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~-~~~--------~~  223 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--E-VSR--------RI  223 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--H-HHH--------HH
Confidence            544433334445699999999998765 47889999999999999999999997433221111  0 000        00


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      ..  .....+...+..+.+++.+||+.||++||     +++|++++
T Consensus       224 ~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         224 LK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             hc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            00  01122334567789999999999999999     77788765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.1e-38  Score=329.15  Aligned_cols=263  Identities=27%  Similarity=0.435  Sum_probs=212.3

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeee
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCL  463 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  463 (684)
                      ++...++|++.+.||+|+||.||++...      ....+|+|..... ......++.+|+++++++ +||||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3444567899999999999999999864      2367999987653 344567789999999999 8999999999999


Q ss_pred             ecCcceEEEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 043157          464 ETEVPLLVYEFIPNGTLFQYIHDQN-------------EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI  530 (684)
Q Consensus       464 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NI  530 (684)
                      +.+..+++|||+++|+|.++++...             ....+++..++.++.|++.||+|||+.+   |+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence            9999999999999999999997531             2345899999999999999999999998   99999999999


Q ss_pred             EECCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhh
Q 043157          531 LLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEED  608 (684)
Q Consensus       531 Ll~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~  608 (684)
                      |+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.....++.
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            9999999999999999865433221 1222335678999999988899999999999999999997 9999875433221


Q ss_pred             hhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       609 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                                      .+.+........+...+..+.+|+.+||+.||++|||++|+++.|+.+.
T Consensus       244 ----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 ----------------FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ----------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                            1111111112233455678999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-39  Score=321.42  Aligned_cols=270  Identities=26%  Similarity=0.339  Sum_probs=215.8

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecc--ccChhHHHHHHHHHHHHhhcCCCcccceeeeeee-----
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSK--VIDESKVEEFINEMVILSQINHRNVVKLLGCCLE-----  464 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----  464 (684)
                      ......|...+.||+|+||.|..+... +|+.||||++.  ..+....++..+|+++|+.++|+||+.+++++..     
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            334456777899999999999999854 78999999987  4667778899999999999999999999999976     


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                      -...|+|+|+| ..+|..+++....   |+.+....+..|+++||.|+|+.+   |+||||||+|+|++.+..+||+|||
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence            24679999999 6799999987643   999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccC-CceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          545 ASRSMAVD-QTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       545 l~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      +|+..... .....+....|..|.|||++.. ..|+...||||.|||+.||++|++-|.+.+.-++-.+.....-...++
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            99987532 2223345567999999998754 679999999999999999999999999877665554443332222222


Q ss_pred             hhhhhh--------hh------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          623 RLFEIL--------DA------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       623 ~~~~~~--------d~------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .+..+-        ..      ......-+.......+|+.+||..||.+|+|++|.+++-
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence            222221        10      001111134566788999999999999999999999863

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.7e-38  Score=328.06  Aligned_cols=259  Identities=25%  Similarity=0.436  Sum_probs=207.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC-Cc--EEEEEeccc-cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD-GK--IVAVKKSKV-IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|++.+.||+|+||.||+|..++ +.  .+++|.++. ......+.+.+|+++++++ +||||+++++++.+....+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468899999999999999998653 33  478887764 3344567899999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcE
Q 043157          472 YEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA  538 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~  538 (684)
                      |||+++++|.++++....             ...+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            999999999999976421             124889999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHH
Q 043157          539 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLF  617 (684)
Q Consensus       539 kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~  617 (684)
                      ||+|||++......  ........+..|+|||++....++.++||||||+++|||++ |..||......+.         
T Consensus       159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---------  227 (297)
T cd05089         159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---------  227 (297)
T ss_pred             EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---------
Confidence            99999998643211  11111223557999999988889999999999999999997 9999975443221         


Q ss_pred             HhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       618 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                             .+.+........+...+..+.+|+.+||+.+|.+||+++++++.|+.+..+.
T Consensus       228 -------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         228 -------YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             -------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                   1111111112223446678999999999999999999999999998887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-38  Score=341.62  Aligned_cols=260  Identities=21%  Similarity=0.256  Sum_probs=200.9

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ..+|++.+.||+|+||.||++... +++.||+|+..      .+.+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999964 68899999643      24578999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +. ++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            95 78988887653   3889999999999999999999998   99999999999999999999999999975433222


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChh-----hhhhHHHHHHHHhhh--------
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLE-----EDKSLAAYFLFAMKE--------  621 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~-----~~~~l~~~~~~~~~~--------  621 (684)
                      .......||+.|+|||++.+..++.++||||||+++|||++|+.||......     ....+.... .....        
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~-~~~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII-RRSGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH-HHhcCChhhcCcc
Confidence            3334456999999999999989999999999999999999999887543211     111111111 10000        


Q ss_pred             --hhhhhhh---hhhh---hcc-----CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          622 --ERLFEIL---DARV---MKE-----SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       622 --~~~~~~~---d~~~---~~~-----~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                        ..+.+..   ....   ...     .....+.++.+|+.+||+.||++|||++|++++=
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp  377 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA  377 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence              0000000   0000   000     0013456799999999999999999999999753

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-39  Score=328.60  Aligned_cols=259  Identities=25%  Similarity=0.336  Sum_probs=205.0

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC--------------hhHHHHHHHHHHHHhhcCCCccc
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID--------------ESKVEEFINEMVILSQINHRNVV  456 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~HpnIv  456 (684)
                      -.+..++|++.+.||+|.||.|-+|.. .+++.||||++....              ....+...+||.+|++++|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            344457899999999999999999995 479999999764311              12246889999999999999999


Q ss_pred             ceeeeeee--cCcceEEEEecCCCCHHHHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC
Q 043157          457 KLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNEDFP-ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD  533 (684)
Q Consensus       457 ~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~  533 (684)
                      +|+.+..+  .+..|||+||+..|.+...=    ...+ +++.++++++.++..||+|||.++   |+||||||+|+||+
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS  244 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence            99999975  45889999999988764432    2334 999999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeccCCccccccC-----CceeeecccccCCCCCccccccCC----CCCccchhhhHHHHHHHHhCCCCCCCCC
Q 043157          534 DKYRAKVSDFGASRSMAVD-----QTHMTTQVHGTFGYLDPEYFRSSQ----FTDKSDVYSFGVVLAELLTGEKPIRFTT  604 (684)
Q Consensus       534 ~~~~~kl~DFgl~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~SlGvil~elltG~~P~~~~~  604 (684)
                      +++++||+|||.+......     ..... ...|||.|+|||...++.    -+.+.||||+||+||.|+.|+.||....
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~-~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLS-RTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHh-hcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            9999999999999866321     11122 246999999999987632    3568999999999999999999997443


Q ss_pred             hhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          605 LEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       605 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      ..+      .         ..+|+...+.....++....+.+||+++|..||++|.+..+|..+..-.+
T Consensus       324 ~~~------l---------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  324 ELE------L---------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             HHH------H---------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            211      1         12333333333333466788999999999999999999999988875443

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-37  Score=320.30  Aligned_cols=259  Identities=26%  Similarity=0.421  Sum_probs=212.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|++|.||+|... +++.+|+|.++.   .+....+.+.+|++++++++|+||+++++.+.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999976 789999997753   33445678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      ||+++++|.+++.... ....+++..++.++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999997532 2345899999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......    +..          +.+.+...
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~----------~~~~~~~~  223 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS----------LCKKIEKC  223 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH----------HHhhhhcC
Confidence            222 122345788999999998888999999999999999999999998643311    111          01111111


Q ss_pred             hhccCC-hhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          632 VMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       632 ~~~~~~-~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      .....+ ...+..+.+++.+||..+|++|||+.+|++.|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            111112 245668999999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=340.89  Aligned_cols=250  Identities=26%  Similarity=0.367  Sum_probs=206.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|.+.+.||+|+||+||++... +++.||+|+++..   .......+.+|++++..++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999965 6899999987642   2345677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++.+..   .+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            9999999999998763   4899999999999999999999998   999999999999999999999999999765433


Q ss_pred             C----------------------------ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 043157          553 Q----------------------------THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTT  604 (684)
Q Consensus       553 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~  604 (684)
                      .                            ........||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                            112234468999999999999999999999999999999999999997554


Q ss_pred             hhhhhhHHHHHHHHhhhhhhhhhhh--hhhhccCChhHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 043157          605 LEEDKSLAAYFLFAMKEERLFEILD--ARVMKESGGDEIITFAKVAKRCLNLNGKKRPT-MREVTSE  668 (684)
Q Consensus       605 ~~~~~~l~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt-~~evl~~  668 (684)
                      ..+..               ..+..  ...........+.++.+|+.+||+ ||++||+ ++|++++
T Consensus       235 ~~~~~---------------~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQETY---------------NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHH---------------HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            22110               01111  000011112256789999999997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.7e-38  Score=325.31  Aligned_cols=260  Identities=26%  Similarity=0.446  Sum_probs=211.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC-----CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeee-cCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD-----GKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLE-TEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  468 (684)
                      .++|++.+.||+|+||.||+|.+.+     ++.|++|++... .....+.+.+|+.+++.++||||+++++++.+ ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678999999999999999999765     678999987653 45567889999999999999999999998776 4678


Q ss_pred             eEEEEecCCCCHHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEecc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNED-----FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF  543 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF  543 (684)
                      ++++||+++++|.+++......     ..+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999999765322     45899999999999999999999998   999999999999999999999999


Q ss_pred             CCccccccCCcee-eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhh
Q 043157          544 GASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKE  621 (684)
Q Consensus       544 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~  621 (684)
                      |+++......... .....++..|+|||++....++.++||||||+++||+++ |+.||......+   +....    ..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL----KD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH----Hc
Confidence            9998654333222 222345678999999988889999999999999999999 999987543211   11110    00


Q ss_pred             hhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       622 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                               ..........+.++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       235 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         235 ---------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             ---------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                     00011122345678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-37  Score=322.20  Aligned_cols=255  Identities=26%  Similarity=0.451  Sum_probs=204.8

Q ss_pred             CCcCceeceeCcEEEEEEEeCC----CcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc-----
Q 043157          399 FNLNRILGQGGQGTVYKGMLPD----GKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEV-----  467 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-----  467 (684)
                      |++.+.||+|+||.||+|.+..    +..||+|+++..  .....+.+.+|++.++.++||||+++++++.+.+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999998642    367999987753  34556789999999999999999999998876554     


Q ss_pred             -ceEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEecc
Q 043157          468 -PLLVYEFIPNGTLFQYIHDQN---EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF  543 (684)
Q Consensus       468 -~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF  543 (684)
                       .+++|||+++++|.+++....   ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999999986532   2235899999999999999999999998   999999999999999999999999


Q ss_pred             CCccccccCCcee-eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhh
Q 043157          544 GASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKE  621 (684)
Q Consensus       544 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~  621 (684)
                      |+++......... .....++..|+|||++....++.++||||||+++|||++ |..||......+   +.         
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~---------  225 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IY---------  225 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HH---------
Confidence            9998764333221 112234678999999988899999999999999999999 889986443211   11         


Q ss_pred             hhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       622 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                          +.+........+...+.++.+++.+||+.||++||++.|+++.|+++
T Consensus       226 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         226 ----DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ----HHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                11111111122345667899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1e-37  Score=318.09  Aligned_cols=247  Identities=28%  Similarity=0.468  Sum_probs=202.4

Q ss_pred             ceeceeCcEEEEEEEeCCCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCHH
Q 043157          403 RILGQGGQGTVYKGMLPDGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF  481 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL~  481 (684)
                      ++||+|+||.||+|...+++.+|+|...... ......+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4789999999999998888999999876543 344567899999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeeccc
Q 043157          482 QYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH  561 (684)
Q Consensus       482 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~  561 (684)
                      +++.....  .+++..++.++.|++.+|.|||+.+   ++||||||+||++++++.+||+|||++...............
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            99976543  3889999999999999999999999   999999999999999999999999998754332222222233


Q ss_pred             ccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhH
Q 043157          562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE  640 (684)
Q Consensus       562 gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  640 (684)
                      ++..|+|||++....++.++||||||+++||+++ |..||.........                ..+........+...
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~  219 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR----------------EQVEKGYRMSCPQKC  219 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH----------------HHHHcCCCCCCCCCC
Confidence            4678999999998889999999999999999998 99999754322210                000111111223445


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          641 IITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       641 ~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      +..+.+++.+||+.+|++||++.|++++|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.4e-38  Score=319.66  Aligned_cols=247  Identities=25%  Similarity=0.429  Sum_probs=200.1

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCH
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL  480 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL  480 (684)
                      +.||+|+||.||++... +++.+|+|.... ...+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999964 788999998654 3345567899999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee-eec
Q 043157          481 FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-TTQ  559 (684)
Q Consensus       481 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~-~~~  559 (684)
                      .+++.....  .+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++......... ...
T Consensus        81 ~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999976432  4899999999999999999999999   9999999999999999999999999987543221111 111


Q ss_pred             ccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCCh
Q 043157          560 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGG  638 (684)
Q Consensus       560 ~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  638 (684)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..||........                ...+........+.
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~----------------~~~~~~~~~~~~~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT----------------REAIEQGVRLPCPE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH----------------HHHHHcCCCCCCcc
Confidence            123457999999998899999999999999999998 8888864332211                11111111122234


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          639 DEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       639 ~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      ..+..+.+|+.+||+.+|++|||+.|+++.|+
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            45678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-37  Score=321.79  Aligned_cols=255  Identities=27%  Similarity=0.465  Sum_probs=201.7

Q ss_pred             CCcCceeceeCcEEEEEEEeCC-Cc--EEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec------Cc
Q 043157          399 FNLNRILGQGGQGTVYKGMLPD-GK--IVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLET------EV  467 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~~-g~--~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~  467 (684)
                      |.+.++||+|+||.||+|.+.+ ++  .+|+|..+.  ......+.+.+|+++++.++||||+++++.+...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999999999999754 33  689997765  3455678899999999999999999999987532      24


Q ss_pred             ceEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          468 PLLVYEFIPNGTLFQYIHDQN---EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                      .+++|||+++|+|.+++....   ....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999885321   2234899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccccCCcee-eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          545 ASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       545 l~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      +++......... .....+++.|++||++....++.++||||||+++|||++ |+.||......+   +..    .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~----~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYD----YLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHcC
Confidence            998764333221 122335678999999999999999999999999999999 889987533211   111    11111


Q ss_pred             hhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       623 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                               .....+...+..+.+++.+||+.||++|||+.|++++|+++
T Consensus       231 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 ---------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     11112234566799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.8e-38  Score=326.44  Aligned_cols=267  Identities=27%  Similarity=0.407  Sum_probs=206.7

Q ss_pred             CCcCceeceeCcEEEEEEEe-----CCCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecC--cceE
Q 043157          399 FNLNRILGQGGQGTVYKGML-----PDGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETE--VPLL  470 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~l  470 (684)
                      |++.+.||+|+||+||++..     .+++.||+|..+... ....+.+.+|+++++.++||||+++++++.+.+  ..++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988653     357789999876543 345677889999999999999999999887543  5789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      +|||+++++|.+++...    .+++..++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999999999999764    2899999999999999999999999   9999999999999999999999999987654


Q ss_pred             cCCce--eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          551 VDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       551 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      .....  ......++..|+|||.+....++.++||||||++++||+||..|+......... .............+.+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhhhh
Confidence            32221  112223566799999998888999999999999999999999998643321100 000000001111222222


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      +.......+...+.++.+++.+||+.+|++|||++++++.|+.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            222222234456788999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.7e-38  Score=321.88  Aligned_cols=254  Identities=24%  Similarity=0.370  Sum_probs=205.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ++|++.++||+|+||+||+|.+++...||+|+.+.... ..+++.+|++++++++||||+++++.+. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            56899999999999999999987777899998875332 3367899999999999999999999874 456899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.+++.+... ..+++..++.++.|+++||+|||+.+   ++|+||||+||++++++.+||+|||+++.........
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          84 KGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            9999999986432 24799999999999999999999998   9999999999999999999999999997654333222


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....++..|++||++.+..++.++||||||+++|||+| |+.||......+.   ..             .+.......
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~-------------~~~~~~~~~  223 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LD-------------QVERGYRMP  223 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HH-------------HHhcCCCCC
Confidence            223346778999999988889999999999999999999 8888864432211   00             000000111


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ...+.+..+.+|+.+||+.||++||+++++++.|+..
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            2245567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.1e-38  Score=341.34  Aligned_cols=251  Identities=25%  Similarity=0.348  Sum_probs=204.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.++||+|+||+||++... +++.+|+|.+..   ......+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            457999999999999999999965 688999998753   2234456688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++|+|.+++...    .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999999754    2788889999999999999999999   99999999999999999999999999976543


Q ss_pred             CCceeeecccccCCCCCccccccC----CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSS----QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ..........||+.|+|||++...    .++.++||||||+++|||++|+.||........      +         ..+
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~---------~~i  259 (370)
T cd05596         195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------Y---------SKI  259 (370)
T ss_pred             CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------H---------HHH
Confidence            333233445699999999998653    478899999999999999999999975443211      0         111


Q ss_pred             hhhhhhccC--ChhHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 043157          628 LDARVMKES--GGDEIITFAKVAKRCLNLNGKK--RPTMREVTSE  668 (684)
Q Consensus       628 ~d~~~~~~~--~~~~~~~l~~Li~~cl~~dp~~--RPt~~evl~~  668 (684)
                      .+.......  ....+.++.+|+.+||+.+|++  ||+++|++++
T Consensus       260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         260 MDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            111100111  1245678999999999999988  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-38  Score=338.14  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=206.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +++.||+|+++..   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999865 6889999987642   2345567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++.+...  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999987633  4899999999999999999999999   999999999999999999999999999876544


Q ss_pred             CceeeecccccCCCCCccccc------cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFR------SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      .........||+.|+|||++.      ...++.++||||||+++|||++|+.||........      +...........
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~  229 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRFLK  229 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCccC
Confidence            443444456899999999986      45678999999999999999999999975443221      111111100000


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                             .......+.++.+|+.+||+ +|++|||+++++++
T Consensus       230 -------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         230 -------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                   01112356778999999997 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=351.11  Aligned_cols=264  Identities=23%  Similarity=0.344  Sum_probs=219.8

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeCCC-cEEEEEeccccChhHHHHHHHHHHHHhhcC-CCcccceee-eeeec-----
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLPDG-KIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVVKLLG-CCLET-----  465 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~-~~~~~-----  465 (684)
                      ....++++.+.|.+|||+.||++....+ ..+|+|++-..++..++...+||++|++|+ |+|||.+++ .....     
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3445778899999999999999997655 999999999999999999999999999996 999999999 33321     


Q ss_pred             -CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          466 -EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       466 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                       -..+|.||||.+|.|.+++....... |++.++++|+.++++|+++||... +||||||||-+||||+.++..||+|||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence             24579999999999999999765443 999999999999999999999988 569999999999999999999999999


Q ss_pred             CccccccCCc--eee------ecccccCCCCCcccc---ccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 043157          545 ASRSMAVDQT--HMT------TQVHGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAA  613 (684)
Q Consensus       545 l~~~~~~~~~--~~~------~~~~gt~~y~aPE~~---~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~  613 (684)
                      .+......-.  ...      -...-|+-|.|||.+   .+...++|+|||+|||+||-|+....||....         
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------  262 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------  262 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---------
Confidence            9865332211  100      012258899999975   56789999999999999999999999997331         


Q ss_pred             HHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCC
Q 043157          614 YFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGA  678 (684)
Q Consensus       614 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~  678 (684)
                                -..|++..........++..+.+||+.||+.||++||++-||+.++..|..+...
T Consensus       263 ----------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  263 ----------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             ----------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence                      1345555554444468999999999999999999999999999999988865443

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.8e-38  Score=329.62  Aligned_cols=263  Identities=27%  Similarity=0.431  Sum_probs=212.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC--------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeec
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP--------DGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCLET  465 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~  465 (684)
                      .++|.+.+.||+|+||.||++...        +...+|+|..+.. ......++.+|+++++.+ +||||+++++++.+.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357999999999999999999742        2357999988753 344567789999999999 799999999999999


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL  532 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl  532 (684)
                      ...++||||+++++|.+++.....             ...+++..+++++.|++.||+|||+.+   ++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999986432             124889999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhh
Q 043157          533 DDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKS  610 (684)
Q Consensus       533 ~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~  610 (684)
                      +.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....++.  
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~--  251 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--  251 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--
Confidence            99999999999998765322111 1112234568999999998889999999999999999998 8899865443221  


Q ss_pred             HHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          611 LAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       611 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                                    .+.+......+.+...+.++.+|+.+||+.+|++|||+.|+++.|+.|...+.
T Consensus       252 --------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         252 --------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             --------------HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence                          11111111122334556789999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-37  Score=323.73  Aligned_cols=257  Identities=23%  Similarity=0.402  Sum_probs=205.0

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCc----EEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGK----IVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      +|++.+.||+|+||+||+|.+. +++    .+++|+..... .....++.+|+..+++++||||+++++++. ....+++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i   86 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV   86 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence            5778899999999999999864 444    47788775432 334567888999999999999999999875 4567899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      +||+++|+|.+++.....  .+++..++.++.||+.||+|||+.+   ++||||||+|||+++++.+||+|||+++....
T Consensus        87 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          87 TQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999999986543  4899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          552 DQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       552 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ... .......++..|++||++.+..++.++||||||+++|||++ |+.||.........                +++.
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~----------------~~~~  225 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP----------------DLLE  225 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----------------HHHH
Confidence            222 22233456778999999998899999999999999999998 99999755432211                1111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .......+...+.++.+++.+||..||++|||+.|+++.|..+....
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         226 KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             CCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            11111112234557889999999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.1e-38  Score=332.94  Aligned_cols=243  Identities=27%  Similarity=0.366  Sum_probs=199.3

Q ss_pred             CceeceeCcEEEEEEEe----CCCcEEEEEecccc----ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          402 NRILGQGGQGTVYKGML----PDGKIVAVKKSKVI----DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .++||+|+||+||++..    .+++.||+|.++..    .......+.+|+.+|++++||||+++++.+.+++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36899999999999985    35789999987642    22344667899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++++|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          81 YLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999999998654   3788899999999999999999999   9999999999999999999999999987543222


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      . ......|++.|+|||++.+..++.++||||||+++|||++|+.||........               +..+....  
T Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---------------~~~~~~~~--  216 (323)
T cd05584         155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---------------IDKILKGK--  216 (323)
T ss_pred             C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---------------HHHHHcCC--
Confidence            2 23345689999999999988899999999999999999999999975432211               01111111  


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      ...+...+..+.+|+.+||+.||++||     ++++++++
T Consensus       217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            122344567889999999999999999     88888774

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=340.62  Aligned_cols=252  Identities=25%  Similarity=0.348  Sum_probs=202.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +++.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999965 6899999988642   2345567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999998654   3899999999999999999999999   999999999999999999999999998754321


Q ss_pred             Cce-------------------------------------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh
Q 043157          553 QTH-------------------------------------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT  595 (684)
Q Consensus       553 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt  595 (684)
                      ...                                     ......||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            100                                     0112358999999999999999999999999999999999


Q ss_pred             CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 043157          596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPT---MREVTSE  668 (684)
Q Consensus       596 G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt---~~evl~~  668 (684)
                      |+.||......+..      .......       ...........+.++.+|+.+||. +|.+|++   ++|++++
T Consensus       235 G~~Pf~~~~~~~~~------~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQETY------RKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHHHHH------HHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99999755432210      0000000       000001112346678899999996 9999998   8888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9e-38  Score=324.63  Aligned_cols=256  Identities=27%  Similarity=0.434  Sum_probs=208.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC------CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .++...++||+|+||+||++...      ++..+|+|..........+.+.+|+++++.++||||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46788999999999999999632      356899998887777778899999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcE
Q 043157          471 VYEFIPNGTLFQYIHDQNED------------FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA  538 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~  538 (684)
                      +|||+++++|.+++......            ..+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            99999999999999865321            24889999999999999999999999   9999999999999999999


Q ss_pred             EEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHH
Q 043157          539 KVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFL  616 (684)
Q Consensus       539 kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~  616 (684)
                      ||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |++||......+.        
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--------  233 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--------  233 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--------
Confidence            99999998765432221 1222335678999999998899999999999999999998 8999864332211        


Q ss_pred             HHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       617 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                              .+..........+...+..+.+|+.+||+.||++||+++||++.|+.
T Consensus       234 --------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         234 --------IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             --------HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                    01111111112223456779999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-37  Score=320.08  Aligned_cols=256  Identities=23%  Similarity=0.388  Sum_probs=209.3

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ..++|++.++||+|+||.||++...++..+++|..... ....+.+.+|++++++++|+||+++++.+.+ ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            34678999999999999999999877888999987643 3345789999999999999999999999887 778999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++..... ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            999999999986532 34889999999999999999999998   99999999999999999999999999876543332


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      .......++..|+|||++....++.++|+||||+++|++++ |+.||........   .             +.+.....
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~-------------~~~~~~~~  221 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---I-------------RALERGYR  221 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---H-------------HHHhCCCC
Confidence            22233345678999999988889999999999999999999 9999875432211   0             01111111


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      .......+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            122344567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=318.45  Aligned_cols=250  Identities=30%  Similarity=0.489  Sum_probs=208.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ++|++.+.||.|++|.||++... ++.||+|..+.... ..+++.+|+.+++.++|+||+++++++.+....++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            46888999999999999999874 78899999876544 56789999999999999999999999999899999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.+++..... ..+++..++.++.|++.||.|||+.+   ++|+||||+|||+++++.+||+|||+++.......  
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999999986543 24899999999999999999999999   99999999999999999999999999986532211  


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                        ....+..|+|||++....++.++||||||++++||++ |+.||......+.                .+.+.......
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~  219 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------------VPHVEKGYRME  219 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH----------------HHHHhcCCCCC
Confidence              2234667999999988889999999999999999997 9999875433221                11111111112


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      .+...+..+.+++.+||..+|++||+++|++++|++|
T Consensus       220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            2334567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.7e-37  Score=320.51  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=209.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC----CcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD----GKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|.+.+.||+|+||.||+|.+.+    ...|++|+..... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            468889999999999999998643    2468999877644 5567789999999999999999999998865 557899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   ++|+||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            999999999999986543  3899999999999999999999998   99999999999999999999999999886654


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ..........++..|+|||.+....++.++||||||++++||++ |+.||......+.   ...    ...         
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~----~~~---------  223 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGR----IEN---------  223 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----HHc---------
Confidence            43333333345678999999988889999999999999999986 9999975543221   000    000         


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      ......+...+..+.+++.+||..+|++|||+.|+++.|+.++..+
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         224 GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            0011123455678999999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7e-38  Score=340.13  Aligned_cols=250  Identities=22%  Similarity=0.296  Sum_probs=200.3

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .|++.+.||+|+||+||++... +++.||+|++...   .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999854 6889999988642   34556789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++|+|.+++.+..   .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++++||+|||+++......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999998654   3889999999999999999999999   9999999999999999999999999975431100


Q ss_pred             ----------------------------------------------ceeeecccccCCCCCccccccCCCCCccchhhhH
Q 043157          554 ----------------------------------------------THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFG  587 (684)
Q Consensus       554 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlG  587 (684)
                                                                    ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence                                                          0011234699999999999988899999999999


Q ss_pred             HHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh--hhhccCChhHHHHHHHHHHHhh--ccCCCCCCCHH
Q 043157          588 VVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA--RVMKESGGDEIITFAKVAKRCL--NLNGKKRPTMR  663 (684)
Q Consensus       588 vil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~l~~Li~~cl--~~dp~~RPt~~  663 (684)
                      +++|||++|+.||......+..               ..++..  ..........+.++.+|+.+++  ..++..||+++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~---------------~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQ---------------LKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHH---------------HHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            9999999999999755432211               011110  0001111235667889998855  45555699999


Q ss_pred             HHHHH
Q 043157          664 EVTSE  668 (684)
Q Consensus       664 evl~~  668 (684)
                      |++++
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99886

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.7e-37  Score=318.24  Aligned_cols=245  Identities=29%  Similarity=0.435  Sum_probs=199.3

Q ss_pred             eeceeCcEEEEEEEe---CCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCC
Q 043157          404 ILGQGGQGTVYKGML---PDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       404 ~LG~G~~g~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      .||+|+||+||+|.+   ++++.+|+|+++..  +....+++.+|+.+++.+.||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999974   35788999987643  3445678999999999999999999999875 45678999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee-
Q 043157          479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT-  557 (684)
Q Consensus       479 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~-  557 (684)
                      +|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......... 
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999997653   3899999999999999999999999   99999999999999999999999999987654332211 


Q ss_pred             -ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          558 -TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       558 -~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                       ....++..|+|||.+....++.++||||||+++|||++ |+.||......+   +             .+.+.......
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~-------------~~~i~~~~~~~  218 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---V-------------TQMIESGERME  218 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H-------------HHHHHCCCCCC
Confidence             12234578999999988889999999999999999998 999997543221   1             11111111122


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      .+...+.++.+|+.+||+.||++||++.+|.+.|++
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            334566789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-37  Score=326.99  Aligned_cols=264  Identities=25%  Similarity=0.420  Sum_probs=212.4

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC--------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeeee
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP--------DGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCLE  464 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~  464 (684)
                      ..++|.+.+.||+|+||.||++...        ++..||+|..... .....+++.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3456889999999999999999731        3457999987643 345567899999999999 89999999999999


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL  531 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NIL  531 (684)
                      ....+++|||+++++|.+++.....             ...+++..++.++.||++||+|||+++   ++||||||+|||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            9999999999999999999986421             134788999999999999999999999   999999999999


Q ss_pred             ECCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhh
Q 043157          532 LDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDK  609 (684)
Q Consensus       532 l~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~  609 (684)
                      +++++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||......+..
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  249 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  249 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            999999999999999866433222 1222345678999999988889999999999999999998 78888654332211


Q ss_pred             hHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          610 SLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       610 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                                      +.+........+...+.++.+|+.+||+.+|++||++.|+++.|++|.....
T Consensus       250 ----------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         250 ----------------KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             ----------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence                            1111111112233556789999999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.6e-37  Score=320.31  Aligned_cols=256  Identities=26%  Similarity=0.455  Sum_probs=207.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CC---cEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DG---KIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .++|+..+.||+|+||.||+|... ++   ..+|+|+.+.. .....+++.+|++++++++||||+++++++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346888999999999999999865 33   37999988654 34556789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++++|.+++.....  .+++..+..++.|++.||+|||+.+   ++|+||||+|||+++++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999986543  4899999999999999999999998   9999999999999999999999999987654


Q ss_pred             cCCceeee--cccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          551 VDQTHMTT--QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       551 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ........  ....+..|+|||++....++.++||||||+++|||++ |+.||......+   +..    .+.       
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~----~i~-------  224 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMK----AIN-------  224 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHH----HHh-------
Confidence            32222111  1123457999999988889999999999999999997 999986443211   110    111       


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                        .........+.+.++.+++.+||+.+|++||++.+|++.|+++
T Consensus       225 --~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         225 --DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              1011112234567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.2e-38  Score=334.49  Aligned_cols=242  Identities=24%  Similarity=0.302  Sum_probs=199.2

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      +.||+|+||+||++... +++.||+|.++..   .......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999854 7899999987642   3345567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       479 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      +|.+++....   .+++..++.++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~  153 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM  153 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence            9999987653   38999999999999999999997 67   99999999999999999999999999875432222 22


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||.....++....               +...  ....+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~---------------i~~~--~~~~p  216 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---------------ILME--EIRFP  216 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH---------------HhcC--CCCCC
Confidence            334689999999999999999999999999999999999999975443221100               0000  01123


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      ...+.++.+|+.+||+.||++|+     +++|++++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            34567889999999999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-37  Score=322.97  Aligned_cols=257  Identities=28%  Similarity=0.408  Sum_probs=206.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC------CcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD------GKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      .++|.+.+.||+|++|.||+|.+.+      +..|++|...... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678999999999999999998653      5678999876533 44456799999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC---cEEEe
Q 043157          469 LLVYEFIPNGTLFQYIHDQNE----DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---RAKVS  541 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~  541 (684)
                      ++||||+++++|.+++++...    ...+++..+++++.||+.||+|||+.+   ++||||||+|||++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999987532    124899999999999999999999999   99999999999998654   69999


Q ss_pred             ccCCccccccCCcee-eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHh
Q 043157          542 DFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAM  619 (684)
Q Consensus       542 DFgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~  619 (684)
                      |||+++......... ......+..|+|||++.+..++.++||||||+++|||++ |+.||...+.++.           
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-----------  230 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-----------  230 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----------
Confidence            999998653222111 112223567999999998899999999999999999997 9999875443221           


Q ss_pred             hhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          620 KEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       620 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                           .+.+........+...+..+.+++.+||+.+|++||++.||+++|+.
T Consensus       231 -----~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         231 -----MEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             -----HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                 11111111112234456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.4e-38  Score=339.21  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=203.2

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ..++|++.+.||+|+||.||++... +++.+|+|.+..   ......+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3467999999999999999999965 588999998753   233345668899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++|+|.+++...    .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999999754    2788999999999999999999999   9999999999999999999999999998764


Q ss_pred             cCCceeeecccccCCCCCccccccC----CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSS----QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ...........||+.|+|||++...    .++.++||||||++||||++|+.||........      +         ..
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~---------~~  258 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------Y---------SK  258 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------H---------HH
Confidence            3333333456799999999998654    378899999999999999999999975543211      0         11


Q ss_pred             hhhhhhhccCC--hhHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 043157          627 ILDARVMKESG--GDEIITFAKVAKRCLNLNGKK--RPTMREVTSE  668 (684)
Q Consensus       627 ~~d~~~~~~~~--~~~~~~l~~Li~~cl~~dp~~--RPt~~evl~~  668 (684)
                      +.+.......+  ...+..+.+++.+||+.++.+  ||+++|++++
T Consensus       259 i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         259 IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            11111111111  234677889999999755544  8899999887

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.9e-37  Score=318.40  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=205.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ++|.+.+.||+|++|+||++.++++..+|+|+..... ...+.+.+|+.++++++|||++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4688899999999999999998777789999876433 23467889999999999999999998875 456899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.++++.... ..+++..+..++.|++.||+|||+.+   ++|+||||+|||+++++.+||+|||++..........
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          84 KGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            9999999986432 34899999999999999999999998   9999999999999999999999999997654332222


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....++..|+|||++....++.++||||||+++|||++ |+.||......+.   ...             +.......
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~-------------~~~~~~~~  223 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ-------------VERGYRMP  223 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-------------HHcCCCCC
Confidence            223346678999999988889999999999999999999 8999875432211   000             00011111


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      .+...+..+.+++.+||+.||++||+++++++.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=318.28  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=205.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC-----hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID-----ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ++|++.+.||+|++|.||++.. .+++.+|+|......     ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5799999999999999999985 468999999765422     2245678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      |+||+++++|.+++....   .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999998654   3889999999999999999999999   9999999999999999999999999987653


Q ss_pred             cCCceee--ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          551 VDQTHMT--TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       551 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      .......  ....++..|+|||++.+..++.++||||||+++|||++|+.||......+.               .....
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~~~~~  220 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---------------IFKIA  220 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---------------HHHHh
Confidence            2221111  234578899999999998899999999999999999999999864322111               01111


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ........+...+..+.+++.+||..+|++|||++|++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            1111122344566789999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.2e-38  Score=338.57  Aligned_cols=261  Identities=25%  Similarity=0.314  Sum_probs=202.8

Q ss_pred             CCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC-----cce
Q 043157          398 NFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETE-----VPL  469 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~  469 (684)
                      +|++.++||+|+||+||++.. .+++.||+|++...  +....+++.+|+++++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999996 47899999987642  3345678899999999999999999999998776     789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+. ++|.+.+....   .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 68888886543   4899999999999999999999999   999999999999999999999999999865


Q ss_pred             ccCCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhh-----
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER-----  623 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~-----  623 (684)
                      ............+++.|+|||++.+. .++.++||||||+++|||++|+.||...........   .........     
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~g~~~~~~~~  230 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL---ITDLLGTPSLEAMR  230 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcCCCCHHHHH
Confidence            43333333344578999999998764 578999999999999999999999986554322111   111100000     


Q ss_pred             -----hhhhhhhh--------hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          624 -----LFEILDAR--------VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       624 -----~~~~~d~~--------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           ....+...        .........+.++.+|+.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                 00000000        0001123346778999999999999999999999976

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-38  Score=320.42  Aligned_cols=256  Identities=27%  Similarity=0.421  Sum_probs=209.5

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ..++|.+.++||+|+||+||++..++++.+|+|.+.... ...+++.+|+.++++++||||+++++++.+....++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            456799999999999999999998888899999877533 2346789999999999999999999999988899999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999999987532 24899999999999999999999998   99999999999999999999999999876543222


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      ........+..|+|||.+.+..++.++||||||++++||++ |+.||........  + .             .+.....
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~-~-------------~~~~~~~  222 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV--L-E-------------QVERGYR  222 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H-H-------------HHHcCCC
Confidence            22222234668999999998889999999999999999998 9999865432211  0 0             0000111


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      ...+...+.++.+++.+||+.+|++||+++|+.+.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            11223346689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-37  Score=339.16  Aligned_cols=265  Identities=24%  Similarity=0.412  Sum_probs=211.4

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcC-CCcccceeeee
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVI-DESKVEEFINEMVILSQIN-HRNVVKLLGCC  462 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~  462 (684)
                      +++...++|.+.++||+|+||.||++.+.      .++.||+|+++.. .....+.+.+|+++|.++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            34555567889999999999999999853      3468999998753 2334567899999999997 99999999999


Q ss_pred             eecCcceEEEEecCCCCHHHHHhhcCC-----------------------------------------------------
Q 043157          463 LETEVPLLVYEFIPNGTLFQYIHDQNE-----------------------------------------------------  489 (684)
Q Consensus       463 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-----------------------------------------------------  489 (684)
                      ......++||||+++|+|.+++++...                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            999999999999999999999976421                                                     


Q ss_pred             ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 043157          490 ------------------------------------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKS  527 (684)
Q Consensus       490 ------------------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp  527 (684)
                                                                ...+++..++.++.|++.||+|||+.+   ++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence                                                      124678888999999999999999988   99999999


Q ss_pred             CCEEECCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCh
Q 043157          528 TNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTL  605 (684)
Q Consensus       528 ~NILl~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~  605 (684)
                      +|||+++++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999976532221 11222346788999999998889999999999999999998 8999864432


Q ss_pred             hhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          606 EEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       606 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      .+.  +             .+.+........+...+.++.+|+.+||+.+|++||+++||++.|+++.
T Consensus       348 ~~~--~-------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NEQ--F-------------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hHH--H-------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            211  0             1111111111223345678999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.7e-37  Score=319.62  Aligned_cols=260  Identities=25%  Similarity=0.385  Sum_probs=210.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|++|.||++.. .+++.++||....   .+....+++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688899999999999999995 4789999997654   23445678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      ||+++++|.+++.... ....+++..++.++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999987522 2345899999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....+.. .+..         .+.+.   .
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~---------~~~~~---~  224 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCK---------KIEQC---D  224 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHhh---------hhhcC---C
Confidence            222 12234588899999999888899999999999999999999999864332110 0000         00000   0


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      .........+..+.+++.+||+.||++|||+.+|++.++++.
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            011112346678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.4e-38  Score=337.51  Aligned_cols=248  Identities=25%  Similarity=0.345  Sum_probs=196.5

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      +|+..++||+|+||+||++... +++.||||.+... .....+.+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4667789999999999999965 6899999987643 3344578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+..       .+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....... 
T Consensus       155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            999986432       2567788899999999999999999   99999999999999999999999999976543221 


Q ss_pred             eeecccccCCCCCcccccc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          556 MTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ......|+..|+|||++..     ...+.++||||||+++|||++|+.||......+...+..             .+..
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~-------------~~~~  290 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC-------------AICM  290 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH-------------HHhc
Confidence            1233468999999998743     234568999999999999999999997332211111100             0000


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ......+...+.++.+|+.+||+.||++|||++|++++-
T Consensus       291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp  329 (353)
T PLN00034        291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP  329 (353)
T ss_pred             cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            011122345667899999999999999999999999873

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-37  Score=326.99  Aligned_cols=260  Identities=25%  Similarity=0.419  Sum_probs=206.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCc--EEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGK--IVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|++.+.||+|+||+||+|.++ ++.  .+++|+.+.. .......+.+|++++.++ +||||+++++++.+++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46888999999999999999964 444  4677776543 344567889999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcE
Q 043157          472 YEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA  538 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~  538 (684)
                      |||+++++|.++++....             ...+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            999999999999986431             124889999999999999999999999   9999999999999999999


Q ss_pred             EEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHH
Q 043157          539 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLF  617 (684)
Q Consensus       539 kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~  617 (684)
                      ||+|||+++.....  .......++..|+|||++....++.++||||||+++|||+| |..||......+.   ..    
T Consensus       164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~----  234 (303)
T cd05088         164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YE----  234 (303)
T ss_pred             EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HH----
Confidence            99999998643211  11111224567999999988889999999999999999998 9999875433221   00    


Q ss_pred             HhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       618 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                               .+........+...+..+.+|+.+||+.+|++||++++++..|+++...+.
T Consensus       235 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         235 ---------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             ---------HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence                     000111111223355678999999999999999999999999988776543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.4e-37  Score=317.31  Aligned_cols=247  Identities=26%  Similarity=0.429  Sum_probs=198.6

Q ss_pred             eeceeCcEEEEEEEeC---CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCC
Q 043157          404 ILGQGGQGTVYKGMLP---DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT  479 (684)
Q Consensus       404 ~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gs  479 (684)
                      .||+|+||.||+|.+.   .+..||+|...... ....+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999753   35679999886643 344577999999999999999999999875 457899999999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeee-
Q 043157          480 LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT-  558 (684)
Q Consensus       480 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~-  558 (684)
                      |.+++.....  .+++..+++++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++........... 
T Consensus        81 L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999976433  4899999999999999999999998   999999999999999999999999999765433222111 


Q ss_pred             -cccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccC
Q 043157          559 -QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES  636 (684)
Q Consensus       559 -~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  636 (684)
                       ...++..|+|||.+....++.++||||||+++|||++ |+.||......+.                ...+........
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV----------------MSFIEQGKRLDC  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH----------------HHHHHCCCCCCC
Confidence             1223578999999988889999999999999999996 9999875432211                111111111223


Q ss_pred             ChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          637 GGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       637 ~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      +...+.++.+++.+||+.+|++||++.+|++.|+.+
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            345577899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.1e-37  Score=336.48  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=199.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +++.||+|++...   .....+.+.+|+.++++++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999865 6889999987642   2344567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++.+..   .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999998653   3899999999999999999999999   999999999999999999999999998754311


Q ss_pred             Cc----------------------------------eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCC
Q 043157          553 QT----------------------------------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEK  598 (684)
Q Consensus       553 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~  598 (684)
                      ..                                  .......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            10                                  00123469999999999999999999999999999999999999


Q ss_pred             CCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCC---CCCCHHHHHHH
Q 043157          599 PIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGK---KRPTMREVTSE  668 (684)
Q Consensus       599 P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~---~RPt~~evl~~  668 (684)
                      ||......+..      .......       ...........+.++.+|+.+++. +|+   .||+++|++++
T Consensus       235 Pf~~~~~~~~~------~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSETPQETY------KKVMNWK-------ETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCHHHHH------HHHHcCc-------CcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence            99754432211      0000000       000000011245577888888664 444   46899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.3e-37  Score=331.29  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=199.1

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ++||+|+||+||++... +++.||+|.++..   .....+.+.+|..+++++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999965 6889999988642   334556788999999998 799999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |+|.+++...+   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~  153 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TT  153 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-cc
Confidence            99999987653   3899999999999999999999999   99999999999999999999999999875322221 23


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhh--hhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED--KSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.  .....+....        +....  ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------ILEKQ--IR  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------HHcCC--CC
Confidence            345689999999999999999999999999999999999999974332211  0111111110        11111  12


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPT------MREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt------~~evl~~  668 (684)
                      .+...+.++.+|+.+||+.||++||+      ++|++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            23445677899999999999999997      6777654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-38  Score=339.03  Aligned_cols=252  Identities=23%  Similarity=0.327  Sum_probs=200.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.++||+|+||+||++... +++.||||++...   .....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36889999999999999999854 7899999987542   2345677889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++....   .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999998653   3889999999999999999999999   999999999999999999999999998632210


Q ss_pred             Cc----------------------------------------------eeeecccccCCCCCccccccCCCCCccchhhh
Q 043157          553 QT----------------------------------------------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSF  586 (684)
Q Consensus       553 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~Sl  586 (684)
                      ..                                              .......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00                                              00012458999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCC---CCHH
Q 043157          587 GVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKR---PTMR  663 (684)
Q Consensus       587 Gvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R---Pt~~  663 (684)
                      ||++|||++|+.||......+..      .......       ...........+.++.+|+.+||+ +|.+|   +++.
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~------~~i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETY------RKIINWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHH------HHHHccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            99999999999999754432210      0000000       000000112345678999999997 67765   5999


Q ss_pred             HHHHH
Q 043157          664 EVTSE  668 (684)
Q Consensus       664 evl~~  668 (684)
                      |++.+
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            99887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.9e-37  Score=318.34  Aligned_cols=255  Identities=25%  Similarity=0.428  Sum_probs=207.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC----CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP----DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .+|++.+.||+|+||.||+|.+.    .+..+|+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46888999999999999999853    2347999987653 244567899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999986543  4899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCceeeec--ccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          552 DQTHMTTQ--VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       552 ~~~~~~~~--~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ........  ..++..|++||++.+..++.++|+||||+++||+++ |+.||......+.   ..    .....      
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~----~~~~~------  225 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IK----AIEEG------  225 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HH----HHhCC------
Confidence            33322221  223567999999998899999999999999999886 9999875432211   00    01100      


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                         .....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       226 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 ---YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence               00111234567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.1e-37  Score=324.29  Aligned_cols=259  Identities=25%  Similarity=0.434  Sum_probs=209.0

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe------CCCcEEEEEeccccC-hhHHHHHHHHHHHHhhc-CCCcccceeeeeeecC
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKVID-ESKVEEFINEMVILSQI-NHRNVVKLLGCCLETE  466 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~  466 (684)
                      ..++|.+.+.||+|+||.||++..      ..+..+|+|..+... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            345799999999999999999974      134579999876543 44467899999999999 7999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..+++|||+++++|.++++.... ..+++.++..++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999986432 23899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          547 RSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       547 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      +........ ......++..|+|||.+....++.++||||||+++|||++ |+.||......+.  .             
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~-------------  253 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--F-------------  253 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--H-------------
Confidence            865433221 1222345778999999998889999999999999999998 9999875432211  0             


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      .+.++.......+...+.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         254 YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            011111111112234456899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2e-37  Score=323.40  Aligned_cols=262  Identities=26%  Similarity=0.408  Sum_probs=207.5

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecC
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETE  466 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  466 (684)
                      ...++|++.++||+|+||.||+|..+      .+..||+|...... ......+.+|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34578999999999999999999743      24579999876433 334556889999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEE
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNE-------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK  539 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k  539 (684)
                      ..++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            99999999999999999976321       234577888999999999999999999   99999999999999999999


Q ss_pred             EeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHH
Q 043157          540 VSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLF  617 (684)
Q Consensus       540 l~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~  617 (684)
                      |+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |..||.....++.   ..    
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~---~~----  232 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV---LK----  232 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----
Confidence            9999998765432221 1122235678999999998899999999999999999998 7888865432221   00    


Q ss_pred             HhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       618 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                              .+.+. .....+...+..+.+++.+||+.||++|||+.|+++.|++...
T Consensus       233 --------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         233 --------FVMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             --------HHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence                    00111 0111223445789999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.2e-37  Score=330.79  Aligned_cols=245  Identities=27%  Similarity=0.340  Sum_probs=197.7

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHH---hhcCCCcccceeeeeeecCcceEE
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVIL---SQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      |++.+.||+|+||+||++... +++.||||+++..   .....+.+.+|++++   +.++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567899999999999999865 6899999987642   233455677776665   566899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|..+++..    .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999999888653    3899999999999999999999999   99999999999999999999999999875332


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .. .......|++.|+|||++.+..++.++||||||+++|||++|+.||......+..               ..+....
T Consensus       154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~---------------~~i~~~~  217 (324)
T cd05589         154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF---------------DSIVNDE  217 (324)
T ss_pred             CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHHhCC
Confidence            22 2233456899999999999999999999999999999999999999755432210               0111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                        ...+...+..+.+++.+||+.||++||     ++.+++++
T Consensus       218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence              112334567789999999999999999     56666664

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-37  Score=330.46  Aligned_cols=242  Identities=27%  Similarity=0.365  Sum_probs=197.4

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ++||+|+||+||++..+ +++.||+|+++..   .....+.+.+|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999965 6889999987642   334566778899999877 699999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |+|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~  153 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT  153 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence            99999997654   3899999999999999999999999   99999999999999999999999999875432222 23


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.   ..            .+....  ...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~------------~i~~~~--~~~~  216 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FE------------AILNDE--VVYP  216 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HH------------HHhcCC--CCCC
Confidence            345689999999999999999999999999999999999999975543221   00            011111  1122


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTM------REVTSE  668 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~------~evl~~  668 (684)
                      ...+.++.+|+.+||+.||++||++      ++++++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            3456678999999999999999998      565554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8e-38  Score=349.42  Aligned_cols=257  Identities=26%  Similarity=0.349  Sum_probs=208.5

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC---
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETE---  466 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---  466 (684)
                      +...++|.+.+.||+|+||+||++.. .+++.||||++..  ........+.+|+.++..++|+||++++..+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34457899999999999999999985 4789999998764  34556678899999999999999999988775432   


Q ss_pred             -----cceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEE
Q 043157          467 -----VPLLVYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV  540 (684)
Q Consensus       467 -----~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl  540 (684)
                           ..++||||+++|+|.++++... ...++++..++.++.|++.||.|||+.+   |+||||||+||||+.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                 2579999999999999997642 2345899999999999999999999998   999999999999999999999


Q ss_pred             eccCCccccccCC-ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh
Q 043157          541 SDFGASRSMAVDQ-THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM  619 (684)
Q Consensus       541 ~DFgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~  619 (684)
                      +|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+.      +.   
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~---  255 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MH---  255 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HH---
Confidence            9999998654322 1223345699999999999999999999999999999999999999975433211      00   


Q ss_pred             hhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          620 KEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       620 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                            .++.. .....+...+.++.+|+.+||+.||++||++.+++++
T Consensus       256 ------~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 ------KTLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ------HHhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                  01110 1112334567789999999999999999999999875

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.5e-37  Score=330.02  Aligned_cols=247  Identities=24%  Similarity=0.331  Sum_probs=200.6

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCC-cccceeeeeeecCcceEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHR-NVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lv~  472 (684)
                      +|++.+.||+|+||+||+|... +++.||+|++...   .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999965 5789999987642   344567788999999999765 5888999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999997654   3889999999999999999999999   999999999999999999999999998753322


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .. ......||+.|+|||++.+..++.++||||||+++|||+||+.||......+.   .            ..+...  
T Consensus       155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~------------~~i~~~--  216 (324)
T cd05587         155 GK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---F------------QSIMEH--  216 (324)
T ss_pred             CC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H------------HHHHcC--
Confidence            22 23345689999999999999999999999999999999999999975442211   0            011111  


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTM-----REVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~-----~evl~~  668 (684)
                      ....+...+.++.+++.+||+.||++|++.     ++++++
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            112233456778999999999999999986     566554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-37  Score=323.72  Aligned_cols=255  Identities=24%  Similarity=0.380  Sum_probs=205.5

Q ss_pred             CCCcCceeceeCcEEEEEEEeC------CCcEEEEEeccccCh-hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVIDE-SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .|++.+.||+|+||+||+|...      +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4677889999999999999853      257899999875433 345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc
Q 043157          471 VYEFIPNGTLFQYIHDQN-------------EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR  537 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~  537 (684)
                      ++||+++++|.+++....             ....+++..+++++.|++.||+|||+++   |+||||||+|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            999999999999986321             1234888899999999999999999999   999999999999999999


Q ss_pred             EEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHH
Q 043157          538 AKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYF  615 (684)
Q Consensus       538 ~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~  615 (684)
                      +||+|||+++....... .......+++.|+|||++....++.++||||||+++|||++ |..||......+.       
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------  235 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV-------  235 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------
Confidence            99999999886543222 12223345778999999988889999999999999999998 8888865432211       


Q ss_pred             HHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       616 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                               .+.+........+.+.+..+.+|+.+||+.+|++||+++|++..|+.
T Consensus       236 ---------~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 ---------IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ---------HHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                     11111111112334567789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3e-37  Score=320.32  Aligned_cols=258  Identities=27%  Similarity=0.479  Sum_probs=207.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCc----EEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGK----IVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ++|++.++||+|+||+||+|.+. +++    .||+|..+.. .....+++.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            45888999999999999999853 444    4899987653 34456788999999999999999999999875 45789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ++||+++|+|.++++....  .+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 ~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            9999999999999986543  3899999999999999999999999   9999999999999999999999999998764


Q ss_pred             cCCcee-eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          551 VDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       551 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ...... .....++..|++||.+.+..++.++||||||+++|||++ |..||.......   +.             ..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~-------------~~~  224 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP-------------DLL  224 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH-------------HHH
Confidence            332221 112235678999999998899999999999999999998 899986443221   11             111


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      ........+...+.++.+++.+||+.||++||++.|+++.|+.+....
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         225 EKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             HCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            111111122345668899999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-37  Score=321.78  Aligned_cols=257  Identities=28%  Similarity=0.428  Sum_probs=208.7

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC------CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD------GKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      .++|++.+.||+|+||.||++...+      ++.+|+|..... .......+.+|+.+++.++||||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4578899999999999999998642      368999987653 334567889999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEe
Q 043157          469 LLVYEFIPNGTLFQYIHDQNE-------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS  541 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~  541 (684)
                      ++||||+++++|.+++.....       ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999999976432       124788999999999999999999998   9999999999999999999999


Q ss_pred             ccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHh
Q 043157          542 DFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAM  619 (684)
Q Consensus       542 DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~  619 (684)
                      |||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.||...+..+.   ..      
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~------  232 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LK------  232 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HH------
Confidence            9999876543322 12233346788999999988889999999999999999998 9999875443221   11      


Q ss_pred             hhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          620 KEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       620 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                             .+........+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus       233 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         233 -------FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                   111111112234457789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.3e-38  Score=310.78  Aligned_cols=263  Identities=23%  Similarity=0.292  Sum_probs=206.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhH--HHHHHHHHHHHhhcCCCcccceeeeeeec--CcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHRNVVKLLGCCLET--EVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv  471 (684)
                      +.|+..+.|++|.||.||+|+.+ ++++||+|+++...+..  --..++||.+|.+.+|||||.+-.+....  +..|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45788999999999999999964 78999999988744321  22357899999999999999998888644  468999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||++. +|..+++..+.  ++...+...+..|+++|++|||.+.   |+|||||++|+|+...|.+||+|||+||.+..
T Consensus       156 Me~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999975 89999998663  5899999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH--hhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA--MKEERLFEIL  628 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~  628 (684)
                      .... .+...-|..|.|||++.+ ..|+...|+||+|||+.||+++++-|.+....++  +...|...  ..+..+..+.
T Consensus       230 p~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--l~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  230 PLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--LDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             Cccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--HHHHHHHhCCCccccCCCcc
Confidence            6443 344557999999999876 5699999999999999999999999987664333  33322221  1111111111


Q ss_pred             hh--------------hhhccCChh-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          629 DA--------------RVMKESGGD-EIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       629 d~--------------~~~~~~~~~-~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..              .+...+... .++.-.+|+..+|..||.+|.|++|.+++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            10              011111111 44677899999999999999999998875

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.2e-37  Score=315.32  Aligned_cols=250  Identities=27%  Similarity=0.456  Sum_probs=207.3

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|++.+.||+|++|.||++..+ +++.|++|.+..  ......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999965 688999998764  3455677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.++++... ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999998752 235899999999999999999999998   99999999999999999999999999876543322


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                       ......+++.|+|||++.+..++.++|+||||++++||++|+.||......+   ..            ..+.. ....
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~------------~~~~~-~~~~  219 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LI------------LKIIR-GVFP  219 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HH------------HHHHc-CCCC
Confidence             2233458889999999999889999999999999999999999997544211   00            00110 1111


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..+...+..+.+++.+||+.+|++||++.|++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            2223456789999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.5e-37  Score=330.65  Aligned_cols=249  Identities=26%  Similarity=0.391  Sum_probs=197.9

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      +.||+|+||+||++... +++.+|+|.++..   .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999965 6789999987642   344556788899998877 899999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |+|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~  153 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT  153 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence            99999887653   3899999999999999999999999   99999999999999999999999999875332221 22


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhh--hhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED--KSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||........  .....+....        +...  ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~~--~~~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEK--QIR  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------HhcC--CCC
Confidence            345689999999999999999999999999999999999999964222111  0011111110        1111  112


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPT------MREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt------~~evl~~  668 (684)
                      .+...+..+.+|+.+||+.||++||+      +.+++++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            33455677899999999999999998      4676554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-37  Score=338.71  Aligned_cols=249  Identities=22%  Similarity=0.311  Sum_probs=199.3

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .|++.++||+|+||+||++... +++.+|+|++...   .....+.+.+|++++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999964 6889999987642   23456788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++|+|.+++.+..   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999998653   3889999999999999999999999   9999999999999999999999999975321000


Q ss_pred             ----------------------------------------------ceeeecccccCCCCCccccccCCCCCccchhhhH
Q 043157          554 ----------------------------------------------THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFG  587 (684)
Q Consensus       554 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlG  587 (684)
                                                                    ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                          0011234689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh--hhhhccCChhHHHHHHHHHHHhhccCCCCCCC---H
Q 043157          588 VVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD--ARVMKESGGDEIITFAKVAKRCLNLNGKKRPT---M  662 (684)
Q Consensus       588 vil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt---~  662 (684)
                      |+||||++|+.||...+..+..               ..++.  ...........+.++.+++.+++ .+|++|++   +
T Consensus       236 vil~elltG~~Pf~~~~~~~~~---------------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQ---------------MKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHH---------------HHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999999754432211               01111  00111111234567888888876 59999997   8


Q ss_pred             HHHHHH
Q 043157          663 REVTSE  668 (684)
Q Consensus       663 ~evl~~  668 (684)
                      .|++++
T Consensus       300 ~ei~~h  305 (382)
T cd05625         300 DEIKAH  305 (382)
T ss_pred             HHHhcC
Confidence            887764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.7e-37  Score=328.53  Aligned_cols=241  Identities=24%  Similarity=0.342  Sum_probs=194.6

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ++||+|+||+||++... +++.||+|.++..   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999965 5889999987642   233455666777777755 899999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~  153 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA  153 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence            99999997654   3899999999999999999999999   9999999999999999999999999997643322 233


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.   ..            .+...  ....+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~---~~------------~i~~~--~~~~~  216 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL---FD------------SILND--RPHFP  216 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH---HH------------HHHcC--CCCCC
Confidence            345689999999999998999999999999999999999999975443211   00            00000  11123


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMR-EVTS  667 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~-evl~  667 (684)
                      ...+.++.+|+.+||+.||++||++. ++++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            34566788999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.7e-37  Score=319.85  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=204.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      ++|++.+.||+|+||.||+|.. .+++.+|+|+...........+.+|+.++++++||||+++++.+...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4689999999999999999996 478899999887655556677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++++..   ++++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus        89 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          89 GGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            9999999997643   4899999999999999999999998   99999999999999999999999999976532221 


Q ss_pred             eeecccccCCCCCccccc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          556 MTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      ......++..|+|||.+.   ...++.++||||||+++|||++|+.||......+...       .+....   ...+..
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~---~~~~~~  231 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSN---FQPPKL  231 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCC---CCCCCC
Confidence            123345788999999874   3457889999999999999999999986332211100       000000   000000


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                        ......+..+.+++.+||+.+|++||++++++++|
T Consensus       232 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 --KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              11123567899999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-37  Score=327.64  Aligned_cols=266  Identities=23%  Similarity=0.338  Sum_probs=203.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|.+.+.||+|+||+||++..+ +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56889999999999999999865 67889999876533 22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++ +|.+++.....  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 88888876543  3789999999999999999999999   99999999999999999999999999876433222


Q ss_pred             eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh----
Q 043157          555 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD----  629 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----  629 (684)
                      . .....+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...+..+................+..+.+    
T Consensus       160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 T-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             c-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            1 223357889999998865 5688999999999999999999999986654332221111100000000000000    


Q ss_pred             -----hhh----hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          630 -----ARV----MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       630 -----~~~----~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                           +..    ........+.++.+|+.+||+.||++|||++|++++-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  287 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA  287 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence                 000    0001123466789999999999999999999999853

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.3e-37  Score=325.98  Aligned_cols=261  Identities=24%  Similarity=0.409  Sum_probs=209.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC--------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeec
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP--------DGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCLET  465 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~  465 (684)
                      .++|.+.++||+|+||.||++...        ....+|+|..+.. ......++.+|+++++++ +||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356889999999999999999742        2457899987753 344567889999999999 699999999999998


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL  532 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl  532 (684)
                      ...+++|||+++|+|.+++.....             ...+++..+.+++.|++.||.|||+++   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            999999999999999999976421             134889999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhh
Q 043157          533 DDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKS  610 (684)
Q Consensus       533 ~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~  610 (684)
                      ++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.. 
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-  246 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF-  246 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence            99999999999999865432211 1112224567999999988889999999999999999999 88998654332211 


Q ss_pred             HHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          611 LAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       611 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                                     +.+........+...+.++.+|+.+||+.+|++|||+.|+++.|+++...
T Consensus       247 ---------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         247 ---------------KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             ---------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence                           11111111122344566889999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=321.99  Aligned_cols=252  Identities=26%  Similarity=0.333  Sum_probs=204.5

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      +|++.++||+|+||+||++... +++.||+|++....   ......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999964 68899999876422   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++|+|.+++..... ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            9999999998876432 34899999999999999999999999   9999999999999999999999999987654322


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      .  .....|++.|+|||++.+..++.++||||||+++|||++|+.||..........            .+...+.. ..
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~------------~~~~~~~~-~~  221 (285)
T cd05605         157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE------------EVERRVKE-DQ  221 (285)
T ss_pred             c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH------------HHHHHhhh-cc
Confidence            2  123458999999999998889999999999999999999999997543221110            00011110 11


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      ...+...+..+.+|+.+||+.||++||     ++++++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            122345677899999999999999999     88898775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.6e-37  Score=329.41  Aligned_cols=242  Identities=24%  Similarity=0.327  Sum_probs=198.1

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ++||+|+||+||+|... +++.||+|.++..   .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 5789999987642   334556788899999876 799999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      ++|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~  153 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT  153 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence            99999997654   3899999999999999999999999   99999999999999999999999999875432222 23


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....|++.|+|||++.+..++.++||||||+++|||++|+.||......+..               ..+....  ...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~---------------~~i~~~~--~~~p  216 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF---------------ESILHDD--VLYP  216 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH---------------HHHHcCC--CCCC
Confidence            3456899999999999989999999999999999999999999855432210               0111111  0112


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRP-------TMREVTSE  668 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RP-------t~~evl~~  668 (684)
                      ...+.++.+|+.+||+.||++||       ++++++++
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            23456789999999999999999       78888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=329.75  Aligned_cols=265  Identities=24%  Similarity=0.366  Sum_probs=217.6

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChh-HHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDES-KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ..+...+.++||+|.||+|.+.....+..||||+++..... ...+|.+|+++|.+++||||++++|+|..++...+|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            34567788999999999999999988899999999875444 35899999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      ||++|+|.++|.++.... +......+|+.||+.||+||.+.+   ++||||.++|+|+++++++||+|||++|......
T Consensus       616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence            999999999999875432 455667789999999999999999   9999999999999999999999999999766554


Q ss_pred             ceeee-cccccCCCCCccccccCCCCCccchhhhHHHHHHHHh--CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          554 THMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT--GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       554 ~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt--G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      .+... ...-+.+|||||.+..++++.+||||+||++|||+++  ...||...+.+...   +.      ...+..-...
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en------~~~~~~~~~~  762 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---EN------AGEFFRDQGR  762 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---Hh------hhhhcCCCCc
Confidence            44333 3445789999999999999999999999999999876  77888754433211   10      1111111111


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ......+.-++..+.+|+.+||..|-++||+++++...|++.
T Consensus       763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            222334566788999999999999999999999999998764

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-37  Score=335.91  Aligned_cols=259  Identities=24%  Similarity=0.341  Sum_probs=205.1

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETE  466 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  466 (684)
                      ++....++|++.+.||+|+||.||++..+ +++.+|+|.+..   ......+.+.+|+.+++.++||||+++++.+.+..
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            33444578999999999999999999965 688999998753   23344566889999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..++||||+++|+|.+++...    .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            999999999999999999754    2788899999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCccccccC----CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSS----QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      +..............||+.|+|||++...    .++.++||||||+++|||++|+.||........      +...+...
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~  263 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNHK  263 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHcCC
Confidence            87654333333456699999999998653    378899999999999999999999975443211      11111100


Q ss_pred             hhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 043157          623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKK--RPTMREVTSEL  669 (684)
Q Consensus       623 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPt~~evl~~L  669 (684)
                      ....       .......+..+.+|+.+||..++.+  ||+++|++++.
T Consensus       264 ~~~~-------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         264 NSLT-------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             Cccc-------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            0000       0112346678899999999744433  78999998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-37  Score=316.95  Aligned_cols=250  Identities=26%  Similarity=0.439  Sum_probs=199.1

Q ss_pred             ceeceeCcEEEEEEEeCC-Cc--EEEEEeccc-cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLPD-GK--IVAVKKSKV-IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~-g~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      +.||+|+||.||+|.+++ +.  .+++|..+. ......+.+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999753 43  468887764 3345567899999999999 899999999999999999999999999


Q ss_pred             CCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          478 GTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       478 gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                      ++|.++++....             ...+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            999999976421             124789999999999999999999998   9999999999999999999999999


Q ss_pred             CccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhh
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEER  623 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~  623 (684)
                      ++......  ........+..|+|||++....++.++||||||++++||++ |..||......+.               
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---------------  220 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---------------  220 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH---------------
Confidence            98632211  11111223567999999988889999999999999999997 9999864332211               


Q ss_pred             hhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          624 LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       624 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                       .+.+......+.+...+.++.+|+.+||+.+|.+|||+.|++..|++|.
T Consensus       221 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         221 -YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -HHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence             1111111111223345567899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.6e-38  Score=338.94  Aligned_cols=251  Identities=22%  Similarity=0.301  Sum_probs=200.3

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      +|++.+.||+|+||+||++... +++.||+|.+...   .....+.+.+|+++|++++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6889999999999999999954 6899999987542   23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC-
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD-  552 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~-  552 (684)
                      |+++|+|.+++.+..   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++...... 
T Consensus        82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999998653   3889999999999999999999999   999999999999999999999999997532100 


Q ss_pred             -----------------------------------------CceeeecccccCCCCCccccccCCCCCccchhhhHHHHH
Q 043157          553 -----------------------------------------QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLA  591 (684)
Q Consensus       553 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~  591 (684)
                                                               .........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                     000112346899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 043157          592 ELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRP---TMREVTSE  668 (684)
Q Consensus       592 elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP---t~~evl~~  668 (684)
                      ||++|+.||......+....      ....       ............+.++.+++.+|+ .+|++|+   ++.|++++
T Consensus       236 ell~G~~Pf~~~~~~~~~~~------i~~~-------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLK------VINW-------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHH------Hhcc-------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999999976543221100      0000       000001111235567888999876 5999999   88999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.7e-37  Score=320.60  Aligned_cols=269  Identities=26%  Similarity=0.397  Sum_probs=206.0

Q ss_pred             CCCcCceeceeCcEEEEEEEe-----CCCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeec--Ccce
Q 043157          398 NFNLNRILGQGGQGTVYKGML-----PDGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPL  469 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~  469 (684)
                      .|++.+.||+|+||.||++..     .+++.||+|.++... ....+.+.+|++++++++||||+++++++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            478899999999999999974     357889999887543 44567899999999999999999999998775  5678


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+++++|.+++.+...  .+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence            99999999999999976533  4899999999999999999999999   999999999999999999999999999865


Q ss_pred             ccCCce--eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          550 AVDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       550 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||+|++.|............... ..........+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT-HGQMTVTRLVRV  238 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc-cccccHHHHHHH
Confidence            433221  12234467789999999888899999999999999999998876532111000000000 000000001111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      +........+...+..+.+|+.+||+.+|++|||++++++.|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111111122345677899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.8e-37  Score=317.75  Aligned_cols=254  Identities=26%  Similarity=0.441  Sum_probs=204.8

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CC---cEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DG---KIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .|++.+.||+|+||.||+|.+. ++   ..||+|..... .....++|.+|+.++++++||||+++++++.+....++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            4788999999999999999864 33   36999988753 4556788999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999986543  3899999999999999999999998   999999999999999999999999998765432


Q ss_pred             Ccee--eeccc--ccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          553 QTHM--TTQVH--GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       553 ~~~~--~~~~~--gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ....  .....  .+..|+|||++....++.++||||||+++||+++ |..||......+.   ..    ...       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~----~i~-------  225 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---IN----AIE-------  225 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HH----HHH-------
Confidence            2211  11111  2357999999999999999999999999999886 9999864432211   00    000       


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                        .......+.+.+..+.+++.+||+.+|++||++++++..|+++
T Consensus       226 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 --QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              0001112234567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.3e-37  Score=321.61  Aligned_cols=247  Identities=23%  Similarity=0.288  Sum_probs=198.6

Q ss_pred             eceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCH
Q 043157          405 LGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL  480 (684)
Q Consensus       405 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL  480 (684)
                      ||+|+||+||++... +++.+|+|++....   ....+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 68899999876422   23346778899999999999999999999999999999999999999


Q ss_pred             HHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeec
Q 043157          481 FQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ  559 (684)
Q Consensus       481 ~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~  559 (684)
                      .+++.... ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            98886532 2345899999999999999999999999   99999999999999999999999999876543322 2334


Q ss_pred             ccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChh
Q 043157          560 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGD  639 (684)
Q Consensus       560 ~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  639 (684)
                      ..|++.|+|||++.+..++.++||||||+++|||++|+.||.........  ..         ....++...  ...+..
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~---------~~~~~~~~~--~~~~~~  223 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KE---------LKQRILNDS--VTYPDK  223 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HH---------HHHhhcccC--CCCccc
Confidence            56899999999999999999999999999999999999999754321110  00         000111111  122345


Q ss_pred             HHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          640 EIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       640 ~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      .+..+.+++.+||+.||++||     +++|++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            677899999999999999999     77888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-37  Score=314.84  Aligned_cols=253  Identities=27%  Similarity=0.329  Sum_probs=209.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC-CcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||.|.-|+||++.+++ +..+|+|.+..   .......+...|-+||+.+.||.++.||..++.+...+|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            357788999999999999999764 68999998764   33555677788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc-
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~-  551 (684)
                      |||+||+|..+++++..+ .+++..++.++.+|+-||+|||-.|   ||.|||||+||||.++|++.|+||.|+..... 
T Consensus       157 eyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999999999987554 5999999999999999999999999   99999999999999999999999998753210 


Q ss_pred             --------------------------------C-C---------------------ceeeecccccCCCCCccccccCCC
Q 043157          552 --------------------------------D-Q---------------------THMTTQVHGTFGYLDPEYFRSSQF  577 (684)
Q Consensus       552 --------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  577 (684)
                                                      . .                     ........||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                     011123569999999999999999


Q ss_pred             CCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCC
Q 043157          578 TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGK  657 (684)
Q Consensus       578 ~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~  657 (684)
                      +.++|+|+|||+|||||.|..||.+....+               .+..++...+.-......+...++||++.|..||+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            999999999999999999999998765433               22333333332222346678899999999999999


Q ss_pred             CCCC----HHHHHHH
Q 043157          658 KRPT----MREVTSE  668 (684)
Q Consensus       658 ~RPt----~~evl~~  668 (684)
                      +|-.    +.||.++
T Consensus       378 kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRH  392 (459)
T ss_pred             hhhccccchHHhhcC
Confidence            9988    6665543

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-37  Score=321.78  Aligned_cols=263  Identities=25%  Similarity=0.389  Sum_probs=204.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC---------------CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceee
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD---------------GKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLG  460 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~  460 (684)
                      ++|++.+.||+|+||.||++....               ...||+|+.+.. .....+.+.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999987532               235899987653 3445678999999999999999999999


Q ss_pred             eeeecCcceEEEEecCCCCHHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 043157          461 CCLETEVPLLVYEFIPNGTLFQYIHDQNE---------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL  531 (684)
Q Consensus       461 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NIL  531 (684)
                      ++...+..++||||+++++|.+++.....         ...+++..+++++.|++.||+|||+.+   ++||||||+|||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            99999999999999999999999975421         123788999999999999999999999   999999999999


Q ss_pred             ECCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh--CCCCCCCCChhhh
Q 043157          532 LDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT--GEKPIRFTTLEED  608 (684)
Q Consensus       532 l~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt--G~~P~~~~~~~~~  608 (684)
                      +++++.+||+|||++......... ......++..|+|||++....++.++||||||++++||++  +..||.....++.
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            999999999999998765432221 1222345678999999988889999999999999999998  5567664332221


Q ss_pred             hhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       609 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      ..  . ...      .............+...+..+.+|+.+||+.||++||++++|++.|++
T Consensus       242 ~~--~-~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         242 IE--N-TGE------FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HH--H-HHH------hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            10  0 000      001001111111223456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.6e-37  Score=314.68  Aligned_cols=249  Identities=28%  Similarity=0.476  Sum_probs=203.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeee-ecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL-ETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lv~E~~  475 (684)
                      ++|++.+.||+|+||.||++... ++.+|+|..+..  ...+.+.+|+.++++++|+|++++++++. +.+..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888999999999999999864 778999987643  33567899999999999999999999765 445789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++++... ..+++..++.++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999999986543 24889999999999999999999999   9999999999999999999999999987543222  


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                        ....++..|+|||++....++.++||||||+++|||++ |+.||......+.   .             ..+......
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~-------------~~~~~~~~~  218 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V-------------PRVEKGYKM  218 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---H-------------HHHhcCCCC
Confidence              22234668999999998889999999999999999998 9999874432211   1             001111111


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|++|
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            22345567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.7e-37  Score=327.92  Aligned_cols=247  Identities=24%  Similarity=0.337  Sum_probs=200.4

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      +|++.+.||+|+||+||++... +++.||+|.+...   .....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999865 5789999987642   233455677888888887 5899999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999999997654   3899999999999999999999999   999999999999999999999999998754322


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .. ......||+.|+|||++....++.++||||||+++|||+||+.||......+.   .            ..+.... 
T Consensus       155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~------------~~i~~~~-  217 (323)
T cd05616         155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---F------------QSIMEHN-  217 (323)
T ss_pred             CC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---H------------HHHHhCC-
Confidence            21 23345689999999999999999999999999999999999999975443221   1            1111111 


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTM-----REVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~-----~evl~~  668 (684)
                       ...+...+.++.+|+.+||+.||++|++.     ++++++
T Consensus       218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence             11234456788999999999999999985     566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.3e-37  Score=320.55  Aligned_cols=264  Identities=25%  Similarity=0.400  Sum_probs=207.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC-----------------CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD-----------------GKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVK  457 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~  457 (684)
                      .++|++.+.||+|+||.||++....                 +..||+|++... .....+++.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578999999999999999988542                 246899987653 3455778999999999999999999


Q ss_pred             eeeeeeecCcceEEEEecCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 043157          458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE--------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN  529 (684)
Q Consensus       458 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~N  529 (684)
                      +++++..++..+++||++++++|.+++.+...        ...+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            99999999999999999999999999986541        124899999999999999999999998   9999999999


Q ss_pred             EEECCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh--CCCCCCCCChh
Q 043157          530 ILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT--GEKPIRFTTLE  606 (684)
Q Consensus       530 ILl~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt--G~~P~~~~~~~  606 (684)
                      ||++.++.+||+|||+++....... .......++..|+|||++....++.++||||||+++|||++  +..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876543222 12233446778999999988889999999999999999998  66777543321


Q ss_pred             hhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          607 EDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       607 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      .   ...........      .........+...+.++.+|+.+||+.||++|||+.||++.|++
T Consensus       241 ~---~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 Q---VIENAGHFFRD------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             H---HHHHHHhcccc------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            1   11111111000      01111111223455789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.9e-37  Score=314.99  Aligned_cols=252  Identities=28%  Similarity=0.464  Sum_probs=204.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ..|++.+.||+|+||.||++.+.+++.+|+|+...... ..+++.+|++++++++|||++++++++.+....+++|||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            35788899999999999999987788999998764322 24578999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.+++.....  .++++.++.++.|++.+|+|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999986543  3889999999999999999999999   9999999999999999999999999987654332222


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+   +..    ..         .......
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~---------~~~~~~~  221 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVE----TI---------NAGFRLY  221 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH----HH---------hCCCCCC
Confidence            222235678999999998889999999999999999998 999987443221   100    00         0000111


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      .+...+..+.+|+.+||+.+|++|||++|++++|.
T Consensus       222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            12234578999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.7e-37  Score=326.94  Aligned_cols=241  Identities=24%  Similarity=0.336  Sum_probs=195.0

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ++||+|+||.||++..+ +++.||+|.++..   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999965 6889999987642   123456677788888765 899999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |+|.+++....   .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA  153 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence            99999997653   3889999999999999999999999   9999999999999999999999999987532222 223


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.   ..    ....        .  ....+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~~----~~~~--------~--~~~~~  216 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---FE----SIRV--------D--TPHYP  216 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH----HHHh--------C--CCCCC
Confidence            345689999999999999999999999999999999999999975442211   00    0000        0  01122


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMR-EVTS  667 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~-evl~  667 (684)
                      ...+.++.+|+.+||+.||++||++. ++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            33556789999999999999999985 5653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.4e-37  Score=327.72  Aligned_cols=249  Identities=26%  Similarity=0.366  Sum_probs=198.6

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ++||+|+||+||++... +++.+|+|.++..   .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999965 6789999988642   334567788999999888 699999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT  153 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence            99999987653   3899999999999999999999999   99999999999999999999999999875332222 22


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....||+.|+|||++.+..++.++||||||++||||++|+.||...................        ...  ....+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~--~~~~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--------LEK--PIRIP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--------HhC--CCCCC
Confidence            34568999999999999999999999999999999999999996543222211111111111        111  11223


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTM------REVTSE  668 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~------~evl~~  668 (684)
                      ...+..+.+++.+||+.||++|+++      ++++++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            4456678999999999999999985      466554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-37  Score=314.53  Aligned_cols=269  Identities=23%  Similarity=0.325  Sum_probs=209.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChh--HHHHHHHHHHHHhhcCCCc-ccceeeeeeecC------
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDES--KVEEFINEMVILSQINHRN-VVKLLGCCLETE------  466 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~------  466 (684)
                      ..|...++||+|.||+||+|+. .+|+.||+|++....++  .-....+|+.+|+.++|+| |+++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3466678899999999999995 47899999998875442  3455689999999999999 999999998877      


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNED-FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                      ..+||+||++ .+|..++...... ..++...+..+..||+.||+|||+++   |+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            7889999995 6999999986532 34777899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH--hhhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA--MKEE  622 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~--~~~~  622 (684)
                      |+....+... .+...+|..|.|||++.+. .|+...||||+|+|+.||+++++-|.+....+  ++...|...  ..+.
T Consensus       167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFRIFRLLGTPNEK  243 (323)
T ss_pred             HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHHHHHHcCCCCcc
Confidence            9977644443 3344589999999998776 79999999999999999999999998766422  222222211  1111


Q ss_pred             hhhhhh---hh----------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 043157          623 RLFEIL---DA----------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGI  672 (684)
Q Consensus       623 ~~~~~~---d~----------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i  672 (684)
                      .+....   +-          +......+....+..+++.+||+.+|.+|.|++.++++  +..+
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            111111   10          00001111122478899999999999999999999997  5544

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-37  Score=328.24  Aligned_cols=255  Identities=22%  Similarity=0.361  Sum_probs=201.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +++.||+|.+..   ......+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999965 688999998753   23345567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++.+...  .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999976433  3899999999999999999999999   999999999999999999999999998765443


Q ss_pred             CceeeecccccCCCCCcccccc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      .........||+.|+|||++..     ..++.++||||||+++|||++|+.||......+.      ............ 
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~-  228 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQ-  228 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCccc-
Confidence            3333333468999999999863     4578899999999999999999999975432211      111111000000 


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKK--RPTMREVTSE  668 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPt~~evl~~  668 (684)
                           ........+..+.+|+.+||..++++  ||++++++++
T Consensus       229 -----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 -----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                 01111235677899999988654443  7899999887

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.8e-37  Score=328.81  Aligned_cols=262  Identities=27%  Similarity=0.417  Sum_probs=205.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe------CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecC-
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETE-  466 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~-  466 (684)
                      .++|++.+.||+|+||+||+|.+      .+++.||||+++.. .......+.+|+.++.++ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35799999999999999999973      35788999988753 234467788999999999 6899999999886544 


Q ss_pred             cceEEEEecCCCCHHHHHhhcCC---------------------------------------------------------
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNE---------------------------------------------------------  489 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------  489 (684)
                      ..+++|||+++|+|.++++....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            56899999999999999975321                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc-eeeeccc
Q 043157          490 -------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVH  561 (684)
Q Consensus       490 -------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~  561 (684)
                             ...+++..+..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||++........ .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   123688889999999999999999998   99999999999999999999999999876532222 1122233


Q ss_pred             ccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhH
Q 043157          562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE  640 (684)
Q Consensus       562 gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  640 (684)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||........  +.    ......         .....+...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~---------~~~~~~~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKEG---------TRMRAPDYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhcc---------CCCCCCCCC
Confidence            5678999999988899999999999999999997 9999865432211  00    011111         111112223


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          641 IITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       641 ~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      +.++.+++.+||+.||++|||+.|++++|+.+...
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            45789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=331.19  Aligned_cols=260  Identities=28%  Similarity=0.474  Sum_probs=222.5

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeCC---Cc--EEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLPD---GK--IVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEV  467 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~---g~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  467 (684)
                      .......+.++||+|.||.||+|...+   |+  .||||..+. ...+..+.|+.|..+|+.++||||++++|++.+ ..
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence            334456678899999999999998532   33  589998776 556668999999999999999999999999965 45


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .|+|||+.+.|.|.+||+..+..  |+......++.||..||+|||+..   .+||||..+|||+...--|||+|||++|
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eeEEEecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence            69999999999999999987664  888999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      .+..+.....+...-+..|||||.+.-..++.+||||.|||.+||++. |.+||.+...                ..+.-
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sDVI~  603 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SDVIG  603 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cceEE
Confidence            988777766666566789999999999999999999999999999986 9999985432                22223


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .++..-+...++.++..+..|+.+||..+|.+||.+.|+...|..+...
T Consensus       604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            3344444556788999999999999999999999999999999877753

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.3e-37  Score=315.88  Aligned_cols=260  Identities=25%  Similarity=0.365  Sum_probs=207.4

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      |++.+++++.....||+|+||.||+|... +++.|++|..........+.+.+|++++++++|+||+++++++...+..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            34556777888889999999999999954 67889999887766677788999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCcEEEeccCCccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRS  548 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgl~~~  548 (684)
                      +|+||+++++|.+++.........++..+..++.||+.||+|||+.+   |+||||||+||+++. ++.+||+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            99999999999999986533212378889999999999999999998   999999999999976 67999999999876


Q ss_pred             cccCCceeeecccccCCCCCccccccCC--CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ...... ......+++.|+|||++....  ++.++||||||+++|+|++|+.||.........   .           ..
T Consensus       159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~-----------~~  223 (268)
T cd06624         159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---M-----------FK  223 (268)
T ss_pred             cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---H-----------hh
Confidence            532222 122335789999999986543  788999999999999999999998643221110   0           00


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..........+...+.++.+++.+||+.+|++|||+.|++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         224 VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            000001112234456779999999999999999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-37  Score=311.80  Aligned_cols=247  Identities=26%  Similarity=0.478  Sum_probs=202.0

Q ss_pred             ceeceeCcEEEEEEEeCCCcEEEEEeccccCh-hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCHH
Q 043157          403 RILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE-SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF  481 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL~  481 (684)
                      ++||+|++|.||++...+++.|++|+...... ...+.+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            47999999999999987799999998776433 35678999999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee-ecc
Q 043157          482 QYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT-TQV  560 (684)
Q Consensus       482 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~-~~~  560 (684)
                      +++.....  .+++..++.++.+++.+|+|||+.+   ++||||||+|||++.++.+||+|||++........... ...
T Consensus        81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99976533  4789999999999999999999999   99999999999999999999999999876542221111 122


Q ss_pred             cccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChh
Q 043157          561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGD  639 (684)
Q Consensus       561 ~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  639 (684)
                      ..+..|+|||.+.+..++.++|+||||+++|||+| |..||.........                +.+........+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR----------------ERIESGYRMPAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH----------------HHHhcCCCCCCCcc
Confidence            24567999999988889999999999999999999 88888654322111                11111111122344


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          640 EIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       640 ~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      .+.++.+++.+||+.+|++|||+.||++.|+
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            5678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.7e-37  Score=319.80  Aligned_cols=257  Identities=25%  Similarity=0.450  Sum_probs=206.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      .++|++.+.||+|+||.||++..+      ++..+|+|.+.... .....++.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457899999999999999999853      46789999876533 34457799999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 043157          469 LLVYEFIPNGTLFQYIHDQNE-------------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN  529 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~N  529 (684)
                      +++|||+++++|.+++.....                   ...+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            999999999999999975321                   124788999999999999999999998   9999999999


Q ss_pred             EEECCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhh
Q 043157          530 ILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE  607 (684)
Q Consensus       530 ILl~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~  607 (684)
                      ||+++++.+||+|||+++....... ........+..|+|||.+.+..++.++||||||+++|||++ |..||.....++
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875432221 11222234667999999988899999999999999999997 888886443222


Q ss_pred             hhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       608 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      .   .    ......        . ....+...+.++.+|+.+||+.+|++|||++|+++.|++
T Consensus       241 ~---~----~~~~~~--------~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 V---I----YYVRDG--------N-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H---H----HHHhcC--------C-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1   0    011111        1 111233456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-37  Score=312.80  Aligned_cols=248  Identities=29%  Similarity=0.454  Sum_probs=199.8

Q ss_pred             ceeceeCcEEEEEEEeC-C---CcEEEEEeccccCh-hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-D---GKIVAVKKSKVIDE-SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ++||+|+||.||+|.+. .   +..+|+|....... ...+++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999753 2   26899998775433 45678999999999999999999999875 4567999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      ++|.+++....   .+++..++.++.|++.||+|||+.+   ++|+||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999998754   4899999999999999999999999   99999999999999999999999999986643332221


Q ss_pred             e--cccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          558 T--QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       558 ~--~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                      .  ...++..|+|||.+....++.++||||||+++|||++ |+.||...+..+   +...             +......
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~-------------~~~~~~~  217 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAM-------------LESGERL  217 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH-------------HHcCCcC
Confidence            1  1223567999999998899999999999999999998 999987543211   1111             1111111


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      ..+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            223445678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.2e-37  Score=326.70  Aligned_cols=242  Identities=25%  Similarity=0.349  Sum_probs=198.5

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      +.||+|+||+||++... +++.||+|.++..   .....+.+.+|+++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999865 5789999987642   334566778899999888 799999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      ++|.+++.+..   .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....... ..
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT  153 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence            99999988654   3899999999999999999999999   99999999999999999999999999875322222 22


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....|++.|+|||++.+..++.++||||||+++|||++|+.||......+.   ..            .+....  ...+
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~------------~i~~~~--~~~~  216 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQ------------SILEDE--VRYP  216 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HH------------HHHcCC--CCCC
Confidence            334589999999999999999999999999999999999999975442211   00            011111  1123


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTM-----REVTSE  668 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~-----~evl~~  668 (684)
                      ...+..+.+|+.+||+.||++||++     .+++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            3456788999999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-37  Score=329.51  Aligned_cols=238  Identities=28%  Similarity=0.322  Sum_probs=195.1

Q ss_pred             ceeceeCcEEEEEEEe----CCCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          403 RILGQGGQGTVYKGML----PDGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      +.||+|+||+||++..    .+++.+|+|++....  ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999874    357899999876422  2344567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +|+|.+++.+..   .+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++....... .
T Consensus        82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~  154 (318)
T cd05582          82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K  154 (318)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence            999999997643   4899999999999999999999999   99999999999999999999999999876543322 2


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccC
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES  636 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  636 (684)
                      .....|++.|+|||.+....++.++||||||+++|||++|+.||......+.   .            ..+....  ...
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~------------~~i~~~~--~~~  217 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---M------------TMILKAK--LGM  217 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---H------------HHHHcCC--CCC
Confidence            3345689999999999988899999999999999999999999975432211   0            0011110  112


Q ss_pred             ChhHHHHHHHHHHHhhccCCCCCCCHHH
Q 043157          637 GGDEIITFAKVAKRCLNLNGKKRPTMRE  664 (684)
Q Consensus       637 ~~~~~~~l~~Li~~cl~~dp~~RPt~~e  664 (684)
                      +...+..+.+|+.+||+.||++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            3345677899999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.7e-37  Score=323.22  Aligned_cols=262  Identities=29%  Similarity=0.425  Sum_probs=206.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.+.||+|+||+||++... +++.+|+|..... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999865 6788999987653 344567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      +++++|.++++...   .+++..+..++.|+++||+|||+. +   ++|+||||+|||++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            99999999998653   389999999999999999999984 6   999999999999999999999999998754322 


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh------------
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE------------  621 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~------------  621 (684)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+....   ...+......            
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCcccccC
Confidence              12334688999999999888899999999999999999999999875432211   1111000000            


Q ss_pred             --------hhhhhhhhhhh---hccCC-hhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          622 --------ERLFEILDARV---MKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       622 --------~~~~~~~d~~~---~~~~~-~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                              ....+..+...   ....+ ...+.++.+|+.+||+.+|++|||++|++++.-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                    00001111000   00111 124667999999999999999999999998853

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.7e-37  Score=323.51  Aligned_cols=265  Identities=24%  Similarity=0.356  Sum_probs=203.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|.+.+.||+|+||.||++..+ +++.||+|.++... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46889999999999999999865 68899999876433 23345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      ++ ++|.+++.....  .+++..++.++.|+++||+|||+.+   |+|+||||+|||+++++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 599999876543  3889999999999999999999999   99999999999999999999999999876443222


Q ss_pred             eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh---
Q 043157          555 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA---  630 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~---  630 (684)
                      . .....+++.|+|||.+.+ ..++.++||||||+++|||++|++||...+..+................+..+++.   
T Consensus       160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             c-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            1 222346889999998765 45788999999999999999999999866543321111100000001111111110   


Q ss_pred             ------hhh----ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 ------RVM----KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ------~~~----~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                            ...    .......+..+.+|+.+||+.||.+|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                  000    01112356678999999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.6e-37  Score=327.08  Aligned_cols=262  Identities=25%  Similarity=0.411  Sum_probs=210.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC--------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeec
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP--------DGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCLET  465 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~  465 (684)
                      ..+|++.+.||+|+||.||++...        ....||+|..+.. .....+++.+|+++++++ +||||+++++++.+.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            356899999999999999999742        1236899987643 344567899999999999 899999999999999


Q ss_pred             CcceEEEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQN-------------EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL  532 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl  532 (684)
                      +..+++|||+++|+|.+++.+..             ....+++..++.++.|++.||+|||+.+   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            99999999999999999997642             1234888999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhh
Q 043157          533 DDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKS  610 (684)
Q Consensus       533 ~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~  610 (684)
                      ++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++ |..||.....++.. 
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-  246 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-  246 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-
Confidence            99999999999998765432211 1122234567999999999999999999999999999998 88998754432211 


Q ss_pred             HHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          611 LAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       611 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                                     +.+........+...+.++.+|+.+||+.+|++||++.|+++.|+.+....
T Consensus       247 ---------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         247 ---------------KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             ---------------HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                           111111111223345678999999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.3e-37  Score=313.69  Aligned_cols=251  Identities=33%  Similarity=0.557  Sum_probs=202.3

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHH--HHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVE--EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      |++.+.||+|+||+||++... +++.+|+|...........  ...+|+.++++++||||+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567899999999999999976 5678999998876544433  3467999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++....   .+++..++.++.|+++||++||+.+   |+|+||||+|||++.++.++|+|||.+.... ....
T Consensus        81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE  153 (260)
T ss_dssp             TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred             ccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccc
Confidence            9999999998433   3899999999999999999999999   9999999999999999999999999987542 2223


Q ss_pred             eeecccccCCCCCccccc-cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          556 MTTQVHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                      ......++..|+|||.+. ....+.++||||||+++++|++|..||.............            +........
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~------------~~~~~~~~~  221 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE------------KILKRPLPS  221 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH------------HHHHTHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh------------hcccccccc
Confidence            344456899999999998 8889999999999999999999999998552222111110            000000000


Q ss_pred             cCC--hhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          635 ESG--GDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       635 ~~~--~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...  ......+.+++.+||+.||++||++.|++++
T Consensus       222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000  1123789999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.3e-37  Score=317.85  Aligned_cols=247  Identities=24%  Similarity=0.308  Sum_probs=195.9

Q ss_pred             eceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCH
Q 043157          405 LGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL  480 (684)
Q Consensus       405 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL  480 (684)
                      ||+|+||+||++..+ +|+.+|+|++...   .......+..|++++++++||||+++++.+.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 6899999987532   122344566799999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecc
Q 043157          481 FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV  560 (684)
Q Consensus       481 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~  560 (684)
                      .+++..... ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......  .....
T Consensus        81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~  154 (277)
T cd05607          81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR  154 (277)
T ss_pred             HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence            998876432 34899999999999999999999999   9999999999999999999999999987654322  22334


Q ss_pred             cccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhH
Q 043157          561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE  640 (684)
Q Consensus       561 ~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  640 (684)
                      .|+..|+|||++.+..++.++||||||+++|||++|+.||.........  ...         ....+..... ......
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~---------~~~~~~~~~~-~~~~~~  222 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EEL---------KRRTLEDEVK-FEHQNF  222 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHH---------HHHhhccccc-cccccC
Confidence            5899999999999888999999999999999999999999743321110  000         0011111110 011245


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          641 IITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       641 ~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      +.++.+|+.+||+.||++||+++|+++++
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            66789999999999999999997766444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.1e-37  Score=324.75  Aligned_cols=241  Identities=25%  Similarity=0.334  Sum_probs=194.6

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      +.||+|+||+||++... +++.||+|.++..   .....+.+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999965 5789999987642   233455677788888765 899999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |+|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT  153 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence            99999998643   3889999999999999999999999   99999999999999999999999999875332222 22


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.   ..    ....      ..    ...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~----~i~~------~~----~~~~  216 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---FQ----SIRM------DN----PCYP  216 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHh------CC----CCCC
Confidence            345689999999999998999999999999999999999999975443211   00    0000      00    0112


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMR-EVTS  667 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~-evl~  667 (684)
                      ...+.++.+++.+||+.||++||++. ++++
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            23456788999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.4e-38  Score=301.15  Aligned_cols=256  Identities=28%  Similarity=0.430  Sum_probs=209.4

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--------hhHHHHHHHHHHHHhhc-CCCcccceeeee
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--------ESKVEEFINEMVILSQI-NHRNVVKLLGCC  462 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  462 (684)
                      +..-.+|...+.||.|..++|-+..++ +|+..|+|++....        ..-.+.-.+|+.+|+++ .||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            334467888899999999999988754 68889999875421        22345667899999999 699999999999


Q ss_pred             eecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEec
Q 043157          463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD  542 (684)
Q Consensus       463 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D  542 (684)
                      +.+...++|+|.|+.|.|.|+|....   .++++..++|+.|+.++++|||.++   |+||||||+|||+|++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            99999999999999999999998765   4999999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCceeeecccccCCCCCccccc------cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH
Q 043157          543 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFR------SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL  616 (684)
Q Consensus       543 Fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~  616 (684)
                      ||++.....  ...-....|||+|+|||.+.      ...|+..+|+|+.||++|.|+.|.+||-..     +++.+  +
T Consensus       167 FGFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-----kQmlM--L  237 (411)
T KOG0599|consen  167 FGFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-----KQMLM--L  237 (411)
T ss_pred             cceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-----HHHHH--H
Confidence            999987653  33456678999999999874      346888999999999999999999998621     12111  1


Q ss_pred             HHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       617 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ..+.+++. ++     ..+.+.+.+.++.+||.+||+.||.+|.|++|++++-
T Consensus       238 R~ImeGky-qF-----~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  238 RMIMEGKY-QF-----RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             HHHHhccc-cc-----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence            11211111 11     2223456778899999999999999999999999874

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-36  Score=318.87  Aligned_cols=263  Identities=25%  Similarity=0.407  Sum_probs=204.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-----------------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-----------------DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKL  458 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l  458 (684)
                      ++|++.++||+|+||+||++...                 +...+|+|+.... .....+++.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999998532                 2346899988753 34456789999999999999999999


Q ss_pred             eeeeeecCcceEEEEecCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 043157          459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNE--------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI  530 (684)
Q Consensus       459 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NI  530 (684)
                      ++++...+..+++|||+++++|.+++.....        ...+++..++.++.|++.||+|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999986431        124778899999999999999999999   99999999999


Q ss_pred             EECCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh--CCCCCCCCChhh
Q 043157          531 LLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT--GEKPIRFTTLEE  607 (684)
Q Consensus       531 Ll~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt--G~~P~~~~~~~~  607 (684)
                      |+++++.+||+|||+++........ ......++..|++||......++.++||||||+++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            9999999999999998765432221 1222334678999999888889999999999999999998  677876433222


Q ss_pred             hhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       608 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      ..   ...      ...............+...+..+.+|+.+||+.||++||++.||++.|++
T Consensus       242 ~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 VI---ENT------GEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HH---HHH------HHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11   000      00000000011111223455789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.7e-37  Score=313.17  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=205.4

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      +|++.+.||+|+||.||++... +++.+|+|..+. ......+.+.+|+.+++.++||||+++++.+.+....+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788999999999999999965 688999998754 33455678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++..... ..+++..++.++.|++.||.|||+++   |+|+||||+|||+++++.++|+|||+++....... 
T Consensus        81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            99999999876432 34889999999999999999999999   99999999999999999999999999876543222 


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||........   .    .......         ...
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~----~~~~~~~---------~~~  219 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---I----LKVCQGS---------YKP  219 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---H----HHHhcCC---------CCC
Confidence            22334588899999999988899999999999999999999999975432211   0    0000110         111


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+...+..+.+|+.+||+.||++||+++|++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            223455678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.9e-37  Score=321.25  Aligned_cols=250  Identities=26%  Similarity=0.420  Sum_probs=206.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .+|++.+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4788999999999999999985 468899999887766666788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++++.    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            999999999753    3789999999999999999999999   99999999999999999999999999876433222 


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........  +..    ...        .......
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~----~~~--------~~~~~~~  237 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYL----IAT--------NGTPELQ  237 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHH----Hhc--------CCCCCCC
Confidence            12233588899999999988899999999999999999999999975432111  100    000        0000111


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+...+..+.+|+.+||..+|++||+++|++++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            223455678999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1e-36  Score=313.07  Aligned_cols=251  Identities=30%  Similarity=0.483  Sum_probs=196.6

Q ss_pred             ceeceeCcEEEEEEEeC----CCcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeee-ecCcceEEEEecC
Q 043157          403 RILGQGGQGTVYKGMLP----DGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCL-ETEVPLLVYEFIP  476 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lv~E~~~  476 (684)
                      +.||+|+||.||+|.+.    +...+|+|+... ......+.+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    235799998754 34456788999999999999999999999776 4556899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce-
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-  555 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~-  555 (684)
                      +++|.+++.+...  .+++..+..++.|+++||+|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999986543  2678888999999999999999998   999999999999999999999999998765332111 


Q ss_pred             --eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhC-CCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          556 --MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTG-EKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       556 --~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG-~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                        ......++..|+|||.+....++.++||||||+++|||++| .+||......+   +...            ..... 
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~------------~~~~~-  219 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVY------------LLQGR-  219 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH------------HhcCC-
Confidence              11223457789999999888999999999999999999995 55665322111   1110            00000 


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      ....+...+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus       220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            011122345679999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-37  Score=312.60  Aligned_cols=249  Identities=32%  Similarity=0.497  Sum_probs=205.6

Q ss_pred             ceeceeCcEEEEEEEeCC----CcEEEEEeccccChh-HHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLPD----GKIVAVKKSKVIDES-KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ++||+|+||.||++....    +..+++|........ ..+.+.+|+++++.++|+||+++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999999653    788999988764433 478899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          478 GTLFQYIHDQNE------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       478 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      ++|.+++.....      ...+++..++.++.|+++||+|||+++   ++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999987521      245899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          552 DQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       552 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ... .......++..|+|||.+....++.++||||||+++|||++ |..||......+.                .+.+.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------~~~~~  221 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV----------------LEYLR  221 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH----------------HHHHH
Confidence            321 22333457889999999988889999999999999999999 6999875532211                01111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      .......+...+.++.+++.+||+.+|++||++.|++++|+
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         222 KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             cCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            11112233455778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.7e-37  Score=326.94  Aligned_cols=237  Identities=26%  Similarity=0.366  Sum_probs=191.6

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHH-HHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMV-ILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      +.||+|+||+||++... +++.||+|++...   ......++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999965 6899999987642   2233345555555 56789999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |+|.+++.+..   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT  153 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence            99999998653   3899999999999999999999999   9999999999999999999999999987543222 223


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.      +         ..++...  ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~---------~~i~~~~--~~~~  216 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------Y---------DNILNKP--LRLK  216 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------H---------HHHHcCC--CCCC
Confidence            345689999999999999999999999999999999999999975432211      0         0111111  1122


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMR  663 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~  663 (684)
                      ...+..+.+++.+||+.||++||+++
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            34567899999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.3e-37  Score=318.16  Aligned_cols=271  Identities=26%  Similarity=0.404  Sum_probs=210.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-----CCcEEEEEeccccChh-HHHHHHHHHHHHhhcCCCcccceeeeeee--cCcc
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDES-KVEEFINEMVILSQINHRNVVKLLGCCLE--TEVP  468 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~  468 (684)
                      +.|++.+.||+|+||+||++.++     +++.+|+|.++..... ..+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35778899999999999999854     3678999988764443 57789999999999999999999999877  5578


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      +++|||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   ++|+||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999999987543  3899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCce--eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          549 MAVDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       549 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      .......  ......++..|++||.+.+..++.++||||||++++||++|+.|+..........+.. .........+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  237 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLE  237 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHH
Confidence            6532221  1112335567999999988899999999999999999999999986433221100000 000000111112


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      .+........+...+.++.+|+.+||+.+|++|||+.||+++|++|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            22222212223345578999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-36  Score=315.20  Aligned_cols=256  Identities=26%  Similarity=0.418  Sum_probs=207.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC------CCcEEEEEeccccChh-HHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVIDES-KVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      ++|++.+.||+|+||+||+++.+      +.+.+++|........ ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46888999999999999999854      3467999987654443 5678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEecc
Q 043157          470 LVYEFIPNGTLFQYIHDQNED------FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF  543 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF  543 (684)
                      +||||+++++|.++++.....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999865422      25899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          544 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       544 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      |+++..............++..|++||.+.+...+.++||||||+++++|++ |..||.......   ...    .... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~----~~~~-  233 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN----RLQA-  233 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH----HHHc-
Confidence            9987544333323333446778999999988888999999999999999998 788886432211   110    0110 


Q ss_pred             hhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       623 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                             .......+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       234 -------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 -------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                   11111122345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-36  Score=311.63  Aligned_cols=248  Identities=28%  Similarity=0.428  Sum_probs=202.2

Q ss_pred             ceeceeCcEEEEEEEeCC--C--cEEEEEeccccCh-hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLPD--G--KIVAVKKSKVIDE-SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ++||+|++|+||++.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3689998877555 667889999999999999999999999988 888999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce--
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--  555 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~--  555 (684)
                      ++|.+++.+... ..+++..++.++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++........  
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999987542 35899999999999999999999999   999999999999999999999999999876542221  


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                      ......++..|+|||++....++.++||||||+++|||++ |+.||...+..+.   ...   ...         .....
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~---~~~---------~~~~~  220 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKK---IDK---------EGERL  220 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH---HHh---------cCCcC
Confidence            1122346788999999999899999999999999999999 9999864433221   000   000         00111


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      ..+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            122345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6e-37  Score=326.61  Aligned_cols=255  Identities=22%  Similarity=0.338  Sum_probs=202.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.++||+|+||+||++..+ +++.+|+|.+..   ......+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36889999999999999999965 578899998753   22334556889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++.+...  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999987433  3899999999999999999999999   999999999999999999999999998765443


Q ss_pred             CceeeecccccCCCCCccccc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      .........||+.|+|||++.     ...++.++||||||+++|||++|+.||......+.      ............ 
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~~-  228 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKERFQ-  228 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCcccc-
Confidence            333334456999999999986     34678999999999999999999999975432221      111111000000 


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKK--RPTMREVTSE  668 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPt~~evl~~  668 (684)
                           ........+.++.+|+.+||..++++  |++++|++++
T Consensus       229 -----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 -----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                 01112345678899999999665554  6899999888

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.5e-37  Score=318.04  Aligned_cols=264  Identities=22%  Similarity=0.347  Sum_probs=202.2

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|++.+.||+|++|+||+|... +++.||+|+++..  +....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999965 6889999987643  233456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      ++ ++|.+++........+++..++.++.|+++||+|||+.+   ++|+||||+|||++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 689999876544446899999999999999999999999   99999999999999999999999999875533221


Q ss_pred             eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hh---------
Q 043157          555 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EE---------  622 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~---------  622 (684)
                       ......+++.|+|||.+.+ ..++.++||||||++++||+||+.||........  +...+.....  +.         
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhH
Confidence             1222346889999998865 4578999999999999999999999975443211  1111100000  00         


Q ss_pred             hhhhhhhh---hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          623 RLFEILDA---RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       623 ~~~~~~d~---~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ......+.   ..........+.++.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00000000   00011112356778899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-36  Score=315.97  Aligned_cols=251  Identities=27%  Similarity=0.403  Sum_probs=200.6

Q ss_pred             CCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          398 NFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      +|++.++||+|+||.||++.. .+++.+|+|..... .....+++.+|++++++++||||+++++.+...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            578889999999999999985 47889999987543 3445577999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|..+.       .+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||++......   
T Consensus        82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---  148 (279)
T cd06619          82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---  148 (279)
T ss_pred             CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence            999996552       2788889999999999999999999   999999999999999999999999998765322   


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.||.............        .....+.+......
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~--------~~~~~~~~~~~~~~  220 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL--------QLLQCIVDEDPPVL  220 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH--------HHHHHHhccCCCCC
Confidence            1233468899999999999899999999999999999999999996432211110000        00001111111111


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .....+.++.+++.+||+.+|++||+++|++++-
T Consensus       221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            1233556789999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.3e-37  Score=324.20  Aligned_cols=241  Identities=24%  Similarity=0.339  Sum_probs=196.7

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      +|+..+.||+|+||+||++... +++.||+|++...   .....+.+..|+.+++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3778899999999999999865 6889999987642   2344567888999998885 577888999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999997654   3899999999999999999999999   999999999999999999999999998754322


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .. ......||+.|+|||++.+..++.++||||||+++|||++|+.||........   .            ..+.... 
T Consensus       155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~------------~~i~~~~-  217 (323)
T cd05615         155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---F------------QSIMEHN-  217 (323)
T ss_pred             Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---H------------HHHHhCC-
Confidence            21 23345689999999999988999999999999999999999999975432211   0            1111111 


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTM  662 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~  662 (684)
                       ...+...+.++.+++.+||+.+|++|++.
T Consensus       218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence             12233456678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-36  Score=313.74  Aligned_cols=258  Identities=27%  Similarity=0.473  Sum_probs=208.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCc----EEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGK----IVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .+|++.+.||+|+||+||+|.++ +++    .+|+|...... .....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45788899999999999999864 333    58999876543 4556789999999999999999999999987 78899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++|+|.+++++...  .+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999999987543  3899999999999999999999988   9999999999999999999999999998765


Q ss_pred             cCCceee-ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          551 VDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       551 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ....... ....++..|+|||.+....++.++|+||||+++|||++ |+.||.....++..                +.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----------------~~~  224 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP----------------DLL  224 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH----------------HHH
Confidence            3322211 11223568999999988889999999999999999998 99999755432211                111


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      ........+...+..+.+++.+||..+|++||++.++++.|+++.+..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         225 EKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            111111122334567899999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-36  Score=316.10  Aligned_cols=251  Identities=26%  Similarity=0.338  Sum_probs=203.6

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      |++.+.||+|+||.||++... ++..+++|..........+.+.+|+++++.++||||+++++.+.+.+..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567788999999999999965 5788899988776677788899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      ++|.+++.+...  ++++..+..++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||++....... ...
T Consensus        87 ~~l~~~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~  160 (282)
T cd06643          87 GAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR  160 (282)
T ss_pred             CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence            999998876432  4899999999999999999999999   9999999999999999999999999987643221 122


Q ss_pred             ecccccCCCCCccccc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          558 TQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      ....++..|+|||++.     ...++.++||||||+++|||++|++||......+.  ..    .....        ...
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~----~~~~~--------~~~  226 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LL----KIAKS--------EPP  226 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HH----HHhhc--------CCC
Confidence            3345889999999974     34577899999999999999999999874432111  00    00000        000


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ....+...+.++.+++.+||+.||++||++.+++++-
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence            1112234567899999999999999999999998654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.5e-37  Score=326.18  Aligned_cols=255  Identities=22%  Similarity=0.344  Sum_probs=201.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +++.||+|.+..   ......+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46899999999999999999965 678999998754   22344566889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++.+...  .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999987433  3899999999999999999999999   999999999999999999999999999766544


Q ss_pred             CceeeecccccCCCCCcccccc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      .........|++.|+|||++..     ..++.++||||||++||||++|+.||......+.      ...........  
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~--  227 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEERF--  227 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCCcc--
Confidence            3333344569999999999865     4678899999999999999999999975432211      10111100000  


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKK--RPTMREVTSE  668 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPt~~evl~~  668 (684)
                         . ......+.+.++.+|+.+||..++++  |+++++++++
T Consensus       228 ---~-~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 ---Q-FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ---c-CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence               0 01111234678899999999866554  4688888776

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-36  Score=317.31  Aligned_cols=251  Identities=28%  Similarity=0.353  Sum_probs=202.7

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      |+..++||+|+||+||++... +++.+|+|++...   .....+.+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677899999999999999865 6889999987542   223345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++..... ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            999999999976432 34899999999999999999999998   99999999999999999999999999876443222


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                        .....|+..|+|||++.+..++.++||||||+++|||++|+.||...........            .....+ ....
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~------------~~~~~~-~~~~  222 (285)
T cd05630         158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE------------VERLVK-EVQE  222 (285)
T ss_pred             --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH------------HHhhhh-hhhh
Confidence              1234689999999999998999999999999999999999999975432111000            000100 0111


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPT-----MREVTSE  668 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt-----~~evl~~  668 (684)
                      ..+...+.++.+|+.+||+.||++|||     ++|++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            223345667899999999999999999     8898874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.8e-37  Score=339.00  Aligned_cols=260  Identities=23%  Similarity=0.349  Sum_probs=194.9

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeec--------C
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLET--------E  466 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~  466 (684)
                      ..+|++.++||+|+||+||+|... +++.||||++....    ....+|+.+|+.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999964 68899999875322    2345799999999999999999887432        1


Q ss_pred             cceEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-cEEEeccC
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFG  544 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFg  544 (684)
                      ..++||||+++ +|.+++... .....+++..++.++.||+.||+|||+.+   |+||||||+||||+.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            35689999974 787777542 22335899999999999999999999999   99999999999998654 79999999


Q ss_pred             CccccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh--
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE--  621 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~--  621 (684)
                      +++.......  .....||+.|+|||++.+ ..++.++||||||++||||++|++||......+.  +.... .....  
T Consensus       217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~-~~~~~p~  291 (440)
T PTZ00036        217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRII-QVLGTPT  291 (440)
T ss_pred             cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH-HHhCCCC
Confidence            9986543222  223458999999999865 4689999999999999999999999986543321  11111 11100  


Q ss_pred             -hhhh------------hhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          622 -ERLF------------EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       622 -~~~~------------~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       ..+.            .+....+....+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence             0000            0000111111223456789999999999999999999999866

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.9e-36  Score=311.68  Aligned_cols=249  Identities=27%  Similarity=0.483  Sum_probs=204.0

Q ss_pred             CCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccC------hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID------ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      +|+..+.||+|+||+||+|...+++.+|+|.++...      ....+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998889999999876421      23346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++.+..   ++++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999997653   3889999999999999999999998   99999999999999999999999999875432


Q ss_pred             C-----CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          552 D-----QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       552 ~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      .     .........++..|+|||++.+..++.++||||||+++++|++|+.||...+..+..               ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---------------~~  219 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM---------------FY  219 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH---------------HH
Confidence            1     111223345889999999999888999999999999999999999999743321110               00


Q ss_pred             hhhh-hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043157          627 ILDA-RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS  667 (684)
Q Consensus       627 ~~d~-~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~  667 (684)
                      +... ......+...+.++.+++.+||+.+|++||++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         220 IGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000 0111233456678899999999999999999999986

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9e-37  Score=318.08  Aligned_cols=262  Identities=24%  Similarity=0.344  Sum_probs=196.5

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhc---CCCcccceeeeeeec-----C
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQI---NHRNVVKLLGCCLET-----E  466 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~-----~  466 (684)
                      +|++.+.||+|+||+||++... +++.||+|.++...  ......+.+|+.+++++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788999999999999999865 68899999876432  22234556777777665   699999999988643     3


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..+++|||++ ++|.+++..... ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            4689999997 589998876432 34899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh--hhhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM--KEERL  624 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~--~~~~~  624 (684)
                      +......  ......++..|+|||++.+..++.++||||||+++|||++|++||.......  .+........  ....+
T Consensus       156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~  231 (288)
T cd07863         156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDDW  231 (288)
T ss_pred             ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChhhC
Confidence            7654221  1233457899999999998899999999999999999999999997544322  1111111000  00000


Q ss_pred             hhh-------hh---hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 FEI-------LD---ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ~~~-------~d---~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...       ..   .........+.+..+.+|+.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000       00   000111123456678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.3e-36  Score=315.90  Aligned_cols=252  Identities=26%  Similarity=0.359  Sum_probs=205.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      ++|++.++||+|+||.||+|... +++.+++|..........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999965 58899999988777777888999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|..++.+...  .+++..++.++.|++.+|+|||+.+   ++||||||+||+++.++.+||+|||++........ 
T Consensus        92 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-  165 (292)
T cd06644          92 PGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-  165 (292)
T ss_pred             CCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence            99999998876433  3899999999999999999999998   99999999999999999999999999875432211 


Q ss_pred             eeecccccCCCCCccccc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          556 MTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ......+++.|+|||++.     ...++.++||||||+++|||++|+.||........      .......      ..+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~------~~~  233 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS------EPP  233 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHhcC------CCc
Confidence            223345788999999984     34578899999999999999999999864432110      0000000      000


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        ....+...+.++.+++.+||+.+|++||+++|++++
T Consensus       234 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         234 --TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             --cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence              011123455678999999999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-36  Score=327.72  Aligned_cols=262  Identities=24%  Similarity=0.315  Sum_probs=200.4

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC-----
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETE-----  466 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----  466 (684)
                      ..++|++.+.||+|+||.||++... +++.||+|++..  ........+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999864 688999998754  33455677889999999999999999999986543     


Q ss_pred             -cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          467 -VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       467 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                       ..++||||+++ +|.+.++.     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             46899999965 67666643     2788999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh-hh--
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK-EE--  622 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~-~~--  622 (684)
                      ++.....  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+.  +......... ..  
T Consensus       170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~  245 (359)
T cd07876         170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ--WNKVIEQLGTPSAEF  245 (359)
T ss_pred             ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCcHHH
Confidence            9754322  222334689999999999999999999999999999999999999986543221  1110000000 00  


Q ss_pred             ------hhhhhhhhh--------------h----hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          623 ------RLFEILDAR--------------V----MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       623 ------~~~~~~d~~--------------~----~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                            .+.......              +    ........+..+.+|+.+||+.||++|||++|++++-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                  000000000              0    0001112346789999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.9e-37  Score=324.70  Aligned_cols=241  Identities=25%  Similarity=0.332  Sum_probs=192.0

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHH-HHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEM-VILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      +.||+|+||+||++... +++.+|+|.+....   ......+..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999965 57889999876421   22233444444 456888999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      ++|.+++....   .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~  153 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT  153 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence            99999998643   3788889999999999999999999   99999999999999999999999999875432222 23


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.      .         ..+....  ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~---------~~i~~~~--~~~~  216 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------Y---------DNILNKP--LQLK  216 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------H---------HHHHhCC--cCCC
Confidence            345699999999999999999999999999999999999999975443221      0         0111111  1122


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMREVTS  667 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~evl~  667 (684)
                      ...+..+.+++.+||+.||++||++.+.+.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            345678899999999999999999875433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.1e-36  Score=311.34  Aligned_cols=240  Identities=24%  Similarity=0.431  Sum_probs=192.3

Q ss_pred             ceeceeCcEEEEEEEeCC-------------CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          403 RILGQGGQGTVYKGMLPD-------------GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      +.||+|+||.||+|++.+             ...|++|.+..........+.+|+.+++.++||||+++++++.+....+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2258888877665666678899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc-------EEEec
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-------AKVSD  542 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-------~kl~D  542 (684)
                      +||||+++++|..++.....  .+++..+++++.||++||+|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999999876433  4899999999999999999999999   999999999999986654       89999


Q ss_pred             cCCccccccCCceeeecccccCCCCCccccc-cCCCCCccchhhhHHHHHHHH-hCCCCCCCCChhhhhhHHHHHHHHhh
Q 043157          543 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLAELL-TGEKPIRFTTLEEDKSLAAYFLFAMK  620 (684)
Q Consensus       543 Fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~SlGvil~ell-tG~~P~~~~~~~~~~~l~~~~~~~~~  620 (684)
                      ||++......     ....++..|+|||.+. ...++.++||||||+++|||+ +|..||......+....         
T Consensus       156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---------  221 (262)
T cd05077         156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---------  221 (262)
T ss_pred             CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH---------
Confidence            9998654322     1234778899999886 466899999999999999998 58888764432221100         


Q ss_pred             hhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          621 EERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       621 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                             .....  ........++.+|+.+||+.||++||+++|++++|+
T Consensus       222 -------~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         222 -------YEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -------HhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                   00000  011223467899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.6e-37  Score=315.76  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=200.9

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeec------C
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLET------E  466 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~------~  466 (684)
                      +.+.|++.+.||+|+||+||+|... +++.+|+|+..... .....+.+|+.+++++ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888999999999999999865 68899999876543 3346788999999998 799999999998753      3


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..+++|||+++++|.+++..... ..+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            56899999999999999987432 34899999999999999999999998   999999999999999999999999998


Q ss_pred             cccccCCceeeecccccCCCCCccccc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE  621 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~  621 (684)
                      ........ ......|++.|+|||++.     ...++.++||||||+++|||++|+.||..........           
T Consensus       159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----------  226 (272)
T cd06637         159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----------  226 (272)
T ss_pred             eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----------
Confidence            76532222 233456889999999986     3457889999999999999999999986433211100           


Q ss_pred             hhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       622 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                          ...............+.++.+|+.+||+.+|++|||++|++++
T Consensus       227 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         227 ----LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ----HHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                0000001111123455679999999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=327.53  Aligned_cols=254  Identities=26%  Similarity=0.448  Sum_probs=217.4

Q ss_pred             CCcCceeceeCcEEEEEEEeC--CCc--EEEEEeccccChh-HHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          399 FNLNRILGQGGQGTVYKGMLP--DGK--IVAVKKSKVIDES-KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ..+.++||+|.||.|++|.|+  +|+  .||||.++..... ...+|++|+.+|.+|+|||+++|||+..+ ....||||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            455789999999999999976  355  5899988875544 78999999999999999999999999998 77889999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      +++.|+|.+.|++. .+..|.......++.|||.||.||.+++   +|||||..+|+||-....|||+||||.+.....+
T Consensus       191 LaplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999983 3345788889999999999999999999   9999999999999999999999999999876444


Q ss_pred             ce--eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          554 TH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       554 ~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ..  +.....-...|.|||.+....++.+||||+|||+||||+| |..||.+..                .-.+.+.+|.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----------------g~qIL~~iD~  330 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----------------GIQILKNIDA  330 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC----------------HHHHHHhccc
Confidence            32  3333445778999999999999999999999999999998 889987543                2334566676


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      +.....++.+++++.+++++||..+|++|||+..+.+.+-..+
T Consensus       331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            6666778899999999999999999999999999986664333

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.7e-37  Score=331.14  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=200.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +++.||+|++...   .....+.+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999865 6889999987642   3345677889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++.+..   .+++..++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||++......
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999998653   3899999999999999999999999   999999999999999999999999998754211


Q ss_pred             Cc----------------------------------eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCC
Q 043157          553 QT----------------------------------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEK  598 (684)
Q Consensus       553 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~  598 (684)
                      ..                                  .......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10                                  01123468999999999999999999999999999999999999


Q ss_pred             CCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC--hhHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 043157          599 PIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG--GDEIITFAKVAKRCLNLNGKKRPT---MREVTSE  668 (684)
Q Consensus       599 P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~--~~~~~~l~~Li~~cl~~dp~~RPt---~~evl~~  668 (684)
                      ||......+..               ..+.........+  ...+.++.+|+.+++ .||++|++   ++|++++
T Consensus       235 Pf~~~~~~~~~---------------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETPQETY---------------RKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCHHHHH---------------HHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            99755432211               0011000000011  124567888999977 59999985   6676665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.9e-36  Score=311.20  Aligned_cols=253  Identities=26%  Similarity=0.374  Sum_probs=194.3

Q ss_pred             ceeceeCcEEEEEEEeCC---CcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCC
Q 043157          403 RILGQGGQGTVYKGMLPD---GKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      +.||+|+||.||+|...+   +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            468999999999998643   4578999876543 334467899999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          479 TLFQYIHDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       479 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +|.++++....  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++++||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999976432  234677888899999999999999999   9999999999999999999999999987543332221


Q ss_pred             -eecccccCCCCCccccccC-------CCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          557 -TTQVHGTFGYLDPEYFRSS-------QFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       557 -~~~~~gt~~y~aPE~~~~~-------~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                       .....++..|+|||++...       .++.++||||||+++|||++ |+.||......+..   ..   ... ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~---~~~-~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TY---TVR-EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HH---Hhh-cccCCC
Confidence             2234567889999998642       35789999999999999996 99999754332210   00   000 001111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      .++    ......+..+.+++.+|+ .+|++|||++||+..|.
T Consensus       231 ~~~----~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKP----RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCC----ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111    111234556888999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.4e-37  Score=325.96  Aligned_cols=241  Identities=27%  Similarity=0.371  Sum_probs=192.8

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHH-HHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMV-ILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      +.||+|+||+||++... +|+.+|+|.+...   .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999864 6899999987542   2334455566655 56778999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |+|..++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~  153 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT  153 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence            99999987643   4899999999999999999999999   9999999999999999999999999987532221 123


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....|++.|+|||++.+..++.++||||||+++|||++|+.||...+..+.      +.         .++...  ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~---------~~~~~~--~~~~  216 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YD---------NILHKP--LVLR  216 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HH---------HHHcCC--ccCC
Confidence            345689999999999999999999999999999999999999975442211      00         111111  1112


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMREVTS  667 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~evl~  667 (684)
                      ...+..+.+++.+||+.+|++||++++.++
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            345667889999999999999998864333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.8e-36  Score=347.92  Aligned_cols=262  Identities=22%  Similarity=0.344  Sum_probs=207.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.++||+|+||+||+|... +++.||+|++...   .....+++.+|++++++++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999965 6899999987642   2344577999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          473 EFIPNGTLFQYIHDQNE--------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                      ||+++++|.+++.....        ...+++..+++++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999975211        123567788999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCc-----------------eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhh
Q 043157          545 ASRSMAVDQT-----------------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE  607 (684)
Q Consensus       545 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~  607 (684)
                      +++.......                 .......||+.|+|||++.+..++.++||||||+++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                 01122468999999999999999999999999999999999999997532211


Q ss_pred             hhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHhhHhh
Q 043157          608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKR-PTMREVTSELAGIKAW  675 (684)
Q Consensus       608 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R-Pt~~evl~~L~~i~~~  675 (684)
                      ..          ...   ...++... ....+.+..+.+++.+||+.||++| ++++++++.|+.....
T Consensus       239 i~----------~~~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 IS----------YRD---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hh----------hhh---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            00          000   01111100 1113455678999999999999999 5678888888876543

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-38  Score=326.73  Aligned_cols=245  Identities=28%  Similarity=0.404  Sum_probs=205.1

Q ss_pred             CCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          399 FNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      |.-.+.||.|+||-||-+.. .+.+.||||++.-.   ..+..+++++|+.+|++++|||++.+-||+..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            66678899999999999985 47889999998763   345678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      | -|+-.|+|.-++.  ++-+..+.-|..+.++||+|||+++   .||||||..||||++.|.|||+|||.+.....   
T Consensus       108 C-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  108 C-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             H-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            9 5688888876654  5889999999999999999999999   89999999999999999999999999876543   


Q ss_pred             eeeecccccCCCCCcccc---ccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          555 HMTTQVHGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~---~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                        ...+.|||.|||||++   ..++|+.|+||||||++..||.-.++|+.....-       .++        ..|-...
T Consensus       179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------SAL--------YHIAQNe  241 (948)
T KOG0577|consen  179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SAL--------YHIAQNE  241 (948)
T ss_pred             --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------HHH--------HHHHhcC
Confidence              3446799999999986   4688999999999999999999999997633211       111        1111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ..-....+.+..+++++..||+.-|.+|||.++++++-
T Consensus       242 sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  242 SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence            11112367889999999999999999999999998763

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.8e-36  Score=309.82  Aligned_cols=250  Identities=27%  Similarity=0.422  Sum_probs=205.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC-CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      ++|++.+.||+|++|.||++...+ ++.+++|.+.....  .+++.+|++++++++||||+++++.+.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578999999999999999999764 78999998865432  678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++.....  .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999999976443  4899999999999999999999999   99999999999999999999999999886543322 


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.||.........  .     ....     .  ......
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~-----~~~~-----~--~~~~~~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--F-----MIPN-----K--PPPTLS  220 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--h-----hhcc-----C--CCCCCC
Confidence            223345788999999999889999999999999999999999998743321110  0     0000     0  000011


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+...+.++.+++.+||+.||++|||++|++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            123455679999999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3e-36  Score=314.08  Aligned_cols=251  Identities=25%  Similarity=0.324  Sum_probs=202.0

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      |+..+.||+|+||+||++... +++.+|+|.+....   ......+.+|++++++++|+||+++++.+.+.+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667889999999999999864 68899999876432   23345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++..... ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            999999999876432 24999999999999999999999999   99999999999999999999999999875432221


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                        .....|+..|+|||++.+..++.++|+||||+++|||++|+.||............   .        ......  ..
T Consensus       158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~--------~~~~~~--~~  222 (285)
T cd05632         158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---D--------RRVLET--EE  222 (285)
T ss_pred             --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H--------Hhhhcc--cc
Confidence              23346899999999999889999999999999999999999999754322111000   0        000000  01


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPT-----MREVTSE  668 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt-----~~evl~~  668 (684)
                      ......+.++.+|+.+||+.||++||+     +++++.+
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            122345667899999999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=309.56  Aligned_cols=255  Identities=25%  Similarity=0.370  Sum_probs=208.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|++.+.||+|++|.||++... +++.+++|..........+.+.+|++++++++||||+++++.+.+....+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357899999999999999999964 5788999988876666778999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++.....  .+++..++.++.|++.||+|||+++   ++|+||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          82 CGGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            999999999986532  4899999999999999999999998   99999999999999999999999999876543221


Q ss_pred             eeeecccccCCCCCccccccC---CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          555 HMTTQVHGTFGYLDPEYFRSS---QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                       ......++..|+|||.+...   .++.++||||||+++|||++|+.||.........  ..     .....    +.+ 
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--~~-----~~~~~----~~~-  223 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--FL-----ISKSN----FPP-  223 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-----HHhcc----CCC-
Confidence             22334578899999998776   7899999999999999999999999754322111  00     00000    000 


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .........+.++.+++.+||+.+|++|||+++++.+
T Consensus       224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0011123456789999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-36  Score=314.95  Aligned_cols=254  Identities=27%  Similarity=0.394  Sum_probs=205.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.+.||+|+||+||++... +++.+|+|.++.. .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35888999999999999999975 7899999987653 445567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      +++++|.++++.......+++..+..++.|++.||.|||+. +   |+|+||||+|||++.++.+||+|||++...... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            99999999998753333589999999999999999999974 6   999999999999999999999999998765322 


Q ss_pred             ceeeecccccCCCCCccccccC------CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSS------QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                        ......+++.|+|||++.+.      .++.++||||||+++|||++|+.||........   ..         .+..+
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~---------~~~~~  222 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FA---------QLSAI  222 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HH---------HHHHH
Confidence              12233478899999998543      358899999999999999999999964322111   00         01111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .+. .....+...+.++.+++.+||+.+|++||++++++.+-
T Consensus       223 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~  263 (286)
T cd06622         223 VDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP  263 (286)
T ss_pred             hhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence            111 11223345778899999999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=311.32  Aligned_cols=249  Identities=24%  Similarity=0.400  Sum_probs=213.2

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      |++..+||+|+||.||++.++ +|+.+|||+...  +.+++++.+|+.+|++...|++|++||.+.....+|+||||+..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            778899999999999999965 699999999876  56788999999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |+..++++..+.  +|+++++..++...++||+|||...   -+|||||..||||+.+|.+||+|||.+....+... ..
T Consensus       113 GSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KR  186 (502)
T KOG0574|consen  113 GSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KR  186 (502)
T ss_pred             CcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-hh
Confidence            999999987644  5999999999999999999999988   78999999999999999999999999977654333 45


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      .++.||+-|||||+++.-.|+.++||||||++..||.-|++||.....--       +++++..       .+...-..+
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR-------AIFMIPT-------~PPPTF~KP  252 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR-------AIFMIPT-------KPPPTFKKP  252 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc-------eeEeccC-------CCCCCCCCh
Confidence            56789999999999999999999999999999999999999987432110       0111111       111122345


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ...+.++.+++++||-.+|++|.|+-+++++-
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            67788999999999999999999999988763

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.5e-36  Score=326.51  Aligned_cols=262  Identities=21%  Similarity=0.290  Sum_probs=200.8

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC----
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETE----  466 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----  466 (684)
                      ...++|++.+.||+|+||.||++... .++.||+|++..  ......+.+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999864 688999998764  23445677889999999999999999999886433    


Q ss_pred             --cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          467 --VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       467 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                        ..++||||+++ +|.+.+..     .+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence              46899999965 67776653     2788999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh----
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK----  620 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~----  620 (684)
                      +++.....  .......||..|+|||++.+..++.++||||||+++|||++|+.||......+...  ........    
T Consensus       165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~  240 (355)
T cd07874         165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVIEQLGTPCPE  240 (355)
T ss_pred             ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHH
Confidence            99764322  22234568999999999999899999999999999999999999998654322111  00000000    


Q ss_pred             -----hhhhhhhhhhh----------h--------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          621 -----EERLFEILDAR----------V--------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       621 -----~~~~~~~~d~~----------~--------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           ...+...++..          .        ...........+.+|+.+||+.||++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                 00000000000          0        001112235678999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.3e-36  Score=311.26  Aligned_cols=249  Identities=27%  Similarity=0.515  Sum_probs=202.6

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---------hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---------ESKVEEFINEMVILSQINHRNVVKLLGCCLETEV  467 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  467 (684)
                      +|.+.+.||+|++|.||+|... +++.+|+|.+....         .+..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999864 67899999765421         1234678899999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .+++|||+++++|.+++....   .+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999998653   3889999999999999999999998   9999999999999999999999999987


Q ss_pred             ccccCCce-----eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          548 SMAVDQTH-----MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       548 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      ........     ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......     .         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~---------  220 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-----A---------  220 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-----H---------
Confidence            66422111     1122457889999999998889999999999999999999999997432111     0         


Q ss_pred             hhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       623 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       +..+.. ......+...+..+.+++.+||+.||++||++.|++++
T Consensus       221 -~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         221 -IFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -HHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence             001101 11112334566789999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.9e-36  Score=317.37  Aligned_cols=250  Identities=24%  Similarity=0.417  Sum_probs=206.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .+|++.+.||.|++|+||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+.+.+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4689999999999999999985 578999999887665566778899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++...    .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            999999998753    3899999999999999999999999   99999999999999999999999999876543222 


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.........  ..     ....       ......
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--~~-----~~~~-------~~~~~~  236 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL-----IATN-------GTPELQ  236 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-----HHhc-------CCcccC
Confidence            122345788999999999888999999999999999999999999754432211  00     0000       000011


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+...+..+.+++.+||..||++||++.+++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            223456678999999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.4e-36  Score=318.63  Aligned_cols=250  Identities=25%  Similarity=0.408  Sum_probs=206.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .+|++.+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5789999999999999999995 478999999887666666678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++.+.    .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            999999999753    3789999999999999999999998   99999999999999999999999999876543322 


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.........  ..     ..       ........
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~~-----~~-------~~~~~~~~  236 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL-----IA-------TNGTPELQ  236 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--ee-----ec-------cCCCCCCC
Confidence            122345788999999999888999999999999999999999999643321110  00     00       00000111


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+...+..+.+|+.+||+.+|++||++++++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            223455678999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.1e-36  Score=308.28  Aligned_cols=251  Identities=29%  Similarity=0.404  Sum_probs=207.3

Q ss_pred             CCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|+..+.||+|+||.||.+.. .+++.+++|+....  ......++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588899999999999999885 46889999986643  355667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++.+.. ...+++..+..++.|++++|+|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999998753 235899999999999999999999998   99999999999999999999999999876543332


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                       ......+++.|+|||.+.+..++.++||||||++++||++|+.||......+..               ..+.... ..
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~---------------~~~~~~~-~~  219 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV---------------VKIVQGN-YT  219 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH---------------HHHHcCC-CC
Confidence             233455899999999998888899999999999999999999998754322110               0111111 11


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ......+.++.+++.+||+.+|++||+++|+++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11234567799999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=313.63  Aligned_cols=248  Identities=27%  Similarity=0.416  Sum_probs=205.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.+.||.|++|.||++... +++.+|+|...... ......+.+|+++++.++||||+++++++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888999999999999999965 68899999876543 45567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++...    ++++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            9999999999864    4899999999999999999999998   99999999999999999999999999977653322


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                       ......+++.|+|||++.+..++.++||||||+++|+|+||+.||........   .             ..+......
T Consensus       154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~-------------~~~~~~~~~  216 (274)
T cd06609         154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---L-------------FLIPKNNPP  216 (274)
T ss_pred             -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---H-------------HHhhhcCCC
Confidence             22334578899999999988899999999999999999999999964431110   0             000001111


Q ss_pred             cCChh-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          635 ESGGD-EIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       635 ~~~~~-~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..... .+..+.+++.+||..+|++|||+++++++
T Consensus       217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            11112 56679999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-36  Score=322.39  Aligned_cols=237  Identities=25%  Similarity=0.369  Sum_probs=190.7

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHH-HHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMV-ILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ++||+|+||+||++... +++.||+|.+...   .......+.+|+. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999965 6889999987542   2233445555554 67889999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      ++|.+.+....   .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (321)
T cd05603          81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT  153 (321)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence            99999887643   3889999999999999999999999   9999999999999999999999999987532222 223


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....|++.|+|||++.+..++.++||||||+++|||++|+.||...+....      .         ..+...  ....+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~---------~~i~~~--~~~~~  216 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM------Y---------DNILHK--PLQLP  216 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH------H---------HHHhcC--CCCCC
Confidence            345689999999999988999999999999999999999999975432211      0         011111  11223


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMR  663 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~  663 (684)
                      ...+..+.+++.+||+.||++||+..
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            45567899999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-36  Score=313.34  Aligned_cols=253  Identities=26%  Similarity=0.398  Sum_probs=203.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      ++|++.+.||+|+||.||++... +++.||+|.++.........+.+|+.+++.++||||+++++.+.+.+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46788899999999999999864 68899999887766666677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++....   .+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++...... ..
T Consensus        89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~  161 (267)
T cd06645          89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IA  161 (267)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-cc
Confidence            9999999997654   3899999999999999999999999   999999999999999999999999998755322 12


Q ss_pred             eeecccccCCCCCccccc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          556 MTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      ......|+..|+|||++.   ...++.++||||||+++|||++|+.||........  +   +  ......    ..+..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~---~--~~~~~~----~~~~~  230 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L---F--LMTKSN----FQPPK  230 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H---H--hhhccC----CCCCc
Confidence            223345899999999974   45688999999999999999999999864332111  0   0  000000    00000


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ... ....+..+.+++.+||+.+|++||++++++++
T Consensus       231 ~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         231 LKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            000 11345678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.9e-36  Score=307.60  Aligned_cols=250  Identities=24%  Similarity=0.373  Sum_probs=203.7

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec-CcceEEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLET-EVPLLVYE  473 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E  473 (684)
                      .|++.+.||+|++|.||++... +++.+|+|++...  .....+.+.+|++++++++|||++++++.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999965 5789999987642  344567789999999999999999999887644 45789999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++++|.+++..... .++++.+++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            9999999999986432 34899999999999999999999999   9999999999999999999999999987654332


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      . ......+++.|+|||++.+..++.++||||||+++++|++|+.||...+.....               ..+. ....
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~---------------~~~~-~~~~  219 (257)
T cd08223         157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV---------------YRII-EGKL  219 (257)
T ss_pred             C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHH-hcCC
Confidence            2 233445889999999999999999999999999999999999998754322110               0000 0111


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+...+..+.+++.+||+.+|++||+++|++++
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            12234566789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=322.69  Aligned_cols=250  Identities=30%  Similarity=0.390  Sum_probs=215.1

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcce
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~  469 (684)
                      ....|++.+.||+|.||.||+++.+ +|+.+|+|.+....   ....+.+.+|+.+|+++. |||||.+++.+.+....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4567999999999999999999976 49999999876532   234578999999999998 999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC----CcEEEeccCC
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK----YRAKVSDFGA  545 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFgl  545 (684)
                      +|||++.||.|.+.+...    .+++..+..++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999877    2899999999999999999999999   9999999999999633    5799999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF  625 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  625 (684)
                      +.....  ........||+.|+|||++....|+..+||||+||++|.|+.|.+||...+..+...               
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---------------  248 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---------------  248 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---------------
Confidence            987765  445667789999999999999999999999999999999999999998665433211               


Q ss_pred             hhhhh--hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          626 EILDA--RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       626 ~~~d~--~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .++..  ....+.....+..+.++++.+|..||.+|+|+.+++++
T Consensus       249 ~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            11111  22233446678889999999999999999999999997

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=314.10  Aligned_cols=253  Identities=26%  Similarity=0.357  Sum_probs=207.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|++.+.||+|++|+||++... +++.+|+|..........+.+.+|++++++++||||+++++.+.+....++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356888999999999999999964 6889999998877777788999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++.+...  ++++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999999986543  4899999999999999999999999   99999999999999999999999998865433222


Q ss_pred             eeeecccccCCCCCccccc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          555 HMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                       ......+++.|++||.+.     ...++.++||||||+++|||++|+.||........  +.    . ....       
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~----~-~~~~-------  223 (280)
T cd06611         159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LL----K-ILKS-------  223 (280)
T ss_pred             -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HH----H-HhcC-------
Confidence             223345889999999874     34577899999999999999999999874432110  00    0 0000       


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .......+...+.++.+++.+||+.+|++||++++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            000011123456678999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.9e-36  Score=307.26  Aligned_cols=251  Identities=33%  Similarity=0.523  Sum_probs=205.0

Q ss_pred             CCcCceeceeCcEEEEEEEeCC-----CcEEEEEeccccChh-HHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          399 FNLNRILGQGGQGTVYKGMLPD-----GKIVAVKKSKVIDES-KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      |++.+.||.|+||.||++...+     +..+|+|........ ..+.+.+|+.++++++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4577899999999999999653     378999988764433 6788999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++...... .+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999865432 2899999999999999999999998   999999999999999999999999999876544


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .........+++.|+|||.+....++.++||||||+++++|++ |+.||........   .             +.+...
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~-------------~~~~~~  220 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---L-------------EYLKKG  220 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H-------------HHHhcC
Confidence            3332222336789999999988889999999999999999998 7888864322111   0             011111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .....+...+.++.+++.+||+.||++|||+.|+++.|
T Consensus       221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      221 YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            11122233567899999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-37  Score=310.39  Aligned_cols=264  Identities=24%  Similarity=0.313  Sum_probs=201.4

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC-----cceEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETE-----VPLLV  471 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lv  471 (684)
                      .|...+++|.|+||.||+|+.. +++.||||+.-...+    .-.+|+++|+.+.|||||+++.+|....     ..-||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            5677899999999999999965 578999998764332    2236999999999999999999886433     23489


Q ss_pred             EEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CcEEEeccCCcccc
Q 043157          472 YEFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASRSM  549 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFgl~~~~  549 (684)
                      ||||+. ||.++++.. ..+..++...+.-+..||++||+|||+.+   |+||||||+|+|+|.+ +.+||+|||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999975 899999852 11233777788889999999999999988   9999999999999966 99999999999987


Q ss_pred             ccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh----
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL----  624 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~----  624 (684)
                      ...+..  ....-|..|.|||++.+ ..|+.+.||||.||++.||+-|++-|.+.+..+  +|...+ ..+.....    
T Consensus       177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIi-k~lG~Pt~e~I~  251 (364)
T KOG0658|consen  177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEII-KVLGTPTREDIK  251 (364)
T ss_pred             ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHH-HHhCCCCHHHHh
Confidence            655554  33456888999999876 579999999999999999999999999765433  233222 22211111    


Q ss_pred             -----------hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhHh
Q 043157          625 -----------FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGIKA  674 (684)
Q Consensus       625 -----------~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i~~  674 (684)
                                 .++....+..-.....+.+..+|+.++|+.+|.+|.++.|++.+  ++.++.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence                       11111111111335667889999999999999999999999865  344443

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-36  Score=314.50  Aligned_cols=265  Identities=26%  Similarity=0.399  Sum_probs=208.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.+.||+|+||+||++... +++.+|+|+..... ....+.+.+|+++++.++||||+++++.+......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46788899999999999999864 68899999776532 44567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      +++++|.+++...+   ++++.....++.+++.+|.|||+. +   ++||||||+||++++++.++|+|||++.......
T Consensus        85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            99999999987643   489999999999999999999974 6   9999999999999999999999999986543221


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                         .....|+..|+|||++.+..++.++||||||+++|+|++|+.||......++.......   . ...+..+......
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~  231 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG---I-LDLLQQIVQEPPP  231 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhH---H-HHHHHHHhhccCC
Confidence               22346899999999998889999999999999999999999999855432211000000   0 0001111111100


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      .......+.++.+|+.+||+.||++|||++|++++..-+++
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            01112356679999999999999999999999998655443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-36  Score=314.65  Aligned_cols=247  Identities=26%  Similarity=0.420  Sum_probs=202.6

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      |+..+.||+|+||.||+|.+. +++.||+|..... .....+.+.+|++++++++||||+++++++......++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            566788999999999999864 5789999987643 24456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.+++...    .+++..++.++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++........ .
T Consensus        86 ~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06642          86 GGSALDLLKPG----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence            99999998643    3899999999999999999999998   99999999999999999999999999876543221 2


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccC
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES  636 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  636 (684)
                      .....++..|+|||++.+..++.++||||||++++||++|+.|+.........                ..+........
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~~~~~  221 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL----------------FLIPKNSPPTL  221 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH----------------hhhhcCCCCCC
Confidence            22345788999999999888999999999999999999999998633221100                00111111122


Q ss_pred             ChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          637 GGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       637 ~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ....+..+.+++.+||+.+|++||++.|++++-
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            334567899999999999999999999999854

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-36  Score=323.30  Aligned_cols=259  Identities=21%  Similarity=0.346  Sum_probs=194.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ..+|++.+.||+|+||.||++... +++.||+|....      .....|+.++++++||||+++++++.+....++|||+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            357999999999999999999975 577899997543      2335699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +. ++|.+++.....  ++++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       139 ~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        139 YS-SDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             cC-CcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            94 689998876433  4899999999999999999999999   999999999999999999999999998753322  


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhh-h---HHHHHHHHhh-----hhhh-
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK-S---LAAYFLFAMK-----EERL-  624 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~-~---l~~~~~~~~~-----~~~~-  624 (684)
                      .......||+.|+|||++.+..++.++||||||+++|||+++..|+......... .   ....+...+.     .... 
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            1223356899999999999999999999999999999999866554322111100 0   0011111000     0000 


Q ss_pred             --------hhhhhhhhhc---------cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 --------FEILDARVMK---------ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 --------~~~~d~~~~~---------~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                              ...++.....         ......+.++.+||.+||+.||++|||++|++++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence                    0000000000         0001234466779999999999999999999875

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.7e-36  Score=310.53  Aligned_cols=248  Identities=26%  Similarity=0.406  Sum_probs=205.9

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .|+..+.||+|+||.||+|... +++.||+|...... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4677889999999999999965 58899999876533 455678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++...    ++++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06640          85 GGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence            999999998753    3889999999999999999999998   99999999999999999999999999976543222 


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ......++..|+|||++.+...+.++|+||||+++|||++|+.||.........                ..........
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~~~~  220 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLIPKNNPPT  220 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhhhcCCCCC
Confidence            223345788999999998888999999999999999999999998744321110                0111111122


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .....+..+.+++.+||+.+|++||++++++.+-
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence            3445677899999999999999999999998873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3e-36  Score=310.75  Aligned_cols=250  Identities=29%  Similarity=0.459  Sum_probs=199.4

Q ss_pred             ceeceeCcEEEEEEEeCC-------CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          403 RILGQGGQGTVYKGMLPD-------GKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +.||+|+||.||+|+..+       ++.+|+|..... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999998642       257899976543 234567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-----cEEEeccCC
Q 043157          475 IPNGTLFQYIHDQN----EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-----RAKVSDFGA  545 (684)
Q Consensus       475 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kl~DFgl  545 (684)
                      +++++|.+++.+..    ....+++..++.++.|++.||+|||+.+   ++|+||||+|||++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999997632    1234789999999999999999999998   99999999999999877     899999999


Q ss_pred             ccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhh
Q 043157          546 SRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEER  623 (684)
Q Consensus       546 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~  623 (684)
                      ++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+   ...          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~----------  224 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQ----------  224 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHH----------
Confidence            8765432211 1122345678999999999999999999999999999998 999987443221   110          


Q ss_pred             hhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          624 LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       624 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                         .+........+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       225 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         225 ---HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ---HHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence               111111112234456789999999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.4e-36  Score=316.59  Aligned_cols=257  Identities=27%  Similarity=0.498  Sum_probs=204.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCc----EEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGK----IVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      +.|+..+.||+|+||.||++.+. +++    .+|+|...... .....++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45778899999999999999853 444    47888776533 34455789999999999999999999998654 5679


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ++||+++|+|.+++.....  .+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            9999999999999986543  3889999999999999999999998   9999999999999999999999999998654


Q ss_pred             cCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          551 VDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       551 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+...                .+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~----------------~~  224 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD----------------LL  224 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------------HH
Confidence            32221 1222335678999999998899999999999999999997 999987543222111                11


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      ........+...+..+.+++.+||..+|++||+++|+++.|+.+...
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         225 EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            11111111233456789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.8e-36  Score=311.50  Aligned_cols=238  Identities=24%  Similarity=0.393  Sum_probs=189.6

Q ss_pred             eeceeCcEEEEEEEeCC-------------------------CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccce
Q 043157          404 ILGQGGQGTVYKGMLPD-------------------------GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKL  458 (684)
Q Consensus       404 ~LG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l  458 (684)
                      +||+|+||.||+|.+..                         ...|++|.+..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         12588888876555556788999999999999999999


Q ss_pred             eeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC--
Q 043157          459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY--  536 (684)
Q Consensus       459 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~--  536 (684)
                      ++++.+....++||||+++|+|..++.+...  .+++..+..++.||++||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999999976433  3889999999999999999999998   99999999999997543  


Q ss_pred             -----cEEEeccCCccccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHH-hCCCCCCCCChhhhh
Q 043157          537 -----RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELL-TGEKPIRFTTLEEDK  609 (684)
Q Consensus       537 -----~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~ell-tG~~P~~~~~~~~~~  609 (684)
                           .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+..
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                 3899999987643321     12246788999998865 56899999999999999985 799998754332211


Q ss_pred             hHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          610 SLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       610 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                         .             ......  ..+......+.+++.+||+.+|++|||++++++.|
T Consensus       232 ---~-------------~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         232 ---R-------------FYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             ---H-------------HHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence               0             001000  11122335689999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-36  Score=323.31  Aligned_cols=261  Identities=22%  Similarity=0.299  Sum_probs=198.0

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec-----
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLET-----  465 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----  465 (684)
                      ...++|++.+.||+|+||+||++.. .+++.||+|++...  .....+.+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999985 46889999987642  223456688999999999999999999988643     


Q ss_pred             -CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          466 -EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       466 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                       ...++++|++ +++|.+++...    .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3458999988 78998887643    3899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH-----
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA-----  618 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~-----  618 (684)
                      +++.....    .....|++.|+|||++.+ ..++.++||||||+++|+|++|+.||........  +.......     
T Consensus       164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  237 (343)
T cd07878         164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTPSP  237 (343)
T ss_pred             cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence            99765322    223458999999999876 5688999999999999999999999975443211  11110000     


Q ss_pred             -----hhhhhhhhhhhh------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          619 -----MKEERLFEILDA------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       619 -----~~~~~~~~~~d~------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           .........+..      .............+.+|+.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 000000000000      00000011233457899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.6e-36  Score=325.86  Aligned_cols=260  Identities=22%  Similarity=0.310  Sum_probs=200.4

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec------
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLET------  465 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------  465 (684)
                      ..++|++.+.||+|+||.||++... .++.||||++..  ......+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999864 688999998764  2344567788999999999999999999987643      


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                      ...++||||+++ +|.+.+..     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            346899999964 77777753     2788999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EER  623 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~~  623 (684)
                      ++.....  .......+|..|+|||++.+..++.++||||||+++|||++|+.||...+..+.....   .....  ...
T Consensus       173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~~~~~  247 (364)
T cd07875         173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV---IEQLGTPCPE  247 (364)
T ss_pred             ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCCHH
Confidence            9764322  2223446899999999999999999999999999999999999999865543221110   00000  000


Q ss_pred             h--------hhhhhhh--------------h----hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          624 L--------FEILDAR--------------V----MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       624 ~--------~~~~d~~--------------~----~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .        ......+              .    ...........+.+|+.+||+.||++|||++|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0        0000000              0    001111234578999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.7e-36  Score=319.24  Aligned_cols=260  Identities=22%  Similarity=0.330  Sum_probs=189.3

Q ss_pred             CceeceeCcEEEEEEEeC---CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeee--cCcceEEEEecC
Q 043157          402 NRILGQGGQGTVYKGMLP---DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE--TEVPLLVYEFIP  476 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~E~~~  476 (684)
                      .++||+|+||+||+|...   +++.+|+|.+....  ....+.+|+.++++++||||+++++.+..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            578999999999999864   46789999876432  23457789999999999999999999864  345789999985


Q ss_pred             CCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----CCCCcEEEeccCCc
Q 043157          477 NGTLFQYIHDQN------EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGAS  546 (684)
Q Consensus       477 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFgl~  546 (684)
                       ++|.+++....      ....+++..++.++.||+.||+|||+.+   |+||||||+|||+    +..+.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             58888876432      1235899999999999999999999999   9999999999999    45678999999999


Q ss_pred             cccccCCc--eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhh-------hhHHHHHH
Q 043157          547 RSMAVDQT--HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED-------KSLAAYFL  616 (684)
Q Consensus       547 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~-------~~l~~~~~  616 (684)
                      +.......  .......||+.|+|||++.+ ..++.++||||||+++|||++|++||.....+..       ..+...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            86543222  12234568999999999876 4589999999999999999999999974432110       11111110


Q ss_pred             HHhhh---hhh------------hhhhhhhh---------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          617 FAMKE---ERL------------FEILDARV---------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       617 ~~~~~---~~~------------~~~~d~~~---------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       .+..   ..+            .+......         ...........+.+|+.+||+.||++|||++|++++
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         240 -VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             -hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             0000   000            00000000         000001123457899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.4e-36  Score=307.90  Aligned_cols=247  Identities=28%  Similarity=0.497  Sum_probs=201.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ++|++.+.||+|+||.||++.. .++.+|+|+.+..  ...+.+.+|+.++++++||||+++++++.+. ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588899999999999999875 6778999987643  2346789999999999999999999998654 5799999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.+++..... ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......   
T Consensus        82 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            9999999986532 34889999999999999999999998   9999999999999999999999999987543211   


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                       .....+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+..                +.+.......
T Consensus       155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~----------------~~~~~~~~~~  217 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK----------------ECVEKGYRME  217 (254)
T ss_pred             -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH----------------HHHhCCCCCC
Confidence             12234567999999988899999999999999999997 99998755433211                1111111112


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      .....+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            234456788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6e-36  Score=306.07  Aligned_cols=248  Identities=25%  Similarity=0.420  Sum_probs=203.9

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-----hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-----ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      +|+..+.||+|++|+||+|... +++.|++|.+....     .+..+.+.+|+.+++.++||||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999976 78999999876533     34567899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++.+..   .+++..++.++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999998653   3889999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCceeeecccccCCCCCccccccCC-CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ..  ......++..|++||.+.... ++.++|+||||+++|+|++|+.||.......  ..             ......
T Consensus       155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~-------------~~~~~~  217 (258)
T cd06632         155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AV-------------FKIGRS  217 (258)
T ss_pred             cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HH-------------HHHHhc
Confidence            32  233455889999999987766 8999999999999999999999986433111  00             000000


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ......+...+..+.+++.+||+.+|++||++++++.+
T Consensus       218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            01112233456778999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.4e-36  Score=307.65  Aligned_cols=250  Identities=25%  Similarity=0.407  Sum_probs=198.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-----ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec--Ccc
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-----DESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVP  468 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~  468 (684)
                      .+|+..+.||+|+||.||++... +++.|++|+....     .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46899999999999999999864 6889999987532     223456788999999999999999999998753  467


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++++||+++++|.+++....   .+++...+.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999998653   3889999999999999999999998   99999999999999999999999999876


Q ss_pred             cccCC--ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          549 MAVDQ--THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       549 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      .....  ........++..|+|||++.+..++.++||||||+++|||++|+.||........               +.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---------------~~~  220 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---------------IFK  220 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---------------HHH
Confidence            43211  1112234578899999999988899999999999999999999999974321110               011


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..........+......+.+++ +||..+|++||+++|++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         221 IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            1111111122334455677787 6888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=309.08  Aligned_cols=273  Identities=26%  Similarity=0.392  Sum_probs=204.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhc--CCCcccceeeeeeecC----cceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI--NHRNVVKLLGCCLETE----VPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l~~~~~~~~----~~~l  470 (684)
                      +..++.++||+|.||.||||+++ ++.||||++.   .++.+.|.+|.+|.+..  +|+||+++++.-....    .++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            45677889999999999999985 4899999986   56678899988888775  8999999999876554    7899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA------SIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                      |+||.+.|+|.++|+.+.    ++|....+++..+++||+|||+..      .++|+|||||++||||..+++.-|+|||
T Consensus       286 Vt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999999774    999999999999999999999643      4789999999999999999999999999


Q ss_pred             CccccccCCce-eeecccccCCCCCccccccCC-CC-----CccchhhhHHHHHHHHhCCCCCCCCChhh-hhhHHHHHH
Q 043157          545 ASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQ-FT-----DKSDVYSFGVVLAELLTGEKPIRFTTLEE-DKSLAAYFL  616 (684)
Q Consensus       545 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~ksDv~SlGvil~elltG~~P~~~~~~~~-~~~l~~~~~  616 (684)
                      +|..+...... ......||.+|||||++.+.- +.     .+.||||+|.+||||++.-.-+......+ +......+.
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            99887643332 222356999999999987642 22     37999999999999999765543211111 000000000


Q ss_pred             H-----Hhhhhhhhhhhhhhhhcc-CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          617 F-----AMKEERLFEILDARVMKE-SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       617 ~-----~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      .     .+++.-+.+-..+.+... ....-...+.+.+..||..||+.|.|+.=+.+++.++.....
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            0     011111111111111111 112345678999999999999999999999999988886654

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.6e-36  Score=308.01  Aligned_cols=253  Identities=26%  Similarity=0.360  Sum_probs=192.3

Q ss_pred             ceeceeCcEEEEEEEeCC---CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCC
Q 043157          403 RILGQGGQGTVYKGMLPD---GKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~---g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      +.||+|+||+||+|...+   ...+++|.+... .......+.+|+++++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997543   347888876543 3444567899999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce-
Q 043157          479 TLFQYIHDQNED--FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-  555 (684)
Q Consensus       479 sL~~~l~~~~~~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~-  555 (684)
                      +|.+++......  ...++...+.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999999875421  23567888999999999999999999   999999999999999999999999998754322211 


Q ss_pred             eeecccccCCCCCcccccc-------CCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          556 MTTQVHGTFGYLDPEYFRS-------SQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..||......+.  +..    ..... ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~----~~~~~-~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQ----VVREQ-DIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHH----Hhhcc-CccC
Confidence            1222345678999998643       456789999999999999999 7888864432211  100    01110 0111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      ..+    ......+..+.+++..|+ .||++|||++||++.|.
T Consensus       231 ~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111    122345667788889998 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.3e-36  Score=308.48  Aligned_cols=253  Identities=25%  Similarity=0.413  Sum_probs=203.4

Q ss_pred             CCCcCceeceeCcEEEEEEEeCC--CcEEEEEeccc----------cChhHHHHHHHHHHHHhh-cCCCcccceeeeeee
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPD--GKIVAVKKSKV----------IDESKVEEFINEMVILSQ-INHRNVVKLLGCCLE  464 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~~~~----------~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~  464 (684)
                      +|++.+.||+|+||+||++.+..  ++.+|+|.+..          .......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999764  68899997653          223345678889998875 799999999999999


Q ss_pred             cCcceEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCcEEEec
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSD  542 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~D  542 (684)
                      .+..+++|||+++++|.+++... .....+++..++.++.|++.+|.|||+ .+   ++|+||+|+|||++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999998652 223358999999999999999999996 56   99999999999999999999999


Q ss_pred             cCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          543 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       543 Fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      ||++.......  ......++..|++||.+.+..++.++||||||+++|||++|+.||.........             
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~-------------  222 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA-------------  222 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH-------------
Confidence            99997654332  333456889999999999888999999999999999999999998644322110             


Q ss_pred             hhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       623 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                        ..+.+...........+..+.+++.+||+.||++||++.|+.+++.
T Consensus       223 --~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         223 --TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence              0111111111111234568999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.1e-36  Score=311.79  Aligned_cols=262  Identities=23%  Similarity=0.309  Sum_probs=205.0

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|++.+.||+|++|.||+|... +++.|++|++....  ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788999999999999999964 68999999876543  34467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      + +++|.+++....  .++++..++.++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999998654  34899999999999999999999999   99999999999999999999999999887654332


Q ss_pred             eeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhh---hhhhhhh-
Q 043157          555 HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE---RLFEILD-  629 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d-  629 (684)
                      .......++..|+|||.+.+. .++.++||||||++++||++|++||......+.  + ..........   ...+..+ 
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ--L-AIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH--H-HHHHHHcCCCChHHHhhccCc
Confidence            223344588999999998654 468999999999999999999888865443211  1 1111111000   0000000 


Q ss_pred             ------------hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          630 ------------ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       630 ------------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                                  .........+.+..+.+|+.+||+.+|++||++++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                        000011112345789999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.5e-36  Score=307.44  Aligned_cols=257  Identities=28%  Similarity=0.420  Sum_probs=207.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.+.||.|++|+||++... +++.+++|+..... ....+.+.+|+++++.++|+||+++++.+.+.+..+++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46899999999999999999954 67899999876432 33678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.++++.......+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999987543345899999999999999999999999   99999999999999999999999999877654332


Q ss_pred             e---eeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          555 H---MTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       555 ~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      .   ......++..|++||++... .++.++|+||||++++||++|+.||.......  ...    .....      ..+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~----~~~~~------~~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLM----LTLQN------DPP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHH----HHhcC------CCC
Confidence            2   22334588899999998776 78999999999999999999999997443211  000    00110      001


Q ss_pred             hhhcc-CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 RVMKE-SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ~~~~~-~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..... .....+..+.+++.+||+.||++||+++|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11111 013456788999999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.1e-36  Score=306.69  Aligned_cols=250  Identities=23%  Similarity=0.367  Sum_probs=205.5

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|++.+.||+|+||+||++... +++.+|+|++...  .....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999999854 6889999987642  344567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++..... ..+++..++.++.|++.||+|||+.+   ++|+||+|+|||++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999999999976432 24789999999999999999999998   99999999999999999999999999876543222


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                       ......|++.|+|||++.+...+.++|+||||+++++|++|+.||......+.      .         ..++... ..
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~---------~~~~~~~-~~  219 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------V---------LKIIRGS-YP  219 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------H---------HHHhcCC-CC
Confidence             12234578899999999988899999999999999999999999874332211      0         1111110 11


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..+...+.++.+++.+||+.+|++||+++||+++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            2234556789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-36  Score=327.35  Aligned_cols=262  Identities=23%  Similarity=0.301  Sum_probs=201.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC---CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP---DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ..+|.+.+.||+|+||+||++...   .++.||+|.+...     ....+|+++|++++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999753   3578999987542     23468999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      |++. ++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus       166 e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9995 68888885432   4899999999999999999999999   999999999999999999999999999765432


Q ss_pred             Cc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhh--------
Q 043157          553 QT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------  623 (684)
Q Consensus       553 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~--------  623 (684)
                      .. .......||+.|+|||++....++.++||||||+++|||++|+.||..................+....        
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            22 222345699999999999999999999999999999999999999976544321111111111111000        


Q ss_pred             --hhhh---hhhhhhcc--C-----ChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          624 --LFEI---LDARVMKE--S-----GGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       624 --~~~~---~d~~~~~~--~-----~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                        +.+.   ........  .     ....+.++.+++.+||+.||++|||+.|++.+=
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p  376 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP  376 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence              0000   00000000  0     012356788999999999999999999999863

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-36  Score=310.17  Aligned_cols=240  Identities=22%  Similarity=0.406  Sum_probs=192.7

Q ss_pred             ceeceeCcEEEEEEEeCC--------CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          403 RILGQGGQGTVYKGMLPD--------GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +.||+|+||+||+|....        ...+++|..........+.+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998642        234788877665556667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc--------EEEeccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR--------AKVSDFGAS  546 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl~DFgl~  546 (684)
                      +++|+|.++++....  .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.        +|++|||++
T Consensus        81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999987543  4899999999999999999999999   999999999999987765        699999988


Q ss_pred             cccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCC-CCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGE-KPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~-~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      ......     ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+...+.....               
T Consensus       156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~---------------  215 (258)
T cd05078         156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL---------------  215 (258)
T ss_pred             cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH---------------
Confidence            654321     22457888999999986 45799999999999999999985 555433221110               


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                       .....  ....+...+.++.+|+.+||+.||++|||++|+++.|+
T Consensus       216 -~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         216 -QFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -HHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             00000  11222334567899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-35  Score=306.04  Aligned_cols=250  Identities=26%  Similarity=0.401  Sum_probs=200.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-----ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec--Ccc
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-----DESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVP  468 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~  468 (684)
                      .+|++.++||+|+||.||++... +++.||+|.+...     .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47899999999999999999964 5889999976532     233467889999999999999999999998764  457


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      +++|||+++++|.+++.+..   .+++..++.++.|++.||+|||+.+   ++|+||||+|||++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            79999999999999998653   3788999999999999999999999   99999999999999999999999999876


Q ss_pred             cccCCc--eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          549 MAVDQT--HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       549 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ......  .......++..|+|||.+.+..++.++||||||+++|||++|+.||........               ..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---------------~~~  220 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA---------------IFK  220 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH---------------HHH
Confidence            432111  112234588899999999888899999999999999999999999874321111               011


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..........+...+..+.+++.+|| .+|++||+++|++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~  261 (265)
T cd06652         221 IATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH  261 (265)
T ss_pred             HhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence            11111112234456678889999999 599999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=298.34  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=205.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .++|++.+.||+|.|+.|++..+ .+|+.+|+|.+..  ......+++.+|+.|-+.|+||||+++++...++...+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45688889999999999999875 4788888886543  22336688899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC---CCCcEEEeccCCcccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSM  549 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFgl~~~~  549 (684)
                      |+|.|++|..-+-+.   ...++..+-...+||++||.|.|..+   |+|||+||+|+||-   ...-+||+|||++...
T Consensus        90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999987666544   24788888899999999999999999   99999999999995   3456999999999887


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      .  .....-...|||+|||||++...+|+..+|||+-||+||-|+.|.+||...+..   .+.+            ++..
T Consensus       164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye------------~I~~  226 (355)
T KOG0033|consen  164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYE------------QIKA  226 (355)
T ss_pred             C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHH------------HHhc
Confidence            6  344455667999999999999999999999999999999999999999853321   1111            1111


Q ss_pred             hhh--hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          630 ARV--MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       630 ~~~--~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ...  ........+++.++|+++||..||.+|.|+.|.+++-
T Consensus       227 g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp  268 (355)
T KOG0033|consen  227 GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP  268 (355)
T ss_pred             cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence            111  1122345677889999999999999999999988653

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.7e-36  Score=312.10  Aligned_cols=264  Identities=23%  Similarity=0.299  Sum_probs=202.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|++.+.||+|++|.||++..+ +++.||+|+.....  ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999976 68999999875432  2234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++++|..++....   .+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999988888776543   3899999999999999999999998   9999999999999999999999999998654332


Q ss_pred             ceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh--
Q 043157          554 THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA--  630 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--  630 (684)
                      . ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+............ .....+..+.  
T Consensus       155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  232 (286)
T cd07847         155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDL-IPRHQQIFSTNQ  232 (286)
T ss_pred             c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-ChHHhhhccccc
Confidence            2 1223347788999999865 557899999999999999999999998654332111100000000 0000000000  


Q ss_pred             --------hh--h---ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 --------RV--M---KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 --------~~--~---~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                              ..  .   .......+..+.+|+.+||+.+|++||++.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                    00  0   00012346778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-36  Score=330.79  Aligned_cols=261  Identities=23%  Similarity=0.323  Sum_probs=198.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ...|.+.+.||+|+||.||++.+. .++.||||....      ..+.+|+++|++++||||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999975 578899996432      3467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +. ++|.+++.....  .+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            94 789998876433  4999999999999999999999999   99999999999999999999999999976543221


Q ss_pred             -eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChh-h----hhhHHHHHHHHhh-hh-----
Q 043157          555 -HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLE-E----DKSLAAYFLFAMK-EE-----  622 (684)
Q Consensus       555 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~-~----~~~l~~~~~~~~~-~~-----  622 (684)
                       .......||..|+|||++.+..++.++|||||||+||||++|..|+...... .    ...+...+..... ..     
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence             1223456999999999999999999999999999999999988765432211 1    1111111111100 00     


Q ss_pred             ---hhhhhhhhh--------hhccCC---hhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          623 ---RLFEILDAR--------VMKESG---GDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       623 ---~~~~~~d~~--------~~~~~~---~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                         ++.......        ......   ......+.+|+.+||+.||++|||+.|++++
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence               000000000        000000   1233478899999999999999999999976

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=323.78  Aligned_cols=241  Identities=25%  Similarity=0.288  Sum_probs=189.7

Q ss_pred             eceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc---CCCcccceeeeeeecCcceEEEEecCC
Q 043157          405 LGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI---NHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       405 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ||+|+||+||++... +++.||+|++...   .......+..|..++..+   +||||+++++.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999965 6899999987542   223345566777777665   699999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |+|.+++....   .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~  153 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT  153 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence            99999997653   3899999999999999999999999   99999999999999999999999999875432222 23


Q ss_pred             ecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccC
Q 043157          558 TQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES  636 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  636 (684)
                      ....||+.|+|||++.+. .++.++||||||+++|||++|+.||......+..   .    .+....      ...   .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~---~----~i~~~~------~~~---~  217 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY---R----NIAFGK------VRF---P  217 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH---H----HHHcCC------CCC---C
Confidence            345689999999998754 4899999999999999999999999754322110   0    000000      000   0


Q ss_pred             ChhHHHHHHHHHHHhhccCCCCCC----CHHHHHHH
Q 043157          637 GGDEIITFAKVAKRCLNLNGKKRP----TMREVTSE  668 (684)
Q Consensus       637 ~~~~~~~l~~Li~~cl~~dp~~RP----t~~evl~~  668 (684)
                      ....+.++.+|+.+||+.||++||    ++.|++++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            123456788999999999999998    56666553

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-36  Score=311.92  Aligned_cols=266  Identities=26%  Similarity=0.332  Sum_probs=204.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|++.+.||+|++|.||++... +++.|++|+++..  .....+.+.+|++++++++|+||+++++++.+.+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999965 5889999987642  33445788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |++++.|..++....   .+++..++.++.||+.||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999876666554432   3899999999999999999999999   9999999999999999999999999988765444


Q ss_pred             ceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh--------h--
Q 043157          554 THMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE--------E--  622 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~--------~--  622 (684)
                      ........++..|+|||++... .++.++||||||+++|+|++|++||......+..............        .  
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence            3233345578899999999887 8899999999999999999999999754332211000000000000        0  


Q ss_pred             ----hhhhhhhhhh-hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          623 ----RLFEILDARV-MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       623 ----~~~~~~d~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                          ...+..++.. ....+...+.++.+|+++||..+|++||++++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                0000000000 011122347789999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1e-35  Score=306.49  Aligned_cols=253  Identities=26%  Similarity=0.462  Sum_probs=204.7

Q ss_pred             CCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC------hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          398 NFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID------ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      +|+..+.||+|++|.||++.. .+++.+|+|.+....      ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999985 578899999876422      2346788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-cEEEeccCCcccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSM  549 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgl~~~~  549 (684)
                      ||||+++++|.+++.+..   ++++..++.++.|++.||+|||+.+   ++|+||||+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999998653   4899999999999999999999999   99999999999998775 5999999998766


Q ss_pred             ccCCce---eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          550 AVDQTH---MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       550 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ......   ......++..|+|||.+.+..++.++||||||+++++|++|+.||..........            ...+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------------~~~~  222 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA------------LIFK  222 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH------------HHHH
Confidence            433211   1223457889999999988889999999999999999999999986433211110            0111


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..........+...+.++.+++.+||+.+|++||++.|++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            111111223344566789999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=312.33  Aligned_cols=249  Identities=24%  Similarity=0.382  Sum_probs=212.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ..-|++.+.||+|.|+.|-++++ -+|+.||||++...  +.-...++++|++.|+.++|||||+||.+......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            34588889999999999999985 48999999988653  3344578899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-CCCCcEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL-DDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DFgl~~~~~~  551 (684)
                      |+=++|+|++||.++...  +.++...+++.||+.|+.|+|+.+   ++||||||+|+.+ ..-|.|||.|||++..+..
T Consensus        97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999999987665  999999999999999999999999   9999999999977 4568999999999987654


Q ss_pred             CCceeeecccccCCCCCccccccCCCC-CccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      .+  .-++..|++.|.|||++.+..|+ +++||||||||||-|+.|++||+.....+               .+-.++|=
T Consensus       172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDC  234 (864)
T KOG4717|consen  172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDC  234 (864)
T ss_pred             cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhcc
Confidence            33  34567899999999999998886 58999999999999999999998443222               22333443


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      +  -..+...+.+.++||..||..||++|.+.+|+...
T Consensus       235 K--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  235 K--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             c--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            2  23467788999999999999999999999998764

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=9.3e-36  Score=305.53  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=204.7

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeee--cCcceEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLE--TEVPLLVY  472 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~  472 (684)
                      +|++.+.||.|+||.||++... +++.+|+|.+..  ......+++.+|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999854 688999998754  345556789999999999999999999998764  34578999


Q ss_pred             EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          473 EFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLH-----SAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH-----~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ||+++++|.+++.... ...++++..++.++.|++.||+|||     +.+   ++|+||||+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            9999999999997642 2345899999999999999999999     666   999999999999999999999999998


Q ss_pred             cccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ........ ......+++.|++||.+....++.++|+||||+++++|++|+.||......+   +.             +
T Consensus       158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~-------------~  220 (265)
T cd08217         158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LA-------------S  220 (265)
T ss_pred             ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HH-------------H
Confidence            87654332 1233458999999999998889999999999999999999999997544211   11             1


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+........+...+..+.+++.+||+.+|++||+++||+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         221 KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            111111223344566789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.1e-35  Score=307.19  Aligned_cols=255  Identities=27%  Similarity=0.489  Sum_probs=201.7

Q ss_pred             CCcCceeceeCcEEEEEEEeC----CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC------
Q 043157          399 FNLNRILGQGGQGTVYKGMLP----DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETE------  466 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------  466 (684)
                      |.+.+.||+|+||+||+|.+.    +++.+|||.+..  ......+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999853    367899997764  34556778999999999999999999999886542      


Q ss_pred             cceEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEecc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQN---EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF  543 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF  543 (684)
                      ..++++||+++|+|.+++....   ....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998876422   2234789999999999999999999998   999999999999999999999999


Q ss_pred             CCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhh
Q 043157          544 GASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKE  621 (684)
Q Consensus       544 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~  621 (684)
                      |+++........ ......+++.|++||.+....++.++||||||+++|||++ |++||......+   +..+   ....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~---~~~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNY---LIKG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHH---HHcC
Confidence            998865432221 1122335678999999998889999999999999999999 889987543221   1111   0000


Q ss_pred             hhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       622 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      .          ....+...+..+.+++.+||+.+|++||++.|+++.|++|
T Consensus       232 ~----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 N----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             C----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0          0111234567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.2e-36  Score=316.76  Aligned_cols=257  Identities=21%  Similarity=0.296  Sum_probs=196.5

Q ss_pred             cCceecee--CcEEEEEEEe-CCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          401 LNRILGQG--GQGTVYKGML-PDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       401 ~~~~LG~G--~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      +.++||+|  +|++||++.. .+|+.||+|++...  .....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  7899999986 47899999988653  3445567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++|+|.+++..... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            99999999976432 24899999999999999999999999   999999999999999999999999865443211110


Q ss_pred             ------eeecccccCCCCCcccccc--CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          556 ------MTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       556 ------~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                            ......++..|+|||++..  ..++.++||||||+++|||++|+.||........  ....    . .......
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~----~-~~~~~~~  230 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEK----L-NGTVPCL  230 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHH----h-cCCcccc
Confidence                  0112246778999999876  4689999999999999999999999974332110  0000    0 0000000


Q ss_pred             hh------------------------------------hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          628 LD------------------------------------ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       628 ~d------------------------------------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ++                                    ...........+..+.+|+.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            00                                    000001122346689999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=314.63  Aligned_cols=253  Identities=26%  Similarity=0.375  Sum_probs=204.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|++|+||++... +++.+|+|......   ....+.+.+|+++++.++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36889999999999999999965 58999999876532   235677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+.+++|.+++.... ...+++..++.++.|+++||+|||+.+   ++|+||||+|||++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999998643 235899999999999999999999999   999999999999999999999999998754321


Q ss_pred             Cce----------------------------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 043157          553 QTH----------------------------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTT  604 (684)
Q Consensus       553 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~  604 (684)
                      ...                            ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                            1112357889999999998889999999999999999999999997544


Q ss_pred             hhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCC----HHHHHHH
Q 043157          605 LEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPT----MREVTSE  668 (684)
Q Consensus       605 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt----~~evl~~  668 (684)
                      ....               +..+.+...........+..+.+++.+||+.||++||+    ++|++.+
T Consensus       237 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         237 RDET---------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hHHH---------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            2211               11111111111111225778999999999999999999    6676664

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.9e-36  Score=311.89  Aligned_cols=263  Identities=23%  Similarity=0.337  Sum_probs=199.0

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|++.+.||+|+||+||++... +|+.+|+|+++..  .......+.+|++++++++||||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999965 6889999987643  223345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      ++ ++|.+++.....  .+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            97 588888875433  3899999999999999999999999   99999999999999999999999999876543222


Q ss_pred             eeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hhh---hhhhh
Q 043157          555 HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EER---LFEIL  628 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~~---~~~~~  628 (684)
                      . .....+++.|+|||.+.+. .++.++||||||+++|||+||+.|+......+ ..+...+.....  ...   +.+..
T Consensus       155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHHHhCCCChHHhHHhhhcc
Confidence            1 2233478899999998664 47899999999999999999998864322211 111111100000  000   00000


Q ss_pred             hhhh---------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          629 DARV---------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       629 d~~~---------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      +...         ........+.++.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            1000         011112356788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8e-36  Score=305.52  Aligned_cols=238  Identities=25%  Similarity=0.458  Sum_probs=190.9

Q ss_pred             ceeceeCcEEEEEEEeCCCc-----------EEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          403 RILGQGGQGTVYKGMLPDGK-----------IVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      +.||+|+||.||+|.+.+..           .+++|........ ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999975432           4777766544333 6788999999999999999999999988 788999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-------cEEEeccC
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-------RAKVSDFG  544 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-------~~kl~DFg  544 (684)
                      |||+++|+|.+++.....  .+++..+..++.||+.||+|||+++   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999987543  4899999999999999999999998   99999999999999887       79999999


Q ss_pred             CccccccCCceeeecccccCCCCCccccccC--CCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhh
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKE  621 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~  621 (684)
                      ++.....     .....++..|+|||++...  .++.++||||||+++|||++ |..||...+..+...   .+   .  
T Consensus       154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~---~--  220 (259)
T cd05037         154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FY---Q--  220 (259)
T ss_pred             ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HH---h--
Confidence            9876543     2223467789999998776  78999999999999999999 577776443221110   00   0  


Q ss_pred             hhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       622 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                             ..   ...+......+.+++.+||..+|++|||+.|+++.|+
T Consensus       221 -------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 -------DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -------cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   00   0011111267899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.3e-35  Score=304.51  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=191.1

Q ss_pred             ceeceeCcEEEEEEEeCCC---cEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCC
Q 043157          403 RILGQGGQGTVYKGMLPDG---KIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      +.||+|+||+||++...++   ..+++|..... .....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975433   35667765543 2345678999999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC-cee
Q 043157          479 TLFQYIHDQNE-DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ-THM  556 (684)
Q Consensus       479 sL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~-~~~  556 (684)
                      +|.+++++... ...+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999986432 223677788899999999999999998   9999999999999999999999999986432211 112


Q ss_pred             eecccccCCCCCcccccc-------CCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          557 TTQVHGTFGYLDPEYFRS-------SQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||......+   ...   .... +......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~---~~~~-~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLN---HVIK-DQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHh-hcccccC
Confidence            233457889999998743       245789999999999999997 567775433211   111   1111 1111112


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      ++.    .....+..+.+++..|| .+|++||+++||++.|.
T Consensus       231 ~~~----~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQ----LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCc----cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            221    12335567888999999 78999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.9e-36  Score=311.58  Aligned_cols=262  Identities=25%  Similarity=0.343  Sum_probs=204.0

Q ss_pred             HHHHHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeee--
Q 043157          389 SKELERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLE--  464 (684)
Q Consensus       389 ~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~--  464 (684)
                      .+.+..+.++|++.+.||+|+||+||++... +++.+|+|...... ...+++.+|+.+++.+ +||||+++++++..  
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            4556667889999999999999999999864 67899999876432 2235678899999999 69999999998853  


Q ss_pred             ---cCcceEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEE
Q 043157          465 ---TEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV  540 (684)
Q Consensus       465 ---~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl  540 (684)
                         .+..++||||+++++|.++++.. .....+++..++.++.|+++||.|||+.+   ++||||||+||++++++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence               34679999999999999988743 22235889999999999999999999998   999999999999999999999


Q ss_pred             eccCCccccccCCceeeecccccCCCCCcccccc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHH
Q 043157          541 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF  615 (684)
Q Consensus       541 ~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~  615 (684)
                      +|||+++....... ......|++.|+|||++..     ..++.++||||||+++|||++|+.||........  +.   
T Consensus       166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~---  239 (286)
T cd06638         166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LF---  239 (286)
T ss_pred             ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hh---
Confidence            99999876543222 2233458999999999753     4478899999999999999999999874432110  00   


Q ss_pred             HHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       616 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                        .....     ..+  ....+...+..+.+|+.+||+.||++|||++|+++++
T Consensus       240 --~~~~~-----~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 --KIPRN-----PPP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             --hcccc-----CCC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence              00000     000  0011122455789999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.6e-36  Score=313.87  Aligned_cols=248  Identities=27%  Similarity=0.391  Sum_probs=202.5

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      |.....||+|+||.||++... +++.||||++........+.+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            444577999999999999864 6889999998776666678899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      ++|.+++...    .+++..++.++.||+.||+|||+++   |+||||||+||++++++.+||+|||++........ ..
T Consensus       104 ~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~  175 (292)
T cd06658         104 GALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR  175 (292)
T ss_pred             CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence            9999988643    3889999999999999999999998   99999999999999999999999999875432222 12


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||.........   .    .     +.....+..  ...
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~----~-----~~~~~~~~~--~~~  241 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---R----R-----IRDNLPPRV--KDS  241 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----H-----HHhcCCCcc--ccc
Confidence            2345889999999998888999999999999999999999998744321110   0    0     001111111  111


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+..+.+++.+||+.||++|||++|++++
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            2345678899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-35  Score=306.75  Aligned_cols=254  Identities=25%  Similarity=0.423  Sum_probs=201.2

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC----------hhHHHHHHHHHHHHhhcCCCcccceeeeeeecC
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID----------ESKVEEFINEMVILSQINHRNVVKLLGCCLETE  466 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  466 (684)
                      +|.+.+.||+|++|.||+|... +++.+|+|..+...          ....+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778899999999999999854 68899999765311          112456888999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..++||||+++++|.+++.+..   .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999999998763   4899999999999999999999998   999999999999999999999999998


Q ss_pred             cccccCCc-eeeecccccCCCCCccccccCC--CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhh
Q 043157          547 RSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER  623 (684)
Q Consensus       547 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~  623 (684)
                      +....... .......++..|+|||.+....  ++.++|+||||++++||++|+.||......+     ..+.  .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~--~~~~~  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AMFK--LGNKR  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HHHH--hhccc
Confidence            76543221 1223345888999999987654  7899999999999999999999986322111     1100  00000


Q ss_pred             hhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          624 LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       624 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                          .............+..+.+++.+||+.+|++||+++|++++
T Consensus       229 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 ----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                01111112223456789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.2e-36  Score=312.55  Aligned_cols=262  Identities=24%  Similarity=0.339  Sum_probs=201.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|++.++||+|+||.||++..+ +++.+|+|+.....  ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888999999999999999975 58899999865422  2345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++++|.++.....   .+++..++.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999999988776543   3899999999999999999999998   9999999999999999999999999987654333


Q ss_pred             ceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EERLFEILDA  630 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~d~  630 (684)
                       .......++..|+|||++.+ ..++.++||||||++++||++|++||......+..  .... ....  .....+..+.
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~  230 (286)
T cd07846         155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL--YHII-KCLGNLIPRHQEIFQK  230 (286)
T ss_pred             -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH--HHHH-HHhCCCchhhHHHhcc
Confidence             22233457889999999865 45788999999999999999999999754432110  0000 0000  0000000000


Q ss_pred             ----------h-----hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 ----------R-----VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ----------~-----~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                                .     .........+..+.+|+.+||+.+|++||+++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence                      0     0001122456789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.9e-36  Score=345.56  Aligned_cols=258  Identities=23%  Similarity=0.360  Sum_probs=201.2

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec--Cc
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLET--EV  467 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~  467 (684)
                      +...++|.+.+.||+|+||+||++... +++.+|+|.+..  ........+..|+.+|++++||||+++++++.+.  ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            344568999999999999999999965 577899998764  3445567899999999999999999999998654  46


Q ss_pred             ceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCEEECC--------
Q 043157          468 PLLVYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAAS----IPIYHRDIKSTNILLDD--------  534 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~----~~iiH~Dlkp~NILl~~--------  534 (684)
                      .+|||||+++++|.++|.... ....+++..++.|+.||+.||+|||+.+.    .+|+||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            789999999999999998632 22359999999999999999999998542    23999999999999964        


Q ss_pred             ---------CCcEEEeccCCccccccCCceeeecccccCCCCCcccccc--CCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 043157          535 ---------KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLAELLTGEKPIRFT  603 (684)
Q Consensus       535 ---------~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltG~~P~~~~  603 (684)
                               ...+||+|||++.......  ......||+.|+|||++..  ..++.++||||||++||||+||+.||...
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     2358999999997653222  2234568999999999854  45889999999999999999999999743


Q ss_pred             ChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          604 TLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       604 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ....     ..+          ..+.... .......+.++.+||.+||+.+|++||++.|++.+
T Consensus       247 ~~~~-----qli----------~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        247 NNFS-----QLI----------SELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CcHH-----HHH----------HHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            3211     110          0010000 00112345679999999999999999999999853

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.8e-36  Score=309.40  Aligned_cols=259  Identities=25%  Similarity=0.392  Sum_probs=203.3

Q ss_pred             HHHHHHHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeee--
Q 043157          389 SKELERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLE--  464 (684)
Q Consensus       389 ~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~--  464 (684)
                      ..++....+.|++.+.||+|+||+||+|.. .+++.+|+|...... ....++..|+.+++++ +||||+++++++..  
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            344445667899999999999999999996 468899999876543 3446788999999999 79999999999863  


Q ss_pred             ----cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEE
Q 043157          465 ----TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV  540 (684)
Q Consensus       465 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl  540 (684)
                          ....+++|||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+   |+|+||||+||++++++.+||
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence                3467899999999999999986432 34888999999999999999999999   999999999999999999999


Q ss_pred             eccCCccccccCCceeeecccccCCCCCccccc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHH
Q 043157          541 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF  615 (684)
Q Consensus       541 ~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~  615 (684)
                      +|||++........ ......|++.|+|||.+.     ...++.++||||||+++|||++|+.||........       
T Consensus       163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-------  234 (282)
T cd06636         163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-------  234 (282)
T ss_pred             eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-------
Confidence            99999875432211 122345888999999875     34678899999999999999999999964321110       


Q ss_pred             HHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       616 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                              ...+.............+..+.+|+.+||+.||++|||+.|++++
T Consensus       235 --------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         235 --------LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             --------hhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                    000111111111223456789999999999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-35  Score=302.47  Aligned_cols=249  Identities=27%  Similarity=0.438  Sum_probs=203.4

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|+..+.||+|++|.||++... +++.+|+|.+...  .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5788999999999999999864 6889999987543  344567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CcEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFgl~~~~~~~~  553 (684)
                      +++++|.+++.... ...+++..+..++.|++++|+|||+++   ++|+||||+||+++++ ..+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999998753 234899999999999999999999998   9999999999999855 468999999998654332


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      .  .....++..|+|||.+....++.++||||||+++|+|++|+.||...+...   ...            .+... ..
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~------------~~~~~-~~  218 (256)
T cd08220         157 K--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVL------------KIMSG-TF  218 (256)
T ss_pred             c--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHH------------HHHhc-CC
Confidence            2  223457889999999998889999999999999999999999986543221   110            01100 01


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+...+.++.+++.+||+.+|++|||++|++.+
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            11223456789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=310.50  Aligned_cols=263  Identities=25%  Similarity=0.367  Sum_probs=198.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.+.||+|++|+||++..+ +++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57889999999999999999965 68899999876432 22234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      ++ ++|.+++.+...  .+++...+.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            97 499999886543  4899999999999999999999999   99999999999999999999999999875432211


Q ss_pred             eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh---hhhhhhhhh-
Q 043157          555 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK---EERLFEILD-  629 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d-  629 (684)
                      . .....++..|+|||++.+ ..++.++||||||+++|||++|+.||........ .+.. ....+.   ........+ 
T Consensus       159 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         159 T-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QLHK-IFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             c-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHH-HHHhcCCCChhhhhhhhhc
Confidence            1 122346788999999865 5588999999999999999999999975442111 1111 111100   000000000 


Q ss_pred             ------------hhhhccCC--hhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          630 ------------ARVMKESG--GDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       630 ------------~~~~~~~~--~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                                  +.......  ......+.+++.+||+.+|++|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                        00000000  1112678899999999999999999998763

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.2e-35  Score=303.15  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=203.2

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh--hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE--SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|++.+.||+|++|.||++... +++.+++|.++....  ...+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788999999999999999864 688999998775444  4778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++....   .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999998653   3788999999999999999999999   99999999999999999999999999887654333


Q ss_pred             eeee---cccccCCCCCccccccCC---CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          555 HMTT---QVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       555 ~~~~---~~~gt~~y~aPE~~~~~~---~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ....   ...++..|++||++....   .+.++||||||++++|+++|+.||........  ..  +.  ....      
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~--~~--~~~~------  222 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IM--FH--VGAG------  222 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HH--HH--HhcC------
Confidence            2221   345788999999998766   88999999999999999999999964321110  00  00  0000      


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS  667 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~  667 (684)
                       ...........+..+.+++.+||+.+|++||+++|++.
T Consensus       223 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 -HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             00000111223667889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.5e-36  Score=314.91  Aligned_cols=261  Identities=22%  Similarity=0.334  Sum_probs=189.2

Q ss_pred             CceeceeCcEEEEEEEeC---CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeee--cCcceEEEEecC
Q 043157          402 NRILGQGGQGTVYKGMLP---DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE--TEVPLLVYEFIP  476 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~E~~~  476 (684)
                      .++||+|+||+||++...   +++.||+|.+....  ....+.+|++++++++||||+++++++..  ....++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999865   35789999876432  23467889999999999999999999854  456789999986


Q ss_pred             CCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----CCCCcEEEeccCCc
Q 043157          477 NGTLFQYIHDQN------EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGAS  546 (684)
Q Consensus       477 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFgl~  546 (684)
                       ++|.+++....      ....+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             57888875321      2235889999999999999999999999   9999999999999    56679999999999


Q ss_pred             cccccCCce--eeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhh-------hhHHHHHH
Q 043157          547 RSMAVDQTH--MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED-------KSLAAYFL  616 (684)
Q Consensus       547 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~-------~~l~~~~~  616 (684)
                      +........  ......+|+.|+|||++.+ ..++.++||||||+++|||+||++||.....+..       ..+...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            865433221  2233468999999999876 4588999999999999999999999975432111       00110000


Q ss_pred             HHh-h-hhhhhh---------hhhh------------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          617 FAM-K-EERLFE---------ILDA------------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       617 ~~~-~-~~~~~~---------~~d~------------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ... . ...+.+         ....            .............+.+|+.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            000 0 000000         0000            00001111234568899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-35  Score=309.68  Aligned_cols=264  Identities=26%  Similarity=0.348  Sum_probs=206.0

Q ss_pred             cCCHHHHHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeee
Q 043157          386 LFTSKELERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCL  463 (684)
Q Consensus       386 ~~~~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  463 (684)
                      ++...++..+.++|++.+.||+|+||.||++... +++.+|+|...... ...+.+.+|+.+++++ +|||++++++++.
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            4455666677889999999999999999999964 68899999876532 2345678899999999 8999999999987


Q ss_pred             ecC-----cceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc
Q 043157          464 ETE-----VPLLVYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR  537 (684)
Q Consensus       464 ~~~-----~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~  537 (684)
                      ..+     ..++||||+++++|.++++... ....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence            543     5799999999999999987522 2235899999999999999999999998   999999999999999999


Q ss_pred             EEEeccCCccccccCCceeeecccccCCCCCccccccC-----CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHH
Q 043157          538 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLA  612 (684)
Q Consensus       538 ~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~  612 (684)
                      +||+|||++......... .....++..|+|||.+...     .++.++||||||+++|||++|+.||......+.  +.
T Consensus       167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~  243 (291)
T cd06639         167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF  243 (291)
T ss_pred             EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence            999999998765432221 2234578899999997643     368899999999999999999999874432111  10


Q ss_pred             HHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          613 AYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       613 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           .........+       ..+......+.+|+.+||+.+|++||++.|++++
T Consensus       244 -----~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 -----KIPRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -----HHhcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                 0000100000       1123345679999999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=322.05  Aligned_cols=247  Identities=27%  Similarity=0.403  Sum_probs=208.7

Q ss_pred             ceeceeCcEEEEEEEeCC-CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCHH
Q 043157          403 RILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF  481 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL~  481 (684)
                      -+||+|.||+||.|++.+ ...+|||.+...+....+-+.+|+.+-++|+|.|||+++|.+.+++..-+.||.++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            479999999999999654 5679999999888888899999999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCcEEEeccCCccccccCCceeeecc
Q 043157          482 QYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQV  560 (684)
Q Consensus       482 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgl~~~~~~~~~~~~~~~  560 (684)
                      ++|+..-....-++..+-.+.+||++||.|||+..   |+|||||-+|+||+ -.|.+||+|||-++.... -...+.++
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF  736 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF  736 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence            99998654322378888999999999999999999   99999999999996 578999999999887542 23345567


Q ss_pred             cccCCCCCccccccC--CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCCh
Q 043157          561 HGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGG  638 (684)
Q Consensus       561 ~gt~~y~aPE~~~~~--~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~  638 (684)
                      .||.-|||||++..+  .|+.++|||||||++.||.||++||......    .+.+|.-.+          -+.....+.
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp----qAAMFkVGm----------yKvHP~iPe  802 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP----QAAMFKVGM----------YKVHPPIPE  802 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh----hHhhhhhcc----------eecCCCCcH
Confidence            799999999999765  4889999999999999999999999744322    222222211          122345567


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043157          639 DEIITFAKVAKRCLNLNGKKRPTMREVTS  667 (684)
Q Consensus       639 ~~~~~l~~Li~~cl~~dp~~RPt~~evl~  667 (684)
                      +.+.+.+.+|.+|+.+||.+||++++++.
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            88889999999999999999999999985

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.5e-36  Score=306.20  Aligned_cols=253  Identities=27%  Similarity=0.410  Sum_probs=205.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|+..+.||+|++|.||++..+ +++.+++|++.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778899999999999999976 68899999876543 45567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      +++++|.+++....  .++++..+..++.|++.||+|||+ .+   ++|+||||+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999998754  348999999999999999999999 78   9999999999999999999999999987653222


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      ..   ...++..|+|||.+.+..++.++||||||+++++|++|+.||........ ......         ..+.... .
T Consensus       156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~---------~~~~~~~-~  221 (265)
T cd06605         156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELL---------QYIVNEP-P  221 (265)
T ss_pred             hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHH---------HHHhcCC-C
Confidence            21   15588899999999988999999999999999999999999874421111 111100         1111111 1


Q ss_pred             ccCChh-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          634 KESGGD-EIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       634 ~~~~~~-~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+.. .+.++.+++.+||..||++|||+.|++.+
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            111222 56779999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-36  Score=322.72  Aligned_cols=246  Identities=25%  Similarity=0.444  Sum_probs=199.0

Q ss_pred             CcCceeceeCcEEEEEEEeC-CCcEEE---EEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc--ceEEE
Q 043157          400 NLNRILGQGGQGTVYKGMLP-DGKIVA---VKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEV--PLLVY  472 (684)
Q Consensus       400 ~~~~~LG~G~~g~Vy~~~~~-~g~~va---vK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--~~lv~  472 (684)
                      ++..+||+|+|-+||+|.+. +|-.||   ||.-+. ..+..++.|..|+.+|+.|+||||+++++.+.+...  .-+|.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            45678999999999999864 466665   332222 446678999999999999999999999999987765  67899


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCcEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgl~~~~~~  551 (684)
                      |++..|+|..|+++.+.   ++.+.+..|++||++||.|||++. +||+|||||-+||||+. .|.|||+|+|||.....
T Consensus       123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999999998865   888999999999999999999987 57999999999999985 48999999999987643


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ..   ...+.|||.|||||.+. ..|++.+||||||+.++||+|+..||..-....  ++..-+....++..+..+-|  
T Consensus       199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--QIYKKV~SGiKP~sl~kV~d--  270 (632)
T KOG0584|consen  199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--QIYKKVTSGIKPAALSKVKD--  270 (632)
T ss_pred             cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--HHHHHHHcCCCHHHhhccCC--
Confidence            22   23377999999999987 889999999999999999999999997433211  11111222233333333333  


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                                .+++++|.+||.. .++|||++|+|+.
T Consensus       271 ----------Pevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  271 ----------PEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ----------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                      4689999999988 9999999999864

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.1e-35  Score=308.49  Aligned_cols=245  Identities=28%  Similarity=0.369  Sum_probs=203.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|++|.||++... +++.+|+|.+...   .....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36889999999999999999965 6889999987542   2345677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++....   .+++..+..++.|+++||+|||+.+   ++|+||+|+|||+++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999998763   4899999999999999999999998   999999999999999999999999998875433


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                          .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||........   .            ..+.... 
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~------------~~~~~~~-  214 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI---Y------------EKILEGK-  214 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---H------------HHHhcCC-
Confidence                2334588999999999888889999999999999999999999975442110   0            0011111 


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                       ...+...+..+.+++.+||+.||++||     +++|++++
T Consensus       215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence             112334467889999999999999999     77777654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.4e-35  Score=308.40  Aligned_cols=263  Identities=24%  Similarity=0.348  Sum_probs=200.2

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|+..+.||+|++|.||++... +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999865 68899999876432  33346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +. ++|.+++..... ..+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            95 689998876432 34899999999999999999999998   99999999999999999999999999876533222


Q ss_pred             eeeecccccCCCCCccccccCC-CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh-hhhhh----hh-
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK-EERLF----EI-  627 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~-~~~~~----~~-  627 (684)
                       ......+++.|+|||++.+.. ++.++||||||+++|||+||+.||......+  .+......... .....    .+ 
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHH
Confidence             122234678899999886644 6889999999999999999999997654322  11111111000 00000    00 


Q ss_pred             -----hh---hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          628 -----LD---ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       628 -----~d---~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           ..   ...........+.++.+++.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                 00   000001112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.5e-35  Score=305.66  Aligned_cols=246  Identities=27%  Similarity=0.432  Sum_probs=202.9

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      |++.+.||+|+||.||+|... +++.+|+|...... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            677889999999999999864 68899999876432 3456788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.+++...    .+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++........ .
T Consensus        86 ~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06641          86 GGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence            99999998753    3899999999999999999999998   99999999999999999999999999876543221 2


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccC
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES  636 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  636 (684)
                      .....++..|++||++.+...+.++|+||||+++|+|++|..||........                ...+........
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~  221 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV----------------LFLIPKNNPPTL  221 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH----------------HHHHhcCCCCCC
Confidence            2234578899999999888889999999999999999999999864322110                000111111122


Q ss_pred             ChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          637 GGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       637 ~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ....+.++.+++.+||+.+|++||++.+++.+
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            34456778999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.9e-35  Score=302.07  Aligned_cols=252  Identities=27%  Similarity=0.406  Sum_probs=208.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh-hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE-SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.+.||+|++|.||+++.. +++.+++|+...... ...+.+.+|+..+++++||||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999976 589999998876543 5568899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      +++++|.+++....   ++++..++.++.|+++||+|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            99999999998652   48999999999999999999999 88   9999999999999999999999999988664333


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      .. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..........+.            ..+... ..
T Consensus       155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~------------~~~~~~-~~  220 (264)
T cd06623         155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM------------QAICDG-PP  220 (264)
T ss_pred             Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH------------HHHhcC-CC
Confidence            22 22345788999999999889999999999999999999999998754321111111            111111 11


Q ss_pred             ccCChh-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          634 KESGGD-EIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       634 ~~~~~~-~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+.. .+..+.+++.+||+.+|++||++.|++++
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            112233 66789999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=305.60  Aligned_cols=254  Identities=29%  Similarity=0.431  Sum_probs=201.7

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecC------
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETE------  466 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~------  466 (684)
                      .+++|++.+.||+|++|+||++..+ +++.+++|....... ..+++.+|+.+++++ .||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4678999999999999999999975 678999998775443 346789999999999 7999999999997655      


Q ss_pred             cceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                      ..++||||+++++|.+++.... ....+++..++.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            3799999999999999987632 2235899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCceeeecccccCCCCCcccccc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK  620 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~  620 (684)
                      +........ ......++..|+|||++..     ..++.++||||||+++++|++|+.||.......  .+         
T Consensus       160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~---------  227 (275)
T cd06608         160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--AL---------  227 (275)
T ss_pred             ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HH---------
Confidence            876433222 2233458889999998753     346789999999999999999999996432111  00         


Q ss_pred             hhhhhhhhhhhh-hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          621 EERLFEILDARV-MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       621 ~~~~~~~~d~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                          .++..... ....+...+.++.+|+.+||..||++|||++|++++
T Consensus       228 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         228 ----FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ----HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                01110000 011123356789999999999999999999999863

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.9e-35  Score=309.41  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=206.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      ++|++.+.||+|+||+||++... +++.+++|..........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57899999999999999999854 67899999887655666678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++.+.    .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            999999999754    2789999999999999999999999   99999999999999999999999998875543322 


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ......+++.|++||.+....++.++||||||+++|++++|+.||..........  .    ..        ........
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~----~~--------~~~~~~~~  236 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----IA--------TNGTPELQ  236 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--e----hh--------cCCCCCCC
Confidence            2223458889999999988889999999999999999999999997543211100  0    00        00001111


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+...+..+.+++.+||+.+|++||++++++.+
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            123345678999999999999999999999977

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.3e-35  Score=311.37  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=201.7

Q ss_pred             cCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCC
Q 043157          401 LNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT  479 (684)
Q Consensus       401 ~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gs  479 (684)
                      ....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++.+...+..+++|||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3457999999999999864 688999999876555566788999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeec
Q 043157          480 LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ  559 (684)
Q Consensus       480 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~  559 (684)
                      |.+++...    .+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++........ ....
T Consensus       105 L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~  176 (297)
T cd06659         105 LTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS  176 (297)
T ss_pred             HHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence            99988653    3899999999999999999999999   99999999999999999999999999875443222 2233


Q ss_pred             ccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChh
Q 043157          560 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGD  639 (684)
Q Consensus       560 ~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~  639 (684)
                      ..++..|+|||++.+..++.++||||||++++||++|+.||......+..   .    .+...     ...  .......
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~----~~~~~-----~~~--~~~~~~~  242 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---K----RLRDS-----PPP--KLKNAHK  242 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHhcc-----CCC--CccccCC
Confidence            45889999999999888999999999999999999999999744322110   0    00000     000  0111123


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          640 EIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       640 ~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .+..+.+++.+||+.+|++||+++|++++-
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~  272 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDHP  272 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence            456789999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.8e-35  Score=306.05  Aligned_cols=266  Identities=22%  Similarity=0.327  Sum_probs=203.3

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      +|++.++||+|++|+||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999975 68899999887543 234567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++ +|.+++........+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 89998877654456899999999999999999999998   99999999999999999999999999875533222 


Q ss_pred             eeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh-----
Q 043157          556 MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD-----  629 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-----  629 (684)
                      ......++..|++||.+.+ ..++.++||||||+++|+|++|+.||......+................+..+.+     
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            1222346888999998865 4578899999999999999999999986554332111100000000000000000     


Q ss_pred             h-------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          630 A-------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       630 ~-------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .       ..........+..+.+++.+||+.||++||+++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0       00011112345678999999999999999999999853

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-35  Score=330.70  Aligned_cols=266  Identities=20%  Similarity=0.281  Sum_probs=195.2

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCC------Ccccceeeeee
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINH------RNVVKLLGCCL  463 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------pnIv~l~~~~~  463 (684)
                      ++....++|++.++||+|+||+||++... .++.||||+++... ....++..|+++++.++|      ++++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445688999999999999999999864 67899999886432 233455667777777754      45888888887


Q ss_pred             ec-CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCC-----
Q 043157          464 ET-EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKY-----  536 (684)
Q Consensus       464 ~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~-----  536 (684)
                      .. ...++|||++ +++|.+++.+..   .+++..+..++.||+.||+|||++ +   |+||||||+|||++.++     
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence            54 4678999988 778999887653   489999999999999999999984 7   99999999999998765     


Q ss_pred             -----------cEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCCh
Q 043157          537 -----------RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTL  605 (684)
Q Consensus       537 -----------~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~  605 (684)
                                 .+||+|||++....    .......||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                       49999999875422    223345689999999999999999999999999999999999999986553


Q ss_pred             hhhhhHHHHHHHHhh--------hhhhhhhh----------hhhhh----cc---CChhHHHHHHHHHHHhhccCCCCCC
Q 043157          606 EEDKSLAAYFLFAMK--------EERLFEIL----------DARVM----KE---SGGDEIITFAKVAKRCLNLNGKKRP  660 (684)
Q Consensus       606 ~~~~~l~~~~~~~~~--------~~~~~~~~----------d~~~~----~~---~~~~~~~~l~~Li~~cl~~dp~~RP  660 (684)
                      .+...+.........        .....++.          ++...    ..   ........+.+||.+||+.||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            322211111000000        00000000          00000    00   0011235688999999999999999


Q ss_pred             CHHHHHHH
Q 043157          661 TMREVTSE  668 (684)
Q Consensus       661 t~~evl~~  668 (684)
                      |++|++++
T Consensus       431 ta~e~L~H  438 (467)
T PTZ00284        431 NARQMTTH  438 (467)
T ss_pred             CHHHHhcC
Confidence            99999985

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.3e-35  Score=309.28  Aligned_cols=254  Identities=24%  Similarity=0.301  Sum_probs=200.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||.||++... +++.|++|.+....   ....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36889999999999999999965 57899999876532   334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999997653   3899999999999999999999998   999999999999999999999999998642111


Q ss_pred             C--------------ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH
Q 043157          553 Q--------------THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA  618 (684)
Q Consensus       553 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~  618 (684)
                      .              ........++..|+|||++....++.++|+||||+++|||++|+.||......+   +   ... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~---~~~-  227 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---L---FGQ-  227 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHH-
Confidence            0              011122457889999999988889999999999999999999999997443221   0   000 


Q ss_pred             hhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          619 MKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       619 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      ....   ....    .......+.++.+++.+||+.||++||++.++.+.|+
T Consensus       228 ~~~~---~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         228 VISD---DIEW----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHhc---ccCC----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            0000   0000    0111245677899999999999999999655555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.6e-35  Score=307.78  Aligned_cols=266  Identities=21%  Similarity=0.308  Sum_probs=198.6

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++++|.+.+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3467999999999999999999864 68899999876533 222346788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+. ++|.+.+.....  .+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9995 678777765432  3788889999999999999999998   999999999999999999999999998764332


Q ss_pred             CceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH-HHhhhhhhh-----
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL-FAMKEERLF-----  625 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~-~~~~~~~~~-----  625 (684)
                      ... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..+..... .........     
T Consensus       157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHHHHcCCCChhhhhhhhh
Confidence            221 223346889999999875 457889999999999999999999997544321 11111000 000000000     


Q ss_pred             ------hhhh---hhhhcc--CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          626 ------EILD---ARVMKE--SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       626 ------~~~d---~~~~~~--~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                            +...   +.....  .....+..+.+++.+||+.||++|||++|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                  0000   000000  001225678899999999999999999999763

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.9e-35  Score=305.76  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=195.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHH-HhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVI-LSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|++.+.||+|+||.||++... +|+.||+|+++... .....++..|+.+ ++.++||||+++++++.+....+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46889999999999999999965 68999999876532 2334455666665 666789999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          474 FIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       474 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |++ ++|.+++... .....+++..++.++.|++.||+|||++ +   ++||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6898888653 2234589999999999999999999987 7   99999999999999999999999999876532


Q ss_pred             CCceeeecccccCCCCCcccccc----CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRS----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ..  ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||.......    .          .+...
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~----------~~~~~  220 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF----Q----------QLKQV  220 (283)
T ss_pred             cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH----H----------HHHHH
Confidence            21  1223457889999998864    456889999999999999999999986322110    0          01111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .............+.++.+++.+||+.+|++||++++++++
T Consensus       221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         221 VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11100001112356789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.4e-35  Score=308.99  Aligned_cols=262  Identities=27%  Similarity=0.327  Sum_probs=201.0

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh-----hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE-----SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      +|++.+.||+|++|.||+|... +++.||+|++.....     .....+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999965 689999998765332     2345677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+ +++|.+++....  ..+++..++.++.||++||+|||+++   |+|+||||+|||++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999998654  24899999999999999999999999   99999999999999999999999999976543


Q ss_pred             CCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hh------
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EE------  622 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~------  622 (684)
                      ... ......+++.|+|||.+.+ ..++.++||||||++++||++|.+||......+.  +...+.....  ..      
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhhcc
Confidence            322 1222346788999998854 4678999999999999999999888765432211  1111100000  00      


Q ss_pred             hhhhhhhhhh-----hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          623 RLFEILDARV-----MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       623 ~~~~~~d~~~-----~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+........     ........+..+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000000     001112346788999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-37  Score=320.94  Aligned_cols=251  Identities=25%  Similarity=0.377  Sum_probs=207.8

Q ss_pred             CCCcCceeceeCcEEEEEEEeCCCc-EEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPDGK-IVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~g~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      .|.+...||.|+||.||++..++.. ..|.|.+.....+.+++|+-||+||....||+||+|++.+..++.+||+.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            3556677999999999999977544 456788888888999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      ||-+..++-.-+.  +|++.++..+..|++.||.|||+..   |||||||..|||++.+|.++|+|||.+..... ....
T Consensus       113 GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk  186 (1187)
T KOG0579|consen  113 GGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK  186 (1187)
T ss_pred             CchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence            9999999887654  4999999999999999999999999   99999999999999999999999999865432 2233


Q ss_pred             eecccccCCCCCcccc-----ccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          557 TTQVHGTFGYLDPEYF-----RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~-----~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ...+.|||.|||||+.     ...+|+.++||||||++|.||..+.+|-.....       +.++..+......      
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllKiaKSePP------  253 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPP------  253 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHHHhhcCCC------
Confidence            4567799999999986     456899999999999999999999999652211       1111111111111      


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       ....+...+..+.+++++||..||+.||++.+++++
T Consensus       254 -TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  254 -TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             -cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence             112346778889999999999999999999999875

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.7e-35  Score=307.27  Aligned_cols=247  Identities=27%  Similarity=0.387  Sum_probs=199.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      +.|+..+.||+|+||+||+|... +++.||+|++..   ...+..+++.+|+++++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888999999999999999965 688999998753   23345577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||++ |+|.+++.....  ++++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++......
T Consensus        95 e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9996 678887765433  4899999999999999999999998   999999999999999999999999998754322


Q ss_pred             CceeeecccccCCCCCccccc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                           ....++..|+|||++.   ...++.++||||||+++|||++|+.||.........               ..+..
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~---------------~~~~~  228 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------------YHIAQ  228 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH---------------HHHhc
Confidence                 2345788999999874   456889999999999999999999998644321110               00000


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ...........+..+.+++.+||+.+|++||++.+++.+.
T Consensus       229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         229 NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            0001111234567899999999999999999999998854

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.8e-35  Score=296.81  Aligned_cols=249  Identities=31%  Similarity=0.444  Sum_probs=206.3

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      |+..+.||+|++|.||++... +++.+++|+.........+.+.+|++++++++|||++++++++......++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            678899999999999999975 6889999998776556778899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      ++|.+++....  ..+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||.+........  .
T Consensus        82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  154 (253)
T cd05122          82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R  154 (253)
T ss_pred             CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence            99999998753  24899999999999999999999988   99999999999999999999999999877654332  3


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....++..|++||++.....+.++||||||+++++|++|+.||...+......       .........       ....
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~-------~~~~  220 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-------KIATNGPPG-------LRNP  220 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-------HHHhcCCCC-------cCcc
Confidence            34568889999999988889999999999999999999999987543211100       000000000       0011


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+..+.+++.+||+.||++|||+.|++++
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1236779999999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.8e-35  Score=307.79  Aligned_cols=262  Identities=23%  Similarity=0.305  Sum_probs=201.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeec--CcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv  471 (684)
                      ++|++.+.||+|+||.||+|... +++.+++|+++...  ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999975 68899999886533  22334677899999999999999999999877  789999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||++ ++|.+++.....  .+++..++.++.|+++||+|||+.+   ++|+||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 599999886543  4899999999999999999999999   99999999999999999999999999887654


Q ss_pred             CCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh---h------
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK---E------  621 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~---~------  621 (684)
                      .... .....+++.|+|||.+.+. .++.++|+||||++++||++|+.||......+...  ..+ ....   .      
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~--~~~-~~~~~~~~~~~~~~  234 (293)
T cd07843         159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN--KIF-KLLGTPTEKIWPGF  234 (293)
T ss_pred             Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHH-HHhCCCchHHHHHh
Confidence            3221 2233478899999998654 46899999999999999999999998654322111  000 0000   0      


Q ss_pred             --------hhhhhhhhhhhhccCChh-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          622 --------ERLFEILDARVMKESGGD-EIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       622 --------~~~~~~~d~~~~~~~~~~-~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                              ..........+....+.. .+..+.+++.+||+.+|++|||++|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                    000000011111112222 46778999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6e-35  Score=304.32  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=203.2

Q ss_pred             CCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          399 FNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      |...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            45568999999999999985 46889999988766666677899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      ++|.+++...    .+++..+..++.|++.||+|||+++   ++||||+|+||+++.++.+||+|||++........ ..
T Consensus       101 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~  172 (285)
T cd06648         101 GALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR  172 (285)
T ss_pred             CCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence            9999999863    3899999999999999999999999   99999999999999999999999998875543222 22


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....|++.|+|||.+.+..++.++||||||++++||++|+.||...+..+.   ..    ...     ....+.  ....
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~----~~~-----~~~~~~--~~~~  238 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MK----RIR-----DNLPPK--LKNL  238 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HH----HHH-----hcCCCC--Cccc
Confidence            334588999999999888899999999999999999999999864332111   00    000     000000  0111


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+..+.+++.+||+.+|++||+++|++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            2355689999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-35  Score=301.15  Aligned_cols=250  Identities=24%  Similarity=0.408  Sum_probs=203.2

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|++.+.||+|+||.||++... +++.+|+|.+...  .....+.+.+|++++++++|+||+++++.+.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788999999999999999965 5888999987643  224456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-cEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgl~~~~~~~~  553 (684)
                      +++++|.+++..... ..+++..+..++.|+++||+|||+.+   ++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999999976432 24799999999999999999999998   99999999999999875 46999999987654322


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      . ......|++.|+|||++....++.++|+||||++++||++|+.||......+      ...         +..... .
T Consensus       157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~---------~~~~~~-~  219 (257)
T cd08225         157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVL---------KICQGY-F  219 (257)
T ss_pred             c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHH---------HHhccc-C
Confidence            2 2233458889999999988889999999999999999999999987443211      111         111111 1


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .......+.++.+++.+||+.+|++|||++|++++
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11223455679999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-36  Score=311.44  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=206.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccc--cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ...|++.++||.||-+.||++...+.+.+|+|+...  .+.+.+.-|.+|+.+|.+| .|.+|++|++|-..++.+||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            356888999999999999999988888999997654  6777889999999999999 5999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      |+= .-+|..+|.+..... ..| .++.+..|+++|+.++|.++   |||.||||.|+|+-.+ .+||+|||+|..+..+
T Consensus       440 E~G-d~DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecc-cccHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccCcc
Confidence            986 569999999876542 234 67788999999999999999   9999999999999654 8999999999988765


Q ss_pred             Cce-eeecccccCCCCCccccccCC-----------CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh
Q 043157          553 QTH-MTTQVHGTFGYLDPEYFRSSQ-----------FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK  620 (684)
Q Consensus       553 ~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~  620 (684)
                      .+. ......||+.||+||.+....           .+.+|||||||||||+|+.|+.||....     .         .
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n---------~  578 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N---------Q  578 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H---------H
Confidence            543 344557999999999874322           4579999999999999999999997221     1         2


Q ss_pred             hhhhhhhhhhhhhccCChhH-HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          621 EERLFEILDARVMKESGGDE-IITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       621 ~~~~~~~~d~~~~~~~~~~~-~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..++..+.++....+++..- ..++.++++.||++||++||+..|||++
T Consensus       579 ~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  579 IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            23455666664433433222 2238999999999999999999999875

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.9e-35  Score=306.83  Aligned_cols=265  Identities=21%  Similarity=0.322  Sum_probs=198.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCc-----
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEV-----  467 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~-----  467 (684)
                      ++|++.+.||+|+||+||++... +++.||+|+.....  ......+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999965 68999999876532  223467889999999995 6999999999987665     


Q ss_pred             ceEEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCcEEEeccC
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFG  544 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFg  544 (684)
                      .++||||+++ +|.+++.....  ...+++..++.++.||++||+|||+.+   |+||||||+|||++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 89888875432  245899999999999999999999999   999999999999998 8899999999


Q ss_pred             CccccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh-hh
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK-EE  622 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~-~~  622 (684)
                      +++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+.  +...+..... ..
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPTE  233 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCCh
Confidence            98765332211 122246788999998765 4578999999999999999999999975443221  1111100000 00


Q ss_pred             hhh-hh---h--------hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          623 RLF-EI---L--------DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       623 ~~~-~~---~--------d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ... ..   .        .+..........+.++.+++.+||+.||++||+++|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000 00   0        0000011112456779999999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=301.24  Aligned_cols=268  Identities=25%  Similarity=0.387  Sum_probs=205.9

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhc--CCCcccceeeeeeecC----cc
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI--NHRNVVKLLGCCLETE----VP  468 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l~~~~~~~~----~~  468 (684)
                      ......+.+.||+|.||+||+|.+ .|+.||||++...++   +.+.+|.++.+.+  +|+||+.+++.-..+.    .+
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            445788999999999999999999 577899999886544   5678888888875  9999999998876554    57


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCEEECCCCcEEEecc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH-----SAASIPIYHRDIKSTNILLDDKYRAKVSDF  543 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH-----~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF  543 (684)
                      |||.+|.+.|||.|||.+.    .++.+..++++..+|.||++||     .++.+.|.|||||+.|||+..+++.-|+|+
T Consensus       285 wLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            8999999999999999874    3899999999999999999999     457788999999999999999999999999


Q ss_pred             CCccccccCCc---eeeecccccCCCCCccccccCC----C--CCccchhhhHHHHHHHHhC----------CCCCCCCC
Q 043157          544 GASRSMAVDQT---HMTTQVHGTFGYLDPEYFRSSQ----F--TDKSDVYSFGVVLAELLTG----------EKPIRFTT  604 (684)
Q Consensus       544 gl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~--~~ksDv~SlGvil~elltG----------~~P~~~~~  604 (684)
                      |||-....+..   .......||.+|||||++...-    +  -..+||||||+++||++..          +.||...-
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            99976554322   2234567999999999986532    1  2469999999999998752          35664322


Q ss_pred             hhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          605 LEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       605 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      . .+.+...+. ...=..++...++.   .....+....+.+|++.||..+|..|-|+-.+.+.|.++...
T Consensus       441 p-~DPs~eeMr-kVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  441 P-SDPSFEEMR-KVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             C-CCCCHHHHh-cceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            1 111211110 00001111111221   223356788899999999999999999999999999988753

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.4e-35  Score=303.50  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=207.7

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ..+.|+..+.||+|++|.||++.++ +++.+++|.+..... ..+.+.+|++++++++|+|++++++.+......++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999976 688999998876544 56788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++++|.+++....  ..+++..++.++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999998764  24999999999999999999999988   9999999999999999999999999886544322


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      . ......++..|++||++.+..++.++||||||+++|+|++|+.||.........  .    . .......       .
T Consensus       171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~----~-~~~~~~~-------~  235 (286)
T cd06614         171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--F----L-ITTKGIP-------P  235 (286)
T ss_pred             h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--H----H-HHhcCCC-------C
Confidence            1 223345788999999998888999999999999999999999998743322110  0    0 0000000       0


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .......+..+.+++.+||+.+|++||++.+++++-
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence            011122566799999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-35  Score=313.74  Aligned_cols=276  Identities=22%  Similarity=0.312  Sum_probs=208.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC-----c
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETE-----V  467 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~  467 (684)
                      .++|.+.+.||+|+||+||++... +++.||||++...  .......+.+|+.+++.++||||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357999999999999999999854 6899999987642  3334567789999999999999999999886543     4


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .++||||+. ++|.+++....   .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 78998887643   4899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH--------
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA--------  618 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~--------  618 (684)
                      ...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||......+...........        
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            654332 22233457889999998765 46889999999999999999999999765432211111100000        


Q ss_pred             hhhhhhhhhhhh---h---hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhHhhcCCC
Q 043157          619 MKEERLFEILDA---R---VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGIKAWNGAS  679 (684)
Q Consensus       619 ~~~~~~~~~~d~---~---~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i~~~~~~~  679 (684)
                      .......+.+..   .   .........+.++.+|+.+||+.+|++|||++|++++  +..++..+..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~  304 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEP  304 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCc
Confidence            000000000000   0   0001123456778999999999999999999999998  77776555433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.9e-35  Score=301.57  Aligned_cols=248  Identities=27%  Similarity=0.353  Sum_probs=204.9

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      +|++.+.||.|+||.||++... +++.+|+|.+...   .....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999975 6889999987642   23456789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++++|.+++...   .++++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999999865   24899999999999999999999998   9999999999999999999999999987654332


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                        ......++..|+|||.+....++.++|+||||+++|+|++|+.||..........+.             ..... ..
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~-~~  218 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-------------AKQET-AD  218 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-------------HHhcc-cc
Confidence              223445888999999998888999999999999999999999999865432111111             00110 11


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCH--HHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTM--REVTS  667 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~--~evl~  667 (684)
                      ...+...+..+.+++.+||+.||++||++  +|+++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            22234456789999999999999999999  66543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=314.60  Aligned_cols=270  Identities=24%  Similarity=0.332  Sum_probs=202.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC-----cc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETE-----VP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~  468 (684)
                      .++|++.++||+|++|+||+|... +++.||+|++... .......+.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999854 6899999988643 2334567889999999999999999999876543     47


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++++||++ ++|.+++...    .+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            89999996 5888887643    3899999999999999999999999   99999999999999999999999999876


Q ss_pred             cccCCce--eeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh
Q 043157          549 MAVDQTH--MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF  625 (684)
Q Consensus       549 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  625 (684)
                      .......  ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.................+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            5432221  1223457899999998654 568899999999999999999999997544322111000000000011111


Q ss_pred             hhhhhhh-----------h---ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhH
Q 043157          626 EILDARV-----------M---KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGIK  673 (684)
Q Consensus       626 ~~~d~~~-----------~---~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i~  673 (684)
                      .+.+...           .   .......+.++.+++.+||+.+|++|||+.|++++  ++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            1111000           0   00112345678999999999999999999999987  55544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-35  Score=308.51  Aligned_cols=267  Identities=24%  Similarity=0.326  Sum_probs=199.9

Q ss_pred             CCCcCceeceeCcEEEEEEEeC---CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeec--Ccce
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP---DGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPL  469 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~  469 (684)
                      +|++.++||+|++|.||+|...   +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999965   47899999887632   44456788999999999999999999999988  7889


Q ss_pred             EEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC----CCcEEEecc
Q 043157          470 LVYEFIPNGTLFQYIHDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDF  543 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~DF  543 (684)
                      +||||+++ +|.+++.....  ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999974 77777754322  235899999999999999999999999   999999999999999    999999999


Q ss_pred             CCccccccCCc--eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhh-------hhHHH
Q 043157          544 GASRSMAVDQT--HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED-------KSLAA  613 (684)
Q Consensus       544 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~-------~~l~~  613 (684)
                      |++........  .......++..|+|||++.+ ..++.++||||||+++++|++|++||.....+..       ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99886543222  12233457889999998766 4578999999999999999999999986544321       01111


Q ss_pred             HHHHHhhhh-----------hhhhhhhhhhhccCC-----------hhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          614 YFLFAMKEE-----------RLFEILDARVMKESG-----------GDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       614 ~~~~~~~~~-----------~~~~~~d~~~~~~~~-----------~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+.......           ......+.......+           ...+.++.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            111000000           000000000000000           1345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-35  Score=303.40  Aligned_cols=247  Identities=24%  Similarity=0.411  Sum_probs=201.8

Q ss_pred             CCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhcC---CCcccceeeeeeecCcceEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI-DESKVEEFINEMVILSQIN---HRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .|+..+.||+|+||.||+|.+ .+++.+|+|.+... .....+++.+|+.++++++   |||++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477889999999999999996 47899999987643 3455678889999999997   999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++...    ++++...+.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999998654    4899999999999999999999999   999999999999999999999999998766543


Q ss_pred             CceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .. ......|+..|+|||.+.+. .++.++|+||||+++|+|++|+.||..........                .+...
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~----------------~~~~~  217 (277)
T cd06917         155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM----------------LIPKS  217 (277)
T ss_pred             cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh----------------ccccC
Confidence            32 22334588899999998654 46889999999999999999999997543221100                00000


Q ss_pred             hhccCCh-hHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGG-DEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~-~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ....... ..+.++.+++.+||+.||++||++.|++++
T Consensus       218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         218 KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            0011111 256789999999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.7e-35  Score=316.55  Aligned_cols=262  Identities=25%  Similarity=0.347  Sum_probs=204.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcC-C-----CcccceeeeeeecCcce
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-H-----RNVVKLLGCCLETEVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~~~~~~~~~~~  469 (684)
                      .+|.+.+.||+|.||.|-++.. ++++.||||+++.. ..-..+-..|+.+|..|+ |     -|+|+++++|...++.+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            3789999999999999999985 57999999999864 445567788999999997 4     48999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC--CcEEEeccCCcc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK--YRAKVSDFGASR  547 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DFgl~~  547 (684)
                      ||+|.+ .-+|.++|+..+-. .++...++.++.||+.||.+||+.+   |||+||||+||||.+.  ..+||+|||.+.
T Consensus       265 iVfELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            999999 46999999987543 4999999999999999999999999   9999999999999754  369999999997


Q ss_pred             ccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh---
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL---  624 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~---  624 (684)
                      .....   .. +...+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+....++.....-+. .+....+   
T Consensus       340 ~~~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l-G~Pp~~mL~~  414 (586)
T KOG0667|consen  340 FESQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL-GLPPPKMLDT  414 (586)
T ss_pred             ccCCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh-CCCCHHHHHh
Confidence            64321   12 4456788999999999999999999999999999999988888765443322211110 0000000   


Q ss_pred             ----hhhhhh---------------------------------hhh---c----cCChhHHHHHHHHHHHhhccCCCCCC
Q 043157          625 ----FEILDA---------------------------------RVM---K----ESGGDEIITFAKVAKRCLNLNGKKRP  660 (684)
Q Consensus       625 ----~~~~d~---------------------------------~~~---~----~~~~~~~~~l~~Li~~cl~~dp~~RP  660 (684)
                          ...++.                                 +..   .    ......-..+.+++++||.+||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                000000                                 000   0    01112345689999999999999999


Q ss_pred             CHHHHHHHH
Q 043157          661 TMREVTSEL  669 (684)
Q Consensus       661 t~~evl~~L  669 (684)
                      |..|.+++=
T Consensus       495 tp~qal~Hp  503 (586)
T KOG0667|consen  495 TPAQALNHP  503 (586)
T ss_pred             CHHHHhcCc
Confidence            999998863

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-34  Score=302.20  Aligned_cols=262  Identities=26%  Similarity=0.326  Sum_probs=203.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecC--cceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETE--VPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lv~  472 (684)
                      ++|...+.||.|++|.||++... +++.+|+|...... .....++.+|++++++++||||+++++++.+..  ..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36888999999999999999975 68899999876532 345677999999999999999999999986543  679999


Q ss_pred             EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      ||+++++|.+++.... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999999886522 2334889999999999999999999999   99999999999999999999999999875432


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ...   ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....+.... ...... ........+.+. 
T Consensus       158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~-  231 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP-IELLSY-IVNMPNPELKDE-  231 (287)
T ss_pred             ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh-HHHHHH-HhcCCchhhccC-
Confidence            221   23347888999999998899999999999999999999999997553211110 110000 000000010000 


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                        .......+..+.+++.+||+.+|++|||+.|++++-
T Consensus       232 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         232 --PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             --CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence              011123567899999999999999999999999854

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-35  Score=304.16  Aligned_cols=261  Identities=25%  Similarity=0.317  Sum_probs=201.8

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec--CcceEEEE
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLLVYE  473 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv~E  473 (684)
                      |++.+.||+|++|.||++... +++.+|+|++...  .....+.+.+|++++++++|||++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567899999999999999965 5889999988764  344456788999999999999999999999988  78999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++ +|.+++....  ..+++..++.++.|+++||+|||+.+   ++|+||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9974 8998887653  24899999999999999999999998   9999999999999999999999999998765443


Q ss_pred             ceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh---hhhhhh---
Q 043157          554 THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK---EERLFE---  626 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~---~~~~~~---  626 (684)
                      ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........  .... ....   ......   
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~  231 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL--EKIF-ELCGSPTDENWPGVSK  231 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHH-HHhCCCchhhcccccc
Confidence            322333456788999998764 45789999999999999999999999765532211  1111 0000   000000   


Q ss_pred             -----------hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 -----------ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 -----------~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                                 .............++..+.+++.+||+.+|++||++++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                       000000011111136788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.2e-34  Score=295.73  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=208.7

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeec--CcceEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLLVY  472 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv~  472 (684)
                      +|+..+.||+|++|.||+|... +++.+++|+.....  ....+.+.+|++++++++||||+++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999976 68899999876544  35678899999999999999999999999988  8899999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++.+..   .+++..++.++.|++.+|+|||+.+   ++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999998764   4899999999999999999999988   999999999999999999999999998876543


Q ss_pred             Cce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 QTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ... ......++..|++||.+.....+.++||||||+++++|++|+.||.......     .         ...+.....
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~---------~~~~~~~~~  220 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----A---------ALYKIGSSG  220 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----H---------HHHhccccC
Confidence            321 1233458889999999988889999999999999999999999997544111     0         001111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .....+...+..+.+++.+||+.+|++||++.|++.+
T Consensus       221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            1223344557789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.7e-35  Score=297.96  Aligned_cols=249  Identities=27%  Similarity=0.396  Sum_probs=206.8

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|++.+.||+|++|.||++... +++.+++|++...  ......++.+|++++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999854 6889999987653  345567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      +++++|.+++.+.. ....+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999987632 2235899999999999999999999999   999999999999999999999999999776543 


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                        ......+++.|++||.+.+..++.++|+||||++++||++|+.||...+.++..                ........
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~----------------~~~~~~~~  218 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR----------------YKVQRGKY  218 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------HHHhcCCC
Confidence              222345788999999999988999999999999999999999999755432211                01111111


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+...+.++.+++.+||+.+|++||++.|++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            22334566789999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-35  Score=302.99  Aligned_cols=262  Identities=24%  Similarity=0.323  Sum_probs=200.0

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      |++.+.||.|++|+||++... +|+.||+|++....  ....+.+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567899999999999999864 78999999876532  233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      + ++|.+++..... ..+++..++.++.|+++||+|||+.+   ++||||+|+||+++.++.+||+|||+++........
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 689999876542 34899999999999999999999998   999999999999999999999999998765432221


Q ss_pred             eeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh-hhh-------hh
Q 043157          556 MTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE-ERL-------FE  626 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~-~~~-------~~  626 (684)
                       .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||........  +...+...... +..       .+
T Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence             1222468889999987654 578999999999999999999999976543221  11111100000 000       00


Q ss_pred             hhh------hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 ILD------ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...      ...........+..+.+++.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000      000011123445688999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=296.72  Aligned_cols=250  Identities=26%  Similarity=0.388  Sum_probs=201.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc-----cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec--Ccc
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV-----IDESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVP  468 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~  468 (684)
                      .+|++.+.||+|+||.||++... +++.+|+|....     ........+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46899999999999999999964 688999997643     1234567889999999999999999999998764  357


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++++||+++++|.+++....   .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999997653   3789999999999999999999999   99999999999999999999999999976


Q ss_pred             cccCC--ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          549 MAVDQ--THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       549 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      .....  ........++..|+|||++.+..++.++|+||||++++||++|+.||......+               .+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------~~~~  220 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---------------AIFK  220 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---------------HHHH
Confidence            53211  111223458899999999988889999999999999999999999997432111               1111


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      +.........+...+..+.+++.+||+ +|.+||+..+++.+
T Consensus       221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            111111223455667889999999998 57999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.1e-34  Score=305.00  Aligned_cols=249  Identities=27%  Similarity=0.405  Sum_probs=200.2

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      |+..+.||+|+||+||++... +++.+|+|++...   ..+..+++.+|++++++++|||++++++++.+....++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            677889999999999999964 6889999987532   334556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      ++ |+|.+++.....  ++++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++......  
T Consensus       107 ~~-g~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         107 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             CC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            96 588888765433  4899999999999999999999999   999999999999999999999999988654321  


Q ss_pred             eeeecccccCCCCCccccc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          555 HMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                         ....+++.|+|||++.   ...++.++||||||+++|||++|+.||........               +..+....
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---------------~~~~~~~~  240 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---------------LYHIAQNE  240 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHhcc
Confidence               2345788999999973   45688999999999999999999999864321111               01111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      .........+..+.+++.+||+.+|++||++.++++++-.+.
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            111112345667999999999999999999999998765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.3e-34  Score=295.57  Aligned_cols=251  Identities=30%  Similarity=0.432  Sum_probs=208.2

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|++.+.||.|++|.||++... +++.+++|++....  ....+.+.+|+++++.++|||++++++.+.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999965 68899999887643  35677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      +++++|.+++.+.. ....+++..+..++.++++||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999998742 1235899999999999999999999998   9999999999999999999999999987654433


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                       .......+++.|+|||.+....++.++|+||||+++++|++|+.||......+   +..   .          ......
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~---~----------~~~~~~  220 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL---K----------ILKGQY  220 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHH---H----------HhcCCC
Confidence             23334468889999999988889999999999999999999999986443211   000   0          001111


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+...+..+.+++.+||..+|++|||++|++++
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            22233566789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1e-34  Score=301.43  Aligned_cols=258  Identities=21%  Similarity=0.296  Sum_probs=195.4

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcC-CCcccceeeeeeec--CcceEEEE
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQIN-HRNVVKLLGCCLET--EVPLLVYE  473 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lv~E  473 (684)
                      |++.+.||+|+||.||++... +++.+|+|+.+.. .........+|+.+++++. |||++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999954 6889999987653 2222334567899999885 99999999999987  88999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |++ ++|.+.+.....  .+++..++.++.|++.||+|||+.+   ++||||||+||+++. +.+||+|||+++......
T Consensus        81 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGRKR--PLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 588888876432  4899999999999999999999999   999999999999999 999999999997654332


Q ss_pred             ceeeecccccCCCCCccccc-cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EERLFEILDA  630 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~d~  630 (684)
                      ..  ....++..|+|||++. ...++.++||||||+++|||++|+.||...+..+..   ........  ...+......
T Consensus       154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI---AKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH---HHHHHHcCCCCHHHHHhhcc
Confidence            21  2234788999999764 455788999999999999999999999765432211   11100000  0000000000


Q ss_pred             hh-------------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 RV-------------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ~~-------------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..             ........+.++.+|+.+||+.+|++||+++|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00             001112457889999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.5e-35  Score=305.76  Aligned_cols=267  Identities=26%  Similarity=0.354  Sum_probs=201.3

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecC---
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETE---  466 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---  466 (684)
                      +...++|++.+.||+|+||+||+|..+ +++.||+|+++...  ......+.+|++++++++||||+++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            345678999999999999999999975 58899999876532  233456788999999999999999999987655   


Q ss_pred             -------cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEE
Q 043157          467 -------VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK  539 (684)
Q Consensus       467 -------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k  539 (684)
                             ..++|+||+++ +|.+.+.....  .+++..++.++.|++.||+|||+.+   |+|+||||+||++++++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLV--HFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence                   68899999975 77777775432  4899999999999999999999998   99999999999999999999


Q ss_pred             EeccCCccccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH
Q 043157          540 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA  618 (684)
Q Consensus       540 l~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~  618 (684)
                      |+|||++...............++..|+|||.+.+ ..++.++||||||++++||++|++||......+  .+.. +...
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~-~~~~  233 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLEL-ISRL  233 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHH
Confidence            99999997654333222222345778999998764 457899999999999999999999997543221  1111 1111


Q ss_pred             hhh---hhhhhh--------hhhh-----hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          619 MKE---ERLFEI--------LDAR-----VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       619 ~~~---~~~~~~--------~d~~-----~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...   ....++        .+..     .........+..+.+++.+||+.||++||++++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            100   000000        0000     0000112346789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.6e-35  Score=307.08  Aligned_cols=264  Identities=24%  Similarity=0.329  Sum_probs=199.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeec--CcceE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l  470 (684)
                      .++|++.+.||+|+||+||++... +++.||+|+++...  ......+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            457999999999999999999965 68999999876432  22234567899999999999999999998765  45799


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||++ ++|.+++....  ..+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            999996 58988887643  34899999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EERLFEI  627 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~~~~~~  627 (684)
                      ..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|++||...+..+....   ......  .......
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~  235 (309)
T cd07845         160 LPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL---IIQLLGTPNESIWPG  235 (309)
T ss_pred             CccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChhhchh
Confidence            33221 222235788999999865 5678999999999999999999999976543322111   111100  0000000


Q ss_pred             h-----------hhhhhc---cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          628 L-----------DARVMK---ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       628 ~-----------d~~~~~---~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      +           ......   ......+.++.+|+.+||+.||++|||++|++.+-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~  291 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS  291 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            0           000000   00012356788999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.5e-35  Score=326.40  Aligned_cols=269  Identities=19%  Similarity=0.264  Sum_probs=193.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCC--CcEEEEE------------------eccccChhHHHHHHHHHHHHhhcCCCc
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPD--GKIVAVK------------------KSKVIDESKVEEFINEMVILSQINHRN  454 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~Hpn  454 (684)
                      ..++|++.+.||+|+||+||++..+.  +...++|                  +.. ........+.+|+.+|++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            34689999999999999999987532  2222222                  111 12234567889999999999999


Q ss_pred             ccceeeeeeecCcceEEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 043157          455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL  532 (684)
Q Consensus       455 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl  532 (684)
                      |+++++++.+.+..++|+|++. ++|.+++.....  ........++.++.||+.||+|||+++   |+||||||+||||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999984 578777764321  112345667789999999999999999   9999999999999


Q ss_pred             CCCCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCC-CCCCChhhhhhH
Q 043157          533 DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP-IRFTTLEEDKSL  611 (684)
Q Consensus       533 ~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P-~~~~~~~~~~~l  611 (684)
                      +.++.+||+|||+++..............||..|+|||++.+..++.++||||||++||||++|..+ +..........+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999999987654444344456799999999999999999999999999999999998754 433222222222


Q ss_pred             HHHHHHHh--h------hhhhhhhhhhhhhccCC---------hhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          612 AAYFLFAM--K------EERLFEILDARVMKESG---------GDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       612 ~~~~~~~~--~------~~~~~~~~d~~~~~~~~---------~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ........  .      ...+.+.++.......+         ...+..+.+++.+||+.||++|||+.|++++
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            22111000  0      00111111111000000         1234467788999999999999999999875

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1e-34  Score=309.97  Aligned_cols=272  Identities=26%  Similarity=0.362  Sum_probs=204.4

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecC--cc
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETE--VP  468 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~--~~  468 (684)
                      ..++|++.+.||+|+||.||+|... +++.+|+|++..  ........+.+|+.+++++ +||||+++++++...+  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567899999999999999999965 688999998753  2344556788899999999 9999999999986543  57


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||++ ++|.+++...    .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 5999988754    3889999999999999999999998   99999999999999999999999999986


Q ss_pred             cccCCc----eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH-------
Q 043157          549 MAVDQT----HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL-------  616 (684)
Q Consensus       549 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~-------  616 (684)
                      ......    .......|+..|+|||++.. ..++.++||||||+++|+|++|+.||......+.........       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            543322    12233458889999998754 567889999999999999999999997544322111000000       


Q ss_pred             -HHhhhhhhhhhhhh------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhHh
Q 043157          617 -FAMKEERLFEILDA------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGIKA  674 (684)
Q Consensus       617 -~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i~~  674 (684)
                       ..+.......+++.      ..........+.++.+++.+||+.||++|||+.+++++  ++++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence             00000000111110      00011112356789999999999999999999999986  455543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.6e-34  Score=296.91  Aligned_cols=242  Identities=26%  Similarity=0.328  Sum_probs=197.5

Q ss_pred             eceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCH
Q 043157          405 LGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL  480 (684)
Q Consensus       405 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL  480 (684)
                      ||.|++|.||++... +++.+++|.+...   .....+.+.+|++++++++||||+++++.+.+....+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999965 5889999987542   234557899999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecc
Q 043157          481 FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV  560 (684)
Q Consensus       481 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~  560 (684)
                      .+++.+..   .+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.......  .....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~  152 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF  152 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence            99998653   3899999999999999999999998   9999999999999999999999999998765432  22334


Q ss_pred             cccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhH
Q 043157          561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE  640 (684)
Q Consensus       561 ~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  640 (684)
                      .++..|++||.+....++.++|+||||+++|+|++|+.||.....+... .            ...+.+.......+...
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~------------~~~~~~~~~~~~~~~~~  219 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME-I------------YNDILKGNGKLEFPNYI  219 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH-H------------HHHHhccCCCCCCCccc
Confidence            5788999999998888999999999999999999999999754421110 0            01111111111223334


Q ss_pred             HHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043157          641 IITFAKVAKRCLNLNGKKRPT-----MREVTS  667 (684)
Q Consensus       641 ~~~l~~Li~~cl~~dp~~RPt-----~~evl~  667 (684)
                      +.++.+++.+||+.+|++||+     ++|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            678999999999999999999     677766

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=293.71  Aligned_cols=247  Identities=27%  Similarity=0.441  Sum_probs=205.3

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh--hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE--SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|++.+.||+|++|.||++... +++.+++|.......  ...+.+.+|++++++++|||++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999865 678999998876443  5678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            99999999998653   4899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                      . .....++..|+|||.+.....+.++|||+||+++++|++|+.||.......     ...          ... .....
T Consensus       155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~~~----------~~~-~~~~~  217 (254)
T cd06627         155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----ALF----------RIV-QDDHP  217 (254)
T ss_pred             c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----HHH----------HHh-ccCCC
Confidence            2 233457889999999988888999999999999999999999987433111     000          000 01111


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS  667 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~  667 (684)
                      ..+...+..+.+++.+||+.+|++|||+.|++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            223345678999999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.7e-34  Score=310.41  Aligned_cols=260  Identities=22%  Similarity=0.333  Sum_probs=200.9

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec------
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLET------  465 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------  465 (684)
                      ..++|+..+.||+|+||+||++... +++.||+|++..  ......+.+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999964 789999998753  3344566788999999999999999999988643      


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                      ...++||||+. ++|.+.+...     +++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            24689999995 5888887643     788999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EER  623 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~~  623 (684)
                      ++......  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+......  . ......  ...
T Consensus       165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--~-~~~~~~~~~~~  239 (353)
T cd07850         165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN--K-IIEQLGTPSDE  239 (353)
T ss_pred             ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--H-HHHhcCCCCHH
Confidence            97654322  2233457889999999999999999999999999999999999997654321110  0 000000  000


Q ss_pred             hh-----------------------hhhhhhhh----ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          624 LF-----------------------EILDARVM----KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       624 ~~-----------------------~~~d~~~~----~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      +.                       +.......    .......+..+.+++.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00                       00000000    00012346678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.5e-34  Score=300.45  Aligned_cols=242  Identities=23%  Similarity=0.326  Sum_probs=190.0

Q ss_pred             eeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhh---cCCCcccceeeeeeecCcceEEEEecC
Q 043157          404 ILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQ---INHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       404 ~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      +||+|+||.||++... +++.+|+|.+....   ......+.+|..+++.   .+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 68899999765421   2223334555544444   479999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......   
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            999999998654   3899999999999999999999999   9999999999999999999999999987543222   


Q ss_pred             eecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..........+..             . .......
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-------------~-~~~~~~~  217 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------------M-TLTVNVE  217 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-------------H-hhcCCcC
Confidence            123458999999999864 568899999999999999999999997543222111100             0 0011122


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      .+...+.++.+++.+||+.||++||     +++|++++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            3345667899999999999999999     69999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.6e-34  Score=304.10  Aligned_cols=267  Identities=24%  Similarity=0.314  Sum_probs=197.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc-----
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEV-----  467 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-----  467 (684)
                      .++|++.+.||+|+||.||++... +++.||+|++....  ......+.+|++++++++||||+++++++...+.     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            356999999999999999999965 68899999875432  2223456789999999999999999999876544     


Q ss_pred             ---ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          468 ---PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       468 ---~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                         .++||||+. ++|.+.+.....  .+++..++.++.|++.||+|||+++   ++|+||||+|||++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence               399999996 588888876432  4899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccccCCce---eeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh
Q 043157          545 ASRSMAVDQTH---MTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK  620 (684)
Q Consensus       545 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~  620 (684)
                      ++.........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....................
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99765432221   11233467889999988654 478899999999999999999999976543322211111110000


Q ss_pred             hhhhh-----hhhhh---------hhhcc-CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          621 EERLF-----EILDA---------RVMKE-SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       621 ~~~~~-----~~~d~---------~~~~~-~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .....     +..+.         ..... ........+.+|+.+||+.||++|||++|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            00000     00000         00000 001123567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=300.09  Aligned_cols=260  Identities=24%  Similarity=0.317  Sum_probs=202.6

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      |+..+.||+|++|.||++... +++.+++|+.....  ......+.+|++++++++||||+++++++......++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999864 68899999876532  235678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++ +|.+++....  ..+++..++.++.|+++||+|||+.+   |+|+||||+||+++.++.+||+|||.+........ 
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            75 8988887754  24899999999999999999999999   99999999999999999999999999877654331 


Q ss_pred             eeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh---hhhhhhhhh--
Q 043157          556 MTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK---EERLFEILD--  629 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d--  629 (684)
                      ......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||......+.....   .....   ...+....+  
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI---FRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCchHhcccchhhh
Confidence            22233477889999998776 7899999999999999999999999765543211110   00000   000000000  


Q ss_pred             ---------h--hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          630 ---------A--RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       630 ---------~--~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                               .  ..........+.++.+++.+||+.||++||+++|++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                     0  00011123456789999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.5e-35  Score=310.30  Aligned_cols=267  Identities=21%  Similarity=0.319  Sum_probs=202.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeee----cCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLE----TEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~  468 (684)
                      .++|++.+.||+|++|.||++... +++.||+|++...  .....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367999999999999999999964 6899999987653  22345678899999999999999999998763    3457


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||+. ++|.+++....   .+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            89999995 68999887543   3899999999999999999999998   99999999999999999999999999876


Q ss_pred             cccCCce---eeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH-------
Q 043157          549 MAVDQTH---MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF-------  617 (684)
Q Consensus       549 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~-------  617 (684)
                      .......   ......++..|+|||.+.. ..++.++||||||+++|||++|+.||.................       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5432221   1223468889999999765 5688999999999999999999999975543221111110000       


Q ss_pred             -Hhhhhhhhhhhhhhh------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          618 -AMKEERLFEILDARV------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       618 -~~~~~~~~~~~d~~~------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                       ......+.+..+...      ........+.++.+++++||+.+|++||++++++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence             000111111111000      0011133567899999999999999999999998864

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.3e-34  Score=301.78  Aligned_cols=253  Identities=26%  Similarity=0.354  Sum_probs=195.7

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|...+.||+|+||+||++... +++.+|+|++... .......+.+|+.++.++. ||||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556788999999999999864 6899999987643 2345677899999999996 99999999999998899999999


Q ss_pred             cCCCCHHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          475 IPNGTLFQYIH---DQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       475 ~~~gsL~~~l~---~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      +. ++|.++..   .. ....+++..+..++.|++.||+|||+. +   ++||||||+|||++.++.+||+|||+++...
T Consensus        85 ~~-~~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          85 MD-ISLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cc-CCHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            86 45555432   22 123589999999999999999999975 6   9999999999999999999999999987654


Q ss_pred             cCCceeeecccccCCCCCccccccC---CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSS---QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ....  .....|+..|+|||++...   .++.++||||||+++|||++|+.||.....     ..........      .
T Consensus       160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~------~  226 (288)
T cd06616         160 DSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK------G  226 (288)
T ss_pred             cCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC------C
Confidence            3222  1223578899999998776   688999999999999999999999864321     1010000000      0


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..+..........+.++.+|+.+||+.+|++|||++|++++
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01111112223467789999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-34  Score=308.80  Aligned_cols=270  Identities=26%  Similarity=0.353  Sum_probs=208.7

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecC-----cce
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETE-----VPL  469 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~  469 (684)
                      +|++.+.||+|++|.||++... +++.+|+|++....  ....+.+.+|+.++++++||||+++++++.+..     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999965 58999999876533  445678999999999999999999999998775     789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      ++|||++ ++|.+++.+..   ++++..++.++.|++.||+|||+.+   |+|+||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 58999887653   5999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCc--eeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh-------
Q 043157          550 AVDQT--HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM-------  619 (684)
Q Consensus       550 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~-------  619 (684)
                      .....  .......++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+............       
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            54321  122334578899999999887 78999999999999999999999998665433211111000000       


Q ss_pred             -hhhhhhhhhhh------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhHh
Q 043157          620 -KEERLFEILDA------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGIKA  674 (684)
Q Consensus       620 -~~~~~~~~~d~------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i~~  674 (684)
                       ......+.+..      ..........+..+.+++.+||+.+|++||++++++.+  +++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence             00000011110      00011122356788999999999999999999999986  555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.6e-34  Score=300.66  Aligned_cols=264  Identities=22%  Similarity=0.335  Sum_probs=199.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|++.+.||+|++|+||+|..+ +++.||+|+.....  ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999965 68899999876432  2345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCcEEEeccCCccccccC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgl~~~~~~~  552 (684)
                      |++ ++|.+++..... ..+++..++.++.||+.||+|||+++   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 588888765432 24688889999999999999999998   999999999999985 567999999999765432


Q ss_pred             CceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH-hhhhhhh-----
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA-MKEERLF-----  625 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~-~~~~~~~-----  625 (684)
                      .. ......+++.|+|||++.+ ..++.++||||||+++|+|+||+.||...+..+.  +...+... ......+     
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChhhcccccc
Confidence            21 1222346889999998865 4578999999999999999999999976543221  11111000 0000000     


Q ss_pred             --hhhh--hh----hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          626 --EILD--AR----VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       626 --~~~d--~~----~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        ....  +.    .........+.++.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0000  00    0001122346678999999999999999999999874

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.1e-34  Score=301.26  Aligned_cols=245  Identities=27%  Similarity=0.397  Sum_probs=200.4

Q ss_pred             CceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCH
Q 043157          402 NRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL  480 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL  480 (684)
                      ..+||+|+||.||++..+ +++.||+|++........+.+.+|+.+++.++|+||+++++.+...+..+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            478999999999999864 7899999998765566677899999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecc
Q 043157          481 FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV  560 (684)
Q Consensus       481 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~  560 (684)
                      .+++...    .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus       105 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~  176 (292)
T cd06657         105 TDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL  176 (292)
T ss_pred             HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence            9988643    3789999999999999999999998   99999999999999999999999998876543221 22334


Q ss_pred             cccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhH
Q 043157          561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE  640 (684)
Q Consensus       561 ~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  640 (684)
                      .+++.|++||++....++.++|+||||+++|+|++|+.||......+..   .    ...     +.+....  ......
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~----~~~-----~~~~~~~--~~~~~~  242 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---K----MIR-----DNLPPKL--KNLHKV  242 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHH-----hhCCccc--CCcccC
Confidence            5788999999998888899999999999999999999998754322110   0    000     0011110  011234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          641 IITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       641 ~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      +..+.+++.+||+.+|++||++.|++++
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            5678899999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.8e-34  Score=300.75  Aligned_cols=258  Identities=17%  Similarity=0.248  Sum_probs=187.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC----CcEEEEEeccccChhH-----------HHHHHHHHHHHhhcCCCcccceee
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD----GKIVAVKKSKVIDESK-----------VEEFINEMVILSQINHRNVVKLLG  460 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~HpnIv~l~~  460 (684)
                      .++|++.++||+|+||+||+|...+    +..+|+|.........           ......+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3579999999999999999999654    3456666543322111           111233445566678999999999


Q ss_pred             eeeecC----cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 043157          461 CCLETE----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY  536 (684)
Q Consensus       461 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~  536 (684)
                      +.....    ..++++|+.. .++.+.+....   ..++..++.++.|+++||+|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            876554    2367777763 46777666532   2578889999999999999999998   99999999999999999


Q ss_pred             cEEEeccCCccccccCCce------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhh
Q 043157          537 RAKVSDFGASRSMAVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKS  610 (684)
Q Consensus       537 ~~kl~DFgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~  610 (684)
                      .+||+|||+++........      ......||+.|+|||++.+..++.++||||||++|+||++|+.||........  
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~--  241 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN--  241 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--
Confidence            9999999999865432211      11234589999999999999999999999999999999999999975532211  


Q ss_pred             HHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          611 LAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       611 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      +..    ..+.+-+..+.....   .....+..+.+++..|++.+|++||++.++++.|
T Consensus       242 ~~~----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 LIH----AAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHH----HhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            110    000111111111111   1123457799999999999999999999999876

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-34  Score=295.50  Aligned_cols=243  Identities=29%  Similarity=0.385  Sum_probs=197.7

Q ss_pred             eceeCcEEEEEEEeC-CCcEEEEEeccccCh---hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCH
Q 043157          405 LGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE---SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL  480 (684)
Q Consensus       405 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL  480 (684)
                      ||+|+||.||++... +++.+++|.+.....   ...+.+.+|++++++++||||+++++.+......+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 489999998765332   4567889999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc------
Q 043157          481 FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT------  554 (684)
Q Consensus       481 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~------  554 (684)
                      .+++++..   .+++..++.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99998754   4899999999999999999999999   99999999999999999999999999876543321      


Q ss_pred             -eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          555 -HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       555 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                       .......++..|++||.+.....+.++||||||+++++|++|+.||......+.      +..         +....  
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~---------~~~~~--  217 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQN---------ILNGK--  217 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHH---------HhcCC--
Confidence             122334578899999999888899999999999999999999999975442211      000         00000  


Q ss_pred             ccCChh--HHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          634 KESGGD--EIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       634 ~~~~~~--~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      ...+..  .+..+.+++.+||+.+|++|||++++.+.|+
T Consensus       218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            011111  3678899999999999999999966655553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.4e-34  Score=298.35  Aligned_cols=245  Identities=25%  Similarity=0.303  Sum_probs=195.8

Q ss_pred             eceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCH
Q 043157          405 LGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL  480 (684)
Q Consensus       405 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL  480 (684)
                      ||+|+||+||++... +++.+|+|.+...   .......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 6889999987542   223355678899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecc
Q 043157          481 FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV  560 (684)
Q Consensus       481 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~  560 (684)
                      .+++..... ..+++..++.++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++.......  .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~  154 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR  154 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence            999987543 34899999999999999999999999   9999999999999999999999999987654321  22234


Q ss_pred             cccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhH
Q 043157          561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE  640 (684)
Q Consensus       561 ~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  640 (684)
                      .++..|++||.+.+..++.++||||||+++++|++|+.||..........            .+.+.... .....+...
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------------~~~~~~~~-~~~~~~~~~  221 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE------------ELKRRTLE-MAVEYPDKF  221 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH------------HHHhcccc-ccccCCccC
Confidence            57889999999988889999999999999999999999997543211110            00000000 011223445


Q ss_pred             HHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          641 IITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       641 ~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      +..+.+++.+||+.||++||     ++.+++++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            77899999999999999999     66667653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=301.41  Aligned_cols=245  Identities=27%  Similarity=0.345  Sum_probs=207.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      +.|..-++||+||||+|+-.+. .+|+.+|.|++..   .........++|-.+|++++.+.||.+-..+...+.++|||
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            5688889999999999999985 4799999997643   22333456789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ..|.||+|.-+|.+.+. ..+++..++.++.+|+-||++||+..   |+.|||||+|||||+.|+++|+|+|||-.+...
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999998765 35999999999999999999999999   999999999999999999999999999887655


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      +...  ...||.+|||||+++++.|+...|.|||||+||||+.|+.||......            .+    .+-+|.++
T Consensus       341 ~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK------------vk----~eEvdrr~  402 (591)
T KOG0986|consen  341 KPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK------------VK----REEVDRRT  402 (591)
T ss_pred             Cccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh------------hh----HHHHHHHH
Confidence            5543  337999999999999999999999999999999999999999743211            11    11223222


Q ss_pred             ---hccCChhHHHHHHHHHHHhhccCCCCCCCHH
Q 043157          633 ---MKESGGDEIITFAKVAKRCLNLNGKKRPTMR  663 (684)
Q Consensus       633 ---~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~  663 (684)
                         ..+++...+++..+|.+..|+.||++|-..+
T Consensus       403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence               2345577888999999999999999997554

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.8e-34  Score=298.51  Aligned_cols=256  Identities=25%  Similarity=0.304  Sum_probs=203.3

Q ss_pred             CCCcCceeceeCcEEEEEEEe----CCCcEEEEEecccc----ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcc
Q 043157          398 NFNLNRILGQGGQGTVYKGML----PDGKIVAVKKSKVI----DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  468 (684)
                      +|++.+.||+|++|.||++..    .+++.+|||.++..    .....+.+.+|+.+++++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999874    35688999987642    123456788999999999 599999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||+++++|.+++....   .+++..+..++.|++++|+|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999997643   3889999999999999999999998   99999999999999999999999999877


Q ss_pred             cccCCceeeecccccCCCCCccccccCC--CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      .............|+..|++||.+.+..  .+.++||||||++++||++|+.||........  ......         .
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~---------~  223 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISR---------R  223 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHH---------H
Confidence            5544333333455889999999987654  78899999999999999999999864321110  001000         0


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      +...  ....+...+..+.+++.+||+.||++|||++++.+.|+..
T Consensus       224 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         224 ILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            0000  0112234556789999999999999999999888877654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-34  Score=292.71  Aligned_cols=243  Identities=26%  Similarity=0.273  Sum_probs=190.5

Q ss_pred             ceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHH-hhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVIL-SQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      +.||+|++|.||++... +++.||+|......   ......+..|..++ .+.+|||++++++++.+.+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999864 68899999876432   22233445555544 455899999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      ++|.+++....   ++++..+..++.|+++||.|||+.+   ++|+||+|+|||+++++.+||+|||+++....     .
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~  150 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N  150 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence            99999998653   3899999999999999999999998   99999999999999999999999999875432     2


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                      ....++..|++||.+.+..++.++||||||+++|||++|..||........   ..   . .....      ........
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~---~-~~~~~------~~~~~~~~  217 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---FD---N-ILSRR------INWPEEVK  217 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HH---H-HHhcc------cCCCCccc
Confidence            234578899999999888899999999999999999999999975432211   00   0 00000      00011112


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          638 GDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       638 ~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ...+..+.+++.+||+.+|++||++.++.+.|
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            24567899999999999999999876655544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.5e-34  Score=293.18  Aligned_cols=247  Identities=23%  Similarity=0.299  Sum_probs=192.4

Q ss_pred             HHHhcCCCcCcee--ceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcc
Q 043157          393 ERATDNFNLNRIL--GQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       393 ~~~~~~~~~~~~L--G~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  468 (684)
                      ....++|++.+.+  |+|+||.||++..+ +++.+|+|..........     |+.....+ +||||+++++.+...+..
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3334567777776  99999999999864 678899998764322111     22222223 799999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-cEEEeccCCcc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASR  547 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgl~~  547 (684)
                      ++||||+++++|.+++....   +++++.++.++.|+++||+|||+.+   ++||||||+||+++.++ .++|+|||+++
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            99999999999999998654   4999999999999999999999999   99999999999999988 99999999987


Q ss_pred             ccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      .....     ....++..|+|||++.+..++.++||||||+++|||++|+.||.....++ .....          +...
T Consensus       159 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~----------~~~~  222 (267)
T PHA03390        159 IIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLES----------LLKR  222 (267)
T ss_pred             ecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHH----------HHHh
Confidence            65322     22357899999999998899999999999999999999999997433221 11111          1111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPT-MREVTSE  668 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt-~~evl~~  668 (684)
                      ...  ........+..+.+++.+||+.+|++||+ ++|++++
T Consensus       223 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        223 QQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             hcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            110  11222356778999999999999999996 6888753

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.3e-34  Score=297.13  Aligned_cols=252  Identities=27%  Similarity=0.334  Sum_probs=199.9

Q ss_pred             CCCcCceeceeCcEEEEEEEe----CCCcEEEEEeccccC----hhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcc
Q 043157          398 NFNLNRILGQGGQGTVYKGML----PDGKIVAVKKSKVID----ESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  468 (684)
                      +|++.+.||+|+||.||++..    .+|+.||+|.+....    ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478899999999999999985    368899999876422    23456788999999999 599999999999998899


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||+++++|.+++....   ++++..+..++.|+++||.|||+.+   ++||||+|+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999998653   3889999999999999999999998   99999999999999999999999999976


Q ss_pred             cccCCceeeecccccCCCCCccccccC--CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      .............|+..|+|||.+...  .++.++||||||+++|+|++|+.||........  ..........      
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~------  226 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILK------  226 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhc------
Confidence            543332223344588899999998753  467899999999999999999999864322111  1111000000      


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                         .  ....+...+..+.+++.+||+.||++||     ++++++++
T Consensus       227 ---~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         227 ---S--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ---c--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence               0  0112334567789999999999999997     77887765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-34  Score=305.69  Aligned_cols=267  Identities=22%  Similarity=0.327  Sum_probs=200.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC------
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETE------  466 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------  466 (684)
                      .++|...+.||+|+||.||+|... +++.||+|++...  .......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999964 6899999987542  2333466889999999999999999999987543      


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..++|+||+. .+|.+++..     .+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEecccc-cCHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            3489999996 477766531     3889999999999999999999999   999999999999999999999999998


Q ss_pred             cccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH--hhhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA--MKEER  623 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~--~~~~~  623 (684)
                      +.....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........  +.. ....  .....
T Consensus       165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~  237 (342)
T cd07879         165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQ-ILKVTGVPGPE  237 (342)
T ss_pred             cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHhcCCCCHH
Confidence            754321    123356888999999866 4688999999999999999999999986543211  111 0000  00000


Q ss_pred             hhhhhhh------------hhh---ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhHhhcCC
Q 043157          624 LFEILDA------------RVM---KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGIKAWNGA  678 (684)
Q Consensus       624 ~~~~~d~------------~~~---~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i~~~~~~  678 (684)
                      ..+.++.            ...   .......+..+.+|+.+||+.||++||+++|++.+  ++.++.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~  309 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE  309 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc
Confidence            0000000            000   00011245678899999999999999999999976  7777654433

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.6e-34  Score=302.63  Aligned_cols=267  Identities=21%  Similarity=0.300  Sum_probs=198.0

Q ss_pred             ceecee--CcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQG--GQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G--~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ..||+|  +||+||++.+. +++.||+|.....  .....+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  99999999964 7899999987642  344567889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee-
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-  556 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~-  556 (684)
                      ++|.+++.+... ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999999987532 24899999999999999999999998   9999999999999999999999998654332111110 


Q ss_pred             -----eecccccCCCCCccccccC--CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH------------
Q 043157          557 -----TTQVHGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF------------  617 (684)
Q Consensus       557 -----~~~~~gt~~y~aPE~~~~~--~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~------------  617 (684)
                           .....++..|++||++.+.  .++.++||||||+++|||++|+.||........  +......            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence                 0112245679999998763  478999999999999999999999975432211  1000000            


Q ss_pred             ----Hhh-----------hhhh-----hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH--HhhHhh
Q 043157          618 ----AMK-----------EERL-----FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL--AGIKAW  675 (684)
Q Consensus       618 ----~~~-----------~~~~-----~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L--~~i~~~  675 (684)
                          ...           +...     ....+..........++..+.+|+++||+.||++|||++|++++-  ++++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence                000           0000     000011111112245677899999999999999999999998764  444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.5e-34  Score=299.29  Aligned_cols=262  Identities=19%  Similarity=0.247  Sum_probs=195.7

Q ss_pred             cCceeceeCcEEEEEEEeCCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCC
Q 043157          401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       401 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      +.+.+|.|+++.|+++.. +++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344555555555555544 7899999987653  4566788999999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc----
Q 043157          479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT----  554 (684)
Q Consensus       479 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~----  554 (684)
                      +|.+++..... ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||.+........    
T Consensus        85 ~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99999986532 24889999999999999999999999   99999999999999999999999998865432211    


Q ss_pred             --eeeecccccCCCCCcccccc--CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh----hhh----
Q 043157          555 --HMTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM----KEE----  622 (684)
Q Consensus       555 --~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~----~~~----  622 (684)
                        .......++..|+|||++..  ..++.++||||||+++|||++|+.||.......  .+........    ...    
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhh
Confidence              11123346778999999865  358899999999999999999999997543211  1111100000    000    


Q ss_pred             ---hhhh----hhh----hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          623 ---RLFE----ILD----ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       623 ---~~~~----~~d----~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                         ....    ..+    ...........+.++.+|+.+||+.||++|||++|++++-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence               0000    000    0011112234567899999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-35  Score=280.26  Aligned_cols=249  Identities=24%  Similarity=0.407  Sum_probs=199.4

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc-cChhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEEEEec
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV-IDESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .+....||.|.-|+|++.+.. +|...|||.+.. .+.++.++++..+.++..-+ .|.||+.+|+|..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            344567999999999999965 689999998865 45666777888888776664 899999999999999999999998


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      . .-++.+|++-..  ++++..+-++...+.+||.||.+++.  |+|||+||+|||+|+.|++||+|||++..+.+...+
T Consensus       174 s-~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  174 S-TCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             H-HHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeeccccc
Confidence            4 456666665433  59999999999999999999998874  999999999999999999999999999877655443


Q ss_pred             eeecccccCCCCCccccc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          556 MTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                        +...|-+.|||||.+.   ...|+.++||||||++|+||.||+.||.....+-.              -+-.+++...
T Consensus       249 --trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--------------~ltkvln~eP  312 (391)
T KOG0983|consen  249 --TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--------------VLTKVLNEEP  312 (391)
T ss_pred             --ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--------------HHHHHHhcCC
Confidence              3335889999999985   35689999999999999999999999986543211              1111222111


Q ss_pred             -hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          633 -MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       633 -~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       .......++..+.+++..||+.|+.+||...+++++
T Consensus       313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence             111113378899999999999999999999999876

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=293.18  Aligned_cols=261  Identities=26%  Similarity=0.353  Sum_probs=197.9

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhc---CCCcccceeeeeeecCc-----
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQI---NHRNVVKLLGCCLETEV-----  467 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~-----  467 (684)
                      |++.+.||+|+||.||++..+ +++.+|+|+++..  .......+.+|+.+++++   +||||+++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567899999999999999976 4899999988642  222345567788877766   59999999999988776     


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .+++|||++ ++|.+++..... ..+++..++.++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            899999997 589998876433 24899999999999999999999998   9999999999999999999999999987


Q ss_pred             ccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh---
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL---  624 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~---  624 (684)
                      .......  .....++..|+|||.+.+..++.++||||||+++|||++|++||......+.  +...+.........   
T Consensus       156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcC
Confidence            6543322  1223468889999999988899999999999999999999999875443221  11111100000000   


Q ss_pred             ------hhhhhhhh---hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 ------FEILDARV---MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ------~~~~d~~~---~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                            ........   ......+.+..+.+++.+||+.||++||+++|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                  00000000   011112445778899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-34  Score=324.55  Aligned_cols=264  Identities=28%  Similarity=0.433  Sum_probs=220.2

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeC----C----CcEEEEEeccc-cChhHHHHHHHHHHHHhhc-CCCcccceee
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLP----D----GKIVAVKKSKV-IDESKVEEFINEMVILSQI-NHRNVVKLLG  460 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~----g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~  460 (684)
                      .++...++..+.+.||+|.||.|++|...    .    ...||||.++. ....+.+.+..|+++|+.+ +||||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            45556667778889999999999999743    1    34699998775 4456788999999999999 6999999999


Q ss_pred             eeeecCcceEEEEecCCCCHHHHHhhcC-------C----C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 043157          461 CCLETEVPLLVYEFIPNGTLFQYIHDQN-------E----D--FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKS  527 (684)
Q Consensus       461 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp  527 (684)
                      ++.+++..++|+||+..|+|.++|++.+       .    .  ..|+....+.++.|||.||+||++..   ++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999999876       0    0  13889999999999999999999999   99999999


Q ss_pred             CCEEECCCCcEEEeccCCccccccCCceeeeccc--ccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 043157          528 TNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH--GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTT  604 (684)
Q Consensus       528 ~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~  604 (684)
                      +||||..+..+||+|||+++............-.  -+..|||||.+....|+.|||||||||+|||++| |..||....
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999976665555433322  2456999999999999999999999999999998 889987522


Q ss_pred             hhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          605 LEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       605 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ..               ..+.+.+......+.+..++.++.++++.||+.+|++||++.|+.+.|+.+
T Consensus       527 ~~---------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 PT---------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             cH---------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            11               112233344444556777889999999999999999999999999999885

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-34  Score=304.39  Aligned_cols=267  Identities=23%  Similarity=0.291  Sum_probs=201.8

Q ss_pred             HHHHHHHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec
Q 043157          389 SKELERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLET  465 (684)
Q Consensus       389 ~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  465 (684)
                      ..++...+++|.+.+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            345666789999999999999999999985 47889999988642  233456788999999999999999999988643


Q ss_pred             ------CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEE
Q 043157          466 ------EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK  539 (684)
Q Consensus       466 ------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k  539 (684)
                            ...+++++++ +++|.+++...    .+++..++.++.|+++||+|||+.+   |+||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  2357788876 78998888643    3899999999999999999999999   99999999999999999999


Q ss_pred             EeccCCccccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH
Q 043157          540 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA  618 (684)
Q Consensus       540 l~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~  618 (684)
                      |+|||+++.....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........  .......
T Consensus       161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~  234 (345)
T cd07877         161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL--KLILRLV  234 (345)
T ss_pred             Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHh
Confidence            9999998754321    223457889999999866 56889999999999999999999999754432211  1100000


Q ss_pred             -hhhhhhh---------hh---hhhhh---hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          619 -MKEERLF---------EI---LDARV---MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       619 -~~~~~~~---------~~---~d~~~---~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                       .....+.         ..   ++...   ........+.++.+++.+||+.||++||++.|++.+=
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence             0000000         00   00000   0000112456789999999999999999999998764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.7e-34  Score=295.72  Aligned_cols=249  Identities=29%  Similarity=0.432  Sum_probs=205.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|.+.+.||+|++|.||++... +++.+|+|....   ......+.+.+|++++++++ ||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36889999999999999999965 789999998754   23445577889999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      ||++++++|.+++.+..   .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999998754   4999999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCc-------------------eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHH
Q 043157          552 DQT-------------------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLA  612 (684)
Q Consensus       552 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~  612 (684)
                      ...                   .......++..|++||.+....++.++||||||++++++++|+.||.......  .  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~--  230 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--T--  230 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--H--
Confidence            221                   12233457889999999988889999999999999999999999997543111  0  


Q ss_pred             HHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 043157          613 AYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTM----REVTSE  668 (684)
Q Consensus       613 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~----~evl~~  668 (684)
                        +         ..+.+  .....+...+..+.+++.+||+.+|++||++    +|++++
T Consensus       231 --~---------~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         231 --F---------QKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             --H---------HHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence              0         00110  1112234456789999999999999999999    777653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=335.91  Aligned_cols=255  Identities=25%  Similarity=0.365  Sum_probs=207.5

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      ...+-+++-...||.|.||.||-+. .++|+..|+|-++..+  ........+|+.++..++|||+|+++|+-.+++..+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            3345678888999999999999998 5679999999766533  445677889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      |.||||++|+|.+.++..+.   +++.....+..|++.|++|||+++   |+||||||+||||+.+|.+|++|||.|...
T Consensus      1311 IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence            99999999999999987653   667777788899999999999999   999999999999999999999999999887


Q ss_pred             ccCCcee---eecccccCCCCCccccccC---CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhh
Q 043157          550 AVDQTHM---TTQVHGTFGYLDPEYFRSS---QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER  623 (684)
Q Consensus       550 ~~~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~  623 (684)
                      .......   .....||+.|||||++.+.   ....+.|||||||+++||+||+.||...+.    .++.++.-++.  .
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn----e~aIMy~V~~g--h 1458 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN----EWAIMYHVAAG--H 1458 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc----hhHHHhHHhcc--C
Confidence            6543222   2245699999999998654   356789999999999999999999974332    12211111111  1


Q ss_pred             hhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          624 LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       624 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                               ...+|...+.+-++++.+||..||++|-++.|++++
T Consensus      1459 ---------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 ---------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ---------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                     122344577788999999999999999998888775

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.1e-33  Score=296.26  Aligned_cols=252  Identities=25%  Similarity=0.410  Sum_probs=196.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC-CcEEEEEeccccC-hhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVID-ESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .++|++.+.||+|++|+||++.+++ ++.||||+++... .....++..|+.++..+. ||||+++++++.+....+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3568889999999999999999764 8999999886532 334566777887777774 999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      ||++ ++|.+++.....  ++++..+..++.|+++||+|||+. +   |+||||+|+||++++++.+||+|||++.....
T Consensus        94 e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9985 578777766433  589999999999999999999974 6   99999999999999999999999999876543


Q ss_pred             CCceeeecccccCCCCCccccccCC----CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQ----FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ...  .....++..|+|||.+....    ++.++||||||+++|||++|+.||....... ..+             ...
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~-------------~~~  231 (296)
T cd06618         168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVL-------------TKI  231 (296)
T ss_pred             CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHH-------------HHH
Confidence            222  12234788999999987553    7889999999999999999999986422110 000             011


Q ss_pred             hhhhh-hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          628 LDARV-MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       628 ~d~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      +.... ........+.++.+|+.+||+.||++||++++++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         232 LQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            11110 0011123567899999999999999999999998875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.3e-33  Score=297.63  Aligned_cols=247  Identities=26%  Similarity=0.388  Sum_probs=197.8

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      |+..+.||+|++|+||+|... +++.+|+|....   ......+++.+|+++++.++|+|++++++++.+....++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            666788999999999999965 678899998753   2334556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +. |+|.+++.....  ++++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......  
T Consensus        97 ~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          97 CL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             cC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            96 688888765433  4899999999999999999999998   999999999999999999999999998754322  


Q ss_pred             eeeecccccCCCCCccccc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          555 HMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                         ....+++.|+|||++.   ...++.++||||||+++|||++|+.||......+..               .......
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---------------~~~~~~~  230 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------------YHIAQNE  230 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH---------------HHHhhcC
Confidence               2335788999999974   356788999999999999999999998643221110               0000000


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      .........+..+.+|+.+||+.+|++||++.+++.+...
T Consensus       231 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence            0111123456778999999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4e-34  Score=301.27  Aligned_cols=266  Identities=24%  Similarity=0.309  Sum_probs=196.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecC------
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETE------  466 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------  466 (684)
                      .++|++.++||+|++|.||++... +++.+|+|++....  ......+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999965 68899999875432  222346788999999999999999999886544      


Q ss_pred             --cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          467 --VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       467 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                        ..++||||+.. +|.+.+.....  .+++..+..++.|+++||+|||+.+   |+|+||||+|||+++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~--~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSV--KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              35899999964 77777765432  4899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCce----------eeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 043157          545 ASRSMAVDQTH----------MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAA  613 (684)
Q Consensus       545 l~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~  613 (684)
                      +++........          ..+...+++.|+|||.+.+ ..++.++||||||+++|||++|++||.............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99765422211          1123456888999998765 458899999999999999999999997554332111110


Q ss_pred             HHHHHhhhhh------hhhhh--------hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          614 YFLFAMKEER------LFEIL--------DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       614 ~~~~~~~~~~------~~~~~--------d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..........      +....        .+... .........+.+++.+||+.||++|||+.|++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLE-ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHH-HHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            0000000000      00000        00000 0011233678899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.4e-33  Score=296.30  Aligned_cols=244  Identities=27%  Similarity=0.390  Sum_probs=195.6

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      |...+.||+|+||+||+|+.. +++.+++|++...   .....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999864 6889999987642   234456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +. ++|.+++.....  ++++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            95 688888875433  4899999999999999999999999   99999999999999999999999998864321   


Q ss_pred             eeeecccccCCCCCccccc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          555 HMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                        .....|+..|+|||++.   ...++.++||||||+++|||++|+.||.........   .            .+....
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~------------~~~~~~  236 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---Y------------HIAQND  236 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---H------------HHHhcC
Confidence              22345888999999974   456888999999999999999999998644321110   0            000000


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .........+..+.+|+.+||+.+|++||++.+++.+
T Consensus       237 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111122345678999999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-34  Score=304.94  Aligned_cols=250  Identities=26%  Similarity=0.391  Sum_probs=211.9

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ....|.+.+.||+|.|++|.++.+. ++..||||.+..  .+....+.+.+|+++|..|+|||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            4567999999999999999999954 689999998765  3445556799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||..+|.++++|.++..   +.+.....++.|+..|++|||++.   |+|||||++||||+.+.++||+|||++..+. 
T Consensus       134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD-  206 (596)
T ss_pred             EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence            999999999999998765   566888899999999999999999   9999999999999999999999999998765 


Q ss_pred             CCceeeecccccCCCCCccccccCCC-CCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                       ......+..|++.|.|||++.+..| ++++|+||+|++||.|+.|..||.+....+-.           +.    .+..
T Consensus       207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~r----vl~g  270 (596)
T KOG0586|consen  207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------PR----VLRG  270 (596)
T ss_pred             -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------ch----heee
Confidence             4556677889999999999998776 57999999999999999999999865543311           11    1111


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      +  ...+.-.+.+..+|++++|-++|.+|++++++.++-
T Consensus       271 k--~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  271 K--YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             e--ecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            1  112334566788999999999999999999998764

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-35  Score=286.23  Aligned_cols=242  Identities=26%  Similarity=0.348  Sum_probs=207.6

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ..++|+..++||+|.||+|-+++-+ +++.+|+|+++.   .....+..-+.|-++|+..+||.+..+-..|+..+.+++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3467999999999999999999854 799999998764   456677888899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||..||.|.-+|.+.+   .+++...+.+..+|..||.|||+++   |+.||||.+|.|||.+|++||+|||+.+...
T Consensus       246 VMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999999999998754   3899999999999999999999999   9999999999999999999999999998644


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      . ......++.|||.|+|||++....|+..+|.|.+||++|||+.|+.||...+.+.                +++++--
T Consensus       320 ~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----------------LFeLIl~  382 (516)
T KOG0690|consen  320 K-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----------------LFELILM  382 (516)
T ss_pred             c-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------------HHHHHHh
Confidence            3 3345667899999999999999999999999999999999999999998554332                2222211


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCC
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRP  660 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP  660 (684)
                      . ...++...+++...|+...|..||.+|.
T Consensus       383 e-d~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  383 E-DLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             h-hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            0 0124556677889999999999999995

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-35  Score=325.92  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=216.9

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETE  466 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  466 (684)
                      ++.-..++|.+.++||+|+||+|.+++++ +++++|+|++..   ........|..|..+|..-+.+.|++++..|.++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            34445577999999999999999999965 688999998876   44556678999999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      .+|||||||+||+|..+|.+..   +++++.++.++.+|.-||.-||+.|   +|||||||+|||||..|++||+|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence            9999999999999999998775   3999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCcccccc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE  621 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~  621 (684)
                      -.+..+..-......|||.|++||+++.     +.|+...|.||+||++|||+.|..||......      ..+...+..
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv------eTY~KIm~h  296 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV------ETYGKIMNH  296 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH------HHHHHHhch
Confidence            8888777777888889999999999852     56899999999999999999999999854433      222222222


Q ss_pred             hhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCC---HHHHHHHH
Q 043157          622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPT---MREVTSEL  669 (684)
Q Consensus       622 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt---~~evl~~L  669 (684)
                      ...+.+.+       ..+.+.+..+||.+.+ -+|+.|-.   ++++..|-
T Consensus       297 k~~l~FP~-------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  297 KESLSFPD-------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             hhhcCCCc-------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCc
Confidence            21111111       1346788999999988 67888877   87777654

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=293.18  Aligned_cols=263  Identities=25%  Similarity=0.346  Sum_probs=201.4

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      |+..+.||+|++|.||+++.. +++.+|+|.....  .....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999965 5899999987764  2444577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      + ++|.+++.+..  ..+++..++.++.|++.||+|||+.+   |+||||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            7 59999998763  24899999999999999999999999   99999999999999999999999999876543322 


Q ss_pred             eeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh-------
Q 043157          556 MTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI-------  627 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------  627 (684)
                      ......++..|+|||.+... .++.++||||||++++||++|++||......+.............+.....+       
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            12223357789999998766 7899999999999999999999999765432211100000000000000000       


Q ss_pred             -----hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          628 -----LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       628 -----~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           .............+..+.+++.+||+.||++||++++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence                 00000001112236679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=309.48  Aligned_cols=274  Identities=27%  Similarity=0.387  Sum_probs=209.4

Q ss_pred             CCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC------cce
Q 043157          398 NFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETE------VPL  469 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~  469 (684)
                      .+...+.||+|+||.||+|+. .+|+.||||.... ......+...+|+++|++++|||||+++++-.+..      .+.
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            355568899999999999994 5799999998765 33445678889999999999999999999876544      678


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC----CCCcEEEeccCC
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD----DKYRAKVSDFGA  545 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~----~~~~~kl~DFgl  545 (684)
                      +||||+.+|||...|.+..+...|++.+.+.+..++..||.|||+++   |+||||||.||++-    ..-..||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999999887788999999999999999999999999   99999999999983    333579999999


Q ss_pred             ccccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      |+....+.  ....+.||..|++||.+.. ..|+..+|.|||||++|+++||..||.............|.....+...+
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            99876544  6677789999999999984 88999999999999999999999999754433211111221111111111


Q ss_pred             hhhhhh------hh------hccCChhHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHhhHhhc
Q 043157          625 FEILDA------RV------MKESGGDEIITFAKVAKRCLNLNGKKRP--TMREVTSELAGIKAWN  676 (684)
Q Consensus       625 ~~~~d~------~~------~~~~~~~~~~~l~~Li~~cl~~dp~~RP--t~~evl~~L~~i~~~~  676 (684)
                      .-..++      .+      .-.+....-..+-..+..+|..+|++|-  ...+...++..|...+
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence            000000      00      1111122334455677788899999998  7777777777766543

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=292.48  Aligned_cols=263  Identities=24%  Similarity=0.321  Sum_probs=197.9

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh-hHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEEEEec
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE-SKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      |++.+.||+|++|+||+|... +++.|+||++..... .......+|+..+++++ ||||+++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567899999999999999975 578999998764322 23334567999999998 999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                       +++|.+++.... ...+++..++.++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             889999998754 234899999999999999999999998   99999999999999999999999999876543222 


Q ss_pred             eeecccccCCCCCccccc-cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHH---------HHHh-hhhhh
Q 043157          556 MTTQVHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF---------LFAM-KEERL  624 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~---------~~~~-~~~~~  624 (684)
                       .....++..|+|||.+. ...++.++|+||||++++||++|++||......+........         .... ....+
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence             22345788999999874 456789999999999999999999999765432211000000         0000 00000


Q ss_pred             hhhhhhh---hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 FEILDAR---VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ~~~~d~~---~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+...   .........+..+.+++.+||+.+|++|||++|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000   0001111225679999999999999999999999764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.1e-33  Score=290.25  Aligned_cols=250  Identities=23%  Similarity=0.320  Sum_probs=196.7

Q ss_pred             CCCcCceeceeCcEEEEEEEeCC-CcEEEEEeccc-----cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKV-----IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      +|.+.+.||+|+||+||++.... +..+++|..+.     .......++..|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47889999999999999998643 34444444332     1233445677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          472 YEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      |||+++++|.+++.... ....+++..++.++.|+++||.|||+.+   ++|+||||+||++++ +.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999999987532 2235899999999999999999999998   999999999999986 469999999987654


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      .... ......+++.|+|||.+....++.++|+||||+++|+|++|..||......+      ...         .... 
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~---------~~~~-  219 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVL---------RIVE-  219 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHH---------HHHc-
Confidence            3322 2334457889999999988888999999999999999999999986432111      000         0100 


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ......+...+.++.+++.+||+.+|++||++.|++++
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            11112234567789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2e-34  Score=324.93  Aligned_cols=254  Identities=28%  Similarity=0.425  Sum_probs=192.8

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec------
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLET------  465 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------  465 (684)
                      +....|+..++||+||||.||+++.+ ||+.+||||+... .......+.+|++.|++|+|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45567899999999999999999976 8999999998764 344456788999999999999999987655320      


Q ss_pred             --------------------------------------------------------------------------------
Q 043157          466 --------------------------------------------------------------------------------  465 (684)
Q Consensus       466 --------------------------------------------------------------------------------  465 (684)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 043157          466 ---------------------------------EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL  512 (684)
Q Consensus       466 ---------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yL  512 (684)
                                                       ..+||-||||+..+|.++++++...  -.....|+++.||++||+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence                                             0126889999998888888765421  13677899999999999999


Q ss_pred             HhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc-----------------cCCceeeecccccCCCCCccccccC
Q 043157          513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA-----------------VDQTHMTTQVHGTFGYLDPEYFRSS  575 (684)
Q Consensus       513 H~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~  575 (684)
                      |+.+   ||||||||.||||+++..|||+|||++....                 .......+...||.-|+|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9999   9999999999999999999999999998721                 0011123445699999999999765


Q ss_pred             C---CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhh
Q 043157          576 Q---FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCL  652 (684)
Q Consensus       576 ~---~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl  652 (684)
                      .   |+.|+|+||||++|+||+.   ||... ++-..     .+..++.+.+...      ..+..+....=+.+|++||
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-MERa~-----iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS-MERAS-----ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCch-HHHHH-----HHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence            4   9999999999999999997   55422 11111     1112222222211      1122333445568999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 043157          653 NLNGKKRPTMREVTS  667 (684)
Q Consensus       653 ~~dp~~RPt~~evl~  667 (684)
                      +.||.+|||+.|++.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999985

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.1e-33  Score=291.63  Aligned_cols=242  Identities=21%  Similarity=0.313  Sum_probs=188.9

Q ss_pred             eeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHH---HHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          404 ILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMV---ILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       404 ~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      .||+|+||.||++... +++.||+|.+....   ......+.+|..   .++...||+|+++++.+.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 68899999765421   122223444444   4444579999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   
T Consensus        81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            999999987543   4899999999999999999999998   9999999999999999999999999987543222   


Q ss_pred             eecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||...........             .... .....+
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-------------~~~~-~~~~~~  217 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------DRMT-LTMAVE  217 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-------------HHHh-hccCCC
Confidence            1234589999999998754 689999999999999999999999975432211100             0000 001112


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      .+...+.++.+++.+||..+|++||     ++.|++++
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            2334567899999999999999999     99999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.3e-34  Score=302.37  Aligned_cols=263  Identities=24%  Similarity=0.311  Sum_probs=197.7

Q ss_pred             cCCC-cCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhH--------------HHHHHHHHHHHhhcCCCcccceee
Q 043157          397 DNFN-LNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--------------VEEFINEMVILSQINHRNVVKLLG  460 (684)
Q Consensus       397 ~~~~-~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~  460 (684)
                      ++|. +.+.||+|+||+||++... +++.||+|+.+......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 4578999999999999965 68999999875432211              125779999999999999999999


Q ss_pred             eeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEE
Q 043157          461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV  540 (684)
Q Consensus       461 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl  540 (684)
                      ++...+..++||||++ ++|.+++....   .+++.....++.|++.||+|||+.+   ++|+||+|+|||++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999996 69999987543   3899999999999999999999999   999999999999999999999


Q ss_pred             eccCCccccccCC-------------ceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChh
Q 043157          541 SDFGASRSMAVDQ-------------THMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLE  606 (684)
Q Consensus       541 ~DFgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~  606 (684)
                      +|||+++......             ........+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999987654111             1111223467889999998764 4689999999999999999999999865533


Q ss_pred             hhhhHHHHHHHHhhhhh---hhhhhh-----------hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          607 EDKSLAAYFLFAMKEER---LFEILD-----------ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       607 ~~~~l~~~~~~~~~~~~---~~~~~d-----------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      +.  +. .+........   +.+..+           +..........+.++.+++.+||+.+|++||+++|++.+-
T Consensus       241 ~~--~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        241 DQ--LG-RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             HH--HH-HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            21  11 1111111000   000000           0000011123466789999999999999999999999753

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.6e-34  Score=304.44  Aligned_cols=262  Identities=24%  Similarity=0.351  Sum_probs=197.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeec---------
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLET---------  465 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---------  465 (684)
                      ..+|.+.+.||+|+||+||+|... +++.||+|++........+.+.+|++++++++||||+++++.+...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367999999999999999999964 6889999998776666778899999999999999999999877654         


Q ss_pred             -----CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCcEE
Q 043157          466 -----EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAK  539 (684)
Q Consensus       466 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~k  539 (684)
                           ...++||||++ ++|.+++...    .+++..++.++.||++||.|||+.+   |+||||||+|||++ +++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 24689999997 5898888643    3889999999999999999999999   99999999999997 456789


Q ss_pred             EeccCCccccccCCcee--eecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH
Q 043157          540 VSDFGASRSMAVDQTHM--TTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL  616 (684)
Q Consensus       540 l~DFgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~  616 (684)
                      |+|||+++.........  .....++..|+|||.+.. ..++.++||||||+++|||++|+.||......+....   ..
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~---~~  232 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL---IL  232 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH
Confidence            99999987643221111  122347888999998654 5678899999999999999999999975443211100   00


Q ss_pred             HHhh---h---hhhhhhhhhhh----------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          617 FAMK---E---ERLFEILDARV----------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       617 ~~~~---~---~~~~~~~d~~~----------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ....   .   ......+....          ........+.++.+|+.+||+.||++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            0000   0   00000000000          001112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-33  Score=300.88  Aligned_cols=264  Identities=21%  Similarity=0.305  Sum_probs=200.5

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeee-cCcc
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLE-TEVP  468 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  468 (684)
                      ...+++|++.+.||+|+||.||++... +++.||+|++..  ......+.+.+|++++++++||||+++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            446788999999999999999999855 789999997643  223345778899999999999999999999875 4578


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++++||+ +++|.++++..    ++++..+..++.|+++||+|||+.+   |+||||+|+|||+++++.+||+|||++..
T Consensus        86 ~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            8999998 56898888643    3788889999999999999999999   99999999999999999999999999875


Q ss_pred             cccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHH--------HHHh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF--------LFAM  619 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~--------~~~~  619 (684)
                      ....    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...............        ....
T Consensus       158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            4321    123356888999998766 56899999999999999999999999765432211111000        0000


Q ss_pred             hhhhhhhhhhhh------hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          620 KEERLFEILDAR------VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       620 ~~~~~~~~~d~~------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ......+.+...      ...+.....+..+.+++.+||+.+|++||++.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000110000      0001112345789999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-33  Score=301.75  Aligned_cols=263  Identities=23%  Similarity=0.311  Sum_probs=199.7

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc-
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEV-  467 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-  467 (684)
                      +....++|++.+.||+|+||+||++.. .+++.||+|+...  ......+.+.+|+.++++++||||+++++++..... 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            344577899999999999999999985 4789999998753  223345678899999999999999999999876543 


Q ss_pred             -----ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEec
Q 043157          468 -----PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD  542 (684)
Q Consensus       468 -----~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D  542 (684)
                           .++||||+ +++|.+++...    .+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence                 48999999 77998888643    3899999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH-----
Q 043157          543 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL-----  616 (684)
Q Consensus       543 Fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~-----  616 (684)
                      ||++......    .....+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||........  +.....     
T Consensus       162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~  235 (343)
T cd07880         162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMKVTGTP  235 (343)
T ss_pred             cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCC
Confidence            9998765322    123356889999999876 4588999999999999999999999975543211  111000     


Q ss_pred             -----HHhhhhhhhhhhhh------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          617 -----FAMKEERLFEILDA------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       617 -----~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           ..+...........      ..........+..+.+++.+||+.||++|||+.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 00000000000000      00011112445678899999999999999999999953

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=290.23  Aligned_cols=240  Identities=26%  Similarity=0.356  Sum_probs=203.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ..|.+..+||+|+||.|-++..+ +.+.+|||+++.   ....+++--+.|-++|... +-|.+++++.+|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            45999999999999999999865 567899998764   3455566677888888877 678899999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+.||+|..++++-+.   +.+..+..+|.+||-||-+||+++   |+.||||.+|||||.+|++||+|||+++....
T Consensus       429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence            999999999999998764   788899999999999999999999   99999999999999999999999999987543


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      +.. .+.+..|||.|+|||++...+|+..+|.|||||+||||+.|++||.+.+.++-.               ..+.+..
T Consensus       503 ~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---------------~aI~ehn  566 (683)
T KOG0696|consen  503 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---------------QAIMEHN  566 (683)
T ss_pred             CCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHHHcc
Confidence            333 456788999999999999999999999999999999999999999876543311               1222222


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCC
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRP  660 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RP  660 (684)
                        ...+...+.+...+.+..|...|.+|.
T Consensus       567 --vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 --VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             --CcCcccccHHHHHHHHHHhhcCCcccc
Confidence              234567778888999999999999995

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.7e-33  Score=298.43  Aligned_cols=264  Identities=23%  Similarity=0.317  Sum_probs=194.6

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-C--CcEEEEEecccc--ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeec----Cc
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-D--GKIVAVKKSKVI--DESKVEEFINEMVILSQI-NHRNVVKLLGCCLET----EV  467 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~--g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~----~~  467 (684)
                      +|++.+.||+|+||.||++... .  ++.+|+|++...  .....+.+.+|+.+++++ .||||+++++.....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999965 4  778999987642  233456788999999999 599999999875432    35


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .++++||+. ++|.+++....   .+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678889885 68999887543   4899999999999999999999999   9999999999999999999999999997


Q ss_pred             ccccCCce---eeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH-------
Q 043157          548 SMAVDQTH---MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL-------  616 (684)
Q Consensus       548 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~-------  616 (684)
                      ........   ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||......+.........       
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            65422211   1223468899999998765 568999999999999999999999997544322110000000       


Q ss_pred             -HHhhhhhhhhhhh---h---hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          617 -FAMKEERLFEILD---A---RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       617 -~~~~~~~~~~~~d---~---~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       ..+..........   .   ..........+..+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             0000000000000   0   00001112235679999999999999999999999765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-33  Score=301.65  Aligned_cols=260  Identities=24%  Similarity=0.331  Sum_probs=199.4

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc----
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEV----  467 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----  467 (684)
                      ..++|++.+.||+|++|.||++... +++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999975 6789999987642  33445678899999999999999999998876554    


Q ss_pred             --ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          468 --PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       468 --~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                        .++|+||+ +++|.+++...    .+++..++.++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              78999998 67999998753    3899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH-------
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF-------  617 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~-------  617 (684)
                      +......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.  +......       
T Consensus       165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~~i~~~~~~~~~~  238 (343)
T cd07851         165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--LKRIMNLVGTPDEE  238 (343)
T ss_pred             ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCCHH
Confidence            8765332    223357888999999865 3678999999999999999999999975443211  1110000       


Q ss_pred             ---Hhhhhhhhhhhhhhh------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          618 ---AMKEERLFEILDARV------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       618 ---~~~~~~~~~~~d~~~------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                         .+........+....      ........+..+.+++.+||+.||++|||+.||+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence               000000000000000      000011236789999999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-34  Score=277.83  Aligned_cols=268  Identities=21%  Similarity=0.322  Sum_probs=205.2

Q ss_pred             HHHHHHHhcCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecC
Q 043157          389 SKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETE  466 (684)
Q Consensus       389 ~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~  466 (684)
                      ++++-+.++     ++||+|+++.|--++ +.+|+.+|||++.....-...+..+|++++.+. .|+||++|+.+|+++.
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            345555444     689999999999887 678999999999877666778899999999999 5999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC---cEEEecc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---RAKVSDF  543 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DF  543 (684)
                      ..|||||-|.||.|.++|+++..   +++.++.++.++|+.||.+||.++   |.||||||+|||-.+..   -+||+||
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence            99999999999999999998754   999999999999999999999999   99999999999986543   4899999


Q ss_pred             CCccccccCC------ceeeecccccCCCCCccccc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHH
Q 043157          544 GASRSMAVDQ------THMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLA  612 (684)
Q Consensus       544 gl~~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~  612 (684)
                      .|..-.....      +..-.+..|+..|||||+..     ...|+.+.|.||||||||-||.|.+||.+.=.+ +-.+-
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~-dCGWd  302 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA-DCGWD  302 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC-cCCcc
Confidence            9875432111      11222346888999999852     345889999999999999999999999754221 11000


Q ss_pred             HHHHHHhhhhhhhhhhhhhhh---ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          613 AYFLFAMKEERLFEILDARVM---KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       613 ~~~~~~~~~~~~~~~~d~~~~---~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .=-.-..=.+.+++-+.....   ..-+...+.+..+|+...|..|+.+|-++.+++.+
T Consensus       303 rGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  303 RGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             CCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            000000001223333322211   11124557788899999999999999999998873

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-33  Score=281.52  Aligned_cols=236  Identities=32%  Similarity=0.371  Sum_probs=194.4

Q ss_pred             eceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCH
Q 043157          405 LGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL  480 (684)
Q Consensus       405 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL  480 (684)
                      ||+|+||.||++... +++.+++|.+...   .....+.+.+|++++++++||||+++++.+......+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999965 5889999987643   233567899999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecc
Q 043157          481 FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV  560 (684)
Q Consensus       481 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~  560 (684)
                      .+++....   .+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~  153 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF  153 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence            99998654   3899999999999999999999988   9999999999999999999999999987654332 123344


Q ss_pred             cccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhH
Q 043157          561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE  640 (684)
Q Consensus       561 ~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  640 (684)
                      .++..|++||.+.+...+.++|+||||+++|+|++|+.||.......   ..            ..+..  .....+...
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~------------~~~~~--~~~~~~~~~  216 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IY------------EKILK--DPLRFPEFL  216 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH------------HHHhc--CCCCCCCCC
Confidence            57889999999988888999999999999999999999996443211   00            01111  011223334


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHH
Q 043157          641 IITFAKVAKRCLNLNGKKRPTMRE  664 (684)
Q Consensus       641 ~~~l~~Li~~cl~~dp~~RPt~~e  664 (684)
                      +..+.+++.+||..||++||++++
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            678899999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=280.16  Aligned_cols=265  Identities=24%  Similarity=0.370  Sum_probs=219.7

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeCC------CcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeee
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLPD------GKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCL  463 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  463 (684)
                      ++.....++++..++-+|.||.||.|.|.+      .+.|-+|..+. ..+-++..++.|-.++..+.|||++.+.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            455556788899999999999999997643      34566776554 45667788999999999999999999999997


Q ss_pred             ec-CcceEEEEecCCCCHHHHHh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc
Q 043157          464 ET-EVPLLVYEFIPNGTLFQYIH-----DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR  537 (684)
Q Consensus       464 ~~-~~~~lv~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~  537 (684)
                      ++ +.++++|.++.-|+|..+|.     +......++..+...++.|++.|++|||+++   |+|.||..+|.+||+..+
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence            65 58899999999999999999     3334456888889999999999999999999   999999999999999999


Q ss_pred             EEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHH
Q 043157          538 AKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYF  615 (684)
Q Consensus       538 ~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~  615 (684)
                      +||+|=.++|.....+.+ .......+..||+||.+++..|+..+|||||||+||||+| |+.|+...+..|        
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--------  506 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--------  506 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--------
Confidence            999999999987654443 3333446779999999999999999999999999999998 999987554433        


Q ss_pred             HHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       616 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                              +...+-...+...+.++++++..++.-||..+|++||+.+|+..-|..+..
T Consensus       507 --------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  507 --------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             --------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence                    223333333444567899999999999999999999999999999977654

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.9e-33  Score=275.12  Aligned_cols=270  Identities=23%  Similarity=0.298  Sum_probs=201.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC---C--CcEEEEEeccccCh--hHHHHHHHHHHHHhhcCCCcccceeeeeee-cCc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP---D--GKIVAVKKSKVIDE--SKVEEFINEMVILSQINHRNVVKLLGCCLE-TEV  467 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~---~--g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~  467 (684)
                      ...|+....||+|.||.||++..+   +  .+.+|||+++...+  .-.....+|+.+++.++|||++.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            356899999999999999999633   2  33789998876432  224567899999999999999999999988 778


Q ss_pred             ceEEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC----CcEEEe
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK----YRAKVS  541 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~  541 (684)
                      .+|++||.+. +|+++|+.+..  ...++......|+.||+.|+.|||+.-   |+||||||.|||+..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            8999999976 89999986432  246899999999999999999999999   9999999999999877    999999


Q ss_pred             ccCCccccccCCcee--eecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhh-------hH
Q 043157          542 DFGASRSMAVDQTHM--TTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK-------SL  611 (684)
Q Consensus       542 DFgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~-------~l  611 (684)
                      |||++|.+.+.-...  ...+.-|..|.|||++.+. .|+.+.|||+.|||+.||+|-++-|......-..       ++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999887554433  3345678999999998764 6999999999999999999999888754332111       11


Q ss_pred             HHHHHHH-h-hhhhh------------hhhhhhhhhcc--------CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          612 AAYFLFA-M-KEERL------------FEILDARVMKE--------SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       612 ~~~~~~~-~-~~~~~------------~~~~d~~~~~~--------~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ...|... . ....+            ..-+.......        ....-++.-.+|+.++|+.||-+|.|++|.+++.
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            1111100 0 00000            00000000000        0011122367899999999999999999998875

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-33  Score=253.50  Aligned_cols=262  Identities=23%  Similarity=0.360  Sum_probs=204.7

Q ss_pred             CCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +|+..++||+|.||+||+++. .++++||+|+.+..+  +.--...++|+-+|+.++|.|||++++....+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466678999999999999994 568999999877633  33356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      + ..+|..+....+..  ++.+..+.++.|+++||.+.|+++   +.||||||+|.||+.+|..||+|||+++.+...-.
T Consensus        83 c-dqdlkkyfdslng~--~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNGD--LDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             h-hHHHHHHHHhcCCc--CCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            9 45888888876554  899999999999999999999999   99999999999999999999999999998775544


Q ss_pred             eeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHH--Hhhhhhhhhh---
Q 043157          555 HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLF--AMKEERLFEI---  627 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~--~~~~~~~~~~---  627 (684)
                      .... ..-|..|.+|+++.+. -|+...|+||.|+++.|+.. |++-|.+.+.++  ++...|..  ...++.+..+   
T Consensus       157 cysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd--qlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  157 CYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             eeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH--HHHHHHHHhCCCccccCCccccC
Confidence            3333 3468999999998775 58899999999999999996 666676655443  33333322  2223333222   


Q ss_pred             hhhhhhc---------cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          628 LDARVMK---------ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       628 ~d~~~~~---------~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .|-....         ..-+.....=++|+++.|.-+|.+|.++++.+++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1111111         1112333455789999999999999999998764

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3e-32  Score=314.74  Aligned_cols=145  Identities=29%  Similarity=0.409  Sum_probs=131.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|.+.++||+|+||+||++... +++.||||+++..   .....+.+.+|+.+++.++||||+++++.+......+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999976 6889999987642   3445678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      ||+++++|.++++...   .+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999998653   3889999999999999999999998   9999999999999999999999999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-33  Score=284.03  Aligned_cols=258  Identities=28%  Similarity=0.441  Sum_probs=203.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccccC---hhH----HHHHHHHHHHHhhcCCCcccceeeeee-ecC
Q 043157          396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID---ESK----VEEFINEMVILSQINHRNVVKLLGCCL-ETE  466 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~---~~~----~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  466 (684)
                      -++|-+..+||+|||++||++. +...+.||+|+-....   ++.    .+...+|..|-+.|.||.||++++++. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            4567788999999999999998 4567889999765422   222    345668999999999999999999996 556


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCcEEEecc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDF  543 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DF  543 (684)
                      ..+-|+||++|.+|.-+|+.++.   +++++++.|+.||+.||.||.+.. +||||-||||.||||-+   -|.+||+||
T Consensus       542 sFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence            77899999999999999998764   899999999999999999999987 56999999999999954   478999999


Q ss_pred             CCccccccCCc------eeeecccccCCCCCcccccc----CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 043157          544 GASRSMAVDQT------HMTTQVHGTFGYLDPEYFRS----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAA  613 (684)
Q Consensus       544 gl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~  613 (684)
                      ||++.+..+..      ..+....||.+|++||.+.-    ...+.|+||||.|||+|+.+.|++||...-...+     
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-----  692 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-----  692 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-----
Confidence            99998864433      23455679999999998743    3468899999999999999999999975433221     


Q ss_pred             HHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          614 YFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       614 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                          .+.++.+....+-  .-...+..+.+...+|++||+..-++|....++...
T Consensus       693 ----ILqeNTIlkAtEV--qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  693 ----ILQENTILKATEV--QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             ----HHhhhchhcceec--cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence                1222222221111  111224456788899999999999999999888754

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-33  Score=270.72  Aligned_cols=252  Identities=22%  Similarity=0.276  Sum_probs=198.7

Q ss_pred             hcCCCc-CceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeee----cCcc
Q 043157          396 TDNFNL-NRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLE----TEVP  468 (684)
Q Consensus       396 ~~~~~~-~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----~~~~  468 (684)
                      +++|.+ .++||-|-.|.|-....+ +++.+|+|.+...     ...++|+++--.. .|||||.+++++..    ...+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            445555 368999999999998865 6889999987643     4456788876655 69999999999864    3467


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCcEEEeccCC
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGA  545 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgl  545 (684)
                      ++|||.|+||.|++.+++++. ..+++.++..|..||..|+.|||+.+   |.||||||+|+|...   +-.+||+|||+
T Consensus       135 LiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             EeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence            899999999999999998754 46999999999999999999999999   999999999999964   56799999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF  625 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  625 (684)
                      ++......  ...+..-|+.|.|||++....|+...|+||+||++|-||.|.+||.......           +..+--.
T Consensus       211 AK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----------ispgMk~  277 (400)
T KOG0604|consen  211 AKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------ISPGMKR  277 (400)
T ss_pred             ccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----------CChhHHh
Confidence            98754322  2344567999999999999999999999999999999999999998544311           1111111


Q ss_pred             hhhhhh--hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          626 EILDAR--VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       626 ~~~d~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ++....  ...+.+...++...++|+.+|+.+|.+|.|+.|++++=
T Consensus       278 rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  278 RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            111111  11222356678899999999999999999999998763

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=5.7e-33  Score=287.43  Aligned_cols=245  Identities=26%  Similarity=0.363  Sum_probs=198.4

Q ss_pred             CceeceeCcEEEEEEEe-CCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCC
Q 043157          402 NRILGQGGQGTVYKGML-PDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      .++||+|.||+||-|++ ++|+.||||.+..  ....+..++++|+.||+++.||.||.+.-.|+..+..++|||-+. |
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence            57899999999999995 5899999997754  334556889999999999999999999999999999999999994 5


Q ss_pred             CHHHHHh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC---CcEEEeccCCccccccCCc
Q 043157          479 TLFQYIH-DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       479 sL~~~l~-~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFgl~~~~~~~~~  554 (684)
                      ++.+.+- ..+.  .|++.....+..||+.||.|||.++   |+|+||||+||||.+.   ..+||+|||++|....  .
T Consensus       648 DMLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--k  720 (888)
T KOG4236|consen  648 DMLEMILSSEKG--RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--K  720 (888)
T ss_pred             hHHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch--h
Confidence            6555554 4333  3899999999999999999999999   9999999999999654   4699999999998753  3


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                      .....+.||+.|+|||++.+..|...-|+||.|||+|.-|+|..||..+....++  +..+.++..             .
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQNAaFMyP-------------p  785 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQNAAFMYP-------------P  785 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhccccccC-------------C
Confidence            4456678999999999999999999999999999999999999999744322211  111111111             1


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      +.+.+.+.+..+||...|+..-.+|.+...-+.+-
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence            22345566788999999999999999988766553

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=5.4e-32  Score=274.20  Aligned_cols=220  Identities=23%  Similarity=0.186  Sum_probs=177.5

Q ss_pred             eCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCHHHHHhh
Q 043157          408 GGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD  486 (684)
Q Consensus       408 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~  486 (684)
                      |.+|+||++... +++.+|+|++....     .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999964 68899999886532     233455555566799999999999999999999999999999999976


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecccccCCC
Q 043157          487 QNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY  566 (684)
Q Consensus       487 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y  566 (684)
                      ..   .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++|||++......    .....++..|
T Consensus        79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y  148 (237)
T cd05576          79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY  148 (237)
T ss_pred             hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence            53   3899999999999999999999999   999999999999999999999999987654322    1223356779


Q ss_pred             CCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHH
Q 043157          567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAK  646 (684)
Q Consensus       567 ~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~  646 (684)
                      +|||.+....++.++||||+|+++|||++|+.|+.......                 .    .......+...+..+++
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~----~~~~~~~~~~~~~~~~~  207 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------N----THTTLNIPEWVSEEARS  207 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------c----cccccCCcccCCHHHHH
Confidence            99999988889999999999999999999998865321110                 0    00001122345567899


Q ss_pred             HHHHhhccCCCCCCCHH
Q 043157          647 VAKRCLNLNGKKRPTMR  663 (684)
Q Consensus       647 Li~~cl~~dp~~RPt~~  663 (684)
                      ++.+||+.||++||++.
T Consensus       208 li~~~l~~dp~~R~~~~  224 (237)
T cd05576         208 LLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHccCCHHHhcCCC
Confidence            99999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=9.9e-34  Score=271.76  Aligned_cols=250  Identities=25%  Similarity=0.332  Sum_probs=192.4

Q ss_pred             CceeceeCcEEEEEEEeC-CCcEEEEEeccccCh-hHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEecCCC
Q 043157          402 NRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE-SKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      ...||.|+||+|+|-.++ .|+..|||+++.... .+.++++.|.+...+- +.||||+++|....++..|+.||+|+ -
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence            567999999999998865 799999999987544 6677888888866555 79999999999999999999999994 4


Q ss_pred             CHHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          479 TLFQYIHD--QNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       479 sL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      ||..+.+.  ...+..+++...-.|......||.||.....  |+|||+||+||||+..|.+||+|||++.....+-  .
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--A  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--A  223 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHHHH--H
Confidence            66555442  1112248999999999999999999998763  9999999999999999999999999987654222  2


Q ss_pred             eecccccCCCCCcccccc--CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh-
Q 043157          557 TTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM-  633 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-  633 (684)
                      .+.-.|-..|||||.+..  ..|+.+|||||||++|+|+.||+.|+......-+ ++           ...-.-|+... 
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe-ql-----------~~Vv~gdpp~l~  291 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE-QL-----------CQVVIGDPPILL  291 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH-HH-----------HHHHcCCCCeec
Confidence            233347778999999854  3589999999999999999999999874332100 00           00111122211 


Q ss_pred             -ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          634 -KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       634 -~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       .....+.+..+..++.-||..|-+.||...++++.
T Consensus       292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             11123577889999999999999999999998764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=3e-31  Score=292.16  Aligned_cols=267  Identities=21%  Similarity=0.248  Sum_probs=184.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe-----------------CCCcEEEEEeccccChhHHHHHH--------------HH
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML-----------------PDGKIVAVKKSKVIDESKVEEFI--------------NE  443 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~~~--------------~E  443 (684)
                      ..++|++.++||+|+||+||+|.+                 ..++.||||++........++|.              .|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            356899999999999999999964                 23567999998764443333343              46


Q ss_pred             HHHHhhcCCCcc-----cceeeeeee--------cCcceEEEEecCCCCHHHHHhhcCC---------------------
Q 043157          444 MVILSQINHRNV-----VKLLGCCLE--------TEVPLLVYEFIPNGTLFQYIHDQNE---------------------  489 (684)
Q Consensus       444 ~~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~---------------------  489 (684)
                      +.++.+++|.++     +++++++..        .+..+|||||+++++|.++|+....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766554     667777653        3567999999999999999975321                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecccccCCCCCc
Q 043157          490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP  569 (684)
Q Consensus       490 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aP  569 (684)
                      ...+++..++.++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++...............+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            112467788999999999999999998   99999999999999999999999999976543222222222357899999


Q ss_pred             cccccCCC----------------------CCccchhhhHHHHHHHHhCCC-CCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          570 EYFRSSQF----------------------TDKSDVYSFGVVLAELLTGEK-PIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       570 E~~~~~~~----------------------~~ksDv~SlGvil~elltG~~-P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      |.+.....                      ..+.||||+||+++||++|.. |+......... +.. .  ......+..
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~-~--~~~~~~~r~  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQ-Y--DNDLNRWRM  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhh-c--cchHHHHHh
Confidence            98754321                      235799999999999999885 66422111100 000 0  000000011


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNG---KKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp---~~RPt~~evl~~  668 (684)
                      ..............+....+|+.++|..+|   .+|+|++|+++|
T Consensus       456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            111111111223446778899999999766   689999999876

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=3.6e-31  Score=266.91  Aligned_cols=236  Identities=30%  Similarity=0.416  Sum_probs=194.5

Q ss_pred             CcEEEEEEEeC-CCcEEEEEeccccChhH-HHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCHHHHHhh
Q 043157          409 GQGTVYKGMLP-DGKIVAVKKSKVIDESK-VEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD  486 (684)
Q Consensus       409 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~  486 (684)
                      +||.||+++.. +++.+++|+........ .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48999999987655444 78999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecccccCCC
Q 043157          487 QNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY  566 (684)
Q Consensus       487 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y  566 (684)
                      ...   +++..++.++.+++++|.|||+.+   ++|+||+|+||++++++.++|+|||.+.......  ......++..|
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~  152 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY  152 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence            543   889999999999999999999998   9999999999999999999999999998765432  23344578899


Q ss_pred             CCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC--hhHHHHH
Q 043157          567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG--GDEIITF  644 (684)
Q Consensus       567 ~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~--~~~~~~l  644 (684)
                      ++||.+....++.++|||+||+++++|++|..||......+  .             +.+.+.........  ...+.++
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~-------------~~~~~~~~~~~~~~~~~~~~~~~  217 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--E-------------LFKKIGKPKPPFPPPEWKISPEA  217 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H-------------HHHHHhccCCCCccccccCCHHH
Confidence            99999988889999999999999999999999987521111  0             11111111111101  1156789


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 043157          645 AKVAKRCLNLNGKKRPTMREVTS  667 (684)
Q Consensus       645 ~~Li~~cl~~dp~~RPt~~evl~  667 (684)
                      .+++.+||..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            99999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-32  Score=291.54  Aligned_cols=241  Identities=23%  Similarity=0.303  Sum_probs=195.7

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++.|.+...+|.|+|+.|-.+.. .+++..++|++...    ..+..+|+.++... +||||+++.+.+.+....|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            56788888899999999999885 46888999987654    22344577666666 79999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-CCCCcEEEeccCCccccccC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL-DDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DFgl~~~~~~~  552 (684)
                      .+.++-|.+.+.....    ....+..|+.||+.|+.|||+++   ++||||||+|||+ ++.++++|+|||.++....+
T Consensus       397 ~l~g~ell~ri~~~~~----~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE----FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhcch----hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            9999998888876542    23677789999999999999999   9999999999999 68899999999999876544


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                          .....-|..|.|||++....|++++|+||||++||+||+|+.||.....+.  .+    ...+.            
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--ei----~~~i~------------  527 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--EI----HTRIQ------------  527 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--HH----HHhhc------------
Confidence                122235788999999999999999999999999999999999998654431  00    00011            


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ........+.+.++|+.+||+.||.+||+|.|+..+=
T Consensus       528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             CCccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence            1112245677899999999999999999999998763

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=292.85  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=209.9

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeee-----
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLE-----  464 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-----  464 (684)
                      +...++.|++.+.||.|.+|.||+++ .++++.+|+|++..... ..++...|.++|+.+ .|||++.++|++..     
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            33346779999999999999999999 45788899998776433 335677789999988 69999999999974     


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                      .+.+|||||||.+||.-|+++... ...+.|+.+..|+.+++.||.+||...   ++|||||=.||||+.++.|||.|||
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence            457899999999999999999866 456999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCceeeecccccCCCCCcccccc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM  619 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~  619 (684)
                      ++....... ....+..||+.|||||++..     ..|+.++|+||||++..||.-|.+|+.....              
T Consensus       169 vSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------------  233 (953)
T KOG0587|consen  169 VSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------------  233 (953)
T ss_pred             eeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--------------
Confidence            998765333 34455679999999999853     3477899999999999999999999863321              


Q ss_pred             hhhhhhhhhhh-hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          620 KEERLFEILDA-RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       620 ~~~~~~~~~d~-~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       -..++.+... ......+...++++.++|..||..|-++||++.+++++
T Consensus       234 -mraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  234 -MRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             -hhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence             1122222222 22223356788999999999999999999999998865

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=4e-31  Score=298.28  Aligned_cols=263  Identities=19%  Similarity=0.248  Sum_probs=173.5

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-C----CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeee------ee
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-D----GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGC------CL  463 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~------~~  463 (684)
                      ..++|++.++||+|+||+||+|.+. +    +..||+|++......  +.+.+|  .++...+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4568999999999999999999965 4    689999987643221  222222  1222223333333222      23


Q ss_pred             ecCcceEEEEecCCCCHHHHHhhcCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 043157          464 ETEVPLLVYEFIPNGTLFQYIHDQNEDF-----------------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIK  526 (684)
Q Consensus       464 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~-----------------~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlk  526 (684)
                      +....++||||+++++|.++++......                 ...+..+..++.||+.||+|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            4567899999999999999997643110                 1123446679999999999999998   9999999


Q ss_pred             CCCEEECC-CCcEEEeccCCccccccCCceeeecccccCCCCCccccccC----------------------CCCCccch
Q 043157          527 STNILLDD-KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS----------------------QFTDKSDV  583 (684)
Q Consensus       527 p~NILl~~-~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksDv  583 (684)
                      |+|||+++ ++.+||+|||+++..............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999985 57999999999986654444444556789999999965321                      23457799


Q ss_pred             hhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH-hhhhhhhhhhhhhhhcc------CChhHHHHHHHHHHHhhccCC
Q 043157          584 YSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA-MKEERLFEILDARVMKE------SGGDEIITFAKVAKRCLNLNG  656 (684)
Q Consensus       584 ~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~d~~~~~~------~~~~~~~~l~~Li~~cl~~dp  656 (684)
                      |||||+||||+++..|+...    ...+...+... .....+...+.+....+      ..........+|+.+||+.||
T Consensus       363 wSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            99999999999977664311    11111000000 00011111111110000      001112245589999999999


Q ss_pred             CCCCCHHHHHHH
Q 043157          657 KKRPTMREVTSE  668 (684)
Q Consensus       657 ~~RPt~~evl~~  668 (684)
                      ++|||++|++++
T Consensus       439 ~kR~ta~e~L~H  450 (566)
T PLN03225        439 RQRISAKAALAH  450 (566)
T ss_pred             ccCCCHHHHhCC
Confidence            999999999986

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-32  Score=266.04  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=205.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      +.|++.++||+|+|++|.++.++ +.+++|+|+++.   .+.++++-...|-.+..+. +||.+|.++.+|..+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57999999999999999999965 688999997664   4556667777788887777 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      .||+++|+|.-++++++.   |+++.++.+..+|..||.|||+++   |+.||||..|+|||.+|++||+|+|+.+....
T Consensus       330 ieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence            999999999998887654   999999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh-hhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI-LDA  630 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~d~  630 (684)
                      +.. .+.++.|||.|+|||++.+..|...+|.|+|||+++||+.|+.||.....+......+..        ++++ ++.
T Consensus       404 ~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy--------lfqvilek  474 (593)
T KOG0695|consen  404 PGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY--------LFQVILEK  474 (593)
T ss_pred             CCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH--------HHHHHhhh
Confidence            333 456788999999999999999999999999999999999999999876655443322222        1222 222


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCC
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPT  661 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt  661 (684)
                      ++  ..+...+-....+++.-|+.||.+|..
T Consensus       475 qi--riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  475 QI--RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             cc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence            22  123444556678899999999999954

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.3e-31  Score=279.53  Aligned_cols=243  Identities=23%  Similarity=0.327  Sum_probs=194.2

Q ss_pred             cCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .-|...+.||-|+||+|-++. .++...+|+|.++.   ....++...+.|..||.....+.||+|+..|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            457888999999999999998 44567889997654   44667788899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc--
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA--  550 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~--  550 (684)
                      ||++||++..+|-+.+-   +.++.++.++.++..|+++.|..|   +|||||||+|||||.+|++||+||||..-+.  
T Consensus       709 dYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            99999999999987753   888889999999999999999999   9999999999999999999999999975321  


Q ss_pred             -c-----CCce---------------------------------eeecccccCCCCCccccccCCCCCccchhhhHHHHH
Q 043157          551 -V-----DQTH---------------------------------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLA  591 (684)
Q Consensus       551 -~-----~~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~  591 (684)
                       +     ...+                                 ......||+.|+|||++....++...|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence             0     0000                                 011245999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCC
Q 043157          592 ELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKR  659 (684)
Q Consensus       592 elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R  659 (684)
                      ||+.|++||...+..+.+.         +...+...++-....    +.+.+..+||.+.. -+++.|
T Consensus       863 em~~g~~pf~~~tp~~tq~---------kv~nw~~~l~~~~~~----~ls~e~~~li~kLc-~sad~R  916 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQY---------KVINWRNFLHIPYQG----NLSKEALDLIQKLC-CSADSR  916 (1034)
T ss_pred             HHhhCCCCccCCCCCccee---------eeeehhhcccccccc----ccCHHHHHHHHHHh-cChhhh
Confidence            9999999998777655431         222233344433333    34445556665544 455555

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1e-32  Score=262.65  Aligned_cols=266  Identities=22%  Similarity=0.334  Sum_probs=199.7

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeec--------C
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLET--------E  466 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~  466 (684)
                      .|....+||+|.||+||++..+ +|+.||+|+.-..+  ..--...++|+++|..|+|+|++.++..|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4555788999999999999854 67889999754422  22235568999999999999999999888632        3


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..+|||++++. +|.-+|.+..-  .++...+.++..++..||.|+|...   |+|||+|+.|+||+.++.+||+|||++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence            46899999975 88888876543  3889999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCce---eeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          547 RSMAVDQTH---MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       547 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      +.+......   ..+...-|..|.+||.+.+ ..|+++.|||..||++.||+|+.+-++..+...+-.++....-....+
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            876533322   2333456999999998765 579999999999999999999999998776544433333222111111


Q ss_pred             --------hhhhhhhhhhhccCC----hhH------HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          623 --------RLFEILDARVMKESG----GDE------IITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       623 --------~~~~~~d~~~~~~~~----~~~------~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                              .+.+.++-....+..    ++.      .++..+|+.++|..||.+|+++.+++.+-
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence                    112222111000000    111      23678999999999999999999998764

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-32  Score=280.13  Aligned_cols=249  Identities=22%  Similarity=0.295  Sum_probs=207.9

Q ss_pred             CCCcCceeceeCcEEEEEEEeCCCc-EEEEEe---ccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPDGK-IVAVKK---SKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~g~-~vavK~---~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      +++....||-||||.|-++..++.+ .+|+|.   .+..+..+.+....|-.+|...+.|.||++|..|.++...||+||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3555677999999999999876544 366664   455777888999999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      -|-||.|+.+|.+.+.   ++......++..+++|++|||+++   ||.|||||+|.+|+.+|-+||.|||+++..... 
T Consensus       501 aClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-  573 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-  573 (732)
T ss_pred             hhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence            9999999999998764   888999999999999999999999   999999999999999999999999999977543 


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                       ..+-++.|||.|.|||++.+...+.++|.||||+++|||++|.+||...+.-...+            .+..-+|   +
T Consensus       574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn------------~ILkGid---~  637 (732)
T KOG0614|consen  574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN------------LILKGID---K  637 (732)
T ss_pred             -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH------------HHHhhhh---h
Confidence             34567789999999999999999999999999999999999999998765432211            1111111   2


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPT-----MREVTSEL  669 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt-----~~evl~~L  669 (684)
                      .+.|........+|+++....+|.+|..     ..++.+|-
T Consensus       638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence            3344556667889999999999999965     56666554

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4e-31  Score=266.44  Aligned_cols=261  Identities=24%  Similarity=0.337  Sum_probs=201.5

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcC-C-C----cccceeeeeeecCc
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQIN-H-R----NVVKLLGCCLETEV  467 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-p----nIv~l~~~~~~~~~  467 (684)
                      .+++|.+...+|+|.||.|-..... .+..||||+++....-. +..+-|+++|+++. + |    -+|++.++|.-.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr-eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR-EAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh-hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            3678999999999999999998854 47899999998764433 55677999999993 2 2    36788888999999


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-------------
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-------------  534 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-------------  534 (684)
                      .++|+|.+ |-|+.++|.+++. .+++...++.++.|++++++|||+.+   ++|-||||+|||+.+             
T Consensus       166 iCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            99999998 6699999998654 46899999999999999999999999   999999999999831             


Q ss_pred             -------CCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhh
Q 043157          535 -------KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE  607 (684)
Q Consensus       535 -------~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~  607 (684)
                             +..+||+|||.+.......    ..+..|..|.|||++.+-.++.++||||+||||+||.||..-|+..+.-|
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                   3458999999997643322    44567889999999999999999999999999999999999998765322


Q ss_pred             hhhHHHHHHHHhh--------hhhhhhh-----hh---------------hh----hhccCChhHHHHHHHHHHHhhccC
Q 043157          608 DKSLAAYFLFAMK--------EERLFEI-----LD---------------AR----VMKESGGDEIITFAKVAKRCLNLN  655 (684)
Q Consensus       608 ~~~l~~~~~~~~~--------~~~~~~~-----~d---------------~~----~~~~~~~~~~~~l~~Li~~cl~~d  655 (684)
                        .|+.+. ..+.        ..+..+.     +|               +.    ........+...+.+|+++||..|
T Consensus       317 --HLaMMe-rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  317 --HLAMME-RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             --HHHHHH-HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence              222111 1110        0000000     01               00    001112345567999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 043157          656 GKKRPTMREVTSE  668 (684)
Q Consensus       656 p~~RPt~~evl~~  668 (684)
                      |.+|+|++|++.+
T Consensus       394 P~~RiTl~EAL~H  406 (415)
T KOG0671|consen  394 PARRITLREALSH  406 (415)
T ss_pred             ccccccHHHHhcC
Confidence            9999999999875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=288.73  Aligned_cols=246  Identities=28%  Similarity=0.399  Sum_probs=189.8

Q ss_pred             CCcCceeceeCcEE-EEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEecC
Q 043157          399 FNLNRILGQGGQGT-VYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       399 ~~~~~~LG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      |.-.+++|.|..|+ ||+|.. +|+.||||++-   .+-.+...+|+..|+.- .|||||++++.-.++...||..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            44567789999877 799998 67899999875   33345567899999998 6999999999999999999999999 


Q ss_pred             CCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-----CCcEEEeccCCccccc
Q 043157          477 NGTLFQYIHDQNED-FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-----KYRAKVSDFGASRSMA  550 (684)
Q Consensus       477 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DFgl~~~~~  550 (684)
                      .-+|.++++..... ........+.+..|++.||++||+.+   |+||||||+||||+.     ..+++|+|||+++...
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            46999999874211 11221345678899999999999999   999999999999975     3689999999999887


Q ss_pred             cCCcee--eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhC-CCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          551 VDQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTG-EKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       551 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG-~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      .+....  .....||.+|+|||++....-+.++|||||||++|+.++| .+||...-..+.       .....+..+..+
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-------NIl~~~~~L~~L  735 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-------NILTGNYTLVHL  735 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-------hhhcCccceeee
Confidence            655443  3456799999999999988888899999999999999985 899973321111       001111111111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                            .. ..+.  +..+||.+|++++|..||++.+|+.+
T Consensus       736 ------~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  736 ------EP-LPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ------cc-CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                  01 1112  78899999999999999999999854

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=4.6e-30  Score=238.21  Aligned_cols=207  Identities=26%  Similarity=0.378  Sum_probs=169.1

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc-cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcc
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV-IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  468 (684)
                      ++...+.......||+|++|.|-+.++ .+|+..|+|++.. .+.+..++.++|+.+..+- ..|.+|.++|...++...
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            444445556677899999999998885 4799999998876 3455567788888877665 799999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          469 LLVYEFIPNGTLFQYIHD-QNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      ++.||.|+ .||..+-.+ -.....+++..+-+||..+.+||.|||++-+  ++|||+||+||||+.+|++|++|||++-
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence            99999994 577766554 2233459999999999999999999999874  9999999999999999999999999987


Q ss_pred             ccccCCceeeecccccCCCCCccccc----cCCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFR----SSQFTDKSDVYSFGVVLAELLTGEKPIRFT  603 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~ksDv~SlGvil~elltG~~P~~~~  603 (684)
                      ...++-.  .+...|-..|||||.+.    ...|+.||||||||+++.||.+++.||...
T Consensus       198 ~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            6543222  22234677899999874    347899999999999999999999998743

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=250.73  Aligned_cols=264  Identities=26%  Similarity=0.332  Sum_probs=201.5

Q ss_pred             CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecC-----cceE
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETE-----VPLL  470 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~l  470 (684)
                      .+-.+.||.|+||.||.+++. +|+.||+|++...-  -...+.+.+|+++|..++|.|++..+++.....     ..|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            344688999999999999864 79999999987633  344678999999999999999999998876543     4567


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      +.|+|. .+|..++-..   .+|+.+.+.-+..||++||.|||+.+   |.||||||.|.|++.+-..||+|||+++...
T Consensus       135 ~TELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence            888884 4677766543   35888999999999999999999999   9999999999999999999999999999877


Q ss_pred             cCCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH-----hh---h
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA-----MK---E  621 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~-----~~---~  621 (684)
                      .++....+...-|..|.|||++.+. .|+.+.||||.|+|+.||+..+.-|......++-.++...+-.     ++   +
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            6655555555678899999998775 6899999999999999999999999876655544443322111     11   1


Q ss_pred             hhhhhhhhhhhh-------cc--CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          622 ERLFEILDARVM-------KE--SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       622 ~~~~~~~d~~~~-------~~--~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      +.-..++.....       -.  .+.+-..+-..++.++|..||++|.+..+.+.++
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            111122221110       01  1123334566788999999999999999888765

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=5.2e-29  Score=234.37  Aligned_cols=259  Identities=20%  Similarity=0.321  Sum_probs=197.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccccChhHHHHHHHHHHHHhhcC-CCcccceeeeeeec--CcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVVKLLGCCLET--EVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lv  471 (684)
                      .++|++.+++|+|.+++||.|. ..+.+.++||.++..   ..+.+.+|+++|+.|. ||||+++++...+.  ..+-||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4679999999999999999998 457788999988854   4467889999999996 99999999999754  477899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CcEEEeccCCccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASRSMA  550 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFgl~~~~~  550 (684)
                      +||+.+.+...+..      .|+...+...+.|++.||.|+|+.|   |+|||+||.|++||.. -.++|+|+|++....
T Consensus       114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            99999988766554      2777888999999999999999999   9999999999999965 469999999998876


Q ss_pred             cCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh--------h-
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM--------K-  620 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~--------~-  620 (684)
                      .......  ...+..|.-||++-. ..|+-.-|+||||++|..|+..+.||..... ...+|+..+.-.-        . 
T Consensus       185 p~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  185 PGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             CCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHHH
Confidence            5444322  234566889999865 5578899999999999999999999864433 3333433321110        0 


Q ss_pred             -----hhhhhhhhhhh--------hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          621 -----EERLFEILDAR--------VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       621 -----~~~~~~~~d~~--------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                           +.+...++...        +..+...-.+++..+|+.+.|..|-++|+|++|.+.+-
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp  323 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP  323 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence                 11111211111        01111122357889999999999999999999998763

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=6.1e-28  Score=237.10  Aligned_cols=211  Identities=36%  Similarity=0.603  Sum_probs=184.7

Q ss_pred             eceeCcEEEEEEEeCC-CcEEEEEeccccChh-HHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCHHH
Q 043157          405 LGQGGQGTVYKGMLPD-GKIVAVKKSKVIDES-KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ  482 (684)
Q Consensus       405 LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~  482 (684)
                      ||+|.+|.||++...+ ++.+++|+....... ..+.+.+|++.++.++|++|+++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 889999988765443 45789999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCcEEEeccCCccccccCCceeeeccc
Q 043157          483 YIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAVDQTHMTTQVH  561 (684)
Q Consensus       483 ~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgl~~~~~~~~~~~~~~~~  561 (684)
                      ++....  ..+++..++.++.+++++|++||+.+   ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  154 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV  154 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence            998753  24899999999999999999999998   999999999999999 89999999999876543321 122344


Q ss_pred             ccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhH
Q 043157          562 GTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE  640 (684)
Q Consensus       562 gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  640 (684)
                      +...|++||.+... ..+.++|+|+||+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            78889999999877 788999999999999999                                               


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          641 IITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       641 ~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                       ..+.+++.+|++.+|++||++++++++|
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence             3578999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=4.7e-29  Score=265.85  Aligned_cols=254  Identities=27%  Similarity=0.378  Sum_probs=208.0

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ..++|.+.+.+|.|.+|.|||++.. .++..|+|.++........-..+|+-+++..+||||+.++|.+...+..|+.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3467999999999999999999954 789999999988777778888899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+.+|+|+++-+-.+   ++++.++..+.++.+++|+|||+.+   -+|||||-.|||+++.+.+|++|||.+..+... 
T Consensus        93 ycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-  165 (829)
T ss_pred             ecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-
Confidence            999999999988654   4999999999999999999999999   789999999999999999999999998765432 


Q ss_pred             ceeeecccccCCCCCcccc---ccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~---~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ..+...+.||+.|||||+.   ..+.|..++|||++|+...|+---++|......       ....+.+...    ..++
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~LmTkS----~~qp  234 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFLMTKS----GFQP  234 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHHhhcc----CCCC
Confidence            2234556799999999986   356789999999999999999988888542211       1111122111    0111


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS  667 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~  667 (684)
                      .-. +-.......+-++++.+|..+|++||+++.++.
T Consensus       235 p~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  235 PTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             Ccc-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            111 112345667889999999999999999988765

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=2.8e-28  Score=240.60  Aligned_cols=260  Identities=23%  Similarity=0.324  Sum_probs=195.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC------c
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETE------V  467 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~  467 (684)
                      .+|.-.+.+|.|.. .|-.+.+ -.++.||+|+...  .+....++..+|..++..++|+||++++.++....      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45677788999988 4544443 2588999998653  33445677789999999999999999999997543      5


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .|+|||+| ..+|.+.++..     ++-+.+..|..|++.|+.|||+.+   |+||||||+||++..+..+||.|||+++
T Consensus        96 ~y~v~e~m-~~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILME-----LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            68999999 46899888832     778889999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHH--------HHHHh
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY--------FLFAM  619 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~--------~~~~~  619 (684)
                      ....+  .+.+....|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+.+.-++-.....        |...+
T Consensus       167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            65433  456667788899999999988899999999999999999999999885443222111100        00000


Q ss_pred             h---------hhhh-----hh-hhhh--hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          620 K---------EERL-----FE-ILDA--RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       620 ~---------~~~~-----~~-~~d~--~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .         .++.     .+ +.|.  ....+.+.......++|+.+||-.||++|.++++++.+
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            0         0000     00 0111  11111222334568899999999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=8.4e-27  Score=232.74  Aligned_cols=199  Identities=36%  Similarity=0.549  Sum_probs=174.3

Q ss_pred             CCcCceeceeCcEEEEEEEeCC-CcEEEEEeccccChh-HHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          399 FNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDES-KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      |.+.+.||+|++|+||++...+ ++.+++|........ ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5678899999999999999765 889999998765554 67889999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.+++......  +++..++.++.+++.+|.+||+.+   ++|+||+|.||+++.++.++|+|||++..........
T Consensus        81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            99999999875432  789999999999999999999998   9999999999999999999999999988765443112


Q ss_pred             eecccccCCCCCcccc-ccCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 043157          557 TTQVHGTFGYLDPEYF-RSSQFTDKSDVYSFGVVLAELLTGEKPIRF  602 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~-~~~~~~~ksDv~SlGvil~elltG~~P~~~  602 (684)
                      .....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2334577889999998 667788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-27  Score=249.30  Aligned_cols=196  Identities=24%  Similarity=0.368  Sum_probs=167.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC-CcEEEEEecccc--------ChhHHHHHHHHHHHHhhcC---CCcccceeeeeee
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVI--------DESKVEEFINEMVILSQIN---HRNVVKLLGCCLE  464 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~  464 (684)
                      ..|...+.||+|+||.|+++.++. ...|+||.+...        ...++-..-.|+.||..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            347889999999999999999764 567888865431        1122333456999999997   9999999999999


Q ss_pred             cCcceEEEEec-CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEecc
Q 043157          465 TEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF  543 (684)
Q Consensus       465 ~~~~~lv~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF  543 (684)
                      ++..||+||-. ++-+|++++..+.+   +++..+..|+.||+.|+++||+.+   |+|||||-+|+.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            99999999965 45689999998754   999999999999999999999999   999999999999999999999999


Q ss_pred             CCccccccCCceeeecccccCCCCCccccccCCC-CCccchhhhHHHHHHHHhCCCCCC
Q 043157          544 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLAELLTGEKPIR  601 (684)
Q Consensus       544 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltG~~P~~  601 (684)
                      |.+....   ......+.||..|.|||++.+..| +..-|||++|++||.++....||.
T Consensus       715 gsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9986543   223445679999999999998886 567999999999999999888875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-27  Score=226.48  Aligned_cols=252  Identities=20%  Similarity=0.318  Sum_probs=187.6

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCC-CcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeee-eecCcceEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCC-LETEVPLLV  471 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~-~~~~~~~lv  471 (684)
                      ..+.|.+.+.||+|.||.+-++.++. .+.+++|-... ....+.+|.+|...--.| .|.||+..++.. +..+..+++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            34679999999999999999999764 56777775543 455678999998877667 599999988665 445566799


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC--CCCcEEEeccCCcccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSM  549 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DFgl~~~~  549 (684)
                      +||++.|+|.+-+...+    +-+..-.+++.|++.||.|||+++   ++|||||.+||||-  +..++||+|||+.+..
T Consensus       101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence            99999999999887643    788888999999999999999999   99999999999993  4458999999998754


Q ss_pred             ccCCceeeecccccCCCCCccccccC-----CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      ..    ......-+..|.+||.....     ...+.+|||.||++++.++||+.||+ .....++...+|..+..+..  
T Consensus       174 g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk~--  246 (378)
T KOG1345|consen  174 GT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRKN--  246 (378)
T ss_pred             Cc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhcccC--
Confidence            31    11222345678999986432     34678999999999999999999998 33444444444433322211  


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS  667 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~  667 (684)
                      .     ... ..-...++.+.++.++-|..++++|=-..++.+
T Consensus       247 ~-----~~P-~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  247 P-----ALP-KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             c-----cCc-hhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            0     111 111345667888999999999999944444433

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=6.3e-27  Score=242.90  Aligned_cols=269  Identities=20%  Similarity=0.218  Sum_probs=206.3

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcC------CCcccceeeeeee
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQIN------HRNVVKLLGCCLE  464 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~~~~~  464 (684)
                      .+....+|.+.-..|+|-|++|-+|... .|+.||||++... +.-.+.=+.|+++|+.|+      --|+++|+..|..
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            3456678888888999999999999854 5789999998763 323344568999999995      4589999999999


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CcEEEecc
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDF  543 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DF  543 (684)
                      .++++||+|-+ .-+|.++|+..+....|....+..++.|+.-||..|...+   |+|.||||.|||+++. ..+||+||
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence            99999999988 5699999999887777999999999999999999999999   9999999999999865 56899999


Q ss_pred             CCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH-----HH
Q 043157          544 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL-----FA  618 (684)
Q Consensus       544 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~-----~~  618 (684)
                      |.|.....++.   +.+..+-.|.|||++.+-+|+...|+||.||+||||.||+.-|++.+...-.-+.+-..     .+
T Consensus       582 GSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  582 GSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM  658 (752)
T ss_pred             ccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence            99876553332   22334557999999999999999999999999999999999998766432111111110     00


Q ss_pred             hhhhh---------------------------hhhhhhh------hhhc--cCC---hhHHHHHHHHHHHhhccCCCCCC
Q 043157          619 MKEER---------------------------LFEILDA------RVMK--ESG---GDEIITFAKVAKRCLNLNGKKRP  660 (684)
Q Consensus       619 ~~~~~---------------------------~~~~~d~------~~~~--~~~---~~~~~~l~~Li~~cl~~dp~~RP  660 (684)
                      +..+.                           ++..+.|      .+..  .++   ......+.+|+.+||.+||++|.
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence            00000                           0000000      0000  112   33467799999999999999999


Q ss_pred             CHHHHHHH
Q 043157          661 TMREVTSE  668 (684)
Q Consensus       661 t~~evl~~  668 (684)
                      |..|.|++
T Consensus       739 t~nqAL~H  746 (752)
T KOG0670|consen  739 TVNQALKH  746 (752)
T ss_pred             CHHHHhcC
Confidence            99999875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9.2e-26  Score=233.42  Aligned_cols=131  Identities=27%  Similarity=0.412  Sum_probs=110.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcC-----C---Ccccceeeeeeec--
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQIN-----H---RNVVKLLGCCLET--  465 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---pnIv~l~~~~~~~--  465 (684)
                      .+|.+.++||+|.|++||++.+. ..+.||+|+.+.... -.+..+.||++|++++     |   ..||+|++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            57889999999999999999854 567899998876322 2356788999999984     3   4799999999765  


Q ss_pred             --CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 043157          466 --EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL  532 (684)
Q Consensus       466 --~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl  532 (684)
                        .+.+||+|++ |-+|..+|.....+ .++...+..|+.||+.||.|||.+..  |||-||||+||||
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence              4778999999 67898988875443 38999999999999999999999874  9999999999998

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=4.6e-26  Score=233.13  Aligned_cols=265  Identities=24%  Similarity=0.334  Sum_probs=197.6

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEeC----CCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecC
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGMLP----DGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETE  466 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~  466 (684)
                      +....+.|...++||+|.|++||++.+.    .++.||+|.+....  ....+.+|+++|..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3344567889999999999999999853    46789999876533  235688999999999 5999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCcEEEeccCC
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGA  545 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgl  545 (684)
                      ...+|+||+++-+..+++..      ++...+..++..++.||+++|+.+   |+||||||+|+|.+. .+.-.|.|||+
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999999888864      677889999999999999999999   999999999999974 46789999999


Q ss_pred             ccccccCC-------------------------------------------ceeeecccccCCCCCcccccc-CCCCCcc
Q 043157          546 SRSMAVDQ-------------------------------------------THMTTQVHGTFGYLDPEYFRS-SQFTDKS  581 (684)
Q Consensus       546 ~~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ks  581 (684)
                      +.......                                           ........||++|.|||++.. +..+.++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            87211000                                           001112459999999999865 5578999


Q ss_pred             chhhhHHHHHHHHhCCCCCCCCChhhhhhHHHH---HHH------Hhhhhh--hh------hh---------hh-hh---
Q 043157          582 DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY---FLF------AMKEER--LF------EI---------LD-AR---  631 (684)
Q Consensus       582 Dv~SlGvil~elltG~~P~~~~~~~~~~~l~~~---~~~------~~~~~~--~~------~~---------~d-~~---  631 (684)
                      ||||.|||++-+++++.||.....+- ..+.+.   +..      +.-.++  +.      .+         ++ ..   
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             ceeeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            99999999999999999997543321 112111   100      000111  00      00         10 00   


Q ss_pred             ------hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 ------VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                            .........+..+.+|+.+||..||.+|.|++|.|++
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                  0001112234578899999999999999999999876

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=2.3e-26  Score=272.11  Aligned_cols=198  Identities=18%  Similarity=0.225  Sum_probs=141.5

Q ss_pred             hhcCC-Ccccceeeee-------eecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 043157          448 SQINH-RNVVKLLGCC-------LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIP  519 (684)
Q Consensus       448 ~~l~H-pnIv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~  519 (684)
                      +.++| +||+++++.+       .+.+..++++|++ +++|.++|....  ..+++..++.++.||++||+|||+++   
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---  100 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---  100 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            34556 6888888887       2334567888987 669999997543  34899999999999999999999999   


Q ss_pred             eEecCCCCCCEEECC-------------------CCcEEEeccCCccccccCC---------------ceeeecccccCC
Q 043157          520 IYHRDIKSTNILLDD-------------------KYRAKVSDFGASRSMAVDQ---------------THMTTQVHGTFG  565 (684)
Q Consensus       520 iiH~Dlkp~NILl~~-------------------~~~~kl~DFgl~~~~~~~~---------------~~~~~~~~gt~~  565 (684)
                      |+||||||+||||+.                   ++.+|++|||+++......               ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   4456666666665421100               000112357889


Q ss_pred             CCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHH
Q 043157          566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFA  645 (684)
Q Consensus       566 y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~  645 (684)
                      |||||++.+..++.++|||||||+||||++|.+|+....    .....     ..    ...+.+..     ........
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~-----~~----~~~~~~~~-----~~~~~~~~  242 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSS-----LR----HRVLPPQI-----LLNWPKEA  242 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHH-----HH----HhhcChhh-----hhcCHHHH
Confidence            999999999999999999999999999999988864211    00000     00    00111111     11223456


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHH
Q 043157          646 KVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       646 ~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .++.+||+.+|.+||++.|++++-
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhch
Confidence            888999999999999999998753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=4.3e-25  Score=212.75  Aligned_cols=171  Identities=23%  Similarity=0.259  Sum_probs=129.1

Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |||.++++..+.  ++++..++.++.|++.||+|||+.+         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            789999986533  4999999999999999999999876         999999999999999  99987654322    


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESG  637 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~  637 (684)
                        ..|++.|||||++.+..++.++||||||+++|||+||+.||....... ..+.. ....+...      ++. .....
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~-~~~~~~~~------~~~-~~~~~  132 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEI-LLNGMPAD------DPR-DRSNL  132 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHH-HHHHhccC------Ccc-ccccH
Confidence              258899999999999999999999999999999999999986432111 11111 11001000      000 00011


Q ss_pred             hhHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          638 GDEII--TFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       638 ~~~~~--~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .....  ++.+++.+||+.+|++||++.|+++++..+....
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~  173 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET  173 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence            22233  6999999999999999999999999998876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.5e-24  Score=214.81  Aligned_cols=265  Identities=17%  Similarity=0.238  Sum_probs=217.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .-+|+++++||+|.||+++.|+ +-++++||||.-..  ..+..++..|.+..+.| ..++|...+.+..+...-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3479999999999999999999 55899999997554  33456788899999988 57999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-----CCcEEEeccCCccc
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-----KYRAKVSDFGASRS  548 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DFgl~~~  548 (684)
                      ++ |.+|+|+..=.++.  ++.+....+|.|++.-++|+|++.   +|.|||||+|+||..     ...+.|+|||+++.
T Consensus       105 LL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            99 88999999877654  899999999999999999999999   999999999999963     34689999999998


Q ss_pred             cccCCcee------eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          549 MAVDQTHM------TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       549 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      +.+..+..      .....||.+||+--.+.+.+.+.+.|+-|||.+++++|.|..||++...+..+.         +.+
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~---------kYe  249 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE---------KYE  249 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH---------HHH
Confidence            87655543      344669999999999999999999999999999999999999999776654332         222


Q ss_pred             hhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       623 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      ++-+........++....+.++...+.-.-.++-++-|..+-+...+..+....+
T Consensus       250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence            2222222222333445678888888888889999999999999988887776544

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.2e-23  Score=220.88  Aligned_cols=263  Identities=24%  Similarity=0.265  Sum_probs=200.9

Q ss_pred             CCCcCceeceeCcEEEEEEEeCCC--cEEEEEeccccChhHHHHHHHHHHHHhhcCC----Ccccceeeee-eecCcceE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPDG--KIVAVKKSKVIDESKVEEFINEMVILSQINH----RNVVKLLGCC-LETEVPLL  470 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~~~~-~~~~~~~l  470 (684)
                      +|.+.++||+|+||.||++.....  +.+|+|............+..|..++..+.+    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999996553  4788887665433333377889999998863    6899999999 47778899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-----CcEEEeccCC
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-----YRAKVSDFGA  545 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DFgl  545 (684)
                      ||+.+ |.+|.++..... ...++.....+|+.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 889999887665 345999999999999999999999999   9999999999999755     4699999999


Q ss_pred             cc--ccccCCce----e---eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH
Q 043157          546 SR--SMAVDQTH----M---TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL  616 (684)
Q Consensus       546 ~~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~  616 (684)
                      ++  ........    .   .....||..|.++..+.+...+.+.|+||++.++.||+.|..||..........      
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~------  247 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS------  247 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH------
Confidence            99  43222211    1   223559999999999999999999999999999999999999996544322110      


Q ss_pred             HHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       617 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                            .+.+..............+.++.++...+-..+..++|....+...|.......+
T Consensus       248 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~  302 (322)
T KOG1164|consen  248 ------KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG  302 (322)
T ss_pred             ------HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence                  0000000000000122344556666666667999999999999999988877653

>PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding

Probab=99.91  E-value=8.5e-25  Score=191.85  Aligned_cols=99  Identities=42%  Similarity=0.836  Sum_probs=82.5

Q ss_pred             CCCCCCCCCccccCcCcCCCCCCCCCCCceecCCCCCCCccccccccceeeEeeecC-CcceeEEeeceeccccCC--C-
Q 043157           15 LSCPDRCGSVLIEYPFGIGAGCYFDESFEVVCDNSSGPPKAILQKIGQEISSYISYS-GSPNIAVNISVTSLSSIN--N-   90 (684)
Q Consensus        15 ~~C~~~CG~v~ipYPFGig~~C~~~~~F~l~C~~~~~~p~~~l~~~~~~v~~~~~~~-~~~~~~~~~~~~~~~~~~--~-   90 (684)
                      ++||++||||+||||||||++|+++++|+|+|++++++|++++...++||++ |+++ ++++  |..++...|...  . 
T Consensus         2 ~~C~~~CGnv~IpYPFgi~~~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~-I~~~~~~i~--v~~~~~~~~~~~~~~~   78 (106)
T PF13947_consen    2 PGCPSSCGNVSIPYPFGIGPGCGRDPGFELTCNNNTSPPKLLLSSGNYEVLS-ISYENGTIR--VSDPISSNCYSSSSSN   78 (106)
T ss_pred             CCCCCccCCEeecCCCccCCCCCCCCCcEEECCCCCCCceeEecCCcEEEEE-EecCCCEEE--EEeccccceecCCCCc
Confidence            5899999999999999999999996699999999988899999889999999 8988 8888  555555444221  1 


Q ss_pred             --CCcccccCCCeEEeccCCEEEEEcccc
Q 043157           91 --AKGINLTGTPFSFSQRINKFLAIGCDN  117 (684)
Q Consensus        91 --~~~~~~~~~pf~~s~~~n~~~~~GC~~  117 (684)
                        ...|++.+ ||++|+++|+|+++||++
T Consensus        79 ~~~~~~~~~~-~~~~s~~~N~~~~~GC~t  106 (106)
T PF13947_consen   79 SSNSNLSLNG-PFFFSSSSNKFTVVGCNT  106 (106)
T ss_pred             ccccEEeecC-CceEccCCcEEEEECCCC
Confidence              23455555 899999999999999986

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=4.3e-24  Score=202.88  Aligned_cols=264  Identities=19%  Similarity=0.243  Sum_probs=211.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEE-eCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCC-CcccceeeeeeecCcceEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH-RNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lv~  472 (684)
                      ...+|.+.++||.|+||.+|.|. ..+|+.||||.-+.  .....++.-|.++.+.|+| ..|..+..+..+.....|||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            35679999999999999999998 56899999997654  2233567789999999975 78889999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC---CcEEEeccCCcccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSM  549 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFgl~~~~  549 (684)
                      |++ |.||++++.-....  ++.++.+.++-|++.-++|+|.++   ++||||||+|+|..-+   ..+.|+|||+++..
T Consensus        91 dLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            999 88999999877654  889999999999999999999999   9999999999999643   46899999999887


Q ss_pred             ccCCce------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhh
Q 043157          550 AVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER  623 (684)
Q Consensus       550 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~  623 (684)
                      .+..+.      ......||.+|.+--.+.+...+.+.|+-|+|.+|.++..|..||++.......+-.         ++
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy---------Ek  235 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY---------EK  235 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH---------HH
Confidence            644332      233456999999988888888899999999999999999999999977655443222         22


Q ss_pred             hhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          624 LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       624 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      +.+..-......+....+.++.-.+.-|-..--++-|...-+.+.+.-|...
T Consensus       236 I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  236 ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence            2221111122233456788889999999999999999988888777666543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-24  Score=209.46  Aligned_cols=250  Identities=21%  Similarity=0.354  Sum_probs=198.0

Q ss_pred             CCCcCceeceeCcEEEEEEEeCCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      ...+..+|.+...|+.|+|+++.+..| +|++..  .......+|..|.-.|+.+.||||+.+++.|.....+.++..||
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgndiv-akil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGNDIV-AKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCcchh-hhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            345667889999999999999765544 454443  33444578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEec--cCCccccccCC
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD--FGASRSMAVDQ  553 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D--Fgl~~~~~~~~  553 (684)
                      +.|+|...||+.. ...++..++.+++.++|+|++|||+..++ |.---|.+..++||++.+++|+-  --++       
T Consensus       270 p~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfs-------  340 (448)
T KOG0195|consen  270 PFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFS-------  340 (448)
T ss_pred             cchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceee-------
Confidence            9999999999874 34578889999999999999999999854 44557899999999999988762  2111       


Q ss_pred             ceeeecccccCCCCCccccccCCCC---CccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFT---DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~---~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                       .......-.+.||+||.++..+.+   ..+|+|||.++||||.|...||.....-+-.               .++.-+
T Consensus       341 -fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkiale  404 (448)
T KOG0195|consen  341 -FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALE  404 (448)
T ss_pred             -eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhc
Confidence             111222346889999999876644   4799999999999999999999855433211               223333


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      .+....++..+..+..|+.-|+..||.+||.+..++-.|++++
T Consensus       405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            4445667788889999999999999999999999999998864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=2.2e-23  Score=220.70  Aligned_cols=169  Identities=20%  Similarity=0.137  Sum_probs=131.3

Q ss_pred             HHHHHHhcCCCcCceeceeCcEEEEEEEeC--CCcEEEEEecccc-----ChhHHHHHHHHHHHHhhcCCCcccceeeee
Q 043157          390 KELERATDNFNLNRILGQGGQGTVYKGMLP--DGKIVAVKKSKVI-----DESKVEEFINEMVILSQINHRNVVKLLGCC  462 (684)
Q Consensus       390 ~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  462 (684)
                      +......++|.+.+.||+|+||+||+|.++  +++.+|||+....     .....+.+.+|+++|++++|+|+++.+.. 
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-   89 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence            344456678999999999999999999864  5778899986432     23345679999999999999999853322 


Q ss_pred             eecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEECCCCcEEEe
Q 043157          463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDI-KSTNILLDDKYRAKVS  541 (684)
Q Consensus       463 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~  541 (684)
                        .+..+|||||+++++|... ..      ..   ...++.|++++|+|||+.+   |+|||| ||+|||++.++.+||+
T Consensus        90 --~~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         90 --TGKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             --cCCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence              2467999999999999632 11      11   1467889999999999999   999999 9999999999999999


Q ss_pred             ccCCccccccCCce-------eeecccccCCCCCcccccc
Q 043157          542 DFGASRSMAVDQTH-------MTTQVHGTFGYLDPEYFRS  574 (684)
Q Consensus       542 DFgl~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~  574 (684)
                      |||+++........       ......+++.|++||++..
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999876433211       1134568888999998753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=3.5e-21  Score=201.74  Aligned_cols=260  Identities=30%  Similarity=0.390  Sum_probs=197.7

Q ss_pred             CCcCceeceeCcEEEEEEEeCCCcEEEEEeccccCh---hHHHHHHHHHHHHhhcCCC-cccceeeeeeecCcceEEEEe
Q 043157          399 FNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE---SKVEEFINEMVILSQINHR-NVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lv~E~  474 (684)
                      |.+.+.||.|+|+.||++...  +.+++|.+.....   .....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667889999999999999976  7788887765332   2478899999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-cEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgl~~~~~~~~  553 (684)
                      +.+++|.+++........++......+..|++.++.|+|+.+   ++|||+||+||+++... .+++.|||+++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977765432124889999999999999999999999   99999999999999988 79999999998554333


Q ss_pred             ce-----eeecccccCCCCCcccccc---CCCCCccchhhhHHHHHHHHhCCCCCCCCChh-hhhhHHHHHHHHhhhhhh
Q 043157          554 TH-----MTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLE-EDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       554 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltG~~P~~~~~~~-~~~~l~~~~~~~~~~~~~  624 (684)
                      ..     ......|+..|++||.+..   .......|+||+|++++++++|..||...... ........+......   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            22     2455679999999999987   57889999999999999999999997654421 000011100000000   


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        .................+.+++.+++..+|..|.++.+....
T Consensus       234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              000000000001223578899999999999999999988775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.9e-22  Score=227.25  Aligned_cols=254  Identities=23%  Similarity=0.305  Sum_probs=191.9

Q ss_pred             CcCceeceeCcEEEEEEEe-CCCcEEEEEecc-----ccChhH-HHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          400 NLNRILGQGGQGTVYKGML-PDGKIVAVKKSK-----VIDESK-VEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       400 ~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~-----~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ...+++|.|++|.|+.... ...+..+.|...     .....+ ...+..|+.+-..++|||++..+....+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4578899999998877663 234444444322     111111 122667888888999999999888888777666669


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++ +|..++....   .++...+..++.|+..|+.|||+.+   |.|||||++|++++.++.+||+|||.+.....+
T Consensus       401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9999998762   2788888999999999999999999   999999999999999999999999998766433


Q ss_pred             Cc---eeeecccccCCCCCccccccCCCCC-ccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          553 QT---HMTTQVHGTFGYLDPEYFRSSQFTD-KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       553 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ..   .....+.|+..|+|||.+....|++ ..||||.|+++..|++|+.||......++..      ..........+.
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~~~  547 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRNIF  547 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccccccc
Confidence            22   5566778999999999999999886 6999999999999999999998655443321      001111111111


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..  ...+....+.+.+.++.+||++||.+|.|++++++.
T Consensus       548 ~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  548 EG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             cC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            11  112224566778899999999999999999999863

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=8.8e-21  Score=187.07  Aligned_cols=172  Identities=13%  Similarity=0.126  Sum_probs=134.1

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccCh---hHHHH------HHHHHHHHhhcCCCcccceeeeeee
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE---SKVEE------FINEMVILSQINHRNVVKLLGCCLE  464 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~HpnIv~l~~~~~~  464 (684)
                      ...++|+..++||.|+||.||+... ++..+|||.+.....   ...+.      +.+|+..+.+++||+|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3568999999999999999999655 577899998764322   22223      6789999999999999999988764


Q ss_pred             c--------CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 043157          465 T--------EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY  536 (684)
Q Consensus       465 ~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~  536 (684)
                      .        ...+|+|||++|.+|.++..       +++.    ...+++.+|..||+.+   ++|||+||+||+++.++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~~----~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISED----VKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccHH----HHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence            4        34789999999999988732       3332    4559999999999999   99999999999999888


Q ss_pred             cEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHH
Q 043157          537 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL  594 (684)
Q Consensus       537 ~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ell  594 (684)
                       ++|+|||.......+...             ..+.....+..++|+|+||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence             999999987654321111             11334455668999999999987664

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.83  E-value=2.7e-21  Score=216.94  Aligned_cols=249  Identities=21%  Similarity=0.286  Sum_probs=182.4

Q ss_pred             CCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccC-hhHHH---HHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID-ESKVE---EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~---~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++...+.||.+.|=+|.+++++.|. |+||..-..+ .-.+.   +.++|++ ...++|||.+++...-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6788899999999999999998887 7778654433 22333   4444555 555699999999888777778889999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc--c
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA--V  551 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~--~  551 (684)
                      |..+ +|.|.|..+.   .|...+...|+.|++.||.-+|..+   |.|||||.+||||+.-..+.|+||..-+...  .
T Consensus       102 yvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9854 8888887543   3777888899999999999999999   9999999999999999999999998765432  1


Q ss_pred             CC----ceeeecccccCCCCCcccccc----------CC-CCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHH
Q 043157          552 DQ----THMTTQVHGTFGYLDPEYFRS----------SQ-FTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYF  615 (684)
Q Consensus       552 ~~----~~~~~~~~gt~~y~aPE~~~~----------~~-~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~  615 (684)
                      +.    .....+...-.+|+|||.+..          .. ++++-||||+||++.||++ |++||..      .+|..+ 
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aY-  247 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAY-  247 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhH-
Confidence            22    222333345568999998743          12 6789999999999999998 6888752      112111 


Q ss_pred             HHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       616 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                          +.+.  +......++..   +...+++|+..|++.||++|-++++.++.-..
T Consensus       248 ----r~~~--~~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  248 ----RSGN--ADDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             ----hccC--ccCHHHHHHhC---cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence                1110  00000111111   12268899999999999999999999998543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.8e-20  Score=182.57  Aligned_cols=139  Identities=19%  Similarity=0.172  Sum_probs=109.1

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccChh--H------------------------HHHHHHHHHHHhhcCCCcc
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDES--K------------------------VEEFINEMVILSQINHRNV  455 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~HpnI  455 (684)
                      ...||+|++|+||+|...+|+.||||+++.....  .                        .....+|++++.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999987643211  0                        1122459999999988887


Q ss_pred             cceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCEEECC
Q 043157          456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL-HSAASIPIYHRDIKSTNILLDD  534 (684)
Q Consensus       456 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~iiH~Dlkp~NILl~~  534 (684)
                      .......  ....+|||||+++++|...+...   .++++..+..++.|++.+|.|| |+.+   |+||||||+|||+++
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~  153 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD  153 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence            5544332  23348999999988776553322   2488999999999999999999 6888   999999999999984


Q ss_pred             CCcEEEeccCCcccc
Q 043157          535 KYRAKVSDFGASRSM  549 (684)
Q Consensus       535 ~~~~kl~DFgl~~~~  549 (684)
                       +.++|+|||++...
T Consensus       154 -~~v~LiDFG~a~~~  167 (190)
T cd05147         154 -GKLYIIDVSQSVEH  167 (190)
T ss_pred             -CcEEEEEccccccC
Confidence             68999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=3e-19  Score=174.42  Aligned_cols=139  Identities=23%  Similarity=0.220  Sum_probs=111.2

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccChh--------------------------HHHHHHHHHHHHhhcCCCcc
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDES--------------------------KVEEFINEMVILSQINHRNV  455 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~HpnI  455 (684)
                      ...||+|++|.||+|...+|+.||||..+.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5789999999999999878999999987643210                          01234679999999999998


Q ss_pred             cceeeeeeecCcceEEEEecCCCCHHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEC
Q 043157          456 VKLLGCCLETEVPLLVYEFIPNGTLFQY-IHDQNEDFPITWEMRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLD  533 (684)
Q Consensus       456 v~l~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiH~Dlkp~NILl~  533 (684)
                      .....+...  ..+|||||++++++... +.+.    .++......++.|++.+|.+||+ .+   |+||||||+|||++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~----~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV----PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhc----cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence            655544332  35899999998865443 4322    37888899999999999999999 88   99999999999999


Q ss_pred             CCCcEEEeccCCccccc
Q 043157          534 DKYRAKVSDFGASRSMA  550 (684)
Q Consensus       534 ~~~~~kl~DFgl~~~~~  550 (684)
                       ++.++|+|||++....
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             7899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=1.9e-19  Score=193.94  Aligned_cols=220  Identities=24%  Similarity=0.462  Sum_probs=165.9

Q ss_pred             HhhcCCCcccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 043157          447 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIK  526 (684)
Q Consensus       447 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlk  526 (684)
                      |+.+.|.|+.+++|.+.+....+.|.+|++.|+|++.+....  ..+++.....+.++|+.||+|||+.. + -.|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence            467899999999999999999999999999999999999843  34899999999999999999999876 1 3999999


Q ss_pred             CCCEEECCCCcEEEeccCCccccccC-CceeeecccccCCCCCccccccC-------CCCCccchhhhHHHHHHHHhCCC
Q 043157          527 STNILLDDKYRAKVSDFGASRSMAVD-QTHMTTQVHGTFGYLDPEYFRSS-------QFTDKSDVYSFGVVLAELLTGEK  598 (684)
Q Consensus       527 p~NILl~~~~~~kl~DFgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDv~SlGvil~elltG~~  598 (684)
                      +.|.++|....+||+|||+....... .........-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998765421 11111111234569999998653       24678999999999999999999


Q ss_pred             CCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          599 PIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       599 P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      ||......+..  .+.+.. ++. .....+.+.+...  .+...++..++.+||..+|++||+++++...++.+....
T Consensus       157 ~~~~~~~~~~~--~eii~~-~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  157 PFDLRNLVEDP--DEIILR-VKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccccccCCh--HHHHHH-HHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            99865443332  111111 111 0011111111111  134447899999999999999999999999998887643

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=8.3e-19  Score=169.40  Aligned_cols=188  Identities=14%  Similarity=0.055  Sum_probs=140.0

Q ss_pred             CCcCceeceeCcEEEEEEEeCCCcEEEEEeccccCh----hHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEEEE
Q 043157          399 FNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE----SKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      +.+...|++|+||+||.+.. .+..++.+.+.....    .....+.+|+++|++|. |+++++++++    +..+++||
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            34578899999999997765 566777666654332    11235789999999995 5889999886    45699999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEECCCCcEEEeccCCccccccC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDI-KSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      |+.|.+|.+.+..         . ...++.|++++|.++|+++   |+|||| ||+|||++.++.++|+|||++......
T Consensus        79 yI~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         79 YLAGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             eecCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            9999998654321         1 1347789999999999999   999999 799999999999999999999854432


Q ss_pred             Cce----e--------eecccccCCCCCccccccC-CCC-CccchhhhHHHHHHHHhCCCCCCCCC
Q 043157          553 QTH----M--------TTQVHGTFGYLDPEYFRSS-QFT-DKSDVYSFGVVLAELLTGEKPIRFTT  604 (684)
Q Consensus       553 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~ksDv~SlGvil~elltG~~P~~~~~  604 (684)
                      ...    .        ......++.|++|+...-- ..+ ...+.++-|..+|.++|+..+.-.+.
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            210    0        0112367788888864321 223 56899999999999999998865443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=3.4e-19  Score=181.05  Aligned_cols=233  Identities=21%  Similarity=0.288  Sum_probs=151.3

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcC----------CCcccceeeeee
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQIN----------HRNVVKLLGCCL  463 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~----------HpnIv~l~~~~~  463 (684)
                      .+...+.||.|+++.||.+++. +++.+|+|.....   .....+++++|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3456789999999999999976 5899999975432   2335677777776555543          223333333322


Q ss_pred             ec------------C-----cceEEEEecCCCCHHHHHhh---cCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 043157          464 ET------------E-----VPLLVYEFIPNGTLFQYIHD---QNE-DFPITWEMRLRIAIEVSGALSYLHSAASIPIYH  522 (684)
Q Consensus       464 ~~------------~-----~~~lv~E~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH  522 (684)
                      -.            .     ..+++|+-+ -++|.+++..   ... ...+....++.+..|+++.+++||+.+   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence            11            1     225778877 5688888653   211 122445566777799999999999999   999


Q ss_pred             cCCCCCCEEECCCCcEEEeccCCccccccCCceeeecccccCCCCCcccccc--------CCCCCccchhhhHHHHHHHH
Q 043157          523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS--------SQFTDKSDVYSFGVVLAELL  594 (684)
Q Consensus       523 ~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDv~SlGvil~ell  594 (684)
                      +||||+|+|++.+|.++|+||+........    ......+..|.+||....        -.++.+.|.|+||+++|.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999876543321    111335678999997633        24788999999999999999


Q ss_pred             hCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCC
Q 043157          595 TGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKR  659 (684)
Q Consensus       595 tG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R  659 (684)
                      ++..||.....+.....                    ....- .+.++.++.||..+|+.||++|
T Consensus       245 C~~lPf~~~~~~~~~~~--------------------~f~~C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW--------------------DFSRC-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG--------------------GGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc--------------------cchhc-CCcCHHHHHHHHHHccCCcccC
Confidence            99999985543322111                    11222 3788899999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.9e-20  Score=201.33  Aligned_cols=225  Identities=27%  Similarity=0.306  Sum_probs=180.3

Q ss_pred             eeceeCcEEEEEEE----eCCCcEEEEEeccccCh--hHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEEEEecC
Q 043157          404 ILGQGGQGTVYKGM----LPDGKIVAVKKSKVIDE--SKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       404 ~LG~G~~g~Vy~~~----~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      .+|+|.||.|+++.    .+.|..+|+|..+....  ........|..++...+ ||.++++...+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999999754    34577788886543211  11126667888999996 9999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +|.|...+.+...   +++.....+..+++-+++++|+.+   |+|||+|++||+++.+|++|+.|||+++..-..+.. 
T Consensus        81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            9999888876543   667777778889999999999999   999999999999999999999999999876533332 


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccC
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES  636 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  636 (684)
                          .||..|||||++.  .....+|.||||++++||+||..||..   +.                ...++-..  ...
T Consensus       154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~----------------~~~Il~~~--~~~  206 (612)
T KOG0603|consen  154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DT----------------MKRILKAE--LEM  206 (612)
T ss_pred             ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HH----------------HHHHhhhc--cCC
Confidence                7899999999998  667899999999999999999999974   10                11111111  223


Q ss_pred             ChhHHHHHHHHHHHhhccCCCCCCCH
Q 043157          637 GGDEIITFAKVAKRCLNLNGKKRPTM  662 (684)
Q Consensus       637 ~~~~~~~l~~Li~~cl~~dp~~RPt~  662 (684)
                      +.+.+....+++.+++..+|..|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            56777888999999999999999655

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=3e-18  Score=168.62  Aligned_cols=136  Identities=17%  Similarity=0.210  Sum_probs=107.2

Q ss_pred             CcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhc-----CCCcccceeeeeeecC---cce-E
Q 043157          400 NLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-----NHRNVVKLLGCCLETE---VPL-L  470 (684)
Q Consensus       400 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~~~~---~~~-l  470 (684)
                      .-.+.||+|+||.||.  +++....+||++........+++.+|+.+++++     .||||+++++++.++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4468899999999996  443333479987765455667899999999999     5799999999998874   223 7


Q ss_pred             EEEe--cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCEEECC----CCcEEEecc
Q 043157          471 VYEF--IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL-SYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDF  543 (684)
Q Consensus       471 v~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~DF  543 (684)
                      |+||  ..+++|.+++.+..    +++.  ..++.|++.++ +|||+++   |+||||||+|||++.    +.+++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  55799999997632    5555  35577888777 9999999   999999999999973    348999995


Q ss_pred             CCc
Q 043157          544 GAS  546 (684)
Q Consensus       544 gl~  546 (684)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=3.5e-17  Score=162.57  Aligned_cols=134  Identities=22%  Similarity=0.314  Sum_probs=113.6

Q ss_pred             ceeceeCcEEEEEEEeCCCcEEEEEeccccC---h-----hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          403 RILGQGGQGTVYKGMLPDGKIVAVKKSKVID---E-----SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +.||+|++|.||+|.. .|..+++|+.....   .     .....+.+|+.++..++|++++....++.+.+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6799999999999987 66778888654321   1     1234678899999999999998888888788889999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      +++++|.+++....      + .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986532      2 77889999999999999999   99999999999999 78999999998754

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=7.1e-18  Score=193.78  Aligned_cols=202  Identities=23%  Similarity=0.336  Sum_probs=161.8

Q ss_pred             HHHHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcC---CCcccceeeeeeec
Q 043157          389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN---HRNVVKLLGCCLET  465 (684)
Q Consensus       389 ~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~  465 (684)
                      ..+.+.-...|.+.+.||+|+||+||+|...+|+.||+|.-+....-   +|.--.+++.+|+   -+.|..+..+..-.
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            34455556789999999999999999999888999999987653321   1111122333333   35566666666677


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-------CCCcE
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-------DKYRA  538 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~-------~~~~~  538 (684)
                      +.-+||+||.+.|||.+++...+   .++|.....++.|++..++.||..+   |||+||||+|+||.       +...+
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             CcceeeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence            78899999999999999998433   3899999999999999999999999   99999999999994       34469


Q ss_pred             EEeccCCccccc-cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCC
Q 043157          539 KVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP  599 (684)
Q Consensus       539 kl~DFgl~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P  599 (684)
                      +|+|||-+-.+. ..........++|-.+-.+|...+..++...|.|.|..+++-||.|+.-
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            999999886654 2233455667789999999999999999999999999999999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=1.3e-18  Score=183.79  Aligned_cols=244  Identities=20%  Similarity=0.309  Sum_probs=160.3

Q ss_pred             CCcCceeceeCcEEEEEEEeCCC----cEEEEEeccccChhHHHHHHHHHHHHhhc-CCCccccee------eeee----
Q 043157          399 FNLNRILGQGGQGTVYKGMLPDG----KIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLL------GCCL----  463 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~------~~~~----  463 (684)
                      ..+.+..+..+++.+.......+    +.++-+..+..+........+++-.+... +|++.+..-      ....    
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v  325 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV  325 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence            34455666666666665543222    22333333333323333344444444444 344433221      1111    


Q ss_pred             -ecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEec
Q 043157          464 -ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD  542 (684)
Q Consensus       464 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D  542 (684)
                       ....+++.|+++...+|.++|.+.......++...+.++.|++.+++|   ++   .+|+|+||.||+...+..+||.|
T Consensus       326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD  399 (516)
T KOG1033|consen  326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD  399 (516)
T ss_pred             ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence             123478999999999999999876555567888899999999999999   77   89999999999999999999999


Q ss_pred             cCCccccccCC-----ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH
Q 043157          543 FGASRSMAVDQ-----THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF  617 (684)
Q Consensus       543 Fgl~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~  617 (684)
                      ||+........     ....+...||..||+||.+.+.+|+.|+||||||++|+||++   +|.... +.     ..+..
T Consensus       400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~-er-----~~t~~  470 (516)
T KOG1033|consen  400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQF-ER-----IATLT  470 (516)
T ss_pred             hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHH-HH-----HHhhh
Confidence            99987765444     334556679999999999999999999999999999999998   222100 00     00001


Q ss_pred             HhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 043157          618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVT  666 (684)
Q Consensus       618 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl  666 (684)
                      .++.+.+    ++....+.    + .=..|+.++|.+.|.+||++.++.
T Consensus       471 d~r~g~i----p~~~~~d~----p-~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  471 DIRDGII----PPEFLQDY----P-EEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             hhhcCCC----ChHHhhcC----c-HHHHHHHHhcCCCcccCchHHHHh
Confidence            1111211    11111121    1 234799999999999999555443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=2.9e-17  Score=166.76  Aligned_cols=197  Identities=20%  Similarity=0.249  Sum_probs=141.4

Q ss_pred             CCCcccceeeeeeec---------------------------CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHH
Q 043157          451 NHRNVVKLLGCCLET---------------------------EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI  503 (684)
Q Consensus       451 ~HpnIv~l~~~~~~~---------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  503 (684)
                      +|||||+++++|.++                           ...|+||...+ -+|.+++....    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence            699999998887642                           23478888774 48999998653    55667777899


Q ss_pred             HHHHHHHHHHhCCCCCeEecCCCCCCEEEC--CC--CcEEEeccCCcccccc-----CCceeeecccccCCCCCcccccc
Q 043157          504 EVSGALSYLHSAASIPIYHRDIKSTNILLD--DK--YRAKVSDFGASRSMAV-----DQTHMTTQVHGTFGYLDPEYFRS  574 (684)
Q Consensus       504 qia~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~--~~~kl~DFgl~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~  574 (684)
                      |+++|+.|||.++   |.|||+|++||||.  ++  ....|+|||.+-....     +...-.-..-|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999999   99999999999993  33  3578999998753221     01111112347788999999754


Q ss_pred             CC------CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHH
Q 043157          575 SQ------FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVA  648 (684)
Q Consensus       575 ~~------~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li  648 (684)
                      -+      .-.|+|.|+.|.+.||+++...||......    +..       ...    ..+......+...+..+++|+
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem----~L~-------~r~----Yqe~qLPalp~~vpp~~rqlV  490 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM----LLD-------TRT----YQESQLPALPSRVPPVARQLV  490 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh----eec-------hhh----hhhhhCCCCcccCChHHHHHH
Confidence            32      235999999999999999999999852211    000       000    111112234556778899999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHH
Q 043157          649 KRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       649 ~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      ...|+.||.+|++..-....|+
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            9999999999999877666653

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=8.1e-17  Score=162.23  Aligned_cols=142  Identities=19%  Similarity=0.152  Sum_probs=110.8

Q ss_pred             CCCcCceeceeCcEEEEEEE--eCCCcEEEEEeccccChh------------------------HHHHHHHHHHHHhhcC
Q 043157          398 NFNLNRILGQGGQGTVYKGM--LPDGKIVAVKKSKVIDES------------------------KVEEFINEMVILSQIN  451 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  451 (684)
                      -|++.+.||+|++|.||+|.  ..+|+.||+|+.......                        ....+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47889999999999999998  568999999987643210                        1123568999999997


Q ss_pred             CCc--ccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 043157          452 HRN--VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN  529 (684)
Q Consensus       452 Hpn--Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~N  529 (684)
                      +.+  +.+++..    ...++||||+++.+|...+....   .+.......++.|++.+|++||+.+.  ++||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhh
Confidence            533  3444432    24589999999988876543222   35666778899999999999999884  9999999999


Q ss_pred             EEECCCCcEEEeccCCcccc
Q 043157          530 ILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       530 ILl~~~~~~kl~DFgl~~~~  549 (684)
                      |+++ ++.++|+|||.+...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEEE-CCCEEEEEChhhhcc
Confidence            9999 789999999988643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.70  E-value=1.8e-17  Score=186.63  Aligned_cols=208  Identities=26%  Similarity=0.366  Sum_probs=147.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC-CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ...|+..+.|..|++|.||...++. .+.+|+|.-+.   ..         +++     ||+.+      .+.++.|   
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq---~l---------ilR-----nilt~------a~npfvv---  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---NL---------ILR-----NILTF------AGNPFVV---  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccccc---ch---------hhh-----ccccc------cCCccee---
Confidence            3579999999999999999998764 56778743221   00         111     11111      2233333   


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                         |+-...++..+   +++.+        .+.+++|||+.+   |+|||+||+|.+|+.-|++|++|||+++.......
T Consensus       136 ---gDc~tllk~~g---~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG---PLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcccCC---CCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               34344444322   23332        278999999999   99999999999999999999999999876432211


Q ss_pred             --------------eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh
Q 043157          555 --------------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK  620 (684)
Q Consensus       555 --------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~  620 (684)
                                    .....+.||+.|.|||++....|+..+|+|++|+|+||++.|..||.+++.++-...      .+.
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~------vis  272 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ------VIS  272 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh------hhh
Confidence                          123456799999999999999999999999999999999999999998877653211      111


Q ss_pred             hhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCC
Q 043157          621 EERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRP  660 (684)
Q Consensus       621 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP  660 (684)
                              |...+.+.....+.+.++++.+.|+.+|..|-
T Consensus       273 --------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  273 --------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             --------hhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                    11112222345667899999999999999993

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.69  E-value=2.3e-16  Score=155.12  Aligned_cols=137  Identities=23%  Similarity=0.234  Sum_probs=108.8

Q ss_pred             CCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccCh----------------------hHHHHHHHHHHHHhhcCCCc-
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE----------------------SKVEEFINEMVILSQINHRN-  454 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~Hpn-  454 (684)
                      .|.+.+.||+|+||.||++..++|+.||||+......                      .....+..|+.++..+.|++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            4777899999999999999988899999997543210                      01123677899999998874 


Q ss_pred             -ccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC
Q 043157          455 -VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD  533 (684)
Q Consensus       455 -Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~  533 (684)
                       ++..++    ....++||||+++++|.+....         .....++.+++.++.++|+.+   |+||||||+||+++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~  159 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVD  159 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEc
Confidence             444443    3456899999999998765431         234578899999999999998   99999999999999


Q ss_pred             CCCcEEEeccCCccccc
Q 043157          534 DKYRAKVSDFGASRSMA  550 (684)
Q Consensus       534 ~~~~~kl~DFgl~~~~~  550 (684)
                      +++.++|+|||++....
T Consensus       160 ~~~~~~liDfg~~~~~~  176 (198)
T cd05144         160 DDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCCcEEEEECCccccCC
Confidence            99999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=1.7e-16  Score=179.54  Aligned_cols=138  Identities=20%  Similarity=0.280  Sum_probs=112.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEec-ccc------ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKS-KVI------DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~-~~~------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      ...|...++||+|+||+||++.+.+...++.++. +..      .....+.+.+|+++++.++|++++....+..+....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            3455778999999999999998755443322222 111      112346788999999999999999888888777788


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||+++++|.+++.           ....++.+++++|.|||+.+   ++||||||+|||+ +++.++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999999886           24578999999999999999   9999999999999 677999999999865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.68  E-value=2.7e-16  Score=154.73  Aligned_cols=130  Identities=22%  Similarity=0.335  Sum_probs=107.4

Q ss_pred             eeceeCcEEEEEEEeCCCcEEEEEeccccC--------hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          404 ILGQGGQGTVYKGMLPDGKIVAVKKSKVID--------ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       404 ~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .||+|++|+||+|.+ +++.+++|......        ....+++.+|+++++.++|+++.....+....+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 56788888744311        112466789999999999988776666666777789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++++|.+.+....    .      .++.+++++|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999876432    1      78899999999999999   99999999999999 78999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=7.1e-15  Score=143.01  Aligned_cols=136  Identities=23%  Similarity=0.278  Sum_probs=98.5

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccCh--hHHHHH----------------------HHHHHHHhhcCCCc--c
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE--SKVEEF----------------------INEMVILSQINHRN--V  455 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~----------------------~~E~~~l~~l~Hpn--I  455 (684)
                      .+.||+|+||+||++...+++.||||.......  .....+                      ..|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            578999999999999988899999997654221  111111                      35666666665443  4


Q ss_pred             cceeeeeeecCcceEEEEecCCCCHHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEC
Q 043157          456 VKLLGCCLETEVPLLVYEFIPNGTLFQ-YIHDQNEDFPITWEMRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLD  533 (684)
Q Consensus       456 v~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiH~Dlkp~NILl~  533 (684)
                      .+++++    ...++||||++++++.. .+....    .. .....++.+++.++.++|+ .+   |+|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence            444443    34689999999854322 121111    11 5667899999999999999 88   99999999999999


Q ss_pred             CCCcEEEeccCCccccc
Q 043157          534 DKYRAKVSDFGASRSMA  550 (684)
Q Consensus       534 ~~~~~kl~DFgl~~~~~  550 (684)
                       ++.++|+|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.59  E-value=1.2e-14  Score=135.22  Aligned_cols=135  Identities=23%  Similarity=0.217  Sum_probs=113.8

Q ss_pred             cCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCC--CcccceeeeeeecCcceEEEEecCCC
Q 043157          401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       401 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      +.+.||+|.++.||++...+ +.+++|.......  ...+.+|+.+++.++|  .++++++......+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999755 7789998765433  5678899999999976  58999998888878899999999887


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       479 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      .+..+          +......++.+++++|++||......++|+|++|+|||+++.+.++++|||.++.
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            76543          4556677899999999999987544599999999999999989999999998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=2.4e-14  Score=144.59  Aligned_cols=135  Identities=20%  Similarity=0.309  Sum_probs=105.8

Q ss_pred             Cceec-eeCcEEEEEEEeCCCcEEEEEecccc-------------ChhHHHHHHHHHHHHhhcCCCcc--cceeeeeeec
Q 043157          402 NRILG-QGGQGTVYKGMLPDGKIVAVKKSKVI-------------DESKVEEFINEMVILSQINHRNV--VKLLGCCLET  465 (684)
Q Consensus       402 ~~~LG-~G~~g~Vy~~~~~~g~~vavK~~~~~-------------~~~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~~  465 (684)
                      ...|| .||.|+||++... +..++||+....             .......+.+|++++.+|+|++|  ++.+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            46788 8999999999875 667888866421             11334668899999999998885  6777765443


Q ss_pred             Cc----ceEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEE
Q 043157          466 EV----PLLVYEFIPN-GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV  540 (684)
Q Consensus       466 ~~----~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl  540 (684)
                      ..    .++|||++++ .+|.+++...    ++++..    +.+|+++|.+||+.+   |+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~~----~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA----PLSEEQ----WQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHHH----HHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            32    3599999997 6999988653    255443    568999999999999   999999999999998889999


Q ss_pred             eccCCccc
Q 043157          541 SDFGASRS  548 (684)
Q Consensus       541 ~DFgl~~~  548 (684)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=5.3e-16  Score=175.20  Aligned_cols=254  Identities=23%  Similarity=0.317  Sum_probs=193.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC--CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP--DGKIVAVKKSKVID--ESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l  470 (684)
                      ...|.+.+.||+|+|+.|-.....  ....+|+|......  ....+....|..+-..+. |+|++++++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            345788888999999999887753  34466777655433  334455566888888886 9999999999999999999


Q ss_pred             EEEecCCCCHHHHH-hhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCEEECCCC-cEEEeccCCcc
Q 043157          471 VYEFIPNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALSYLH-SAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASR  547 (684)
Q Consensus       471 v~E~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgl~~  547 (684)
                      ++|+..++++.+.+ +....  ..+......++.|+..++.|+| ..+   +.|+||||+|.+++..+ ..|++|||++.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence            99999999999988 43321  2555666788999999999999 777   99999999999999999 99999999998


Q ss_pred             cccc--CCceeeecccc-cCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhh
Q 043157          548 SMAV--DQTHMTTQVHG-TFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER  623 (684)
Q Consensus       548 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~  623 (684)
                      ....  ..........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+.........              
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------------  239 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------------  239 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------
Confidence            7765  23333444568 9999999998874 4567899999999999999999998755433311              


Q ss_pred             hhhhhhhhh--hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          624 LFEILDARV--MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       624 ~~~~~d~~~--~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .....+...  .............+++.+++..+|+.|.+.+++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  240 YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             ceeecccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence            011111110  112223445567788999999999999999887654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=1.1e-12  Score=143.82  Aligned_cols=141  Identities=21%  Similarity=0.213  Sum_probs=101.7

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccChhHH----------------------------------------HHHH
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKV----------------------------------------EEFI  441 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~~~  441 (684)
                      .+.||.|++|.||+|++++|+.||||+.+....+..                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            468999999999999999999999998654221110                                        1244


Q ss_pred             HHHHHHhhcC----CCcccceeeee-eecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 043157          442 NEMVILSQIN----HRNVVKLLGCC-LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG-ALSYLHSA  515 (684)
Q Consensus       442 ~E~~~l~~l~----HpnIv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~yLH~~  515 (684)
                      +|...+.+++    |.+-+.+-..+ ......+|||||++|++|.++.......  ++   +..++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhC
Confidence            5666666652    33333333333 2345679999999999998887643211  22   3456666666 47889998


Q ss_pred             CCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       516 ~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      +   ++|+|+||.||+++++++++|+|||++....
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8   9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=2.2e-13  Score=135.88  Aligned_cols=206  Identities=20%  Similarity=0.269  Sum_probs=142.5

Q ss_pred             HHHHhhcCCCcccceeeeeeecC-----cceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 043157          444 MVILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAAS  517 (684)
Q Consensus       444 ~~~l~~l~HpnIv~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~  517 (684)
                      +.-|-++-|.|||+++.++.+..     ...++.|||+.|+|.++|++.+ ....+......+|.-||+.||.|||+-. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            34455667999999999987543     4578999999999999999743 3345788888999999999999999987 


Q ss_pred             CCeEecCCCCCCEEECCCCcEEEeccCCccccc---cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHH
Q 043157          518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA---VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL  594 (684)
Q Consensus       518 ~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ell  594 (684)
                      +||+|+++.-+-|++..++-+|+.----.....   ...........+-++|.+||+=.....+..+|||+||...+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            569999999999999999888876311110000   00011111223678999999988788888999999999999998


Q ss_pred             hCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          595 TGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       595 tG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .+..--.....   ..        ..+..+    ..-+..    -+...-+.++.+|++..|..||+|++++.+.
T Consensus       277 ilEiq~tnseS---~~--------~~ee~i----a~~i~~----len~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  277 ILEIQSTNSES---KV--------EVEENI----ANVIIG----LENGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HheeccCCCcc---ee--------ehhhhh----hhheee----ccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence            87654211110   00        000000    000000    0001124678899999999999999998764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=3.8e-13  Score=145.49  Aligned_cols=248  Identities=22%  Similarity=0.263  Sum_probs=184.7

Q ss_pred             cCCCcCceece--eCcEEEEEEEe---CCCcEEEEEeccc--cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcc
Q 043157          397 DNFNLNRILGQ--GGQGTVYKGML---PDGKIVAVKKSKV--IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       397 ~~~~~~~~LG~--G~~g~Vy~~~~---~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  468 (684)
                      ..|...+.+|.  |.+|.||.+..   .++..+|+|+.+.  ........=.+|+.....+ .|+|.++.+..+.+.+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34677888999  99999999886   3678899997544  2223334445666666666 499999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCEEECCC-CcEEEecc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG----ALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDF  543 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DF  543 (684)
                      ++-.|++ +.+|.++.+.....  ++....+....+..+    ||.++|+..   ++|-|+||.||++..+ ...+++||
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~--~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNF--LPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeeccc-cchhHHhhhccccc--CCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            9999988 47898988875432  677788888888888    999999999   9999999999999998 88999999


Q ss_pred             CCccccccCCc----eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh
Q 043157          544 GASRSMAVDQT----HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM  619 (684)
Q Consensus       544 gl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~  619 (684)
                      |+...+....-    .......|...|++||..+ ..++.++|+|++|.+..+..++..+....-..             
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------------  333 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS-------------  333 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-------------
Confidence            99987754332    1223335788999999874 55788999999999999999988775422100             


Q ss_pred             hhhhhhhhhhh-hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          620 KEERLFEILDA-RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       620 ~~~~~~~~~d~-~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                         .+.+ ++. .+..++...-+.++...+.+|++.+|-.|++.+++..+
T Consensus       334 ---~W~~-~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  334 ---SWSQ-LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ---Cccc-cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence               0000 111 01122222334456669999999999999998877653

>PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins

Probab=99.31  E-value=3.3e-12  Score=109.81  Aligned_cols=86  Identities=27%  Similarity=0.530  Sum_probs=61.8

Q ss_pred             CCCCCccc---ccCCCCCCceeecc-ccccccCCCCCCccEEEEecCccccccccCCCcCccCCCCccEEEEeeeecccc
Q 043157          152 SDCCDMVC---NIPHNSSTKVLDAN-TSYVYSQSIPQGCTSLSLVDPDWIFSNYLKTPSGLKDKKKIPAVLEWGKYKGVC  227 (684)
Q Consensus       152 ~~C~g~gC---~ip~~~~~~~~~~~-~~~~~~~~~~~~c~~a~~~e~~~~~~~~~~~~~~~~~~~~~P~vLdW~i~~~~C  227 (684)
                      ..|+|++|   +||.+. +++++++ ...........+|++|||+|+.| |.+...++..+...+++||||||+|.....
T Consensus         2 ~~CsG~~CCQt~iP~~~-~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~-~~~n~t~p~~~~~~~y~pv~L~W~i~t~~~   79 (103)
T PF08488_consen    2 SSCSGIGCCQTSIPSGL-LQVFNVTIESTDGNNQTSNGCKVAFLVDEDW-FSSNITDPEDFHAMGYVPVVLDWFIDTSDS   79 (103)
T ss_pred             CccCCcceeccCCCCCC-ceEEEEEeEecCCCcccCCCceEEEEecccc-ccccCCChHHhccCCeeEEEEEEEEecCCc
Confidence            47999999   788752 4566765 22222223347999999999999 777788888888899999999999965433


Q ss_pred             ccccCCCccccccCC
Q 043157          228 YEDYNSHTKVCNKDD  242 (684)
Q Consensus       228 ~~~~~~~~~aC~~~~  242 (684)
                      .   ...+++|....
T Consensus        80 ~---~~~s~~C~~~~   91 (103)
T PF08488_consen   80 S---FSNSLACKNNT   91 (103)
T ss_pred             C---cCcCccCCCce
Confidence            2   22347887665

WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.27  E-value=1.7e-11  Score=117.04  Aligned_cols=130  Identities=22%  Similarity=0.157  Sum_probs=96.4

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCccc-ceeeeeeecCcceEEEEecCCCCH
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV-KLLGCCLETEVPLLVYEFIPNGTL  480 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv~E~~~~gsL  480 (684)
                      .+.|+.|.++.||++... ++.+++|....... ....+.+|+.+++.+.+.+++ +++...  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            367889999999999875 67899998654322 223567899999998665554 454443  3456899999999887


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          481 FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA--SIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       481 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .+.   .     .   ....++.+++++|+.||+..  ...++|+|++|.||+++ ++.++++||+.+.
T Consensus        79 ~~~---~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTE---D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc---c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            543   0     1   11245679999999999987  22259999999999999 5689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.25  E-value=1.4e-10  Score=126.83  Aligned_cols=166  Identities=19%  Similarity=0.197  Sum_probs=128.1

Q ss_pred             eCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHH
Q 043157          418 LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM  497 (684)
Q Consensus       418 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~  497 (684)
                      ..++.+|.|...+..+.+..+...+-++.|+.+|||||+++++...++...|||.|-+.  -|..++++.      ....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHH
Confidence            44678888887777666666778889999999999999999999999999999999874  577777754      3456


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCC
Q 043157          498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF  577 (684)
Q Consensus       498 ~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  577 (684)
                      ....+.||+.||.|||+.+.  ++|++|.-..|+++..|..||++|.++........ ......---.|..|+.+.... 
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence            66778999999999997664  99999999999999999999999998765432211 111111122356666543222 


Q ss_pred             CCccchhhhHHHHHHHHhC
Q 043157          578 TDKSDVYSFGVVLAELLTG  596 (684)
Q Consensus       578 ~~ksDv~SlGvil~elltG  596 (684)
                       -..|.|-||++++|++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             346999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.25  E-value=3.8e-11  Score=133.32  Aligned_cols=144  Identities=18%  Similarity=0.185  Sum_probs=95.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC-CcEEEEEeccccChh----------------------------------HHH--
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDES----------------------------------KVE--  438 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~----------------------------------~~~--  438 (684)
                      ...|+. +.||+|++|.||+|++++ |+.||||+.+..-.+                                  -.+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 799999999999999887 999999987642111                                  011  


Q ss_pred             ----HHHHHHHHHhhcC----CCcccceeeeeee-cCcceEEEEecCCCCHHHHH--hhcCCC-CCCCHHHHHHHHHHHH
Q 043157          439 ----EFINEMVILSQIN----HRNVVKLLGCCLE-TEVPLLVYEFIPNGTLFQYI--HDQNED-FPITWEMRLRIAIEVS  506 (684)
Q Consensus       439 ----~~~~E~~~l~~l~----HpnIv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l--~~~~~~-~~l~~~~~~~i~~qia  506 (684)
                          ++.+|...+.+++    +.+.+.+-.++.+ ....+|||||++|+.|.++-  ...+.+ ..+.+.....++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                1334444444442    4444444444433 45678999999999998753  322210 112233333333333 


Q ss_pred             HHHHHHHhCCCCCeEecCCCCCCEEECCCC----cEEEeccCCccccc
Q 043157          507 GALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFGASRSMA  550 (684)
Q Consensus       507 ~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFgl~~~~~  550 (684)
                            +..+   ++|+|+||.||+++.++    ++++.|||++....
T Consensus       277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                  4566   99999999999999887    99999999987664

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.22  E-value=8.6e-12  Score=135.10  Aligned_cols=262  Identities=19%  Similarity=0.217  Sum_probs=187.7

Q ss_pred             cccCCHHH-HHHHhcCCCcCceeceeCcEEEEEEEeC--CCcEEEEEeccccChhHH--HHHHHHHHHHhhc-CCCcccc
Q 043157          384 TKLFTSKE-LERATDNFNLNRILGQGGQGTVYKGMLP--DGKIVAVKKSKVIDESKV--EEFINEMVILSQI-NHRNVVK  457 (684)
Q Consensus       384 ~~~~~~~e-~~~~~~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~HpnIv~  457 (684)
                      .+++..++ .......|.++..||.|.|+.|++...+  ++..+++|.+...-....  ..-..|+.+...+ .|.++++
T Consensus       251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence            33444444 4445678999999999999999987743  577899997654322222  2234577777666 5999999


Q ss_pred             eeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-C
Q 043157          458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-Y  536 (684)
Q Consensus       458 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~  536 (684)
                      .+..+.+....++-.||++++++...+.-   ...+++..++++..|++.++.++|+..   ++|+|+||+||++..+ +
T Consensus       331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~  404 (524)
T KOG0601|consen  331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGF  404 (524)
T ss_pred             CCCCccccccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchh
Confidence            99999888888899999999988776632   223778888999999999999999988   9999999999999875 8


Q ss_pred             cEEEeccCCccccccCCceeeecccccCCCC--CccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHH
Q 043157          537 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYL--DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY  614 (684)
Q Consensus       537 ~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~  614 (684)
                      .-++.|||....+....    .......++.  +++......+..+.|+||||..+.+.+++..--.     ...     
T Consensus       405 ~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-----~~~-----  470 (524)
T KOG0601|consen  405 FSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-----SGV-----  470 (524)
T ss_pred             hhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCc-----ccc-----
Confidence            88999999886422111    1112233344  5666667788999999999999999998775421     100     


Q ss_pred             HHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          615 FLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       615 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                              .+..+.. ...... ......+..+++.++..++..||.+.++..+.+.++..
T Consensus       471 --------~~~~i~~-~~~p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~  521 (524)
T KOG0601|consen  471 --------QSLTIRS-GDTPNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS  521 (524)
T ss_pred             --------cceeeec-ccccCC-CchHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence                    0111111 111111 22336788899999999999999999998877766543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.18  E-value=4.3e-10  Score=108.91  Aligned_cols=136  Identities=18%  Similarity=0.162  Sum_probs=98.5

Q ss_pred             CceeceeCcEEEEEEEeCC-------CcEEEEEecccc-------------C---------hhHHHHHH----HHHHHHh
Q 043157          402 NRILGQGGQGTVYKGMLPD-------GKIVAVKKSKVI-------------D---------ESKVEEFI----NEMVILS  448 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~-------g~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~  448 (684)
                      ...||.|-.+.||.|...+       +..+|||..+..             +         ......+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998543       478999953320             0         11122333    8999999


Q ss_pred             hcCC--CcccceeeeeeecCcceEEEEecCCCCHHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecC
Q 043157          449 QINH--RNVVKLLGCCLETEVPLLVYEFIPNGTLFQ-YIHDQNEDFPITWEMRLRIAIEVSGALSYL-HSAASIPIYHRD  524 (684)
Q Consensus       449 ~l~H--pnIv~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~iiH~D  524 (684)
                      ++..  -++++++++    ...+|||||+.+..+.. .+++.    .++.+....+..+++.+|..| |+.+   |+|+|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            9953  456666654    56789999997654322 23221    255566677889999999999 7888   99999


Q ss_pred             CCCCCEEECCCCcEEEeccCCcccc
Q 043157          525 IKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       525 lkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      |++.|||+++ +.+.|+|||.+-..
T Consensus       151 Ls~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEEC-CcEEEEECCCceeC
Confidence            9999999974 57999999987544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.16  E-value=6.9e-12  Score=142.21  Aligned_cols=247  Identities=22%  Similarity=0.277  Sum_probs=177.9

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ..+.+.+.+-+-+|.++.++...-. .|...++|....   ....+.+....+-.++-..+||-+++..--+......+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4567788888999999999987633 343344443222   122223333444444444566777776666667788899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      +++|..+++|...|+...   ..+.+........+.++++|||+..   +.|+|++|.|+|+..++..+++||+......
T Consensus       882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence            999999999999999765   3566666677788999999999987   8999999999999999999999998433211


Q ss_pred             c------C------------------------CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCC
Q 043157          551 V------D------------------------QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI  600 (684)
Q Consensus       551 ~------~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~  600 (684)
                      .      .                        .........+|+.|++||.+.+......+|+|++|++++|.++|.+||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            0      0                        000122345899999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh--hccCChhHHHHHHHHHHHhhccCCCCCCCHH
Q 043157          601 RFTTLEEDKSLAAYFLFAMKEERLFEILDARV--MKESGGDEIITFAKVAKRCLNLNGKKRPTMR  663 (684)
Q Consensus       601 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~--~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~  663 (684)
                      ...+.+.                +++.+-...  +...+.+.+.+..+++...|..+|.+|-.+.
T Consensus      1036 na~tpq~----------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQ----------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcchhh----------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            8554332                222222221  2233455677888999999999999997765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.09  E-value=7.4e-10  Score=110.46  Aligned_cols=142  Identities=20%  Similarity=0.240  Sum_probs=110.1

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccCh-hHHHHHHHHHHHHhhcCC--CcccceeeeeeecC---cceEEEEec
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE-SKVEEFINEMVILSQINH--RNVVKLLGCCLETE---VPLLVYEFI  475 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~---~~~lv~E~~  475 (684)
                      .+.|+.|..+.||++...+|+.+++|....... .....+.+|+++++.+++  .++.+++.+..+..   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            367899999999999987778899998764322 235678899999999976  34577777776543   668999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA---------------------------------------  516 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------------  516 (684)
                      ++.+|.+.+..    ..++...+..++.+++++|..||+..                                       
T Consensus        83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99888776532    13677778888888888888888531                                       


Q ss_pred             --------------CCCeEecCCCCCCEEECC--CCcEEEeccCCcc
Q 043157          517 --------------SIPIYHRDIKSTNILLDD--KYRAKVSDFGASR  547 (684)
Q Consensus       517 --------------~~~iiH~Dlkp~NILl~~--~~~~kl~DFgl~~  547 (684)
                                    ...++|+|++|.|||++.  ++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                          234799999999999998  6678999998775

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.08  E-value=2.3e-09  Score=99.83  Aligned_cols=143  Identities=22%  Similarity=0.252  Sum_probs=110.1

Q ss_pred             cCceeceeCcEEEEEEEeCCCcEEEEEeccc-------c-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKV-------I-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       401 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~-------~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ....|-+|+.+.|+++.+ .|+...||.-..       . ..-..++.++|+++|.+++--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567899999999999987 566666663221       1 1123466788999999998777777777788888889999


Q ss_pred             EecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC---cEEEeccCCccc
Q 043157          473 EFIPN-GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---RAKVSDFGASRS  548 (684)
Q Consensus       473 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFgl~~~  548 (684)
                      ||+++ .++.+++....... ...+....++..|-+.+.-||..+   |+|+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 47888888754432 233333678899999999999999   99999999999996443   468999999854

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.08  E-value=1.6e-09  Score=101.45  Aligned_cols=131  Identities=22%  Similarity=0.279  Sum_probs=102.6

Q ss_pred             ceeceeCcEEEEEEEeCCCcEEEEEec-c-ccC------hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          403 RILGQGGQGTVYKGMLPDGKIVAVKKS-K-VID------ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~g~~vavK~~-~-~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ..+++|+-+.+|.+.+.+.. +.+|.- + ...      .-..+...+|..++.+++--.|.-..=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45789999999999774433 555521 1 111      11245567899999999877777777777788888999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++|..|.+++....          ..++..+-.-+.-||..+   |+|+||.++||++.++. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~~----------~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEAR----------PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhcc----------hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999998987651          346677778888999999   99999999999998874 99999999864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.04  E-value=4.5e-09  Score=111.64  Aligned_cols=169  Identities=22%  Similarity=0.331  Sum_probs=127.6

Q ss_pred             cEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeee----ecCcceEEEEecCC-CCHHHH
Q 043157          410 QGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL----ETEVPLLVYEFIPN-GTLFQY  483 (684)
Q Consensus       410 ~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----~~~~~~lv~E~~~~-gsL~~~  483 (684)
                      -.+.|++... ||..+.+|++..........-..-+++++++.|+|+|++..++.    .+..+++||+|.++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3678898854 89999999984432222223344578899999999999999887    34467899999886 467665


Q ss_pred             HhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          484 IHDQN------------EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       484 l~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      -....            ....+++..+|.++.|+..||.++|+.|   +.-+-|.|.+||++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            44321            1234788999999999999999999999   88999999999999999999999887765443


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCC
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP  599 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P  599 (684)
                      +..               |.+...   .+-|.=.||.+++.|.||..-
T Consensus       446 d~~---------------~~le~~---Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT---------------EPLESQ---QQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC---------------cchhHH---hhhhHHHHHHHHHHHhhcccc
Confidence            321               111111   267888999999999999654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.03  E-value=6.6e-09  Score=107.64  Aligned_cols=267  Identities=16%  Similarity=0.142  Sum_probs=160.1

Q ss_pred             CCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeee-------eecCcceE
Q 043157          399 FNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCC-------LETEVPLL  470 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~-------~~~~~~~l  470 (684)
                      ...++.||+|+.+-+|-.-.-.+ .|| |+...-......+.   +..|... .||-+-.-+.+-       ......-+
T Consensus        13 i~~gr~LgqGgea~ly~l~e~~d-~VA-KIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEVRD-QVA-KIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             cCCCccccCCccceeeecchhhc-hhh-eeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            34678899999999996321111 222 32221111111111   2223232 455443311111       11223557


Q ss_pred             EEEecCCCCH-HHHHhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          471 VYEFIPNGTL-FQYIHD---QNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       471 v~E~~~~gsL-~~~l~~---~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      +|..+++.-- ..++.-   ...-...+|+..++++..++.+.+-||.++   ..-+|+.++|+|+++++.+.|.|-..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence            7887776532 222221   111123789999999999999999999999   889999999999999999999986544


Q ss_pred             cccccCCceeeecccccCCCCCccccc-----cCCCCCccchhhhHHHHHHHHhC-CCCCCCCChhh--hhhHH---HHH
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLAELLTG-EKPIRFTTLEE--DKSLA---AYF  615 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltG-~~P~~~~~~~~--~~~l~---~~~  615 (684)
                      ...  .......-..|...|++||.-.     +..-+..+|-|.|||++++|+.| ++||.+.....  ...+.   ...
T Consensus       165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            333  2223334446889999999753     44567889999999999999986 99998643321  11111   000


Q ss_pred             HHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHHhhHhhc
Q 043157          616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN--GKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       616 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~d--p~~RPt~~evl~~L~~i~~~~  676 (684)
                      .+.....+-... .+........-.+..+..|..+|+...  +.-|||++.++..|..++++-
T Consensus       243 ~f~ya~~~~~g~-~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         243 RFAYASDQRRGL-KPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             eeeechhccCCC-CCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            010000000000 000011111234567888999999553  568999999999999888653

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.85  E-value=5.9e-08  Score=99.30  Aligned_cols=141  Identities=16%  Similarity=0.109  Sum_probs=101.2

Q ss_pred             ceeceeCcEEEEEEEeCCCcEEEEEeccccChh-HH----------HHHHHHHHHHhhcCCCccc--ceeeeeeec----
Q 043157          403 RILGQGGQGTVYKGMLPDGKIVAVKKSKVIDES-KV----------EEFINEMVILSQINHRNVV--KLLGCCLET----  465 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~HpnIv--~l~~~~~~~----  465 (684)
                      +.+-.-....|.+..+ +|+.+.||+....... ..          ..+.+|...+.++..-+|.  +++.+....    
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444444667665 6778999976433211 11          1477899999998654444  445555432    


Q ss_pred             -CcceEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-------CC
Q 043157          466 -EVPLLVYEFIPNG-TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-------KY  536 (684)
Q Consensus       466 -~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-------~~  536 (684)
                       ...+||+|++++. +|.+++.+... .+.+......++.+++..+.-||..+   |+|+|++++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence             2468999999886 89999864321 23566777889999999999999999   999999999999975       57


Q ss_pred             cEEEeccCCccc
Q 043157          537 RAKVSDFGASRS  548 (684)
Q Consensus       537 ~~kl~DFgl~~~  548 (684)
                      .+.|+||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.84  E-value=2.4e-08  Score=96.37  Aligned_cols=125  Identities=27%  Similarity=0.291  Sum_probs=82.5

Q ss_pred             EEEEEEeCCCcEEEEEecccc--------------------------ChhHHHHHHHHHHHHhhcCCC--cccceeeeee
Q 043157          412 TVYKGMLPDGKIVAVKKSKVI--------------------------DESKVEEFINEMVILSQINHR--NVVKLLGCCL  463 (684)
Q Consensus       412 ~Vy~~~~~~g~~vavK~~~~~--------------------------~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~  463 (684)
                      .||.|...+|..+|||..+..                          .........+|.+.|.++..-  ++++++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            489999989999999953321                          001134567899999999766  45666644  


Q ss_pred             ecCcceEEEEecC--CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCEEECCCCcEEE
Q 043157          464 ETEVPLLVYEFIP--NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY-LHSAASIPIYHRDIKSTNILLDDKYRAKV  540 (684)
Q Consensus       464 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~iiH~Dlkp~NILl~~~~~~kl  540 (684)
                        ....|||||++  +..+..+....     ++.+....++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              35689999998  54444433322     1123445677788886665 57888   9999999999999988 9999


Q ss_pred             eccCCcccc
Q 043157          541 SDFGASRSM  549 (684)
Q Consensus       541 ~DFgl~~~~  549 (684)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999987544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.69  E-value=7.1e-09  Score=114.12  Aligned_cols=152  Identities=21%  Similarity=0.253  Sum_probs=107.0

Q ss_pred             HHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc--------eeeecccccCCCCCccccc
Q 043157          502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT--------HMTTQVHGTFGYLDPEYFR  573 (684)
Q Consensus       502 ~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~  573 (684)
                      +.+++.||.|+|....  ++|+.|.|++|.++.++.+||..|+.+-.......        ......+-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3456699999998874  99999999999999999999999998755432111        1111223466899999999


Q ss_pred             cCCCCCccchhhhHHHHHHHHhCCCC-CCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhh
Q 043157          574 SSQFTDKSDVYSFGVVLAELLTGEKP-IRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCL  652 (684)
Q Consensus       574 ~~~~~~ksDv~SlGvil~elltG~~P-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl  652 (684)
                      ....+.++|+||||+++|.+..|..+ +.........             ......+.-.......+.+.++++=+.++|
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-------------SFSRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchh-------------hhhhcccccccccccccCcHHHHHHHHHHh
Confidence            98889999999999999999955444 3322111100             001111111122233567788999999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 043157          653 NLNGKKRPTMREVTSE  668 (684)
Q Consensus       653 ~~dp~~RPt~~evl~~  668 (684)
                      ..++..||++.++...
T Consensus       250 ~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cCCcccCcchhhhhcc
Confidence            9999999988777543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.68  E-value=1.5e-07  Score=93.56  Aligned_cols=133  Identities=21%  Similarity=0.230  Sum_probs=95.9

Q ss_pred             CCcCceeceeCcEEEEEEEeCCCcEEEEEeccccC----------------------hhHHHHHHHHHHHHhhcCCC--c
Q 043157          399 FNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID----------------------ESKVEEFINEMVILSQINHR--N  454 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~Hp--n  454 (684)
                      ..++.+||-|--+.||.|..+.|..+|||.-+...                      ........+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            35678999999999999999999999999432210                      11123456899999999655  6


Q ss_pred             ccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC
Q 043157          455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD  534 (684)
Q Consensus       455 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~  534 (684)
                      +.+.+++    +...+|||++++--|...-        ++.+..-.++..|++-+.-+-..|   |+|+|+++-|||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            6776644    3567999999886553322        122333344555555555555777   999999999999999


Q ss_pred             CCcEEEeccCCc
Q 043157          535 KYRAKVSDFGAS  546 (684)
Q Consensus       535 ~~~~kl~DFgl~  546 (684)
                      +|.+.++||--+
T Consensus       238 dg~~~vIDwPQ~  249 (304)
T COG0478         238 DGDIVVIDWPQA  249 (304)
T ss_pred             CCCEEEEeCccc
Confidence            999999999544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.56  E-value=6.9e-07  Score=88.29  Aligned_cols=106  Identities=20%  Similarity=0.265  Sum_probs=85.2

Q ss_pred             HHHHHHHHHHHhhcCCCc--ccceeeeeeecC----cceEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 043157          437 VEEFINEMVILSQINHRN--VVKLLGCCLETE----VPLLVYEFIPNG-TLFQYIHDQNEDFPITWEMRLRIAIEVSGAL  509 (684)
Q Consensus       437 ~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL  509 (684)
                      .....+|...+..|...+  .++++.+.....    ..+||+|++++. +|.+++.....   ++......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            456788888888885443  456666666543    347999999884 79999987433   56667788999999999


Q ss_pred             HHHHhCCCCCeEecCCCCCCEEECCCC---cEEEeccCCccc
Q 043157          510 SYLHSAASIPIYHRDIKSTNILLDDKY---RAKVSDFGASRS  548 (684)
Q Consensus       510 ~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFgl~~~  548 (684)
                      +-||..+   |+|+|+++.|||++.+.   .+.|+||+-++.
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999   99999999999999886   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.51  E-value=2e-06  Score=83.62  Aligned_cols=138  Identities=19%  Similarity=0.143  Sum_probs=102.0

Q ss_pred             ceeCcEEEEEEEeCCCcEEEEEeccccC------hhHHHHHHHHHHHHhhcCCCc--ccceeeeeeecC----cceEEEE
Q 043157          406 GQGGQGTVYKGMLPDGKIVAVKKSKVID------ESKVEEFINEMVILSQINHRN--VVKLLGCCLETE----VPLLVYE  473 (684)
Q Consensus       406 G~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~----~~~lv~E  473 (684)
                      |+||-+-|+...+. |+.+-+|+....-      +-....|.+|+..|.+|..-+  ++++........    ..+||+|
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            56888999997764 4468888765211      334578999999999995332  455552222211    3579999


Q ss_pred             ecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc--EEEeccCCccc
Q 043157          474 FIPN-GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR--AKVSDFGASRS  548 (684)
Q Consensus       474 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFgl~~~  548 (684)
                      -+++ -+|.+++.+.... +.+...+..++.+++++++-||+.+   +.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       106 ~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            7754 5898888764322 4677888899999999999999999   999999999999986666  99999986654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.37  E-value=2.3e-06  Score=94.82  Aligned_cols=141  Identities=20%  Similarity=0.197  Sum_probs=92.9

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccChhH------------------------------HH----------HHH
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESK------------------------------VE----------EFI  441 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------------------------~~----------~~~  441 (684)
                      .+.|+.++-|.||+|++++|+.||||+.+..-++.                              .+          ++.
T Consensus       130 ~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         130 PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            37899999999999999999999999654321110                              11          133


Q ss_pred             HHHHHHhhcC----CCcccceeeeee-ecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 043157          442 NEMVILSQIN----HRNVVKLLGCCL-ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA-LSYLHSA  515 (684)
Q Consensus       442 ~E~~~l~~l~----HpnIv~l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a-L~yLH~~  515 (684)
                      +|...+.+++    ...-+++=.++. -.....|+|||++|-.+.++..-....  ++.+.+   +..++++ +.-+-..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~i---a~~~~~~f~~q~~~d  284 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKEL---AELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHHH---HHHHHHHHHHHHHhc
Confidence            4555555542    222233333333 466789999999999888884332221  453333   3223222 1222234


Q ss_pred             CCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       516 ~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      +   ++|.|.+|.||+++.++++-+.|||+.....
T Consensus       285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             C---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            5   9999999999999999999999999987654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.28  E-value=8.5e-06  Score=79.61  Aligned_cols=138  Identities=18%  Similarity=0.236  Sum_probs=91.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHH---------HHHHHHHhhcCCCccc---ceeeee
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEF---------INEMVILSQINHRNVV---KLLGCC  462 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~HpnIv---~l~~~~  462 (684)
                      ...+|...+++-......|.+-.. +|+.+.+|..+.......+.|         .+++..+.+++..++.   .++-+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            456788888888877777777665 567888997665333222222         2344444444333332   222222


Q ss_pred             ee-----cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc
Q 043157          463 LE-----TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR  537 (684)
Q Consensus       463 ~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~  537 (684)
                      ..     ....+|+|||++|-.|.++..       +++    .++..+.+++.-||+.|   ++|+|.+|.|++++++ .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence            21     234468999999987766532       332    24567888899999999   9999999999999966 4


Q ss_pred             EEEeccCCccc
Q 043157          538 AKVSDFGASRS  548 (684)
Q Consensus       538 ~kl~DFgl~~~  548 (684)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.28  E-value=1.1e-05  Score=80.88  Aligned_cols=138  Identities=17%  Similarity=0.173  Sum_probs=84.1

Q ss_pred             ceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCc--ccceeeeeeecCcceEEEEecCCCC-
Q 043157          403 RILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN--VVKLLGCCLETEVPLLVYEFIPNGT-  479 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~~gs-  479 (684)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-+  +.+.+++..+.+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   24456778765422  3345688999999986444  4677777777777789999999863 


Q ss_pred             HHHHH---------------------hhcCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeEecCC
Q 043157          480 LFQYI---------------------HDQNEDFPITWEMRL-RIAI----------EVSG-ALSYLHSA-ASIPIYHRDI  525 (684)
Q Consensus       480 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------qia~-aL~yLH~~-~~~~iiH~Dl  525 (684)
                      +...+                     |..... ........ ++..          .+.+ ...+|.+. ....++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            21111                     110000 01111100 0100          0111 12222211 1234789999


Q ss_pred             CCCCEEECCCCcEEEeccCCcc
Q 043157          526 KSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       526 kp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .|.||++++++ +.|+||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999887 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.16  E-value=2.4e-05  Score=79.49  Aligned_cols=139  Identities=18%  Similarity=0.134  Sum_probs=85.0

Q ss_pred             eceeCc-EEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEEEEecCCCCHHH
Q 043157          405 LGQGGQ-GTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ  482 (684)
Q Consensus       405 LG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~  482 (684)
                      |-.|.. ..||+...+ +..+.+|+.....   ..++.+|+++++.+. +--+.+++++....+..++|||+++|.+|.+
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444554 789998764 3678888776543   345678999988884 4446677877776677899999999987764


Q ss_pred             HH-------------------hhcCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----CC
Q 043157          483 YI-------------------HDQNE-DFPITWE--MRLRIAI--------------------EVSGALSYLHS----AA  516 (684)
Q Consensus       483 ~l-------------------~~~~~-~~~l~~~--~~~~i~~--------------------qia~aL~yLH~----~~  516 (684)
                      ..                   |.... ..++...  .......                    .+...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            42                   11100 0011100  0000000                    01111222211    12


Q ss_pred             CCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       517 ~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            2448999999999999998778999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.15  E-value=2.9e-07  Score=100.47  Aligned_cols=186  Identities=18%  Similarity=0.128  Sum_probs=132.7

Q ss_pred             CCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCc-ccceeeeeeecCcceEEEEecCC
Q 043157          399 FNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN-VVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      +...+-+++++.++++|.+-...+....+.+...     ....-++++|.+++||| .+..++-+..+...++.+++...
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3344557889999999987433333334433321     44556899999999999 77777777777888999999987


Q ss_pred             C-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          478 G-TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       478 g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      + +.......  ....+..-+...+...-++++++||+.-   -+|+|    ||+..+ ...|..||+.........  .
T Consensus       319 ~rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~  386 (829)
T KOG0576|consen  319 GRSSALEMTV--SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--K  386 (829)
T ss_pred             CccccccCCh--hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--c
Confidence            6 21111110  1111334445556677788899999865   57998    787766 489999999887655333  3


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCC
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR  601 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~  601 (684)
                      .+...+++.+++||+.+...+..+.|+|++++-..++.-|-+|-.
T Consensus       387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            455678999999999999999999999999998778877777754

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.12  E-value=3.7e-05  Score=76.97  Aligned_cols=143  Identities=22%  Similarity=0.224  Sum_probs=85.3

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCC--cccceeeeeeec---CcceEEEEecC
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHR--NVVKLLGCCLET---EVPLLVYEFIP  476 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~~---~~~~lv~E~~~  476 (684)
                      .+.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++......   ...+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3678999999999999877 58899986543  4567788899999888533  356677644332   24689999999


Q ss_pred             CCCHHH----------------HHh---hc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 043157          477 NGTLFQ----------------YIH---DQ-NEDFPITWEM---------RLRI------------AIEVSG-ALSYLHS  514 (684)
Q Consensus       477 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~qia~-aL~yLH~  514 (684)
                      +.++..                .+.   +. ....++....         ....            ...+.+ .++.+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                111   11 0111111111         0000            112222 3333332


Q ss_pred             ----CCCCCeEecCCCCCCEEEC-CCCcEEEeccCCcc
Q 043157          515 ----AASIPIYHRDIKSTNILLD-DKYRAKVSDFGASR  547 (684)
Q Consensus       515 ----~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgl~~  547 (684)
                          .....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                1334599999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.09  E-value=6.8e-05  Score=74.17  Aligned_cols=149  Identities=21%  Similarity=0.254  Sum_probs=99.5

Q ss_pred             HHHHHHHhcCCCcCce---eceeCcEEEEEEEeCCCcEEEEEeccccChh--H----------------------HHHHH
Q 043157          389 SKELERATDNFNLNRI---LGQGGQGTVYKGMLPDGKIVAVKKSKVIDES--K----------------------VEEFI  441 (684)
Q Consensus       389 ~~e~~~~~~~~~~~~~---LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~----------------------~~~~~  441 (684)
                      .+.+.....+..+...   |+.|--+.||+|...++..+|+|+.+.....  .                      ..-..
T Consensus        37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~  116 (268)
T COG1718          37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR  116 (268)
T ss_pred             HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence            4455555555555554   5678888999999888999999975542110  0                      01123


Q ss_pred             HHHHHHhhcC--CCcccceeeeeeecCcceEEEEecCCCCH-HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCC
Q 043157          442 NEMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFIPNGTL-FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS-AAS  517 (684)
Q Consensus       442 ~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~  517 (684)
                      +|+..|+++.  +-.+.+.+.+.    .-.|||||+...-+ .-.|    ...++..+....+..++++.+.-|-. .+ 
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~-  187 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG-  187 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC-
Confidence            5777777773  44455555444    45799999964310 0001    11223444677788899999998887 56 


Q ss_pred             CCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       518 ~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                        ++|+||+.-|||+. ++.+.|+||+-+-..
T Consensus       188 --LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         188 --LVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             --cccccchhhheEEE-CCeEEEEECcccccc
Confidence              99999999999999 779999999977543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.06  E-value=1.7e-05  Score=76.83  Aligned_cols=104  Identities=25%  Similarity=0.368  Sum_probs=82.6

Q ss_pred             HHHHHHHhhcCC-CcccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 043157          441 INEMVILSQINH-RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIP  519 (684)
Q Consensus       441 ~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~  519 (684)
                      .+|.-+++.+++ +++++++|.|    ..+++.||...+++...-..-..-...+|..|.+||.++++.+.+|++...-.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888999976 6999999999    45889999987766432100001112689999999999999999999865555


Q ss_pred             eEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          520 IYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       520 iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      +.-.|++++|+-+++++++|++|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            89999999999999999999999986644

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.98  E-value=0.00015  Score=70.68  Aligned_cols=129  Identities=22%  Similarity=0.306  Sum_probs=93.4

Q ss_pred             cCceeceeCcEEEEEEEeCCCcEEEEEeccccC----------------hhHHHHHHHHHHHHhhcC------CCcccce
Q 043157          401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID----------------ESKVEEFINEMVILSQIN------HRNVVKL  458 (684)
Q Consensus       401 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------HpnIv~l  458 (684)
                      -...||+|+.=.||.  ++++....||+.....                .....+..+|+.-..++.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            356899999999997  5555566777665543                223466677777666665      8899999


Q ss_pred             eeeeeecCcceEEEEecCC------CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 043157          459 LGCCLETEVPLLVYEFIPN------GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL  532 (684)
Q Consensus       459 ~~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl  532 (684)
                      +|+...+..+-+|+|.+.+      -||.+++.+..    ++. .   +...+-+-..||-+++   |+.+|++|.||++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEE
Confidence            9999999999999998653      37888886543    555 3   3334445566777888   9999999999999


Q ss_pred             CCC---C-cEEEec
Q 043157          533 DDK---Y-RAKVSD  542 (684)
Q Consensus       533 ~~~---~-~~kl~D  542 (684)
                      ...   . .+.|+|
T Consensus       152 ~~~~~~~~~lvlID  165 (199)
T PF10707_consen  152 QRRDSGEFRLVLID  165 (199)
T ss_pred             EecCCCceEEEEEe
Confidence            532   2 577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.93  E-value=7.7e-05  Score=89.04  Aligned_cols=78  Identities=15%  Similarity=0.279  Sum_probs=57.1

Q ss_pred             CceeceeCcEEEEEEEeCCC---cEEEEEeccccC-hhHHHHHHHHHHHHhhcC-CCcc--cceeeeeeec---CcceEE
Q 043157          402 NRILGQGGQGTVYKGMLPDG---KIVAVKKSKVID-ESKVEEFINEMVILSQIN-HRNV--VKLLGCCLET---EVPLLV  471 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnI--v~l~~~~~~~---~~~~lv  471 (684)
                      .+.|+.|....+|+....++   ..+++|+..... ......+.+|+++|+.+. |+++  .+++.++.+.   +.+|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            57789999999999876554   357777654322 123357889999999995 6765  7777777654   468999


Q ss_pred             EEecCCCC
Q 043157          472 YEFIPNGT  479 (684)
Q Consensus       472 ~E~~~~gs  479 (684)
                      |||+++..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998764

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.89  E-value=0.00011  Score=81.46  Aligned_cols=142  Identities=16%  Similarity=0.144  Sum_probs=89.6

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccChhH-------------------------------------HHHHHHHH
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESK-------------------------------------VEEFINEM  444 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------------------------------------~~~~~~E~  444 (684)
                      .+.||.-+.|.||++++++|+.||||.-+..-+..                                     .-+|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            57899999999999999999999999644311100                                     01233444


Q ss_pred             HHHhh----cCCCcc---cceeeeeee-cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 043157          445 VILSQ----INHRNV---VKLLGCCLE-TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA  516 (684)
Q Consensus       445 ~~l~~----l~HpnI---v~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~  516 (684)
                      +...+    ++|-++   |.+-.++.+ .....|+|||++|.-+.+.-.-.+..  ++...+..-+.+...-+  |=..|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~l~~~~~~q--If~~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILNKLVEAYLEQ--IFKTG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHHHHHHHHHHH--HHhcC
Confidence            43333    345551   223333332 45678999999998665553322221  55554444333332222  22345


Q ss_pred             CCCeEecCCCCCCEEECC----CCcEEEeccCCccccc
Q 043157          517 SIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMA  550 (684)
Q Consensus       517 ~~~iiH~Dlkp~NILl~~----~~~~kl~DFgl~~~~~  550 (684)
                         ++|.|-+|.||+++.    ++.+.+-|||+.....
T Consensus       322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence               999999999999983    6789999999987654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.73  E-value=0.00018  Score=67.41  Aligned_cols=129  Identities=18%  Similarity=0.188  Sum_probs=88.6

Q ss_pred             CCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccc-eeeeeeecCcceEEEEecCC
Q 043157          399 FNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVK-LLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~~~~~~lv~E~~~~  477 (684)
                      .+..+.|++|.+|.||++.+.. ..+|+|.-+.  +.....+..|.++|..+.-.++-+ ++.+.    ..++.|||+.|
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G   96 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWRG-GEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhhcccccEEEEeeccC-ceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence            3456789999999999999854 4788887654  344567889999999998766654 44333    23455999998


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC-CCCEEECCCCcEEEeccCCcc
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIK-STNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlk-p~NILl~~~~~~kl~DFgl~~  547 (684)
                      -.|.+.-...      +.+    -...++++-.-|...+   |-|+.|+ |..++|-.+..+.|+||..+.
T Consensus        97 ~~L~~~~~~~------~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          97 RPLGKLEIGG------DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             cchhhhhhcc------cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence            8886655421      122    2334555545566667   8899887 444444444499999999876

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.69  E-value=0.00029  Score=71.07  Aligned_cols=73  Identities=19%  Similarity=0.254  Sum_probs=45.8

Q ss_pred             ceeceeCcE-EEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCC---cccceeeeeeecC---cceEEEEec
Q 043157          403 RILGQGGQG-TVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHR---NVVKLLGCCLETE---VPLLVYEFI  475 (684)
Q Consensus       403 ~~LG~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~~~~---~~~lv~E~~  475 (684)
                      +.|+.|+.. .||+.    +..+++|..+.  ......+.+|.++++.+...   .+.+++......+   ..+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            567767766 48875    23466776543  22345788999999988532   3444444433322   458999999


Q ss_pred             CCCCHH
Q 043157          476 PNGTLF  481 (684)
Q Consensus       476 ~~gsL~  481 (684)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.67  E-value=0.00042  Score=69.79  Aligned_cols=74  Identities=23%  Similarity=0.217  Sum_probs=48.4

Q ss_pred             CceeceeCcEEEEEEEeCC--CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcc-cceeeeeeecCcceEEEEecCCC
Q 043157          402 NRILGQGGQGTVYKGMLPD--GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV-VKLLGCCLETEVPLLVYEFIPNG  478 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~E~~~~g  478 (684)
                      .+.|..|-...+|+....+  ++.+++|+....... .-...+|+.+++.+...++ +++++...    ..++|||+++.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            3567778888999988664  677888876542221 1233478889988854444 34443322    24899999987


Q ss_pred             CH
Q 043157          479 TL  480 (684)
Q Consensus       479 sL  480 (684)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.67  E-value=0.0008  Score=70.41  Aligned_cols=78  Identities=10%  Similarity=0.032  Sum_probs=56.8

Q ss_pred             CcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCC---Ccccceeeeeee---cCcceEEEE
Q 043157          400 NLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH---RNVVKLLGCCLE---TEVPLLVYE  473 (684)
Q Consensus       400 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~---~~~~~lv~E  473 (684)
                      .-.+.||+|..+.||+....+++ +.+|..+.  ......+..|.+.|+.|.-   -.+.++++.+..   .+..+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            34578999999999998766664 55565332  1123578899999999853   367788887754   356899999


Q ss_pred             ecCCCCH
Q 043157          474 FIPNGTL  480 (684)
Q Consensus       474 ~~~~gsL  480 (684)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.64  E-value=0.00017  Score=84.53  Aligned_cols=199  Identities=18%  Similarity=0.216  Sum_probs=139.8

Q ss_pred             HHHHHHHHHHHhhcCCCcccceeeeeeecCcce----EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 043157          437 VEEFINEMVILSQINHRNVVKLLGCCLETEVPL----LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL  512 (684)
Q Consensus       437 ~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~----lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yL  512 (684)
                      +....-|++.+....|+|++.++.+..++...-    +..|++..-++.+.+....   .++....+.+..++.+||+|+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHH
Confidence            344455777788889999999999988765332    4457788888888887654   378888888999999999999


Q ss_pred             HhCCCCCeEecCCCCC---CEEECCCCcEEEe--ccCCccccccCCceeeecccccCCCCCccccccCCCCC--ccchhh
Q 043157          513 HSAASIPIYHRDIKST---NILLDDKYRAKVS--DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD--KSDVYS  585 (684)
Q Consensus       513 H~~~~~~iiH~Dlkp~---NILl~~~~~~kl~--DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDv~S  585 (684)
                      |+..   ..|.-+..+   +.-.+.++.+.++  ||+.++...+......  ..-+..+.+||......++.  ..|+|.
T Consensus       303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHH
Confidence            9986   555544444   4455667777777  9998877654433222  22345677888776665544  479999


Q ss_pred             hHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHH
Q 043157          586 FGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV  665 (684)
Q Consensus       586 lGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~ev  665 (684)
                      +|..+..+..|..+-....                  ....+++.        .......++..+|+..++++|+...++
T Consensus       378 lgll~~~~~~~~~i~~~~~------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSA------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHhhhhhcCccccccc------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhh
Confidence            9999999998877632110                  11111111        111156788899999999999999999


Q ss_pred             HHHH
Q 043157          666 TSEL  669 (684)
Q Consensus       666 l~~L  669 (684)
                      +.+.
T Consensus       432 l~~~  435 (1351)
T KOG1035|consen  432 LTHP  435 (1351)
T ss_pred             hhch
Confidence            8875

>KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms]

Probab=97.59  E-value=7.5e-05  Score=90.25  Aligned_cols=45  Identities=20%  Similarity=0.342  Sum_probs=36.1

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCC--cCccccc--cccccCcceeecccccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRC--SPKRSRD--SFFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c--~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      ..||.| +|+.||.|   .        .|  ..++||.  .|-.  .+.|.|+.|+     |+|-|.+
T Consensus      3921 ~n~f~C-nC~~gyTG---~--------~Ce~~Gi~eCs~n~C~~--gg~C~n~~gs-----f~CncT~ 3969 (4289)
T KOG1219|consen 3921 YNGFLC-NCPNGYTG---K--------RCEARGISECSKNVCGT--GGQCINIPGS-----FHCNCTP 3969 (4289)
T ss_pred             CCCeeE-eCCCCccC---c--------eeecccccccccccccC--CceeeccCCc-----eEeccCh
Confidence            568999 99999998   2        44  2488888  5644  5789999999     9999977

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.40  E-value=0.0015  Score=63.25  Aligned_cols=125  Identities=30%  Similarity=0.482  Sum_probs=90.0

Q ss_pred             cCCCcCceeceeCc-EEEEEEEeCCCcEEEEEeccc---c---------C--h-------hHHHHHHHHHHHHhhcC---
Q 043157          397 DNFNLNRILGQGGQ-GTVYKGMLPDGKIVAVKKSKV---I---------D--E-------SKVEEFINEMVILSQIN---  451 (684)
Q Consensus       397 ~~~~~~~~LG~G~~-g~Vy~~~~~~g~~vavK~~~~---~---------~--~-------~~~~~~~~E~~~l~~l~---  451 (684)
                      .+++..+.||.|.. |.||++.. +|+.+|+|..+.   .         .  +       ...+.|..|-+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67999999999999 99999998 567999998221   0         0  0       12345778888877774   


Q ss_pred             CCcc--cceeeeeeecC------------------cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 043157          452 HRNV--VKLLGCCLETE------------------VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY  511 (684)
Q Consensus       452 HpnI--v~l~~~~~~~~------------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~y  511 (684)
                      +.++  |+.+|+..-..                  ..-||.||++...            .+..    +-+.++.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence            5566  89999984321                  1136788775432            1222    334577788889


Q ss_pred             HHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       512 LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ||..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99999   999999999986     4589999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.38  E-value=0.00081  Score=68.80  Aligned_cols=138  Identities=14%  Similarity=0.140  Sum_probs=77.6

Q ss_pred             eeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcc-cceeeeeeecCcceEEEEecCCCCHHH
Q 043157          404 ILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV-VKLLGCCLETEVPLLVYEFIPNGTLFQ  482 (684)
Q Consensus       404 ~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~E~~~~gsL~~  482 (684)
                      .+..|-...+|+... +++.+++|..........-...+|.++++.+...++ .+++...    ..++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence            345677788998874 566778886543222111235678899998864434 3444433    2479999999866532


Q ss_pred             H-----------------HhhcC-CCCCCCHHH-HHHHHHH---------HHHHHHHHHhC-----CCCCeEecCCCCCC
Q 043157          483 Y-----------------IHDQN-EDFPITWEM-RLRIAIE---------VSGALSYLHSA-----ASIPIYHRDIKSTN  529 (684)
Q Consensus       483 ~-----------------l~~~~-~~~~l~~~~-~~~i~~q---------ia~aL~yLH~~-----~~~~iiH~Dlkp~N  529 (684)
                      .                 ||... ...+++... +..+..+         +...+..+...     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 12111 111222221 1111111         11222222221     12348999999999


Q ss_pred             EEECCCCcEEEeccCCcc
Q 043157          530 ILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       530 ILl~~~~~~kl~DFgl~~  547 (684)
                      |++++++ +.|+||..+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999876 7899998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.34  E-value=0.0052  Score=66.44  Aligned_cols=76  Identities=21%  Similarity=0.211  Sum_probs=55.2

Q ss_pred             CceeceeCcEEEEEEEeCCC-cEEEEEecccc----C---hhHHHHHHHHHHHHhhcC---CCcccceeeeeeecCcceE
Q 043157          402 NRILGQGGQGTVYKGMLPDG-KIVAVKKSKVI----D---ESKVEEFINEMVILSQIN---HRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g-~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~l  470 (684)
                      .+.||.|....||+....+| +.+.||.....    .   +-..+++..|.+.|+.+.   ...+++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35789999999999998777 58999975421    1   224567778888888873   2456677766  4466789


Q ss_pred             EEEecCCCC
Q 043157          471 VYEFIPNGT  479 (684)
Q Consensus       471 v~E~~~~gs  479 (684)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998644

>PRK05231 homoserine kinase; Provisional

Probab=97.27  E-value=0.0062  Score=64.41  Aligned_cols=141  Identities=16%  Similarity=0.212  Sum_probs=76.3

Q ss_pred             ceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCc--ccceeee------eeecCcceEEEEe
Q 043157          403 RILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN--VVKLLGC------CLETEVPLLVYEF  474 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lv~E~  474 (684)
                      +.|+.|...++|+....+| .+++|+......   +....|+.+++.|...+  +.+++..      ....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4566777789999887666 578887652222   33344556665553222  3333321      1234567899999


Q ss_pred             cCCCCHH-----------HH---HhhcCCCC--------CCCH-HHHHH------------HH-HHHHHHHHHHHhC---
Q 043157          475 IPNGTLF-----------QY---IHDQNEDF--------PITW-EMRLR------------IA-IEVSGALSYLHSA---  515 (684)
Q Consensus       475 ~~~gsL~-----------~~---l~~~~~~~--------~l~~-~~~~~------------i~-~qia~aL~yLH~~---  515 (684)
                      ++|..+.           +.   +|......        .+.| .....            .. ..+...++.+.+.   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            9887431           11   11111110        1111 11111            11 1122222333311   


Q ss_pred             -CCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          516 -ASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       516 -~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                       -+..++|+|+.|.|||++++...-|+||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             22349999999999999977556899998764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.17  E-value=0.0023  Score=67.08  Aligned_cols=140  Identities=24%  Similarity=0.329  Sum_probs=82.6

Q ss_pred             ceeceeCcEEEEEEEeCC-------CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcc-cceeeeeeecCcceEEEEe
Q 043157          403 RILGQGGQGTVYKGMLPD-------GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV-VKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~E~  474 (684)
                      +.|..|-.-.+|+....+       ++.+++|+..... ....+..+|.++++.+...++ .++++.+.    ..+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            456667777899988655       4788888865432 233456788888888854333 34555543    2468999


Q ss_pred             cCCCCHHHH-----------------HhhcCCCC------CCC--HHHHHH--------------------------HHH
Q 043157          475 IPNGTLFQY-----------------IHDQNEDF------PIT--WEMRLR--------------------------IAI  503 (684)
Q Consensus       475 ~~~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~  503 (684)
                      ++|.++...                 +|+.....      ..+  +..+..                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988766431                 11111110      000  111111                          111


Q ss_pred             HHHHHHHHHHh------CCCCCeEecCCCCCCEEECCC----CcEEEeccCCcc
Q 043157          504 EVSGALSYLHS------AASIPIYHRDIKSTNILLDDK----YRAKVSDFGASR  547 (684)
Q Consensus       504 qia~aL~yLH~------~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFgl~~  547 (684)
                      ++...+.+|..      .....++|+|+.+.|||++++    +.++|+||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22233344432      134558999999999999974    789999998774

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.15  E-value=0.0041  Score=65.47  Aligned_cols=143  Identities=20%  Similarity=0.252  Sum_probs=81.0

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCc--ccceeeee------eecCcceEEEE
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN--VVKLLGCC------LETEVPLLVYE  473 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~------~~~~~~~lv~E  473 (684)
                      .+.++.|....+|+....++ .+++|+.....  ..++...|++++..|...+  +.+++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45567777789999876555 46678654321  1234556777777774222  34444321      12345689999


Q ss_pred             ecCCCCHH-----------H---HHhhcCCCCC---------CCHHHHH------------HHHHHHHHHHHHHHh----
Q 043157          474 FIPNGTLF-----------Q---YIHDQNEDFP---------ITWEMRL------------RIAIEVSGALSYLHS----  514 (684)
Q Consensus       474 ~~~~gsL~-----------~---~l~~~~~~~~---------l~~~~~~------------~i~~qia~aL~yLH~----  514 (684)
                      |++|..+.           .   .+|......+         -.|....            .....+.+.+++|..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99885431           1   1222111100         0111100            011223345555543    


Q ss_pred             CCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       515 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .....++|+|+++.||++++++.+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            123459999999999999988777899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.10  E-value=6.6e-05  Score=89.43  Aligned_cols=164  Identities=13%  Similarity=-0.010  Sum_probs=119.4

Q ss_pred             HHHHHHHHHHHhhcCCCcccceeeeeeec--CcceEEEEecCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHH
Q 043157          437 VEEFINEMVILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGTLFQYIHDQNED-FPITWEMRLRIAIEVSGALSYLH  513 (684)
Q Consensus       437 ~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~yLH  513 (684)
                      .+....|...++...|+++.....-....  ...+..++++.+|.+.+.|-+.... .+++.......-.+...+..-.|
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            34455566667777899988876655433  3568999999999999999875433 23444433333334355566655


Q ss_pred             hCCC--CCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHH
Q 043157          514 SAAS--IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLA  591 (684)
Q Consensus       514 ~~~~--~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~  591 (684)
                      +...  ...+|+++|+.|.+|..+.++|+.++|+.+..... ........+++.|+.|++...-.++.++|+|..+..+|
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence            4432  23789999999999999999999999999843322 22333445788899999998888999999999999999


Q ss_pred             HHHhCCCCCC
Q 043157          592 ELLTGEKPIR  601 (684)
Q Consensus       592 elltG~~P~~  601 (684)
                      ++--|..+|.
T Consensus      1432 ~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1432 LRSDGNAYFI 1441 (2724)
T ss_pred             HHhcccHHHH
Confidence            9988888864

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.06  E-value=0.01  Score=61.89  Aligned_cols=142  Identities=18%  Similarity=0.185  Sum_probs=84.2

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCc--ccceeee------eeecCcceEEEE
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN--VVKLLGC------CLETEVPLLVYE  473 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lv~E  473 (684)
                      .+.|..|....+|+....++ .+++|+....   ..+....|++++..+.+.+  +.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            45677787789999876554 5788876542   2345667888888885333  4444432      123345689999


Q ss_pred             ecCCCCHHH----H----------HhhcCCC--------CCCCHHHHH----------HHHHHHHHHHHHHHhC----CC
Q 043157          474 FIPNGTLFQ----Y----------IHDQNED--------FPITWEMRL----------RIAIEVSGALSYLHSA----AS  517 (684)
Q Consensus       474 ~~~~gsL~~----~----------l~~~~~~--------~~l~~~~~~----------~i~~qia~aL~yLH~~----~~  517 (684)
                      |++|..+..    .          +|.....        ....|....          .....+..++.++...    ..
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876421    1          1111100        011111110          0112234445555531    12


Q ss_pred             CCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          518 IPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       518 ~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      ..++|+|+.|.|||++++..+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            348999999999999998777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.83  E-value=0.0018  Score=66.41  Aligned_cols=132  Identities=17%  Similarity=0.206  Sum_probs=92.8

Q ss_pred             CCcCceeceeCcEEEEEEEeCCCcEEEEEeccccC---------h--------h-----HHHHHHHHHHHHhhcCC--Cc
Q 043157          399 FNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID---------E--------S-----KVEEFINEMVILSQINH--RN  454 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~---------~--------~-----~~~~~~~E~~~l~~l~H--pn  454 (684)
                      +.++++||-|--+-||.+....|++.++|.-+...         .        .     ..-...+|+..|+.|..  --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            56789999999999999999999999999432210         0        0     01123468888888843  23


Q ss_pred             ccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC
Q 043157          455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD  534 (684)
Q Consensus       455 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~  534 (684)
                      +++.+++    ...++|||++.+-.|...-+-.      +..   .+...+..-+--|..+|   +||+|..-=||++++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~------d~~---~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVE------DPP---TLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeecC------ChH---HHHHHHHHHHHHHHHcC---ceecccchheeEEec
Confidence            4444443    4567999999887775543321      122   33444555566777888   999999999999999


Q ss_pred             CCcEEEeccCCc
Q 043157          535 KYRAKVSDFGAS  546 (684)
Q Consensus       535 ~~~~kl~DFgl~  546 (684)
                      +..++++||--.
T Consensus       238 d~~i~vIDFPQm  249 (465)
T KOG2268|consen  238 DDKIVVIDFPQM  249 (465)
T ss_pred             CCCEEEeechHh
Confidence            999999999643

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.79  E-value=0.014  Score=60.38  Aligned_cols=30  Identities=23%  Similarity=0.496  Sum_probs=24.9

Q ss_pred             CCeEecCCCCCCEEECCCCc-EEEeccCCcc
Q 043157          518 IPIYHRDIKSTNILLDDKYR-AKVSDFGASR  547 (684)
Q Consensus       518 ~~iiH~Dlkp~NILl~~~~~-~kl~DFgl~~  547 (684)
                      ..++|+|++|.|||++++++ .-|+||+.+.
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            34899999999999997555 5699999764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=96.67  E-value=0.014  Score=62.53  Aligned_cols=140  Identities=20%  Similarity=0.223  Sum_probs=80.1

Q ss_pred             ceeceeCcEEEEEEEeCC-----CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCccc-ceeeeeeecCcceEEEEecC
Q 043157          403 RILGQGGQGTVYKGMLPD-----GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV-KLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv~E~~~  476 (684)
                      +.|-.|-.-.+|+....+     ++.+++|..........+ ..+|..+++.+..-++- ++++.+.. .   .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence            345457777889887532     357888876553322222 36788999888644443 45565532 2   5899998


Q ss_pred             CCCHHHH-----------------HhhcCC---CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 043157          477 NGTLFQY-----------------IHDQNE---DFPITWEMRLRIAIEV-----------------SGALSYL----HS-  514 (684)
Q Consensus       477 ~gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~qi-----------------a~aL~yL----H~-  514 (684)
                      +.+|...                 +|+...   ..+..+..+.++..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7766421                 121110   0112233333332211                 1122222    22 


Q ss_pred             CCCCCeEecCCCCCCEEECC-CCcEEEeccCCcc
Q 043157          515 AASIPIYHRDIKSTNILLDD-KYRAKVSDFGASR  547 (684)
Q Consensus       515 ~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgl~~  547 (684)
                      ...+.++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            22345899999999999986 4689999998764

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.53  E-value=0.027  Score=58.85  Aligned_cols=128  Identities=16%  Similarity=0.277  Sum_probs=75.4

Q ss_pred             CcEEEEEecc-ccChhHHHHHHHHHHHHhhcCC--CcccceeeeeeecC--cceEEEEecCCCCHH--------------
Q 043157          421 GKIVAVKKSK-VIDESKVEEFINEMVILSQINH--RNVVKLLGCCLETE--VPLLVYEFIPNGTLF--------------  481 (684)
Q Consensus       421 g~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~--~~~lv~E~~~~gsL~--------------  481 (684)
                      ++.+++.+-. ...........+|..+++.+.-  --+...++.+.++.  .+|.||+|++|..+.              
T Consensus        48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~  127 (321)
T COG3173          48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL  127 (321)
T ss_pred             CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence            6667777321 2344556677788888888743  33445666676665  789999999873221              


Q ss_pred             ----HHHhh---cC----C----------CCCCCHHHHHHHH--------HHHHHHHHHHHhCC-----CCCeEecCCCC
Q 043157          482 ----QYIHD---QN----E----------DFPITWEMRLRIA--------IEVSGALSYLHSAA-----SIPIYHRDIKS  527 (684)
Q Consensus       482 ----~~l~~---~~----~----------~~~l~~~~~~~i~--------~qia~aL~yLH~~~-----~~~iiH~Dlkp  527 (684)
                          ++|..   -.    .          .....|....+.+        -.......||+.+.     .+.++|+|+++
T Consensus       128 ~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~  207 (321)
T COG3173         128 DALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRP  207 (321)
T ss_pred             HHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCccc
Confidence                22211   00    0          0000111111100        02223344555433     35699999999


Q ss_pred             CCEEECCCCcEEEeccCCccc
Q 043157          528 TNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       528 ~NILl~~~~~~kl~DFgl~~~  548 (684)
                      .||+++.+.-+=|.||+++..
T Consensus       208 gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         208 GNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CCEEEeCCCeeEEEecccccc
Confidence            999999988899999998864

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.29  E-value=0.024  Score=58.79  Aligned_cols=75  Identities=23%  Similarity=0.216  Sum_probs=48.8

Q ss_pred             CcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcC---CCcccceeeeeeecCcceEEEEecC
Q 043157          400 NLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN---HRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       400 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      +..+.|+.|....+|+.. .+++.+.||...   ......|..|.+-|+.|.   --.+++++++....+..+|||||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            345678989999999987 567788999766   333456778888888883   4557789998887888899999998


Q ss_pred             CC
Q 043157          477 NG  478 (684)
Q Consensus       477 ~g  478 (684)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.05  E-value=0.21  Score=53.82  Aligned_cols=74  Identities=16%  Similarity=0.093  Sum_probs=49.5

Q ss_pred             CceeceeCcEEEEEEEeCC-CcEEEEEeccc------cChhHHHHHHHHHHHHhhcC--CCc-ccceeeeeeecCcceEE
Q 043157          402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKV------IDESKVEEFINEMVILSQIN--HRN-VVKLLGCCLETEVPLLV  471 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--Hpn-Iv~l~~~~~~~~~~~lv  471 (684)
                      .+.||.|.-.-||++...+ ++.|+||....      .-+-..++..-|.+.|+.+.  -|. +++++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4678999999999999753 56799995332      11334567777888888773  343 4445433  45556788


Q ss_pred             EEecCC
Q 043157          472 YEFIPN  477 (684)
Q Consensus       472 ~E~~~~  477 (684)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888754

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.03  E-value=0.14  Score=55.43  Aligned_cols=73  Identities=16%  Similarity=0.165  Sum_probs=50.1

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccc----cCh---hHHHHHHHHHHHHhhcC---CCcccceeeeeeecCcceEE
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKV----IDE---SKVEEFINEMVILSQIN---HRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~----~~~---~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .+.||.|..-.||+.... ++.++||+...    ...   -..++-..|.+.|+.+.   ...+++++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            567899999999998764 45688996542    111   13444455677776663   347778887776  556889


Q ss_pred             EEecCC
Q 043157          472 YEFIPN  477 (684)
Q Consensus       472 ~E~~~~  477 (684)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.84  E-value=0.014  Score=63.49  Aligned_cols=164  Identities=23%  Similarity=0.257  Sum_probs=91.5

Q ss_pred             HHHHHHHHHHhhcCCCcccceeeeeeec-CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 043157          438 EEFINEMVILSQINHRNVVKLLGCCLET-EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA  516 (684)
Q Consensus       438 ~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~  516 (684)
                      .+++....+++.+.|+|+-.++++-... +...+|||++ +.+|++++..+...    ..       ++   +    .++
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~----~~-------s~---~----~~~   87 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK----DE-------SL---L----AHG   87 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc----hh-------hh---c----ccc
Confidence            4566778899999999999999888644 3467899998 67999998866421    00       00   0    111


Q ss_pred             CCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhC
Q 043157          517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTG  596 (684)
Q Consensus       517 ~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG  596 (684)
                         +.|     .||       .+.+| -++    ..             |  |-     ...+|+||||+|.++.|+.-|
T Consensus        88 ---~~~-----~~~-------~~~td-~~~----t~-------------~--~~-----~~~pKsdVwsl~~i~~el~L~  127 (725)
T KOG1093|consen   88 ---VLH-----LNI-------IYITD-HFL----TK-------------Y--PS-----PIGPKSDVWSLGFIILELYLG  127 (725)
T ss_pred             ---cce-----ehh-------hhccc-ccc----cc-------------C--CC-----CCCcchhhhhHHHHHHHHHHh
Confidence               222     111       23333 000    00             0  10     011499999999999999988


Q ss_pred             CCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHH
Q 043157          597 EKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV  665 (684)
Q Consensus       597 ~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~ev  665 (684)
                      ..-+......+  .+.........+..........   ....+....+..+...|+-..|..||...++
T Consensus       128 ~~l~~~~~~s~--~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  128 ISLEAELTESE--YLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             hHHHHHHHHHH--HHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            87654222111  1111111111111111111111   1123456678899999999999998865443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.84  E-value=0.082  Score=56.18  Aligned_cols=79  Identities=16%  Similarity=0.165  Sum_probs=50.4

Q ss_pred             eeceeCcEEEEEEEeCCC-cEEEEEeccc-------cChhHHHHHHHHHHHHhhcC--CCc-ccceeeeeeecCcceEEE
Q 043157          404 ILGQGGQGTVYKGMLPDG-KIVAVKKSKV-------IDESKVEEFINEMVILSQIN--HRN-VVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       404 ~LG~G~~g~Vy~~~~~~g-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--Hpn-Iv~l~~~~~~~~~~~lv~  472 (684)
                      .||.|....||++..++| +.|+||....       .-+-..++..-|.+.|+...  -|. +++++.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            478899999999997654 6899995432       11334556667888887763  343 444443  3455667999


Q ss_pred             EecCCC-CHHHHH
Q 043157          473 EFIPNG-TLFQYI  484 (684)
Q Consensus       473 E~~~~g-sL~~~l  484 (684)
                      |+++.. .|.+.|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            998643 233444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.77  E-value=0.11  Score=54.68  Aligned_cols=31  Identities=13%  Similarity=0.225  Sum_probs=27.2

Q ss_pred             CCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       518 ~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ..++|+|+.+.|+|+++++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            3499999999999999998999999987653

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.76  E-value=0.094  Score=55.08  Aligned_cols=140  Identities=21%  Similarity=0.234  Sum_probs=94.2

Q ss_pred             CcCceeceeCcEEEEEEEeCCCcEEEEEeccc-----cCh--------------------hHHH-HHHHHHHHHhhcCCC
Q 043157          400 NLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV-----IDE--------------------SKVE-EFINEMVILSQINHR  453 (684)
Q Consensus       400 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~-----~~~--------------------~~~~-~~~~E~~~l~~l~Hp  453 (684)
                      .+.-.|..|--+.||.+...+|+.+|||+.+.     .+.                    .-++ -...|++-|.+|+.-
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            34557889999999999999999999995432     111                    1111 123577778887655


Q ss_pred             cccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC
Q 043157          454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD  533 (684)
Q Consensus       454 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~  533 (684)
                      .|.-.--+..  ....|||+|+.. +=+..  -.-....++...+..+-.|++.-|.-|-+..+  ++|.||.--|+|+.
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGr-dgw~a--PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGR-DGWAA--PKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccC-CCCcC--cccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE
Confidence            5443322222  234699999853 21110  00122347777788888899999998887774  99999999999996


Q ss_pred             CCCcEEEeccCCcc
Q 043157          534 DKYRAKVSDFGASR  547 (684)
Q Consensus       534 ~~~~~kl~DFgl~~  547 (684)
                      ++ .+.|+|-+-+-
T Consensus       300 dG-~lyiIDVSQSV  312 (520)
T KOG2270|consen  300 DG-KLYIIDVSQSV  312 (520)
T ss_pred             CC-EEEEEEccccc
Confidence            55 89999987553

>PF12662 cEGF: Complement Clr-like EGF-like

Probab=95.67  E-value=0.0073  Score=36.91  Aligned_cols=24  Identities=29%  Similarity=0.767  Sum_probs=18.9

Q ss_pred             ccccCCCCCCCCCCCCCccccCCCCCCcCccc
Q 043157          260 GHNCSKCPDGYNYYRPAYYRPLQERRCSPKRS  291 (684)
Q Consensus       260 gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~  291 (684)
                      +|.| .|+.||.-   +|    ++..|+||||
T Consensus         1 sy~C-~C~~Gy~l---~~----d~~~C~DIdE   24 (24)
T PF12662_consen    1 SYTC-SCPPGYQL---SP----DGRSCEDIDE   24 (24)
T ss_pred             CEEe-eCCCCCcC---CC----CCCccccCCC
Confidence            5899 99999875   33    3568999997

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.67  E-value=0.23  Score=52.18  Aligned_cols=29  Identities=34%  Similarity=0.398  Sum_probs=24.7

Q ss_pred             CCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          518 IPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       518 ~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      ..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            34899999999999988 578999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.24  E-value=0.026  Score=55.76  Aligned_cols=30  Identities=27%  Similarity=0.412  Sum_probs=21.0

Q ss_pred             CeEecCCCCCCEEE-CCCCcEEEeccCCccc
Q 043157          519 PIYHRDIKSTNILL-DDKYRAKVSDFGASRS  548 (684)
Q Consensus       519 ~iiH~Dlkp~NILl-~~~~~~kl~DFgl~~~  548 (684)
                      .+.|+|+.|.|||+ +.++.++|+||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            37899999999999 8888999999987753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1214 consensus Nidogen and related basement membrane protein proteins [Cell wall/membrane/envelope biogenesis; Extracellular structures]

Probab=95.22  E-value=0.025  Score=63.64  Aligned_cols=53  Identities=13%  Similarity=0.310  Sum_probs=42.6

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCcccccc--ccccCcceeecccccceeeeEEEeecc-cccCcc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRDS--FFSKKTRIIFGNISSFIIYRYAISILR-LSSSGV  327 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  327 (684)
                      +..|.| .|-.||.|         |+-.|+|+|||.+  |..  ...|.|+.++     ++|.|.+ .++.|.
T Consensus       806 gs~y~C-~CLPGfsG---------DG~~c~dvDeC~psrChp--~A~Cyntpgs-----fsC~C~pGy~GDGf  861 (1289)
T KOG1214|consen  806 GSTYSC-ACLPGFSG---------DGHQCTDVDECSPSRCHP--AATCYNTPGS-----FSCRCQPGYYGDGF  861 (1289)
T ss_pred             CceEEE-eecCCccC---------CccccccccccCccccCC--CceEecCCCc-----ceeecccCccCCCc
Confidence            456999 99999999         3445999999994  665  6799999999     9999998 444443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.12  E-value=0.15  Score=54.32  Aligned_cols=140  Identities=19%  Similarity=0.231  Sum_probs=77.1

Q ss_pred             ceeceeCcEEEEEEEeCC----CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCccc-ceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLPD----GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV-KLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      +.|..|=.-.+|+....+    +..|.+|....... ..-.-.+|..+++.+..-++- ++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            445447677788886543    23788887654322 222335788889888655553 5565552 22   58899877


Q ss_pred             CCHHH-----------------HHhhcC---CCCCCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 043157          478 GTLFQ-----------------YIHDQN---EDFPITWEMRLRIAIEV----------------------SGALSYLH--  513 (684)
Q Consensus       478 gsL~~-----------------~l~~~~---~~~~l~~~~~~~i~~qi----------------------a~aL~yLH--  513 (684)
                      .+|..                 .+|...   ...+--+..+..+..++                      .+-+..+.  
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            65521                 011111   00011233332222221                      11122221  


Q ss_pred             --hC-CCCCeEecCCCCCCEEECC-CCcEEEeccCCcc
Q 043157          514 --SA-ASIPIYHRDIKSTNILLDD-KYRAKVSDFGASR  547 (684)
Q Consensus       514 --~~-~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgl~~  547 (684)
                        +. ...-+.|+|+.+.|||+++ ++.++++||..+.
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence              11 1223789999999999974 5789999998764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.08  E-value=0.078  Score=51.83  Aligned_cols=152  Identities=16%  Similarity=0.152  Sum_probs=90.2

Q ss_pred             eCcEEEEEEEeCCCcEEEEEeccccChh-HHHHHHHHHHHHhhcCCCcccceeeeeeecC-cceEEEEecCCCCHHHHHh
Q 043157          408 GGQGTVYKGMLPDGKIVAVKKSKVIDES-KVEEFINEMVILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGTLFQYIH  485 (684)
Q Consensus       408 G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lv~E~~~~gsL~~~l~  485 (684)
                      ++.++.-++..+-| ...+|++...+-. ...-|.++.+++.++.  .|+++.   .+.. ..-++.|++-.-.      
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~---NDn~~~yGvIlE~Cy~~~------  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK---NDNNYKYGVILERCYKIK------  140 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee---cCCCceeEEEEeeccCcc------
Confidence            34555555544333 3456666554433 4466788888888875  566666   2233 3458888873210      


Q ss_pred             hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecccccCC
Q 043157          486 DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG  565 (684)
Q Consensus       486 ~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~  565 (684)
                             ..   ...++..=+++|.-.|+... ..+|+|-.|+||+-|..|.+||.|=+..-..             +..
T Consensus       141 -------i~---~~N~i~agi~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~-------------~V~  196 (308)
T PF07387_consen  141 -------IN---FSNFITAGIKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN-------------QVN  196 (308)
T ss_pred             -------cc---hhHHHHHhHHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhhhhhh-------------eee
Confidence                   11   11122222467888896543 3999999999999999999999997643211             111


Q ss_pred             CCCccccccCCCCCccchhhhHHHHHHHHhCCC
Q 043157          566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEK  598 (684)
Q Consensus       566 y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~  598 (684)
                      |.--|   ....+.++.+-+|=.-++++.....
T Consensus       197 ~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  197 MVNIE---YESLTQEAEVKVFVKSCLKLVEKQR  226 (308)
T ss_pred             EEeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence            22211   2334667777777777777765433

The function of this family is unknown.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.37  E-value=0.45  Score=50.36  Aligned_cols=140  Identities=21%  Similarity=0.337  Sum_probs=81.7

Q ss_pred             eeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcc------cceeeeee--ec--CcceEEEE
Q 043157          404 ILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV------VKLLGCCL--ET--EVPLLVYE  473 (684)
Q Consensus       404 ~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI------v~l~~~~~--~~--~~~~lv~E  473 (684)
                      .|.+ .--.+|+....+|+. ++|.....  ....++..|+..|..|.-.+|      ..+=|-..  -.  ...+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            4444 566789988877776 77776654  344566778888888742222      22111111  12  36678999


Q ss_pred             ecCCCCHHH---------------HHhhcCCCC---------CCCHHH-------------HHHHHHHHHHHHHHHHhCC
Q 043157          474 FIPNGTLFQ---------------YIHDQNEDF---------PITWEM-------------RLRIAIEVSGALSYLHSAA  516 (684)
Q Consensus       474 ~~~~gsL~~---------------~l~~~~~~~---------~l~~~~-------------~~~i~~qia~aL~yLH~~~  516 (684)
                      |++|..+..               -||....+.         ...|..             -.....++...+..+.+.-
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999887762               111111111         123320             0112234444444444321


Q ss_pred             ----C---CCeEecCCCCCCEEECCCCc-EEEeccCCcc
Q 043157          517 ----S---IPIYHRDIKSTNILLDDKYR-AKVSDFGASR  547 (684)
Q Consensus       517 ----~---~~iiH~Dlkp~NILl~~~~~-~kl~DFgl~~  547 (684)
                          .   ..++|+|+.|.|||++++.. +.+.||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                1   22899999999999999875 8999999764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.36  E-value=0.55  Score=46.40  Aligned_cols=75  Identities=19%  Similarity=0.221  Sum_probs=53.2

Q ss_pred             ceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcC---CCcccceeeeeeecCcceEEEEecCCCC
Q 043157          403 RILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN---HRNVVKLLGCCLETEVPLLVYEFIPNGT  479 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv~E~~~~gs  479 (684)
                      +.+..|.--+-|.... +...+-||.-.   .+....|..|+.-|+.|.   .-.+.+++.+..+....|+||||++-+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            4455555555565443 45567787543   455677888888777773   4567888888889999999999999865


Q ss_pred             HH
Q 043157          480 LF  481 (684)
Q Consensus       480 L~  481 (684)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            54

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	684
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-47
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-46
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-45
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-44
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-36
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-36
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-35
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-31
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-28
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-28
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-27
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-27
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-27
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-26
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-26
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-26
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-26
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-26
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-26
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-26
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-25
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-25
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-25
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-25
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-25
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-25
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-25
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-25
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-25
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-25
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-24
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-24
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-24
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-24
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-24
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-24
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-24
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-24
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-24
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-24
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-24
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-24
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-24
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-23
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-23
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-23
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-23
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-23
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-23
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-23
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-23
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-23
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-23
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-23
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-23
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-23
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-23
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-22
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-22
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-20
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-20
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-20
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-19
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-19
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-19
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-19
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-19
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-19
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-19
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-19
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-19
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-19
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-19
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-19
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-19
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-19
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-19
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-19
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-19
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-19
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-19
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-19
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-19
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		8e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-18
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-18
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-18
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-18
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-18
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-18
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-18
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-18
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-18
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-18
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-18
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-18
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-18
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-18
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-18
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-18
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-18
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-18
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-18
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-18
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-18
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-18
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-18
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-18
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-18
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-18
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-18
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-18
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-18
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-18
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-18
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-17
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-17
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-17
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-17
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-17
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-17
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-17
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-17
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-17
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-17
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-17
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-17
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-17
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-17
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-17
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-16
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-16
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-16
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-16
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-16
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-16
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-16
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-14
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-14
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-12
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-09
3soa_A	444	Full-Length Human Camkii Length = 444		6e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		9e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-06
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		6e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-06
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  185 bits (469), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 105/293 (35%), Positives = 168/293 (57%), Gaps = 4/293 (1%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVE-EFI 441
           + K F+ +EL+ A+DNF+   ILG+GG G VYKG L DG +VAVK+ K       E +F 
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 442 NEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEMRLR 500
            E+ ++S   HRN+++L G C+     LLVY ++ NG++   + ++ E   P+ W  R R
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
           IA+  +  L+YLH      I HRD+K+ NILLD+++ A V DFG ++ M     H+   V
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 203
Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTL--EEDKSLAAYFLFA 618
            GT G++ PEY  + + ++K+DV+ +GV+L EL+TG++      L  ++D  L  +    
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 263
Query: 619 MKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG 671
           +KE++L  ++D  +      +E+    +VA  C   +  +RP M EV   L G
Sbjct: 264 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  183 bits (464), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 104/296 (35%), Positives = 168/296 (56%), Gaps = 10/296 (3%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVE---- 438
           + K F+ +EL+ A+DNF    ILG+GG G VYKG L DG +VAVK+ K   E + +    
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLK---EERTQGGEL 72
Query: 439 EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP-ITWEM 497
           +F  E+ ++S   HRN+++L G C+     LLVY ++ NG++   + ++ E  P + W  
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 557
           R RIA+  +  L+YLH      I HRD+K+ NILLD+++ A V DFG ++ M     H+ 
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX 192
Query: 558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTL--EEDKSLAAYF 615
             V G  G++ PEY  + + ++K+DV+ +GV+L EL+TG++      L  ++D  L  + 
Sbjct: 193 XAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG 671
              +KE++L  ++D  +      +E+    +VA  C   +  +RP M EV   L G
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  179 bits (455), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 110/283 (38%), Positives = 166/283 (58%), Gaps = 9/283 (3%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           +LE AT+NF+   ++G G  G VYKG+L DG  VA+K+        +EEF  E+  LS  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP---ITWEMRLRIAIEVSG 507
            H ++V L+G C E    +L+Y+++ NG L ++++    D P   ++WE RL I I  + 
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQRLEICIGAAR 150
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS-MAVDQTHMTTQVHGTFGY 566
            L YLH+ A   I HRD+KS NILLD+ +  K++DFG S+    +DQTH+   V GT GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
           +DPEYF   + T+KSDVYSFGVVL E+L     I  +   E  +LA + + +    +L +
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
           I+D  +  +   + +  F   A +CL L+ + RP+M +V  +L
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  176 bits (447), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 109/283 (38%), Positives = 165/283 (58%), Gaps = 9/283 (3%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           +LE AT+NF+   ++G G  G VYKG+L DG  VA+K+        +EEF  E+  LS  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP---ITWEMRLRIAIEVSG 507
            H ++V L+G C E    +L+Y+++ NG L ++++    D P   ++WE RL I I  + 
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQRLEICIGAAR 150
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS-MAVDQTHMTTQVHGTFGY 566
            L YLH+ A   I HRD+KS NILLD+ +  K++DFG S+    + QTH+   V GT GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
           +DPEYF   + T+KSDVYSFGVVL E+L     I  +   E  +LA + + +    +L +
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
           I+D  +  +   + +  F   A +CL L+ + RP+M +V  +L
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  150 bits (380), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 162/298 (54%), Gaps = 16/298 (5%)
Query: 387 FTSKELERATDNFNLNRI------LGQGGQGTVYKGMLPDGKIVAVKKSKVID---ESKV 437
           F+  EL+  T+NF+   I      +G+GG G VYKG + +  +   K + ++D   E   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
           ++F  E+ ++++  H N+V+LLG   + +   LVY ++PNG+L   +   +   P++W M
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHM 556
           R +IA   +  +++LH    I   HRDIKS NILLD+ + AK+SDFG +R S    QT M
Sbjct: 135 RCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL 616
            +++ GT  Y+ PE  R  + T KSD+YSFGVVL E++TG  P      E    L     
Sbjct: 192 XSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEE 249
Query: 617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
              +E+ + + +D + M ++    +     VA +CL+    KRP +++V   L  + A
Sbjct: 250 IEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  150 bits (378), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 161/298 (54%), Gaps = 16/298 (5%)
Query: 387 FTSKELERATDNFNLNRI------LGQGGQGTVYKGMLPDGKIVAVKKSKVID---ESKV 437
           F+  EL+  T+NF+   I      +G+GG G VYKG + +  +   K + ++D   E   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
           ++F  E+ ++++  H N+V+LLG   + +   LVY ++PNG+L   +   +   P++W M
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHM 556
           R +IA   +  +++LH    I   HRDIKS NILLD+ + AK+SDFG +R S    QT M
Sbjct: 135 RCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL 616
             ++ GT  Y+ PE  R  + T KSD+YSFGVVL E++TG  P      E    L     
Sbjct: 192 XXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEE 249
Query: 617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
              +E+ + + +D + M ++    +     VA +CL+    KRP +++V   L  + A
Sbjct: 250 IEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  148 bits (373), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 160/298 (53%), Gaps = 16/298 (5%)
Query: 387 FTSKELERATDNFNLNRI------LGQGGQGTVYKGMLPDGKIVAVKKSKVID---ESKV 437
           F+  EL+  T+NF+   I      +G+GG G VYKG + +  +   K + ++D   E   
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
           ++F  E+ ++++  H N+V+LLG   + +   LVY ++PNG+L   +   +   P++W M
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 128
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHM 556
           R +IA   +  +++LH    I   HRDIKS NILLD+ + AK+SDFG +R S    Q  M
Sbjct: 129 RCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVM 185
Query: 557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL 616
             ++ GT  Y+ PE  R  + T KSD+YSFGVVL E++TG  P      E    L     
Sbjct: 186 XXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEE 243
Query: 617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
              +E+ + + +D + M ++    +     VA +CL+    KRP +++V   L  + A
Sbjct: 244 IEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 300

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 95/293 (32%), Positives = 152/293 (51%), Gaps = 16/293 (5%)
Query: 387 FTSKELERATDNFNLNRI------LGQGGQGTVYKGMLPDGKIVAVKKSKVID---ESKV 437
           F+  EL+  T+NF+   I       G+GG G VYKG + +  +   K + ++D   E   
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
           ++F  E+ + ++  H N+V+LLG   + +   LVY + PNG+L   +   +   P++W  
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHX 125
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHM 556
           R +IA   +  +++LH    I   HRDIKS NILLD+ + AK+SDFG +R S    Q   
Sbjct: 126 RCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVX 182
Query: 557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL 616
            +++ GT  Y  PE  R  + T KSD+YSFGVVL E++TG  P      E    L     
Sbjct: 183 XSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEE 240
Query: 617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
              +E+ + + +D +   ++    +     VA +CL+    KRP +++V   L
Sbjct: 241 IEDEEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  122 bits (306), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 145/300 (48%), Gaps = 38/300 (12%)
Query: 387 FTSKELERATDN-FNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDES--------KV 437
           F    L    DN     + +G+GG G V+KG L   K V   KS ++ +S        K 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
           +EF  E+ I+S +NH N+VKL G  L    P +V EF+P G L+  + D+    PI W +
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSV 123
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-----AKVSDFGASRSMAVD 552
           +LR+ ++++  + Y+ +    PI HRD++S NI L          AKV+DFG S+     
Sbjct: 124 KLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ---- 178
Query: 553 QTHMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKS 610
             H  + + G F ++ PE   + +  +T+K+D YSF ++L  +LTGE P      +E   
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-----FDEYSY 233
Query: 611 LAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
               F+  ++EE L   +          D       V + C + + KKRP    +  EL+
Sbjct: 234 GKIKFINMIREEGLRPTIPE--------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  122 bits (305), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 145/300 (48%), Gaps = 38/300 (12%)
Query: 387 FTSKELERATDN-FNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDES--------KV 437
           F    L    DN     + +G+GG G V+KG L   K V   KS ++ +S        K 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
           +EF  E+ I+S +NH N+VKL G  L    P +V EF+P G L+  + D+    PI W +
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSV 123
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-----AKVSDFGASRSMAVD 552
           +LR+ ++++  + Y+ +    PI HRD++S NI L          AKV+DFG S+     
Sbjct: 124 KLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---- 178
Query: 553 QTHMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKS 610
             H  + + G F ++ PE   + +  +T+K+D YSF ++L  +LTGE P      +E   
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-----FDEYSY 233
Query: 611 LAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
               F+  ++EE L   +          D       V + C + + KKRP    +  EL+
Sbjct: 234 GKIKFINMIREEGLRPTIPE--------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 111/204 (54%), Gaps = 5/204 (2%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVK--KSKVIDESKVEEFINEMVILSQINHRNV 455
           + N+   +G G  GTV++     G  VAVK    +     +V EF+ E+ I+ ++ H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           V  +G   +     +V E++  G+L++ +H       +    RL +A +V+  ++YLH+ 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN- 155
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
            + PI HRD+KS N+L+D KY  KV DFG SR +       +    GT  ++ PE  R  
Sbjct: 156 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 576 QFTDKSDVYSFGVVLAELLTGEKP 599
              +KSDVYSFGV+L EL T ++P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP 238

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  120 bits (300), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 92/297 (30%), Positives = 141/297 (47%), Gaps = 43/297 (14%)
Query: 392 LERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFI----NEMVIL 447
           LE       L  I+G GG G VY+     G  VAVK ++   +  + + I     E  + 
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN--EDFPITWEMRLRIAIEV 505
           + + H N++ L G CL+     LV EF   G L + +  +    D  + W      A+++
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQI 114
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYR--------AKVSDFGASRSMAVDQTHMT 557
           +  ++YLH  A +PI HRD+KS+NIL+  K           K++DFG +R     + H T
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRT 169
Query: 558 TQVH--GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
           T++   G + ++ PE  R+S F+  SDV+S+GV+L ELLTGE P R         LA  +
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-----DGLAVAY 224
Query: 616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
             AM +  L           S   E   FAK+ + C N +   RP+   +  +L  I
Sbjct: 225 GVAMNKLAL--------PIPSTCPE--PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 145/300 (48%), Gaps = 38/300 (12%)
Query: 387 FTSKELERATDN-FNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDES--------KV 437
           F    L    DN     + +G+GG G V+KG L   K V   KS ++ +S        K 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
           +EF  E+ I+S +NH N+VKL G  L    P +V EF+P G L+  + D+    PI W +
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSV 123
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-----AKVSDFGASRSMAVD 552
           +LR+ ++++  + Y+ +    PI HRD++S NI L          AKV+DF    S++  
Sbjct: 124 KLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADF----SLSQQ 178
Query: 553 QTHMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKS 610
             H  + + G F ++ PE   + +  +T+K+D YSF ++L  +LTGE P      +E   
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-----FDEYSY 233
Query: 611 LAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
               F+  ++EE L   +          D       V + C + + KKRP    +  EL+
Sbjct: 234 GKIKFINMIREEGLRPTIPE--------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 71/205 (34%), Positives = 115/205 (56%), Gaps = 7/205 (3%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVK--KSKVIDESKVEEFINEMVILSQINHRNV 455
           + N+   +G G  GTV++     G  VAVK    +     +V EF+ E+ I+ ++ H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           V  +G   +     +V E++  G+L++ +H       +    RL +A +V+  ++YLH+ 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN- 155
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ-VHGTFGYLDPEYFRS 574
            + PI HR++KS N+L+D KY  KV DFG SR  A   T ++++   GT  ++ PE  R 
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRD 213
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKP 599
               +KSDVYSFGV+L EL T ++P
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + +L 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M     D  H  T       ++  E
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 317
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 318 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + +L 
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 154
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M     D  H  T       ++  E
Sbjct: 155 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 263
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 264 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + +L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 149
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M     D  H  T       ++  E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 258
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 259 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + +L 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 150
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M     D  H  T       ++  E
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 259
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 260 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + +L 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 147
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M     D  H  T       ++  E
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 256
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 257 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  115 bits (288), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + +L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 149
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M     D  H  T       ++  E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 258
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 259 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  115 bits (288), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + +L 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 150
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M     D  H  T       ++  E
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE 208
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 259
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 260 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 144/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + YL 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 148
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M        H  T       ++  E
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 257
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 258 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + YL 
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 168
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ---THMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M   +    H  T       ++  E
Sbjct: 169 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 277
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 278 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + YL 
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 167
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ---THMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M   +    H  T       ++  E
Sbjct: 168 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 276
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 277 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + YL 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 149
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ---THMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M   +    H  T       ++  E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 258
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 259 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + YL 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 144
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ---THMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M   +    H  T       ++  E
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 253
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 254 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + YL 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 146
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ---THMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M   +    H  T       ++  E
Sbjct: 147 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 255
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 256 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + YL 
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 141
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ---THMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M   +    H  T       ++  E
Sbjct: 142 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 250
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 251 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + YL 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 147
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ---THMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M   +    H  T       ++  E
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 256
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 257 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + YL 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 148
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ---THMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M   +    H  T       ++  E
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 257
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 258 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 145/282 (51%), Gaps = 29/282 (10%)
Query: 400 NLNRILGQGGQGTVYKGML--PDGKIV--AVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           + N ++G+G  G VY G L   DGK +  AVK  +++ D  +V +F+ E +I+   +H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 455 VVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           V+ LLG CL +E  PL+V  ++ +G L  +I  +NE    T +  +   ++V+  + YL 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 149
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ---THMTTQVHGTFGYLDPE 570
             AS    HRD+ + N +LD+K+  KV+DFG +R M   +    H  T       ++  E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++  RL +    
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQ---- 258
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D +    +V  +C +   + RP+  E+ S ++ I
Sbjct: 259 ---PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 27/290 (9%)
Query: 379 GTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVE 438
           G ++ +  +   E+ER   +  +   LG G  G VY+G+     +    K+   D  +VE
Sbjct: 1   GAMDPSPNYDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE 58
Query: 439 EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR 498
           EF+ E  ++ +I H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + 
Sbjct: 59  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVL 117
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
           L +A ++S A+ YL     I   HRD+ + N L+ + +  KV+DFG SR M  D      
Sbjct: 118 LYMATQISSAMEYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
Query: 559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLF 617
                  +  PE    ++F+ KSDV++FGV+L E+ T G  P     L +          
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------- 224
Query: 618 AMKEERLFEIL--DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                 ++E+L  D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 225 ------VYELLEKDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 266

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 7   EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 64
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    ++  + L +A ++S A+ 
Sbjct: 65  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 123
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 124 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P                   +   +++E+L 
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP----------------GIDPSQVYELLE 224
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 225 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 260

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 14  EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 130
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 131 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 187
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 231
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 232 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 14  EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    ++  + L +A ++S A+ 
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 130
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 131 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 231
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 232 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 10  EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 67
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 68  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 126
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 127 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 183
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 227
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 228 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 263

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 9   EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    ++  + L +A ++S A+ 
Sbjct: 67  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 125
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 126 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 226
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 227 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 9   EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    ++  + L +A ++S A+ 
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 125
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 126 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 226
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 227 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 262

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 14  EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 72  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 130
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 131 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 231
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 232 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 9   EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    ++  + L +A ++S A+ 
Sbjct: 67  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 125
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 126 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 226
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 227 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 262

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  108 bits (271), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 9   EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    ++  + L +A ++S A+ 
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 125
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 126 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 226
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 227 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 9   EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 125
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 126 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 226
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 227 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 262

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 14  EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 130
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 131 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 231
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 232 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 9   EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 125
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 126 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 226
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 227 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 262

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 10  EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 67
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 68  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 126
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 127 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 183
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 227
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 228 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 263

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 6/205 (2%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 28  EMERT--DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 85
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       +V E++P G L  Y+ + N +  +T  + L +A ++S A+ 
Sbjct: 86  KHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE-EVTAVVLLYMATQISSAME 144
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 145 YLEKKNFI---HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 201
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT 595
               + F+ KSDV++FGV+L E+ T
Sbjct: 202 SLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 11  EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 68
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 127
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 128 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 184
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 228
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 229 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 264

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 14  EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 130
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 131 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 231
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 232 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 22  EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 79
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 80  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 138
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 139 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 195
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 196 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 239
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 240 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 275

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 11  EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 68
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 127
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 128 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 228
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 229 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 264

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 11  EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 68
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 127
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 128 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 228
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 229 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 264

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 7   EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 64
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    ++  + L +A ++S A+ 
Sbjct: 65  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 123
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 124 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE 180
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P                   +   +++E+L 
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP----------------GIDPSQVYELLE 224
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 225 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 260

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 7   EMERT--DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 64
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    ++  + L +A ++S A+ 
Sbjct: 65  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 123
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 124 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P                   +   +++E+L 
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP----------------GIDPSQVYELLE 224
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 225 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 260

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 216 EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 273
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    ++  + L +A ++S A+ 
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAME 332
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HR++ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 333 YLEKKNFI---HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 433
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 434 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 469

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ER   +  +   LG G  G VY+G+     +    K+   D  +VEEF+ E  ++ +I
Sbjct: 255 EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 312
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N+V+LLG C       ++ EF+  G L  Y+ + N    +   + L +A ++S A+ 
Sbjct: 313 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAME 371
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HR++ + N L+ + +  KV+DFG SR M  D             +  PE
Sbjct: 372 YLEKKNFI---HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 428
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL- 628
               ++F+ KSDV++FGV+L E+ T G  P     L +                ++E+L 
Sbjct: 429 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 472
Query: 629 -DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            D R+ +  G  E +   ++ + C   N   RP+  E+
Sbjct: 473 KDYRMERPEGCPEKVY--ELMRACWQWNPSDRPSFAEI 508

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 108/203 (53%), Gaps = 10/203 (4%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVK 457
              +  ++G+G  G V K      K VA+K+  +  ES+ + FI E+  LS++NH N+VK
Sbjct: 10  EIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVK 66
Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           L G CL      LV E+   G+L+  +H        T    +   ++ S  ++YLHS   
Sbjct: 67  LYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 518 IPIYHRDIKSTNILL-DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
             + HRD+K  N+LL       K+ DFG +  +   QTHMT    G+  ++ PE F  S 
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSN 180
Query: 577 FTDKSDVYSFGVVLAELLTGEKP 599
           +++K DV+S+G++L E++T  KP
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKP 203

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 108/203 (53%), Gaps = 10/203 (4%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVK 457
              +  ++G+G  G V K      K VA+K+  +  ES+ + FI E+  LS++NH N+VK
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVK 65
Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           L G CL      LV E+   G+L+  +H        T    +   ++ S  ++YLHS   
Sbjct: 66  LYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 518 IPIYHRDIKSTNILL-DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
             + HRD+K  N+LL       K+ DFG +  +   QTHMT    G+  ++ PE F  S 
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSN 179
Query: 577 FTDKSDVYSFGVVLAELLTGEKP 599
           +++K DV+S+G++L E++T  KP
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKP 202

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 125/225 (55%), Gaps = 21/225 (9%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKS-KVIDESKVE-- 438
           + ++    EL+R        ++LG G  GTVYKG+ +P+G+ V +  + K+++E+     
Sbjct: 31  QLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA 83
Query: 439 --EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWE 496
             EF++E +I++ ++H ++V+LLG CL   +  LV + +P+G L +Y+H+  ++  I  +
Sbjct: 84  NVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDN--IGSQ 140
Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 556
           + L   ++++  + YL       + HRD+ + N+L+      K++DFG +R +  D+   
Sbjct: 141 LLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 197
Query: 557 TTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                     ++  E     +FT +SDV+S+GV + EL+T G KP
Sbjct: 198 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 125/225 (55%), Gaps = 21/225 (9%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKS-KVIDESKVE-- 438
           + ++    EL+R        ++LG G  GTVYKG+ +P+G+ V +  + K+++E+     
Sbjct: 8   QLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA 60
Query: 439 --EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWE 496
             EF++E +I++ ++H ++V+LLG CL   +  LV + +P+G L +Y+H+  ++  I  +
Sbjct: 61  NVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDN--IGSQ 117
Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 556
           + L   ++++  + YL       + HRD+ + N+L+      K++DFG +R +  D+   
Sbjct: 118 LLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 174
Query: 557 TTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                     ++  E     +FT +SDV+S+GV + EL+T G KP
Sbjct: 175 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 143/292 (48%), Gaps = 38/292 (13%)
Query: 403 RILGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVK 457
           R LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 458 LLGCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
             G C         L+ EF+P G+L +Y+    E   I     L+   ++   + YL + 
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER--IDHIKLLQYTSQICKGMEYLGTK 136
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYF 572
             I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE  
Sbjct: 137 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESL 192
Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------L 624
             S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L
Sbjct: 193 TESKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 244
Query: 625 FEIL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
            E+L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 245 IELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 293

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 105/194 (54%), Gaps = 6/194 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           +G G  G V+ G   +   VA+K  +    S+ E+FI E  ++ +++H  +V+L G CLE
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                LV+EF+ +G L  Y+  Q   F    E  L + ++V   ++YL  A+ I   HRD
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEASVI---HRD 128
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L+ +    KVSDFG +R +  DQ   +T       +  PE F  S+++ KSDV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 585 SFGVVLAELLTGEK 598
           SFGV++ E+ +  K
Sbjct: 189 SFGVLMWEVFSEGK 202

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 103/191 (53%), Gaps = 6/191 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           +G G  G V+ G   +   VA+K  +    S+ E+FI E  ++ +++H  +V+L G CLE
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                LV+EF+ +G L  Y+  Q   F    E  L + ++V   ++YL  A  I   HRD
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI---HRD 131
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L+ +    KVSDFG +R +  DQ   +T       +  PE F  S+++ KSDV+
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191
Query: 585 SFGVVLAELLT 595
           SFGV++ E+ +
Sbjct: 192 SFGVLMWEVFS 202

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 136 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA-PESLTE 191
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 192 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 244 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 290

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 134
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 135 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 190
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 191 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 242
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 243 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 289

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 133
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 134 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 189
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 190 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 241
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 242 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 288

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 136 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 191
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 192 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 244 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 290

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 104/194 (53%), Gaps = 6/194 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           +G G  G V+ G   +   VA+K  +    S+ E+FI E  ++ +++H  +V+L G CLE
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                LV+EF+ +G L  Y+  Q   F    E  L + ++V   ++YL  A  I   HRD
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI---HRD 128
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L+ +    KVSDFG +R +  DQ   +T       +  PE F  S+++ KSDV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 585 SFGVVLAELLTGEK 598
           SFGV++ E+ +  K
Sbjct: 189 SFGVLMWEVFSEGK 202

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 139 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 194
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 195 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 246
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 247 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 293

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 140
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 141 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 196
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 197 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 248
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 249 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 295

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 142
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 143 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 198
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 199 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 250
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 251 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 297

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 104/194 (53%), Gaps = 6/194 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           +G G  G V+ G   +   VA+K  +    S+ E+FI E  ++ +++H  +V+L G CLE
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                LV+EF+ +G L  Y+  Q   F    E  L + ++V   ++YL  A  I   HRD
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI---HRD 126
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L+ +    KVSDFG +R +  DQ   +T       +  PE F  S+++ KSDV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 585 SFGVVLAELLTGEK 598
           SFGV++ E+ +  K
Sbjct: 187 SFGVLMWEVFSEGK 200

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 136 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 191
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 192 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 244 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 290

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 167 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 222
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 223 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 275 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 321

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 141
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 142 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 197
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 198 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 249
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 250 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 296

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 139
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 140 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 195
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 196 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 247
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 248 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 294

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 153
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 154 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 209
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 210 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 261
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 262 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 308

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 153
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 154 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 209
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 210 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 261
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 262 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 308

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 104/194 (53%), Gaps = 6/194 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           +G G  G V+ G   +   VA+K  K    S+ ++FI E  ++ +++H  +V+L G CLE
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                LV+EF+ +G L  Y+  Q   F    E  L + ++V   ++YL  A  I   HRD
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI---HRD 148
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L+ +    KVSDFG +R +  DQ   +T       +  PE F  S+++ KSDV+
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 208
Query: 585 SFGVVLAELLTGEK 598
           SFGV++ E+ +  K
Sbjct: 209 SFGVLMWEVFSEGK 222

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 142/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKRY 136
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HR++ + NIL++++ R K+ DFG ++ +  D+ +   +  G    F Y  PE    
Sbjct: 137 I---HRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA-PESLTE 192
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 193 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 244
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 245 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 291

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 114/207 (55%), Gaps = 14/207 (6%)
Query: 402 NRILGQGGQGTVYKGMLP--DGK---IVAVKKSKV-IDESKVEEFINEMVILSQINHRNV 455
            +++G G  G VYKGML    GK    VA+K  K    E +  +F+ E  I+ Q +H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           ++L G   + +  +++ E++ NG L +++ +++ +F +     L++   + G  + +   
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV-----LQLVGMLRGIAAGMKYL 163
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD--QTHMTTQVHGTFGYLDPEYFR 573
           A++   HRD+ + NIL++     KVSDFG SR +  D   T+ T+       +  PE   
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 574 SSQFTDKSDVYSFGVVLAELLT-GEKP 599
             +FT  SDV+SFG+V+ E++T GE+P
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 405 LGQGGQGTV----YKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           LG+G  G+V    Y  +  + G++VAVKK +   E  + +F  E+ IL  + H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 460 GCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           G C         L+ E++P G+L  Y+    E   I     L+   ++   + YL +   
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRS 574
           I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G    F Y  PE    
Sbjct: 139 I---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA-PESLTE 194
Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER--------LFE 626
           S+F+  SDV+SFGVVL EL        FT +E+ KS  A F+  +  ++        L E
Sbjct: 195 SKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 246
Query: 627 IL--DARVMKESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           +L  + R+ +  G  DEI     +   C N N  +RP+ R++   +  I+
Sbjct: 247 LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIR 293

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           +G G  G V+ G   +   VA+K  +    S+ E+FI E  ++ +++H  +V+L G CLE
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                LV EF+ +G L  Y+  Q   F    E  L + ++V   ++YL  A  I   HRD
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI---HRD 129
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L+ +    KVSDFG +R +  DQ   +T       +  PE F  S+++ KSDV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 585 SFGVVLAELLTGEK 598
           SFGV++ E+ +  K
Sbjct: 190 SFGVLMWEVFSEGK 203

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 143/282 (50%), Gaps = 33/282 (11%)
Query: 402 NRILGQGGQGTVYKGMLPD---GKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVV 456
           +R++G+G  G VY G   D    +I  A+K  S++ +  +VE F+ E +++  +NH NV+
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 457 KLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
            L+G  L  E +P ++  ++ +G L Q+I     + P   ++ +   ++V+  + YL   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDL-ISFGLQVARGMEYL--- 140
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG----TFGYLDPEY 571
           A     HRD+ + N +LD+ +  KV+DFG +R + +D+ + + Q H        +   E 
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPVKWTALES 199
Query: 572 FRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
            ++ +FT KSDV+SFGV+L ELLT G  P R      D     +FL   +  RL +    
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----DPFDLTHFL--AQGRRLPQ---- 249
Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               E   D   +  +V ++C   +   RPT R +  E+  I
Sbjct: 250 ---PEYCPD---SLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 405 LGQGGQGTVY----KGMLP--DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           LG+G  G V+      +LP  D  +VAVK  K   ES  ++F  E  +L+ + H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF------------PITWEMRLRIAIEVS 506
            G C E    L+V+E++ +G L +++     D             P+     L +A +V+
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFG 565
             + YL   A +   HRD+ + N L+      K+ DFG SR + + D   +  +      
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           ++ PE     +FT +SDV+SFGVVL E+ T G++P
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 405 LGQGGQGTVY----KGMLP--DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           LG+G  G V+      +LP  D  +VAVK  K   ES  ++F  E  +L+ + H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF------------PITWEMRLRIAIEVS 506
            G C E    L+V+E++ +G L +++     D             P+     L +A +V+
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFG 565
             + YL   A +   HRD+ + N L+      K+ DFG SR + + D   +  +      
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           ++ PE     +FT +SDV+SFGVVL E+ T G++P
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 119/233 (51%), Gaps = 20/233 (8%)
Query: 379 GTIEKTKLF------TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVI 432
           GT EK K+       +S   E       L+  +G G  GTVYKG       VAVK  KV+
Sbjct: 12  GTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGD--VAVKILKVV 69
Query: 433 DES--KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED 490
           D +  + + F NE+ +L +  H N++  +G   +  + + V ++    +L++++H Q   
Sbjct: 70  DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAI-VTQWCEGSSLYKHLHVQETK 128
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSM 549
           F +     + IA + +  + YLH+     I HRD+KS NI L +    K+ DFG A+   
Sbjct: 129 FQMF--QLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKP 599
               +    Q  G+  ++ PE  R   ++ F+ +SDVYS+G+VL EL+TGE P
Sbjct: 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 405 LGQGGQGTVY----KGMLP--DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKL 458
           LG+G  G V+      +LP  D  +VAVK  K   ES  ++F  E  +L+ + H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF------------PITWEMRLRIAIEVS 506
            G C E    L+V+E++ +G L +++     D             P+     L +A +V+
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFG 565
             + YL   A +   HRD+ + N L+      K+ DFG SR + + D   +  +      
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           ++ PE     +FT +SDV+SFGVVL E+ T G++P
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 118/231 (51%), Gaps = 15/231 (6%)
Query: 379 GTIEKTKLFTSKELERATD--NFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV- 431
           G + +    T  E  +  D  N ++++++G G  G V  G L  P  K   VA+K  KV 
Sbjct: 13  GLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 72
Query: 432 IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF 491
             E +  +F+ E  I+ Q +H N+++L G   +++  ++V E++ NG+L  ++   +  F
Sbjct: 73  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF 132
Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 551
            +     +++   + G  S +   + +   HRD+ + NIL++     KVSDFG SR +  
Sbjct: 133 TV-----IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 187
Query: 552 DQTHMTTQVHGTFG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           D     T   G     +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 188 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 112/218 (51%), Gaps = 14/218 (6%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
           +S + E       + + +G G  GTVYKG       V +         +++ F NE+ +L
Sbjct: 15  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 74
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR--LRIAIEV 505
            +  H N++  +G   + ++ + V ++    +L+ ++H     F    EM+  + IA + 
Sbjct: 75  RKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHASETKF----EMKKLIDIARQT 129
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTF 564
           +  + YLH+ +   I HRD+KS NI L +    K+ DFG A+       +H   Q+ G+ 
Sbjct: 130 ARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 565 GYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKP 599
            ++ PE  R   S+ ++ +SDVY+FG+VL EL+TG+ P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 116/219 (52%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           +KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E
Sbjct: 10  AKELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G   +++  ++V E++ NG+L  ++   +  F +     +++  
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVG 122
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            + G  S +   + +   HRD+ + NIL++     KVSDFG SR +  D     T   G 
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 116/219 (52%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           +KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E
Sbjct: 39  AKELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G   +++  ++V E++ NG+L  ++   +  F +     +++  
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVG 151
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            + G  S +   + +   HRD+ + NIL++     KVSDFG SR +  D     T   G 
Sbjct: 152 MLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 138/301 (45%), Gaps = 40/301 (13%)
Query: 371 QQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK-- 427
           ++ELAS +   E      SK+ + A ++F + R LG+G  G VY       K I+A+K  
Sbjct: 14  EEELASKQKNEE------SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL 67
Query: 428 -KSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD 486
            K+++       +   E+ I S + H N+++L G   +     L+ E+ P GT+++ +  
Sbjct: 68  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 127
Query: 487 QNE-DFPITWEMRLRIAI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
            ++ D     E R    I E++ ALSY HS   I   HRDIK  N+LL      K++DFG
Sbjct: 128 LSKFD-----EQRTATYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFG 179
Query: 545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTT 604
            S  +    +  TT + GT  YL PE        +K D++S GV+  E L G+ P    T
Sbjct: 180 WS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 236
Query: 605 LEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
            +E     +   F   +               G  ++I+      R L  N  +RP +RE
Sbjct: 237 YQETYKRISRVEFTFPD-----------FVTEGARDLIS------RLLKHNPSQRPMLRE 279
Query: 665 V 665
           V
Sbjct: 280 V 280

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 116/219 (52%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           +KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E
Sbjct: 39  AKELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G   +++  ++V E++ NG+L  ++   +  F +     +++  
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVG 151
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            + G  S +   + +   HRD+ + NIL++     KVSDFG SR +  D     T   G 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 116/219 (52%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           +KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E
Sbjct: 39  AKELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G   +++  ++V E++ NG+L  ++   +  F +     +++  
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVG 151
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            + G  S +   + +   HRD+ + NIL++     KVSDFG SR +  D     T   G 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 116/219 (52%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           +KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E
Sbjct: 39  AKELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G   +++  ++V E++ NG+L  ++   +  F +     +++  
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVG 151
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            + G  S +   + +   HRD+ + NIL++     KVSDFG SR +  D     T   G 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 112/218 (51%), Gaps = 14/218 (6%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
           +S + E       + + +G G  GTVYKG       V +         +++ F NE+ +L
Sbjct: 3   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 62
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR--LRIAIEV 505
            +  H N++  +G   + ++ + V ++    +L+ ++H     F    EM+  + IA + 
Sbjct: 63  RKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHASETKF----EMKKLIDIARQT 117
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTF 564
           +  + YLH+ +   I HRD+KS NI L +    K+ DFG A+       +H   Q+ G+ 
Sbjct: 118 ARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 565 GYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKP 599
            ++ PE  R   S+ ++ +SDVY+FG+VL EL+TG+ P
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 116/219 (52%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           +KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E
Sbjct: 39  AKELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G   +++  ++V E++ NG+L  ++   +  F +     +++  
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVG 151
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            + G  S +   + +   HRD+ + NIL++     KVSDFG SR +  D     T   G 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 116/219 (52%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           +KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E
Sbjct: 37  AKELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 94
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G   +++  ++V E++ NG+L  ++   +  F +     +++  
Sbjct: 95  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVG 149
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            + G  S +   + +   HRD+ + NIL++     KVSDFG SR +  D     T   G 
Sbjct: 150 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 210 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 121/220 (55%), Gaps = 14/220 (6%)
Query: 390 KELERATDNFNLNRI-LGQGGQGTVYKGMLPDGKI---VAVKKSKV-IDESKVEEFINEM 444
           K+L    DN  +  I LG G  G+V +G+    K    VA+K  K   +++  EE + E 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
            I+ Q+++  +V+L+G C + E  +LV E    G L +++  + E+ P++      +  +
Sbjct: 62  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQ 118
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           VS  + YL     +   HRD+ + N+LL +++ AK+SDFG S+++  D ++ T +  G +
Sbjct: 119 VSMGMKYLEEKNFV---HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 565 --GYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
              +  PE     +F+ +SDV+S+GV + E L+ G+KP +
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 136/302 (45%), Gaps = 42/302 (13%)
Query: 371 QQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK-- 427
           ++ELAS +   E      SK+ + A ++F + R LG+G  G VY       K I+A+K  
Sbjct: 5   EEELASKQKNEE------SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL 58
Query: 428 -KSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QY 483
            K+++       +   E+ I S + H N+++L G   +     L+ E+ P GT++   Q 
Sbjct: 59  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 118
Query: 484 IHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 543
           +   +E    T+        E++ ALSY HS   I   HRDIK  N+LL      K++DF
Sbjct: 119 LSKFDEQRTATY------ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADF 169
Query: 544 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFT 603
           G S  +    +  TT + GT  YL PE        +K D++S GV+  E L G+ P    
Sbjct: 170 GWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 226
Query: 604 TLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMR 663
           T +E     +   F   +               G  ++I+      R L  N  +RP +R
Sbjct: 227 TYQETYKRISRVEFTFPD-----------FVTEGARDLIS------RLLKHNPSQRPMLR 269
Query: 664 EV 665
           EV
Sbjct: 270 EV 271

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 14/201 (6%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           +G G  GTVYKG       V +         +++ F NE+ +L +  H N++  +G    
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR--LRIAIEVSGALSYLHSAASIPIYH 522
            ++ + V ++    +L+ ++H     F    EM+  + IA + +  + YLH+ +   I H
Sbjct: 92  PQLAI-VTQWCEGSSLYHHLHASETKF----EMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 523 RDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGYLDPEYFR---SSQFT 578
           RD+KS NI L +    K+ DFG A+       +H   Q+ G+  ++ PE  R   S+ ++
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 579 DKSDVYSFGVVLAELLTGEKP 599
            +SDVY+FG+VL EL+TG+ P
Sbjct: 204 FQSDVYAFGIVLYELMTGQLP 224

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           +KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E
Sbjct: 10  AKELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G   +++  ++V E + NG+L  ++   +  F +     +++  
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV-----IQLVG 122
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            + G  S +   + +   HRD+ + NIL++     KVSDFG SR +  D     T   G 
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 116/219 (52%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           +KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E
Sbjct: 39  AKELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G   +++  ++V E++ NG+L  ++   +  F +     +++  
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVG 151
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            + G  S +   + +   HRD+ + NIL++     KVSDFG +R +  D     T   G 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK 211
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 141/307 (45%), Gaps = 35/307 (11%)
Query: 379 GTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKV 431
           G+     ++   E E A +   ++R LGQG  G VY+G+        P+ ++     ++ 
Sbjct: 1   GSFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 60
Query: 432 IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF 491
               +  EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  Y+     + 
Sbjct: 61  ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 120
Query: 492 -------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                  P +    +++A E++  ++YL++   +   HRD+ + N ++ + +  K+ DFG
Sbjct: 121 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFG 177
Query: 545 ASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            +R +   D      +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P + 
Sbjct: 178 MTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 237
Query: 603 TTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTM 662
            +                E+ L  +++  ++ +      + F ++ + C   N K RP+ 
Sbjct: 238 LS---------------NEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSF 281
Query: 663 REVTSEL 669
            E+ S +
Sbjct: 282 LEIISSI 288

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           +KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E
Sbjct: 39  AKELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G   +++  ++V E + NG+L  ++   +  F +   + +   I
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
             +  + YL    ++   HRD+ + NIL++     KVSDFG SR +  D     T   G 
Sbjct: 157 --ASGMKYLSDMGAV---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           +KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E
Sbjct: 39  AKELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G   +++  ++V E++ NG+L  ++   +  F +     +++  
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVG 151
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            + G  S +   + +   HRD+ + NIL++     KVSDFG  R +  D     T   G 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P GT++   Q +   +E    T+      
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 114
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +    T + 
Sbjct: 115 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLC 168
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 228
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 229 -----------FVTEGARDLIS------RLLKHNPSQRPMLREV 255

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P GT++   Q +   +E    T+      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 118
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +    T + 
Sbjct: 119 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLC 172
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 232
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 233 -----------FVTEGARDLIS------RLLKHNPSQRPMLREV 259

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           +KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E
Sbjct: 39  AKELD--ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G   +++  ++V E + NG+L  ++   +  F +     +++  
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV-----IQLVG 151
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            + G  S +   + +   HRD+ + NIL++     KVSDFG SR +  D     T   G 
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P GT++   Q +   +E    T+      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 118
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +    T + 
Sbjct: 119 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLC 172
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 173 GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 232
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 233 -----------FVTEGARDLIS------RLLKHNPSQRPXLREV 259

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 16/213 (7%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVKKSK---VIDESKVEEFINEMVIL 447
           A ++  LNRILG+G  G VY+G+  + K     VAVK  K    +D    E+F++E VI+
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIM 63
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
             ++H ++VKL+G  +E E   ++ E  P G L  Y+        +     +  ++++  
Sbjct: 64  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQICK 120
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           A++YL S   +   HRDI   NIL+      K+ DFG SR +  +  +  +       ++
Sbjct: 121 AMAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 177
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            PE     +FT  SDV+ F V + E+L+ G++P
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 141/307 (45%), Gaps = 35/307 (11%)
Query: 379 GTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKV 431
           G+     ++   E E A +   ++R LGQG  G VY+G+        P+ ++     ++ 
Sbjct: 1   GSFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 60
Query: 432 IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF 491
               +  EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  Y+     + 
Sbjct: 61  ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 120
Query: 492 -------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                  P +    +++A E++  ++YL++   +   HRD+ + N ++ + +  K+ DFG
Sbjct: 121 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFG 177
Query: 545 ASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            +R +   D      +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P + 
Sbjct: 178 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 237
Query: 603 TTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTM 662
            +                E+ L  +++  ++ +      + F ++ + C   N K RP+ 
Sbjct: 238 LS---------------NEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSF 281
Query: 663 REVTSEL 669
            E+ S +
Sbjct: 282 LEIISSI 288

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P GT++   Q +   +E    T+      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 118
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +    T + 
Sbjct: 119 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLC 172
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 232
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 233 -----------FVTEGARDLIS------RLLKHNPSQRPMLREV 259

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 16/213 (7%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVKKSK---VIDESKVEEFINEMVIL 447
           A ++  LNRILG+G  G VY+G+  + K     VAVK  K    +D    E+F++E VI+
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIM 79
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
             ++H ++VKL+G  +E E   ++ E  P G L  Y+        +     +  ++++  
Sbjct: 80  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQICK 136
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           A++YL S   +   HRDI   NIL+      K+ DFG SR +  +  +  +       ++
Sbjct: 137 AMAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 193
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            PE     +FT  SDV+ F V + E+L+ G++P
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 135/301 (44%), Gaps = 40/301 (13%)
Query: 371 QQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK-- 427
           ++ELAS +   E      SK+ + A ++F + R LG+G  G VY       K I+A+K  
Sbjct: 14  EEELASKQKNEE------SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL 67
Query: 428 -KSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD 486
            K+++       +   E+ I S + H N+++L G   +     L+ E+ P GT+++ +  
Sbjct: 68  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 127
Query: 487 QNE-DFPITWEMRLRIAI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
            ++ D     E R    I E++ ALSY HS   I   HRDIK  N+LL      K++DFG
Sbjct: 128 LSKFD-----EQRTATYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFG 179
Query: 545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTT 604
            S      +      + GT  YL PE        +K D++S GV+  E L G+ P    T
Sbjct: 180 WSVHAPSSRR---DDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 236
Query: 605 LEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
            +E     +   F   +               G  ++I+      R L  N  +RP +RE
Sbjct: 237 YQETYKRISRVEFTFPD-----------FVTEGARDLIS------RLLKHNPSQRPMLRE 279
Query: 665 V 665
           V
Sbjct: 280 V 280

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 8/210 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           LG G  G V  G       VA+K  K    S+ +EFI E  ++  ++H  +V+L G C +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                ++ E++ NG L  Y+ +    F    +  L +  +V  A+ YL S   +   HRD
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---HRD 145
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L++D+   KVSDFG SR +  D+   +        +  PE    S+F+ KSD++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 585 SFGVVLAELLT-GEKPI-RFTTLEEDKSLA 612
           +FGV++ E+ + G+ P  RFT  E  + +A
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 235

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 15/208 (7%)
Query: 402 NRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++ LG G  GTV KG            V + K++  D +  +E + E  ++ Q+++  +V
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +++G C E E  +LV E    G L +Y+  QN    +  +  + +  +VS  + YL  + 
Sbjct: 76  RMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRH--VKDKNIIELVHQVSMGMKYLEESN 131
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRS 574
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   Q HG +   +  PE    
Sbjct: 132 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 188
Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIR 601
            +F+ KSDV+SFGV++ E  + G+KP R
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQKPYR 216

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P GT++   Q +   +E    T+      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 116
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +    T + 
Sbjct: 117 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLC 170
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 230
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 231 -----------FVTEGARDLIS------RLLKHNPSQRPMLREV 257

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 16/213 (7%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVKKSK---VIDESKVEEFINEMVIL 447
           A ++  LNRILG+G  G VY+G+  + K     VAVK  K    +D    E+F++E VI+
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIM 67
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
             ++H ++VKL+G  +E E   ++ E  P G L  Y+        +     +  ++++  
Sbjct: 68  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQICK 124
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           A++YL S   +   HRDI   NIL+      K+ DFG SR +  +  +  +       ++
Sbjct: 125 AMAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            PE     +FT  SDV+ F V + E+L+ G++P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 15/208 (7%)
Query: 402 NRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++ LG G  GTV KG            V + K++  D +  +E + E  ++ Q+++  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +++G C E E  +LV E    G L +Y+  QN    +  +  + +  +VS  + YL  + 
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRH--VKDKNIIELVHQVSMGMKYLEESN 127
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRS 574
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   Q HG +   +  PE    
Sbjct: 128 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIR 601
            +F+ KSDV+SFGV++ E  + G+KP R
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYR 212

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 8/210 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           LG G  G V  G       VA+K  K    S+ +EFI E  ++  ++H  +V+L G C +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                ++ E++ NG L  Y+ +    F    +  L +  +V  A+ YL S   +   HRD
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---HRD 145
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L++D+   KVSDFG SR +  D+   +        +  PE    S+F+ KSD++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 585 SFGVVLAELLT-GEKPI-RFTTLEEDKSLA 612
           +FGV++ E+ + G+ P  RFT  E  + +A
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 235

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 15/208 (7%)
Query: 402 NRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++ LG G  GTV KG            V + K++  D +  +E + E  ++ Q+++  +V
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +++G C E E  +LV E    G L +Y+  QN    +  +  + +  +VS  + YL  + 
Sbjct: 70  RMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRH--VKDKNIIELVHQVSMGMKYLEESN 125
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRS 574
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   Q HG +   +  PE    
Sbjct: 126 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 182
Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIR 601
            +F+ KSDV+SFGV++ E  + G+KP R
Sbjct: 183 YKFSSKSDVWSFGVLMWEAFSYGQKPYR 210

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 15/208 (7%)
Query: 402 NRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++ LG G  GTV KG            V + K++  D +  +E + E  ++ Q+++  +V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +++G C E E  +LV E    G L +Y+  QN    +  +  + +  +VS  + YL  + 
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRH--VKDKNIIELVHQVSMGMKYLEESN 147
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRS 574
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   Q HG +   +  PE    
Sbjct: 148 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIR 601
            +F+ KSDV+SFGV++ E  + G+KP R
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKPYR 232

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 15/208 (7%)
Query: 402 NRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++ LG G  GTV KG            V + K++  D +  +E + E  ++ Q+++  +V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +++G C E E  +LV E    G L +Y+  QN    +  +  + +  +VS  + YL  + 
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRH--VKDKNIIELVHQVSMGMKYLEESN 147
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRS 574
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   Q HG +   +  PE    
Sbjct: 148 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIR 601
            +F+ KSDV+SFGV++ E  + G+KP R
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKPYR 232

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 15/208 (7%)
Query: 402 NRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++ LG G  GTV KG            V + K++  D +  +E + E  ++ Q+++  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +++G C E E  +LV E    G L +Y+  QN    +  +  + +  +VS  + YL  + 
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRH--VKDKNIIELVHQVSMGMKYLEESN 137
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRS 574
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   Q HG +   +  PE    
Sbjct: 138 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIR 601
            +F+ KSDV+SFGV++ E  + G+KP R
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYR 222

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 111/220 (50%), Gaps = 17/220 (7%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           ++E+E      ++ +I+G G  G V  G L  P  +   VA+K  K    E +  +F++E
Sbjct: 43  TREIE--ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSE 100
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G      + ++V E++ NG+L  ++   +  F I   M+L   +
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI---MQLVGML 157
Query: 504 EVSGA-LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
              GA + YL     +   HRD+ + N+L+D     KVSDFG SR +  D     T   G
Sbjct: 158 RGVGAGMRYLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGG 214
Query: 563 TFG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                +  PE      F+  SDV+SFGVV+ E+L  GE+P
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 21/220 (9%)
Query: 398 NFNLNRILGQGGQGTVYKG----MLP--DGKIVAVKKSKVIDESKVEEFINEMVILSQIN 451
           N  L R LG+G  G V+      + P  D  +VAVK  K   ++  ++F  E  +L+ + 
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF----------PITWEMRLRI 501
           H ++VK  G C+E +  ++V+E++ +G L +++     D            +T    L I
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQV 560
           A +++  + YL   AS    HRD+ + N L+ +    K+ DFG SR + + D   +    
Sbjct: 134 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 190
Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                ++ PE     +FT +SDV+S GVVL E+ T G++P
Sbjct: 191 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 15/208 (7%)
Query: 402 NRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++ LG G  GTV KG            V + K++  D +  +E + E  ++ Q+++  +V
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +++G C E E  +LV E    G L +Y+  QN    +  +  + +  +VS  + YL  + 
Sbjct: 90  RMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRH--VKDKNIIELVHQVSMGMKYLEESN 145
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRS 574
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   Q HG +   +  PE    
Sbjct: 146 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 202
Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIR 601
            +F+ KSDV+SFGV++ E  + G+KP R
Sbjct: 203 YKFSSKSDVWSFGVLMWEAFSYGQKPYR 230

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 133/302 (44%), Gaps = 38/302 (12%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMV 445
           K+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRIA 502
           I S + H N+++L G   +     L+ E+ P GT++   Q +   +E    T+       
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------I 115
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            E++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +    T + G
Sbjct: 116 TELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSCHAPSSRR---TTLSG 169
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE 622
           T  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   + 
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD- 228
Query: 623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASNSN 682
                         G  ++I+      R L  N  +RP +REV  E   I A N +  SN
Sbjct: 229 ----------FVTEGARDLIS------RLLKHNPSQRPMLREVL-EHPWITA-NSSKPSN 270
Query: 683 SM 684
           S 
Sbjct: 271 SQ 272

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 398 NFNLNRILGQGGQGTVYKGML--PDGKIVAVK----KSKVIDESK-VEEFINEMVILSQI 450
           +  L   LG G  G V +G    P GK V+V     K  V+ + + +++FI E+  +  +
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +HRN+++L G  L   + + V E  P G+L   +      F +      R A++V+  + 
Sbjct: 79  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMG 135
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG--TFGYLD 568
           YL S   I   HRD+ + N+LL  +   K+ DFG  R++  +  H   Q H    F +  
Sbjct: 136 YLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 192
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           PE  ++  F+  SD + FGV L E+ T G++P
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 15/208 (7%)
Query: 402 NRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++ LG G  GTV KG            V + K++  D +  +E + E  ++ Q+++  +V
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +++G C E E  +LV E    G L +Y+  QN    +  +  + +  +VS  + YL  + 
Sbjct: 434 RMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRH--VKDKNIIELVHQVSMGMKYLEESN 489
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRS 574
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   Q HG +   +  PE    
Sbjct: 490 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546
Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIR 601
            +F+ KSDV+SFGV++ E  + G+KP R
Sbjct: 547 YKFSSKSDVWSFGVLMWEAFSYGQKPYR 574

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P GT++   Q +   +E    T+      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 116
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +    T + 
Sbjct: 117 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLC 170
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 230
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 231 -----------FVTEGARDLIS------RLLKHNPSQRPMLREV 257

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 8/210 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           LG G  G V  G       VA+K  K    S+ +EFI E  ++  ++H  +V+L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                ++ E++ NG L  Y+ +    F    +  L +  +V  A+ YL S   +   HRD
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---HRD 130
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L++D+   KVSDFG SR +  D+   +        +  PE    S+F+ KSD++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 585 SFGVVLAELLT-GEKPI-RFTTLEEDKSLA 612
           +FGV++ E+ + G+ P  RFT  E  + +A
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 220

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 34/277 (12%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQI 450
           A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEMRLRIAI-EVSGA 508
            H N+++L G   +     L+ E+ P GT+++ +   ++ D     E R    I E++ A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANA 120
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           LSY HS   I   HRDIK  N+LL      K++DFG S      +    T++ GT  YL 
Sbjct: 121 LSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TELCGTLDYLP 174
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           PE        +K D++S GV+  E L G+ P    T +E     +   F   +       
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------- 227
Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                   G  ++I+      R L  N  +RP +REV
Sbjct: 228 ----FVTEGARDLIS------RLLKHNPSQRPMLREV 254

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 8/210 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           LG G  G V  G       VA+K  K    S+ +EFI E  ++  ++H  +V+L G C +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                ++ E++ NG L  Y+ +    F    +  L +  +V  A+ YL S   +   HRD
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---HRD 136
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L++D+   KVSDFG SR +  D+   +        +  PE    S+F+ KSD++
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 585 SFGVVLAELLT-GEKPI-RFTTLEEDKSLA 612
           +FGV++ E+ + G+ P  RFT  E  + +A
Sbjct: 197 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 226

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 121/223 (54%), Gaps = 14/223 (6%)
Query: 387 FTSKELERATDNFNLNRI-LGQGGQGTVYKGMLPDGKI---VAVKKSKV-IDESKVEEFI 441
              K+L    DN  +  I LG G  G+V +G+    K    VA+K  K   +++  EE +
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 384
Query: 442 NEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI 501
            E  I+ Q+++  +V+L+G C + E  +LV E    G L +++  + E+ P++    L  
Sbjct: 385 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-- 441
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             +VS  + YL     +   HR++ + N+LL +++ AK+SDFG S+++  D ++ T +  
Sbjct: 442 LHQVSMGMKYLEEKNFV---HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498
Query: 562 GTF--GYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
           G +   +  PE     +F+ +SDV+S+GV + E L+ G+KP +
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 139/300 (46%), Gaps = 35/300 (11%)
Query: 386 LFTSKELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKVIDESKVE 438
           +F   E E A +   ++R LGQG  G VY+G+        P+ ++     ++     +  
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 439 EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF------- 491
           EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  Y+     +        
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-A 550
           P +    +++A E++  ++YL++   +   HRD+ + N ++ + +  K+ DFG +R +  
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDK 609
            D      +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P +  +     
Sbjct: 182 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----- 236
Query: 610 SLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                      E+ L  +++  ++ +      + F ++ + C   N K RP+  E+ S +
Sbjct: 237 ----------NEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSI 285

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
           +S + E       + + +G G  GTVYKG       V +         +++ F NE+ +L
Sbjct: 19  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 78
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            +  H N++  +G   + ++ + V ++    +L+ ++H     F +     + IA + + 
Sbjct: 79  RKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQ 135
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGY 566
            + YLH+ +   I HRD+KS NI L +    K+ DFG A+       +H   Q+ G+  +
Sbjct: 136 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 192
Query: 567 LDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKP 599
           + PE  R    + ++ +SDVY+FG+VL EL+TG+ P
Sbjct: 193 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 398 NFNLNRILGQGGQGTVYKGML--PDGKIVAVK----KSKVIDESK-VEEFINEMVILSQI 450
           +  L   LG G  G V +G    P GK V+V     K  V+ + + +++FI E+  +  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +HRN+++L G  L   + + V E  P G+L   +      F +      R A++V+  + 
Sbjct: 69  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMG 125
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG--TFGYLD 568
           YL S   I   HRD+ + N+LL  +   K+ DFG  R++  +  H   Q H    F +  
Sbjct: 126 YLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 182
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           PE  ++  F+  SD + FGV L E+ T G++P
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P G ++   Q +   +E    T+      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY------ 118
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +    T + 
Sbjct: 119 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLC 172
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 232
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 233 -----------FVTEGARDLIS------RLLKHNPSQRPMLREV 259

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 15/208 (7%)
Query: 402 NRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++ LG G  GTV KG            V + K++  D +  +E + E  ++ Q+++  +V
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +++G C E E  +LV E    G L +Y+  QN    +  +  + +  +VS  + YL  + 
Sbjct: 435 RMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRH--VKDKNIIELVHQVSMGMKYLEESN 490
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRS 574
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   Q HG +   +  PE    
Sbjct: 491 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 547
Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIR 601
            +F+ KSDV+SFGV++ E  + G+KP R
Sbjct: 548 YKFSSKSDVWSFGVLMWEAFSYGQKPYR 575

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
           +S + E       + + +G G  GTVYKG       V +         +++ F NE+ +L
Sbjct: 27  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 86
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            +  H N++  +G   + ++ + V ++    +L+ ++H     F +     + IA + + 
Sbjct: 87  RKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQ 143
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGY 566
            + YLH+ +   I HRD+KS NI L +    K+ DFG A+       +H   Q+ G+  +
Sbjct: 144 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 200
Query: 567 LDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKP 599
           + PE  R    + ++ +SDVY+FG+VL EL+TG+ P
Sbjct: 201 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 8/210 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           LG G  G V  G       VA+K  K    S+ +EFI E  ++  ++H  +V+L G C +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                ++ E++ NG L  Y+ +    F    +  L +  +V  A+ YL S   +   HRD
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---HRD 129
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L++D+   KVSDFG SR +  D+   +        +  PE    S+F+ KSD++
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 585 SFGVVLAELLT-GEKPI-RFTTLEEDKSLA 612
           +FGV++ E+ + G+ P  RFT  E  + +A
Sbjct: 190 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 219

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 398 NFNLNRILGQGGQGTVYKGML--PDGKIVAVK----KSKVIDESK-VEEFINEMVILSQI 450
           +  L   LG G  G V +G    P GK V+V     K  V+ + + +++FI E+  +  +
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 72
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +HRN+++L G  L   + + V E  P G+L   +      F +      R A++V+  + 
Sbjct: 73  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMG 129
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG--TFGYLD 568
           YL S   I   HRD+ + N+LL  +   K+ DFG  R++  +  H   Q H    F +  
Sbjct: 130 YLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           PE  ++  F+  SD + FGV L E+ T G++P
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 398 NFNLNRILGQGGQGTVYKGML--PDGKIVAVK----KSKVIDESK-VEEFINEMVILSQI 450
           +  L   LG G  G V +G    P GK V+V     K  V+ + + +++FI E+  +  +
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +HRN+++L G  L   + + V E  P G+L   +      F +      R A++V+  + 
Sbjct: 79  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMG 135
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG--TFGYLD 568
           YL S   I   HRD+ + N+LL  +   K+ DFG  R++  +  H   Q H    F +  
Sbjct: 136 YLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           PE  ++  F+  SD + FGV L E+ T G++P
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 111/220 (50%), Gaps = 17/220 (7%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINE 443
           ++E+E      ++ +I+G G  G V  G L  P  +   VA+K  K    E +  +F++E
Sbjct: 43  TREIE--ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSE 100
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N+++L G      + ++V E++ NG+L  ++   +  F I   M+L   +
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI---MQLVGML 157
Query: 504 EVSGA-LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
              GA + YL     +   HRD+ + N+L+D     KVSDFG SR +  D     T   G
Sbjct: 158 RGVGAGMRYLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 563 TFG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                +  PE      F+  SDV+SFGVV+ E+L  GE+P
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 398 NFNLNRILGQGGQGTVYKGML--PDGKIVAVK----KSKVIDESK-VEEFINEMVILSQI 450
           +  L   LG G  G V +G    P GK V+V     K  V+ + + +++FI E+  +  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +HRN+++L G  L   + + V E  P G+L   +      F +      R A++V+  + 
Sbjct: 69  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMG 125
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG--TFGYLD 568
           YL S   I   HRD+ + N+LL  +   K+ DFG  R++  +  H   Q H    F +  
Sbjct: 126 YLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           PE  ++  F+  SD + FGV L E+ T G++P
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 398 NFNLNRILGQGGQGTVYKGML--PDGKIVAVK----KSKVIDESK-VEEFINEMVILSQI 450
           +  L   LG G  G V +G    P GK V+V     K  V+ + + +++FI E+  +  +
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 72
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +HRN+++L G  L   + + V E  P G+L   +      F +      R A++V+  + 
Sbjct: 73  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMG 129
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG--TFGYLD 568
           YL S   I   HRD+ + N+LL  +   K+ DFG  R++  +  H   Q H    F +  
Sbjct: 130 YLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           PE  ++  F+  SD + FGV L E+ T G++P
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 8/210 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           LG G  G V  G       VA+K  K    S+ +EFI E  ++  ++H  +V+L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                ++ E++ NG L  Y+ +    F    +  L +  +V  A+ YL S   +   HRD
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---HRD 130
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L++D+   KVSDFG SR +  D+   +        +  PE    S+F+ KSD++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 585 SFGVVLAELLT-GEKPI-RFTTLEEDKSLA 612
           +FGV++ E+ + G+ P  RFT  E  + +A
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 220

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 398 NFNLNRILGQGGQGTVYKGML--PDGKIVAVK----KSKVIDESK-VEEFINEMVILSQI 450
           +  L   LG G  G V +G    P GK V+V     K  V+ + + +++FI E+  +  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +HRN+++L G  L   + + V E  P G+L   +      F +      R A++V+  + 
Sbjct: 69  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMG 125
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG--TFGYLD 568
           YL S   I   HRD+ + N+LL  +   K+ DFG  R++  +  H   Q H    F +  
Sbjct: 126 YLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           PE  ++  F+  SD + FGV L E+ T G++P
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 10/199 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           +G G  GTVYKG       V +         +++ F NE+ +L +  H N++  +G   +
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
            ++ + V ++    +L+ ++H     F +     + IA + +  + YLH+ +   I HRD
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 525 IKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGYLDPEYFR---SSQFTDK 580
           +KS NI L +    K+ DFG A+       +H   Q+ G+  ++ PE  R    + ++ +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 581 SDVYSFGVVLAELLTGEKP 599
           SDVY+FG+VL EL+TG+ P
Sbjct: 190 SDVYAFGIVLYELMTGQLP 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 127/281 (45%), Gaps = 32/281 (11%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMV 445
           K+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ 
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-E 504
           I S + H N+++L G   +     L+ E+ P GT+++ +   ++ F    E R    I E
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FD---EQRTATYITE 116
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           ++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +    T + GT 
Sbjct: 117 LANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTL 170
Query: 565 GYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
            YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +   
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--- 227
Query: 625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                       G  ++I+      R L  N  +RP +REV
Sbjct: 228 --------FVTEGARDLIS------RLLKHNPSQRPMLREV 254

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 111/208 (53%), Gaps = 15/208 (7%)
Query: 402 NRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++ LG G  GTV KG            V + K++  D +  +E + E  ++ Q+++  +V
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +++G C E E  +LV E    G L +Y+  QN    +  +  + +  +VS  + YL  + 
Sbjct: 76  RMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRH--VKDKNIIELVHQVSMGMKYLEESN 131
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRS 574
            +   HRD+ + N+LL  ++ AK+SDFG S+++  D+     Q HG +   +  PE    
Sbjct: 132 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINY 188
Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIR 601
            +F+ KSDV+SFGV++ E  + G+KP R
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQKPYR 216

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 8/210 (3%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           LG G  G V  G       VA+K  K    S+ +EFI E  ++  ++H  +V+L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
                ++ E++ NG L  Y+ +    F    +  L +  +V  A+ YL S   +   HRD
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESKQFL---HRD 125
Query: 525 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
           + + N L++D+   KVSDFG SR +  D+   +        +  PE    S+F+ KSD++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 585 SFGVVLAELLT-GEKPI-RFTTLEEDKSLA 612
           +FGV++ E+ + G+ P  RFT  E  + +A
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAEHIA 215

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
           +S + E       + + +G G  GTVYKG       V +         +++ F NE+ +L
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            +  H N++  +G   + ++ + V ++    +L+ ++H     F +     + IA + + 
Sbjct: 64  RKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQ 120
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGY 566
            + YLH+ +   I HRD+KS NI L +    K+ DFG A+       +H   Q+ G+  +
Sbjct: 121 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 177
Query: 567 LDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKP 599
           + PE  R    + ++ +SDVY+FG+VL EL+TG+ P
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
           +S + E       + + +G G  GTVYKG       V +         +++ F NE+ +L
Sbjct: 1   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            +  H N++  +G   + ++ + V ++    +L+ ++H     F +     + IA + + 
Sbjct: 61  RKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQ 117
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGY 566
            + YLH+ +   I HRD+KS NI L +    K+ DFG A+       +H   Q+ G+  +
Sbjct: 118 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 174
Query: 567 LDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKP 599
           + PE  R    + ++ +SDVY+FG+VL EL+TG+ P
Sbjct: 175 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
           +S + E       + + +G G  GTVYKG       V +         +++ F NE+ +L
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            +  H N++  +G   + ++ + V ++    +L+ ++H     F +     + IA + + 
Sbjct: 64  RKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQ 120
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGY 566
            + YLH+ +   I HRD+KS NI L +    K+ DFG A+       +H   Q+ G+  +
Sbjct: 121 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 177
Query: 567 LDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKP 599
           + PE  R    + ++ +SDVY+FG+VL EL+TG+ P
Sbjct: 178 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKS-KVI------DESKVEEFINEMVILSQINHRNVVK 457
           LG GG  TVY   L +  I+ +K + K I       E  ++ F  E+   SQ++H+N+V 
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           ++    E +   LV E+I   TL +YI       P++ +  +    ++   + + H    
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHD--- 129
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 577
           + I HRDIK  NIL+D     K+ DFG +++++      T  V GT  Y  PE  +    
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 578 TDKSDVYSFGVVLAELLTGEKP 599
            + +D+YS G+VL E+L GE P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP 211

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLP-DGK---IVAVKKSKV-IDESKVEEFINE 443
           +KEL+ +     + R++G G  G V  G L   GK    VA+K  KV   E +  +F+ E
Sbjct: 37  AKELDASC--IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCE 94
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H NVV L G     +  ++V EF+ NG L  ++   +  F +     +++  
Sbjct: 95  ASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV-----IQLVG 149
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            + G  + +   A +   HRD+ + NIL++     KVSDFG SR +  D   + T   G 
Sbjct: 150 MLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE  +  +FT  SDV+S+G+V+ E+++ GE+P
Sbjct: 210 IPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
           +S + E       + + +G G  GTVYKG       V +         +++ F NE+ +L
Sbjct: 27  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 86
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            +  H N++  +G   + ++ + V ++    +L+ ++H     F +     + IA + + 
Sbjct: 87  RKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQ 143
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGY 566
            + YLH+ +   I HRD+KS NI L +    K+ DFG A+       +H   Q+ G+  +
Sbjct: 144 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 200
Query: 567 LDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKP 599
           + PE  R    + ++ +SDVY+FG+VL EL+TG+ P
Sbjct: 201 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 34/277 (12%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQI 450
           A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEMRLRIAI-EVSGA 508
            H N+++L G   +     L+ E+ P GT+++ +   ++ D     E R    I E++ A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANA 120
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           LSY HS   I   HRDIK  N+LL      K++DFG S      +    T + GT  YL 
Sbjct: 121 LSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLP 174
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           PE        +K D++S GV+  E L G+ P    T +E     +   F   +       
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------- 227
Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                   G  ++I+      R L  N  +RP +REV
Sbjct: 228 ----FVTEGARDLIS------RLLKHNPSQRPMLREV 254

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P G ++   Q +   +E    T+      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY------ 118
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +      + 
Sbjct: 119 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLX 172
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 232
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 233 -----------FVTEGARDLIS------RLLKHNPSQRPMLREV 259

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 126/284 (44%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P GT++   Q +   +E    T+      
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 115
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K+++FG S      +    T + 
Sbjct: 116 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLC 169
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 229
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 230 -----------FVTEGARDLIS------RLLKHNPSQRPMLREV 256

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
           +S + E       + + +G G  GTVYKG       V +         +++ F NE+ +L
Sbjct: 26  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 85
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            +  H N++  +G   + ++ + V ++    +L+ ++H     F +     + IA + + 
Sbjct: 86  RKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQ 142
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGY 566
            + YLH+ +   I HRD+KS NI L +    K+ DFG A+       +H   Q+ G+  +
Sbjct: 143 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 199
Query: 567 LDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKP 599
           + PE  R    + ++ +SDVY+FG+VL EL+TG+ P
Sbjct: 200 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 140/305 (45%), Gaps = 35/305 (11%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKVID 433
           +    ++   E E A +   ++R LGQG  G VY+G+        P+ ++     ++   
Sbjct: 2   VSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 61
Query: 434 ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-- 491
             +  EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  Y+     +   
Sbjct: 62  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 121
Query: 492 -----PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 546
                P +    +++A E++  ++YL++   +   HRD+ + N ++ + +  K+ DFG +
Sbjct: 122 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMT 178
Query: 547 RSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTT 604
           R +   D      +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P +  +
Sbjct: 179 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 238
Query: 605 LEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
                           E+ L  +++  ++ +      + F ++ + C   N K RP+  E
Sbjct: 239 ---------------NEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLE 282
Query: 665 VTSEL 669
           + S +
Sbjct: 283 IISSI 287

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 140/305 (45%), Gaps = 35/305 (11%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKVID 433
           +    ++   E E A +   ++R LGQG  G VY+G+        P+ ++     ++   
Sbjct: 2   VSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 61
Query: 434 ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-- 491
             +  EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  Y+     +   
Sbjct: 62  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 121
Query: 492 -----PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 546
                P +    +++A E++  ++YL++   +   HRD+ + N ++ + +  K+ DFG +
Sbjct: 122 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMT 178
Query: 547 RSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTT 604
           R +   D      +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P +  +
Sbjct: 179 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 238
Query: 605 LEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
                           E+ L  +++  ++ +      + F ++ + C   N K RP+  E
Sbjct: 239 ---------------NEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLE 282
Query: 665 VTSEL 669
           + S +
Sbjct: 283 IISSI 287

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P GT++   Q +   +E    T+      
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 114
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +        
Sbjct: 115 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC--- 168
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 228
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 229 -----------FVTEGARDLIS------RLLKHNPSQRPMLREV 255

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 122/278 (43%), Gaps = 36/278 (12%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQI 450
           A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRIAIEVSG 507
            H N+++L G   +     L+ E+ P GT++   Q +   +E    T+        E++ 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           ALSY HS   I   HRDIK  N+LL      K++DFG S      +    T + GT  YL
Sbjct: 120 ALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYL 173
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
            PE        +K D++S GV+  E L G+ P    T +E     +   F   +      
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------ 227
Query: 628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                    G  ++I+      R L  N  +RP +REV
Sbjct: 228 -----FVTEGARDLIS------RLLKHNPSQRPMLREV 254

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 117/258 (45%), Gaps = 31/258 (12%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV---IDESKVEEFINEMVILSQIN 451
           +D + L  ILG GG   V+    L D + VAVK  +     D S    F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 452 HRNVVKLLGCCLETE-----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVS 506
           H  +V +     E E     +P +V E++   TL   +H +    P+T +  + +  +  
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADAC 126
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV--DQTHMTTQVHGTF 564
            AL++ H      I HRD+K  NIL+      KV DFG +R++A   +    T  V GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 565 GYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP--------IRFTTLEEDKSLAAYFL 616
            YL PE  R      +SDVYS G VL E+LTGE P        + +  + ED        
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-----IP 238
Query: 617 FAMKEERLFEILDARVMK 634
            + + E L   LDA V+K
Sbjct: 239 PSARHEGLSADLDAVVLK 256

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 139/300 (46%), Gaps = 35/300 (11%)
Query: 386 LFTSKELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKVIDESKVE 438
           ++   E E A +   ++R LGQG  G VY+G+        P+ ++     ++     +  
Sbjct: 36  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 95
Query: 439 EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF------- 491
           EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  Y+     +        
Sbjct: 96  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-A 550
           P +    +++A E++  ++YL++   +   HRD+ + N ++ + +  K+ DFG +R +  
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212
Query: 551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDK 609
            D      +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P +  +     
Sbjct: 213 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----- 267
Query: 610 SLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                      E+ L  +++  ++ +      + F ++ + C   N K RP+  E+ S +
Sbjct: 268 ----------NEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSI 316

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 34/277 (12%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQI 450
           A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEMRLRIAI-EVSGA 508
            H N+++L G   +     L+ E+ P GT+++ +   ++ D     E R    I E++ A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANA 120
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           LSY HS   I   HRDIK  N+LL      K++DFG S      +    T + GT  YL 
Sbjct: 121 LSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TXLCGTLDYLP 174
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           PE        +K D++S GV+  E L G+ P    T +E     +   F   +       
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------- 227
Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                   G  ++I+      R L  N  +RP +REV
Sbjct: 228 ----FVTEGARDLIS------RLLKHNPSQRPMLREV 254

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P GT++   Q +   +E    T+      
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 115
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +      + 
Sbjct: 116 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLC 169
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 229
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 230 -----------FVTEGARDLIS------RLLKHNPSQRPMLREV 256

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 138/285 (48%), Gaps = 48/285 (16%)
Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKKS-KVIDESKV----EEFINEMVILSQINHRNVV 456
           ++LG G  GTVYKG+ +PDG+ V +  + KV+ E+      +E ++E  +++ +    V 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-----NEDFPITWEMRLRIAIEVSGALSY 511
           +LLG CL + V L V + +P G L  ++ +      ++D  + W M      +++  +SY
Sbjct: 83  RLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDL-LNWCM------QIAKGMSY 134
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     + + HRD+ + N+L+      K++DFG +R + +D+    T+ H   G     +
Sbjct: 135 LED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGGKVPIKW 187
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
           +  E     +FT +SDV+S+GV + EL+T G KP       E   L        K ERL 
Sbjct: 188 MALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE------KGERLP 241
Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
           +               I    +  +C  ++ + RP  RE+ SE +
Sbjct: 242 QPPIC----------TIDVYMIMVKCWMIDSECRPRFRELVSEFS 276

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 139/300 (46%), Gaps = 35/300 (11%)
Query: 386 LFTSKELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKVIDESKVE 438
           ++   E E A +   ++R LGQG  G VY+G+        P+ ++     ++     +  
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 439 EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF------- 491
           EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  Y+     +        
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-A 550
           P +    +++A E++  ++YL++   +   HRD+ + N ++ + +  K+ DFG +R +  
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDK 609
            D      +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P +  +     
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----- 245
Query: 610 SLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                      E+ L  +++  ++ +      + F ++ + C   N K RP+  E+ S +
Sbjct: 246 ----------NEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 34/277 (12%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQI 450
           A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ I S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEMRLRIAI-EVSGA 508
            H N+++L G   +     L+ E+ P GT+++ +   ++ D     E R    I E++ A
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANA 124
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           LSY HS   I   HRDIK  N+LL      K++DFG S      +    T + GT  YL 
Sbjct: 125 LSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLP 178
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           PE        +K D++S GV+  E L G+ P    T +E     +   F   +       
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------- 231
Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                   G  ++I+      R L  N  +RP +REV
Sbjct: 232 ----FVTEGARDLIS------RLLKHNPSQRPMLREV 258

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 126/284 (44%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P GT++   Q +   +E    T+      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 116
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K+++FG S      +    T + 
Sbjct: 117 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLC 170
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 230
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 231 -----------FVTEGARDLIS------RLLKHNPSQRPMLREV 257

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 10/199 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           +G G  GTVYKG       V +         +++ F NE+ +L +  H N++  +G   +
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
            ++ + V ++    +L+ ++H     F +     + IA + +  + YLH+ +   I HRD
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 525 IKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGYLDPEYFR---SSQFTDK 580
           +KS NI L +    K+ DFG A+       +H   Q+ G+  ++ PE  R    + ++ +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 581 SDVYSFGVVLAELLTGEKP 599
           SDVY+FG+VL EL+TG+ P
Sbjct: 190 SDVYAFGIVLYELMTGQLP 208

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVI---DESKVEEFINEMVILSQIN 451
           +D + L  ILG GG   V+    L D + VAVK  +     D S    F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 452 HRNVVKLLGCCLETE-----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVS 506
           H  +V +     E E     +P +V E++   TL   +H +    P+T +  + +  +  
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADAC 126
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ---VHGT 563
            AL++ H      I HRD+K  NI++      KV DFG +R++A D  +  TQ   V GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGT 182
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP--------IRFTTLEEDKSLAAYF 615
             YL PE  R      +SDVYS G VL E+LTGE P        + +  + ED       
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDP-----I 237
Query: 616 LFAMKEERLFEILDARVMK 634
             + + E L   LDA V+K
Sbjct: 238 PPSARHEGLSADLDAVVLK 256

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 34/277 (12%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQI 450
           A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ I S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEMRLRIAI-EVSGA 508
            H N+++L G   +     L+ E+ P GT+++ +   ++ D     E R    I E++ A
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANA 119
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           LSY HS   I   HRDIK  N+LL      K++DFG S      +    T + GT  YL 
Sbjct: 120 LSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLP 173
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           PE        +K D++S GV+  E L G+ P    T +E     +   F   +       
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------- 226
Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                   G  ++I+      R L  N  +RP +REV
Sbjct: 227 ----FVTEGARDLIS------RLLKHNPSQRPMLREV 253

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRI 501
            I S + H N+++L G   +     L+ E+ P GT++   Q +   +E    T+      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 116
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             E++ ALSY HS   I   HRDIK  N+LL      K++DFG S      +      + 
Sbjct: 117 ITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLC 170
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
           GT  YL PE        +K D++S GV+  E L G+ P    T +E     +   F   +
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 230
Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          G  ++I+      R L  N  +RP +REV
Sbjct: 231 -----------FVTEGARDLIS------RLLKHNPSQRPMLREV 257

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV---IDESKVEEFINEMVILSQIN 451
           +D + L  ILG GG   V+    L D + VAVK  +     D S    F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 452 HRNVVKLLGCCLETE-----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVS 506
           H  +V +     E E     +P +V E++   TL   +H +    P+T +  + +  +  
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADAC 126
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ---VHGT 563
            AL++ H      I HRD+K  NI++      KV DFG +R++A D  +  TQ   V GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGT 182
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP--------IRFTTLEEDKSLAAYF 615
             YL PE  R      +SDVYS G VL E+LTGE P        + +  + ED       
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-----I 237
Query: 616 LFAMKEERLFEILDARVMK 634
             + + E L   LDA V+K
Sbjct: 238 PPSARHEGLSADLDAVVLK 256

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 130/266 (48%), Gaps = 31/266 (11%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +GQG  GTVY  M +  G+ VA+++  +  + K E  INE++++ +  + N+V  L   L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGALSYLHSAASIPIYH 522
             +   +V E++  G+L   + +   D     E ++  +  E   AL +LHS   I   H
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSNQVI---H 139
Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 582
           RDIKS NILL      K++DFG    +  +Q+  +T V GT  ++ PE      +  K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 583 VYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK---EERLFEILDARVMKESGGD 639
           ++S G++  E++ GE P     L E+  L A +L A     E +  E L A         
Sbjct: 199 IWSLGIMAIEMIEGEPPY----LNEN-PLRALYLIATNGTPELQNPEKLSA--------- 244
Query: 640 EIITFAKVAKRCLNLNGKKRPTMREV 665
               F     RCL+++ +KR + +E+
Sbjct: 245 ---IFRDFLNRCLDMDVEKRGSAKEL 267

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 19/225 (8%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKVIDESKVEEFINE 443
           E E A +   ++R LGQG  G VY+G+        P+ ++     ++     +  EF+NE
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-------PITWE 496
             ++ + N  +VV+LLG   + +  L++ E +  G L  Y+     +        P +  
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA-VDQTH 555
             +++A E++  ++YL++   +   HRD+ + N ++ + +  K+ DFG +R +   D   
Sbjct: 124 KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
              +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 225

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE 464
           +G G  GTVYKG       V +         +++ F NE+ +L +  H N++  +G    
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD 524
            ++ + V ++    +L+ ++H     F +     + IA + +  + YLH+ +   I HRD
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 525 IKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGYLDPEYFR---SSQFTDK 580
           +KS NI L +    K+ DFG A+       +H   Q+ G+  ++ PE  R    + ++ +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 581 SDVYSFGVVLAELLTGEKP 599
           SDVY+FG+VL EL+TG+ P
Sbjct: 190 SDVYAFGIVLYELMTGQLP 208

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 138/300 (46%), Gaps = 35/300 (11%)
Query: 386 LFTSKELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKVIDESKVE 438
           ++   E E A +   ++R LGQG  G VY+G+        P+ ++     ++     +  
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 439 EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF------- 491
           EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  Y+              
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-A 550
           P +    +++A E++  ++YL++   +   HRD+ + N ++ + +  K+ DFG +R +  
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDK 609
            D      +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P +  +     
Sbjct: 181 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----- 235
Query: 610 SLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                      E+ L  +++  ++ +      + F ++ + C   N K RP+  E+ S +
Sbjct: 236 ----------NEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSI 284

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 138/300 (46%), Gaps = 35/300 (11%)
Query: 386 LFTSKELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKVIDESKVE 438
           ++   E E A +   ++R LGQG  G VY+G+        P+ ++     ++     +  
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 439 EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF------- 491
           EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  Y+              
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-A 550
           P +    +++A E++  ++YL++   +   HRD+ + N ++ + +  K+ DFG +R +  
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDK 609
            D      +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P +  +     
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----- 245
Query: 610 SLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                      E+ L  +++  ++ +      + F ++ + C   N K RP+  E+ S +
Sbjct: 246 ----------NEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 137/295 (46%), Gaps = 35/295 (11%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKVIDESKVEEFINE 443
           E E A +   ++R LGQG  G VY+G+        P+ ++     ++     +  EF+NE
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-------PITWE 496
             ++ + N  +VV+LLG   + +  L++ E +  G L  Y+     +        P +  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTH 555
             +++A E++  ++YL++   +   HRD+ + N ++ + +  K+ DFG +R +   D   
Sbjct: 126 KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAY 614
              +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P +  +          
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------- 232
Query: 615 FLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                 E+ L  +++  ++ +      + F ++ + C   N K RP+  E+ S +
Sbjct: 233 -----NEQVLRFVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 138/285 (48%), Gaps = 38/285 (13%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L++ + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 78  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 134
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 135 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGRAKLLGAEE----KEYHAEGGKVPIKW 187
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
           +  E      +T +SDV+S+GV + EL+T G KP       E  S+        K ERL 
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------KGERLP 241
Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
           +               I    + ++C  ++   RP  RE+  E +
Sbjct: 242 QPPIC----------TIDVYMIMRKCWMIDADSRPKFRELIIEFS 276

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 141/300 (47%), Gaps = 33/300 (11%)
Query: 378 EGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPD--GKIVAVKKSKVIDES 435
           EGT+     F             L + +G+G  G V   ML D  G  VAVK  K  +++
Sbjct: 174 EGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDA 228
Query: 436 KVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPIT 494
             + F+ E  +++Q+ H N+V+LLG  +E +  L +V E++  G+L  Y+  +     + 
Sbjct: 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LG 287
Query: 495 WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 554
            +  L+ +++V  A+ YL     +   HRD+ + N+L+ +   AKVSDFG ++  +  Q 
Sbjct: 288 GDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344
Query: 555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAA 613
                V  T     PE  R  +F+ KSDV+SFG++L E+ + G  P     L++      
Sbjct: 345 TGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------ 394
Query: 614 YFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
                 + E+ ++      M    G     +  V K C +L+   RPT  ++  +L  I+
Sbjct: 395 ---VVPRVEKGYK------MDAPDGCPPAVY-DVMKNCWHLDAATRPTFLQLREQLEHIR 444

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 34/277 (12%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQI 450
           A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ I S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEMRLRIAI-EVSGA 508
            H N+++L G   +     L+ E+ P GT+++ +   ++ D     E R    I E++ A
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANA 117
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           LSY HS   I   HRDIK  N+LL      K++DFG S      +    T + GT  YL 
Sbjct: 118 LSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLP 171
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           PE        +K D++S GV+  E L G+ P    T +E     +   F   +       
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------- 224
Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                   G  ++I+      R L  N  +RP +REV
Sbjct: 225 ----FVTEGARDLIS------RLLKHNPSQRPMLREV 251

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 121/278 (43%), Gaps = 36/278 (12%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQI 450
           A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ I S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRIAIEVSG 507
            H N+++L G   +     L+ E+ P GT++   Q +   +E    T+        E++ 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           ALSY HS   I   HRDIK  N+LL      K++DFG S      +      + GT  YL
Sbjct: 123 ALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYL 176
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
            PE        +K D++S GV+  E L G+ P    T +E     +   F   +      
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------ 230
Query: 628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                    G  ++I+      R L  N  +RP +REV
Sbjct: 231 -----FVTEGARDLIS------RLLKHNPSQRPMLREV 257

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 137/285 (48%), Gaps = 38/285 (13%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 132
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 133 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 185
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
           +  E      +T +SDV+S+GV + EL+T G KP       E  S+        K ERL 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------KGERLP 239
Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
           +               I    + ++C  ++   RP  RE+  E +
Sbjct: 240 QPPIC----------TIDVYMIMRKCWMIDADSRPKFRELIIEFS 274

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 137/285 (48%), Gaps = 38/285 (13%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 79  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 135
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 136 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 188
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
           +  E      +T +SDV+S+GV + EL+T G KP       E  S+        K ERL 
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------KGERLP 242
Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
           +               I    + ++C  ++   RP  RE+  E +
Sbjct: 243 QPPIC----------TIDVYMIMRKCWMIDADSRPKFRELIIEFS 277

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 137/285 (48%), Gaps = 38/285 (13%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 78  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 134
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 135 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGRAKLLGAEE----KEYHAEGGKVPIKW 187
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
           +  E      +T +SDV+S+GV + EL+T G KP       E  S+        K ERL 
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------KGERLP 241
Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
           +               I    + ++C  ++   RP  RE+  E +
Sbjct: 242 QPPIC----------TIDVYMIMRKCWMIDADSRPKFRELIIEFS 276

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 112/230 (48%), Gaps = 19/230 (8%)
Query: 386 LFTSKELERATDNFNLNRILGQGGQGTVYKGML-------PDGKIVAVKKSKVIDESKVE 438
           ++   E E A +   ++R LGQG  G VY+G+        P+ ++     ++     +  
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 439 EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF------- 491
           EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  Y+     +        
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-A 550
           P +    +++A E++  ++YL++   +   HRD+ + N  + + +  K+ DFG +R +  
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            D      +      ++ PE  +   FT  SDV+SFGVVL E+ T  E+P
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 227

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 138/287 (48%), Gaps = 38/287 (13%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 86  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 142
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 143 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 195
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
           +  E      +T +SDV+S+GV + EL+T G KP       E  S+        K ERL 
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------KGERLP 249
Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
           +               I    + ++C  ++   RP  RE+  E + +
Sbjct: 250 QPPIC----------TIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 286

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 123/277 (44%), Gaps = 34/277 (12%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQI 450
           A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEMRLRIAI-EVSGA 508
            H N+++L G   +     L+ E+ P GT+++ +   ++ D     E R    I E++ A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANA 120
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           LSY HS   I   HRDIK  N+LL      K++DFG S      +      + GT  YL 
Sbjct: 121 LSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLCGTLDYLP 174
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           PE        +K D++S GV+  E L G+ P    T +E     +   F   +       
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------- 227
Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                   G  ++I+      R L  N  +RP +REV
Sbjct: 228 ----FVTEGARDLIS------RLLKHNPSQRPMLREV 254

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 121/278 (43%), Gaps = 36/278 (12%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQI 450
           A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRIAIEVSG 507
            H N+++L G   +     L+ E+ P GT++   Q +   +E    T+        E++ 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           ALSY HS   I   HRDIK  N+LL      K++DFG S      +      + GT  YL
Sbjct: 120 ALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYL 173
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
            PE        +K D++S GV+  E L G+ P    T +E     +   F   +      
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------ 227
Query: 628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                    G  ++I+      R L  N  +RP +REV
Sbjct: 228 -----FVTEGARDLIS------RLLKHNPSQRPMLREV 254

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 15/219 (6%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLP-DGK---IVAVKKSKV-IDESKVEEFINE 443
           +KE+E +     + R++G G  G V  G L   GK    VA+K  KV   E +  +F+ E
Sbjct: 16  AKEIEASC--ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGE 73
Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q +H N++ L G   +++  ++V E++ NG+L  ++   +  F +   + +   I
Sbjct: 74  ASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGI 133
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
             S  + YL     +   HRD+ + NIL++     KVSDFG SR +  D     T   G 
Sbjct: 134 --SAGMKYLSDMGYV---HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 188
Query: 564 FG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +  PE     +FT  SDV+S+G+V+ E+++ GE+P
Sbjct: 189 IPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 123/277 (44%), Gaps = 34/277 (12%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQI 450
           A ++F + R LG+G  G VY       K I+A+K   K+++       +   E+ I S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEMRLRIAI-EVSGA 508
            H N+++L G   +     L+ E+ P GT+++ +   ++ D     E R    I E++ A
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANA 123
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           LSY HS   I   HRDIK  N+LL      K++DFG S      +      + GT  YL 
Sbjct: 124 LSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DDLCGTLDYLP 177
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           PE        +K D++S GV+  E L G+ P    T +E     +   F   +       
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------- 230
Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                   G  ++I+      R L  N  +RP +REV
Sbjct: 231 ----FVTEGARDLIS------RLLKHNPSQRPMLREV 257

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 116/214 (54%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L++ + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 77  NPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 133
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 134 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 186
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 116/214 (54%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L++ + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 80  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 136
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 137 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 189
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 125/277 (45%), Gaps = 34/277 (12%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQI 450
           A ++F + R LG+G  G VY     + K I+A+K   K+++       +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEMRLRIAI-EVSGA 508
            H N+++L G   ++    L+ E+ P GT+++ +   ++ D     E R    I E++ A
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFD-----EQRTATYITELANA 120
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           LSY HS   I   HRDIK  N+LL      K++DFG S      +      + GT  YL 
Sbjct: 121 LSYCHSKKVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDYLP 174
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           PE        +K D++S GV+  E L G+ P    T ++     +   F   +       
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPD------- 227
Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                   G  ++I+      R L  N  +RP +REV
Sbjct: 228 ----FVTEGARDLIS------RLLKHNPSQRPMLREV 254

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 116/214 (54%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L++ + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 78  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 134
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 135 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 187
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 116/214 (54%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L++ + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 76  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 132
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 133 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 185
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 116/214 (54%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L++ + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 78  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 134
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 135 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGRAKLLGAEE----KEYHAEGGKVPIKW 187
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 116/214 (54%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L++ + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 80  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 136
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 137 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGRAKLLGAEE----KEYHAEGGKVPIKW 189
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 116/214 (54%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L++ + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 79  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 135
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 136 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 188
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 116/214 (54%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L++ + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 77  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 133
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 134 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 186
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 31/266 (11%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +GQG  GTVY  M +  G+ VA+++  +  + K E  INE++++ +  + N+V  L   L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGALSYLHSAASIPIYH 522
             +   +V E++  G+L   + +   D     E ++  +  E   AL +LHS   I   H
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSNQVI---H 139
Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 582
           RDIKS NILL      K++DFG    +  +Q+  +  V GT  ++ PE      +  K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 583 VYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK---EERLFEILDARVMKESGGD 639
           ++S G++  E++ GE P     L E+  L A +L A     E +  E L A         
Sbjct: 199 IWSLGIMAIEMIEGEPPY----LNEN-PLRALYLIATNGTPELQNPEKLSA--------- 244
Query: 640 EIITFAKVAKRCLNLNGKKRPTMREV 665
               F     RCL+++ +KR + +E+
Sbjct: 245 ---IFRDFLNRCLDMDVEKRGSAKEL 267

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 82  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 138
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L       + HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 139 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 191
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 83  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 139
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L       + HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 140 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE----KEYHAEGGKVPIKW 192
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 138/303 (45%), Gaps = 37/303 (12%)
Query: 384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVKKSKVIDES----K 436
           + +F   E E + +   L R LGQG  G VY+G   D   G+       K ++ES    +
Sbjct: 1   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 60
Query: 437 VEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF----- 491
             EF+NE  ++      +VV+LLG   + +  L+V E + +G L  Y+     +      
Sbjct: 61  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 120
Query: 492 --PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
             P T +  +++A E++  ++YL++   +   HRD+ + N ++   +  K+ DFG +R +
Sbjct: 121 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI 177
Query: 550 A-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
              D      +      ++ PE  +   FT  SD++SFGVVL E+ +  E+P +  +   
Sbjct: 178 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--- 234
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGG-DEIITFAKVAKRCLNLNGKKRPTMREVT 666
                        E+ L  ++D   + +     E +T   + + C   N K RPT  E+ 
Sbjct: 235 ------------NEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIV 280
Query: 667 SEL 669
           + L
Sbjct: 281 NLL 283

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 83  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 139
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L       + HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 140 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 192
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 132
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 133 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 185
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 138/303 (45%), Gaps = 37/303 (12%)
Query: 384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVKKSKVIDES----K 436
           + +F   E E + +   L R LGQG  G VY+G   D   G+       K ++ES    +
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 437 VEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF----- 491
             EF+NE  ++      +VV+LLG   + +  L+V E + +G L  Y+     +      
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 492 --PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
             P T +  +++A E++  ++YL++   +   HRD+ + N ++   +  K+ DFG +R +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 550 A-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
              D      +      ++ PE  +   FT  SD++SFGVVL E+ +  E+P +  +   
Sbjct: 181 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--- 237
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGG-DEIITFAKVAKRCLNLNGKKRPTMREVT 666
                        E+ L  ++D   + +     E +T   + + C   N K RPT  E+ 
Sbjct: 238 ------------NEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIV 283
Query: 667 SEL 669
           + L
Sbjct: 284 NLL 286

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 79  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 135
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 136 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 188
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 116/259 (44%), Gaps = 33/259 (12%)
Query: 396 TDNFNLNRILGQGGQGTVYKG----MLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN 451
           +D + L  ILG GG   V+      +  D  +  ++     D S    F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 452 HRNVVKLLGCCLETE-----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVS 506
           H  +V +     E E     +P +V E++   TL   +H +    P+T +  + +  +  
Sbjct: 71  HPAIVAVYATG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADAC 126
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ---VHGT 563
            AL++ H      I HRD+K  NI++      KV DFG +R++A D  +  TQ   V GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGT 182
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP--------IRFTTLEEDKSLAAYF 615
             YL PE  R      +SDVYS G VL E+LTGE P        + +  + ED       
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-----I 237
Query: 616 LFAMKEERLFEILDARVMK 634
             + + E L   LDA V+K
Sbjct: 238 PPSARHEGLSADLDAVVLK 256

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 79  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 135
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 136 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 188
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 132
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 133 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGRAKLLGAEE----KEYHAEGGKVPIKW 185
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 70  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 126
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 127 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 179
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 132
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 133 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 185
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 101 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 157
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 158 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 210
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKG--MLPD--GKIVAVKKSK-VIDESKVEEFIN 442
           ++++ E   +   L R +G+G  G V++G  M P+     VA+K  K    +S  E+F+ 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E + + Q +H ++VKL+G   E  V  ++ E    G L  ++  Q   F +     +  A
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYA 117
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++S AL+YL S   +   HRDI + N+L+      K+ DFG SR M     +  ++   
Sbjct: 118 YQLSTALAYLESKRFV---HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL 174
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
              ++ PE     +FT  SDV+ FGV + E+L  G KP +
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 78  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 134
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 135 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 187
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKG--MLPD--GKIVAVKKSK-VIDESKVEEFIN 442
           ++++ E   +   L R +G+G  G V++G  M P+     VA+K  K    +S  E+F+ 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E + + Q +H ++VKL+G   E  V  ++ E    G L  ++  Q   F +     +  A
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYA 117
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++S AL+YL S   +   HRDI + N+L+      K+ DFG SR M        ++   
Sbjct: 118 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL 174
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
              ++ PE     +FT  SDV+ FGV + E+L  G KP +
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 31/266 (11%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +GQG  GTVY  M +  G+ VA+++  +  + K E  INE++++ +  + N+V  L   L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGALSYLHSAASIPIYH 522
             +   +V E++  G+L   + +   D     E ++  +  E   AL +LHS   I   H
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSNQVI---H 139
Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 582
           RDIKS NILL      K++DFG    +  +Q+  +  V GT  ++ PE      +  K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 583 VYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK---EERLFEILDARVMKESGGD 639
           ++S G++  E++ GE P     L E+  L A +L A     E +  E L A         
Sbjct: 199 IWSLGIMAIEMIEGEPPY----LNEN-PLRALYLIATNGTPELQNPEKLSA--------- 244
Query: 640 EIITFAKVAKRCLNLNGKKRPTMREV 665
               F     RCL ++ +KR + +E+
Sbjct: 245 ---IFRDFLNRCLEMDVEKRGSAKEL 267

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 31/266 (11%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +GQG  GTVY  M +  G+ VA+++  +  + K E  INE++++ +  + N+V  L   L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGALSYLHSAASIPIYH 522
             +   +V E++  G+L   + +   D     E ++  +  E   AL +LHS   I   H
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSNQVI---H 140
Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 582
           R+IKS NILL      K++DFG    +  +Q+  +T V GT  ++ PE      +  K D
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 199
Query: 583 VYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK---EERLFEILDARVMKESGGD 639
           ++S G++  E++ GE P     L E+  L A +L A     E +  E L A         
Sbjct: 200 IWSLGIMAIEMIEGEPPY----LNEN-PLRALYLIATNGTPELQNPEKLSA--------- 245
Query: 640 EIITFAKVAKRCLNLNGKKRPTMREV 665
               F     RCL ++ +KR + +E+
Sbjct: 246 ---IFRDFLNRCLEMDVEKRGSAKEL 268

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 73  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAEGMNY 129
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 130 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 182
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 137/279 (49%), Gaps = 33/279 (11%)
Query: 399 FNLNRILGQGGQGTVYKGMLPD--GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
             L + +G+G  G V   ML D  G  VAVK  K  +++  + F+ E  +++Q+ H N+V
Sbjct: 14  LKLLQTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 68
Query: 457 KLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           +LLG  +E +  L +V E++  G+L  Y+  +     +  +  L+ +++V  A+ YL   
Sbjct: 69  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN 127
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
             +   HRD+ + N+L+ +   AKVSDFG ++  +  Q      V  T     PE  R +
Sbjct: 128 NFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREA 180
Query: 576 QFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK 634
            F+ KSDV+SFG++L E+ + G  P     L++            + E+ ++      M 
Sbjct: 181 AFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGYK------MD 225
Query: 635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
              G     + +V K C +L+   RP+  ++  +L  IK
Sbjct: 226 APDGCPPAVY-EVMKNCWHLDAAMRPSFLQLREQLEHIK 263

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 138/303 (45%), Gaps = 37/303 (12%)
Query: 384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVKKSKVIDES----K 436
           + +F   E E + +   L R LGQG  G VY+G   D   G+       K ++ES    +
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 437 VEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF----- 491
             EF+NE  ++      +VV+LLG   + +  L+V E + +G L  Y+     +      
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 492 --PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
             P T +  +++A E++  ++YL++   +   HRD+ + N ++   +  K+ DFG +R +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 550 -AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
              D      +      ++ PE  +   FT  SD++SFGVVL E+ +  E+P +  +   
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--- 237
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGG-DEIITFAKVAKRCLNLNGKKRPTMREVT 666
                        E+ L  ++D   + +     E +T   + + C   N K RPT  E+ 
Sbjct: 238 ------------NEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIV 283
Query: 667 SEL 669
           + L
Sbjct: 284 NLL 286

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 31/266 (11%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +GQG  GTVY  M +  G+ VA+++  +  + K E  INE++++ +  + N+V  L   L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGALSYLHSAASIPIYH 522
             +   +V E++  G+L   + +   D     E ++  +  E   AL +LHS   I   H
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSNQVI---H 140
Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 582
           RDIKS NILL      K++DFG    +  +Q+  +  V GT  ++ PE      +  K D
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKVD 199
Query: 583 VYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK---EERLFEILDARVMKESGGD 639
           ++S G++  E++ GE P     L E+  L A +L A     E +  E L A         
Sbjct: 200 IWSLGIMAIEMIEGEPPY----LNEN-PLRALYLIATNGTPELQNPEKLSA--------- 245
Query: 640 EIITFAKVAKRCLNLNGKKRPTMREV 665
               F     RCL ++ +KR + +E+
Sbjct: 246 ---IFRDFLNRCLEMDVEKRGSAKEL 268

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 116/259 (44%), Gaps = 33/259 (12%)
Query: 396 TDNFNLNRILGQGGQGTVYKG----MLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN 451
           +D + L  ILG GG   V+      +  D  +  ++     D S    F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 452 HRNVVKLLGCCLETE-----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVS 506
           H  +V +     E E     +P +V E++   TL   +H +    P+T +  + +  +  
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADAC 126
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ---VHGT 563
            AL++ H      I HRD+K  NI++      KV DFG +R++A D  +  TQ   V GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGT 182
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP--------IRFTTLEEDKSLAAYF 615
             YL PE  R      +SDVYS G VL E+LTGE P        + +  + ED       
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-----I 237
Query: 616 LFAMKEERLFEILDARVMK 634
             + + E L   LDA V+K
Sbjct: 238 PPSARHEGLSADLDAVVLK 256

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKG--MLPDGKI--VAVKKSK-VIDESKVEEFIN 442
           ++++ E   +   L R +G+G  G V++G  M P+     VA+K  K    +S  E+F+ 
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E + + Q +H ++VKL+G   E  V  ++ E    G L  ++  Q   + +     +  A
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYA 122
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++S AL+YL S   +   HRDI + N+L+      K+ DFG SR M     +  ++   
Sbjct: 123 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
              ++ PE     +FT  SDV+ FGV + E+L  G KP +
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 139/304 (45%), Gaps = 39/304 (12%)
Query: 384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVKKSKVIDES----K 436
           + +F   E E + +   L R LGQG  G VY+G   D   G+       K ++ES    +
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 437 VEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF----- 491
             EF+NE  ++      +VV+LLG   + +  L+V E + +G L  Y+     +      
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 492 --PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
             P T +  +++A E++  ++YL++   +   HRD+ + N ++   +  K+ DFG +R +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 550 AVDQTHMTTQVHGTFG--YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLE 606
             +  +      G     ++ PE  +   FT  SD++SFGVVL E+ +  E+P +  +  
Sbjct: 181 -YETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-- 237
Query: 607 EDKSLAAYFLFAMKEERLFEILDARVMKESGG-DEIITFAKVAKRCLNLNGKKRPTMREV 665
                         E+ L  ++D   + +     E +T   + + C   N K RPT  E+
Sbjct: 238 -------------NEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEI 282
Query: 666 TSEL 669
            + L
Sbjct: 283 VNLL 286

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKG--MLPDGKI--VAVKKSK-VIDESKVEEFIN 442
           ++++ E   +   L R +G+G  G V++G  M P+     VA+K  K    +S  E+F+ 
Sbjct: 29  STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 88
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E + + Q +H ++VKL+G   E  V  ++ E    G L  ++  Q   + +     +  A
Sbjct: 89  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYA 145
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++S AL+YL S   +   HRDI + N+L+      K+ DFG SR M     +  ++   
Sbjct: 146 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 202
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
              ++ PE     +FT  SDV+ FGV + E+L  G KP +
Sbjct: 203 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKG--MLPD--GKIVAVKKSK-VIDESKVEEFIN 442
           ++++ E   +   L R +G+G  G V++G  M P+     VA+K  K    +S  E+F+ 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E + + Q +H ++VKL+G   E  V  ++ E    G L  ++  Q   + +     +  A
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYA 117
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++S AL+YL S   +   HRDI + N+L+      K+ DFG SR M     +  ++   
Sbjct: 118 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 174
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
              ++ PE     +FT  SDV+ FGV + E+L  G KP +
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 137/280 (48%), Gaps = 33/280 (11%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPD--GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
              L + +G+G  G V   ML D  G  VAVK  K  +++  + F+ E  +++Q+ H N+
Sbjct: 22  ELKLLQTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNL 76
Query: 456 VKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           V+LLG  +E +  L +V E++  G+L  Y+  +     +  +  L+ +++V  A+ YL  
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG 135
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
              +   HRD+ + N+L+ +   AKVSDFG ++  +  Q      V  T     PE  R 
Sbjct: 136 NNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALRE 188
Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM 633
            +F+ KSDV+SFG++L E+ + G  P     L++            + E+ ++      M
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGYK------M 233
Query: 634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
               G     + +V K C +L+   RP+  ++  +L  IK
Sbjct: 234 DAPDGCPPAVY-EVMKNCWHLDAAMRPSFLQLREQLEHIK 272

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKG--MLPDGKI--VAVKKSK-VIDESKVEEFIN 442
           ++++ E   +   L R +G+G  G V++G  M P+     VA+K  K    +S  E+F+ 
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E + + Q +H ++VKL+G   E  V  ++ E    G L  ++  Q   + +     +  A
Sbjct: 64  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYA 120
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++S AL+YL S   +   HRDI + N+L+      K+ DFG SR M     +  ++   
Sbjct: 121 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 177
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
              ++ PE     +FT  SDV+ FGV + E+L  G KP +
Sbjct: 178 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 217

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKG--MLPDGKI--VAVKKSK-VIDESKVEEFIN 442
           ++++ E   +   L R +G+G  G V++G  M P+     VA+K  K    +S  E+F+ 
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 62
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E + + Q +H ++VKL+G   E  V  ++ E    G L  ++  Q   + +     +  A
Sbjct: 63  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYA 119
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++S AL+YL S   +   HRDI + N+L+      K+ DFG SR M     +  ++   
Sbjct: 120 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 176
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
              ++ PE     +FT  SDV+ FGV + E+L  G KP +
Sbjct: 177 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 216

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKG--MLPDGKI--VAVKKSK-VIDESKVEEFIN 442
           ++++ E   +   L R +G+G  G V++G  M P+     VA+K  K    +S  E+F+ 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E + + Q +H ++VKL+G   E  V  ++ E    G L  ++  Q   + +     +  A
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYA 117
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++S AL+YL S   +   HRDI + N+L+      K+ DFG SR M     +  ++   
Sbjct: 118 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 174
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
              ++ PE     +FT  SDV+ FGV + E+L  G KP +
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 137/279 (49%), Gaps = 33/279 (11%)
Query: 399 FNLNRILGQGGQGTVYKGMLPD--GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
             L + +G+G  G V   ML D  G  VAVK  K  +++  + F+ E  +++Q+ H N+V
Sbjct: 8   LKLLQTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 62
Query: 457 KLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           +LLG  +E +  L +V E++  G+L  Y+  +     +  +  L+ +++V  A+ YL   
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN 121
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
             +   HRD+ + N+L+ +   AKVSDFG ++  +  Q      V  T     PE  R  
Sbjct: 122 NFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 174
Query: 576 QFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK 634
           +F+ KSDV+SFG++L E+ + G  P     L++            + E+ ++      M 
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGYK------MD 219
Query: 635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
              G     + +V K C +L+   RP+  ++  +L  IK
Sbjct: 220 APDGCPPAVY-EVMKNCWHLDAAMRPSFLQLREQLEHIK 257

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKG--MLPD--GKIVAVKKSK-VIDESKVEEFIN 442
           ++++ E   +   L R +G+G  G V++G  M P+     VA+K  K    +S  E+F+ 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E + + Q +H ++VKL+G   E  V  ++ E    G L  ++  Q   F +     +  A
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYA 497
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++S AL+YL S   +   HRDI + N+L+      K+ DFG SR M     +  ++   
Sbjct: 498 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
              ++ PE     +FT  SDV+ FGV + E+L  G KP +
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 404 ILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           +LG+G  G   K    + G+++ +K+    DE     F+ E+ ++  + H NV+K +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
            + +    + E+I  GTL   I   +  +P  W  R+  A +++  ++YLH   S+ I H
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQYP--WSQRVSFAKDIASGMAYLH---SMNIIH 131
Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-------------MTTQVHGTFGYLDP 569
           RD+ S N L+ +     V+DFG +R M  ++T                  V G   ++ P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELL 594
           E      + +K DV+SFG+VL E++
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 116/259 (44%), Gaps = 33/259 (12%)
Query: 396 TDNFNLNRILGQGGQGTVYKG----MLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN 451
           +D + L  ILG GG   V+      +  D  +  ++     D S    F  E    + +N
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 452 HRNVVKLLGCCLETE-----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVS 506
           H  +V +     E E     +P +V E++   TL   +H +    P+T +  + +  +  
Sbjct: 88  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADAC 143
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ---VHGT 563
            AL++ H      I HRD+K  NI++      KV DFG +R++A D  +  TQ   V GT
Sbjct: 144 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGT 199
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP--------IRFTTLEEDKSLAAYF 615
             YL PE  R      +SDVYS G VL E+LTGE P        + +  + ED       
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-----I 254
Query: 616 LFAMKEERLFEILDARVMK 634
             + + E L   LDA V+K
Sbjct: 255 PPSARHEGLSADLDAVVLK 273

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++L  G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L++ + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 83  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 139
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L       + HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 140 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 192
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKG--MLPD--GKIVAVKKSK-VIDESKVEEFIN 442
           ++++ E   +   L R +G+G  G V++G  M P+     VA+K  K    +S  E+F+ 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E + + Q +H ++VKL+G   E  V  ++ E    G L  ++  Q   F +     +  A
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYA 497
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++S AL+YL S   +   HRDI + N+L+      K+ DFG SR M     +  ++   
Sbjct: 498 YQLSTALAYLESKRFV---HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
              ++ PE     +FT  SDV+ FGV + E+L  G KP +
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 114/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++L  G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 83  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 139
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L       + HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 140 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 192
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 114/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++L  G  GTVYKG+ +P+G+     VA+K+ +     K  +E ++E  +++ ++
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 132
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L     +   HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 133 LEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 185
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 114/214 (53%), Gaps = 22/214 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKKSKVIDESKV-EEFINEMVILSQIN 451
            F   ++LG G  GTVYKG+ +P+G+     VA+ + +     K  +E ++E  +++ ++
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V +LLG CL + V L+  + +P G L  Y+ +  ++  I  +  L   ++++  ++Y
Sbjct: 110 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 166
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----Y 566
           L       + HRD+ + N+L+      K++DFG ++ +  ++     + H   G     +
Sbjct: 167 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAEGGKVPIKW 219
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 220 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 14/217 (6%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKG--MLPDGKI--VAVKKSK-VIDESKVEEFINEMV 445
           E++R  +   L R +G+G  G V++G  M P+     VA+K  K    +S  E+F+ E +
Sbjct: 3   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
            + Q +H ++VKL+G   E  V  ++ E    G L  ++  Q   + +     +  A ++
Sbjct: 61  TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQL 117
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
           S AL+YL S   +   HRDI + N+L+      K+ DFG SR M     +  ++      
Sbjct: 118 STALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR 601
           ++ PE     +FT  SDV+ FGV + E+L  G KP +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 113/232 (48%), Gaps = 19/232 (8%)
Query: 384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVKKSKVIDES----K 436
           + ++   E E + +   L R LGQG  G VY+G   D   G+       K ++ES    +
Sbjct: 4   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 437 VEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF----- 491
             EF+NE  ++      +VV+LLG   + +  L+V E + +G L  Y+     +      
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 492 --PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
             P T +  +++A E++  ++YL++   +   HRD+ + N ++   +  K+ DFG +R +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 550 A-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
              D      +      ++ PE  +   FT  SD++SFGVVL E+ +  E+P
Sbjct: 181 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 15/209 (7%)
Query: 401 LNRILGQGGQGTVYKGMLP-DGK---IVAVKKSKV-IDESKVEEFINEMVILSQINHRNV 455
           + +++G G  G V  G L   GK    VA+K  K    E +  +F++E  I+ Q +H NV
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 96
Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           + L G   ++   +++ EF+ NG+L  ++   +  F +     +++   + G  + +   
Sbjct: 97  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV-----IQLVGMLRGIAAGMKYL 151
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT-TQVHG---TFGYLDPEY 571
           A +   HRD+ + NIL++     KVSDFG SR +  D +  T T   G      +  PE 
Sbjct: 152 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 572 FRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            +  +FT  SDV+S+G+V+ E+++ GE+P
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 96/181 (53%), Gaps = 12/181 (6%)
Query: 421 GKIVAVKKSKVIDE-SKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLLVYEFIPN 477
           G+ VAVK  K     + + +   E+ IL  + H N+VK  G C E       L+ EF+P+
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
           G+L +Y+        I  + +L+ A+++   + YL S   +   HRD+ + N+L++ +++
Sbjct: 110 GSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQ 164
Query: 538 AKVSDFGASRSMAVDQTHMTTQVH---GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL 594
            K+ DFG ++++  D+   T +       F Y  PE    S+F   SDV+SFGV L ELL
Sbjct: 165 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECLMQSKFYIASDVWSFGVTLHELL 223
Query: 595 T 595
           T
Sbjct: 224 T 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 96/181 (53%), Gaps = 12/181 (6%)
Query: 421 GKIVAVKKSKVIDE-SKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLLVYEFIPN 477
           G+ VAVK  K     + + +   E+ IL  + H N+VK  G C E       L+ EF+P+
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
           G+L +Y+        I  + +L+ A+++   + YL S   +   HRD+ + N+L++ +++
Sbjct: 98  GSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQ 152
Query: 538 AKVSDFGASRSMAVDQTHMTTQVH---GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL 594
            K+ DFG ++++  D+   T +       F Y  PE    S+F   SDV+SFGV L ELL
Sbjct: 153 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECLMQSKFYIASDVWSFGVTLHELL 211
Query: 595 T 595
           T
Sbjct: 212 T 212

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F++ R LG+G  G VY       K I+A+K   K+++       +   E+ I S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            N+++L G   +     L+ E+ P GT++   Q +   +E    T+        E++ AL
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY------ITELANAL 125
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           SY HS   I   HRDIK  N+LL      K++DFG S      +    T + GT  YL P
Sbjct: 126 SYCHSKRVI---HRDIKPENLLLGSNGELKIADFGWSVHAPSSRR---TTLCGTLDYLPP 179
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           E        +K D++S GV+  E L G  P    T +E
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 20/219 (9%)
Query: 398 NFNLNRILGQGGQGTVYKGML--PDGKIVAVK----KSKVIDESKVEEFINEMVILSQIN 451
            F L R+LG+G  G+V +  L   DG  V V     K+ +I  S +EEF+ E   + + +
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 452 HRNVVKLLGCCLETE------VPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIA 502
           H +V KL+G  L +       +P+++  F+ +G L  ++         F +  +  +R  
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVH 561
           ++++  + YL S   I   HRD+ + N +L +     V+DFG SR + + D         
Sbjct: 144 VDIACGMEYLSSRNFI---HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +L  E    + +T  SDV++FGV + E++T G+ P
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 24/220 (10%)
Query: 401 LNRILGQGGQGTVYKG----MLP--DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN 454
           L R LG+G  G V+      + P  D  +VAVK  K    +  ++F  E  +L+ + H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWE-------------MRLRI 501
           +VK  G C + +  ++V+E++ +G L +++     D  I  +               L I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQV 560
           A +++  + YL   AS    HRD+ + N L+      K+ DFG SR + + D   +    
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                ++ PE     +FT +SDV+SFGV+L E+ T G++P
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEIXINKML 61
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEIXINKML 62
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 119
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 61
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 9/202 (4%)
Query: 399 FNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVK 457
           F++   LG+G  G+VYK +  + G+IVA+K+  V  ES ++E I E+ I+ Q +  +VVK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
             G   +     +V E+   G++   I  +N+   +T +    I       L YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYLHFMRK 146
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 577
           I   HRDIK+ NILL+ +  AK++DFG +  +  D       V GT  ++ PE  +   +
Sbjct: 147 I---HRDIKAGNILLNTEGHAKLADFGVAGQLT-DXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 578 TDKSDVYSFGVVLAELLTGEKP 599
              +D++S G+   E+  G+ P
Sbjct: 203 NCVADIWSLGITAIEMAEGKPP 224

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 61
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG A+     ++  +  ++ GT  Y+ P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 61
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 62
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 119
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG A+     ++  +  ++ GT  Y+ P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 61
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 61
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I + +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINAML 62
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 119
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 113/242 (46%), Gaps = 23/242 (9%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D  NL + LG+G  G V +            + VAVK  K     S+   
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 493 ----ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 548
               +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +R 
Sbjct: 137 YKDFLTLEHLIXYSFQVAKGMEFLASRKXI---HRDLAARNILLSEKNVVKIXDFGLARD 193
Query: 549 MAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLE 606
           +  D  ++          ++ PE      +T +SDV+SFGV+L E+ + G  P     ++
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 253
Query: 607 ED 608
           E+
Sbjct: 254 EE 255

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 138/319 (43%), Gaps = 47/319 (14%)
Query: 380 TIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVKKSKV-I 432
           +++  K+    + E    N  L + LG+G  G V K      K       VAVK  K   
Sbjct: 6   SVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA 65
Query: 433 DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH------- 485
             S++ + ++E  +L Q+NH +V+KL G C +    LL+ E+   G+L  ++        
Sbjct: 66  SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 486 --------------DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL 531
                         D  ++  +T    +  A ++S  + YL   A + + HRD+ + NIL
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNIL 182
Query: 532 LDDKYRAKVSDFGASRSMAVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVL 590
           + +  + K+SDFG SR +  + +++  +Q      ++  E      +T +SDV+SFGV+L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 591 AELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKR 650
            E++T               L       +  ERLF +L      E   +      ++  +
Sbjct: 243 WEIVT---------------LGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQ 287
Query: 651 CLNLNGKKRPTMREVTSEL 669
           C      KRP   +++ +L
Sbjct: 288 CWKQEPDKRPVFADISKDL 306

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 405 LGQGGQGTV-YKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +G+G  G V    +   GK+VAVKK  +  + + E   NE+VI+    H NVV++    L
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHR 523
             +   +V EF+  G L   +        +  E    + + V  ALS LH+   I   HR
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVI---HR 151
Query: 524 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 583
           DIKS +ILL    R K+SDFG    ++ +       V GT  ++ PE      +  + D+
Sbjct: 152 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDI 210
Query: 584 YSFGVVLAELLTGEKP 599
           +S G+++ E++ GE P
Sbjct: 211 WSLGIMVIEMVDGEPP 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 405 LGQGGQGTV-YKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +G+G  G V    +   GK+VAVKK  +  + + E   NE+VI+    H NVV++    L
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHR 523
             +   +V EF+  G L   +        +  E    + + V  ALS LH+   I   HR
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVI---HR 140
Query: 524 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 583
           DIKS +ILL    R K+SDFG    ++ +       V GT  ++ PE      +  + D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDI 199
Query: 584 YSFGVVLAELLTGEKP 599
           +S G+++ E++ GE P
Sbjct: 200 WSLGIMVIEMVDGEPP 215

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 405 LGQGGQGTV-YKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +G+G  G V    +   GK+VAVKK  +  + + E   NE+VI+    H NVV++    L
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHR 523
             +   +V EF+  G L   +        +  E    + + V  ALS LH+   I   HR
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVI---HR 194
Query: 524 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 583
           DIKS +ILL    R K+SDFG    ++ +       V GT  ++ PE      +  + D+
Sbjct: 195 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDI 253
Query: 584 YSFGVVLAELLTGEKP 599
           +S G+++ E++ GE P
Sbjct: 254 WSLGIMVIEMVDGEPP 269

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 405 LGQGGQGTV-YKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +G+G  G V    +   GK+VAVKK  +  + + E   NE+VI+    H NVV++    L
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHR 523
             +   +V EF+  G L   +        +  E    + + V  ALS LH+   I   HR
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVI---HR 271
Query: 524 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 583
           DIKS +ILL    R K+SDFG    ++ +       V GT  ++ PE      +  + D+
Sbjct: 272 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDI 330
Query: 584 YSFGVVLAELLTGEKP 599
           +S G+++ E++ GE P
Sbjct: 331 WSLGIMVIEMVDGEPP 346

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 60
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 117
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 62
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 119
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 62
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 119
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 62
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 119
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
            +E   +   L + LG G  G V  G       VAVK  K    S+ +EF  E   + ++
Sbjct: 2   HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKL 60
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +H  +VK  G C +     +V E+I NG L  Y+    +    +    L +  +V   ++
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPS--QLLEMCYDVCEGMA 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           +L S   I   HRD+ + N L+D     KVSDFG +R +  DQ   +        +  PE
Sbjct: 119 FLESHQFI---HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPE 175
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD 629
            F   +++ KSDV++FG+++ E+ + G+ P    T  E                      
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---------------------- 213
Query: 630 ARVMKESGGDEII-------TFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
             V+K S G  +        T  ++   C +   +KRPT +++ S +  ++
Sbjct: 214 -VVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 405 LGQGGQGTV-YKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +G+G  G V    +   GK+VAVKK  +  + + E   NE+VI+    H NVV++    L
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHR 523
             +   +V EF+  G L   +        +  E    + + V  ALS LH+   I   HR
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVI---HR 144
Query: 524 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 583
           DIKS +ILL    R K+SDFG    ++ +       V GT  ++ PE      +  + D+
Sbjct: 145 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDI 203
Query: 584 YSFGVVLAELLTGEKP 599
           +S G+++ E++ GE P
Sbjct: 204 WSLGIMVIEMVDGEPP 219

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 61
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 405 LGQGGQGTV-YKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           +G+G  G V    +   GK+VAVKK  +  + + E   NE+VI+    H NVV++    L
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHR 523
             +   +V EF+  G L   +        +  E    + + V  ALS LH+   I   HR
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVI---HR 149
Query: 524 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 583
           DIKS +ILL    R K+SDFG    ++ +       V GT  ++ PE      +  + D+
Sbjct: 150 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDI 208
Query: 584 YSFGVVLAELLTGEKP 599
           +S G+++ E++ GE P
Sbjct: 209 WSLGIMVIEMVDGEPP 224

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/229 (32%), Positives = 110/229 (48%), Gaps = 23/229 (10%)
Query: 397 DNFNLNRILGQGGQGTVY-----KGMLPDGKIVA---VKKSKVIDESKVEEFI-NEMVIL 447
           +NF L ++LG G  G V+      G    GK+ A   +KK+ ++ ++K  E    E  +L
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGH-DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 448 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EV 505
             I     +  L    +TE  L L+ ++I  G LF ++  Q E F    E  ++I + E+
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-SQRERFT---EHEVQIYVGEI 168
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
             AL +LH    + I +RDIK  NILLD      ++DFG S+    D+T       GT  
Sbjct: 169 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 566 YLDPEYFR--SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLA 612
           Y+ P+  R   S      D +S GV++ ELLTG  P  FT   E  S A
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQA 272

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 140/313 (44%), Gaps = 49/313 (15%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYK----GMLPDGKI--VAVKKSKVIDE 434
           I+ T+L  +++ E   +N    + LG G  G V +    G+  +  +  VAVK  K    
Sbjct: 22  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 81
Query: 435 S-KVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH------- 485
           + + E  ++E+ I+S +  H N+V LLG C      L++ E+   G L  ++        
Sbjct: 82  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADL 141
Query: 486 DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 545
           D+ +  P+     L  + +V+  +++L S   I   HRD+ + N+LL + + AK+ DFG 
Sbjct: 142 DKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGL 198
Query: 546 SRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPI--- 600
           +R +  D  ++          ++ PE      +T +SDV+S+G++L E+ + G  P    
Sbjct: 199 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 258
Query: 601 ----RFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNG 656
               +F  L +D    A   FA K   ++ I+ A                    C  L  
Sbjct: 259 LVNSKFYKLVKDGYQMAQPAFAPK--NIYSIMQA--------------------CWALEP 296
Query: 657 KKRPTMREVTSEL 669
             RPT +++ S L
Sbjct: 297 THRPTFQQICSFL 309

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 13/209 (6%)
Query: 399 FNLNRILGQGGQGTVYKGMLP-DGK---IVAVKKSKV-IDESKVEEFINEMVILSQINHR 453
             + +++G G  G V  G L   GK    VA+K  K    + +  +F++E  I+ Q +H 
Sbjct: 31  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 90
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N++ L G   + +  +++ E++ NG+L  ++   +  F +   + +   I     + YL 
Sbjct: 91  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGI--GSGMKYLS 148
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG--YLDPEY 571
             +++   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE 
Sbjct: 149 DMSAV---HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 205
Query: 572 FRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +FT  SDV+S+G+V+ E+++ GE+P
Sbjct: 206 IAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 140/313 (44%), Gaps = 49/313 (15%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYK----GMLPDGKI--VAVKKSKVIDE 434
           I+ T+L  +++ E   +N    + LG G  G V +    G+  +  +  VAVK  K    
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 435 S-KVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH------- 485
           + + E  ++E+ I+S +  H N+V LLG C      L++ E+   G L  ++        
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADL 149
Query: 486 DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 545
           D+ +  P+     L  + +V+  +++L S   I   HRD+ + N+LL + + AK+ DFG 
Sbjct: 150 DKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGL 206
Query: 546 SRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPI--- 600
           +R +  D  ++          ++ PE      +T +SDV+S+G++L E+ + G  P    
Sbjct: 207 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 266
Query: 601 ----RFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNG 656
               +F  L +D    A   FA K   ++ I+ A                    C  L  
Sbjct: 267 LVNSKFYKLVKDGYQMAQPAFAPK--NIYSIMQA--------------------CWALEP 304
Query: 657 KKRPTMREVTSEL 669
             RPT +++ S L
Sbjct: 305 THRPTFQQICSFL 317

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 61
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 401 LNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINEMVILSQINHRNV 455
           +  ++G G  G V +G L  P  K   VA+K  K    E +  EF++E  I+ Q  H N+
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           ++L G    +   +++ EF+ NG L  ++   +  F +     +++   + G  S +   
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV-----IQLVGMLRGIASGMRYL 132
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFG--YLDPE 570
           A +   HRD+ + NIL++     KVSDFG SR +   + D T+ T+ + G     +  PE
Sbjct: 133 AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY-TSSLGGKIPIRWTAPE 191
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                +FT  SD +S+G+V+ E+++ GE+P
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 113/242 (46%), Gaps = 23/242 (9%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D  NL + LG+G  G V +            + VAVK  K     S+   
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 493 ----ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 548
               +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +R 
Sbjct: 137 YKDFLTLEHLICYSFQVAKGMEFLASRKXI---HRDLAARNILLSEKNVVKICDFGLARD 193
Query: 549 MAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLE 606
           +  D  ++          ++ PE      +T +SDV+SFGV+L E+ + G  P     ++
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 253
Query: 607 ED 608
           E+
Sbjct: 254 EE 255

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEIXINKML 61
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 62
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 119
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 108/228 (47%), Gaps = 15/228 (6%)
Query: 371 QQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKS 429
           QQ L    G +    +   K +    D   L   +G+G  G V+ G L  D  +VAVK  
Sbjct: 89  QQPLTKKSGVVLHRAVPKDKWVLNHED-LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC 147
Query: 430 K-VIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN 488
           +  +      +F+ E  IL Q +H N+V+L+G C + +   +V E +  G    ++  + 
Sbjct: 148 RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG 207
Query: 489 EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 548
               +  +  L++  + +  + YL S   I   HRD+ + N L+ +K   K+SDFG SR 
Sbjct: 208 ARLRV--KTLLQMVGDAAAGMEYLESKCCI---HRDLAARNCLVTEKNVLKISDFGMSRE 262
Query: 549 MAVDQTHMTT----QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAE 592
            A D  +  +    QV     +  PE     +++ +SDV+SFG++L E
Sbjct: 263 EA-DGVYAASGGLRQV--PVKWTAPEALNYGRYSSESDVWSFGILLWE 307

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 61
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 134/294 (45%), Gaps = 37/294 (12%)
Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVKKSKVIDES----KVEEFINEMV 445
           E + +   L R LGQG  G VY+G   D   G+       K ++ES    +  EF+NE  
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-------PITWEMR 498
           ++      +VV+LLG   + +  L+V E + +G L  Y+     +        P T +  
Sbjct: 72  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 131
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMT 557
           +++A E++  ++YL++   +   HRD+ + N ++   +  K+ DFG +R +   D     
Sbjct: 132 IQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFL 616
            +      ++ PE  +   FT  SD++SFGVVL E+ +  E+P +  +            
Sbjct: 189 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS------------ 236
Query: 617 FAMKEERLFEILDARVMKESGG-DEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
               E+ L  ++D   + +     E +T   + + C   N K RPT  E+ + L
Sbjct: 237 ---NEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 401 LNRILGQGGQGTVYKGMLP-DGK---IVAVKKSKV-IDESKVEEFINEMVILSQINHRNV 455
           + +++G G  G V  G L   GK    VA+K  K    E +  +F++E  I+ Q +H NV
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           + L G   ++   +++ EF+ NG+L  ++   +  F +     +++   + G  + +   
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV-----IQLVGMLRGIAAGMKYL 125
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT-TQVHG---TFGYLDPEY 571
           A +   HR + + NIL++     KVSDFG SR +  D +  T T   G      +  PE 
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 572 FRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            +  +FT  SDV+S+G+V+ E+++ GE+P
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 61
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 9/225 (4%)
Query: 371 QQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKS 429
           QQ L    G +    +   K +    D   L   +G+G  G V+ G L  D  +VAVK  
Sbjct: 89  QQPLTKKSGVVLHRAVPKDKWVLNHED-LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC 147
Query: 430 K-VIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN 488
           +  +      +F+ E  IL Q +H N+V+L+G C + +   +V E +  G    ++  + 
Sbjct: 148 RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG 207
Query: 489 EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 548
               +  +  L++  + +  + YL S   I   HRD+ + N L+ +K   K+SDFG SR 
Sbjct: 208 ARLRV--KTLLQMVGDAAAGMEYLESKCCI---HRDLAARNCLVTEKNVLKISDFGMSRE 262
Query: 549 MAVDQTHMTTQVHGT-FGYLDPEYFRSSQFTDKSDVYSFGVVLAE 592
            A      +  +      +  PE     +++ +SDV+SFG++L E
Sbjct: 263 EADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 118/265 (44%), Gaps = 30/265 (11%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVID----ESKVEEFINEMVILSQINHRNVVKLLG 460
           +G+G  G V+KG+  D +   V   K+ID    E ++E+   E+ +LSQ +   V K  G
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
             L+     ++ E++  G+      D  E  P+       I  E+   L YLHS   I  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI-- 126
Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRDIK+ N+LL +    K++DFG +  +   Q    T V GT  ++ PE  + S +  K
Sbjct: 127 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 184
Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE 640
           +D++S G+   EL  GE P       E   +   FL         E   ++ +KE     
Sbjct: 185 ADIWSLGITAIELARGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKE----- 234
Query: 641 IITFAKVAKRCLNLNGKKRPTMREV 665
                   + CLN     RPT +E+
Sbjct: 235 ------FVEACLNKEPSFRPTAKEL 253

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 106/209 (50%), Gaps = 13/209 (6%)
Query: 399 FNLNRILGQGGQGTVYKGMLP-DGK---IVAVKKSKV-IDESKVEEFINEMVILSQINHR 453
             + +++G G  G V  G L   GK    VA+K  K    + +  +F++E  I+ Q +H 
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N++ L G   + +  +++ E++ NG+L  ++   +  F +     +++   + G  S + 
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGIGSGMK 124
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG--YLDPEY 571
             + +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE 
Sbjct: 125 YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 572 FRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +FT  SDV+S+G+V+ E+++ GE+P
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 61
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 118
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 106/209 (50%), Gaps = 13/209 (6%)
Query: 399 FNLNRILGQGGQGTVYKGMLP-DGK---IVAVKKSKV-IDESKVEEFINEMVILSQINHR 453
             + +++G G  G V  G L   GK    VA+K  K    + +  +F++E  I+ Q +H 
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N++ L G   + +  +++ E++ NG+L  ++   +  F +     +++   + G  S + 
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGIGSGMK 130
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG--YLDPEY 571
             + +   HRD+ + NIL++     KVSDFG SR +  D     T   G     +  PE 
Sbjct: 131 YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 572 FRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +FT  SDV+S+G+V+ E+++ GE+P
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 137/303 (45%), Gaps = 37/303 (12%)
Query: 384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVKKSKVIDES----K 436
           + ++   E E + +   L R LGQG  G VY+G   D   G+       K ++ES    +
Sbjct: 5   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 64
Query: 437 VEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF----- 491
             EF+NE  ++      +VV+LLG   + +  L+V E + +G L  Y+     +      
Sbjct: 65  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 124
Query: 492 --PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
             P T +  +++A E++  ++YL++   +   HR++ + N ++   +  K+ DFG +R +
Sbjct: 125 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRNLAARNCMVAHDFTVKIGDFGMTRDI 181
Query: 550 -AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
              D      +      ++ PE  +   FT  SD++SFGVVL E+ +  E+P +  +   
Sbjct: 182 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--- 238
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGG-DEIITFAKVAKRCLNLNGKKRPTMREVT 666
                        E+ L  ++D   + +     E +T   + + C   N   RPT  E+ 
Sbjct: 239 ------------NEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPNMRPTFLEIV 284
Query: 667 SEL 669
           + L
Sbjct: 285 NLL 287

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV----EEFINEMVILSQI 450
            ++++L + LG+G  G V   +     + VAVK   ++D  +     E    E+ I   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKML 62
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           NH NVVK  G   E  +  L  E+   G LF  I     D  +      R   ++   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV 119
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDP 569
           YLH    I I HRDIK  N+LLD++   K+SDFG +      ++  +  ++ GT  Y+ P
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 570 EYFRSSQF-TDKSDVYSFGVVLAELLTGEKP 599
           E  +  +F  +  DV+S G+VL  +L GE P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 118/265 (44%), Gaps = 30/265 (11%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVID----ESKVEEFINEMVILSQINHRNVVKLLG 460
           +G+G  G V+KG+  D +   V   K+ID    E ++E+   E+ +LSQ +   V K  G
Sbjct: 35  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
             L+     ++ E++  G+      D  E  P+       I  E+   L YLHS   I  
Sbjct: 93  SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI-- 146
Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRDIK+ N+LL +    K++DFG +  +   Q    T V GT  ++ PE  + S +  K
Sbjct: 147 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 204
Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE 640
           +D++S G+   EL  GE P       E   +   FL         E   ++ +KE     
Sbjct: 205 ADIWSLGITAIELARGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKE----- 254
Query: 641 IITFAKVAKRCLNLNGKKRPTMREV 665
                   + CLN     RPT +E+
Sbjct: 255 ------FVEACLNKEPSFRPTAKEL 273

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 398 NFNLNRILGQGGQGTVY---KGMLPD-GKIVAVK-----KSKVIDESKVEEFINEMVILS 448
           +F L ++LGQG  G V+   K   PD G + A+K       KV D  + +    E  IL+
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTK---MERDILA 85
Query: 449 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            +NH  VVKL     +TE  L L+ +F+  G LF  +    E      +++  +A E++ 
Sbjct: 86  DVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELAL 141
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
            L +LHS   + I +RD+K  NILLD++   K++DFG S+  A+D         GT  Y+
Sbjct: 142 GLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-AIDHEKKAYSFCGTVEYM 197
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
            PE       +  +D +S+GV++ E+LTG  P +    +E  +L
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTL 241

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 118/256 (46%), Gaps = 36/256 (14%)
Query: 421 GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 480
           GK VAVKK  +  + + E   NE+VI+   +H NVV +    L  +   +V EF+  G L
Sbjct: 70  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 481 FQYI-HDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 539
              + H +  +  I       + + V  ALSYLH+   I   HRDIKS +ILL    R K
Sbjct: 130 TDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQGVI---HRDIKSDSILLTSDGRIK 181
Query: 540 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           +SDFG    ++ +       V GT  ++ PE      +  + D++S G+++ E++ GE P
Sbjct: 182 LSDFGFCAQVSKEVPKRKXLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240
Query: 600 IRFTTLEEDKSLAAYF----LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
                         YF    L AM+  R+ + L  RV       ++   + V +  L+L 
Sbjct: 241 --------------YFNEPPLQAMR--RIRDSLPPRV------KDLHKVSSVLRGFLDLM 278
Query: 656 GKKRPTMREVTSELAG 671
             + P+ R    EL G
Sbjct: 279 LVREPSQRATAQELLG 294

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 137/319 (42%), Gaps = 47/319 (14%)
Query: 380 TIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVKKSKV-I 432
           +++  K+    + E    N  L + LG+G  G V K      K       VAVK  K   
Sbjct: 6   SVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA 65
Query: 433 DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH------- 485
             S++ + ++E  +L Q+NH +V+KL G C +    LL+ E+   G+L  ++        
Sbjct: 66  SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 486 --------------DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL 531
                         D  ++  +T    +  A ++S  + YL   A + + HRD+ + NIL
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNIL 182
Query: 532 LDDKYRAKVSDFGASRSMAVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVL 590
           + +  + K+SDFG SR +  + + +  +Q      ++  E      +T +SDV+SFGV+L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 591 AELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKR 650
            E++T               L       +  ERLF +L      E   +      ++  +
Sbjct: 243 WEIVT---------------LGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQ 287
Query: 651 CLNLNGKKRPTMREVTSEL 669
           C      KRP   +++ +L
Sbjct: 288 CWKQEPDKRPVFADISKDL 306

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 137/303 (45%), Gaps = 37/303 (12%)
Query: 384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVKKSKVIDES----K 436
           + ++   E E + +   L R LGQG  G VY+G   D   G+       K ++ES    +
Sbjct: 4   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 437 VEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF----- 491
             EF+NE  ++      +VV+LLG   + +  L+V E + +G L  Y+     +      
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 492 --PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
             P T +  +++A E++  ++YL++   +   HR++ + N ++   +  K+ DFG +R +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRNLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 550 -AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
              D      +      ++ PE  +   FT  SD++SFGVVL E+ +  E+P +  +   
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--- 237
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGG-DEIITFAKVAKRCLNLNGKKRPTMREVT 666
                        E+ L  ++D   + +     E +T   + + C   N   RPT  E+ 
Sbjct: 238 ------------NEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPNMRPTFLEIV 283
Query: 667 SEL 669
           + L
Sbjct: 284 NLL 286

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 137/319 (42%), Gaps = 47/319 (14%)
Query: 380 TIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVKKSKV-I 432
           +++  K+    + E    N  L + LG+G  G V K      K       VAVK  K   
Sbjct: 6   SVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA 65
Query: 433 DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH------- 485
             S++ + ++E  +L Q+NH +V+KL G C +    LL+ E+   G+L  ++        
Sbjct: 66  SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 486 --------------DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL 531
                         D  ++  +T    +  A ++S  + YL   A + + HRD+ + NIL
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNIL 182
Query: 532 LDDKYRAKVSDFGASRSMAVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVL 590
           + +  + K+SDFG SR +  + + +  +Q      ++  E      +T +SDV+SFGV+L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 591 AELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKR 650
            E++T               L       +  ERLF +L      E   +      ++  +
Sbjct: 243 WEIVT---------------LGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQ 287
Query: 651 CLNLNGKKRPTMREVTSEL 669
           C      KRP   +++ +L
Sbjct: 288 CWKQEPDKRPVFADISKDL 306

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 142/295 (48%), Gaps = 41/295 (13%)
Query: 384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKS-KVI-DESKVEEF 440
            ++F   EL +        ++LG G  GTV+KG+ +P+G+ + +    KVI D+S  + F
Sbjct: 7   ARIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59
Query: 441 ---INEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
               + M+ +  ++H ++V+LLG C  + + L V +++P G+L  ++        +  ++
Sbjct: 60  QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGA--LGPQL 116
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 557
            L   ++++  + YL     +   HR++ + N+LL    + +V+DFG +  +  D   + 
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173
Query: 558 -TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYF 615
            ++      ++  E     ++T +SDV+S+GV + EL+T G +P     L E   L    
Sbjct: 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-- 231
Query: 616 LFAMKEERLFEILDARVMKESGGDEI--ITFAKVAKRCLNLNGKKRPTMREVTSE 668
               K ERL +             +I  I    V  +C  ++   RPT +E+ +E
Sbjct: 232 ----KGERLAQ------------PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F++ R LG+G  G VY       K I+A+K   K+++       +   E+ I S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLF---QYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            N+++L G   +     L+ E+ P GT++   Q +   +E    T+        E++ AL
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY------ITELANAL 125
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           SY HS   I   HRDIK  N+LL      K++DFG S      +        GT  YL P
Sbjct: 126 SYCHSKRVI---HRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC---GTLDYLPP 179
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           E        +K D++S GV+  E L G  P    T +E
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 142/295 (48%), Gaps = 41/295 (13%)
Query: 384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKS-KVI-DESKVEEF 440
            ++F   EL +        ++LG G  GTV+KG+ +P+G+ + +    KVI D+S  + F
Sbjct: 25  ARIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 77
Query: 441 ---INEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
               + M+ +  ++H ++V+LLG C  + + L V +++P G+L  ++        +  ++
Sbjct: 78  QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGA--LGPQL 134
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 557
            L   ++++  + YL     +   HR++ + N+LL    + +V+DFG +  +  D   + 
Sbjct: 135 LLNWGVQIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 191
Query: 558 -TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYF 615
            ++      ++  E     ++T +SDV+S+GV + EL+T G +P     L E   L    
Sbjct: 192 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-- 249
Query: 616 LFAMKEERLFEILDARVMKESGGDEI--ITFAKVAKRCLNLNGKKRPTMREVTSE 668
               K ERL +             +I  I    V  +C  ++   RPT +E+ +E
Sbjct: 250 ----KGERLAQ------------PQICTIDVYMVMVKCWMIDENIRPTFKELANE 288

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 33/270 (12%)
Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID----ESKVEEFINEMVILSQINHRNVV 456
           L RI G+G  G V+KG+  D +   V   K+ID    E ++E+   E+ +LSQ +   V 
Sbjct: 28  LERI-GKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSA 515
           K  G  L+     ++ E++  G+    +     ++F I   ++     E+   L YLHS 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLHSE 139
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
             I   HRDIK+ N+LL ++   K++DFG +  +   Q    T V GT  ++ PE  + S
Sbjct: 140 KKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 195
Query: 576 QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE 635
            +  K+D++S G+   EL  GE P        D          M   R+  ++       
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPP------NSD----------MHPMRVLFLIPKNNPPT 239
Query: 636 SGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             GD   +F +    CLN +   RPT +E+
Sbjct: 240 LVGDFTKSFKEFIDACLNKDPSFRPTAKEL 269

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 8/217 (3%)
Query: 380 TIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEE 439
           T +  K +   E E   +   L   LG G  G V+ G       VAVK  K    S  + 
Sbjct: 4   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DA 62
Query: 440 FINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMR 498
           F+ E  ++ Q+ H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    
Sbjct: 63  FLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKL 119
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
           L +A +++  ++++     I   HRD+++ NIL+ D    K++DFG +R +  ++     
Sbjct: 120 LDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 176
Query: 559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                  +  PE      FT KSDV+SFG++L E++T
Sbjct: 177 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 8/217 (3%)
Query: 380 TIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEE 439
           T +  K +   E E   +   L   LG G  G V+ G       VAVK  K    S  + 
Sbjct: 2   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DA 60
Query: 440 FINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMR 498
           F+ E  ++ Q+ H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKL 117
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
           L +A +++  ++++     I   HRD+++ NIL+ D    K++DFG +R +  ++     
Sbjct: 118 LDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE 174
Query: 559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                  +  PE      FT KSDV+SFG++L E++T
Sbjct: 175 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 8/212 (3%)
Query: 385 KLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEM 444
           K +   E E   +   L   LG G  G V+ G       VAVK  K    S  + F+ E 
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 59
Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
            ++ Q+ H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    L +A 
Sbjct: 60  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 116
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +++  ++++     I   HRD+++ NIL+ D    K++DFG +R +  ++          
Sbjct: 117 QIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
             +  PE      FT KSDV+SFG++L E++T
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 8/212 (3%)
Query: 385 KLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEM 444
           K +   E E   +   L   LG G  G V+ G       VAVK  K    S  + F+ E 
Sbjct: 3   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 61
Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
            ++ Q+ H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    L +A 
Sbjct: 62  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 118
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +++  ++++     I   HRD+++ NIL+ D    K++DFG +R +  ++          
Sbjct: 119 QIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 175
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
             +  PE      FT KSDV+SFG++L E++T
Sbjct: 176 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 8/212 (3%)
Query: 385 KLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEM 444
           K +   E E   +   L   LG G  G V+ G       VAVK  K    S  + F+ E 
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 59
Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
            ++ Q+ H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    L +A 
Sbjct: 60  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 116
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +++  ++++     I   HRD+++ NIL+ D    K++DFG +R +  ++          
Sbjct: 117 QIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
             +  PE      FT KSDV+SFG++L E++T
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 8/212 (3%)
Query: 385 KLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEM 444
           K +   E E   +   L   LG G  G V+ G       VAVK  K    S  + F+ E 
Sbjct: 2   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 60
Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
            ++ Q+ H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    L +A 
Sbjct: 61  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 117
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +++  ++++     I   HRD+++ NIL+ D    K++DFG +R +  ++          
Sbjct: 118 QIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 174
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
             +  PE      FT KSDV+SFG++L E++T
Sbjct: 175 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 6/203 (2%)
Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           E   ++  L + LG G  G V+ G       VA+K  K    S  E F+ E  I+ ++ H
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKH 63
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             +V+L     E  +  +V E++  G+L  ++ D  E   +     + +A +V+  ++Y+
Sbjct: 64  DKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYI 121
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
                I   HRD++S NIL+ +    K++DFG +R +  ++            +  PE  
Sbjct: 122 ERMNYI---HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAA 178
Query: 573 RSSQFTDKSDVYSFGVVLAELLT 595
              +FT KSDV+SFG++L EL+T
Sbjct: 179 LYGRFTIKSDVWSFGILLTELVT 201

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 18/213 (8%)
Query: 399 FNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVV 456
           + +   LG GG G V + +  D G+ VA+K+ +  +     E +  E+ I+ ++NH NVV
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 457 KL------LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSGAL 509
                   L      ++PLL  E+   G L +Y+ +Q E+     E  +R  + ++S AL
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSAL 134
Query: 510 SYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
            YLH      I HRD+K  NI+L     +   K+ D G ++ +  DQ  + T+  GT  Y
Sbjct: 135 RYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQY 189
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           L PE     ++T   D +SFG +  E +TG +P
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 18/213 (8%)
Query: 399 FNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVV 456
           + +   LG GG G V + +  D G+ VA+K+ +  +     E +  E+ I+ ++NH NVV
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 457 KL------LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSGAL 509
                   L      ++PLL  E+   G L +Y+ +Q E+     E  +R  + ++S AL
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSAL 135
Query: 510 SYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
            YLH      I HRD+K  NI+L     +   K+ D G ++ +  DQ  + T+  GT  Y
Sbjct: 136 RYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQY 190
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           L PE     ++T   D +SFG +  E +TG +P
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 8/212 (3%)
Query: 385 KLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEM 444
           K +   E E   +   L   LG G  G V+ G       VAVK  K    S  + F+ E 
Sbjct: 10  KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 68
Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
            ++ Q+ H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    L +A 
Sbjct: 69  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 125
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +++  ++++     I   HRD+++ NIL+ D    K++DFG +R +  ++          
Sbjct: 126 QIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 182
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
             +  PE      FT KSDV+SFG++L E++T
Sbjct: 183 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 17/210 (8%)
Query: 401 LNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINEMVILSQINHRNV 455
           +  ++G G  G V +G L  P  K   VA+K  K    E +  EF++E  I+ Q  H N+
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           ++L G    +   +++ EF+ NG L  ++   +  F +     +++   + G  S +   
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV-----IQLVGMLRGIASGMRYL 134
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFG--YLDPE 570
           A +   HRD+ + NIL++     KVSDFG SR +   + D T  T+ + G     +  PE
Sbjct: 135 AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTE-TSSLGGKIPIRWTAPE 193
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                +FT  SD +S+G+V+ E+++ GE+P
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 8/217 (3%)
Query: 380 TIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEE 439
           T +  K +   E E   +   L   LG G  G V+ G       VAVK  K    S  + 
Sbjct: 1   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DA 59
Query: 440 FINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMR 498
           F+ E  ++ Q+ H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    
Sbjct: 60  FLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKL 116
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
           L +A +++  ++++     I   HRD+++ NIL+ D    K++DFG +R +  ++     
Sbjct: 117 LDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 173
Query: 559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                  +  PE      FT KSDV+SFG++L E++T
Sbjct: 174 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 8/217 (3%)
Query: 380 TIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEE 439
           T +  K +   E E   +   L   LG G  G V+ G       VAVK  K    S  + 
Sbjct: 2   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DA 60
Query: 440 FINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMR 498
           F+ E  ++ Q+ H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKL 117
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
           L +A +++  ++++     I   HRD+++ NIL+ D    K++DFG +R +  ++     
Sbjct: 118 LDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 174
Query: 559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                  +  PE      FT KSDV+SFG++L E++T
Sbjct: 175 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 8/217 (3%)
Query: 380 TIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEE 439
           T +  K +   E E   +   L   LG G  G V+ G       VAVK  K    S  + 
Sbjct: 6   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DA 64
Query: 440 FINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMR 498
           F+ E  ++ Q+ H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    
Sbjct: 65  FLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKL 121
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
           L +A +++  ++++     I   HRD+++ NIL+ D    K++DFG +R +  ++     
Sbjct: 122 LDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 178
Query: 559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                  +  PE      FT KSDV+SFG++L E++T
Sbjct: 179 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 8/212 (3%)
Query: 385 KLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEM 444
           K +   E E   +   L   LG G  G V+ G       VAVK  K    S  + F+ E 
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEA 59
Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
            ++ Q+ H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    L +A 
Sbjct: 60  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAA 116
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +++  ++++     I   HRD+++ NIL+ D    K++DFG +R +  ++          
Sbjct: 117 QIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
             +  PE      FT KSDV+SFG++L E++T
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL  C  + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 153
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 154 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 211 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 240

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 117/265 (44%), Gaps = 30/265 (11%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVID----ESKVEEFINEMVILSQINHRNVVKLLG 460
           +G+G  G V+KG+  D +   V   K+ID    E ++E+   E+ +LSQ +   V K  G
Sbjct: 30  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
             L+     ++ E++  G+      D  E  P+       I  E+   L YLHS   I  
Sbjct: 88  SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI-- 141
Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRDIK+ N+LL +    K++DFG +  +   Q      V GT  ++ PE  + S +  K
Sbjct: 142 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDSK 199
Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE 640
           +D++S G+   EL  GE P       E   +   FL         E   ++ +KE     
Sbjct: 200 ADIWSLGITAIELARGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKE----- 249
Query: 641 IITFAKVAKRCLNLNGKKRPTMREV 665
                   + CLN     RPT +E+
Sbjct: 250 ------FVEACLNKEPSFRPTAKEL 268

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 18/210 (8%)
Query: 401 LNRILGQGGQGTVYKGML--PDGKI--VAVKKSKVIDESK--VEEFINEMVILSQINHRN 454
           L +ILG+G  G+V +G L   DG    VAVK  K+ + S+  +EEF++E   +   +H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 455 VVKLLGCCLETEV-----PLLVYEFIPNGTLFQY-IHDQNEDFP--ITWEMRLRIAIEVS 506
           V++LLG C+E        P+++  F+  G L  Y ++ + E  P  I  +  L+  ++++
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT-FG 565
             + YL +   +   HRD+ + N +L D     V+DFG S+ +     +   ++      
Sbjct: 158 LGMEYLSNRNFL---HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
           ++  E      +T KSDV++FGV + E+ T
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 117/265 (44%), Gaps = 30/265 (11%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVID----ESKVEEFINEMVILSQINHRNVVKLLG 460
           +G+G  G V+KG+  D +   V   K+ID    E ++E+   E+ +LSQ +   V K  G
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
             L+     ++ E++  G+      D  E  P+       I  E+   L YLHS   I  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI-- 126
Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRDIK+ N+LL +    K++DFG +  +   Q      V GT  ++ PE  + S +  K
Sbjct: 127 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDSK 184
Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDE 640
           +D++S G+   EL  GE P       E   +   FL         E   ++ +KE     
Sbjct: 185 ADIWSLGITAIELARGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKE----- 234
Query: 641 IITFAKVAKRCLNLNGKKRPTMREV 665
                   + CLN     RPT +E+
Sbjct: 235 ------FVEACLNKEPSFRPTAKEL 253

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 398 NFNLNRILGQGGQGTVY---------KGMLPDGKIVAVKKSKVIDESKVEEFINEMVILS 448
            F L ++LGQG  G V+            L   K++     KV D  + +    E  IL 
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK---MERDILV 82
Query: 449 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           ++NH  +VKL     +TE  L L+ +F+  G LF  +    E      +++  +A E++ 
Sbjct: 83  EVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELAL 138
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           AL +LHS   + I +RD+K  NILLD++   K++DFG S+  ++D         GT  Y+
Sbjct: 139 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYM 194
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
            PE       T  +D +SFGV++ E+LTG  P +
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 228

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 112/245 (45%), Gaps = 26/245 (10%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D  NL + LG+G  G V +            + VAVK  K     S+   
Sbjct: 18  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 77
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 78  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTP 137
Query: 493 -------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 545
                  +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGL 194
Query: 546 SRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFT 603
           +R +  D   +          ++ PE      +T +SDV+SFGV+L E+ + G  P    
Sbjct: 195 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 604 TLEED 608
            ++E+
Sbjct: 255 KIDEE 259

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 398 NFNLNRILGQGGQGTVY---------KGMLPDGKIVAVKKSKVIDESKVEEFINEMVILS 448
            F L ++LGQG  G V+            L   K++     KV D  + +    E  IL 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK---MERDILV 81
Query: 449 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           ++NH  +VKL     +TE  L L+ +F+  G LF  +    E      +++  +A E++ 
Sbjct: 82  EVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELAL 137
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           AL +LHS   + I +RD+K  NILLD++   K++DFG S+  ++D         GT  Y+
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYM 193
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
            PE       T  +D +SFGV++ E+LTG  P +
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 398 NFNLNRILGQGGQGTVY---------KGMLPDGKIVAVKKSKVIDESKVEEFINEMVILS 448
            F L ++LGQG  G V+            L   K++     KV D  + +    E  IL 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK---MERDILV 81
Query: 449 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           ++NH  +VKL     +TE  L L+ +F+  G LF  +    E      +++  +A E++ 
Sbjct: 82  EVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELAL 137
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           AL +LHS   + I +RD+K  NILLD++   K++DFG S+  ++D         GT  Y+
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYM 193
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
            PE       T  +D +SFGV++ E+LTG  P +
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 121/270 (44%), Gaps = 31/270 (11%)
Query: 400 NLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID----ESKVEEFINEMVILSQINHRNV 455
            L+RI G+G  G VYKG+  D     V   K+ID    E ++E+   E+ +LSQ +   +
Sbjct: 23  KLDRI-GKGSFGEVYKGI--DNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
            +  G  L++    ++ E++  G+      D  +  P+       I  E+   L YLHS 
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSAL----DLLKPGPLEETYIATILREILKGLDYLHSE 135
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
             I   HRDIK+ N+LL ++   K++DFG +  +   Q      V GT  ++ PE  + S
Sbjct: 136 RKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQS 191
Query: 576 QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE 635
            +  K+D++S G+   EL  GE P       +   +   FL         E         
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPN-----SDLHPMRVLFLIPKNSPPTLE--------- 237
Query: 636 SGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             G     F +  + CLN + + RPT +E+
Sbjct: 238 --GQHSKPFKEFVEACLNKDPRFRPTAKEL 265

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 104/223 (46%), Gaps = 16/223 (7%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           DNF   R+LG+G  G V    + + G + AVK   K  ++ +  VE  + E  ILS   +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 453 RNVVKLLGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALS 510
              +  L CC +T   L  V EF+  G L  +I  ++  F    E R R  A E+  AL 
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEIISALM 138
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           +LH      I +RD+K  N+LLD +   K++DFG  +    +    T    GT  Y+ PE
Sbjct: 139 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-TTATFCGTPDYIAPE 194
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAA 613
             +   +    D ++ GV+L E+L G  P  F    ED    A
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAP--FEAENEDDLFEA 235

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 6/199 (3%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++  L   LGQG  G V+ G       VA+K  K    S  E F+ E  ++ ++ H  +V
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 66
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +L     E  +  +V E++  G+L  ++  +   + +     + +A +++  ++Y+    
Sbjct: 67  QLYAVVSEEPI-XIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMN 124
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
            +   HRD+++ NIL+ +    KV+DFG +R +  ++            +  PE     +
Sbjct: 125 YV---HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR 181
Query: 577 FTDKSDVYSFGVVLAELLT 595
           FT KSDV+SFG++L EL T
Sbjct: 182 FTIKSDVWSFGILLTELTT 200

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 8/206 (3%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E E   +   L   LG G  G V+ G       VAVK  K    S  + F+ E  ++ Q+
Sbjct: 2   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 60
Query: 451 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    L +A +++  +
Sbjct: 61  QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGM 117
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           +++     I   HRD+++ NIL+ D    K++DFG +R +  ++            +  P
Sbjct: 118 AFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 174
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLT 595
           E      FT KSDV+SFG++L E++T
Sbjct: 175 EAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 398 NFNLNRILGQGGQGTVYK-GMLPDGKIVA---VKKSKVIDESKVEEFINEMVILSQINHR 453
           +F + R LG G  G V+      +G+  A   +KK  V+   +VE   +E ++LS + H 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
            ++++ G   + +   ++ ++I  G LF  +  +++ FP    +    A EV  AL YLH
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNP--VAKFYAAEVCLALEYLH 123
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     I +RD+K  NILLD     K++DFG ++ +      +T  + GT  Y+ PE   
Sbjct: 124 SKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYXLCGTPDYIAPEVVS 176
Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKPI 600
           +  +    D +SFG+++ E+L G  P 
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID--ESKVE-EFINEMVILSQINHR 453
           NF + + +G+G    VY+   L DG  VA+KK ++ D  ++K   + I E+ +L Q+NH 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALSYL 512
           NV+K     +E     +V E    G L + I H + +   I      +  +++  AL ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HS     + HRDIK  N+ +      K+ D G  R  +   T   + V GT  Y+ PE  
Sbjct: 153 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 208
Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKP 599
             + +  KSD++S G +L E+   + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 111/244 (45%), Gaps = 25/244 (10%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 78
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE 138
Query: 493 ------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 546
                 +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +
Sbjct: 139 DLYKDFLTLEHLIXYSFQVAKGMEFLASRKXI---HRDLAARNILLSEKNVVKICDFGLA 195
Query: 547 RSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTT 604
           R +  D   +          ++ PE      +T +SDV+SFGV+L E+ + G  P     
Sbjct: 196 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 605 LEED 608
           ++E+
Sbjct: 256 IDEE 259

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           E   +   L   LG G  G V+ G       VAVK  K    S  + F+ E  ++ Q+ H
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQH 67
Query: 453 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           + +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    L +A +++  +++
Sbjct: 68  QRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAF 124
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDP 569
           +     I   HRD+++ NIL+ D    K++DFG +R   ++    T +    F   +  P
Sbjct: 125 IEERNYI---HRDLRAANILVSDTLSCKIADFGLAR--LIEDAEXTAREGAKFPIKWTAP 179
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLT 595
           E      FT KSDV+SFG++L E++T
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 62
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ +I H  +V+L     E  +  +V E++  G+L  ++  +   + +     + +A
Sbjct: 63  EAQVMKKIRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMA 120
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 121 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 177
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 253 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 311
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G+L  ++  +   + +     + +A
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMA 369
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 370 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 426
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 62
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G+L  ++  +   + +     + +A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEEPI-YIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMA 120
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 121 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF 177
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           +F    ++G GG G V+K     DGK   +K+ K  +E K E    E+  L++++H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-KAE---REVKALAKLDHVNIV 67
Query: 457 KLLGCC----------------LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR 500
              GC                  +T+   +  EF   GTL Q+I  +  +  +   + L 
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALE 126
Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
           +  +++  + Y+HS   I   +RD+K +NI L D  + K+ DFG   S+  D     ++ 
Sbjct: 127 LFEQITKGVDYIHSKKLI---NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK- 182
Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL 594
            GT  Y+ PE   S  +  + D+Y+ G++LAELL
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 6/199 (3%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++  L   LGQG  G V+ G       VA+K  K    S  E F+ E  ++ ++ H  +V
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 69
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +L     E  +  +V E++  G+L  ++  +   + +     + +A +++  ++Y+    
Sbjct: 70  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMN 127
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
            +   HRD+++ NIL+ +    KV+DFG +R +  ++            +  PE     +
Sbjct: 128 YV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 184
Query: 577 FTDKSDVYSFGVVLAELLT 595
           FT KSDV+SFG++L EL T
Sbjct: 185 FTIKSDVWSFGILLTELTT 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 23/280 (8%)
Query: 392 LERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKV-IDESKVEEFINEMVILSQ 449
           +E   D+F     LG G  G V+K    P G ++A K   + I  +   + I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            N   +V   G         +  E +  G+L Q +        I  ++  +++I V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           +YL     I   HRD+K +NIL++ +   K+ DFG S  + +D   M     GT  Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSP 172
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD 629
           E  + + ++ +SD++S G+ L E+  G  PI     +ED         +     +FE+LD
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKED---------SRPPMAIFELLD 223
Query: 630 ARV----MKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             V     K   G   + F     +CL  N  +R  ++++
Sbjct: 224 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 263

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 170 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 228
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G+L  ++  +   + +     + +A
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMA 286
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 287 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 40  KEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 97
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S++NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 98  EALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 158 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 170 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 228
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G+L  ++  +   + +     + +A
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMA 286
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 287 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 26  KEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 83
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S++NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 84  EALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 143
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 144 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 200
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 201 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/319 (24%), Positives = 139/319 (43%), Gaps = 55/319 (17%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYK----GMLPDGKI--VAVKKSKVIDE 434
           I+ T+L  +++ E   +N    + LG G  G V +    G+  +  +  VAVK  K    
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 435 S-KVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFI-------------PNGT 479
           + + E  ++E+ I+S +  H N+V LLG C      L++ E+              P G 
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGL 149
Query: 480 LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 539
            + Y    N +  ++    L  + +V+  +++L S   I   HRD+ + N+LL + + AK
Sbjct: 150 EYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAK 206
Query: 540 VSDFGASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GE 597
           + DFG +R +  D  ++          ++ PE      +T +SDV+S+G++L E+ + G 
Sbjct: 207 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 266
Query: 598 KPI-------RFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKR 650
            P        +F  L +D    A   FA K   ++ I+ A                    
Sbjct: 267 NPYPGILVNSKFYKLVKDGYQMAQPAFAPK--NIYSIMQA-------------------- 304
Query: 651 CLNLNGKKRPTMREVTSEL 669
           C  L    RPT +++ S L
Sbjct: 305 CWALEPTHRPTFQQICSFL 323

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 62
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G+L  ++  +   + +     + +A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEEPI-YIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMA 120
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 121 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 177
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K  + S  E F+ 
Sbjct: 171 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP-EAFLQ 229
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G+L  ++  +   + +     + +A
Sbjct: 230 EAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMA 287
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG  R +  ++         
Sbjct: 288 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF 344
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 345 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 170 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 228
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G+L  ++  +   + +     + +A
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEEPI-YIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMA 286
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 287 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 17  KEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 74
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 75  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 134
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 135 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 191
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 192 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 112/246 (45%), Gaps = 27/246 (10%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLVY-EFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 493 --------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                   +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 184
Query: 545 ASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            +R +  D  ++          ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 185 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 603 TTLEED 608
             ++E+
Sbjct: 245 VKIDEE 250

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 40  KEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 97
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 98  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 158 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 6/199 (3%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++  L   LGQG  G V+ G       VA+K  K    S  E F+ E  ++ ++ H  +V
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 65
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +L     E  +  +V E++  G+L  ++  +   + +     + +A +++  ++Y+    
Sbjct: 66  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMN 123
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
            +   HRD+++ NIL+ +    KV+DFG +R +  ++            +  PE     +
Sbjct: 124 YV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 180
Query: 577 FTDKSDVYSFGVVLAELLT 595
           FT KSDV+SFG++L EL T
Sbjct: 181 FTIKSDVWSFGILLTELTT 199

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 62
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G+L  ++  +   + +     + +A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMA 120
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 121 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 177
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/326 (24%), Positives = 140/326 (42%), Gaps = 62/326 (19%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYK----GMLPDGKI--VAVKKSKVIDE 434
           I+ T+L  +++ E   +N    + LG G  G V +    G+  +  +  VAVK  K    
Sbjct: 15  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 74
Query: 435 S-KVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH------- 485
           + + E  ++E+ I+S +  H N+V LLG C      L++ E+   G L  ++        
Sbjct: 75  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAML 134
Query: 486 -------------DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 532
                        D+ +  P+     L  + +V+  +++L S   I   HRD+ + N+LL
Sbjct: 135 GPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLL 191
Query: 533 DDKYRAKVSDFGASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLA 591
            + + AK+ DFG +R +  D  ++          ++ PE      +T +SDV+S+G++L 
Sbjct: 192 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 251
Query: 592 ELLT-GEKPI-------RFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIIT 643
           E+ + G  P        +F  L +D    A   FA K   ++ I+ A             
Sbjct: 252 EIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPK--NIYSIMQA------------- 296
Query: 644 FAKVAKRCLNLNGKKRPTMREVTSEL 669
                  C  L    RPT +++ S L
Sbjct: 297 -------CWALEPTHRPTFQQICSFL 315

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 25  KEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 143 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 8/206 (3%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E E   +   L   LG G  G V+ G       VAVK  K    S  + F+ E  ++ Q+
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 61
Query: 451 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            H+ +V+L      T+ P+ ++ E++ NG+L  ++   +    +T    L +A +++  +
Sbjct: 62  QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGM 118
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           +++     I   HR++++ NIL+ D    K++DFG +R +  ++            +  P
Sbjct: 119 AFIEERNYI---HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 175
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLT 595
           E      FT KSDV+SFG++L E++T
Sbjct: 176 EAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 62
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G+L  ++  +   + +     + +A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEEPI-YIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMA 120
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 121 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 177
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 112/246 (45%), Gaps = 27/246 (10%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 493 --------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                   +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 193
Query: 545 ASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            +R +  D  ++          ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 194 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 603 TTLEED 608
             ++E+
Sbjct: 254 VKIDEE 259

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 25  KEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 143 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 62
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G L  ++  +   + +     + +A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEEPI-YIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMA 120
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 121 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 177
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 6/199 (3%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++  L   LGQG  G V+ G       VA+K  K    S  E F+ E  ++ ++ H  +V
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 67
Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +L     E  +  +V E++  G+L  ++  +   + +     + +A +++  ++Y+    
Sbjct: 68  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMN 125
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
            +   HRD+++ NIL+ +    KV+DFG +R +  ++            +  PE     +
Sbjct: 126 YV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 182
Query: 577 FTDKSDVYSFGVVLAELLT 595
           FT KSDV+SFG++L EL T
Sbjct: 183 FTIKSDVWSFGILLTELTT 201

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 91/183 (49%), Gaps = 18/183 (9%)
Query: 421 GKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP--LLVYEFIPN 477
           G++VAVK  K          +  E+ IL  + H +++K  GCC +       LV E++P 
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
           G+L  Y+   +    I     L  A ++   ++YLH+   I   HRD+ + N+LLD+   
Sbjct: 120 GSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQHYI---HRDLAARNVLLDNDRL 172
Query: 538 AKVSDFGASRSMAVDQTHMTTQVH-----GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAE 592
            K+ DFG ++  AV + H   +V        F Y  PE  +  +F   SDV+SFGV L E
Sbjct: 173 VKIGDFGLAK--AVPEGHEXYRVREDGDSPVFWYA-PECLKEYKFYYASDVWSFGVTLYE 229
Query: 593 LLT 595
           LLT
Sbjct: 230 LLT 232

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 112/246 (45%), Gaps = 27/246 (10%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA 138
Query: 493 --------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                   +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 139 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 195
Query: 545 ASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            +R +  D  ++          ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 196 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 255
Query: 603 TTLEED 608
             ++E+
Sbjct: 256 VKIDEE 261

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 32  KEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 89
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 90  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 149
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 150 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 206
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 207 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 38/231 (16%)
Query: 394 RATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           R   +F    +LGQG  G V K     D +  A+KK +  +E K+   ++E+++L+ +NH
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNH 61
Query: 453 RNVVKLLGCCLE--------TEVP-----LLVYEFIPNGTLFQYIHDQN--EDFPITWEM 497
           + VV+     LE        T V       +  E+  NGTL+  IH +N  +     W  
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-- 119
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS-------MA 550
             R+  ++  ALSY+HS     I HRD+K  NI +D+    K+ DFG +++       + 
Sbjct: 120 --RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 551 VDQTHM------TTQVHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLAELL 594
           +D  ++       T   GT  Y+  E    +  + +K D+YS G++  E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 125/283 (44%), Gaps = 26/283 (9%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRN 454
           D++ L  ++G G    V      P  + VA+K+  +   ++ ++E + E+  +SQ +H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD-----QNEDFPITWEMRLRIAIEVSGAL 509
           +V      +  +   LV + +  G++   I       +++   +       I  EV   L
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG---- 565
            YLH    I   HRD+K+ NILL +    +++DFG S  +A        +V  TF     
Sbjct: 130 EYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 566 YLDPEYFRSSQFTD-KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
           ++ PE     +  D K+D++SFG+   EL TG  P       +   +    L    +   
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP-----YHKYPPMKVLMLTLQNDPPS 241
Query: 625 FE--ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            E  + D  ++K+ G     +F K+   CL  + +KRPT  E+
Sbjct: 242 LETGVQDKEMLKKYGK----SFRKMISLCLQKDPEKRPTAAEL 280

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 112/246 (45%), Gaps = 27/246 (10%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 54  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 113
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 173
Query: 493 --------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                   +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 174 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 230
Query: 545 ASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            +R +  D  ++          ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 231 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290
Query: 603 TTLEED 608
             ++E+
Sbjct: 291 VKIDEE 296

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 40  KEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLM 97
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 98  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 158 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 42  KEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 99
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 100 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 159
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 160 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 216
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 217 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 112/246 (45%), Gaps = 27/246 (10%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLVY-EFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 493 --------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                   +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 184
Query: 545 ASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            +R +  D  ++          ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 185 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 603 TTLEED 608
             ++E+
Sbjct: 245 VKIDEE 250

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 26  KEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 83
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 84  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 143
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 144 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 200
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 201 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 43  KEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 100
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 101 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 160
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 161 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 217
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 218 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D+F++ R LG+G  G VY       K I+A+K   KS++  E    +   E+ I S + H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
            N++++     + +   L+ EF P G L++ +           +       E++ AL Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYC 131
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS-RSMAVDQTHMTTQVHGTFGYLDPEY 571
           H    I   HRDIK  N+L+  K   K++DFG S  + ++ +  M     GT  YL PE 
Sbjct: 132 HERKVI---HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEM 184
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
                  +K D++  GV+  E L G  P 
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 88/179 (49%), Gaps = 8/179 (4%)
Query: 421 GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 480
           G+ VAVK   +  + + E   NE+VI+    H NVV++    L  E   ++ EF+  G L
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129
Query: 481 FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 540
              +        +  E    +   V  AL+YLH+   I   HRDIKS +ILL    R K+
Sbjct: 130 TDIVSQVR----LNEEQIATVCEAVLQALAYLHAQGVI---HRDIKSDSILLTLDGRVKL 182
Query: 541 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           SDFG    ++ D       V GT  ++ PE    S +  + D++S G+++ E++ GE P
Sbjct: 183 SDFGFCAQISKDVPKRKXLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 62
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G L  ++  +   + +     + +A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMA 120
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 121 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 177
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 102/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 1   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 59
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G+L  ++  +   + +     + ++
Sbjct: 60  EAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMS 117
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 118 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF 174
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 175 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 28/225 (12%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 26  KEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 83
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 84  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 143
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG    MA D   
Sbjct: 144 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFG----MAQDIYR 196
Query: 556 MTTQVHG-----TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
            +    G        ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 125/283 (44%), Gaps = 26/283 (9%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRN 454
           D++ L  ++G G    V      P  + VA+K+  +   ++ ++E + E+  +SQ +H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD-----QNEDFPITWEMRLRIAIEVSGAL 509
           +V      +  +   LV + +  G++   I       +++   +       I  EV   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG---- 565
            YLH    I   HRD+K+ NILL +    +++DFG S  +A        +V  TF     
Sbjct: 135 EYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 566 YLDPEYFRSSQFTD-KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
           ++ PE     +  D K+D++SFG+   EL TG  P       +   +    L    +   
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH-----KYPPMKVLMLTLQNDPPS 246
Query: 625 FE--ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            E  + D  ++K+ G     +F K+   CL  + +KRPT  E+
Sbjct: 247 LETGVQDKEMLKKYGK----SFRKMISLCLQKDPEKRPTAAEL 285

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 40/227 (17%)
Query: 398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           +F    ++G GG G V+K     DGK   +++ K  +E K E    E+  L++++H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNE-KAE---REVKALAKLDHVNIV 68
Query: 457 KLLGC-------------CLE----------------TEVPLLVYEFIPNGTLFQYIHDQ 487
              GC              LE                T+   +  EF   GTL Q+I  +
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 488 NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 547
             +  +   + L +  +++  + Y+HS   I   HRD+K +NI L D  + K+ DFG   
Sbjct: 129 RGE-KLDKVLALELFEQITKGVDYIHSKKLI---HRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 548 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL 594
           S+  D     T+  GT  Y+ PE   S  +  + D+Y+ G++LAELL
Sbjct: 185 SLKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 111/246 (45%), Gaps = 27/246 (10%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 493 --------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                   +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 184
Query: 545 ASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            +R +  D   +          ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 185 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 603 TTLEED 608
             ++E+
Sbjct: 245 VKIDEE 250

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 66  KEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 123
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 184 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 111/246 (45%), Gaps = 27/246 (10%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 493 --------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                   +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 193
Query: 545 ASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            +R +  D   +          ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 603 TTLEED 608
             ++E+
Sbjct: 254 VKIDEE 259

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 111/246 (45%), Gaps = 27/246 (10%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLVY-EFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 493 --------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                   +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 184
Query: 545 ASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            +R +  D   +          ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 185 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 603 TTLEED 608
             ++E+
Sbjct: 245 VKIDEE 250

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 102/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 1   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 59
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G+L  ++  +   + +     + ++
Sbjct: 60  EAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMS 117
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+++ NIL+ +    KV+DFG +R +  ++         
Sbjct: 118 AQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 174
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 175 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 92/181 (50%), Gaps = 14/181 (7%)
Query: 421 GKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLET-EVPL-LVYEFIPN 477
           G++VAVK  K          +  E+ IL  + H +++K  GCC +  E  L LV E++P 
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
           G+L  Y+   +    I     L  A ++   ++YLHS   I   HR++ + N+LLD+   
Sbjct: 103 GSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHSQHYI---HRNLAARNVLLDNDRL 155
Query: 538 AKVSDFGASRSMAVDQTHMTTQVHG---TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL 594
            K+ DFG ++++     +   +  G    F Y  PE  +  +F   SDV+SFGV L ELL
Sbjct: 156 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PECLKEYKFYYASDVWSFGVTLYELL 214
Query: 595 T 595
           T
Sbjct: 215 T 215

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVIDESKVEEFIN 442
           KE+ R   N  L R LG G  G VY+G +      P    VAVK   +V  E    +F+ 
Sbjct: 52  KEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 109
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEM--R 498
           E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++ +       P +  M   
Sbjct: 110 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 169
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTH 555
           L +A +++    YL     I   HRDI + N LL        AK+ DFG +R +     +
Sbjct: 170 LHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 226
Query: 556 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
                      ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 227 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 6/213 (2%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T+       E   ++  L   LGQG  G V+ G       VA+K  K    S  E F+ 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQ 62
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  ++ ++ H  +V+L     E  +  +V E++  G+L  ++  +   + +     + +A
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMA 120
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            +++  ++Y+     +   HRD+ + NIL+ +    KV+DFG +R +  ++         
Sbjct: 121 AQIASGMAYVERMNYV---HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 177
Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              +  PE     +FT KSDV+SFG++L EL T
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 148
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                 +  SD+++ G ++ +L+ G  P R
Sbjct: 206 LTEKSASKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 146
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPEL 203
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 233

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 44/307 (14%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK----GMLPDGK----IVAVKKSKV-IDESKVEEFINE 443
           E   D   L + LG+G  G V      G+  D       VAVK  K    E  + + I+E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-------------DQNE 489
           M ++  I  H+N++ LLG C +     ++ E+   G L +Y+                N 
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNP 143
Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           +  ++ +  +  A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 550 A-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
             +D    TT       ++ PE      +T +SDV+SFGV+L E+ T G  P     +EE
Sbjct: 201 HHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 260
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
                           LF++L      +   +       + + C +    +RPT +++  
Sbjct: 261 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304
Query: 668 ELAGIKA 674
           +L  I A
Sbjct: 305 DLDRIVA 311

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 111/246 (45%), Gaps = 27/246 (10%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFP----- 492
            ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  Y+  +  +F      
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 493 --------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                   +T E  +  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 193
Query: 545 ASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            +R +  D   +          ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 194 LARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 603 TTLEED 608
             ++E+
Sbjct: 254 VKIDEE 259

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 44/307 (14%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK----GMLPDGK----IVAVKKSKV-IDESKVEEFINE 443
           E   D   L + LG+G  G V      G+  D       VAVK  K    E  + + I+E
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-------------DQNE 489
           M ++  I  H+N++ LLG C +     ++ E+   G L +Y+                N 
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 128
Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           +  ++ +  +  A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 550 A-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
             +D    TT       ++ PE      +T +SDV+SFGV+L E+ T G  P     +EE
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
                           LF++L      +   +       + + C +    +RPT +++  
Sbjct: 246 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
Query: 668 ELAGIKA 674
           +L  I A
Sbjct: 290 DLDRIVA 296

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 148
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 12/214 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCC 462
           +G+G  G VYK     G+IVA+K+ ++   DE      I E+ +L +++H N+V L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
                  LV+EF+      + + D+N+    T     +I I +   L  +       I H
Sbjct: 89  HSERCLTLVFEFMEKD--LKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-SSQFTDKS 581
           RD+K  N+L++     K++DFG +R+  +     T +V  T  Y  P+    S +++   
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV-VTLWYRAPDVLMGSKKYSTSV 201
Query: 582 DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
           D++S G + AE++TG KP+ F  + +D  L   F
Sbjct: 202 DIWSIGCIFAEMITG-KPL-FPGVTDDDQLPKIF 233

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 12/214 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCC 462
           +G+G  G VYK     G+IVA+K+ ++   DE      I E+ +L +++H N+V L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
                  LV+EF+      + + D+N+    T     +I I +   L  +       I H
Sbjct: 89  HSERCLTLVFEFMEKD--LKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-SSQFTDKS 581
           RD+K  N+L++     K++DFG +R+  +     T +V  T  Y  P+    S +++   
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV-VTLWYRAPDVLMGSKKYSTSV 201
Query: 582 DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
           D++S G + AE++TG KP+ F  + +D  L   F
Sbjct: 202 DIWSIGCIFAEMITG-KPL-FPGVTDDDQLPKIF 233

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/317 (25%), Positives = 141/317 (44%), Gaps = 53/317 (16%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYK----GMLPDGKI--VAVKKSKVIDE 434
           I+ T+L  +++ E   +N    + LG G  G V +    G+  +  +  VAVK  K    
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 435 S-KVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH------D 486
           + + E  ++E+ I+S +  H N+V LLG C      L++ E+   G L  ++       +
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLE 149
Query: 487 QNEDFPI---TWEMR--LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 541
            +  F I   T   R  L  + +V+  +++L S   I   HRD+ + N+LL + + AK+ 
Sbjct: 150 TDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIG 206
Query: 542 DFGASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           DFG +R +  D  ++          ++ PE      +T +SDV+S+G++L E+ + G  P
Sbjct: 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 600 I-------RFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCL 652
                   +F  L +D    A   FA K   ++ I+ A                    C 
Sbjct: 267 YPGILVNSKFYKLVKDGYQMAQPAFAPKN--IYSIMQA--------------------CW 304
Query: 653 NLNGKKRPTMREVTSEL 669
            L    RPT +++ S L
Sbjct: 305 ALEPTHRPTFQQICSFL 321

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 136/319 (42%), Gaps = 44/319 (13%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYK----GMLPDGK----IVAVKKSKV- 431
           + + +L      E   D   L + LG+G  G V      G+  D       VAVK  K  
Sbjct: 12  VSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD 71
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH----- 485
             E  + + I+EM ++  I  H+N++ LLG C +     ++ E+   G L +Y+      
Sbjct: 72  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 131
Query: 486 --------DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                     N +  ++ +  +  A +V+  + YL S   I   HRD+ + N+L+ +   
Sbjct: 132 GLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNV 188
Query: 538 AKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV+L E+ T 
Sbjct: 189 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 248
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G  P     +EE                LF++L      +   +       + + C +  
Sbjct: 249 GGSPYPGVPVEE----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAV 292
Query: 656 GKKRPTMREVTSELAGIKA 674
             +RPT +++  +L  I A
Sbjct: 293 PSQRPTFKQLVEDLDRIVA 311

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 11/214 (5%)
Query: 393 ERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILS 448
           ++  ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +++H   VKL     + E       +  NG L +YI      F  T   R   A E+  A
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSA 122
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYL 567
           L YLH      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+
Sbjct: 123 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
            PE          SD+++ G ++ +L+ G  P R
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 213

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 146
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 233

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGG-QGTVYKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G    TV    L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 146
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 233

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 11/214 (5%)
Query: 393 ERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILS 448
           ++  ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +++H   VKL     + E       +  NG L +YI      F  T   R   A E+  A
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSA 121
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYL 567
           L YLH      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+
Sbjct: 122 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
            PE          SD+++ G ++ +L+ G  P R
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 212

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 11/214 (5%)
Query: 393 ERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILS 448
           ++  ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +++H   VKL     + E       +  NG L +YI      F  T   R   A E+  A
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSA 119
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYL 567
           L YLH      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+
Sbjct: 120 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
            PE          SD+++ G ++ +L+ G  P R
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 210

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 44/307 (14%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK----GMLPDGK----IVAVKKSKV-IDESKVEEFINE 443
           E   D   L + LG+G  G V      G+  D       VAVK  K    E  + + I+E
Sbjct: 16  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 75
Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-------------DQNE 489
           M ++  I  H+N++ LLG C +     ++ E+   G L +Y+                N 
Sbjct: 76  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 135
Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           +  ++ +  +  A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 136 EEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 192
Query: 550 A-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
             +D    TT       ++ PE      +T +SDV+SFGV+L E+ T G  P     +EE
Sbjct: 193 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 252
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
                           LF++L      +   +       + + C +    +RPT +++  
Sbjct: 253 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 296
Query: 668 ELAGIKA 674
           +L  I A
Sbjct: 297 DLDRIVA 303

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 146
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 149
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 150 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 206
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 236

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 148
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 11/214 (5%)
Query: 393 ERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILS 448
           ++  ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +++H   VKL     + E       +  NG L +YI      F  T   R   A E+  A
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSA 120
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYL 567
           L YLH      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
            PE          SD+++ G ++ +L+ G  P R
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 211

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 44/307 (14%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK----GMLPDGK----IVAVKKSKV-IDESKVEEFINE 443
           E   D   L + LG+G  G V      G+  D       VAVK  K    E  + + I+E
Sbjct: 13  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 72
Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-------------DQNE 489
           M ++  I  H+N++ LLG C +     ++ E+   G L +Y+                N 
Sbjct: 73  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 132
Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           +  ++ +  +  A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 133 EEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 189
Query: 550 A-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
             +D    TT       ++ PE      +T +SDV+SFGV+L E+ T G  P     +EE
Sbjct: 190 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 249
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
                           LF++L      +   +       + + C +    +RPT +++  
Sbjct: 250 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 293
Query: 668 ELAGIKA 674
           +L  I A
Sbjct: 294 DLDRIVA 300

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 151
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 152 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 208
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 209 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 238

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 148
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/317 (25%), Positives = 141/317 (44%), Gaps = 53/317 (16%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYK----GMLPDGKI--VAVKKSKVIDE 434
           I+ T+L  +++ E   +N    + LG G  G V +    G+  +  +  VAVK  K    
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 435 S-KVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH------D 486
           + + E  ++E+ I+S +  H N+V LLG C      L++ E+   G L  ++       +
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLE 149
Query: 487 QNEDFPI---TWEMR--LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 541
            +  F I   T   R  L  + +V+  +++L S   I   HRD+ + N+LL + + AK+ 
Sbjct: 150 TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIG 206
Query: 542 DFGASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           DFG +R +  D  ++          ++ PE      +T +SDV+S+G++L E+ + G  P
Sbjct: 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 600 I-------RFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCL 652
                   +F  L +D    A   FA K   ++ I+ A                    C 
Sbjct: 267 YPGILVNSKFYKLVKDGYQMAQPAFAPKN--IYSIMQA--------------------CW 304
Query: 653 NLNGKKRPTMREVTSEL 669
            L    RPT +++ S L
Sbjct: 305 ALEPTHRPTFQQICSFL 321

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D+F++ R LG+G  G VY       K I+A+K   KS++  E    +   E+ I S + H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
            N++++     + +   L+ EF P G L++ +           +       E++ AL Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYC 130
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS-RSMAVDQTHMTTQVHGTFGYLDPEY 571
           H    I   HRDIK  N+L+  K   K++DFG S  + ++ +  M     GT  YL PE 
Sbjct: 131 HERKVI---HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEM 183
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
                  +K D++  GV+  E L G  P 
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 148
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 148
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 401 LNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESK-VEEFINEMVILSQINHRNVVKL 458
           L+ ILGQG    V++G     G + A+K    I   + V+  + E  +L ++NH+N+VKL
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 459 LGCCLETEV--PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
                ET     +L+ EF P G+L+  + + +  + +     L +  +V G +++L    
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 517 SIPIYHRDIKSTNILL----DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
              I HR+IK  NI+     D +   K++DFGA+R +  D+  +   ++GT  YL P+ +
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYGTEEYLHPDMY 187
Query: 573 RSS--------QFTDKSDVYSFGVVLAELLTGEKPIR 601
             +        ++    D++S GV      TG  P R
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 44/307 (14%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK----GMLPDGK----IVAVKKSKV-IDESKVEEFINE 443
           E   D   L + LG+G  G V      G+  D       VAVK  K    E  + + I+E
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-------------DQNE 489
           M ++  I  H+N++ LLG C +     ++ E+   G L +Y+                N 
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           +  ++ +  +  A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 550 A-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
             +D    TT       ++ PE      +T +SDV+SFGV+L E+ T G  P     +EE
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
                           LF++L      +   +       + + C +    +RPT +++  
Sbjct: 302 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345
Query: 668 ELAGIKA 674
           +L  I A
Sbjct: 346 DLDRIVA 352

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 92/181 (50%), Gaps = 14/181 (7%)
Query: 421 GKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLET-EVPL-LVYEFIPN 477
           G++VAVK  K          +  E+ IL  + H +++K  GCC +  E  L LV E++P 
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
           G+L  Y+   +    I     L  A ++   ++YLH+   I   HR++ + N+LLD+   
Sbjct: 103 GSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQHYI---HRNLAARNVLLDNDRL 155
Query: 538 AKVSDFGASRSMAVDQTHMTTQVHG---TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL 594
            K+ DFG ++++     +   +  G    F Y  PE  +  +F   SDV+SFGV L ELL
Sbjct: 156 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PECLKEYKFYYASDVWSFGVTLYELL 214
Query: 595 T 595
           T
Sbjct: 215 T 215

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 397 DNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKVIDESKVEEFINEMV---ILSQINH 452
           D F   R+LG+GG G V+   M   GK+ A KK       K + +   MV   IL++++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-IHDQNEDFPITWEMR-LRIAIEVSGALS 510
           R +V L     ET+  L +   I NG   +Y I++ +ED P   E R +    ++   L 
Sbjct: 245 RFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           +LH      I +RD+K  N+LLDD    ++SD G +  +   QT  T    GT G++ PE
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPE 359
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                ++    D ++ GV L E++    P R
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 401 LNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESK-VEEFINEMVILSQINHRNVVKL 458
           L+ ILGQG    V++G     G + A+K    I   + V+  + E  +L ++NH+N+VKL
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 459 LGCCLETEV--PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
                ET     +L+ EF P G+L+  + + +  + +     L +  +V G +++L    
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 517 SIPIYHRDIKSTNILL----DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
              I HR+IK  NI+     D +   K++DFGA+R +  D+  ++  ++GT  YL P+ +
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMY 187
Query: 573 RSS--------QFTDKSDVYSFGVVLAELLTGEKPIR 601
             +        ++    D++S GV      TG  P R
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 44/307 (14%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK----GMLPDGK----IVAVKKSKV-IDESKVEEFINE 443
           E   D   L + LG+G  G V      G+  D       VAVK  K    E  + + I+E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-------------DQNE 489
           M ++  I  H+N++ LLG C +     ++ E+   G L +Y+                N 
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 143
Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           +  ++ +  +  A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 550 A-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
             +D    TT       ++ PE      +T +SDV+SFGV+L E+ T G  P     +EE
Sbjct: 201 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 260
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
                           LF++L      +   +       + + C +    +RPT +++  
Sbjct: 261 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304
Query: 668 ELAGIKA 674
           +L  I A
Sbjct: 305 DLDRIVA 311

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 44/307 (14%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK----GMLPDGK----IVAVKKSKV-IDESKVEEFINE 443
           E   D   L + LG+G  G V      G+  D       VAVK  K    E  + + I+E
Sbjct: 17  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 76
Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-------------DQNE 489
           M ++  I  H+N++ LLG C +     ++ E+   G L +Y+                N 
Sbjct: 77  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 136
Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           +  ++ +  +  A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 137 EEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 193
Query: 550 A-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
             +D    TT       ++ PE      +T +SDV+SFGV+L E+ T G  P     +EE
Sbjct: 194 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 253
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
                           LF++L      +   +       + + C +    +RPT +++  
Sbjct: 254 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 297
Query: 668 ELAGIKA 674
           +L  I A
Sbjct: 298 DLDRIVA 304

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 44/307 (14%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK----GMLPDGK----IVAVKKSKV-IDESKVEEFINE 443
           E   D   L + LG+G  G V      G+  D       VAVK  K    E  + + I+E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-------------DQNE 489
           M ++  I  H+N++ LLG C +     ++ E+   G L +Y+                N 
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNP 143
Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
           +  ++ +  +  A +V+  + YL S   I   HRD+ + N+L+ +    K++DFG +R +
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 550 A-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE 607
             +D    TT       ++ PE      +T +SDV+SFGV+L E+ T G  P     +EE
Sbjct: 201 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 260
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
                           LF++L      +   +       + + C +    +RPT +++  
Sbjct: 261 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304
Query: 668 ELAGIKA 674
           +L  I A
Sbjct: 305 DLDRIVA 311

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 130
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 131 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 187
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 188 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 217

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 149
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 150 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 206
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 236

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 404 ILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFI--NEMVILSQINHRNVVKLLG 460
           ++G+G  G V K    D G+IVA+KK    D+ K+ + I   E+ +L Q+ H N+V LL 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP--ITWEMRLRIAIEVSGALSYLHSAASI 518
            C + +   LV+EF+ +  L     D  E FP  + +++  +   ++   + + HS    
Sbjct: 92  VCKKKKRWYLVFEFVDHTIL-----DDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN-- 144
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QF 577
            I HRDIK  NIL+      K+ DFG +R++A        +V  T  Y  PE      ++
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPELLVGDVKY 202
Query: 578 TDKSDVYSFGVVLAELLTGEK----------------------PIRFTTLEEDKSLAAYF 615
               DV++ G ++ E+  GE                       P       ++   A   
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
           L  +KE    E L+ R  K S   E++    +AK+CL+++  KRP   E+
Sbjct: 263 LPEIKER---EPLERRYPKLS---EVVI--DLAKKCLHIDPDKRPFCAEL 304

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 145
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEY 571
           H      I HRD+K  NILL++    +++DFG ++ ++ +          GT  Y+ PE 
Sbjct: 146 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 202
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                    SD+++ G ++ +L+ G  P R
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLPPFR 232

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 397 DNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           ++     ++G+G  G V K      G+  D  I  +K+    D+ +  +F  E+ +L ++
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKL 72
Query: 451 NHR-NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-----DQNEDFPI--------TWE 496
            H  N++ LLG C       L  E+ P+G L  ++      + +  F I        + +
Sbjct: 73  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 132
Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 556
             L  A +V+  + YL     I   HRD+ + NIL+ + Y AK++DFG SR   V     
Sbjct: 133 QLLHFAADVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV----- 184
Query: 557 TTQVHGTFG-----YLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              V  T G     ++  E    S +T  SDV+S+GV+L E+++
Sbjct: 185 --YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 403 RILGQGGQGTVYK-GMLPDGKIVAVKKSKVIDESKVEEFINEMV---ILSQINHRNVVKL 458
           R+LG+GG G V+   M   GK+ A KK       K + +   MV   IL++++ R +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQY-IHDQNEDFPITWEMR-LRIAIEVSGALSYLHSAA 516
                ET+  L +   I NG   +Y I++ +ED P   E R +    ++   L +LH   
Sbjct: 251 -AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
              I +RD+K  N+LLDD    ++SD G +  +   QT  T    GT G++ PE     +
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEE 365
Query: 577 FTDKSDVYSFGVVLAELLTGEKPIR 601
           +    D ++ GV L E++    P R
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 403 RILGQGGQGTVYK-GMLPDGKIVAVKKSKVIDESKVEEFINEMV---ILSQINHRNVVKL 458
           R+LG+GG G V+   M   GK+ A KK       K + +   MV   IL++++ R +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQY-IHDQNEDFPITWEMR-LRIAIEVSGALSYLHSAA 516
                ET+  L +   I NG   +Y I++ +ED P   E R +    ++   L +LH   
Sbjct: 251 -AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
              I +RD+K  N+LLDD    ++SD G +  +   QT  T    GT G++ PE     +
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEE 365
Query: 577 FTDKSDVYSFGVVLAELLTGEKPIR 601
           +    D ++ GV L E++    P R
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 397 DNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           ++     ++G+G  G V K      G+  D  I  +K+    D+ +  +F  E+ +L ++
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKL 82
Query: 451 NHR-NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-----DQNEDFPI--------TWE 496
            H  N++ LLG C       L  E+ P+G L  ++      + +  F I        + +
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 556
             L  A +V+  + YL     I   HRD+ + NIL+ + Y AK++DFG SR   V     
Sbjct: 143 QLLHFAADVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV----- 194
Query: 557 TTQVHGTFG-----YLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              V  T G     ++  E    S +T  SDV+S+GV+L E+++
Sbjct: 195 --YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 403 RILGQGGQGTVYK-GMLPDGKIVAVKKSKVIDESKVEEFINEMV---ILSQINHRNVVKL 458
           R+LG+GG G V+   M   GK+ A KK       K + +   MV   IL++++ R +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQY-IHDQNEDFPITWEMR-LRIAIEVSGALSYLHSAA 516
                ET+  L +   I NG   +Y I++ +ED P   E R +    ++   L +LH   
Sbjct: 251 -AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
              I +RD+K  N+LLDD    ++SD G +  +   QT  T    GT G++ PE     +
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEE 365
Query: 577 FTDKSDVYSFGVVLAELLTGEKPIR 601
           +    D ++ GV L E++    P R
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 98/203 (48%), Gaps = 5/203 (2%)
Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           E   ++  L + LG G  G V+ G   +   VAVK  K    S V+ F+ E  ++  + H
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQH 67
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             +V+L       E   ++ E++  G+L  ++   +E   +     +  + +++  ++Y+
Sbjct: 68  DKLVRLYAVVTREEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYI 126
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
                I   HRD+++ N+L+ +    K++DFG +R +  ++            +  PE  
Sbjct: 127 ERKNYI---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 183
Query: 573 RSSQFTDKSDVYSFGVVLAELLT 595
               FT KSDV+SFG++L E++T
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVT 206

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 115/245 (46%), Gaps = 33/245 (13%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK----GMLPDGKIVAVKKSKVIDESKVE---EFINEMV 445
           E   +N    R +G+G  G V++    G+LP      V    + +E+  +   +F  E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-------------- 491
           ++++ ++ N+VKLLG C   +   L++E++  G L +++   +                 
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 492 -------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                  P++   +L IA +V+  ++YL     +   HRD+ + N L+ +    K++DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFG 219
Query: 545 ASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF 602
            SR++ + D             ++ PE    +++T +SDV+++GVVL E+ + G +P   
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 603 TTLEE 607
              EE
Sbjct: 280 MAHEE 284

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 110/220 (50%), Gaps = 24/220 (10%)
Query: 398 NFNLNRILGQGGQGTV-YKGMLPDGKIVAVKKSKVIDESKV-----EEFINEMVILSQIN 451
           N+ L + +G+G    V     +  G+ VAVK   +ID++++     ++   E+ I+  +N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVK---IIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 452 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRIAIEVSGA 508
           H N+VKL    +ETE  L LV E+   G +F Y+  H + ++     + R     ++  A
Sbjct: 73  HPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----QIVSA 126
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           + Y H      I HRD+K+ N+LLD     K++DFG S    V     T    G+  Y  
Sbjct: 127 VQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCGSPPYAA 181
Query: 569 PEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           PE F+  ++   + DV+S GV+L  L++G  P     L+E
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S+++H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
              VKL     + E       +  NG L +YI      F  T   R   A E+  AL YL
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC-TRFYTA-EIVSALEYL 145
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD--QTHMTTQVHGTFGYLDPE 570
           H      I HRD+K  NILL++    +++DFG ++ ++ +  Q    + V GT  Y+ PE
Sbjct: 146 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPE 201
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
                     SD+++ G ++ +L+ G  P R
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPPFR 232

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 99/203 (48%), Gaps = 5/203 (2%)
Query: 393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           E   ++  L + LG G  G V+ G   +   VAVK  K    S V+ F+ E  ++  + H
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQH 66
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             +V+L     + E   ++ EF+  G+L  ++   +E   +     +  + +++  ++Y+
Sbjct: 67  DKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYI 125
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
                I   HRD+++ N+L+ +    K++DFG +R +  ++            +  PE  
Sbjct: 126 ERKNYI---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 573 RSSQFTDKSDVYSFGVVLAELLT 595
               FT KS+V+SFG++L E++T
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVT 205

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 118/253 (46%), Gaps = 24/253 (9%)
Query: 420 DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLE-TEVPL-LVYEFI 475
           DGKI+  K+     + E++ +  ++E+ +L ++ H N+V+     ++ T   L +V E+ 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 476 PNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALSYLH--SAASIPIYHRDIKSTNILL 532
             G L   I     E   +  E  LR+  +++ AL   H  S     + HRD+K  N+ L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 533 DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAE 592
           D K   K+ DFG +R +  D +   T V GT  Y+ PE      + +KSD++S G +L E
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 593 LLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCL 652
           L     P  FT   + K LA         E  F  +  R   E   +EIIT      R L
Sbjct: 209 LCALMPP--FTAFSQ-KELAGKI-----REGKFRRIPYRYSDEL--NEIIT------RML 252
Query: 653 NLNGKKRPTMREV 665
           NL    RP++ E+
Sbjct: 253 NLKDYHRPSVEEI 265

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 25/288 (8%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVKKSKVIDESKVEEFINEM 444
           S +++   ++F L+++LG+G  G V+            I A+KK  V+ +  VE  + E 
Sbjct: 10  SLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 69
Query: 445 VILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
            +LS       +  + C  +T+  L  V E++  G L  +I   ++ F ++       A 
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLS--RATFYAA 126
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           E+   L +LHS     I +RD+K  NILLD     K++DFG  +   +     T +  GT
Sbjct: 127 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNEFCGT 182
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER 623
             Y+ PE     ++    D +SFGV+L E+L G+ P  F   +E++   +         R
Sbjct: 183 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEELFHSI--------R 232
Query: 624 LFEILDARVMKESGGDEIIT-FAKVAKRCLNLNG--KKRPTMREVTSE 668
           +      R +++   D ++  F +  ++ L + G  ++ P  RE+  E
Sbjct: 233 MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 280

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 123/270 (45%), Gaps = 28/270 (10%)
Query: 421 GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNG 478
           G +VAVK+ +     +  +F  E+ IL  ++   +VK  G       +   LV E++P+G
Sbjct: 39  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 98
Query: 479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 538
            L  ++  Q     +     L  + ++   + YL S   +   HRD+ + NIL++ +   
Sbjct: 99  CLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHV 153
Query: 539 KVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
           K++DFG ++ + +D+ +   +  G    F Y  PE    + F+ +SDV+SFGVVL EL  
Sbjct: 154 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYA-PESLSDNIFSRQSDVWSFGVVLYEL-- 210
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEI-------ITFAKVA 648
                 FT  ++  S +A FL  M  ER    L   +     G  +           ++ 
Sbjct: 211 ------FTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELM 264
Query: 649 KRCLNLNGKKRPTMREVTSELAGIKAWNGA 678
           K C   + + RP+   +  +L  +  W+G+
Sbjct: 265 KLCWAPSPQDRPSFSALGPQLDML--WSGS 292

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 18/227 (7%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK--KSKVIDESKVEEFINEM 444
           TS + +    N+ L + +G+G    V     +  GK VAVK      ++ S +++   E+
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV 64
Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRI 501
            I+  +NH N+VKL    +ETE  L LV E+   G +F Y+  H + ++     + R   
Sbjct: 65  RIMKVLNHPNIVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR--- 120
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S          T    
Sbjct: 121 --QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FC 173
Query: 562 GTFGYLDPEYFRSSQFTD-KSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           G+  Y  PE F+  ++   + DV+S GV+L  L++G  P     L+E
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 107/232 (46%), Gaps = 32/232 (13%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK----GMLPDGK--IVAVKKSKV-IDESKVEEFINEMV 445
           E   +N    ++LG G  G V      G+   G    VAVK  K   D S+ E  ++E+ 
Sbjct: 41  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 446 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP------------ 492
           +++Q+ +H N+V LLG C  +    L++E+   G L  Y+  + E F             
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 493 --------ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                   +T+E  L  A +V+  + +L   + +   HRD+ + N+L+      K+ DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHGKVVKICDFG 217
Query: 545 ASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
            +R +  D  ++          ++ PE      +T KSDV+S+G++L E+ +
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/317 (23%), Positives = 137/317 (43%), Gaps = 44/317 (13%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSKV- 431
           + + +L    + E   D   L + LG+G  G V         K    +   VAVK  K  
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI------ 484
             E  + + ++EM ++  I  H+N++ LLG C +     ++ E+   G L +Y+      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 485 -----HDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                +D N   +  +T++  +    +++  + YL S   I   HRD+ + N+L+ +   
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNV 195
Query: 538 AKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV++ E+ T 
Sbjct: 196 MKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G  P     +EE                LF++L      +   +       + + C +  
Sbjct: 256 GGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 299
Query: 656 GKKRPTMREVTSELAGI 672
             +RPT +++  +L  I
Sbjct: 300 PSQRPTFKQLVEDLDRI 316

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 18/227 (7%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK--KSKVIDESKVEEFINEM 444
           TS + +    N+ L + +G+G    V     +  GK VAVK      ++ S +++   E+
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV 64
Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRI 501
            I+  +NH N+VKL    +ETE  L LV E+   G +F Y+  H + ++     + R   
Sbjct: 65  RIMKVLNHPNIVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR--- 120
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S          T    
Sbjct: 121 --QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FC 173
Query: 562 GTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           G+  Y  PE F+  ++   + DV+S GV+L  L++G  P     L+E
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 10/211 (4%)
Query: 392 LERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKV-IDESKVEEFINEMVILSQ 449
           +E   D+F     LG G  G V+K    P G ++A K   + I  +   + I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            N   +V   G         +  E +  G+L Q +        I  ++  +++I V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           +YL     I   HRD+K +NIL++ +   K+ DFG S  + +D   M     GT  Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSP 172
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           E  + + ++ +SD++S G+ L E+  G  PI
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 38/231 (16%)
Query: 394 RATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           R   +F    +LGQG  G V K     D +  A+KK +  +E K+   ++E+++L+ +NH
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNH 61
Query: 453 RNVVKLLGCCLE--------TEVP-----LLVYEFIPNGTLFQYIHDQN--EDFPITWEM 497
           + VV+     LE        T V       +  E+  N TL+  IH +N  +     W  
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW-- 119
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS-------MA 550
             R+  ++  ALSY+HS     I HRD+K  NI +D+    K+ DFG +++       + 
Sbjct: 120 --RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 551 VDQTHM------TTQVHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLAELL 594
           +D  ++       T   GT  Y+  E    +  + +K D+YS G++  E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/317 (23%), Positives = 137/317 (43%), Gaps = 44/317 (13%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSKV- 431
           + + +L    + E   D   L + LG+G  G V         K    +   VAVK  K  
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI------ 484
             E  + + ++EM ++  I  H+N++ LLG C +     ++ E+   G L +Y+      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 485 -----HDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                +D N   +  +T++  +    +++  + YL S   I   HRD+ + N+L+ +   
Sbjct: 139 GMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNV 195
Query: 538 AKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV++ E+ T 
Sbjct: 196 MKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G  P     +EE                LF++L      +   +       + + C +  
Sbjct: 256 GGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 299
Query: 656 GKKRPTMREVTSELAGI 672
             +RPT +++  +L  I
Sbjct: 300 PSQRPTFKQLVEDLDRI 316

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/317 (23%), Positives = 137/317 (43%), Gaps = 44/317 (13%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSKV- 431
           + + +L    + E   D   L + LG+G  G V         K    +   VAVK  K  
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI------ 484
             E  + + ++EM ++  I  H+N++ LLG C +     ++ E+   G L +Y+      
Sbjct: 79  ATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 485 -----HDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                +D N   +  +T++  +    +++  + YL S   I   HRD+ + N+L+ +   
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNV 195
Query: 538 AKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV++ E+ T 
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G  P     +EE                LF++L      +   +       + + C +  
Sbjct: 256 GGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 299
Query: 656 GKKRPTMREVTSELAGI 672
             +RPT +++  +L  I
Sbjct: 300 PSQRPTFKQLVEDLDRI 316

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 18/227 (7%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK--KSKVIDESKVEEFINEM 444
           TS + +    N+ L + +G+G    V     +  GK VAV+      ++ S +++   E+
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREV 64
Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRI 501
            I+  +NH N+VKL    +ETE  L LV E+   G +F Y+  H + ++     + R   
Sbjct: 65  RIMKVLNHPNIVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR--- 120
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S            +  
Sbjct: 121 --QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDEFC 173
Query: 562 GTFGYLDPEYFRSSQFTD-KSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           G+  Y  PE F+  ++   + DV+S GV+L  L++G  P     L+E
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 10/211 (4%)
Query: 392 LERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKV-IDESKVEEFINEMVILSQ 449
           +E   D+F     LG G  G V+K    P G ++A K   + I  +   + I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            N   +V   G         +  E +  G+L Q +        I  ++  +++I V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           +YL     I   HRD+K +NIL++ +   K+ DFG S  + +D   M     GT  Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSP 172
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           E  + + ++ +SD++S G+ L E+  G  PI
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/317 (23%), Positives = 137/317 (43%), Gaps = 44/317 (13%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSKV- 431
           + + +L    + E   D   L + LG+G  G V         K    +   VAVK  K  
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI------ 484
             E  + + ++EM ++  I  H+N++ LLG C +     ++ E+   G L +Y+      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 485 -----HDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                +D N   +  +T++  +    +++  + YL S   I   HRD+ + N+L+ +   
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNV 195
Query: 538 AKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV++ E+ T 
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G  P     +EE                LF++L      +   +       + + C +  
Sbjct: 256 GGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 299
Query: 656 GKKRPTMREVTSELAGI 672
             +RPT +++  +L  I
Sbjct: 300 PSQRPTFKQLVEDLDRI 316

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 10/211 (4%)
Query: 392 LERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKV-IDESKVEEFINEMVILSQ 449
           +E   D+F     LG G  G V+K    P G ++A K   + I  +   + I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            N   +V   G         +  E +  G+L Q +        I  ++  +++I V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           +YL     I   HRD+K +NIL++ +   K+ DFG S  + +D   M     GT  Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSP 172
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           E  + + ++ +SD++S G+ L E+  G  PI
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 10/211 (4%)
Query: 392 LERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKV-IDESKVEEFINEMVILSQ 449
           +E   D+F     LG G  G V+K    P G ++A K   + I  +   + I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            N   +V   G         +  E +  G+L Q +        I  ++  +++I V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           +YL     I   HRD+K +NIL++ +   K+ DFG S  + +D   M     GT  Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSP 172
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           E  + + ++ +SD++S G+ L E+  G  PI
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/317 (23%), Positives = 137/317 (43%), Gaps = 44/317 (13%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSKV- 431
           + + +L    + E   D   L + LG+G  G V         K    +   VAVK  K  
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI------ 484
             E  + + ++EM ++  I  H+N++ LLG C +     ++ E+   G L +Y+      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 485 -----HDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                +D N   +  +T++  +    +++  + YL S   I   HRD+ + N+L+ +   
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNV 195
Query: 538 AKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV++ E+ T 
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G  P     +EE                LF++L      +   +       + + C +  
Sbjct: 256 GGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 299
Query: 656 GKKRPTMREVTSELAGI 672
             +RPT +++  +L  I
Sbjct: 300 PSQRPTFKQLVEDLDRI 316

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/317 (23%), Positives = 137/317 (43%), Gaps = 44/317 (13%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSKV- 431
           + + +L    + E   D   L + LG+G  G V         K    +   VAVK  K  
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI------ 484
             E  + + ++EM ++  I  H+N++ LLG C +     ++ E+   G L +Y+      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 485 -----HDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                +D N   +  +T++  +    +++  + YL S   I   HRD+ + N+L+ +   
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNV 195
Query: 538 AKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV++ E+ T 
Sbjct: 196 MKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G  P     +EE                LF++L      +   +       + + C +  
Sbjct: 256 GGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 299
Query: 656 GKKRPTMREVTSELAGI 672
             +RPT +++  +L  I
Sbjct: 300 PSQRPTFKQLVEDLDRI 316

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++  L + LG G  G V+         VAVK  K    S VE F+ E  ++  + H  +V
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 73
Query: 457 KLLGCCLETEVPL-LVYEFIPNGTLFQYIH-DQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           KL      T+ P+ ++ EF+  G+L  ++  D+    P+     +  + +++  ++++  
Sbjct: 74  KLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ 129
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
              I   HRD+++ NIL+      K++DFG +R +  ++            +  PE    
Sbjct: 130 RNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 186
Query: 575 SQFTDKSDVYSFGVVLAELLT 595
             FT KSDV+SFG++L E++T
Sbjct: 187 GSFTIKSDVWSFGILLMEIVT 207

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 28/270 (10%)
Query: 421 GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP--LLVYEFIPNG 478
           G +VAVK+ +     +  +F  E+ IL  ++   +VK  G       P   LV E++P+G
Sbjct: 36  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSG 95
Query: 479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 538
            L  ++  Q     +     L  + ++   + YL S   +   HRD+ + NIL++ +   
Sbjct: 96  CLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHV 150
Query: 539 KVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
           K++DFG ++ + +D+     +  G    F Y  PE    + F+ +SDV+SFGVVL EL  
Sbjct: 151 KIADFGLAKLLPLDKDXXVVREPGQSPIFWYA-PESLSDNIFSRQSDVWSFGVVLYEL-- 207
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEI-------ITFAKVA 648
                 FT  ++  S +A FL  M  ER    L   +     G  +           ++ 
Sbjct: 208 ------FTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELM 261
Query: 649 KRCLNLNGKKRPTMREVTSELAGIKAWNGA 678
           K C   + + RP+   +  +L  +  W+G+
Sbjct: 262 KLCWAPSPQDRPSFSALGPQLDML--WSGS 289

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 397 DNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           ++     ++G+G  G V K      G+  D  I  +K+    D+ +  +F  E+ +L ++
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKL 79
Query: 451 NHR-NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-----DQNEDFPI--------TWE 496
            H  N++ LLG C       L  E+ P+G L  ++      + +  F I        + +
Sbjct: 80  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 139
Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 556
             L  A +V+  + YL     I   HR++ + NIL+ + Y AK++DFG SR   V     
Sbjct: 140 QLLHFAADVARGMDYLSQKQFI---HRNLAARNILVGENYVAKIADFGLSRGQEV----- 191
Query: 557 TTQVHGTFG-----YLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
              V  T G     ++  E    S +T  SDV+S+GV+L E+++
Sbjct: 192 --YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 18/227 (7%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK--KSKVIDESKVEEFINEM 444
           TS + +    N+ L + +G+G    V     +  GK VAV+      ++ S +++   E+
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREV 64
Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRI 501
            I+  +NH N+VKL    +ETE  L LV E+   G +F Y+  H + ++     + R   
Sbjct: 65  RIMKVLNHPNIVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR--- 120
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S          T    
Sbjct: 121 --QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FC 173
Query: 562 GTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           G+  Y  PE F+  ++   + DV+S GV+L  L++G  P     L+E
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 10/210 (4%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKV-IDESKVEEFINEMVILSQI 450
           E   D+F     LG G  G V K    P G I+A K   + I  +   + I E+ +L + 
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           N   +V   G         +  E +  G+L Q + +      I  E+  +++I V   L+
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLA 128
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+K +NIL++ +   K+ DFG S  + +D   M     GT  Y+ PE
Sbjct: 129 YLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMAPE 183
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             + + ++ +SD++S G+ L EL  G  PI
Sbjct: 184 RLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 108/227 (47%), Gaps = 18/227 (7%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK--KSKVIDESKVEEFINEM 444
           TS + +    N+ L + +G+G    V     +  GK VAVK      ++ S +++   E+
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV 64
Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRI 501
            I+  +NH N+VKL    +ETE  L LV E+   G +F Y+  H + ++     + R   
Sbjct: 65  RIMKVLNHPNIVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR--- 120
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S               
Sbjct: 121 --QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDAFC 173
Query: 562 GTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           G   Y  PE F+  ++   + DV+S GV+L  L++G  P     L+E
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/317 (23%), Positives = 137/317 (43%), Gaps = 44/317 (13%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSKV- 431
           + + +L    + E   D   L + LG+G  G V         K    +   VAVK  K  
Sbjct: 8   VSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 67
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI------ 484
             E  + + ++EM ++  I  H+N++ LLG C +     ++ E+   G L +Y+      
Sbjct: 68  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 127
Query: 485 -----HDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                +D N   +  +T++  +    +++  + YL S   I   HRD+ + N+L+ +   
Sbjct: 128 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNV 184
Query: 538 AKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV++ E+ T 
Sbjct: 185 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 244
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G  P     +EE                LF++L      +   +       + + C +  
Sbjct: 245 GGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 288
Query: 656 GKKRPTMREVTSELAGI 672
             +RPT +++  +L  I
Sbjct: 289 PSQRPTFKQLVEDLDRI 305

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 123/270 (45%), Gaps = 28/270 (10%)
Query: 421 GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNG 478
           G +VAVK+ +     +  +F  E+ IL  ++   +VK  G       +   LV E++P+G
Sbjct: 52  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 538
            L  ++  Q     +     L  + ++   + YL S   +   HRD+ + NIL++ +   
Sbjct: 112 CLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHV 166
Query: 539 KVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
           K++DFG ++ + +D+ +   +  G    F Y  PE    + F+ +SDV+SFGVVL EL  
Sbjct: 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYA-PESLSDNIFSRQSDVWSFGVVLYEL-- 223
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEI-------ITFAKVA 648
                 FT  ++  S +A FL  M  ER    L   +     G  +           ++ 
Sbjct: 224 ------FTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELM 277
Query: 649 KRCLNLNGKKRPTMREVTSELAGIKAWNGA 678
           K C   + + RP+   +  +L  +  W+G+
Sbjct: 278 KLCWAPSPQDRPSFSALGPQLDML--WSGS 305

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 10/210 (4%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKV-IDESKVEEFINEMVILSQI 450
           E   D+F     LG G  G V+K    P G ++A K   + I  +   + I E+ +L + 
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           N   +V   G         +  E +  G+L Q +        I  ++  +++I V   L+
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 180
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+K +NIL++ +   K+ DFG S  + +D   M     GT  Y+ PE
Sbjct: 181 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPE 235
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             + + ++ +SD++S G+ L E+  G  PI
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 421 GKIVAVKKSKVIDESKVEE-FINEMVILSQINHRNVVKLLGCCLET--EVPLLVYEFIPN 477
           G++VAVK  K     ++   +  E+ IL  + H ++VK  GCC +   +   LV E++P 
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
           G+L  Y+        +     L  A ++   ++YLH+   I   HR + + N+LLD+   
Sbjct: 97  GSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLHAQHYI---HRALAARNVLLDNDRL 149
Query: 538 AKVSDFGASRSMAVDQTHMTTQVHG---TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL 594
            K+ DFG ++++     +   +  G    F Y  PE  +  +F   SDV+SFGV L ELL
Sbjct: 150 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PECLKECKFYYASDVWSFGVTLYELL 208
Query: 595 T 595
           T
Sbjct: 209 T 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 421 GKIVAVKKSKVIDESKVEE-FINEMVILSQINHRNVVKLLGCCLET--EVPLLVYEFIPN 477
           G++VAVK  K     ++   +  E+ IL  + H ++VK  GCC +   +   LV E++P 
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
           G+L  Y+        +     L  A ++   ++YLH+   I   HR + + N+LLD+   
Sbjct: 98  GSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLHAQHYI---HRALAARNVLLDNDRL 150
Query: 538 AKVSDFGASRSMAVDQTHMTTQVHG---TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL 594
            K+ DFG ++++     +   +  G    F Y  PE  +  +F   SDV+SFGV L ELL
Sbjct: 151 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PECLKECKFYYASDVWSFGVTLYELL 209
Query: 595 T 595
           T
Sbjct: 210 T 210

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 10/209 (4%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKV-IDESKVEEFINEMVILSQI 450
           E   D+F     LG G  G V+K    P G ++A K   + I  +   + I E+ +L + 
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           N   +V   G         +  E +  G+L Q +        I  ++  +++I V   L+
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 121
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+K +NIL++ +   K+ DFG S  + +D+  M  +  GT  Y+ PE
Sbjct: 122 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDE--MANEFVGTRSYMSPE 176
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
             + + ++ +SD++S G+ L E+  G  P
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 117/253 (46%), Gaps = 24/253 (9%)
Query: 420 DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLE-TEVPL-LVYEFI 475
           DGKI+  K+     + E++ +  ++E+ +L ++ H N+V+     ++ T   L +V E+ 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 476 PNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALSYLH--SAASIPIYHRDIKSTNILL 532
             G L   I     E   +  E  LR+  +++ AL   H  S     + HRD+K  N+ L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 533 DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAE 592
           D K   K+ DFG +R +  D +     V GT  Y+ PE      + +KSD++S G +L E
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 593 LLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCL 652
           L     P  FT   + K LA         E  F  +  R   E   +EIIT      R L
Sbjct: 209 LCALMPP--FTAFSQ-KELAGKI-----REGKFRRIPYRYSDEL--NEIIT------RML 252
Query: 653 NLNGKKRPTMREV 665
           NL    RP++ E+
Sbjct: 253 NLKDYHRPSVEEI 265

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++  L + LG G  G V+         VAVK  K    S VE F+ E  ++  + H  +V
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 246
Query: 457 KLLGCCLETEVPL-LVYEFIPNGTLFQYIH-DQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           KL      T+ P+ ++ EF+  G+L  ++  D+    P+     +  + +++  ++++  
Sbjct: 247 KLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ 302
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
              I   HRD+++ NIL+      K++DFG +R +  ++            +  PE    
Sbjct: 303 RNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 575 SQFTDKSDVYSFGVVLAELLT 595
             FT KSDV+SFG++L E++T
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT 380

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/317 (23%), Positives = 137/317 (43%), Gaps = 44/317 (13%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSKV- 431
           + + +L    + E   D   L + LG+G  G V         K    +   VAVK  K  
Sbjct: 6   VSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 65
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI------ 484
             E  + + ++EM ++  I  H+N++ LLG C +     ++ E+   G L +Y+      
Sbjct: 66  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 125
Query: 485 -----HDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                +D N   +  +T++  +    +++  + YL S   I   HRD+ + N+L+ +   
Sbjct: 126 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLTARNVLVTENNV 182
Query: 538 AKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV++ E+ T 
Sbjct: 183 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 242
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G  P     +EE                LF++L      +   +       + + C +  
Sbjct: 243 GGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 286
Query: 656 GKKRPTMREVTSELAGI 672
             +RPT +++  +L  I
Sbjct: 287 PSQRPTFKQLVEDLDRI 303

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/317 (23%), Positives = 137/317 (43%), Gaps = 44/317 (13%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSKV- 431
           + + +L    + E   D   L + LG+G  G V         K    +   VAVK  K  
Sbjct: 11  VSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 70
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI------ 484
             E  + + ++EM ++  I  H+N++ LLG C +     ++ E+   G L +Y+      
Sbjct: 71  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 130
Query: 485 -----HDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                +D N   +  +T++  +    +++  + YL S   I   HRD+ + N+L+ +   
Sbjct: 131 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNV 187
Query: 538 AKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV++ E+ T 
Sbjct: 188 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 247
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G  P     +EE                LF++L      +   +       + + C +  
Sbjct: 248 GGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 291
Query: 656 GKKRPTMREVTSELAGI 672
             +RPT +++  +L  I
Sbjct: 292 PSQRPTFKQLVEDLDRI 308

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/317 (23%), Positives = 137/317 (43%), Gaps = 44/317 (13%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSKV- 431
           + + +L    + E   D   L + LG+G  G V         K    +   VAVK  K  
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI------ 484
             E  + + ++EM ++  I  H+N++ LLG C +     ++ E+   G L +Y+      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 485 -----HDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                +D N   +  +T++  +    +++  + YL S   I   HRD+ + N+L+ +   
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNV 195
Query: 538 AKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            +++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV++ E+ T 
Sbjct: 196 MRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G  P     +EE                LF++L      +   +       + + C +  
Sbjct: 256 GGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 299
Query: 656 GKKRPTMREVTSELAGI 672
             +RPT +++  +L  I
Sbjct: 300 PSQRPTFKQLVEDLDRI 316

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 392 LERATDNFNLNRILGQGGQGTV----YKGMLPDGKIVAVK---KSKVIDESKVEEFINEM 444
           L+   +++++ +++G+G  G V    +K      K+ A+K   K ++I  S    F  E 
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKA---SQKVYAMKLLSKFEMIKRSDSAFFWEER 126
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
            I++  N   VV+L     + +   +V E++P G L   +   N D P  W  +   A E
Sbjct: 127 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKW-AKFYTA-E 182
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT---HMTTQVH 561
           V  AL  +HS   I   HRD+K  N+LLD     K++DFG    M +D+T   H  T V 
Sbjct: 183 VVLALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVHCDTAV- 236
Query: 562 GTFGYLDPEYFRSS----QFTDKSDVYSFGVVLAELLTGEKPIRFTTL 605
           GT  Y+ PE  +S      +  + D +S GV L E+L G+ P    +L
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 284

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 24/253 (9%)
Query: 420 DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLE-TEVPL-LVYEFI 475
           DGKI+  K+     + E++ +  ++E+ +L ++ H N+V+     ++ T   L +V E+ 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 476 PNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALSYLH--SAASIPIYHRDIKSTNILL 532
             G L   I     E   +  E  LR+  +++ AL   H  S     + HRD+K  N+ L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 533 DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAE 592
           D K   K+ DFG +R +  D+     +  GT  Y+ PE      + +KSD++S G +L E
Sbjct: 150 DGKQNVKLGDFGLARILNHDED-FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 593 LLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCL 652
           L     P  FT   + K LA         E  F  +  R   E   +EIIT      R L
Sbjct: 209 LCALMPP--FTAFSQ-KELAGKI-----REGKFRRIPYRYSDEL--NEIIT------RML 252
Query: 653 NLNGKKRPTMREV 665
           NL    RP++ E+
Sbjct: 253 NLKDYHRPSVEEI 265

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPDGK-------IVAVKKSKVIDESKVEEFINEMVILSQI 450
           +FN   +LG+G  G V   ML D K       I  +KK  VI +  VE  + E  +L+ +
Sbjct: 20  DFNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALL 76
Query: 451 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           +    +  L  C +T   L  V E++  G L  +I    +         +  A E+S  L
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISIGL 133
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            +LH      I +RD+K  N++LD +   K++DFG  +   +D    T +  GT  Y+ P
Sbjct: 134 FFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV-TTREFCGTPDYIAP 189
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
           E      +    D +++GV+L E+L G+ P  F   +ED+
Sbjct: 190 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPP--FDGEDEDE 227

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 13/234 (5%)
Query: 372 QELASTEGTIEKTKLFTSKEL---ERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVK 427
           +EL   E   ++ + F +++    E   D+F     LG G  G V+K    P G ++A K
Sbjct: 5   EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 428 KSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD 486
              + I  +   + I E+ +L + N   +V   G         +  E +  G+L Q +  
Sbjct: 65  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124
Query: 487 QNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 546
                 I  ++  +++I V   L+YL     I   HRD+K +NIL++ +   K+ DFG S
Sbjct: 125 AGR---IPEQILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS 179
Query: 547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             + +D   M     GT  Y+ PE  + + ++ +SD++S G+ L E+  G  PI
Sbjct: 180 GQL-IDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 108/227 (47%), Gaps = 18/227 (7%)
Query: 388 TSKELERATDNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK--KSKVIDESKVEEFINEM 444
           TS + +    N+ L + +G+G    V     +  GK VAVK      ++ S +++   E+
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV 64
Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRI 501
            I   +NH N+VKL    +ETE  L LV E+   G +F Y+  H + ++     + R   
Sbjct: 65  RIXKVLNHPNIVKLFEV-IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR--- 120
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S        +      
Sbjct: 121 --QIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTF--GNKLDAFC 173
Query: 562 GTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           G   Y  PE F+  ++   + DV+S GV+L  L++G  P     L+E
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 25/288 (8%)
Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVKKSKVIDESKVEEFINEM 444
           S +++   ++F L+++LG+G  G V+            I A+KK  V+ +  VE  + E 
Sbjct: 9   SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 445 VILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
            +LS       +  + C  +T+  L  V E++  G L  +I   ++            A 
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAA 125
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           E+   L +LHS     I +RD+K  NILLD     K++DFG  +   +     T    GT
Sbjct: 126 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGT 181
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER 623
             Y+ PE     ++    D +SFGV+L E+L G+ P  F   +E++   +         R
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEELFHSI--------R 231
Query: 624 LFEILDARVMKESGGDEIIT-FAKVAKRCLNLNG--KKRPTMREVTSE 668
           +      R +++   D ++  F +  ++ L + G  ++ P  RE+  E
Sbjct: 232 MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 112/239 (46%), Gaps = 29/239 (12%)
Query: 370 LQQELASTEGTIE-KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGK-IVAVK 427
           +Q+ + ++ GT +  T+ FT        D+F + R LG+G  G VY         IVA+K
Sbjct: 2   MQKVMENSSGTPDILTRHFT-------IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALK 54
Query: 428 ---KSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 484
              KS++  E    +   E+ I + ++H N+++L     +     L+ E+ P G L++ +
Sbjct: 55  VLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL 114
Query: 485 HDQ---NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 541
                 +E    T      I  E++ AL Y H    I   HRDIK  N+LL  K   K++
Sbjct: 115 QKSCTFDEQRTAT------IMEELADALMYCHGKKVI---HRDIKPENLLLGLKGELKIA 165
Query: 542 DFGAS-RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           DFG S  + ++ +  M     GT  YL PE        +K D++  GV+  ELL G  P
Sbjct: 166 DFGWSVHAPSLRRKTMC----GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 10/210 (4%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKV-IDESKVEEFINEMVILSQI 450
           E   D+F     LG G  G V+K    P G ++A K   + I  +   + I E+ +L + 
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           N   +V   G         +  E +  G+L Q +        I  ++  +++I V   L+
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 137
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL     I   HRD+K +NIL++ +   K+ DFG S  + +D   M     GT  Y+ PE
Sbjct: 138 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPE 192
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             + + ++ +SD++S G+ L E+  G  PI
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 24/220 (10%)
Query: 398 NFNLNRILGQGGQGTV-YKGMLPDGKIVAVKKSKVIDESKV-----EEFINEMVILSQIN 451
           N+ L + +G+G    V     +  G+ VA+K   +ID++++     ++   E+ I+  +N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILN 69
Query: 452 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRIAIEVSGA 508
           H N+VKL    +ETE  L L+ E+   G +F Y+  H + ++     + R     ++  A
Sbjct: 70  HPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-----QIVSA 123
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           + Y H      I HRD+K+ N+LLD     K++DFG S    V     T    G+  Y  
Sbjct: 124 VQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCGSPPYAA 178
Query: 569 PEYFRSSQFTD-KSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           PE F+  ++   + DV+S GV+L  L++G  P     L+E
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 218

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 123/270 (45%), Gaps = 28/270 (10%)
Query: 421 GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNG 478
           G +VAVK+ +     +  +F  E+ IL  ++   +VK  G       +   LV E++P+G
Sbjct: 40  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 99
Query: 479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 538
            L  ++  Q     +     L  + ++   + YL S   +   HRD+ + NIL++ +   
Sbjct: 100 CLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHV 154
Query: 539 KVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
           K++DFG ++ + +D+ +   +  G    F Y  PE    + F+ +SDV+SFGVVL EL  
Sbjct: 155 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYA-PESLSDNIFSRQSDVWSFGVVLYEL-- 211
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEI-------ITFAKVA 648
                 FT  ++  S +A FL  M  ER    L   +     G  +           ++ 
Sbjct: 212 ------FTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELM 265
Query: 649 KRCLNLNGKKRPTMREVTSELAGIKAWNGA 678
           K C   + + RP+   +  +L  +  W+G+
Sbjct: 266 KLCWAPSPQDRPSFSALGPQLDML--WSGS 293

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 115/227 (50%), Gaps = 12/227 (5%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           LG G   TVYKG+    G  VA+K+ K+  +E      I E+ ++ ++ H N+V+L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQN-EDFPITWEMRL--RIAIEVSGALSYLHSAASIP 519
                  LV+EF+ N  L +Y+  +   + P   E+ L      ++   L++ H      
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128
Query: 520 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ-FT 578
           I HRD+K  N+L++ + + K+ DFG +R+  +     +++V  T  Y  P+    S+ ++
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV-VTLWYRAPDVLMGSRTYS 187
Query: 579 DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
              D++S G +LAE++TG KP+   T +E++    + +     E L+
Sbjct: 188 TSIDIWSCGCILAEMITG-KPLFPGTNDEEQLKLIFDIMGTPNESLW 233

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/329 (23%), Positives = 142/329 (43%), Gaps = 49/329 (14%)
Query: 374 LASTEGT-----IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPD 420
           L+ST  T     + + +L    + E   D   L + LG+G  G V         K    +
Sbjct: 53  LSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKE 112
Query: 421 GKIVAVKKSKV-IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNG 478
              VAVK  K    E  + + ++EM ++  I  H+N++ LLG C +     ++ E+   G
Sbjct: 113 AVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 172
Query: 479 TLFQYI-----------HDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDI 525
            L +Y+           +D N   +  +T++  +    +++  + YL S   I   HRD+
Sbjct: 173 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDL 229
Query: 526 KSTNILLDDKYRAKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
            + N+L+ +    K++DFG +R +  +D    TT       ++ PE      +T +SDV+
Sbjct: 230 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 289
Query: 585 SFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIIT 643
           SFGV++ E+ T G  P     +EE                LF++L      +   +    
Sbjct: 290 SFGVLMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNE 333
Query: 644 FAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              + + C +    +RPT +++  +L  I
Sbjct: 334 LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 398 NFNLNRILGQGGQGTV-YKGMLPDGKIVAVK--KSKVIDESKVEEFINEMVILSQINHRN 454
           N+ L + +G+G    V     +  GK VAVK      ++ S +++   E+ I+  +NH N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 455 VVKLLGCCLETEVPL-LVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRIAIEVSGALSY 511
           +VKL    +ETE  L LV E+   G +F Y+  H   ++     + R     ++  A+ Y
Sbjct: 68  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-----QIVSAVQY 121
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            H      I HRD+K+ N+LLD     K++DFG S          T    G+  Y  PE 
Sbjct: 122 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPEL 176
Query: 572 FRSSQFTD-KSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           F+  ++   + DV+S GV+L  L++G  P     L+E
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 213

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 398 NFNLNRILGQGGQGTV-YKGMLPDGKIVAVKKSKVIDESKV-----EEFINEMVILSQIN 451
           N+ L + +G+G    V     +  G+ VA+K   +ID++++     ++   E+ I+  +N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 452 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRIAIEVSGA 508
           H N+VKL    +ETE  L L+ E+   G +F Y+  H + ++     + R     ++  A
Sbjct: 73  HPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-----QIVSA 126
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           + Y H      I HRD+K+ N+LLD     K++DFG S    V          G   Y  
Sbjct: 127 VQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAA 181
Query: 569 PEYFRSSQFTD-KSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           PE F+  ++   + DV+S GV+L  L++G  P     L+E
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 31/240 (12%)
Query: 386 LFTSKELERATDNFNLNRILGQGGQGTVYKGML--PDGKIVAVKK--------------- 428
           ++ +K ++      N  RI+    QG   K +L   D K  A+KK               
Sbjct: 17  IYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKS 76
Query: 429 --SKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY--- 483
              K+  +SK ++F NE+ I++ I +   +   G     +   ++YE++ N ++ ++   
Sbjct: 77  NNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY 136
Query: 484 --IHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 541
             + D+N    I  ++   I   V  + SY+H+  +I   HRD+K +NIL+D   R K+S
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLS 194
Query: 542 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYF--RSSQFTDKSDVYSFGVVLAELLTGEKP 599
           DFG S  M VD+    ++  GT+ ++ PE+F   SS    K D++S G+ L  +     P
Sbjct: 195 DFGESEYM-VDKKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 15/224 (6%)
Query: 390 KELERATDNFNLNRILGQGGQGTV----YKGMLPDGKIVAVKKSKVIDESKVEEFINEMV 445
           ++L    +++ + +++G+G  G V    +K       +  + K ++I  S    F  E  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           I++  N   VV+L     +     +V E++P G L   +   N D P  W  R   A EV
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EV 177
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
             AL  +HS   I   HRD+K  N+LLD     K++DFG    M  +         GT  
Sbjct: 178 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 566 YLDPEYFRSS----QFTDKSDVYSFGVVLAELLTGEKPIRFTTL 605
           Y+ PE  +S      +  + D +S GV L E+L G+ P    +L
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/317 (23%), Positives = 136/317 (42%), Gaps = 44/317 (13%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSKV- 431
           + + +L    + E   D   L + LG+G  G V         K    +   VAVK  K  
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI------ 484
             E  + + ++EM ++  I  H+N++ LLG C +     ++  +   G L +Y+      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPP 138
Query: 485 -----HDQNE--DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                +D N   +  +T++  +    +++  + YL S   I   HRD+ + N+L+ +   
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNV 195
Query: 538 AKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV++ E+ T 
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 596 GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           G  P     +EE                LF++L      +   +       + + C +  
Sbjct: 256 GGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 299
Query: 656 GKKRPTMREVTSELAGI 672
             +RPT +++  +L  I
Sbjct: 300 PSQRPTFKQLVEDLDRI 316

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 108/227 (47%), Gaps = 17/227 (7%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D+F + R +G+G  G V      D  K+ A+K   K K ++ ++V     E+ I+  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSGALSY 511
             +V L     + E   +V + +  G L +Y   QN  F    E  +++ I E+  AL Y
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFK---EETVKLFICELVMALDY 130
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           L +     I HRD+K  NILLD+     ++DF  + +M   +T +TT   GT  Y+ PE 
Sbjct: 131 LQNQR---IIHRDMKPDNILLDEHGHVHITDFNIA-AMLPRETQITTMA-GTKPYMAPEM 185
Query: 572 FRSSQ---FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
           F S +   ++   D +S GV   ELL G +P    +    K +   F
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 15/224 (6%)
Query: 390 KELERATDNFNLNRILGQGGQGTV----YKGMLPDGKIVAVKKSKVIDESKVEEFINEMV 445
           ++L    +++ + +++G+G  G V    +K       +  + K ++I  S    F  E  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           I++  N   VV+L     +     +V E++P G L   +   N D P  W  R   A EV
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EV 182
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
             AL  +HS   I   HRD+K  N+LLD     K++DFG    M  +         GT  
Sbjct: 183 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 566 YLDPEYFRSS----QFTDKSDVYSFGVVLAELLTGEKPIRFTTL 605
           Y+ PE  +S      +  + D +S GV L E+L G+ P    +L
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 283

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 15/224 (6%)
Query: 390 KELERATDNFNLNRILGQGGQGTV----YKGMLPDGKIVAVKKSKVIDESKVEEFINEMV 445
           ++L    +++ + +++G+G  G V    +K       +  + K ++I  S    F  E  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           I++  N   VV+L     +     +V E++P G L   +   N D P  W  R   A EV
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWA-RFYTA-EV 182
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
             AL  +HS   I   HRD+K  N+LLD     K++DFG    M  +         GT  
Sbjct: 183 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 566 YLDPEYFRSS----QFTDKSDVYSFGVVLAELLTGEKPIRFTTL 605
           Y+ PE  +S      +  + D +S GV L E+L G+ P    +L
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 283

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 10/214 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKG-MLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F +  +LG+G    VY+   +  G  VA+K   K  +     V+   NE+ I  Q+ H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
            ++++L     ++    LV E   NG + +Y+ ++ + F    E R  +   ++G L YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN-EARHFMHQIITGML-YL 128
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HS     I HRD+  +N+LL      K++DFG +  + +      T   GT  Y+ PE  
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIA 184
Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLE 606
             S    +SDV+S G +   LL G  P    T++
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK 218

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 399 FNLNRILGQGGQGTVYKGM----LPDGKIVA---VKKSKVIDESKVEEFIN-EMVILSQI 450
           F L R+LG+GG G V++         GKI A   +KK+ ++  +K       E  IL ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN---EDFPITWEMRLRIAIEVSG 507
            H  +V L+          L+ E++  G LF  +  +    ED    +        E+S 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY------LAEISM 132
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           AL +LH      I +RD+K  NI+L+ +   K++DFG  +    D T +T    GT  Y+
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEYM 188
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            PE    S      D +S G ++ ++LTG  P
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 110/236 (46%), Gaps = 17/236 (7%)
Query: 375 ASTEGTIEKTKLFTSKELERAT-----DNFNLNRILGQGGQGTVYKGMLPD-GKIVA--- 425
           A   G  E+ +   ++E  +A+      +F+L R++G+G    V    L    +I A   
Sbjct: 25  AMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRV 84
Query: 426 VKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGTLFQYI 484
           VKK  V D+  ++    E  +  Q ++   +  L  C +TE  L  V E++  G L  ++
Sbjct: 85  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 144
Query: 485 HDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
             Q +   +  E     + E+S AL+YLH      I +RD+K  N+LLD +   K++D+G
Sbjct: 145 QRQRK---LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             +   +     T+   GT  Y+ PE  R   +    D ++ GV++ E++ G  P 
Sbjct: 199 MCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 106/226 (46%), Gaps = 17/226 (7%)
Query: 385 KLFTSKELER---ATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVE-- 438
           +    K LER     + F   R+LG+GG G V    +   GK+ A KK +     K +  
Sbjct: 169 RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 228
Query: 439 -EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL-FQYIHDQNEDFPITWE 496
              +NE  IL ++N R VV L       +   LV   +  G L F   H     FP   E
Sbjct: 229 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---E 285
Query: 497 MR-LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 555
            R +  A E+   L  LH      I +RD+K  NILLDD    ++SD G +  +   QT 
Sbjct: 286 ARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341
Query: 556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
           +  +V GT GY+ PE  ++ ++T   D ++ G +L E++ G+ P +
Sbjct: 342 IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 399 FNLNRILGQGGQGTVYKGM----LPDGKIVA---VKKSKVIDESKVEEFIN-EMVILSQI 450
           F L R+LG+GG G V++         GKI A   +KK+ ++  +K       E  IL ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H  +V L+          L+ E++  G LF  +  +      T    L    E+S AL 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL---AEISMALG 135
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           +LH      I +RD+K  NI+L+ +   K++DFG  +    D T +T    GT  Y+ PE
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPE 191
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
               S      D +S G ++ ++LTG  P
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+      +   D +    I   +      ++   LS+ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 138/318 (43%), Gaps = 46/318 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVY--------KGMLPDGKIVAVKKSKV- 431
           + + +L    + E   D   L + LG+G  G V         K    +   VAVK  K  
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 432 IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVY----------EFI----P 476
             E  + + ++EM ++  I  H+N++ LLG C + + PL V           E++    P
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVGYASKGNLREYLRARRP 137
Query: 477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY 536
            G  + Y  ++  +  +T++  +    +++  + YL S   I   HRD+ + N+L+ +  
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENN 194
Query: 537 RAKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
             K++DFG +R +  +D    TT       ++ PE      +T +SDV+SFGV++ E+ T
Sbjct: 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 596 -GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNL 654
            G  P     +EE                LF++L      +   +       + + C + 
Sbjct: 255 LGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHA 298
Query: 655 NGKKRPTMREVTSELAGI 672
              +RPT +++  +L  I
Sbjct: 299 VPSQRPTFKQLVEDLDRI 316

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 106/226 (46%), Gaps = 17/226 (7%)
Query: 385 KLFTSKELER---ATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVE-- 438
           +    K LER     + F   R+LG+GG G V    +   GK+ A KK +     K +  
Sbjct: 169 RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 228
Query: 439 -EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL-FQYIHDQNEDFPITWE 496
              +NE  IL ++N R VV L       +   LV   +  G L F   H     FP   E
Sbjct: 229 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---E 285
Query: 497 MR-LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 555
            R +  A E+   L  LH      I +RD+K  NILLDD    ++SD G +  +   QT 
Sbjct: 286 ARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341
Query: 556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
           +  +V GT GY+ PE  ++ ++T   D ++ G +L E++ G+ P +
Sbjct: 342 IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVA---VKKSKVIDESKVEEFINEMVILSQINHR 453
           +F+L R++G+G    V    L    +I A   VKK  V D+  ++    E  +  Q ++ 
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 454 NVVKLLGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             +  L  C +TE  L  V E++  G L  ++  Q +   +  E     + E+S AL+YL
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYL 137
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           H      I +RD+K  N+LLD +   K++D+G  +   +     T+   GT  Y+ PE  
Sbjct: 138 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPNYIAPEIL 193
Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           R   +    D ++ GV++ E++ G  P 
Sbjct: 194 RGEDYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 396 TDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQ 449
           +DN+++   LG+G    V +      G+    KI+  KK    D  K+E    E  I  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 61
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           + H N+V+L     E     LV++ +  G LF+ I     +F    +    I  ++  ++
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQ-QILESI 118
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGY 566
           +Y HS     I HR++K  N+LL  K +    K++DFG +  + V+ +       GT GY
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGY 173
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           L PE  +   ++   D+++ GV+L  LL G  P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 396 TDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQ 449
           +DN+++   LG+G    V +      G+    KI+  KK    D  K+E    E  I  +
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 84
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           + H N+V+L     E     LV++ +  G LF+ I     +F    +    I  ++  ++
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQ-QILESI 141
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGY 566
           +Y HS     I HR++K  N+LL  K +    K++DFG +  + V+ +       GT GY
Sbjct: 142 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGY 196
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           L PE  +   ++   D+++ GV+L  LL G  P
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 396 TDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQ 449
           +DN+++   LG+G    V +      G+    KI+  KK    D  K+E    E  I  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 61
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           + H N+V+L     E     LV++ +  G LF+ I     +F    +    I  ++  ++
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQ-QILESI 118
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGY 566
           +Y HS     I HR++K  N+LL  K +    K++DFG +  + V+ +       GT GY
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGY 173
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           L PE  +   ++   D+++ GV+L  LL G  P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 396 TDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQ 449
           +DN+++   LG+G    V +      G+    KI+  KK    D  K+E    E  I  +
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 60
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           + H N+V+L     E     LV++ +  G LF+ I     +F    +    I  ++  ++
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQ-QILESI 117
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGY 566
           +Y HS     I HR++K  N+LL  K +    K++DFG +  + V+ +       GT GY
Sbjct: 118 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGY 172
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           L PE  +   ++   D+++ GV+L  LL G  P
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE 
Sbjct: 120 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEI 175
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+ +  L +++ D +    I   +      ++   L++ H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 128 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 183
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 405 LGQGGQGTVYKGML----PDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKL 458
           L + G+G+  K +L     DG+   +K+  +  +   + EE   E+ +L+ + H N+V+ 
Sbjct: 29  LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQ-----NEDFPITWEMRLRIAIEVSGALSYLH 513
                E     +V ++   G LF+ I+ Q      ED  + W       +++  AL ++H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVH 142
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
                 I HRDIKS NI L      ++ DFG +R +      +     GT  YL PE   
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACIGTPYYLSPEICE 198
Query: 574 SSQFTDKSDVYSFGVVLAELLT 595
           +  + +KSD+++ G VL EL T
Sbjct: 199 NKPYNNKSDIWALGCVLYELCT 220

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+      +   D +    I   +      ++   L++ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVA---VKKSKVIDESKVEEFINEMVILSQINHR 453
           +F+L R++G+G    V    L    +I A   VKK  V D+  ++    E  +  Q ++ 
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 454 NVVKLLGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             +  L  C +TE  L  V E++  G L  ++  Q +   +  E     + E+S AL+YL
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYL 126
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           H      I +RD+K  N+LLD +   K++D+G  +   +     T+   GT  Y+ PE  
Sbjct: 127 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPNYIAPEIL 182
Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           R   +    D ++ GV++ E++ G  P 
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVA---VKKSKVIDESKVEEFINEMVILSQINHR 453
           +F+L R++G+G    V    L    +I A   VKK  V D+  ++    E  +  Q ++ 
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 454 NVVKLLGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             +  L  C +TE  L  V E++  G L  ++  Q +   +  E     + E+S AL+YL
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYL 122
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           H      I +RD+K  N+LLD +   K++D+G  +   +     T+   GT  Y+ PE  
Sbjct: 123 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPNYIAPEIL 178
Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           R   +    D ++ GV++ E++ G  P 
Sbjct: 179 RGEDYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+ +  L +++ D +    I   +      ++   L++ H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 128 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 183
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+      +   D +    I   +      ++   L++ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+      +   D +    I   +      ++   L++ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+      +   D +    I   +      ++   L++ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+      +   D +    I   +      ++   L++ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+ +  L +++ D +    I   +      ++   L++ H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 125 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 180
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 12/224 (5%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRN 454
           D F   R LG G  G V+        +  V K+   D S+V  E+   E+ +L  ++H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           ++K+     +     +V E    G L + I   Q     ++      +  ++  AL+Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 514 SAASIPIYHRDIKSTNILLDD---KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           S     + H+D+K  NIL  D       K+ DFG +     D+   +T   GT  Y+ PE
Sbjct: 142 SQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPE 196
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY 614
            F+    T K D++S GVV+  LLTG  P   T+LEE +  A Y
Sbjct: 197 VFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 38/231 (16%)
Query: 394 RATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           R   +F    +LGQG  G V K     D +  A+KK +  +E K+   ++E+ +L+ +NH
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVXLLASLNH 61
Query: 453 RNVVKLLGCCLE--------TEVP-----LLVYEFIPNGTLFQYIHDQN--EDFPITWEM 497
           + VV+     LE        T V       +  E+  N TL+  IH +N  +     W  
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW-- 119
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS-------MA 550
             R+  ++  ALSY+HS     I HR++K  NI +D+    K+ DFG +++       + 
Sbjct: 120 --RLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 551 VDQTHM------TTQVHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLAELL 594
           +D  ++       T   GT  Y+  E    +  + +K D YS G++  E +
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 39/227 (17%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVI--LSQINHRN 454
           DN  L  ++G+G  G VYKG L D + VAVK   V   +  + FINE  I  +  + H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVK---VFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 455 VVKLLGCCLETEVP-----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           + + +              LLV E+ PNG+L +Y+     D    W    R+A  V+  L
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD----WVSSCRLAHSVTRGL 124
Query: 510 SYLHSAASIP--------IYHRDIKSTNILLDDKYRAKVSDFGASRSMA-------VDQT 554
           +YLH+   +P        I HRD+ S N+L+ +     +SDFG S  +         ++ 
Sbjct: 125 AYLHT--ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 555 HMTTQVHGTFGYLDPEYFRSS-------QFTDKSDVYSFGVVLAELL 594
           +      GT  Y+ PE    +           + D+Y+ G++  E+ 
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 396 TDNFNLNRILGQGGQGTVY----KGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN 451
           +D +   + LG G  G V     K    +  I  +KKS V   S     ++E+ +L Q++
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N++KL     +     LV E    G LF  I  + +   +   +   I  +V    +Y
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGTTY 136
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           LH      I HRD+K  N+LL+ K R    K+ DFG S    V    M  ++ GT  Y+ 
Sbjct: 137 LHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG-GKMKERL-GTAYYIA 191
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           PE  R  ++ +K DV+S GV+L  LL G  P    T +E
Sbjct: 192 PEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQE 229

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 399 FNLNRILGQGGQGTVYKG-MLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVV 456
           F L  ++G G  G VYKG  +  G++ A+K   V  + + EE   E+ +L +  +HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 84
Query: 457 KLLGCCLETEVP------LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
              G  ++   P       LV EF   G++   I +   +  +  E    I  E+   LS
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLS 143
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           +LH    I   HRDIK  N+LL +    K+ DFG S  +        T + GT  ++ PE
Sbjct: 144 HLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 199
Query: 571 YFRSSQFTD-----KSDVYSFGVVLAELLTGEKPI 600
                +  D     KSD++S G+   E+  G  P+
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 25/217 (11%)
Query: 405 LGQGGQGTVYKGML------PDGKIVAVKKSKVIDESKV-EEFINEMVILSQINHRNVVK 457
           LG+   G VYKG L         + VA+K  K   E  + EEF +E ++ +++ H NVV 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYI--HDQNEDFPITWEMR-----------LRIAIE 504
           LLG   + +   +++ +  +G L +++     + D   T + R           + +  +
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGT 563
           ++  + YL S   +   H+D+ + N+L+ DK   K+SD G  R + A D   +       
Sbjct: 137 IAAGMEYLSSHHVV---HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
             ++ PE     +F+  SD++S+GVVL E+ + G +P
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 20/224 (8%)
Query: 389 SKELERATDNFNLNRI------LGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFI 441
           S+E E    + + N +      LG G  G VYK    + G + A K  +   E ++E++I
Sbjct: 5   SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 64
Query: 442 NEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI 501
            E+ IL+  +H  +VKLLG         ++ EF P G +   + + +       E ++++
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQV 121
Query: 502 AI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
              ++  AL++LHS     I HRD+K+ N+L+  +   +++DFG S +  +         
Sbjct: 122 VCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSF 177
Query: 561 HGTFGYLDPEYFRSSQFTD-----KSDVYSFGVVLAELLTGEKP 599
            GT  ++ PE        D     K+D++S G+ L E+   E P
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 114/259 (44%), Gaps = 15/259 (5%)
Query: 356 KLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVY- 414
           +L++KF +   G   +     T  TI K     +++  + TD FN   +LG+G  G V  
Sbjct: 301 ELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD-FNFLMVLGKGSFGKVML 359
Query: 415 ---KGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-L 470
              KG      +  +KK  VI +  VE  + E  +L+       +  L  C +T   L  
Sbjct: 360 SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419
Query: 471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI 530
           V E++  G L  +I              +  A E++  L +L S     I +RD+K  N+
Sbjct: 420 VMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNV 473
Query: 531 LLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVL 590
           +LD +   K++DFG  +    D    T    GT  Y+ PE      +    D ++FGV+L
Sbjct: 474 MLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 532
Query: 591 AELLTGEKPIRFTTLEEDK 609
            E+L G+ P  F   +ED+
Sbjct: 533 YEMLAGQAP--FEGEDEDE 549

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 398 NFNLNRILGQGGQGTVY--KGMLPDGKIVA---VKKSKVIDESKVEEFINEMVILSQINH 452
            F    +LG G    V+  K  L  GK+ A   +KKS    +S +E   NE+ +L +I H
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKH 65
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSGALSY 511
            N+V L      T    LV + +  G LF  I ++     +  E    + I +V  A+ Y
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKY 121
Query: 512 LHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           LH      I HRD+K  N+L    ++  +  ++DFG S+   ++Q  + +   GT GY+ 
Sbjct: 122 LHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTPGYVA 175
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           PE      ++   D +S GV+   LL G  P
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++  L + LG G  G V+         VAVK  K    S VE F+ E  ++  + H  +V
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 240
Query: 457 KLLGCCLETEVPL-LVYEFIPNGTLFQYIH-DQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           KL      T+ P+ ++ EF+  G+L  ++  D+    P+     +  + +++  ++++  
Sbjct: 241 KLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ 296
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
              I   HRD+++ NIL+      K++DFG +R  A      T           PE    
Sbjct: 297 RNYI---HRDLRAANILVSASLVCKIADFGLARVGAKFPIKWTA----------PEAINF 343
Query: 575 SQFTDKSDVYSFGVVLAELLT 595
             FT KSDV+SFG++L E++T
Sbjct: 344 GSFTIKSDVWSFGILLMEIVT 364

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 25/217 (11%)
Query: 405 LGQGGQGTVYKGML------PDGKIVAVKKSKVIDESKV-EEFINEMVILSQINHRNVVK 457
           LG+   G VYKG L         + VA+K  K   E  + EEF +E ++ +++ H NVV 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYI--HDQNEDFPITWEMR-----------LRIAIE 504
           LLG   + +   +++ +  +G L +++     + D   T + R           + +  +
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGT 563
           ++  + YL S     + H+D+ + N+L+ DK   K+SD G  R + A D   +       
Sbjct: 154 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
             ++ PE     +F+  SD++S+GVVL E+ + G +P
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKK---SKVIDESKVEEFINEMVILSQINHRNVVKL 458
           R +G G  G VY    + + ++VA+KK   S      K ++ I E+  L ++ H N ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 459 LGCCLETEVPLLVYEF-IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL---SYLHS 514
            GC L      LV E+ + + +    +H +    P+     + IA    GAL   +YLHS
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQ---EVEIAAVTHGALQGLAYLHS 172
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
              I   HRD+K+ NILL +    K+ DFG++  MA     +     GT  ++ PE   +
Sbjct: 173 HNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILA 224
Query: 575 ---SQFTDKSDVYSFGVVLAELLTGEKPI 600
               Q+  K DV+S G+   EL   + P+
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 132/313 (42%), Gaps = 47/313 (15%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQG-----TVYKGMLPDGKI-VAVKKSKVIDE 434
           I+ T+L    + E   +  +  + LG G  G     T Y  +  D  + VAVK  K    
Sbjct: 7   IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 435 -SKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF- 491
            ++ E  ++E+ +LS + NH N+V LLG C      L++ E+   G L  ++  + + F 
Sbjct: 67  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 492 --------------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                          +  E  L  + +V+  +++L S   I   HRD+ + NILL     
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRI 183
Query: 538 AKVSDFGASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K+ DFG +R +  D  ++          ++ PE   +  +T +SDV+S+G+ L EL + 
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 596 GEKPIRFTTLEED--KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLN 653
           G  P     ++    K +   F     E    E+ D                 + K C +
Sbjct: 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWD 286
Query: 654 LNGKKRPTMREVT 666
            +  KRPT +++ 
Sbjct: 287 ADPLKRPTFKQIV 299

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 174
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+ +  L +++ D +    I   +      ++   L++
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 121 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 176
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKK---SKVIDESKVEEFINEMVILSQINHRNVVKL 458
           R +G G  G VY    + + ++VA+KK   S      K ++ I E+  L ++ H N ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 459 LGCCLETEVPLLVYEF-IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL---SYLHS 514
            GC L      LV E+ + + +    +H +    P+     + IA    GAL   +YLHS
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQ---EVEIAAVTHGALQGLAYLHS 133
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
              I   HRD+K+ NILL +    K+ DFG++  MA     +     GT  ++ PE   +
Sbjct: 134 HNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILA 185
Query: 575 ---SQFTDKSDVYSFGVVLAELLTGEKPI 600
               Q+  K DV+S G+   EL   + P+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+ +  L +++ D +    I   +      ++   L++
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 122 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 177
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD--LKTFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 122 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 177
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 122 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 177
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 121 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 176
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 123 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 178
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+ +  L +++ D +    I   +      ++   L++
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 121 CHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 176
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP-------ITWEMRLRIAIE 504
           H N+VKLL   + TE  L +        +F+++H   +DF        I   +      +
Sbjct: 61  HPNIVKLLDV-IHTENKLYL--------VFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ 111
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           +   L++ HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T 
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTL 167
Query: 565 GYLDPEYFRSSQFTDKS-DVYSFGVVLAELLT 595
            Y  PE     ++   + D++S G + AE++T
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 174
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 174
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 20  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 79
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 80  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 138
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 139 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 190
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 191 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 245
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 246 EEIIGGQVFFRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 287

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 21  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 80
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 81  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 139
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 140 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 191
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 192 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 246
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 247 EEIIGGQVFFRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 288

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 120 CHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 175
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 174
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 120 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 175
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 21  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 80
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 81  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 139
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 140 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 191
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 192 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 246
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 247 EEIIGGQVFFRQ----------RVSXEC--------QHLIRWCLALRPSDRPTFEEIQNH 288

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 21  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 80
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 81  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 139
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 140 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 191
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 192 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 246
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 247 EEIIGGQVFFRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 288

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 20  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 79
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 80  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 138
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 139 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 190
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 191 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 245
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 246 EEIIGGQVFFRQ----------RVSXEC--------QHLIRWCLALRPSDRPTFEEIQNH 287

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 20  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 79
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 80  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 138
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 139 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 190
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 191 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 245
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 246 EEIIGGQVFFRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 287

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 132/313 (42%), Gaps = 47/313 (15%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQG-----TVYKGMLPDGKI-VAVKKSKVIDE 434
           I+ T+L    + E   +  +  + LG G  G     T Y  +  D  + VAVK  K    
Sbjct: 30  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 89
Query: 435 -SKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF- 491
            ++ E  ++E+ +LS + NH N+V LLG C      L++ E+   G L  ++  + + F 
Sbjct: 90  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 149
Query: 492 --------------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                          +  E  L  + +V+  +++L S   I   HRD+ + NILL     
Sbjct: 150 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRI 206
Query: 538 AKVSDFGASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K+ DFG +R +  D  ++          ++ PE   +  +T +SDV+S+G+ L EL + 
Sbjct: 207 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 266
Query: 596 GEKPIRFTTLEED--KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLN 653
           G  P     ++    K +   F     E    E+ D                 + K C +
Sbjct: 267 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWD 309
Query: 654 LNGKKRPTMREVT 666
            +  KRPT +++ 
Sbjct: 310 ADPLKRPTFKQIV 322

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 132/313 (42%), Gaps = 47/313 (15%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQG-----TVYKGMLPDGKI-VAVKKSKVIDE 434
           I+ T+L    + E   +  +  + LG G  G     T Y  +  D  + VAVK  K    
Sbjct: 30  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 89
Query: 435 -SKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF- 491
            ++ E  ++E+ +LS + NH N+V LLG C      L++ E+   G L  ++  + + F 
Sbjct: 90  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 149
Query: 492 --------------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                          +  E  L  + +V+  +++L S   I   HRD+ + NILL     
Sbjct: 150 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRI 206
Query: 538 AKVSDFGASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K+ DFG +R +  D  ++          ++ PE   +  +T +SDV+S+G+ L EL + 
Sbjct: 207 TKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 266
Query: 596 GEKPIRFTTLEED--KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLN 653
           G  P     ++    K +   F     E    E+ D                 + K C +
Sbjct: 267 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWD 309
Query: 654 LNGKKRPTMREVT 666
            +  KRPT +++ 
Sbjct: 310 ADPLKRPTFKQIV 322

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 21  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 80
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 81  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 139
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 140 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 191
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 192 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 246
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 247 EEIIGGQVFFRQ----------RVSXEC--------QHLIRWCLALRPSDRPTFEEIQNH 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+      +   D +    I   +      ++   L++ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE   
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILL 175
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+ +  L +++ D +    I   +      ++   L++ H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE   
Sbjct: 122 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILL 177
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+      +   D +    I   +      ++   L++ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE   
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILL 175
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 114/207 (55%), Gaps = 22/207 (10%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
            +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V+L  
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIVRLRY 81
Query: 461 CCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
               +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y+
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAYI 139
Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE 
Sbjct: 140 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPEL 194
Query: 572 -FRSSQFTDKSDVYSFGVVLAELLTGE 597
            F ++ +T   DV+S G VLAELL G+
Sbjct: 195 IFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 116/211 (54%), Gaps = 22/211 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++   +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 110
Query: 457 KLLGCCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +L      +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRS 168
Query: 509 LSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           L+Y+HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y 
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYR 223
Query: 568 DPEY-FRSSQFTDKSDVYSFGVVLAELLTGE 597
            PE  F ++ +T   DV+S G VLAELL G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 122 CHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 177
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+ K ++  E++      I E+ +L ++NH 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+      +   D +    I   +      ++   L++ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+ K ++  E++      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+      +   D +    I   +      ++   L++ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 7   LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 66
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 67  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 125
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 126 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 177
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 178 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 232
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 233 EEIIRGQVFFRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 274

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 114/207 (55%), Gaps = 22/207 (10%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
            +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V+L  
Sbjct: 29  TKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIVRLRY 84
Query: 461 CCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
               +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y+
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAYI 142
Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE 
Sbjct: 143 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPEL 197
Query: 572 -FRSSQFTDKSDVYSFGVVLAELLTGE 597
            F ++ +T   DV+S G VLAELL G+
Sbjct: 198 IFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 120 CHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 175
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 114/207 (55%), Gaps = 22/207 (10%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
            +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V+L  
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIVRLRY 92
Query: 461 CCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
               +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y+
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAYI 150
Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE 
Sbjct: 151 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPEL 205
Query: 572 -FRSSQFTDKSDVYSFGVVLAELLTGE 597
            F ++ +T   DV+S G VLAELL G+
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 114/207 (55%), Gaps = 22/207 (10%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
            +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V+L  
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIVRLRY 92
Query: 461 CCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
               +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y+
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAYI 150
Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE 
Sbjct: 151 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPEL 205
Query: 572 -FRSSQFTDKSDVYSFGVVLAELLTGE 597
            F ++ +T   DV+S G VLAELL G+
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 132/313 (42%), Gaps = 47/313 (15%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQG-----TVYKGMLPDGKI-VAVKKSKVIDE 434
           I+ T+L    + E   +  +  + LG G  G     T Y  +  D  + VAVK  K    
Sbjct: 25  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 84
Query: 435 -SKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF- 491
            ++ E  ++E+ +LS + NH N+V LLG C      L++ E+   G L  ++  + + F 
Sbjct: 85  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 144
Query: 492 --------------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                          +  E  L  + +V+  +++L S   I   HRD+ + NILL     
Sbjct: 145 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRI 201
Query: 538 AKVSDFGASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K+ DFG +R +  D  ++          ++ PE   +  +T +SDV+S+G+ L EL + 
Sbjct: 202 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 261
Query: 596 GEKPIRFTTLEED--KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLN 653
           G  P     ++    K +   F     E    E+ D                 + K C +
Sbjct: 262 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWD 304
Query: 654 LNGKKRPTMREVT 666
            +  KRPT +++ 
Sbjct: 305 ADPLKRPTFKQIV 317

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 8   LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 67
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 68  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 126
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 127 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 178
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 179 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 233
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 234 EEIIRGQVFFRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 275

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 114/207 (55%), Gaps = 22/207 (10%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
            +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V+L  
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIVRLRY 99
Query: 461 CCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
               +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y+
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAYI 157
Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE 
Sbjct: 158 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPEL 212
Query: 572 -FRSSQFTDKSDVYSFGVVLAELLTGE 597
            F ++ +T   DV+S G VLAELL G+
Sbjct: 213 IFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 132/313 (42%), Gaps = 47/313 (15%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQG-----TVYKGMLPDGKI-VAVKKSKVIDE 434
           I+ T+L    + E   +  +  + LG G  G     T Y  +  D  + VAVK  K    
Sbjct: 23  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 82
Query: 435 -SKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF- 491
            ++ E  ++E+ +LS + NH N+V LLG C      L++ E+   G L  ++  + + F 
Sbjct: 83  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 142
Query: 492 --------------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                          +  E  L  + +V+  +++L S   I   HRD+ + NILL     
Sbjct: 143 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRI 199
Query: 538 AKVSDFGASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
            K+ DFG +R +  D  ++          ++ PE   +  +T +SDV+S+G+ L EL + 
Sbjct: 200 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 259
Query: 596 GEKPIRFTTLEED--KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLN 653
           G  P     ++    K +   F     E    E+ D                 + K C +
Sbjct: 260 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWD 302
Query: 654 LNGKKRPTMREVT 666
            +  KRPT +++ 
Sbjct: 303 ADPLKRPTFKQIV 315

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 8   LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 67
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 68  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 126
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 127 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 178
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 179 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 233
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 234 EEIIRGQVFFRQ----------RVSXEC--------QHLIRWCLALRPSDRPTFEEIQNH 275

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 114/207 (55%), Gaps = 22/207 (10%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
            +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V+L  
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIVRLRY 80
Query: 461 CCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
               +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAYI 138
Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE 
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPEL 193
Query: 572 -FRSSQFTDKSDVYSFGVVLAELLTGE 597
            F ++ +T   DV+S G VLAELL G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 114/207 (55%), Gaps = 22/207 (10%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
            +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V+L  
Sbjct: 33  TKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIVRLRY 88
Query: 461 CCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
               +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y+
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAYI 146
Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE 
Sbjct: 147 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPEL 201
Query: 572 -FRSSQFTDKSDVYSFGVVLAELLTGE 597
            F ++ +T   DV+S G VLAELL G+
Sbjct: 202 IFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 403 RILGQGGQGTVY----KGMLPDGKIVAVKKS-----KVIDESK-----VEEFINEMVILS 448
           R LG G  G V     K    +  I  +KKS     +  D++K      EE  NE+ +L 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
            ++H N++KL     + +   LV EF   G LF+ I ++++           I  ++   
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD---AANIMKQILSG 158
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
           + YLH      I HRDIK  NILL++K      K+ DFG S   + D  +      GT  
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAY 213
Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           Y+ PE  +  ++ +K DV+S GV++  LL G  P 
Sbjct: 214 YIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 114/207 (55%), Gaps = 22/207 (10%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
            +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V+L  
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIVRLRY 80
Query: 461 CCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
               +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAYI 138
Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE 
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPEL 193
Query: 572 -FRSSQFTDKSDVYSFGVVLAELLTGE 597
            F ++ +T   DV+S G VLAELL G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 7   LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 66
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 67  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 125
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 126 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 177
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 178 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 232
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 233 EEIIRGQVFFRQ----------RVSXEC--------QHLIRWCLALRPSDRPTFEEIQNH 274

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 8   LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 67
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 68  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 126
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 127 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 178
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 179 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 233
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 234 EEIIRGQVFFRQ----------RVSXEC--------QHLIRWCLALRPXDRPTFEEIQNH 275

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 27  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 86
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 87  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 145
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 146 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 197
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 252
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 253 EEIIRGQVFFRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 294

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 116/211 (54%), Gaps = 22/211 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++   +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 114
Query: 457 KLLGCCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +L      +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRS 172
Query: 509 LSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           L+Y+HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y 
Sbjct: 173 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 227
Query: 568 DPEY-FRSSQFTDKSDVYSFGVVLAELLTGE 597
            PE  F ++ +T   DV+S G VLAELL G+
Sbjct: 228 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+E +      +   D +    I   +      ++   L++ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQD--LKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V  T  Y  PE   
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175
Query: 574 SSQFTDKS-DVYSFGVVLAELLT 595
             ++   + D++S G + AE++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 116/211 (54%), Gaps = 22/211 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++   +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 104
Query: 457 KLLGCCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +L      +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRS 162
Query: 509 LSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           L+Y+HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y 
Sbjct: 163 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 217
Query: 568 DPEY-FRSSQFTDKSDVYSFGVVLAELLTGE 597
            PE  F ++ +T   DV+S G VLAELL G+
Sbjct: 218 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 35  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 94
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 95  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 153
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 154 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 205
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 206 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 260
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 261 EEIIRGQVFFRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 302

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 14/221 (6%)
Query: 404 ILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           +LG+G  G VY G  L +   +A+K+    D    +    E+ +   + H+N+V+ LG  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
            E     +  E +P G+L   +  +        +       ++   L YLH      I H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 523 RDIKSTNILLDDKYRA--KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ--FT 578
           RDIK  N+L+ + Y    K+SDFG S+ +A      T    GT  Y+ PE        + 
Sbjct: 146 RDIKGDNVLI-NTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 579 DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM 619
             +D++S G  + E+ TG+ P  F  L E +  AA F   M
Sbjct: 204 KAADIWSLGCTIIEMATGKPP--FYELGEPQ--AAMFKVGM 240

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 116/211 (54%), Gaps = 22/211 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++   +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 112
Query: 457 KLLGCCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +L      +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRS 170
Query: 509 LSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           L+Y+HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y 
Sbjct: 171 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 225
Query: 568 DPEY-FRSSQFTDKSDVYSFGVVLAELLTGE 597
            PE  F ++ +T   DV+S G VLAELL G+
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 40  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 99
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 100 LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 158
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 159 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 210
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 211 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 265
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 266 EEIIRGQVFFRQ----------RVSXEC--------QHLIRWCLALRPSDRPTFEEIQNH 307

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMD--LKDFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 122 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 177
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 396 TDNFNLNRILGQGGQGTVY----KGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN 451
           +D +   + LG G  G V     K    +  I  +KKS V   S     ++E+ +L Q++
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N++KL     +     LV E    G LF  I  + +   +   +   I  +V    +Y
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGTTY 119
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           LH      I HRD+K  N+LL+ K R    K+ DFG S    V    M  ++ GT  Y+ 
Sbjct: 120 LHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG-GKMKERL-GTAYYIA 174
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           PE  R  ++ +K DV+S GV+L  LL G  P    T +E
Sbjct: 175 PEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQE 212

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 20  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 79
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 80  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 138
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 139 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 190
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 191 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 245
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 246 EEIIRGQVFFRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 287

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 114/207 (55%), Gaps = 22/207 (10%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
            +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V+L  
Sbjct: 30  TKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIVRLRY 85
Query: 461 CCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
               +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y+
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAYI 143
Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE 
Sbjct: 144 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPEL 198
Query: 572 -FRSSQFTDKSDVYSFGVVLAELLTGE 597
            F ++ +T   DV+S G VLAELL G+
Sbjct: 199 IFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 116/211 (54%), Gaps = 22/211 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++   +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 110
Query: 457 KLLGCCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +L      +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRS 168
Query: 509 LSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           L+Y+HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y 
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 223
Query: 568 DPEY-FRSSQFTDKSDVYSFGVVLAELLTGE 597
            PE  F ++ +T   DV+S G VLAELL G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 116/211 (54%), Gaps = 22/211 (10%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++   +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 155
Query: 457 KLLGCCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +L      +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRS 213
Query: 509 LSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           L+Y+HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y 
Sbjct: 214 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 268
Query: 568 DPEY-FRSSQFTDKSDVYSFGVVLAELLTGE 597
            PE  F ++ +T   DV+S G VLAELL G+
Sbjct: 269 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 396 TDNFNLNRILGQGGQGTVYKGMLPDGKIV----AVK---KSKVIDESKVEEFINEMVILS 448
           +D +   R+LG+G  G V   +L   KI     AVK   K +V  ++  E  + E+ +L 
Sbjct: 31  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           Q++H N++KL     +     LV E    G LF  I  +     +      RI  +V   
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSG 144
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFG 565
           ++Y+H      I HRD+K  N+LL+ K +    ++ DFG S      +  M  ++ GT  
Sbjct: 145 ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI-GTAY 199
Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           Y+ PE    + + +K DV+S GV+L  LL+G  P
Sbjct: 200 YIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 232

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+EF+      +   D +    I   +      ++   L++
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMD--LKDFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 121 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 176
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKI---VAVKKSKVIDESKVEEFI--NEMVILSQINH 452
           +F+  +++G+G  G V        ++   V V + K I + K E+ I     V+L  + H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +V L       +    V ++I  G LF ++  +        E R R  A E++ AL Y
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGY 154
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + I +RD+K  NILLD +    ++DFG  +   ++    T+   GT  YL PE 
Sbjct: 155 LHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPEV 210
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
                +    D +  G VL E+L G  P 
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 114/207 (55%), Gaps = 22/207 (10%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
            +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V+L  
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIVRLRY 93
Query: 461 CCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
               +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y+
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAYI 151
Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE 
Sbjct: 152 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPEL 206
Query: 572 -FRSSQFTDKSDVYSFGVVLAELLTGE 597
            F ++ +T   DV+S G VLAELL G+
Sbjct: 207 IFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 46/290 (15%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFIN--- 442
           K+ E     + L  +LG+GG GTV+ G  L D   VA+K   +++V+  S + + +    
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 443 EMVILSQI----NHRNVVKLLGCCLETEVPLLVYEF-IPNGTLFQYIHDQNEDFPITWEM 497
           E+ +L ++     H  V++LL      E  +LV E  +P   LF YI    E  P+    
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGP 140
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-AKVSDFGASRSMAVDQTHM 556
                 +V  A+ + HS     + HRDIK  NIL+D +   AK+ DFG S ++  D+ + 
Sbjct: 141 SRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPY- 195
Query: 557 TTQVHGTFGYLDPEYFRSSQFTD-KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
            T   GT  Y  PE+    Q+    + V+S G++L +++ G+ P                
Sbjct: 196 -TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF--------------- 239
Query: 616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                 ER  EIL+A +   +          + +RCL      RP++ E+
Sbjct: 240 ------ERDQEILEAELHFPAHVSP--DCCALIRRCLAPKPSSRPSLEEI 281

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 114/207 (55%), Gaps = 22/207 (10%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
            +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V+L  
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIVRLRY 80
Query: 461 CCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
               +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAYI 138
Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE 
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPEL 193
Query: 572 -FRSSQFTDKSDVYSFGVVLAELLTGE 597
            F ++ +T   DV+S G VLAELL G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 405 LGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL 463
           LG G  G VYK    + G + A K  +   E ++E++I E+ IL+  +H  +VKLLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 464 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSGALSYLHSAASIPIYH 522
                 ++ EF P G +   + + +       E ++++   ++  AL++LHS     I H
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSKR---IIH 132
Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD--- 579
           RD+K+ N+L+  +   +++DFG S +  +          GT  ++ PE        D   
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 191
Query: 580 --KSDVYSFGVVLAELLTGEKP 599
             K+D++S G+ L E+   E P
Sbjct: 192 DYKADIWSLGITLIEMAQIEPP 213

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 35  LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 94
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 95  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 153
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 154 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 205
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 206 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 260
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 261 EEIIRGQVFFRQ----------RVSXEC--------QHLIRWCLALRPSDRPTFEEIQNH 302

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 405 LGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFIN-----EMVILSQINHRNVVKL 458
           LG+G   TVYK    +  +IVA+KK K+   S+ ++ IN     E+ +L +++H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
           L          LV++F+   T  + I   N        ++  + + + G L YLH     
Sbjct: 78  LDAFGHKSNISLVFDFM--ETDLEVIIKDNSLVLTPSHIKAYMLMTLQG-LEYLHQHW-- 132
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQF 577
            I HRD+K  N+LLD+    K++DFG ++S          QV  T  Y  PE  F +  +
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQV-VTRWYRAPELLFGARMY 190
Query: 578 TDKSDVYSFGVVLAELL 594
               D+++ G +LAELL
Sbjct: 191 GVGVDMWAVGCILAELL 207

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK--KSKVIDESKVEEF-INEMVILSQINH 452
           ++F+++RI+G+GG G VY     D GK+ A+K    K I   + E   +NE ++LS ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 453 RN--VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            +   +  +     T   L     + NG    Y   Q+  F    +MR   A E+   L 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRF-YAAEIILGLE 306
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           ++H+     + +RD+K  NILLD+    ++SD G +   +  + H +    GT GY+ PE
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 360
Query: 571 YFRSSQFTDKS-DVYSFGVVLAELLTGEKPIR 601
             +     D S D +S G +L +LL G  P R
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 14/221 (6%)
Query: 404 ILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           +LG+G  G VY G  L +   +A+K+    D    +    E+ +   + H+N+V+ LG  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
            E     +  E +P G+L   +  +        +       ++   L YLH      I H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 131
Query: 523 RDIKSTNILLDDKYRA--KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ--FT 578
           RDIK  N+L+ + Y    K+SDFG S+ +A      T    GT  Y+ PE        + 
Sbjct: 132 RDIKGDNVLI-NTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 579 DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM 619
             +D++S G  + E+ TG+ P  F  L E +  AA F   M
Sbjct: 190 KAADIWSLGCTIIEMATGKPP--FYELGEPQ--AAMFKVGM 226

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK--KSKVIDESKVEEF-INEMVILSQINH 452
           ++F+++RI+G+GG G VY     D GK+ A+K    K I   + E   +NE ++LS ++ 
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 453 RN--VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            +   +  +     T   L     + NG    Y   Q+  F    +MR   A E+   L 
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRF-YAAEIILGLE 305
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           ++H+     + +RD+K  NILLD+    ++SD G +   +  + H +    GT GY+ PE
Sbjct: 306 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 359
Query: 571 YFRSSQFTDKS-DVYSFGVVLAELLTGEKPIR 601
             +     D S D +S G +L +LL G  P R
Sbjct: 360 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 391

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDG-----KIVAVKKSKVIDESKVEEFINEMVILSQ 449
           TD + L   LG+G    V + M +P G     KI+  KK    D  K+E    E  I   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ------YIHDQNEDFPITWEMRLRIAI 503
           + H N+V+L     E     LV++ +  G LF+      Y  + +    I          
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ--------- 110
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQV 560
           ++  ++++ H      I HRD+K  N+LL  K +    K++DFG +  +  DQ       
Sbjct: 111 QILESVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGF 166
Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            GT GYL PE  R   +    D+++ GV+L  LL G  P
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK--KSKVIDESKVEEF-INEMVILSQINH 452
           ++F+++RI+G+GG G VY     D GK+ A+K    K I   + E   +NE ++LS ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 453 RN--VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            +   +  +     T   L     + NG    Y   Q+  F    +MR   A E+   L 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRF-YAAEIILGLE 306
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           ++H+     + +RD+K  NILLD+    ++SD G +   +  + H +    GT GY+ PE
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 360
Query: 571 YFRSSQFTDKS-DVYSFGVVLAELLTGEKPIR 601
             +     D S D +S G +L +LL G  P R
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK--KSKVIDESKVEEF-INEMVILSQINH 452
           ++F+++RI+G+GG G VY     D GK+ A+K    K I   + E   +NE ++LS ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 453 RN--VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            +   +  +     T   L     + NG    Y   Q+  F    +MR   A E+   L 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRF-YAAEIILGLE 306
Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           ++H+     + +RD+K  NILLD+    ++SD G +   +  + H +    GT GY+ PE
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 360
Query: 571 YFRSSQFTDKS-DVYSFGVVLAELLTGEKPIR 601
             +     D S D +S G +L +LL G  P R
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVK-KSKVIDESKVEEFINEM 444
           K+ E   D ++   +LG G    V   +L + K    +VA+K  +K   E K     NE+
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEI 67
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
            +L +I H N+V L           L+ + +  G LF  I ++      T     R+  +
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQ 124
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNIL---LDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
           V  A+ YLH    + I HRD+K  N+L   LD+  +  +SDFG S+    D   + +   
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTAC 179
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           GT GY+ PE      ++   D +S GV+   LL G  P
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVK-KSKVIDESKVEEFINEM 444
           K+ E   D ++   +LG G    V   +L + K    +VA+K  +K   E K     NE+
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEI 67
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
            +L +I H N+V L           L+ + +  G LF  I ++      T     R+  +
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQ 124
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNIL---LDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
           V  A+ YLH    + I HRD+K  N+L   LD+  +  +SDFG S+    D   + +   
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTAC 179
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           GT GY+ PE      ++   D +S GV+   LL G  P
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDG-----KIVAVKKSKVIDESKVEEFINEMVILSQ 449
           TD + L   LG+G    V + M +P G     KI+  KK    D  K+E    E  I   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ------YIHDQNEDFPITWEMRLRIAI 503
           + H N+V+L     E     LV++ +  G LF+      Y  + +    I          
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ--------- 110
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQV 560
           ++  ++++ H      I HRD+K  N+LL  K +    K++DFG +  +  DQ       
Sbjct: 111 QILESVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGF 166
Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            GT GYL PE  R   +    D+++ GV+L  LL G  P
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGC 461
           LG G  G VYK    +  ++A   +KVID   E ++E+++ E+ IL+  +H N+VKLL  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
                   ++ EF   G +   + +     P+T      +  +   AL+YLH      I 
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---II 157
Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF-----RSSQ 576
           HRD+K+ NIL       K++DFG S +             GT  ++ PE       +   
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS-AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 577 FTDKSDVYSFGVVLAELLTGEKP 599
           +  K+DV+S G+ L E+   E P
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPP 239

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGC 461
           LG G  G VYK    +  ++A   +KVID   E ++E+++ E+ IL+  +H N+VKLL  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
                   ++ EF   G +   + +     P+T      +  +   AL+YLH      I 
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---II 157
Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF-----RSSQ 576
           HRD+K+ NIL       K++DFG S +             GT  ++ PE       +   
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS-AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 577 FTDKSDVYSFGVVLAELLTGEKP 599
           +  K+DV+S G+ L E+   E P
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPP 239

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 112/207 (54%), Gaps = 22/207 (10%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLL- 459
            +++G G  G VY+  L D G++VA+KK  V+ + + +    E+ I+ +++H N+V+L  
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIVRLRY 80
Query: 460 -----GCCLETEVPLLVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
                G   +     LV +++P     + ++     +  P+ + ++L +  ++  +L+Y+
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAYI 138
Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE 
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPEL 193
Query: 572 -FRSSQFTDKSDVYSFGVVLAELLTGE 597
            F ++ +T   DV+S G VLAELL G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGC 461
           LG G  G VYK    +  ++A   +KVID   E ++E+++ E+ IL+  +H N+VKLL  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
                   ++ EF   G +   + +     P+T      +  +   AL+YLH      I 
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---II 157
Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF-----RSSQ 576
           HRD+K+ NIL       K++DFG S +             GT  ++ PE       +   
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS-AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 577 FTDKSDVYSFGVVLAELLTGEKP 599
           +  K+DV+S G+ L E+   E P
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPP 239

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVK-KSKVIDESKVEEFINEM 444
           K+ E   D ++   +LG G    V   +L + K    +VA+K  +K   E K     NE+
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEI 67
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
            +L +I H N+V L           L+ + +  G LF  I ++      T     R+  +
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQ 124
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNIL---LDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
           V  A+ YLH    + I HRD+K  N+L   LD+  +  +SDFG S+    D   + +   
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTAC 179
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           GT GY+ PE      ++   D +S GV+   LL G  P
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 405 LGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESK--VEEFINEMVILSQINHRNVVKLLGC 461
           +G+G  GTV+K    +  +IVA+K+ ++ D+ +      + E+ +L ++ H+N+V+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
               +   LV+EF  +  L +Y    N D  +  E+      ++   L + HS     + 
Sbjct: 70  LHSDKKLTLVFEFC-DQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTDK 580
           HRD+K  N+L++     K++DFG +R+  +     + +V  T  Y  P+  F +  ++  
Sbjct: 124 HRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV-VTLWYRPPDVLFGAKLYSTS 182
Query: 581 SDVYSFGVVLAELLTGEKPI 600
            D++S G + AEL    +P+
Sbjct: 183 IDMWSAGCIFAELANAARPL 202

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEE-----FINEMVILSQIN 451
           + +N+  +LG+G  G V K    D         KVI+++  +       + E+ +L +++
Sbjct: 22  ERYNIVCMLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N++KL     ++    +V E    G LF  I  +      +     RI  +V   ++Y
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITY 136
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           +H      I HRD+K  NILL+ K +    K+ DFG S       T M  ++ GT  Y+ 
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-GTAYYIA 191
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           PE  R + + +K DV+S GV+L  LL+G  P
Sbjct: 192 PEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEE-----FINEMVILSQIN 451
           + +N+  +LG+G  G V K    D         KVI+++  +       + E+ +L +++
Sbjct: 22  ERYNIVCMLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N++KL     ++    +V E    G LF  I  +      +     RI  +V   ++Y
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITY 136
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           +H      I HRD+K  NILL+ K +    K+ DFG S       T M  ++ GT  Y+ 
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-GTAYYIA 191
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           PE  R + + +K DV+S GV+L  LL+G  P
Sbjct: 192 PEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVK-KSKVIDESKVEEFINEM 444
           K+ E   D ++   +LG G    V   +L + K    +VA+K  +K   E K     NE+
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEI 67
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
            +L +I H N+V L           L+ + +  G LF  I ++      T     R+  +
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQ 124
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNIL---LDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
           V  A+ YLH    + I HRD+K  N+L   LD+  +  +SDFG S+    D   + +   
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTAC 179
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           GT GY+ PE      ++   D +S GV+   LL G  P
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 405 LGQGGQGTVYKGML-PDGKIVAVKKSK-VIDESKVEEFINEM-VILSQINHRNVVKLLGC 461
           +G+G  G+V K +  P G+I+AVK+ +  +DE + ++ + ++ V++   +   +V+  G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 462 CLETEVPLLVYEFIPNG--TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIP 519
                   +  E +       ++Y++   +D  I  E+  +I +    AL++L    ++ 
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDV-IPEEILGKITLATVKALNHLKE--NLK 146
Query: 520 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ--- 576
           I HRDIK +NILLD     K+ DFG S  + VD    T    G   Y+ PE    S    
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDA-GCRPYMAPERIDPSASRQ 204
Query: 577 -FTDKSDVYSFGVVLAELLTGEKP 599
            +  +SDV+S G+ L EL TG  P
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFP 228

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 396 TDNFNLNRILGQGGQGTVYKGMLPDGKIV----AVK---KSKVIDESKVEEFINEMVILS 448
           +D +   R+LG+G  G V   +L   KI     AVK   K +V  ++  E  + E+ +L 
Sbjct: 49  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 105
Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           Q++H N++KL     +     LV E    G LF  I  +     +      RI  +V   
Sbjct: 106 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSG 162
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFG 565
           ++Y+H      I HRD+K  N+LL+ K +    ++ DFG S      +  M  ++ GT  
Sbjct: 163 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI-GTAY 217
Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           Y+ PE    + + +K DV+S GV+L  LL+G  P
Sbjct: 218 YIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 250

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 396 TDNFNLNRILGQGGQGTVYKGMLPDGKIV----AVK---KSKVIDESKVEEFINEMVILS 448
           +D +   R+LG+G  G V   +L   KI     AVK   K +V  ++  E  + E+ +L 
Sbjct: 48  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 104
Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           Q++H N++KL     +     LV E    G LF  I  +     +      RI  +V   
Sbjct: 105 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSG 161
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFG 565
           ++Y+H      I HRD+K  N+LL+ K +    ++ DFG S      +  M  ++ GT  
Sbjct: 162 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI-GTAY 216
Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           Y+ PE    + + +K DV+S GV+L  LL+G  P
Sbjct: 217 YIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 249

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESK--VEEFINEMVILSQIN 451
           + +NF     +G+G  G VYK      G++VA+KK ++  E++      I E+ +L ++N
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N+VKLL          LV+E + +  L +++ D +    I   +      ++   L++
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            HS     + HRD+K  N+L++ +   K++DFG +R+  V       +V  T  Y  PE 
Sbjct: 122 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEI 177
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLT 595
               ++   + D++S G + AE++T
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++P G +F ++           E   R  A ++     Y
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEY 157
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL PE 
Sbjct: 158 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 210
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + +G G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   KV+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 396 TDNFNLNRILGQGGQGTVYKGMLPDGKIV----AVK---KSKVIDESKVEEFINEMVILS 448
           +D +   R+LG+G  G V   +L   KI     AVK   K +V  ++  E  + E+ +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           Q++H N++KL     +     LV E    G LF  I  +     +      RI  +V   
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSG 138
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFG 565
           ++Y+H      I HRD+K  N+LL+ K +    ++ DFG S      +  M  ++ GT  
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI-GTAY 193
Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           Y+ PE    + + +K DV+S GV+L  LL+G  P
Sbjct: 194 YIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++P G +F ++           E   R  A ++     Y
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 157
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL PE 
Sbjct: 158 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 210
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++P G +F ++           E   R  A ++     Y
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 157
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL PE 
Sbjct: 158 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEYLAPEI 210
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV-----IDESKVEEF----INEMVI 446
           +N+    ILG+G    V + +  P  K  AVK   V         +V+E     + E+ I
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 447 LSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           L +++ H N+++L           LV++ +  G LF Y+ ++           +R  +EV
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
             AL  L+      I HRD+K  NILLDD    K++DFG   S  +D      +V GT  
Sbjct: 124 ICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLREVCGTPS 175
Query: 566 YLDPEYFRSSQ------FTDKSDVYSFGVVLAELLTGEKP 599
           YL PE    S       +  + D++S GV++  LL G  P
Sbjct: 176 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 121/249 (48%), Gaps = 27/249 (10%)
Query: 368 LLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVK 427
           L  Q +L +T G      +F + +    ++ +   + LG G  G V   +L   K+  V+
Sbjct: 14  LYFQGDLQATPG------MFITSKKGHLSEMYQRVKKLGSGAYGEV---LLCRDKVTHVE 64
Query: 428 KS-KVIDESKVE-----EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF 481
           ++ K+I ++ V      + + E+ +L  ++H N++KL     +     LV E    G LF
Sbjct: 65  RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 482 QYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR---A 538
             I  + +   +   + ++   +V   ++YLH      I HRD+K  N+LL+ K +    
Sbjct: 125 DEIIHRMKFNEVDAAVIIK---QVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALI 178
Query: 539 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEK 598
           K+ DFG S ++  +Q  M  ++ GT  Y+ PE  R  ++ +K DV+S GV+L  LL G  
Sbjct: 179 KIVDFGLS-AVFENQKKMKERL-GTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYP 235
Query: 599 PIRFTTLEE 607
           P    T +E
Sbjct: 236 PFGGQTDQE 244

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 31/219 (14%)
Query: 396 TDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQ 449
           TD + L   +G+G    V +      G     KI+  KK    D  K+E    E  I   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ------YIHDQNEDFPITWEMRLRIAI 503
           + H N+V+L     E     LV++ +  G LF+      Y  + +    I          
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ--------- 110
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQV 560
           ++  A+ + H    + + HRD+K  N+LL  K +    K++DFG +  +  DQ       
Sbjct: 111 QILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG-F 166
Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            GT GYL PE  R   +    D+++ GV+L  LL G  P
Sbjct: 167 AGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + +G G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   KV+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + +G G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   KV+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 116/209 (55%), Gaps = 26/209 (12%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFIN-EMVILSQINHRNVVKLL 459
            +++G G  G VY+  L D G++VA+KK   + + K   F N E+ I+ +++H N+V+L 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQGKA--FKNRELQIMRKLDHCNIVRLR 79
Query: 460 GCCLET-----EVPL-LVYEFIPNGTLFQ---YIHDQNEDFPITWEMRLRIAIEVSGALS 510
                +     EV L LV +++P  T+++   +     +  P+ + ++L +  ++  +L+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLA 136
Query: 511 YLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           Y+HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  P
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAP 191
Query: 570 EY-FRSSQFTDKSDVYSFGVVLAELLTGE 597
           E  F ++ +T   DV+S G VLAELL G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++P G +F ++           E   R  A ++     Y
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 142
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL PE 
Sbjct: 143 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEYLAPEI 195
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 15/165 (9%)
Query: 443 EMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI 501
           E  IL Q+  H +++ L+     +    LV++ +  G LF Y+    E   ++ +    I
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSI 205
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
              +  A+S+LH+     I HRD+K  NILLDD  + ++SDFG   S  ++      ++ 
Sbjct: 206 MRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGF--SCHLEPGEKLRELC 260
Query: 562 GTFGYLDPEYFRSSQ------FTDKSDVYSFGVVLAELLTGEKPI 600
           GT GYL PE  + S       +  + D+++ GV+L  LL G  P 
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 114/208 (54%), Gaps = 24/208 (11%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFIN-EMVILSQINHRNVVKLL 459
            +++G G  G VY+  L D G++VA+KK   + + K   F N E+ I+ +++H N+V+L 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQGKA--FKNRELQIMRKLDHCNIVRLR 79
Query: 460 GCCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAY 137
Query: 512 LHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           +HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPE 192
Query: 571 Y-FRSSQFTDKSDVYSFGVVLAELLTGE 597
             F ++ +T   DV+S G VLAELL G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E+ P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+++D +   KV+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 114/208 (54%), Gaps = 24/208 (11%)
Query: 402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFIN-EMVILSQINHRNVVKLL 459
            +++G G  G VY+  L D G++VA+KK   + + K   F N E+ I+ +++H N+V+L 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQGKA--FKNRELQIMRKLDHCNIVRLR 79
Query: 460 GCCLET-----EVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                +     EV L LV +++P     + ++     +  P+ + ++L +  ++  +L+Y
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYM-YQLFRSLAY 137
Query: 512 LHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           +HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++     +  Y  PE
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPE 192
Query: 571 Y-FRSSQFTDKSDVYSFGVVLAELLTGE 597
             F ++ +T   DV+S G VLAELL G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGK-------IVAVKKSKVIDESKVEEFINEMVILSQ 449
           D F   + LG G  G V   ML   K       +  + K KV+   ++E  +NE  IL  
Sbjct: 34  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++P G +F ++           E   R  A ++   
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FXEPHARFYAAQIVLT 146
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 147 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 199
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV-----IDESKVEEF----INEMVI 446
           +N+    ILG+G    V + +  P  K  AVK   V         +V+E     + E+ I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 447 LSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           L +++ H N+++L           LV++ +  G LF Y+ ++           +R  +EV
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
             AL  L+      I HRD+K  NILLDD    K++DFG   S  +D      +V GT  
Sbjct: 137 ICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLREVCGTPS 188
Query: 566 YLDPEYFRSSQ------FTDKSDVYSFGVVLAELLTGEKP 599
           YL PE    S       +  + D++S GV++  LL G  P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F   + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++P G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F   + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++P G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F   + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 42  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++P G +F ++           E   R  A ++   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 154
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 207
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F   + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++P G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEE-----FINEMVILSQIN 451
           + +N+  +LG+G  G V K    D         KVI+++  +       + E+ +L +++
Sbjct: 22  ERYNIVCMLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N++KL     ++    +V E    G LF  I  +      +     RI  +V   ++Y
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITY 136
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           +H      I HRD+K  NILL+ K +    K+ DFG S       T M  ++ GT  Y+ 
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-GTAYYIA 191
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           PE  R + + +K DV+S GV+L  LL+G  P
Sbjct: 192 PEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F   + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 42  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++P G +F ++           E   R  A ++   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 154
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 207
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F   + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 62  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++P G +F ++           E   R  A ++   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 174
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 227
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E+ P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+++D +   KV+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F   + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 42  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++P G +F ++           E   R  A ++   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 154
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 207
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E+ P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+++D +   KV+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 15/238 (6%)
Query: 377 TEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVY----KGMLPDGKIVAVKKSKVI 432
           T  T+ K     +++  + TD FN   +LG+G  G V     KG      +  +KK  VI
Sbjct: 1   TTNTVSKFDNNGNRDRMKLTD-FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI 59
Query: 433 DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDF 491
            +  VE  + E  +L+       +  L  C +T   L  V E++  G L  +I       
Sbjct: 60  QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-- 117
Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 551
                  +  A E++  L +L S     I +RD+K  N++LD +   K++DFG  +    
Sbjct: 118 -FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173
Query: 552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
           D    T    GT  Y+ PE      +    D ++FGV+L E+L G+ P  F   +ED+
Sbjct: 174 DGV-TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--FEGEDEDE 228

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGK-------IVAVKKSKVIDESKVEEFINEMVILSQ 449
           D F   + LG G  G V   ML   K       +  + K KV+   ++E  +NE  IL  
Sbjct: 34  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++P G +F ++           E   R  A ++   
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 146
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 147 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 199
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 12/215 (5%)
Query: 405 LGQGGQGTVYKGMLPD-GKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGC 461
           +G+G  GTV+K    +  +IVA+K+ ++ D  E      + E+ +L ++ H+N+V+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
               +   LV+EF  +  L +Y    N D  +  E+      ++   L + HS     + 
Sbjct: 70  LHSDKKLTLVFEFC-DQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTDK 580
           HRD+K  N+L++     K+++FG +R+  +     + +V  T  Y  P+  F +  ++  
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV-VTLWYRPPDVLFGAKLYSTS 182
Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
            D++S G + AEL    +P+ F   + D  L   F
Sbjct: 183 IDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIF 216

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV-----IDESKVEEF----INEMVI 446
           +N+    ILG+G    V + +  P  K  AVK   V         +V+E     + E+ I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 447 LSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           L +++ H N+++L           LV++ +  G LF Y+ ++           +R  +EV
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
             AL  L+      I HRD+K  NILLDD    K++DFG   S  +D       V GT  
Sbjct: 137 ICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLRSVCGTPS 188
Query: 566 YLDPEYFRSSQ------FTDKSDVYSFGVVLAELLTGEKP 599
           YL PE    S       +  + D++S GV++  LL G  P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 131/291 (45%), Gaps = 44/291 (15%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN------ 442
           KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E  N      
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 443 EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRL 499
           E+V+L +++     V++LL      +  +L+ E + P   LF +I ++     +  E+  
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGA---LQEELAR 117
Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTT 558
               +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S A+ +  + T
Sbjct: 118 SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT 171
Query: 559 QVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF 617
              GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D+ +    +F
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRGQVF 226
Query: 618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
             +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 227 FRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 259

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F   + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 42  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E+ P G +F ++           E   R  A ++   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 154
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+++D +   KV+DFG ++ +       T  + GT  YL 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLA 207
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 394 RATDNFNLNRILGQGGQGTVYKGMLPD------GKIVAVKKSKVIDESKVEEFINEMVIL 447
           R TD++ L   LG+G    V + +          KI+  KK    D  K+E    E  I 
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE---REARIC 84
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ------YIHDQNEDFPITWEMRLRI 501
             + H N+V+L     E     LV++ +  G LF+      Y  + +    I        
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH------- 137
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTT 558
             ++  +++++H      I HRD+K  N+LL  K +    K++DFG +  +  +Q     
Sbjct: 138 --QILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ-QAWF 191
Query: 559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
              GT GYL PE  R   +    D+++ GV+L  LL G  P
Sbjct: 192 GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 11/218 (5%)
Query: 394 RATDNFNLNRILGQGGQGTVYKGMLPDGKIV----AVKKSKVIDESKVEEFINEMVILSQ 449
           R    +   R LG+GG    Y+    D K V     V KS ++   + E+   E+ I   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           +++ +VV   G   + +   +V E     +L + +H + +      E R  +   + G +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAV-TEPEARYFMRQTIQG-V 155
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            YLH+   I   HRD+K  N+ L+D    K+ DFG +  +  D     T + GT  Y+ P
Sbjct: 156 QYLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAP 211
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           E       + + D++S G +L  LL G+ P   + L+E
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 249

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLXGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 29/237 (12%)
Query: 397 DNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F+  ++LG+G  G V        G+  A+K   K  +I + +V   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +  L       +    V E+   G LF ++  +     +  E R R    E+  AL Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEY 120
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   +   +RDIK  N++LD     K++DFG  +    D   M T   GT  YL PE 
Sbjct: 121 LHSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEV 176
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
              + +    D +  GVV+ E++ G  P                 +    ERLFE++
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP----------------FYNQDHERLFELI 217

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLAGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E+ P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+++D +   +V+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F   R LG G  G V   ML      G   A+K   K KV+   ++E  +NE  I   
Sbjct: 42  DQFERIRTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E+ P G +F ++           E   R  A ++   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 154
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   KV+DFG ++ +       T  + GT  YL 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLA 207
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             + KL     +     +V E+ P G +F ++           E   R  A ++     Y
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEY 157
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+++D +   KV+DFG ++ +       T  + GT  YL PE 
Sbjct: 158 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 210
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E+ P G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+++D +   +V+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 54/238 (22%)
Query: 399 FNLNRILGQGGQGTVYKGM-LPDGKIVAVKK--SKVIDESKVEEFINEMVILSQIN-HRN 454
           + L + LG+G  G V+K +    G++VAVKK      + +  +    E++IL++++ H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 455 VVKLLGCCL---ETEVPLLVYEFIPN-------GTLFQYIHDQNEDFPITWEMRLRIAIE 504
           +V LL       + +V  LV++++           + + +H Q             +  +
Sbjct: 71  IVNLLNVLRADNDRDV-YLVFDYMETDLHAVIRANILEPVHKQ------------YVVYQ 117
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV------------- 551
           +   + YLHS     + HRD+K +NILL+ +   KV+DFG SRS                
Sbjct: 118 LIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 552 --------DQTHMTTQVHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLAELLTGEKPI 600
                   DQ  +T  V  T  Y  PE    S+++T   D++S G +L E+L G KPI
Sbjct: 175 ENTENFDDDQPILTDYV-ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 29/237 (12%)
Query: 397 DNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F+  ++LG+G  G V        G+  A+K   K  +I + +V   + E  +L    H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +  L       +    V E+   G LF ++  +     +  E R R    E+  AL Y
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEY 123
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   +   +RDIK  N++LD     K++DFG  +    D   M T   GT  YL PE 
Sbjct: 124 LHSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEV 179
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
              + +    D +  GVV+ E++ G  P                 +    ERLFE++
Sbjct: 180 LEDNDYGRAVDWWGLGVVMYEMMCGRLP----------------FYNQDHERLFELI 220

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 109/238 (45%), Gaps = 16/238 (6%)
Query: 381 IEKTKLFTSK--ELERATDNFNLNRILGQGGQGTVYKGMLPDG-KIVAVK---KSKVIDE 434
           +E  K FTSK  ++    ++F + +++G+G  G V    L +  K+ A+K   K +++  
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115
Query: 435 SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPIT 494
           ++   F  E  +L   + + +  L     +     LV ++   G L   +    +  P  
Sbjct: 116 AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE- 174
Query: 495 WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 554
            EM      E+  A+  +H    +   HRDIK  NIL+D     +++DFG+   +  D T
Sbjct: 175 -EMARFYLAEMVIAIDSVHQLHYV---HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230
Query: 555 HMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
             ++   GT  Y+ PE  ++      ++  + D +S GV + E+L GE P    +L E
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 44/291 (15%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN------ 442
           KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E  N      
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 443 EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRL 499
           E+V+L +++     V++LL      +  +L+ E   P   LF +I ++     +  E+  
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELAR 118
Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTT 558
               +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S A+ +  + T
Sbjct: 119 SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT 172
Query: 559 QVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF 617
              GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D+ +    +F
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRGQVF 227
Query: 618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
             +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 228 FRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 260

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 29/237 (12%)
Query: 397 DNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F+  ++LG+G  G V        G+  A+K   K  +I + +V   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +  L       +    V E+   G LF ++  +     +  E R R    E+  AL Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEY 120
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   +   +RDIK  N++LD     K++DFG  +    D   M T   GT  YL PE 
Sbjct: 121 LHSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEV 176
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
              + +    D +  GVV+ E++ G  P                 +    ERLFE++
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP----------------FYNQDHERLFELI 217

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 19/218 (8%)
Query: 390 KELERATDNFNLNRILGQGG-QGTVYKGMLPDGKIVAVK----KSKVIDESKVEEFINEM 444
           K+ E     F     LG G     V       GK+ AVK    K+    ES +E   NE+
Sbjct: 15  KQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIE---NEI 71
Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
            +L +I H N+V L           LV + +  G LF  I ++   F    +    I  +
Sbjct: 72  AVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKG--FYTEKDASTLIR-Q 128
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
           V  A+ YLH    + I HRD+K  N+L    D++ +  +SDFG S+ M      M+T   
Sbjct: 129 VLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTAC- 183
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           GT GY+ PE      ++   D +S GV+   LL G  P
Sbjct: 184 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             + KL     +     +V E+ P G +F ++           E   R  A ++     Y
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 157
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+++D +   KV+DFG ++ +       T  + GT  YL PE 
Sbjct: 158 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 210
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             + KL     +     +V E+ P G +F ++           E   R  A ++     Y
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 157
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+++D +   KV+DFG ++ +       T  + GT  YL PE 
Sbjct: 158 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 210
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 22/233 (9%)
Query: 383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFIN 442
           +T +F  +E +   +   +  ++G+G  G VY G       + +   +  +E +++ F  
Sbjct: 20  QTSIFL-QEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKR 78
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E++   Q  H NVV  +G C+      ++       TL+  + D      +      +IA
Sbjct: 79  EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVN--KTRQIA 136
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-----HMT 557
            E+   + YLH+     I H+D+KS N+  D+  +  ++DFG      V Q       + 
Sbjct: 137 QEIVKGMGYLHAKG---ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLR 192
Query: 558 TQVHGTFGYLDPEYFRSSQ---------FTDKSDVYSFGVVLAELLTGEKPIR 601
            Q +G   +L PE  R            F+  SDV++ G +  EL   E P +
Sbjct: 193 IQ-NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 405 LGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFI--NEMVILSQINHRNVVKLLGC 461
           +G+G  G V+K    D G+IVA+KK    ++  V + I   E+ +L Q+ H N+V LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
                   LV+E+  +  L +    Q     +   +   I  +   A+++ H    I   
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHNCI--- 124
Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-SSQFTDK 580
           HRD+K  NIL+      K+ DFG +R +     +   +V  T  Y  PE     +Q+   
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELLVGDTQYGPP 183
Query: 581 SDVYSFGVVLAELLTG 596
            DV++ G V AELL+G
Sbjct: 184 VDVWAIGCVFAELLSG 199

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 62  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLT 174
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 227
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 44/291 (15%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN------ 442
           KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E  N      
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 443 EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRL 499
           E+V+L +++     V++LL      +  +L+ E   P   LF +I ++     +  E+  
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELAR 117
Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTT 558
               +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S A+ +  + T
Sbjct: 118 SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT 171
Query: 559 QVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF 617
              GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D+ +    +F
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRGQVF 226
Query: 618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
             +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 227 FRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 259

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 28  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 140
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D++   +V+DFG ++ +       T  + GT  YL 
Sbjct: 141 FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 193
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 394 RATDNFNLNRILGQGGQGTVYKG--MLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQ 449
           RA   +     +G+G  G V+K   +   G+ VA+K+ +V   +E      I E+ +L  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 450 IN---HRNVVKLLGCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR 500
           +    H NVV+L   C       ET++  LV+E + +  L  Y+ D+  +  +  E    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHV-DQDLTTYL-DKVPEPGVPTETIKD 124
Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
           +  ++   L +LHS     + HRD+K  NIL+    + K++DFG +R  +       T V
Sbjct: 125 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSV 179
Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             T  Y  PE    S +    D++S G + AE+    KP+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 394 RATDNFNLNRILGQGGQGTVYKG--MLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQ 449
           RA   +     +G+G  G V+K   +   G+ VA+K+ +V   +E      I E+ +L  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 450 IN---HRNVVKLLGCCL----ETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI 501
           +    H NVV+L   C     + E  L LV+E + +  L  Y+ D+  +  +  E    +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDM 125
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             ++   L +LHS     + HRD+K  NIL+    + K++DFG +R  +       T V 
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVV 180
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            T  Y  PE    S +    D++S G + AE+    KP+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVK---KSKVIDESKVEEFINEMVILSQINHR 453
           ++ L   LG G  G V  G     G  VAVK   + K+     V +   E+  L    H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRIAIEVSGALSY 511
           +++KL           +V E++  G LF YI  H + E+     E R R+  ++  A+ Y
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EAR-RLFQQILSAVDY 126
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            H    +   HRD+K  N+LLD    AK++DFG S  M+ D   + T   G+  Y  PE 
Sbjct: 127 CHRHMVV---HRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEV 181
Query: 572 FRSSQFTD-KSDVYSFGVVLAELLTGEKP 599
                +   + D++S GV+L  LL G  P
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 44/291 (15%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN------ 442
           KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E  N      
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 443 EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRL 499
           E+V+L +++     V++LL      +  +L+ E   P   LF +I ++     +  E+  
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELAR 118
Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTT 558
               +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S A+ +  + T
Sbjct: 119 SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT 172
Query: 559 QVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF 617
              GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D+ +    +F
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRGQVF 227
Query: 618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
             +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 228 FRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 260

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FAEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 36  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 92
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLT 148
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 149 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 201
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 11/218 (5%)
Query: 394 RATDNFNLNRILGQGGQGTVYKGMLPDGKIV----AVKKSKVIDESKVEEFINEMVILSQ 449
           R    +   R LG+GG    Y+    D K V     V KS ++   + E+   E+ I   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           +++ +VV   G   + +   +V E     +L + +H + +      E R  +   + G +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAV-TEPEARYFMRQTIQG-V 155
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            YLH+   I   HRD+K  N+ L+D    K+ DFG +  +  D       + GT  Y+ P
Sbjct: 156 QYLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAP 211
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           E       + + D++S G +L  LL G+ P   + L+E
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 249

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 10/195 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCC 462
           +G+G  G VYK     G+  A+KK ++   DE      I E+ IL ++ H N+VKL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
              +  +LV+E +      + + D  E    +   +    +++   ++Y H      + H
Sbjct: 70  HTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCHDRR---VLH 123
Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-SSQFTDKS 581
           RD+K  N+L++ +   K++DFG +R+  +     T +V  T  Y  P+    S +++   
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV-VTLWYRAPDVLMGSKKYSTTI 182
Query: 582 DVYSFGVVLAELLTG 596
           D++S G + AE++ G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 10/195 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCC 462
           +G+G  G VYK     G+  A+KK ++   DE      I E+ IL ++ H N+VKL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
              +  +LV+E +      + + D  E    +   +    +++   ++Y H      + H
Sbjct: 70  HTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCHDRR---VLH 123
Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-SSQFTDKS 581
           RD+K  N+L++ +   K++DFG +R+  +     T +V  T  Y  P+    S +++   
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV-VTLWYRAPDVLMGSKKYSTTI 182
Query: 582 DVYSFGVVLAELLTG 596
           D++S G + AE++ G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 394 RATDNFNLNRILGQGGQGTVYKG--MLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQ 449
           RA   +     +G+G  G V+K   +   G+ VA+K+ +V   +E      I E+ +L  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 450 IN---HRNVVKLLGCCL----ETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI 501
           +    H NVV+L   C     + E  L LV+E + +  L  Y+ D+  +  +  E    +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDM 125
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
             ++   L +LHS     + HRD+K  NIL+    + K++DFG +R  +       T V 
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVV 180
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            T  Y  PE    S +    D++S G + AE+    KP+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 79/324 (24%), Positives = 139/324 (42%), Gaps = 44/324 (13%)
Query: 363 KRNGGLLL------QQELASTEGTIEKTKLFTS---KELERATDNFNLNRILGQGGQGTV 413
           KRN GL +      Q + +ST      +K   S   +  E   D+      LG+G  G V
Sbjct: 8   KRNPGLKIPKEAFEQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELGRGAYGVV 67
Query: 414 YK-GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV-----VKLLGCCLETEV 467
            K   +P G+I+AVK+ +    S+ ++    +++   I+ R V     V   G       
Sbjct: 68  EKMRHVPSGQIMAVKRIRATVNSQEQK---RLLMDLDISMRTVDCPFTVTFYGALFREGD 124
Query: 468 PLLVYEFIPNG--TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDI 525
             +  E +       ++ + D+ +  P   ++  +IA+ +  AL +LHS  S+   HRD+
Sbjct: 125 VWICMELMDTSLDKFYKQVIDKGQTIP--EDILGKIAVSIVKALEHLHSKLSV--IHRDV 180
Query: 526 KSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY----FRSSQFTDKS 581
           K +N+L++   + K+ DFG S  + VD    T    G   Y+ PE          ++ KS
Sbjct: 181 KPSNVLINALGQVKMCDFGISGYL-VDSVAKTIDA-GCKPYMAPERINPELNQKGYSVKS 238
Query: 582 DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEI 641
           D++S G+ + EL      +RF           Y  +    ++L ++++    +       
Sbjct: 239 DIWSLGITMIELAI----LRF----------PYDSWGTPFQQLKQVVEEPSPQLPADKFS 284
Query: 642 ITFAKVAKRCLNLNGKKRPTMREV 665
             F     +CL  N K+RPT  E+
Sbjct: 285 AEFVDFTSQCLKKNSKERPTYPEL 308

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 130/290 (44%), Gaps = 44/290 (15%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN------ 442
           KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E  N      
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 443 EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRL 499
           E+V+L +++     V++LL      +  +L+ E   P   LF +I ++     +  E+  
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELAR 118
Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTT 558
               +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S A+ +  + T
Sbjct: 119 SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT 172
Query: 559 QVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF 617
              GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D+ +    +F
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRGQVF 227
Query: 618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
             +          RV  E           + + CL L    RPT  E+ +
Sbjct: 228 FRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQN 259

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 11/218 (5%)
Query: 394 RATDNFNLNRILGQGGQGTVYKGMLPDGKIV----AVKKSKVIDESKVEEFINEMVILSQ 449
           R    +   R LG+GG    Y+    D K V     V KS ++   + E+   E+ I   
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           +++ +VV   G   + +   +V E     +L + +H + +      E R  +   + G +
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAV-TEPEARYFMRQTIQG-V 139
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            YLH+   I   HRD+K  N+ L+D    K+ DFG +  +  D       + GT  Y+ P
Sbjct: 140 QYLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAP 195
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           E       + + D++S G +L  LL G+ P   + L+E
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 233

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 42  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 154
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 207
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 44/291 (15%)
Query: 390 KELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN------ 442
           KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E  N      
Sbjct: 24  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 83
Query: 443 EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRL 499
           E+V+L +++     V++LL      +  +L+ E   P   LF +I ++     +  E+  
Sbjct: 84  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELAR 140
Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTT 558
               +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S A+ +  + T
Sbjct: 141 SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT 194
Query: 559 QVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF 617
              GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D+ +    +F
Sbjct: 195 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRGQVF 249
Query: 618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
             +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 250 FRQ----------RVSXEC--------QHLIRWCLALRPSDRPTFEEIQNH 282

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 62  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 174
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGATWTLCGTPEYLA 227
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 11/218 (5%)
Query: 394 RATDNFNLNRILGQGGQGTVYKGMLPDGKIV----AVKKSKVIDESKVEEFINEMVILSQ 449
           R    +   R LG+GG    Y+    D K V     V KS ++   + E+   E+ I   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           +++ +VV   G   + +   +V E     +L + +H + +      E R  +   + G +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAV-TEPEARYFMRQTIQG-V 155
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            YLH+   I   HRD+K  N+ L+D    K+ DFG +  +  D       + GT  Y+ P
Sbjct: 156 QYLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTPNYIAP 211
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           E       + + D++S G +L  LL G+ P   + L+E
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 249

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVY-KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   + LG G  G V     +  G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +VKL     +     +V E++  G +F ++           E   R  A ++     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL PE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEI 209
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             S  +    D ++ GV++ E+  G  P 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 106/228 (46%), Gaps = 31/228 (13%)
Query: 396 TDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           +D + L + +G G  G     ++ D    ++VAVK   + + IDE+   E IN       
Sbjct: 17  SDRYELVKDIGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENVKREIINH----RS 70
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVS 506
           + H N+V+     L      +V E+   G LF+ I +    +ED     E R      +S
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLIS 125
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           G +SY H   ++ + HRD+K  N LLD     R K+ DFG S+S  +     +T   GT 
Sbjct: 126 G-VSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTP 179
Query: 565 GYLDPEYFRSSQFTDK-SDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
            Y+ PE     ++  K +DV+S GV L  +L G  P  F   EE K+ 
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNF 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 396 TDNFNLNRILGQGGQGTVYKGMLPDGKIV----AVK---KSKVIDESKVEEFINEMVILS 448
           +D +   R+LG+G  G V   +L   KI     AVK   K +V  ++  E  + E+ +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           Q++H N+ KL     +     LV E    G LF  I  +     +      RI  +V   
Sbjct: 82  QLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSG 138
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFG 565
           ++Y H      I HRD+K  N+LL+ K +    ++ DFG S     + +       GT  
Sbjct: 139 ITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXKDKIGTAY 193
Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           Y+ PE    + + +K DV+S GV+L  LL+G  P
Sbjct: 194 YIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 109/228 (47%), Gaps = 31/228 (13%)
Query: 396 TDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           +D + L + +G G  G     ++ D    ++VAVK   + + IDE+   E IN       
Sbjct: 18  SDRYELVKDIGAGNFGVAR--LMRDKQANELVAVKYIERGEKIDENVKREIINH----RS 71
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVS 506
           + H N+V+     L      +V E+   G LF+ I +    +ED     E R      +S
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLIS 126
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           G +SY H+   + + HRD+K  N LLD     R K++DFG S++ +V  +   + V GT 
Sbjct: 127 G-VSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA-SVLHSQPKSAV-GTP 180
Query: 565 GYLDPEYFRSSQFTDK-SDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
            Y+ PE     ++  K +DV+S GV L  +L G  P  F   EE K+ 
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNF 226

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 178
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 95/195 (48%), Gaps = 10/195 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCC 462
           +G+G  G VYK     G+  A+KK ++   DE      I E+ IL ++ H N+VKL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
              +  +LV+E +      + + D  E    +   +    +++   ++Y H      + H
Sbjct: 70  HTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCHDRR---VLH 123
Query: 523 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-SSQFTDKS 581
           RD+K  N+L++ +   K++DFG +R+  +     T ++  T  Y  P+    S +++   
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI-VTLWYRAPDVLMGSKKYSTTI 182
Query: 582 DVYSFGVVLAELLTG 596
           D++S G + AE++ G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 29/237 (12%)
Query: 397 DNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F+  ++LG+G  G V        G+  A+K   K  +I + +V   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +  L       +    V E+   G LF ++  +     +  E R R    E+  AL Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEY 120
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   +   +RDIK  N++LD     K++DFG  +    D   M     GT  YL PE 
Sbjct: 121 LHSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC-GTPEYLAPEV 176
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
              + +    D +  GVV+ E++ G  P                 +    ERLFE++
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP----------------FYNQDHERLFELI 217

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ ++  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 405 LGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKL----- 458
           LG GG G V+  +  D  K VA+KK  + D   V+  + E+ I+ +++H N+VK+     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 459 ---------LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
                    +G   E     +V E++        + +  E  P+  E       ++   L
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLLEEHARLFMYQLLRGL 133
Query: 510 SYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHG--TFGY 566
            Y+HSA    + HRD+K  N+ ++ +    K+ DFG +R M    +H      G  T  Y
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 567 LDPEYFRS-SQFTDKSDVYSFGVVLAELLTGE 597
             P    S + +T   D+++ G + AE+LTG+
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 29/237 (12%)
Query: 397 DNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F+  ++LG+G  G V        G+  A+K   K  +I + +V   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +  L       +    V E+   G LF ++  +     +  E R R    E+  AL Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEY 120
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   +   +RDIK  N++LD     K++DFG  +    D   M     GT  YL PE 
Sbjct: 121 LHSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEYLAPEV 176
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
              + +    D +  GVV+ E++ G  P                 +    ERLFE++
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP----------------FYNQDHERLFELI 217

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 29/237 (12%)
Query: 397 DNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F+  ++LG+G  G V        G+  A+K   K  +I + +V   + E  +L    H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +  L       +    V E+   G LF ++  +     +  E R R    E+  AL Y
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEY 125
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   +   +RDIK  N++LD     K++DFG  +    D   M     GT  YL PE 
Sbjct: 126 LHSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEYLAPEV 181
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
              + +    D +  GVV+ E++ G  P                 +    ERLFE++
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLP----------------FYNQDHERLFELI 222

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSK----VIDESKVEEFINEMVILSQIN 451
           D + +   +G G  G V        G+ VA+KK      V+  +K    + E+ IL    
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAK--RTLRELKILKHFK 112
Query: 452 HRNVVKLLGCCLETEVP------LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           H N++ +    L   VP      + V   +    L Q IH      P+T E       ++
Sbjct: 113 HDNIIAIKDI-LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQ---PLTLEHVRYFLYQL 168
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHG 562
              L Y+HSA  I   HRD+K +N+L+++    K+ DFG +R +     +  +  T+   
Sbjct: 169 LRGLKYMHSAQVI---HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 563 TFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLT 595
           T  Y  PE   S  ++T   D++S G +  E+L 
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQI 123
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 178
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQI 123
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 178
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 29/237 (12%)
Query: 397 DNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F+  ++LG+G  G V        G+  A+K   K  +I + +V   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALSY 511
             +  L       +    V E+   G LF ++  +     +  E R R    E+  AL Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEY 120
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS   +   +RDIK  N++LD     K++DFG  +    D   M     GT  YL PE 
Sbjct: 121 LHSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEYLAPEV 176
Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
              + +    D +  GVV+ E++ G  P                 +    ERLFE++
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP----------------FYNQDHERLFELI 217

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 13/225 (5%)
Query: 382 EKTKLFTSKELERATDN-FNLNRILGQGGQGTV-YKGMLPDGKIVA---VKKSKVIDESK 436
           E+ ++  +K   R T N F   ++LG+G  G V        G+  A   +KK  ++ + +
Sbjct: 132 EEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE 191
Query: 437 VEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWE 496
           V   + E  +L    H  +  L       +    V E+   G LF ++  +     +  E
Sbjct: 192 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSE 247
Query: 497 MRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 555
            R R    E+  AL YLHS  ++   +RD+K  N++LD     K++DFG  +    D   
Sbjct: 248 DRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305
Query: 556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           M T   GT  YL PE    + +    D +  GVV+ E++ G  P 
Sbjct: 306 MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+++D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 44/283 (15%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN------EMVILSQI 450
            + +  +LG GG G+VY G+ + D   VA+K  +    S   E  N      E+V+L ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 451 N--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           +     V++LL      +  +L+ E   P   LF +I ++     +  E+      +V  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLE 121
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
           A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S A+ +  + T   GT  Y
Sbjct: 122 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYTDFDGTRVY 175
Query: 567 LDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
             PE+ R  ++  +S  V+S G++L +++ G+ P      E D+ +    +F  +     
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIGGQVFFRQ----- 225
Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
                RV  E           + + CL L    RPT  E+ + 
Sbjct: 226 -----RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 255

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 112/255 (43%), Gaps = 32/255 (12%)
Query: 394 RATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQIN 451
           R   +F   + LG+GG G V++     D    A+K+ ++ + E   E+ + E+  L+++ 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITW-------EMR-----L 499
           H  +V+     LE      +    P   L+  +    ++    W       E R     L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT- 558
            I ++++ A+ +LHS     + HRD+K +NI        KV DFG   +M  D+   T  
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 559 -----------QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT--GEKPIRFTTL 605
                      QV GT  Y+ PE    + ++ K D++S G++L ELL     +  R  TL
Sbjct: 179 TPMPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTL 237
Query: 606 EEDKSLAAYFLFAMK 620
            + ++L    LF  K
Sbjct: 238 TDVRNLKFPPLFTQK 252

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 13/225 (5%)
Query: 382 EKTKLFTSKELERATDN-FNLNRILGQGGQGTV-YKGMLPDGKIVAVK---KSKVIDESK 436
           E+ ++  +K   R T N F   ++LG+G  G V        G+  A+K   K  ++ + +
Sbjct: 135 EEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE 194
Query: 437 VEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWE 496
           V   + E  +L    H  +  L       +    V E+   G LF ++  +     +  E
Sbjct: 195 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSE 250
Query: 497 MRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 555
            R R    E+  AL YLHS  ++   +RD+K  N++LD     K++DFG  +    D   
Sbjct: 251 DRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 308
Query: 556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           M T   GT  YL PE    + +    D +  GVV+ E++ G  P 
Sbjct: 309 MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 44/289 (15%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN------E 443
           E E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E  N      E
Sbjct: 1   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 60
Query: 444 MVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRLR 500
           +V+L +++     V++LL      +  +L+ E   P   LF +I    E   +  E+   
Sbjct: 61  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARS 117
Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQ 559
              +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S A+ +  + T 
Sbjct: 118 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYTD 171
Query: 560 VHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA 618
             GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D+ +    +F 
Sbjct: 172 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRGQVFF 226
Query: 619 MKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS 667
            +          RV  E           + + CL L    RPT  E+ +
Sbjct: 227 RQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQN 257

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 178
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 178
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 178
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSK----VIDESKVEEFINEMVILSQIN 451
           D + +   +G G  G V        G+ VA+KK      V+  +K    + E+ IL    
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAK--RTLRELKILKHFK 111
Query: 452 HRNVVKLLGCCLETEVP------LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           H N++ +    L   VP      + V   +    L Q IH      P+T E       ++
Sbjct: 112 HDNIIAIKDI-LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQ---PLTLEHVRYFLYQL 167
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHG 562
              L Y+HSA  I   HRD+K +N+L+++    K+ DFG +R +     +  +  T+   
Sbjct: 168 LRGLKYMHSAQVI---HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 563 TFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLT 595
           T  Y  PE   S  ++T   D++S G +  E+L 
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 18/239 (7%)
Query: 381 IEKTKLFTS--KELERATDNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK---KSKVIDE 434
           +E  K FT   KE++   ++F + +++G+G  G V    M    +I A+K   K +++  
Sbjct: 72  LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 131
Query: 435 SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPIT 494
           ++   F  E  +L   + + +  L     +     LV ++   G L   +    +  P  
Sbjct: 132 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLP-- 189
Query: 495 WEMRLRIAI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 553
            E   R  I E+  A+  +H    +   HRDIK  N+LLD     +++DFG+   M  D 
Sbjct: 190 -EDMARFYIGEMVLAIDSIHQLHYV---HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG 245
Query: 554 THMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           T  ++   GT  Y+ PE  ++      ++  + D +S GV + E+L GE P    +L E
Sbjct: 246 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 304

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 108/243 (44%), Gaps = 27/243 (11%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVI--DESKVEEFINEMVILSQIN 451
           AT  +     +G G  GTVYK   P  G  VA+K  +V   +E      + E+ +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 452 ---HRNVVKLLGCCL----ETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
              H NVV+L+  C     + E+ + LV+E + +  L  Y+ D+     +  E    +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR----SMAVDQTHMTTQ 559
           +    L +LH+     I HRD+K  NIL+      K++DFG +R     MA+D       
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALD------P 170
Query: 560 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM 619
           V  T  Y  PE    S +    D++S G + AE+    KP+     E D+    + L  +
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGL 229
Query: 620 KEE 622
             E
Sbjct: 230 PPE 232

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 122
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 177
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 122
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 177
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 178
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 16/222 (7%)
Query: 390 KELERATDNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK---KSKVIDESKVEEFINEMV 445
           KE+    D+F + +++G+G    V    M   G++ A+K   K  ++   +V  F  E  
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           +L   + R + +L     +     LV E+   G L   +    E  P   EM      E+
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA--EMARFYLAEI 171
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
             A+  +H    +   HRDIK  NILLD     +++DFG+   +  D T  +    GT  
Sbjct: 172 VMAIDSVHRLGYV---HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 566 YLDPEYFRS-------SQFTDKSDVYSFGVVLAELLTGEKPI 600
           YL PE  ++         +  + D ++ GV   E+  G+ P 
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVK---KSKVIDESKVEEFINEMVILSQINHR 453
           ++ L   LG G  G V  G     G  VAVK   + K+     V +   E+  L    H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYI--HDQNEDFPITWEMRLRIAIEVSGALSY 511
           +++KL           +V E++  G LF YI  H + E+     E R R+  ++  A+ Y
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EAR-RLFQQILSAVDY 126
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
            H    +   HRD+K  N+LLD    AK++DFG S  M+ D   +     G+  Y  PE 
Sbjct: 127 CHRHMVV---HRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRDSC-GSPNYAAPEV 181
Query: 572 FRSSQFTD-KSDVYSFGVVLAELLTGEKP 599
                +   + D++S GV+L  LL G  P
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVE-EFINEMVILSQINHR 453
           + +F L  +LG+G  G V      P G+IVA+KK +  D+       + E+ IL    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 454 NVVKLLGC----CLETEVPLLVYEFIPNGTLF-----QYIHDQNEDFPITWEMRLRIAIE 504
           N++ +         E    + + + +    L      Q + D +  + I   +R      
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR------ 123
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVH 561
              A+  LH +  I   HRD+K +N+L++     KV DFG +R +   A D +  T Q  
Sbjct: 124 ---AVKVLHGSNVI---HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 562 GTFGYLDPEYFR-------SSQFTDKSDVYSFGVVLAELLTGEKPI 600
           G   Y+   ++R       S++++   DV+S G +LAEL    +PI
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 178
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 18/239 (7%)
Query: 381 IEKTKLFTS--KELERATDNFNLNRILGQGGQGTV-YKGMLPDGKIVAVK---KSKVIDE 434
           +E  K FT   KE++   ++F + +++G+G  G V    M    +I A+K   K +++  
Sbjct: 56  LEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKR 115
Query: 435 SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPIT 494
           ++   F  E  +L   + + +  L     +     LV ++   G L   +    +  P  
Sbjct: 116 AETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLP-- 173
Query: 495 WEMRLRIAI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 553
            E   R  I E+  A+  +H    +   HRDIK  N+LLD     +++DFG+   M  D 
Sbjct: 174 -EDMARFYIGEMVLAIDSIHQLHYV---HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG 229
Query: 554 THMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           T  ++   GT  Y+ PE  ++      ++  + D +S GV + E+L GE P    +L E
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 16/219 (7%)
Query: 405 LGQGGQGTVYKGM--LPDGKIVAVKKSKVIDESKVE-EFINEMVILSQINHRNVVKLLGC 461
           LG+G   TVYKG   L D  +VA+K+ ++  E       I E+ +L  + H N+V L   
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
               +   LV+E++ +  L QY+ D      I          ++   L+Y H      + 
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VL 122
Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-SSQFTDK 580
           HRD+K  N+L++++   K++DFG +R+ ++       +V  T  Y  P+    S+ ++ +
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV-VTLWYRPPDILLGSTDYSTQ 181
Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM 619
            D++  G +  E+ TG      +T+EE      +F+F +
Sbjct: 182 IDMWGVGCIFYEMATGRPLFPGSTVEEQ----LHFIFRI 216

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 396 TDNFNLNRILGQGGQGTVY----KGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN 451
           +D F +   LG+G    VY    KG      +  +KK+  +D+  V     E+ +L +++
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVR---TEIGVLLRLS 106
Query: 452 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSGAL 509
           H N++KL     ET   + LV E +  G LF  I ++        E     A+ ++  A+
Sbjct: 107 HPNIIKL-KEIFETPTEISLVLELVTGGELFDRIVEKG----YYSERDAADAVKQILEAV 161
Query: 510 SYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
           +YLH      I HRD+K  N+L          K++DFG S+   V+   +   V GT GY
Sbjct: 162 AYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK--IVEHQVLMKTVCGTPGY 216
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
             PE  R   +  + D++S G++   LL G +P
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 178
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDES--KVEEFINEMVILSQINHRNVVKLLGCC 462
           L +   G ++KG    G  + VK  KV D S  K  +F  E   L   +H NV+ +LG C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 463 LETEV--PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
                  P L+  ++P G+L+  +H +  +F +     ++ A++++  +++LH+   + I
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHTLEPL-I 134
Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF---GYLDPEYF-RSSQ 576
               + S ++++D+   A++S         +     + Q  G      ++ PE   +  +
Sbjct: 135 PRHALNSRSVMIDEDMTARIS---------MADVKFSFQSPGRMYAPAWVAPEALQKKPE 185
Query: 577 FTDK--SDVYSFGVVLAELLTGEKP 599
            T++  +D++SF V+L EL+T E P
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVP 210

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT  YL 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           P    S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 178
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
           E+   E+ IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEE 115
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQ 553
                 ++   + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D 
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDF 170
Query: 554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
            +    + GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 396 TDNFNLNRILGQG--GQGTVYKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQI 450
           +D ++  + +G G  G   + +  L   ++VAVK   +   IDE+   E IN       +
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAIDENVQREIINH----RSL 73
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVSG 507
            H N+V+     L      ++ E+   G L++ I +    +ED     E R      +SG
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED-----EARFFFQQLLSG 128
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
            +SY HS   + I HRD+K  N LLD     R K+ DFG S+S  +     +T   GT  
Sbjct: 129 -VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPA 182
Query: 566 YLDPEYFRSSQFTDK-SDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
           Y+ PE     ++  K +DV+S GV L  +L G  P  F   EE +
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP--FEDPEEPR 225

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 44/283 (15%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN------EMVILSQI 450
            + +  +LG GG G+VY G+ + D   VA+K  +    S   E  N      E+V+L ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 451 N--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           +     V++LL      +  +L+ E   P   LF +I ++     +  E+      +V  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLE 121
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
           A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S A+ +  + T   GT  Y
Sbjct: 122 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYTDFDGTRVY 175
Query: 567 LDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
             PE+ R  ++  +S  V+S G++L +++ G+ P      E D+ +    +F  +     
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRGQVFFRQ----- 225
Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
                RV  E           + + CL L    RPT  E+ + 
Sbjct: 226 -----RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 255

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   +  +L  G  VAVKK      +++  +    E+V+L  +NH+N++ LL
Sbjct: 30  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q IH + +   +++     +  ++   + +LH
Sbjct: 88  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-----LLYQMLCGIKHLH 141
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+ + +   M T    T  Y  PE   
Sbjct: 142 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTN--FMMTPYVVTRYYRAPEVIL 196
Query: 574 SSQFTDKSDVYSFGVVLAELLTG 596
              + +  D++S G ++ EL+ G
Sbjct: 197 GMGYKENVDIWSVGCIMGELVKG 219

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 19/239 (7%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVI--DESKVEEFINEMVILSQIN 451
           AT  +     +G G  GTVYK   P  G  VA+K  +V   +E      + E+ +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 452 ---HRNVVKLLGCCL----ETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
              H NVV+L+  C     + E+ + LV+E + +  L  Y+ D+     +  E    +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +    L +LH+     I HRD+K  NIL+      K++DFG +R  +         V  T
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV--T 174
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE 622
             Y  PE    S +    D++S G + AE+    KP+     E D+    + L  +  E
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLPPE 232

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 398 NFNLNRILGQGGQGTVYKG-MLPDGKIVAVK--KSKVIDESKVEEFIN-EMVILSQINHR 453
           N+ + + LG+G  G V        G+ VA+K    KV+ +S ++  I  E+  L  + H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +++KL       +  ++V E+  N  LF YI  +++   ++ +   R   ++  A+ Y H
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDK---MSEQEARRFFQQIISAVEYCH 129
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
                 I HRD+K  N+LLD+    K++DFG S  M  D   + T   G+  Y  PE   
Sbjct: 130 RHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVIS 184
Query: 574 SSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
              +   + DV+S GV+L  +L    P       +D+S+   F
Sbjct: 185 GKLYAGPEVDVWSCGVILYVMLCRRLPF------DDESIPVLF 221

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 398 NFNLNRILGQGGQGTVYKG-MLPDGKIVAVK--KSKVIDESKVEEFIN-EMVILSQINHR 453
           N+ + + LG+G  G V        G+ VA+K    KV+ +S ++  I  E+  L  + H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +++KL       +  ++V E+  N  LF YI  +++   ++ +   R   ++  A+ Y H
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDK---MSEQEARRFFQQIISAVEYCH 130
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
                 I HRD+K  N+LLD+    K++DFG S  M  D   + T   G+  Y  PE   
Sbjct: 131 RHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVIS 185
Query: 574 SSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
              +   + DV+S GV+L  +L    P       +D+S+   F
Sbjct: 186 GKLYAGPEVDVWSCGVILYVMLCRRLPF------DDESIPVLF 222

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 44/283 (15%)
Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN------EMVILSQI 450
            + +  +LG GG G+VY G+ + D   VA+K  +    S   E  N      E+V+L ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 451 N--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           +     V++LL      +  +L+ E   P   LF +I ++     +  E+      +V  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLE 121
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
           A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S A+ +  + T   GT  Y
Sbjct: 122 AVRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYTDFDGTRVY 175
Query: 567 LDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
             PE+ R  ++  +S  V+S G++L +++ G+ P      E D+ +    +F  +     
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRGQVFFRQ----- 225
Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
                RV  E           + + CL L    RPT  E+ + 
Sbjct: 226 -----RVSXEC--------QHLIRWCLALRPSDRPTFEEIQNH 255

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 19/239 (7%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVI--DESKVEEFINEMVILSQIN 451
           AT  +     +G G  GTVYK   P  G  VA+K  +V   +E      + E+ +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 452 ---HRNVVKLLGCCL----ETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
              H NVV+L+  C     + E+ + LV+E + +  L  Y+ D+     +  E    +  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +    L +LH+     I HRD+K  NIL+      K++DFG +R  +         V  T
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV--T 174
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE 622
             Y  PE    S +    D++S G + AE+    KP+     E D+    + L  +  E
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLPPE 232

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 36/209 (17%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 460 GCCLETEVPLLVYEFIPNGTL--FQ--YIHDQNEDFPITWEMRLRIAIEVSGALSY---- 511
                         F P  +L  FQ  YI  +  D  ++  +++ +  E    L Y    
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 512 ----LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
               LHSA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRYYR 192
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTG 596
            PE      + +  D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 404 ILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVK 457
           ILG G  G V+K      G+    KI+  +  K       EE  NE+ +++Q++H N+++
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK-----DKEEVKNEISVMNQLDHANLIQ 150
Query: 458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           L          +LV E++  G LF  I D  E + +T    +    ++   + ++H    
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIID--ESYNLTELDTILFMKQICEGIRHMH---Q 205
Query: 518 IPIYHRDIKSTNILL--DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
           + I H D+K  NIL    D  + K+ DFG +R     +        GT  +L PE     
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN--FGTPEFLAPEVVNYD 263
Query: 576 QFTDKSDVYSFGVVLAELLTGEKP 599
             +  +D++S GV+   LL+G  P
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 398 NFNLNRILGQGGQGTVYKG-MLPDGKIVAVK--KSKVIDESKVEEFIN-EMVILSQINHR 453
           N+ + + LG+G  G V        G+ VA+K    KV+ +S ++  I  E+  L  + H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +++KL       +  ++V E+  N  LF YI  +++   ++ +   R   ++  A+ Y H
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDK---MSEQEARRFFQQIISAVEYCH 120
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
                 I HRD+K  N+LLD+    K++DFG S  M  D   + T   G+  Y  PE   
Sbjct: 121 RHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVIS 175
Query: 574 SSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
              +   + DV+S GV+L  +L    P       +D+S+   F
Sbjct: 176 GKLYAGPEVDVWSCGVILYVMLCRRLPF------DDESIPVLF 212

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFIN-EMV 445
           E   D ++    LG G    V K      G+    K +  +++K        E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS   + I H D+K  NI+L D    K R K+ DFG +    +D  +    + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 178
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 398 NFNLNRILGQGGQGTVYKG-MLPDGKIVAVK--KSKVIDESKVEEFIN-EMVILSQINHR 453
           N+ + + LG+G  G V        G+ VA+K    KV+ +S ++  I  E+  L  + H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +++KL       +  ++V E+  N  LF YI  +++   ++ +   R   ++  A+ Y H
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDK---MSEQEARRFFQQIISAVEYCH 124
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
                 I HRD+K  N+LLD+    K++DFG S  M  D   + T   G+  Y  PE   
Sbjct: 125 RHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVIS 179
Query: 574 SSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
              +   + DV+S GV+L  +L    P       +D+S+   F
Sbjct: 180 GKLYAGPEVDVWSCGVILYVMLCRRLPF------DDESIPVLF 216

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVE-EFINEMVILSQINHR 453
           + +F L  +LG+G  G V      P G+IVA+KK +  D+       + E+ IL    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 454 NVVKLLGC----CLETEVPLLVYEFIPNGTLF-----QYIHDQNEDFPITWEMRLRIAIE 504
           N++ +         E    + + + +    L      Q + D +  + I   +R      
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR------ 123
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVH 561
              A+  LH +  I   HRD+K +N+L++     KV DFG +R +   A D +  T Q  
Sbjct: 124 ---AVKVLHGSNVI---HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 562 GTFGYLDPEYFR-------SSQFTDKSDVYSFGVVLAELLTGEKPI 600
           G   ++   ++R       S++++   DV+S G +LAEL    +PI
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIV----AVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
           LG+GG    ++    D K V     V KS ++   + E+   E+ I   + H++VV   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
              + +   +V E     +L + +H + +      E R  +   V G   YLH    I  
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKAL-TEPEARYYLRQIVLGC-QYLHRNRVI-- 139
Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRD+K  N+ L++    K+ DFG +  +  D     T + GT  Y+ PE       + +
Sbjct: 140 -HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFE 197
Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEE 607
            DV+S G ++  LL G+ P   + L+E
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 22/242 (9%)
Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEF-----INEMVILS 448
           AT  +     +G G  GTVYK   P  G  VA+K  +V +            + E+ +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 449 QIN---HRNVVKLLGCCL----ETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLR 500
           ++    H NVV+L+  C     + E+ + LV+E + +  L  Y+ D+     +  E    
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
           +  +    L +LH+     I HRD+K  NIL+      K++DFG +R  +       T V
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPV 179
Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
             T  Y  PE    S +    D++S G + AE+    KP+     E D+    + L  + 
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLP 238
Query: 621 EE 622
            E
Sbjct: 239 PE 240

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 36/209 (17%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVVAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 460 GCCLETEVPLLVYEFIPNGTL--FQ--YIHDQNEDFPITWEMRLRIAIEVSGALSY---- 511
                         F P  +L  FQ  YI  +  D  ++  +++ +  E    L Y    
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 512 ----LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
               LHSA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRYYR 192
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTG 596
            PE      + +  D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE--DFPITWEMRLRIAIEVSGAL 509
           H N+VKL     +     LV E +  G LF+ I  +    +   ++ MR     ++  A+
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-----KLVSAV 119
Query: 510 SYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
           S++H    + + HRD+K  N+L    +D    K+ DFG +R    D   + T    T  Y
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHY 175
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
             PE    + + +  D++S GV+L  +L+G+ P +      D+SL
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ----SHDRSL 216

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIV----AVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
           LG+GG    ++    D K V     V KS ++   + E+   E+ I   + H++VV   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
              + +   +V E     +L + +H + +      E R  +   V G   YLH    I  
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKAL-TEPEARYYLRQIVLGC-QYLHRNRVI-- 139
Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRD+K  N+ L++    K+ DFG +  +  D     T + GT  Y+ PE       + +
Sbjct: 140 -HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFE 197
Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEE 607
            DV+S G ++  LL G+ P   + L+E
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 123/286 (43%), Gaps = 35/286 (12%)
Query: 392 LERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           +E   D+      LG+G  G V K   +P G+I+AVK+ +    S+ ++    +++   I
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK---RLLMDLDI 58
Query: 451 NHRNV-----VKLLGCCLETEVPLLVYEFIPNG--TLFQYIHDQNEDFPITWEMRLRIAI 503
           + R V     V   G         +  E +       ++ + D+ +  P   ++  +IA+
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIP--EDILGKIAV 116
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            +  AL +LHS  S+   HRD+K +N+L++   + K+ DFG S  +  D         G 
Sbjct: 117 SIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GC 172
Query: 564 FGYLDPEY----FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM 619
             Y+ PE          ++ KSD++S G+ + EL      +RF           Y  +  
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI----LRF----------PYDSWGT 218
Query: 620 KEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             ++L ++++    +         F     +CL  N K+RPT  E+
Sbjct: 219 PFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIV----AVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
           LG+GG    ++    D K V     V KS ++   + E+   E+ I   + H++VV   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
              + +   +V E     +L + +H + +      E R  +   V G   YLH    I  
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLE-LHKRRKAL-TEPEARYYLRQIVLGC-QYLHRNRVI-- 143
Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRD+K  N+ L++    K+ DFG +  +  D     T + GT  Y+ PE       + +
Sbjct: 144 -HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFE 201
Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEE 607
            DV+S G ++  LL G+ P   + L+E
Sbjct: 202 VDVWSIGCIMYTLLVGKPPFETSCLKE 228

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   +  +L  G  VAVKK      +++  +    E+V+L  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 89
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q IH + +   +++     +  ++   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+   +   M T    T  Y  PE   
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVIL 198
Query: 574 SSQFTDKSDVYSFGVVLAELLTG 596
              +    D++S G ++ EL+ G
Sbjct: 199 GMGYAANVDIWSVGCIMGELVKG 221

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGA 508
           +N   +VKL     +     +V E++  G +F ++           E   R  A ++   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT 153
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             YLHS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT   L 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEALA 206
Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 396 TDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           +D + L + +G G  G     ++ D    ++VAVK   + + IDE+   E IN       
Sbjct: 18  SDRYELVKDIGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENVKREIINH----RS 71
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVS 506
           + H N+V+     L      +V E+   G LF+ I +    +ED     E R      +S
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLIS 126
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           G +SY H   ++ + HRD+K  N LLD     R K+  FG S+S  +     +T   GT 
Sbjct: 127 G-VSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV--GTP 180
Query: 565 GYLDPEYFRSSQFTDK-SDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
            Y+ PE     ++  K +DV+S GV L  +L G  P  F   EE K+ 
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNF 226

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 112/296 (37%), Gaps = 77/296 (26%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 12  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLVY------------------EFIP---N 477
            ++E+ IL  I H  NVV LLG C +   PL+V                   EF+P    
Sbjct: 72  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131
Query: 478 GTLFQYIHDQNEDFPITWEMRLRI------------------------------------ 501
           G  F+   D     P+  + RL                                      
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 502 -------AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 554
                  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +R +  D  
Sbjct: 192 LEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248
Query: 555 HMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEED 608
           ++          ++ PE      +T +SDV+SFGV+L E+ + G  P     ++E+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 112/296 (37%), Gaps = 77/296 (26%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 10  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 69
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLVY------------------EFIP---N 477
            ++E+ IL  I H  NVV LLG C +   PL+V                   EF+P    
Sbjct: 70  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 129
Query: 478 GTLFQYIHDQNEDFPITWEMRLRI------------------------------------ 501
           G  F+   D     P+  + RL                                      
Sbjct: 130 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 189
Query: 502 -------AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 554
                  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +R +  D  
Sbjct: 190 LEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKDPD 246
Query: 555 HMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEED 608
           ++          ++ PE      +T +SDV+SFGV+L E+ + G  P     ++E+
Sbjct: 247 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 302

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 112/296 (37%), Gaps = 77/296 (26%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLVY------------------EFIP---N 477
            ++E+ IL  I H  NVV LLG C +   PL+V                   EF+P    
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 138
Query: 478 GTLFQYIHDQNEDFPITWEMRLRI------------------------------------ 501
           G  F+   D     P+  + RL                                      
Sbjct: 139 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 198
Query: 502 -------AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 554
                  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +R +  D  
Sbjct: 199 LEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKDPD 255
Query: 555 HMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEED 608
           ++          ++ PE      +T +SDV+SFGV+L E+ + G  P     ++E+
Sbjct: 256 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 311

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 48/274 (17%)
Query: 405 LGQGGQGTVYKGML-PDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGC 461
           +G G  G V+K      G ++AVK+ +     E      ++  V+L   +   +V+  G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
            +      +  E +  GT  + +  + +  PI   +  ++ + +  AL YL     +   
Sbjct: 93  FITNTDVFIAMELM--GTCAEKLKKRMQG-PIPERILGKMTVAIVKALYYLKEKHGV--I 147
Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD-- 579
           HRD+K +NILLD++ + K+ DFG S  +  D+     +  G   Y+ PE       T   
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 580 ---KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES 636
              ++DV+S G+ L EL TG+ P +    +                  FE+L  +V++E 
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTD------------------FEVL-TKVLQEE 246
Query: 637 ----------GGDEIITFAKVAKRCLNLNGKKRP 660
                      GD    F    K CL  + +KRP
Sbjct: 247 PPLLPGHMGFSGD----FQSFVKDCLTKDHRKRP 276

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 112/296 (37%), Gaps = 77/296 (26%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKG------MLPDGKIVAVKKSKV-IDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK  K     S+   
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPLLVY------------------EFIP---N 477
            ++E+ IL  I H  NVV LLG C +   PL+V                   EF+P    
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 136
Query: 478 GTLFQYIHDQNEDFPITWEMRLRI------------------------------------ 501
           G  F+   D     P+  + RL                                      
Sbjct: 137 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 196
Query: 502 -------AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 554
                  + +V+  + +L S   I   HRD+ + NILL +K   K+ DFG +R +  D  
Sbjct: 197 LEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKDPD 253
Query: 555 HMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEED 608
           ++          ++ PE      +T +SDV+SFGV+L E+ + G  P     ++E+
Sbjct: 254 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 309

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 399 FNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           + L   LG+G    V +      G     KI+  KK    D  K+E    E  I   + H
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLE---REARICRLLKH 80
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQ------YIHDQNEDFPITWEMRLRIAIEVS 506
            N+V+L     E     L+++ +  G LF+      Y  + +    I          ++ 
Sbjct: 81  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ---------QIL 131
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGT 563
            A+ + H      + HRD+K  N+LL  K +    K++DFG +  +  +Q        GT
Sbjct: 132 EAVLHCHQMG---VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGT 187
Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            GYL PE  R   +    D+++ GV+L  LL G  P
Sbjct: 188 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 396 TDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           +D + L + +G G  G     ++ D    ++VAVK   + + IDE+   E IN       
Sbjct: 18  SDRYELVKDIGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENVKREIINH----RS 71
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVS 506
           + H N+V+     L      +V E+   G LF+ I +    +ED     E R      +S
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLIS 126
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           G +SY H   ++ + HRD+K  N LLD     R K+  FG S+S  +      T   GT 
Sbjct: 127 G-VSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV--GTP 180
Query: 565 GYLDPEYFRSSQFTDK-SDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
            Y+ PE     ++  K +DV+S GV L  +L G  P  F   EE K+ 
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNF 226

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 31/221 (14%)
Query: 394 RATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVIL 447
           R T+ + L   LG+G    V +      G      I+  KK    D  K+E    E  I 
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARIC 64
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ------YIHDQNEDFPITWEMRLRI 501
             + H N+V+L     E     L+++ +  G LF+      Y  + +    I        
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ------- 117
Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTT 558
             ++  A+ + H      + HR++K  N+LL  K +    K++DFG +  +  +Q     
Sbjct: 118 --QILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWF 171
Query: 559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
              GT GYL PE  R   +    D+++ GV+L  LL G  P
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK-GMLPDGKIVAVK--KSKVIDESKV----EEFINEMV 445
           E   D++ +   LG G    V K      GK  A K  K + +  S+     EE   E+ 
Sbjct: 8   EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 67
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL +I H N++ L          +L+ E +  G LF ++ ++     +T +   +   ++
Sbjct: 68  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQI 124
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFGASRSMAVDQTHMTTQVH 561
              + YLHS     I H D+K  NI+L DK     R K+ DFG +    ++  +    + 
Sbjct: 125 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF 179
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 225

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 48/288 (16%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQ--INHRNV 455
           +  L  I  +G  G V+K  L +   VAVK   + D+   + + +E  I S   + H N+
Sbjct: 16  SLQLLEIKARGRFGCVWKAQLMN-DFVAVKIFPLQDK---QSWQSEREIFSTPGMKHENL 71
Query: 456 VKLL-----GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           ++ +     G  LE E+  L+  F   G+L  Y+        ITW     +A  +S  LS
Sbjct: 72  LQFIAAEKRGSNLEVEL-WLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLS 126
Query: 511 YLHSAASIP----------IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
           YLH    +P          I HRD KS N+LL     A ++DFG +      +    T  
Sbjct: 127 YLHE--DVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDT-- 182
Query: 561 HGTFG---YLDPEY------FRSSQFTDKSDVYSFGVVLAELLT----GEKPIRFTTLEE 607
           HG  G   Y+ PE       F+   F  + D+Y+ G+VL EL++     + P+    L  
Sbjct: 183 HGQVGTRRYMAPEVLEGAINFQRDAFL-RIDMYAMGLVLWELVSRCKAADGPVDEYMLPF 241
Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLN 655
           ++ +  +       E L E++  + M+ +  D  +    +A+ C+ + 
Sbjct: 242 EEEIGQHPSL----EELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIE 285

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 403 RILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           +++G G  G V++  L +   VA+KK  V+ + + +    E+ I+  + H NVV L    
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKK--VLQDKRFKN--RELQIMRIVKHPNVVDLKAFF 101
Query: 463 L-----ETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
                 + EV L LV E++P        H       +   +      ++  +L+Y+HS  
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-- 159
Query: 517 SIPIYHRDIKSTNILLDDKYRA-KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY-FRS 574
            I I HRDIK  N+LLD      K+ DFG+++ +   + +++     +  Y  PE  F +
Sbjct: 160 -IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC--SRYYRAPELIFGA 216
Query: 575 SQFTDKSDVYSFGVVLAELLTGE 597
           + +T   D++S G V+AEL+ G+
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 460 GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM---RLRIAI-EVSGALSYLHSA 515
                   P    E   +  L   + D N    I  E+   R+   + ++   + +LHSA
Sbjct: 90  NVF----TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSA 145
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
               I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE     
Sbjct: 146 G---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 200
Query: 576 QFTDKSDVYSFGVVLAELL 594
            + +  D++S G ++ E++
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 460 GCCLETEVPLLVYEFIPNGTL--FQ--YIHDQNEDFPITWEMRLRIAIEVSGALSY---- 511
                         F P  +L  FQ  YI  +  D  ++  +++ +  E    L Y    
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC 137
Query: 512 ----LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
               LHSA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRYYR 192
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTG 596
            PE      + +  D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIV----AVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
           LG+GG    ++    D K V     V KS ++   + E+   E+ I   + H++VV   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
              + +   +V E     +L + +H + +      E R  +   V G   YLH    I  
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLE-LHKRRKAL-TEPEARYYLRQIVLGC-QYLHRNRVI-- 163
Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRD+K  N+ L++    K+ DFG +  +  D       + GT  Y+ PE       + +
Sbjct: 164 -HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFE 221
Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEE 607
            DV+S G ++  LL G+ P   + L+E
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKE 248

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 405 LGQGGQGTV--YKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           LG+GG   V   +G L DG   A+K+    ++   EE   E  +    NH N+++L+  C
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 463 LE----TEVPLLVYEFIPNGTLFQYIHD-QNEDFPITWEMRLRIAIEVSGALSYLHSAAS 517
           L          L+  F   GTL+  I   +++   +T +  L + + +   L  +H+   
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGY 155
Query: 518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD----QTHMTTQVHG----TFGYLDP 569
               HRD+K TNILL D+ +  + D G+     +     +  +T Q       T  Y  P
Sbjct: 156 A---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 570 EYFRSSQ---FTDKSDVYSFGVVLAELLTGEKP 599
           E F         +++DV+S G VL  ++ GE P
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 13/215 (6%)
Query: 392 LERATDN-FNLNRILGQGGQGTV-YKGMLPDGKIVA---VKKSKVIDESKVEEFINEMVI 446
           + R T N F   ++LG+G  G V        G+  A   +KK  ++ + +V   + E  +
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 62
Query: 447 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEV 505
           L    H  +  L       +    V E+   G LF ++  +     +  E R R    E+
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEI 118
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
             AL YLHS  ++   +RD+K  N++LD     K++DFG  +    D   M     GT  
Sbjct: 119 VSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC-GTPE 175
Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           YL PE    + +    D +  GVV+ E++ G  P 
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 10/158 (6%)
Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E+  L  + H +++KL          ++V E+   G LF YI ++     +T +   R  
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKR---MTEDEGRRFF 114
Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++  A+ Y H      I HRD+K  N+LLDD    K++DFG S  M  D   + T   G
Sbjct: 115 QQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSC-G 169
Query: 563 TFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKP 599
           +  Y  PE      +   + DV+S G+VL  +L G  P
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
           EE   E+ IL +I H N++ L          +L+ E +  G LF ++ ++     +T + 
Sbjct: 53  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDE 109
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFGASRSMAVDQ 553
             +   ++   + YLHS     I H D+K  NI+L DK     R K+ DFG +    ++ 
Sbjct: 110 ATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEA 164
Query: 554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
            +    + GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 218

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
           EE   E+ IL +I H N++ L          +L+ E +  G LF ++ ++     +T + 
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDE 130
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFGASRSMAVDQ 553
             +   ++   + YLHS     I H D+K  NI+L DK     R K+ DFG +    ++ 
Sbjct: 131 ATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEA 185
Query: 554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
            +    + GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 186 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 239

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIV----AVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
           LG+GG    ++    D K V     V KS ++   + E+   E+ I   + H++VV   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
              + +   +V E     +L + +H + +      E R  +   V G   YLH    I  
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLE-LHKRRKAL-TEPEARYYLRQIVLGC-QYLHRNRVI-- 161
Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRD+K  N+ L++    K+ DFG +  +  D       + GT  Y+ PE       + +
Sbjct: 162 -HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFE 219
Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEE 607
            DV+S G ++  LL G+ P   + L+E
Sbjct: 220 VDVWSIGCIMYTLLVGKPPFETSCLKE 246

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 13/213 (6%)
Query: 394 RATDN-FNLNRILGQGGQGTV-YKGMLPDGKIVA---VKKSKVIDESKVEEFINEMVILS 448
           R T N F   ++LG+G  G V        G+  A   +KK  ++ + +V   + E  +L 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSG 507
              H  +  L       +    V E+   G LF ++  +     +  E R R    E+  
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVS 119
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           AL YLHS  ++   +RD+K  N++LD     K++DFG  +    D   M     GT  YL
Sbjct: 120 ALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC-GTPEYL 176
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            PE    + +    D +  GVV+ E++ G  P 
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/313 (20%), Positives = 128/313 (40%), Gaps = 47/313 (15%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMV 445
           F  + +E       + R+L +GG   VY+   +  G+  A+K+    +E K    I E+ 
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC 77
Query: 446 ILSQIN-HRNVVKLLGCCL-------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
            + +++ H N+V+               +   L+   +  G L +++       P++ + 
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG------------- 544
            L+I  +   A+ ++H     PI HRD+K  N+LL ++   K+ DFG             
Sbjct: 138 VLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 545 -ASRSMAVDQ--THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
            A R   V++  T  TT ++ T   +D   + +    +K D+++ G +L  L   + P  
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIID--LYSNFPIGEKQDIWALGCILYLLCFRQHPF- 253
Query: 602 FTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPT 661
                ED +                I++ +        +   F  + +  L +N ++R +
Sbjct: 254 -----EDGA-------------KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLS 295
Query: 662 MREVTSELAGIKA 674
           + EV  +L  I A
Sbjct: 296 IAEVVHQLQEIAA 308

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 460 GCCLETEVPLLVYEFIPNGTL--FQ--YIHDQNEDFPITWEMRLRIAIEVSGALSY---- 511
                         F P  +L  FQ  YI  +  D  ++  +++ +  E    L Y    
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 512 ----LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
               LHSA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRYYR 192
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTG 596
            PE      + +  D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 460 GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM---RLRIAI-EVSGALSYLHSA 515
                   P    E   +  L   + D N    I  E+   R+   + ++   + +LHSA
Sbjct: 90  NVF----TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
               I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE     
Sbjct: 146 G---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 200
Query: 576 QFTDKSDVYSFGVVLAELL 594
            + +  D++S G ++ E++
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 405 LGQGGQGTVYKGMLPDGKIV----AVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
           LG+GG    ++    D K V     V KS ++   + E+   E+ I   + H++VV   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
              + +   +V E     +L + +H + +      E R  +   V G   YLH    I  
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLE-LHKRRKAL-TEPEARYYLRQIVLGC-QYLHRNRVI-- 137
Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 580
            HRD+K  N+ L++    K+ DFG +  +  D       + GT  Y+ PE       + +
Sbjct: 138 -HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFE 195
Query: 581 SDVYSFGVVLAELLTGEKPIRFTTLEE 607
            DV+S G ++  LL G+ P   + L+E
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKE 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVE-EFINEMVILSQINHR 453
           + +F L  +LG+G  G V      P G+IVA+KK +  D+       + E+ IL    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 454 NVVKLLGC----CLETEVPLLVYEFIPNGTLF-----QYIHDQNEDFPITWEMRLRIAIE 504
           N++ +         E    + + + +    L      Q + D +  + I   +R      
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR------ 123
Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVH 561
              A+  LH +  I   HRD+K +N+L++     KV DFG +R +   A D +  T Q  
Sbjct: 124 ---AVKVLHGSNVI---HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 562 G------TFGYLDPE-YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           G      T  Y  PE    S++++   DV+S G +LAEL    +PI
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 13/213 (6%)
Query: 394 RATDN-FNLNRILGQGGQGTV-YKGMLPDGKIVA---VKKSKVIDESKVEEFINEMVILS 448
           R T N F   ++LG+G  G V        G+  A   +KK  ++ + +V   + E  +L 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSG 507
              H  +  L       +    V E+   G LF ++  +     +  E R R    E+  
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVS 121
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           AL YLHS  ++   +RD+K  N++LD     K++DFG  +    D   M     GT  YL
Sbjct: 122 ALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC-GTPEYL 178
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            PE    + +    D +  GVV+ E++ G  P 
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 204 GYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 208 GYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 460 GCCLETEVPLLVYEFIPNGTL--FQ--YIHDQNEDFPITWEMRLRIAIEVSGALSY---- 511
                         F P  +L  FQ  YI  +  D  ++  +++ +  E    L Y    
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC 137
Query: 512 ----LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
               LHSA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRYYR 192
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTG 596
            PE      + +  D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESK--VEEFINEMVILSQINHRNVVKLLGC 461
           LG+G  G VYK +     + VA+K+ ++  E +      I E+ +L ++ HRN+++L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
                   L++E+  N  L +Y+ D+N D  ++  +      ++   +++ HS   +   
Sbjct: 102 IHHNHRLHLIFEYAEND-LKKYM-DKNPD--VSMRVIKSFLYQLINGVNFCHSRRCL--- 154
Query: 522 HRDIKSTNILL-----DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
           HRD+K  N+LL      +    K+ DFG +R+  +     T ++  T  Y  PE    S+
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI-ITLWYRPPEILLGSR 213
Query: 577 -FTDKSDVYSFGVVLAELL 594
            ++   D++S   + AE+L
Sbjct: 214 HYSTSVDIWSIACIWAEML 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 208 GYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + +   +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 165 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 224 GYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 204 GYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 204 GYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 149
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 209 GYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 150
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 151 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 210 GYTKSIDIWSVGCILAEMLSN-RPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 141
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 142 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 201 GYTKSIDIWSVGCILAEMLSN-RPI 224

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 208 GYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 13/207 (6%)
Query: 398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVK---KSKVIDESKVEEFINEMVILSQINHR 453
           ++ L   LG G  G V  G     G  VAVK   + K+     V +   E+  L    H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +++KL           +V E++  G LF YI        +  +   R+  ++   + Y H
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCH 133
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
                 + HRD+K  N+LLD    AK++DFG S  M+ D   +     G+  Y  PE   
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRXSC-GSPNYAAPEVIS 188
Query: 574 SSQFT-DKSDVYSFGVVLAELLTGEKP 599
              +   + D++S GV+L  LL G  P
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLP 215

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 206 GYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 152
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 153 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 212 GYTKSIDIWSVGCILAEMLSN-RPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 204 GYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 54/108 (50%), Gaps = 16/108 (14%)
Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
           L I I+++ A+ +LHS     + HRD+K +NI        KV DFG   +M  D+   T 
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 559 ------------QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELL 594
                       QV GT  Y+ PE    + ++ K D++S G++L ELL
Sbjct: 224 LTPMPAYATHXGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 204 GYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 460 GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM---RLRIAI-EVSGALSYLHSA 515
                   P    E   +  L   + D N    I  E+   R+   + ++   + +LHSA
Sbjct: 83  NVF----TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSA 138
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
               I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE     
Sbjct: 139 G---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 193
Query: 576 QFTDKSDVYSFGVVLAELL 594
            + +  D++S G ++ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 142
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 202 GYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 460 GCCLETEVPLLVYEFIPNGTL--FQ--YIHDQNEDFPITWEMRLRIAIEVSGALSY---- 511
                         F P  +L  FQ  YI  +  D  ++  +++ +  E    L Y    
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC 137
Query: 512 ----LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
               LHSA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYR 192
Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTG 596
            PE      + +  D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 460 GC-----CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
                   LE    + +   + +  L Q I  + +   +++     +  ++   + +LHS
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           A    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE    
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG 199
Query: 575 SQFTDKSDVYSFGVVLAELLTG 596
             + +  D++S G ++ E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 24/223 (10%)
Query: 394 RATDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEF-INEMVILSQIN 451
           +  D F + R+ GQG  GTV  G     G  VA+KK  VI + +     +  M  L+ ++
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK--VIQDPRFRNRELQIMQDLAVLH 77
Query: 452 HRNVVKL------LGCCLETEVPL-LVYEFIPNGTLFQ----YIHDQNEDFPITWEMRLR 500
           H N+V+L      LG     ++ L +V E++P+ TL +    Y   Q    PI  ++ L 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAVDQTHMTTQ 559
             I   G L       S+ + HRDIK  N+L+++     K+ DFG+++ ++  + ++   
Sbjct: 137 QLIRSIGCLHL----PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 560 VHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
              +  Y  PE  F +  +T   D++S G + AE++ GE   R
Sbjct: 193 C--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 396 TDNFNLNRILGQGGQGTVYKGMLPD---GKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           +D + L + +G G  G     ++ D    ++VAVK   + + I  +   E IN       
Sbjct: 18  SDRYELVKDIGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIAANVKREIINH----RS 71
Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVS 506
           + H N+V+     L      +V E+   G LF+ I +    +ED     E R      +S
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLIS 126
Query: 507 GALSYLHSAASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           G +SY H+   + + HRD+K  N LLD     R K+ DFG S+S  +     +T   GT 
Sbjct: 127 G-VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTP 180
Query: 565 GYLDPEYFRSSQFTDK-SDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
            Y+ PE     ++  K +DV+S GV L  +L G  P  F   EE K+ 
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNF 226

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 460 GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM---RLRIAI-EVSGALSYLHSA 515
                   P    E   +  L   + D N    I  E+   R+   + ++   + +LHSA
Sbjct: 90  NVF----TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSA 145
Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
               I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE     
Sbjct: 146 G---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 200
Query: 576 QFTDKSDVYSFGVVLAELL 594
            + +  D++S G ++ E++
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 142
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 202 GYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 165 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 224 GYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 33  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 460 GC-----CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
                   LE    + +   + +  L Q I  + +   +++     +  ++   + +LHS
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 145
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           A    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE    
Sbjct: 146 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG 200
Query: 575 SQFTDKSDVYSFGVVLAELLTG 596
             + +  D++S G ++ E++ G
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKG 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q I  + +   +++     +  ++   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE   
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 198
Query: 574 SSQFTDKSDVYSFGVVLAELL 594
              + +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 460 GC-----CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
                   LE    + +   + +  L Q I  + +   +++     +  ++   + +LHS
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           A    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE    
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG 199
Query: 575 SQFTDKSDVYSFGVVLAELLTG 596
             + +  D++S G ++ E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 460 GC-----CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
                   LE    + +   + +  L Q I  + +   +++     +  ++   + +LHS
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           A    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE    
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPEVVTRYYRAPEVILG 199
Query: 575 SQFTDKSDVYSFGVVLAELLTG 596
             + +  D++S G ++ E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 147 -VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 206 GYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQH----LSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 208 GYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 399 FNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVK 457
             L  +  +G  G V+K  L + + VAVK   + D +S   E+  E+  L  + H N+++
Sbjct: 26  LQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQ 82
Query: 458 LLGC---CLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
            +G        +V L L+  F   G+L  ++        ++W     IA  ++  L+YLH
Sbjct: 83  FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLH 138
Query: 514 SAASIP---------IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
               IP         I HRDIKS N+LL +   A ++DFG +      ++   T  HG  
Sbjct: 139 E--DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT--HGQV 194
Query: 565 G---YLDPEY------FRSSQFTDKSDVYSFGVVLAEL 593
           G   Y+ PE       F+   F  + D+Y+ G+VL EL
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFL-RIDMYAMGLVLWEL 231

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 206 GYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 24/201 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q I        +  E    +  ++   + +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 181
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE   
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 236
Query: 574 SSQFTDKSDVYSFGVVLAELL 594
              + +  D++S G ++ E++
Sbjct: 237 GMGYKENVDIWSVGCIMGEMV 257

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA++K S    ++  +  + E+ IL +  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE   +S+
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 208 GYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH-RN 454
           D++ L R LG+G    V++ + + + + V VK  K + ++K++    E+ IL  +    N
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR---EIKILENLRGGPN 93
Query: 455 VVKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
           ++ L     +  +  P LV+E + N T F+ ++    D+ I + M      E+  AL Y 
Sbjct: 94  IITLADIVKDPVSRTPALVFEHV-NNTDFKQLYQTLTDYDIRFYM-----YEILKALDYC 147
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRA-KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRD+K  N+++D ++R  ++ D+G +      Q +        F    PE 
Sbjct: 148 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK--GPEL 202
Query: 572 FRSSQFTDKS-DVYSFGVVLAELLTGEKPI 600
               Q  D S D++S G +LA ++  ++P 
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDES--KVEEFINEMVILSQINHRNVVKLLGCC 462
           L +   G ++KG    G  + VK  KV D S  K  +F  E   L   +H NV+ +LG C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 463 LETEV--PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPI 520
                  P L+  + P G+L+  +H +  +F +     ++ A++ +   ++LH+   + I
Sbjct: 77  QSPPAPHPTLITHWXPYGSLYNVLH-EGTNFVVDQSQAVKFALDXARGXAFLHTLEPL-I 134
Query: 521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF-RSSQFTD 579
               + S ++ +D+   A++S      S                 ++ PE   +  + T+
Sbjct: 135 PRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAP------AWVAPEALQKKPEDTN 188
Query: 580 K--SDVYSFGVVLAELLTGEKP 599
           +  +D +SF V+L EL+T E P
Sbjct: 189 RRSADXWSFAVLLWELVTREVP 210

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 24/201 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q I        +  E    +  ++   + +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 181
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE   
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 236
Query: 574 SSQFTDKSDVYSFGVVLAELL 594
              + +  D++S G ++ E++
Sbjct: 237 GMGYKENVDIWSVGCIMGEMV 257

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVK----L 458
           +G+G  G V        K  VA+KK S    ++  +  + E+ IL +  H NV+     L
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               LE    + + + +    L++ +  Q     ++ +       ++   L Y+HSA   
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQ----LSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASR--SMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+L++     K+ DFG +R      D T   T+   T  Y  PE   +S+
Sbjct: 165 -VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSK 223
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 224 GYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q I  + +   +++     +  ++   + +LH
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 137
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE   
Sbjct: 138 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 192
Query: 574 SSQFTDKSDVYSFGVVLAELL 594
              + +  D++S G ++ E++
Sbjct: 193 GMGYKENVDIWSVGCIMGEMV 213

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 17/170 (10%)
Query: 437 VEEFINEMVILSQINHRNVVKLLGCCLETEVPLL--VYEFIPNGTLFQY--IHDQNEDFP 492
           +E+   E+ IL +++H NVVKL+    +     L  V+E +  G + +   +   +ED  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-- 137
Query: 493 ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 552
              + R      + G + YLH      I HRDIK +N+L+ +    K++DFG S      
Sbjct: 138 ---QARFYFQDLIKG-IEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 553 QTHMTTQVHGTFGYLDPEYFRSSQ--FTDKS-DVYSFGVVLAELLTGEKP 599
              ++  V GT  ++ PE    ++  F+ K+ DV++ GV L   + G+ P
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q I  + +   +++     +  ++   + +LH
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 144
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE   
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 199
Query: 574 SSQFTDKSDVYSFGVVLAELL 594
              + +  D++S G ++ E++
Sbjct: 200 GMGYKENVDIWSVGCIMGEMV 220

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 34  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 460 GC-----CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
                   LE    + +   + +  L Q I  + +   +++     +  ++   + +LHS
Sbjct: 92  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 146
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           A    I HRD+K +NI++      K+ DFG +R+     + M      T  Y  PE    
Sbjct: 147 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMVPFVVTRYYRAPEVILG 201
Query: 575 SQFTDKSDVYSFGVVLAELLTG 596
             + +  D++S G ++ E++ G
Sbjct: 202 MGYKENVDIWSVGCIMGEMIKG 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q I  + +   +++     +  ++   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE   
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 198
Query: 574 SSQFTDKSDVYSFGVVLAELL 594
              + +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q I  + +   +++     +  ++   + +LH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 136
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE   
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 191
Query: 574 SSQFTDKSDVYSFGVVLAELL 594
              + +  D++S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 20/222 (9%)
Query: 397 DNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
           D+++++  LG G  G V++      G   A K      ES  E    E+  +S + H  +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN----EDFPITWEMRLRIAIEVSGALSY 511
           V L     +    +++YEF+  G LF+ + D++    ED  + + MR     +V   L +
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-MR-----QVCKGLCH 270
Query: 512 LHSAASIPIYHRDIKSTNILLDDKY--RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           +H    +   H D+K  NI+   K     K+ DFG +  +   Q+   T   GT  +  P
Sbjct: 271 MHENNYV---HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAP 325
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
           E          +D++S GV+   LL+G  P  F    +D++L
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETL 365

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q I  + +   +++     +  ++   + +LH
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 137
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE   
Sbjct: 138 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 192
Query: 574 SSQFTDKSDVYSFGVVLAELL 594
              + +  D++S G ++ E++
Sbjct: 193 GMGYKENVDIWSVGCIMGEMV 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q I  + +   +++     +  ++   + +LH
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 144
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE   
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 199
Query: 574 SSQFTDKSDVYSFGVVLAELL 594
              + +  D++S G ++ E++
Sbjct: 200 GMGYKENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q I  + +   +++     +  ++   + +LH
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 142
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE   
Sbjct: 143 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 197
Query: 574 SSQFTDKSDVYSFGVVLAELL 594
              + +  D++S G ++ E++
Sbjct: 198 GMGYKENVDIWSVGCIMGEMV 218

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 109/238 (45%), Gaps = 52/238 (21%)
Query: 397 DNFNLNRILGQGGQGTV---YKGMLPDGKIVAVKKSKVIDESKVE--EFINEMVILSQIN 451
           D + +  ++G G  G V   Y  +  + ++VA+KK   + E  ++    + E+ IL+++N
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKL--EKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF------PITW-EMRLRIAI- 503
           H +VVK+L       +P  V +F     L+  +   + DF      P+   E+ ++  + 
Sbjct: 111 HDHVVKVLDIV----IPKDVEKF---DELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY 163
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV------------ 551
            +   + Y+HSA    I HRD+K  N L++     KV DFG +R++              
Sbjct: 164 NLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 552 --DQTHMTTQVHGT------FGYLDPEYFRSSQ-------FTDKSDVYSFGVVLAELL 594
             D  ++ T  H         G++   ++R+ +       +T+  DV+S G + AELL
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H     +   T  Y  PE   +S+
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 208 GYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKI-VAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKL---- 458
           +G+G  G V        K+ VA+KK S    ++  +  + E+ IL +  H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
               +E    + + + +    L++ +  Q+    ++ +       ++   L Y+HSA   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN-- 149
Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSSQ 576
            + HRD+K +N+LL+     K+ DFG +R    D  H     +   T  Y  PE   +S+
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 577 -FTDKSDVYSFGVVLAELLTGEKPI 600
            +T   D++S G +LAE+L+  +PI
Sbjct: 209 GYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 460 GCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                     E +   LV E + +  L Q I  + +   +++     +  ++   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH 143
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           SA    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE   
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 198
Query: 574 SSQFTDKSDVYSFGVVLAELL 594
              + +  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 404 ILGQGGQGT-VYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCC 462
           +LG G +GT VY+GM  D + VAVK  +++ E          ++     H NV++     
Sbjct: 31  VLGHGAEGTIVYRGMF-DNRDVAVK--RILPECFSFADREVQLLRESDEHPNVIRYFCTE 87
Query: 463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYH 522
            + +   +  E     TL +Y+  + +DF       + +  + +  L++LH   S+ I H
Sbjct: 88  KDRQFQYIAIELC-AATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVH 141
Query: 523 RDIKSTNILL-----DDKYRAKVSDFGASRSMAVDQTHMTTQ--VHGTFGYLDPEYFRS- 574
           RD+K  NIL+       K +A +SDFG  + +AV +   + +  V GT G++ PE     
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 575 --SQFTDKSDVYSFGVVL 590
                T   D++S G V 
Sbjct: 202 CKENPTYTVDIFSAGCVF 219

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 20/222 (9%)
Query: 397 DNFNLNRILGQGGQGTVYK-GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
           D+++++  LG G  G V++      G   A K      ES  E    E+  +S + H  +
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN----EDFPITWEMRLRIAIEVSGALSY 511
           V L     +    +++YEF+  G LF+ + D++    ED  + + MR     +V   L +
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-MR-----QVCKGLCH 164
Query: 512 LHSAASIPIYHRDIKSTNILLDDKY--RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           +H    +   H D+K  NI+   K     K+ DFG +  +   Q+   T   GT  +  P
Sbjct: 165 MHENNYV---HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAP 219
Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
           E          +D++S GV+   LL+G  P  F    +D++L
Sbjct: 220 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETL 259

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 402 NRILGQGGQGTVYKGM-LPDGKIVAVKK-SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           + +LG+G    V   + L +GK  AVK   K    S+   F     +     ++N+++L+
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 460 GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIP 519
               +     LV+E +  G++  +I  Q            R+  +V+ AL +LH+     
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKH---FNEREASRVVRDVAAALDFLHTKG--- 131
Query: 520 IYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQT-------HMTTQVHGTFGYLDP 569
           I HRD+K  NIL +   +    K+ DF     M ++ +        +TT   G+  Y+ P
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC-GSAEYMAP 190
Query: 570 E----YFRSSQFTDKS-DVYSFGVVLAELLTGEKPI 600
           E    +   + F DK  D++S GVVL  +L+G  P 
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 116/286 (40%), Gaps = 35/286 (12%)
Query: 392 LERATDNFNLNRILGQGGQGTVYKG-MLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
            E   D+      LG+G  G V K   +P G+I AVK+ +    S+ ++    ++    I
Sbjct: 29  FEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQK---RLLXDLDI 85
Query: 451 NHRNV-----VKLLGCCLETEVPLLVYEFIPNG--TLFQYIHDQNEDFPITWEMRLRIAI 503
           + R V     V   G         +  E         ++ + D+ +  P   ++  +IA+
Sbjct: 86  SXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIP--EDILGKIAV 143
Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            +  AL +LHS  S+   HRD+K +N+L++   + K  DFG S  +  D         G 
Sbjct: 144 SIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA--GC 199
Query: 564 FGYLDPEY----FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM 619
             Y  PE          ++ KSD++S G+   EL      +RF           Y  +  
Sbjct: 200 KPYXAPERINPELNQKGYSVKSDIWSLGITXIELAI----LRF----------PYDSWGT 245
Query: 620 KEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             ++L ++++    +         F     +CL  N K+RPT  E+
Sbjct: 246 PFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/290 (22%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 401 LNRILGQGGQGTVYKGMLPD-GKIVAVKKS----KVIDESK---VEEFINEMVILSQINH 452
            N  LGQG    ++KG+  + G    + ++    KV+D++     E F     ++S+++H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
           +++V   G C+  +  +LV EF+  G+L  Y+        I W  +L +A +++ A+ +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFL 129
Query: 513 HSAASIPIYHRDIKSTNILL---DDKYRA-----KVSDFGASRSMAVDQTHMTTQVHGTF 564
                I   H ++ + NILL   +D+        K+SD G S ++          +    
Sbjct: 130 EENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-----LQERI 181
Query: 565 GYLDPEYFRSSQFTD-KSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEE 622
            ++ PE   + +  +  +D +SFG  L E+ + G+KP+  + L+  + L  Y      E+
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--SALDSQRKLQFY------ED 233
Query: 623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
           R           +    +    A +   C++     RP+ R +  +L  +
Sbjct: 234 R----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 22/200 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 37  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 460 GC-----CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
                   LE    + +   + +  L Q I  + +   +++     +  ++   + +LHS
Sbjct: 95  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 149
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           A    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE    
Sbjct: 150 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG 204
Query: 575 SQFTDKSDVYSFGVVLAELL 594
             + +  D++S G ++ E++
Sbjct: 205 MGYKENVDLWSVGCIMGEMV 224

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 96/234 (41%), Gaps = 29/234 (12%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKK--SKVIDESKV---------EE 439
           EL      + + R +  G  G V  G+  +G  VA+K+  + V D   V         + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 440 FINEMVILSQINHRNVVKLLGCCLETEVP-----LLVYEFIPNGTLFQYIHDQNEDFPIT 494
            + E+ +L+  +H N++ L    +  E P      LV E +    L Q IHDQ     I+
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQR--IVIS 132
Query: 495 WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD-- 552
            +        +   L  LH A    + HRD+   NILL D     + DF  +R    D  
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 553 QTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPIRFTTL 605
           +TH  T       Y  PE     + FT   D++S G V+AE+   +   R +T 
Sbjct: 190 KTHYVTHR----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 96/234 (41%), Gaps = 29/234 (12%)
Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKK--SKVIDESKV---------EE 439
           EL      + + R +  G  G V  G+  +G  VA+K+  + V D   V         + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 440 FINEMVILSQINHRNVVKLLGCCLETEVP-----LLVYEFIPNGTLFQYIHDQNEDFPIT 494
            + E+ +L+  +H N++ L    +  E P      LV E +    L Q IHDQ     I+
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQR--IVIS 132
Query: 495 WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD-- 552
            +        +   L  LH A    + HRD+   NILL D     + DF  +R    D  
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 553 QTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPIRFTTL 605
           +TH  T       Y  PE     + FT   D++S G V+AE+   +   R +T 
Sbjct: 190 KTHYVTHR----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 11/197 (5%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V   +    G+ VA+KK     +S++  +    E+++L  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
                     Y+F       Q    +      + E    +  ++   L Y+HSA  +   
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVV--- 148
Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDK 580
           HRD+K  N+ +++    K+ DFG +R    + T        T  Y  PE   S   +   
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILSWMHYNQT 204
Query: 581 SDVYSFGVVLAELLTGE 597
            D++S G ++AE+LTG+
Sbjct: 205 VDIWSVGCIMAEMLTGK 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 11/197 (5%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V   +    G+ VA+KK     +S++  +    E+++L  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
                     Y+F       Q    +      + E    +  ++   L Y+HSA    + 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VV 166
Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDK 580
           HRD+K  N+ +++    K+ DFG +R    + T        T  Y  PE   S   +   
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILSWMHYNQT 222
Query: 581 SDVYSFGVVLAELLTGE 597
            D++S G ++AE+LTG+
Sbjct: 223 VDIWSVGCIMAEMLTGK 239

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 405 LGQGGQGTVYKG-MLPDGKIVAVKKSKVIDESKVEEF----INEMVILSQINHRNVVKLL 459
           +GQG  G V+K      G+ VA+KK  V+ E++ E F    + E+ IL  + H NVV L+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 460 GCCLETEVPL--------LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
             C     P         LV++F  +  L   + +    F ++ E++  + + ++G L Y
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEHD-LAGLLSNVLVKFTLS-EIKRVMQMLLNG-LYY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLD 568
           +H      I HRD+K+ N+L+      K++DFG +R+ ++ +     +      T  Y  
Sbjct: 141 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 569 PEYFRSSQ-FTDKSDVYSFGVVLAELLT 595
           PE     + +    D++  G ++AE+ T
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 115/281 (40%), Gaps = 34/281 (12%)
Query: 397 DNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           D + L  ++G+G    V +      G     KIV V K         E+   E  I   +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTL-FQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            H ++V+LL       +  +V+EF+    L F+ +   +  F  +  +      ++  AL
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGY 566
            Y H      I HRD+K  N+LL  K  +   K+ DFG +  +         +V GT  +
Sbjct: 144 RYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV-GTPHF 199
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
           + PE  +   +    DV+  GV+L  LL+G  P                 F   +ERLFE
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLP-----------------FYGTKERLFE 242
Query: 627 -ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMRE 664
            I+  +  M       I   AK + +R L L+  +R T+ E
Sbjct: 243 GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYE 283

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 22/200 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 26  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 460 GC-----CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
                   LE    + +   + +  L Q I  + +   +++     +  ++   + +LHS
Sbjct: 84  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 138
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           A    I HRD+K +NI++      K+ DFG +R+     + M T    T  Y  PE    
Sbjct: 139 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG 193
Query: 575 SQFTDKSDVYSFGVVLAELL 594
             + +  D++S G ++ E++
Sbjct: 194 MGYKENVDLWSVGCIMGEMV 213

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L+V E +  G LF  I D+  D   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 105 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 160
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K      K++DFG ++        +TT  +  + Y+ PE     ++    D++S
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 218
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 219 LGVIMYILLCGYPP 232

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 405 LGQGGQGTVYKG-MLPDGKIVAVKKSKVIDESKVEEF----INEMVILSQINHRNVVKLL 459
           +GQG  G V+K      G+ VA+KK  V+ E++ E F    + E+ IL  + H NVV L+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 460 GCCLETEVPL--------LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
             C     P         LV++F  +  L   + +    F ++ E++  + + ++G L Y
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS-EIKRVMQMLLNG-LYY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLD 568
           +H      I HRD+K+ N+L+      K++DFG +R+ ++ +     +      T  Y  
Sbjct: 141 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 569 PEYFRSSQ-FTDKSDVYSFGVVLAELLT 595
           PE     + +    D++  G ++AE+ T
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 405 LGQGGQGTVYKG-MLPDGKIVAVKKSKVIDESKVEEF----INEMVILSQINHRNVVKLL 459
           +GQG  G V+K      G+ VA+KK  V+ E++ E F    + E+ IL  + H NVV L+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 460 GCCLETEVPL--------LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
             C     P         LV++F  +  L   + +    F ++ E++  + + ++G L Y
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLS-EIKRVMQMLLNG-LYY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLD 568
           +H      I HRD+K+ N+L+      K++DFG +R+ ++ +     +      T  Y  
Sbjct: 141 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 569 PEYFRSSQ-FTDKSDVYSFGVVLAELLT 595
           PE     + +    D++  G ++AE+ T
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 405 LGQGGQGTVYKG-MLPDGKIVAVKKSKVIDESKVEEF----INEMVILSQINHRNVVKLL 459
           +GQG  G V+K      G+ VA+KK  V+ E++ E F    + E+ IL  + H NVV L+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 460 GCCLETEVPL--------LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
             C     P         LV++F  +  L   + +    F ++ E++  + + ++G L Y
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLS-EIKRVMQMLLNG-LYY 139
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLD 568
           +H      I HRD+K+ N+L+      K++DFG +R+ ++ +     +      T  Y  
Sbjct: 140 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 569 PEYFRSSQ-FTDKSDVYSFGVVLAELLT 595
           PE     + +    D++  G ++AE+ T
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDES-KVEEFINEMV 445
           ++  D +++   LG G    V K      G+    K +  ++S+        EE   E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL Q+ H NV+ L          +L+ E +  G LF ++  +     ++ E       ++
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFGASRSMAVDQTHMTTQVH 561
              ++YLH+     I H D+K  NI+L DK       K+ DFG +    ++       + 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF 179
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDES-KVEEFINEMV 445
           ++  D +++   LG G    V K      G+    K +  ++S+        EE   E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL Q+ H NV+ L          +L+ E +  G LF ++  +     ++ E       ++
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFGASRSMAVDQTHMTTQVH 561
              ++YLH+     I H D+K  NI+L DK       K+ DFG +    ++       + 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF 179
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L+V E +  G LF  I D+  D   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 97  LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 152
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K      K++DFG ++        +TT  +  + Y+ PE     ++    D++S
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 210
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 211 LGVIMYILLCGYPP 224

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L+V E +  G LF  I D+  D   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 141 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 196
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K      K++DFG ++        +TT  +  + Y+ PE     ++    D++S
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 254
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 255 LGVIMYILLCGYPP 268

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L+V E +  G LF  I D+  D   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 190
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K      K++DFG ++        +TT  +  + Y+ PE     ++    D++S
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 248
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 249 LGVIMYILLCGYPP 262

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L+V E +  G LF  I D+  D   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 89  LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 144
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K      K++DFG ++        +TT  +  + Y+ PE     ++    D++S
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 202
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 203 LGVIMYILLCGYPP 216

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDG------KIVAVKKSKVIDESKVEEFIN---EMVIL 447
           D + +++ LG G  G V              KI++ +K  +    + +  +N   E+ IL
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            ++NH  ++K+     + E   +V E +  G LF  +         T ++      ++  
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---YQMLL 124
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTF 564
           A+ YLH      I HRD+K  N+LL  +      K++DFG S+ +   +T +   + GT 
Sbjct: 125 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 179
Query: 565 GYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKP 599
            YL PE   S   + +    D +S GV+L   L+G  P
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDG------KIVAVKKSKVIDESKVEEFIN---EMVIL 447
           D + +++ LG G  G V              KI++ +K  +    + +  +N   E+ IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            ++NH  ++K+     + E   +V E +  G LF  +         T ++      ++  
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---YQMLL 125
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTF 564
           A+ YLH      I HRD+K  N+LL  +      K++DFG S+ +   +T +   + GT 
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 180
Query: 565 GYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKP 599
            YL PE   S   + +    D +S GV+L   L+G  P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L+V E +  G LF  I D+  D   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 91  LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 146
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K      K++DFG ++        +TT  +  + Y+ PE     ++    D++S
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 204
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 205 LGVIMYILLCGYPP 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDES-KVEEFINEMV 445
           ++  D +++   LG G    V K      G+    K +  ++S+        EE   E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL Q+ H NV+ L          +L+ E +  G LF ++  +     ++ E       ++
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFGASRSMAVDQTHMTTQVH 561
              ++YLH+     I H D+K  NI+L DK       K+ DFG +    ++       + 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF 179
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L+V E +  G LF  I D+  D   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 90  LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 145
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K      K++DFG ++        +TT  +  + Y+ PE     ++    D++S
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 203
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 204 LGVIMYILLCGYPP 217

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/290 (22%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 401 LNRILGQGGQGTVYKGMLPD-GKIVAVKKS----KVIDESK---VEEFINEMVILSQINH 452
            N  LGQG    ++KG+  + G    + ++    KV+D++     E F     ++S+++H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
           +++V   G C   +  +LV EF+  G+L  Y+        I W  +L +A +++ A+ +L
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFL 129
Query: 513 HSAASIPIYHRDIKSTNILL---DDKYRA-----KVSDFGASRSMAVDQTHMTTQVHGTF 564
                I   H ++ + NILL   +D+        K+SD G S ++          +    
Sbjct: 130 EENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-----LQERI 181
Query: 565 GYLDPEYFRSSQFTD-KSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEE 622
            ++ PE   + +  +  +D +SFG  L E+ + G+KP+  + L+  + L  Y      E+
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--SALDSQRKLQFY------ED 233
Query: 623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
           R           +    +    A +   C++     RP+ R +  +L  +
Sbjct: 234 R----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 61/119 (51%), Gaps = 5/119 (4%)
Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 551
           PIT E  +  + +V+  + +L S   I   HRD+ + NILL +    K+ DFG +R +  
Sbjct: 195 PITMEDLISYSFQVARGMEFLSSRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 552 DQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEED 608
           +  ++          ++ PE      ++ KSDV+S+GV+L E+ + G  P     ++ED
Sbjct: 252 NPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDED 310

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDES-KVEEFINEMV 445
           ++  D +++   LG G    V K      G+    K +  ++S+        EE   E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL Q+ H NV+ L          +L+ E +  G LF ++  +     ++ E       ++
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFGASRSMAVDQTHMTTQVH 561
              ++YLH+     I H D+K  NI+L DK       K+ DFG +    ++       + 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF 179
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDES-KVEEFINEMV 445
           ++  D +++   LG G    V K      G+    K +  ++S+        EE   E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL Q+ H NV+ L          +L+ E +  G LF ++  +     ++ E       ++
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFGASRSMAVDQTHMTTQVH 561
              ++YLH+     I H D+K  NI+L DK       K+ DFG +    ++       + 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF 179
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L+V E +  G LF  I D+  D   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 96  LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 151
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K      K++DFG ++        +TT  +  + Y+ PE     ++    D++S
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 209
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 210 LGVIMYILLCGYPP 223

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDG------KIVAVKKSKVIDESKVEEFIN---EMVIL 447
           D + +++ LG G  G V              KI++ +K  +    + +  +N   E+ IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            ++NH  ++K+     + E   +V E +  G LF  +         T ++      ++  
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---YQMLL 125
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTF 564
           A+ YLH      I HRD+K  N+LL  +      K++DFG S+ +   +T +   + GT 
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 180
Query: 565 GYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKP 599
            YL PE   S   + +    D +S GV+L   L+G  P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI--NHRNVVKLLGCC 462
           +G+G  G V++G+   G+ VAVK     DE   + +  E  I + +   H N++  +   
Sbjct: 16  VGKGRYGEVWRGLW-HGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 463 LETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH----- 513
           + +        L+  +  +G+L+ ++  Q     +   + LR+A+  +  L++LH     
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT----LEPHLALRLAVSAACGLAHLHVEIFG 127
Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS--RSMAVDQTHMTTQVH-GTFGYLDPE 570
           +     I HRD KS N+L+    +  ++D G +   S   D   +      GT  Y+ PE
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 571 YFRSSQFTD------KSDVYSFGVVLAEL 593
                  TD       +D+++FG+VL E+
Sbjct: 188 VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDG------KIVAVKKSKVIDESKVEEFIN---EMVIL 447
           D + +++ LG G  G V              KI++ +K  +    + +  +N   E+ IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            ++NH  ++K+     + E   +V E +  G LF  +         T ++      ++  
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---YQMLL 125
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTF 564
           A+ YLH      I HRD+K  N+LL  +      K++DFG S+ +   +T +   + GT 
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 180
Query: 565 GYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKP 599
            YL PE   S   + +    D +S GV+L   L+G  P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L+V E +  G LF  I D+  D   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 95  LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 150
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K      K++DFG ++        +TT  +  + Y+ PE     ++    D++S
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 208
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 209 LGVIMYILLCGYPP 222

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDG------KIVAVKKSKVIDESKVEEFIN---EMVIL 447
           D + +++ LG G  G V              KI++ +K  +    + +  +N   E+ IL
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            ++NH  ++K+     + E   +V E +  G LF  +         T ++      ++  
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---YQMLL 131
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTF 564
           A+ YLH      I HRD+K  N+LL  +      K++DFG S+ +   +T +   + GT 
Sbjct: 132 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 186
Query: 565 GYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKP 599
            YL PE   S   + +    D +S GV+L   L+G  P
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L+V E +  G LF  I D+  D   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 91  LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 146
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K      K++DFG ++        +TT  +  + Y+ PE     ++    D++S
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 204
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 205 LGVIMYILLCGYPP 218

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAV---KKSKVIDESKVEEFINEMVILSQINHRNVVKLLGC 461
           +G+G   TVYKG+  +  +       + + + +S+ + F  E   L  + H N+V+    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 462 CLET----EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGALSYLHSAA 516
              T    +  +LV E   +GTL  Y+    + F +     LR    ++   L +LH+  
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYL----KRFKVXKIKVLRSWCRQILKGLQFLHTRT 149
Query: 517 SIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
             PI HRD+K  NI +       K+ D G +    + +      V GT  +  PE +   
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFXAPEXY-EE 204
Query: 576 QFTDKSDVYSFGVVLAELLTGEKP 599
           ++ +  DVY+FG    E  T E P
Sbjct: 205 KYDESVDVYAFGXCXLEXATSEYP 228

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 13/175 (7%)
Query: 430 KVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE 489
           KVID+SK +      ++L    H N++ L     + +   LV E +  G L   I  Q  
Sbjct: 58  KVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK- 116
Query: 490 DFPITWEMRLRIAIEVSG-ALSYLHSAASIPIYHRDIKSTNILLDDKYR----AKVSDFG 544
                 E      +   G  + YLHS     + HRD+K +NIL  D+       ++ DFG
Sbjct: 117 ---FFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFG 170
Query: 545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            ++ +  +   + T  + T  ++ PE  +   + +  D++S G++L  +L G  P
Sbjct: 171 FAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDES---KVEEFINEMVILSQINHRN 454
           +  L   +G+G  G V++G    G+ VAVK     DE    +  E  N +++     H N
Sbjct: 9   DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHEN 63
Query: 455 VVKLLGCCLETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           ++  +   + +        L+  +   G+L+ Y+     D        LRI + ++  L+
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC----LRIVLSIASGLA 119
Query: 511 YLH-----SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH---- 561
           +LH     +     I HRD+KS NIL+    +  ++D G    +AV  +  T Q+     
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG----LAVMHSQSTNQLDVGNN 175
Query: 562 ---GTFGYLDPEYFRSSQFTD------KSDVYSFGVVLAEL 593
              GT  Y+ PE    +   D      + D+++FG+VL E+
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDG------KIVAVKKSKVIDESKVEEFIN---EMVIL 447
           D + +++ LG G  G V              +I++ +K  +    + +  +N   E+ IL
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            ++NH  ++K+     + E   +V E +  G LF  +         T ++      ++  
Sbjct: 209 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---YQMLL 264
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTF 564
           A+ YLH      I HRD+K  N+LL  +      K++DFG S+ +   +T +   + GT 
Sbjct: 265 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 319
Query: 565 GYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKP 599
            YL PE   S   + +    D +S GV+L   L+G  P
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 108/233 (46%), Gaps = 25/233 (10%)
Query: 405 LGQGGQGTVYKGMLPDGK----IVAVKKSKV-----IDESKVEEFINEMVILSQINHRNV 455
           LG G  G V+  +  +      +  +KK KV     I++ K+ +   E+ ILS++ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 456 VKLLGCCLETEVPLLVYEFIPNGT-LFQYI--HDQNEDFPITWEMRLRIAIEVSGALSYL 512
           +K+L          LV E   +G  LF +I  H + ++   ++  R     ++  A+ YL
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR-----QLVSAVGYL 146
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
                  I HRDIK  NI++ + +  K+ DFG++  +  ++  +     GT  Y  PE  
Sbjct: 147 RLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGTIEYCAPEVL 201
Query: 573 RSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
             + +     +++S GV L  L+  E P  F  LEE    A +  + + +E +
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENP--FCELEETVEAAIHPPYLVSKELM 252

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 38/214 (17%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDES---KVEEFINEMVILSQINHRNVVKLLGC 461
           +G+G  G V++G    G+ VAVK     DE    +  E  N +++     H N++  +  
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 99
Query: 462 CLETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH---- 513
            + +        L+  +   G+L+ Y+     D        LRI + ++  L++LH    
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC----LRIVLSIASGLAHLHIEIF 155
Query: 514 -SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-------GTFG 565
            +     I HRD+KS NIL+    +  ++D G    +AV  +  T Q+        GT  
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLG----LAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 566 YLDPEYFRSSQFTD------KSDVYSFGVVLAEL 593
           Y+ PE    +   D      + D+++FG+VL E+
Sbjct: 212 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 13/175 (7%)
Query: 430 KVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE 489
           KVID+SK +      ++L    H N++ L     + +   LV E +  G L   I  Q  
Sbjct: 58  KVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK- 116
Query: 490 DFPITWEMRLRIAIEVSG-ALSYLHSAASIPIYHRDIKSTNILLDDKYR----AKVSDFG 544
                 E      +   G  + YLHS     + HRD+K +NIL  D+       ++ DFG
Sbjct: 117 ---FFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFG 170
Query: 545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            ++ +  +   + T  + T  ++ PE  +   + +  D++S G++L  +L G  P
Sbjct: 171 FAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 397 DNFNLNRILGQGGQGTVYKGMLPDG------KIVAVKKSKVIDESKVEEFIN---EMVIL 447
           D + +++ LG G  G V              +I++ +K  +    + +  +N   E+ IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            ++NH  ++K+     + E   +V E +  G LF  +         T ++      ++  
Sbjct: 195 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---YQMLL 250
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTF 564
           A+ YLH      I HRD+K  N+LL  +      K++DFG S+ +   +T +   + GT 
Sbjct: 251 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 305
Query: 565 GYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKPI 600
            YL PE   S   + +    D +S GV+L   L+G  P 
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 38/214 (17%)
Query: 405 LGQGGQGTVYKGMLPDGKIVAVKKSKVIDES---KVEEFINEMVILSQINHRNVVKLLGC 461
           +G+G  G V++G    G+ VAVK     DE    +  E  N +++     H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 462 CLETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH---- 513
            + +        L+  +   G+L+ Y+     D        LRI + ++  L++LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC----LRIVLSIASGLAHLHIEIF 126
Query: 514 -SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-------GTFG 565
            +     I HRD+KS NIL+    +  ++D G    +AV  +  T Q+        GT  
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLG----LAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 566 YLDPEYFRSSQFTD------KSDVYSFGVVLAEL 593
           Y+ PE    +   D      + D+++FG+VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 129/305 (42%), Gaps = 39/305 (12%)
Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI--NHRNVVKL 458
           L   +G+G  G V++G    G+ VAVK   +    +   +  E  I   +   H N++  
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGF 101
Query: 459 LGCCLE---TEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH- 513
           +    +   T   L LV ++  +G+LF Y++     + +T E  +++A+  +  L++LH 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHM 157
Query: 514 ----SAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVH--GTFGY 566
               +     I HRD+KS NIL+       ++D G A R  +   T      H  GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 567 LDPEYFRSS------QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
           + PE    S      +   ++D+Y+ G+V  E+    +      + ED  L  Y L    
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI---ARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 621 E--ERLFEILDARVMKES------GGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              E + +++  + ++ +        + +   AK+ + C   NG  R T   +   L+ +
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
Query: 673 KAWNG 677
               G
Sbjct: 335 SQQEG 339

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 460 GC-----CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
                   LE    + +   + +  L Q I  + +   +++     +  ++   + +LHS
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           A    I HRD+K +NI++      K+ DFG +R+     + M      T  Y  PE    
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMEPEVVTRYYRAPEVILG 199
Query: 575 SQFTDKSDVYSFGVVLAELL 594
             + +  D++S G ++ E++
Sbjct: 200 MGYKENVDIWSVGCIMGEMV 219

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 127/305 (41%), Gaps = 39/305 (12%)
Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI--NHRNVVKL 458
           L   +G+G  G V++G    G+ VAVK   +    +   +  E  I   +   H N++  
Sbjct: 8   LQESIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGF 63
Query: 459 LGCCLE---TEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH- 513
           +    +   T   L LV ++  +G+LF Y++     + +T E  +++A+  +  L++LH 
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHM 119
Query: 514 ----SAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVH--GTFGY 566
               +     I HRD+KS NIL+       ++D G A R  +   T      H  GT  Y
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 567 LDPEYFRSS------QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
           + PE    S      +   ++D+Y+ G+V  E+    +      + ED  L  Y L    
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI---ARRCSIGGIHEDYQLPYYDLVPSD 236
Query: 621 ---EERLFEILDARVM-----KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              EE    + + ++      +    + +   AK+ + C   NG  R T   +   L+ +
Sbjct: 237 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 296
Query: 673 KAWNG 677
               G
Sbjct: 297 SQQEG 301

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 127/305 (41%), Gaps = 39/305 (12%)
Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI--NHRNVVKL 458
           L   +G+G  G V++G    G+ VAVK   +    +   +  E  I   +   H N++  
Sbjct: 13  LQESIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGF 68
Query: 459 LGCCLE---TEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH- 513
           +    +   T   L LV ++  +G+LF Y++     + +T E  +++A+  +  L++LH 
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHM 124
Query: 514 ----SAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVH--GTFGY 566
               +     I HRD+KS NIL+       ++D G A R  +   T      H  GT  Y
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 567 LDPEYFRSS------QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
           + PE    S      +   ++D+Y+ G+V  E+    +      + ED  L  Y L    
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI---ARRCSIGGIHEDYQLPYYDLVPSD 241
Query: 621 ---EERLFEILDARVM-----KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              EE    + + ++      +    + +   AK+ + C   NG  R T   +   L+ +
Sbjct: 242 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 301
Query: 673 KAWNG 677
               G
Sbjct: 302 SQQEG 306

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 11/174 (6%)
Query: 430 KVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE 489
           K+ID+SK +      ++L    H N++ L     + +   +V E +  G L   I  Q  
Sbjct: 53  KIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK- 111
Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK----YRAKVSDFGA 545
            F    E    +   ++  + YLH+     + HRD+K +NIL  D+       ++ DFG 
Sbjct: 112 -FFSEREASA-VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGF 166
Query: 546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           ++ +  +   + T  + T  ++ PE      +    D++S GV+L  +LTG  P
Sbjct: 167 AKQLRAENGLLMTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 127/305 (41%), Gaps = 39/305 (12%)
Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI--NHRNVVKL 458
           L   +G+G  G V++G    G+ VAVK   +    +   +  E  I   +   H N++  
Sbjct: 33  LQESIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGF 88
Query: 459 LGCCLE---TEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH- 513
           +    +   T   L LV ++  +G+LF Y++     + +T E  +++A+  +  L++LH 
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHM 144
Query: 514 ----SAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVH--GTFGY 566
               +     I HRD+KS NIL+       ++D G A R  +   T      H  GT  Y
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 567 LDPEYFRSS------QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
           + PE    S      +   ++D+Y+ G+V  E+    +      + ED  L  Y L    
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI---ARRCSIGGIHEDYQLPYYDLVPSD 261
Query: 621 ---EERLFEILDARVM-----KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              EE    + + ++      +    + +   AK+ + C   NG  R T   +   L+ +
Sbjct: 262 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 321
Query: 673 KAWNG 677
               G
Sbjct: 322 SQQEG 326

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 19/226 (8%)
Query: 393 ERATDNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKV-EEFINEMV 445
           ++  D +++   LG G    V K      G+    K +  ++S+        EE   E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           IL Q+ H N++ L          +L+ E +  G LF ++  +     ++ E       ++
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFGASRSMAVDQTHMTTQVH 561
              ++YLH+     I H D+K  NI+L DK       K+ DFG +    ++       + 
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF 179
Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
           GT  ++ PE         ++D++S GV+   LL+G  P    T +E
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 127/305 (41%), Gaps = 39/305 (12%)
Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI--NHRNVVKL 458
           L   +G+G  G V++G    G+ VAVK   +    +   +  E  I   +   H N++  
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGF 62
Query: 459 LGCCLE---TEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH- 513
           +    +   T   L LV ++  +G+LF Y++     + +T E  +++A+  +  L++LH 
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHM 118
Query: 514 ----SAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVH--GTFGY 566
               +     I HRD+KS NIL+       ++D G A R  +   T      H  GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 567 LDPEYFRSS------QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
           + PE    S      +   ++D+Y+ G+V  E+    +      + ED  L  Y L    
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI---ARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 621 ---EERLFEILDARVM-----KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              EE    + + ++      +    + +   AK+ + C   NG  R T   +   L+ +
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
Query: 673 KAWNG 677
               G
Sbjct: 296 SQQEG 300

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 127/305 (41%), Gaps = 39/305 (12%)
Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI--NHRNVVKL 458
           L   +G+G  G V++G    G+ VAVK   +    +   +  E  I   +   H N++  
Sbjct: 10  LQESIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGF 65
Query: 459 LGCCLE---TEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH- 513
           +    +   T   L LV ++  +G+LF Y++     + +T E  +++A+  +  L++LH 
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHM 121
Query: 514 ----SAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVH--GTFGY 566
               +     I HRD+KS NIL+       ++D G A R  +   T      H  GT  Y
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 567 LDPEYFRSS------QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
           + PE    S      +   ++D+Y+ G+V  E+    +      + ED  L  Y L    
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI---ARRCSIGGIHEDYQLPYYDLVPSD 238
Query: 621 ---EERLFEILDARVM-----KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              EE    + + ++      +    + +   AK+ + C   NG  R T   +   L+ +
Sbjct: 239 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 298
Query: 673 KAWNG 677
               G
Sbjct: 299 SQQEG 303

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 61/134 (45%), Gaps = 9/134 (6%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L+V E +  G LF  I D+  D   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 135 LIVXECLDGGELFSRIQDRG-DQAFTEREASEIXKSIGEAIQYLHS---INIAHRDVKPE 190
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K      K++DFG ++        +TT  +  + Y+ PE     ++    D +S
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDXWS 248
Query: 586 FGVVLAELLTGEKP 599
            GV+   LL G  P
Sbjct: 249 LGVIXYILLCGYPP 262

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 405 LGQGGQGTV---YKGMLPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNVVKLL 459
           +G G QG V   Y  +L   + VA+KK      +++  +    E+V++  +NH+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 460 GC-----CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
                   LE    + +   + +  L Q I  + +   +++     +  ++   + +LHS
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           A    I HRD+K +NI++      K+ DFG +R+     + M      T  Y  PE    
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMEPEVVTRYYRAPEVILG 199
Query: 575 SQFTDKSDVYSFGVVLAELL 594
             + +  D++S G ++ E++
Sbjct: 200 MGYKENVDLWSVGCIMGEMV 219

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 9/134 (6%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L+V E +  G LF  I D+  D   T      I   +  A+ YLHS   I I HRD+K  
Sbjct: 89  LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 144
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K      K++DFG ++        +T   +  + Y+ PE     ++    D++S
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTEPCYTPY-YVAPEVLGPEKYDKSCDMWS 202
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 203 LGVIMYILLCGYPP 216

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 147
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R  A + T          GY+   +
Sbjct: 148 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----------GYVATRW 194
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 147
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R  A + T          GY+   +
Sbjct: 148 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----------GYVATRW 194
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 147
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R  A + T          GY+   +
Sbjct: 148 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----------GYVATRW 194
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D +++   LG G  G V++ +    G++   K       +D+  V+   NE+ I++Q++H
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHH 107
Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             ++ L     +    +L+ EF+  G LF  I    ED+ ++    +    +    L ++
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 513 HSAASIPIYHRDIKSTNILLDDKYRA--KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           H  +   I H DIK  NI+ + K  +  K+ DFG +  +  D+    T     F    PE
Sbjct: 166 HEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAA--PE 220
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
                     +D+++ GV+   LL+G  P
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 46/217 (21%)
Query: 403 RILGQGGQGTV---YKGMLPDGKIVAVKKSKVIDESKVE--EFINEMVILSQINHRNVVK 457
           R +G G  G+V   Y   L   + VAVKK     +S +       E+ +L  + H NV+ 
Sbjct: 34  RPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 458 LL-----GCCLE--TEVPL---LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           LL        +E  +EV L   L+   + N    Q + D++  F +   +R         
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLR--------- 142
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
            L Y+HSA    I HRD+K +N+ +++    ++ DFG +R    + T          GY+
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT----------GYV 189
Query: 568 DPEYFRSSQ-------FTDKSDVYSFGVVLAELLTGE 597
              ++R+ +       +    D++S G ++AELL G+
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 106/266 (39%), Gaps = 59/266 (22%)
Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESK--------VE 438
           F    L      ++L   +GQG  G V   +  + +  A++  K+++++K        VE
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAI--ENQTRAIRAIKIMNKNKIRQINPKDVE 73
Query: 439 EFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ----YIHDQ------- 487
               E+ ++ +++H N+ +L     + +   LV E    G L      +I D        
Sbjct: 74  RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133
Query: 488 ------------NE--------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIY 521
                       NE              DF    ++   I  ++  AL YLH+     I 
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---IC 190
Query: 522 HRDIKSTNILL--DDKYRAKVSDFGASRSMAV----DQTHMTTQVHGTFGYLDPEYFRSS 575
           HRDIK  N L   +  +  K+ DFG S+        +   MTT+  GT  ++ PE   ++
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTT 249
Query: 576 Q--FTDKSDVYSFGVVLAELLTGEKP 599
              +  K D +S GV+L  LL G  P
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGAVP 275

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 430 KVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE 489
           K+ID+SK +      ++L    H N++ L     + +   +V E    G L   I  Q  
Sbjct: 53  KIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK- 111
Query: 490 DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK----YRAKVSDFGA 545
            F    E    +   ++  + YLH+     + HRD+K +NIL  D+       ++ DFG 
Sbjct: 112 -FFSEREASA-VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGF 166
Query: 546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           ++ +  +   + T  + T  ++ PE      +    D++S GV+L   LTG  P
Sbjct: 167 AKQLRAENGLLXTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 46/217 (21%)
Query: 403 RILGQGGQGTV---YKGMLPDGKIVAVKKSKVIDESKVE--EFINEMVILSQINHRNVVK 457
           R +G G  G+V   Y   L   + VAVKK     +S +       E+ +L  + H NV+ 
Sbjct: 34  RPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 458 LL-----GCCLE--TEVPL---LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           LL        +E  +EV L   L+   + N    Q + D++  F +   +R         
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR--------- 142
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
            L Y+HSA    I HRD+K +N+ +++    ++ DFG +R    + T          GY+
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT----------GYV 189
Query: 568 DPEYFRSSQ-------FTDKSDVYSFGVVLAELLTGE 597
              ++R+ +       +    D++S G ++AELL G+
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT----------GYVATRW 187
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 46/217 (21%)
Query: 403 RILGQGGQGTV---YKGMLPDGKIVAVKKSKVIDESKVE--EFINEMVILSQINHRNVVK 457
           R +G G  G+V   Y   L   + VAVKK     +S +       E+ +L  + H NV+ 
Sbjct: 26  RPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 83
Query: 458 LL-----GCCLE--TEVPL---LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           LL        +E  +EV L   L+   + N    Q + D++  F +   +R         
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR--------- 134
Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
            L Y+HSA    I HRD+K +N+ +++    ++ DFG +R    + T          GY+
Sbjct: 135 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT----------GYV 181
Query: 568 DPEYFRSSQ-------FTDKSDVYSFGVVLAELLTGE 597
              ++R+ +       +    D++S G ++AELL G+
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 145
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 146 IHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT----------GYVATRW 192
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 394 RATDNFNLNR-ILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN 451
           R  D + L   +LG+G    V   + L   +  AVK  +            E+ +L Q  
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 452 -HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE-VSGAL 509
            HRNV++L+    E +   LV+E +  G++  +IH +        E+   + ++ V+ AL
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASAL 124
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMAVD------QTHMTTQV 560
            +LH+     I HRD+K  NIL +   +    K+ DFG    + ++       T      
Sbjct: 125 DFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTP 181
Query: 561 HGTFGYLDPEYF-----RSSQFTDKSDVYSFGVVLAELLTGEKP 599
            G+  Y+ PE        +S +  + D++S GV+L  LL+G  P
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L++ E +  G LF  I ++  D   T      I  ++  A+ +LHS     I HRD+K  
Sbjct: 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPE 157
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K +    K++DFG ++     Q  + T  +  + Y+ PE     ++    D++S
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWS 214
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 215 LGVIMYILLCGFPP 228

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 136
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 183
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 159
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 160 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 206
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 160
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 161 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 207
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST 528
           L++ E +  G LF  I ++  D   T      I  ++  A+ +LHS     I HRD+K  
Sbjct: 83  LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPE 138
Query: 529 NILLDDKYR---AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
           N+L   K +    K++DFG ++     Q  + T  +  + Y+ PE     ++    D++S
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWS 195
Query: 586 FGVVLAELLTGEKP 599
            GV++  LL G  P
Sbjct: 196 LGVIMYILLCGFPP 209

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 151
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 152 IHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT----------GYVATRW 198
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNV 455
              + + +G+G  G V+ G    G+ VAVK     +E+    E  I + V++    H N+
Sbjct: 38  QIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLM---RHENI 93
Query: 456 VKLLGCCLE-----TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +  +   ++     T++  L+ ++  NG+L+ Y+     D     +  L++A      L 
Sbjct: 94  LGFIAADIKGTGSWTQL-YLITDYHENGSLYDYLKSTTLDA----KSMLKLAYSSVSGLC 148
Query: 511 YLHS-----AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM----TTQVH 561
           +LH+          I HRD+KS NIL+       ++D G +     D   +     T+V 
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV- 207
Query: 562 GTFGYLDPEYFRSS------QFTDKSDVYSFGVVLAEL 593
           GT  Y+ PE    S      Q    +D+YSFG++L E+
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 145
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 146 IHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT----------GYVATRW 192
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 187
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 150
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 151 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 197
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 229

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 30/206 (14%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE- 570
           +HSA    I HRD+K +N+ +++    K+ DFG +R        MT  V  T  Y  PE 
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYV-ATRWYRAPEI 193
Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTG 596
              +  +    D++S G ++AELLTG
Sbjct: 194 MLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 187
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 146
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 147 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 193
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 138
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 139 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 185
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 142
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 143 IHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT----------GYVATRW 189
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 137
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 138 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 184
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 146
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 147 IHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT----------GYVATRW 193
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 159
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 160 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 206
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 152
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 153 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 199
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 136
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 183
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 152
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 153 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 199
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 142
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 143 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 189
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 160
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 161 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 207
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 137
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 138 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 184
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 152
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 153 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 199
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 187
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 146
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 147 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 193
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 187
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 454 NVVKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           N++KL+    +  ++ P LV+E+I N T F+ ++    DF I + M      E+  AL Y
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYI-NNTDFKQLYQILTDFDIRFYM-----YELLKALDY 147
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRA-KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
            HS     I HRD+K  N+++D + +  ++ D+G +      Q +        F    PE
Sbjct: 148 CHSKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFK--GPE 202
Query: 571 YFRSSQFTDKS-DVYSFGVVLAELLTGEKPI 600
                Q  D S D++S G +LA ++   +P 
Sbjct: 203 LLVDYQMYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 187
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 142
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 143 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 189
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 142
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 143 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 189
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 151
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 152 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 198
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 163
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 164 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 210
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 187
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 145
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 146 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 192
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 147
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 148 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 194
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 39/78 (50%)
Query: 522 HRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS 581
           HRD+K  NIL+     A + DFG + +   ++        GT  Y  PE F  S  T ++
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 582 DVYSFGVVLAELLTGEKP 599
           D+Y+   VL E LTG  P
Sbjct: 217 DIYALTCVLYECLTGSPP 234

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 454 NVVKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           N++KL+    +  ++ P LV+E+I N T F+ ++    DF I + M      E+  AL Y
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYI-NNTDFKQLYQILTDFDIRFYM-----YELLKALDY 152
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRA-KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
            HS     I HRD+K  N+++D + +  ++ D+G +      Q +        F    PE
Sbjct: 153 CHSKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFK--GPE 207
Query: 571 YFRSSQFTDKS-DVYSFGVVLAELLTGEKPI 600
                Q  D S D++S G +LA ++   +P 
Sbjct: 208 LLVDYQMYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 187
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 30/206 (14%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R        MT  V  T  Y  PE 
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGXV-ATRWYRAPEI 193
Query: 572 FRS-SQFTDKSDVYSFGVVLAELLTG 596
             +   +    D++S G ++AELLTG
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 187
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 187
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 145
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 146 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 192
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 139
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 140 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 186
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 187 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 44/300 (14%)
Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE 439
           +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K  +    S   E
Sbjct: 35  LHATKLAPGKEKEPLESQYQVGPLLGSGGSGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 94
Query: 440 FIN------EMVILSQIN--HRNVVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNED 490
             N      E+V+L +++     V++LL      +  +L+ E   P   LF +I ++   
Sbjct: 95  LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 153
Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 549
             +  E+      +V  A+ + H+     + HRDIK  NIL+D ++   K+ DFG   S 
Sbjct: 154 --LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG---SG 205
Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEED 608
           A+ +  + T   GT  Y  PE+ R  ++  +S  V+S G++L +++ G+ P      E D
Sbjct: 206 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD 260
Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
           + +    +F  +          RV  E           + + CL L    RPT  E+ + 
Sbjct: 261 EEIIRGQVFFRQ----------RVSSEC--------QHLIRWCLALRPSDRPTFEEIQNH 302

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 48/215 (22%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 462 CLETEVPLLVYEFIPNGTLFQY------IHDQNEDF-------PITWEMRLRIAIEVSGA 508
                       F P  +L ++       H    D         +T +    +  ++   
Sbjct: 86  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRG 133
Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           L Y+HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+ 
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVA 180
Query: 569 PEYFRSSQ-------FTDKSDVYSFGVVLAELLTG 596
             ++R+ +       +    D++S G ++AELLTG
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLL-- 459
           +G G  G+V     +  G  +AVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 460 ---GCCLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 169
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 170 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 216
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 217 YRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 146
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG +R    + T          GY+   +
Sbjct: 147 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 193
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 160
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLD 568
           +HSA    I HRD+K +N+ +++    K+ DFG +R       H   ++ G   T  Y  
Sbjct: 161 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRWYRA 210
Query: 569 PEYFRS-SQFTDKSDVYSFGVVLAELLTG 596
           PE   +   +    D++S G ++AELLTG
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 42/212 (19%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HSA    I HRD+K +N+ +++    K+ DFG  R    + T          GY+   +
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT----------GYVATRW 187
Query: 572 FRSSQ-------FTDKSDVYSFGVVLAELLTG 596
           +R+ +       +    D++S G ++AELLTG
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 136
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLD 568
           +HSA    I HRD+K +N+ +++    K+ DFG +R       H   ++ G   T  Y  
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRA 186
Query: 569 PEYFRS-SQFTDKSDVYSFGVVLAELLTG 596
           PE   +   +    D++S G ++AELLTG
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 113/281 (40%), Gaps = 34/281 (12%)
Query: 397 DNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           D + L  ++G+G    V +      G     KIV V K         E+   E  I   +
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTL-FQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            H ++V+LL       +  +V+EF+    L F+ +   +  F  +  +      ++  AL
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 145
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGY 566
            Y H      I HRD+K   +LL  K  +   K+  FG +  +         +V GT  +
Sbjct: 146 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHF 201
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
           + PE  +   +    DV+  GV+L  LL+G  P                 F   +ERLFE
Sbjct: 202 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLP-----------------FYGTKERLFE 244
Query: 627 -ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMRE 664
            I+  +  M       I   AK + +R L L+  +R T+ E
Sbjct: 245 GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYE 285

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 394 RATDNFNLNR-ILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN 451
           R  D + L   +LG+G    V   + L   +  AVK  +            E+ +L Q  
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 452 -HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE-VSGAL 509
            HRNV++L+    E +   LV+E +  G++  +IH +        E+   + ++ V+ AL
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASAL 124
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDF--GASRSMAVDQTHMTT----QV 560
            +LH+     I HRD+K  NIL +   +    K+ DF  G+   +  D + ++T      
Sbjct: 125 DFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 561 HGTFGYLDPEYF-----RSSQFTDKSDVYSFGVVLAELLTGEKP 599
            G+  Y+ PE        +S +  + D++S GV+L  LL+G  P
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLD 568
           +HSA    I HRD+K +N+ +++    K+ DFG +R       H   ++ G   T  Y  
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRA 190
Query: 569 PEYFRS-SQFTDKSDVYSFGVVLAELLTG 596
           PE   +   +    D++S G ++AELLTG
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKV--EEFINEMVILSQINHRNVVKLLGC 461
           +G G  G+V        G  VAVKK     +S +  +    E+ +L  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 462 -----CLE--TEVPLLVYEF---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
                 LE   +V L+ +     + N    Q + D +  F I   +R          L Y
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 140
Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLD 568
           +HSA    I HRD+K +N+ +++    K+ DFG +R       H   ++ G   T  Y  
Sbjct: 141 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRA 190
Query: 569 PEYFRS-SQFTDKSDVYSFGVVLAELLTG 596
           PE   +   +    D++S G ++AELLTG
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 107/227 (47%), Gaps = 38/227 (16%)
Query: 403 RILGQGGQGTV-YKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVVKLLG 460
           +ILG G  GTV ++G    G+ VAVK+  +ID   +   + E+ +L++ + H NV++   
Sbjct: 21  KILGYGSSGTVVFQGSF-QGRPVAVKR-MLIDFCDIA--LMEIKLLTESDDHPNVIRYY- 75
Query: 461 CCLETEVPLLVYEFIPNGTLFQYIHDQN---EDFPITWEMR-LRIAIEVSGALSYLHSAA 516
           C   T+  L +   + N  L   +  +N   E+  +  E   + +  +++  +++LHS  
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 133
Query: 517 SIPIYHRDIKSTNILLD-------------DKYRAKVSDFGASRSMAVDQTHMTTQVH-- 561
            + I HRD+K  NIL+              +  R  +SDFG  + +   Q+   T ++  
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 562 -GTFGYLDPEYFRSS-------QFTDKSDVYSFGVVLAELLT-GEKP 599
            GT G+  PE    S       + T   D++S G V   +L+ G+ P
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 113/281 (40%), Gaps = 34/281 (12%)
Query: 397 DNFNLNRILGQGGQGTVYK------GMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           D + L  ++G+G    V +      G     KIV V K         E+   E  I   +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTL-FQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            H ++V+LL       +  +V+EF+    L F+ +   +  F  +  +      ++  AL
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGY 566
            Y H      I HRD+K   +LL  K  +   K+  FG +  +         +V GT  +
Sbjct: 144 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHF 199
Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
           + PE  +   +    DV+  GV+L  LL+G  P                 F   +ERLFE
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLP-----------------FYGTKERLFE 242
Query: 627 -ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMRE 664
            I+  +  M       I   AK + +R L L+  +R T+ E
Sbjct: 243 GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYE 283
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	684
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-119
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-112
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-107
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-75
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-74
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-74
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-69
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-68
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-67
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-59
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-58
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-50
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-44
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-43
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-43
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-42
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-42
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-42
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-42
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-41
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-41
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-41
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-41
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-41
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-41
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-41
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-40
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-40
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-39
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-39
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-39
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-38
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-37
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-37
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-37
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-37
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-36
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-36
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-36
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-36
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-35
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-35
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-35
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-34
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-33
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-31
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-31
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-30
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-29
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-28
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-28
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-28
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-28
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-27
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-27
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-26
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-07
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-26
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-26
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-25
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-25
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-24
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-24
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-23
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-23
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-23
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-23
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-23
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-22
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-22
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-22
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-21
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-21
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-21
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  357 bits (919), Expect = e-119
 Identities = 110/301 (36%), Positives = 171/301 (56%), Gaps = 5/301 (1%)

Query: 374 LASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID 433
           L+S+     ++      +LE AT+NF+   ++G G  G VYKG+L DG  VA+K+     
Sbjct: 16  LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75

Query: 434 ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED-FP 492
              +EEF  E+  LS   H ++V L+G C E    +L+Y+++ NG L ++++  +     
Sbjct: 76  SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135

Query: 493 ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV- 551
           ++WE RL I I  +  L YLH+     I HRD+KS NILLD+ +  K++DFG S+     
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192

Query: 552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
           DQTH++T V GT GY+DPEYF   + T+KSDVYSFGVVL E+L     I  +   E  +L
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

Query: 612 AAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG 671
           A + + +    +L +I+D  +  +   + +  F   A +CL L+ + RP+M +V  +L  
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

Query: 672 I 672
            
Sbjct: 313 A 313

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  340 bits (874), Expect = e-112
 Identities = 108/292 (36%), Positives = 170/292 (58%), Gaps = 4/292 (1%)

Query: 384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVE-EFIN 442
            K F+ +EL+ A+DNF+   ILG+GG G VYKG L DG +VAVK+ K       E +F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED-FPITWEMRLRI 501
           E+ ++S   HRN+++L G C+     LLVY ++ NG++   + ++ E   P+ W  R RI
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
           A+  +  L+YLH      I HRD+K+ NILLD+++ A V DFG ++ M    TH+TT V 
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTL--EEDKSLAAYFLFAM 619
           GT G++ PEY  + + ++K+DV+ +GV+L EL+TG++      L  ++D  L  +    +
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 620 KEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG 671
           KE++L  ++D  +      +E+    +VA  C   +  +RP M EV   L G
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  326 bits (838), Expect = e-107
 Identities = 103/311 (33%), Positives = 167/311 (53%), Gaps = 20/311 (6%)

Query: 376 STEGTIEKTKLFTSKELERATDNFN------LNRILGQGGQGTVYKGMLPDGKIVAVKKS 429
           S E +  +   F+  EL+  T+NF+          +G+GG G VYKG + +   VAVKK 
Sbjct: 4   SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62

Query: 430 KVIDESKV----EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 485
             + +       ++F  E+ ++++  H N+V+LLG   + +   LVY ++PNG+L   + 
Sbjct: 63  AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122

Query: 486 DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 545
             +   P++W MR +IA   +  +++LH    I   HRDIKS NILLD+ + AK+SDFG 
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGL 179

Query: 546 SRSMAV-DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTT 604
           +R+     QT MT+++ GT  Y+ PE  R  + T KSD+YSFGVVL E++TG   +    
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH- 237

Query: 605 LEEDKSLAAYFLFAMKEER-LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMR 663
             E + L         EE+ + + +D + M ++    +     VA +CL+    KRP ++
Sbjct: 238 -REPQLLLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295

Query: 664 EVTSELAGIKA 674
           +V   L  + A
Sbjct: 296 KVQQLLQEMTA 306

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  242 bits (620), Expect = 6e-75
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 36/284 (12%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
               +  ++G+G  G V K      K VA+K+  +  ES+ + FI E+  LS++NH N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIV 64

Query: 457 KLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           KL G CL    P+ LV E+   G+L+  +H        T    +   ++ S  ++YLHS 
Sbjct: 65  KLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 516 ASIPIYHRDIKSTNILLDDKYR-AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
               + HRD+K  N+LL       K+ DFG +  +   QTHMT    G+  ++ PE F  
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPEVFEG 177

Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK 634
           S +++K DV+S+G++L E++T  KP  F  +                 R           
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKP--FDEI--GGPAFRIMWAVHNGTRP---------- 223

Query: 635 ESGGDEIIT-----FAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
                 +I         +  RC + +  +RP+M E+   +  + 
Sbjct: 224 -----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  241 bits (618), Expect = 1e-74
 Identities = 82/278 (29%), Positives = 130/278 (46%), Gaps = 20/278 (7%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRN 454
            + N+   +G G  GTV++     G  VAVK          +V EF+ E+ I+ ++ H N
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           +V  +G   +     +V E++  G+L++ +H       +    RL +A +V+  ++YLH+
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
             + PI HR++KS N+L+D KY  KV DFG SR  A       +   GT  ++ PE  R 
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRD 213

Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK 634
               +KSDVYSFGV+L EL T ++P  +  L              K +RL EI       
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP--WGNLN---PAQVVAAVGFKCKRL-EI------- 260

Query: 635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
               +     A + + C      KRP+   +   L  +
Sbjct: 261 PRNLNP--QVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  241 bits (617), Expect = 2e-74
 Identities = 63/310 (20%), Positives = 117/310 (37%), Gaps = 31/310 (10%)

Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVI 446
             ++ L   +    L  +  +G  G V+K      + VAVK   + D+    +   E+  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 447 LSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           L  + H N+++ +G             L+  F   G+L  ++        ++W     IA
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIA 127

Query: 503 IEVSGALSYLHSAASI-------PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 555
             ++  L+YLH             I HRDIKS N+LL +   A ++DFG +      ++ 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 556 --MTTQVHGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLAELLTGEKPIRFTTLE-- 606
                QV GT  Y+ PE    +         + D+Y+ G+VL EL +          E  
Sbjct: 188 GDTHGQV-GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 607 ---EDKSLAAYFLFAMKEERLFEILDARVMKESGGDEII-TFAKVAKRCLNLNGKKRPTM 662
              E++      L  M+E  + +     +         +    +  + C + + + R + 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 663 REVTSELAGI 672
             V   +  +
Sbjct: 307 GCVGERITQM 316

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  225 bits (575), Expect = 7e-69
 Identities = 88/284 (30%), Positives = 139/284 (48%), Gaps = 35/284 (12%)

Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDES----KVEEFINEMVILSQINHRNVV 456
           L  I+G GG G VY+     G  VAVK ++   +      +E    E  + + + H N++
Sbjct: 11  LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
            L G CL+     LV EF   G L + +  +     I  ++ +  A++++  ++YLH  A
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEA 125

Query: 517 SIPIYHRDIKSTNILLDDKYR--------AKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
            +PI HRD+KS+NIL+  K           K++DFG +R     +T   +   G + ++ 
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYAWMA 182

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           PE  R+S F+  SDV+S+GV+L ELLTGE P  F  ++    LA  +  AM +  L  I 
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVP--FRGID---GLAVAYGVAMNKLAL-PIP 236

Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
                  S   E   FAK+ + C N +   RP+   +  +L  I
Sbjct: 237 -------STCPE--PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  224 bits (574), Expect = 2e-68
 Identities = 90/309 (29%), Positives = 148/309 (47%), Gaps = 37/309 (11%)

Query: 379 GTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDES-- 435
           G +  ++   S+    A +     + +G+GG G V+KG  + D  +VA+K   + D    
Sbjct: 1   GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60

Query: 436 -----KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED 490
                K +EF  E+ I+S +NH N+VKL G       P +V EF+P G L+  + D+   
Sbjct: 61  TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH- 117

Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-----YRAKVSDFGA 545
            PI W ++LR+ ++++  + Y+ +  + PI HRD++S NI L          AKV+DFG 
Sbjct: 118 -PIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175

Query: 546 SRSMAVDQTHMTTQVHGTFGYLDPEYF--RSSQFTDKSDVYSFGVVLAELLTGEKPIRFT 603
           S+       H  + + G F ++ PE        +T+K+D YSF ++L  +LTGE P  F 
Sbjct: 176 SQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--F- 228

Query: 604 TLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMR 663
             +E       F+  ++EE L      R               V + C + + KKRP   
Sbjct: 229 --DEYSYGKIKFINMIREEGL------RPTIPEDCPP--RLRNVIELCWSGDPKKRPHFS 278

Query: 664 EVTSELAGI 672
            +  EL+ +
Sbjct: 279 YIVKELSEL 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  219 bits (561), Expect = 9e-67
 Identities = 62/292 (21%), Positives = 119/292 (40%), Gaps = 31/292 (10%)

Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVI 446
           +K         N    L +   G ++KG    G  + VK  KV      K  +F  E   
Sbjct: 2   NKHSGIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60

Query: 447 LSQINHRNVVKLLGCCLETEVPLL--VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
           L   +H NV+ +LG C     P    +  ++P G+L+  +H+   +F +     ++ A++
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFALD 119

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           ++  +++LH+     I    + S ++++D+   A++S      S          ++    
Sbjct: 120 MARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSF-----QSPGRM-YAP 172

Query: 565 GYLDPEYFRSSQ---FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
            ++ PE  +          +D++SF V+L EL+T E P  F  L    ++      A++ 
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP--FADL---SNMEIGMKVALEG 227

Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
            R   I         G       +K+ K C+N +  KRP    +   L  ++
Sbjct: 228 LRP-TI-------PPGISP--HVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  205 bits (523), Expect = 8e-61
 Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 38/288 (13%)

Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKL 458
           +  ++G+G  G VY G    G+ VA++   +   +E +++ F  E++   Q  H NVV  
Sbjct: 37  IGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
           +G C+      ++       TL+  + D             +IA E+   + YLH   + 
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD--VNKTRQIAQEIVKGMGYLH---AK 149

Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV----DQTHMTTQVHGTFGYLDPEYFRS 574
            I H+D+KS N+  D+  +  ++DFG      V     +       +G   +L PE  R 
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 575 SQ---------FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
                      F+  SDV++ G +  EL   E P       + +   A         +  
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF------KTQPAEAIIWQMGTGMKP- 261

Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
            +    + KE         + +   C     ++RPT  ++   L  + 
Sbjct: 262 NLSQIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDMLEKLP 301

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  205 bits (524), Expect = 1e-60
 Identities = 68/324 (20%), Positives = 122/324 (37%), Gaps = 48/324 (14%)

Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVI 446
             + E     DN  L  ++G+G  G VYKG L D + VAVK     +    + FINE  I
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58

Query: 447 --LSQINHRNVVKLLGCCLETEVP-----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRL 499
             +  + H N+ + +              LLV E+ PNG+L +Y+          W    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSC 114

Query: 500 RIAIEVSGALSYLHSAASI------PIYHRDIKSTNILLDDKYRAKVSDFGASRSMA--- 550
           R+A  V+  L+YLH+           I HRD+ S N+L+ +     +SDFG S  +    
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 551 -----VDQTHMTTQVHGTFGYLDPEYFRSS-------QFTDKSDVYSFGVVLAELLTGEK 598
                 +     ++V GT  Y+ PE    +           + D+Y+ G++  E+     
Sbjct: 175 LVRPGEEDNAAISEV-GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 599 PIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK----------ESGGDEIITFAKVA 648
            +       +    A+           ++      +          +     + +  +  
Sbjct: 234 DLFPGESVPE-YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 649 KRCLNLNGKKRPTMREVTSELAGI 672
           + C + + + R T +     +A +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAEL 316

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  201 bits (513), Expect = 2e-59
 Identities = 66/296 (22%), Positives = 121/296 (40%), Gaps = 35/296 (11%)

Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVI 446
             +       +     +LG+G  G   K      G+++ +K+    DE     F+ E+ +
Sbjct: 3   PHRIFRP--SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKV 60

Query: 447 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVS 506
           +  + H NV+K +G   + +    + E+I  GTL   I   +  +P  W  R+  A +++
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP--WSQRVSFAKDIA 118

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT--------- 557
             ++YLH   S+ I HRD+ S N L+ +     V+DFG +R M  ++T            
Sbjct: 119 SGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175

Query: 558 ----TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAA 613
                 V G   ++ PE      + +K DV+SFG+VL E++           +       
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP----DYLPRTMD 231

Query: 614 YFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
           + L                      +   +F  +  RC +L+ +KRP+  ++   L
Sbjct: 232 FGLNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  199 bits (509), Expect = 4e-59
 Identities = 73/289 (25%), Positives = 133/289 (46%), Gaps = 27/289 (9%)

Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMV 445
            + + E       + + +G G  GTVYKG    G  VAVK   V      +++ F NE+ 
Sbjct: 15  AADDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVG 72

Query: 446 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
           +L +  H N++  +G    T   L +V ++    +L+ ++H     F    +  + IA +
Sbjct: 73  VLRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHASETKFE--MKKLIDIARQ 128

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ-THMTTQVHGT 563
            +  + YLH+     I HRD+KS NI L +    K+ DFG +   +    +H   Q+ G+
Sbjct: 129 TARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185

Query: 564 FGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
             ++ PE  R   S+ ++ +SDVY+FG+VL EL+TG+ P  ++ +    +         +
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP--YSNI---NNRDQIIEMVGR 240

Query: 621 EERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                ++   R    S   +     ++   CL     +RP+   + +E+
Sbjct: 241 GSLSPDLSKVR----SNCPK--RMKRLMAECLKKKRDERPSFPRILAEI 283

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  185 bits (472), Expect = 3e-53
 Identities = 64/307 (20%), Positives = 115/307 (37%), Gaps = 43/307 (14%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINE--MVILSQINHRN 454
               + + +G+G  G V+ G    G+ VAVK   V   ++   +  E  +     + H N
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVK---VFFTTEEASWFRETEIYQTVLMRHEN 92

Query: 455 VVKLLGCCLETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           ++  +   ++         L+ ++  NG+L+ Y+        +  +  L++A      L 
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLC 148

Query: 511 YLHSAASI-----PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH----MTTQVH 561
           +LH+          I HRD+KS NIL+       ++D G +     D         T+V 
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV- 207

Query: 562 GTFGYLDPE------YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
           GT  Y+ PE           Q    +D+YSFG++L E+           +EE +    Y 
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS--GGIVEEYQ--LPYH 263

Query: 616 LFAMKEERLFEILDARVMK---------ESGGDEIITFAKVAKRCLNLNGKKRPTMREVT 666
                +    ++ +   +K          S  + +    K+   C   N   R T   V 
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323

Query: 667 SELAGIK 673
             LA + 
Sbjct: 324 KTLAKMS 330

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  182 bits (463), Expect = 2e-52
 Identities = 60/314 (19%), Positives = 116/314 (36%), Gaps = 50/314 (15%)

Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINE--MVI 446
           ++++        L   +G+G  G V++G    G+ VAVK   +      + +  E  +  
Sbjct: 7   ARDIT-------LLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYN 55

Query: 447 LSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
              + H N++  +   + +        L+  +   G+L+ Y+        +     LRI 
Sbjct: 56  TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIV 111

Query: 503 IEVSGALSYLHSAASI-----PIYHRDIKSTNILLDDKYRAKVSDFGASR----SMAVDQ 553
           + ++  L++LH           I HRD+KS NIL+    +  ++D G +     S     
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171

Query: 554 THMTTQVHGTFGYLDPE------YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE 607
                +V GT  Y+ PE               + D+++FG+VL E+           +E+
Sbjct: 172 VGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS--NGIVED 228

Query: 608 DKSLAAYFLFAMKEERLFEILDARVMK--------ESGGDEII-TFAKVAKRCLNLNGKK 658
            K    ++     +    ++     +             D  + + AK+ K C   N   
Sbjct: 229 YK--PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSA 286

Query: 659 RPTMREVTSELAGI 672
           R T   +   L  I
Sbjct: 287 RLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  177 bits (451), Expect = 3e-50
 Identities = 60/303 (19%), Positives = 116/303 (38%), Gaps = 43/303 (14%)

Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVI--LSQINHRNVVKL 458
           L   +G+G  G V++G    G+ VAVK   +    +   +  E  I     + H N++  
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGF 101

Query: 459 LGCCLETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           +    +         LV ++  +G+LF Y++       +T E  +++A+  +  L++LH 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHM 157

Query: 515 AAS-----IPIYHRDIKSTNILLDDKYRAKVSDFGASR----SMAVDQTHMTTQVHGTFG 565
                     I HRD+KS NIL+       ++D G +     +          +V GT  
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKR 216

Query: 566 YLDPEYFRSS------QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM 619
           Y+ PE    S      +   ++D+Y+ G+V  E+              +     Y+    
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG----IHEDYQLPYYDLVP 272

Query: 620 KEERLFEILDARVMKE---------SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
            +  + E+      ++            + +   AK+ + C   NG  R T   +   L+
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

Query: 671 GIK 673
            + 
Sbjct: 333 QLS 335

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  159 bits (405), Expect = 2e-44
 Identities = 71/277 (25%), Positives = 119/277 (42%), Gaps = 25/277 (9%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHR 453
           +++ +   +G G  G   K     DGKI+  K+     + E++ +  ++E+ +L ++ H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 454 NVVKLLGCCLETEVPLL--VYEFIPNGTLFQYI-HDQNEDFPITWEMRLRIAIEVSGALS 510
           N+V+     ++     L  V E+   G L   I     E   +  E  LR+  +++ AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 511 YLHS--AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             H        + HRD+K  N+ LD K   K+ DFG +R +  D +   T V GT  Y+ 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           PE      + +KSD++S G +L EL     P    + +E        L     E  F  +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRRI 236

Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             R   E          ++  R LNL    RP++ E+
Sbjct: 237 PYRYSDE--------LNEIITRMLNLKDYHRPSVEEI 265

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  156 bits (397), Expect = 4e-43
 Identities = 68/274 (24%), Positives = 118/274 (43%), Gaps = 22/274 (8%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK---SKVIDESKVEEFINEMVILSQINH 452
            NF + + +G+G    VY+   L DG  VA+KK     ++D     + I E+ +L Q+NH
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-PITWEMRLRIAIEVSGALSY 511
            NV+K     +E     +V E    G L + I    +    I      +  +++  AL +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           +HS     + HRDIK  N+ +      K+ D G  R  +   T   + V GT  Y+ PE 
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207

Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR 631
              + +  KSD++S G +L E+   + P  F    +  +L +      + +         
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP--FYG--DKMNLYSLCKKIEQCDY------PP 257

Query: 632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
           +  +   +E+         C+N + +KRP +  V
Sbjct: 258 LPSDHYSEELRQL---VNMCINPDPEKRPDVTYV 288

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  157 bits (399), Expect = 7e-43
 Identities = 61/272 (22%), Positives = 110/272 (40%), Gaps = 24/272 (8%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHR 453
           + +   + +G+G  G         DG+   +K+  +  +   + EE   E+ +L+ + H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+V+      E     +V ++   G LF+ I+ Q        +  L   +++  AL ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV-LFQEDQILDWFVQICLALKHVH 142

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
                 I HRDIKS NI L      ++ DFG +R +          + GT  YL PE   
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198

Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM 633
           +  + +KSD+++ G VL EL T +    F    E  S+    L        F  +     
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA--F----EAGSMKN--LVLKIISGSFPPVSLHYS 250

Query: 634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            +           +  +    N + RP++  +
Sbjct: 251 YD--------LRSLVSQLFKRNPRDRPSVNSI 274

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  153 bits (389), Expect = 4e-42
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 401 LNRILGQGGQGTVYKGMLPD---GKIVAVK---KSKVIDESKVEEFINEMVILSQINHRN 454
           +   LG GG  TVY     D      VA+K         E  ++ F  E+   SQ++H+N
Sbjct: 15  IVDKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           +V ++    E +   LV E+I   TL +YI       P++ +  +    ++   + + H 
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT--QVHGTFGYLDPEYF 572
                I HRDIK  NIL+D     K+ DFG ++  A+ +T +T    V GT  Y  PE  
Sbjct: 130 MR---IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQA 184

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKP 599
           +     + +D+YS G+VL E+L GE P
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPP 211

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  155 bits (394), Expect = 7e-42
 Identities = 68/292 (23%), Positives = 124/292 (42%), Gaps = 37/292 (12%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKI-VAVKKSKV-IDESKVEEFINEMVILS 448
            L    ++  L   +G+G  G V+ G L      VAVK  +  +      +F+ E  IL 
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167

Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           Q +H N+V+L+G C + +   +V E +  G    ++  + E   +  +  L++  + +  
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAG 225

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY-- 566
           + YL S   I   HRD+ + N L+ +K   K+SDFG SR  A D  +  +          
Sbjct: 226 MEYLESKCCI---HRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKW 281

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE--DKSLAAYFLFAMKE-- 621
             PE     +++ +SDV+SFG++L E  + G  P    + ++  +       L   +   
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP 341

Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           + +F +     M               ++C      +RP+   +  EL  I+
Sbjct: 342 DAVFRL-----M---------------EQCWAYEPGQRPSFSTIYQELQSIR 373

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  153 bits (388), Expect = 7e-42
 Identities = 69/304 (22%), Positives = 128/304 (42%), Gaps = 57/304 (18%)

Query: 394 RATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           R   +F    +LGQG  G V K     D +  A+KK +   E K+   ++E+++L+ +NH
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61

Query: 453 RNVVKLLGCCLETEVPL-------------LVYEFIPNGTLFQYIHDQNEDFPITWEMRL 499
           + VV+     LE    +             +  E+  NGTL+  IH +N +     +   
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR--DEYW 119

Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---------- 549
           R+  ++  ALSY+HS     I HRD+K  NI +D+    K+ DFG ++++          
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 550 ----AVDQTHMTTQVHGTFGYLDPEYFRSSQFTD-KSDVYSFGVVLAELLTGEKPIRFTT 604
                    ++T+ + GT  Y+  E    +   + K D+YS G++  E++          
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-------- 227

Query: 605 LEEDKSLAAYFLFAMKEERLFEIL---DARVMKESGGDEIITFAKVAKRCLNLNGKKRPT 661
                     F   M+   + + L         +   +++    K+ +  ++ +  KRP 
Sbjct: 228 ----------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277

Query: 662 MREV 665
            R +
Sbjct: 278 ARTL 281

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  153 bits (389), Expect = 8e-42
 Identities = 77/302 (25%), Positives = 120/302 (39%), Gaps = 40/302 (13%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGML-----PDGKIVAVKKSKV-IDESKVEEFINEM 444
              +        R LG+G  G V            G++VAVK  K          +  E+
Sbjct: 27  VFHK--RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI 84

Query: 445 VILSQINHRNVVKLLGCCLETEVP--LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
            IL  + H +++K  GCC +       LV E++P G+L  Y+   +    I     L  A
Sbjct: 85  DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFA 140

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++   ++YLH+   I   HRD+ + N+LLD+    K+ DFG ++++     +   +  G
Sbjct: 141 QQICEGMAYLHAQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 197

Query: 563 TF--GYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAM 619
                +  PE  +  +F   SDV+SFGV L ELLT  +      T   +    A     M
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQM 255

Query: 620 KEERLFEILDARVMKESGG---------DEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
              RL E+L      E G           E+     + K C       RPT   +   L 
Sbjct: 256 TVLRLTELL------ERGERLPRPDKCPAEV---YHLMKNCWETEASFRPTFENLIPILK 306

Query: 671 GI 672
            +
Sbjct: 307 TV 308

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  158 bits (400), Expect = 9e-42
 Identities = 79/319 (24%), Positives = 130/319 (40%), Gaps = 34/319 (10%)

Query: 360 KFFKRNGGLL---LQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKG 416
                    L   L                    + E    +  +   LG G  G VY+G
Sbjct: 180 HHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEG 239

Query: 417 MLPDGKI-VAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI 475
           +     + VAVK  K  D  +VEEF+ E  ++ +I H N+V+LLG C       ++ EF+
Sbjct: 240 VWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298

Query: 476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK 535
             G L  Y+ +      ++  + L +A ++S A+ YL     I   HR++ + N L+ + 
Sbjct: 299 TYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFI---HRNLAARNCLVGEN 354

Query: 536 YRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT 595
           +  KV+DFG SR M  D             +  PE    ++F+ KSDV++FGV+L E+ T
Sbjct: 355 HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

Query: 596 -GEKPIRFTTLEE--DKSLAAYFLFAMKE--ERLFEILDARVMKESGGDEIITFAKVAKR 650
            G  P     L +  +     Y +   +   E+++E+     M               + 
Sbjct: 415 YGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL-----M---------------RA 454

Query: 651 CLNLNGKKRPTMREVTSEL 669
           C   N   RP+  E+    
Sbjct: 455 CWQWNPSDRPSFAEIHQAF 473

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  152 bits (386), Expect = 1e-41
 Identities = 65/290 (22%), Positives = 122/290 (42%), Gaps = 48/290 (16%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN 451
           +R   +F    ++G GG G V+K     DGK   +K+   +  +  E+   E+  L++++
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNN-EKAEREVKALAKLD 62

Query: 452 HRNVVKLLGCCLETEVPL----------------LVYEFIPNGTLFQYIHDQNEDFPITW 495
           H N+V   GC    +                   +  EF   GTL Q+I  +  +  +  
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDK 121

Query: 496 EMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 555
            + L +  +++  + Y+HS     + +RD+K +NI L D  + K+ DFG   S+  D   
Sbjct: 122 VLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
             ++  GT  Y+ PE   S  +  + D+Y+ G++LAELL                     
Sbjct: 179 TRSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---------------- 220

Query: 616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             A +  + F  L   ++ +    +      + ++ L+   + RP   E+
Sbjct: 221 --AFETSKFFTDLRDGIISDIFDKK---EKTLLQKLLSKKPEDRPNTSEI 265

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  152 bits (387), Expect = 2e-41
 Identities = 55/212 (25%), Positives = 109/212 (51%), Gaps = 16/212 (7%)

Query: 397 DNFNLNRILGQGGQGTVYKGML--PDGKI---VAVKKSKV-IDESKVEEFINEMVILSQI 450
             F   ++LG G  GTVYKG+      K+   VA+K+ +        +E ++E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           ++ +V +LLG CL + V  L+ + +P G L  Y+ +  ++     +  L   ++++  ++
Sbjct: 75  DNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMN 131

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLD 568
           YL     +   HRD+ + N+L+      K++DFG ++ +  ++     +  G     ++ 
Sbjct: 132 YLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMA 187

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            E      +T +SDV+S+GV + EL+T G KP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  152 bits (386), Expect = 2e-41
 Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 37/299 (12%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKG---MLPDGK--IVAVKKSKVIDESKVEEFINEM 444
              E    +      LG+G  G+V       L D    +VAVK+ +     +  +F  E+
Sbjct: 18  TIFEE--RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI 75

Query: 445 VILSQINHRNVVKLLGCCLET-EVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
            IL  ++   +VK  G         L LV E++P+G L  ++  Q     +     L  +
Sbjct: 76  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYS 133

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++   + YL S   +   HRD+ + NIL++ +   K++DFG ++ + +D+ +   +  G
Sbjct: 134 SQICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190

Query: 563 TF--GYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAM 619
                +  PE    + F+ +SDV+SFGVVL EL T  +K    +   E   +        
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVP 248

Query: 620 KEERLFEILDARVMKESGG---------DEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
              RL E+L      E G           E+    ++ K C   + + RP+   +  +L
Sbjct: 249 ALSRLLELL------EEGQRLPAPPACPAEV---HELMKLCWAPSPQDRPSFSALGPQL 298

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  151 bits (383), Expect = 3e-41
 Identities = 71/221 (32%), Positives = 114/221 (51%), Gaps = 19/221 (8%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVKKSKVI-DESKVEEFINEMV 445
            +  ++   + N ++G+G  G VY G L D        AVK    I D  +V +F+ E +
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78

Query: 446 ILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
           I+   +H NV+ LLG CL +E   L V  ++ +G L  +I  +NE    T +  +   ++
Sbjct: 79  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQ 136

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           V+  + YL S   +   HRD+ + N +LD+K+  KV+DFG +R   +      +  + T 
Sbjct: 137 VAKGMKYLASKKFV---HRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTG 191

Query: 565 GYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
             L       E  ++ +FT KSDV+SFGV+L EL+T G  P
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  150 bits (382), Expect = 3e-41
 Identities = 65/226 (28%), Positives = 112/226 (49%), Gaps = 17/226 (7%)

Query: 378 EGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKV 437
            G++     F             L + +G+G  G V  G    G  VAVK  K  +++  
Sbjct: 2   GGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATA 58

Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWE 496
           + F+ E  +++Q+ H N+V+LLG  +E +  L +V E++  G+L  Y+        +  +
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGD 117

Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 556
             L+ +++V  A+ YL     +   HRD+ + N+L+ +   AKVSDFG ++  +      
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEAS------ 168

Query: 557 TTQVHGTFGY--LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +TQ  G        PE  R  +F+ KSDV+SFG++L E+ + G  P
Sbjct: 169 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  150 bits (382), Expect = 4e-41
 Identities = 80/297 (26%), Positives = 132/297 (44%), Gaps = 34/297 (11%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMV 445
           + E    +    + LG+G  G+V            G++VAVKK +   E  + +F  E+ 
Sbjct: 6   QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63

Query: 446 ILSQINHRNVVKLLGCCLET-EVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
           IL  + H N+VK  G C       L L+ E++P G+L  Y+  Q     I     L+   
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 121

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           ++   + YL +   I   HRD+ + NIL++++ R K+ DFG ++ +  D+     +  G 
Sbjct: 122 QICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 564 F--GYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
               +  PE    S+F+  SDV+SFGVVL EL T  +  +    E  + +       M  
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 622 ERLFEILDARVMKESGG---------DEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
             L E+L      ++ G         DEI     +   C N N  +RP+ R++   +
Sbjct: 239 FHLIELL------KNNGRLPRPDGCPDEI---YMIMTECWNNNVNQRPSFRDLALRV 286

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  150 bits (380), Expect = 6e-41
 Identities = 73/213 (34%), Positives = 111/213 (52%), Gaps = 13/213 (6%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKI-VAVKKSKVIDESKVEEFINEMVILSQ 449
           E+ER   +  +   LG G  G VY+G+     + VAVK  K  D  +VEEF+ E  ++ +
Sbjct: 9   EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 65

Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           I H N+V+LLG C       ++ EF+  G L  Y+ + N    ++  + L +A ++S A+
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAM 124

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY--L 567
            YL     I   HRD+ + N L+ + +  KV+DFG SR M  D    T      F     
Sbjct: 125 EYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWT 179

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            PE    ++F+ KSDV++FGV+L E+ T G  P
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  158 bits (400), Expect = 6e-41
 Identities = 46/210 (21%), Positives = 87/210 (41%), Gaps = 29/210 (13%)

Query: 401 LNRILGQGGQGTVYKG--MLPDGKIVAVKKSKVI----DESKVEEFINEMVILSQINHRN 454
           +   +  GG G +Y       +G+ V +K    +    D       + E   L+++ H +
Sbjct: 84  VKGCIAHGGLGWIYLALDRNVNGRPVVLK---GLVHSGDAEAQAMAMAERQFLAEVVHPS 140

Query: 455 VVKLL-----GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           +V++             V  +V E++   +L +          +     +   +E+  AL
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPAL 195

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           SYLHS     + + D+K  NI+L ++ + K+ D GA   +  +       ++GT G+  P
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGY---LYGTPGFQAP 246

Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           E  R+   T  +D+Y+ G  LA L      
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLPT 275

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  151 bits (383), Expect = 6e-41
 Identities = 81/300 (27%), Positives = 134/300 (44%), Gaps = 34/300 (11%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVIDESKVEEFINEMV 445
           + E    +    + LG+G  G+V            G++VAVKK +   E  + +F  E+ 
Sbjct: 37  QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94

Query: 446 ILSQINHRNVVKLLGCCLET-EVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
           IL  + H N+VK  G C       L L+ E++P G+L  Y+  Q     I     L+   
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 152

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           ++   + YL +   I   HRD+ + NIL++++ R K+ DFG ++ +  D+ +   +  G 
Sbjct: 153 QICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209

Query: 564 F--GYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
               +  PE    S+F+  SDV+SFGVVL EL T  +  +    E  + +       M  
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269

Query: 622 ERLFEILDARVMKESGG---------DEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
             L E+L      ++ G         DEI     +   C N N  +RP+ R++   +  I
Sbjct: 270 FHLIELL------KNNGRLPRPDGCPDEI---YMIMTECWNNNVNQRPSFRDLALRVDQI 320

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  152 bits (386), Expect = 7e-41
 Identities = 72/221 (32%), Positives = 113/221 (51%), Gaps = 19/221 (8%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVKKSKVI-DESKVEEFINEMV 445
            +  ++   + N ++G+G  G VY G L D        AVK    I D  +V +F+ E +
Sbjct: 83  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142

Query: 446 ILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
           I+   +H NV+ LLG CL +E   L V  ++ +G L  +I  +NE    T +  +   ++
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQ 200

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           V+  + +L   AS    HRD+ + N +LD+K+  KV+DFG +R M   +         T 
Sbjct: 201 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTG 255

Query: 565 GYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
             L       E  ++ +FT KSDV+SFGV+L EL+T G  P
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  150 bits (380), Expect = 7e-41
 Identities = 61/297 (20%), Positives = 117/297 (39%), Gaps = 46/297 (15%)

Query: 394 RATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID-ESKVEEFINEMVILSQIN 451
           R   +F   + LG+GG G V++     D    A+K+ ++ + E   E+ + E+  L+++ 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 452 HRNVVKLLGCCLE---------TEVPLLVY---EFIPNGTLFQYIHDQNEDFPITWEMRL 499
           H  +V+     LE         +   + +Y   +      L  +++ +         + L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 559
            I ++++ A+ +LHS     + HRD+K +NI        KV DFG   +M  D+   T  
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 560 VH-----------GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED 608
                        GT  Y+ PE    + ++ K D++S G++L ELL       F+T    
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----PFST---- 229

Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                     M+  R    +           +      + +  L+ +  +RP    +
Sbjct: 230 ---------QMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  150 bits (380), Expect = 9e-41
 Identities = 73/302 (24%), Positives = 128/302 (42%), Gaps = 38/302 (12%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVI-DESKVEEFINEM 444
             E+        R LG+G  G V            G+ VAVK  K     + + +   E+
Sbjct: 17  HFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI 74

Query: 445 VILSQINHRNVVKLLGCCLETEV-PL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
            IL  + H N+VK  G C E     + L+ EF+P+G+L +Y+        I  + +L+ A
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYA 132

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
           +++   + YL S   +   HRD+ + N+L++ +++ K+ DFG ++++  D+ + T +   
Sbjct: 133 VQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189

Query: 563 TF--GYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAM 619
                +  PE    S+F   SDV+SFGV L ELLT  +       L        +    M
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH--GQM 247

Query: 620 KEERLFEILDARVMKESGG---------DEIITFAKVAKRCLNLNGKKRPTMREVTSELA 670
              RL   L      + G          DE+    ++ ++C       R + + +     
Sbjct: 248 TVTRLVNTL------KEGKRLPCPPNCPDEV---YQLMRKCWEFQPSNRTSFQNLIEGFE 298

Query: 671 GI 672
            +
Sbjct: 299 AL 300

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  153 bits (389), Expect = 1e-40
 Identities = 67/228 (29%), Positives = 113/228 (49%), Gaps = 17/228 (7%)

Query: 376 STEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDES 435
             EGT+     F             L + +G+G  G V  G    G  VAVK  K  +++
Sbjct: 172 VMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDA 228

Query: 436 KVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPIT 494
             + F+ E  +++Q+ H N+V+LLG  +E +  L +V E++  G+L  Y+        + 
Sbjct: 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLG 287

Query: 495 WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 554
            +  L+ +++V  A+ YL     +   HRD+ + N+L+ +   AKVSDFG ++  +    
Sbjct: 288 GDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEAS---- 340

Query: 555 HMTTQVHGTFGY--LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
             +TQ  G        PE  R  +F+ KSDV+SFG++L E+ + G  P
Sbjct: 341 --STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  150 bits (380), Expect = 1e-40
 Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 30/230 (13%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVK--KSKVIDESKVEEFINEM 444
            +      F L R+LG+G  G+V +  L         VAVK  K+ +I  S +EEF+ E 
Sbjct: 19  LIPE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76

Query: 445 VILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGTLFQYI---HDQNEDFPITW 495
             + + +H +V KL+G  L +       +P+++  F+ +G L  ++         F +  
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136

Query: 496 EMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 555
           +  +R  ++++  + YL   +S    HRD+ + N +L +     V+DFG SR +     +
Sbjct: 137 QTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY 193

Query: 556 MTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                 G    L       E    + +T  SDV++FGV + E++T G+ P
Sbjct: 194 ----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  148 bits (376), Expect = 1e-40
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 13/212 (6%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           EL+R  +   L + LG G  G V  G       VAVK  K       +EF  E   + ++
Sbjct: 4   ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKL 60

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +H  +VK  G C +     +V E+I NG L  Y+  ++    +     L +  +V   ++
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMA 118

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY--LD 568
           +L S   I   HRD+ + N L+D     KVSDFG +R +  DQ    + V   F      
Sbjct: 119 FLESHQFI---HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSA 173

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           PE F   +++ KSDV++FG+++ E+ + G+ P
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  148 bits (375), Expect = 2e-40
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 15/213 (7%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ R  +   L   LG G  G V+ G       VAVK  K       + F+ E  ++ Q+
Sbjct: 9   EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQL 65

Query: 451 NHRNVVKLLGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            H+ +V+L      T+ P+  + E++ NG+L  ++        +T    L +A +++  +
Sbjct: 66  QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGM 122

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY--L 567
           +++     I   HRD+++ NIL+ D    K++DFG +R +  ++   T +    F     
Sbjct: 123 AFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWT 177

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            PE      FT KSDV+SFG++L E++T G  P
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  148 bits (377), Expect = 3e-40
 Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 29/229 (12%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVK--KSKVIDESKVEEFINEM 444
            ++R  +   L +ILG+G  G+V +G L         VAVK  K     + ++EEF++E 
Sbjct: 30  VIDR--NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEA 87

Query: 445 VILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGTLFQYI---HDQNEDFPITWE 496
             +   +H NV++LLG C+E        P+++  F+  G L  Y+     +     I  +
Sbjct: 88  ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147

Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 556
             L+  ++++  + YL   ++    HRD+ + N +L D     V+DFG S+ +     + 
Sbjct: 148 TLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY- 203

Query: 557 TTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                G    +       E      +T KSDV++FGV + E+ T G  P
Sbjct: 204 ---RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  148 bits (376), Expect = 4e-40
 Identities = 55/210 (26%), Positives = 84/210 (40%), Gaps = 24/210 (11%)

Query: 401 LNRILGQGGQGTVYKGMLPD---GKIVAVKKSKVI------DESKVEEFINEMVILSQIN 451
           L R++G+GG G VY+    D    +IVA+K   ++      D         E     ++ 
Sbjct: 38  LRRLVGRGGMGDVYEAE--DTVRERIVALK---LMSETLSSDPVFRTRMQREARTAGRLQ 92

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
             +VV +           +    I    L   +       P+     + I  ++  AL  
Sbjct: 93  EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDA 149

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT--QVHGTFGYLDP 569
            H+A      HRD+K  NIL+     A + DFG +   A     +T      GT  Y+ P
Sbjct: 150 AHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAP 204

Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           E F  S  T ++D+Y+   VL E LTG  P
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPP 234

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  147 bits (374), Expect = 7e-40
 Identities = 65/308 (21%), Positives = 115/308 (37%), Gaps = 42/308 (13%)

Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMV 445
           F    +     ++   + LG+GG   V     L DG   A+K+    ++   EE   E  
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREAD 78

Query: 446 ILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGTLFQYI---HDQNEDFPITWEMR 498
           +    NH N+++L+  CL          L+  F   GTL+  I    D+        E +
Sbjct: 79  MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT---EDQ 135

Query: 499 -LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG---------ASRS 548
            L + + +   L  +H+       HRD+K TNILL D+ +  + D G             
Sbjct: 136 ILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192

Query: 549 MAVDQTHMTTQVHGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTL 605
            A+       Q   T  Y  PE F         +++DV+S G VL  ++ GE P  +   
Sbjct: 193 QALTLQDWAAQ-RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--Y--- 246

Query: 606 EEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            +        +    + +L      R              ++    + ++  +RP +  +
Sbjct: 247 -DMVFQKGDSVALAVQNQLSIPQSPRHSSA--------LWQLLNSMMTVDPHQRPHIPLL 297

Query: 666 TSELAGIK 673
            S+L  ++
Sbjct: 298 LSQLEALQ 305

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  148 bits (375), Expect = 7e-40
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 15/218 (6%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML---PDGKI-VAVKKSKV-IDESKVEEFINEM 444
           +E+E      ++ +I+G G  G V  G L       + VA+K  K    E +  +F++E 
Sbjct: 44  REIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101

Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
            I+ Q +H N+++L G      + ++V E++ NG+L  ++  +  D   T    + +   
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRG 159

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           V   + YL     +   HRD+ + N+L+D     KVSDFG SR +  D     T   G  
Sbjct: 160 VGAGMRYLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216

Query: 565 GYL--DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                 PE      F+  SDV+SFGVV+ E+L  GE+P
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  151 bits (383), Expect = 7e-40
 Identities = 70/316 (22%), Positives = 131/316 (41%), Gaps = 33/316 (10%)

Query: 360 KFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLP 419
            ++ ++   L  +       +  +T+       E   ++  L   LGQG  G V+ G   
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206

Query: 420 DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNG 478
               VA+K  K       E F+ E  ++ ++ H  +V+L      +E P+ +V E++  G
Sbjct: 207 GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKG 263

Query: 479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 538
           +L  ++        +     + +A +++  ++Y+     +   HRD+++ NIL+ +    
Sbjct: 264 SLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVC 319

Query: 539 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GE 597
           KV+DFG +R +  ++            +  PE     +FT KSDV+SFG++L EL T G 
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

Query: 598 KPIRFTTLEE--DKSLAAYFLFAMKE--ERLFEILDARVMKESGGDEIITFAKVAKRCLN 653
            P       E  D+    Y +    E  E L ++     M                +C  
Sbjct: 380 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDL-----M---------------CQCWR 419

Query: 654 LNGKKRPTMREVTSEL 669
              ++RPT   + + L
Sbjct: 420 KEPEERPTFEYLQAFL 435

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  146 bits (371), Expect = 1e-39
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 13/212 (6%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E++    +    + LG G  G V  G       VA+K  K       +EFI E  ++  +
Sbjct: 20  EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNL 76

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +H  +V+L G C +     ++ E++ NG L  Y+  +        +  L +  +V  A+ 
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAME 134

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY--LD 568
           YL S   +   HRD+ + N L++D+   KVSDFG SR +  D+   T+ V   F      
Sbjct: 135 YLESKQFL---HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP 189

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           PE    S+F+ KSD+++FGV++ E+ + G+ P
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  147 bits (374), Expect = 1e-39
 Identities = 50/219 (22%), Positives = 101/219 (46%), Gaps = 18/219 (8%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML----PDGKI-VAVKKSKVI-DESKVEEFINE 443
           +  +         ++LG G  GTV+KG+        KI V +K  +        +   + 
Sbjct: 8   RIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDH 65

Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
           M+ +  ++H ++V+LLG C       LV +++P G+L  ++           ++ L   +
Sbjct: 66  MLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGV 122

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +++  + YL     +   HR++ + N+LL    + +V+DFG +  +  D   +       
Sbjct: 123 QIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS-EAK 178

Query: 564 F--GYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               ++  E     ++T +SDV+S+GV + EL+T G +P
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  145 bits (369), Expect = 1e-39
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 13/212 (6%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
            ++         + +G G  G V+ G   +   VA+K  +       E+FI E  ++ ++
Sbjct: 4   VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKL 60

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +H  +V+L G CLE     LV EF+ +G L  Y+  + +      E  L + ++V   ++
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMA 118

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY--LD 568
           YL  A  I   HRD+ + N L+ +    KVSDFG +R +  DQ   T+     F      
Sbjct: 119 YLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWAS 173

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           PE F  S+++ KSDV+SFGV++ E+ + G+ P
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  146 bits (371), Expect = 1e-39
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 20/220 (9%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGML--PDGKI--VAVK--KSKVIDESKV-EEFINE 443
            +     +  L   LG G  G V +G    P GK   VAVK  K  V+ + +  ++FI E
Sbjct: 14  LIGE--KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71

Query: 444 MVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           +  +  ++HRN+++L G  L    P+ +V E  P G+L   +      F +      R A
Sbjct: 72  VNAMHSLDHRNLIRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYA 127

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
           ++V+  + YL S   I   HRD+ + N+LL  +   K+ DFG  R++  +  H   Q H 
Sbjct: 128 VQVAEGMGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184

Query: 563 TFGY--LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
              +    PE  ++  F+  SD + FGV L E+ T G++P
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  146 bits (370), Expect = 1e-39
 Identities = 61/275 (22%), Positives = 114/275 (41%), Gaps = 36/275 (13%)

Query: 401 LNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESK--VEEFINEMVILSQINHRNVVK 457
            +  +G+G   TVYKG+       VA  + +    +K   + F  E  +L  + H N+V+
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 458 LLGCCLETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
                  T       +LV E + +GTL  Y+        +  ++      ++   L +LH
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH 146

Query: 514 SAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           +  + PI HRD+K  NI +       K+ D G +    + +      V GT  ++ PE +
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFMAPEMY 202

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER---LFEILD 629
              ++ +  DVY+FG+ + E+ T E P       E ++ A  +       +     ++  
Sbjct: 203 E-EKYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVKPASFDKVAI 256

Query: 630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
             V       EII      + C+  N  +R ++++
Sbjct: 257 PEVK------EII------EGCIRQNKDERYSIKD 279

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  147 bits (372), Expect = 2e-39
 Identities = 55/212 (25%), Positives = 106/212 (50%), Gaps = 16/212 (7%)

Query: 397 DNFNLNRILGQGGQGTVYKGML--PDGKI---VAVKKSKVI-DESKVEEFINEMVILSQI 450
             F   ++LG G  GTVYKG+      K+   VA+K+ +        +E ++E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           ++ +V +LLG CL      L+ + +P G L  Y+  +     I  +  L   ++++  ++
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLD 568
           YL     +   HRD+ + N+L+      K++DFG ++ +  ++     +  G     ++ 
Sbjct: 132 YLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMA 187

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            E      +T +SDV+S+GV + EL+T G KP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  145 bits (369), Expect = 2e-39
 Identities = 64/207 (30%), Positives = 112/207 (54%), Gaps = 15/207 (7%)

Query: 401 LNRILGQGGQGTVYKGMLPDGKI---VAVK--KSKVIDESKVEEFINEMVILSQINHRNV 455
            ++ LG G  GTV KG     K+   VAVK  K++  D +  +E + E  ++ Q+++  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           V+++G C   E  +LV E    G L +Y+        +  +  + +  +VS  + YL  +
Sbjct: 81  VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 136

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFR 573
             +   HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   Q HG +   +  PE   
Sbjct: 137 NFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193

Query: 574 SSQFTDKSDVYSFGVVLAELLT-GEKP 599
             +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  145 bits (369), Expect = 3e-39
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 19/221 (8%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVKKSKVI-DESKVEEFINEMV 445
            +       + +R++G+G  G VY G   D        A+K    I +  +VE F+ E +
Sbjct: 15  LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74

Query: 446 ILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
           ++  +NH NV+ L+G  L  E +P ++  ++ +G L Q+I  ++     T +  +   ++
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQ 132

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           V+  + YL     +   HRD+ + N +LD+ +  KV+DFG +R   +      +      
Sbjct: 133 VARGMEYLAEQKFV---HRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRH 187

Query: 565 GYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
             L       E  ++ +FT KSDV+SFGV+L ELLT G  P
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  145 bits (369), Expect = 3e-39
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 20/211 (9%)

Query: 401 LNRILGQGGQGTVYKGMLPD---GKIVAVKKSK---VIDESKVEEFINEMVILSQINHRN 454
           L  ILG GG   V+     D    + VAVK  +     D S    F  E    + +NH  
Sbjct: 16  LGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 455 VVKLL--GC--CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           +V +   G        +P +V E++   TL   +H    + P+T +  + +  +   AL+
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALN 130

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT--QVHGTFGYLD 568
           + H      I HRD+K  NI++      KV DFG +R++A     +T    V GT  YL 
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           PE  R      +SDVYS G VL E+LTGE P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  143 bits (364), Expect = 9e-39
 Identities = 65/219 (29%), Positives = 113/219 (51%), Gaps = 16/219 (7%)

Query: 390 KELERATDNFNLNRI-LGQGGQGTVYKGML--PDGKI-VAVK--KSKVIDESKVEEFINE 443
           K+L    DN  +  I LG G  G+V +G+      +I VA+K  K         EE + E
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMRE 60

Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
             I+ Q+++  +V+L+G C    + +LV E    G L +++    +   I       +  
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLH 117

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +VS  + YL     +   HRD+ + N+LL +++ AK+SDFG S+++  D ++ T +  G 
Sbjct: 118 QVSMGMKYLEEKNFV---HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174

Query: 564 F--GYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +   +  PE     +F+ +SDV+S+GV + E L+ G+KP
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  145 bits (367), Expect = 1e-38
 Identities = 64/220 (29%), Positives = 112/220 (50%), Gaps = 18/220 (8%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML--PDGKI---VAVK--KSKVIDESKVEEFIN 442
            E+          +++G G  G VYKGML    GK    VA+K  K+   ++ +  +F+ 
Sbjct: 39  TEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLG 95

Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  I+ Q +H N+++L G   + +  +++ E++ NG L +++  + +D   +    + + 
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGML 153

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
             ++  + YL +   +   HRD+ + NIL++     KVSDFG SR +  D     T   G
Sbjct: 154 RGIAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210

Query: 563 TFGY--LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                   PE     +FT  SDV+SFG+V+ E++T GE+P
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  143 bits (364), Expect = 1e-38
 Identities = 74/294 (25%), Positives = 115/294 (39%), Gaps = 24/294 (8%)

Query: 376 STEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDE 434
           S   T E        E +   D      +LG+G  G VY G  L +   +A+K+    D 
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 435 SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPIT 494
              +    E+ +   + H+N+V+ LG   E     +  E +P G+L   +  +       
Sbjct: 61  RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120

Query: 495 WEMRLR-IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAVD 552
            E  +     ++   L YLH      I HRDIK  N+L++      K+SDFG S+ +A  
Sbjct: 121 -EQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176

Query: 553 QTHMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKS 610
                T   GT  Y+ PE        +   +D++S G  + E+ TG+ P  F  L E   
Sbjct: 177 NPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP--FYELGE--P 231

Query: 611 LAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
            AA F   M +           + ES   E   F     +C   +  KR    +
Sbjct: 232 QAAMFKVGMFK-------VHPEIPESMSAEAKAF---ILKCFEPDPDKRACAND 275

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  144 bits (365), Expect = 2e-38
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 29/230 (12%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVKKSKVI-DESKVEEFIN 442
            E+ R  +   ++R LGQG  G VY+G+            VA+K         +  EF+N
Sbjct: 20  WEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77

Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------IHDQNEDFPITW 495
           E  ++ + N  +VV+LLG   + +  L++ E +  G L  Y       + +     P + 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137

Query: 496 EMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 555
              +++A E++  ++YL    +    HRD+ + N ++ + +  K+ DFG +R +     +
Sbjct: 138 SKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194

Query: 556 MTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                 G  G L      PE  +   FT  SDV+SFGVVL E+ T  E+P
Sbjct: 195 RK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  148 bits (376), Expect = 2e-38
 Identities = 70/316 (22%), Positives = 131/316 (41%), Gaps = 33/316 (10%)

Query: 360 KFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLP 419
            ++ ++   L  +       +  +T+       E   ++  L   LGQG  G V+ G   
Sbjct: 230 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 289

Query: 420 DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNG 478
               VA+K  K       E F+ E  ++ ++ H  +V+L      +E P+ +V E++  G
Sbjct: 290 GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKG 346

Query: 479 TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 538
           +L  ++        +     + +A +++  ++Y+     +   HRD+++ NIL+ +    
Sbjct: 347 SLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVC 402

Query: 539 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GE 597
           KV+DFG +R +  ++            +  PE     +FT KSDV+SFG++L EL T G 
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462

Query: 598 KPIRFTTLEE--DKSLAAYFLFAMKE--ERLFEILDARVMKESGGDEIITFAKVAKRCLN 653
            P       E  D+    Y +    E  E L ++     M                +C  
Sbjct: 463 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDL-----M---------------CQCWR 502

Query: 654 LNGKKRPTMREVTSEL 669
              ++RPT   + + L
Sbjct: 503 KEPEERPTFEYLQAFL 518

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  147 bits (372), Expect = 2e-38
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 13/222 (5%)

Query: 382 EKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFI 441
           +  K +     E   ++  L + LG G  G V+         VAVK  K      VE F+
Sbjct: 173 KPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFL 231

Query: 442 NEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLR 500
            E  ++  + H  +VKL      T+ P+ ++ EF+  G+L  ++   +E         + 
Sbjct: 232 AEANVMKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLID 288

Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
            + +++  ++++     I   HRD+++ NIL+      K++DFG +R +  ++   T + 
Sbjct: 289 FSAQIAEGMAFIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNE--YTARE 343

Query: 561 HGTFGY--LDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
              F      PE      FT KSDV+SFG++L E++T G  P
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  143 bits (363), Expect = 2e-38
 Identities = 63/294 (21%), Positives = 118/294 (40%), Gaps = 58/294 (19%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINHRN 454
            +++ + +G GG   V++ +    +I A+K     +  D   ++ + NE+  L+++   +
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 87

Query: 455 --VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             +++L    +  +   +V E   N  L  ++  + +     WE +      +  A+  +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDP-WERK-SYWKNMLEAVHTI 143

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT--HMTTQVHGTFGYLDPE 570
           H      I H D+K  N L+ D    K+ DFG +  M  D T     +QV GT  Y+ PE
Sbjct: 144 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPE 198

Query: 571 -----------YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM 619
                          S+ + KSDV+S G +L  +  G+ P  F  +              
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQI---------- 246

Query: 620 KEERLFEILDARVMKESGGDEIITFAKVA--------KRCLNLNGKKRPTMREV 665
              +L  I+D         +  I F  +         K CL  + K+R ++ E+
Sbjct: 247 --SKLHAIID--------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  143 bits (363), Expect = 3e-38
 Identities = 59/282 (20%), Positives = 99/282 (35%), Gaps = 33/282 (11%)

Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVE--EFINEMV 445
           S+       +F     LG G  G V+K     DG++ AVK+S        +    + E+ 
Sbjct: 49  SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108

Query: 446 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAI 503
              ++  H   V+L     E  +  L  E     +L Q+        P   E ++     
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP---EAQVWGYLR 164

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           +   AL++LHS     + H D+K  NI L  + R K+ DFG    +            G 
Sbjct: 165 DTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQEGD 219

Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER 623
             Y+ PE  +   +   +DV+S G+ + E+    +       E            +++  
Sbjct: 220 PRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMEL--PHGGEG--------WQQLRQGY 268

Query: 624 LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
           L     A +  E           V    L  + K R T   +
Sbjct: 269 LPPEFTAGLSSE--------LRSVLVMMLEPDPKLRATAEAL 302

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  141 bits (359), Expect = 5e-38
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 18/217 (8%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGML--PDGKI--VAVKKSKV-IDESKVEEFINEMV 445
           E++R  +   L R +G+G  G V++G+   P+     VA+K  K    +S  E+F+ E +
Sbjct: 11  EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68

Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
            + Q +H ++VKL+G   E     ++ E    G L  ++  Q   + +     +  A ++
Sbjct: 69  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQL 125

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF- 564
           S AL+YL S   +   HRDI + N+L+      K+ DFG SR M            G   
Sbjct: 126 STALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLP 180

Query: 565 -GYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
             ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  144 bits (365), Expect = 5e-38
 Identities = 66/218 (30%), Positives = 112/218 (51%), Gaps = 15/218 (6%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGML--PDGK--IVAVKKSKV-IDESKVEEFINEM 444
           KEL+    N ++++++G G  G V  G L  P  K   VA+K  KV   E +  +F+ E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97

Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
            I+ Q +H N+++L G   +++  ++V E++ NG+L  ++   +  F  T    + +   
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRG 155

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           ++  + YL     +   HRD+ + NIL++     KVSDFG  R +  D     T   G  
Sbjct: 156 IASGMKYLSDMGYV---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212

Query: 565 GYL--DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                 PE     +FT  SDV+S+G+VL E+++ GE+P
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  143 bits (362), Expect = 5e-38
 Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 35/235 (14%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVKKSKVIDESKVEEFINE 443
             ++R   +  L   LG+G  G V+     +        +VAVK  K   ES  ++F  E
Sbjct: 36  HHIKR--RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQRE 93

Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY------------IHDQNEDF 491
             +L+ + H+++V+  G C E    L+V+E++ +G L ++              +     
Sbjct: 94  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-A 550
           P+     L +A +V+  + YL   A +   HRD+ + N L+      K+ DFG SR + +
Sbjct: 154 PLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210

Query: 551 VDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            D   +  +       L      PE     +FT +SDV+SFGVVL E+ T G++P
Sbjct: 211 TDYYRVGGR-----TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  141 bits (358), Expect = 6e-38
 Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 20/218 (9%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGML--PDGKI--VAVK--KSKVIDESKVEEFINEM 444
            + R  ++  LNRILG+G  G VY+G+     G+   VAVK  K     ++K E+F++E 
Sbjct: 8   GIAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEA 64

Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
           VI+  ++H ++VKL+G   E E   ++ E  P G L  Y+        +     +  +++
Sbjct: 65  VIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQ 121

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           +  A++YL S   +   HRDI   NIL+      K+ DFG SR +  +            
Sbjct: 122 ICKAMAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY--YKASVTRL 176

Query: 565 --GYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
              ++ PE     +FT  SDV+ F V + E+L+ G++P
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  147 bits (372), Expect = 1e-37
 Identities = 70/332 (21%), Positives = 133/332 (40%), Gaps = 27/332 (8%)

Query: 289 KRSRDSFFSKKTRIIFGNISSFIIYRYAISILRLSSSGVGCT------SGGLGMFLLIGA 342
            + +   +       F  +   + Y    +   +      C       + G     L   
Sbjct: 214 SQDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAH 273

Query: 343 WWLFKFVKRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLN 402
                  +RR +      +      +    +           +   S   E       L 
Sbjct: 274 PSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLK 333

Query: 403 RI--------LGQGGQGTVYKGML--PDGKI-VAVKKSKV-IDESKVEEFINEMVILSQI 450
           R         LG G  G+V +G+      +I VA+K  K   +++  EE + E  I+ Q+
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           ++  +V+L+G C    + +LV E    G L +++    +   I       +  +VS  + 
Sbjct: 394 DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMK 450

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY--LD 568
           YL     +   HR++ + N+LL +++ AK+SDFG S+++  D ++ T +  G +      
Sbjct: 451 YLEEKNFV---HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 507

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           PE     +F+ +SDV+S+GV + E L+ G+KP
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  140 bits (356), Expect = 4e-37
 Identities = 63/293 (21%), Positives = 115/293 (39%), Gaps = 56/293 (19%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVK--KSKVIDESKVEEFINEMVILSQINH--R 453
            +++ + +G GG   V++ +    +I A+K    +  D   ++ + NE+  L+++     
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
            +++L    +  +   +V E   N  L  ++  +     I    R      +  A+  +H
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH 125

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT--HMTTQVHGTFGYLDPE- 570
                 I H D+K  N L+ D    K+ DFG +  M  D T     +QV GT  Y+ PE 
Sbjct: 126 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEA 180

Query: 571 ----------YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
                         S+ + KSDV+S G +L  +  G+ P  F  +               
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQI----------- 227

Query: 621 EERLFEILDARVMKESGGDEIITFAKVA--------KRCLNLNGKKRPTMREV 665
             +L  I+D         +  I F  +         K CL  + K+R ++ E+
Sbjct: 228 -SKLHAIID--------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  140 bits (355), Expect = 5e-37
 Identities = 65/303 (21%), Positives = 103/303 (33%), Gaps = 34/303 (11%)

Query: 370 LQQELASTEGTIEKTKLF-TSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK 427
           L  E    EG +   KL     E             +G+G  G V++      G   AVK
Sbjct: 30  LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89

Query: 428 KSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ 487
           K ++           E+V  + ++   +V L G   E     +  E +  G+L Q I  Q
Sbjct: 90  KVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQ 143

Query: 488 NEDFPITWEMRLR-IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGA 545
               P   E R      +    L YLH+   +   H D+K+ N+LL     RA + DFG 
Sbjct: 144 MGCLP---EDRALYYLGQALEGLEYLHTRRIL---HGDVKADNVLLSSDGSRAALCDFGH 197

Query: 546 SRSMAVDQTHMTTQ----VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
           +  +  D    +      + GT  ++ PE         K D++S   ++  +L G  P  
Sbjct: 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP-- 255

Query: 602 FTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPT 661
           +T              A +   + EI        S            +  L      R +
Sbjct: 256 WTQYFR---GPLCLKIASEPPPIREI------PPSCAPLTAQA---IQEGLRKEPVHRAS 303

Query: 662 MRE 664
             E
Sbjct: 304 AME 306

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  141 bits (358), Expect = 5e-37
 Identities = 66/323 (20%), Positives = 126/323 (39%), Gaps = 59/323 (18%)

Query: 371 QQELASTEGTIEKTKLFTSKELERATDN---FNLNRILGQGGQGTVYKGMLPDGKIVAVK 427
           +Q + S +   +     +S   E  +     +++ + +G GG   V++ +    +I A+K
Sbjct: 27  RQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 86

Query: 428 --KSKVIDESKVEEFINEMVILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 483
               +  D   ++ + NE+  L+++      +++L    +  +   +V E   N  L  +
Sbjct: 87  YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 145

Query: 484 IHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 543
           +  + +     WE +      +  A+  +H      I H D+K  N L+ D    K+ DF
Sbjct: 146 LK-KKKSIDP-WERK-SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDF 198

Query: 544 GASRSMAVDQT--HMTTQVHGTFGYLDPE-----------YFRSSQFTDKSDVYSFGVVL 590
           G +  M  D T     +QV G   Y+ PE               S+ + KSDV+S G +L
Sbjct: 199 GIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

Query: 591 AELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVA-- 648
             +  G+ P  F  +                 +L  I+D         +  I F  +   
Sbjct: 258 YYMTYGKTP--FQQIINQI------------SKLHAIID--------PNHEIEFPDIPEK 295

Query: 649 ------KRCLNLNGKKRPTMREV 665
                 K CL  + K+R ++ E+
Sbjct: 296 DLQDVLKCCLKRDPKQRISIPEL 318

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  139 bits (353), Expect = 7e-37
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 43/243 (17%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVKKSKVI-DESKVEEFINE 443
           E  R   N  L + LG+G  G V K      K       VAVK  K     S++ + ++E
Sbjct: 19  EFPR--KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76

Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------------------- 483
             +L Q+NH +V+KL G C +    LL+ E+   G+L  +                    
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136

Query: 484 -IHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 542
              D  ++  +T    +  A ++S  + YL   A + + HRD+ + NIL+ +  + K+SD
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISD 193

Query: 543 FGASRSMAVDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-G 596
           FG SR +  + +++      + G +       E      +T +SDV+SFGV+L E++T G
Sbjct: 194 FGLSRDVYEEDSYVK----RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249

Query: 597 EKP 599
             P
Sbjct: 250 GNP 252

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  138 bits (351), Expect = 8e-37
 Identities = 61/235 (25%), Positives = 106/235 (45%), Gaps = 34/235 (14%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVKKSKVIDESKVEEFINE 443
           + ++R   +  L R LG+G  G V+     +        +VAVK  K    +  ++F  E
Sbjct: 10  QHIKR--RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQRE 67

Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------------IHDQNED 490
             +L+ + H ++VK  G C + +  ++V+E++ +G L ++                +   
Sbjct: 68  AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 491 FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 550
             +     L IA +++  + YL   AS    HRD+ + N L+      K+ DFG SR + 
Sbjct: 128 GELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184

Query: 551 VDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
               +      G    L      PE     +FT +SDV+SFGV+L E+ T G++P
Sbjct: 185 STDYYRV----GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  138 bits (349), Expect = 1e-36
 Identities = 50/235 (21%), Positives = 95/235 (40%), Gaps = 46/235 (19%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKI--------VAVKKSKVIDESKVEEFIN 442
           ++    ++   N  LGQG    ++KG+  +           V +K       +  E F  
Sbjct: 4   KIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61

Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
              ++S+++H+++V   G C+  +  +LV EF+  G+L  Y+        I W+  L +A
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVA 119

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR--------AKVSDFGASRSMAVDQT 554
            +++ A+ +L     I   H ++ + NILL  +           K+SD G S ++     
Sbjct: 120 KQLAAAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD- 175

Query: 555 HMTTQVHGTFGYLDP---------EYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                        +          E  +       +D +SFG  L E+ + G+KP
Sbjct: 176 ----------ILQERIPWVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKP 218

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  138 bits (351), Expect = 2e-36
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 31/231 (13%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVK--KSKVIDESKVEEFI 441
           KE+ R   N  L R LG G  G VY+G +           VAVK       ++ +  +F+
Sbjct: 25  KEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFL 81

Query: 442 NEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI----HDQNEDFPITWEM 497
            E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++       ++   +    
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141

Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQT 554
            L +A +++    YL         HRDI + N LL        AK+ DFG +R +     
Sbjct: 142 LLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198

Query: 555 HMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +      G    L      PE F    FT K+D +SFGV+L E+ + G  P
Sbjct: 199 Y----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  144 bits (365), Expect = 2e-36
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 12/218 (5%)

Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGML--PDGKI--VAVKKSKV-IDESKVEEFIN 442
           ++++ E   +   L R +G+G  G V++G+   P+     VA+K  K    +S  E+F+ 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440

Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E + + Q +H ++VKL+G   E  V  ++ E    G L  ++  Q   F +     +  A
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYA 497

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            ++S AL+YL S   +   HRDI + N+L+      K+ DFG SR M     +  ++   
Sbjct: 498 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554

Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
              ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  140 bits (355), Expect = 3e-36
 Identities = 59/280 (21%), Positives = 114/280 (40%), Gaps = 35/280 (12%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVV 456
           +F    +LG G +GT+    + D + VAV   K I          E+ +L + + H NV+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAV---KRILPECFSFADREVQLLRESDEHPNVI 81

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +      + +   +  E     TL +Y+  + +DF       + +  + +  L++LHS  
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138

Query: 517 SIPIYHRDIKSTNILLDDK-----YRAKVSDFGASRSMAVDQ---THMTTQVHGTFGYLD 568
              I HRD+K  NIL+         +A +SDFG  + +AV +   +  +    GT G++ 
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIA 194

Query: 569 PEYFRSSQF---TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
           PE          T   D++S G V   +++        +L+            +    L 
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------ANILLGACSLD 248

Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            +   +       + I       ++ + ++ +KRP+ + V
Sbjct: 249 CLHPEKHEDVIARELI-------EKMIAMDPQKRPSAKHV 281

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  136 bits (345), Expect = 3e-36
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 16/218 (7%)

Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEM 444
           +  +    ++F +  +LG+G    VY+   +  G  VA+K   K  +     V+   NE+
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62

Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
            I  Q+ H ++++L     E    + LV E   NG + +Y+ ++ + F    E   R  +
Sbjct: 63  KIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS---ENEARHFM 118

Query: 504 -EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVH 561
            ++   + YLHS     I HRD+  +N+LL      K++DFG A++     + H T    
Sbjct: 119 HQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-- 173

Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           GT  Y+ PE    S    +SDV+S G +   LL G  P
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  137 bits (347), Expect = 4e-36
 Identities = 67/308 (21%), Positives = 124/308 (40%), Gaps = 39/308 (12%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-SKVIDESKVEEFINEMVILSQINHRN 454
             + L+ ILGQG    V++G     G + A+K  + +     V+  + E  +L ++NH+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 455 VVKLLGC--CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
           +VKL        T   +L+ EF P G+L+  + + +  + +     L +  +V G +++L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 513 HSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
                  I HR+IK  NI+     D +   K++DFGA+R +  D     +   GT  YL 
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLH 183

Query: 569 PEYFRSS--------QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
           P+ +  +        ++    D++S GV      TG  P  F   E  +      ++ + 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPFEGPRRNKE-VMYKII 240

Query: 621 EERLFEILDARVMKESGGDEIIT---------------FAKVAKRCLNLNGKKRPTMREV 665
             +    +      E+G  +                     V    L  + +K     + 
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 666 TSELAGIK 673
            +E + I 
Sbjct: 301 FAETSDIL 308

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  138 bits (350), Expect = 5e-36
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 31/231 (13%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVK--KSKVIDESKVEEFI 441
           KE+ R   N  L R LG G  G VY+G +           VAVK       ++ +  +F+
Sbjct: 66  KEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFL 122

Query: 442 NEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI----HDQNEDFPITWEM 497
            E +I+S+ NH+N+V+ +G  L++    ++ E +  G L  ++       ++   +    
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182

Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQT 554
            L +A +++    YL         HRDI + N LL        AK+ DFG +R +     
Sbjct: 183 LLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239

Query: 555 HMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +      G    L      PE F    FT K+D +SFGV+L E+ + G  P
Sbjct: 240 Y----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  135 bits (343), Expect = 7e-36
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 17/217 (7%)

Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEM 444
           SK+ + A ++F + R LG+G  G VY         I+A+K   K+++       +   E+
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60

Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IA 502
            I S + H N+++L G        + L+ E+ P GT+++ +  +   F    E R     
Sbjct: 61  EIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFD---EQRTATYI 115

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 562
            E++ ALSY HS     + HRDIK  N+LL      K++DFG S   A           G
Sbjct: 116 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC--G 169

Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           T  YL PE        +K D++S GV+  E L G+ P
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  138 bits (348), Expect = 1e-35
 Identities = 67/308 (21%), Positives = 124/308 (40%), Gaps = 39/308 (12%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-SKVIDESKVEEFINEMVILSQINHRN 454
             + L+ ILGQG    V++G     G + A+K  + +     V+  + E  +L ++NH+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 455 VVKLLGC--CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
           +VKL        T   +L+ EF P G+L+  + + +  + +     L +  +V G +++L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 513 HSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
                  I HR+IK  NI+     D +   K++DFGA+R +  D     +   GT  YL 
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLH 183

Query: 569 PEYFRSS--------QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
           P+ +  +        ++    D++S GV      TG  P  F   E  +      ++ + 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPFEGPRRNKE-VMYKII 240

Query: 621 EERLFEILDARVMKESGGDEIIT---------------FAKVAKRCLNLNGKKRPTMREV 665
             +    +      E+G  +                     V    L  + +K     + 
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 666 TSELAGIK 673
            +E + I 
Sbjct: 301 FAETSDIL 308

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  136 bits (344), Expect = 1e-35
 Identities = 70/237 (29%), Positives = 103/237 (43%), Gaps = 37/237 (15%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKVI-DESKVEEFINE 443
           E  R  D   L + LG+G  G V +            + VAVK  K     S+    ++E
Sbjct: 23  EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80

Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLV-YEFIPNGTLFQY-------------IHDQN 488
           + IL  I +H NVV LLG C +   PL+V  EF   G L  Y               +  
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140

Query: 489 EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 548
               +T E  +  + +V+  + +L   AS    HRD+ + NILL +K   K+ DFG +R 
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197

Query: 549 MAVDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +  D  ++          L      PE      +T +SDV+SFGV+L E+ + G  P
Sbjct: 198 IYKDPDYVRK----GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  137 bits (345), Expect = 2e-35
 Identities = 36/329 (10%), Positives = 75/329 (22%), Gaps = 52/329 (15%)

Query: 373 ELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---K 428
           E  +     +  +      L +      L   L  G +  V+    +   +  A+K    
Sbjct: 38  EAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTM 97

Query: 429 SKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP-------------------- 468
                 S++E         +++   +  +                               
Sbjct: 98  GAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDD 157

Query: 469 ------LLVYEFIPNGTLFQYIHD----QNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
                 LL+     +  L                        +  ++    + L S    
Sbjct: 158 YAVANYLLLMPA-ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214

Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS--Q 576
            + H      N+ +    R  + D                       Y   E+  +S   
Sbjct: 215 -LVHGHFTPDNLFIMPDGRLMLGDVS----ALWKVGTRGPASSVPVTYAPREFLNASTAT 269

Query: 577 FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES 636
           FT   + +  G+ +  +     P    T     S     L     + L       +    
Sbjct: 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL--PD 327

Query: 637 GGDEIITFAKVAKRCLNLNGKKRPTMREV 665
               +I       R LN + ++R    E 
Sbjct: 328 FVKTLI------GRFLNFDRRRRLLPLEA 350

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  135 bits (343), Expect = 2e-35
 Identities = 60/238 (25%), Positives = 103/238 (43%), Gaps = 38/238 (15%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK--------IVAVKKSKVI-DESKVEEFI 441
           E  R  D   L + LG+G  G V                  VAVK  K    E  + + +
Sbjct: 31  EFPR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 88

Query: 442 NEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------------IHDQ 487
           +EM ++  I  H+N++ LLG C +     ++ E+   G L +Y               ++
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148

Query: 488 NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 547
             +  +T++  +    +++  + YL   AS    HRD+ + N+L+ +    K++DFG +R
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

Query: 548 SMAVDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            +     +       T G L      PE      +T +SDV+SFGV++ E+ T G  P
Sbjct: 206 DINNIDYYKK----TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  135 bits (341), Expect = 3e-35
 Identities = 57/244 (23%), Positives = 99/244 (40%), Gaps = 58/244 (23%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK---IVAVKKSKVI-DESKVEEFINEMVI 446
            L+   ++     ++G+G  G V K  +         A+K+ K    +    +F  E+ +
Sbjct: 21  VLDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 78

Query: 447 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------------IHDQNEDFP 492
           L ++ +H N++ LLG C       L  E+ P+G L  +                 +    
Sbjct: 79  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138

Query: 493 ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS---- 548
           ++ +  L  A +V+  + YL   +     HRD+ + NIL+ + Y AK++DFG SR     
Sbjct: 139 LSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 195

Query: 549 ------------MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT- 595
                       MA                   E    S +T  SDV+S+GV+L E+++ 
Sbjct: 196 VKKTMGRLPVRWMA------------------IESLNYSVYTTNSDVWSYGVLLWEIVSL 237

Query: 596 GEKP 599
           G  P
Sbjct: 238 GGTP 241

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  140 bits (355), Expect = 4e-35
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 18/221 (8%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-SKVIDESKVEEFINEMVILSQI 450
            +    + +   LG GG G V + +    G+ VA+K+  + +     E +  E+ I+ ++
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 451 NHRNVVKLLGCCLETE-------VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
           NH NVV       +         +PLL  E+   G L +Y++       +       +  
Sbjct: 70  NHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTHMTTQV 560
           ++S AL YLH      I HRD+K  NI+L     +   K+ D G ++ +  DQ  + T+ 
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF 183

Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR 601
            GT  YL PE     ++T   D +SFG +  E +TG +P  
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  135 bits (342), Expect = 6e-35
 Identities = 60/238 (25%), Positives = 103/238 (43%), Gaps = 38/238 (15%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK--------IVAVKKSKVI-DESKVEEFI 441
           E  R  D   L + LG+G  G V                  VAVK  K    E  + + +
Sbjct: 77  EFPR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 134

Query: 442 NEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------------IHDQ 487
           +EM ++  I  H+N++ LLG C +     ++ E+   G L +Y               ++
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194

Query: 488 NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 547
             +  +T++  +    +++  + YL   AS    HRD+ + N+L+ +    K++DFG +R
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

Query: 548 SMAVDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            +     +       T G L      PE      +T +SDV+SFGV++ E+ T G  P
Sbjct: 252 DINNIDYYKK----TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  134 bits (339), Expect = 8e-35
 Identities = 58/243 (23%), Positives = 107/243 (44%), Gaps = 43/243 (17%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVKKSKVI-DESKVEEFINE 443
           E  R  +N    R +G+G  G V++   P         +VAVK  K         +F  E
Sbjct: 43  EYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 100

Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------------------- 483
             ++++ ++ N+VKLLG C   +   L++E++  G L ++                    
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160

Query: 484 -IHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 542
                    P++   +L IA +V+  ++YL   +     HRD+ + N L+ +    K++D
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIAD 217

Query: 543 FGASRSMAVDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-G 596
           FG SR++     +           +      PE    +++T +SDV+++GVVL E+ + G
Sbjct: 218 FGLSRNIYSADYYKA----DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273

Query: 597 EKP 599
            +P
Sbjct: 274 LQP 276

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  133 bits (337), Expect = 2e-34
 Identities = 47/254 (18%), Positives = 83/254 (32%), Gaps = 27/254 (10%)

Query: 370 LQQELASTEGTIEKT----KLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVA 425
           L + ++S   T E       +    E +  +    ++ +LG+G    VY+    D     
Sbjct: 34  LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93

Query: 426 VKKS---KVIDESKVEEF---INEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 479
            K+    KV   +   EF      M  L        +K     L     +LV E    GT
Sbjct: 94  NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153

Query: 480 LFQYIHD--QNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
           L   I+      +  +   + +  A+ +   +  +H      I H DIK  N +L + + 
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210

Query: 538 A-----------KVSDFGASRSMAVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYS 585
                        + D G S  M +       T    T G+   E   +  +  + D + 
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270

Query: 586 FGVVLAELLTGEKP 599
               +  +L G   
Sbjct: 271 VAATVYCMLFGTYM 284

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  131 bits (333), Expect = 2e-34
 Identities = 57/237 (24%), Positives = 102/237 (43%), Gaps = 37/237 (15%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVK--KSKVIDESKVEEFI 441
           KE+            LG+   G VYKG L           VA+K  K K     + EEF 
Sbjct: 4   KEISL--SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFR 60

Query: 442 NEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------------IHDQN 488
           +E ++ +++ H NVV LLG   + +   +++ +  +G L ++               D+ 
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120

Query: 489 EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 548
               +     + +  +++  + YL   +S  + H+D+ + N+L+ DK   K+SD G  R 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177

Query: 549 MAVDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
           +     +           L      PE     +F+  SD++S+GVVL E+ + G +P
Sbjct: 178 VYAADYYKL----LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  134 bits (338), Expect = 3e-34
 Identities = 65/238 (27%), Positives = 103/238 (43%), Gaps = 38/238 (15%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK--------IVAVKKSKVI-DESKVEEFI 441
           EL R  D   L + LG+G  G V                  VAVK  K    E  + + I
Sbjct: 65  ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 122

Query: 442 NEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------------IHDQ 487
           +EM ++  I  H+N++ LLG C +     ++ E+   G L +Y                 
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182

Query: 488 NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 547
           N +  ++ +  +  A +V+  + YL   AS    HRD+ + N+L+ +    K++DFG +R
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

Query: 548 SMAVDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            +     +       T G L      PE      +T +SDV+SFGV+L E+ T G  P
Sbjct: 240 DIHHIDYYKK----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  135 bits (341), Expect = 5e-34
 Identities = 71/291 (24%), Positives = 121/291 (41%), Gaps = 35/291 (12%)

Query: 385 KLFTSKELERATDNFNLNRILGQGGQGTVYKG-MLPDGKIVAVK---KSKVIDESKVEEF 440
            +F        +D +   R+LG+G  G V        G+  AVK   K +V  ++  E  
Sbjct: 14  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73

Query: 441 INEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR 500
           + E+ +L Q++H N++KL     +     LV E    G LF  I  +      +     R
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAAR 130

Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQTHMT 557
           I  +V   ++Y+H      I HRD+K  N+LL+ K      ++ DFG S      +  M 
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MK 186

Query: 558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF 617
            ++ GT  Y+ PE    + + +K DV+S GV+L  LL+G  P  F               
Sbjct: 187 DKI-GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP--F--------------N 228

Query: 618 AMKEERLFE-ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
              E  + + +   +   +     ++   AK + ++ L      R + R+ 
Sbjct: 229 GANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  134 bits (338), Expect = 6e-34
 Identities = 70/304 (23%), Positives = 120/304 (39%), Gaps = 60/304 (19%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNV 455
           +     +ILG G  GTV       G+ VAV   K +     +  + E+ +L++  +H NV
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAV---KRMLIDFCDIALMEIKLLTESDDHPNV 71

Query: 456 VKLLGCCLETEVPL-LVYEFIPNGTLFQYI---HDQNEDFPITWEMRLRIAI-EVSGALS 510
           ++   C   T+  L +  E   N  L   +   +  +E+  +  E      + +++  ++
Sbjct: 72  IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 511 YLHSAASIPIYHRDIKSTNILLDDK-------------YRAKVSDFGASRSMAVDQTHMT 557
           +LH   S+ I HRD+K  NIL+                 R  +SDFG  + +   Q+   
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 558 TQVH---GTFGYLDPEYFRSSQF-------TDKSDVYSFGVVLAELLT-GEKPIRFTTLE 606
           T ++   GT G+  PE    S         T   D++S G V   +L+ G+ P       
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP------- 239

Query: 607 EDKSLAAYFLFAMKEERLFEILDARV----MKESGGDEIITFAK-VAKRCLNLNGKKRPT 661
                     F  K  R   I+        MK      +I  A  +  + ++ +  KRPT
Sbjct: 240 ----------FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289

Query: 662 MREV 665
             +V
Sbjct: 290 AMKV 293

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  130 bits (330), Expect = 7e-34
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 38/238 (15%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVKKSK-VIDESKVEEFINE 443
           E  R  +  +  + LG G  G V +              VAVK  K     ++ E  ++E
Sbjct: 19  EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76

Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY---------------IHDQ 487
           + +LS + NH N+V LLG C      L++ E+   G L  +                  +
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 488 NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 547
           +++  +  E  L  + +V+  +++L   AS    HRD+ + NILL      K+ DFG +R
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 548 SMAVDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
            +  D  ++          L      PE   +  +T +SDV+S+G+ L EL + G  P
Sbjct: 194 DIKNDSNYVVK----GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  131 bits (331), Expect = 8e-34
 Identities = 61/283 (21%), Positives = 108/283 (38%), Gaps = 48/283 (16%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
             +   R LG+GG    ++       ++ A K   KS ++   + E+   E+ I   + H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 453 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVSGA 508
           ++VV   G   E    + +V E     +L +    +    E      E R     ++   
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 153

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGYL 567
             YLH      + HRD+K  N+ L++    K+ DFG A++     +        GT  Y+
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYI 208

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
            PE       + + DV+S G ++  LL G+ P  F    E   L     +   ++  + I
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP--F----ETSCLKE--TYLRIKKNEYSI 260

Query: 628 -----LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                  A          +I      ++ L  +   RPT+ E+
Sbjct: 261 PKHINPVAA--------SLI------QKMLQTDPTARPTINEL 289

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  130 bits (329), Expect = 8e-34
 Identities = 61/283 (21%), Positives = 108/283 (38%), Gaps = 48/283 (16%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
             +   R LG+GG    ++       ++ A K   KS ++   + E+   E+ I   + H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 453 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVSGA 508
           ++VV   G   E    + +V E     +L +    +    E      E R     ++   
Sbjct: 75  QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 127

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGYL 567
             YLH      + HRD+K  N+ L++    K+ DFG A++     +        GT  Y+
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYI 182

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
            PE       + + DV+S G ++  LL G+ P  F    E   L     +   ++  + I
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP--F----ETSCLKE--TYLRIKKNEYSI 234

Query: 628 -----LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                  A          +I      ++ L  +   RPT+ E+
Sbjct: 235 PKHINPVAA--------SLI------QKMLQTDPTARPTINEL 263

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  129 bits (327), Expect = 9e-34
 Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 21/224 (9%)

Query: 384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKG-MLPDGKIVAVK---KSKVIDESKVEE 439
           T L    + +   D+F++ R LG+G  G VY      +  I+A+K   KS++  E    +
Sbjct: 1   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60

Query: 440 FINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITW 495
              E+ I S + H N++++          + L+ EF P G L++ +      +E      
Sbjct: 61  LRREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ----- 114

Query: 496 EMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 555
                   E++ AL Y H      + HRDIK  N+L+  K   K++DFG S   A     
Sbjct: 115 RSA-TFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRR 169

Query: 556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            T    GT  YL PE        +K D++  GV+  E L G  P
Sbjct: 170 RTMC--GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  130 bits (330), Expect = 1e-33
 Identities = 57/246 (23%), Positives = 97/246 (39%), Gaps = 58/246 (23%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPD------GKIVAVKKSK-VIDESKVEEFINE 443
           E  R  +N    + LG G  G V +              VAVK  K      + E  ++E
Sbjct: 42  EFPR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99

Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF----------- 491
           + I+S +  H N+V LLG C      L++ E+   G L  ++  ++              
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159

Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 551
             +    L  + +V+  +++L   AS    HRD+ + N+LL + + AK+ DFG +R +  
Sbjct: 160 TASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-- 214

Query: 552 DQTHMTTQVHGTFGYLDPEYFRSSQ-----------------FTDKSDVYSFGVVLAELL 594
                           D  Y                      +T +SDV+S+G++L E+ 
Sbjct: 215 --------------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

Query: 595 T-GEKP 599
           + G  P
Sbjct: 261 SLGLNP 266

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (328), Expect = 2e-33
 Identities = 61/243 (25%), Positives = 104/243 (42%), Gaps = 43/243 (17%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK------IVAVKKSK-VIDESKVEEFINE 443
           E  R  +N    ++LG G  G V                VAVK  K   D S+ E  ++E
Sbjct: 41  EFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 98

Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY------------------- 483
           + +++Q+ +H N+V LLG C  +    L++E+   G L  Y                   
Sbjct: 99  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158

Query: 484 -IHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 542
            + ++ +   +T+E  L  A +V+  + +L         HRD+ + N+L+      K+ D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICD 215

Query: 543 FGASRSMAVDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLAELLT-G 596
           FG +R +  D  ++          L      PE      +T KSDV+S+G++L E+ + G
Sbjct: 216 FGLARDIMSDSNYVVR----GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271

Query: 597 EKP 599
             P
Sbjct: 272 VNP 274

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  132 bits (334), Expect = 4e-33
 Identities = 66/305 (21%), Positives = 116/305 (38%), Gaps = 36/305 (11%)

Query: 371 QQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKG-MLPDGKIVAVK-- 427
           ++ L           +F + +    ++ +   + LG G  G V            A+K  
Sbjct: 11  RENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70

Query: 428 -KSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD 486
            K+ V       + + E+ +L  ++H N++KL     +     LV E    G LF  I  
Sbjct: 71  RKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129

Query: 487 QNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDF 543
           +             I  +V   ++YLH      I HRD+K  N+LL+ K      K+ DF
Sbjct: 130 RM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDF 183

Query: 544 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFT 603
           G S      +  M  ++ GT  Y+ PE  R   + +K DV+S GV+L  LL G  P    
Sbjct: 184 GLSAVFENQKK-MKERL-GTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPF--- 237

Query: 604 TLEEDKSLAAYFLFAMKEERLFE-ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRP 660
                            ++ +   +   +          +   AK + K+ L  + ++R 
Sbjct: 238 -------------GGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI 284

Query: 661 TMREV 665
           + ++ 
Sbjct: 285 SAQQA 289

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  127 bits (322), Expect = 1e-32
 Identities = 62/311 (19%), Positives = 125/311 (40%), Gaps = 43/311 (13%)

Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMV 445
           F  + +E       + R+L +GG   VY+   +  G+  A+K+    +E K    I E+ 
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC 77

Query: 446 ILSQI-NHRNVVKLLGCCLETEVP-------LLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
            + ++  H N+V+        +          L+   +  G L +++       P++ + 
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137

Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 557
            L+I  +   A+ ++H     PI HRD+K  N+LL ++   K+ DFG++ +++    +  
Sbjct: 138 VLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196

Query: 558 T-----------QVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLAELLTGEKPIRFT 603
           +             + T  Y  PE           +K D+++ G +L  L   + P  F 
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--F- 253

Query: 604 TLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMR 663
              ED +                I++ +        +   F  + +  L +N ++R ++ 
Sbjct: 254 ---EDGAKLR-------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIA 297

Query: 664 EVTSELAGIKA 674
           EV  +L  I A
Sbjct: 298 EVVHQLQEIAA 308

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  124 bits (313), Expect = 8e-32
 Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 33/231 (14%)

Query: 394 RATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEE--FINEMVILSQI 450
           R T  F+    +G G  G+V+K +   DG I A+K+SK      V+E   + E+   + +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 451 -NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLR-IAIEVSGA 508
             H +VV+      E +  L+  E+   G+L   I +         E  L+ + ++V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 509 LSYLHSAASIPIYHRDIKSTNILLD-------------------DKYRAKVSDFGASRSM 549
           L Y+HS +   + H DIK +NI +                    +K   K+ D G    +
Sbjct: 128 LRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKP 599
               +    +  G   +L  E  + +     K+D+++  + +      E  
Sbjct: 185 ----SSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  124 bits (313), Expect = 1e-31
 Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 35/276 (12%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN 454
              +     +GQG  GTVY  M +  G+ VA+++  +  + K E  INE++++ +  + N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ--NEDFPITWEMRLRIAI---EVSGAL 509
           +V  L   L  +   +V E++  G+L   + +   +E          +IA    E   AL
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG---------QIAAVCRECLQAL 129

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            +LHS   I   HRDIKS NILL      K++DFG    +  +Q+  +T V GT  ++ P
Sbjct: 130 EFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 185

Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE-RLFEIL 628
           E      +  K D++S G++  E++ GE P        +  L A +L A      L    
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP-----YLNENPLRALYLIATNGTPELQN-- 238

Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
                 E        F     RCL ++ +KR + +E
Sbjct: 239 -----PEKLSAIFRDF---LNRCLEMDVEKRGSAKE 266

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  127 bits (319), Expect = 1e-31
 Identities = 26/236 (11%), Positives = 66/236 (27%), Gaps = 42/236 (17%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINE--------------- 443
            +LGQ       +      G+   V     ++    + +++   E               
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 444 -------MVILSQINHRNVVKLLGCCLETEVPLLVYEFIP-------NGTLFQYIHDQN- 488
                  +     +      K++   L+     ++  F           T  + +   + 
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 489 EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 548
               +    RL++ ++V   L+ LH      + H  ++  +I+LD +    ++ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQ-----FTDKSDVYSFGVVLAELLTGEKP 599
                     +                Q      T   D ++ G+ +  +   + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  123 bits (310), Expect = 4e-31
 Identities = 71/271 (26%), Positives = 113/271 (41%), Gaps = 25/271 (9%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN 454
               +    +G+G  G V        G+ VAVK   +  + + E   NE+VI+    H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           VV++    L  E   ++ EF+  G L     D      +  E    +   V  AL+YLH+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
              I   HRDIKS +ILL    R K+SDFG    ++ D     + V GT  ++ PE    
Sbjct: 160 QGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215

Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE-RLFEILDARVM 633
           S +  + D++S G+++ E++ GE P        D  + A          +L         
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPP-----YFSDSPVQAMKRLRDSPPPKLKN------- 263

Query: 634 KESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
                  +  F    +R L  + ++R T +E
Sbjct: 264 SHKVSPVLRDF---LERMLVRDPQERATAQE 291

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  126 bits (318), Expect = 6e-31
 Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 45/300 (15%)

Query: 386 LFTSKELERATDNFNLNRILGQGGQGTVYKG-MLPDGKIVAVK---KSKVID-------- 433
           ++  K+  +  +++   R LG G  G V            A+K   KS+           
Sbjct: 25  MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84

Query: 434 --ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF 491
             E   EE  NE+ +L  ++H N++KL     + +   LV EF   G LF+ I +++   
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--- 141

Query: 492 PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRS 548
                    I  ++   + YLH      I HRDIK  NILL++K      K+ DFG S  
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198

Query: 549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED 608
            + D   +  ++ GT  Y+ PE  +   + +K DV+S GV++  LL G  P  F      
Sbjct: 199 FSKDYK-LRDRL-GTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPP--F------ 247

Query: 609 KSLAAYFLFAMKEERLFE-ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
                       ++ + + +   +     +    I   AK + K  L  +  KR T  E 
Sbjct: 248 --------GGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  125 bits (316), Expect = 9e-31
 Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 38/281 (13%)

Query: 396 TDNFNLNRILGQGGQGTVYKG-MLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQIN 451
            + +N+  +LG+G  G V K       +  AVK   K+   ++      + E+ +L +++
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLD 79

Query: 452 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           H N++KL     E      +V E    G LF  I  +      +     RI  +V   ++
Sbjct: 80  HPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGIT 135

Query: 511 YLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           Y+H      I HRD+K  NILL+ K      K+ DFG S     +   M  ++ GT  Y+
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYI 190

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE- 626
            PE  R + + +K DV+S GV+L  LL+G  P  F              +   E  + + 
Sbjct: 191 APEVLRGT-YDEKCDVWSAGVILYILLSGTPP--F--------------YGKNEYDILKR 233

Query: 627 ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
           +   +          I   AK + ++ L  +   R T  + 
Sbjct: 234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  122 bits (307), Expect = 9e-31
 Identities = 71/275 (25%), Positives = 120/275 (43%), Gaps = 33/275 (12%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID-ESKVEEFINEMVILSQINHR 453
            + F++   LG+G  G+VYK +    G+IVA+K    +  ES ++E I E+ I+ Q +  
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK---QVPVESDLQEIIKEISIMQQCDSP 84

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI---EVSGALS 510
           +VVK  G   +     +V E+   G++   I  +N+           IA         L 
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-----IATILQSTLKGLE 139

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YLH    I   HRDIK+ NILL+ +  AK++DFG +  +        T + GT  ++ PE
Sbjct: 140 YLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPE 195

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE-RLFEILD 629
             +   +   +D++S G+   E+  G+ P       +   + A F+          +   
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPP-----YADIHPMRAIFMIPTNPPPTFRK--- 247

Query: 630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
                E   D    F    K+CL  + ++R T  +
Sbjct: 248 ----PELWSDNFTDF---VKQCLVKSPEQRATATQ 275

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  122 bits (308), Expect = 1e-30
 Identities = 66/302 (21%), Positives = 118/302 (39%), Gaps = 45/302 (14%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVK-----------------KSKVIDESKVEE 439
           +++ + R L QG    +      D K  A+K                   K+  +SK ++
Sbjct: 31  NDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 440 FINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIH-----DQNEDFPI 493
           F NE+ I++ I +   +   G  +     + ++YE++ N ++ ++       D+N    I
Sbjct: 90  FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 494 TWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 553
             ++   I   V  + SY+H+  +I   HRD+K +NIL+D   R K+SDFG S  M    
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGESEYM--VD 204

Query: 554 THMTTQVHGTFGYLDPEYFRSSQFTD--KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
             +     GT+ ++ PE+F +    +  K D++S G+ L  +     P  F       SL
Sbjct: 205 KKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP--F---SLKISL 258

Query: 612 AAYFL------FAM-KEERLFEILDARVMKESGGDEIITFAK-VAKRCLNLNGKKRPTMR 663
              F            +   F             + +        K  L  N  +R T  
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318

Query: 664 EV 665
           + 
Sbjct: 319 DA 320

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  120 bits (304), Expect = 2e-30
 Identities = 78/282 (27%), Positives = 124/282 (43%), Gaps = 48/282 (17%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID----ESKVEEFINEMVILSQI 450
            + F     +G+G  G V+KG+     K+VA+K   +ID    E ++E+   E+ +LSQ 
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDIQQEITVLSQC 77

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ--NEDFPITWEMRLRIAI---EV 505
           +   V K  G  L+     ++ E++  G+    +     +E           IA    E+
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---------IATILREI 128

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
              L YLHS   I   HRDIK+ N+LL +    K++DFG +  +   Q    T V GT  
Sbjct: 129 LKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPF 184

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF-LFAMKEERL 624
           ++ PE  + S +  K+D++S G+   EL  GE P              +  L  MK   L
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPP--------------HSELHPMKV--L 228

Query: 625 FEIL--DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
           F I   +   ++ +    +  F    + CLN     RPT +E
Sbjct: 229 FLIPKNNPPTLEGNYSKPLKEF---VEACLNKEPSFRPTAKE 267

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  120 bits (304), Expect = 2e-30
 Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 32/285 (11%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVID----ESKVEEFINEMVILSQIN 451
           D++ L  ++G G    V      P  + VA+K    I+    ++ ++E + E+  +SQ +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIK---RINLEKCQTSMDELLKEIQAMSQCH 71

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNG---TLFQYIHDQNEDFPITWEMRLRIAI---EV 505
           H N+V      +  +   LV + +  G    + ++I  + E      +    IA    EV
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREV 130

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF- 564
              L YLH    I   HRD+K+ NILL +    +++DFG S  +A        +V  TF 
Sbjct: 131 LEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 565 G---YLDPEYF-RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
           G   ++ PE   +   +  K+D++SFG+   EL TG  P  +      K L    L    
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP--YHKYPPMKVL---MLTLQN 242

Query: 621 EE-RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
           +   L   +  + M +  G        ++  CL  + +KRPT  E
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKM--ISL-CLQKDPEKRPTAAE 284

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  120 bits (303), Expect = 3e-30
 Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 18/213 (8%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN 454
            + + +   LG G  G VYK      G + A K  +   E ++E++I E+ IL+  +H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI---EVSGALSY 511
           +VKLLG         ++ EF P G +   + + +            I +   ++  AL++
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQMLEALNF 132

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE- 570
           LHS   I   HRD+K+ N+L+  +   +++DFG S           + + GT  ++ PE 
Sbjct: 133 LHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188

Query: 571 ----YFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
                 + + +  K+D++S G+ L E+   E P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  120 bits (301), Expect = 1e-29
 Identities = 45/338 (13%), Positives = 95/338 (28%), Gaps = 74/338 (21%)

Query: 373 ELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---- 427
            L ST             EL           +LGQ       +      G+   V     
Sbjct: 49  SLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYF 108

Query: 428 ----KSKVIDESKVEE--------------------FINEMVILSQINHRNVVKLLGCCL 463
                S  I + K E                     FI    ++     + ++++     
Sbjct: 109 TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 168

Query: 464 ETEVP--LLVYEFI--PNGTLFQYIHD-QNEDFPITWEMRLRIAIEVSGALSYLHSAASI 518
           +  V     +Y  +     T  + +    +    +    RL++ ++V   L+ LH     
Sbjct: 169 DMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226

Query: 519 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF------ 572
            + H  ++  +I+LD +    ++ F                   + G+  PE        
Sbjct: 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSS-----VSRGFEPPELEARRATI 280

Query: 573 -----RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
                R +  T   D ++ G+V+  +   + P       +D +L          E +F  
Sbjct: 281 SYHRDRRTLMTFSFDAWALGLVIYWIWCADLP--I---TKDAALGGS-------EWIFR- 327

Query: 628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
              + + +     +       +  L    + R    + 
Sbjct: 328 -SCKNIPQPVRALL-------EGFLRYPKEDRLLPLQA 357

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  119 bits (300), Expect = 2e-29
 Identities = 74/309 (23%), Positives = 126/309 (40%), Gaps = 45/309 (14%)

Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV-IDESKVEEFINEMVI 446
            K  E   D+F     LG G  G V+K    P G ++A K   + I  +   + I E+ +
Sbjct: 25  QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 84

Query: 447 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVS 506
           L + N   +V   G         +  E +  G+L Q +        I  ++  +++I V 
Sbjct: 85  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVI 141

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS----RSMAVDQTHMTTQVHG 562
             L+YL     I   HRD+K +NIL++ +   K+ DFG S     SMA       + V G
Sbjct: 142 KGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA------NSFV-G 192

Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE 622
           T  Y+ PE  + + ++ +SD++S G+ L E+  G  PI     +E + +    +     E
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252

Query: 623 R-----------------------LFEILDARVMKESGGDEIITFAKVAK----RCLNLN 655
                                   +FE+LD  V +         F+   +    +CL  N
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312

Query: 656 GKKRPTMRE 664
             +R  +++
Sbjct: 313 PAERADLKQ 321

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  115 bits (289), Expect = 1e-28
 Identities = 69/281 (24%), Positives = 110/281 (39%), Gaps = 36/281 (12%)

Query: 396 TDNFNLNRILGQGGQGTVYKG-MLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQIN 451
            D F   R LG G  G V+       G    +K   K +   +  +E+   E+ +L  ++
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD 78

Query: 452 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMR-LRIAIEVSGAL 509
           H N++K+     E    + +V E    G L + I           E     +  ++  AL
Sbjct: 79  HPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGY 566
           +Y HS     + H+D+K  NIL  D       K+ DFG +     D+   T    GT  Y
Sbjct: 138 AYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAA-GTALY 192

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
           + PE F+    T K D++S GVV+  LLTG  P  F       S           E + +
Sbjct: 193 MAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP--F----TGTS----------LEEVQQ 235

Query: 627 -ILDARVMKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
                          +   A  + K+ L  + ++RP+  +V
Sbjct: 236 KATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  117 bits (295), Expect = 1e-28
 Identities = 47/221 (21%), Positives = 81/221 (36%), Gaps = 25/221 (11%)

Query: 396 TDNFNLNRILGQGGQ--GTVYKGM-LPDGKIVAVKKSKV--IDESKVEEFINEMVILSQI 450
              + L  ++G+G +   TV      P G+ V V++  +       V     E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEMRLRIAI---EVS 506
           NH N+V      +      +V  F+  G+    I     +           IA     V 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH----- 561
            AL Y+H    +   HR +K+++IL+    +  +S   ++ SM                 
Sbjct: 139 KALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 562 -GTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLAELLTGEKP 599
                +L PE  + +   +  KSD+YS G+   EL  G  P
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  115 bits (290), Expect = 1e-28
 Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 21/213 (9%)

Query: 397 DNFNLNRILGQGGQGTVY----KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           ++F   +ILG+G   TV            +  A+K   K  +I E+KV     E  ++S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86

Query: 450 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSG 507
           ++H   VKL     + +  L     +  NG L +YI      F    E   R    E+  
Sbjct: 87  LDHPFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGS-FD---ETCTRFYTAEIVS 141

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGY 566
           AL YLH      I HRD+K  NILL++    +++DFG A       +        GT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           + PE          SD+++ G ++ +L+ G  P
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  116 bits (293), Expect = 1e-28
 Identities = 71/294 (24%), Positives = 119/294 (40%), Gaps = 36/294 (12%)

Query: 386 LFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESK--VEE 439
           L  + +     D + L  ++G+G    V + +    G+  AVK    +K         E+
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72

Query: 440 FINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMR 498
              E  I   + H ++V+LL     ++  L +V+EF+    L   I  + +   +  E  
Sbjct: 73  LKREASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131

Query: 499 LRIAI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQT 554
               + ++  AL Y H      I HRD+K   +LL  K  +   K+  FG +  +     
Sbjct: 132 ASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188

Query: 555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY 614
               +V GT  ++ PE  +   +    DV+  GV+L  LL+G  P               
Sbjct: 189 VAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP--------------- 232

Query: 615 FLFAMKEERLFE-ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
             F   +ERLFE I+  +  M       I   AK + +R L L+  +R T+ E 
Sbjct: 233 --FYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  116 bits (292), Expect = 5e-28
 Identities = 69/291 (23%), Positives = 110/291 (37%), Gaps = 48/291 (16%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVI-----DESKVEEFINEMVI 446
            D + +++ LG G  G V         K VA++   K K       +         E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 447 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAI 503
           L ++NH  ++K+     + E   +V E +  G LF  +       E        +     
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFY 246

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQTHMTTQV 560
           ++  A+ YLH      I HRD+K  N+LL  +      K++DFG S+ +  + + M T  
Sbjct: 247 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC 302

Query: 561 HGTFGYLDPEYFRSSQF---TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF 617
            GT  YL PE   S          D +S GV+L   L+G  P               F  
Sbjct: 303 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---------------FSE 346

Query: 618 AMKEERLFE-ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
              +  L + I   +         E+   A  + K+ L ++ K R T  E 
Sbjct: 347 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  113 bits (284), Expect = 7e-28
 Identities = 69/285 (24%), Positives = 126/285 (44%), Gaps = 35/285 (12%)

Query: 392 LERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV-IDESKVEEFINEM-VILS 448
           +E   D+      LG+G  G V K   +P G+I+AVK+ +  ++  + +  + ++ + + 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 449 QINHRNVVKLLGCCL-ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRL-RIAIEVS 506
            ++    V   G    E +V  +  E +       Y    ++   I  E  L +IA+ + 
Sbjct: 62  TVDCPFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIP-EDILGKIAVSIV 119

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
            AL +LHS  S+ I HRD+K +N+L++   + K+ DFG S  + VD         G   Y
Sbjct: 120 KALEHLHSKLSV-I-HRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDA-GCKPY 175

Query: 567 LDPE----YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE 622
           + PE          ++ KSD++S G+ + EL     P              Y  +    +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP--------------YDSWGTPFQ 221

Query: 623 RLFEILDA---RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
           +L ++++    ++  +    E + F     +CL  N K+RPT  E
Sbjct: 222 QLKQVVEEPSPQLPADKFSAEFVDF---TSQCLKKNSKERPTYPE 263

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  117 bits (295), Expect = 7e-28
 Identities = 74/241 (30%), Positives = 109/241 (45%), Gaps = 19/241 (7%)

Query: 369 LLQQELASTEGTIEKTKLFTSKELERAT---DNFNLNRILGQGGQGTVYKGMLPD-GKIV 424
           L     A    +I   +    K LER     + F   R+LG+GG G V    +   GK+ 
Sbjct: 153 LSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMY 212

Query: 425 AVK---KSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTL 480
           A K   K ++         +NE  IL ++N R VV L     ET+  L LV   +  G L
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDL 271

Query: 481 FQYIHDQNED-FPITWEMRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 538
             +I+   +  FP   E R    A E+   L  LH      I +RD+K  NILLDD    
Sbjct: 272 KFHIYHMGQAGFP---EARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHI 325

Query: 539 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEK 598
           ++SD G +  +   QT       GT GY+ PE  ++ ++T   D ++ G +L E++ G+ 
Sbjct: 326 RISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

Query: 599 P 599
           P
Sbjct: 384 P 384

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  117 bits (294), Expect = 8e-28
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 11/209 (5%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F   R+LG+GG G V+   +   GK+ A K   K ++      +  + E  IL++++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 453 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALS 510
           R +V L     ET+  L LV   +  G +  +I++ +ED P   E R      ++   L 
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           +LH      I +RD+K  N+LLDD    ++SD G +  +   QT       GT G++ PE
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
                ++    D ++ GV L E++    P
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  112 bits (282), Expect = 9e-28
 Identities = 30/219 (13%), Positives = 62/219 (28%), Gaps = 46/219 (21%)

Query: 401 LNRILGQGGQGTVYKGMLPD---GKIVAVK---KSKVIDESKVEEFINEMVILSQINHRN 454
           L    G       ++ +  D    + VA+       V+ +  ++E ++  + LS+I+   
Sbjct: 35  LLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           V ++L         L+V E+I  G+L +           +    +R    ++ A    H 
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHR 147

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
           A    +       + + +       +                          +       
Sbjct: 148 A---GVALSIDHPSRVRVSIDGDVVL---------------------AYPATMPDA---- 179

Query: 575 SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAA 613
                + D+   G  L  LL    P           LA 
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWP--LPEAGVRSGLAP 213

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  114 bits (288), Expect = 9e-28
 Identities = 59/283 (20%), Positives = 107/283 (37%), Gaps = 37/283 (13%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILS 448
               D +++   LG G  G V++ +    G++   K       +D        NE+ I++
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMN 103

Query: 449 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVS 506
           Q++H  ++ L     E +  + L+ EF+  G LF  I  ++       E  +   + +  
Sbjct: 104 QLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMS---EAEVINYMRQAC 159

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRA--KVSDFGASRSMAVDQTHMTTQVHGTF 564
             L ++H  +   I H DIK  NI+ + K  +  K+ DFG +  +  +   +      T 
Sbjct: 160 EGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATA 214

Query: 565 GYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
            +  PE          +D+++ GV+   LL+G  P               F      E L
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP---------------FAGEDDLETL 259

Query: 625 FEILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
             +        E     +   AK   K  L    +KR T+ + 
Sbjct: 260 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  113 bits (284), Expect = 1e-27
 Identities = 75/307 (24%), Positives = 131/307 (42%), Gaps = 52/307 (16%)

Query: 375 ASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSK 430
            +    +  TKL   KE E     + +  +LG GG G+VY G+ + D   VA+K   K +
Sbjct: 21  MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80

Query: 431 VIDESKVEEFIN---EMVILSQINHR--NVVKLLGCCLETEVPL-LVYEFI-PNGTLFQY 483
           + D  ++        E+V+L +++     V++LL    E      L+ E   P   LF +
Sbjct: 81  ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDF 139

Query: 484 IHDQ---NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAK 539
           I ++    E+       R     +V  A+ + H+     + HRDIK  NIL+D ++   K
Sbjct: 140 ITERGALQEE-----LAR-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190

Query: 540 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEK 598
           + DFG+   +    T  T    GT  Y  PE+ R  ++    + V+S G++L +++ G+ 
Sbjct: 191 LIDFGSGALL--KDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247

Query: 599 PIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKK 658
           P       +++ +     F     R     + +         +I      + CL L    
Sbjct: 248 PFE----HDEEIIRGQVFF-----RQRVSSECQ--------HLI------RWCLALRPSD 284

Query: 659 RPTMREV 665
           RPT  E+
Sbjct: 285 RPTFEEI 291

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  113 bits (284), Expect = 1e-27
 Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 49/292 (16%)

Query: 388 TSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINE 443
           +  + +    N+ L + +G+G    V     +  G+ VA+K   K++ ++ + +++   E
Sbjct: 6   SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFRE 64

Query: 444 MVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRL 499
           + I+  +NH N+VKL    +ETE  L L+ E+   G +F Y+       E      E R 
Sbjct: 65  VRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EAR- 117

Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 559
               ++  A+ Y H      I HRD+K+ N+LLD     K++DFG S    V    +   
Sbjct: 118 SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF 173

Query: 560 VHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA 618
             G   Y  PE F+  ++   + DV+S GV+L  L++G  P  F    + ++L    L  
Sbjct: 174 C-GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--F----DGQNLKE--LRE 224

Query: 619 MKEERLFEI-----LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                 + I      D                 + KR L LN  KR T+ ++
Sbjct: 225 RVLRGKYRIPFYMSTDCE--------------NLLKRFLVLNPIKRGTLEQI 262

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  114 bits (288), Expect = 2e-27
 Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 26/226 (11%)

Query: 390 KELERATDNFNLNRILGQGGQGTVY----KGMLPDGKIVAVK---KSKVIDESKVEEFIN 442
           KE+    D+F + +++G+G    V     K     G++ A+K   K  ++   +V  F  
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFRE 110

Query: 443 EMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI 501
           E  +L   + R + +L     + E  L LV E+   G L   +    E  P       R 
Sbjct: 111 ERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP---AEMARF 166

Query: 502 -AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
              E+  A+  +H    +   HRDIK  NILLD     +++DFG+   +  D T  +   
Sbjct: 167 YLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223

Query: 561 HGTFGYLDPEYFRSSQFTDKSDVY-------SFGVVLAELLTGEKP 599
            GT  YL PE  ++      +  Y       + GV   E+  G+ P
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  111 bits (281), Expect = 2e-27
 Identities = 78/288 (27%), Positives = 118/288 (40%), Gaps = 40/288 (13%)

Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEM 444
           S +       F    +LG G    V+       GK+ A+K   KS    +S +E   NE+
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEI 57

Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
            +L +I H N+V L     E+     LV + +  G LF  I ++      T +    +  
Sbjct: 58  AVLKKIKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQ 113

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMAVDQTHMTTQV 560
           +V  A+ YLH      I HRD+K  N+L    ++  +  ++DFG S+        M+T  
Sbjct: 114 QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTAC 168

Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
            GT GY+ PE      ++   D +S GV+   LL G  P      EE             
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY----EET------------ 211

Query: 621 EERLFE-ILDARVMKESGG-DEIITFAK-VAKRCLNLNGKKRPTMREV 665
           E +LFE I +     ES   D+I   AK      L  +  +R T  + 
Sbjct: 212 ESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  111 bits (279), Expect = 3e-27
 Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 36/280 (12%)

Query: 396 TDNFNLNRILGQGGQGTVYKG-MLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQIN 451
            + +N+  +LG+G  G V K       +  AVK   K+   ++      + E+ +L +++
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD 79

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H N++KL     ++    +V E    G LF  I  +      +     RI  +V   ++Y
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITY 136

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           +H      I HRD+K  NILL+ K +    K+ DFG S     +   M  ++ GT  Y+ 
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYIA 191

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE-I 627
           PE  R + + +K DV+S GV+L  LL+G  P  F              +   E  + + +
Sbjct: 192 PEVLRGT-YDEKCDVWSAGVILYILLSGTPP--F--------------YGKNEYDILKRV 234

Query: 628 LDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
              +          I   AK + ++ L  +   R T  + 
Sbjct: 235 ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  112 bits (281), Expect = 4e-27
 Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 24/214 (11%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESK---VEEFINEMVILSQIN 451
              F+  R +G G  G VY    + + ++VA+KK     +      ++ I E+  L ++ 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI---EVSGA 508
           H N ++  GC L      LV E+   G+    +    +           IA         
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE-----IAAVTHGALQG 166

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           L+YLHS   I   HRD+K+ NILL +    K+ DFG++  M        + V GT  ++ 
Sbjct: 167 LAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMA 218

Query: 569 PE---YFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           PE        Q+  K DV+S G+   EL   + P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  109 bits (274), Expect = 1e-26
 Identities = 64/284 (22%), Positives = 106/284 (37%), Gaps = 46/284 (16%)

Query: 396 TDNFNLNRILGQGGQGTVYKG-MLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQIN 451
              + L   +G+G  G V            A K   K  V D  + +    E+ I+  ++
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLD 64

Query: 452 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVSG 507
           H N+++L     E    + LV E    G LF+ +  +    E          RI  +V  
Sbjct: 65  HPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRE------SDAARIMKDVLS 117

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
           A++Y H      + HRD+K  N L          K+ DFG +      +  M T+V GT 
Sbjct: 118 AVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTP 172

Query: 565 GYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
            Y+ P+      +  + D +S GV++  LL G  P  F               A  +  +
Sbjct: 173 YYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP--F--------------SAPTDSEV 215

Query: 625 FE-ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
              I +      E     +   A+ + +R L  + K+R T  + 
Sbjct: 216 MLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  110 bits (277), Expect = 1e-26
 Identities = 69/340 (20%), Positives = 119/340 (35%), Gaps = 74/340 (21%)

Query: 380 TIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK-----KSKVID 433
           +  +   F    L      ++L   +GQG  G V   +      I A+K     K + I+
Sbjct: 9   SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68

Query: 434 ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPI 493
              VE    E+ ++ +++H N+ +L     + +   LV E    G L   ++   +D   
Sbjct: 69  PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128

Query: 494 TWEMRL-------------------------------------RIAIEVSGALSYLHSAA 516
              M +                                      I  ++  AL YLH+  
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188

Query: 517 SIPIYHRDIKSTNILLDDK--YRAKVSDFGASRSMAV----DQTHMTTQVHGTFGYLDPE 570
              I HRDIK  N L      +  K+ DFG S+        +   MTT+  GT  ++ PE
Sbjct: 189 ---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE 244

Query: 571 YFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE-I 627
              ++   +  K D +S GV+L  LL G  P  F                + +      +
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVP--F--------------PGVNDADTISQV 288

Query: 628 LDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
           L+ ++  +    + +   A+ +    LN N  +R      
Sbjct: 289 LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  109 bits (275), Expect = 1e-26
 Identities = 81/300 (27%), Positives = 131/300 (43%), Gaps = 64/300 (21%)

Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFIN-- 442
            K+ E     + L  +LG+GG GTV+ G  L D   VA+K   +++V+  S + + +   
Sbjct: 23  GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82

Query: 443 -EMVILSQIN----HRNVVKLLGCCLETEVPL-LVYEF-IPNGTLFQYIHDQ---NEDFP 492
            E+ +L ++     H  V++LL    ET+    LV E  +P   LF YI ++    E   
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEG-- 139

Query: 493 ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAV 551
                R     +V  A+ + HS     + HRDIK  NIL+D +   AK+ DFG+   +  
Sbjct: 140 ---PSR-CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL-- 190

Query: 552 DQTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKS 610
                T    GT  Y  PE+    Q+    + V+S G++L +++ G+ P  F   E D+ 
Sbjct: 191 HDEPYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP--F---ERDQ- 243

Query: 611 LAAYFLFAMKEERLFEILDARV-----MKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                          EIL+A +     +       I       +RCL      RP++ E+
Sbjct: 244 ---------------EILEAELHFPAHVSPDCCALI-------RRCLAPKPSSRPSLEEI 281

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  110 bits (276), Expect = 2e-26
 Identities = 70/284 (24%), Positives = 121/284 (42%), Gaps = 25/284 (8%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV-IDESKVEEFINEM-VI 446
           +  +   ++      +G+G  G+V K +  P G+I+AVK+ +  +DE + ++ + ++ V+
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 447 LSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRL-RIAIE 504
           +   +   +V+  G    E +   +  E +       Y +  +    +  E  L +I + 
Sbjct: 75  MRSSDCPYIVQFYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
              AL++L     I   HRDIK +NILLD     K+ DFG S  + VD    T    G  
Sbjct: 134 TVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDA-GCR 189

Query: 565 GYLDPEYFRSSQFTD----KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
            Y+ PE    S        +SDV+S G+ L EL TG  P  +             L  + 
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP--YPKWNSVFDQ----LTQVV 243

Query: 621 EERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
           +    ++ ++   + S     I F      CL  +  KRP  +E
Sbjct: 244 KGDPPQLSNSEEREFS--PSFINF---VNLCLTKDESKRPKYKE 282

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  113 bits (284), Expect = 2e-26
 Identities = 65/323 (20%), Positives = 119/323 (36%), Gaps = 31/323 (9%)

Query: 350 KRRREIKLKRKFFKRNGGLLLQQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGG 409
           +R  ++  + K  +  G +    +    +   +        + +   D+++++  LG G 
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169

Query: 410 QGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP 468
            G V++      G   A K      ES  E    E+  +S + H  +V L     E +  
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-EDDNE 228

Query: 469 L-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI-EVSGALSYLHSAASIPIYHRDIK 526
           + ++YEF+  G LF+ + D++       E      + +V   L ++H        H D+K
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNKMS---EDEAVEYMRQVCKGLCHMHENN---YVHLDLK 282

Query: 527 STNILLDDK--YRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 584
             NI+   K     K+ DFG +  +  D         GT  +  PE          +D++
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340

Query: 585 SFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV-MKESGGDEIIT 643
           S GV+   LL+G  P               F     +E L  +      M +S    I  
Sbjct: 341 SVGVLSYILLSGLSP---------------FGGENDDETLRNVKSCDWNMDDSAFSGISE 385

Query: 644 FAK-VAKRCLNLNGKKRPTMREV 665
             K   ++ L  +   R T+ + 
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQA 408

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  111 bits (279), Expect = 2e-26
 Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 26/235 (11%)

Query: 381 IEKTKLFTS--KELERATDNFNLNRILGQGGQGTVY----KGMLPDGKIVAVK---KSKV 431
           +E  K FTS  K++    ++F + +++G+G  G V     K      K+ A+K   K ++
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEM 112

Query: 432 IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNED 490
           +  ++   F  E  +L   + + +  L     + +  L LV ++   G L   +    + 
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR 171

Query: 491 FPITWEMRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 549
            P   E   R    E+  A+  +H    +   HRDIK  NIL+D     +++DFG+   +
Sbjct: 172 LP---EEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225

Query: 550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-----DVYSFGVVLAELLTGEKP 599
             D T  ++   GT  Y+ PE  ++ +          D +S GV + E+L GE P
Sbjct: 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  110 bits (276), Expect = 3e-26
 Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 37/290 (12%)

Query: 387 FTSKELERATDNFNLNR--ILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEF 440
             + +       + +++  ILG G  G V+K      G  +A K      + D    EE 
Sbjct: 77  IVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEV 133

Query: 441 INEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRL 499
            NE+ +++Q++H N+++L     E++  + LV E++  G LF  I D++ +   T    +
Sbjct: 134 KNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNL--TELDTI 190

Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA--KVSDFGASRSMAVDQTHMT 557
               ++   + ++H      I H D+K  NIL  ++     K+ DFG +R     +  + 
Sbjct: 191 LFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LK 246

Query: 558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF 617
               GT  +L PE       +  +D++S GV+   LL+G  P               FL 
Sbjct: 247 VNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP---------------FLG 290

Query: 618 AMKEERLFEILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
               E L  IL  R  +++    +I   AK    + L      R +  E 
Sbjct: 291 DNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA 340

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (271), Expect = 3e-26
 Identities = 67/284 (23%), Positives = 116/284 (40%), Gaps = 37/284 (13%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILS 448
            + +DN+++   LG+G    V + +    G   A K     K+      ++   E  I  
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICR 60

Query: 449 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           ++ H N+V+L     + E    LV++ +  G LF+ I  +      +         ++  
Sbjct: 61  KLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILE 116

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTF 564
           +++Y HS     I HR++K  N+LL  K +    K++DFG +  +  D         GT 
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA-GTP 171

Query: 565 GYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
           GYL PE  +   ++   D+++ GV+L  LL G  P  F              +   + RL
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP--F--------------WDEDQHRL 215

Query: 625 FE-ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
           +  I            D +   AK +    L +N KKR T  + 
Sbjct: 216 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  108 bits (273), Expect = 3e-26
 Identities = 70/291 (24%), Positives = 111/291 (38%), Gaps = 48/291 (16%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVI-----DESKVEEFINEMVI 446
            D + +++ LG G  G V         K VA+K   K K       +         E+ I
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 447 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAI 503
           L ++NH  ++K+     + E   +V E +  G LF  +       E        +     
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFY 121

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQTHMTTQV 560
           ++  A+ YLH      I HRD+K  N+LL  +      K++DFG S+ +  + + M T  
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC 177

Query: 561 HGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF 617
            GT  YL PE   S     +    D +S GV+L   L+G  P               F  
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---------------FSE 221

Query: 618 AMKEERLFE-ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
              +  L + I   +         E+   A  + K+ L ++ K R T  E 
Sbjct: 222 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  113 bits (284), Expect = 3e-26
 Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 23/223 (10%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQIN- 451
           ++F+++RI+G+GG G VY     D GK+ A+K   K ++  +      +NE ++LS ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 452 --HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSG 507
                +V +      T   L  + + +  G L  ++  Q+  F    E  +R  A E+  
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFS---EADMRFYAAEIIL 303

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
            L ++H+     + +RD+K  NILLD+    ++SD G +   +  + H    V GT GY+
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYM 357

Query: 568 DPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDK 609
            PE  +     D S D +S G +L +LL G  P  F   +   
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKD 398

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  109 bits (273), Expect = 4e-26
 Identities = 48/245 (19%), Positives = 97/245 (39%), Gaps = 34/245 (13%)

Query: 433 DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP 492
             S ++    ++  +   + +N V  L          +  +      L  +++ +     
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 493 ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 552
               + L I I+++ A+ +LHS     + HRD+K +NI        KV DFG   +M  D
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217

Query: 553 Q------------THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           +               T QV GT  Y+ PE    + ++ K D++S G++L ELL      
Sbjct: 218 EEEQTVLTPMPAYATHTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS---- 272

Query: 601 RFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRP 660
            F+T  E   +    +  ++  +   +   +  +E     ++      +  L+ +  +RP
Sbjct: 273 -FSTQMERVRI----ITDVRNLKFPLLFTQKYPQEH---MMV------QDMLSPSPTERP 318

Query: 661 TMREV 665
              ++
Sbjct: 319 EATDI 323

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 20/112 (17%), Positives = 41/112 (36%), Gaps = 2/112 (1%)

Query: 394 RATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFI-NEMVILSQIN 451
           R   +F   + +G+GG G V++     D    A+K+ ++ +     E +  E+  L+++ 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
           H  +V+     LET       E        +                ++I  
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  110 bits (277), Expect = 4e-26
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 25/216 (11%)

Query: 397 DNFNLNRILGQGGQGTVY----KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           +++ + +++G+G  G V     K      K+ A+K   K ++I  S    F  E  I++ 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125

Query: 450 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSG 507
            N   VV+L     + +  L +V E++P G L   +   N D P   E   R    EV  
Sbjct: 126 ANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVP---EKWARFYTAEVVL 179

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           AL  +HS   +   HRD+K  N+LLD     K++DFG    M  +         GT  Y+
Sbjct: 180 ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236

Query: 568 DPEYFRSSQFT---DKS-DVYSFGVVLAELLTGEKP 599
            PE  +S        +  D +S GV L E+L G+ P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  110 bits (277), Expect = 5e-26
 Identities = 64/281 (22%), Positives = 111/281 (39%), Gaps = 36/281 (12%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQIN 451
           T+ + L   LG+G    V + + +  G+  A       K+      ++   E  I   + 
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK 68

Query: 452 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
           H N+V+L       E    L+++ +  G LF+ I  +      +         ++  A+ 
Sbjct: 69  HPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVL 124

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           + H      + HR++K  N+LL  K +    K++DFG +  +  +Q        GT GYL
Sbjct: 125 HCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYL 180

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE- 626
            PE  R   +    D+++ GV+L  LL G  P  F              +   + RL++ 
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPP--F--------------WDEDQHRLYQQ 224

Query: 627 ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
           I            D +   AK +  + L +N  KR T  E 
Sbjct: 225 IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  108 bits (271), Expect = 6e-26
 Identities = 68/285 (23%), Positives = 114/285 (40%), Gaps = 42/285 (14%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK--KSKVIDESKVEEFINEMVILSQ 449
           +   + + +   LG+G  G V++ +     K    K  K K  D+  V+    E+ IL+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNI 57

Query: 450 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFP---ITWEMRLRIAIEV 505
             HRN++ L     E+   L +++EFI    +F+ I+    +     I   +      +V
Sbjct: 58  ARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-----QV 111

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRA--KVSDFGASRSMAVDQTHMTTQVHGT 563
             AL +LHS     I H DI+  NI+   +  +  K+ +FG +R +              
Sbjct: 112 CEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TA 166

Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER 623
             Y  PE  +    +  +D++S G ++  LL+G  P  F  L E              ++
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP--F--LAET------------NQQ 210

Query: 624 LFE-ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
           + E I++A     E    EI   A     R L    K R T  E 
Sbjct: 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  109 bits (274), Expect = 6e-26
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D+F + R +G+G  G V      D  K+ A+K   K K ++ ++V     E+ I+  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 453 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALS 510
             +V L     + E  + +V + +  G L  ++  QN  F    E  +++   E+  AL 
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFK---EETVKLFICELVMALD 129

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           YL +     I HRD+K  NILLD+     ++DF  +  +  +    T  + GT  Y+ PE
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPE 184

Query: 571 YFRSSQFT--DKS-DVYSFGVVLAELLTGEKP 599
            F S +      + D +S GV   ELL G +P
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  107 bits (270), Expect = 7e-26
 Identities = 65/240 (27%), Positives = 100/240 (41%), Gaps = 25/240 (10%)

Query: 376 STEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDE 434
           +++             L      F L  ++G G  G VYKG  +  G++ A+K   V   
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TG 61

Query: 435 SKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPL------LVYEFIPNGTLFQYIHDQ 487
            + EE   E+ +L +  +HRN+    G  ++   P       LV EF   G++   I   
Sbjct: 62  DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK-N 120

Query: 488 NEDFPITWEMRLRIAI---EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
            +   +  E    IA    E+   LS+LH    I   HRDIK  N+LL +    K+ DFG
Sbjct: 121 TKGNTLKEEW---IAYICREILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFG 174

Query: 545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD-----KSDVYSFGVVLAELLTGEKP 599
            S  +        T + GT  ++ PE     +  D     KSD++S G+   E+  G  P
Sbjct: 175 VSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  107 bits (270), Expect = 8e-26
 Identities = 62/276 (22%), Positives = 109/276 (39%), Gaps = 33/276 (11%)

Query: 401 LNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKL 458
            ++ LG+G      K +     +  AVK   +I +        E+  L     H N+VKL
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVKL 71

Query: 459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVSGALSYLHSA 515
                +     LV E +  G LF+ I  +   +E           I  ++  A+S++H  
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSE------TEASYIMRKLVSAVSHMHDV 125

Query: 516 ASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
               + HRD+K  N+L  D+      K+ DFG +R    D   + T    T  Y  PE  
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE-ILDAR 631
             + + +  D++S GV+L  +L+G+ P  F + +   +  +          + + I    
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVP--FQSHDRSLTCTS-------AVEIMKKIKKGD 232

Query: 632 VMKESGG-DEIITFAK-VAKRCLNLNGKKRPTMREV 665
              E      +   AK + +  L ++  KR  M  +
Sbjct: 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (268), Expect = 1e-25
 Identities = 66/288 (22%), Positives = 121/288 (42%), Gaps = 38/288 (13%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV-IDESKVEEFINEM-VI 446
           +  +   ++      +G G  G V+K      G ++AVK+ +   ++ + +  + ++ V+
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 447 LSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           L   +   +V+  G  +  T+V  +  E +           Q    PI   +  ++ + +
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQG---PIPERILGKMTVAI 133

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
             AL YL     + I HRD+K +NILLD++ + K+ DFG S  + VD         G   
Sbjct: 134 VKALYYLKEKHGV-I-HRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSA-GCAA 189

Query: 566 YLDPE-----YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
           Y+ PE           +  ++DV+S G+ L EL TG+ P              Y      
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP--------------YKNCKTD 235

Query: 621 EERLFEIL--DARVMKESGG--DEIITFAKVAKRCLNLNGKKRPTMRE 664
            E L ++L  +  ++    G   +  +F    K CL  + +KRP   +
Sbjct: 236 FEVLTKVLQEEPPLLPGHMGFSGDFQSF---VKDCLTKDHRKRPKYNK 280

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  107 bits (269), Expect = 2e-25
 Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 39/303 (12%)

Query: 375 ASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSK 430
            +    + +   F      + +DN+++   LG+G    V + +    G   A K     K
Sbjct: 7   MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66

Query: 431 VIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNE 489
           +      ++   E  I  ++ H N+V+L     + E    LV++ +  G LF+ I    E
Sbjct: 67  LSARD-FQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDI-VARE 123

Query: 490 DFPITWEMRLRIAI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGA 545
            +    E      I ++  +++Y HS     I HR++K  N+LL  K +    K++DFG 
Sbjct: 124 FYS---EADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177

Query: 546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTL 605
           +  +  D         GT GYL PE  +   ++   D+++ GV+L  LL G  P  F   
Sbjct: 178 AIEVN-DSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP--F--- 230

Query: 606 EEDKSLAAYFLFAMKEERLFE-ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTM 662
                      +   + RL+  I            D +   AK +    L +N KKR T 
Sbjct: 231 -----------WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA 279

Query: 663 REV 665
            + 
Sbjct: 280 DQA 282

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  106 bits (267), Expect = 3e-25
 Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 37/281 (13%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN 454
           TD + +   +G G      + +        AVK   +ID+SK +      ++L    H N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPTEEIEILLRYGQHPN 77

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVSGALSY 511
           ++ L     + +   +V E +  G L   I  Q   +E      E    +   ++  + Y
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER-----EAS-AVLFTITKTVEY 131

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRA----KVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           LH+     + HRD+K +NIL  D+       ++ DFG ++ +  +   + T    T  ++
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFV 187

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE- 626
            PE      +    D++S GV+L  +LTG  P  F    +D             E +   
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTP--FANGPDD-----------TPEEILAR 234

Query: 627 ILDARVMKESGG-DEIITFAK-VAKRCLNLNGKKRPTMREV 665
           I   +     G  + +   AK +  + L+++  +R T   V
Sbjct: 235 IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  106 bits (266), Expect = 3e-25
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 27/217 (12%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFIN-----EMVILS 448
            ++    LG G  G V+  +     K V VK   K KV+++  +E+        E+ ILS
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 449 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGT-LFQYIHDQ---NEDFPITWEMRLRIAI 503
           ++ H N++K+L    E +    LV E   +G  LF +I      +E           I  
Sbjct: 85  RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP-----LAS-YIFR 137

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           ++  A+ YL       I HRDIK  NI++ + +  K+ DFG++  +   +    T   GT
Sbjct: 138 QLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GT 192

Query: 564 FGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKP 599
             Y  PE    + +   + +++S GV L  L+  E P
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  106 bits (266), Expect = 3e-25
 Identities = 72/308 (23%), Positives = 118/308 (38%), Gaps = 60/308 (19%)

Query: 379 GTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDE 434
           GT+ + +           D ++    LG G    V K      G   A K   K +    
Sbjct: 1   GTVFRQENVD--------DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS 52

Query: 435 SK---VEEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQN-- 488
            +    E+   E+ IL +I H NV+ L     E +  + L+ E +  G LF ++ ++   
Sbjct: 53  RRGVSREDIEREVSILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESL 111

Query: 489 -EDFPITWEMRLRIAIE----VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA----K 539
            E            A E    +   + YLHS     I H D+K  NI+L D+       K
Sbjct: 112 TE----------EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIK 158

Query: 540 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           + DFG +  +  D  +    + GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 159 IIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

Query: 600 IRFTTLEEDKSLAAYFLFAMKEERLFEILDARV-MKESGGDEIITFAK-VAKRCLNLNGK 657
                          FL   K+E L  +       ++         AK   +R L  + K
Sbjct: 217 ---------------FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261

Query: 658 KRPTMREV 665
           KR T+++ 
Sbjct: 262 KRMTIQDS 269

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  106 bits (266), Expect = 3e-25
 Identities = 67/284 (23%), Positives = 109/284 (38%), Gaps = 38/284 (13%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESK---VEEFINEMVILS 448
            D +++   LG G    V K      G   A K   K +     +    EE   E+ IL 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 449 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           Q+ H NV+ L     E    + L+ E +  G LF ++    +   ++ E       ++  
Sbjct: 71  QVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILD 126

Query: 508 ALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
            ++YLH+     I H D+K  NI+L          K+ DFG +  +  +       + GT
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGT 181

Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER 623
             ++ PE         ++D++S GV+   LL+G  P               FL   K+E 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FLGDTKQET 226

Query: 624 LFEILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
           L  I        E         AK   ++ L    +KR T++E 
Sbjct: 227 LANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  104 bits (262), Expect = 5e-25
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 21/211 (9%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINHR 453
           ++ L   LG G  G V  G     G  VAVK   + K+     V +   E+  L    H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 454 NVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVSGAL 509
           +++KL    + T     +V E++  G LF YI       E      E R R+  ++  A+
Sbjct: 72  HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-----EAR-RLFQQILSAV 124

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            Y H      + HRD+K  N+LLD    AK++DFG S  M+  +   T+   G+  Y  P
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAP 179

Query: 570 EYFRSSQFT-DKSDVYSFGVVLAELLTGEKP 599
           E      +   + D++S GV+L  LL G  P
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  105 bits (263), Expect = 5e-25
 Identities = 75/294 (25%), Positives = 119/294 (40%), Gaps = 52/294 (17%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVID------ESKVEEFINEMV 445
            +N+    ILG+G    V + +  P  K  AVK    +          +   E  + E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 446 ILSQIN-HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLR 500
           IL +++ H N+++L     ET     LV++ +  G LF Y+ ++   +E      E R +
Sbjct: 76  ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK-----ETR-K 128

Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
           I   +   +  LH      I HRD+K  NILLDD    K++DFG S  +   +  +    
Sbjct: 129 IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC 184

Query: 561 HGTFGYLDPEYFRSSQFTDKS------DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY 614
            GT  YL PE    S   +        D++S GV++  LL G  P  F            
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--F------------ 229

Query: 615 FLFAMKEERLFE-ILDARVMKESGG-DEIITFAK-VAKRCLNLNGKKRPTMREV 665
             +  K+  +   I+       S   D+     K +  R L +  +KR T  E 
Sbjct: 230 --WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 281

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  105 bits (265), Expect = 5e-25
 Identities = 75/285 (26%), Positives = 123/285 (43%), Gaps = 36/285 (12%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-SKVIDESKVEEFINEMVIL 447
              +  +D F +   LG+G    VY+       K  A+K   K +D+  V     E+ +L
Sbjct: 46  SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVL 102

Query: 448 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVS 506
            +++H N++KL     ET   + LV E +  G LF  I ++      +         ++ 
Sbjct: 103 LRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQIL 158

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGT 563
            A++YLH      I HRD+K  N+L          K++DFG S+ +   Q  M T   GT
Sbjct: 159 EAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMKTVC-GT 213

Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER 623
            GY  PE  R   +  + D++S G++   LL G +P               F     ++ 
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP---------------FYDERGDQF 258

Query: 624 LFE-ILDARVMKESGG-DEIITFAK-VAKRCLNLNGKKRPTMREV 665
           +F  IL+      S   DE+   AK + ++ + L+ KKR T  + 
Sbjct: 259 MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  104 bits (262), Expect = 6e-25
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 23/216 (10%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFIN-EMVILSQINH 452
            + +  +LG+G  G V + +        AVK   K K+      E  +  E+ +L ++ H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 453 RNVVKLLG-CCLETEVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +NV++L+     E +  + +V E+   G   +   +    + FP+  +       ++   
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV--PEKRFPV-CQAH-GYFCQLIDG 121

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFG 565
           L YLHS     I H+DIK  N+LL      K+S  G + ++   A D T  T+Q  G+  
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPA 176

Query: 566 YLDPEYFRSSQFTD--KSDVYSFGVVLAELLTGEKP 599
           +  PE           K D++S GV L  + TG  P
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  107 bits (269), Expect = 6e-25
 Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 17/241 (7%)

Query: 376 STEGTIEKTKLFTSKELERAT-DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK---KSK 430
           S     E+ ++  +K   R T + F   ++LG+G  G V        G+  A+K   K  
Sbjct: 126 SDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEV 185

Query: 431 VIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNE 489
           ++ + +V   + E  +L    H  +  L     +T   L  V E+   G LF ++  +  
Sbjct: 186 IVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS-RER 243

Query: 490 DFPITWEMRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 548
            F    E R R    E+  AL YLHS  ++ +Y RD+K  N++LD     K++DFG  + 
Sbjct: 244 VFS---EDRARFYGAEIVSALDYLHSEKNV-VY-RDLKLENLMLDKDGHIKITDFGLCK- 297

Query: 549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED 608
             +          GT  YL PE    + +    D +  GVV+ E++ G  P  F   + +
Sbjct: 298 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 355

Query: 609 K 609
           K
Sbjct: 356 K 356

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  103 bits (260), Expect = 7e-25
 Identities = 69/281 (24%), Positives = 116/281 (41%), Gaps = 40/281 (14%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN----EMVILSQIN 451
           ++++L + LG+G  G V   +     + VAVK   ++D  +  +       E+ I   +N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63

Query: 452 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVSG 507
           H NVVK  G          L  E+   G LF  I       E      + + R   ++  
Sbjct: 64  HENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----DAQ-RFFHQLMA 116

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT--HMTTQVHGTFG 565
            + YLH      I HRDIK  N+LLD++   K+SDFG +     +     +     GT  
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172

Query: 566 YLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
           Y+ PE  +  +F  +  DV+S G+VL  +L GE P  +   +   S   Y      +E+ 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP--WD--QPSDSCQEYSD---WKEKK 225

Query: 625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             +   + +  +    +        + L  N   R T+ ++
Sbjct: 226 TYLNPWKKIDSAPLALL-------HKILVENPSARITIPDI 259

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  106 bits (266), Expect = 1e-24
 Identities = 66/224 (29%), Positives = 115/224 (51%), Gaps = 39/224 (17%)

Query: 396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFIN-EMVILSQINHR 453
             ++   +++G G  G VY+  L   G++VA+KK  V+ + +   F N E+ I+ +++H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKR---FKNRELQIMRKLDHC 107

Query: 454 NVVKLLGCCLET-----EVPL-LVYEFIPNGTLFQYIHD---QNEDFPI------TWEMR 498
           N+V+L      +     EV L LV +++P  T+++         +  P+       +++ 
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL- 165

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMT 557
            R       +L+Y+HS     I HRDIK  N+LLD D    K+ DFG+++ +   +    
Sbjct: 166 FR-------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NV 214

Query: 558 TQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           + +  +  Y  PE  F ++ +T   DV+S G VLAELL G +PI
Sbjct: 215 SYI-CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  105 bits (265), Expect = 1e-24
 Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 38/243 (15%)

Query: 376 STEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDES 435
                + K      K  E+    +   +++G G  G V++  L +   VA+K  KV+ + 
Sbjct: 19  DDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQD- 75

Query: 436 KVEEFIN-EMVILSQINHRNVVKLLGCCLET-----EVPL-LVYEFIPNGTLFQYIHD-- 486
             + F N E+ I+  + H NVV L            EV L LV E++P  T+++      
Sbjct: 76  --KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYA 132

Query: 487 -QNEDFPI------TWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRA 538
              +  P+       +++ LR       +L+Y+HS     I HRDIK  N+LLD      
Sbjct: 133 KLKQTMPMLLIKLYMYQL-LR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVL 181

Query: 539 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLAELLTGE 597
           K+ DFG+++ +   +    + +  +  Y  PE  F ++ +T   D++S G V+AEL+ G 
Sbjct: 182 KLIDFGSAKILIAGEP-NVSYI-CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG- 238

Query: 598 KPI 600
           +P+
Sbjct: 239 QPL 241

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  103 bits (259), Expect = 1e-24
 Identities = 69/292 (23%), Positives = 110/292 (37%), Gaps = 54/292 (18%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESK---VEEFINEMVILS 448
            D++ +   LG G    V K      GK  A K   K ++    +    EE   E+ IL 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 449 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQN---EDFPITWEMRLRIAIE 504
           +I H N++ L     E +  + L+ E +  G LF ++ ++    E            A +
Sbjct: 64  EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTE----------DEATQ 112

Query: 505 ----VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA----KVSDFGASRSMAVDQTHM 556
               +   + YLHS     I H D+K  NI+L DK       K+ DFG +  +       
Sbjct: 113 FLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-F 168

Query: 557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL 616
                GT  ++ PE         ++D++S GV+   LL+G  P  F  L E         
Sbjct: 169 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--F--LGET-------- 215

Query: 617 FAMKEERLFE-ILDARV-MKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
               ++     I        E         AK   +R L  + K+R T+ + 
Sbjct: 216 ----KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  104 bits (262), Expect = 2e-24
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 21/219 (9%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESK---VEEFINEMV 445
           ++  D +++   LG G    V K      G   A K   K +     +    EE   E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 446 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
           IL Q+ H N++ L     E    + L+ E +  G LF ++  +     ++ E       +
Sbjct: 68  ILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQ 123

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDK----YRAKVSDFGASRSMAVDQTHMTTQV 560
           +   ++YLH+     I H D+K  NI+L DK       K+ DFG +    ++       +
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNI 178

Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  104 bits (261), Expect = 2e-24
 Identities = 71/293 (24%), Positives = 124/293 (42%), Gaps = 51/293 (17%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKV-----IDESKVEEFINEMVI 446
              ++   ++G+G    V + +    G   AVK    +         E   E    E  I
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 447 LSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRI 501
           L Q+  H +++ L+    E+   + LV++ +  G LF Y+ ++   +E      E R  I
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEK-----ETR-SI 205

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
              +  A+S+LH+     I HRD+K  NILLDD  + ++SDFG S  +   +  +     
Sbjct: 206 MRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC- 260

Query: 562 GTFGYLDPEYFRSSQFTD------KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF 615
           GT GYL PE  + S          + D+++ GV+L  LL G  P  F             
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP--F------------- 305

Query: 616 LFAMKEERLFE-ILDARVMKESGG-DEIITFAK-VAKRCLNLNGKKRPTMREV 665
            +  ++  +   I++ +    S   D+  +  K +  R L ++ + R T  + 
Sbjct: 306 -WHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  103 bits (258), Expect = 3e-24
 Identities = 69/281 (24%), Positives = 116/281 (41%), Gaps = 40/281 (14%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN----EMVILSQIN 451
           ++++L + LG+G  G V   +     + VAVK   ++D  +  +       E+ I   +N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63

Query: 452 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVSG 507
           H NVVK  G          L  E+   G LF  I       E      + + R   ++  
Sbjct: 64  HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----DAQ-RFFHQLMA 116

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT--HMTTQVHGTFG 565
            + YLH      I HRDIK  N+LLD++   K+SDFG +     +     +     GT  
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172

Query: 566 YLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
           Y+ PE  +  +F  +  DV+S G+VL  +L GE P  +   +   S   Y      +E+ 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP--WD--QPSDSCQEYSD---WKEKK 225

Query: 625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             +   + +  +    +        + L  N   R T+ ++
Sbjct: 226 TYLNPWKKIDSAPLALL-------HKILVENPSARITIPDI 259

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  101 bits (253), Expect = 9e-24
 Identities = 70/303 (23%), Positives = 119/303 (39%), Gaps = 61/303 (20%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVI--------------------- 432
            + L   +G+G  G V       D    A+K   K K+I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 433 --DESKVEEFINEMVILSQINHRNVVKL---LGCCLETEVPLLVYEFIPNGTLFQYIHDQ 487
                 +E+   E+ IL +++H NVVKL   L    E  +  +V+E +  G + +    +
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLK 132

Query: 488 --NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 545
             +ED     + R     ++   + YLH      I HRDIK +N+L+ +    K++DFG 
Sbjct: 133 PLSED-----QAR-FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT---DKSDVYSFGVVLAELLTGEKPIRF 602
           S         ++  V GT  ++ PE    ++        DV++ GV L   + G+ P  F
Sbjct: 184 SNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP--F 240

Query: 603 TTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTM 662
                D+ +    L +  + +  E  D   + E   D I        R L+ N + R  +
Sbjct: 241 ----MDERIMC--LHSKIKSQALEFPDQPDIAEDLKDLI-------TRMLDKNPESRIVV 287

Query: 663 REV 665
            E+
Sbjct: 288 PEI 290

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  101 bits (254), Expect = 2e-23
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           D F+  + LG G  G V   ML      G   A+K   K KV+   ++E  +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97

Query: 450 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSG 507
           +N   +VKL     +    L +V E++  G +F ++      F    E   R  A ++  
Sbjct: 98  VNFPFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGR-FS---EPHARFYAAQIVL 152

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
              YLHS     + +RD+K  N+L+D +   +V+DFG     A      T  + GT   L
Sbjct: 153 TFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWTLCGTPEAL 205

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            PE   S  +    D ++ GV++ E+  G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  101 bits (253), Expect = 2e-23
 Identities = 74/243 (30%), Positives = 118/243 (48%), Gaps = 22/243 (9%)

Query: 378 EGTIEKTKL--FTSKELERAT-DNFNLNRILGQGGQGTVY---KGMLPD-GKIVAVK--K 428
           EG+I++  +     +  E+A    F L ++LGQG  G V+   K    D  ++ A+K  K
Sbjct: 2   EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61

Query: 429 SKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ 487
              +          E  IL ++NH  +VKL     +TE  L L+ +F+  G LF  +  +
Sbjct: 62  KATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-K 119

Query: 488 NEDFPITWEMRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 546
              F    E  ++    E++ AL +LHS     I +RD+K  NILLD++   K++DFG S
Sbjct: 120 EVMFT---EEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS 173

Query: 547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLE 606
           +  ++D         GT  Y+ PE       T  +D +SFGV++ E+LTG  P  F   +
Sbjct: 174 K-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP--FQGKD 230

Query: 607 EDK 609
             +
Sbjct: 231 RKE 233

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  101 bits (254), Expect = 2e-23
 Identities = 77/248 (31%), Positives = 114/248 (45%), Gaps = 26/248 (10%)

Query: 378 EGTIEKTKLFTSKELERAT-DNFNLNRILGQGGQGTVY---KGMLPD-GKIVAVK---KS 429
               E      +   E+   +NF L ++LG G  G V+   K    D GK+ A+K   K+
Sbjct: 34  TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 93

Query: 430 KVIDESK-VEEFINEMVILSQINHRN-VVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHD 486
            ++ ++K  E    E  +L  I     +V L     +TE  L L+ ++I  G LF ++  
Sbjct: 94  TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL-- 150

Query: 487 QNED-FPITWEMRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
              + F    E  ++I   E+  AL +LH      I +RDIK  NILLD      ++DFG
Sbjct: 151 SQRERFT---EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 204

Query: 545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF-TDKS-DVYSFGVVLAELLTGEKPIRF 602
            S+    D+T       GT  Y+ P+  R      DK+ D +S GV++ ELLTG  P  F
Sbjct: 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--F 262

Query: 603 TTLEEDKS 610
           T   E  S
Sbjct: 263 TVDGEKNS 270

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  100 bits (252), Expect = 3e-23
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 29/226 (12%)

Query: 389 SKELERATDNFN-LNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN---- 442
           + +++     +  L+ + G+G   TVYK       +IVA+KK K+   S+ ++ IN    
Sbjct: 2   ALDVKSRAKRYEKLDFL-GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60

Query: 443 -EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP------ITW 495
            E+ +L +++H N++ LL          LV++F+    L   I D +             
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYML 119

Query: 496 EMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 555
            M L+        L YLH      I HRD+K  N+LLD+    K++DFG ++S       
Sbjct: 120 -MTLQ-------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 168

Query: 556 MTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            T QV  T  Y  PE  F +  +    D+++ G +LAELL    P 
Sbjct: 169 YTHQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPF 212

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  102 bits (256), Expect = 3e-23
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINHR 453
           ++ L   LG G  G V  G     G  VAVK   + K+     V +   E+  L    H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 454 NVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI--HDQ-NEDFPITWEMRLRIAIEVSGAL 509
           +++KL    + T   + +V E++  G LF YI  + + +E      E R R+  ++   +
Sbjct: 77  HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----ESR-RLFQQILSGV 129

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            Y H      + HRD+K  N+LLD    AK++DFG S  M+  +   T+   G+  Y  P
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAP 184

Query: 570 EYFRSSQFT-DKSDVYSFGVVLAELLTGEKP 599
           E      +   + D++S GV+L  LL G  P
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =   99 bits (250), Expect = 3e-23
 Identities = 55/224 (24%), Positives = 108/224 (48%), Gaps = 29/224 (12%)

Query: 389 SKELERATDNF-NLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEF----INE 443
           +   +   + +  L ++ G+G  G VYK     G+IVA+K+ ++  +++ E      I E
Sbjct: 13  NLYFQGLMEKYQKLEKV-GEGTYGVVYKAKDSQGRIVALKRIRL--DAEDEGIPSTAIRE 69

Query: 444 MVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP------ITWEM 497
           + +L +++H N+V L+          LV+EF+    L + + +              +++
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQL 128

Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 557
            LR        +++ H      I HRD+K  N+L++     K++DFG +R+  +     T
Sbjct: 129 -LR-------GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177

Query: 558 TQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            +V  T  Y  P+    S +++   D++S G + AE++TG KP+
Sbjct: 178 HEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPL 219

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =   99 bits (250), Expect = 4e-23
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 25/223 (11%)

Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           ++F+  ++LG+G  G V   +L      G+  A+K   K  +I + +V   + E  +L  
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 450 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSG 507
             H  +  L     +T   L  V E+   G LF ++  +   F    E R R    E+  
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS-RERVFT---EERARFYGAEIVS 116

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHMTTQVHGTFGY 566
           AL YLHS     + +RDIK  N++LD     K++DFG  +  ++   T       GT  Y
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 171

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
           L PE    + +    D +  GVV+ E++ G  P  F   + ++
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHER 212

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 99.7 bits (249), Expect = 4e-23
 Identities = 74/298 (24%), Positives = 120/298 (40%), Gaps = 43/298 (14%)

Query: 396 TDNFNLNR-ILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQI 450
            D + L   +LG+G    V   + L   +  AVK   K      S+V     E+ +L Q 
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQC 67

Query: 451 -NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVS 506
             HRNV++L+    E +   LV+E +  G++  +IH +   NE      E    +  +V+
Sbjct: 68  QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVA 121

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSM-------AVDQTHM 556
            AL +LH+     I HRD+K  NIL +   +    K+ DF     +        +    +
Sbjct: 122 SALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 557 TTQVHGTFGYLDPEYFRSSQFTDKS-----DVYSFGVVLAELLTGEKPIRF-TTLEEDKS 610
            T   G+  Y+ PE   +            D++S GV+L  LL+G  P  F      D  
Sbjct: 179 LTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP--FVGRCGSDCG 235

Query: 611 LAAYFLFAMKEERLFE-ILDARVMKESGG-DEIITFAK-VAKRCLNLNGKKRPTMREV 665
                     +  LFE I + +          I   AK +  + L  + K+R +  +V
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 99.5 bits (249), Expect = 5e-23
 Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 21/223 (9%)

Query: 397 DNFNLNRILGQGGQGTVY---KGMLPD-GKIVAVK---KSKVIDESK-VEEFINEMVILS 448
           + F L R+LG+GG G V+   K    + GKI A+K   K+ ++  +K       E  IL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 449 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVS 506
           ++ H  +V L+    +T   L L+ E++  G LF  +  +   F    E        E+S
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFM---EDTACFYLAEIS 131

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
            AL +LH      I +RD+K  NI+L+ +   K++DFG  +  ++    +T    GT  Y
Sbjct: 132 MALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEY 187

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
           + PE    S      D +S G ++ ++LTG  P  FT     K
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP--FTGENRKK 228

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 99.6 bits (249), Expect = 5e-23
 Identities = 64/294 (21%), Positives = 110/294 (37%), Gaps = 33/294 (11%)

Query: 383 KTKLFTSKELERATDNFNLN-RILGQGGQGTVYKGM-LPDGKIVAVK--KSKVIDESKVE 438
            T+    + +E   + + L  + LG+G    V + +    G+  A K  K +   +    
Sbjct: 14  GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA 73

Query: 439 EFINEMVILSQINHR-NVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWE 496
           E ++E+ +L        V+ L     E    + L+ E+   G +F     +  +  ++  
Sbjct: 74  EILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEM-VSEN 131

Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---RAKVSDFGASRSMAVDQ 553
             +R+  ++   + YLH      I H D+K  NILL   Y     K+ DFG SR +    
Sbjct: 132 DVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HA 187

Query: 554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAA 613
             +   + GT  YL PE       T  +D+++ G++   LLT   P              
Sbjct: 188 CELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP-------------- 232

Query: 614 YFLFAMKEERLFEILDARVMKESGG-DEIITFAK-VAKRCLNLNGKKRPTMREV 665
            F+    +E    I    V         +   A    +  L  N +KRPT    
Sbjct: 233 -FVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 99.2 bits (248), Expect = 6e-23
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN--EMVILSQINHR 453
           + +     +G+G  G V+K      G+IVA+KK    ++  V + I   E+ +L Q+ H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP------ITWEMRLRIAIEVSG 507
           N+V LL          LV+E+  + T+   +       P      ITW   L+       
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITW-QTLQ------- 113

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           A+++ H        HRD+K  NIL+      K+ DFG +R +     +   +V  T  Y 
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYR 169

Query: 568 DPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            PE     +Q+    DV++ G V AELL+G  P+
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPL 202

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 98.4 bits (246), Expect = 7e-23
 Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 29/217 (13%)

Query: 397 DNF-NLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF----INEMVILSQI 450
             +  L +I G+G  GTV+K       +IVA+K+ ++ D+   E      + E+ +L ++
Sbjct: 2   QKYEKLEKI-GEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKEL 58

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP------ITWEMRLRIAIE 504
            H+N+V+L       +   LV+EF     L +Y    N D          +++ L+    
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL-LK---- 112

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
               L + HS     + HRD+K  N+L++     K+++FG +R+  +     + +V  T 
Sbjct: 113 ---GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TL 165

Query: 565 GYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            Y  P+  F +  ++   D++S G + AEL    +P+
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 97.6 bits (244), Expect = 1e-22
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 27/215 (12%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEF----INEMVILSQINH 452
           + ++    +G+G  G VYK     G+  A+KK ++  E   E      I E+ IL ++ H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKH 59

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP------ITWEMRLRIAIEVS 506
            N+VKL       +  +LV+E +    L + +                 ++ L       
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQL-LN------ 111

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
             ++Y H      + HRD+K  N+L++ +   K++DFG +R+  +     T ++  T  Y
Sbjct: 112 -GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWY 166

Query: 567 LDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             P+    S +++   D++S G + AE++ G  P+
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPL 200

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 70/296 (23%), Positives = 116/296 (39%), Gaps = 54/296 (18%)

Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEM 444
              +   +D ++  + +G G  G           ++VAVK   +   IDE  V+    E+
Sbjct: 12  DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQ---REI 67

Query: 445 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLR 500
           +    + H N+V+     + T   L ++ E+   G L++ I +    +ED     E R  
Sbjct: 68  INHRSLRHPNIVRFKE-VILTPTHLAIIMEYASGGELYERICNAGRFSED-----EAR-F 120

Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY--RAKVSDFGASRSMAVDQTHMTT 558
              ++   +SY HS     I HRD+K  N LLD     R K+ DFG S+S  +     +T
Sbjct: 121 FFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177

Query: 559 QVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF 617
              GT  Y+ PE     ++    +DV+S GV L  +L G  P  F    ED         
Sbjct: 178 V--GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP--F----EDPEEP----- 224

Query: 618 AMKEERLFEILDARVMKESGGD----EIITFAKVAK----RCLNLNGKKRPTMREV 665
                R +     R++          + I  +        R    +   R ++ E+
Sbjct: 225 -----RDYRKTIQRILS---VKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 67/247 (27%), Positives = 114/247 (46%), Gaps = 30/247 (12%)

Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
            +F+L R++G+G    V   +L       +I A+K   K  V D+  ++    E  +  Q
Sbjct: 9   QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 450 I-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVS 506
             NH  +V L   C +TE  L  V E++  G L  ++  +    P   E   R  + E+S
Sbjct: 66  ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEIS 120

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
            AL+YLH      I +RD+K  N+LLD +   K++D+G  +   +     T+   GT  Y
Sbjct: 121 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNY 176

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
           + PE  R   +    D ++ GV++ E++ G  P  F  +    +          E+ LF+
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDN-----PDQNTEDYLFQ 229

Query: 627 -ILDARV 632
            IL+ ++
Sbjct: 230 VILEKQI 236

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 97.7 bits (244), Expect = 4e-22
 Identities = 59/228 (25%), Positives = 105/228 (46%), Gaps = 35/228 (15%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDES--KVEEFINEMVILSQ 449
            +  D F + R+ GQG  GTV  G     G  VA+KK  VI +   +  E +  M  L+ 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK--VIQDPRFRNRE-LQIMQDLAV 75

Query: 450 INHRNVVKLL------GCCLETEVPL-LVYEFIPNGTLFQYI-HDQNEDFPITWEMR--- 498
           ++H N+V+L       G     ++ L +V E++P+ TL +   +           +    
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134

Query: 499 ----LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQ 553
               +R       ++  LH   S+ + HRDIK  N+L++      K+ DFG+++ ++  +
Sbjct: 135 LFQLIR-------SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186

Query: 554 THMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
                 +  +  Y  PE  F +  +T   D++S G + AE++ G +PI
Sbjct: 187 P-NVAYI-CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 97.3 bits (243), Expect = 4e-22
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 22/211 (10%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINHR 453
            + +   LG+G  G V         + VA+K   +  +           E+  L  + H 
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 454 NVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEMRLRIAIEVSGAL 509
           +++KL    + T   + +V E+   G LF YI ++    ED     E R R   ++  A+
Sbjct: 70  HIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----EGR-RFFQQIICAI 121

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            Y H      I HRD+K  N+LLDD    K++DFG S  M       T+   G+  Y  P
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAP 176

Query: 570 EYFRSSQFT-DKSDVYSFGVVLAELLTGEKP 599
           E      +   + DV+S G+VL  +L G  P
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 98.2 bits (245), Expect = 4e-22
 Identities = 66/247 (26%), Positives = 113/247 (45%), Gaps = 30/247 (12%)

Query: 397 DNFNLNRILGQGGQGTVY----KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
            +F+L R++G+G    V     K      +I A++   K  V D+  ++    E  +  Q
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108

Query: 450 I-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVS 506
             NH  +V L   C +TE  L  V E++  G L  ++  +    P   E   R  + E+S
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEIS 163

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
            AL+YLH      I +RD+K  N+LLD +   K++D+G  +   +     T+   GT  Y
Sbjct: 164 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNY 219

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
           + PE  R   +    D ++ GV++ E++ G  P  F  +    +          E+ LF+
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDN-----PDQNTEDYLFQ 272

Query: 627 -ILDARV 632
            IL+ ++
Sbjct: 273 VILEKQI 279

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 96.9 bits (242), Expect = 5e-22
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 24/217 (11%)

Query: 394 RATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN--EMVILSQI 450
           ++ + +    ++G+G  G V K      G+IVA+KK    D+ K+ + I   E+ +L Q+
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP------ITWEMRLRIAIE 504
            H N+V LL  C + +   LV+EF+ + T+   +                +++ +     
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI-IN---- 135

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 564
               + + HS     I HRDIK  NIL+      K+ DFG +R++A        +V  T 
Sbjct: 136 ---GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATR 188

Query: 565 GYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            Y  PE      ++    DV++ G ++ E+  G +P+
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPL 224

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 96.4 bits (241), Expect = 6e-22
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 26/213 (12%)

Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
            +F + R LG G  G V    L     +G+  A+K   K  V+   +VE   +E ++LS 
Sbjct: 6   QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 450 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNED-FPITWEMRLRI-AIEVS 506
           + H  ++++ G   +    + ++ ++I  G LF  +  +    FP       +  A EV 
Sbjct: 63  VTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLL--RKSQRFP---NPVAKFYAAEVC 116

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
            AL YLHS     I +RD+K  NILLD     K++DFG     A     +T  + GT  Y
Sbjct: 117 LALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG----FAKYVPDVTYTLCGTPDY 169

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           + PE   +  +    D +SFG+++ E+L G  P
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 96.6 bits (241), Expect = 6e-22
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHR 453
            D++ L R LG+G    V++ + + + + V VK  K + + K+     E+ IL  +    
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGP 91

Query: 454 NVVKLLGCCL--ETEVPLLVYEFIPNGTLFQYIHDQNEDFPI---TWEMRLRIAIEVSGA 508
           N++ L        +  P LV+E + N    Q       D+ I    +E+ L+       A
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEI-LK-------A 142

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRA-KVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           L Y HS     I HRD+K  N+++D ++R  ++ D+G +      Q     +V  +  + 
Sbjct: 143 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRV-ASRYFK 197

Query: 568 DPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPI 600
            PE     Q  D S D++S G +LA ++  ++P 
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 95.7 bits (239), Expect = 8e-22
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 27/215 (12%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEF----INEMVILSQIN 451
           + +     LG+G   TVYKG       +VA+K+ ++  E   E      I E+ +L  + 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITW-----EMRLRIAIEVS 506
           H N+V L       +   LV+E++    L QY+ D      +          LR      
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLR------ 111

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
             L+Y H      + HRD+K  N+L++++   K++DFG +R+ ++       +V  T  Y
Sbjct: 112 -GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWY 166

Query: 567 LDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             P+    S+ ++ + D++  G +  E+ TG +P+
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPL 200

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 74/224 (33%), Positives = 105/224 (46%), Gaps = 26/224 (11%)

Query: 397 DNFNLNRILGQGGQGTVY----KGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           DNF   R+LG+G  G V     K     G + AVK   K  ++ +  VE  + E  ILS 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79

Query: 450 I-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVS 506
             NH  + +L  CC +T   L  V EF+  G L  +I  ++  F    E R R  A E+ 
Sbjct: 80  ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEII 134

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHMTTQVHGTFG 565
            AL +LH      I +RD+K  N+LLD +   K++DFG  +  +    T  T    GT  
Sbjct: 135 SALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPD 189

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
           Y+ PE  +   +    D ++ GV+L E+L G  P  F    ED 
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP--FEAENEDD 231

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 24/214 (11%)

Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
            +F+  +++G+G  G V   +L     +    AVK   K  ++ + + +  ++E  +L +
Sbjct: 38  SDFHFLKVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94

Query: 450 -INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVS 506
            + H  +V L     +T   L  V ++I  G LF ++  +   F    E R R  A E++
Sbjct: 95  NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ-RERCFL---EPRARFYAAEIA 149

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS-RSMAVDQTHMTTQVHGTFG 565
            AL YLHS     I +RD+K  NILLD +    ++DFG    ++  + T  T+   GT  
Sbjct: 150 SALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPE 204

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
           YL PE      +    D +  G VL E+L G  P
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 94.2 bits (235), Expect = 5e-21
 Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 26/224 (11%)

Query: 397 DNFNLNRILGQGGQGTV----YKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
            +FN   +LG+G  G V     KG     ++ AVK   K  VI +  VE  + E  +L+ 
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76

Query: 450 I-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVS 506
                 + +L   C +T   L  V E++  G L  +I  Q   F    E      A E++
Sbjct: 77  PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFK---EPHAVFYAAEIA 131

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHMTTQVHGTFG 565
             L +L S     I +RD+K  N++LD +   K++DFG  + ++    T  T    GT  
Sbjct: 132 IGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPD 186

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
           Y+ PE      +    D ++FGV+L E+L G+ P  F   +ED+
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--FEGEDEDE 228

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 93.4 bits (233), Expect = 5e-21
 Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 24/222 (10%)

Query: 394 RATDNFN-LNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN-----EMVI 446
            AT  +  +  I G G  GTVYK      G  VA+K  +V +       +      E+ +
Sbjct: 6   MATSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 447 LSQIN---HRNVVKLLGCCLETEVPL-----LVYEFIPNGTLFQYIHDQNEDFPITWEMR 498
           L ++    H NVV+L+  C  +         LV+E +    L  Y+        +  E  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG-LPAETI 122

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
             +  +    L +LH+     I HRD+K  NIL+      K++DFG +R  +     +T 
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTP 178

Query: 559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            V  T  Y  PE    S +    D++S G + AE+    KP+
Sbjct: 179 VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPL 218

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 93.4 bits (233), Expect = 6e-21
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)

Query: 395 ATDNF-NLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF----INEMVILS 448
           ++  F  L ++ G G   TVYKG+    G  VA+K+ K+  E   E      I E+ ++ 
Sbjct: 3   SSSQFKQLEKL-GNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMK 58

Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF---PITWEMRLRIAIEV 505
           ++ H N+V+L           LV+EF+ N  L +Y+  +        +   +      ++
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
              L++ H      I HRD+K  N+L++ + + K+ DFG +R+  +     +++V  T  
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLW 173

Query: 566 YLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           Y  P+    S  ++   D++S G +LAE++TG KP+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPL 208

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.5 bits (235), Expect = 7e-21
 Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 28/233 (12%)

Query: 388 TSKELERATDNFN-LNRILGQGGQGTVYKGM---LPDGKIVAVKKSKVIDESKVEEFINE 443
            S E ER  D F      +G+G  G VYK       D K  A+K+ +            E
Sbjct: 11  LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACRE 68

Query: 444 MVILSQINHRNVVKLLGCCLE-TEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI 501
           + +L ++ H NV+ L    L   +  + L++++  +  L+  I            ++L  
Sbjct: 69  IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPR 127

Query: 502 AIEVS------GALSYLHSAASIPIYHRDIKSTNILLDDKYRA----KVSDFGASRSMAV 551
            +  S        + YLH+     + HRD+K  NIL+  +       K++D G +R    
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184

Query: 552 ---DQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
                  +   V  TF Y  PE    +  +T   D+++ G + AELLT  +PI
Sbjct: 185 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 235

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 93.4 bits (233), Expect = 7e-21
 Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 26/224 (11%)

Query: 397 DNFNLNRILGQGGQGTV----YKGMLPDGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
           ++F L+++LG+G  G V    +K      +  A+K   K  V+ +  VE  + E  +LS 
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73

Query: 450 -INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVS 506
              H  +  +  C  +T+  L  V E++  G L  +I      F      R    A E+ 
Sbjct: 74  AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFD---LSRATFYAAEII 128

Query: 507 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHMTTQVHGTFG 565
             L +LHS     I +RD+K  NILLD     K++DFG  + +M  D    T    GT  
Sbjct: 129 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPD 183

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
           Y+ PE     ++    D +SFGV+L E+L G+ P  F   +E++
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEE 225

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 59/228 (25%), Positives = 89/228 (39%), Gaps = 38/228 (16%)

Query: 396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKK--SKVIDESKVEEFIN---------EM 444
              + + R +  G  G V  G+  +G  VA+K+  + V D   V    +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 445 VILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGTLFQYIHDQNEDFP------I 493
            +L+  +H N++ L    +  E P      LV E +    L Q IHDQ            
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139

Query: 494 TWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 553
            + + L         L  LH A    + HRD+   NILL D     + DF  +R    D 
Sbjct: 140 MYHI-LL-------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 554 THMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            + T  V     Y  PE   +   FT   D++S G V+AE+    K +
Sbjct: 189 -NKTHYV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 62/292 (21%), Positives = 114/292 (39%), Gaps = 55/292 (18%)

Query: 396 TDNFNLNR-ILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NH 452
           TD++ L++ +LG G  G V +      G+  A+K   ++      +   E+    Q    
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLY--DSPKARQEVDHHWQASGG 81

Query: 453 RNVVKLLGCCLETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
            ++V +L             L++ E +  G LF  I ++ +    T      I  ++  A
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTA 140

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFG 565
           + +LHS     I HRD+K  N+L   K +    K++DFG ++     Q  + T    T  
Sbjct: 141 IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPC-YTPY 194

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
           Y+ PE     ++    D++S GV++  LL G  P  F              ++   + + 
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP--F--------------YSNTGQAIS 238

Query: 626 EILDARVMKESGGDEIITF-----------AK-VAKRCLNLNGKKRPTMREV 665
             +  R+     G     F           AK + +  L  +  +R T+ + 
Sbjct: 239 PGMKRRIRL---GQ--YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 40/231 (17%)

Query: 394 RATDNFN-LNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF----INEMVIL 447
                +  L +I GQG  G V+K      G+ VA+KK  +  E++ E F    + E+ IL
Sbjct: 14  DEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLM--ENEKEGFPITALREIKIL 70

Query: 448 SQINHRNVVKLLGCCLETEVPL--------LVYEFIPNGTLFQYIHD-----QNEDFPIT 494
             + H NVV L+  C     P         LV++F          HD      N     T
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFT 122

Query: 495 WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV--- 551
                R+   +   L Y+H      I HRD+K+ N+L+      K++DFG +R+ ++   
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 552 -DQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
                 T +V  T  Y  PE       +    D++  G ++AE+ T   PI
Sbjct: 180 SQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPI 228

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 95.1 bits (236), Expect = 2e-20
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 18/220 (8%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
            +FN   +LG+G  G V         ++ AVK   K  VI +  VE  + E  +L+    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 453 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRI-AIEVSGALS 510
              +  L  C +T   L  V E++  G L  +I      F    E      A E++  L 
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FK---EPHAVFYAAEIAIGLF 456

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHMTTQVHGTFGYLDP 569
           +L S     I +RD+K  N++LD +   K++DFG  + ++    T  T    GT  Y+ P
Sbjct: 457 FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAP 511

Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK 609
           E      +    D ++FGV+L E+L G+ P  F   +ED+
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--FEGEDEDE 549

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 53/219 (24%), Positives = 103/219 (47%), Gaps = 24/219 (10%)

Query: 394 RATDNF-NLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEF----INEMVIL 447
            + D +  + ++ G+G  G VYK +     + VA+K+ ++  E + E      I E+ +L
Sbjct: 31  TSIDRYRRITKL-GEGTYGEVYKAIDTVTNETVAIKRIRL--EHEEEGVPGTAIREVSLL 87

Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            ++ HRN+++L           L++E+  N  L +Y+ D+N D  +   ++     ++  
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMR-VIK-SFLYQLIN 143

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRA-----KVSDFGASRSMAVDQTHMTTQVHG 562
            +++ HS       HRD+K  N+LL     +     K+ DFG +R+  +     T ++  
Sbjct: 144 GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199

Query: 563 TFGYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           T  Y  PE    S  ++   D++S   + AE+L    P+
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPL 237

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 90.7 bits (226), Expect = 6e-20
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 24/221 (10%)

Query: 394 RATDNFN-LNRILGQGGQGTVYKG--MLPDGKIVAVKKSKVIDE------SKVEEFINEM 444
           RA   +  +  I G+G  G V+K   +   G+ VA+K+ +V         S + E +  +
Sbjct: 8   RADQQYECVAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVL 65

Query: 445 VILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGTLFQYIHDQNEDFPITWEMRL 499
             L    H NVV+L   C  +         LV+E +    L  Y+    E   +  E   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-VPTETIK 123

Query: 500 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 559
            +  ++   L +LHS     + HRD+K  NIL+    + K++DFG +R  +     +T+ 
Sbjct: 124 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSV 179

Query: 560 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           V  T  Y  PE    S +    D++S G + AE+    KP+
Sbjct: 180 VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPL 218

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 90.8 bits (225), Expect = 7e-20
 Identities = 64/284 (22%), Positives = 96/284 (33%), Gaps = 81/284 (28%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSK-VIDESKVEEFINE 443
           E  R  D   L + LG+G  G V +            + VAVK  K     S+    ++E
Sbjct: 18  EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 75

Query: 444 MVILSQI-NHRNVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFPITWEMRLRI 501
           + IL  I +H NVV LLG C +   PL+V  EF   G L  Y+  +  +F        R 
Sbjct: 76  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARF 135

Query: 502 AIEVS------------------------------GALSYLHSAASIPIYHRDIKSTNIL 531
                                               +LS +    +    ++D  +   L
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195

Query: 532 L------------------------------DDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
           +                               +K   K+ DFG +R +  D  +    V 
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VR 251

Query: 562 GTFGYLD-----PEYFRSSQFTDKSDVYSFGVVLAELLT-GEKP 599
                L      PE      +T +SDV+SFGV+L E+ + G  P
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 56/260 (21%), Positives = 108/260 (41%), Gaps = 71/260 (27%)

Query: 392 LERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFIN-EMVILSQ 449
           LE ++  ++L + LG G  G V +   +  GK  A+KK  V+ + +   + N E+ I+  
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--VLQDPR---YKNRELDIMKV 56

Query: 450 INHRNVVKLLGC-------------------------------------CLETEVPL-LV 471
           ++H N++KL+                                              L ++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 472 YEFIPNGTLFQYIH---DQNEDFPI------TWEMRLRIAIEVSGALSYLHSAASIPIYH 522
            E++P+ TL + +          P+       +++  R       A+ ++HS     I H
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQL-FR-------AVGFIHSLG---ICH 164

Query: 523 RDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTDK 580
           RDIK  N+L++      K+ DFG+++ +   +      +  +  Y  PE    ++++T  
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYI-CSRFYRAPELMLGATEYTPS 222

Query: 581 SDVYSFGVVLAELLTGEKPI 600
            D++S G V  EL+ G KP+
Sbjct: 223 IDLWSIGCVFGELILG-KPL 241

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 33/220 (15%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-----SKVIDESKVEEFINEMVILSQ 449
              +   + +G G QG V         + VA+KK            +      E+V++  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA---YRELVLMKC 80

Query: 450 INHRNVVKLLGCCLETEVPL------LVYEFIPNGTLFQYIHDQNEDF---PITWEMRLR 500
           +NH+N++ LL      +         +V E +    L Q I  + +      + ++M L 
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQM-LC 138

Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 560
                   + +LHSA    I HRD+K +NI++      K+ DFG +R+ A     MT  V
Sbjct: 139 -------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYV 187

Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             T  Y  PE      + +  D++S G ++ E++ G   +
Sbjct: 188 -VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 60/278 (21%), Positives = 107/278 (38%), Gaps = 37/278 (13%)

Query: 401 LNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKL 458
            +++LG G  G V +       +  A+K   ++      +   E+ +  +     ++V++
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCPKARREVELHWRASQCPHIVRI 120

Query: 459 LGCCLETEVP-----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +    E         L+V E +  G LF  I D+ +    T      I   +  A+ YLH
Sbjct: 121 VDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLH 178

Query: 514 SAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           S   I I HRD+K  N+L   K      K++DFG ++      + +TT    T  Y+ PE
Sbjct: 179 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPE 233

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE-ILD 629
                ++    D++S GV++  LL G  P  F +                   +   I  
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAI----------SPGMKTRIRM 281

Query: 630 ARVMKESGG-DEIITFAK-VAKRCLNLNGKKRPTMREV 665
            +    +    E+    K + +  L     +R T+ E 
Sbjct: 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 87.2 bits (216), Expect = 3e-18
 Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 31/219 (14%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-----SKVIDESKVEEFINEMVILSQ 449
              +   + +G G QG V         + VA+KK            +      E+V++  
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA---YRELVLMKC 117

Query: 450 INHRNVVKLL-----GCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEM--RLRI 501
           +NH+N++ LL        LE    + LV E +    L Q I  + +   +++ +   L  
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLC- 175

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
                  + +LHSA    I HRD+K +NI++      K+ DFG +R+       MT  V 
Sbjct: 176 ------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV- 224

Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            T  Y  PE      + +  D++S G ++ E++   K +
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 29/218 (13%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-----SKVIDESKVEEFINEMVILSQ 449
              +   + +G G  G V   +    G  VA+KK        +   +      E+ +L  
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA---YRELRLLKH 80

Query: 450 INHRNVVKLLGCCLETEVPL------LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAI 503
           + H NV+ LL      E         LV  F+    L + +  +     +  +    +  
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE----KLGEDRIQFLVY 135

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           ++   L Y+H+A    I HRD+K  N+ +++    K+ DFG +R      + MT  V  T
Sbjct: 136 QMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYV-VT 188

Query: 564 FGYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             Y  PE      ++T   D++S G ++AE++TG K +
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 34/220 (15%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-----SKVIDESKVEEFINEMVILSQ 449
              +     +G G  G+V   +    G+ VA+KK        I   +      E+++L  
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA---YRELLLLKH 79

Query: 450 INHRNVVKLLGCCLETEVPL------LVYEFIPNGTLFQYIHDQNEDFPITWEM--RLRI 501
           + H NV+ LL                LV  F+    L + +  +  +  I + +   L+ 
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK- 137

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
                  L Y+HSA    + HRD+K  N+ +++    K+ DFG +R        MT  V 
Sbjct: 138 ------GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYV- 184

Query: 562 GTFGYLDPE-YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            T  Y  PE       +    D++S G ++AE+LTG K +
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 37/224 (16%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK----SKVIDESKVEEFINEMVILSQI 450
              +     +G+G  G V       +   VA+KK           +    + E+ IL + 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIKILLRF 82

Query: 451 NHRNVVKLLGCCLETEVPL-----LVYEFIPNGT-LFQYIHDQN--EDFP--ITWEMRLR 500
            H N++ +        +       +V + +   T L++ +  Q+   D      +++ LR
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFLYQI-LR 139

Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH---MT 557
                   L Y+HSA    + HRD+K +N+LL+     K+ DFG +R    D  H   +T
Sbjct: 140 -------GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 558 TQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             V  T  Y  PE    S  +T   D++S G +LAE+L+  +PI
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 29/218 (13%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVE--EFINEMVILSQINH 452
            + +     +G G  G+V        G  VAVKK     +S +       E+ +L  + H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 453 RNVVKLLGCCLETEVPL------LVYEFIPNGTLFQYIHDQN-EDFPITWEMR--LRIAI 503
            NV+ LL                LV   +    L   +  Q   D  + + +   LR   
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR--- 143

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
                L Y+HSA    I HRD+K +N+ +++    K+ DFG +R  A     MT  V  T
Sbjct: 144 ----GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA---DEMTGYV-AT 192

Query: 564 FGYLDPE-YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
             Y  PE       +    D++S G ++AELLTG + +
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 60/240 (25%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK---SKVIDESKVEEFINEMVILSQIN 451
              +   + LG GG G V+  +     K VA+KK   +           + E+ I+ +++
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRRLD 66

Query: 452 HRNVVKLL------GCCLETEVPL--------LVYEF--------IPNGTL----FQYIH 485
           H N+VK+       G  L  +V          +V E+        +  G L     +   
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126

Query: 486 DQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFG 544
            Q           LR        L Y+HSA    + HRD+K  N+ ++ +    K+ DFG
Sbjct: 127 YQ----------LLR-------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFG 166

Query: 545 ASRSMAVDQTH---MTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
            +R M    +H   ++  +  T  Y  P      + +T   D+++ G + AE+LTG K +
Sbjct: 167 LARIMDPHYSHKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 40/229 (17%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK----SKVIDESKVEEFINEMVILSQI 450
           + +F L  +LG+G  G V      P G+IVA+KK     K +   +    + E+ IL   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT---LREIKILKHF 66

Query: 451 NHRNVVKLLGCCLETEVPL-----LVYEFIPNGT-LFQYIHDQN-EDFPITWEMR--LRI 501
            H N++ +                ++ E +   T L + I  Q   D  I + +   LR 
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFIYQTLR- 123

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 561
                 A+  LH +    + HRD+K +N+L++     KV DFG +R +       +    
Sbjct: 124 ------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

Query: 562 GTFG---------YLDPEY-FRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
              G         Y  PE    S++++   DV+S G +LAEL    +PI
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 47/245 (19%), Positives = 88/245 (35%), Gaps = 59/245 (24%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-----SKVIDESKVEEFINEMVILSQ 449
            DN+ +  ++G+G  G VY        K VA+KK       +ID  ++   + E+ IL++
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREITILNR 81

Query: 450 INHRNVVKLLGCCLETEVPL-----LVYEF--------IPNGTLFQYIHDQNEDFPITWE 496
           +    +++L    +  ++       +V E                   H +     I + 
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT----ILYN 137

Query: 497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 556
           + L          +++H +    I HRD+K  N LL+     KV DFG +R++  ++   
Sbjct: 138 L-LL-------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186

Query: 557 TTQVHGTFGYLDP----------EY------------FRSSQFTDKSDVYSFGVVLAELL 594
                       P           +                 +T   D++S G + AELL
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

Query: 595 TGEKP 599
              + 
Sbjct: 247 NMLQS 251

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 54/275 (19%), Positives = 105/275 (38%), Gaps = 67/275 (24%)

Query: 371 QQELASTEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK- 428
           +++  S++ T    +  +  ++    D + +  ++G G  G V +     + ++VA+KK 
Sbjct: 30  RKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86

Query: 429 ----SKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL-----LVYEF----- 474
                 +ID  ++   + E+ IL+++NH +VVK+L   +  +V       +V E      
Sbjct: 87  LRVFEDLIDCKRI---LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDF 143

Query: 475 ---IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL 531
                       +H +     + + + L         + Y+HSA    I HRD+K  N L
Sbjct: 144 KKLFRTPVYLTELHIKT----LLYNL-LV-------GVKYVHSAG---ILHRDLKPANCL 188

Query: 532 LDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP---------------EY----- 571
           ++     KV DFG +R++   +   +                            +     
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW 248

Query: 572 -------FRSSQFTDKSDVYSFGVVLAELLTGEKP 599
                       +T+  DV+S G + AELL   K 
Sbjct: 249 YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 62/245 (25%), Positives = 102/245 (41%), Gaps = 62/245 (25%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-----SKVIDESKVEEFINEMVILSQ 449
              + L + LG+G  G V+K +    G++VAVKK         D  +      E++IL++
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIMILTE 64

Query: 450 IN-HRNVVKLLGCCLETEVPL--------LVYEFIPNGT-LFQYIHDQN-EDFPITWEMR 498
           ++ H N+V LL       V          LV++++   T L   I     E     + + 
Sbjct: 65  LSGHENIVNLL------NVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVY 116

Query: 499 --LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 556
             ++        + YLHS     + HRD+K +NILL+ +   KV+DFG SRS    +   
Sbjct: 117 QLIK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166

Query: 557 TTQVHGTFGYLDP---------EY------------FRSSQFTDKSDVYSFGVVLAELLT 595
                      +          +Y              S+++T   D++S G +L E+L 
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226

Query: 596 GEKPI 600
           G KPI
Sbjct: 227 G-KPI 230

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 50/259 (19%), Positives = 92/259 (35%), Gaps = 63/259 (24%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVK--KSK------VIDESKVEEFINEMVILSQ--IN 451
           R LG G   TV+    + +   VA+K  +          DE K+ + +N+     +  + 
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 452 HRNVVKLLGC-----------CLETEVPLL---VYEFIPNGTLFQYIHDQNEDFPITWEM 497
             +++KLL              +  E  +L   +   I           + E   I    
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALI----------KKYEHRGIPLIY 132

Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA------KVSDFGASRSMAV 551
             +I+ ++   L Y+H    I I H DIK  N+L++           K++D G +     
Sbjct: 133 VKQISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEIVDSPENLIQIKIADLGNACW--Y 188

Query: 552 DQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLAELLTGEKPIRFTTL 605
           D+ +           +    +RS      + +   +D++S   ++ EL+TG+    F   
Sbjct: 189 DEHYTN--------SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD--FLFEPD 238

Query: 606 EEDKSLAAYFLFAMKEERL 624
           E           A   E L
Sbjct: 239 EGHSYTKDDDHIAQIIELL 257

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 54/278 (19%), Positives = 96/278 (34%), Gaps = 58/278 (20%)

Query: 401 LNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKL 458
            +++LG G  G V +       +  A+K   ++      +   E+ +  +     ++V++
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCPKARREVELHWRASQCPHIVRI 76

Query: 459 LGCCLETEVP-----LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +    E         L+V E +  G LF  I D+ +    T      I   +  A+ YLH
Sbjct: 77  VDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLH 134

Query: 514 SAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           S     I HRD+K  N+L   K      K++DFG                         E
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFG----------------------FAKE 169

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE-ILD 629
                ++    D++S GV++  LL G  P  F +                   +   I  
Sbjct: 170 -TTGEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAI----------SPGMKTRIRM 216

Query: 630 ARVMKESGG-DEIITFAK-VAKRCLNLNGKKRPTMREV 665
            +    +    E+    K + +  L     +R T+ E 
Sbjct: 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 59/224 (26%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVK----KSKVIDESKVEEFINEMVILSQINHR---- 453
           +++G+G  G V K       + VA+K    + +   ++  E  I    IL  +  +    
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE--IR---ILEHLRKQDKDN 157

Query: 454 --NVVKLLGC-------CLETEVPLL---VYEFIPNGTLFQYIHDQNEDFPITWEMRLRI 501
             NV+ +L         C+  E  LL   +YE I           +N+    +  +  + 
Sbjct: 158 TMNVIHMLENFTFRNHICMTFE--LLSMNLYELI----------KKNKFQGFSLPLVRKF 205

Query: 502 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA--KVSDFGASRSMAVDQTHMTTQ 559
           A  +   L  LH      I H D+K  NILL  + R+  KV DFG+S      Q   T  
Sbjct: 206 AHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYT-- 258

Query: 560 VHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLAELLTGE 597
                 Y+   ++R+      +++    D++S G +LAELLTG 
Sbjct: 259 ------YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 74/377 (19%), Positives = 116/377 (30%), Gaps = 130/377 (34%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK--KSKVIDESKVEEFINEMVILSQI-- 450
              +++ R LG G   TV+    +   K VA+K  KS    E   E  ++E+ +L  +  
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRN 92

Query: 451 ------NHRNVVKLLGC-----------CLETEVPLLVYEFIPNG-TLFQYIHDQNEDFP 492
                 N   VV+LL             C+       V+E    G  L ++I  ++    
Sbjct: 93  SDPNDPNREMVVQLLDDFKISGVNGTHICM-------VFE--VLGHHLLKWII-KSNYQG 142

Query: 493 ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL-------------------- 532
           +      +I  +V   L YLH+   I   H DIK  NILL                    
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEATEWQRS 200

Query: 533 -----------------------------DDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
                                         +K + K++D G +    V +    T+   T
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHF--TEDIQT 256

Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM---- 619
             Y   E    S +   +D++S   +  EL TG+    F     ++        A+    
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL--FEPHSGEEYTRDEDHIALIIEL 314

Query: 620 -------------------------------KEERLFEILDARVMKESGGDEIITFAKVA 648
                                          K   LFE+L  +   E   +E   F    
Sbjct: 315 LGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDFL 372

Query: 649 KRCLNLNGKKRPTMREV 665
              L L  +KR T  E 
Sbjct: 373 LPMLELIPEKRATAAEC 389

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 52/246 (21%), Positives = 102/246 (41%), Gaps = 59/246 (23%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK----KSKVIDESKVEEFINEMVILSQI 450
            D + ++ ++G+G  G V K     + + VA+K    K   ++++++E     + +L  +
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-----VRLLELM 107

Query: 451 NHR------NVVKLLGC-------CLETEVPLL---VYEFIPNGTLFQYIHDQNEDFPIT 494
           N         +V L          CL  E  +L   +Y+ +                 ++
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLL----------RNTNFRGVS 155

Query: 495 WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA--KVSDFGASRSMAVD 552
             +  + A ++  AL +L +   + I H D+K  NILL +  R+  K+ DFG+S    + 
Sbjct: 156 LNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLG 212

Query: 553 QTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLE 606
           Q            Y+   ++RS        +    D++S G +L E+ TG +P+ F+   
Sbjct: 213 QRIYQ--------YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPL-FSGAN 262

Query: 607 EDKSLA 612
           E   + 
Sbjct: 263 EVDQMN 268

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.7 bits (141), Expect = 2e-09
 Identities = 38/259 (14%), Positives = 77/259 (29%), Gaps = 66/259 (25%)

Query: 395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE--------SKVEEFINEMVI 446
            T+       +G+G  G V++ +  D   VA+K   +              EE + E++I
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 447 LSQI---------NHRNVVKLLGCCL----------------------ETEVPL------ 469
             ++              + L                             + P       
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 470 --LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKS 527
             +V EF   G   + +  +      +      I  +++ +L+   +  S+   HRD+  
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 528 TNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL-DPEYFRSSQFTDKSDVYSF 586
            N+LL      K+      +S  +           + G       +  S+      V   
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTI----------PSCGLQVSIIDYTLSRLERDGIVVFC 240

Query: 587 GVVLA-ELLTGEKPIRFTT 604
            V +  +L TG+   +F  
Sbjct: 241 DVSMDEDLFTGDGDYQFDI 259

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 48/242 (19%), Positives = 81/242 (33%), Gaps = 77/242 (31%)

Query: 403 RILGQGGQGTVYKGM--LPDGKIVAVK----KSKVIDESKVEEFINEMVILSQINHR--- 453
             LG+G  G V + +        VA+K      K  + +++E  IN   +L +I  +   
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE--IN---VLKKIKEKDKE 79

Query: 454 ---NVVKLLGC-------CLETEVPLL---VYEFIPNGTLFQYIHDQNEDFPITWEMRLR 500
                V +          C+  E  LL    +EF+           +N   P        
Sbjct: 80  NKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFL----------KENNFQPYPLPHVRH 127

Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA-------------------KVS 541
           +A ++  AL +LH        H D+K  NIL  +                       +V+
Sbjct: 128 MAYQLCHALRFLHENQLT---HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 542 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLAELLT 595
           DFG++      + H T         +   ++R         +    DV+S G +L E   
Sbjct: 185 DFGSA--TFDHEHHTT--------IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

Query: 596 GE 597
           G 
Sbjct: 235 GF 236

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 40/179 (22%), Positives = 65/179 (36%), Gaps = 28/179 (15%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV--------IDESKVE------EFIN 442
            + L + +G GG G +Y        +  A    KV          E K        + I 
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 443 EMVILSQINHRNVVKLLGC----CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR 498
           + +   Q+++  +    G             +V E +  G   Q I  QN  F       
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKK--STV 153

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV--SDFGASRSMAVDQTH 555
           L++ I +   L Y+H    +   H DIK+ N+LL  K   +V  +D+G S     +  H
Sbjct: 154 LQLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 58.3 bits (140), Expect = 8e-09
 Identities = 50/317 (15%), Positives = 99/317 (31%), Gaps = 94/317 (29%)

Query: 341 GAWWLFKFVKRRREIKLKRKFF----KRNGGLLLQQELASTEGTIEKTKLFTSKELERAT 396
           G   LF  +  ++E  +++ F     + N   L+             T+++  +      
Sbjct: 63  GTLRLFWTLLSKQEEMVQK-FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN 121

Query: 397 DN-----FNLNRI-----LGQG------GQGTVYKGMLPDGKIVAVKKSKVIDESKVEEF 440
           DN     +N++R+     L Q        +  +  G+L  GK        V    KV+  
Sbjct: 122 DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA--LDVCLSYKVQCK 179

Query: 441 INEMVI-LSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGTLFQYIHDQNEDFPIT 494
           ++  +  L+          L  C   E  L     L+Y+  PN T          D    
Sbjct: 180 MDFKIFWLN----------LKNCNSPETVLEMLQKLLYQIDPNWT-------SRSDHSSN 222

Query: 495 WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD-- 552
            ++R+     +   L  L       +  +  ++  ++L +   AK  +       A +  
Sbjct: 223 IKLRIH---SIQAELRRL-------LKSKPYENCLLVLLNVQNAKAWN-------AFNLS 265

Query: 553 -QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSL 611
            +  +TT              R  Q TD     +   +  +  +        TL  D+  
Sbjct: 266 CKILLTT--------------RFKQVTDFLSAATTTHISLDHHSM-------TLTPDEVK 304

Query: 612 AAYFLFA----MKEERL 624
           +   L       + + L
Sbjct: 305 S---LLLKYLDCRPQDL 318

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 29/159 (18%), Positives = 61/159 (38%), Gaps = 17/159 (10%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRN 454
            ++ + R +G+G  G +++G  L + + VA+K       S   +  +E      +     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67

Query: 455 VVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +  +     E    +LV + + P+  L   +      F +  +     A ++   +  +H
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLGPS--LEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIH 123

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAK-----VSDFGASR 547
             + +   +RDIK  N L+            V DFG  +
Sbjct: 124 EKSLV---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 39/166 (23%), Positives = 72/166 (43%), Gaps = 15/166 (9%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH-RN 454
           + + L R +G G  G +Y G  +  G+ VA+K   V  ++K  +   E  I   +     
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66

Query: 455 VVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +  +  C  E +  ++V E + P+  L    +  +  F +  +  L +A ++   + Y+H
Sbjct: 67  IPTIRWCGAEGDYNVMVMELLGPS--LEDLFNFCSRKFSL--KTVLLLADQMISRIEYIH 122

Query: 514 SAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMAVDQTHM 556
           S   I   HRD+K  N L+          + DFG ++     +TH 
Sbjct: 123 SKNFI---HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 63/240 (26%), Positives = 87/240 (36%), Gaps = 69/240 (28%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVK----KSKVIDESKVEEFINEMVILSQINHR---- 453
           R +G G  G V     + + K  AVK      K    +K+E   +   IL +I +     
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE--AD---ILKKIQNDDINN 95

Query: 454 -NVVKLLGC-------CLETEVPLL---VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
            N+VK  G        CL  E   L   +YE I           +N       E      
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFE--PLGPSLYEII----------TRNNYNGFHIEDIKLYC 143

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA------------------------ 538
           IE+  AL+YL   +     H D+K  NILLDD Y                          
Sbjct: 144 IEILKALNYLRKMSLT---HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200

Query: 539 -KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGE 597
            K+ DFG          +  + ++    Y  PE   +  +   SD++SFG VLAEL TG 
Sbjct: 201 IKLIDFG---CATFKSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 56/257 (21%), Positives = 94/257 (36%), Gaps = 79/257 (30%)

Query: 403 RILGQGGQGTVYKG--MLPDGKIVAVK----KSKVIDESKVEEFINEMVILSQINHR--- 453
             LG+G  G V +       G+ VAVK      +  + ++ E  I    +L  +N     
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE--IQ---VLEHLNTTDPN 74

Query: 454 ---NVVKLLGC-------CLETEVPLL---VYEFIPNGTLFQYIHDQNEDFPITWEMRLR 500
                V++L         C+  E  LL    Y+FI           +N   P   +   +
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFI----------KENGFLPFRLDHIRK 122

Query: 501 IAIEVSGALSYLHSAASIPIYHRDIKSTNILL-DDKYRA------------------KVS 541
           +A ++  ++++LHS       H D+K  NIL     Y                    KV 
Sbjct: 123 MAYQICKSVNFLHSNKLT---HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 542 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLAELLT 595
           DFG++     D+ H T         +   ++R+        ++   DV+S G +L E   
Sbjct: 180 DFGSA--TYDDEHHST--------LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229

Query: 596 GEKPIRFTTLEEDKSLA 612
           G   + F T +  + LA
Sbjct: 230 GF-TV-FPTHDSKEHLA 244

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 36/183 (19%), Positives = 69/183 (37%), Gaps = 33/183 (18%)

Query: 398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVI-----------DESKV------EEF 440
            + +   +GQGG G +Y   +   + V      V+            E K        E 
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 441 INEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI------PNGTLFQYIHDQNEDFPIT 494
           I + +   ++ +  V K  G  L  +     Y F+       +  L +      + F   
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLH-DKNGKSYRFMIMDRFGSD--LQKIYEANAKRFSR- 151

Query: 495 WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV--SDFGASRSMAVD 552
            +  L++++ +   L Y+H    +   H DIK++N+LL+ K   +V   D+G +     +
Sbjct: 152 -KTVLQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207

Query: 553 QTH 555
             H
Sbjct: 208 GVH 210

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 33/221 (14%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRN 454
           + F L R +G G  G +Y G  +   + VA+K   V  ++K  + + E  I   +     
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64

Query: 455 VVKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           +  +    +E +  +LV + + P+  L    +  +    +  +  L +A ++   + ++H
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLLGPS--LEDLFNFCSRKLSL--KTVLMLADQMINRVEFVH 120

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAK---VSDFGASRSMAVDQTHM------TTQVHGTF 564
           S + +   HRDIK  N L+    RA    + DFG ++      TH          + GT 
Sbjct: 121 SKSFL---HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177

Query: 565 GY------LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP 599
            Y      L  E  R      + D+ S G VL   L G  P
Sbjct: 178 RYASVNTHLGIEQSR------RDDLESLGYVLMYFLRGSLP 212

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 33/158 (20%), Positives = 64/158 (40%), Gaps = 17/158 (10%)

Query: 398 NFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNV 455
           NF + + +G G  G +  G  L   + VA+K   +  +S+  +   E     Q+ +   +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67

Query: 456 VKLLGCCLETEVPLLVYEFI-PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
            ++       +   +V E + P+  L       +  F +  +  L IAI++   + Y+HS
Sbjct: 68  PQVYYFGPCGKYNAMVLELLGPS--LEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVS-----DFGASR 547
              I   +RD+K  N L+              DF  ++
Sbjct: 124 KNLI---YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 28/181 (15%), Positives = 65/181 (35%), Gaps = 27/181 (14%)

Query: 398 NFNLNRILGQGGQGTVYKGM---------LPDGKIVAVK----KSKVIDESKV------E 438
            + L     +  QG +Y+            P  +  ++K      ++ +E          
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102

Query: 439 EFINEMVILSQINHRNVVKLLGC-CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
             +N+   L       +   +G    + +   LV   +  G   Q   D +    ++   
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERS 160

Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV--SDFGASRSMAVDQTH 555
            L++A  +  AL +LH    +   H ++ + NI +D + +++V  + +G +        H
Sbjct: 161 VLQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217

Query: 556 M 556
           +
Sbjct: 218 V 218

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	684
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.63
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.06
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.0
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.95
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.67
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.44
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.42
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.3
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.2
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.13
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.95
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.93
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.64
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.62
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.5
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.23
1z6c_A	87	Vitamin K-dependent protein S; EGF module, blood c	97.09
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.07
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.06
1emn_A	82	Fibrillin; extracellular matrix, calcium-binding,	96.95
1lmj_A	86	Fibrillin 1; EGF, calcium, microfibril, neonatal,	96.94
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.92
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.92
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.86
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.74
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.65
2w2n_E	107	LDL receptor, low-density lipoprotein receptor; hy	96.6
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.45
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.38
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.97
3p5b_L	400	Low density lipoprotein receptor variant; B-propel	95.75
3h5c_B	317	Vitamin K-dependent protein Z; protein Z-protein Z	95.73
1yo8_A	634	Thrombospondin-2; EGF, Ca(2+)-binding domains, lec	95.55
2bou_A	143	EGF-like module containing mucin-like hormone rece	95.34
1x7a_L	146	Coagulation factor IX, light chain; inhibition, bl	95.27
3v65_B	386	Low-density lipoprotein receptor-related protein;	95.25
1nfu_B	195	Coagulation factor XA, light chain; hydrolase; HET	95.19
1aut_L	114	Activated protein C; serine proteinase, plasma cal	95.06
1yo8_A	634	Thrombospondin-2; EGF, Ca(2+)-binding domains, lec	94.74
2vj3_A	135	Neurogenic locus notch homolog protein 1; transcri	94.55
2c4f_L	142	Coagulation factor VII precursor; blood coagulatio	94.55
2bou_A	143	EGF-like module containing mucin-like hormone rece	94.43
2vh0_B	134	Activated factor XA light chain; serine protease,	94.37
4d90_A	143	EGF-like repeat and discoidin I-like domain-conta	94.37
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.33
1z1y_A	186	Ookinete surface protein PVS25; four EGF-like doma	93.11
2vj3_A	135	Neurogenic locus notch homolog protein 1; transcri	92.93
1dx5_I	118	Thrombomodulin; serine proteinase, EGF-like domain	92.89
1z1y_A	186	Ookinete surface protein PVS25; four EGF-like doma	91.47
4d90_A	143	EGF-like repeat and discoidin I-like domain-conta	91.0
1n7d_A	699	LDL receptor, low-density lipoprotein receptor; fa	90.89
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	90.38
1tpg_A	91	T-plasminogen activator F1-G; plasminogen activati	89.49
1kig_L	51	Factor XA; glycoprotein, serine protease, plasma,	89.4
3m0c_C	791	LDL receptor, low-density lipoprotein receptor; pr	88.88
1uzk_A	162	Fibrillin-1; glycoprotein, extra-cellular matrix,	88.27
2w86_A	147	Fibrillin-1, fibrillin1; phosphoprotein, EGF-like	87.05
1gl4_A	285	Nidogen-1, entactin; immunoglobulin-like domain, e	86.97
1uzk_A	162	Fibrillin-1; glycoprotein, extra-cellular matrix,	86.43
2jkh_L	55	Factor X light chain; plasma, calcium, zymogen, se	85.04
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.79
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.49

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.5e-54  Score=451.26  Aligned_cols=261  Identities=25%  Similarity=0.419  Sum_probs=220.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC------CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||++++++.+.+..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46888999999999999999863      477899999988777788899999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEE
Q 043157          471 VYEFIPNGTLFQYIHDQN----------EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV  540 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl  540 (684)
                      ||||+++|+|.++|+...          ....++|..++.|+.||+.||+|||+++   |+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999998642          2345999999999999999999999998   999999999999999999999


Q ss_pred             eccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHH
Q 043157          541 SDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFA  618 (684)
Q Consensus       541 ~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~  618 (684)
                      +|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||...+..+   +.      
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~------  240 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI------  240 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH------
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH------
Confidence            999999876543332 2334568999999999999999999999999999999999 899998654322   11      


Q ss_pred             hhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          619 MKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       619 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                             ..+........+...+.++.+|+.+||+.||++|||++||.+.|+++.+..
T Consensus       241 -------~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          241 -------ECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             -------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             -------HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                   111111122345567788999999999999999999999999999998654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.4e-54  Score=452.59  Aligned_cols=260  Identities=26%  Similarity=0.428  Sum_probs=214.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC------CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++..+....++|.+|+++|++++|||||++++++.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45788899999999999999864      478999999988778888999999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcE
Q 043157          471 VYEFIPNGTLFQYIHDQNE------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA  538 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~  538 (684)
                      ||||+++|+|.++|+....            ..+++|.+++.|+.||++||+|||+++   |+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999986532            235999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCccccccCC-ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHH
Q 043157          539 KVSDFGASRSMAVDQ-THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFL  616 (684)
Q Consensus       539 kl~DFgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~  616 (684)
                      ||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||......+.   .    
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~----  270 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---I----  270 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---H----
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---H----
Confidence            999999998764333 233445679999999999999999999999999999999999 8999985543221   1    


Q ss_pred             HHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       617 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                               +.+......+.+...+.++.+|+.+||+.||++|||++||+++|+.|...
T Consensus       271 ---------~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          271 ---------DCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ---------HHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---------HHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                     11111112234456778899999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-53  Score=445.34  Aligned_cols=258  Identities=24%  Similarity=0.386  Sum_probs=215.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      ..+++.++||+|+||+||+|.+.      +++.||||+++.. .....++|.+|+.+|++++|||||+++|++.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34677899999999999999863      4678999998653 3344678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 043157          470 LVYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY  536 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~  536 (684)
                      |||||+++|+|.++|+....             ...++|..+++|+.|||+||+|||+++   |+||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999976421             235899999999999999999999999   99999999999999999


Q ss_pred             cEEEeccCCccccccCC-ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHH
Q 043157          537 RAKVSDFGASRSMAVDQ-THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAY  614 (684)
Q Consensus       537 ~~kl~DFgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~  614 (684)
                      ++||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||...+..+   +   
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~---  256 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V---  256 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H---
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H---
Confidence            99999999998765333 233445679999999999999999999999999999999998 899998654322   1   


Q ss_pred             HHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          615 FLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       615 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                                .+.+........+.+.+.++.+|+.+||+.||++|||++||+++|+.+.
T Consensus       257 ----------~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          257 ----------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             ----------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ----------HHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence                      1111122223345677888999999999999999999999999998753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.9e-53  Score=437.85  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=210.0

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ..+++++.++||+|+||+||+|++++  .||||.++.  ...+..+.|.+|+++|++++|||||++++++.+ +..+|||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            44678899999999999999999754  489998765  345667889999999999999999999998864 5689999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.++|+....  ++++..++.|+.|||+||+|||+++   |+||||||+||||++++++||+|||+|+.....
T Consensus       111 Ey~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             ECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            99999999999987543  4999999999999999999999998   999999999999999999999999999875432


Q ss_pred             -CceeeecccccCCCCCcccccc---CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          553 -QTHMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       553 -~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                       .........||+.|||||++..   ..|+.++|||||||+||||+||+.||........  +.    ......    ..
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~----~~~~~~----~~  255 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--II----FMVGRG----YA  255 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HH----HHHHTT----CC
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HH----HHHhcC----CC
Confidence             2233455679999999999864   4589999999999999999999999975432211  10    011110    00


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .+ .....+.+.+.++.+|+.+||+.||++|||+.||+++|+.|+..
T Consensus       256 ~p-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          256 SP-DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             CC-CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             CC-CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            11 11233456778899999999999999999999999999999754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4e-52  Score=439.46  Aligned_cols=251  Identities=23%  Similarity=0.372  Sum_probs=207.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|++.+.||+|+||+||+++.. +|+.||||++..  ......+.+.+|+++|++++|||||++++++.+.+..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999964 699999998764  345567889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++|+|.++|...+. ..+++..++.|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999986543 34799999999999999999999999   9999999999999999999999999998764322


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                       .......||+.|||||++.+..|+.++|||||||+||||+||+.||...+..+.      +         ..++.... 
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~---------~~i~~~~~-  242 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------V---------LKIISGSF-  242 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------H---------HHHHHTCC-
T ss_pred             -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------H---------HHHHcCCC-
Confidence             223456799999999999999999999999999999999999999986543221      1         11111111 


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            12334567789999999999999999999999875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6e-52  Score=437.43  Aligned_cols=250  Identities=26%  Similarity=0.379  Sum_probs=212.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      +.|++.++||+|+||+||+|.+. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999965 79999999987665556677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++|+|.+++.+.    .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....... 
T Consensus       154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence            999999999864    3899999999999999999999999   99999999999999999999999999987654333 


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ......||+.|||||++.+..|+.++|||||||+||||++|++||......+..   .    .+.     +...+  ...
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~----~i~-----~~~~~--~~~  291 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---K----MIR-----DNLPP--RLK  291 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H----HHH-----HSSCC--CCS
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---H----HHH-----cCCCC--CCC
Confidence            344567999999999999999999999999999999999999999754432210   0    010     00001  111


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .....+.++.+|+.+||+.||++|||++|++++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            224567789999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.7e-52  Score=440.29  Aligned_cols=273  Identities=27%  Similarity=0.406  Sum_probs=225.6

Q ss_pred             CCHHHHHHHhcCCCcCceeceeCcEEEEEEEeCC------CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCC-Ccccce
Q 043157          387 FTSKELERATDNFNLNRILGQGGQGTVYKGMLPD------GKIVAVKKSKVI-DESKVEEFINEMVILSQINH-RNVVKL  458 (684)
Q Consensus       387 ~~~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H-pnIv~l  458 (684)
                      +..++++...++|++.+.||+|+||+||+|.+..      ++.||||+++.. .....+.|.+|+++|++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3445667777899999999999999999998542      368999988653 34556789999999999965 999999


Q ss_pred             eeeeeec-CcceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 043157          459 LGCCLET-EVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD  524 (684)
Q Consensus       459 ~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~D  524 (684)
                      +++|.+. +..+|||||+++|+|.++|+....             ...+++..++.++.|||+||+|||+++   |+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9999765 467999999999999999986422             235899999999999999999999999   99999


Q ss_pred             CCCCCEEECCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCC
Q 043157          525 IKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF  602 (684)
Q Consensus       525 lkp~NILl~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~  602 (684)
                      |||+||||++++.+||+|||+|+....+.. .......||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987654433 34445679999999999999999999999999999999998 9999975


Q ss_pred             CChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          603 TTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       603 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      ....+.               +...+........+...+.++.+|+.+||+.||++|||+.||+++|++|...+.
T Consensus       291 ~~~~~~---------------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          291 VKIDEE---------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             CCCSHH---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             CCHHHH---------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            432221               111122222233455667889999999999999999999999999999876553

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-51  Score=428.27  Aligned_cols=248  Identities=24%  Similarity=0.368  Sum_probs=212.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||+++.. +++.||||++...   +....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999964 7999999988642   3345678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.++|.+.+   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.....
T Consensus       112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999998764   3999999999999999999999999   999999999999999999999999999876533


Q ss_pred             -CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 -QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 -~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                       ......+..||+.|||||++.+..|+.++|||||||+||||+||+.||...+..+.   .            ..++...
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~------------~~i~~~~  250 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI---F------------AKIIKLE  250 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H------------HHHHHTC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---H------------HHHHcCC
Confidence             23345567899999999999999999999999999999999999999986543221   1            1111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS  667 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~  667 (684)
                        ...+...+.++.+|+.+||+.||++|||++|++.
T Consensus       251 --~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          251 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             --CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             --CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence              1234456778999999999999999999999754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.1e-51  Score=429.79  Aligned_cols=253  Identities=22%  Similarity=0.241  Sum_probs=209.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .+.|++.++||+|+||+||+|++. +|+.||||+++....     ..+|+.+|++++|||||++++++.+.+..||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            346888899999999999999965 699999999875321     24799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-cEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgl~~~~~~~~  553 (684)
                      +++|+|.++|++.+   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++ ++||+|||+++....+.
T Consensus       132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999998764   3999999999999999999999999   99999999999999887 69999999998765432


Q ss_pred             ce----eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          554 TH----MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       554 ~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ..    ......||+.|||||++.+..|+.++|||||||+||||+||++||......+   +..            .+..
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~------------~i~~  270 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCL------------KIAS  270 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHH------------HHHH
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHH------------HHHc
Confidence            21    2234579999999999999999999999999999999999999997543322   111            1111


Q ss_pred             h-hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          630 A-RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       630 ~-~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      . ....+.+...+.++.+|+.+||+.||++|||+.|++++|.....
T Consensus       271 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          271 EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            1 11123456677889999999999999999999999999876553

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.8e-51  Score=419.74  Aligned_cols=247  Identities=22%  Similarity=0.385  Sum_probs=200.6

Q ss_pred             CcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeee----cCcceEEE
Q 043157          400 NLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLE----TEVPLLVY  472 (684)
Q Consensus       400 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lv~  472 (684)
                      ++.++||+|+||+||+|.+. +++.||+|++..  ......+.|.+|+++|++++|||||++++++.+    ....+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            66788999999999999965 688999998754  345567889999999999999999999999875    34579999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCcEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgl~~~~~~  551 (684)
                      ||+++|+|.++|++..   .+++..++.++.||+.||+|||+++. +|+||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999998764   39999999999999999999999873 4999999999999984 78999999999975432


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                         .......||+.|||||++.+ .|+.++|||||||+||||+||+.||.......     ..+. .+...        .
T Consensus       185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~-~i~~~--------~  246 (290)
T 3fpq_A          185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYR-RVTSG--------V  246 (290)
T ss_dssp             ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHH-HHTTT--------C
T ss_pred             ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HHHH-HHHcC--------C
Confidence               23345679999999999865 69999999999999999999999997433211     1111 11111        0


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .....+...+.++.+|+.+||+.||++|||++|++++
T Consensus       247 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0111223345678999999999999999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-50  Score=438.50  Aligned_cols=250  Identities=26%  Similarity=0.380  Sum_probs=213.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      +.|++.++||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999965 69999999987766666678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++|+|.++++...    +++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....... 
T Consensus       231 ~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-  302 (423)
T 4fie_A          231 EGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  302 (423)
T ss_dssp             TTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred             CCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence            9999999997643    899999999999999999999999   99999999999999999999999999987654333 


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ......||+.|||||++.+..|+.++|||||||+||||++|+.||......+..   .    .+.     ....+  ...
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~----~i~-----~~~~~--~~~  368 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---K----MIR-----DNLPP--RLK  368 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H----HHH-----HSCCC--CCS
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---H----HHH-----cCCCC--CCc
Confidence            344567999999999999999999999999999999999999999754432210   0    010     00111  112


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .....+.++.+|+.+||+.||++|||++|++++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            224567789999999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4e-50  Score=411.60  Aligned_cols=246  Identities=25%  Similarity=0.366  Sum_probs=194.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +|+.||||++...   +....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999964 7999999987542   2344678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+ +|+|.+++.+.+   .+++..++.++.||+.||+|||+++   |+||||||+||||++++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 689999998754   3999999999999999999999999   999999999999999999999999999865432


Q ss_pred             CceeeecccccCCCCCccccccCCC-CCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .  ...+..||+.|||||++.+..+ +.++|||||||+||||+||+.||...+..+.      +.         .+....
T Consensus       166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~------~~---------~i~~~~  228 (275)
T 3hyh_A          166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL------FK---------NISNGV  228 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH---------HHHHTC
T ss_pred             C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HH---------HHHcCC
Confidence            2  3345679999999999998876 5799999999999999999999975443221      10         011111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus       229 --~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 --YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              12334567789999999999999999999999885

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.9e-50  Score=421.22  Aligned_cols=270  Identities=21%  Similarity=0.298  Sum_probs=202.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC----cceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETE----VPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lv~  472 (684)
                      ++|.+.++||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||++++++.+++    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3578889999999999999998 589999999865322 2223344666667889999999999998765    468999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-----ASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      ||+++|+|.++|++.    +++|+.+.+++.|+++||+|||++     ..++|+||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            999999999999865    389999999999999999999987     12349999999999999999999999999998


Q ss_pred             ccccCCce---eeecccccCCCCCccccccC------CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhh--------h
Q 043157          548 SMAVDQTH---MTTQVHGTFGYLDPEYFRSS------QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK--------S  610 (684)
Q Consensus       548 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~--------~  610 (684)
                      ........   ......||+.|||||++.+.      .++.|+|||||||+||||+||++||.........        .
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76543332   22345699999999998754      4678999999999999999998877533221100        0


Q ss_pred             HHHHHHHHhhhhhhhhhhhhhhhc-cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          611 LAAYFLFAMKEERLFEILDARVMK-ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       611 l~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      ..........    .+.+++.+.. ....+.+..+.+|+.+||+.||++||||+||++.|++|...+
T Consensus       237 ~~~~~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          237 SVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CHHHHHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hHHHHHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            0000000110    0111111111 112356778999999999999999999999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.9e-50  Score=419.67  Aligned_cols=248  Identities=28%  Similarity=0.317  Sum_probs=200.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC----CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP----DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ++|++.+.||+|+||+||+++..    +++.||||+++..  ......++.+|+++|++++|||||++++++.+++..||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56999999999999999999852    4789999987542  22234568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++|+|.++|.+.+   .+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999998765   3999999999999999999999999   9999999999999999999999999998654


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      .... ......||+.|||||++.+..|+.++|||||||+||||+||+.||...+..+..               ..+...
T Consensus       178 ~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---------------~~i~~~  241 (304)
T 3ubd_A          178 DHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM---------------TMILKA  241 (304)
T ss_dssp             ---C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------------HHHHHC
T ss_pred             CCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH---------------HHHHcC
Confidence            3322 334567999999999999999999999999999999999999999865432211               011111


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTM-----REVTSE  668 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~-----~evl~~  668 (684)
                      .  ...+...+.++.+|+.+||+.||++|||+     +|++++
T Consensus       242 ~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          242 K--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             C--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            1  12344567789999999999999999984     677654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.9e-49  Score=408.68  Aligned_cols=251  Identities=23%  Similarity=0.371  Sum_probs=191.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc-------
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEV-------  467 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-------  467 (684)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35899999999999999999965 78999999887543 4456789999999999999999999999976553       


Q ss_pred             -----ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEec
Q 043157          468 -----PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD  542 (684)
Q Consensus       468 -----~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D  542 (684)
                           .||||||+++|+|.++++........++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                 5899999999999999987654444677888999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCce-----------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhH
Q 043157          543 FGASRSMAVDQTH-----------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSL  611 (684)
Q Consensus       543 Fgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l  611 (684)
                      ||+|+........           ..+...||+.|||||++.+..|+.++|||||||+||||++   ||....  +.  .
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~--~  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ER--V  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH--H
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HH--H
Confidence            9999876533221           1234569999999999999999999999999999999997   765211  10  0


Q ss_pred             HHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          612 AAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       612 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..  ...........         .....++.+.+|+.+||+.||++|||+.|++++
T Consensus       235 ~~--~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          235 RT--LTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HH--HHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HH--HHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            00  00011111000         012334567789999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.2e-47  Score=408.39  Aligned_cols=265  Identities=22%  Similarity=0.318  Sum_probs=205.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeee------cCc
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLE------TEV  467 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~  467 (684)
                      ++|++.+.||+|+||+||+|.+. +|+.||||+++.  ......+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999964 799999999864  334556788999999999999999999998764      356


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .||||||++ |+|.+++.+..   ++++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            799999996 78999998654   4999999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccC---CceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhh
Q 043157          548 SMAVD---QTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER  623 (684)
Q Consensus       548 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~  623 (684)
                      .....   .........||+.|||||++.+. .++.++||||+||++|||++|++||...+..+................
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            76432   22234456799999999998775 568999999999999999999999987654332211111000000000


Q ss_pred             --------hhhhhhh---h---hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          624 --------LFEILDA---R---VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       624 --------~~~~~d~---~---~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                              ....+..   .   .........+.++.+|+.+||+.||++|||++|++++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                    0000000   0   0001112345678999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6e-46  Score=392.18  Aligned_cols=286  Identities=38%  Similarity=0.618  Sum_probs=246.4

Q ss_pred             CCHHHHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC
Q 043157          387 FTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETE  466 (684)
Q Consensus       387 ~~~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  466 (684)
                      ++..+++..+++|++.+.||+|+||+||+|.+++++.||||+.........+.+.+|++++++++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            44456667789999999999999999999998889999999988777777889999999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNE-DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                      ..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999976532 235899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccC-CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          546 SRSMAVD-QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       546 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      ++..... .........||+.|+|||++.+..++.++||||||+++|||++|+.||......+...+..+.........+
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            9865422 222334456899999999999889999999999999999999999999876655555555555555555556


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .+.+++........+.+..+.+++.+||+.||++|||++|++++|+.+.+.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            666666666667788899999999999999999999999999999988764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.5e-46  Score=395.73  Aligned_cols=263  Identities=19%  Similarity=0.294  Sum_probs=201.4

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeC----CCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcc
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLP----DGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  468 (684)
                      ...++|++.++||+|+||+||+|+.+    +++.||+|++....  ...++.+|+++|+.+ +||||+++++++.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            35678999999999999999999853    46889999876433  345688999999998 699999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CcEEEeccCCcc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASR  547 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFgl~~  547 (684)
                      +|||||+++|+|.++++      .+++..++.++.||+.||+|||+++   |+||||||+||||+.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            99999999999999984      2899999999999999999999999   9999999999999876 799999999997


Q ss_pred             ccccCCc---------------------------eeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCC
Q 043157          548 SMAVDQT---------------------------HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKP  599 (684)
Q Consensus       548 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P  599 (684)
                      .......                           .......||+.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            6532211                           112345699999999998775 589999999999999999999999


Q ss_pred             CCCCChhhhhhHHHHHHHHhhh---------------------hhhhhhhh---------hh---------hhccCChhH
Q 043157          600 IRFTTLEEDKSLAAYFLFAMKE---------------------ERLFEILD---------AR---------VMKESGGDE  640 (684)
Q Consensus       600 ~~~~~~~~~~~l~~~~~~~~~~---------------------~~~~~~~d---------~~---------~~~~~~~~~  640 (684)
                      |.....+. ..+...+...-..                     .......+         +.         ...+.....
T Consensus       247 f~~~~~~~-~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          247 FYKASDDL-TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSCCSSHH-HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCHH-HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            96544322 1222111100000                     00000000         00         001112345


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          641 IITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       641 ~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      +.++.+|+.+||+.||++|||++|++++
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            6778999999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.3e-45  Score=414.60  Aligned_cols=253  Identities=22%  Similarity=0.300  Sum_probs=213.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|++.+.||+|+||+||++..+ +|+.||+|++........+.+.+|+++|++++|||||++++++.+....+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            367999999999999999999965 7999999998877777788899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC--CcEEEeccCCccccccC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK--YRAKVSDFGASRSMAVD  552 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DFgl~~~~~~~  552 (684)
                      +++|+|.++|.+...  .+++..+..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+++.....
T Consensus       236 ~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999975433  4999999999999999999999999   9999999999999854  89999999999876543


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .  ......||+.|||||++.+..|+.++|||||||+||||++|+.||......+...       .+...      +...
T Consensus       311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~-------~i~~~------~~~~  375 (573)
T 3uto_A          311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-------NVKSC------DWNM  375 (573)
T ss_dssp             S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------HHHTT------CCCC
T ss_pred             C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-------HHHhC------CCCC
Confidence            3  2344579999999999999999999999999999999999999998654332110       00000      0011


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ........+.++.+||.+||+.||++|||+.|+++|
T Consensus       376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111223456788999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.9e-45  Score=387.63  Aligned_cols=292  Identities=36%  Similarity=0.631  Sum_probs=244.3

Q ss_pred             ccccCCHHHHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccCh-hHHHHHHHHHHHHhhcCCCcccceeee
Q 043157          383 KTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE-SKVEEFINEMVILSQINHRNVVKLLGC  461 (684)
Q Consensus       383 ~~~~~~~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~  461 (684)
                      ..+.++..+++...++|++.+.||+|+||+||++..++++.||||++..... .....+.+|++++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3456888999999999999999999999999999988899999998875332 223468999999999999999999999


Q ss_pred             eeecCcceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEE
Q 043157          462 CLETEVPLLVYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV  540 (684)
Q Consensus       462 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl  540 (684)
                      +.+.+..++||||+++|+|.++++... ...++++..++.++.|++.||+|||++....|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999998754 2345999999999999999999999992112999999999999999999999


Q ss_pred             eccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCCh--hhhhhHHHHHHHH
Q 043157          541 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTL--EEDKSLAAYFLFA  618 (684)
Q Consensus       541 ~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~--~~~~~l~~~~~~~  618 (684)
                      +|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||.....  .....+..+....
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            99999987765555555666799999999999888899999999999999999999999963221  1222233333334


Q ss_pred             hhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          619 MKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       619 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      .....+....+.........+.+..+.+|+.+||+.||++|||++||+++|+....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            44555566666666666778889999999999999999999999999999986543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.2e-44  Score=408.09  Aligned_cols=249  Identities=21%  Similarity=0.291  Sum_probs=202.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHH---HHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEF---INEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~---~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      ++|++.++||+|+||+||+++.. +|+.||||++...   .......+   .+++.+++.++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999965 6999999987531   11122233   34566777889999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      |||||++||+|.++|.+.+   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++++||+|||+|+..
T Consensus       269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999998764   3999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ....   ..+..||+.|||||++.. ..|+.++|||||||+||||++|++||......+..   ...         ..+.
T Consensus       343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~---------~~i~  407 (689)
T 3v5w_A          343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EID---------RMTL  407 (689)
T ss_dssp             SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHH---------HHHH
T ss_pred             CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHH---------Hhhc
Confidence            4332   345679999999999964 57999999999999999999999999743322111   100         0111


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPT-----MREVTSE  668 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt-----~~evl~~  668 (684)
                      ..  ....+...+.++.+|+.+||+.||++|++     ++|+++|
T Consensus       408 ~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          408 TM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            11  12234566788999999999999999998     6787765

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=372.87  Aligned_cols=260  Identities=25%  Similarity=0.427  Sum_probs=217.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      ++|.+.++||+|+||+||++.+. +++.||+|++...+....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            46889999999999999999965 68999999988777888899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.++++....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus        90 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           90 KGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             TTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            99999999987543  3899999999999999999999999   999999999999999999999999999876433221


Q ss_pred             e-------------eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          556 M-------------TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       556 ~-------------~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      .             .....||+.|+|||++.+..++.++||||||+++|||++|..|+..........          ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----------~~  234 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------GL  234 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----------SB
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----------hh
Confidence            1             114569999999999999999999999999999999999999987543222110          00


Q ss_pred             hhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       623 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      ......+    ...+...+..+.+|+.+||+.||++|||++|+++.|+.|+..
T Consensus       235 ~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          235 NVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             CHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            0111111    122344556789999999999999999999999999999865

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.3e-43  Score=365.82  Aligned_cols=285  Identities=34%  Similarity=0.564  Sum_probs=232.1

Q ss_pred             ccccCCHHHHHHHhcCCCcC------ceeceeCcEEEEEEEeCCCcEEEEEeccc----cChhHHHHHHHHHHHHhhcCC
Q 043157          383 KTKLFTSKELERATDNFNLN------RILGQGGQGTVYKGMLPDGKIVAVKKSKV----IDESKVEEFINEMVILSQINH  452 (684)
Q Consensus       383 ~~~~~~~~e~~~~~~~~~~~------~~LG~G~~g~Vy~~~~~~g~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~H  452 (684)
                      ....|+..++..++++|...      +.||+|+||+||+|.. +++.||+|++..    ......+.+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34568999999999999887      8999999999999987 678999998754    234456789999999999999


Q ss_pred             CcccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 043157          453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL  532 (684)
Q Consensus       453 pnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl  532 (684)
                      |||+++++++.+.+..++||||+++++|.+++.......++++..++.++.|++.||+|||+++   |+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999986554556999999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeccCCccccccCC-ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhH
Q 043157          533 DDKYRAKVSDFGASRSMAVDQ-THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSL  611 (684)
Q Consensus       533 ~~~~~~kl~DFgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l  611 (684)
                      +.++.+||+|||+++...... ........||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........  +
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~  243 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L  243 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence            999999999999998654332 223344568999999998865 578999999999999999999999976543221  1


Q ss_pred             HHHHHHHh-hhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          612 AAYFLFAM-KEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       612 ~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      ..+..... ....+.+.+++.. ...+...+..+.+++.+||+.||++|||++|++++|++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s  307 (307)
T 2nru_A          244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS  307 (307)
T ss_dssp             THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred             HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence            11111111 1122233333322 334567788999999999999999999999999999998763

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-43  Score=363.58  Aligned_cols=260  Identities=26%  Similarity=0.376  Sum_probs=218.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .++|++.+.||+|+||+||++.++++..||+|+++.... ..+++.+|++++++++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            457899999999999999999998888999998875433 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++++|.+++.....  .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            99999999987543  3899999999999999999999999   999999999999999999999999999876655444


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                      ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..                ..+......
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----------------~~~~~~~~~  224 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV----------------LKVSQGHRL  224 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----------------HHHHTTCCC
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH----------------HHHHcCCCC
Confidence            4444557788999999998899999999999999999999 99999755432211                001111111


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      ..+...+..+.+++.+||+.||++|||++|++++|+.|+.+.+
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k  267 (268)
T 3sxs_A          225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK  267 (268)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred             CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence            2233456689999999999999999999999999999987654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.4e-44  Score=372.35  Aligned_cols=275  Identities=27%  Similarity=0.406  Sum_probs=215.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-----CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeec--Ccc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-----PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~  468 (684)
                      .++|++.+.||+|+||+||++.+     .+++.||||++........+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35789999999999999999984     36889999999887788888999999999999999999999998654  458


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||+++++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            999999999999999987543  3899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCc--eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          549 MAVDQT--HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       549 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ......  .......++..|+|||.+.+..++.++||||||+++|||+||..|+.....+.................+.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            643322  122334477789999999999999999999999999999999999864322110000000000000011122


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .+........+...+.++.+|+.+||+.||++|||++|++++|++|+..
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            2222223334556778999999999999999999999999999999863

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.3e-43  Score=377.98  Aligned_cols=263  Identities=25%  Similarity=0.438  Sum_probs=219.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe--------CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeec
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML--------PDGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCLET  465 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~--------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~  465 (684)
                      .++|++.+.||+|+||+||++.+        .++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            46789999999999999999985        23567999998754 445678899999999999 899999999999999


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL  532 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl  532 (684)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+++   |+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999987542             234899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhh
Q 043157          533 DDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKS  610 (684)
Q Consensus       533 ~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~  610 (684)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.  
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~--  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence            9999999999999986543322 22233457889999999999999999999999999999999 9999976543321  


Q ss_pred             HHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          611 LAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       611 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                                    ...+........+...+.++.+|+.+||+.||++|||++|+++.|++|.....
T Consensus       315 --------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          315 --------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             --------------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             --------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence                          11111222223445667789999999999999999999999999999886543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3e-43  Score=369.80  Aligned_cols=268  Identities=29%  Similarity=0.420  Sum_probs=212.2

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      ++...++|++.+.||+|+||+||++.. +++.||||++...  .....+++.+|++++++++||||+++++++.+.+..+
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            334456799999999999999999987 6888999987653  3556788999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+++|+|.+++........+++..++.++.|++.||+|||+++. +|+||||||+|||++.++.+||+|||+++..
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999999875433348999999999999999999999873 4999999999999999999999999999754


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      .... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..   .            .+..
T Consensus       190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~------------~~~~  253 (309)
T 3p86_A          190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---A------------AVGF  253 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---H------------HHHH
T ss_pred             cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H------------HHHh
Confidence            3322 2233456899999999999999999999999999999999999999755432211   0            0001


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      .......+...+.++.+|+.+||+.||++|||++|+++.|+.+.....
T Consensus       254 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            111223345667789999999999999999999999999999886543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=371.46  Aligned_cols=262  Identities=26%  Similarity=0.414  Sum_probs=215.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC----CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP----DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .++|++.+.||+|+||+||+|.+.    .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            357889999999999999999974    3556999998753 45567889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++++|.++++....  .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999976533  4999999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCce--eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          551 VDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       551 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      .....  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.                ...
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------------~~~  266 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV----------------ISS  266 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH----------------HHH
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH----------------HHH
Confidence            43222  2223346778999999998999999999999999999999 9999975443221                111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCC
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGA  678 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~  678 (684)
                      +........+...+..+.+|+.+||+.||++|||++|+++.|+.+......
T Consensus       267 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence            111122233456678899999999999999999999999999999875443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5e-43  Score=365.91  Aligned_cols=251  Identities=25%  Similarity=0.409  Sum_probs=212.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|++.+.||+|+||+||++.. .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            35799999999999999999995 57899999998766556677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++.+.    .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999999865    3899999999999999999999999   99999999999999999999999999987654333


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                       ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........  .    ...        ......
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~----~~~--------~~~~~~  236 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--L----IAT--------NGTPEL  236 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--H----HHH--------HCSCCC
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----HHh--------CCCCCC
Confidence             2344569999999999999999999999999999999999999997544322110  0    000        000011


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..+...+..+.+|+.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            2234566789999999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-43  Score=363.28  Aligned_cols=257  Identities=28%  Similarity=0.431  Sum_probs=217.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ++|++.+.||+|+||+||++.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+....++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            56899999999999999999998899999999875433 23678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.........
T Consensus        89 ~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           89 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             TCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            9999999976543  4899999999999999999999999   9999999999999999999999999998665443333


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....+++.|+|||++....++.++||||||+++|||++ |+.||......+.                .+.+.......
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~----------------~~~~~~~~~~~  227 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------------VEDISTGFRLY  227 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------HHHHHTTCCCC
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH----------------HHHHhcCccCC
Confidence            344457788999999998999999999999999999999 9999975443221                11111111122


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .+...+.++.+|+.+||+.||++|||++|++++|+++..+
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            2344567899999999999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-43  Score=382.24  Aligned_cols=262  Identities=24%  Similarity=0.421  Sum_probs=218.2

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ...++|.+.+.||+|+||+||+|.+. +++.||||.++.. .....+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34467899999999999999999976 7899999988753 344567899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++|+|.++++....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       191 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            999999999999987543  3899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCceee-ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          552 DQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       552 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ...... ....+++.|+|||.+....++.++||||||+++|||+| |..||......+.                .+.+.
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~----------------~~~~~  329 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT----------------REFVE  329 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH----------------HHHHH
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHH
Confidence            222111 12235778999999998899999999999999999998 9999975543221                11122


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .......+...+.++.+|+.+||+.||++|||++|+++.|+.|+++.
T Consensus       330 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence            22222334556778999999999999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-42  Score=362.37  Aligned_cols=264  Identities=27%  Similarity=0.408  Sum_probs=213.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++..   ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            357999999999999999999964 688999998743   3455668899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++....   ++++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999998764   3899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ..........||+.|+|||++.+..++.++||||||+++|||++|+.||......+..      ...... .     .+.
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~-~-----~~~  231 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQD-S-----VPN  231 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSS-C-----CCC
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhc-c-----CCC
Confidence            4444445566999999999999999999999999999999999999999865432210      000110 0     011


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhHhhcC
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRP-TMREVTSELAGIKAWNG  677 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-t~~evl~~L~~i~~~~~  677 (684)
                      .......+.+..+.+++.+||+.||++|| +++++.+.|..+...+.
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            11223345677899999999999999998 99999999998876443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.2e-43  Score=371.72  Aligned_cols=272  Identities=22%  Similarity=0.310  Sum_probs=211.7

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc----ceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEV----PLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----~~lv  471 (684)
                      .++|++.++||+|+||+||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.+...    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467999999999999999999875 7899999987543 334556679999999999999999999987654    5999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCCEEECCCCcEEEe
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA----------ASIPIYHRDIKSTNILLDDKYRAKVS  541 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~----------~~~~iiH~Dlkp~NILl~~~~~~kl~  541 (684)
                      |||+++|+|.++++...    +++..++.++.|++.||+|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            99999999999998643    89999999999999999999998          7   9999999999999999999999


Q ss_pred             ccCCccccccCCce-eeecccccCCCCCcccccc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHH
Q 043157          542 DFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF  615 (684)
Q Consensus       542 DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~  615 (684)
                      |||+++........ ......||+.|+|||++.+     ..++.++||||||+++|||+||+.||...............
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999776543322 2333568999999999876     35667899999999999999999999765432221111110


Q ss_pred             HHHhhhhhhhhhhhh-hhhcc-----CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          616 LFAMKEERLFEILDA-RVMKE-----SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       616 ~~~~~~~~~~~~~d~-~~~~~-----~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      ........+.+.... .....     .....+.++.+|+.+||+.||++|||++|+++.|++|+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            000001111111110 00011     12345677999999999999999999999999999998754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.7e-43  Score=375.96  Aligned_cols=259  Identities=25%  Similarity=0.435  Sum_probs=205.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC----CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP----DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .++|++.+.||+|+||+||+|.+.    ++..||||+++.. .....+++.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999864    5678999998764 45567789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++|+|.++++....  .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999986543  4899999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCcee--eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          551 VDQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       551 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ......  .....+++.|+|||++....++.++||||||+++|||++ |+.||......+                +.+.
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~----------------~~~~  262 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----------------VIKA  262 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH----------------HHHH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHH
Confidence            432221  122235778999999999999999999999999999998 999997543221                1111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      +........+...+..+.+|+.+||+.||++||+++|+++.|+++...
T Consensus       263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            222222233445677899999999999999999999999999998754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.4e-43  Score=374.56  Aligned_cols=273  Identities=27%  Similarity=0.404  Sum_probs=223.5

Q ss_pred             cCCHHHHHHHhcCCCcCceeceeCcEEEEEEEe------CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccc
Q 043157          386 LFTSKELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVK  457 (684)
Q Consensus       386 ~~~~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~  457 (684)
                      .+...+++...++|++.+.||+|+||.||++.+      .+++.||||+++.. .....+.+.+|+++++++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            345566777788999999999999999999973      24679999998753 445567899999999999 7999999


Q ss_pred             eeeeeeecCc-ceEEEEecCCCCHHHHHhhcCC-----------------------------------------------
Q 043157          458 LLGCCLETEV-PLLVYEFIPNGTLFQYIHDQNE-----------------------------------------------  489 (684)
Q Consensus       458 l~~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~-----------------------------------------------  489 (684)
                      +++++.+.+. .++||||+++|+|.++++....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999987654 8999999999999999987542                                               


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          490 ----------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       490 ----------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                                      ...+++..++.++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            122899999999999999999999999   9999999999999999999999999998654332


Q ss_pred             -ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          554 -THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       554 -~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                       ........||+.|+|||++.+..++.++||||||+++|||+| |+.||......+.               +...+...
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---------------~~~~~~~~  312 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------------FCRRLKEG  312 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---------------HHHHHHHT
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---------------HHHHHHcC
Confidence             233344568899999999999999999999999999999998 9999975543221               11111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .....+...+.++.+|+.+||+.||++|||++|++++|+.+...+
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            122334456678999999999999999999999999999998654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.3e-43  Score=361.41  Aligned_cols=259  Identities=25%  Similarity=0.394  Sum_probs=214.4

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ..++|++.+.||+|+||+||++.+.+++.||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3467999999999999999999998888999999875433 236789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       101 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            999999999987433  3899999999999999999999999   99999999999999999999999999986654333


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..                +.+.....
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~----------------~~~~~~~~  239 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----------------EHIAQGLR  239 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----------------HHHHTTCC
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH----------------HHHhcccC
Confidence            33334456788999999998899999999999999999998 99999755432211                11111111


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      ...+...+..+.+|+.+||+.||++|||++|++++|+++...
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            222344567899999999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.9e-42  Score=366.58  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=210.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .++|++.+.||+|+||+||++.+ .+|+.||||++..  .+....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46799999999999999999996 5799999998754  34566788999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++.....   +++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        94 e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999987643   899999999999999999999999   999999999999999999999999999865433


Q ss_pred             CceeeecccccCCCCCccccccCCCC-CccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .  ......||+.|+|||++.+..++ .++||||||+++|||++|+.||......+...               .+....
T Consensus       168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---------------~i~~~~  230 (328)
T 3fe3_A          168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE---------------RVLRGK  230 (328)
T ss_dssp             C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHHCC
T ss_pred             C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH---------------HHHhCC
Confidence            2  23455699999999999888765 79999999999999999999998654322110               111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus       231 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 --YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             --CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             --CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              12234456789999999999999999999999876

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.3e-43  Score=390.60  Aligned_cols=267  Identities=23%  Similarity=0.368  Sum_probs=221.2

Q ss_pred             HHHHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       389 ~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      .++++...++|++.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+.+|++++||||+++++++. .+..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            344555667899999999999999999999888999999987543 34678999999999999999999999986 6678


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||+++|+|.++++.... ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             EEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            999999999999999986421 23889999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      .............+++.|+|||++....++.++||||||++||||+| |+.||......+.                .+.
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~----------------~~~  397 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV----------------IRA  397 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----------------HHH
T ss_pred             cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH----------------HHH
Confidence            64332222333446788999999998999999999999999999999 9999975443221                111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      +........+...+.++.+|+.+||+.||++|||+++|++.|+.+.....
T Consensus       398 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~  447 (454)
T 1qcf_A          398 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE  447 (454)
T ss_dssp             HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence            11112222345667889999999999999999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.1e-42  Score=363.09  Aligned_cols=263  Identities=25%  Similarity=0.361  Sum_probs=217.1

Q ss_pred             ccCCHHHHHHHhcC----------CCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCC
Q 043157          385 KLFTSKELERATDN----------FNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHR  453 (684)
Q Consensus       385 ~~~~~~e~~~~~~~----------~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp  453 (684)
                      ..++.++++.+++.          |+..+.||+|+||+||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34667777766653          677789999999999999976 7999999998776666678899999999999999


Q ss_pred             cccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC
Q 043157          454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD  533 (684)
Q Consensus       454 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~  533 (684)
                      ||+++++++...+..++||||+++++|.+++.+.    .+++..++.++.|++.||+|||+.+   |+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            9999999999999999999999999999998753    3899999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 043157          534 DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAA  613 (684)
Q Consensus       534 ~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~  613 (684)
                      .++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.   ..
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~~  251 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MK  251 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH
T ss_pred             CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence            999999999999987654322 23345699999999999999999999999999999999999999975433211   00


Q ss_pred             HHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          614 YFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       614 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                          ..     .....+.  .......+..+.+|+.+||+.||++|||++|++++-
T Consensus       252 ----~~-----~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          252 ----RL-----RDSPPPK--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             ----HH-----HHSSCCC--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             ----HH-----hcCCCCC--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                00     0100000  111234567899999999999999999999999863

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-42  Score=372.44  Aligned_cols=269  Identities=26%  Similarity=0.423  Sum_probs=222.6

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeC--------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeee
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLP--------DGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCC  462 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  462 (684)
                      +...++|.+.++||+|+||+||++...        .++.||||+++.. .....+++.+|+++++++ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            334578999999999999999999852        2357999988653 455668899999999999 999999999999


Q ss_pred             eecCcceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 043157          463 LETEVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN  529 (684)
Q Consensus       463 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~N  529 (684)
                      .+.+..++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+.+   |+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence            999999999999999999999987542             235899999999999999999999999   9999999999


Q ss_pred             EEECCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhh
Q 043157          530 ILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE  607 (684)
Q Consensus       530 ILl~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~  607 (684)
                      |||+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999986643322 22333457889999999999999999999999999999999 999997554322


Q ss_pred             hhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCCC
Q 043157          608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASN  680 (684)
Q Consensus       608 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~  680 (684)
                      .                .+.+........+...+.++.+|+.+||+.||++|||++||+++|+++.+.....+
T Consensus       302 ~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          302 L----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             H----------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             H----------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence            1                11111222223345567789999999999999999999999999999987655443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-42  Score=364.94  Aligned_cols=263  Identities=27%  Similarity=0.426  Sum_probs=219.6

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEe------CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETE  466 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  466 (684)
                      ...++|.+.+.||+|+||+||++..      .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            3456799999999999999999985      24578999998753 4566788999999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNE---------------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDI  525 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dl  525 (684)
                      ..++||||+++++|.+++.....                     ...+++..++.++.||++||+|||+++   |+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence            99999999999999999987543                     124899999999999999999999999   999999


Q ss_pred             CCCCEEECCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 043157          526 KSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFT  603 (684)
Q Consensus       526 kp~NILl~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~  603 (684)
                      ||+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876543332 2233457788999999998889999999999999999999 99999755


Q ss_pred             ChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          604 TLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       604 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .....                .+.+........+...+.++.+|+.+||+.||++|||+.|++++|+++..+
T Consensus       257 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          257 PPERL----------------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             CGGGH----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CHHHH----------------HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            43221                111111112233455677899999999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.5e-42  Score=357.27  Aligned_cols=260  Identities=25%  Similarity=0.394  Sum_probs=203.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCC----CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPD----GKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      ..++|++.+.||+|+||+||+|.+..    +..||+|+.... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            34679999999999999999998643    457999987753 4455678999999999999999999999984 56789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+++++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            99999999999999987543  4899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ............+++.|+|||.+....++.++||||||+++|||++ |..||......+.   ..             .+
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~-------------~i  230 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG-------------RI  230 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH-------------HH
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HH-------------HH
Confidence            5443333344457789999999998899999999999999999997 9999975543221   10             11


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      ........+...+..+.+|+.+||+.||++|||+.|++++|+++...+
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            111112234556778999999999999999999999999999987654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-42  Score=354.32  Aligned_cols=257  Identities=28%  Similarity=0.420  Sum_probs=216.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ++|++.+.||+|+||+||++...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            56889999999999999999998889999999876433 23678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..........
T Consensus        87 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           87 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             TCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            9999999987543  4899999999999999999999999   9999999999999999999999999998654333223


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....+++.|+|||.+....++.++||||||+++|||++ |+.||......+..                +.+.......
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----------------~~i~~~~~~~  225 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV----------------EDISTGFRLY  225 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----------------HHHHTTCCCC
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH----------------HHHhcCCcCC
Confidence            333457788999999998899999999999999999999 89999754432210                0011111112


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .+...+..+.+|+.+||+.||++|||++|++++|+++..+
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            2344567899999999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.9e-42  Score=360.79  Aligned_cols=265  Identities=21%  Similarity=0.324  Sum_probs=207.1

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ..++|++.++||+|+||+||++...+++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            44689999999999999999999988999999988653  2334578899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||++ ++|.+++.....  .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFME-KDLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCS-EEHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCC-CCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9997 588888876543  4899999999999999999999999   999999999999999999999999999875433


Q ss_pred             CceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh--hhhhhhhh--
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM--KEERLFEI--  627 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~--~~~~~~~~--  627 (684)
                      .. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+..  ........  ....+...  
T Consensus       173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HHHHHHHCCCCTTTSGGGTT
T ss_pred             cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHHCCCChHHhhhhhc
Confidence            22 2333458999999999876 56899999999999999999999999865543321  11111110  00000000  


Q ss_pred             -----------hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          628 -----------LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       628 -----------~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                                 .+...........+.++.+|+.+||+.||++|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                       00001111123345688999999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.9e-41  Score=353.20  Aligned_cols=269  Identities=16%  Similarity=0.176  Sum_probs=218.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .++|++.+.||+|+||+||++.. .+++.||||++....  ..+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            45799999999999999999995 578999999875432  335678899999999 79999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc-----EEEeccCCccc
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-----AKVSDFGASRS  548 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DFgl~~~  548 (684)
                      |+ +++|.+++.....  ++++..++.++.||+.||+|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 9999999987543  4899999999999999999999999   999999999999987766     99999999987


Q ss_pred             cccCCce------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          549 MAVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       549 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      .......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6543321      2344569999999999999999999999999999999999999998654332222211111111101


Q ss_pred             hhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCCCC
Q 043157          623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASNS  681 (684)
Q Consensus       623 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~  681 (684)
                      .         ........+.++.+|+.+||+.||++||++++|++.|+++..+......
T Consensus       241 ~---------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~  290 (298)
T 1csn_A          241 P---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED  290 (298)
T ss_dssp             C---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred             c---------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCC
Confidence            0         1111234567899999999999999999999999999999987665443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.8e-42  Score=351.63  Aligned_cols=254  Identities=31%  Similarity=0.521  Sum_probs=201.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccCh----hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE----SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.+.||+|+||+||++.+. ++.||||+.+....    ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357899999999999999999974 88999998765332    2357889999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC--------CCcEEEecc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD--------KYRAKVSDF  543 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~--------~~~~kl~DF  543 (684)
                      |||+++++|.+++...    .+++..++.++.|++.||+|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999999999643    3899999999999999999999998556899999999999986        778999999


Q ss_pred             CCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhh
Q 043157          544 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER  623 (684)
Q Consensus       544 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~  623 (684)
                      |+++.......   ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.........              
T Consensus       161 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--------------  223 (271)
T 3dtc_A          161 GLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA--------------  223 (271)
T ss_dssp             CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--------------
T ss_pred             Ccccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------------
Confidence            99976543222   2345899999999999999999999999999999999999999754422210              


Q ss_pred             hhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          624 LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       624 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                       ............+...+..+.+|+.+||+.||++|||++|++++|++|
T Consensus       224 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          224 -YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence             111111122233455677899999999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.1e-42  Score=360.05  Aligned_cols=268  Identities=24%  Similarity=0.416  Sum_probs=221.2

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEe------CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeee
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCL  463 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  463 (684)
                      ++...++|++.+.||+|+||+||++.+      .+++.||+|++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            334456799999999999999999984      35678999988753 345568899999999999 9999999999999


Q ss_pred             ecCcceEEEEecCCCCHHHHHhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 043157          464 ETEVPLLVYEFIPNGTLFQYIHDQNED---------------FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST  528 (684)
Q Consensus       464 ~~~~~~lv~E~~~~gsL~~~l~~~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~  528 (684)
                      +.+..++||||+++|+|.+++......               ..+++..++.++.|++.||+|||+++   |+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence            999999999999999999999875431               24899999999999999999999999   999999999


Q ss_pred             CEEECCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChh
Q 043157          529 NILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLE  606 (684)
Q Consensus       529 NILl~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~  606 (684)
                      |||++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||+| |+.||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            999999999999999999876544332 2334457889999999999999999999999999999999 99999755432


Q ss_pred             hhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          607 EDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       607 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      ..               ....+........+...+..+.+|+.+||+.||++|||++|++++|+++.....
T Consensus       255 ~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          255 SK---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             HH---------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             hH---------------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            21               111111112222334567789999999999999999999999999999887543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.1e-42  Score=377.69  Aligned_cols=256  Identities=27%  Similarity=0.457  Sum_probs=214.2

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC-cceEEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETE-VPLLVYE  473 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lv~E  473 (684)
                      ..++|++.+.||+|+||+||+|.+. ++.||||+++...  ..+.|.+|+.+|++++||||+++++++.+.. ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467889999999999999999885 7799999987543  4578999999999999999999999987765 6899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++|+|.++++.... ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       268 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            9999999999987643 24799999999999999999999999   999999999999999999999999999854322 


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                         .....+++.|+|||.+.+..++.++||||||++||||+| |+.||......+.                .+.+....
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~----------------~~~i~~~~  403 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------------VPRVEKGY  403 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH----------------HHHHHTTC
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHHcCC
Confidence               122357889999999999999999999999999999998 9999975543221                11111122


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      ....+...+.++.+|+.+||+.||++|||++|+++.|+.|+....
T Consensus       404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l  448 (450)
T 1k9a_A          404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL  448 (450)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence            233445677889999999999999999999999999999987543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-42  Score=380.12  Aligned_cols=259  Identities=22%  Similarity=0.328  Sum_probs=213.9

Q ss_pred             HHHHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeec
Q 043157          390 KELERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLET  465 (684)
Q Consensus       390 ~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  465 (684)
                      .++....++|++.++||+|+||+||+++++ +++.||+|++....   ....+.+.+|+.++..++||||+++++++.+.
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            344455678999999999999999999976 58899999886421   22234488999999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                      +..+|||||+++|+|.+++.+...  .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence            999999999999999999987433  3999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK  620 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~  620 (684)
                      ++..............||+.|+|||++.     ...++.++||||||+++|||++|+.||......+..           
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-----------  290 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-----------  290 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----------
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH-----------
Confidence            9877655555555667999999999987     567899999999999999999999999865433211           


Q ss_pred             hhhhhhhhhhhh---hccCChhHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 043157          621 EERLFEILDARV---MKESGGDEIITFAKVAKRCLNLNGKK--RPTMREVTSE  668 (684)
Q Consensus       621 ~~~~~~~~d~~~---~~~~~~~~~~~l~~Li~~cl~~dp~~--RPt~~evl~~  668 (684)
                          ..++....   ........+.++.+|+.+||..+|++  ||+++|++++
T Consensus       291 ----~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          291 ----GKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ----HHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ----HhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence                11111110   11111346778999999999988888  9999999876

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=357.43  Aligned_cols=272  Identities=25%  Similarity=0.381  Sum_probs=215.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecC--cceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETE--VPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lv~  472 (684)
                      ++|++.++||+|+||+||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            57999999999999999999975 58999999886533 334677889999999999999999999998765  678999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----CCCCcEEEeccCCccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASRS  548 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFgl~~~  548 (684)
                      ||+++++|.+++........+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999998665556999999999999999999999999   9999999999999    8888899999999987


Q ss_pred             cccCCceeeecccccCCCCCccccc--------cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhh-hHHHHHHHHh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFR--------SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK-SLAAYFLFAM  619 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~-~l~~~~~~~~  619 (684)
                      ......  .....||+.|+|||++.        +..++.++||||||+++|||++|+.||......... ..........
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            654332  23446899999999986        567899999999999999999999999754332221 1111111111


Q ss_pred             hhhhhhhhh-----------hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          620 KEERLFEIL-----------DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       620 ~~~~~~~~~-----------d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      ....+....           +...........+..+.+|+.+||+.||++|||++|++++.....
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            111000000           001112344678889999999999999999999999999997544

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5e-42  Score=365.14  Aligned_cols=265  Identities=24%  Similarity=0.407  Sum_probs=217.2

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLET  465 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  465 (684)
                      +...++|++.+.||+|+||+||++...      +++.||||.++.. .....+.+.+|+.++++++||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            334578999999999999999999964      3488999998753 445567899999999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNE---------------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD  524 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~D  524 (684)
                      +..++||||+++++|.+++.....                     ...+++..++.++.||++||+|||+++   |+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            999999999999999999987431                     145899999999999999999999999   99999


Q ss_pred             CCCCCEEECCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCC
Q 043157          525 IKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF  602 (684)
Q Consensus       525 lkp~NILl~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~  602 (684)
                      |||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999976543222 22334457889999999998899999999999999999999 9999975


Q ss_pred             CChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          603 TTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       603 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      ....+..       ..+..         ......+...+.++.+|+.+||+.||++|||+.|++++|+++..+.
T Consensus       280 ~~~~~~~-------~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          280 MAHEEVI-------YYVRD---------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             SCHHHHH-------HHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CChHHHH-------HHHhC---------CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            5432210       01111         1112234456778999999999999999999999999999987643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1e-41  Score=362.24  Aligned_cols=248  Identities=25%  Similarity=0.306  Sum_probs=209.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++..+ +++.||+|+++..   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57999999999999999999965 6899999988642   2344678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++.+..   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9999999999998754   3899999999999999999999999   999999999999999999999999999864322


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      . .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..   .            .+.... 
T Consensus       159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~------------~i~~~~-  221 (337)
T 1o6l_A          159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---E------------LILMEE-  221 (337)
T ss_dssp             T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H------------HHHHCC-
T ss_pred             C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH---H------------HHHcCC-
Confidence            2 2234556999999999999999999999999999999999999999754432210   0            011111 


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                       ...+...+.++.+|+.+||+.||++||     +++|++++
T Consensus       222 -~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence             123345677899999999999999999     89999876

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3e-42  Score=385.54  Aligned_cols=260  Identities=28%  Similarity=0.468  Sum_probs=220.2

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeCC-CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ...++|++.++||+|+||+||+|.+.. ++.||||+++... ...++|.+|+.+|++++||||+++++++.+.+..+|||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            345678899999999999999999764 8899999987543 34678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.++++.... ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus       296 E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             ECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            99999999999987533 34899999999999999999999999   999999999999999999999999999876544


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .........+++.|+|||++....++.++||||||++||||+| |+.||......+                +.+.+...
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~  435 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKD  435 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------HHHHHHTT
T ss_pred             ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcC
Confidence            4333344456788999999998999999999999999999999 999997654322                11222222


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      .....+...+..+.+|+.+||+.||++|||++||++.|+.+..
T Consensus       436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            2333455677889999999999999999999999999998753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-42  Score=383.41  Aligned_cols=265  Identities=23%  Similarity=0.363  Sum_probs=213.6

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .++...++|++.+.||+|+||+||+|.++++..||||+++.... ..+.|.+|+++|++++||||+++++++.+ +..++
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            34445577999999999999999999998888899999876432 34689999999999999999999999876 67899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++|+|.++++.... ..+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus       256 v~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EehhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            9999999999999986421 23899999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ...........++..|+|||.+....++.++||||||++||||++ |+.||......+.                .+.+.
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~----------------~~~i~  395 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------LDQVE  395 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------------HHHHH
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHH
Confidence            433333334457889999999998999999999999999999999 9999975443221                11111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      .......+...+..+.+|+.+||+.||++|||+++|++.|+.+.....
T Consensus       396 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            112223345667889999999999999999999999999999876543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=370.55  Aligned_cols=261  Identities=25%  Similarity=0.382  Sum_probs=215.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      .++|++.+.||+|+||+||+|.+.      +++.||||+++.. ......++.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357999999999999999999843      4678999998653 455667899999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC---cEEEe
Q 043157          469 LLVYEFIPNGTLFQYIHDQNE----DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---RAKVS  541 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~  541 (684)
                      ++||||+++|+|.+++.....    ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999987532    234899999999999999999999999   99999999999999544   59999


Q ss_pred             ccCCccccccCC-ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHh
Q 043157          542 DFGASRSMAVDQ-THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAM  619 (684)
Q Consensus       542 DFgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~  619 (684)
                      |||+++...... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.           
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~-----------  295 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-----------  295 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-----------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------
Confidence            999997543221 222334457899999999999999999999999999999998 9999975543221           


Q ss_pred             hhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          620 KEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       620 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                           .+.+........+...+..+.+|+.+||+.||++|||++||+++|+.+...
T Consensus       296 -----~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          296 -----LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             -----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence                 111111112223445667899999999999999999999999999988754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.5e-42  Score=363.71  Aligned_cols=256  Identities=25%  Similarity=0.484  Sum_probs=206.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCc----EEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGK----IVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ++|++.++||+|+||+||+|.+. +++    .||+|.+... .....+++.+|+.++++++||||+++++++.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            46899999999999999999954 444    3688877542 3345678999999999999999999999998754 789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      |+||+++|+|.+++.....  .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        94 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            9999999999999987543  4899999999999999999999999   9999999999999999999999999998764


Q ss_pred             cCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          551 VDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       551 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ..... ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||......+                +.+.+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~~  232 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSIL  232 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHHH
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----------------HHHHH
Confidence            33322 2233456889999999999999999999999999999999 999997554332                11222


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      ........+...+.++.+|+.+||+.||++||+++|++++|+.+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          233 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            2222223345567789999999999999999999999999988764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.4e-42  Score=353.07  Aligned_cols=262  Identities=24%  Similarity=0.391  Sum_probs=217.0

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      +...++|++.+.||+|+||+||++...+++.||+|++.... ...+.+.+|++++++++||||+++++++. .+..++||
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   86 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT   86 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence            33456799999999999999999998888899999886533 23578999999999999999999999986 45689999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++..... ..+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++......
T Consensus        87 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             ECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             ecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999999976421 24899999999999999999999999   999999999999999999999999999876544


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .........+++.|+|||.+....++.++||||||+++|||++ |+.||......+.                .+.+...
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----------------~~~~~~~  226 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV----------------IQNLERG  226 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------------HHHHHTT
T ss_pred             ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH----------------HHHHhcc
Confidence            4333444557889999999988889999999999999999999 9999975443221                0111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .....+...+.++.+|+.+||+.||++|||++++++.|+.+....
T Consensus       227 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            112233456678999999999999999999999999999988653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.5e-41  Score=354.44  Aligned_cols=260  Identities=22%  Similarity=0.365  Sum_probs=203.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhh--cCCCcccceeeeeeec----Ccce
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQ--INHRNVVKLLGCCLET----EVPL  469 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~----~~~~  469 (684)
                      .++|++.+.||+|+||+||+|.+ +++.||||++...   ..+.+.+|.+++..  ++||||+++++++.+.    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999988 6889999988643   34556677777777  7999999999997653    4578


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEECCCCcEEEe
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH--------SAASIPIYHRDIKSTNILLDDKYRAKVS  541 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~kl~  541 (684)
                      +||||+++|+|.++++..    .+++..++.++.|++.||+|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            999999999999999653    3999999999999999999999        777   9999999999999999999999


Q ss_pred             ccCCccccccCCcee---eecccccCCCCCccccccC------CCCCccchhhhHHHHHHHHhC----------CCCCCC
Q 043157          542 DFGASRSMAVDQTHM---TTQVHGTFGYLDPEYFRSS------QFTDKSDVYSFGVVLAELLTG----------EKPIRF  602 (684)
Q Consensus       542 DFgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDv~SlGvil~elltG----------~~P~~~  602 (684)
                      |||+++.........   .....||+.|+|||++.+.      .++.++||||||+++|||+||          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999997655433322   2234699999999999876      455799999999999999999          888864


Q ss_pred             CChhhhhhHHHHHHHHhhhhhhhhhhhhhh-hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          603 TTLEEDKSLAAYFLFAMKEERLFEILDARV-MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       603 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      ....... .... .......    ...+.. ........+.++.+|+.+||+.||++|||++|+++.|++|
T Consensus       236 ~~~~~~~-~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPS-FEDM-RKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCC-HHHH-HHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcc-hhhh-hHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            3322111 1110 0000000    000100 1112245778899999999999999999999999999987

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-41  Score=359.85  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=202.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc------
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEV------  467 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------  467 (684)
                      .++|++.+.||+|+||+||++.+. +++.||||+++.. .....+.+.+|++++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            356999999999999999999976 7999999988653 34466889999999999999999999999866542      


Q ss_pred             ---------------------------------------------------ceEEEEecCCCCHHHHHhhcCCCCCCCHH
Q 043157          468 ---------------------------------------------------PLLVYEFIPNGTLFQYIHDQNEDFPITWE  496 (684)
Q Consensus       468 ---------------------------------------------------~~lv~E~~~~gsL~~~l~~~~~~~~l~~~  496 (684)
                                                                         .++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               68999999999999999987655557788


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc-----------eeeecccccCC
Q 043157          497 MRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-----------HMTTQVHGTFG  565 (684)
Q Consensus       497 ~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~-----------~~~~~~~gt~~  565 (684)
                      .++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999999   99999999999999999999999999987654321           12233469999


Q ss_pred             CCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHH
Q 043157          566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFA  645 (684)
Q Consensus       566 y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~  645 (684)
                      |+|||++.+..++.++||||||+++|||++|..|+.     +.....    ........         .......+.++.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~----~~~~~~~~---------~~~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRII----TDVRNLKF---------PLLFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHH----HHHHTTCC---------CHHHHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHH----HHhhccCC---------CcccccCChhHH
Confidence            999999999999999999999999999999877742     111000    00000000         011133456778


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 043157          646 KVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       646 ~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      +|+.+||+.||++|||++|++++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCCCCcCCCHHHHhhc
Confidence            99999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.7e-42  Score=354.93  Aligned_cols=260  Identities=29%  Similarity=0.458  Sum_probs=222.0

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ..++|++.+.||+|+||+||++.+. +++.||+|++... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4567999999999999999999976 4889999988753 3456789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++++|.+++..... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            9999999999987543 35899999999999999999999999   9999999999999999999999999998776555


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      ........+++.|+|||++.+..++.++||||||+++|+|++ |..||........                .+.+....
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~----------------~~~~~~~~  229 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YELLEKDY  229 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----------------HHHHHTTC
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHhccC
Confidence            545555567889999999998999999999999999999999 9999975543221                12222222


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      ....+...+..+.+|+.+||+.||++|||++|+++.|+.+...
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            2333456678899999999999999999999999999987754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.2e-42  Score=360.19  Aligned_cols=274  Identities=26%  Similarity=0.367  Sum_probs=217.7

Q ss_pred             CCcCceeceeCcEEEEEEEeC-----CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec--CcceE
Q 043157          399 FNLNRILGQGGQGTVYKGMLP-----DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLL  470 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l  470 (684)
                      |++.+.||+|+||+||++.+.     +++.||||++... .....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            489999999999999988643     6789999988753 345577899999999999999999999999874  46789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++++|.+++....    +++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999997653    899999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCce--eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          551 VDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       551 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      .....  ......+++.|+|||++.+..++.++||||||+++|||++|+.||........ .+............+.+.+
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence            43322  23344578889999999998999999999999999999999999864321110 0000000011112233333


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCCC
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASN  680 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~  680 (684)
                      ........+...+.++.+|+.+||+.||++|||++|+++.|+.+..+-..+.
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~  316 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA  316 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence            3333344456678899999999999999999999999999999987654443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.4e-41  Score=351.51  Aligned_cols=259  Identities=27%  Similarity=0.430  Sum_probs=210.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC----CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD----GKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .++|++.+.||+|+||+||+|.+..    +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4679999999999999999998542    346999988754 45567889999999999999999999999764 56789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            9999999999999987543  3899999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ...........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..                +.+.
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~----------------~~~~  228 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI----------------GVLE  228 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH----------------HHHH
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH----------------HHHh
Confidence            444333444557889999999998899999999999999999998 99999754432211                1111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .......+...+..+.+|+.+||+.||++|||+.|++++|+++...+
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          229 KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            11111223445678999999999999999999999999999987653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.3e-41  Score=357.38  Aligned_cols=265  Identities=16%  Similarity=0.192  Sum_probs=213.9

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .++|++.+.||+|+||+||+|.. .+++.||||.+....  ..+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            35799999999999999999996 578999999876432  234688999999999 99999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc-----EEEeccCCccc
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-----AKVSDFGASRS  548 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DFgl~~~  548 (684)
                      |+ +++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 9999999987533  4999999999999999999999999   999999999999998887     99999999987


Q ss_pred             cccCCce------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          549 MAVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       549 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      .......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..........    .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~----~  235 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD----T  235 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH----H
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh----h
Confidence            6433321      12456799999999999999999999999999999999999999986543322111111100    0


Q ss_pred             hhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCC
Q 043157          623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGA  678 (684)
Q Consensus       623 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~  678 (684)
                      ..     +..........+ ++.+|+.+||+.||++||++++|++.|+.+..+.+.
T Consensus       236 ~~-----~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          236 KR-----ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             HH-----HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hc-----cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            00     000001112234 899999999999999999999999999998876543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=362.58  Aligned_cols=267  Identities=25%  Similarity=0.435  Sum_probs=216.0

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEe------CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeee
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCL  463 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  463 (684)
                      ++...++|++.+.||+|+||+||++..      .+++.||+|.+... .....+.+.+|+.+++++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            344567899999999999999999985      24568999988653 334567899999999999 8999999999999


Q ss_pred             ecCcceEEEEecCCCCHHHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 043157          464 ETEVPLLVYEFIPNGTLFQYIHDQNED--------------------FPITWEMRLRIAIEVSGALSYLHSAASIPIYHR  523 (684)
Q Consensus       464 ~~~~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~  523 (684)
                      +.+..++||||+++|+|.+++......                    ..+++..++.++.||+.||+|||+++   |+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            999999999999999999999875432                    23799999999999999999999999   9999


Q ss_pred             CCCCCCEEECCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCC
Q 043157          524 DIKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIR  601 (684)
Q Consensus       524 Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~  601 (684)
                      ||||+|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986654332 22334457889999999999999999999999999999998 999997


Q ss_pred             CCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          602 FTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       602 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .......               ....+........+...+.++.+|+.+||+.||++|||+.|++++|+.+.+..
T Consensus       277 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          277 GIPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             TCCCSHH---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cCCcHHH---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            5543221               11111122222334456778999999999999999999999999999887654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.3e-42  Score=362.96  Aligned_cols=275  Identities=23%  Similarity=0.328  Sum_probs=218.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-----CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeee--ecCcce
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-----PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL--ETEVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~~  469 (684)
                      ++|++.+.||+|+||+||++.+     .+++.||||++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4689999999999999999984     368899999998877778888999999999999999999999987  445678


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            99999999999999987533  3899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCce--eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          550 AVDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       550 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ......  ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||.....+...... ..........+.+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CERDVPALSRLLEL  256 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cccccccHHHHHHH
Confidence            543332  223345788899999999988999999999999999999999998643221100000 00000011122233


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      +........+...+.++.+|+.+||+.||++|||++|++++|+.+.....
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            33333334456678899999999999999999999999999998876443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.8e-41  Score=363.68  Aligned_cols=252  Identities=25%  Similarity=0.321  Sum_probs=207.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh------hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE------SKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      .++|++.+.||+|+||+||++... +|+.||+|.++....      ...+.+.+|+.+|++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999965 689999998765322      1357899999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC----cEEEeccC
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFG  544 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFg  544 (684)
                      ++||||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||+++++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999997643   4999999999999999999999999   99999999999998776    79999999


Q ss_pred             CccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      ++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+..   .   . +.....
T Consensus       165 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~---~---~-i~~~~~  235 (361)
T 2yab_A          165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---A---N-ITAVSY  235 (361)
T ss_dssp             SCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H---H-HHTTCC
T ss_pred             CceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---H-HHhcCC
Confidence            998764332  233456999999999999999999999999999999999999999765432211   0   0 000000


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        .+++    ......+..+.+|+.+||+.||++|||++|++++
T Consensus       236 --~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          236 --DFDE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             --CCCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --CCCc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              0000    1112345678999999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-41  Score=353.42  Aligned_cols=263  Identities=21%  Similarity=0.321  Sum_probs=204.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccCh--hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE--SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.+.||+|+||+||++...+++.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57899999999999999999998899999998865332  2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++ +|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            975 99999986533  4899999999999999999999999   99999999999999999999999999976543222


Q ss_pred             eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hhhhhhh----
Q 043157          555 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EERLFEI----  627 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~~~~~~----  627 (684)
                       ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.  +...+.....  ...+...    
T Consensus       156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGST
T ss_pred             -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhhccc
Confidence             2233458999999999876 4589999999999999999999999986543321  1111111000  0000000    


Q ss_pred             -hhhh-------hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          628 -LDAR-------VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       628 -~d~~-------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       .++.       .........+.++.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             0000       0111223456788999999999999999999999874

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.3e-41  Score=359.00  Aligned_cols=262  Identities=25%  Similarity=0.429  Sum_probs=200.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCC-Cc---EEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPD-GK---IVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-g~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      ..++|++.+.||+|+||+||++.+.. ++   .||||+++..  .....+.+.+|++++++++||||+++++++.+....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34679999999999999999999654 32   7999988653  455678899999999999999999999999877655


Q ss_pred             ------eEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEE
Q 043157          469 ------LLVYEFIPNGTLFQYIHDQN---EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK  539 (684)
Q Consensus       469 ------~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k  539 (684)
                            ++||||+++|+|.+++....   ....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence                  99999999999999997642   2225899999999999999999999999   99999999999999999999


Q ss_pred             EeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHH
Q 043157          540 VSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLF  617 (684)
Q Consensus       540 l~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~  617 (684)
                      |+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.         
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---------  248 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---------  248 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---------
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---------
Confidence            999999986543322 22223446788999999999999999999999999999999 9999975543221         


Q ss_pred             HhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       618 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                             ...+........+...+.++.+|+.+||+.||++|||+.|+++.|+++...
T Consensus       249 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          249 -------YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             -------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -------HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                   111111111223455667899999999999999999999999999988754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6e-42  Score=357.81  Aligned_cols=271  Identities=25%  Similarity=0.373  Sum_probs=212.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-----CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec--Ccc
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-----PDGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVP  468 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~  468 (684)
                      ++|++.+.||+|+||+||++.+     .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588999999999999999983     36889999988743 334567899999999999999999999999876  567


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||+++++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            899999999999999976543  3899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCc--eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          549 MAVDQT--HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       549 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ......  .......+|..|+|||++.+..++.++||||||+++|||++|..|+......... .............+..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK-MIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCGGGHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhh-ccCCcccccCHHHHHH
Confidence            654433  2233455788899999999999999999999999999999999986421100000 0000000001111222


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      .+........+...+.++.+|+.+||+.||++|||++|+++.|++|.
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            22222233345567788999999999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.3e-41  Score=347.08  Aligned_cols=254  Identities=22%  Similarity=0.365  Sum_probs=211.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec--CcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLET--EVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||+|.++ ++.||+|+++..  .....+.+.+|+.++++++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56899999999999999999985 888999987653  355667899999999999999999999999877  6789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.++++.... ..+++..++.++.|++.||+|||+++. +|+||||||+|||++.++.+||+|||+...... 
T Consensus        89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQS-  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred             cccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence            99999999999987543 358999999999999999999999763 499999999999999999999999988754322 


Q ss_pred             CceeeecccccCCCCCccccccCCCCC---ccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTD---KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                           ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||......+.               ......
T Consensus       166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~~~~~~  225 (271)
T 3kmu_A          166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---------------GMKVAL  225 (271)
T ss_dssp             -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---------------HHHHHH
T ss_pred             -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---------------HHHHHh
Confidence                 2235789999999998765544   89999999999999999999975443221               011111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      .......+...+.++.+++.+||+.||++|||++|+++.|++|+.
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            122223345667789999999999999999999999999999874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-41  Score=358.30  Aligned_cols=253  Identities=23%  Similarity=0.298  Sum_probs=209.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|++.+.||+|+||+||++... +++.+|+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467999999999999999999965 6889999988754 34556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC--CCcEEEeccCCccccccC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD--KYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DFgl~~~~~~~  552 (684)
                      +++++|.+++.....  .+++..++.++.||+.||+|||+++   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus        83 ~~g~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999976532  4899999999999999999999999   999999999999987  789999999999876533


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+.   ...   ... ...  ..+.  
T Consensus       158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~---i~~-~~~--~~~~--  224 (321)
T 1tki_A          158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IEN---IMN-AEY--TFDE--  224 (321)
T ss_dssp             C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHH---HHH-TCC--CCCH--
T ss_pred             C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH---HHH---HHc-CCC--CCCh--
Confidence            2  23345689999999999988899999999999999999999999976543221   110   000 000  0000  


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                        ......+.++.+|+.+||+.||++|||+.|++++-
T Consensus       225 --~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          225 --EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             --HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             --hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence              01123466889999999999999999999999865

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.7e-42  Score=373.81  Aligned_cols=257  Identities=24%  Similarity=0.336  Sum_probs=212.2

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETE  466 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  466 (684)
                      ++....++|++.++||+|+||+||++..+ +++.||+|+++..   .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34445678999999999999999999975 5889999987642   1222345889999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..+|||||+++|+|.+++++.    .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence            999999999999999999764    2899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCccccccCC----CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ----FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      +..............||+.|+|||++....    ++.++||||||++||||++|+.||......+..             
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------------  282 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-------------  282 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------------
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH-------------
Confidence            876655444455677999999999997655    789999999999999999999999865432211             


Q ss_pred             hhhhhhhhhhhccC--ChhHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 043157          623 RLFEILDARVMKES--GGDEIITFAKVAKRCLNLNGKK--RPTMREVTSEL  669 (684)
Q Consensus       623 ~~~~~~d~~~~~~~--~~~~~~~l~~Li~~cl~~dp~~--RPt~~evl~~L  669 (684)
                        ..++........  ....+.++.+|+.+||+.+|++  ||+++|++++-
T Consensus       283 --~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          283 --SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             --HHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             --HHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence              111111111111  1245678999999999999988  99999999863

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.5e-42  Score=360.60  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=205.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh-hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE-SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .++|++.+.||+|+||+||++... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            357999999999999999999965 789999998765332 334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++++|.+++....   .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999997653   3899999999999999999999999   9999999999999999999999999998654322


Q ss_pred             -ceeeecccccCCCCCccccccCCC-CCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          554 -THMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       554 -~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                       ........||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ..             ......
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~-------------~~~~~~  225 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS-------------DWKEKK  225 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HH-------------HHHTTC
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HH-------------HHhccc
Confidence             222344569999999999987765 77999999999999999999999754432111 00             000111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .........+..+.+|+.+||+.||++|||++|++++-
T Consensus       226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence            11111234567788999999999999999999998764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.7e-41  Score=357.61  Aligned_cols=264  Identities=25%  Similarity=0.435  Sum_probs=217.4

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC--------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeeeee
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP--------DGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCCLE  464 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~  464 (684)
                      ..++|++.+.||+|+||+||++.+.        +++.||+|++... .....+.+.+|+++++++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3467999999999999999999863        4678999998753 445678899999999999 89999999999999


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL  531 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NIL  531 (684)
                      .+..++||||+++++|.+++.....             ...+++..++.++.||+.||+|||+++   |+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999987542             124899999999999999999999999   999999999999


Q ss_pred             ECCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhh
Q 043157          532 LDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDK  609 (684)
Q Consensus       532 l~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~  609 (684)
                      ++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. 
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  268 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-  268 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence            999999999999999876543322 2233456788999999988889999999999999999999 9999975543221 


Q ss_pred             hHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          610 SLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       610 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                                     .+.+........+...+..+.+|+.+||+.||++|||++|++++|++|.....
T Consensus       269 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          269 ---------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             ---------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ---------------HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence                           11111111122344566789999999999999999999999999999986543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-41  Score=350.56  Aligned_cols=260  Identities=26%  Similarity=0.407  Sum_probs=214.8

Q ss_pred             cCCCcCc-eeceeCcEEEEEEEeC---CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNR-ILGQGGQGTVYKGMLP---DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~-~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|.+.+ .||+|+||+||+|.+.   +++.||+|+++.. .....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566665 9999999999999853   5788999998763 455678899999999999999999999999 56678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999976433  4899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCcee--eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          552 DQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       552 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      .....  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.                .+.+
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------------~~~i  226 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV----------------MAFI  226 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH----------------HHHH
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH----------------HHHH
Confidence            33322  223346889999999988889999999999999999998 9999975443221                1111


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCC
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGA  678 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~  678 (684)
                      ........+...+.++.+|+.+||+.||++||+++|++++|+++..+...
T Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          227 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence            11112233456678899999999999999999999999999999876543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=353.21  Aligned_cols=257  Identities=27%  Similarity=0.444  Sum_probs=203.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ++|++.+.||+|+||+||++.+. ++.||+|++..  ....+.+.+|++++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            46889999999999999999874 78899999864  345678999999999999999999999886  45899999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc-EEEeccCCccccccCCce
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-AKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DFgl~~~~~~~~~~  555 (684)
                      +++|.++++.......+++..++.++.|+++||+|||+.+...|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999987654445789999999999999999999932222999999999999988876 799999998754322   


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                       .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........  .            ..........
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~------------~~~~~~~~~~  224 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI--M------------WAVHNGTRPP  224 (307)
T ss_dssp             ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH--H------------HHHHTTCCCC
T ss_pred             -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH--H------------HHHhcCCCCC
Confidence             223358999999999999999999999999999999999999997443221110  0            0000111112


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .....+..+.+|+.+||+.||++|||++|+++.|+.+...-
T Consensus       225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            23455678999999999999999999999999999987653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=363.74  Aligned_cols=250  Identities=27%  Similarity=0.354  Sum_probs=204.9

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcce
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~  469 (684)
                      ..++|++.++||+|+||+||++..+ +++.||||+++..   .....+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3478999999999999999999965 6899999988642   334567788999999998 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+++|+|.+++.+...   +++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999987643   999999999999999999999999   999999999999999999999999999854


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      .... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..               ..+..
T Consensus       175 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---------------~~i~~  238 (353)
T 3txo_A          175 ICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF---------------EAILN  238 (353)
T ss_dssp             CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------------HHHHH
T ss_pred             ccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH---------------HHHHc
Confidence            3222 2344557999999999999989999999999999999999999999865432211               11111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTM------REVTSE  668 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~------~evl~~  668 (684)
                      ..  ...+...+.++.+|+.+||+.||++||++      +|++++
T Consensus       239 ~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          239 DE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            11  12234466789999999999999999998      777654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.5e-41  Score=366.21  Aligned_cols=251  Identities=27%  Similarity=0.397  Sum_probs=202.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .++|++.++||+|+||+||+++.+ +++.||+|+++..   .....+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357999999999999999999965 6889999987642   334456688999999887 89999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++|+|.+++.+..   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999998764   3999999999999999999999999   9999999999999999999999999998633


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh-hhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE-ILD  629 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~d  629 (684)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....       .....+.+ +..
T Consensus       205 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~~~~~~~i~~  276 (396)
T 4dc2_A          205 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYLFQVILE  276 (396)
T ss_dssp             CTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHHHHHHHHH
T ss_pred             cCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhHHHHHHHHhc
Confidence            222 234456799999999999999999999999999999999999999975432211100       00000111 111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTM  662 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~  662 (684)
                      .  ....+...+.++.+|+.+||+.||++||++
T Consensus       277 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          277 K--QIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             C--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             c--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            1  122345567789999999999999999996

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.6e-42  Score=364.15  Aligned_cols=267  Identities=24%  Similarity=0.408  Sum_probs=218.3

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeCC-C-----cEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccceeeee
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLPD-G-----KIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKLLGCC  462 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  462 (684)
                      +++...++|++.+.||+|+||+||++.... +     +.||+|.+... .....+.+.+|+.+++++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            445556789999999999999999999642 2     47999988653 345667899999999999 899999999999


Q ss_pred             eecCcceEEEEecCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 043157          463 LETEVPLLVYEFIPNGTLFQYIHDQNE-----------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL  531 (684)
Q Consensus       463 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NIL  531 (684)
                      .+.+..++||||+++|+|.+++.....           ...+++..++.++.||+.||+|||+++   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            999999999999999999999986421           234899999999999999999999999   999999999999


Q ss_pred             ECCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhh
Q 043157          532 LDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDK  609 (684)
Q Consensus       532 l~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~  609 (684)
                      ++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||........ 
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence            99999999999999986543332 22333457889999999998899999999999999999999 9999975432221 


Q ss_pred             hHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          610 SLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       610 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                                    +...+........+...+..+.+|+.+||+.||++|||++|+++.|+++...
T Consensus       276 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          276 --------------FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             --------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence                          1111111112222344567899999999999999999999999999988754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=357.57  Aligned_cols=252  Identities=25%  Similarity=0.346  Sum_probs=207.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh------hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE------SKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      .++|++.+.||+|+||+||++... +++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356999999999999999999975 689999998765322      2367899999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC----cEEEeccC
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFG  544 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFg  544 (684)
                      ++||||+++++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999997643   4999999999999999999999999   99999999999999887    89999999


Q ss_pred             CccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      +++.......  .....||+.|+|||++....++.++||||||+++|+|++|+.||......+...  .     ....  
T Consensus       164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~-----~~~~--  232 (326)
T 2y0a_A          164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA--N-----VSAV--  232 (326)
T ss_dssp             TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH--H-----HHHT--
T ss_pred             CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH--H-----HHhc--
Confidence            9987643322  234569999999999999999999999999999999999999997654322110  0     0000  


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                          ............+..+.+|+.+||+.||++|||++|++++
T Consensus       233 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          233 ----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ----CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                0000001112345678999999999999999999999975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=360.73  Aligned_cols=271  Identities=27%  Similarity=0.417  Sum_probs=217.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-----CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC--cc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-----PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETE--VP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~  468 (684)
                      .++|++.+.||+|+||+||++.+     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35689999999999999999983     368899999988777777889999999999999999999999987654  78


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            999999999999999987643  3899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCcee--eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH----Hhhhh
Q 043157          549 MAVDQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF----AMKEE  622 (684)
Q Consensus       549 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~----~~~~~  622 (684)
                      ........  .....++..|+|||.+.+..++.++||||||+++|||+||..|+.....+    .......    .....
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhhhHH
Confidence            65443321  22334677899999999888999999999999999999999997532111    0000000    00001


Q ss_pred             hhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       623 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .+.+.+........+...+.++.+|+.+||+.||++|||++|+++.|++|+..
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            11222222222233456778899999999999999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.7e-41  Score=350.49  Aligned_cols=264  Identities=22%  Similarity=0.339  Sum_probs=204.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|++.++||+|+||+||++... +++.||+|++..  ......+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999975 689999998764  334456788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++ +|.+.+.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9975 66666665433  4999999999999999999999999   9999999999999999999999999998654332


Q ss_pred             ceeeecccccCCCCCccccccCC-CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hhhhhhhh--
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EERLFEIL--  628 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~--  628 (684)
                      . ......||+.|+|||++.+.. ++.++||||||+++|||++|..||....... ..+...+.....  ...+....  
T Consensus       156 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             c-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhhhhhhccc
Confidence            2 233446899999999987765 7999999999999999999888864332221 111111111100  00000000  


Q ss_pred             -h---------hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          629 -D---------ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       629 -d---------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       +         ...........+.++.+|+.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence             0         000111223466789999999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.5e-41  Score=355.35  Aligned_cols=273  Identities=27%  Similarity=0.412  Sum_probs=222.0

Q ss_pred             CCHHHHHHHhcCCCcCceeceeCcEEEEEEEe------CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhc-CCCcccce
Q 043157          387 FTSKELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKVI-DESKVEEFINEMVILSQI-NHRNVVKL  458 (684)
Q Consensus       387 ~~~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l  458 (684)
                      +...+++...++|++.+.||+|+||+||++.+      .+++.||||++... .....+.+.+|+.+++++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34455556678899999999999999999984      35689999988653 345567899999999999 79999999


Q ss_pred             eeeeeecC-cceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 043157          459 LGCCLETE-VPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRD  524 (684)
Q Consensus       459 ~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~D  524 (684)
                      ++++.+.+ ..++||||+++++|.+++.....             ...+++..++.++.|++.||+|||+++   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99987765 58999999999999999987543             123889999999999999999999999   99999


Q ss_pred             CCCCCEEECCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCC
Q 043157          525 IKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRF  602 (684)
Q Consensus       525 lkp~NILl~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~  602 (684)
                      |||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999986643332 23334557889999999999999999999999999999998 9999975


Q ss_pred             CChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          603 TTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       603 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      ....+.  +             ...+........+...+.++.+++.+||+.||++|||++|++++|+.+...+.
T Consensus       254 ~~~~~~--~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          254 VKIDEE--F-------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             CCCSHH--H-------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             cchhHH--H-------------HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            443221  1             11111111122334456789999999999999999999999999999987654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.6e-41  Score=369.35  Aligned_cols=254  Identities=22%  Similarity=0.286  Sum_probs=208.0

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ..++|++.+.||+|+||+||++... +++.+|+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4567999999999999999999864 7899999987653  344567899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC---CCCcEEEeccCCccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRS  548 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFgl~~~  548 (684)
                      |||+++|+|.+.+....   .+++..+..++.||+.||+|||+++   |+||||||+|||++   .++.+||+|||++..
T Consensus        89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999998754   3999999999999999999999999   99999999999998   467899999999987


Q ss_pred             cccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ...... ......||+.|+|||++.+..++.++||||||+++|+|++|++||......+.   ..    .+.....    
T Consensus       163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~---~~----~i~~~~~----  230 (444)
T 3soa_A          163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL---YQ----QIKAGAY----  230 (444)
T ss_dssp             CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH----HHHHTCC----
T ss_pred             ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH---HH----HHHhCCC----
Confidence            654332 23345699999999999999999999999999999999999999975443221   00    0111100    


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        ..........+.++.+|+.+||+.||++|||+.|++++
T Consensus       231 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 --DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence              00111123456789999999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=353.15  Aligned_cols=250  Identities=22%  Similarity=0.333  Sum_probs=198.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh--------------------------hHHHHHHHHHHHHh
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE--------------------------SKVEEFINEMVILS  448 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  448 (684)
                      .++|++.+.||+|+||+||++... +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999964 688999998754321                          22467899999999


Q ss_pred             hcCCCcccceeeeeee--cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 043157          449 QINHRNVVKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIK  526 (684)
Q Consensus       449 ~l~HpnIv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlk  526 (684)
                      +++||||+++++++.+  ....++||||+++++|.+++..    .++++..++.++.||+.||+|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999986  5578999999999999886543    24999999999999999999999999   9999999


Q ss_pred             CCCEEECCCCcEEEeccCCccccccCCceeeecccccCCCCCccccccCC---CCCccchhhhHHHHHHHHhCCCCCCCC
Q 043157          527 STNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLAELLTGEKPIRFT  603 (684)
Q Consensus       527 p~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~SlGvil~elltG~~P~~~~  603 (684)
                      |+|||++.++.+||+|||+++....... ......||+.|+|||++.+..   ++.++||||||+++|||++|+.||...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999987654332 233456999999999997655   478899999999999999999999754


Q ss_pred             ChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          604 TLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       604 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .....   ..    ..        .............+.++.+|+.+||+.||++|||++|++++
T Consensus       244 ~~~~~---~~----~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          244 RIMCL---HS----KI--------KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SHHHH---HH----HH--------HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             cHHHH---HH----HH--------hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            32211   00    00        01111111123456789999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.4e-41  Score=362.34  Aligned_cols=273  Identities=17%  Similarity=0.229  Sum_probs=212.2

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCC------CcEEEEEeccccChhH-----------HHHHHHHHHHHhhcCCCcccc
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPD------GKIVAVKKSKVIDESK-----------VEEFINEMVILSQINHRNVVK  457 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~HpnIv~  457 (684)
                      ..++|++.++||+|+||+||+|.+..      ++.||||++.......           ...+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34579999999999999999998754      4789999876543221           123445667778889999999


Q ss_pred             eeeeeeec----CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC
Q 043157          458 LLGCCLET----EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD  533 (684)
Q Consensus       458 l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~  533 (684)
                      +++++.+.    ...+|||||+ +++|.+++.....  .+++..++.++.||+.||+|||+++   |+||||||+||||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99999875    4479999999 9999999987533  4999999999999999999999999   99999999999998


Q ss_pred             --CCCcEEEeccCCccccccCCcee------eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCCh
Q 043157          534 --DKYRAKVSDFGASRSMAVDQTHM------TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTL  605 (684)
Q Consensus       534 --~~~~~kl~DFgl~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~  605 (684)
                        .++.+||+|||+++.........      .....||+.|+|||++.+..++.++||||||++||||+||+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              88999999999998764332211      1334599999999999999999999999999999999999999974322


Q ss_pred             hhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCC
Q 043157          606 EEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGAS  679 (684)
Q Consensus       606 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~  679 (684)
                      ..  ....... ......+.++++..+.   ....+.++.+|+.+||+.||++||++++|++.|+++....+..
T Consensus       267 ~~--~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  334 (364)
T 3op5_A          267 DP--KYVRDSK-IRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK  334 (364)
T ss_dssp             CH--HHHHHHH-HHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CH--HHHHHHH-HHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence            21  1111111 1112223333333221   1345678999999999999999999999999999988765543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-41  Score=362.80  Aligned_cols=253  Identities=21%  Similarity=0.274  Sum_probs=211.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|++.+.||+|+||+||++... +++.||+|.+..........+.+|+++|++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999965 6899999998876666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC--CCcEEEeccCCccccccC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD--KYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DFgl~~~~~~~  552 (684)
                      +++|+|.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999976532  4899999999999999999999999   999999999999974  578999999999876543


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      ..  .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+..   .    .+...      ....
T Consensus       205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~----~i~~~------~~~~  269 (387)
T 1kob_A          205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---Q----NVKRC------DWEF  269 (387)
T ss_dssp             SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H----HHHHC------CCCC
T ss_pred             cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---H----HHHhC------CCCC
Confidence            32  23346899999999999999999999999999999999999999865432110   0    00000      0011


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ........+.++.+|+.+||+.||++|||++|++++
T Consensus       270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            112223566789999999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.2e-41  Score=360.59  Aligned_cols=253  Identities=24%  Similarity=0.356  Sum_probs=208.4

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ..++|++.+.||+|+||+||++... +++.||+|++..  ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3467999999999999999999965 689999998764  3455667899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC---CcEEEeccCCccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRS  548 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFgl~~~  548 (684)
                      |||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.+   +.+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999997653   4899999999999999999999999   9999999999999865   4599999999986


Q ss_pred             cccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      .....  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+   +..    .+..... .  
T Consensus       181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~----~i~~~~~-~--  248 (362)
T 2bdw_A          181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYA----QIKAGAY-D--  248 (362)
T ss_dssp             CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHTCC-C--
T ss_pred             ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH----HHHhCCC-C--
Confidence            65322  2334569999999999999999999999999999999999999997544221   111    0111000 0  


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                         .........+.++.+|+.+||+.||++|||+.|++++
T Consensus       249 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ---CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               0011113456789999999999999999999999876

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.8e-41  Score=360.21  Aligned_cols=255  Identities=24%  Similarity=0.326  Sum_probs=205.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-----hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-----ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      .++|++.+.||+|+||+||++... +++.||||++....     ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            356999999999999999999865 68999999875421     224578999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc---EEEeccCC
Q 043157          470 LVYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGA  545 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFgl  545 (684)
                      +||||+++++|.+++.... ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999998886532 2345899999999999999999999999   999999999999986554   99999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF  625 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  625 (684)
                      ++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....    .+...    ...... 
T Consensus       180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~----i~~~~~-  249 (351)
T 3c0i_A          180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEG----IIKGKY-  249 (351)
T ss_dssp             CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHH----HHHTCC-
T ss_pred             eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHH----HHcCCC-
Confidence            987654322 23345699999999999999999999999999999999999999975321    11110    000000 


Q ss_pred             hhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       626 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       ...+..    ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       250 -~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          250 -KMNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             -CCCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -CCCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             000000    12345678999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-41  Score=358.91  Aligned_cols=270  Identities=26%  Similarity=0.420  Sum_probs=220.3

Q ss_pred             cCCHHHHHHHhcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccce
Q 043157          386 LFTSKELERATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKL  458 (684)
Q Consensus       386 ~~~~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l  458 (684)
                      .+..++++...++|++.+.||+|+||+||+|.+.      +++.||+|++... .......+.+|+.++++++||||+++
T Consensus        14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            3445566667788999999999999999999854      3678999988653 34556789999999999999999999


Q ss_pred             eeeeeecCcceEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 043157          459 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL  531 (684)
Q Consensus       459 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NIL  531 (684)
                      ++++.+.+..++||||+++++|.++++....       ..++++..++.++.|++.||+|||+++   |+||||||+|||
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl  170 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM  170 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence            9999999999999999999999999986321       134799999999999999999999999   999999999999


Q ss_pred             ECCCCcEEEeccCCccccccCCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhh
Q 043157          532 LDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDK  609 (684)
Q Consensus       532 l~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~  609 (684)
                      ++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  250 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  250 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence            999999999999999865433222 2223346889999999998899999999999999999999 89998754432210


Q ss_pred             hHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          610 SLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       610 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                                      ..+........+...+..+.+|+.+||+.||++|||+.|++++|+++..
T Consensus       251 ----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 ----------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ----------------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                            1111111122334567789999999999999999999999999987643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.3e-41  Score=354.60  Aligned_cols=265  Identities=24%  Similarity=0.370  Sum_probs=194.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .++|++.+.||+|+||+||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357999999999999999999965 68999999886533 3344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          474 FIPNGTLFQYIHDQN---EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      |++ ++|.+++....   ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 69999987642   2234899999999999999999999999   9999999999999999999999999998754


Q ss_pred             cCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EERLFEI  627 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~~~~~~  627 (684)
                      .... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+...  ..+ ....  .......
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~-~~~~~~~~~~~~~  235 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK--LIF-DIMGTPNESLWPS  235 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHH-HHHCSCCTTTCGG
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHH-HHhCCCChhHhhh
Confidence            3322 2233458999999999876 468999999999999999999999998665433211  111 1110  0000000


Q ss_pred             hh------------------hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          628 LD------------------ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       628 ~d------------------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..                  ...........+.++.+|+.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            00                  000111122356689999999999999999999999876

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.5e-42  Score=386.93  Aligned_cols=264  Identities=23%  Similarity=0.365  Sum_probs=218.1

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .++...++|++.++||+|+||+||+|.+.++..||||+++.... ..++|.+|+++|++++||||+++++++.+ +..+|
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            34445677999999999999999999998888899999875432 34689999999999999999999999876 67899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++|+|.++|+.... ..+++..++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++...
T Consensus       339 v~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             eeehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            9999999999999986421 23899999999999999999999999   9999999999999999999999999998764


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ...........++..|+|||++....++.++||||||++||||++ |+.||......+.                .+.+.
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~----------------~~~i~  478 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------LDQVE  478 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH----------------HHHHH
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHH
Confidence            332222233446788999999998999999999999999999999 9999975443221                11111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .......+...+..+.+|+.+||+.||++|||+++|++.|+.+....
T Consensus       479 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          479 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            11122334566778999999999999999999999999999987543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.7e-41  Score=347.37  Aligned_cols=254  Identities=32%  Similarity=0.564  Sum_probs=206.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChh---H----HHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDES---K----VEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~----~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      ++|++.+.||+|+||+||++.+. +++.||+|++......   .    .+.+.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            67999999999999999999964 7899999987543221   1    267899999999999999999999986544  


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc-----EEEecc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-----AKVSDF  543 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DF  543 (684)
                      ++||||+++++|.+++.+...  .+++..++.++.|++.||+|||+++. +|+||||||+|||++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            799999999999999976543  49999999999999999999999873 4999999999999988776     999999


Q ss_pred             CCccccccCCceeeecccccCCCCCcccc--ccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 043157          544 GASRSMAVDQTHMTTQVHGTFGYLDPEYF--RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE  621 (684)
Q Consensus       544 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~  621 (684)
                      |+++....    ......||+.|+|||++  ....++.++||||||+++|||++|+.||...........          
T Consensus       174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----------  239 (287)
T 4f0f_A          174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI----------  239 (287)
T ss_dssp             TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH----------
T ss_pred             Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH----------
Confidence            99975432    23345689999999998  445678999999999999999999999975443221110          


Q ss_pred             hhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       622 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                         ............+...+.++.+|+.+||+.||++|||++|+++.|++|
T Consensus       240 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 ---NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ---HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ---HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence               111111222334456678899999999999999999999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=370.03  Aligned_cols=259  Identities=23%  Similarity=0.308  Sum_probs=211.7

Q ss_pred             HHHHHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeee
Q 043157          389 SKELERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLE  464 (684)
Q Consensus       389 ~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  464 (684)
                      .+++....++|++.++||+|+||+||++..+ +++.||+|++...   .....+.+.+|+.++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444455688999999999999999999975 7899999988642   22334568899999999999999999999999


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                      .+..+|||||+++|+|.+++.+...  .+++..++.++.||+.||+|||+++   |+||||||+||||+.++++||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence            9999999999999999999987543  3899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCceeeecccccCCCCCccccc-------cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFR-------SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF  617 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~  617 (684)
                      +++..............||+.|+|||++.       ...++.++||||||+++|||++|+.||......+..        
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--------  279 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY--------  279 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--------
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH--------
Confidence            99876655444445567999999999987       456899999999999999999999999865433211        


Q ss_pred             Hhhhhhhhhhhhhhh---hccCChhHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 043157          618 AMKEERLFEILDARV---MKESGGDEIITFAKVAKRCLNLNGKKR---PTMREVTSE  668 (684)
Q Consensus       618 ~~~~~~~~~~~d~~~---~~~~~~~~~~~l~~Li~~cl~~dp~~R---Pt~~evl~~  668 (684)
                             ..++....   ........+.++.+|+.+||+ +|++|   |+++|++++
T Consensus       280 -------~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          280 -------GKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             -------HHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             -------HHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                   01111000   011123466789999999998 99998   689998765

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.6e-41  Score=352.12  Aligned_cols=270  Identities=25%  Similarity=0.375  Sum_probs=206.4

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ..++|++.+.||+|+||+||++.. .+++.||+|++..   .+....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            345799999999999999999996 4789999998764   345667889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          471 VYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      ||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999999997521 2335899999999999999999999999   999999999999999999999999998765


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ..... ......|++.|+|||++.+..++.++||||||+++|||++|+.||........ .+..    ....        
T Consensus       187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~----~~~~--------  252 (310)
T 2wqm_A          187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCK----KIEQ--------  252 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHH----HHHT--------
T ss_pred             cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHH----Hhhc--------
Confidence            43222 22334689999999999999999999999999999999999999974332111 0100    0110        


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCCCC
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASNS  681 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~  681 (684)
                      ...........+.++.+|+.+||+.||++|||++|+++.|++|++....+-+
T Consensus       253 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE  304 (310)
T ss_dssp             TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred             ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence            0111111234567899999999999999999999999999999987665543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.1e-41  Score=356.61  Aligned_cols=256  Identities=27%  Similarity=0.395  Sum_probs=207.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|++.+.||+|+||+||+++.+ +++.||+|+++.   ......+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46899999999999999999975 689999998764   2455677889999999998 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++|+|.+++.+..   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999998754   3899999999999999999999999   99999999999999999999999999986432


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh-hhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF-EILDA  630 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~d~  630 (684)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........       .....+. .+...
T Consensus       163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------~~~~~~~~~i~~~  234 (345)
T 3a8x_A          163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYLFQVILEK  234 (345)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHHHHHHHHHC
T ss_pred             CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-------ccHHHHHHHHHcC
Confidence            22 223455799999999999999999999999999999999999999975322111100       0000011 11111


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTM------REVTSE  668 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~------~evl~~  668 (684)
                        ....+...+.++.+|+.+||+.||++||++      +|++++
T Consensus       235 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          235 --QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             --CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence              112345567789999999999999999996      566554

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.9e-41  Score=351.65  Aligned_cols=253  Identities=22%  Similarity=0.394  Sum_probs=206.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CC-------cEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DG-------KIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      ++|++.+.||+|+||+||++... ++       +.||+|++........+.+.+|++++++++||||+++++++.+.+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            56899999999999999999864 33       47999998776677778999999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc--------EEE
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR--------AKV  540 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl  540 (684)
                      ++||||+++++|.+++.....  .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.        +||
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             EEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence            999999999999999987543  3899999999999999999999999   999999999999998877        999


Q ss_pred             eccCCccccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCC-CCCCCChhhhhhHHHHHHHH
Q 043157          541 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEK-PIRFTTLEEDKSLAAYFLFA  618 (684)
Q Consensus       541 ~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~-P~~~~~~~~~~~l~~~~~~~  618 (684)
                      +|||++......     ....+++.|+|||++.+ ..++.++||||||+++|||++|.. |+.........         
T Consensus       163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~---------  228 (289)
T 4fvq_A          163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL---------  228 (289)
T ss_dssp             CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---------
T ss_pred             ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH---------
Confidence            999998754322     23457899999999987 678999999999999999999554 44432221110         


Q ss_pred             hhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          619 MKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       619 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                             .....  ....+...+.++.+|+.+||+.||++|||++|++++|++|.....
T Consensus       229 -------~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          229 -------QFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             -------HHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             -------HHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence                   00000  111222335568899999999999999999999999999986543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-41  Score=353.08  Aligned_cols=245  Identities=26%  Similarity=0.370  Sum_probs=207.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +|+.||+|.++..   .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56899999999999999999965 6899999987642   2234577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            9999999999998754   3899999999999999999999999   999999999999999999999999999865422


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                          .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.               ...++... 
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---------------~~~i~~~~-  219 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---------------YEKILNAE-  219 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---------------HHHHHHCC-
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---------------HHHHHhCC-
Confidence                2345699999999999999999999999999999999999999975443211               01111111 


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                       ...+...+.++.+|+.+||+.||++||     +++|++++
T Consensus       220 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          220 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence             122345667899999999999999999     88998865

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=349.51  Aligned_cols=266  Identities=24%  Similarity=0.291  Sum_probs=203.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            367999999999999999999975 5899999987543  3344677889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999999887653   3899999999999999999999999   999999999999999999999999999875433


Q ss_pred             CceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh--------hh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE--------ER  623 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~--------~~  623 (684)
                      .. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+..............        ..
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            22 2234468999999999876 67899999999999999999999999876544322211111000000        00


Q ss_pred             hhhh---hhhhh---hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          624 LFEI---LDARV---MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       624 ~~~~---~d~~~---~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ....   .++..   ........+..+.+|+.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000   00000   000012456678999999999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.5e-41  Score=352.13  Aligned_cols=267  Identities=22%  Similarity=0.335  Sum_probs=212.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeee----cCcceE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE----TEVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~l  470 (684)
                      .++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46799999999999999999996 5789999999877777788899999999999999999999999973    346789


Q ss_pred             EEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          471 VYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      ||||+++++|.+++.... ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            999999999999998631 2335999999999999999999999999   999999999999999999999999998764


Q ss_pred             ccCCce--------eeecccccCCCCCccccccCC---CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH
Q 043157          550 AVDQTH--------MTTQVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA  618 (684)
Q Consensus       550 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~  618 (684)
                      ......        ......||+.|+|||++....   ++.++||||||+++|||++|+.||.......           
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----------  253 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-----------  253 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-----------
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-----------
Confidence            321111        012234799999999987554   6889999999999999999999985211100           


Q ss_pred             hhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCC
Q 043157          619 MKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGAS  679 (684)
Q Consensus       619 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~  679 (684)
                         ..+................+.++.+|+.+||+.||++|||++|++++|+.++.....+
T Consensus       254 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  311 (317)
T 2buj_A          254 ---DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ  311 (317)
T ss_dssp             ---SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred             ---chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence               0111111111111223456678999999999999999999999999999998655443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-41  Score=358.56  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=203.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCC--CcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINH--RNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.+.||+|+||+||++...+++.||||++..  ......+.+.+|+.+|++++|  |||+++++++.+....++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            456999999999999999999988899999998764  345566889999999999976  9999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      || +.+++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++ ++.+||+|||+++....
T Consensus        88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 56889999998754   3899999999999999999999999   99999999999997 56899999999987653


Q ss_pred             CCce-eeecccccCCCCCcccccc-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh
Q 043157          552 DQTH-MTTQVHGTFGYLDPEYFRS-----------SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM  619 (684)
Q Consensus       552 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~  619 (684)
                      .... ......||+.|+|||++.+           ..++.++||||||+++|||++|+.||.......            
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------------  227 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------------  227 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------------
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH------------
Confidence            3322 2334569999999999864           678899999999999999999999997432211            


Q ss_pred             hhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          620 KEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       620 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                        ..+..++++......+...+.++.+|+.+||+.||++|||+.|++++.
T Consensus       228 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          228 --SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             --HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence              112233333333344445567899999999999999999999998764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.4e-41  Score=360.37  Aligned_cols=251  Identities=25%  Similarity=0.323  Sum_probs=207.6

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCc
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEV  467 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~  467 (684)
                      ....++|++.+.||+|+||+||++..+ +++.||||+++..   .....+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999975 6899999988642   133456788999999987 99999999999999999


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .++||||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            999999999999999998754   3899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+..   .            .+
T Consensus       167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~------------~i  230 (345)
T 1xjd_A          167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF---H------------SI  230 (345)
T ss_dssp             CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H------------HH
T ss_pred             hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH---H------------HH
Confidence            643222 2244567999999999999999999999999999999999999999865432210   0            01


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMR-EVTS  667 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~-evl~  667 (684)
                      ...  ....+...+.++.+|+.+||+.||++||++. |+++
T Consensus       231 ~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          231 RMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            111  0122344567899999999999999999998 6654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-40  Score=347.55  Aligned_cols=260  Identities=30%  Similarity=0.447  Sum_probs=208.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCC----CcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeee-ecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPD----GKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCL-ETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~l  470 (684)
                      .+|++.++||+|+||+||+|.+.+    ...+|+|.+.. ......+.+.+|+.++++++||||+++++++. +++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            468889999999999999998642    23689998765 44556788999999999999999999999865 4567899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++++|.++++....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       105 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence            9999999999999986443  4899999999999999999999999   9999999999999999999999999998654


Q ss_pred             cCCc---eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          551 VDQT---HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       551 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ....   .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+.   ..             
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~-------------  243 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV-------------  243 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HH-------------
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HH-------------
Confidence            3322   12333457889999999999999999999999999999999 5566654332211   00             


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      .+........+...+..+.+++.+||+.||++|||++|+++.|+.+...-.
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            001111112234456789999999999999999999999999999987543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.5e-40  Score=345.84  Aligned_cols=268  Identities=20%  Similarity=0.256  Sum_probs=210.1

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeee-eecCcceEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCC-LETEVPLLVY  472 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lv~  472 (684)
                      ..++|++.+.||+|+||+||++.. .+++.||||+....  ...+++.+|++++++++|++++..+..+ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999996 57899999975542  2234688899999999988877776666 5566779999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCcEEEeccCCcccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSM  549 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgl~~~~  549 (684)
                      ||+ +++|.+++.....  .+++..++.++.||+.||+|||+++   |+||||||+|||+   ++++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 9999999986443  3999999999999999999999999   9999999999999   78899999999999876


Q ss_pred             ccCCce------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhh
Q 043157          550 AVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER  623 (684)
Q Consensus       550 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~  623 (684)
                      ......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...................... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  237 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-
Confidence            543321      2234568999999999999999999999999999999999999998654333222211111100000 


Q ss_pred             hhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCC
Q 043157          624 LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGAS  679 (684)
Q Consensus       624 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~  679 (684)
                              .........+.++.+|+.+||+.||++|||++|+++.|+++..+.+.+
T Consensus       238 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~  285 (296)
T 4hgt_A          238 --------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             --------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             --------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence                    001111334678999999999999999999999999999999876644

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4e-40  Score=342.77  Aligned_cols=269  Identities=19%  Similarity=0.249  Sum_probs=214.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeee-eecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCC-LETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lv~E  473 (684)
                      .++|++.+.||+|+||+||++.. .+++.||||++.....  .+++.+|+.+++.++|++++..+..+ .+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46799999999999999999996 5789999998765332  24688999999999998877766665 55667799999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCcEEEeccCCccccc
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgl~~~~~  550 (684)
                      |+ +++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 9999999986443  4999999999999999999999999   9999999999999   488899999999998765


Q ss_pred             cCCce------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          551 VDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       551 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      .....      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................  
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  237 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--  237 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS--
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC--
Confidence            43331      1244569999999999999999999999999999999999999998654332222211111100000  


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCCCC
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASNS  681 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~  681 (684)
                             .........+.++.+|+.+||+.||++|||++|+++.|+++....+.+.+
T Consensus       238 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~  287 (296)
T 3uzp_A          238 -------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD  287 (296)
T ss_dssp             -------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred             -------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence                   00111234567899999999999999999999999999999987766543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.7e-41  Score=351.67  Aligned_cols=246  Identities=22%  Similarity=0.244  Sum_probs=197.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.++||+|+||+||+|.+. +++.||||++..  ........+..|+..+.++ +||||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999976 799999998654  3344455566666666665 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+ +++|.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++.....
T Consensus       136 ~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 6799999987643  4999999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ..  ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.....     ..     .+....    .   
T Consensus       210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~-----~~~~~~----~---  269 (311)
T 3p1a_A          210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----WQ-----QLRQGY----L---  269 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----HH-----HHTTTC----C---
T ss_pred             CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HH-----HHhccC----C---
Confidence            22  2334568999999999876 789999999999999999999777642110     00     011111    0   


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       ....+...+.++.+|+.+||+.||++|||++|++++
T Consensus       270 -~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          270 -PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             -CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence             111123356789999999999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=354.24  Aligned_cols=259  Identities=26%  Similarity=0.421  Sum_probs=207.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC-----CcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD-----GKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      .++|++.+.||+|+||+||+|.+..     +..||||+++.. .......+.+|+.++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3567888999999999999998642     246999988753 4455678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+++++|.+++.....  .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       123 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999987533  4899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCce--eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          550 AVDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       550 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ......  ......+++.|+|||.+....++.++||||||+++|||++ |+.||......+.                .+
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~----------------~~  261 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV----------------MK  261 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------HH
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH----------------HH
Confidence            433221  1222346788999999998999999999999999999999 9999975433211                11


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .+........+...+..+.+|+.+||+.||++||++.|++++|+++...
T Consensus       262 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          262 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            1111111222345677899999999999999999999999999988653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.4e-41  Score=359.54  Aligned_cols=256  Identities=23%  Similarity=0.435  Sum_probs=206.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcE----EEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKI----VAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ++|++.++||+|+||+||+|.+. +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            46889999999999999999964 4443    788876432 2333456788999999999999999999886 566889


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++|+|.+++.....  .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            9999999999999986532  4889999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          551 VDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       551 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      .... .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+.                .+.+
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~  230 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV----------------PDLL  230 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH----------------HHHH
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH----------------HHHH
Confidence            4332 22344557889999999999999999999999999999999 9999986543321                1111


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      ........+...+.++.+|+.+||+.||++|||++|++++|+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          231 EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1111122233455578899999999999999999999999998764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-40  Score=352.88  Aligned_cols=249  Identities=27%  Similarity=0.365  Sum_probs=198.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe----CCCcEEEEEecccc----ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML----PDGKIVAVKKSKVI----DESKVEEFINEMVILSQINHRNVVKLLGCCLETEV  467 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  467 (684)
                      .++|++.+.||+|+||+||++..    .+++.||+|+++..    .......+.+|+.++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35799999999999999999986    47899999987653    23345678899999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .++||||+++++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999998754   3899999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..               ..+
T Consensus       170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---------------~~i  233 (327)
T 3a62_A          170 ESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI---------------DKI  233 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---------------HHH
T ss_pred             ccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH---------------HHH
Confidence            5432222 234456999999999999999999999999999999999999999855432210               111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      ...  ....+...+.++.+|+.+||+.||++||     +++|++++
T Consensus       234 ~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          234 LKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             HHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             HhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            111  1123345667899999999999999999     77788765

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.4e-41  Score=347.38  Aligned_cols=261  Identities=26%  Similarity=0.467  Sum_probs=200.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ..++|++.++||+|+||+||++.+..  .+|+|+++.  ......+.+.+|++++++++||||++++++. .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            45689999999999999999998654  489998765  3455678899999999999999999999965 556789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc-
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~-  551 (684)
                      ||+++++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        99 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence            99999999999976543  4899999999999999999999999   99999999999999999999999999976542 


Q ss_pred             CCceeeecccccCCCCCccccc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ..........||+.|+|||.+.   ...++.++||||||+++|||++|+.||......+.  +..    .......    
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~----~~~~~~~----  243 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIE----MVGRGSL----  243 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHH----HHHHTSC----
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHH----Hhccccc----
Confidence            1222334456899999999986   56788899999999999999999999975432221  111    1111111    


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      . ..........+.++.+|+.+||+.||++|||++|+++.|+++..
T Consensus       244 ~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          244 S-PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             C-CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             C-cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            0 01122234567889999999999999999999999999998864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-40  Score=349.96  Aligned_cols=269  Identities=23%  Similarity=0.342  Sum_probs=205.8

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhc--CCCcccceeeeeeec---
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI--NHRNVVKLLGCCLET---  465 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l~~~~~~~---  465 (684)
                      ......++|++.+.||+|+||+||+++.. ++.||||++...   ....+.+|.+++..+  +||||+++++++.+.   
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            33445578999999999999999999875 899999987643   234455666666655  899999999999877   


Q ss_pred             -CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEecCCCCCCEEECCCC
Q 043157          466 -EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA--------ASIPIYHRDIKSTNILLDDKY  536 (684)
Q Consensus       466 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~--------~~~~iiH~Dlkp~NILl~~~~  536 (684)
                       ...++||||+++|+|.++++..    .+++..++.++.|++.||+|||++        +   |+||||||+|||++.++
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred             CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence             6789999999999999999765    389999999999999999999998        7   99999999999999999


Q ss_pred             cEEEeccCCccccccCCcee---eecccccCCCCCccccccCCCCCc------cchhhhHHHHHHHHhC----------C
Q 043157          537 RAKVSDFGASRSMAVDQTHM---TTQVHGTFGYLDPEYFRSSQFTDK------SDVYSFGVVLAELLTG----------E  597 (684)
Q Consensus       537 ~~kl~DFgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------sDv~SlGvil~elltG----------~  597 (684)
                      .+||+|||+++.........   .....||+.|+|||++.+...+.+      +||||||+++|||+||          +
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            99999999997654333221   224569999999999987766665      9999999999999999          6


Q ss_pred             CCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc-cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          598 KPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK-ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       598 ~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .||......... . ..........    ...+.... ....+.+.++.+|+.+||+.||++|||++|++++|++|....
T Consensus       260 ~p~~~~~~~~~~-~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          260 LPYHDLVPSDPS-Y-EDMREIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CTTTTTSCSSCC-H-HHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccHhhhcCCCCc-h-hhhHHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            666533221111 0 0000001000    01111100 112367888999999999999999999999999999998754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-40  Score=344.22  Aligned_cols=260  Identities=27%  Similarity=0.400  Sum_probs=210.0

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-C---CcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc-eEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-D---GKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP-LLV  471 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~---g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~-~lv  471 (684)
                      .|+..++||+|+||+||+|.+. +   +..+|+|++.. ......+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4667799999999999999853 2   23799998765 3445678899999999999999999999999876655 999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+.+++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999987433  4899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CC---ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCC-CCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          552 DQ---THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI-RFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       552 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~-~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ..   ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+ ......+                +...
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----------------~~~~  240 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------------LTHF  240 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----------------HHHH
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----------------HHHH
Confidence            22   12223345788999999999999999999999999999999966554 3222111                1111


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCC
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGA  678 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~  678 (684)
                      +........+...+..+.+|+.+||+.||++|||++|+++.|+++...-..
T Consensus       241 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          241 LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             hhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            111112223345667899999999999999999999999999999876543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.9e-41  Score=348.77  Aligned_cols=257  Identities=28%  Similarity=0.397  Sum_probs=210.8

Q ss_pred             hcCCCcCc-eeceeCcEEEEEEEe---CCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          396 TDNFNLNR-ILGQGGQGTVYKGML---PDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       396 ~~~~~~~~-~LG~G~~g~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      .++|.+.+ .||+|+||+||++.+   .+++.||||+++..  .....+++.+|++++++++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45688887 999999999999964   34688999987653  234467899999999999999999999999 667789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+++++|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            9999999999999998754   3899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCceee--ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          550 AVDQTHMT--TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       550 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ........  ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.                .+
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------~~  231 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----------------TA  231 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------------HH
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH----------------HH
Confidence            54433222  22346788999999988889999999999999999999 9999975543221                11


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .+........+...+..+.+++.+||+.||++||++.|+++.|+++...
T Consensus       232 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          232 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            1111112233456677899999999999999999999999999988764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-40  Score=356.47  Aligned_cols=245  Identities=22%  Similarity=0.293  Sum_probs=208.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            56999999999999999999965 6899999987642   2234678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++.+...   +++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999987643   899999999999999999999999   999999999999999999999999999865432


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                          .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.   .            ..+.... 
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~------------~~i~~~~-  254 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---Y------------EKIVSGK-  254 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H------------HHHHHCC-
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH---H------------HHHHcCC-
Confidence                2345689999999999999999999999999999999999999975543211   0            1111111 


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPT-----MREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt-----~~evl~~  668 (684)
                       ...+...+.++.+|+.+||+.||++||+     ++|++++
T Consensus       255 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence             1233456778999999999999999998     8888765

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=355.65  Aligned_cols=256  Identities=25%  Similarity=0.478  Sum_probs=204.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCc----EEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGK----IVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ++|++.++||+|+||+||++.+. +++    .||+|.+.. ......+.+.+|+.++++++||||+++++++.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            57999999999999999999964 444    357776643 33445688999999999999999999999998654 789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      |+|++++|+|.+++.....  .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        94 v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            9999999999999987644  3899999999999999999999999   9999999999999999999999999998764


Q ss_pred             cCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          551 VDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       551 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      .... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.                .+.+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------------~~~~  232 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------SSIL  232 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------------HHHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH----------------HHHH
Confidence            3322 12223446788999999999999999999999999999999 9999976543321                1222


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      ........+...+.++.+|+.+||+.||++|||++|+++.|+.+..
T Consensus       233 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          233 EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2222223345567789999999999999999999999999998863

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-40  Score=349.02  Aligned_cols=262  Identities=24%  Similarity=0.305  Sum_probs=204.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999965 6889999988653   334467899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++....   ++++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999998764   3899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ..........|++.|+|||++.+..++.++||||||+++|||++|+.||.......   +..    .....     .  .
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~----~~~~~-----~--~  252 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MGA----HINQA-----I--P  252 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HHH----HHHSC-----C--C
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HHH----HhccC-----C--C
Confidence            43333445568999999999999999999999999999999999999997543211   000    00000     0  0


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhHhhcC
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRP-TMREVTSELAGIKAWNG  677 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-t~~evl~~L~~i~~~~~  677 (684)
                      .....+...+.++.+|+.+||+.||++|| +++++++.|+++.....
T Consensus       253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            01122345667899999999999999999 99999999988765443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.5e-41  Score=346.49  Aligned_cols=255  Identities=27%  Similarity=0.461  Sum_probs=206.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeec-CcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLET-EVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E~  474 (684)
                      .++|++.+.||+|+||+||++.. .++.||+|.++..  ...+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46799999999999999999987 4889999998753  3557899999999999999999999997654 478999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++..... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....... 
T Consensus        97 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            999999999986532 23789999999999999999999999   9999999999999999999999999987543221 


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                         ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.                ...+.....
T Consensus       172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~----------------~~~~~~~~~  232 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------------VPRVEKGYK  232 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH----------------HHHHTTTCC
T ss_pred             ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHhcCCC
Confidence               22347889999999998999999999999999999998 9999975543221                111111112


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      ...+...+..+.+++.+||+.||++|||++|+++.|++|+..+.
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~  276 (278)
T 1byg_A          233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL  276 (278)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence            23345567889999999999999999999999999999987653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8.9e-41  Score=358.30  Aligned_cols=275  Identities=25%  Similarity=0.281  Sum_probs=213.3

Q ss_pred             cccCCHHHHHHHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcC-----CCcccc
Q 043157          384 TKLFTSKELERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-----HRNVVK  457 (684)
Q Consensus       384 ~~~~~~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~  457 (684)
                      ...++.++.....++|++.++||+|+||+||++.. .+++.||||+++. .....+.+..|+.+++.++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            33455666666778999999999999999999996 4788999998864 3445567888999999996     999999


Q ss_pred             eeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---
Q 043157          458 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---  534 (684)
Q Consensus       458 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---  534 (684)
                      +++++...+..++||||+ +++|.+++...... .+++..++.++.||+.||+|||+++   |+||||||+||||+.   
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence            999999999999999999 99999999876432 4899999999999999999999999   999999999999975   


Q ss_pred             ----------------------CCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHH
Q 043157          535 ----------------------KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAE  592 (684)
Q Consensus       535 ----------------------~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~e  592 (684)
                                            ++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++||
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                  789999999999764322    234568999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh--------hhhh-hcc-----------------C---ChhHHHH
Q 043157          593 LLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL--------DARV-MKE-----------------S---GGDEIIT  643 (684)
Q Consensus       593 lltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--------d~~~-~~~-----------------~---~~~~~~~  643 (684)
                      |++|+.||......+................+.+..        +... ...                 .   .......
T Consensus       252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            999999998655433221111110000000000000        0000 000                 0   0111267


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          644 FAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       644 l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      +.+|+.+||+.||++|||++|++++
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhcC
Confidence            8899999999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=360.23  Aligned_cols=249  Identities=24%  Similarity=0.366  Sum_probs=206.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +++.||+|++...   .....+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57999999999999999999965 6889999987542   2334678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999998653   3999999999999999999999999   999999999999999999999999999865432


Q ss_pred             CceeeecccccCCCCCcccccc---CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                        .......||+.|+|||++..   ..++.++||||||+++|||++|+.||..........+...             +.
T Consensus       169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-------------~~  233 (384)
T 4fr4_A          169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-------------FE  233 (384)
T ss_dssp             --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-------------HH
T ss_pred             --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-------------Hh
Confidence              23345679999999999864   4589999999999999999999999975443222111110             00


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPT-MREVTS  667 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt-~~evl~  667 (684)
                      . .....+...+.++.+|+.+||+.||++||+ ++++++
T Consensus       234 ~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          234 T-TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             H-CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             h-cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            0 112234556778999999999999999998 677665

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.1e-41  Score=357.32  Aligned_cols=247  Identities=24%  Similarity=0.344  Sum_probs=205.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|.+.+.||+|+||+||++.+ .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6799999999999999999996 578999999876421   122457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+ +|+|.+++....   .+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 789999998764   3999999999999999999999999   999999999999999999999999999865433


Q ss_pred             CceeeecccccCCCCCccccccCCC-CCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .  ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......+.                .+.+.. 
T Consensus       162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~-  222 (336)
T 3h4j_B          162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNS-  222 (336)
T ss_dssp             B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCS-
T ss_pred             c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHc-
Confidence            2  2334569999999999988776 6899999999999999999999975432211                010100 


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .....+...+.++.+|+.+||+.||++|||++|++++-
T Consensus       223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence            01123345677899999999999999999999998764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.4e-41  Score=356.49  Aligned_cols=260  Identities=24%  Similarity=0.297  Sum_probs=205.7

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-----ChhHHHHHHHHHHHHhhcCCCcccceeeeeee
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-----DESKVEEFINEMVILSQINHRNVVKLLGCCLE  464 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  464 (684)
                      ++....++|++.+.||+|+||+||++... +++.||+|++...     .....+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            45566778999999999999999999964 6889999987542     34567889999999999999999999999999


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQN-------------------------------------EDFPITWEMRLRIAIEVSG  507 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~  507 (684)
                      .+..++||||+++|+|.+++....                                     ....+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999996311                                     0112467788899999999


Q ss_pred             HHHHHHhCCCCCeEecCCCCCCEEECCCC--cEEEeccCCccccccCC---ceeeecccccCCCCCcccccc--CCCCCc
Q 043157          508 ALSYLHSAASIPIYHRDIKSTNILLDDKY--RAKVSDFGASRSMAVDQ---THMTTQVHGTFGYLDPEYFRS--SQFTDK  580 (684)
Q Consensus       508 aL~yLH~~~~~~iiH~Dlkp~NILl~~~~--~~kl~DFgl~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~k  580 (684)
                      ||+|||+.+   |+||||||+|||++.++  .+||+|||+++......   ........||+.|+|||++..  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999999   99999999999998766  89999999998654322   122344568999999999865  678999


Q ss_pred             cchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh--hccCChhHHHHHHHHHHHhhccCCCC
Q 043157          581 SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV--MKESGGDEIITFAKVAKRCLNLNGKK  658 (684)
Q Consensus       581 sDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~--~~~~~~~~~~~l~~Li~~cl~~dp~~  658 (684)
                      +||||||+++|||++|+.||......+..               ..++....  ........+.++.+|+.+||+.||++
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTI---------------SQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------------HHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHH---------------HHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence            99999999999999999999765433211               11111111  00111235678999999999999999


Q ss_pred             CCCHHHHHHH
Q 043157          659 RPTMREVTSE  668 (684)
Q Consensus       659 RPt~~evl~~  668 (684)
                      |||+.|++++
T Consensus       322 Rps~~~~l~h  331 (345)
T 3hko_A          322 RFDAMRALQH  331 (345)
T ss_dssp             SCCHHHHHHS
T ss_pred             CCCHHHHhcC
Confidence            9999999885

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.6e-41  Score=350.80  Aligned_cols=260  Identities=28%  Similarity=0.384  Sum_probs=202.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc---
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP---  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~---  468 (684)
                      .++|++.+.||+|+||+||++.. .+++.||||++...   +....+.+.+|++++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999996 57899999988653   345567899999999999999999999999877655   


Q ss_pred             -eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          469 -LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       469 -~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                       ++||||+++++|.++++...   ++++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             99999999999999998764   3899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCc--eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh
Q 043157          548 SMAVDQT--HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF  625 (684)
Q Consensus       548 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  625 (684)
                      .......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..      ......... 
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~-  237 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPI-  237 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCC-
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCC-
Confidence            6543322  2233456899999999999999999999999999999999999999765432210      000111000 


Q ss_pred             hhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHH-HHHHHHhhHh
Q 043157          626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE-VTSELAGIKA  674 (684)
Q Consensus       626 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~e-vl~~L~~i~~  674 (684)
                            .........+.++.+|+.+||+.||++||+..+ +...|.++..
T Consensus       238 ------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          238 ------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                  001112345678999999999999999996555 4555655543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.3e-41  Score=359.37  Aligned_cols=254  Identities=23%  Similarity=0.313  Sum_probs=197.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|++.+.||+|+||+||++... +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999976 789999998865322 235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc--EEEeccCCccccccC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR--AKVSDFGASRSMAVD  552 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFgl~~~~~~~  552 (684)
                      +++|+|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            99999999998754   3899999999999999999999999   999999999999987765  999999999753322


Q ss_pred             CceeeecccccCCCCCccccccCCCCCc-cchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDK-SDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .  ......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||........  ....         +..+....
T Consensus       172 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~---------~~~~~~~~  238 (361)
T 3uc3_A          172 S--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKT---------IQRILSVK  238 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHH---------HHHHHTTC
T ss_pred             C--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHH---------HHHHhcCC
Confidence            2  2233469999999999988887665 9999999999999999999975432211  1110         11111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .........+.++.+|+.+||+.||++|||++|++++-
T Consensus       239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence            11111224567899999999999999999999999874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.6e-40  Score=358.65  Aligned_cols=267  Identities=20%  Similarity=0.263  Sum_probs=206.8

Q ss_pred             hcCCCcCceecee--CcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          396 TDNFNLNRILGQG--GQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G--~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .++|++.++||+|  +||+||++... +++.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3579999999999  99999999976 6899999987643  35566788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999987532 24899999999999999999999999   9999999999999999999999999886543


Q ss_pred             cCCc------eeeecccccCCCCCcccccc--CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--
Q 043157          551 VDQT------HMTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--  620 (684)
Q Consensus       551 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--  620 (684)
                      ....      .......||+.|+|||++.+  ..++.++||||||+++|||++|+.||.........  .........  
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~  257 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCL  257 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC--------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCcc
Confidence            2211      11122368899999999987  67899999999999999999999999754432211  000000000  


Q ss_pred             -------hhh-------------hhhhhh---------hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          621 -------EER-------------LFEILD---------ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       621 -------~~~-------------~~~~~d---------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                             ...             +.+.+.         .......+...+.++.+|+.+||+.||++|||++|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                   000             000000         000011223456789999999999999999999999976

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-40  Score=361.61  Aligned_cols=251  Identities=23%  Similarity=0.360  Sum_probs=203.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcC--CCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQIN--HRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++...+++.||||++..  ......+.+.+|+.+|++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            46999999999999999999988899999998754  34566788999999999996  599999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      | +.+++|.+++....   .+++..++.++.||+.||+|||+.+   |+||||||+||||+ ++.+||+|||+++.....
T Consensus       136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 56889999998764   4899999999999999999999999   99999999999996 579999999999876533


Q ss_pred             Cce-eeecccccCCCCCcccccc-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh
Q 043157          553 QTH-MTTQVHGTFGYLDPEYFRS-----------SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK  620 (684)
Q Consensus       553 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~  620 (684)
                      ... ......||+.|+|||++.+           ..++.++||||||++||||++|+.||.......             
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------------  274 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------------  274 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-------------
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-------------
Confidence            322 2344569999999999865           468899999999999999999999997432111             


Q ss_pred             hhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          621 EERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       621 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                       ..+..++++......+...+.++.+|+.+||+.||++|||+.|++++-
T Consensus       275 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          275 -SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             -HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence             112223333333333344467899999999999999999999998763

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-41  Score=360.68  Aligned_cols=258  Identities=30%  Similarity=0.471  Sum_probs=200.2

Q ss_pred             CCCcCceeceeCcEEEEEEEeC--CC--cEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeee-cCcceEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP--DG--KIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLE-TEVPLLV  471 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~--~g--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lv  471 (684)
                      .|++.++||+|+||+||+|.+.  ++  ..||+|.++. ......+++.+|+.++++++||||+++++++.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4677899999999999999853  32  3689998765 345667889999999999999999999998754 4578999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++|+|.++++....  .+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999986543  3889999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCce---eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          552 DQTH---MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       552 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ....   ......+++.|+|||++.+..++.++||||||+++|||+| |.+||......+.   ...             
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~-------------  308 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY-------------  308 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHH-------------
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHH-------------
Confidence            2211   1233457788999999999999999999999999999999 6777764432221   110             


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      +........+...+..+.+++.+||+.||++|||++|++++|+.+...-
T Consensus       309 ~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          309 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            0001111223455678999999999999999999999999999988653

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.6e-40  Score=349.13  Aligned_cols=263  Identities=25%  Similarity=0.409  Sum_probs=204.2

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeC----CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLP----DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEV  467 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  467 (684)
                      ...++|.+.+.||+|+||+||+|...    +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34567999999999999999999853    3458999988653  45567889999999999999999999999987653


Q ss_pred             -----ceEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEE
Q 043157          468 -----PLLVYEFIPNGTLFQYIHDQN---EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK  539 (684)
Q Consensus       468 -----~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k  539 (684)
                           .++||||+++++|.+++....   ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence                 499999999999999996431   2345999999999999999999999999   99999999999999999999


Q ss_pred             EeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHH
Q 043157          540 VSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLF  617 (684)
Q Consensus       540 l~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~  617 (684)
                      |+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+..        
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--------  259 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY--------  259 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--------
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--------
Confidence            999999986543322 12233457889999999999999999999999999999999 88998755432211        


Q ss_pred             HhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       618 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                              +.+........+...+..+.+|+.+||+.||++|||++|++++|+.+..+
T Consensus       260 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          260 --------DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             --------HHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------HHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                    11111111222345667899999999999999999999999999998764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.5e-40  Score=355.43  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=208.1

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcce
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~  469 (684)
                      ..++|++.+.||+|+||+||++..+ +++.||+|+++..   .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3467999999999999999999976 4889999987642   233467788999999988 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+++|+|.+++.+...   +++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999987543   899999999999999999999999   999999999999999999999999999864


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      .... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.   .            ..+..
T Consensus       172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~------------~~i~~  235 (353)
T 2i0e_A          172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---F------------QSIME  235 (353)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H------------HHHHH
T ss_pred             ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---H------------HHHHh
Confidence            3222 233456799999999999999999999999999999999999999985543221   0            11111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPT-----MREVTSE  668 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt-----~~evl~~  668 (684)
                      ..  ...+...+.++.+|+.+||+.||++||+     ++|++++
T Consensus       236 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          236 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11  1233456778999999999999999995     5777655

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-40  Score=352.55  Aligned_cols=260  Identities=26%  Similarity=0.436  Sum_probs=210.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcE--EEEEeccc-cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKI--VAVKKSKV-IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~--vavK~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|++.+.||+|+||+||++... +++.  +|+|+++. ......+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56999999999999999999964 5664  48898764 2344567799999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcE
Q 043157          472 YEFIPNGTLFQYIHDQN-------------EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA  538 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~  538 (684)
                      |||+++++|.+++....             ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999998653             1235899999999999999999999999   9999999999999999999


Q ss_pred             EEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHH
Q 043157          539 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLF  617 (684)
Q Consensus       539 kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~  617 (684)
                      ||+|||+++.....  .......+++.|+|||++....++.++||||||+++|||++ |+.||......+.         
T Consensus       182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---------  250 (327)
T 1fvr_A          182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---------  250 (327)
T ss_dssp             EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---------
T ss_pred             EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH---------
Confidence            99999998743321  11223346889999999988889999999999999999998 9999975543221         


Q ss_pred             HhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       618 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                             .+.+........+...+..+.+|+.+||+.||++|||++|++++|+++.....
T Consensus       251 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          251 -------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             -------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             -------HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence                   11111111223344567789999999999999999999999999999886543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=380.72  Aligned_cols=260  Identities=25%  Similarity=0.405  Sum_probs=209.5

Q ss_pred             cCCCcCc-eeceeCcEEEEEEEeC---CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNR-ILGQGGQGTVYKGMLP---DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~-~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      +++.+.+ .||+|+||+||+|.+.   ++..||||+++.. .....+++.+|+++|++++||||+++++++.+ +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444444 7999999999999864   4668999998763 34467889999999999999999999999975 568999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++|+|.+++.....  .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       414 ~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EECCTTCBHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EEeCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            999999999999976533  4899999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCcee--eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          552 DQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       552 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      .....  .....+++.|+|||++....++.++||||||++||||++ |+.||......+                +.+.+
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i  552 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFI  552 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----------------HHHHH
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHH
Confidence            33221  122335689999999999999999999999999999998 999998554322                11112


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCC
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGA  678 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~  678 (684)
                      ........+...+.++.+|+.+||+.||++||++++|++.|+.+..+...
T Consensus       553 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          553 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence            22222334456778999999999999999999999999999988765443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.3e-40  Score=342.09  Aligned_cols=249  Identities=29%  Similarity=0.411  Sum_probs=205.9

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999865 57799999875422   22356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999998764   3899999999999999999999999   99999999999999999999999998865432


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .   ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+...               .+.  .
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~--~  221 (279)
T 3fdn_A          162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK---------------RIS--R  221 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---------------HHH--H
T ss_pred             c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH---------------HHH--h
Confidence            2   2234468999999999999999999999999999999999999998554332110               000  0


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      .....+...+..+.+|+.+||+.||++|||++|++++--
T Consensus       222 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          222 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence            111233446678899999999999999999999998753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.1e-40  Score=340.05  Aligned_cols=253  Identities=24%  Similarity=0.347  Sum_probs=209.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++..  ......+.+.+|+.++++++||||+++++++.+....++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999965 688999998754  34556688999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc---EEEeccCCcccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSM  549 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFgl~~~~  549 (684)
                      ||+++++|.+.+....   .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999999998764   3899999999999999999999999   999999999999986655   999999999765


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      .....  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........   .    .......     
T Consensus       159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~----~~~~~~~-----  224 (284)
T 3kk8_A          159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---A----QIKAGAY-----  224 (284)
T ss_dssp             CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHTCC-----
T ss_pred             ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH---H----HHHhccc-----
Confidence            43322  23456899999999999999999999999999999999999999754432211   0    0110000     


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                       ..........+.++.+|+.+||+.||++|||++|++++-
T Consensus       225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (284)
T 3kk8_A          225 -DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  263 (284)
T ss_dssp             -CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred             -cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence             001111234567899999999999999999999999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.9e-40  Score=348.96  Aligned_cols=274  Identities=23%  Similarity=0.370  Sum_probs=214.7

Q ss_pred             CCHHHHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhh--cCCCcccceeeeeee
Q 043157          387 FTSKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQ--INHRNVVKLLGCCLE  464 (684)
Q Consensus       387 ~~~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~  464 (684)
                      .+........++|++.+.||+|+||+||++.. +++.||||++..   ...+.+.+|++++..  ++||||+++++++.+
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            34444455667899999999999999999998 589999998864   334677889999988  789999999999987


Q ss_pred             cC----cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEE
Q 043157          465 TE----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH--------SAASIPIYHRDIKSTNILL  532 (684)
Q Consensus       465 ~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~iiH~Dlkp~NILl  532 (684)
                      ..    ..++||||+++|+|.+++.+.    .+++..++.++.|++.||+|||        +.+   |+||||||+||||
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll  180 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV  180 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence            76    789999999999999999864    3899999999999999999999        777   9999999999999


Q ss_pred             CCCCcEEEeccCCccccccCCce---eeecccccCCCCCccccccC------CCCCccchhhhHHHHHHHHhC-------
Q 043157          533 DDKYRAKVSDFGASRSMAVDQTH---MTTQVHGTFGYLDPEYFRSS------QFTDKSDVYSFGVVLAELLTG-------  596 (684)
Q Consensus       533 ~~~~~~kl~DFgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~SlGvil~elltG-------  596 (684)
                      +.++.+||+|||++.........   ......||+.|+|||++.+.      .++.++||||||+++|||+||       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            99999999999999876544332   22345689999999998765      234689999999999999999       


Q ss_pred             ---CCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc-cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          597 ---EKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK-ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       597 ---~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                         +.||........ ....+ ........    ..+.... ....+.+..+.+|+.+||+.||++|||++||+++|++|
T Consensus       261 ~~~~~p~~~~~~~~~-~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDP-SVEEM-RKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCCCCTTTTTSCSSC-CHHHH-HHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCccccCcCcc-cHHHH-HHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence               778764432111 11111 11111110    1111110 11236678899999999999999999999999999999


Q ss_pred             HhhcC
Q 043157          673 KAWNG  677 (684)
Q Consensus       673 ~~~~~  677 (684)
                      ....+
T Consensus       335 ~~~~~  339 (342)
T 1b6c_B          335 SQQEG  339 (342)
T ss_dssp             HHTTC
T ss_pred             HHHhc
Confidence            87654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.7e-41  Score=353.57  Aligned_cols=251  Identities=23%  Similarity=0.313  Sum_probs=181.8

Q ss_pred             CceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEEEEecCCCC
Q 043157          402 NRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGT  479 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~~gs  479 (684)
                      .+.||+|+||+||++... +++.||||++..   .....+.+|+.+++++. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999975 689999998864   34467789999999997 9999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC---cEEEeccCCccccccCCcee
Q 043157          480 LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---RAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       480 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFgl~~~~~~~~~~~  556 (684)
                      |.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++   .+||+|||+++....... .
T Consensus        93 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~  165 (325)
T 3kn6_A           93 LFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P  165 (325)
T ss_dssp             HHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence            999998754   4999999999999999999999999   99999999999997665   899999999986543322 2


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccC
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES  636 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~  636 (684)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||..................+.....      ....+.
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~  239 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEA  239 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHH
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCccc
Confidence            33445899999999999999999999999999999999999999754332111111111111111100      000011


Q ss_pred             ChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          637 GGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       637 ~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ....+.++.+|+.+||+.||++|||++|++++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            12356789999999999999999999999865

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-40  Score=359.12  Aligned_cols=263  Identities=24%  Similarity=0.370  Sum_probs=197.7

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcC-CCcccceeeeeeecC--cc
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQIN-HRNVVKLLGCCLETE--VP  468 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~--~~  468 (684)
                      ..++|++.+.||+|+||+||++... +++.||||++..  ......+.+.+|+.+++++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999964 789999998753  34566778899999999997 999999999997554  67


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||++ ++|.+++...    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999997 6999999864    3899999999999999999999999   99999999999999999999999999986


Q ss_pred             cccC--------------------CceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhh
Q 043157          549 MAVD--------------------QTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE  607 (684)
Q Consensus       549 ~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~  607 (684)
                      ....                    .........||+.|+|||++.+ ..++.++||||||+++|||++|++||...+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            5321                    1112334569999999999876 678999999999999999999999998765433


Q ss_pred             hhhHHHHHHHHhhhhh---hh--------hhhh---------------------hh-hhccCChhHHHHHHHHHHHhhcc
Q 043157          608 DKSLAAYFLFAMKEER---LF--------EILD---------------------AR-VMKESGGDEIITFAKVAKRCLNL  654 (684)
Q Consensus       608 ~~~l~~~~~~~~~~~~---~~--------~~~d---------------------~~-~~~~~~~~~~~~l~~Li~~cl~~  654 (684)
                      .....  . .......   +.        ..++                     .. .........+.++.+|+.+||+.
T Consensus       239 ~~~~i--~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          239 QLERI--I-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHH--H-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHH--H-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            22111  1 1110000   00        0000                     00 00001124466899999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 043157          655 NGKKRPTMREVTSE  668 (684)
Q Consensus       655 dp~~RPt~~evl~~  668 (684)
                      ||++|||++|++++
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999987

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.5e-40  Score=355.09  Aligned_cols=247  Identities=27%  Similarity=0.402  Sum_probs=204.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      +.|+..+.||+|+||+||+|.. .+++.||||++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588999999999999999996 57899999987643   2345678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||++ |+|.+++.....  ++++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       134 e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 688888876443  4899999999999999999999999   999999999999999999999999999765432


Q ss_pred             CceeeecccccCCCCCccccc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                           ....||+.|+|||++.   ...++.++||||||+++|||++|+.||......+.  +             ..+..
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~-------------~~~~~  267 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L-------------YHIAQ  267 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H-------------HHHHH
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H-------------HHHHh
Confidence                 2346899999999984   56789999999999999999999999975432211  0             01111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ...........+..+.+|+.+||+.||++|||++|++++.
T Consensus       268 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          268 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            1111112234567899999999999999999999998764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=352.91  Aligned_cols=263  Identities=22%  Similarity=0.362  Sum_probs=197.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcC-CCcccceeeeee--------e
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVVKLLGCCL--------E  464 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~--------~  464 (684)
                      ...+|++.++||+|+||+||++.+. +++.||||++........+.+.+|+.+++++. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            4457999999999999999999964 78999999987777777889999999999996 999999999994        3


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                      ....++||||++ |+|.+++.......++++..++.++.||+.||+|||+++. +|+||||||+|||++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEEecCc
Confidence            334789999995 7999999874444469999999999999999999999863 49999999999999999999999999


Q ss_pred             CccccccCCce-----------eeecccccCCCCCcccc---ccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhh
Q 043157          545 ASRSMAVDQTH-----------MTTQVHGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKS  610 (684)
Q Consensus       545 l~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~  610 (684)
                      +++........           ......||+.|+|||++   .+..++.++||||||+++|||++|+.||......    
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----  259 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----  259 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----
Confidence            99876533221           11134589999999998   5667899999999999999999999999632211    


Q ss_pred             HHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCC
Q 043157          611 LAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGA  678 (684)
Q Consensus       611 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~  678 (684)
                                     +++............+..+.+|+.+||+.||++|||++|++++|+.+......
T Consensus       260 ---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~  312 (337)
T 3ll6_A          260 ---------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV  312 (337)
T ss_dssp             ---------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred             ---------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence                           11111111111223344588999999999999999999999999999876543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-40  Score=344.21  Aligned_cols=254  Identities=26%  Similarity=0.397  Sum_probs=207.4

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeee---------
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE---------  464 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---------  464 (684)
                      ..++|++.+.||+|+||.||++... +++.||+|++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3456999999999999999999976 78999999887543    356789999999999999999998864         


Q ss_pred             -------cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc
Q 043157          465 -------TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR  537 (684)
Q Consensus       465 -------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~  537 (684)
                             ....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++   |+||||||+|||+++++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   4457899999999999999986532 34899999999999999999999999   999999999999999999


Q ss_pred             EEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH
Q 043157          538 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF  617 (684)
Q Consensus       538 ~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~  617 (684)
                      +||+|||++........  .....|++.|+|||.+.+..++.++||||||+++|||++|..|+..     .....     
T Consensus       161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~~~-----  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TSKFF-----  228 (284)
T ss_dssp             EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HHHHH-----
T ss_pred             EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HHHHH-----
Confidence            99999999987654322  2334589999999999999999999999999999999999998631     10000     


Q ss_pred             HhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCC
Q 043157          618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGAS  679 (684)
Q Consensus       618 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~  679 (684)
                             ..+.+    ...+...+..+.+|+.+||+.||++|||+.|++++|..++++....
T Consensus       229 -------~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          229 -------TDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             -------HHHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             -------HHhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence                   00111    1122345567899999999999999999999999999998765443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=358.61  Aligned_cols=246  Identities=26%  Similarity=0.308  Sum_probs=201.2

Q ss_pred             cCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCCCC
Q 043157          401 LNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT  479 (684)
Q Consensus       401 ~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~gs  479 (684)
                      ..+.||+|+||+||++... +++.||+|+++.......+.+.+|++++++++||||+++++++.+.+..+|||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3678999999999999964 689999999887776777899999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE--CCCCcEEEeccCCccccccCCceee
Q 043157          480 LFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL--DDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       480 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl--~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      |.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+|||+  ++++.+||+|||+++.......  .
T Consensus       173 L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~  245 (373)
T 2x4f_A          173 LFDRIIDESY--NLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L  245 (373)
T ss_dssp             EHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred             HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence            9999976432  4899999999999999999999999   9999999999999  6778999999999987643322  2


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh--hcc
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV--MKE  635 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~--~~~  635 (684)
                      ....||+.|+|||++....++.++||||||+++|||++|+.||......+.  +.             .++....  ...
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~-------------~i~~~~~~~~~~  310 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LN-------------NILACRWDLEDE  310 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH-------------HHHHTCCCSCSG
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-------------HHHhccCCCChh
Confidence            334599999999999988999999999999999999999999986543221  11             1111110  011


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .....+.++.+|+.+||+.||++|||++|++++
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            113456789999999999999999999999984

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.8e-40  Score=340.92  Aligned_cols=251  Identities=23%  Similarity=0.309  Sum_probs=207.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|++.+.||+|+||+||++... +++.+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            457999999999999999999965 5779999988765556678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCcEEEeccCCcccccc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgl~~~~~~  551 (684)
                      +++++|.+++.....   +++..++.++.|++.||+|||+++   |+||||||+|||+   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999999987643   899999999999999999999999   9999999999999   7889999999999976543


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ..  ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+..   .    ....... .     
T Consensus       162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~----~~~~~~~-~-----  225 (277)
T 3f3z_A          162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM---L----KIREGTF-T-----  225 (277)
T ss_dssp             TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHCCC-C-----
T ss_pred             cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH---H----HHHhCCC-C-----
Confidence            32  23344689999999998654 899999999999999999999999765432211   0    0100000 0     


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .........+..+.+|+.+||+.||++|||+.|++++
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000001346789999999999999999999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=349.21  Aligned_cols=264  Identities=24%  Similarity=0.328  Sum_probs=202.6

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC-----hhHHHHHHHHHHHHhhcC---CCcccceeeeeeec
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID-----ESKVEEFINEMVILSQIN---HRNVVKLLGCCLET  465 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~  465 (684)
                      ..++|++.++||+|+||+||++.. .+++.||||++....     ......+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999996 478999999876422     112345667777777764   99999999999876


Q ss_pred             C-----cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEE
Q 043157          466 E-----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV  540 (684)
Q Consensus       466 ~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl  540 (684)
                      .     ..++||||++ ++|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4789999997 699999987643 24899999999999999999999999   999999999999999999999


Q ss_pred             eccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh
Q 043157          541 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK  620 (684)
Q Consensus       541 ~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~  620 (684)
                      +|||+++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..  .... ....
T Consensus       162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~i~-~~~~  236 (308)
T 3g33_A          162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL--GKIF-DLIG  236 (308)
T ss_dssp             CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH--HHHH-HHHC
T ss_pred             eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-HHhC
Confidence            9999998654322  234456899999999999999999999999999999999999999865543321  1111 1110


Q ss_pred             ---hhhhhhh-------h---hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          621 ---EERLFEI-------L---DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       621 ---~~~~~~~-------~---d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                         ...+...       +   .+........+.+.++.+|+.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence               0000000       0   0000011123456789999999999999999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.2e-41  Score=368.95  Aligned_cols=249  Identities=23%  Similarity=0.301  Sum_probs=199.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.++||+|+||+||++... +++.||||++..   ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999964 689999998764   2344567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      |||+++|+|.+++....   .+++..++.++.||+.||+|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999999998764   38999999999999999999998 88   9999999999999999999999999998643


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      .... ......||+.|+|||++.+..++.++||||||++||||++|+.||.........   .            .+...
T Consensus       301 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~------------~i~~~  364 (446)
T 4ejn_A          301 KDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---E------------LILME  364 (446)
T ss_dssp             C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H------------HHHHC
T ss_pred             CCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH---H------------HHHhC
Confidence            3322 234467999999999999999999999999999999999999999755432211   0            00111


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      .  ...+...+.++.+|+.+||+.||++||     +++|++++
T Consensus       365 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          365 E--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            0  122345667899999999999999999     99999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=361.87  Aligned_cols=274  Identities=25%  Similarity=0.373  Sum_probs=216.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecC--cceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETE--VPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lv~  472 (684)
                      ++|.+.++||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            57999999999999999999975 58999999886532 334677889999999999999999999998765  679999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----CCCCcEEEeccCCccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASRS  548 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFgl~~~  548 (684)
                      ||+++|+|.+++........+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999987655555999999999999999999999999   9999999999999    7888899999999987


Q ss_pred             cccCCceeeecccccCCCCCcccccc--------CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhh-hHHHHHHHHh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRS--------SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK-SLAAYFLFAM  619 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~-~l~~~~~~~~  619 (684)
                      ......  .....||+.|+|||++..        ..++.++||||||+++|||++|+.||......... ..........
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             CCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             ccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            643322  234568999999999865        56788999999999999999999999754322211 1111111111


Q ss_pred             hhhhhhhh---h--------hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          620 KEERLFEI---L--------DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       620 ~~~~~~~~---~--------d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      ....+...   .        +...........+..+.+++.+||+.||++||+++|+++.++.|..+
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            11000000   0        00111234467888999999999999999999999999999988765

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.1e-41  Score=354.51  Aligned_cols=266  Identities=23%  Similarity=0.340  Sum_probs=200.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChh-HHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDES-KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|.+.+.||+|+||+||++... +++.||+|++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57899999999999999999975 7899999988653322 223456899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      ++ ++|.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            97 599999987643  4899999999999999999999999   99999999999999999999999999976543322


Q ss_pred             eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh-
Q 043157          555 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV-  632 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~-  632 (684)
                       ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+................+........ 
T Consensus       156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence             2233458999999999876 5689999999999999999999999987654432221111110011111111111000 


Q ss_pred             ------------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          633 ------------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       633 ------------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                                  ........+.++.+|+.+||+.||++|||++|++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  283 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP  283 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence                        0011123467789999999999999999999998853

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-40  Score=349.89  Aligned_cols=264  Identities=23%  Similarity=0.306  Sum_probs=200.3

Q ss_pred             cCCCcC-ceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLN-RILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      +.|++. ++||+|+||+||++... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567774 78999999999999954 7899999998766556678899999999995 79999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc---EEEeccCCccccc
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSMA  550 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFgl~~~~~  550 (684)
                      |+++++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||+++...
T Consensus        92 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            999999999998764   3899999999999999999999999   999999999999988766   9999999987654


Q ss_pred             cCCc------eeeecccccCCCCCcccccc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh
Q 043157          551 VDQT------HMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM  619 (684)
Q Consensus       551 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~  619 (684)
                      ....      .......||+.|+|||++..     ..++.++||||||+++|||++|+.||......+.......... .
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~  244 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP-A  244 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH-H
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch-h
Confidence            2211      11223458999999999875     5588999999999999999999999976532210000000000 0


Q ss_pred             hhhhhhhhhhhhhhccCC----hhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          620 KEERLFEILDARVMKESG----GDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       620 ~~~~~~~~~d~~~~~~~~----~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ....+.+.+.... ...+    ...+.++.+|+.+||+.||++|||++|++++
T Consensus       245 ~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          245 CQNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0000001000000 0111    2345689999999999999999999999885

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=354.18  Aligned_cols=251  Identities=25%  Similarity=0.344  Sum_probs=193.2

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ...++|++.+.||+|+||+||++... +++.||||+++..  ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            35678999999999999999999976 5889999988753  23467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCcEEEeccCCcccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGASRSM  549 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgl~~~~  549 (684)
                      ||+++++|.+++....   .+++..++.++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||+++..
T Consensus       128 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          128 ELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            9999999999998653   3899999999999999999999999   999999999999975   889999999999865


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ...  .......||+.|+|||++.+..++.++||||||+++|||++|+.||........  +.            ..+..
T Consensus       202 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~------------~~i~~  265 (349)
T 2w4o_A          202 EHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF------------RRILN  265 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH------------HHHHT
T ss_pred             Ccc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH------------HHHHh
Confidence            432  223345689999999999999999999999999999999999999975432211  10            01111


Q ss_pred             hh--hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          630 AR--VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       630 ~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..  .......+.+.++.+|+.+||+.||++|||+.|++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11  0111224566789999999999999999999999875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=341.08  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=187.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.+.||+|+||+||++.. .+++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35699999999999999999996 478999999876422   22347789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++.....  ++++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999986533  4899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+..               ..+....
T Consensus       165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~  228 (278)
T 3cok_A          165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLAD  228 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred             CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhcc
Confidence            222 223346899999999999888999999999999999999999999754432210               0010000


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus       229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence              12234456789999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=354.74  Aligned_cols=269  Identities=14%  Similarity=0.188  Sum_probs=210.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC---------CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccc---------
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD---------GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVK---------  457 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~---------  457 (684)
                      .++|++.+.||+|+||+||++....         ++.||+|.+...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3679999999999999999999763         789999987643     46789999999999999998         


Q ss_pred             ------eeeeeee-cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 043157          458 ------LLGCCLE-TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI  530 (684)
Q Consensus       458 ------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NI  530 (684)
                            +++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5667765 66789999999 999999998752 234999999999999999999999999   99999999999


Q ss_pred             EECCCC--cEEEeccCCccccccCCce------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 043157          531 LLDDKY--RAKVSDFGASRSMAVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRF  602 (684)
Q Consensus       531 Ll~~~~--~~kl~DFgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~  602 (684)
                      |++.++  .+||+|||+++........      ......||+.|+|||++.+..++.++||||||++||||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  9999999999876533221      12334689999999999999999999999999999999999999975


Q ss_pred             CChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCCC
Q 043157          603 TTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGASN  680 (684)
Q Consensus       603 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~  680 (684)
                      ....... +........  .......+.   .......+.++.+|+.+||+.||++|||++|+++.|+++....+...
T Consensus       271 ~~~~~~~-~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~  342 (352)
T 2jii_A          271 CLPNTED-IMKQKQKFV--DKPGPFVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP  342 (352)
T ss_dssp             GTTCHHH-HHHHHHHHH--HSCCCEECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred             CCcCHHH-HHHHHHhcc--CChhhhhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence            4321111 111000000  000000000   00012346789999999999999999999999999999988766543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.5e-40  Score=348.12  Aligned_cols=252  Identities=25%  Similarity=0.331  Sum_probs=207.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh------hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE------SKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      .++|++.+.||+|+||+||++... +++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456999999999999999999965 689999998765322      1367899999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC----cEEEeccC
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFG  544 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFg  544 (684)
                      ++||||+++++|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            99999999999999998643   4899999999999999999999999   99999999999999887    79999999


Q ss_pred             CccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      ++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+..  ..     +.....
T Consensus       165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~-----i~~~~~  235 (321)
T 2a2a_A          165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--AN-----ITSVSY  235 (321)
T ss_dssp             TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--HH-----HHTTCC
T ss_pred             cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH--HH-----HHhccc
Confidence            998765332  223446899999999999999999999999999999999999999765432211  00     000000


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        ..++    ......+..+.+|+.+||+.||++|||++|++++
T Consensus       236 --~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 --DFDE----EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             --CCCH----HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             --ccCh----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0000    0112345678999999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=342.09  Aligned_cols=253  Identities=24%  Similarity=0.363  Sum_probs=204.8

Q ss_pred             CCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          398 NFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      .|....+||+|+||+||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            355566999999999999996 4688999999887666677889999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCcEEEeccCCccccccCCce
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      +++|.+++........+++..++.++.|++.||+|||+++   |+||||||+|||++. ++.+||+|||++........ 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            9999999988655556789999999999999999999999   999999999999987 89999999999986543222 


Q ss_pred             eeecccccCCCCCccccccCC--CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhh
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM  633 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~  633 (684)
                      ......|++.|+|||++....  ++.++||||||+++|||++|+.||........    ...          ........
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~----------~~~~~~~~  244 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMF----------KVGMFKVH  244 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HHH----------HHHHHCCC
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HHH----------hhcccccc
Confidence            233456899999999987643  78999999999999999999999963322111    000          00001111


Q ss_pred             ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       634 ~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ...+...+.++.+|+.+||+.||++||+++|++++
T Consensus       245 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          245 PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            23345567789999999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.8e-40  Score=340.33  Aligned_cols=250  Identities=22%  Similarity=0.336  Sum_probs=210.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|.+.+.||+|+||+||++... +++.+|+|.+..   ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            367999999999999999999976 588999998754   2455678899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999998754   3899999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+..               ..+... 
T Consensus       168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---------------~~~~~~-  230 (294)
T 2rku_A          168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY---------------LRIKKN-  230 (294)
T ss_dssp             TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------------HHHHTT-
T ss_pred             Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHhhc-
Confidence            322 233456899999999999988999999999999999999999999765432210               000010 


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                       ....+...+..+.+|+.+||+.||++|||++|++++-
T Consensus       231 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          231 -EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             -cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence             0122344567899999999999999999999999864

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.7e-40  Score=354.69  Aligned_cols=264  Identities=25%  Similarity=0.400  Sum_probs=209.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.+.||+|+||+||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            57999999999999999999975 6899999987653 455668899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      +++++|.+++....   .+++..++.++.|++.||+|||+. +   |+||||||+|||++.++.+||+|||++...... 
T Consensus       113 ~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999998764   389999999999999999999996 7   999999999999999999999999998754322 


Q ss_pred             ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHH------------------
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF------------------  615 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~------------------  615 (684)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+........                  
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence              223346899999999999999999999999999999999999999865543321111000                  


Q ss_pred             -----HHHhhhhhhhhhhhhh----hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          616 -----LFAMKEERLFEILDAR----VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       616 -----~~~~~~~~~~~~~d~~----~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                           ..........+.++..    .........+.++.+|+.+||+.||++|||++|++++-
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                 0000000111111111    11111234567899999999999999999999999864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.1e-40  Score=349.33  Aligned_cols=262  Identities=25%  Similarity=0.397  Sum_probs=210.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe------CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEV  467 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  467 (684)
                      ..++|++.+.||+|+||+||++.+      .+++.||||++... ......++.+|+.++++++||||+++++++.+...
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            346799999999999999999984      24678999998643 45566789999999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC---CCCcEEE
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNED----FPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKV  540 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl  540 (684)
                      .++||||+++++|.+++......    ..+++..++.++.|++.||+|||+++   |+||||||+|||++   .+..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999875421    34899999999999999999999999   99999999999998   4456999


Q ss_pred             eccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHH
Q 043157          541 SDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFA  618 (684)
Q Consensus       541 ~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~  618 (684)
                      +|||+++....... .......+++.|+|||++.+..++.++||||||+++|||+| |+.||......+.          
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------  254 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV----------  254 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----------
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH----------
Confidence            99999875433222 22334457889999999998899999999999999999998 9999975443221          


Q ss_pred             hhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          619 MKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       619 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                            .+.+........+...+..+.+|+.+||+.||++||++.|++++|+.+...
T Consensus       255 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          255 ------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             ------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------HHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence                  111111111223345667899999999999999999999999999988753

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-40  Score=344.11  Aligned_cols=260  Identities=27%  Similarity=0.408  Sum_probs=202.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC--CCc--EEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP--DGK--IVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      ++|++.+.||+|+||+||++.+.  +++  .||+|+++..   .....+.+.+|++++++++||||+++++++.+.. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            56999999999999999999853  333  6899987653   3456788999999999999999999999998654 88


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+++++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence            99999999999999987532  3899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCce--eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          550 AVDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       550 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ......  ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.   .            ..
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~------------~~  236 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---L------------HK  236 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H------------HH
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---H------------HH
Confidence            543332  2223457788999999988889999999999999999999 9999975543221   0            11


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      +.........+...+.++.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       237 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  287 (291)
T 1u46_A          237 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM  287 (291)
T ss_dssp             HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             HHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence            111111122234567789999999999999999999999999998876543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-40  Score=351.80  Aligned_cols=265  Identities=20%  Similarity=0.308  Sum_probs=196.8

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ...++|++.++||+|+||+||++... +++.||||+++...  ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34568999999999999999999854 78999999886533  2335678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-----CCCCcEEEeccCC
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL-----DDKYRAKVSDFGA  545 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl-----~~~~~~kl~DFgl  545 (684)
                      ||||++ ++|.+++.....   +++..++.++.||+.||+|||+++   |+||||||+|||+     ++++.+||+|||+
T Consensus       111 v~e~~~-~~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCS-EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCC-CCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999997 599999987643   899999999999999999999999   9999999999999     4556699999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh-h-hh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM-K-EE  622 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~-~-~~  622 (684)
                      ++....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+.  +...+.... . ..
T Consensus       184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPDDT  260 (329)
T ss_dssp             HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTT
T ss_pred             ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCchh
Confidence            976543322 22334589999999998774 489999999999999999999999986543321  111111100 0 00


Q ss_pred             hhhhhh-------------hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          623 RLFEIL-------------DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       623 ~~~~~~-------------d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ......             ............+.++.+|+.+||+.||++|||++|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            000000             0000000112245788999999999999999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6e-40  Score=363.68  Aligned_cols=259  Identities=21%  Similarity=0.304  Sum_probs=199.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC------
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETE------  466 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------  466 (684)
                      .++|++.++||+|+||+||++... +++.||||++..  ......+++.+|+.+|+.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467999999999999999999864 689999998864  34566788999999999999999999999997654      


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..++||||+++ +|.+.+..     .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            45999999975 57776643     2899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh-----
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE-----  621 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~-----  621 (684)
                      +.....  .......||+.|+|||++.+..++.++||||||++||||++|+.||...+..+...  ..+ .....     
T Consensus       212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~--~i~-~~lg~p~~~~  286 (464)
T 3ttj_A          212 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVI-EQLGTPCPEF  286 (464)
T ss_dssp             -----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHH-HHHCSCCHHH
T ss_pred             eecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-HhcCCCCHHH
Confidence            865432  22344579999999999999999999999999999999999999998765433211  111 10000     


Q ss_pred             -----hhhhhhhhhh---------------hhc---cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          622 -----ERLFEILDAR---------------VMK---ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       622 -----~~~~~~~d~~---------------~~~---~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           ......+...               ...   +.....+.++.+|+.+||+.||++|||++|++++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 0000000000               000   0001236789999999999999999999999886

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=352.57  Aligned_cols=265  Identities=19%  Similarity=0.264  Sum_probs=202.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC----CCcEEEEEeccccChh-----------HHHHHHHHHHHHhhcCCCcccceee
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP----DGKIVAVKKSKVIDES-----------KVEEFINEMVILSQINHRNVVKLLG  460 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~HpnIv~l~~  460 (684)
                      .++|++.+.||+|+||+||++...    ++..+|+|+.......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357999999999999999999975    5678999987653321           1234668899999999999999999


Q ss_pred             eeee----cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 043157          461 CCLE----TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY  536 (684)
Q Consensus       461 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~  536 (684)
                      ++.+    ....++||||+ +++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    67889999999 999999998764   4999999999999999999999999   99999999999998877


Q ss_pred             --cEEEeccCCccccccCCce------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhh
Q 043157          537 --RAKVSDFGASRSMAVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED  608 (684)
Q Consensus       537 --~~kl~DFgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~  608 (684)
                        .+||+|||+++........      ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876432211      11345689999999999999999999999999999999999999963221111


Q ss_pred             hhHHHHHHHHhhhhhhhhhhhhhhhcc-CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          609 KSLAAYFLFAMKEERLFEILDARVMKE-SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       609 ~~l~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      . . .....     .....+....... .....+.++.+|+.+||+.||++|||++||++.|+++..
T Consensus       269 ~-~-~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          269 A-V-QTAKT-----NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             H-H-HHHHH-----HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             H-H-HHHHH-----hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1 0 00000     0111111111110 112466789999999999999999999999999988764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.5e-40  Score=341.14  Aligned_cols=246  Identities=22%  Similarity=0.308  Sum_probs=202.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++..  .......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            457999999999999999999975 789999998765  3345567889999999999 999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC----------------
Q 043157          472 YEFIPNGTLFQYIHDQNE-DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD----------------  534 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~----------------  534 (684)
                      |||+++++|.+++..... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999986421 134899999999999999999999999   999999999999984                


Q ss_pred             ---CCcEEEeccCCccccccCCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhh
Q 043157          535 ---KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKS  610 (684)
Q Consensus       535 ---~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~  610 (684)
                         ...+||+|||++.......     ...||+.|+|||.+.+. .++.++||||||+++|||++|.+|+.....     
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-----  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred             cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence               4479999999998764332     23489999999998765 567899999999999999999987642210     


Q ss_pred             HHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          611 LAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       611 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .             ..+ ........+...+.++.+|+.+||+.||++|||++|++++
T Consensus       237 ~-------------~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 W-------------HEI-RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             H-------------HHH-HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             H-------------HHH-HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            0             001 1111123344567789999999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.3e-40  Score=339.16  Aligned_cols=261  Identities=25%  Similarity=0.345  Sum_probs=209.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh------hHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE------SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      ++|++.+.||+|+||+||++... +++.||+|.++....      ...+.+.+|+.++++++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56899999999999999999976 689999998764321      23678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC----cEEEeccCC
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFGA  545 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFgl  545 (684)
                      +||||+++++|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            9999999999999998654   3899999999999999999999999   99999999999998877    899999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF  625 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  625 (684)
                      +........  .....|++.|+|||++....++.++||||||+++|+|++|+.||......+..   .    .....   
T Consensus       159 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~----~~~~~---  226 (283)
T 3bhy_A          159 AHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---T----NISAV---  226 (283)
T ss_dssp             CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H----HHHTT---
T ss_pred             ceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH---H----HhHhc---
Confidence            986543222  23345899999999999999999999999999999999999999765432211   0    00000   


Q ss_pred             hhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhHhhcCC
Q 043157          626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGIKAWNGA  678 (684)
Q Consensus       626 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i~~~~~~  678 (684)
                         ............+..+.+|+.+||+.||++|||+.|++++  ++.++..+..
T Consensus       227 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  278 (283)
T 3bhy_A          227 ---NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR  278 (283)
T ss_dssp             ---CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC-
T ss_pred             ---ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhh
Confidence               0000001112345678999999999999999999999984  5777665543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.6e-40  Score=356.11  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=197.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHH-HhhcCCCcccceeeeeeecCcceE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVI-LSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .++|++.+.||+|+||+||+++.+ +++.||+|+++..   .....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357999999999999999999975 5889999987642   23445667778777 577899999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++|+|.+++.+..   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999998754   3899999999999999999999999   9999999999999999999999999998643


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..               ..++..
T Consensus       191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---------------~~i~~~  254 (373)
T 2r5t_A          191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---------------DNILNK  254 (373)
T ss_dssp             CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH---------------HHHHHS
T ss_pred             cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHHhc
Confidence            222 2344567999999999999999999999999999999999999999755432210               111111


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .  ...+...+.++.+|+.+||+.||++||++.+.++++
T Consensus       255 ~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          255 P--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             C--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             c--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence            1  122345667899999999999999999986444433

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.7e-40  Score=378.47  Aligned_cols=249  Identities=28%  Similarity=0.416  Sum_probs=204.4

Q ss_pred             ceeceeCcEEEEEEEeC---CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP---DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      +.||+|+||+||+|.+.   .++.||||+++..  +....+++.+|+++|++++||||+++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999653   4678999988753  3445688999999999999999999999985 4567899999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc--e
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT--H  555 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~--~  555 (684)
                      |+|.++++...   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.......  .
T Consensus       454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999998654   3899999999999999999999999   99999999999999999999999999987654332  1


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                      ......+|+.|+|||++....++.++||||||++||||++ |+.||......+                +.+.+......
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i~~~~~~  591 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGERM  591 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCC
Confidence            2233346788999999999999999999999999999998 999997554322                11222222223


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      ..+...+.++.+|+.+||+.||++||++++|++.|+++..
T Consensus       592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            3445677889999999999999999999999999998865

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.2e-40  Score=338.38  Aligned_cols=253  Identities=26%  Similarity=0.398  Sum_probs=207.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            356999999999999999999975 6899999987643 23456789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++++|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999987543   4899999999999999999999999   9999999999999999999999999997654322


Q ss_pred             c-eeeecccccCCCCCccccccCCC-CCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          554 T-HMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       554 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      . .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||......... ...             .....
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~-------------~~~~~  225 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD-------------WKEKK  225 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHH-------------HHTTC
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHH-------------hhhcc
Confidence            2 22334568999999999987665 77999999999999999999999754432110 100             00000


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .........+..+.+|+.+||+.||++|||++|++++
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence            0111123456788999999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=350.26  Aligned_cols=270  Identities=25%  Similarity=0.395  Sum_probs=198.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHH--HhhcCCCcccceeeeeee-----cCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVI--LSQINHRNVVKLLGCCLE-----TEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~HpnIv~l~~~~~~-----~~~~  468 (684)
                      .++|++.+.||+|+||+||+|+. +++.||||++....   .+.+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46799999999999999999977 68999999986432   3344445554  445899999999986543     2356


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCCEEECCCCcEE
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA---------ASIPIYHRDIKSTNILLDDKYRAK  539 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~---------~~~~iiH~Dlkp~NILl~~~~~~k  539 (684)
                      ++||||+++|+|.+++....    +++..++.++.||++||+|||+.         +   |+||||||+||||+.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            89999999999999997654    68999999999999999999999         7   99999999999999999999


Q ss_pred             EeccCCccccccCC-------ceeeecccccCCCCCcccccc-------CCCCCccchhhhHHHHHHHHhCCCCCCCCCh
Q 043157          540 VSDFGASRSMAVDQ-------THMTTQVHGTFGYLDPEYFRS-------SQFTDKSDVYSFGVVLAELLTGEKPIRFTTL  605 (684)
Q Consensus       540 l~DFgl~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~SlGvil~elltG~~P~~~~~~  605 (684)
                      |+|||+++......       ........||+.|+|||++.+       ..++.++||||||+++|||++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998764322       112234469999999999876       4566799999999999999999777643322


Q ss_pred             hhh-hhHHHHHH-HHhhhhhhhhhhh-hhhhcc------CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          606 EED-KSLAAYFL-FAMKEERLFEILD-ARVMKE------SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       606 ~~~-~~l~~~~~-~~~~~~~~~~~~d-~~~~~~------~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      ... ........ .......+...+. ......      .....+.++.+|+.+||+.||++|||++|+++.|++|...-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence            111 00000000 0000000000000 000111      12346778999999999999999999999999999988543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.5e-40  Score=347.02  Aligned_cols=249  Identities=22%  Similarity=0.344  Sum_probs=210.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|.+.+.||+|+||+||++... +++.+|+|.+..   ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999975 578999998754   2455678899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++....   .+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999998754   3899999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+..      .         .+... 
T Consensus       194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~---------~~~~~-  256 (335)
T 2owb_A          194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------L---------RIKKN-  256 (335)
T ss_dssp             TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------H---------HHHHT-
T ss_pred             Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH------H---------HHhcC-
Confidence            322 233456899999999999989999999999999999999999999755432211      0         00000 


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       ....+...+..+.+|+.+||+.||++|||++|++++
T Consensus       257 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 -EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             011233456678999999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=351.14  Aligned_cols=259  Identities=21%  Similarity=0.300  Sum_probs=200.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC------
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETE------  466 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------  466 (684)
                      .++|++.+.||+|+||+||++... +|+.||||++..  ......+.+.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999964 789999998854  34455678999999999999999999999998664      


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..++||||+ +++|.+++...    .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            359999999 88999999863    3899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH-------
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA-------  618 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~-------  618 (684)
                      +.....    .....+|+.|+|||++.+ ..++.++||||||++++||++|+.||...+..+..  .......       
T Consensus       176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l--~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL--KEIMKVTGTPPAEF  249 (367)
T ss_dssp             EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHH
T ss_pred             cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCCHHH
Confidence            865432    234568999999999877 67999999999999999999999999866543221  1111100       


Q ss_pred             ---hhhhhhhhhhh------hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          619 ---MKEERLFEILD------ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       619 ---~~~~~~~~~~d------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                         +........+.      ...........+..+.+|+.+||+.||++|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence               00000000000      001112223456789999999999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.1e-40  Score=342.08  Aligned_cols=261  Identities=25%  Similarity=0.403  Sum_probs=208.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeee--cCcceE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLE--TEVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l  470 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++..  ......+.+.+|++++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357999999999999999999975 689999998764  345567889999999999999999999998854  557899


Q ss_pred             EEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          471 VYEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAA--SIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      ||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999998642 2335899999999999999999999976  2349999999999999999999999999987


Q ss_pred             ccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI  627 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~  627 (684)
                      ....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+   +..    .+.       
T Consensus       165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----~i~-------  229 (279)
T 2w5a_A          165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAG----KIR-------  229 (279)
T ss_dssp             HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHH-------
T ss_pred             eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHH----HHh-------
Confidence            6543222 2233468999999999999899999999999999999999999998554221   110    011       


Q ss_pred             hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       628 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                        .......+...+.++.+|+.+||+.||++|||++|+++++..-.
T Consensus       230 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          230 --EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             --HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             --hcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence              11112233456778999999999999999999999998775433

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.9e-40  Score=342.18  Aligned_cols=251  Identities=26%  Similarity=0.406  Sum_probs=210.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      +.|++.+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            46899999999999999999864 68999999876533 34568899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++...    ++++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus       102 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          102 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            9999999999753    4899999999999999999999999   99999999999999999999999999977543322


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                       ......|++.|+|||++.+..++.++||||||+++|||++|+.||.........                ..+......
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------~~~~~~~~~  237 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL----------------FLIPKNNPP  237 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----------------HHHHHSCCC
T ss_pred             -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH----------------HHhhcCCCC
Confidence             233456899999999999999999999999999999999999999754322110                001111112


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAG  671 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~  671 (684)
                      ......+..+.+|+.+||+.||++|||++|++++.--
T Consensus       238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  274 (303)
T 3a7i_A          238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI  274 (303)
T ss_dssp             CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred             CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence            2334566789999999999999999999999987543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.2e-40  Score=341.98  Aligned_cols=252  Identities=25%  Similarity=0.333  Sum_probs=205.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|.+.+.||+|+||+||++... +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            457999999999999999999965 7899999998765555567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCcEEEeccCCcccccc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgl~~~~~~  551 (684)
                      +++++|.+++....   .+++..++.++.|++.||+|||+.+   |+||||||+|||+   ++++.+||+|||+++....
T Consensus        88 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999999998754   3899999999999999999999999   9999999999999   7889999999999875432


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .   ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+.   ..    .+.....      .
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~----~i~~~~~------~  225 (304)
T 2jam_A          162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---FE----KIKEGYY------E  225 (304)
T ss_dssp             B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH----HHHHCCC------C
T ss_pred             C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HH----HHHcCCC------C
Confidence            2   22334589999999999999999999999999999999999999975442211   10    0111000      0


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .........+.++.+|+.+||+.||++|||++|++++-
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (304)
T 2jam_A          226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP  263 (304)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence            01122245567899999999999999999999998753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.9e-40  Score=368.46  Aligned_cols=254  Identities=26%  Similarity=0.351  Sum_probs=210.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.++||+|+||+||++... +|+.||+|++...   .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            457999999999999999999975 7999999987642   223456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++|+|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999987542 34899999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ...  .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........            .+.+.+.. 
T Consensus       339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~------------~i~~~i~~-  403 (576)
T 2acx_A          339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE------------EVERLVKE-  403 (576)
T ss_dssp             TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH------------HHHHHHHH-
T ss_pred             Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH------------HHHHHhhc-
Confidence            332  334579999999999999899999999999999999999999998653221110            01111110 


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      .....+...+.++.+|+.+||+.||++||     +++|++++
T Consensus       404 ~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            11223455678899999999999999999     78888865

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-40  Score=349.57  Aligned_cols=268  Identities=24%  Similarity=0.275  Sum_probs=201.2

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChh-----HHHHHHHHHHHHhhcCCCcccceeeeeeecC
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDES-----KVEEFINEMVILSQINHRNVVKLLGCCLETE  466 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  466 (684)
                      ....++|++.+.||+|+||+||++... +++.||||++......     ..+.+.+|++++++++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344578999999999999999999965 6899999988653221     1346889999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..++||||+++ +|.+++.....  .+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999975 89999876543  4888999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EER  623 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~~  623 (684)
                      +....... ......||+.|+|||++.+. .++.++||||||+++|||++|.+||......+.  +...+.....  ...
T Consensus       160 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          160 KSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQ  236 (346)
T ss_dssp             STTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTT
T ss_pred             eeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCChhh
Confidence            87643322 23345689999999998654 588999999999999999999999986543221  1111111000  000


Q ss_pred             hhhhh---hh---h-----hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          624 LFEIL---DA---R-----VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       624 ~~~~~---d~---~-----~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      +.+..   +.   .     .........+.++.+|+.+||+.||++|||++|++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            00000   00   0     00011134457899999999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.1e-40  Score=362.58  Aligned_cols=247  Identities=26%  Similarity=0.379  Sum_probs=207.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|.+.+.||+|+||+||+|.+. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57999999999999999999975 79999999886432   233567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++.+..   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999997643   3999999999999999999999999   999999999999999999999999999876433


Q ss_pred             CceeeecccccCCCCCccccccCCC-CCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .  ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........      +         ..+.+..
T Consensus       170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~---------~~i~~~~  232 (476)
T 2y94_A          170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL------F---------KKICDGI  232 (476)
T ss_dssp             C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH------H---------HHHHTTC
T ss_pred             c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH------H---------HHHhcCC
Confidence            2  2334569999999999988765 6899999999999999999999975443211      0         0111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus       233 --~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          233 --FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence              11233456789999999999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-40  Score=354.71  Aligned_cols=255  Identities=28%  Similarity=0.360  Sum_probs=208.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe----CCCcEEEEEecccc----ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecC
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML----PDGKIVAVKKSKVI----DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETE  466 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~  466 (684)
                      .++|++.++||+|+||+||++..    .+++.||||+++..    .....+.+.+|+++++++ +||||+++++++.+..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36799999999999999999987    37899999987642    123345677899999999 6999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..++||||+++++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999998764   3899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCcccccc--CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      +..............||+.|+|||++.+  ..++.++||||||++||||++|+.||.........  .....        
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~--------  276 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISR--------  276 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHH--------
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHH--------
Confidence            8765444444455679999999999975  45789999999999999999999999754322211  11100        


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSEL  669 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~L  669 (684)
                       .+...  ....+...+..+.+|+.+||+.||++||     +++|++++.
T Consensus       277 -~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          277 -RILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -HHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -HHhcc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence             01100  1123445667899999999999999999     999998875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.3e-40  Score=350.56  Aligned_cols=254  Identities=20%  Similarity=0.304  Sum_probs=203.7

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ..++|++.+.||+|+||+||++..+ +++.||+|++.....    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3467999999999999999999975 689999998865322    245688888888 7999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC----CcEEEeccCCccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK----YRAKVSDFGASRS  548 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFgl~~~  548 (684)
                      ||+++|+|.+++.+..   .+++..++.++.||+.||+|||+++   |+||||||+|||+.++    +.+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            9999999999998654   3899999999999999999999999   9999999999998543    3599999999987


Q ss_pred             cccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........+..    .+.....    
T Consensus       170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i~~~~~----  240 (342)
T 2qr7_A          170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RIGSGKF----  240 (342)
T ss_dssp             CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HHHHCCC----
T ss_pred             CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HHccCCc----
Confidence            544332 2334568999999999988889999999999999999999999997543222111111    1111100    


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                        ..........+.++.+|+.+||+.||++|||+.|++++-
T Consensus       241 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             --CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             --ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence              011112245677899999999999999999999998864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.2e-40  Score=340.21  Aligned_cols=252  Identities=26%  Similarity=0.351  Sum_probs=199.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|.+.++||+|+||+||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46999999999999999999964 68899999876532 33467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCcEEEeccCCccccc
Q 043157          475 IPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       475 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgl~~~~~  550 (684)
                      +++++|.+++.... ....+++..++.++.|++.||+|||+++   |+||||||+|||+   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999999996531 2234999999999999999999999999   9999999999999   456789999999997654


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ...  ......||+.|+|||++. ..++.++||||||+++|||++|+.||......+.....       .      ....
T Consensus       179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~-------~------~~~~  242 (285)
T 3is5_A          179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-------T------YKEP  242 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------H------HCCC
T ss_pred             Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh-------c------cCCc
Confidence            322  233456899999999985 56889999999999999999999999865433211100       0      0000


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .. .......+.++.+|+.+||+.||++|||++|++++
T Consensus       243 ~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          243 NY-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CC-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cc-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00 00112245678899999999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-39  Score=361.71  Aligned_cols=265  Identities=24%  Similarity=0.329  Sum_probs=190.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec-----Cc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLET-----EV  467 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~  467 (684)
                      .++|++.++||+|+||+||++... +++.||||++..  .+....+.+.+|+++|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999865 789999998754  3455678899999999999999999999999543     46


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .++||||+ +++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            79999998 579999998653   4999999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCc--------------------------eeeecccccCCCCCcccc-ccCCCCCccchhhhHHHHHHHHh-----
Q 043157          548 SMAVDQT--------------------------HMTTQVHGTFGYLDPEYF-RSSQFTDKSDVYSFGVVLAELLT-----  595 (684)
Q Consensus       548 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~SlGvil~ellt-----  595 (684)
                      .......                          .......||+.|+|||++ ....++.++|||||||+||||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            7642211                          123345689999999976 56679999999999999999999     


Q ss_pred             ------CCCCCCCCChh------------------hhhhHHHHHHHHhhhh---h--------hhhhhh---h---hhhc
Q 043157          596 ------GEKPIRFTTLE------------------EDKSLAAYFLFAMKEE---R--------LFEILD---A---RVMK  634 (684)
Q Consensus       596 ------G~~P~~~~~~~------------------~~~~l~~~~~~~~~~~---~--------~~~~~d---~---~~~~  634 (684)
                            |+++|.+....                  ....+.. +.......   .        ....+.   .   ....
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNV-IFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHH-HHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHH-HHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                  66666543210                  0011111 11111000   0        000000   0   0001


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      +.....+.++.+|+.+||+.||++|||++|++++
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1123346789999999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.9e-40  Score=350.27  Aligned_cols=266  Identities=24%  Similarity=0.360  Sum_probs=203.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357999999999999999999975 5899999987543  3444667889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++....   .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999988876543   3899999999999999999999999   999999999999999999999999999765433


Q ss_pred             CceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH--------Hhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF--------AMKEER  623 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~--------~~~~~~  623 (684)
                      .. ......|++.|+|||++.+. .++.++||||||+++|||++|+.||......+..........        ......
T Consensus       178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            22 23344589999999998775 789999999999999999999999986654332111110000        000000


Q ss_pred             h------hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          624 L------FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       624 ~------~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .      .+..............+..+.+|+.+||+.||++|||++|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0      00000000011112456789999999999999999999999875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-39  Score=336.55  Aligned_cols=247  Identities=25%  Similarity=0.360  Sum_probs=207.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56999999999999999999975 67899999875422   223467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            9999999999998764   3899999999999999999999999   999999999999999999999999998755432


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .   .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+..               ..+...  
T Consensus       168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------------~~~~~~--  227 (284)
T 2vgo_A          168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH---------------RRIVNV--  227 (284)
T ss_dssp             C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------------HHHHTT--
T ss_pred             c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH---------------HHHhcc--
Confidence            2   23456899999999999999999999999999999999999999755432211               011111  


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ....+...+..+.+|+.+||+.||++|||++|++++-
T Consensus       228 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~  264 (284)
T 2vgo_A          228 DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP  264 (284)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred             ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence            1122345567899999999999999999999999853

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3e-40  Score=350.87  Aligned_cols=243  Identities=24%  Similarity=0.341  Sum_probs=204.6

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC--------hhHHHHHHHHHHHHhhcCCCcccceeeeeeec
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID--------ESKVEEFINEMVILSQINHRNVVKLLGCCLET  465 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  465 (684)
                      ..++|++.+.||+|+||+||++.. .+++.||||++....        ....+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            456799999999999999999995 478999999876532        12345678899999999999999999999999


Q ss_pred             CcceEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          466 EVPLLVYEFIPNG-TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       466 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                      +..++||||+..| +|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 9999998654   3999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCceeeecccccCCCCCccccccCCC-CCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhh
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER  623 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~  623 (684)
                      +++.......  .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....                  
T Consensus       176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------  235 (335)
T 3dls_A          176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------  235 (335)
T ss_dssp             TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------
T ss_pred             cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------
Confidence            9987654332  234568999999999988776 7899999999999999999999963210                  


Q ss_pred             hhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          624 LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       624 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                         .....  ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus       236 ---~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 ---TVEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---GTTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---HHhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00100  11123356789999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.3e-40  Score=357.59  Aligned_cols=243  Identities=14%  Similarity=0.162  Sum_probs=193.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc---cChhHHHHHHHHH---HHHhhcCCCccccee-------ee
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV---IDESKVEEFINEM---VILSQINHRNVVKLL-------GC  461 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~HpnIv~l~-------~~  461 (684)
                      .++|++.+.||+|+||+||+|.+ .+++.||||++..   ......+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46789999999999999999996 5699999998863   3455678899999   455555899999998       55


Q ss_pred             eeecC-----------------cceEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 043157          462 CLETE-----------------VPLLVYEFIPNGTLFQYIHDQNE----DFPITWEMRLRIAIEVSGALSYLHSAASIPI  520 (684)
Q Consensus       462 ~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i  520 (684)
                      +.+.+                 ..+|||||+ +|+|.+++.....    ...+++..++.++.||+.||+|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            54443                 278999999 6899999986421    112446888899999999999999999   9


Q ss_pred             EecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecccccCCCCCccccccC-----------CCCCccchhhhHHH
Q 043157          521 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-----------QFTDKSDVYSFGVV  589 (684)
Q Consensus       521 iH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDv~SlGvi  589 (684)
                      +||||||+||||+.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++||||||++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999985322    3344567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          590 LAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       590 l~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ||||++|+.||........               ...+.      ......+.++.+|+.+||+.||++|||+.|++++
T Consensus       303 l~elltg~~Pf~~~~~~~~---------------~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGG---------------SEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHSSCCC------CC---------------SGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHCCCCCcccccccc---------------hhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            9999999999964332110               11111      1123456789999999999999999999999873

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-39  Score=348.52  Aligned_cols=266  Identities=22%  Similarity=0.297  Sum_probs=203.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeec--------
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLET--------  465 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------  465 (684)
                      ++|++.+.||+|+||+||++.. .+++.||+|++....  ......+.+|++++++++||||+++++++.+.        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5799999999999999999997 478999999875432  23356788999999999999999999999874        


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                      +..++||||+++ +|.+.+.....  .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            457899999975 88888876533  3899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccC---CceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 043157          546 SRSMAVD---QTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE  621 (684)
Q Consensus       546 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~  621 (684)
                      ++.....   .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+..............
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9865422   2222344568999999999876 55899999999999999999999999876543322221111110111


Q ss_pred             hhhhhhhhhhhhcc--------CC-h------hHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          622 ERLFEILDARVMKE--------SG-G------DEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       622 ~~~~~~~d~~~~~~--------~~-~------~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ......-.......        .. .      ..+..+.+|+.+||+.||++|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            10000000000000        00 0      114568899999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-39  Score=354.14  Aligned_cols=252  Identities=21%  Similarity=0.297  Sum_probs=194.3

Q ss_pred             cCCCcC-ceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhh-cCCCcccceeeeeee----cCcce
Q 043157          397 DNFNLN-RILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQ-INHRNVVKLLGCCLE----TEVPL  469 (684)
Q Consensus       397 ~~~~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~----~~~~~  469 (684)
                      ++|.+. ++||+|+||+||++... +++.||||+++..     ..+.+|++++.+ .+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 78999999999999965 6899999988632     456788888754 489999999999875    56789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCcEEEeccCCc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGAS  546 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgl~  546 (684)
                      |||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+||||+.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999987532 35999999999999999999999999   999999999999997   789999999999


Q ss_pred             cccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhh-hHHHHHHHHhhhhhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK-SLAAYFLFAMKEERLF  625 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~-~l~~~~~~~~~~~~~~  625 (684)
                      +......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .....    +..... 
T Consensus       212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~-  284 (400)
T 1nxk_A          212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQY-  284 (400)
T ss_dssp             EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCC-
T ss_pred             cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCcc-
Confidence            8654322  233456899999999999999999999999999999999999999755432211 01000    000000 


Q ss_pred             hhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       626 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                           ..........+.++.+|+.+||+.||++|||++|++++-
T Consensus       285 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          285 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             -----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                 000111234567899999999999999999999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-39  Score=348.32  Aligned_cols=269  Identities=23%  Similarity=0.298  Sum_probs=204.1

Q ss_pred             HHHHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEecccc-----------ChhHHHHHHHHHHHHhhcCCCcccc
Q 043157          389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVI-----------DESKVEEFINEMVILSQINHRNVVK  457 (684)
Q Consensus       389 ~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~HpnIv~  457 (684)
                      ..++....++|++.+.||+|+||+||++...+++.||||++...           +....+.+.+|++++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            46778888999999999999999999999888999999987532           2334578999999999999999999


Q ss_pred             eeeeeeecC-----cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 043157          458 LLGCCLETE-----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL  532 (684)
Q Consensus       458 l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl  532 (684)
                      +++++...+     ..++||||++ |+|.+++....  ..+++..++.++.||+.||+|||+++   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            999996433     4689999997 68988888643  34899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeccCCccccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhH
Q 043157          533 DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSL  611 (684)
Q Consensus       533 ~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l  611 (684)
                      +.++.+||+|||+++......  ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999997543222  2334468999999999876 6789999999999999999999999986654322111


Q ss_pred             HHHHHHHhhhhh-----------hhhhhhhhh-------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          612 AAYFLFAMKEER-----------LFEILDARV-------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       612 ~~~~~~~~~~~~-----------~~~~~d~~~-------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                         .........           ..+.+....       ........+..+.+|+.+||+.||++|||++|++++
T Consensus       246 ---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          246 ---IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             ---HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence               111111110           011110000       011123346679999999999999999999999976

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.2e-39  Score=358.46  Aligned_cols=267  Identities=20%  Similarity=0.281  Sum_probs=212.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCC-CcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINH-RNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .++|++.++||+|+||+||++.+ .+++.||||+......  .+++.+|+++++.++| +++..+..+..+.+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46799999999999999999996 5789999998664322  2457899999999987 555566666677778899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCcEEEeccCCccccc
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgl~~~~~  550 (684)
                      |+ +++|.+++.....  .+++..++.|+.||+.||+|||+++   |+||||||+||||   +.++.+||+|||+++...
T Consensus        84 ~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 9999999986543  3999999999999999999999999   9999999999999   588999999999998765


Q ss_pred             cCCce------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          551 VDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       551 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      .....      ......||+.|+|||++.+..++.++||||||++||||++|+.||................    ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~----~~~~  233 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS----EKKV  233 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH----HHHH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh----hccc
Confidence            43322      1225569999999999999999999999999999999999999998654433222211111    1111


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCC
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGAS  679 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~  679 (684)
                      ...+     .......+.++.+|+.+||+.||++||++++|++.|+.+....+..
T Consensus       234 ~~~~-----~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~  283 (483)
T 3sv0_A          234 ATSI-----EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ  283 (483)
T ss_dssp             HSCH-----HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             cccH-----HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence            1101     1111244678999999999999999999999999999998765543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.4e-39  Score=335.22  Aligned_cols=250  Identities=22%  Similarity=0.388  Sum_probs=201.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec----Ccce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLET----EVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----~~~~  469 (684)
                      ..|++.+.||+|+||+||+|... ++..||+|++..  ......+.+.+|+.++++++||||+++++++...    ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34788899999999999999864 678999998764  3456678899999999999999999999998753    4579


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCcEEEeccCCccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRS  548 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgl~~~  548 (684)
                      +||||+++++|.+++....   .+++..++.++.|++.||+|||+.+. +|+||||||+|||++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999998754   38999999999999999999999862 499999999999998 789999999999975


Q ss_pred             cccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ....   ......||+.|+|||++. ..++.++||||||+++|+|++|+.||........  .   . ....        
T Consensus       182 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~---~-~~~~--------  243 (290)
T 1t4h_A          182 KRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I---Y-RRVT--------  243 (290)
T ss_dssp             CCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H---H-HHHT--------
T ss_pred             cccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--H---H-HHHh--------
Confidence            4332   223446899999999886 4589999999999999999999999975332211  0   0 0011        


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ........+...+.++.+|+.+||+.||++|||++|++++
T Consensus       244 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            0001111223344679999999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-39  Score=373.84  Aligned_cols=264  Identities=25%  Similarity=0.389  Sum_probs=213.1

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeC----CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLP----DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLET  465 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  465 (684)
                      +.+...++|++.+.||+|+||+||+|.+.    .+..||+|+.+.. .....+.+.+|+.++++++||||+++++++. +
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            34445577999999999999999999864    2467999988753 4455678999999999999999999999985 4


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                      +..++||||+++|+|.++++....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence            668999999999999999986543  4899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      ++..............+++.|+|||++....++.++||||||+++|||++ |..||......+.   .            
T Consensus       538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~------------  602 (656)
T 2j0j_A          538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I------------  602 (656)
T ss_dssp             CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H------------
T ss_pred             CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---H------------
Confidence            98765444333344457789999999998899999999999999999997 9999975543221   0            


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                       ..+........+...+..+.+|+.+||+.||++|||+.|+++.|+++...+
T Consensus       603 -~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          603 -GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             -HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -HHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence             011111112234556778999999999999999999999999999987543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=346.93  Aligned_cols=260  Identities=17%  Similarity=0.217  Sum_probs=210.3

Q ss_pred             HHHHHHhcCCCcCceeceeCcEEEEEEE------eCCCcEEEEEeccccChhHHHHHHHHHHHHhhcC---CCcccceee
Q 043157          390 KELERATDNFNLNRILGQGGQGTVYKGM------LPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN---HRNVVKLLG  460 (684)
Q Consensus       390 ~e~~~~~~~~~~~~~LG~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~  460 (684)
                      .+++...++|.+.++||+|+||+||+|.      ..+++.||||++....   ..++.+|++++++++   |+||+++++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            3444456789999999999999999994      4468899999987543   346777888887776   999999999


Q ss_pred             eeeecCcceEEEEecCCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC----
Q 043157          461 CCLETEVPLLVYEFIPNGTLFQYIHDQN--EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD----  534 (684)
Q Consensus       461 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~----  534 (684)
                      ++...+..++||||+++|+|.++++...  ....+++..++.++.||+.||+|||+++   |+||||||+||||+.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence            9999999999999999999999998532  2335999999999999999999999999   999999999999998    


Q ss_pred             -------CCcEEEeccCCccccc-cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChh
Q 043157          535 -------KYRAKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLE  606 (684)
Q Consensus       535 -------~~~~kl~DFgl~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~  606 (684)
                             ++.+||+|||+++... ...........||+.|+|||++.+..++.++||||||+++|||+||+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   8999999999997653 22333445567999999999999999999999999999999999999998632211


Q ss_pred             hhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHhhHhhc
Q 043157          607 EDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKR-PTMREVTSELAGIKAWN  676 (684)
Q Consensus       607 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R-Pt~~evl~~L~~i~~~~  676 (684)
                      .              ..+...+     ..  ......+.+++.+||+.+|.+| |+++++.+.|+.+...+
T Consensus       292 ~--------------~~~~~~~-----~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          292 E--------------CKPEGLF-----RR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             E--------------EEECSCC-----TT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             c--------------eeechhc-----cc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            1              0000000     00  1235568899999999999999 78999999998877654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.4e-40  Score=358.18  Aligned_cols=254  Identities=24%  Similarity=0.333  Sum_probs=193.7

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--------hhHHHHHHHHHHHHhhcCCCcccceeeeeee
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--------ESKVEEFINEMVILSQINHRNVVKLLGCCLE  464 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  464 (684)
                      ...++|.+.+.||+|+||+||+|... +++.||||++....        ......+.+|+.+|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            35678999999999999999999865 68999999875421        222345889999999999999999999975 


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC---CcEEEe
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVS  541 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~  541 (684)
                      .+..++||||+++|+|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.+   ..+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            455799999999999999987653   4899999999999999999999999   9999999999999654   459999


Q ss_pred             ccCCccccccCCceeeecccccCCCCCcccccc---CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH
Q 043157          542 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA  618 (684)
Q Consensus       542 DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~  618 (684)
                      |||+++.....  .......||+.|+|||++..   ..++.++||||||+++|||++|+.||........  +...    
T Consensus       285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~----  356 (419)
T 3i6u_A          285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ----  356 (419)
T ss_dssp             CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHH----
T ss_pred             ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHH----
Confidence            99999875432  23345669999999999853   6688899999999999999999999975432211  1110    


Q ss_pred             hhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          619 MKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       619 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ....... .     ........+..+.+|+.+||+.||++|||++|++++
T Consensus       357 i~~~~~~-~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          357 ITSGKYN-F-----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHTTCCC-C-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCCCC-C-----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0110000 0     000112346678999999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.8e-39  Score=346.42  Aligned_cols=265  Identities=21%  Similarity=0.290  Sum_probs=205.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec-----Ccc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLET-----EVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~  468 (684)
                      .++|++.+.||+|+||+||++... +++.||||++... .....+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999965 6889999988653 345567899999999999999999999999754     357


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||++ ++|.+++...    .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            89999997 5999999764    3899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCce--eeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh
Q 043157          549 MAVDQTH--MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF  625 (684)
Q Consensus       549 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  625 (684)
                      .......  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+................+.
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            6533222  1234568999999998654 458999999999999999999999998665433221111000000000000


Q ss_pred             h--------hhhhh------hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          626 E--------ILDAR------VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       626 ~--------~~d~~------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .        .....      .........+.++.+|+.+||+.||++|||++|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0        00000      0011113346789999999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=339.37  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=202.8

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ...++|++.+.||+|+||+||++... +++.||+|++....  ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34568999999999999999999975 58999999886532  3467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++++|.+++.....  .+++..++.++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999999975433  4899999999999999999999999   999999999999999999999999999765433


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.........     .  .....       ...
T Consensus       179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~--~~~~~-------~~~  243 (314)
T 3com_A          179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-----F--MIPTN-------PPP  243 (314)
T ss_dssp             BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----H--HHHHS-------CCC
T ss_pred             cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-----H--HHhcC-------CCc
Confidence            22 233446899999999999999999999999999999999999999754322110     0  00000       000


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            111223456789999999999999999999999874

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.4e-39  Score=354.88  Aligned_cols=265  Identities=22%  Similarity=0.294  Sum_probs=199.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec-----Cc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLET-----EV  467 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~  467 (684)
                      .++|++.+.||+|+||+||++... +++.||||++..  ......+.+.+|+++|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999965 688999998865  3455678899999999999999999999999876     56


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .++||||++ ++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 69999998653   4999999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCc---------------------eeeecccccCCCCCcccc-ccCCCCCccchhhhHHHHHHHHhCCCCCC----
Q 043157          548 SMAVDQT---------------------HMTTQVHGTFGYLDPEYF-RSSQFTDKSDVYSFGVVLAELLTGEKPIR----  601 (684)
Q Consensus       548 ~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~SlGvil~elltG~~P~~----  601 (684)
                      .......                     .......||+.|+|||++ ....++.++||||||+++|||++|..||.    
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            7643321                     123456789999999986 56679999999999999999998554443    


Q ss_pred             -------CCChh---------------hhhhHHHHHHHHhhh-----------hhhhhhhhhhh------hccCChhHHH
Q 043157          602 -------FTTLE---------------EDKSLAAYFLFAMKE-----------ERLFEILDARV------MKESGGDEII  642 (684)
Q Consensus       602 -------~~~~~---------------~~~~l~~~~~~~~~~-----------~~~~~~~d~~~------~~~~~~~~~~  642 (684)
                             ....-               ....+.. +......           ....+.+....      ........+.
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  336 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNI-IFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD  336 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHH-HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHH-HHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence                   22100               0001111 1111100           01111110000      0001123567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          643 TFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       643 ~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ++.+|+.+||+.||++|||++|++++
T Consensus       337 ~~~dLl~~mL~~dP~~R~ta~e~L~H  362 (432)
T 3n9x_A          337 DGINLLESMLKFNPNKRITIDQALDH  362 (432)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            89999999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.7e-39  Score=345.85  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=207.3

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--------hhHHHHHHHHHHHHhhc-CCCcccceee
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--------ESKVEEFINEMVILSQI-NHRNVVKLLG  460 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~HpnIv~l~~  460 (684)
                      ......++|++.+.||+|+||.||++.+. +|+.||||++....        ....+.+.+|+.+++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34455678999999999999999999975 79999999875432        12246788999999999 7999999999


Q ss_pred             eeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEE
Q 043157          461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV  540 (684)
Q Consensus       461 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl  540 (684)
                      ++......++||||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999998654   3899999999999999999999999   999999999999999999999


Q ss_pred             eccCCccccccCCceeeecccccCCCCCcccccc------CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHH
Q 043157          541 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY  614 (684)
Q Consensus       541 ~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~  614 (684)
                      +|||++.......  ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||........   .. 
T Consensus       242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~-  315 (365)
T 2y7j_A          242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM---LR-  315 (365)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH-
T ss_pred             EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH---HH-
Confidence            9999998664332  2334569999999999863      3588899999999999999999999975432211   00 


Q ss_pred             HHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          615 FLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       615 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                         .+..... ....+     .....+..+.+|+.+||+.||++|||++|++++
T Consensus       316 ---~i~~~~~-~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          316 ---MIMEGQY-QFSSP-----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             ---HHHHTCC-CCCHH-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---HHHhCCC-CCCCc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence               0100000 00000     002345678999999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=8e-40  Score=341.69  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=202.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            457999999999999999999976 5899999998776666778999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++++|.+++.....  .+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++....... 
T Consensus        98 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           98 CPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             CTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             CCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            999999999987543  3899999999999999999999999   9999999999999999999999999875432111 


Q ss_pred             eeeecccccCCCCCcccc-----ccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          555 HMTTQVHGTFGYLDPEYF-----RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~-----~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      .......|++.|+|||++     ....++.++||||||+++|+|++|+.||........  +    .......       
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~-------  238 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L----LKIAKSD-------  238 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----HHHHHSC-------
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--H----HHHhccC-------
Confidence            112334589999999998     466789999999999999999999999975443211  0    0000000       


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       ......+...+..+.+|+.+||+.||++|||++|++++
T Consensus       239 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          239 -PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             00011224456789999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.7e-39  Score=333.12  Aligned_cols=248  Identities=25%  Similarity=0.358  Sum_probs=199.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.+.||+|+||+||++... +++.||||.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            357999999999999999999976 78999999876432   23356789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||+++   |+|+||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999998764   3899999999999999999999999   99999999999999999999999999976543


Q ss_pred             CCceeeecccccCCCCCccccccCCC-CCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ..  ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||........   ..    .....        
T Consensus       164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~----~~~~~--------  226 (276)
T 2h6d_A          164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FK----KIRGG--------  226 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHC--------
T ss_pred             Cc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HH----HhhcC--------
Confidence            22  2233458999999999987765 6899999999999999999999975432211   00    00000        


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        ....+...+..+.+|+.+||+.||++|||++|++++
T Consensus       227 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          227 --VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              011233456779999999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.9e-39  Score=362.37  Aligned_cols=254  Identities=23%  Similarity=0.301  Sum_probs=208.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|.+.++||+|+||+||++... +|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67889999999999999999975 69999999886422   233567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQNE-DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      ||+++|+|.+++..... ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999986532 335999999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........  .....         ..++.. 
T Consensus       342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~---------~~i~~~-  408 (543)
T 3c4z_A          342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELK---------QRVLEQ-  408 (543)
T ss_dssp             TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHH---------HHHHHC-
T ss_pred             CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHH---------HHHhhc-
Confidence            332 23345799999999999999999999999999999999999999975432111  01100         011111 


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTM-----REVTS  667 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~-----~evl~  667 (684)
                       ....+...+.++.+|+.+||+.||++||++     +|+++
T Consensus       409 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 -AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence             112345667889999999999999999975     56654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.4e-39  Score=337.68  Aligned_cols=253  Identities=23%  Similarity=0.365  Sum_probs=191.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc-C-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI-D-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .++|++.+.||+|+||+||++.. .+++.||+|++... . ....+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46799999999999999999996 47899999988653 2 233344555666688889999999999999999999999


Q ss_pred             EecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          473 EFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       473 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||++ |+|.+++... .....+++..++.++.|++.||+|||++ +   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 5888887652 1223599999999999999999999998 8   9999999999999999999999999997654


Q ss_pred             cCCceeeecccccCCCCCcccc----ccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYF----RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ....  .....||+.|+|||++    ....++.++||||||+++|||++|+.||........              .+..
T Consensus       162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~  225 (290)
T 3fme_A          162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ--------------QLKQ  225 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH--------------HHHH
T ss_pred             cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH--------------HHHH
Confidence            3322  2334589999999996    566789999999999999999999999974332211              0111


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..............+.++.+|+.+||+.||++|||++|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          226 VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            111111112223566789999999999999999999999984

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.2e-39  Score=374.58  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=209.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcce
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~  469 (684)
                      ..++|++.++||+|+||+||++... +++.||||+++..   .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4568999999999999999999965 6889999987642   234457788999999988 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      |||||+++|+|.++++...   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999999764   3999999999999999999999999   999999999999999999999999999864


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ..... ......||+.|+|||++.+..++.++||||||++||||++|+.||...+..+..               ..++.
T Consensus       493 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~---------------~~i~~  556 (674)
T 3pfq_A          493 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---------------QSIME  556 (674)
T ss_dssp             CCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------------HHHHS
T ss_pred             ccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH---------------HHHHh
Confidence            33322 344567999999999999999999999999999999999999999865432210               11111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTM-----REVTSE  668 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~-----~evl~~  668 (684)
                      ..  ...+...+.++.+|+.+||+.||++||++     +||+++
T Consensus       557 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          557 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             SC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             CC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            11  12345667889999999999999999998     666653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-39  Score=343.37  Aligned_cols=260  Identities=23%  Similarity=0.292  Sum_probs=207.9

Q ss_pred             HHHHHHhcCCCcC-ceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhc-CCCcccceeeeeee
Q 043157          390 KELERATDNFNLN-RILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQI-NHRNVVKLLGCCLE  464 (684)
Q Consensus       390 ~e~~~~~~~~~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~  464 (684)
                      +..+...++|.+. +.||+|+||+||++... +++.||+|++...  .......+.+|+.+++++ +||||+++++++.+
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3445556678777 89999999999999965 6899999987642  233467899999999999 56999999999999


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCcEEEe
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVS  541 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~  541 (684)
                      .+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++   |+||||||+|||++.   ++.+||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence            999999999999999999986542 235999999999999999999999999   999999999999987   7899999


Q ss_pred             ccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 043157          542 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE  621 (684)
Q Consensus       542 DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~  621 (684)
                      |||+++......  ......||+.|+|||++....++.++||||||+++|||++|+.||......+....       .. 
T Consensus       177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-------i~-  246 (327)
T 3lm5_A          177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-------IS-  246 (327)
T ss_dssp             CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HH-
T ss_pred             eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-------HH-
Confidence            999998654322  22345689999999999999999999999999999999999999976543321100       00 


Q ss_pred             hhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       622 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           ..............+..+.+|+.+||+.||++|||++|++++
T Consensus       247 -----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          247 -----QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -----HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -----hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                 000111122224566789999999999999999999999876

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.1e-39  Score=339.51  Aligned_cols=256  Identities=23%  Similarity=0.323  Sum_probs=202.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcC-CCcccceeeeeee--cCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVVKLLGCCLE--TEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~--~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++.. .+++.||||+++...   .+.+.+|++++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            5799999999999999999985 578999999987433   467889999999997 9999999999987  56789999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-cEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgl~~~~~~  551 (684)
                      ||+++++|.+++..      +++..++.++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       113 e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999999853      789999999999999999999999   99999999999999766 899999999986543


Q ss_pred             CCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ...  .....|+..|+|||++.+ ..++.++||||||+++|||++|+.||....... ..+... ........+.+.++.
T Consensus       184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~-~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRI-AKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHH-HHHHCHHHHHHHHHH
T ss_pred             CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHH-HHhcCCchhhhHHHH
Confidence            322  233468999999999877 678999999999999999999999996443221 111111 111111111111111


Q ss_pred             h-----------------------hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 R-----------------------VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ~-----------------------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .                       .........+.++.+|+.+||+.||++|||++|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0                       0011112357889999999999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1e-38  Score=338.19  Aligned_cols=263  Identities=22%  Similarity=0.331  Sum_probs=207.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe--CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCc------ccceeeeeeecCc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML--PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN------VVKLLGCCLETEV  467 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~~  467 (684)
                      .++|++.+.||+|+||+||++..  .+++.||||+++.. ....+.+.+|+++++.++|++      ++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            45799999999999999999986  36889999998743 345678889999999987654      9999999999999


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-------------
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-------------  534 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-------------  534 (684)
                      .++||||+ +++|.+++..... .++++..++.++.||+.||+|||+++   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 8999999987643 35899999999999999999999999   999999999999987             


Q ss_pred             ------CCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhh
Q 043157          535 ------KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED  608 (684)
Q Consensus       535 ------~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~  608 (684)
                            ++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+.
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                  668999999999764322    2344689999999999999999999999999999999999999987654432


Q ss_pred             hhHHHHHHHHhhhhhhh--------------------------hhhhh-hhhccCChhHHHHHHHHHHHhhccCCCCCCC
Q 043157          609 KSLAAYFLFAMKEERLF--------------------------EILDA-RVMKESGGDEIITFAKVAKRCLNLNGKKRPT  661 (684)
Q Consensus       609 ~~l~~~~~~~~~~~~~~--------------------------~~~d~-~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt  661 (684)
                      ...............+.                          +...+ ..........+.++.+|+.+||+.||++|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            22111110000000000                          00000 0001123456788999999999999999999


Q ss_pred             HHHHHHH
Q 043157          662 MREVTSE  668 (684)
Q Consensus       662 ~~evl~~  668 (684)
                      ++|++++
T Consensus       323 ~~ell~h  329 (339)
T 1z57_A          323 LREALKH  329 (339)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999876

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=341.75  Aligned_cols=262  Identities=24%  Similarity=0.340  Sum_probs=199.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeee-----------
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCL-----------  463 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----------  463 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++...+....+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367999999999999999999976 58999999988777778889999999999999999999999874           


Q ss_pred             ---ecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCcEE
Q 043157          464 ---ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAK  539 (684)
Q Consensus       464 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~k  539 (684)
                         +....++||||++ |+|.+++.+.    ++++..++.++.|++.||+|||+++   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3456789999997 6999999753    3899999999999999999999999   99999999999997 567999


Q ss_pred             EeccCCccccccCCc--eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH
Q 043157          540 VSDFGASRSMAVDQT--HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL  616 (684)
Q Consensus       540 l~DFgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~  616 (684)
                      |+|||+++.......  .......++..|+|||.+.. ..++.++||||||+++|||++|+.||......+....   ..
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~---~~  238 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL---IL  238 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH---HH
Confidence            999999987543221  12233457899999998865 6789999999999999999999999986654322111   11


Q ss_pred             HHhh---hhhhhhh-------hhhhh------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          617 FAMK---EERLFEI-------LDARV------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       617 ~~~~---~~~~~~~-------~d~~~------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ....   .....+.       +....      ........+.++.+|+.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            1100   0000000       00000      011123456789999999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.7e-39  Score=333.60  Aligned_cols=254  Identities=26%  Similarity=0.373  Sum_probs=206.8

Q ss_pred             HHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---------hhHHHHHHHHHHHHhhcC-CCcccceeeee
Q 043157          394 RATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---------ESKVEEFINEMVILSQIN-HRNVVKLLGCC  462 (684)
Q Consensus       394 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~  462 (684)
                      ...++|++.+.||+|+||+||++... +++.||||++....         ....+.+.+|+++++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999975 68999999876432         233567889999999995 99999999999


Q ss_pred             eecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEec
Q 043157          463 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD  542 (684)
Q Consensus       463 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D  542 (684)
                      .+....++||||+++++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence            99999999999999999999998753   3899999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCceeeecccccCCCCCccccc------cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH
Q 043157          543 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFR------SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL  616 (684)
Q Consensus       543 Fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~  616 (684)
                      ||++.......  ......|++.|+|||++.      ...++.++||||||+++|||++|+.||......+.   ..   
T Consensus       168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~---  239 (298)
T 1phk_A          168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---LR---  239 (298)
T ss_dssp             CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---
T ss_pred             ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH---HH---
Confidence            99998654332  233456899999999985      45688999999999999999999999975443221   00   


Q ss_pred             HHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       617 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       .......      ..........+..+.+|+.+||+.||++|||++|++++
T Consensus       240 -~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          240 -MIMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             -HHHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -HHhcCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence             0000000      00011123566789999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.7e-40  Score=354.43  Aligned_cols=255  Identities=13%  Similarity=0.073  Sum_probs=186.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC---hhHHHHHHHHHHHHhhc--CCCccccee-------eee
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID---ESKVEEFINEMVILSQI--NHRNVVKLL-------GCC  462 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~HpnIv~l~-------~~~  462 (684)
                      ..+|++.+.||+|+||+||++.+. +++.||||++....   ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            456899999999999999999965 78999999887643   34566778886555555  699988755       344


Q ss_pred             eec-----------------CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 043157          463 LET-----------------EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMR------LRIAIEVSGALSYLHSAASIP  519 (684)
Q Consensus       463 ~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~aL~yLH~~~~~~  519 (684)
                      ...                 ...+|||||++ |+|.+++......  +++..+      +.++.||+.||+|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--YVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--cchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            332                 23699999998 8999999875322  455556      788899999999999999   


Q ss_pred             eEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecccccCCCCCcccccc--CCCCCccchhhhHHHHHHHHhCC
Q 043157          520 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLAELLTGE  597 (684)
Q Consensus       520 iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltG~  597 (684)
                      |+||||||+||||+.++.+||+|||+++....    ......+|+.|+|||++.+  ..++.++||||||++||||++|+
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999986532    1223457799999999987  67999999999999999999999


Q ss_pred             CCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          598 KPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       598 ~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .||..........        ......................+..+.+|+.+||+.||++|||+.|++++
T Consensus       291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9998553321110        00000001111111111223567889999999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.4e-40  Score=341.34  Aligned_cols=266  Identities=24%  Similarity=0.372  Sum_probs=190.2

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ....++|++.+.||+|+||+||++... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            344578999999999999999999854 68899999876533 3446778999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          471 VYEFIPNGTLFQYIHDQ-----NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                      ||||+++++|.+++...     .....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999999751     12235899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCc----eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh
Q 043157          546 SRSMAVDQT----HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK  620 (684)
Q Consensus       546 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~  620 (684)
                      +........    .......||+.|+|||++.. ..++.++||||||+++|||++|+.||.........   .   ....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~---~~~~  241 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---M---LTLQ  241 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---H---HHHT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---H---HHhc
Confidence            876543221    12234568999999999876 56899999999999999999999999765432211   0   0011


Q ss_pred             hhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          621 EERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       621 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .. .................+.++.+|+.+||+.||++|||++|++++
T Consensus       242 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          242 ND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             SS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00 000000001112223456789999999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.3e-39  Score=358.83  Aligned_cols=252  Identities=24%  Similarity=0.338  Sum_probs=204.9

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .++|++.++||+|+||+||++... +++.||||++...  .....+.+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            456999999999999999999975 7899999987542  2334678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC---CCCcEEEeccCCcccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSM  549 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFgl~~~~  549 (684)
                      ||+++++|.+.+....   .+++..++.++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+++..
T Consensus       101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999999998764   3899999999999999999999999   99999999999995   4567999999999865


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ....  ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+..   .    .+......    
T Consensus       175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~----~i~~~~~~----  240 (486)
T 3mwu_A          175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---K----RVETGKYA----  240 (486)
T ss_dssp             CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHTCCC----
T ss_pred             CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHHhCCCC----
Confidence            4332  2334569999999999875 5899999999999999999999999765432211   0    01111000    


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                        .........+.++.+|+.+||+.||++|||+.|++++-
T Consensus       241 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp  278 (486)
T 3mwu_A          241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (486)
T ss_dssp             --SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred             --CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence              00111234567899999999999999999999999863

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.6e-39  Score=351.61  Aligned_cols=263  Identities=23%  Similarity=0.287  Sum_probs=206.0

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhc------CCCcccceeeeeeecCc
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQI------NHRNVVKLLGCCLETEV  467 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~~~~~~~~~  467 (684)
                      ...+|++.++||+|+||+||++... +++.||||+++.. ....+++.+|+++++.+      +|+||+++++++.....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            3467999999999999999999865 5899999998753 44456788899888887      57799999999999999


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc--EEEeccCC
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR--AKVSDFGA  545 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFgl  545 (684)
                      .++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.  +||+|||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence            999999996 699999987543 24899999999999999999999999   999999999999999887  99999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH-hhhhhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA-MKEERL  624 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~-~~~~~~  624 (684)
                      +......    .....||+.|+|||++.+..++.++||||||++||||++|++||......+.  +....... .....+
T Consensus       249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~--l~~i~~~~~~p~~~~  322 (429)
T 3kvw_A          249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ--LACMIELLGMPSQKL  322 (429)
T ss_dssp             CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred             ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCCHHH
Confidence            9754322    2345689999999999999999999999999999999999999986654332  22111110 000110


Q ss_pred             -------hhhhhhh------------------------------------hhccCChhHHHHHHHHHHHhhccCCCCCCC
Q 043157          625 -------FEILDAR------------------------------------VMKESGGDEIITFAKVAKRCLNLNGKKRPT  661 (684)
Q Consensus       625 -------~~~~d~~------------------------------------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt  661 (684)
                             ...++..                                    +........+..+.+|+.+||+.||++|||
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt  402 (429)
T 3kvw_A          323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT  402 (429)
T ss_dssp             HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence                   0011000                                    000011122567899999999999999999


Q ss_pred             HHHHHHHH
Q 043157          662 MREVTSEL  669 (684)
Q Consensus       662 ~~evl~~L  669 (684)
                      ++|++++-
T Consensus       403 a~e~L~Hp  410 (429)
T 3kvw_A          403 PGQALRHP  410 (429)
T ss_dssp             HHHHHTST
T ss_pred             HHHHhCCh
Confidence            99999863

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.9e-39  Score=349.02  Aligned_cols=261  Identities=23%  Similarity=0.297  Sum_probs=187.7

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec------C
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLET------E  466 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~  466 (684)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++..  ......+.+.+|++++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999985 4789999999864  3455677899999999999999999999998754      4


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..++|+|++ +++|.+++...    .+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 78999998753    3999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH-------
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA-------  618 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~-------  618 (684)
                      +.....    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+...........       
T Consensus       180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            865322    234568999999999876 67899999999999999999999999866543321111100000       


Q ss_pred             -hhhhhhhhhhhhh------hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          619 -MKEERLFEILDAR------VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       619 -~~~~~~~~~~d~~------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       +........+..-      .........+..+.+|+.+||+.||++|||++|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence             0000000110000      0000112345678999999999999999999999876

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.1e-39  Score=358.99  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=201.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .++|++.+.||+|+||+||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456999999999999999999975 68899999876532  334577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCcEEEeccCCcccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGASRSM  549 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgl~~~~  549 (684)
                      ||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.   ++.+||+|||+++..
T Consensus       116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999999998764   3899999999999999999999999   999999999999976   455999999999876


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ....  ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+..   .    .+.....     
T Consensus       190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~----~i~~~~~-----  254 (494)
T 3lij_A          190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL---R----KVEKGKY-----  254 (494)
T ss_dssp             BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHTCC-----
T ss_pred             CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHHhCCC-----
Confidence            5332  233456999999999986 56899999999999999999999999865433211   0    0111100     


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       ..........+..+.+|+.+||+.||++|||++|++++
T Consensus       255 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          255 -TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             -CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence             00001113456789999999999999999999999876

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=342.96  Aligned_cols=258  Identities=26%  Similarity=0.401  Sum_probs=201.7

Q ss_pred             HHHHHHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeee---
Q 043157          390 KELERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLE---  464 (684)
Q Consensus       390 ~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---  464 (684)
                      .++....++|++.+.||+|+||+||+|.+ .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++..   
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            34444667899999999999999999996 478999999886533 2346788999999999 89999999999987   


Q ss_pred             ---cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEe
Q 043157          465 ---TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS  541 (684)
Q Consensus       465 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~  541 (684)
                         .+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence               457899999999999999998753 234899999999999999999999999   9999999999999999999999


Q ss_pred             ccCCccccccCCceeeecccccCCCCCccccc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHH
Q 043157          542 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFL  616 (684)
Q Consensus       542 DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~  616 (684)
                      |||++........ ......|++.|+|||++.     ...++.++||||||+++|+|++|+.||.........       
T Consensus       172 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------  243 (326)
T 2x7f_A          172 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------  243 (326)
T ss_dssp             CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------
T ss_pred             eCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH-------
Confidence            9999876543221 223446899999999986     567889999999999999999999999754322110       


Q ss_pred             HHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          617 FAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       617 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                              ..+.............+..+.+|+.+||+.||++|||++|++++
T Consensus       244 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          244 --------FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             --------HHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             --------HHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                    00111111111223456789999999999999999999999884

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=331.88  Aligned_cols=253  Identities=22%  Similarity=0.260  Sum_probs=202.2

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC----hhHHHHHHHHHHHHhhcCCCcccceeeeee--ecCc
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID----ESKVEEFINEMVILSQINHRNVVKLLGCCL--ETEV  467 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~  467 (684)
                      ..++|++.+.||+|+||.||++... +++.||+|.+....    ....+.+.+|++++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3478999999999999999999964 68899999876532    345678999999999999999999999984  4557


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .++||||++++ |.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            89999999876 7787776432 35899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccC-CceeeecccccCCCCCccccccCC--CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          548 SMAVD-QTHMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       548 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      ..... .........|++.|+|||++.+..  .+.++||||||+++|||++|+.||......+..       ..+..   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~i~~---  227 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF-------ENIGK---  227 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHH---
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-------HHHhc---
Confidence            65422 222334456899999999987644  377999999999999999999999854432210       00000   


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                           .  ....+...+..+.+|+.+||+.||++|||++|++++-
T Consensus       228 -----~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          228 -----G--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             -----C--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             -----C--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence                 0  1122345667899999999999999999999999863

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.8e-39  Score=347.17  Aligned_cols=261  Identities=26%  Similarity=0.289  Sum_probs=203.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcC--------CCcccceeeeee---
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQIN--------HRNVVKLLGCCL---  463 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~l~~~~~---  463 (684)
                      .++|++.++||+|+||+||++... +++.||||+++.. ....+.+.+|++++++++        ||||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            468999999999999999999854 6889999998743 445678899999999995        788999999997   


Q ss_pred             -ecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCC-----
Q 043157          464 -ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKY-----  536 (684)
Q Consensus       464 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~-----  536 (684)
                       +....++||||+ +++|.+.+..... ..+++..++.++.||+.||+|||++ +   |+||||||+||||+.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             456789999999 5677776665432 3499999999999999999999998 8   99999999999999775     


Q ss_pred             --------------------------------------------cEEEeccCCccccccCCceeeecccccCCCCCcccc
Q 043157          537 --------------------------------------------RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF  572 (684)
Q Consensus       537 --------------------------------------------~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~  572 (684)
                                                                  .+||+|||++......    .....||+.|+|||++
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence                                                        7999999999765432    2334689999999999


Q ss_pred             ccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhh---hHHHHHHHHhhhhhh-------------------------
Q 043157          573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK---SLAAYFLFAMKEERL-------------------------  624 (684)
Q Consensus       573 ~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~---~l~~~~~~~~~~~~~-------------------------  624 (684)
                      .+..++.++||||||++||||++|+.||......+..   ...............                         
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            9999999999999999999999999999765432211   111111111110000                         


Q ss_pred             -----hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 -----FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 -----~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           .+.+..  ....+...+..+.+|+.+||+.||++|||++|++++
T Consensus       346 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          346 KPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                 000000  112346678889999999999999999999999874

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-39  Score=349.26  Aligned_cols=264  Identities=22%  Similarity=0.294  Sum_probs=199.5

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC----
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETE----  466 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----  466 (684)
                      ++...++|++.+.||+|+||+||++.. .+++.||||++.....    ...+|+++++.++||||+++++++....    
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            345667899999999999999999986 5789999998764322    2347999999999999999999985432    


Q ss_pred             ----------------------------------cceEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHH
Q 043157          467 ----------------------------------VPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALSY  511 (684)
Q Consensus       467 ----------------------------------~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~y  511 (684)
                                                        ..++||||++ ++|.+.+... .....+++..++.++.||+.||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                              3789999998 5888887642 122359999999999999999999


Q ss_pred             HHhCCCCCeEecCCCCCCEEEC-CCCcEEEeccCCccccccCCceeeecccccCCCCCccccccC-CCCCccchhhhHHH
Q 043157          512 LHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVV  589 (684)
Q Consensus       512 LH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvi  589 (684)
                      ||+++   |+||||||+|||++ .++.+||+|||+++.......  .....+|+.|+|||++.+. .++.++||||||++
T Consensus       157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99999   99999999999997 688999999999986543332  2344689999999998764 58999999999999


Q ss_pred             HHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh---------------hhhhhhccCChhHHHHHHHHHHHhhcc
Q 043157          590 LAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI---------------LDARVMKESGGDEIITFAKVAKRCLNL  654 (684)
Q Consensus       590 l~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~---------------~d~~~~~~~~~~~~~~l~~Li~~cl~~  654 (684)
                      +|||++|+.||......+.  +.... ..........+               ....+....+...+.++.+|+.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~~~--~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQ--LVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHH--HHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChHHH--HHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            9999999999986554332  11111 11111100000               011111223345677899999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 043157          655 NGKKRPTMREVTSE  668 (684)
Q Consensus       655 dp~~RPt~~evl~~  668 (684)
                      ||++|||+.|++++
T Consensus       309 dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          309 EPDLRINPYEAMAH  322 (383)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             ChhhCCCHHHHhcC
Confidence            99999999999865

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.5e-38  Score=342.61  Aligned_cols=260  Identities=22%  Similarity=0.307  Sum_probs=196.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC------
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETE------  466 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------  466 (684)
                      .++|++.+.||+|+||+||++... +++.||||++..  ......+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367999999999999999999864 688999998764  34556678999999999999999999999997665      


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..++||||++ ++|.+++..     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            6799999997 578888863     2899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh-----
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE-----  621 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~-----  621 (684)
                      +.....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+..  .... .....     
T Consensus       175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i~-~~~~~~~~~~  249 (371)
T 2xrw_A          175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW--NKVI-EQLGTPCPEF  249 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH-C-CCCCCHHH
T ss_pred             cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-HHhCCCCHHH
Confidence            765422  2233456899999999999999999999999999999999999999865533211  1100 00000     


Q ss_pred             -----hhhhhhhhh--------------hhh-c---cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          622 -----ERLFEILDA--------------RVM-K---ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       622 -----~~~~~~~d~--------------~~~-~---~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                           ..+......              ... .   +.....+.++.+|+.+||+.||++|||++|++++-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence                 000000000              000 0   00122367899999999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.1e-39  Score=360.57  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=207.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.++||+|+||+||++... +++.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457999999999999999999975 7899999987542   234567899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCcEEEeccCCccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRS  548 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgl~~~  548 (684)
                      |||+.+++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999998654   3899999999999999999999999   9999999999999   5678999999999976


Q ss_pred             cccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ......  .....||+.|+|||++.+ .++.++||||||+++|+|++|++||......+..   .    .+......   
T Consensus       179 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~----~i~~~~~~---  245 (484)
T 3nyv_A          179 FEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL---K----KVEKGKYT---  245 (484)
T ss_dssp             BCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHCCCC---
T ss_pred             cccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH---H----HHHcCCCC---
Confidence            543322  234469999999999866 6899999999999999999999999865432211   0    11111000   


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                         .........+.++.+|+.+||+.||++|||++|++++-
T Consensus       246 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          246 ---FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             ---CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence               00111234567899999999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.3e-39  Score=343.63  Aligned_cols=271  Identities=21%  Similarity=0.288  Sum_probs=195.4

Q ss_pred             HHHHHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc
Q 043157          389 SKELERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEV  467 (684)
Q Consensus       389 ~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  467 (684)
                      ..+.....++|++.+.||+|+||+||++... +++.||||++... ......+.+|++.++.++||||+++++++.....
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            3456667789999999999999999999975 6899999987542 2233466788888999999999999999976543


Q ss_pred             -------ceEEEEecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCEEECC-CC
Q 043157          468 -------PLLVYEFIPNGTLFQYIHD-QNEDFPITWEMRLRIAIEVSGALSYLH--SAASIPIYHRDIKSTNILLDD-KY  536 (684)
Q Consensus       468 -------~~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~yLH--~~~~~~iiH~Dlkp~NILl~~-~~  536 (684)
                             .++||||+++ +|.+.+.. ......+++..++.++.|++.||.|||  +.+   |+||||||+||||+. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence                   7899999986 55554443 233345899999999999999999999  888   999999999999996 89


Q ss_pred             cEEEeccCCccccccCCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHH
Q 043157          537 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF  615 (684)
Q Consensus       537 ~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~  615 (684)
                      .+||+|||+++.......  .....||+.|+|||++.+. .++.++||||||+++|||++|+.||.........  ....
T Consensus       170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~  245 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIV  245 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH
T ss_pred             cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHH
Confidence            999999999987653332  2344689999999998654 4899999999999999999999999865543221  1111


Q ss_pred             HHH-hhhhhhhhhhhh----------------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          616 LFA-MKEERLFEILDA----------------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       616 ~~~-~~~~~~~~~~d~----------------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ... .........+++                ..........+.++.+|+.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            100 000111111110                01112223367889999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.2e-40  Score=346.59  Aligned_cols=267  Identities=24%  Similarity=0.386  Sum_probs=204.9

Q ss_pred             HHHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc
Q 043157          390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEV  467 (684)
Q Consensus       390 ~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  467 (684)
                      ++.+...++|++.+.||+|+||+||+|...+  .+|+|+++..  .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            4444556789999999999999999998754  3899987653  23344667889999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .++||||+++++|.+++.....  .+++..++.++.||+.||+|||+++   |+||||||+|||++ ++.+||+|||++.
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             eEEEeecccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            9999999999999999987542  4899999999999999999999999   99999999999998 6799999999987


Q ss_pred             ccccCC----ceeeecccccCCCCCcccccc---------CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHH
Q 043157          548 SMAVDQ----THMTTQVHGTFGYLDPEYFRS---------SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY  614 (684)
Q Consensus       548 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~  614 (684)
                      ......    ........|++.|+|||++..         ..++.++||||||+++|||++|+.||.....+...     
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----  252 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-----  252 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-----
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----
Confidence            543211    112233458999999999864         45788999999999999999999999755432210     


Q ss_pred             HHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCC
Q 043157          615 FLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGAS  679 (684)
Q Consensus       615 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~  679 (684)
                        ......     ..   ........+.++.+|+.+||+.||++|||++|+++.|+++..+....
T Consensus       253 --~~~~~~-----~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~  307 (319)
T 2y4i_B          253 --WQMGTG-----MK---PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL  307 (319)
T ss_dssp             --HHHHTT-----CC---CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred             --HHhccC-----CC---CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence              001110     00   01111234567899999999999999999999999999998765543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.5e-39  Score=358.35  Aligned_cols=253  Identities=27%  Similarity=0.355  Sum_probs=204.0

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccCh-------------hHHHHHHHHHHHHhhcCCCcccceee
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE-------------SKVEEFINEMVILSQINHRNVVKLLG  460 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~l~~  460 (684)
                      ..++|.+.++||+|+||+||++... +++.||+|++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999965 688999998764321             33577899999999999999999999


Q ss_pred             eeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC---c
Q 043157          461 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---R  537 (684)
Q Consensus       461 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~  537 (684)
                      ++.+....++||||+++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999998764   3999999999999999999999999   99999999999998775   6


Q ss_pred             EEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH
Q 043157          538 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF  617 (684)
Q Consensus       538 ~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~  617 (684)
                      +||+|||++.......  ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+..   .    
T Consensus       188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~----  257 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII---K----  257 (504)
T ss_dssp             EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----
T ss_pred             EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----
Confidence            9999999998764332  233456999999999987 46899999999999999999999999865433211   0    


Q ss_pred             HhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       618 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      .+......  .+..    .....+.++.+|+.+||+.||++|||++|++++-
T Consensus       258 ~i~~~~~~--~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          258 KVEKGKYY--FDFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             HHHHCCCC--CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHcCCCC--CCcc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence            11111100  0000    0123456799999999999999999999998763

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.3e-39  Score=348.99  Aligned_cols=266  Identities=22%  Similarity=0.278  Sum_probs=200.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc------ce
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEV------PL  469 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------~~  469 (684)
                      ..+|++.++||+|+||+||++.+..+..+|+|++.....    ...+|+++++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            356999999999999999999987777799998754221    22369999999999999999999975543      68


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCcEEEeccCCccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRS  548 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgl~~~  548 (684)
                      +||||++++.+....+.......+++..++.++.||+.||+|||+++   |+||||||+||||+ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987544444333223345999999999999999999999999   99999999999999 799999999999987


Q ss_pred             cccCCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh--h
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL--F  625 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~--~  625 (684)
                      ......  .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+.  +..... .......  .
T Consensus       192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~-~~g~p~~~~~  266 (394)
T 4e7w_A          192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIK-VLGTPSREQI  266 (394)
T ss_dssp             CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-HHCCCCHHHH
T ss_pred             ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH-HhCCCCHHHH
Confidence            643332  2344689999999998764 589999999999999999999999986654322  111111 1100000  0


Q ss_pred             hhhhhh-------------hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhH
Q 043157          626 EILDAR-------------VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGIK  673 (684)
Q Consensus       626 ~~~d~~-------------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i~  673 (684)
                      ....+.             +........+.++.+|+.+||+.||++|||+.|++++  ++.++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            000110             1111223456789999999999999999999999986  44444

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.8e-39  Score=337.56  Aligned_cols=264  Identities=26%  Similarity=0.369  Sum_probs=204.7

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe--CCCcEEEEEeccccC--hhHHHHHHHHHHHHhhc---CCCcccceeeeee----
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML--PDGKIVAVKKSKVID--ESKVEEFINEMVILSQI---NHRNVVKLLGCCL----  463 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~----  463 (684)
                      ..++|++.+.||+|+||+||++..  .+++.||+|++....  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            456899999999999999999997  468899999876422  22234566777777766   8999999999987    


Q ss_pred             -ecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEec
Q 043157          464 -ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD  542 (684)
Q Consensus       464 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D  542 (684)
                       .....++||||++ |+|.+++..... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999997 699999987543 24899999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--
Q 043157          543 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--  620 (684)
Q Consensus       543 Fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--  620 (684)
                      ||+++......  ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+.  +.. ......  
T Consensus       164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~-i~~~~~~~  238 (326)
T 1blx_A          164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGK-ILDVIGLP  238 (326)
T ss_dssp             CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCC
T ss_pred             CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHHcCCC
Confidence            99997654322  23345689999999999999999999999999999999999999986553321  111 111110  


Q ss_pred             -hhhhhhh----------hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          621 -EERLFEI----------LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       621 -~~~~~~~----------~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                       ...+...          .............+..+.+|+.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             0000000          00011112234567789999999999999999999999965

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.7e-39  Score=336.40  Aligned_cols=258  Identities=23%  Similarity=0.360  Sum_probs=205.1

Q ss_pred             HHHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcC--CCcccceeeeeeec
Q 043157          390 KELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQIN--HRNVVKLLGCCLET  465 (684)
Q Consensus       390 ~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~  465 (684)
                      +.+....++|++.+.||+|+||+||++...+++.||+|++..  ......+.+.+|++++++++  ||||+++++++.+.
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            334445577999999999999999999988899999998764  34566788999999999997  59999999999999


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                      +..++||| +.+++|.+++....   .+++..++.++.|+++||+|||+++   |+||||||+|||+++ +.+||+|||+
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             CEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence            99999999 56889999998754   4899999999999999999999999   999999999999965 7999999999


Q ss_pred             ccccccCCce-eeecccccCCCCCcccccc-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 043157          546 SRSMAVDQTH-MTTQVHGTFGYLDPEYFRS-----------SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAA  613 (684)
Q Consensus       546 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~  613 (684)
                      ++........ ......|++.|+|||.+..           ..++.++||||||+++|||++|+.||.......      
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------  246 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------  246 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH------
Confidence            9876433221 2234468999999999865           468889999999999999999999997433211      


Q ss_pred             HHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          614 YFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       614 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                              ..+...+++......+...+.++.+|+.+||+.||++||+++|++++-
T Consensus       247 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          247 --------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             --------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence                    011222233222333344567899999999999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.9e-38  Score=330.75  Aligned_cols=252  Identities=27%  Similarity=0.469  Sum_probs=196.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeee----------
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE----------  464 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----------  464 (684)
                      .++|++.+.||+|+||+||++... +++.||||++.. .....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            457999999999999999999964 789999998864 34556889999999999999999999998865          


Q ss_pred             ---cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEe
Q 043157          465 ---TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS  541 (684)
Q Consensus       465 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~  541 (684)
                         ....++||||+++++|.+++.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               3567899999999999999986542  4788999999999999999999999   9999999999999999999999


Q ss_pred             ccCCccccccCC-------------ceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhh
Q 043157          542 DFGASRSMAVDQ-------------THMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE  607 (684)
Q Consensus       542 DFgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~  607 (684)
                      |||++.......             ........|++.|+|||.+.+. .++.++||||||+++|||++   ||...  .+
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--ME  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hh
Confidence            999997654221             1122345689999999998764 68999999999999999998   54321  11


Q ss_pred             hhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       608 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ......    .+.      ..............+..+.+|+.+||+.||++|||++|++++
T Consensus       234 ~~~~~~----~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 RVNILK----KLR------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHH----HHH------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHH----hcc------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            111100    000      011111223345566788999999999999999999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-38  Score=340.97  Aligned_cols=263  Identities=22%  Similarity=0.301  Sum_probs=203.9

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec-----Ccc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLET-----EVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~  468 (684)
                      .++|++.+.||+|+||+||++... +++.||||++... .......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999965 6899999988653 345567889999999999999999999988754     567


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++||||++ ++|.+++...    .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 6999999864    3899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCce---------eeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH
Q 043157          549 MAVDQTH---------MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA  618 (684)
Q Consensus       549 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~  618 (684)
                      .......         ......||+.|+|||++.. ..++.++||||||+++|||++|+.||......+...  ..+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~  239 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL--LIFGII  239 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HHHHHh
Confidence            6432211         1223468999999998754 678999999999999999999999998665432211  111000


Q ss_pred             hh-----------hhhhhhhhhhh------hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          619 MK-----------EERLFEILDAR------VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       619 ~~-----------~~~~~~~~d~~------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..           .....+.+...      .........+.++.+|+.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00           00000110000      0011113456789999999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.2e-39  Score=338.59  Aligned_cols=253  Identities=24%  Similarity=0.332  Sum_probs=197.6

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC--------hhHHHHHHHHHHHHhhcCCCcccceeeeeeec
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID--------ESKVEEFINEMVILSQINHRNVVKLLGCCLET  465 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  465 (684)
                      ..++|++.+.||+|+||+||++... +++.||||.+....        ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999965 68899999875421        22345688999999999999999999998655


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc---EEEec
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSD  542 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~D  542 (684)
                      . .++||||+++++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 899999999999999997643   4899999999999999999999999   999999999999987654   99999


Q ss_pred             cCCccccccCCceeeecccccCCCCCccccc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh
Q 043157          543 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM  619 (684)
Q Consensus       543 Fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~  619 (684)
                      ||+++......  ......||+.|+|||++.   ...++.++||||||+++|+|++|+.||.......  .+....    
T Consensus       161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----  232 (322)
T 2ycf_A          161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----  232 (322)
T ss_dssp             CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----
T ss_pred             Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----
Confidence            99998654321  223456899999999974   5678999999999999999999999997543221  111111    


Q ss_pred             hhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          620 KEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       620 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ......  ..+    ......+..+.+|+.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~--~~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          233 TSGKYN--FIP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHTCCC--CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhCccc--cCc----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            000000  000    0112345678999999999999999999999853

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.7e-38  Score=342.35  Aligned_cols=258  Identities=22%  Similarity=0.314  Sum_probs=200.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc----
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP----  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~----  468 (684)
                      .++|.+.+.||+|+||+||++... +++.||||++..  ......+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999965 689999998865  3445568899999999999999999999999877655    


Q ss_pred             --eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          469 --LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       469 --~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                        ++||||++ ++|.+++..     .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 688888743     2899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH-hhhhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA-MKEERL  624 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~-~~~~~~  624 (684)
                      +.....    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+..  ....... ......
T Consensus       192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~  265 (371)
T 4exu_A          192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL--TQILKVTGVPGTEF  265 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCHHH
T ss_pred             cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCCcHHH
Confidence            754322    234568999999999877 67899999999999999999999999865533221  1111100 000000


Q ss_pred             ---------hhhhhhh---h---hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 ---------FEILDAR---V---MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ---------~~~~d~~---~---~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                               .......   .   ........+..+.+|+.+||+.||++|||++|++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                     0000000   0   001112446789999999999999999999999886

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-39  Score=350.89  Aligned_cols=267  Identities=23%  Similarity=0.332  Sum_probs=186.0

Q ss_pred             cCCCc-CceeceeCcEEEEEEEeC---CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeee--cCcceE
Q 043157          397 DNFNL-NRILGQGGQGTVYKGMLP---DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE--TEVPLL  470 (684)
Q Consensus       397 ~~~~~-~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l  470 (684)
                      +.|.+ .++||+|+||+||++.+.   +++.||||++.....  .+.+.+|+.+|++++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34655 568999999999999965   578999999875332  3467899999999999999999999964  567899


Q ss_pred             EEEecCCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----CCCCcEEE
Q 043157          471 VYEFIPNGTLFQYIHDQN------EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKV  540 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl  540 (684)
                      ||||++ ++|.+++....      ....+++..++.++.||+.||+|||+++   |+||||||+||||    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999996 58888886421      2234899999999999999999999999   9999999999999    67889999


Q ss_pred             eccCCccccccCCc--eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhh-------hhh
Q 043157          541 SDFGASRSMAVDQT--HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE-------DKS  610 (684)
Q Consensus       541 ~DFgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~-------~~~  610 (684)
                      +|||+++.......  .......||+.|+|||++.+ ..++.++||||||++||||++|++||.......       ...
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987643222  22344568999999999877 458999999999999999999999997554321       011


Q ss_pred             HHHHHHHHh-h-hhhhhhh------------hhhh---------hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043157          611 LAAYFLFAM-K-EERLFEI------------LDAR---------VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTS  667 (684)
Q Consensus       611 l~~~~~~~~-~-~~~~~~~------------~d~~---------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~  667 (684)
                      +...+...- . ...+..+            +...         .........+..+.+|+.+||+.||++|||++|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111100 0 0000000            0000         000011112557889999999999999999999998


Q ss_pred             HH
Q 043157          668 EL  669 (684)
Q Consensus       668 ~L  669 (684)
                      +-
T Consensus       334 hp  335 (405)
T 3rgf_A          334 DP  335 (405)
T ss_dssp             SG
T ss_pred             Ch
Confidence            64

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-38  Score=349.37  Aligned_cols=259  Identities=24%  Similarity=0.322  Sum_probs=196.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC------cce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETE------VPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~  469 (684)
                      .+|++.+.||+|+||+||++.+. +++.||||++....    ..+.+|+++|++++||||+++++++....      ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46899999999999999999975 68999999875422    22347999999999999999999986432      357


Q ss_pred             EEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CcEEEeccCCcc
Q 043157          470 LVYEFIPNGTLFQYIHDQ-NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASR  547 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFgl~~  547 (684)
                      +||||+++ +|.+.+... .....+++..++.++.||++||+|||+++   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999975 677666531 22335999999999999999999999999   9999999999999954 678999999998


Q ss_pred             ccccCCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh--hhhhh
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM--KEERL  624 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~--~~~~~  624 (684)
                      .......  .....||+.|+|||++.+. .++.++||||||++||||++|+.||......+  .+...+...-  ....+
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHH
T ss_pred             hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence            7543322  2345689999999998764 78999999999999999999999998654322  2222111100  00111


Q ss_pred             hhhhhh-------------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 FEILDA-------------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ~~~~d~-------------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+. .+             .+........+.++.+|+.+||+.||++|||+.|++++
T Consensus       282 ~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          282 REM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             Hhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            110 00             01111223456789999999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.8e-39  Score=342.26  Aligned_cols=259  Identities=24%  Similarity=0.357  Sum_probs=205.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChh-----------------HHHHHHHHHHHHhhcCCCcccce
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDES-----------------KVEEFINEMVILSQINHRNVVKL  458 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~HpnIv~l  458 (684)
                      .++|++.+.||+|+||+||++.. +++.||||++......                 ..+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 9999999987642211                 12789999999999999999999


Q ss_pred             eeeeeecCcceEEEEecCCCCHHHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEE
Q 043157          459 LGCCLETEVPLLVYEFIPNGTLFQY------IHDQNEDFPITWEMRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNIL  531 (684)
Q Consensus       459 ~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiH~Dlkp~NIL  531 (684)
                      ++++.+.+..++||||+++++|.++      +.... ...+++..++.++.|++.||+|||+ .+   |+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      55421 3459999999999999999999999 88   999999999999


Q ss_pred             ECCCCcEEEeccCCccccccCCceeeecccccCCCCCccccccC-CCCC-ccchhhhHHHHHHHHhCCCCCCCCChhhhh
Q 043157          532 LDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTD-KSDVYSFGVVLAELLTGEKPIRFTTLEEDK  609 (684)
Q Consensus       532 l~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDv~SlGvil~elltG~~P~~~~~~~~~~  609 (684)
                      ++.++.+||+|||++......   ......|++.|+|||++.+. .++. ++||||||+++|||++|+.||.......  
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--  259 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--  259 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred             EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence            999999999999999865433   33445689999999999877 6666 9999999999999999999998554311  


Q ss_pred             hHHHHHHHHhhhhhhhhh---------hhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          610 SLAAYFLFAMKEERLFEI---------LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       610 ~l~~~~~~~~~~~~~~~~---------~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+..    .+......-.         .............+.++.+|+.+||+.||++|||++|++++
T Consensus       260 ~~~~----~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          260 ELFN----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHH----HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHH----HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111    1111100000         00000001114456789999999999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.3e-38  Score=337.56  Aligned_cols=258  Identities=22%  Similarity=0.318  Sum_probs=200.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc-----
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEV-----  467 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-----  467 (684)
                      .++|.+.+.||+|+||+||++... +|+.||||++..  ......+.+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            357999999999999999999965 689999998764  344556789999999999999999999999987654     


Q ss_pred             -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          468 -PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       468 -~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                       .++||||++ ++|.+++..     .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 688877743     3899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH-hhhhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA-MKEERL  624 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~-~~~~~~  624 (684)
                      +.....    .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.  +....... ......
T Consensus       174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~  247 (353)
T 3coi_A          174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEF  247 (353)
T ss_dssp             TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHHH
T ss_pred             cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence            764322    233468999999999876 6789999999999999999999999986553321  11111100 000000


Q ss_pred             ---------hhhhh---hh---hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 ---------FEILD---AR---VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ---------~~~~d---~~---~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                               ...+.   ..   .........+.++.+|+.+||+.||++|||++|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                     00000   00   0111224567889999999999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.2e-38  Score=326.53  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=204.4

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ..++|++.+.||+|+||+||++... +++.||+|++...  .....+.+.+|++++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            4467999999999999999999975 6899999987542  234567899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC---CcEEEeccCCccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRS  548 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFgl~~~  548 (684)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||+++   |+||||||+|||++.+   +.+||+|||++..
T Consensus       100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            99999999999988654   3899999999999999999999999   9999999999999754   4799999999876


Q ss_pred             cccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ......  .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......+.   ..    .+......   
T Consensus       174 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~---  240 (287)
T 2wei_A          174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LK----RVETGKYA---  240 (287)
T ss_dssp             BCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHCCCC---
T ss_pred             ecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHcCCCC---
Confidence            543322  223358899999999875 489999999999999999999999976543221   10    01111000   


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                         .........+.++.+|+.+||+.||++|||++|++++
T Consensus       241 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             ---CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence               0000112456789999999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.7e-38  Score=337.69  Aligned_cols=204  Identities=25%  Similarity=0.357  Sum_probs=174.2

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcC-CC-----cccceeeeeeec
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HR-----NVVKLLGCCLET  465 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~l~~~~~~~  465 (684)
                      +...++|++.+.||+|+||+||+|... +++.||||+++. .....+++.+|+.+++.++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            334578999999999999999999965 688999999874 3445677888999998885 55     499999999999


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEecCCCCCCEEEC--CCCcEEEe
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS--AASIPIYHRDIKSTNILLD--DKYRAKVS  541 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~--~~~~~iiH~Dlkp~NILl~--~~~~~kl~  541 (684)
                      +..++||||++ ++|.+++..... ..+++..++.++.|++.||+|||+  .+   |+||||||+||||+  .++.+||+
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEEC
T ss_pred             CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEE
Confidence            99999999996 599999987642 248999999999999999999995  45   99999999999994  57889999


Q ss_pred             ccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChh
Q 043157          542 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLE  606 (684)
Q Consensus       542 DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~  606 (684)
                      |||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~  264 (382)
T 2vx3_A          204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV  264 (382)
T ss_dssp             CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999865422    23456899999999999999999999999999999999999999866543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=331.72  Aligned_cols=248  Identities=29%  Similarity=0.429  Sum_probs=194.8

Q ss_pred             HHHHHHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccCh------hHHHHHHHHHHHHhhc----CCCcccce
Q 043157          390 KELERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDE------SKVEEFINEMVILSQI----NHRNVVKL  458 (684)
Q Consensus       390 ~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~HpnIv~l  458 (684)
                      .+.+...++|++.+.||+|+||+||++.. .+++.||||++.....      .....+.+|+.+++++    +||||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            34556678899999999999999999986 4688999998865332      2334566799999999    89999999


Q ss_pred             eeeeeecCcceEEEEe-cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCC
Q 043157          459 LGCCLETEVPLLVYEF-IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKY  536 (684)
Q Consensus       459 ~~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~  536 (684)
                      ++++.+.+..++|||+ +.+++|.+++.+..   .+++..++.++.||+.||+|||+++   |+||||||+|||++ .++
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence            9999999999999999 78999999998754   3899999999999999999999999   99999999999999 889


Q ss_pred             cEEEeccCCccccccCCceeeecccccCCCCCccccccCCCC-CccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHH
Q 043157          537 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF  615 (684)
Q Consensus       537 ~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~  615 (684)
                      .+||+|||+++......   .....|+..|+|||++.+..+. .++||||||+++|||++|+.||....           
T Consensus       178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------  243 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----------  243 (312)
T ss_dssp             EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred             eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------
Confidence            99999999998764332   2344589999999998876664 58999999999999999999986321           


Q ss_pred             HHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          616 LFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       616 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                                ++...  ....+...+..+.+|+.+||+.||++|||++|++++-
T Consensus       244 ----------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~  285 (312)
T 2iwi_A          244 ----------EILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP  285 (312)
T ss_dssp             ----------HHHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred             ----------HHhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                      00000  1122345667899999999999999999999999853

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.5e-37  Score=331.73  Aligned_cols=263  Identities=20%  Similarity=0.285  Sum_probs=203.7

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CC-cEEEEEeccccChhHHHHHHHHHHHHhhcCCCc------ccceeeeeeecCc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DG-KIVAVKKSKVIDESKVEEFINEMVILSQINHRN------VVKLLGCCLETEV  467 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~~  467 (684)
                      .++|++.+.||+|+||+||++... ++ +.||+|+++.. ....+.+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999964 44 68999998643 345677889999999997766      8999999999999


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---------------
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---------------  532 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl---------------  532 (684)
                      .++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 6777777776532 34899999999999999999999999   9999999999999               


Q ss_pred             ----CCCCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhh
Q 043157          533 ----DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED  608 (684)
Q Consensus       533 ----~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~  608 (684)
                          +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                56789999999999764322    2344689999999999999999999999999999999999999986554332


Q ss_pred             hhHHHHHHHHhhhhhhhh----------------------hhh----h-hhhccCChhHHHHHHHHHHHhhccCCCCCCC
Q 043157          609 KSLAAYFLFAMKEERLFE----------------------ILD----A-RVMKESGGDEIITFAKVAKRCLNLNGKKRPT  661 (684)
Q Consensus       609 ~~l~~~~~~~~~~~~~~~----------------------~~d----~-~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt  661 (684)
                      ...............+..                      .+.    + ..........+.++.+|+.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            111111000000000000                      000    0 0001122345678999999999999999999


Q ss_pred             HHHHHHH
Q 043157          662 MREVTSE  668 (684)
Q Consensus       662 ~~evl~~  668 (684)
                      ++|++++
T Consensus       328 ~~e~l~h  334 (355)
T 2eu9_A          328 LAEALLH  334 (355)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999865

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1e-37  Score=335.80  Aligned_cols=259  Identities=23%  Similarity=0.299  Sum_probs=202.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcC-----------CCcccceeeeeee
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-----------HRNVVKLLGCCLE  464 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~  464 (684)
                      ++|++.+.||+|+||+||++.. .+++.||||++.. +....+.+.+|+.++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5799999999999999999996 4789999998864 3445677889999999886           8999999999986


Q ss_pred             cC----cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEC------
Q 043157          465 TE----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLD------  533 (684)
Q Consensus       465 ~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~------  533 (684)
                      .+    ..++|||++ +++|.+++..... ..+++..++.++.||+.||+|||++ +   |+||||||+||||+      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence            55    678999999 8999999987533 2489999999999999999999998 8   99999999999994      


Q ss_pred             CCCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhh----hh
Q 043157          534 DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE----DK  609 (684)
Q Consensus       534 ~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~----~~  609 (684)
                      ..+.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......    ..
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            4558999999999765432    223468999999999999999999999999999999999999998554221    11


Q ss_pred             hHHHHHHHHhhhh--------h----------------------hhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCC
Q 043157          610 SLAAYFLFAMKEE--------R----------------------LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKR  659 (684)
Q Consensus       610 ~l~~~~~~~~~~~--------~----------------------~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R  659 (684)
                      .+.... ......        .                      +.+.+..  ....+...+.++.+|+.+||+.||++|
T Consensus       249 ~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          249 HIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             HHHHHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCcccc
Confidence            111111 111000        0                      0000000  112446778899999999999999999


Q ss_pred             CCHHHHHHH
Q 043157          660 PTMREVTSE  668 (684)
Q Consensus       660 Pt~~evl~~  668 (684)
                      ||++|++++
T Consensus       326 pt~~ell~h  334 (373)
T 1q8y_A          326 ADAGGLVNH  334 (373)
T ss_dssp             BCHHHHHTC
T ss_pred             CCHHHHhhC
Confidence            999999885

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5e-38  Score=332.31  Aligned_cols=257  Identities=24%  Similarity=0.353  Sum_probs=183.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHH-HHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMV-ILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .++|++.+.||+|+||+||++... +++.||||++... ......++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            467999999999999999999975 7899999988653 3444556666666 777789999999999999999999999


Q ss_pred             EecCCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          473 EFIPNGTLFQYIHDQ--NEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       473 E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      ||+++ +|.+++...  .....+++..++.++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 888887641  1233589999999999999999999998 8   999999999999999999999999999765


Q ss_pred             ccCCceeeecccccCCCCCcccc----ccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYF----RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF  625 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  625 (684)
                      .....  .....||+.|+|||++    .+..++.++||||||+++|||++|+.||.........         .  ....
T Consensus       177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------~--~~~~  243 (327)
T 3aln_A          177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------L--TQVV  243 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCC
T ss_pred             ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------H--HHHh
Confidence            43222  2233589999999998    4567899999999999999999999999743211100         0  0000


Q ss_pred             hhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       626 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      ....+..........+..+.+|+.+||+.||++|||++|++++-
T Consensus       244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  287 (327)
T 3aln_A          244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP  287 (327)
T ss_dssp             CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence            00001111112234677899999999999999999999998753

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8e-38  Score=332.38  Aligned_cols=255  Identities=20%  Similarity=0.269  Sum_probs=176.3

Q ss_pred             HhcCCCcC-ceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeee----cCcc
Q 043157          395 ATDNFNLN-RILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLE----TEVP  468 (684)
Q Consensus       395 ~~~~~~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~  468 (684)
                      ..++|.+. ++||+|+||+||++... +++.||||++... ...   ..+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            34678885 46999999999999976 6899999988642 111   1223334566799999999999976    4457


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCcEEEeccCC
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGA  545 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgl  545 (684)
                      ++||||+++|+|.+++.+... ..+++..++.++.||+.||+|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            999999999999999987543 35999999999999999999999999   999999999999976   45599999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF  625 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  625 (684)
                      ++.....   ......||+.|+|||++....++.++||||||+++|+|++|+.||...........   ......     
T Consensus       178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~-----  246 (336)
T 3fhr_A          178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIR-----  246 (336)
T ss_dssp             CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhh-----
Confidence            9765422   22334589999999999888899999999999999999999999975432211000   000000     


Q ss_pred             hhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       626 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                       ..............+.++.+|+.+||+.||++|||++|++++-
T Consensus       247 -~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          247 -LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             -ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence             0000011111235677899999999999999999999999854

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.2e-38  Score=336.36  Aligned_cols=251  Identities=26%  Similarity=0.423  Sum_probs=202.2

Q ss_pred             cCCHHHHHHHhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccCh------hHHHHHHHHHHHHhhcC--CCccc
Q 043157          386 LFTSKELERATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDE------SKVEEFINEMVILSQIN--HRNVV  456 (684)
Q Consensus       386 ~~~~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--HpnIv  456 (684)
                      ..+..+.+...++|++.+.||+|+||+||++.. .+++.||||++.....      ...+.+.+|+.++++++  ||||+
T Consensus        32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~  111 (320)
T 3a99_A           32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI  111 (320)
T ss_dssp             --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence            344455566678899999999999999999985 4789999998764321      12345778999999996  59999


Q ss_pred             ceeeeeeecCcceEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-C
Q 043157          457 KLLGCCLETEVPLLVYEFIPN-GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-D  534 (684)
Q Consensus       457 ~l~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~  534 (684)
                      ++++++.+.+..++|||++.+ ++|.+++....   .+++..++.++.||++||+|||+.+   |+||||||+|||++ +
T Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          112 RLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN  185 (320)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred             EEEEEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCC
Confidence            999999999999999999976 89999998754   3899999999999999999999999   99999999999999 7


Q ss_pred             CCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCC-CCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 043157          535 KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAA  613 (684)
Q Consensus       535 ~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~  613 (684)
                      ++.+||+|||+++......   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....        
T Consensus       186 ~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------  254 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------  254 (320)
T ss_dssp             TTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred             CCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------
Confidence            8899999999998764322   233458999999999887665 6889999999999999999999863210        


Q ss_pred             HHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          614 YFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       614 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                                   +....  ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus       255 -------------~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          255 -------------IIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             -------------HHHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------------hhccc--ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                         00000  11223456789999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-37  Score=343.02  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=189.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      +.|...++||+|+||+||.+...+|+.||||++...   ..+.+.+|+.+++++ +||||+++++++.+.+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            345567899999999998776778999999987642   345678999999987 8999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-------------CcE
Q 043157          476 PNGTLFQYIHDQNEDF----PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-------------YRA  538 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~-------------~~~  538 (684)
                      + |+|.+++.......    ..++..++.++.||+.||+|||+++   |+||||||+||||+.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 69999998754211    0133345789999999999999999   9999999999999653             589


Q ss_pred             EEeccCCccccccCCce---eeecccccCCCCCcccccc-------CCCCCccchhhhHHHHHHHHh-CCCCCCCCChhh
Q 043157          539 KVSDFGASRSMAVDQTH---MTTQVHGTFGYLDPEYFRS-------SQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEE  607 (684)
Q Consensus       539 kl~DFgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~  607 (684)
                      ||+|||+++........   ......||+.|+|||++.+       ..++.++||||||+++|||++ |+.||......+
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876543322   1234569999999999865       568999999999999999999 999996443221


Q ss_pred             hhhHHHHHHHHhhhhhhhhhhh-hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          608 DKSLAAYFLFAMKEERLFEILD-ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       608 ~~~l~~~~~~~~~~~~~~~~~d-~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .    . .   ..     .... +..........+.++.+|+.+||+.||++|||+.|++++
T Consensus       248 ~----~-i---~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 S----N-I---IR-----GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             H----H-H---HH-----TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             H----H-H---hc-----CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            1    0 0   00     0000 001111234567889999999999999999999999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=324.42  Aligned_cols=251  Identities=23%  Similarity=0.393  Sum_probs=182.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hh-HHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ES-KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .++|++.+.||+|+||+||++... +++.||||++.... .. ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            457899999999999999999975 78999999886532 22 2344455556788889999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      ||+ ++.+..++.....  .+++..++.++.|+++||+|||++ +   |+||||||+|||++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 5566665554332  489999999999999999999995 8   99999999999999999999999999976543


Q ss_pred             CCceeeecccccCCCCCccccc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ...  .....|++.|+|||++.     ...++.++||||||+++|||++|+.||........  ..            ..
T Consensus       178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~------------~~  241 (318)
T 2dyl_A          178 DKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VL------------TK  241 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HH------------HH
T ss_pred             Ccc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HH------------HH
Confidence            222  23345899999999984     55688999999999999999999999975322111  00            01


Q ss_pred             hhhhhh-hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 ILDARV-MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ++.... ........+.++.+|+.+||+.||++||+++|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          242 VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111000 011112456789999999999999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=338.81  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=189.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ..+|++.++||+|+||+|+.....+++.||||++.....   +.+.+|+++|+++ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            346888999999999997665566889999998864322   2356899999999 799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-----CCCcEEEeccCCcccc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-----DKYRAKVSDFGASRSM  549 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~-----~~~~~kl~DFgl~~~~  549 (684)
                      ++ |+|.+++......  +++..++.++.||+.||+|||+++   |+||||||+||||+     ....+||+|||+++..
T Consensus       100 ~~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 6999999875432  455566789999999999999999   99999999999994     3346889999999876


Q ss_pred             ccCCc--eeeecccccCCCCCccccc---cCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhh
Q 043157          550 AVDQT--HMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEER  623 (684)
Q Consensus       550 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~  623 (684)
                      .....  .......||+.|+|||++.   ...++.++||||||+++|||++ |..||.........       .......
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~~  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILLGACS  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHTTCCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHhccCC
Confidence            53322  2234456999999999997   4567889999999999999999 99998533221100       0010000


Q ss_pred             hhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          624 LFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       624 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      . .      ........+..+.+|+.+||+.||++|||++|++++
T Consensus       247 ~-~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          247 L-D------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             C-T------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             c-c------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            0 0      011123456678999999999999999999999953

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.5e-37  Score=351.08  Aligned_cols=273  Identities=24%  Similarity=0.345  Sum_probs=209.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeee------cCcc
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLE------TEVP  468 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~~  468 (684)
                      ++|++.++||+|+||+||++... +++.||||++.. ......+.+.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            67999999999999999999864 689999998765 345667889999999999999999999999765      6678


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCc---EEEeccCC
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGA  545 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFgl  545 (684)
                      ++||||+++|+|.+++........+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999998665556899999999999999999999999   999999999999986654   99999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH-Hhhhhhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF-AMKEERL  624 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~-~~~~~~~  624 (684)
                      +.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........  ..... .......
T Consensus       171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~--~~i~~~~~~~~~~  246 (676)
T 3qa8_A          171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH--GKVREKSNEHIVV  246 (676)
T ss_dssp             CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSS--TTCC------CCS
T ss_pred             cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhh--hhhhcccchhhhh
Confidence            98764332  2344568999999999999999999999999999999999999997542211000  00000 0000000


Q ss_pred             hhhhhh--------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHhhHhhc
Q 043157          625 FEILDA--------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE-----VTSELAGIKAWN  676 (684)
Q Consensus       625 ~~~~d~--------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~e-----vl~~L~~i~~~~  676 (684)
                      .+....        ..........+..+.+|+.+||+.||++|||++|     +.+.++.+....
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence            000000        1112344567889999999999999999999988     567777666543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-36  Score=315.40  Aligned_cols=235  Identities=15%  Similarity=0.118  Sum_probs=188.4

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .++|++.+.||+|+||+||++... +++.||||.+...   +....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999975 5899999988653   245568899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++++.     .....+.+++.|++.||+|||+++   |+||||||+||||+.++.+||++++       
T Consensus       110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999999999643     355678889999999999999999   9999999999999999999998553       


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                                    |++|       ++.++||||||+++|||+||+.||......+.....        ...+...  ..
T Consensus       175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~--~~  223 (286)
T 3uqc_A          175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAGQ--PI  223 (286)
T ss_dssp             --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTSC--BC
T ss_pred             --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhccC--CC
Confidence                          3332       678999999999999999999999865432210000        0000000  00


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      .........+.++.+|+.+||+.||++| |+.|+++.|+++.....
T Consensus       224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            0111223456789999999999999999 99999999999886543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.1e-36  Score=351.27  Aligned_cols=239  Identities=22%  Similarity=0.353  Sum_probs=195.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC--CCcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc-----c
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP--DGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEV-----P  468 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-----~  468 (684)
                      ++|++.++||+|+||+||++.+.  +++.||||++.. ......+.+.+|++++++++||||+++++++.+.+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67999999999999999999975  689999998764 344566789999999999999999999999988766     6


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      +|||||+++++|.+++..     .+++..++.++.||+.||+|||+++   |+||||||+||||+.+ .+||+|||+++.
T Consensus       160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence            999999999999988754     3899999999999999999999999   9999999999999986 999999999986


Q ss_pred             cccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ....     ....||+.|+|||++.+.. +.++||||||++||+|++|.+||.......                +.   
T Consensus       231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~---  285 (681)
T 2pzi_A          231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP---  285 (681)
T ss_dssp             TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC---
T ss_pred             cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------cc---
Confidence            5432     3456999999999987654 889999999999999999999876321110                00   


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRP-TMREVTSELAGIK  673 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-t~~evl~~L~~i~  673 (684)
                      ..    ......+..+.+|+.+||+.||++|| +++++...|..+.
T Consensus       286 ~~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 ED----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             TT----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cc----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            00    00012345788999999999999999 5677777776553

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.6e-35  Score=309.25  Aligned_cols=230  Identities=21%  Similarity=0.297  Sum_probs=180.6

Q ss_pred             cCCCcC-ceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHH-hhcCCCcccceeeeeee----cCcce
Q 043157          397 DNFNLN-RILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVIL-SQINHRNVVKLLGCCLE----TEVPL  469 (684)
Q Consensus       397 ~~~~~~-~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~----~~~~~  469 (684)
                      ++|.+. +.||+|+||+||++.. .+++.||+|+++.     ...+.+|+.++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            457776 7899999999999996 4789999998864     24567888888 55699999999999987    67789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCcEEEeccCCc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGAS  546 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgl~  546 (684)
                      +||||+++++|.+++..... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999987543 35999999999999999999999999   999999999999998   789999999998


Q ss_pred             cccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ....                       +..++.++||||||+++|||++|+.||.........           ......
T Consensus       168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~  213 (299)
T 3m2w_A          168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTR  213 (299)
T ss_dssp             EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred             cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHH
Confidence            6432                       234678999999999999999999999744321100           000000


Q ss_pred             hhhhhh--hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043157          627 ILDARV--MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL  669 (684)
Q Consensus       627 ~~d~~~--~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L  669 (684)
                      +.....  ........+.++.+|+.+||+.||++|||++|++++-
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            000000  0000023567899999999999999999999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-36  Score=328.13  Aligned_cols=244  Identities=14%  Similarity=0.161  Sum_probs=183.9

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccCh---hHHHHHHHHHHHHhhcCC-Cccccee---------e
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDE---SKVEEFINEMVILSQINH-RNVVKLL---------G  460 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-pnIv~l~---------~  460 (684)
                      ...+|...++||+|+||+||+|.+ .+|+.||||++.....   ...+.+.+|+.+++.++| +|.....         .
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            345688889999999999999995 4799999998774322   236789999999999987 3222111         1


Q ss_pred             e------------eee-----cCcceEEEEecCCCCHHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 043157          461 C------------CLE-----TEVPLLVYEFIPNGTLFQYIHDQ----NEDFPITWEMRLRIAIEVSGALSYLHSAASIP  519 (684)
Q Consensus       461 ~------------~~~-----~~~~~lv~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~  519 (684)
                      .            ...     ....+++|+++ +++|.++++..    .....+++..++.++.||++||+|||+++   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence            1            111     11345666655 68999998521    12334888999999999999999999999   


Q ss_pred             eEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecccccCCCCCcccc----------ccCCCCCccchhhhHHH
Q 043157          520 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF----------RSSQFTDKSDVYSFGVV  589 (684)
Q Consensus       520 iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDv~SlGvi  589 (684)
                      |+||||||+||||+.++.+||+|||+++.....    .....| +.|+|||++          ....++.++||||||++
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            999999999999999999999999998764322    344567 999999998          55568889999999999


Q ss_pred             HHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          590 LAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       590 l~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      +|||++|+.||......+.               ...++.      .....+.++.+|+.+||+.||++||++.|++++
T Consensus       307 l~elltg~~Pf~~~~~~~~---------------~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGG---------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSC---------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHCCCCCCCcchhhh---------------HHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            9999999999975432211               111111      112345789999999999999999998877654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.2e-36  Score=319.83  Aligned_cols=242  Identities=16%  Similarity=0.213  Sum_probs=183.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccC--------hhHHHHHHHHHHHHhhcC---------CCcccce
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID--------ESKVEEFINEMVILSQIN---------HRNVVKL  458 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------HpnIv~l  458 (684)
                      .++|++.++||+|+||+||+++. +++.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688999999999999999998 78999999886532        233578899999999886         5555554


Q ss_pred             -----------------eeeeee-------------cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHH
Q 043157          459 -----------------LGCCLE-------------TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA  508 (684)
Q Consensus       459 -----------------~~~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a  508 (684)
                                       ++++.+             .+..+|||||+++|++.+.+.+    ..+++..++.++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence                             444443             6788999999999987777744    238999999999999999


Q ss_pred             HHHHH-hCCCCCeEecCCCCCCEEECCCC--------------------cEEEeccCCccccccCCceeeecccccCCCC
Q 043157          509 LSYLH-SAASIPIYHRDIKSTNILLDDKY--------------------RAKVSDFGASRSMAVDQTHMTTQVHGTFGYL  567 (684)
Q Consensus       509 L~yLH-~~~~~~iiH~Dlkp~NILl~~~~--------------------~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~  567 (684)
                      |+||| +++   |+||||||+||||+.++                    .+||+|||+++.....      ...||+.|+
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~  244 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM  244 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence            99999 899   99999999999999887                    8999999999865432      236899999


Q ss_pred             CccccccCCCCCccchhhhHHH-HHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhh--hhhhhhccCChhHHHHH
Q 043157          568 DPEYFRSSQFTDKSDVYSFGVV-LAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI--LDARVMKESGGDEIITF  644 (684)
Q Consensus       568 aPE~~~~~~~~~ksDv~SlGvi-l~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~d~~~~~~~~~~~~~~l  644 (684)
                      |||++.+.. +.++|||||+.+ .+++++|..||....      ......     ..+...  .............+.++
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLT-----DKMLKQMTFKTKCNTPAMKQIKRKI  312 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHH-----HHHHHTCCCSSCCCSHHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHH-----HhhhhhhccCcccchhhhhhcCHHH
Confidence            999998766 889999998777 777889999974110      000000     000000  00001111224578899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHH-HH
Q 043157          645 AKVAKRCLNLNGKKRPTMREVT-SE  668 (684)
Q Consensus       645 ~~Li~~cl~~dp~~RPt~~evl-~~  668 (684)
                      .+|+.+||+.|     |++|++ ++
T Consensus       313 ~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHhccC-----CHHHHHhcC
Confidence            99999999976     999988 53

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.5e-29  Score=286.30  Aligned_cols=184  Identities=19%  Similarity=0.133  Sum_probs=129.3

Q ss_pred             eceeCcEEEEEEE-eCCCcEEEEEecccc----------ChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEEE
Q 043157          405 LGQGGQGTVYKGM-LPDGKIVAVKKSKVI----------DESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       405 LG~G~~g~Vy~~~-~~~g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++.|++|.+..+. .-.|+.+++|.+...          .+...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4455555555443 224778999976532          123457799999999999 7999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||++|++|.++|.+..   ++++.   +|+.||+.||+|||+++   |+||||||+||||++++++||+|||+++....+
T Consensus       322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999998754   36654   48899999999999999   999999999999999999999999999876543


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCC
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP  599 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P  599 (684)
                      .. ......||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            33 2344569999999999865 467789999999998877665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=3.3e-26  Score=257.56  Aligned_cols=185  Identities=15%  Similarity=0.192  Sum_probs=147.1

Q ss_pred             CcCceeceeCcEEEEEEEeCCCcEEEEEeccccC--------hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          400 NLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID--------ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       400 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ...++||+|+||+||++.. .++.+++|+.....        ....+++.+|++++++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 56778888643311        12245689999999999999999777777788888999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++++|.+++++           +..++.|+++||+|||+++   |+||||||+|||+++  ++||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999976           3579999999999999999   999999999999999  999999999987654


Q ss_pred             CCcee------eecccccCCCCCcccccc--CCCCCccchhhhHHHHHHHHhCCCCCC
Q 043157          552 DQTHM------TTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLAELLTGEKPIR  601 (684)
Q Consensus       552 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltG~~P~~  601 (684)
                      .....      .....||+.|||||++..  ..|+.++|+|+..+-.++-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            32221      235679999999999977  668889999999999999888877764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=7.7e-23  Score=211.13  Aligned_cols=149  Identities=17%  Similarity=0.149  Sum_probs=121.1

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccCh------------------hHHHHHHHHHHHHhhcCCCc
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDE------------------SKVEEFINEMVILSQINHRN  454 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~Hpn  454 (684)
                      ......|.+.+.||+|+||.||++.+.+|+.||+|.++....                  .....+.+|+.++++++  |
T Consensus        86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~  163 (282)
T 1zar_A           86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G  163 (282)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred             HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence            334456677799999999999999997799999998764221                  24567899999999999  4


Q ss_pred             ccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC
Q 043157          455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD  534 (684)
Q Consensus       455 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~  534 (684)
                       +++.+++ +.+..++||||+++++|.+ +..         .....++.|++.||.|||+++   |+||||||+|||++ 
T Consensus       164 -~~v~~~~-~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-  227 (282)
T 1zar_A          164 -LAVPKVY-AWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-  227 (282)
T ss_dssp             -SSSCCEE-EEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred             -CCcCeEE-eccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence             6666654 3467799999999999988 421         123469999999999999999   99999999999999 


Q ss_pred             CCcEEEeccCCccccccCCceeeecccccCCCCCccccc
Q 043157          535 KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR  573 (684)
Q Consensus       535 ~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~  573 (684)
                      ++.+||+|||+++.              +..++|||++.
T Consensus       228 ~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            99999999999863              44578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=4.9e-19  Score=180.26  Aligned_cols=136  Identities=21%  Similarity=0.202  Sum_probs=107.1

Q ss_pred             CCcCceeceeCcEEEEEEEe-CCCcE--EEEEeccccCh------------------------hHHHHHHHHHHHHhhcC
Q 043157          399 FNLNRILGQGGQGTVYKGML-PDGKI--VAVKKSKVIDE------------------------SKVEEFINEMVILSQIN  451 (684)
Q Consensus       399 ~~~~~~LG~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~  451 (684)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||..+....                        .....+.+|+.+|++++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56789999999999999997 68888  99997543211                        11246889999999998


Q ss_pred             CCcc--cceeeeeeecCcceEEEEecCC-C----CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEec
Q 043157          452 HRNV--VKLLGCCLETEVPLLVYEFIPN-G----TLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH-SAASIPIYHR  523 (684)
Q Consensus       452 HpnI--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~iiH~  523 (684)
                      |+++  +.++..    ...+|||||+.+ |    +|.++...      .++..+..++.|++.+|.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8864  334432    467899999942 4    67666532      224456789999999999999 888   9999


Q ss_pred             CCCCCCEEECCCCcEEEeccCCcccc
Q 043157          524 DIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       524 Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      ||||+|||+++  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999998653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.63  E-value=2e-16  Score=167.98  Aligned_cols=138  Identities=13%  Similarity=0.164  Sum_probs=98.7

Q ss_pred             CCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccC--------------hhHHHHH--------HHHHHHHhhcCCCcc
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID--------------ESKVEEF--------INEMVILSQINHRNV  455 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~--------------~~~~~~~--------~~E~~~l~~l~HpnI  455 (684)
                      -|.+.+.||+|++|.||+|...+|+.||||+.+...              .......        .+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            388999999999999999999899999999754210              0011112        345556666644443


Q ss_pred             cceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC
Q 043157          456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK  535 (684)
Q Consensus       456 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~  535 (684)
                      .-..-+  .....+|||||+++++|.++..       .  +....++.|++.+|.|||+.+   |+||||||.||||+++
T Consensus       176 ~vp~p~--~~~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          176 PVPEPI--AQSRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE  241 (397)
T ss_dssp             SCCCEE--EEETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred             CCCeee--eccCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence            221111  1224479999999988865432       1  123568899999999999999   9999999999999877


Q ss_pred             C----------cEEEeccCCcccc
Q 043157          536 Y----------RAKVSDFGASRSM  549 (684)
Q Consensus       536 ~----------~~kl~DFgl~~~~  549 (684)
                      +          .+.|+||+-+-..
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCcccccccccceEEEEeCCcccC
Confidence            6          4899999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.28  E-value=8.9e-12  Score=126.46  Aligned_cols=146  Identities=14%  Similarity=0.093  Sum_probs=113.9

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEE
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ....+.|.+...++.|+.+.||+.... ++.+++|............+.+|+.+++.+. |..+.+++++..+.+..++|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344567888888999999999999754 6789999876422222346889999999994 67788999999888899999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA-----------------------------------  516 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----------------------------------  516 (684)
                      |||++|.+|.+.+..        ......++.+++++|+.||+..                                   
T Consensus        89 ~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999999876321        1123467889999999999821                                   


Q ss_pred             ---------------------CCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          517 ---------------------SIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       517 ---------------------~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                                           ...++|+|++|.|||++++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 1338999999999999876566799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.06  E-value=1.2e-10  Score=117.49  Aligned_cols=136  Identities=15%  Similarity=0.182  Sum_probs=100.4

Q ss_pred             CCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCc--ccceeeeeeecCcceEEEEec
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN--VVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .+.+..+.+.|..+.||+....+|+.+++|.....   ....+.+|+.+++.+.+.+  +.+++++..+.+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            44443333456669999998777888999986543   2246778999999996545  556888888777889999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA---------------------------------------  516 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------------  516 (684)
                      +|.+|.  ...      .+   ...++.++++.|..||+..                                       
T Consensus        98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            998883  211      12   1256778888888888753                                       


Q ss_pred             ----------------CCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          517 ----------------SIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       517 ----------------~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                                      ...++|+|++|.|||++++..+.|+||+.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                            1129999999999999887667799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.00  E-value=9.4e-10  Score=116.99  Aligned_cols=142  Identities=15%  Similarity=0.206  Sum_probs=105.9

Q ss_pred             cCceeceeCcEEEEEEEeCCCcEEEEEecc--ccC-hhHHHHHHHHHHHHhhcC--CCcccceeeeeeec---CcceEEE
Q 043157          401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSK--VID-ESKVEEFINEMVILSQIN--HRNVVKLLGCCLET---EVPLLVY  472 (684)
Q Consensus       401 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~---~~~~lv~  472 (684)
                      ..+.|+.|.+..||+....+ ..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            35678999999999988755 567888765  321 123457888999999997  45678888888766   4589999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA------------------------------------  516 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------  516 (684)
                      ||++|.++.+..     ...++...+..++.+++++|+.||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999988774311     112678888899999999999999831                                    


Q ss_pred             -------------------CCCeEecCCCCCCEEECCCCc--EEEeccCCccc
Q 043157          517 -------------------SIPIYHRDIKSTNILLDDKYR--AKVSDFGASRS  548 (684)
Q Consensus       517 -------------------~~~iiH~Dlkp~NILl~~~~~--~kl~DFgl~~~  548 (684)
                                         ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               245999999999999987653  69999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.95  E-value=6.5e-10  Score=115.39  Aligned_cols=184  Identities=20%  Similarity=0.208  Sum_probs=123.8

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCc--ccceeeeeeecC---cceEEEEec
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRN--VVKLLGCCLETE---VPLLVYEFI  475 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~Hpn--Iv~l~~~~~~~~---~~~lv~E~~  475 (684)
                      .+.++.|....||+..    +.+++|+...  ......+.+|.++|+.+ .+..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999853    4578887543  34457789999999988 3433  344554443333   458999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA---------------------------------------  516 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------------  516 (684)
                      +|.+|.+....     .++.+++..++.++++.|+.||+..                                       
T Consensus        99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            99888764432     2777888889999999999999621                                       


Q ss_pred             ----------------CCCeEecCCCCCCEEECC--CCcEEEeccCCccccccCCceeeecccccCCC---CCcccccc-
Q 043157          517 ----------------SIPIYHRDIKSTNILLDD--KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY---LDPEYFRS-  574 (684)
Q Consensus       517 ----------------~~~iiH~Dlkp~NILl~~--~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-  574 (684)
                                      ...++|+|++|.||++++  +..+.|+||+.+........ ..    .....   ..|+.... 
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~----~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FI----SLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HH----TTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HH----HHHhhccccCHHHHHHH
Confidence                            134899999999999998  55689999998764321000 00    00011   22222110 


Q ss_pred             ----CCC---------CCccchhhhHHHHHHHHhCCCCCC
Q 043157          575 ----SQF---------TDKSDVYSFGVVLAELLTGEKPIR  601 (684)
Q Consensus       575 ----~~~---------~~ksDv~SlGvil~elltG~~P~~  601 (684)
                          +..         ....+.|+++.+++.+.+|..+|.
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                000         123689999999999999998863

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.44  E-value=1.8e-06  Score=89.39  Aligned_cols=135  Identities=15%  Similarity=0.167  Sum_probs=96.5

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCC---cccceeeeee-ecCcceEEEEecCC
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHR---NVVKLLGCCL-ETEVPLLVYEFIPN  477 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~-~~~~~~lv~E~~~~  477 (684)
                      .+.++.|....||+.    ++.+++|+..  .......+.+|.++|+.+.+.   .+.+++.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888888999987    4567788743  234567889999999999653   3556666664 44568999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA-----------------------------------------  516 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----------------------------------------  516 (684)
                      .+|.+....     .++......++.++++.|+.||+..                                         
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            888764321     1455566666666666666666532                                         


Q ss_pred             ----------------CCCeEecCCCCCCEEECC---CCc-EEEeccCCcc
Q 043157          517 ----------------SIPIYHRDIKSTNILLDD---KYR-AKVSDFGASR  547 (684)
Q Consensus       517 ----------------~~~iiH~Dlkp~NILl~~---~~~-~kl~DFgl~~  547 (684)
                                      ...++|+|++|.|||+++   ++. +.|+||+.+.
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                            223699999999999987   455 5899999764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.30  E-value=5.1e-06  Score=84.03  Aligned_cols=134  Identities=20%  Similarity=0.207  Sum_probs=96.1

Q ss_pred             eeceeCc-EEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEEEEecCCCCH
Q 043157          404 ILGQGGQ-GTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTL  480 (684)
Q Consensus       404 ~LG~G~~-g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~~gsL  480 (684)
                      .+..|.. ..||+.... ++..+.+|+...   .....+.+|...|+.+. +-.+.+++.++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            3444544 479987754 456788887653   34567888999999884 44477888999888999999999999888


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 043157          481 FQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA--------------------------------------------  516 (684)
Q Consensus       481 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------------  516 (684)
                      .+......       .....+..++++.|+-||+..                                            
T Consensus       108 ~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            77654321       122345566666666666421                                            


Q ss_pred             -----------CCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          517 -----------SIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       517 -----------~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                                 .+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       1227899999999999988777799998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.13  E-value=2.2e-06  Score=90.68  Aligned_cols=80  Identities=4%  Similarity=-0.017  Sum_probs=55.4

Q ss_pred             Ccee-ceeCcEEEEEEEeC-------CCcEEEEEeccccC---hhHHHHHHHHHHHHhhcC-C--Ccccceeeeeeec--
Q 043157          402 NRIL-GQGGQGTVYKGMLP-------DGKIVAVKKSKVID---ESKVEEFINEMVILSQIN-H--RNVVKLLGCCLET--  465 (684)
Q Consensus       402 ~~~L-G~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~--  465 (684)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.+. +  -.+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 88888999998754       26678888754321   001245678888888884 3  3567788777655  


Q ss_pred             -CcceEEEEecCCCCHH
Q 043157          466 -EVPLLVYEFIPNGTLF  481 (684)
Q Consensus       466 -~~~~lv~E~~~~gsL~  481 (684)
                       +..++|||+++|.++.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3578999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.95  E-value=3.7e-05  Score=80.25  Aligned_cols=140  Identities=16%  Similarity=0.189  Sum_probs=79.5

Q ss_pred             ceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCC--Ccccceee------eeeecCcceEEEEe
Q 043157          403 RILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH--RNVVKLLG------CCLETEVPLLVYEF  474 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~------~~~~~~~~~lv~E~  474 (684)
                      +.|+.|....||+....+++ +++|+... ..   +++..|+.+++.|..  -.+++++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGA-VCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTEE-EEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCCC-EEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            45666778899999876654 88888764 22   233445555555531  12333332      12245667899999


Q ss_pred             cCCCCHH--------------HHHhhcCCCC-----------CCCHHHH-------------------------------
Q 043157          475 IPNGTLF--------------QYIHDQNEDF-----------PITWEMR-------------------------------  498 (684)
Q Consensus       475 ~~~gsL~--------------~~l~~~~~~~-----------~l~~~~~-------------------------------  498 (684)
                      ++|.++.              ..+|......           .-.|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              2233211100           0122211                               


Q ss_pred             HHHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          499 LRIAIEVSGALSYLHS----------AASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       499 ~~i~~qia~aL~yLH~----------~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      ..+..++..++++|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1111234456667763          123449999999999999888899999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.93  E-value=3.3e-05  Score=82.82  Aligned_cols=75  Identities=15%  Similarity=0.171  Sum_probs=50.0

Q ss_pred             CceeceeCcEEEEEEEeC-CCcEEEEEeccccCh-------hHHHHHHHHHHHHhhcCC--Cc-ccceeeeeeecCcceE
Q 043157          402 NRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDE-------SKVEEFINEMVILSQINH--RN-VVKLLGCCLETEVPLL  470 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--pn-Iv~l~~~~~~~~~~~l  470 (684)
                      .+.||.|..+.||++... +++.++||.......       ...+.+..|.++++.+..  |. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999999754 467899997543211       123456789999988742  43 3455543  4556789


Q ss_pred             EEEecCCC
Q 043157          471 VYEFIPNG  478 (684)
Q Consensus       471 v~E~~~~g  478 (684)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.64  E-value=0.00022  Score=73.72  Aligned_cols=139  Identities=17%  Similarity=0.130  Sum_probs=92.5

Q ss_pred             cCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcC---CCcccceeeeeeecCcceEEEEecCC
Q 043157          401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN---HRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       401 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      -.+.|+.|....+|+... +++.+++|+...   .....+..|...|+.|.   ...+++++.+....+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            356789999999999886 456788887653   23567889999999884   36688888888877889999999998


Q ss_pred             CCHH-----------HHHhhcCC--CC-----------------CCCHHHHH---HHHH----------------HHHHH
Q 043157          478 GTLF-----------QYIHDQNE--DF-----------------PITWEMRL---RIAI----------------EVSGA  508 (684)
Q Consensus       478 gsL~-----------~~l~~~~~--~~-----------------~l~~~~~~---~i~~----------------qia~a  508 (684)
                      ..+.           ..||....  ..                 .-+|....   ++..                ++...
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7642           22343221  10                 12454321   1111                11111


Q ss_pred             -HHHHHh-CCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          509 -LSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       509 -L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                       ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             123432 2245699999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.62  E-value=0.00025  Score=72.37  Aligned_cols=79  Identities=18%  Similarity=0.117  Sum_probs=58.2

Q ss_pred             CCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcC-CC--cccceeeeeeecCcceEEEEe
Q 043157          398 NFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HR--NVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-Hp--nIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .+.-.+.+|.|..+.||+..+.+|+.+.+|+...........|..|...|+.|. ..  .++++++.    +..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            455567899999999999999999999999866544433456788999999884 21  24445543    345899999


Q ss_pred             cCCCCH
Q 043157          475 IPNGTL  480 (684)
Q Consensus       475 ~~~gsL  480 (684)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.50  E-value=0.00052  Score=74.06  Aligned_cols=79  Identities=9%  Similarity=-0.006  Sum_probs=46.1

Q ss_pred             CCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceeeecccccCCCCCccccccCC---CCCccchhhhHHHHHHHH
Q 043157          518 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLAELL  594 (684)
Q Consensus       518 ~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~SlGvil~ell  594 (684)
                      ..++|+|++|.|||+++++ ++|+||+.+........-......-...|++|+......   .....++......+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            3499999999999998876 999999987643211000000000112355665543211   112355567788888777


Q ss_pred             hCC
Q 043157          595 TGE  597 (684)
Q Consensus       595 tG~  597 (684)
                      ++.
T Consensus       311 ~~~  313 (420)
T 2pyw_A          311 NKR  313 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.23  E-value=0.00097  Score=68.92  Aligned_cols=158  Identities=13%  Similarity=0.170  Sum_probs=87.7

Q ss_pred             CCHHHHHHHhcCCCc-----CceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCc--cccee
Q 043157          387 FTSKELERATDNFNL-----NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN--VVKLL  459 (684)
Q Consensus       387 ~~~~e~~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~  459 (684)
                      ++.+++.....+|.+     .+.|+.|....+|+....++ .+++|.....  ...+++..|+.+++.+...+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            345556555555655     24566788899999987666 4778876542  12234556777777774222  23333


Q ss_pred             ee------eeecCcceEEEEecCCCCHH--------------HHHhhcCCCCC------C---CHHHHHH----------
Q 043157          460 GC------CLETEVPLLVYEFIPNGTLF--------------QYIHDQNEDFP------I---TWEMRLR----------  500 (684)
Q Consensus       460 ~~------~~~~~~~~lv~E~~~~gsL~--------------~~l~~~~~~~~------l---~~~~~~~----------  500 (684)
                      ..      ....+..+++|+|++|..+.              ..+|.......      .   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      12235578999999886531              11232111100      1   1222110          


Q ss_pred             --HHHHHHHHHHHHHhC----CCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          501 --IAIEVSGALSYLHSA----ASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       501 --i~~qia~aL~yLH~~----~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                        +...+.+.++.|+..    ....++|+|+++.|||++++..+.|+||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              011244556666532    12348999999999999887556899998764

>1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens}

Probab=97.09  E-value=0.00019  Score=59.08  Aligned_cols=50  Identities=16%  Similarity=0.458  Sum_probs=40.6

Q ss_pred             CCCcccCCCCccccCCCCCCCCCCCCCccccCCCCCCcCccccc--cccccCcceeecccccceeeeEEEeec
Q 043157          250 SGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD--SFFSKKTRIIFGNISSFIIYRYAISIL  320 (684)
Q Consensus       250 c~~~~~~~~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (684)
                      |.+.    ..+|.| .|+.||.+   ++..    ..|++++||.  +|    .+.|.|..++     |.|.|+
T Consensus        18 C~n~----~g~y~C-~C~~G~~~---~~~g----~~C~dideC~~~~C----~~~C~n~~g~-----y~C~C~   69 (87)
T 1z6c_A           18 CKNI----PGDFEC-ECPEGYRY---NLKS----KSCEDIDECSENMC----AQLCVNYPGG-----YTCYCD   69 (87)
T ss_dssp             CCCB----TTBCCC-SSSTTCEE---ETTT----TEEECCCHHHHSCC----SSEECCCSSS-----CCEECC
T ss_pred             eECC----CCCEEE-ECCCCceE---CCCC----CcCCCcCeeCCCCC----CCEEEccCCC-----EEEECC
Confidence            5554    568999 99999997   6543    4799999998  46    4699999999     999996

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.07  E-value=0.0018  Score=66.24  Aligned_cols=71  Identities=15%  Similarity=0.123  Sum_probs=44.3

Q ss_pred             CceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcc-cceeeeeeecCcceEEEEec-CCCC
Q 043157          402 NRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV-VKLLGCCLETEVPLLVYEFI-PNGT  479 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~E~~-~~gs  479 (684)
                      .+.|+.|....+|+.     +.+++|+...... ......+|+.+++.+...++ .++++.  +.+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            688998999999998     4477776543211 11123468888877743333 455544  344567999999 6544


Q ss_pred             H
Q 043157          480 L  480 (684)
Q Consensus       480 L  480 (684)
                      |
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.06  E-value=0.0033  Score=65.24  Aligned_cols=141  Identities=12%  Similarity=0.104  Sum_probs=73.1

Q ss_pred             ceeceeCcEE-EEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCC--CcccceeeeeeecCcceEEEEecCCCC
Q 043157          403 RILGQGGQGT-VYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGT  479 (684)
Q Consensus       403 ~~LG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lv~E~~~~gs  479 (684)
                      +.|+.|+... +|+....+++.+++|.......   +.+..|+.+++.+..  -.+.+++.+..  +.-+++||++.+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence            3455554444 6677654466777776543221   234456777777642  23456666532  33388999998777


Q ss_pred             HHHHHhhcC---------------------C-CCC-CCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 043157          480 LFQYIHDQN---------------------E-DFP-ITWEMRL-------R-I------------AIEVSGALSYLH---  513 (684)
Q Consensus       480 L~~~l~~~~---------------------~-~~~-l~~~~~~-------~-i------------~~qia~aL~yLH---  513 (684)
                      +.+.+....                     . ..+ ++.....       . +            ...+...++.|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            655443210                     0 001 2221110       0 0            011222233331   


Q ss_pred             hCCCCCeEecCCCCCCEEECCC----CcEEEeccCCccc
Q 043157          514 SAASIPIYHRDIKSTNILLDDK----YRAKVSDFGASRS  548 (684)
Q Consensus       514 ~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFgl~~~  548 (684)
                      ......++|+|+.+.|||++.+    ..+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1123349999999999999874    6899999998754

>1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A

Probab=96.95  E-value=0.0003  Score=57.13  Aligned_cols=47  Identities=17%  Similarity=0.269  Sum_probs=38.0

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCccccc---cccccCcceeecccccceeeeEEEeeccc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD---SFFSKKTRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      ..+|+| .|+.||.+   +      +..|+|++||.   +|.   .++|.|..++     |.|.|+..
T Consensus        23 ~g~y~C-~C~~Gy~~---~------g~~C~dideC~~~~~C~---~~~C~n~~g~-----y~C~C~~G   72 (82)
T 1emn_A           23 DGSYRC-ECPFGYIL---A------GNECVDTDECSVGNPCG---NGTCKNVIGG-----FECTCEEG   72 (82)
T ss_dssp             SSCCCE-ECCTTEEE---E------TTEEEECCGGGTCCTTS---SSCEEECSSS-----EEECCSSS
T ss_pred             CCCEEE-ECCCCeEC---C------CCccCCcccccCCCCCC---CCEeECCCCC-----EEeECCCC
Confidence            568999 99999975   1      35799999997   352   3699999999     99999873

>1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1

Probab=96.94  E-value=0.0002  Score=58.76  Aligned_cols=50  Identities=16%  Similarity=0.343  Sum_probs=41.2

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCccccc--c--ccccCcceeecccccceeeeEEEeeccc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD--S--FFSKKTRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      ..+|.| .|+.||.+   +++.   +..|+|||||.  +  | .  .+.|.|..|+     |.|.|+..
T Consensus        22 ~g~y~C-~C~~Gy~~---~~~~---g~~C~dideC~~~~~~C-~--~~~C~n~~g~-----y~C~C~~G   75 (86)
T 1lmj_A           22 PGDFEC-KCDEGYES---GFMM---MKNCMDIDECQRDPLLC-R--GGVCHNTEGS-----YRCECPPG   75 (86)
T ss_dssp             TTEEEE-CCCSSEEE---CTTT---SSSEEECCHHHHCSSTT-T--TSEEEEETTE-----EEEESCTT
T ss_pred             CCCEEe-eCCCCcCc---cCCC---CCccCCcccccCCCCcC-C--CCEeEcCCCC-----EEEECcCC
Confidence            568999 99999997   6655   56799999997  3  4 2  3799999999     99999873

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.92  E-value=0.0053  Score=58.97  Aligned_cols=103  Identities=17%  Similarity=0.109  Sum_probs=67.8

Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCceee
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT  557 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~~  557 (684)
                      -||.++|...+.  ||+++++|.++.|.+.+|.-+-.....  ..+=+.|..|+|..+|.|-+.+ ..+.          
T Consensus        33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc----------
Confidence            489999998654  699999999999999998776322211  1223346899999999988774 1110          


Q ss_pred             ecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCC
Q 043157          558 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP  599 (684)
Q Consensus       558 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P  599 (684)
                         .....+.+||... ...+.+.=|||||++||..+--..|
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence               0122366888763 3456789999999999998864443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.92  E-value=0.0087  Score=61.78  Aligned_cols=141  Identities=14%  Similarity=0.121  Sum_probs=80.4

Q ss_pred             ceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCc--ccceeee-----eeecCcceEEEEec
Q 043157          403 RILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRN--VVKLLGC-----CLETEVPLLVYEFI  475 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~-----~~~~~~~~lv~E~~  475 (684)
                      +.|+ |....||+....+|+.+++|...... ...+.+..|..+++.+....  +++++..     ....+..+++||++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4577 88889999887778788999875321 12345667888888874222  4444443     11234557899999


Q ss_pred             CCCCHH-----H---------HHhhcCC------CCCCCHHHH----HHH---------------HHHHHHHHHHHHhC-
Q 043157          476 PNGTLF-----Q---------YIHDQNE------DFPITWEMR----LRI---------------AIEVSGALSYLHSA-  515 (684)
Q Consensus       476 ~~gsL~-----~---------~l~~~~~------~~~l~~~~~----~~i---------------~~qia~aL~yLH~~-  515 (684)
                      +|.++.     .         .+|....      ...+++...    ..+               ...+...++.+... 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875432     1         1222110      011222211    001               11111223333321 


Q ss_pred             ---CCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          516 ---ASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       516 ---~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                         ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence               223488999999999999 4 89999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.86  E-value=0.0014  Score=70.77  Aligned_cols=73  Identities=19%  Similarity=0.240  Sum_probs=49.4

Q ss_pred             CceeceeCcEEEEEEEeCC--------CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcc-cceeeeeeecCcceEEE
Q 043157          402 NRILGQGGQGTVYKGMLPD--------GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV-VKLLGCCLETEVPLLVY  472 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~  472 (684)
                      .+.|+.|....+|+....+        ++.+.+|+.....  ..+.+.+|..+++.+...++ +++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4668888889999998653        4678888764311  12455689999998853344 566665532    3899


Q ss_pred             EecCCCCH
Q 043157          473 EFIPNGTL  480 (684)
Q Consensus       473 E~~~~gsL  480 (684)
                      ||+++.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.74  E-value=0.0075  Score=65.60  Aligned_cols=74  Identities=14%  Similarity=0.034  Sum_probs=47.2

Q ss_pred             CceeceeCcEEEEEEEeCC-CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcc-cceeeeeeecCcceEEEEecCCCC
Q 043157          402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV-VKLLGCCLETEVPLLVYEFIPNGT  479 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~E~~~~gs  479 (684)
                      .+.|+.|-...+|+....+ ++.+++|+....... .-...+|..+++.|...++ .++++.+.    ..+||||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCcc
Confidence            4678888889999998765 467888865332111 1112578999998865555 46776662    236999998754


Q ss_pred             H
Q 043157          480 L  480 (684)
Q Consensus       480 L  480 (684)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.65  E-value=0.0059  Score=64.69  Aligned_cols=141  Identities=20%  Similarity=0.237  Sum_probs=82.3

Q ss_pred             CceeceeCcEEEEEEEeC--------CCcEEEEEeccccChhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCcceEEE
Q 043157          402 NRILGQGGQGTVYKGMLP--------DGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      .+.|..|-...+|+....        +++.+.+|+.... ......+.+|..+++.|. +.-..++++.+.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            356666778889998864        2467888875332 123456678999998884 3223566666543    2999


Q ss_pred             EecCCCCHHH--------------H---HhhcCC--CCCC--CHHHHHHHHHHHHH-------------------HHHHH
Q 043157          473 EFIPNGTLFQ--------------Y---IHDQNE--DFPI--TWEMRLRIAIEVSG-------------------ALSYL  512 (684)
Q Consensus       473 E~~~~gsL~~--------------~---l~~~~~--~~~l--~~~~~~~i~~qia~-------------------aL~yL  512 (684)
                      ||++|.+|..              .   ||....  ..+.  -+.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9999765431              1   121111  0111  24455555544322                   23333


Q ss_pred             ----HhC-CCCCeEecCCCCCCEEECCC----CcEEEeccCCcc
Q 043157          513 ----HSA-ASIPIYHRDIKSTNILLDDK----YRAKVSDFGASR  547 (684)
Q Consensus       513 ----H~~-~~~~iiH~Dlkp~NILl~~~----~~~kl~DFgl~~  547 (684)
                          ... ....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                222 22348999999999999876    789999998764

>2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A

Probab=96.60  E-value=0.00029  Score=60.35  Aligned_cols=46  Identities=22%  Similarity=0.506  Sum_probs=17.7

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCccccc---cccccCcceeecccccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD---SFFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      ..+|.| .|+.||.|   ++     +..|+|||||.   +|    .+.|.|..++     |.|.|+.
T Consensus        47 ~g~y~C-~C~~Gy~g---~~-----g~~C~dideC~~~~~C----~~~C~n~~gs-----y~C~C~~   95 (107)
T 2w2n_E           47 KIGYEC-LCPDGFQL---VA-----QRRCEDIDECQDPDTC----SQLCVNLEGG-----YKCQCEE   95 (107)
T ss_dssp             SBSCEE-ECCTTCEE---ET-----TTEEEC------------------------------------
T ss_pred             CCCeEE-ECCCCccc---cC-----CCccccccccCCCCCc----CCeeecCCCC-----EEEECCC
Confidence            568999 99999998   31     35799999997   35    4689999999     9999986

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.45  E-value=0.0037  Score=65.99  Aligned_cols=74  Identities=12%  Similarity=0.099  Sum_probs=44.3

Q ss_pred             CceeceeCcEEEEEEEeCC---------CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCc-ccceeeeeeecCcceEE
Q 043157          402 NRILGQGGQGTVYKGMLPD---------GKIVAVKKSKVIDESKVEEFINEMVILSQINHRN-VVKLLGCCLETEVPLLV  471 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lv  471 (684)
                      .+.|+.|..-.+|+....+         ++.+++|+...... .......|..+++.+...+ ..++++..    ..++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence            3567778888999988654         26788887653221 1122457888888885334 34666543    24789


Q ss_pred             EEecCCCCH
Q 043157          472 YEFIPNGTL  480 (684)
Q Consensus       472 ~E~~~~gsL  480 (684)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.38  E-value=0.017  Score=60.10  Aligned_cols=66  Identities=9%  Similarity=0.089  Sum_probs=42.1

Q ss_pred             eCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcC---CCcccceeee------eeecCcceEEEEecCCC
Q 043157          408 GGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN---HRNVVKLLGC------CLETEVPLLVYEFIPNG  478 (684)
Q Consensus       408 G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~------~~~~~~~~lv~E~~~~g  478 (684)
                      |....||+....+| .+++|+......      ..|+.+++.|.   -|.+++++..      ....+..+++|+|++|.
T Consensus        34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            33678999987777 888997655332      34566666652   2224454432      12345678999999987


Q ss_pred             CH
Q 043157          479 TL  480 (684)
Q Consensus       479 sL  480 (684)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            65

>3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L

Probab=95.75  E-value=0.002  Score=68.93  Aligned_cols=46  Identities=22%  Similarity=0.520  Sum_probs=37.9

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCccccc---cccccCcceeecccccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD---SFFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      ..||.| .|+.||.+   +     ++..|.|+|||.   +|    ...|.|..|+     |.|.|..
T Consensus        18 ~~~y~C-~C~~G~~~---~-----~~~~C~dideC~~~~~C----~~~C~n~~g~-----~~C~C~~   66 (400)
T 3p5b_L           18 KIGYEC-LCPDGFQL---V-----AQRRCEDIDECQDPDTC----SQLCVNLEGG-----YKCQCEE   66 (400)
T ss_dssp             SSSEEE-ECCTTEEE---C-----SSSCEEECCCCSTTSSC----SSCCBCCSSS-----CBCCCCT
T ss_pred             CCCeEE-ECCCCCCc---C-----CCCcccCchhhhccCCC----CCccCCCccc-----eeeeccc
Confidence            568999 99999986   1     145799999997   35    3489999999     9999987

>3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens}

Probab=95.73  E-value=0.0093  Score=61.50  Aligned_cols=49  Identities=24%  Similarity=0.400  Sum_probs=39.0

Q ss_pred             ccCCCcccCCCCccccCCCCCCCCCCCCCccccCCCCCCc-Ccccccc-----ccccCcceeecccccceeeeEEEeecc
Q 043157          248 LSSGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCS-PKRSRDS-----FFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       248 ~~c~~~~~~~~~gy~C~~C~~G~~g~~~npy~~~~~~~c~-~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      ..|.+.    ..+|.| .|+.||.|           ..|. |++||..     |    ...|.|..++     |.|.|+.
T Consensus        17 g~C~~~----~~~~~C-~C~~g~~g-----------~~C~~~~~eC~~~~~~~C----~~~C~~~~g~-----~~C~C~~   71 (317)
T 3h5c_B           17 GSCQDS----IWGYTC-TCSPGYEG-----------SNCELAKNECHPERTDGC----QHFCLPGQES-----YTCSCAQ   71 (317)
T ss_dssp             CCCCCC----SSSCCC-CCSSSCCS-----------SSSCCCSSSCCTTCTTSC----SSEEECCSSS-----CEEECCT
T ss_pred             CEeECC----CCCeEE-ECCCCCcC-----------CccccCcccCCCCCCCCC----cCccccCCCe-----eEEeccc
Confidence            335554    568999 99999988           3687 9999963     5    3389999999     9999987

>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A*

Probab=95.55  E-value=0.0074  Score=67.51  Aligned_cols=53  Identities=15%  Similarity=0.243  Sum_probs=41.3

Q ss_pred             CCccccCC-CCCCCCCCCCCcccc-------CCCCCCcCccccc----cccccCcceeeccc----ccceeeeEEEeecc
Q 043157          258 TSGHNCSK-CPDGYNYYRPAYYRP-------LQERRCSPKRSRD----SFFSKKTRIIFGNI----SSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~-C~~G~~g~~~npy~~-------~~~~~c~~~~~~~----~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  321 (684)
                      ..+|+| . |+.||.|   +.+..       .+...|.+++||.    +|..  .+.|.+..    ++     |.|.|+.
T Consensus        67 ~gsY~C-~~C~~Gy~G---~~c~g~g~~~~~~dg~~C~dideC~~~~~pC~~--~~~Cvnt~~~~~Gs-----Y~C~C~~  135 (634)
T 1yo8_A           67 QPGFHC-LPCPPRYRG---NQPVGVGLEAAKTEKQVCEPENPCKDKTHNCHK--HAECIYLGHFSDPM-----YKCECQT  135 (634)
T ss_dssp             SSSEEE-CCCCTTEEE---CCCEESSSHHHHSCCCCEEECCTTTTTCCCCCT--TEEEEECCTTCSSS-----EEEEECT
T ss_pred             cCceec-ccCCCCccc---CccccccccccccCCCcccccccccCCCccccc--Cccccccccccccc-----eeeeccC
Confidence            568999 7 9999999   76541       1234699999997    4643  57899998    88     9999988

>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A

Probab=95.34  E-value=0.0045  Score=55.86  Aligned_cols=54  Identities=19%  Similarity=0.301  Sum_probs=41.1

Q ss_pred             CCccccCCCCCCCCCCCCCcccc----CCCCCCcCccccc----cccccCcceeecccccceeeeEEEeeccc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRP----LQERRCSPKRSRD----SFFSKKTRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~----~~~~~c~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      ..+|.| .|+.||.|   +++..    .+...|+|++||.    +|..  .++|.+..++     |.|.|+..
T Consensus        65 ~g~y~C-~C~~Gy~g---~~~~~~~~~~~~~~C~dideC~~~~~~C~~--~~~C~n~~g~-----y~C~C~~G  126 (143)
T 2bou_A           65 EGSYDC-VCSPGYEP---VSGAKTFKNESENTCQDVDECSSGQHQCDS--STVCFNTVGS-----YSCRCRPG  126 (143)
T ss_dssp             SSCEEE-EECTTEEE---TTCCSCBSSGGGCCEEECCHHHHTCCCCCT--TSEEEECSSC-----EEEECCSS
T ss_pred             CCCeEe-ECCCCccc---CcCccccccCCCCCcCCccCccCcCCCCCC--CCEEECCCCC-----EEeeCCCC
Confidence            558999 99999998   54421    0134799999997    3633  4799999999     99999873

>1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L*

Probab=95.27  E-value=0.0044  Score=56.14  Aligned_cols=44  Identities=16%  Similarity=0.240  Sum_probs=36.1

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCcccccc----ccccCccee-ecccccceeeeEEEeeccc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRDS----FFSKKTRII-FGNISSFIIYRYAISILRL  322 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  322 (684)
                      ..+|.| .|+.||.|           ..|.++++|..    |    ...| .+..++     |.|.|+..
T Consensus        66 ~~~y~C-~C~~G~~G-----------~~C~~~deC~~~~~~C----~~~C~~n~~g~-----y~C~C~~G  114 (146)
T 1x7a_L           66 INSYEC-WCQVGFEG-----------KNCELDATCNIKNGRC----KQFCKTGADSK-----VLCSCTTG  114 (146)
T ss_dssp             SSCEEE-ECCSSEES-----------TTTCEECCTTSGGGSC----SSBCCCCSSSC-----CCCBCCTT
T ss_pred             CCCEEE-ecCCCCcC-----------CcCCCCccccCCCCCC----cCCCCCCCCCC-----EEeEcCCC
Confidence            568999 99999987           46888899873    4    3389 899998     99999873

>3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus}

Probab=95.25  E-value=0.0038  Score=66.39  Aligned_cols=47  Identities=13%  Similarity=0.220  Sum_probs=10.9

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCccccc---cccccCcceeecccccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD---SFFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      .++|.| .|+.||..   +|.    +..|+|++||.   +|    ...|.|..|+     |.|.|+.
T Consensus        21 ~g~~~C-~C~~G~~l---~~~----~~~C~d~~eC~~~~~C----~~~C~~~~g~-----~~C~C~~   70 (386)
T 3v65_B           21 RGAVQC-TCHTGYRL---TED----GRTCQDVNECAEEGYC----SQGCTNSEGA-----FQCWCEA   70 (386)
T ss_dssp             ---------------------------------------CC----TTEEC----------CCEECCT
T ss_pred             CCCcEe-ECCCCceE---CCC----CCccCccceeCCcCcc----cCcCCCCCCC-----CeEEECC
Confidence            445999 99999985   433    35799999996   46    3459999999     9999987

>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L*

Probab=95.19  E-value=0.0068  Score=57.56  Aligned_cols=43  Identities=16%  Similarity=0.329  Sum_probs=18.9

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcC-c-ccccc----ccccCcceeecccccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSP-K-RSRDS----FFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~-~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      ..+|.| .|+.||.|           ..|.+ + ++|..    |    ...|.+..++     |.|.|+.
T Consensus        60 ~g~y~C-~C~~Gf~G-----------~~Ce~~i~deC~~~~~~C----~~~C~n~~gs-----y~C~C~~  108 (195)
T 1nfu_B           60 LGEYTC-TCLEGFEG-----------KNCELFTRKLCSLDNGDC----DQFCHEEQNS-----VVCSCAR  108 (195)
T ss_dssp             ---------------------------------CCGGGTGGGGC----SSEEEEETTE-----EEEECCT
T ss_pred             CCCeeE-eCCCCcee-----------ccccccccccccCCCCCC----CCEeECCCCC-----eEEECCC
Confidence            568999 99999987           35876 5 88873    4    3489999998     9999998

>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L*

Probab=95.06  E-value=0.011  Score=51.12  Aligned_cols=43  Identities=16%  Similarity=0.301  Sum_probs=33.1

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCcc---cccc----ccccCcceeecccccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKR---SRDS----FFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~---~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      ..+|.| .|+.||.|           ..|++++   +|..    |    ...|.+..++     |.|.|+.
T Consensus        32 ~~~y~C-~C~~G~~G-----------~~C~~~~~~~~C~~~~~~C----~~~C~n~~g~-----y~C~C~~   81 (114)
T 1aut_L           32 IGSFSC-DCRSGWEG-----------RFCQREVSFLNCSLDNGGC----THYCLEEVGW-----RRCSCAP   81 (114)
T ss_dssp             SSCCCE-EECTTEES-----------TTSCEECCSSSSSSGGGGC----SSEEEECSSS-----EEEECCT
T ss_pred             CCCcEe-eCCCCCcC-----------CCcCcCCcCCcCcCCCCCC----CCEeECCCCC-----EEeECCC
Confidence            568999 99999988           2476654   4541    3    2389999999     9999987

>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A*

Probab=94.74  E-value=0.021  Score=63.88  Aligned_cols=48  Identities=19%  Similarity=0.326  Sum_probs=38.3

Q ss_pred             CCc-cccCCCCCCCCCCCCCccccCCCCCCcCccccc--c--ccccCcc---eeecccccceeeeEEEe-ecc
Q 043157          258 TSG-HNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD--S--FFSKKTR---IIFGNISSFIIYRYAIS-ILR  321 (684)
Q Consensus       258 ~~g-y~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~--~--~~~~~~~---~~~~~~~~~~~~~~~~~-~~~  321 (684)
                      ..| |+|..|+.||.|   |      +..|.+++||.  +  |..  .+   .|.+..++     |.|. |+.
T Consensus        21 ~~Gsy~C~~C~~GytG---d------g~~CeDiDEC~~~p~~C~~--gg~~~~CvNt~gs-----Y~C~~C~~   77 (634)
T 1yo8_A           21 PDGSWSCGFCPVGFLG---N------GTHCEDLDECALVPDICFS--TSKVPRCVNTQPG-----FHCLPCPP   77 (634)
T ss_dssp             TTSCEEECCCCTTBCS---C------SSSCCBCCTTTTSCCCSCC--CSSSCCEEECSSS-----EEECCCCT
T ss_pred             CCCCeECCcCCCccCC---C------CCCccccccccCCCCcccC--CccccceeeccCc-----eecccCCC
Confidence            335 999679999998   4      34699999998  3  643  34   89999999     9998 998

>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A*

Probab=94.55  E-value=0.021  Score=50.82  Aligned_cols=45  Identities=16%  Similarity=0.347  Sum_probs=28.2

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCC-cCccccc--cccccCcceeecccccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRC-SPKRSRD--SFFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c-~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      ..+|.| .|+.||.|           ..| .++++|.  +|..  .+.|.+..++     |.|.|++
T Consensus        25 ~g~~~C-~C~~Gy~G-----------~~C~~~~~~C~~~~C~~--~~~C~~~~g~-----~~C~C~~   72 (135)
T 2vj3_A           25 LGSFEC-QCLQGYTG-----------PRCEIDVNECVSNPCQN--DATCLDQIGE-----FQCICMP   72 (135)
T ss_dssp             SSSEEE-ECCTTEES-----------TTSCEECCTTTTCCCCS--SCEEEECSSC-----EEEECCT
T ss_pred             CCCEEE-ECCCCCcC-----------CcccccCccCCCCCCCC--CCEEeCCCCC-----ceeeCCC
Confidence            345777 77777776           245 3666665  3432  4567777776     7777765

>2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ...

Probab=94.55  E-value=0.014  Score=52.52  Aligned_cols=48  Identities=10%  Similarity=0.121  Sum_probs=35.0

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcC-ccccccccccCcc---eeecccc-cceeeeEEEeeccc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSP-KRSRDSFFSKKTR---IIFGNIS-SFIIYRYAISILRL  322 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~-~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~  322 (684)
                      ..+|.| .|+.||.|           ..|++ +++|..|.....+   .|.+..+ +     |.|.|+..
T Consensus        65 ~g~y~C-~C~~G~~G-----------~~C~~~~~~c~~c~~~~~~C~~~C~~~~g~~-----y~C~C~~G  117 (142)
T 2c4f_L           65 LQSYIC-FCLPAFEG-----------RNCETHKDDQLICVNENGGCEQYCSDHTGTK-----RSCRCHEG  117 (142)
T ss_dssp             TTEEEE-ECCTTEES-----------TTSCEEGGGCCSTTTGGGGCSSEEECCTTSC-----CEEECCTT
T ss_pred             CCCEEe-eCCCCccC-----------CccccCccccccccCCCCCccCEeECCCCCC-----EEEECCCC
Confidence            568999 99999987           35765 6776443211122   8999999 8     99999873

>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A

Probab=94.43  E-value=0.023  Score=51.08  Aligned_cols=52  Identities=12%  Similarity=0.107  Sum_probs=39.7

Q ss_pred             ccccCCCCCCCCCCCCCcccc-CCCCCCcCcccccc-----ccccCcceeecccccceeeeEEEeeccc
Q 043157          260 GHNCSKCPDGYNYYRPAYYRP-LQERRCSPKRSRDS-----FFSKKTRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       260 gy~C~~C~~G~~g~~~npy~~-~~~~~c~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      +|.| .|+.||.|   ++++. .+...|+|++||..     |..  .+.|.+..++     |.|.|+..
T Consensus        18 ~~~C-~C~~G~~g---~~~~~~~~~~~C~dideC~~~~~~~C~~--~~~C~n~~g~-----y~C~C~~G   75 (143)
T 2bou_A           18 ATAC-RCNPGFSS---FSEIITTPMETCDDINECATLSKVSCGK--FSDCWNTEGS-----YDCVCSPG   75 (143)
T ss_dssp             SSCE-EECTTEEC---SSSSBCSTTCCCEECCGGGC----CCCT--TEEEEECSSC-----EEEEECTT
T ss_pred             CCEE-eCCCCCcC---ccccccCCCCcCCccccccCCCCCCCCC--CCEEEcCCCC-----eEeECCCC
Confidence            4899 99999999   65321 12357999999983     532  4799999999     99999973

>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ...

Probab=94.37  E-value=0.015  Score=51.74  Aligned_cols=43  Identities=16%  Similarity=0.329  Sum_probs=18.6

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcC-c-ccccc----ccccCcceeecccccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSP-K-RSRDS----FFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~-~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      ..+|.| .|+.||.|           ..|++ + ++|..    |    ...|.+..++     |.|.|++
T Consensus        60 ~~~y~C-~C~~G~~G-----------~~C~~~i~d~C~~~~~~C----~~~C~~~~g~-----y~C~C~~  108 (134)
T 2vh0_B           60 LGEYTC-TCLEGFEG-----------KNCELFTRKLCSLDNGDC----DQFCHEEQNS-----VVCSCAR  108 (134)
T ss_dssp             ---------------------------------CCGGGTGGGGC----SSEEEEETTE-----EEEECCT
T ss_pred             CCCEEe-eCCCCccC-----------CccccCCCCccccCCCCC----CCEeECCCCC-----EEEECCC
Confidence            568999 99999987           36876 6 78863    4    3489999998     9999987

>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens}

Probab=94.37  E-value=0.018  Score=51.63  Aligned_cols=50  Identities=20%  Similarity=0.361  Sum_probs=39.4

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCc-Cccccc--cccccCcceeecccccceeeeEEEeecc-cccCc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCS-PKRSRD--SFFSKKTRIIFGNISSFIIYRYAISILR-LSSSG  326 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~-~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  326 (684)
                      ..+|.| .|+.||.|           ..|. ++++|.  +|..  .+.|.+..++     |.|.|+. ..+..
T Consensus        77 ~~~~~C-~C~~G~~G-----------~~C~~~i~~C~~~~C~~--~~~C~~~~g~-----~~C~C~~G~~G~~  130 (143)
T 4d90_A           77 FIGYVC-KCPRGFNG-----------IHCQHNINECEVEPCKN--GGICTDLVAN-----YSCECPGEFMGRN  130 (143)
T ss_dssp             ECCEEE-ECCTTEES-----------TTSCEECCTTTTCCSCT--TCEEEEETTE-----EEEECCTTCBSTT
T ss_pred             CCCeEe-ECcCCCcC-----------CCcccCCCcCCCCCCCC--CCEeECCCCC-----eEeECCCCCccCC
Confidence            457999 99999987           4686 999997  4543  5799999998     9999998 44433

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.33  E-value=0.24  Score=53.07  Aligned_cols=140  Identities=15%  Similarity=0.140  Sum_probs=82.8

Q ss_pred             CceeceeCcEEEEEEEeCC--------CcEEEEEeccccChhHHHHHHHHHHHHhhcCCCc-ccceeeeeeecCcceEEE
Q 043157          402 NRILGQGGQGTVYKGMLPD--------GKIVAVKKSKVIDESKVEEFINEMVILSQINHRN-VVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lv~  472 (684)
                      .+.|..|-...+|+....+        ++.+++++...... ..-...+|..+++.+.-.+ ..++++.+    ..++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence            4567778888999988753        57788887543221 1122356888888884323 34555533    248999


Q ss_pred             EecCCCCHHH-----------------HHhhc-------C---CCCCCCHHHHHHHHHHH-------------------H
Q 043157          473 EFIPNGTLFQ-----------------YIHDQ-------N---EDFPITWEMRLRIAIEV-------------------S  506 (684)
Q Consensus       473 E~~~~gsL~~-----------------~l~~~-------~---~~~~l~~~~~~~i~~qi-------------------a  506 (684)
                      ||++|.+|..                 -||..       .   ...+.-+.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999865421                 01110       0   11112244444444322                   2


Q ss_pred             HHHHHHHh---------------------CCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          507 GALSYLHS---------------------AASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       507 ~aL~yLH~---------------------~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      ..+.+|.+                     .....++|+|+.+.||+ ++++.+.|+||..+.
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence            22333321                     11234899999999999 778899999998775

>1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A

Probab=93.11  E-value=0.02  Score=53.98  Aligned_cols=48  Identities=15%  Similarity=0.243  Sum_probs=37.8

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCccccc------cccccCcceeeccc-----ccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD------SFFSKKTRIIFGNI-----SSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~------~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~  321 (684)
                      ..+|.| .|+.||.|   +.     ...|++++||.      +|..  .+.|.+..     ++     |.|.|+.
T Consensus        22 ~g~~~C-~C~~G~~g---~~-----~~~C~~id~C~~~~~~~~C~~--~~~C~~~~~~~~~g~-----y~C~C~~   80 (186)
T 1z1y_A           22 SNHFXC-MCNEGLVH---LS-----ENTCEEXNECXXETLGXACGE--FGQCIENPDPAQVNM-----YXCGCIE   80 (186)
T ss_dssp             SSCEEE-EECTTEEE---EE-----TTEEEECCCCSGGGTTSEEET--TEEEEECSSTTSSCS-----EEEEECT
T ss_pred             CCCeEe-ECCCCCcc---CC-----CCccCCCCcccCCCCCCCCCC--CCEeecCCCCcCCCC-----EECCCCC
Confidence            457999 99999998   31     23699999997      2533  47899998     78     9999997

>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A*

Probab=92.93  E-value=0.051  Score=48.26  Aligned_cols=45  Identities=13%  Similarity=0.308  Sum_probs=36.0

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCc-Cccccc--cccccCcceeecccccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCS-PKRSRD--SFFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~-~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      ..+|.| .|+.||.|           ..|. ++++|.  +|..  .+.|.+..++     |.|.|+.
T Consensus        63 ~g~~~C-~C~~G~~G-----------~~C~~~~~~C~~~~C~~--~g~C~~~~g~-----~~C~C~~  110 (135)
T 2vj3_A           63 IGEFQC-ICMPGYEG-----------VHCEVNTDECASSPCLH--NGRCLDKINE-----FQCECPT  110 (135)
T ss_dssp             SSCEEE-ECCTTEES-----------SSSCEECCTTTTCCSTT--TCEEEECSSC-----EEEECCT
T ss_pred             CCCcee-eCCCCCcC-----------CcceecCCcccCCCcCC--CCEeECCCCC-----eEEECCC
Confidence            457999 99999987           3564 788887  4533  5799999998     9999988

>1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A

Probab=92.89  E-value=0.029  Score=48.68  Aligned_cols=46  Identities=13%  Similarity=0.256  Sum_probs=37.5

Q ss_pred             CccccCCCCCCCCCCCCCccccCCCCCCcCccccc---cccccCcceeecccccceeeeEEEeeccc
Q 043157          259 SGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD---SFFSKKTRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       259 ~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      .+|.| .|+.||.+   ++     +..|.|++||.   +|    .++|.+..++     |.|.|+..
T Consensus        59 ~~y~C-~C~~Gy~~---~~-----g~~C~dideC~~~~~C----~~~C~n~~g~-----y~C~C~~G  107 (118)
T 1dx5_I           59 TQASC-ECPEGYIL---DD-----GFICTDIDECENGGFC----SGVCHNLPGT-----FECICGPD  107 (118)
T ss_dssp             STTCE-ECCTTEEE---ET-----TTEEEECCHHHHCSSC----SSEEEECSSS-----EEEEECSS
T ss_pred             CCeEe-ECCCCccC---CC-----CCccccccccCCCCCC----cCeEEeCCCC-----EEEECCCC
Confidence            57999 99999986   32     23699999997   35    5789999999     99999873

>1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A

Probab=91.47  E-value=0.03  Score=52.77  Aligned_cols=51  Identities=12%  Similarity=0.206  Sum_probs=39.6

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCc--cccc-cc-cccCcceeecccccceeeeEEEeeccc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPK--RSRD-SF-FSKKTRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~--~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      ..+|.| .|+.||.|   ++..   ...|.++  +||. +| ..  .++|.+..++     |.|.|+..
T Consensus       113 ~g~~~C-~C~~Gy~g---~~~~---~~~C~~~~~~~C~~~C~~~--~~~C~n~~g~-----y~C~C~~G  167 (186)
T 1z1y_A          113 IQSAGC-SCAIGXVP---NPED---EXXCTXTGETACQLXCNTD--NEVCXNVEGV-----YXCQCMEG  167 (186)
T ss_dssp             EEEEEE-EECTEEEE---ETTT---TTEEEEEECCCCCCCCCTT--TEEEEEETTE-----EEEEECTT
T ss_pred             CCCceE-ECCCCCcc---cCCC---CCcceEcCCCccccccccc--CcceecCCCC-----eeeECCCC
Confidence            457999 99999998   6543   4568876  7887 45 33  5799999999     99999883

>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens}

Probab=91.00  E-value=0.23  Score=44.25  Aligned_cols=52  Identities=15%  Similarity=0.296  Sum_probs=35.5

Q ss_pred             CccccCCCCCCCCCCCCCcccc-----CCCCCCcCccccc--cccccCcceee-------cccccceeeeEEEeecc
Q 043157          259 SGHNCSKCPDGYNYYRPAYYRP-----LQERRCSPKRSRD--SFFSKKTRIIF-------GNISSFIIYRYAISILR  321 (684)
Q Consensus       259 ~gy~C~~C~~G~~g~~~npy~~-----~~~~~c~~~~~~~--~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~  321 (684)
                      .+|.| .|+.||.|   .-...     .+..+|.++++|.  +|..  .+.|.       +..++     |.|.|+.
T Consensus        21 g~~~C-~C~~G~~G---~~C~~~~~~~~~~~~c~~~~~C~~~~C~~--~g~C~~~~~~~~~~~~~-----~~C~C~~   86 (143)
T 4d90_A           21 GSFSC-ECPDGFTD---PNCSSVVEVASDEEEPTSAGPCTPNPCHN--GGTCEISEAYRGDTFIG-----YVCKCPR   86 (143)
T ss_dssp             -CCEE-ECCTTCCT---TTTCSCCCCTTTTTSCCCCCTTSSCCCCT--TCEEEECCCEETTEECC-----EEEECCT
T ss_pred             CCEEe-ECCCCCCC---CCCccCccccccccccccCCcCCCCCCCC--CCEecCCCccccCCCCC-----eEeECcC
Confidence            47999 99999998   33321     1224566778877  3543  56888       66677     9999987

>1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A

Probab=90.89  E-value=0.12  Score=59.29  Aligned_cols=47  Identities=21%  Similarity=0.478  Sum_probs=38.5

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCccccc---cccccCcceeecccccceeeeEEEeeccc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD---SFFSKKTRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      ..||.| .|+.||++   +     ++..|.|++||.   +|    ..+|.|..|+     |.|.|+..
T Consensus       312 ~~~~~C-~C~~G~~~---~-----~~~~C~dideC~~~~~C----~~~C~n~~g~-----y~C~C~~G  361 (699)
T 1n7d_A          312 KIGYEC-LCPDGFQL---V-----AQRRCEDIDECQDPDTC----SQLCVNLEGG-----YKCQCEEG  361 (699)
T ss_dssp             TTCCCC-CCCSSSCC---C-----SSSCCCCCCCCSSSSSC----TTTCCBCSSC-----BCCCCCSS
T ss_pred             CCCcEE-eCCCCeEc---C-----CCCcccCccccCCCCcc----ccccccCCCC-----eeeeeecc
Confidence            568999 99999986   1     145799999997   36    4589999999     99999883

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=90.38  E-value=0.64  Score=49.27  Aligned_cols=29  Identities=34%  Similarity=0.465  Sum_probs=24.5

Q ss_pred             eEecCCCCCCEEE------CCCCcEEEeccCCccc
Q 043157          520 IYHRDIKSTNILL------DDKYRAKVSDFGASRS  548 (684)
Q Consensus       520 iiH~Dlkp~NILl------~~~~~~kl~DFgl~~~  548 (684)
                      ++|+|+.+.|||+      +++..++++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567799999988753

>1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A

Probab=89.49  E-value=0.25  Score=40.41  Aligned_cols=43  Identities=19%  Similarity=0.370  Sum_probs=33.8

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCc--Cccccc--cccccCcceeeccc--ccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCS--PKRSRD--SFFSKKTRIIFGNI--SSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~--~~~~~~--~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  321 (684)
                      ..+|.| .|+.||.             .|.  ++++|.  +|..  .++|.+..  ++     |.|.|+.
T Consensus        29 ~~~y~C-~C~~G~~-------------~C~~~~~~~C~~~pC~n--gg~C~~~~~~~~-----~~C~C~~   77 (91)
T 1tpg_A           29 NRVEYC-WCNSGRA-------------QCHSVPVKSCSEPRCFN--GGTCQQALYFSD-----FVCQCPE   77 (91)
T ss_dssp             SCEEEE-ECSSSCC-------------BCCEECEEECSSCCSCT--TCEEEEESSSSC-----EEEECCT
T ss_pred             CCCcEe-ECCCCCc-------------ccccCcCCcccCCCCCC--CCEeecCCCCCC-----eEeECCC
Confidence            568999 9999984             364  788887  4643  47899887  77     9999987

>1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1

Probab=89.40  E-value=0.13  Score=37.07  Aligned_cols=31  Identities=19%  Similarity=0.437  Sum_probs=22.5

Q ss_pred             CCCcccCCCCccccCCCCCCCCCCCCCccccCCCCCCcCcccc
Q 043157          250 SGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSR  292 (684)
Q Consensus       250 c~~~~~~~~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~  292 (684)
                      |.+.    .++|+| .|+.||.=       ..|+..|.|++||
T Consensus        12 C~n~----~gs~~C-~C~~Gy~L-------~~d~~tC~dide~   42 (51)
T 1kig_L           12 CREE----RSEVRC-SCAHGYVL-------GDDSKSCVSTERF   42 (51)
T ss_dssp             CCEE----TTEECC-CCCTTEEE-------CTTSSCEEECSSS
T ss_pred             eEcC----CCCeEE-eCCCCcEE-------CCCCCccccCCcc
Confidence            5554    568999 99999862       1135679999985

>3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens}

Probab=88.88  E-value=0.14  Score=59.45  Aligned_cols=46  Identities=22%  Similarity=0.520  Sum_probs=37.3

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCccccc---cccccCcceeecccccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD---SFFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      ..||.| .|+.||.+   .     ++..|.|++||.   .|    ..+|.|..|+     |.|.|+.
T Consensus       330 ~~~y~C-~C~~Gy~l---~-----~g~~C~dideC~~~~~C----~~~C~n~~gs-----y~C~C~~  378 (791)
T 3m0c_C          330 KIGYEC-LCPDGFQL---V-----AQRRCEDIDECQDPDTC----SQLCVNLEGG-----YKCQCEE  378 (791)
T ss_dssp             SBSEEE-ECCTTCEE---E-----TTTEEECCCCCSSSSSC----TTTCCBCSSC-----BCCCCCS
T ss_pred             CCCccc-CCCCCCcc---C-----CCCccccCcccCCCCCC----CCeeecCCCC-----ceeecCC
Confidence            568999 99999975   1     135799999997   35    4589999999     9999987

>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A

Probab=88.27  E-value=0.11  Score=47.63  Aligned_cols=48  Identities=13%  Similarity=0.057  Sum_probs=37.2

Q ss_pred             CCccccCCCCC--CCCCCCCCccccCCCCCCcCccccc----cccccCcceeecccccceeeeEEEeecc
Q 043157          258 TSGHNCSKCPD--GYNYYRPAYYRPLQERRCSPKRSRD----SFFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       258 ~~gy~C~~C~~--G~~g~~~npy~~~~~~~c~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      ..+|.| .|+.  ||.|   ++..    ..|+|||||.    +|.   ++.|+|..++     |.|.|+.
T Consensus        97 ~~~y~C-~C~~g~G~~~---~~~~----~~c~dideC~~~~~~C~---~g~C~n~~gs-----y~C~C~~  150 (162)
T 1uzk_A           97 TSEYKI-LCPGGEGFRP---NPIT----VILEDIDECQELPGLCQ---GGKCINTFGS-----FQCRCPT  150 (162)
T ss_dssp             SHHHHH-HCTTCTTEEE---CTTT----CCEEECCHHHHCGGGGB---TSEEEECSSC-----EEEECCT
T ss_pred             CCCcee-ECCCCCCccc---CCCC----CccCccccccCCCCCcC---CCEeEcCCCC-----EEeeCCC
Confidence            457899 8987  7776   5433    3689999997    263   3699999999     9999987

>2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens}

Probab=87.05  E-value=0.17  Score=45.47  Aligned_cols=44  Identities=11%  Similarity=0.216  Sum_probs=34.8

Q ss_pred             cccCCCCCCCCCCCCCccccCCCCCCcCccccc--c--ccccCcceeecccccceeeeEEEeecc
Q 043157          261 HNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD--S--FFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       261 y~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      |.| .|+.||.+   +     ++..|.|||||.  +  |.   ++.|.|..++     |.|.|+.
T Consensus        88 ~~C-~C~~Gy~~---~-----~g~~C~dideC~~~~~~C~---~g~C~n~~g~-----y~C~C~~  135 (147)
T 2w86_A           88 VDP-ICGKGYSR---I-----KGTQCEDIDECEVFPGVCK---NGLCVNTRGS-----FKCQCPS  135 (147)
T ss_dssp             CCT-TTCTTEEE---E-----ETTEEEECCHHHHSTTCSS---SSEEEEETTE-----EEEECCT
T ss_pred             Ccc-cCCCcccc---C-----CCCccCccccccCCCCCCC---CCEEECCCCC-----EEeeCCC
Confidence            788 99999963   1     134699999997  3  53   3599999999     9999987

>1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A

Probab=86.97  E-value=0.077  Score=52.89  Aligned_cols=40  Identities=25%  Similarity=0.553  Sum_probs=27.7

Q ss_pred             CCCcccCCCCccccCCCCCCCCCCCCCccccCCCCCCcCccccccccccCcceeeccc
Q 043157          250 SGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRDSFFSKKTRIIFGNI  307 (684)
Q Consensus       250 c~~~~~~~~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~~~~~~~~~~~~~~~  307 (684)
                      |.|.    .++|.| .|+.||.|   |      +..|.|+|+..    |..+.|.|.+
T Consensus        21 C~Nt----~Gsy~C-~C~~Gy~G---n------G~~C~d~d~Pq----RvnGs~sG~i   60 (285)
T 1gl4_A           21 CRDY----ATGFCC-RCVANYTG---N------GRQCVAEGSPQ----RVNGKVKGRI   60 (285)
T ss_dssp             EEEC----SSCEEE-EECTTEEE---C------SSSEEETTCEE----EEEEEEEEEE
T ss_pred             eEcC----CCCeEE-EcCCCCCC---C------CCcCCCCCCCc----eeceeEeEEE
Confidence            5555    668999 99999998   5      45699988733    2345555544

>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A

Probab=86.43  E-value=0.065  Score=49.19  Aligned_cols=60  Identities=12%  Similarity=0.099  Sum_probs=34.8

Q ss_pred             cCCCcccCCCCccccCCCCCCCCCCCCCccccCCCCCCcCccc--ccc----ccccCcceeecccccceeeeEEEeecc
Q 043157          249 SSGDLICNTTSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRS--RDS----FFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       249 ~c~~~~~~~~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~--~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      .|.+.    ..+|+| .|+.||.+   +|    ++..|.+++|  |..    |.....+.|.+..+.. .-.|.|.|+.
T Consensus        16 ~C~n~----~gsy~C-~C~~Gy~~---~~----~g~~C~d~~~~~C~~~~~~c~~~~~~~C~~~~~~~-~~~~~C~C~~   81 (162)
T 1uzk_A           16 NCVNT----PGSYIC-DCPPDFEL---NP----TRVGCVDTRSGNCYLDIRPRGDNGDTACSNEIGVG-VSKASCCCSL   81 (162)
T ss_dssp             EEEEE----TTEEEE-ECCTTCEE---CT----TSSBEECCCCEEEEEEC----------CEEEEEEE-ECHHHHHTTT
T ss_pred             EeECC----CCCEEE-eCCCCCeE---CC----CCCcccCCCCCcccCCCcccCCCCCCcccCCcCCc-ccCceeeCCC
Confidence            35554    568999 99999986   43    1457999887  652    2111245777776610 0128888876

>2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ...

Probab=85.04  E-value=0.15  Score=37.47  Aligned_cols=28  Identities=25%  Similarity=0.593  Sum_probs=20.9

Q ss_pred             CCccccCCCCCCCCCCCCCccccCCCCCCcCccccc
Q 043157          258 TSGHNCSKCPDGYNYYRPAYYRPLQERRCSPKRSRD  293 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g~~~npy~~~~~~~c~~~~~~~  293 (684)
                      .++|.| .|+.||.-   +    .|...|.|++||.
T Consensus        19 ~Gsy~C-~C~~Gy~L---~----~d~~~C~didec~   46 (55)
T 2jkh_L           19 QNSVVC-SCARGYTL---A----DNGKACIPTGPYP   46 (55)
T ss_dssp             TTEEEE-ECCTTEEE---C----TTSSCEEESSSSC
T ss_pred             CCCeEE-eCCCCCEE---C----CCCCeeccCcccc
Confidence            568999 99999863   1    1346799999864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.79  E-value=1  Score=42.94  Aligned_cols=116  Identities=9%  Similarity=0.113  Sum_probs=75.6

Q ss_pred             CCCcccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 043157          451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI  530 (684)
Q Consensus       451 ~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NI  530 (684)
                      .||+++.. .+-.+++...+.++.-+.+.=+..++      .++...+++++.+|+....++++     =+|=-|.|+||
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            68888876 45555555555555443222112222      27788999999999988866554     35778999999


Q ss_pred             EECCCCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCC
Q 043157          531 LLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR  601 (684)
Q Consensus       531 Ll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~  601 (684)
                      +++.++.+++.-.|+-..+.                  |.     ..++..=.-.+=+++..+++++..|.
T Consensus       111 ~f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999887643321                  21     11112223356678888899988874

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.49  E-value=2.2  Score=40.81  Aligned_cols=115  Identities=14%  Similarity=0.120  Sum_probs=74.2

Q ss_pred             CCCcccceeeeeeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCCC
Q 043157          451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS-YLHSAASIPIYHRDIKSTN  529 (684)
Q Consensus       451 ~HpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~-yLH~~~~~~iiH~Dlkp~N  529 (684)
                      .||.+  -..+-.+++...+.++.-+++.=+..++.      ++...+++++.+|+.... ++++     -+|=-|.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            57887  34444556666666665544433334432      678899999988887666 4544     4677899999


Q ss_pred             EEECCCCcEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCC
Q 043157          530 ILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR  601 (684)
Q Consensus       530 ILl~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~  601 (684)
                      |+++.++.+++.-.|+-..+                  +|.-+     ++.-=.-.+=+++..++.++..|.
T Consensus       115 L~f~~~~~p~i~hRGi~~~l------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESL------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EEECTTCCEEESCCEETTTB------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEEeCCCcEEEEEcCCcccC------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999988864332                  22211     111112345677778888877764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	684
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-72
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-70
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-67
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-67
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-66
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-66
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-64
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-63
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-63
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-62
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-62
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-62
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-62
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-60
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-60
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-58
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-58
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-57
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-56
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-54
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-54
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-53
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-53
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-49
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-48
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-48
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-48
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-46
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-46
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-46
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-46
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-45
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-44
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-42
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-41
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-41
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-41
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-38
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-38
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-36
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-35
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-20

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (597), Expect = 1e-72
 Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 21/288 (7%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           + E       + + +G G  GTVYKG       V +         +++ F NE+ +L + 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H N++  +G     ++  +V ++    +L+ ++H     F       + IA + +  + 
Sbjct: 62  RHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFE--MIKLIDIARQTAQGMD 118

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ-THMTTQVHGTFGYLDP 569
           YLH+     I HRD+KS NI L +    K+ DFG +   +    +H   Q+ G+  ++ P
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 570 EYFRSSQ---FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
           E  R      ++ +SDVY+FG+VL EL+TG+ P        + +     +F +    L  
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMVGRGYLSP 229

Query: 627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
            L                 ++   CL     +RP   ++ + +  +  
Sbjct: 230 DLSKVRSNCPKA-----MKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (584), Expect = 4e-70
 Identities = 71/303 (23%), Positives = 126/303 (41%), Gaps = 37/303 (12%)

Query: 392 LERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-SKVIDESKVEEFINEMVILSQ 449
           +E   D+F     LG G  G V+K    P G ++A K     I  +   + I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            N   +V   G         +  E +  G+L Q +        I  ++  +++I V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
           +YL     I   HRD+K +NIL++ +   K+ DFG S  +      M     GT  Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172

Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED--------------------- 608
           E  + + ++ +SD++S G+ L E+  G  PI     +E                      
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 609 --KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAK----RCLNLNGKKRPTM 662
             + L++Y + +     +FE+LD  V +         F+   +    +CL  N  +R  +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 663 REV 665
           +++
Sbjct: 293 KQL 295

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 2e-67
 Identities = 61/279 (21%), Positives = 117/279 (41%), Gaps = 23/279 (8%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ R  +   L   LG G  G V+ G       VAVK  K       + F+ E  ++ Q+
Sbjct: 9   EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQL 65

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H+ +V+L     +  +  ++ E++ NG+L  ++   +    +T    L +A +++  ++
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMA 123

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           ++         HRD+++ NIL+ D    K++DFG +R +  ++            +  PE
Sbjct: 124 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
                 FT KSDV+SFG++L E++T  +                    M    + + L+ 
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLER 225

Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                   +      ++ + C     + RPT   + S L
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 3e-67
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 21/276 (7%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
                 + +G G  G V+ G   +   VA+K  +       E+FI E  ++ +++H  +V
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +L G CLE     LV+EF+ +G L  Y+  Q        E  L + ++V   ++YL  A 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA- 120

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
              + HRD+ + N L+ +    KVSDFG +R +  DQ   +T       +  PE F  S+
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 577 FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES 636
           ++ KSDV+SFGV++ E+ +  K                         + E +        
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI---------------PYENRSNSEVVEDISTGFRLYK 223

Query: 637 GGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
                    ++   C     + RP    +  +LA I
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 2e-66
 Identities = 69/278 (24%), Positives = 128/278 (46%), Gaps = 27/278 (9%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
               L + +G+G  G V  G    G  VAVK  K  +++  + F+ E  +++Q+ H N+V
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63

Query: 457 KLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           +LLG  +E +  L +V E++  G+L  Y+  +     +  +  L+ +++V  A+ YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 516 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 575
                 HRD+ + N+L+ +   AKVSDFG ++      +           +  PE  R  
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREK 175

Query: 576 QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE 635
           +F+ KSDV+SFG++L E+ +  +        +D       +  +++    +  D      
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD-GCPPA 228

Query: 636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
                     +V K C +L+   RP+  ++  +L  IK
Sbjct: 229 --------VYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  218 bits (555), Expect = 3e-66
 Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 21/283 (7%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQ 449
           + E    +  +   LG G  G VY+G+       VAVK  K  D  +VEEF+ E  ++ +
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKE 69

Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           I H N+V+LLG C       ++ EF+  G L  Y+ + N    ++  + L +A ++S A+
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAM 128

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            YL         HRD+ + N L+ + +  KV+DFG SR M  D             +  P
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185

Query: 570 EYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD 629
           E    ++F+ KSDV++FGV+L E+ T                       +   +++E+L+
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLE 230

Query: 630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
                E          ++ + C   N   RP+  E+      +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 5e-65
 Identities = 69/277 (24%), Positives = 117/277 (42%), Gaps = 25/277 (9%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK--KSKVIDESKVEEFINEMVILSQINHR 453
           +++ +   +G G  G   K     DGKI+  K      + E++ +  ++E+ +L ++ H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 454 NVVKLLGCCLETE--VPLLVYEFIPNGTLFQYIHD-QNEDFPITWEMRLRIAIEVSGALS 510
           N+V+     ++       +V E+   G L   I     E   +  E  LR+  +++ AL 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 511 YLH--SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
             H  S     + HRD+K  N+ LD K   K+ DFG +R +  D +       GT  Y+ 
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMS 182

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           PE      + +KSD++S G +L EL     P    + +E        L     E  F  +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRRI 234

Query: 629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             R   E          ++  R LNL    RP++ E+
Sbjct: 235 PYRYSDE--------LNEIITRMLNLKDYHRPSVEEI 263

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 1e-64
 Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 23/279 (8%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQI 450
           E+ R  ++  L   LGQG  G V+ G       VA+K  K       E F+ E  ++ ++
Sbjct: 13  EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 69

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
            H  +V+L     E  +  +V E++  G+L  ++  +   +       + +A +++  ++
Sbjct: 70  RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLR-LPQLVDMAAQIASGMA 127

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           Y+         HRD+++ NIL+ +    KV+DFG +R +  ++            +  PE
Sbjct: 128 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
                +FT KSDV+SFG++L EL T  +                    M    + + ++ 
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVER 229

Query: 631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                   +   +   +  +C     ++RPT   + + L
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 5e-64
 Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 21/273 (7%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV 456
            +    + LG G  G V  G       VA+K  K       +EFI E  ++  ++H  +V
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +L G C +     ++ E++ NG L  Y+ +    F    +  L +  +V  A+ YL S  
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLESK- 119

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
                HRD+ + N L++D+   KVSDFG SR +  D+   +        +  PE    S+
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 577 FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKES 636
           F+ KSD+++FGV++ E+ +  K                           E +   +    
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLYR 222

Query: 637 GGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                     +   C +    +RPT + + S +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  210 bits (536), Expect = 2e-63
 Identities = 63/312 (20%), Positives = 127/312 (40%), Gaps = 47/312 (15%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKK-SKVIDESKVEEFIN 442
             LE   +N    R +G+G  G V++   P         +VAVK   +        +F  
Sbjct: 6   LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65

Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF----------- 491
           E  ++++ ++ N+VKLLG C   +   L++E++  G L +++   +              
Sbjct: 66  EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 492 ----------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 541
                     P++   +L IA +V+  ++YL         HRD+ + N L+ +    K++
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182

Query: 542 DFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPI 600
           DFG SR++   D             ++ PE    +++T +SDV+++GVVL E+ +     
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ- 241

Query: 601 RFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRP 660
                         +     EE ++ + D  ++     +  +    + + C +     RP
Sbjct: 242 -------------PYYGMAHEEVIYYVRDGNILACP-ENCPLELYNLMRLCWSKLPADRP 287

Query: 661 TMREVTSELAGI 672
           +   +   L  +
Sbjct: 288 SFCSIHRILQRM 299

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  210 bits (535), Expect = 2e-63
 Identities = 67/316 (21%), Positives = 126/316 (39%), Gaps = 43/316 (13%)

Query: 387 FTSKELERATDNFN---------LNRILGQGGQGTVYKGMLP----DGKIVAVKK-SKVI 432
           FT ++   A   F          + +++G G  G V  G L         VA+K      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 433 DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP 492
            E +  +F++E  I+ Q +H NV+ L G   ++   +++ EF+ NG+L  ++   +    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--Q 124

Query: 493 ITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 552
            T    + +   ++  + YL         HRD+ + NIL++     KVSDFG SR +  D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 553 QTHMTT----QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEED 608
            +  T            +  PE  +  +FT  SDV+S+G+V+ E+++  +          
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--------- 232

Query: 609 KSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
                   + M  + +   ++         D      ++   C   +   RP   ++ + 
Sbjct: 233 ------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 669 LAGIKAWNGASNSNSM 684
           L  +       N NS+
Sbjct: 287 LDKMI-----RNPNSL 297

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 5e-63
 Identities = 71/273 (26%), Positives = 112/273 (41%), Gaps = 30/273 (10%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F + R LG+G  G VY         I+A+K   K+++       +   E+ I S + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
            N+++L G   +     L+ E+ P GT+++ +   +       +       E++ ALSY 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HS     + HRDIK  N+LL      K++DFG S      +      + GT  YL PE  
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMI 176

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV 632
                 +K D++S GV+  E L G+ P               F     +E    I     
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPP---------------FEANTYQETYKRISRVEF 221

Query: 633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                  E      +  R L  N  +RP +REV
Sbjct: 222 TFPDFVTE--GARDLISRLLKHNPSQRPMLREV 252

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 1e-62
 Identities = 79/293 (26%), Positives = 141/293 (48%), Gaps = 29/293 (9%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPDGK----IVAVKK-SKVIDESKVEEFINEMV 445
            +  ++   + N ++G+G  G VY G L D        AVK  +++ D  +V +F+ E +
Sbjct: 21  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 80

Query: 446 ILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
           I+   +H NV+ LLG CL +E  PL+V  ++ +G L  +I ++  +   T +  +   ++
Sbjct: 81  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQ 138

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA---VDQTHMTTQVH 561
           V+  + +L S       HRD+ + N +LD+K+  KV+DFG +R M     D  H  T   
Sbjct: 139 VAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195

Query: 562 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE 621
               ++  E  ++ +FT KSDV+SFGV+L EL+T   P        D +     ++ ++ 
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQG 250

Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA 674
            RL                     +V  +C +   + RP+  E+ S ++ I +
Sbjct: 251 RRLL--QPEYCPDP--------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 3e-62
 Identities = 61/296 (20%), Positives = 114/296 (38%), Gaps = 29/296 (9%)

Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLG 460
           L   +G+G  G V++G    G+ VAVK      E +      E+     + H N++  + 
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIA 64

Query: 461 CCLETE----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
              +         LV ++  +G+LF Y++       +T E  +++A+  +  L++LH   
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEI 120

Query: 517 -----SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM---TTQVHGTFGYLD 568
                   I HRD+KS NIL+       ++D G +         +        GT  Y+ 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 569 PEYFRSS------QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE----DKSLAAYFLFA 618
           PE    S      +   ++D+Y+ G+V  E+             +    D   +   +  
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 619 MKEERLFEILDARVMKESGGDEII-TFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           M++    + L   +       E +   AK+ + C   NG  R T   +   L+ + 
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 3e-62
 Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 30/288 (10%)

Query: 390 KELERATDNFNL-NRILGQGGQGTVYKGML---PDGKIVAVKK-SKVIDESKVEEFINEM 444
           K+L    DN  + +  LG G  G+V +G+         VA+K   +  +++  EE + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 445 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIE 504
            I+ Q+++  +V+L+G C + E  +LV E    G L +++  + E+ P        +  +
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQ 117

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT--TQVHG 562
           VS  + YL         HRD+ + N+LL +++ AK+SDFG S+++  D ++ T  +    
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKE 621
              +  PE     +F+ +SDV+S+GV + E L+ G+KP +     E        + A  E
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIE 226

Query: 622 ERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
           +            E           +   C     + RP    V   +
Sbjct: 227 QGKRMECPPECPPE--------LYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 5e-62
 Identities = 65/319 (20%), Positives = 126/319 (39%), Gaps = 46/319 (14%)

Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGMLPD------GKIVAVKK-SKVID 433
           ++  +     + E   +N    ++LG G  G V                VAVK   +  D
Sbjct: 21  VDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 80

Query: 434 ESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF- 491
            S+ E  ++E+ +++Q+ +H N+V LLG C  +    L++E+   G L  Y+  + E F 
Sbjct: 81  SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140

Query: 492 -------------------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 532
                               +T+E  L  A +V+  + +L         HRD+ + N+L+
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLV 197

Query: 533 DDKYRAKVSDFGASRSMAVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLA 591
                 K+ DFG +R +  D  ++          ++ PE      +T KSDV+S+G++L 
Sbjct: 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257

Query: 592 ELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRC 651
           E+ +                   +     +   ++++      +           + + C
Sbjct: 258 EIFSLGVNP--------------YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSC 303

Query: 652 LNLNGKKRPTMREVTSELA 670
              + +KRP+   +TS L 
Sbjct: 304 WAFDSRKRPSFPNLTSFLG 322

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 8e-62
 Identities = 65/316 (20%), Positives = 126/316 (39%), Gaps = 41/316 (12%)

Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVID 433
           I+ T+L    + E   +  +  + LG G  G V +              VAVK       
Sbjct: 7   IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66

Query: 434 ESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD------ 486
            ++ E  ++E+ +LS + NH N+V LLG C      L++ E+   G L  ++        
Sbjct: 67  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126

Query: 487 ---------QNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 537
                    ++++  +  E  L  + +V+  +++L S       HRD+ + NILL     
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183

Query: 538 AKVSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTG 596
            K+ DFG +R +  D  ++          ++ PE   +  +T +SDV+S+G+ L EL + 
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243

Query: 597 EKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNG 656
                             +     + + ++++       S          + K C + + 
Sbjct: 244 GSS--------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289

Query: 657 KKRPTMREVTSELAGI 672
            KRPT +++   +   
Sbjct: 290 LKRPTFKQIVQLIEKQ 305

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (524), Expect = 1e-61
 Identities = 73/292 (25%), Positives = 132/292 (45%), Gaps = 27/292 (9%)

Query: 376 STEGTIEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDE 434
           S E  +EK +   S  +      +     +GQG  GTVY  M +  G+ VA+++  +  +
Sbjct: 1   SDEEILEKLRSIVS--VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58

Query: 435 SKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPIT 494
            K E  INE++++ +  + N+V  L   L  +   +V E++  G+L   + +      + 
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMD 114

Query: 495 WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 554
                 +  E   AL +LHS     + HRDIKS NILL      K++DFG    +  +Q+
Sbjct: 115 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY 614
             +T V GT  ++ PE      +  K D++S G++  E++ GE P               
Sbjct: 172 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--------------- 215

Query: 615 FLFAMKEERLFEILDARVMKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
           +L       L+ I      +    +++    +    RCL+++ +KR + +E+
Sbjct: 216 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 2e-61
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 31/276 (11%)

Query: 402 NRILGQGGQGTVYKGMLPD---GKIVAVK--KSKVIDESKVEEFINEMVILSQINHRNVV 456
           ++ LG G  GTV KG        K VAVK  K++  D +  +E + E  ++ Q+++  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
           +++G C E E  +LV E    G L +Y+        +  +  + +  +VS  + YL  + 
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES- 126

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH--GTFGYLDPEYFRS 574
                HRD+ + N+LL  ++ AK+SDFG S+++  D+ +   Q H      +  PE    
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 575 SQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM 633
            +F+ KSDV+SFGV++ E  + G+KP R     E        + AM E+       A   
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERMGCPAGCP 236

Query: 634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
           +E           +   C   + + RP    V   L
Sbjct: 237 RE--------MYDLMNLCWTYDVENRPGFAAVELRL 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 2e-61
 Identities = 65/292 (22%), Positives = 128/292 (43%), Gaps = 30/292 (10%)

Query: 389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDG-----KIVAVKK-SKVIDESKVEEFIN 442
           + E+          +++G G  G VYKGML          VA+K       E +  +F+ 
Sbjct: 1   TTEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG 58

Query: 443 EMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
           E  I+ Q +H N+++L G   + +  +++ E++ NG L +++ +++ +F       + + 
Sbjct: 59  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGML 116

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ--THMTTQV 560
             ++  + YL +       HRD+ + NIL++     KVSDFG SR +  D   T+ T+  
Sbjct: 117 RGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173

Query: 561 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK 620
                +  PE     +FT  SDV+SFG+V+ E++T  +                  + + 
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELS 218

Query: 621 EERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              + + ++      +  D      ++  +C      +RP   ++ S L  +
Sbjct: 219 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 4e-61
 Identities = 59/276 (21%), Positives = 118/276 (42%), Gaps = 32/276 (11%)

Query: 399 FNLNRILGQGGQGTVYKGMLPD-GKIVAVKK--SKVIDESKVEEFINEMVILSQINHRNV 455
              +  +G+G   TVYKG+  +    VA  +   + + +S+ + F  E  +L  + H N+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 456 VKLLGCCLET----EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           V+       T    +  +LV E + +GTL  Y+        +  ++      ++   L +
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQF 127

Query: 512 LHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 570
           LH+  + PI HRD+K  NI +       K+ D G +    + +      V GT  ++ PE
Sbjct: 128 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPE 183

Query: 571 YFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
            +   ++ +  DVY+FG+ + E+ T E P               +       +++  + +
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYP---------------YSECQNAAQIYRRVTS 227

Query: 631 RVMKESGGDEIITFAK-VAKRCLNLNGKKRPTMREV 665
            V   S     I   K + + C+  N  +R +++++
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  203 bits (518), Expect = 1e-60
 Identities = 67/291 (23%), Positives = 106/291 (36%), Gaps = 36/291 (12%)

Query: 382 EKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKV 437
           +  +LF   + E     F+  R +G G  G VY    + + ++VA+K    S      K 
Sbjct: 3   DVAELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59

Query: 438 EEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEM 497
           ++ I E+  L ++ H N ++  GC L      LV E+            +    P+    
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVE 116

Query: 498 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 557
              +       L+YLHS     + HRD+K+ NILL +    K+ DFG++  M        
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APA 168

Query: 558 TQVHGTFGYLDPEYFRSS---QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY 614
               GT  ++ PE   +    Q+  K DV+S G+   EL   + P               
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--------------- 213

Query: 615 FLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                    L+ I          G     F      CL    + RPT   +
Sbjct: 214 LFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-60
 Identities = 68/276 (24%), Positives = 109/276 (39%), Gaps = 26/276 (9%)

Query: 396 TDNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRN 454
            D + +   LG G  G VYK    +   + A K      E ++E+++ E+ IL+  +H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           +VKLL          ++ EF   G +   + +     P+T      +  +   AL+YLH 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD 128

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
                I HRD+K+ NIL       K++DFG S           + + GT  ++ PE    
Sbjct: 129 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 184

Query: 575 SQ-----FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD 629
                  +  K+DV+S G+ L E+   E P        + +     L   K E       
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPH------HELNPMRVLLKIAKSEPPTLAQP 238

Query: 630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
           +R            F    K+CL  N   R T  ++
Sbjct: 239 SRWSSN--------FKDFLKKCLEKNVDARWTTSQL 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-59
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 30/288 (10%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLPD----GKIVAVKK-SKVIDESKVEEFINEMV 445
           E++R  +   L R +G+G  G V++G+          VA+K       +S  E+F+ E +
Sbjct: 3   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 446 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
            + Q +H ++VKL+G   E  V  ++ E    G L  ++  +   + +     +  A ++
Sbjct: 61  TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQL 117

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
           S AL+YL S       HRDI + N+L+      K+ DFG SR M     +  ++      
Sbjct: 118 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
           ++ PE     +FT  SDV+ FGV + E+L  G KP +     +        +    E   
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGE 226

Query: 625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
              +                  +  +C   +  +RP   E+ ++L+ I
Sbjct: 227 RLPMPPNCPPT--------LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 3e-59
 Identities = 69/273 (25%), Positives = 113/273 (41%), Gaps = 24/273 (8%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-SKVIDESKVEEFINEMVILSQINHRN 454
           ++++L + LG+G  G V   +     + VAVK           E    E+ I   +NH N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           VVK  G   E  +  L  E+   G LF  I        +      R   ++   + YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG 121

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD-QTHMTTQVHGTFGYLDPEYFR 573
                I HRDIK  N+LLD++   K+SDFG +     + +  +  ++ GT  Y+ PE  +
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 574 SSQFTD-KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV 632
             +F     DV+S G+VL  +L GE P       +  S +       KE++ +     ++
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI 232

Query: 633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                         +  + L  N   R T+ ++
Sbjct: 233 DSA--------PLALLHKILVENPSARITIPDI 257

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 4e-58
 Identities = 61/294 (20%), Positives = 115/294 (39%), Gaps = 38/294 (12%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDG---KIVAVKK-SKVIDESKVEEFINEMVILSQI-N 451
           ++     ++G+G  G V K  +         A+K+  +   +    +F  E+ +L ++ +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-------------PITWEMR 498
           H N++ LLG C       L  E+ P+G L  ++                     ++ +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 499 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 558
           L  A +V+  + YL         HRD+ + NIL+ + Y AK++DFG SR    +     T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ--EVYVKKT 184

Query: 559 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA 618
                  ++  E    S +T  SDV+S+GV+L E+++                       
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229

Query: 619 MKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI 672
           M    L+E L      E   +       + ++C      +RP+  ++   L  +
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 6e-58
 Identities = 63/278 (22%), Positives = 110/278 (39%), Gaps = 28/278 (10%)

Query: 393 ERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILS 448
           ++  ++F   +ILG+G   TV     L   +  A+K   K  +I E+KV     E  ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
           +++H   VKL     + E       +  NG L +YI                   E+  A
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSA 120

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD-QTHMTTQVHGTFGYL 567
           L YLH      I HRD+K  NILL++    +++DFG ++ ++ + +        GT  Y+
Sbjct: 121 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
            PE          SD+++ G ++ +L+ G  P               F    +     +I
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP---------------FRAGNEYLIFQKI 222

Query: 628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
           +                  + ++ L L+  KR    E+
Sbjct: 223 IKLEYDFPEKFFP--KARDLVEKLLVLDATKRLGCEEM 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  197 bits (501), Expect = 1e-57
 Identities = 55/272 (20%), Positives = 107/272 (39%), Gaps = 23/272 (8%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
           D+++++  LG G  G V++      G   A K      ES  E    E+  +S + H  +
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           V L     +    +++YEF+  G LF+ + D++    ++ +  +    +V   L ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 516 ASIPIYHRDIKSTNILLDDKY--RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
                 H D+K  NI+   K     K+ DFG +  +   Q+   T   GT  +  PE   
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAE 198

Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM 633
                  +D++S GV+   LL+G  P      +E             +  + +   + + 
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-----TLRNVKSCDWNMDDSAFSGIS 253

Query: 634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
           ++             ++ L  +   R T+ + 
Sbjct: 254 ED--------GKDFIRKLLLADPNTRMTIHQA 277

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-57
 Identities = 66/282 (23%), Positives = 109/282 (38%), Gaps = 29/282 (10%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLP----DGKIVAVK---KSKVIDESKVEEFINEMVILSQ 449
            +  L   LG G  G V +G           VAVK      +     +++FI E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           ++HRN+++L G  L   +  +V E  P G+L   +      F        R A++V+  +
Sbjct: 68  LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL--LGTLSRYAVQVAEGM 124

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYL 567
            YL S       HRD+ + N+LL  +   K+ DFG  R++  +  H  M       F + 
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
            PE  ++  F+  SD + FGV L E+ T  +                ++     + L +I
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--------------PWIGLNGSQILHKI 227

Query: 628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
                      D       V  +C     + RPT   +   L
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 4e-57
 Identities = 62/287 (21%), Positives = 129/287 (44%), Gaps = 29/287 (10%)

Query: 394 RATDNFNLNRILGQGGQGTVYKGM-LPDGK----IVAVKK-SKVIDESKVEEFINEMVIL 447
           + T+ F   ++LG G  GTVYKG+ +P+G+     VA+K+  +       +E ++E  ++
Sbjct: 7   KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           + +++ +V +LLG CL + V  L+ + +P G L  Y+ +  ++     +  L   ++++ 
Sbjct: 66  ASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAK 122

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-TTQVHGTFGY 566
            ++YL       + HRD+ + N+L+      K++DFG ++ +  ++             +
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
           +  E      +T +SDV+S+GV + EL+T                       +    +  
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISS 224

Query: 627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK 673
           IL+            I    +  +C  ++   RP  RE+  E + + 
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  189 bits (482), Expect = 6e-56
 Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 32/293 (10%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQIN 451
           +D + L  ILG GG   V+    L   + VAVK        D S    F  E    + +N
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 452 HRNVVKLLGCCLETE----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           H  +V +            +P +V E++   TL   +H +    P+T +  + +  +   
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM--TTQVHGTFG 565
           AL++ H      I HRD+K  NI++      KV DFG +R++A     +  T  V GT  
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
           YL PE  R      +SDVYS G VL E+LTGE P          S  +     ++E+ + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSVAYQHVREDPIP 233

Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRP-TMREVTSELAGIKAWNG 677
                  +             V  + L  N + R  T  E+ ++L  ++  NG
Sbjct: 234 PSARHEGLSAD-------LDAVVLKALAKNPENRYQTAAEMRADL--VRVHNG 277

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 1e-54
 Identities = 72/308 (23%), Positives = 133/308 (43%), Gaps = 33/308 (10%)

Query: 381 IEKTKLFTSKELERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKK-SKVID 433
                ++   E E A +   ++R LGQG  G VY+G+            VA+K  ++   
Sbjct: 4   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63

Query: 434 ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-- 491
             +  EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  Y+         
Sbjct: 64  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123

Query: 492 -----PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 546
                P +    +++A E++  ++YL++       HRD+ + N ++ + +  K+ DFG +
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180

Query: 547 RSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTL 605
           R +   D      +      ++ PE  +   FT  SDV+SFGVVL E+ T  +   +  L
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGL 239

Query: 606 EEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             ++      L  + E  L +  D         +      ++ + C   N K RP+  E+
Sbjct: 240 SNEQ-----VLRFVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEI 285

Query: 666 TSELAGIK 673
            S +    
Sbjct: 286 ISSIKEEM 293

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (475), Expect = 1e-54
 Identities = 68/278 (24%), Positives = 111/278 (39%), Gaps = 20/278 (7%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-SKVIDESKVEEFINEMVIL 447
           K+ E   D ++   +LG G    V         K+VA+K  +K   E K     NE+ +L
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 448 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            +I H N+V L           L+ + +  G LF  I ++      T     R+  +V  
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLD 118

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           A+ YLH    +    +        LD+  +  +SDFG S+    D   + +   GT GY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYV 176

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEI 627
            PE      ++   D +S GV+   LL G  P        D++ A  F   +K E  F+ 
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF------YDENDAKLFEQILKAEYEFDS 230

Query: 628 LDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                + +S  D I       +  +  + +KR T  + 
Sbjct: 231 PYWDDISDSAKDFI-------RHLMEKDPEKRFTCEQA 261

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 2e-54
 Identities = 74/309 (23%), Positives = 121/309 (39%), Gaps = 40/309 (12%)

Query: 387 FTSKELERATDNFNLNRILGQGGQGTVYKGM------LPDGKIVAVKK-SKVIDESKVEE 439
           + + + E   D   L + LG+G  G V +            + VAVK   +    S+   
Sbjct: 3   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62

Query: 440 FINEMVILSQINHR-NVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDF------ 491
            ++E+ IL  I H  NVV LLG C +   PL ++ EF   G L  Y+  +  +F      
Sbjct: 63  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122

Query: 492 -------PITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 544
                   +T E  +  + +V+  + +L S       HRD+ + NILL +K   K+ DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179

Query: 545 ASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFT 603
            +R +  D  +           ++ PE      +T +SDV+SFGV+L E+ +        
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-- 237

Query: 604 TLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMR 663
                  +   F   +KE       D                +    C +    +RPT  
Sbjct: 238 ---PGVKIDEEFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFS 285

Query: 664 EVTSELAGI 672
           E+   L  +
Sbjct: 286 ELVEHLGNL 294

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-53
 Identities = 62/281 (22%), Positives = 109/281 (38%), Gaps = 31/281 (11%)

Query: 390 KELERATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILS 448
           KEL    + + +   LG+G  G V++ +     K    K  K +  +       E+ IL+
Sbjct: 1   KEL---YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILN 56

Query: 449 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGA 508
              HRN++ L       E  ++++EFI    +F+ I+     F +     +    +V  A
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEA 114

Query: 509 LSYLHSAASIPIYHRDIKSTNILLDDK--YRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
           L +LHS     I H DI+  NI+   +     K+ +FG +R +                Y
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEY 169

Query: 567 LDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE 626
             PE  +    +  +D++S G ++  LL+G  P               FL    ++ +  
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP---------------FLAETNQQIIEN 214

Query: 627 ILDARVMKESGGDEIIT--FAKVAKRCLNLNGKKRPTMREV 665
           I++A    +    + I+        R L    K R T  E 
Sbjct: 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  185 bits (470), Expect = 2e-53
 Identities = 55/272 (20%), Positives = 102/272 (37%), Gaps = 23/272 (8%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
           D +++   LG G  G V++ +    G++   K              NE+ I++Q++H  +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           + L     +    +L+ EF+  G LF  I  ++  + ++    +    +    L ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH 146

Query: 516 ASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
               I H DIK  NI+ +       K+ DFG +  +  D+    T    T  +  PE   
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVD 201

Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVM 633
                  +D+++ GV+   LL+G  P        +  L         +    E   + V 
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSP-----FAGEDDLETLQNVKRCDWEFDEDAFSSVS 256

Query: 634 KESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            E             K  L    +KR T+ + 
Sbjct: 257 PE--------AKDFIKNLLQKEPRKRLTVHDA 280

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 3e-53
 Identities = 70/308 (22%), Positives = 125/308 (40%), Gaps = 44/308 (14%)

Query: 391 ELERATDNFNLNRILGQGGQGTVYKGMLP--------DGKIVAVKK-SKVIDESKVEEFI 441
           EL R  D   L + LG+G  G V                  VAVK       E  + + I
Sbjct: 9   ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66

Query: 442 NEMVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ------------- 487
           +EM ++  I  H+N++ LLG C +     ++ E+   G L +Y+  +             
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126

Query: 488 NEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 547
           N +  ++ +  +  A +V+  + YL S       HRD+ + N+L+ +    K++DFG +R
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 183

Query: 548 SMAVDQTHMTTQVH-GTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLE 606
            +     +  T        ++ PE      +T +SDV+SFGV+L E+ T           
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------- 236

Query: 607 EDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVT 666
                       +  E LF++L      +   +       + + C +    +RPT +++ 
Sbjct: 237 --------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288

Query: 667 SELAGIKA 674
            +L  I A
Sbjct: 289 EDLDRIVA 296

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  182 bits (462), Expect = 4e-53
 Identities = 68/286 (23%), Positives = 111/286 (38%), Gaps = 38/286 (13%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK---------SKVIDESKVEEFINEMVI 446
           +N+    ILG+G    V + +  P  K  AVK          S    +   E  + E+ I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 447 LSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEV 505
           L +++ H N+++L           LV++ +  G LF Y+ ++     ++ +   +I   +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 119

Query: 506 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
              +  LH      I HRD+K  NILLDD    K++DFG S  +  D      +V GT  
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPS 174

Query: 566 YLDPEYFRSSQ------FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM 619
           YL PE    S       +  + D++S GV++  LL G  P         K +    +   
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQMLMLRMIMS 229

Query: 620 KEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
              +                       +  R L +  +KR T  E 
Sbjct: 230 GNYQFGSPEWDDYSDT--------VKDLVSRFLVVQPQKRYTAEEA 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 7e-49
 Identities = 65/273 (23%), Positives = 105/273 (38%), Gaps = 29/273 (10%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILS-QIN 451
           ++F L+++LG+G  G V+        +  A+K   K  V+ +  VE  + E  +LS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 452 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
           H  +  +       E    V E++  G L  +I   +             A E+   L +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQF 118

Query: 512 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           LHS     I +RD+K  NILLD     K++DFG  +   +      T   GT  Y+ PE 
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174

Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR 631
               ++    D +SFGV+L E+L G+ P      EE      +    M        L+  
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----LFHSIRMDNPFYPRWLEKE 229

Query: 632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE 664
                          +  +      +KR  +R 
Sbjct: 230 ------------AKDLLVKLFVREPEKRLGVRG 250

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  169 bits (429), Expect = 2e-48
 Identities = 52/283 (18%), Positives = 110/283 (38%), Gaps = 20/283 (7%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRN 454
           + ++    +G+G  G VYK     G+  A+KK ++   DE      I E+ IL ++ H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 455 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           +VKL       +  +LV+E +           +     +         +++   ++Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD 118

Query: 515 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 574
                + HRD+K  N+L++ +   K++DFG +R+  +     T ++   +         S
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 575 SQFTDKSDVYSFGVVLAELLTGEKP------------IRFTTLEEDKSLAAYFLFAMKEE 622
            +++   D++S G + AE++ G               I       +           K +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
             F + +    +        +   +  + L L+  +R T ++ 
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  170 bits (431), Expect = 3e-48
 Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 31/276 (11%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
            +F + R LG G  G V+      +G+  A+K   K  V+   +VE   +E ++LS + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             ++++ G   + +   ++ ++I  G LF  +            +    A EV  AL YL
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYL 120

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HS     I +RD+K  NILLD     K++DFG ++ +      +T  + GT  Y+ PE  
Sbjct: 121 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVV 173

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV 632
            +  +    D +SFG+++ E+L G  P               F  +   +   +IL+A +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP---------------FYDSNTMKTYEKILNAEL 218

Query: 633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
                 +E      +  R +  +  +R    +  +E
Sbjct: 219 RFPPFFNE--DVKDLLSRLITRDLSQRLGNLQNGTE 252

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  170 bits (432), Expect = 8e-48
 Identities = 57/282 (20%), Positives = 114/282 (40%), Gaps = 35/282 (12%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVK---KSKVIDESKVEEFINE---MVILSQ 449
           ++F+++RI+G+GG G VY     D GK+ A+K   K ++  +      +NE   + ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
            +   +V +       +    + + +  G L  ++         +       A E+   L
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGL 120

Query: 510 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 569
            ++H+     + +RD+K  NILLD+    ++SD G +   +  + H +    GT GY+ P
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174

Query: 570 EYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
           E  +    +   +D +S G +L +LL G  P R                  K +   EI 
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR----------------QHKTKDKHEID 218

Query: 629 DARVMKESGGDEIIT--FAKVAKRCLNLNGKKRPTMREVTSE 668
              +       +  +     + +  L  +  +R       ++
Sbjct: 219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 260

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 4e-47
 Identities = 55/284 (19%), Positives = 110/284 (38%), Gaps = 20/284 (7%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK--KSKVIDESKVEEFINEMVILSQINHR 453
           +NF     +G+G  G VYK      G++VA+K  +     E      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+VKLL          LV+EF+          D +    I   +      ++   L++ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++ +   K++DFG +R+  V     T +V   +         
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKPIRFTT--------LEEDKSLAAYFLFAMKEERLF 625
              ++   D++S G + AE++T        +             +        +     +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 626 EILDARVMKESGGDEIITFAKVAK----RCLNLNGKKRPTMREV 665
           +    +  ++     +    +  +    + L+ +  KR + +  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 6e-47
 Identities = 62/292 (21%), Positives = 113/292 (38%), Gaps = 25/292 (8%)

Query: 394 RATDNFNLNRILGQGGQGTVYKG--MLPDGKIVAVK--KSKVIDESKVEEFINEMVILSQ 449
           RA   +     +G+G  G V+K   +   G+ VA+K  + +  +E      I E+ +L  
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 450 I---NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ---YIHDQNEDFPITWEMRLRIAI 503
           +    H NVV+L   C  +         +    + Q      D+  +  +  E    +  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 504 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 563
           ++   L +LHS     + HRD+K  NIL+    + K++DFG +R  +      +  V  T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVT 178

Query: 564 FGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE- 622
             Y  PE    S +    D++S G + AE+   +   R ++  +        +    EE 
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 623 ---------RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
                    + F    A+ +++   D       +  +CL  N  KR +    
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 2e-46
 Identities = 56/289 (19%), Positives = 113/289 (39%), Gaps = 22/289 (7%)

Query: 396 TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK-SKVIDESKVEEFINEMVILSQINHR 453
              +     +G+G  G V       +   VA+KK S    ++  +  + E+ IL +  H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N++ +        +  +   ++    +   ++   +   ++ +       ++   L Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT--TQVHGTFGYLDPEY 571
           SA    + HRD+K +N+LL+     K+ DFG +R    D  H    T+   T  Y  PE 
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 572 FRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
             +S+   KS D++S G +LAE+L+           +  +     L +  +E L  I++ 
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 631 RVMK---ESGGDEIITFAKVA-----------KRCLNLNGKKRPTMREV 665
           +             + + ++             + L  N  KR  + + 
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 5e-46
 Identities = 62/281 (22%), Positives = 104/281 (37%), Gaps = 25/281 (8%)

Query: 403 RILGQGGQGTVYKGM-LPDGKIVAVKKSKV-----IDESKVEEFINEMVILSQINHRNVV 456
             LG+G   TVYK       +IVA+KK K+       +      + E+ +L +++H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 457 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA 516
            LL          LV++F+          +      +T        +     L YLH   
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 517 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 576
              I HRD+K  N+LLD+    K++DFG ++S        T QV  T  Y  PE    ++
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176

Query: 577 FTD-KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE 635
                 D+++ G +LAELL     +   +  +  +     L    EE+  ++        
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 636 SGGDEIITFAKVA-----------KRCLNLNGKKRPTMREV 665
                 I    +            +     N   R T  + 
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 6e-46
 Identities = 57/274 (20%), Positives = 101/274 (36%), Gaps = 29/274 (10%)

Query: 401 LNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKL 458
            +++LG G  G V +       +  A+K  +        +   E+ +  +     ++V++
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRI 70

Query: 459 LGCC----LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS 514
           +          +  L+V E +  G LF  I D+ +    T      I   +  A+ YLHS
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS 129

Query: 515 AASIPIYHRDIKSTNILLDDKY---RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
                I HRD+K  N+L   K      K++DFG ++      +  T     T  Y+ PE 
Sbjct: 130 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEV 184

Query: 572 FRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR 631
               ++    D++S GV++  LL G  P  F +                 +  F   +  
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242

Query: 632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
            + E     I       +  L     +R T+ E 
Sbjct: 243 EVSEEVKMLI-------RNLLKTEPTQRMTITEF 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 7e-46
 Identities = 69/280 (24%), Positives = 110/280 (39%), Gaps = 32/280 (11%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESK---VEEFINEMVILSQ 449
           D ++    LG G    V K      G   A K   K +     +    E+   E+ IL +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 450 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           I H NV+ L          +L+ E +  G LF ++ ++     +T E       ++   +
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 126

Query: 510 SYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 565
            YLHS     I H D+K  NI+L D    K R K+ DFG +  +  D  +    + GT  
Sbjct: 127 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPE 181

Query: 566 YLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
           ++ PE         ++D++S GV+   LL+G  P    T +E          A      +
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANVSAVNY 233

Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
           E  D      S            +R L  + KKR T+++ 
Sbjct: 234 EFEDEYFSNTSA-----LAKDFIRRLLVKDPKKRMTIQDS 268

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 7e-45
 Identities = 55/286 (19%), Positives = 112/286 (39%), Gaps = 24/286 (8%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHR 453
             +     +G+G  GTV+K       +IVA+K+ ++   DE      + E+ +L ++ H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 454 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLH 513
           N+V+L       +   LV+EF        +     +      E+      ++   L + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH 118

Query: 514 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 573
           S     + HRD+K  N+L++     K+++FG +R+  +     + +V   +       F 
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 574 SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYF----------LFAMKEER 623
           +  ++   D++S G + AEL    +P+ F   + D  L   F            +M +  
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 624 LFEILDARVMKESGGDEIITFAKVAK----RCLNLNGKKRPTMREV 665
            ++         S  + +       +      L  N  +R +  E 
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 7e-45
 Identities = 55/287 (19%), Positives = 95/287 (33%), Gaps = 28/287 (9%)

Query: 394 RATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH 452
           R  + + L R +G G  G +Y G  +  G+ VA+K   V  ++K  +   E  I   +  
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQG 61

Query: 453 RNVVKLLG-CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSY 511
              +  +  C  E +  ++V E +       +          + +  L +A ++   + Y
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEY 118

Query: 512 LHSAASIPIYHRDIKSTNIL---LDDKYRAKVSDFGASRSMAVDQTH------MTTQVHG 562
           +HS       HRD+K  N L           + DFG ++     +TH          + G
Sbjct: 119 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175

Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE 622
           T  Y         + + + D+ S G VL     G            K      +   K  
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLG-SLPWQGLKAATKRQKYERISEKKMS 234

Query: 623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
              E+L      E        FA     C +L    +P    +    
Sbjct: 235 TPIEVLCKGYPSE--------FATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-44
 Identities = 64/289 (22%), Positives = 115/289 (39%), Gaps = 28/289 (9%)

Query: 397 DNFNLNRILGQGGQGTVYKGMLPD-GKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
            ++   +++G G  G VY+  L D G++VA+KK              E+ I+ +++H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75

Query: 456 VKLLGCCLETEVP------LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGAL 509
           V+L      +          LV +++P        H       +          ++  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 510 SYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 568
           +Y+HS     I HRDIK  N+LLD D    K+ DFG+++ +   + +++  +   +    
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191

Query: 569 PEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL 628
              F ++ +T   DV+S G VLAELL G+      +  +        L     E++ E+ 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 629 DARVMKESGGDEIITFAKVA------------KRCLNLNGKKRPTMREV 665
                 +    +   + KV              R L      R T  E 
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 6e-44
 Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 42/280 (15%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVE---EFINEMVILSQ 449
             + +  +LG GG G+VY G+ + D   VA+K   K ++ D  ++        E+V+L +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 450 IN--HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           ++     V++LL      +  +L+ E             +     +  E+      +V  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLE 121

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 566
           A+ + H+     + HRDIK  NIL+D ++   K+ DFG+     + +  + T   GT  Y
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVY 175

Query: 567 LDPEYFRSSQFTDKS-DVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
             PE+ R  ++  +S  V+S G++L +++ G+ P                          
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------------- 214

Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREV 665
           EI+  +V              + + CL L    RPT  E+
Sbjct: 215 EIIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 4e-43
 Identities = 66/276 (23%), Positives = 106/276 (38%), Gaps = 28/276 (10%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           ++F+  ++LG+G  G V        G+  A+K   K  +I + +V   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             +  L       +    V E+   G LF ++     +   T E       E+  AL YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HS     + +RDIK  N++LD     K++DFG  +    D   M T   GT  YL PE  
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV 632
             + +    D +  GVV+ E++ G  P      E       + L  M+E R    L    
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILMEEIRFPRTLSPE- 231

Query: 633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
                         +    L  + K+R       ++
Sbjct: 232 -----------AKSLLAGLLKKDPKQRLGGGPSDAK 256

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  152 bits (385), Expect = 4e-42
 Identities = 45/285 (15%), Positives = 91/285 (31%), Gaps = 28/285 (9%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNV 455
            ++ + R +G+G  G +++G  L + + VA+K       S   +  +E      +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62

Query: 456 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA 515
           +  +    +  +  ++   +   +L   +      F    +     A ++   +  +H  
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS--VKTVAMAAKQMLARVQSIHEK 120

Query: 516 ASIPIYHRDIKSTNILLDDKYR-----AKVSDFGASRSMAVDQT------HMTTQVHGTF 564
               + +RDIK  N L+            V DFG  +      T           + GT 
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 565 GYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL 624
            Y+        + + + D+ + G V    L G  P +      +           K ER+
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN---------KQKYERI 228

Query: 625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSEL 669
            E   +  ++E        F K      NL     P    +    
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-41
 Identities = 57/302 (18%), Positives = 111/302 (36%), Gaps = 36/302 (11%)

Query: 394 RATDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK--SKVIDESKVEEFINEMVILSQI 450
                +     +GQG  G V+K      G+ VA+KK   +   E      + E+ IL  +
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66

Query: 451 NHRNVVKLLGCCLETEVP--------LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIA 502
            H NVV L+  C     P         LV++F  +       +        T     R+ 
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 123

Query: 503 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT---HMTTQ 559
             +   L+ L+      I HRD+K+ N+L+      K++DFG +R+ ++ +    +  T 
Sbjct: 124 QML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 560 VHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA 618
              T  Y  PE     + +    D++  G ++AE+ T    ++  T +   +L +    +
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 619 MKEERLFEILDARVMKE---------------SGGDEIITFAKVAKRCLNLNGKKRPTMR 663
           +  E    + +  + ++                          +  + L L+  +R    
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 664 EV 665
           + 
Sbjct: 301 DA 302

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (382), Expect = 4e-41
 Identities = 61/276 (22%), Positives = 104/276 (37%), Gaps = 31/276 (11%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK---KSKVIDESKVEEFINEMVILSQINH 452
           D F+  + LG G  G V        G   A+K   K KV+   ++E  +NE  IL  +N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 453 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
             +VKL     +     +V E++  G +F ++         +       A ++     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157

Query: 513 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 572
           HS     + +RD+K  N+L+D +   +V+DFG     A      T  + GT   L PE  
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWTLCGTPEALAPEII 210

Query: 573 RSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV 632
            S  +    D ++ GV++ E+  G  P        D+ +  Y      + R      +  
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP-----FFADQPIQIYEKIVSGKVRFPSHFSSD- 264

Query: 633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
                         + +  L ++  KR    +    
Sbjct: 265 -----------LKDLLRNLLQVDLTKRFGNLKNGVN 289

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 9e-41
 Identities = 57/304 (18%), Positives = 111/304 (36%), Gaps = 34/304 (11%)

Query: 387 FTSKELERAT----DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK--KSKVIDESKVEE 439
           F  +E+ +        +   + +G G  G V   +    G  VA+K        E   + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 440 FINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN----GTLFQYIHDQNEDFPITW 495
              E+ +L  + H NV+ LL      E      +F       GT    +        +  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGE 120

Query: 496 EMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 555
           +    +  ++   L Y+H+A    I HRD+K  N+ +++    K+ DFG +R      + 
Sbjct: 121 DRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSE 174

Query: 556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKP--------IRFTTLEE 607
           MT  V   +           ++T   D++S G ++AE++TG+               ++ 
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234

Query: 608 DKSLAAYFLFAMKEERLFEILDARVMKESGGDEIIT------FAKVAKRCLNLNGKKRPT 661
             +  A F+  ++ +     +      E      I          + ++ L L+ ++R T
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294

Query: 662 MREV 665
             E 
Sbjct: 295 AGEA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-38
 Identities = 74/283 (26%), Positives = 113/283 (39%), Gaps = 30/283 (10%)

Query: 397 DNFNLNRILGQGGQGTVYKGML----PDGKIVAVK---KSKVIDESK-VEEFINEMVILS 448
           +NF L ++LG G  G V+          GK+ A+K   K+ ++ ++K  E    E  +L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 449 QINHR-NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
            I     +V L           L+ ++I  G LF ++  +      T         E+  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVL 140

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
           AL +LH      I +RDIK  NILLD      ++DFG S+    D+T       GT  Y+
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 568 DPEYFRSSQ--FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF 625
            P+  R          D +S GV++ ELLTG  P  FT   E  S A      +K E  +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEPPY 255

Query: 626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE 668
                 +              + +R L  + KKR       ++
Sbjct: 256 ---PQEMSAL--------AKDLIQRLLMKDPKKRLGCGPRDAD 287

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  141 bits (356), Expect = 8e-38
 Identities = 60/298 (20%), Positives = 114/298 (38%), Gaps = 45/298 (15%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRN 454
           D++ L R LG+G    V++ + + + + V VK   ++   K ++   E+ IL  +    N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK---ILKPVKKKKIKREIKILENLRGGPN 91

Query: 455 VVKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYL 512
           ++ L     +  +  P LV+E + N    Q          +T         E+  AL Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145

Query: 513 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 571
           HS     I HRD+K  N+++D +  + ++ D+G +      Q +       +  +  PE 
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200

Query: 572 FRSSQFTD-KSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA 630
               Q  D   D++S G +LA ++  ++P  F    ++          +  E L++ +D 
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258

Query: 631 RVMKESGGDEIITFAKVAK-----------------------RCLNLNGKKRPTMREV 665
             ++       I      K                       + L  + + R T RE 
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 5e-36
 Identities = 65/305 (21%), Positives = 111/305 (36%), Gaps = 36/305 (11%)

Query: 387 FTSKELERA----TDNFNLNRILGQGGQGTVYKGM-LPDGKIVAVK--KSKVIDESKVEE 439
           F  +EL +      + +     +G G  G+V        G  VAVK            + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 440 FINEMVILSQINHRNVVKLLGCC-----LETEVPLLVYEFIPNGTLFQYIHDQNEDFPIT 494
              E+ +L  + H NV+ LL        LE    + +   +    L   +  Q     +T
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLT 119

Query: 495 WEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 554
            +    +  ++   L Y+HSA    I HRD+K +N+ +++    K+ DFG +R       
Sbjct: 120 DDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT---DD 173

Query: 555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAY 614
            MT  V   +            +    D++S G ++AELLTG      T   +   L   
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233

Query: 615 FLFAMKEERLFEILDA----------RVMKESGGDEIITFAKVAK----RCLNLNGKKRP 660
            +     E L +I             ++ K +  +  I    +A     + L L+  KR 
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293

Query: 661 TMREV 665
           T  + 
Sbjct: 294 TAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 1e-35
 Identities = 53/303 (17%), Positives = 110/303 (36%), Gaps = 45/303 (14%)

Query: 397 DNFNLNRILGQGGQGTVYKGM-LPDGKIVAVKK--SKVIDESKVEEFINEMVILSQINHR 453
             +   + +G G QG V         + VA+KK      +++  +    E+V++  +NH+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 454 NVVKLLGCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSG 507
           N++ LL          E +   LV E +                 +  E    +  ++  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLC 130

Query: 508 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 567
            + +LH   S  I HRD+K +NI++      K+ DFG +R+     + M T    T  Y 
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 185

Query: 568 DPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEE--DKSLAAYFLFAMKEERLF 625
            PE      + +  D++S G ++ E++  +         +  +K +        +  +  
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 626 EILDARVMKESGGDEIITFAKVA-----------------------KRCLNLNGKKRPTM 662
           +      ++       +TF K+                         + L ++  KR ++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 663 REV 665
            + 
Sbjct: 306 DDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  118 bits (295), Expect = 2e-29
 Identities = 60/314 (19%), Positives = 104/314 (33%), Gaps = 50/314 (15%)

Query: 399 FNLNRILGQGGQGTVYKGM-LPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVK 457
           + L R LG G   TV+    + +   VA+K  +  D+   E   +E+ +L ++N  +  K
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 458 LLGCCLETEVPLLVY--EFIPNGTLFQYIH-----------DQNEDFPITWEMRLRIAIE 504
                    + LL +     PNG     +             + E   I      +I+ +
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 505 VSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFG-ASRSMAVDQTHMTTQVHG 562
           +   L Y+H    I   H DIK  N+L++       +     A    A       T    
Sbjct: 134 LLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 563 TFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR----FTTLEEDKSLAAYF--L 616
           T  Y  PE    + +   +D++S   ++ EL+TG+         +  ++D  +A     L
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251

Query: 617 FAMKEERLFEILDARVMKESGG-------------------------DEIITFAKVAKRC 651
             +    L      R    S G                         DE    +      
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311

Query: 652 LNLNGKKRPTMREV 665
           L L+ +KR     +
Sbjct: 312 LQLDPRKRADAGGL 325

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 88.3 bits (218), Expect = 1e-20
 Identities = 29/201 (14%), Positives = 62/201 (30%), Gaps = 36/201 (17%)

Query: 401 LNRILGQGGQGTVYKGMLPDGKIVAVK----------KSKVIDESKVEEFINEMVILSQI 450
           + +++G+G +  V+           VK          K K   +     F    +  ++ 
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 451 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALS 510
             R + KL G  +        Y +  N  L + I  +             +   +   ++
Sbjct: 64  EFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVA 117

Query: 511 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP- 569
             +      I H D+   N+L+ +     + DF      +V+      +       L+  
Sbjct: 118 KFYHR---GIVHGDLSQYNVLVSE-EGIWIIDFP----QSVEVGEEGWR-----EILERD 164

Query: 570 -----EYFRSSQFTDKSDVYS 585
                 YF    +  + D+ S
Sbjct: 165 VRNIITYFS-RTYRTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	684
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.72
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.54
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.21
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.14
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.81
d1emoa1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	95.1
d1emoa1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	93.09
d1lmja1	44	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	92.84
d1uzka2	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	92.59
d1uzka1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	91.67
d1dx5i3	40	Thrombomodulin, different EGF-like domains {Human	91.4
d1gl4a2	40	EGF-like domain of nidogen-1 {Mouse (Mus musculus)	91.29
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	91.19
d1lmja2	42	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	90.74
d1i0ua2	41	Low density lipoprotein (LDL) receptor, different	89.45
d1g1sa2	40	E-selectin, EGF-domain {Human (Homo sapiens) [TaxI	88.61
d1lmja1	44	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	88.55
d1xkba1	39	Factor X, N-terminal module {Human (Homo sapiens)	86.98
d1apqa_	53	Complement protease C1R {Human (Homo sapiens) [Tax	85.56
d1g1ta2	39	E-selectin, EGF-domain {Human (Homo sapiens) [TaxI	85.53
d1edmb_	39	Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606	85.2
d2vj3a3	35	Neurogenic locus notch homolog protein 1, Notch1 {	84.41
d1dx5i3	40	Thrombomodulin, different EGF-like domains {Human	84.37
d2vj3a2	39	Neurogenic locus notch homolog protein 1, Notch1 {	83.88
d2c4fl1	37	Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]}	83.6
d1tpga1	41	Plasminogen activator (tissue-type), t-PA {Human (	83.6
d1apqa_	53	Complement protease C1R {Human (Homo sapiens) [Tax	83.52
d1uzka1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	81.61

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=424.69  Aligned_cols=256  Identities=27%  Similarity=0.435  Sum_probs=205.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ++|++.+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++|||||++++++.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4688999999999999999999889999999987533 334789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +|+|.+++.....  .++++.++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++.........
T Consensus        84 ~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            9999999986543  4899999999999999999999999   9999999999999999999999999998776554444


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhC-CCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTG-EKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG-~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....||+.|+|||++.+..++.++||||||++||||+|+ ++||......+   +             .+.+.......
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~-------------~~~i~~~~~~~  222 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---V-------------VEDISTGFRLY  222 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---H-------------HHHHHHTCCCC
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---H-------------HHHHHhcCCCC
Confidence            4556789999999999999999999999999999999995 55554332211   1             11111112223


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      .+...+.++.+|+.+||+.||++|||++||+++|++|+.
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            344566789999999999999999999999999999975

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-52  Score=424.13  Aligned_cols=262  Identities=25%  Similarity=0.422  Sum_probs=209.6

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ..++|++.++||+|+||+||+|++++  .||||+++.  .+....+.|.+|+++|++++|||||++++++.+ +..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            35679999999999999999998754  599998764  345667899999999999999999999998754 5689999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.++++..+.  .+++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        83 Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             ECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             ecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            99999999999986543  4999999999999999999999998   999999999999999999999999999876533


Q ss_pred             C-ceeeecccccCCCCCcccccc---CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          553 Q-THMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       553 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      . ........||+.|||||++..   ..++.++|||||||+||||+||+.||...+....  +..    ......    .
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~----~~~~~~----~  227 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIF----MVGRGY----L  227 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHH----HHHHTS----C
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHH----HHhcCC----C
Confidence            2 233455679999999999864   3588999999999999999999999975433221  111    111110    0


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      . ......+.+.+.++.+|+.+||+.||++|||++||+++|+.|+++
T Consensus       228 ~-p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         228 S-PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             C-CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             C-CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            0 111233455678899999999999999999999999999999863

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=422.00  Aligned_cols=261  Identities=24%  Similarity=0.378  Sum_probs=216.9

Q ss_pred             HHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          393 ERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       393 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      +...++|++.+.||+|+||+||+|.+++++.||||+++... ...++|.+|+++|++++|||||++++++.+ +..++||
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            33456799999999999999999999888999999987533 335689999999999999999999998754 5679999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++..... ..+++..+++++.||++||+|||+++   |+||||||+||||++++.+||+|||+++.....
T Consensus        87 Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             ECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence            99999999998875432 24899999999999999999999999   999999999999999999999999999987665


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCC-CCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIR-FTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .........||+.|+|||++.+..++.++||||||++||||+||..|+. .....+   +             ...+...
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~-------------~~~i~~~  226 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---V-------------IQNLERG  226 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H-------------HHHHHTT
T ss_pred             ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH---H-------------HHHHHhc
Confidence            5555556678999999999999999999999999999999999665543 322111   1             1111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .....+...+.++.+|+.+||+.||++||||+||++.|+.+..+
T Consensus       227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            22233455677899999999999999999999999999988764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-51  Score=425.12  Aligned_cols=263  Identities=28%  Similarity=0.425  Sum_probs=222.7

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      ++...++|++.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+++|++++|||||++++++.+.+..++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3444567999999999999999999975 5889999998753 3345789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++|+|.+++.+... ..+++..++.++.||++||+|||+++   |+||||||+||||++++++||+|||+++...
T Consensus        91 v~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence            9999999999999987533 35999999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      .+.........|++.|+|||++.+..++.++||||||+++|||++|..|+.......               .+.+.+..
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~---------------~~~~~i~~  231 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------------QVYELLEK  231 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---------------HHHHHHHT
T ss_pred             CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH---------------HHHHHHhc
Confidence            655555555668999999999999999999999999999999999777654322111               11222333


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      ......+...+.++.+|+.+||+.||++|||++||++.|+.+..
T Consensus       232 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            33344456677889999999999999999999999999988764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=411.53  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=218.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecC
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIP  476 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~  476 (684)
                      ++|++.++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||+++++++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57999999999999999999998899999998875433 34689999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee
Q 043157          477 NGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM  556 (684)
Q Consensus       477 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~  556 (684)
                      +|+|.+++.....  .+++..+++++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus        83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             CCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            9999999876544  3899999999999999999999999   9999999999999999999999999998766555544


Q ss_pred             eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          557 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       557 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      .....||+.|+|||.+.+..++.|+||||||+++|||+| |+.||......+..                ..+.......
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~----------------~~i~~~~~~~  221 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----------------EHIAQGLRLY  221 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----------------HHHHTTCCCC
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH----------------HHHHhCCCCC
Confidence            555678999999999999999999999999999999998 89999865533211                1111111223


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      .+...+.++.+|+.+||+.||++|||++|++++|..|
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            3455667899999999999999999999999999764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-50  Score=419.46  Aligned_cols=257  Identities=25%  Similarity=0.429  Sum_probs=204.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CC---cEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DG---KIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|++.++||+|+||+||+|.++ ++   ..||||++.. ......++|.+|+++|++++|||||++++++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45778899999999999999975 33   3689998765 4556678899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++|+|.+++.....  .+++..++.++.||++||+|||+++   |+||||||+||||+.++++||+|||+++....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999887543  4899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCcee----eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          552 DQTHM----TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       552 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      .....    .....||+.|||||.+.+..++.++|||||||+||||+| |+.||......+.                ..
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~----------------~~  244 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV----------------IN  244 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------HH
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH----------------HH
Confidence            33221    222457899999999999999999999999999999998 8999975443221                11


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      .+........+.+.+.++.+|+.+||+.||++|||++||++.|++|.+
T Consensus       245 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         245 AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            111122223345677889999999999999999999999999998865

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-51  Score=415.85  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=206.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.... .+..+.+.+|+++|++++||||+++++++.+.+..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            56999999999999999999975 68999999876533 33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC-
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ-  553 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~-  553 (684)
                      +++|+|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++...... 
T Consensus        85 ~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999997543   4999999999999999999999999   9999999999999999999999999998765433 


Q ss_pred             ceeeecccccCCCCCccccccCCC-CCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      ........||+.|||||++.+..+ +.++|||||||+||||+||+.||......... ..             .......
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~-------------~~~~~~~  224 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS-------------DWKEKKT  224 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HH-------------HHHTTCT
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HH-------------HHhcCCC
Confidence            233455679999999999988776 57899999999999999999999754322110 00             0111111


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ........+.++.+|+.+||+.||++|||++|++++
T Consensus       225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111123456788999999999999999999999764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-50  Score=415.58  Aligned_cols=250  Identities=26%  Similarity=0.418  Sum_probs=211.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+++|++++||||+++++++.+.+..+|||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4699999999999999999996 479999999987665556788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++|+|.+++.+.    .+++..++.++.||+.||+|||+++   |+||||||+||||+.++++||+|||+++....... 
T Consensus       100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            999999988764    3899999999999999999999999   99999999999999999999999999987654333 


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhcc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMKE  635 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~  635 (684)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+.  +..    ....        ......
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~----~~~~--------~~~~~~  237 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYL----IATN--------GTPELQ  237 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHH----HHHH--------CSCCCS
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--HHH----HHhC--------CCCCCC
Confidence            33445699999999999999999999999999999999999999975442221  100    0000        011112


Q ss_pred             CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          636 SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       636 ~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .+...+.++.+|+.+||+.||++|||++|++++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            234567789999999999999999999999874

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=409.69  Aligned_cols=246  Identities=28%  Similarity=0.412  Sum_probs=209.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||+++.+ +++.||+|++...   +....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46999999999999999999975 6899999987542   2334577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++.+..   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999998764   3999999999999999999999999   999999999999999999999999999765433


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .   .....||+.|||||++.+..++.++|||||||+||||++|+.||...+..+..               ..+...  
T Consensus       160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---------------~~i~~~--  219 (263)
T d2j4za1         160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY---------------KRISRV--  219 (263)
T ss_dssp             C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------------HHHHTT--
T ss_pred             c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH---------------HHHHcC--
Confidence            2   33456999999999999999999999999999999999999999765432211               011111  


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ....+...+.++.+|+.+||+.||++|||++|++++
T Consensus       220 ~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            112334567789999999999999999999999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=414.30  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=199.1

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeee--cCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLE--TEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv  471 (684)
                      ++|++.+.||+|+||+||+++.+ +|+.||+|++..  .++...+.+.+|+++|++++|||||++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            56999999999999999999964 789999998764  345567889999999999999999999999865  3467899


Q ss_pred             EEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          472 YEFIPNGTLFQYIHDQN-EDFPITWEMRLRIAIEVSGALSYLHSAA--SIPIYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      |||+++|+|.+++.+.. ....+++..++.++.||+.||+|||+++  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999997532 2335999999999999999999999865  13499999999999999999999999999987


Q ss_pred             cccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          549 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ...... ......||+.|||||++.+..++.++||||||+++|||+||+.||...+..+   +..            .+.
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~------------~i~  227 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAG------------KIR  227 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH------------HHH
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHH------------HHH
Confidence            654332 3345679999999999999999999999999999999999999997554322   110            111


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      . ......+...+.++.+|+.+||+.||++|||++|++++
T Consensus       228 ~-~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         228 E-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             H-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             c-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            1 11123345567789999999999999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-50  Score=413.29  Aligned_cols=251  Identities=26%  Similarity=0.355  Sum_probs=210.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      +.|++.+.||+|+||+||+|.+. +++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999965 68999999988777777789999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++|+|.+++.+...  ++++..+..++.||+.||+|||+++   |+||||||+||||+.++++||+|||+++...... .
T Consensus        92 ~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~  165 (288)
T d2jfla1          92 AGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q  165 (288)
T ss_dssp             TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred             CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence            99999999876543  4999999999999999999999999   9999999999999999999999999997653221 1


Q ss_pred             eeecccccCCCCCccccc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          556 MTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                      ......||+.|+|||++.     ...++.++|||||||+||||+||+.||......+.  +             ..+...
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~-------------~~i~~~  230 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--L-------------LKIAKS  230 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--H-------------HHHHHS
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--H-------------HHHHcC
Confidence            233456999999999984     45688999999999999999999999975543221  1             111111


Q ss_pred             h-hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 R-VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ~-~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      . .....+...+.++.+|+.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         231 EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1 1112234567789999999999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=410.27  Aligned_cols=256  Identities=27%  Similarity=0.428  Sum_probs=212.2

Q ss_pred             cCCCcCce-eceeCcEEEEEEEeC---CCcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRI-LGQGGQGTVYKGMLP---DGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~-LG~G~~g~Vy~~~~~---~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      +++.+.+. ||+|+||+||+|.++   ++..||||+++. ......++|.+|+++|++++|||||++++++.+ +..+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666774 999999999999864   355899998865 445667889999999999999999999999864 568999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++|+|.+++...+.  .+++..+++++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        87 mE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999999876543  4999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCcee--eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          552 DQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       552 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      .....  .....||+.|+|||++....++.++||||||+++|||+| |+.||......+.                ...+
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~----------------~~~i  225 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV----------------MAFI  225 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH----------------HHHH
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH----------------HHHH
Confidence            33322  233458899999999999999999999999999999998 9999975443221                1111


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      ......+.+...+.++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       226 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1122233456677889999999999999999999999999987653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=409.06  Aligned_cols=258  Identities=24%  Similarity=0.409  Sum_probs=207.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCC-----cEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDG-----KIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      +.|++.++||+|+||+||+|.++..     ..||||++.. ......++|.+|++++++++|||||++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4688899999999999999986532     3799998865 345556789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+.+++|.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999998876543  4999999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCc--eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          551 VDQT--HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       551 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ....  .......||+.|||||++.+..++.++||||||++||||++|..|+.......               .+.+.+
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~---------------~~~~~i  226 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKAI  226 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---------------HHHHHH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH---------------HHHHHH
Confidence            4322  22333458999999999999999999999999999999999766654322111               112222


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      ........+.+.+.++.+|+.+||+.||++||||+||++.|++|.+
T Consensus       227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            2333334455677889999999999999999999999999998865

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=406.97  Aligned_cols=248  Identities=28%  Similarity=0.417  Sum_probs=204.9

Q ss_pred             ceeceeCcEEEEEEEeC---CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEecCC
Q 043157          403 RILGQGGQGTVYKGMLP---DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN  477 (684)
Q Consensus       403 ~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  477 (684)
                      ++||+|+||+||+|.++   .++.||||+++.  .+....++|.+|+++|++++|||||++++++. .+..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence            57999999999999864   356899998764  33445678999999999999999999999985 4567899999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCcee-
Q 043157          478 GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-  556 (684)
Q Consensus       478 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~~-  556 (684)
                      |+|.+++++..   ++++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++......... 
T Consensus        92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999998754   3999999999999999999999999   9999999999999999999999999998765443332 


Q ss_pred             -eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          557 -TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       557 -~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                       .....||+.|||||.+.+..++.++||||||+++|||+| |+.||......+                +.+.+......
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----------------~~~~i~~~~~~  229 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGERM  229 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCCC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH----------------HHHHHHcCCCC
Confidence             233568999999999999999999999999999999998 899998544322                11112222223


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      ..+...+.++.+|+.+||+.||++|||++||++.|+...
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            345567788999999999999999999999999998764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=415.51  Aligned_cols=258  Identities=26%  Similarity=0.460  Sum_probs=211.8

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCC-C-----cEEEEEeccc-cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecC
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPD-G-----KIVAVKKSKV-IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETE  466 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-g-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~  466 (684)
                      ..++|++.++||+|+||+||+|++.. +     ..||+|++.. .+......+.+|+.+|+++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            44679999999999999999998642 2     3689998754 3444567899999999998 8999999999999999


Q ss_pred             cceEEEEecCCCCHHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNE--------------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIK  526 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlk  526 (684)
                      ..++||||+++|+|.++|+....                    ...+++..++.++.||++||+|||+++   |+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence            99999999999999999986532                    134899999999999999999999999   9999999


Q ss_pred             CCCEEECCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 043157          527 STNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTT  604 (684)
Q Consensus       527 p~NILl~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~  604 (684)
                      |+|||++.++.+||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654433 23345568999999999999999999999999999999998 899997544


Q ss_pred             hhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043157          605 LEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELA  670 (684)
Q Consensus       605 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~  670 (684)
                      ..+.               +.+++........+...+.++.+|+.+||+.||++|||++||+++|.
T Consensus       272 ~~~~---------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CSHH---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHH---------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            3221               11222222223445567788999999999999999999999999995

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=409.21  Aligned_cols=262  Identities=22%  Similarity=0.363  Sum_probs=209.6

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ..++|++.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++||||
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            346799999999999999999999888899999987543 334789999999999999999999999854 568999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +++|+|.+++...... .++|..++.++.||++||+|||+.+   |+||||||+||||++++++||+|||+++.......
T Consensus        93 ~~~g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          93 MSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             CTTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             cCCCchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            9999999999864322 4999999999999999999999999   99999999999999999999999999987655444


Q ss_pred             eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          555 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                      .......||+.|+|||++....++.++||||||++||||++|..|+........  +             ...+......
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~-------------~~~i~~~~~~  233 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--V-------------LDQVERGYRM  233 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--H-------------HHHHHTTCCC
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--H-------------HHHHHhcCCC
Confidence            444556689999999999999999999999999999999997666543322110  1             1111111222


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      ..+...+.++.+|+.+||+.||++||++++|++.|+.......
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            3445667789999999999999999999999999998776443

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-50  Score=420.33  Aligned_cols=269  Identities=25%  Similarity=0.396  Sum_probs=212.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .++|++.++||+|+||+||+|... +|+.||+|+++.. .....+++.+|+.+|++++|||||++++++.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467999999999999999999964 7899999987653 34556789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      |+++|+|.+++.+.+.   +++..++.++.|++.||.|||++ +   |+||||||+||||++++++||+|||+|+.....
T Consensus        85 y~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            9999999999987643   89999999999999999999975 7   999999999999999999999999999865432


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH--------------
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFA--------------  618 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~--------------  618 (684)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...........              
T Consensus       159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence               233457999999999999999999999999999999999999999865443221110000000              


Q ss_pred             ---------hhhhhhhhhhhhhhh---ccCC-hhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhH
Q 043157          619 ---------MKEERLFEILDARVM---KESG-GDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGIK  673 (684)
Q Consensus       619 ---------~~~~~~~~~~d~~~~---~~~~-~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i~  673 (684)
                               .......+.++....   ...+ ...+.++.+|+.+||+.||++|||++|++++  +++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                     000001111111000   0111 2346789999999999999999999999986  44433

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=399.56  Aligned_cols=247  Identities=22%  Similarity=0.379  Sum_probs=199.9

Q ss_pred             CcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeee----cCcceEEE
Q 043157          400 NLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLE----TEVPLLVY  472 (684)
Q Consensus       400 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lv~  472 (684)
                      ++.++||+|+||+||+|.+. +++.||+|++..  ......+.+.+|+++|++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            66778999999999999965 688999998764  345667889999999999999999999999875    34578999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCcEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgl~~~~~~  551 (684)
                      ||+++|+|.+++.+..   .+++..++.++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999998764   3899999999999999999999986 3499999999999996 578999999999976433


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      .   ......||+.|||||++.+ .++.++|||||||+||||++|+.||........  +..    .+...        .
T Consensus       168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~----~i~~~--------~  229 (270)
T d1t4ha_         168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR----RVTSG--------V  229 (270)
T ss_dssp             T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH----HHTTT--------C
T ss_pred             C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHH----HHHcC--------C
Confidence            2   2345679999999999865 599999999999999999999999974332211  111    11110        0


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .....+...+.++.+|+.+||+.||++|||++|++++
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            0111223345678999999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=405.12  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=204.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC----CcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD----GKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  470 (684)
                      .++|++.+.||+|+||+||+|.+..    +..||||+++. ......+.|.+|+++|++++||||+++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4679999999999999999998643    35789998865 34555678999999999999999999999996 467899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA  550 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~  550 (684)
                      ||||+++|+|.+++.....  .+++..++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        85 v~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999999876543  4899999999999999999999999   9999999999999999999999999998766


Q ss_pred             cCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          551 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ...........||+.|+|||.+....++.++||||||+++|||+| |.+||......+.   .             +.+.
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~-------------~~i~  223 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I-------------GRIE  223 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H-------------HHHH
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---H-------------HHHH
Confidence            555545555678999999999999999999999999999999998 8999876543321   1             1111


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      .......+...+.++.+|+.+||+.||++|||++||+++|+.|...
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            1111234456778899999999999999999999999999988654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-49  Score=405.98  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=207.7

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||+|... +++.||||++...   .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46999999999999999999964 7899999987642   2344678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++...+.   +++..++.++.|++.||+|||+.+   |+||||||+||||++++.+||+|||+++.....
T Consensus        88 Ey~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999999987653   999999999999999999999999   999999999999999999999999999876533


Q ss_pred             C-ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          553 Q-THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       553 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      . ........||+.|+|||++.+..++.++|||||||+||||++|+.||...+..+.   .            ..+....
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~------------~~i~~~~  226 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---F------------QKIIKLE  226 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H------------HHHHTTC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH---H------------HHHHcCC
Confidence            2 2334456799999999999999999999999999999999999999985543221   0            0111111


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus       227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence              12344567789999999999999999999997654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.3e-48  Score=409.59  Aligned_cols=253  Identities=22%  Similarity=0.298  Sum_probs=212.7

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|++.+.||+|+||+||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999964 7999999998877777788899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC--CCCcEEEeccCCccccccC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DFgl~~~~~~~  552 (684)
                      +++|+|.+++.+...  .+++..++.++.||+.||+|||+++   |+||||||+||||+  .++.+||+|||+++.....
T Consensus       105 ~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999999975433  4999999999999999999999999   99999999999996  4678999999999876543


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      ..  .....||+.|||||++.+..++.++|||||||++|||++|+.||...+..+..   ..    +...      +...
T Consensus       180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---~~----i~~~------~~~~  244 (350)
T d1koaa2         180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---RN----VKSC------DWNM  244 (350)
T ss_dssp             SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH----HHHT------CCCS
T ss_pred             cc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH---HH----HHhC------CCCC
Confidence            32  34456999999999999999999999999999999999999999765432211   00    0000      0001


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ........+.++.+|+.+||+.||++|||++|++++
T Consensus       245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111223456789999999999999999999999886

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-48  Score=406.22  Aligned_cols=263  Identities=24%  Similarity=0.393  Sum_probs=216.4

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeee
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLE  464 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  464 (684)
                      ++...++|++.+.||+|+||+||+|+++      +++.||||+++.. .....++|.+|+++|++++||||+++++++.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3445678999999999999999999863      4578999998753 34456789999999999999999999999999


Q ss_pred             cCcceEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 043157          465 TEVPLLVYEFIPNGTLFQYIHDQNE---------------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHR  523 (684)
Q Consensus       465 ~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~  523 (684)
                      .+..+++|||+++|+|.++++....                     ...+++..++.++.|++.||+|||+.+   |+||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence            9999999999999999999975321                     234899999999999999999999999   9999


Q ss_pred             CCCCCCEEECCCCcEEEeccCCccccccCC-ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCC-CCCC
Q 043157          524 DIKSTNILLDDKYRAKVSDFGASRSMAVDQ-THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGE-KPIR  601 (684)
Q Consensus       524 Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~-~P~~  601 (684)
                      ||||+||||+.++.+||+|||+++...... ........|++.|+|||.+.+..++.++||||||++||||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998654332 23344566899999999999999999999999999999999986 5676


Q ss_pred             CCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 043157          602 FTTLEEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIK  673 (684)
Q Consensus       602 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~  673 (684)
                      .....+..   .    .+.         .......+...+.++.+|+.+||+.||++||||.||++.|++|.
T Consensus       245 ~~~~~e~~---~----~v~---------~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHEEVI---Y----YVR---------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHHHHH---H----HHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHHHHH---H----HHH---------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            54433211   0    111         11122334566778999999999999999999999999999885

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-48  Score=406.04  Aligned_cols=245  Identities=27%  Similarity=0.385  Sum_probs=204.2

Q ss_pred             CCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          398 NFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .|+..+.||+|+||+||+|.. .+++.||||++...   .....+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            489999999999999999996 47899999987643   24456789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+++|+|..++....   ++++..++.++.||+.||.|||+++   |+||||||+||||+.++++||+|||+++..... 
T Consensus        96 ~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             CCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             ecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            999999987766543   4999999999999999999999999   999999999999999999999999999865432 


Q ss_pred             ceeeecccccCCCCCcccccc---CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhh
Q 043157          554 THMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDA  630 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  630 (684)
                          ....||+.|||||++.+   ..|+.++|||||||++|||++|+.||......+.               +..+...
T Consensus       169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~---------------~~~i~~~  229 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---------------LYHIAQN  229 (309)
T ss_dssp             ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---------------HHHHHHS
T ss_pred             ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH---------------HHHHHhC
Confidence                33469999999999854   4689999999999999999999999975432211               0111111


Q ss_pred             hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ......+...+.++.+|+.+||+.||++|||++|++++
T Consensus       230 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            11111234566789999999999999999999999863

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=396.73  Aligned_cols=253  Identities=27%  Similarity=0.482  Sum_probs=205.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeec-CcceEEEEec
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLET-EVPLLVYEFI  475 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E~~  475 (684)
                      ++|++.+.||+|+||+||+|.+ .|+.||||+++.  ....++|.+|++++++++||||+++++++.++ +..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            4688899999999999999998 477899999864  34457899999999999999999999998654 5679999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++|+|.++|..... ..+++..+++++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99999999976432 24899999999999999999999998   999999999999999999999999999865432   


Q ss_pred             eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhhhc
Q 043157          556 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARVMK  634 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~  634 (684)
                       .....+++.|+|||++.+..++.++||||||+++|||+| |++||......+   +             ...+......
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~-------------~~~i~~~~~~  219 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V-------------VPRVEKGYKM  219 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H-------------HHHHTTTCCC
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---H-------------HHHHHcCCCC
Confidence             223457899999999999999999999999999999998 688876543322   1             1111222233


Q ss_pred             cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          635 ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       635 ~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      +.+...+.++.+|+.+||+.||++|||++|++++|++|+..+
T Consensus       220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~  261 (262)
T d1byga_         220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  261 (262)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence            445567788999999999999999999999999999998643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-48  Score=405.11  Aligned_cols=251  Identities=25%  Similarity=0.336  Sum_probs=194.5

Q ss_pred             HhcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC-hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          395 ATDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID-ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       395 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ..+.|++.+.||+|+||+||++... +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..+|||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3467999999999999999999965 68999999876432 333467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC---CCCcEEEeccCCcccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSM  549 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFgl~~~~  549 (684)
                      ||+++|+|.++|.+..   .+++..+..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999998653   4999999999999999999999999   99999999999994   5789999999999865


Q ss_pred             ccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      ....  ......||+.|||||++.+..++.++|||||||+||||++|+.||......+.   ..            .+..
T Consensus       161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~------------~i~~  223 (307)
T d1a06a_         161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---FE------------QILK  223 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH------------HHHT
T ss_pred             cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH---HH------------HHhc
Confidence            4322  23445699999999999999999999999999999999999999985543221   00            1111


Q ss_pred             hh--hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          630 AR--VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       630 ~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..  .......+.+.++.+|+.+||+.||++|||++|++++
T Consensus       224 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11  1112234567789999999999999999999999885

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.7e-48  Score=407.57  Aligned_cols=253  Identities=21%  Similarity=0.282  Sum_probs=213.5

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999996 47999999998876666778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC--CCCcEEEeccCCccccccC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DFgl~~~~~~~  552 (684)
                      +++|+|.+++.....  ++++..++.++.||+.||+|||+++   |+||||||+||||+  .++.+||+|||+++.....
T Consensus       108 ~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999998876533  4999999999999999999999999   99999999999998  6789999999999876543


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .  ......||+.|+|||++.+..++.++|||||||+||||+||+.||......+..   .    .+..      .+...
T Consensus       183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~----~i~~------~~~~~  247 (352)
T d1koba_         183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---Q----NVKR------CDWEF  247 (352)
T ss_dssp             S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H----HHHH------CCCCC
T ss_pred             C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHHh------CCCCC
Confidence            3  234456899999999999999999999999999999999999999865432210   0    0000      01111


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ........+.++.+|+.+||+.||++|||++|++++
T Consensus       248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            222334567789999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=401.56  Aligned_cols=269  Identities=27%  Similarity=0.394  Sum_probs=209.2

Q ss_pred             HHHHHHhcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEeccc-cChhHHHHHHHHHHHHhhc-CCCcccceeee
Q 043157          390 KELERATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKV-IDESKVEEFINEMVILSQI-NHRNVVKLLGC  461 (684)
Q Consensus       390 ~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~  461 (684)
                      .+++...++|++.++||+|+||+||+|.+.      +++.||||+++. ......+.+.+|+.++.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            344444578999999999999999999853      346899999865 3445567788898888887 68999999999


Q ss_pred             eeecC-cceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 043157          462 CLETE-VPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKS  527 (684)
Q Consensus       462 ~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp  527 (684)
                      +.+.+ ..++||||+++|+|.++|+....             ...+++..++.++.||++||+|||+++   |+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence            87654 67899999999999999986431             235899999999999999999999999   99999999


Q ss_pred             CCEEECCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCC-CCCCCCCh
Q 043157          528 TNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGE-KPIRFTTL  605 (684)
Q Consensus       528 ~NILl~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~-~P~~~~~~  605 (684)
                      +||||++++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+||. +||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987653332 2334567999999999999999999999999999999999975 57764432


Q ss_pred             hhhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          606 EEDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       606 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                      .+.               +...+........+...+.++.+|+.+||+.||++|||++|++++|++|..+|
T Consensus       243 ~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         243 DEE---------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             SHH---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHH---------------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence            211               11112222223344556778999999999999999999999999999987654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-48  Score=402.57  Aligned_cols=255  Identities=25%  Similarity=0.484  Sum_probs=207.3

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCc----EEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGK----IVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      .|++.++||+|+||+||+|.+. +|+    .||+|+++. ......++|.+|++++++++|||||++++++.+ +..+++
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v   88 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLI   88 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEE
Confidence            5899999999999999999864 444    589998764 334456789999999999999999999999976 456788


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      +|++.+|+|.+++.....  .+++..+++++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        89 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          89 TQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            999999999999887643  4999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCce-eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhh
Q 043157          552 DQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILD  629 (684)
Q Consensus       552 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  629 (684)
                      .... ......||+.|+|||++.+..++.++||||||++||||+| |++||......+                +...+.
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----------------~~~~i~  227 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILE  227 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----------------HHHHHH
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHH
Confidence            3332 2334568999999999999999999999999999999999 788887554322                112222


Q ss_pred             hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          630 ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       630 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                      .......+...+.++.+|+.+||+.||++|||++|++++|+.+.+
T Consensus       228 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            222233445677889999999999999999999999999988753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=396.50  Aligned_cols=252  Identities=26%  Similarity=0.343  Sum_probs=208.3

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc------ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI------DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVP  468 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  468 (684)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++..      .....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            36799999999999999999996 47999999987532      122467899999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC----cEEEeccC
Q 043157          469 LLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFG  544 (684)
Q Consensus       469 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFg  544 (684)
                      +|||||+++|+|.+++.+.+   .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999998764   3999999999999999999999999   99999999999998776    59999999


Q ss_pred             CccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          545 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       545 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      +++......  ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+..+..   .    .+.... 
T Consensus       163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~----~i~~~~-  232 (293)
T d1jksa_         163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---A----NVSAVN-  232 (293)
T ss_dssp             TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHTTC-
T ss_pred             hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH---H----HHHhcC-
Confidence            998764332  234456899999999999999999999999999999999999999865433211   0    000000 


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           .......+...+.++.+|+.+||+.||++|||++|++++
T Consensus       233 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         233 -----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             -----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 000011113456678999999999999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.1e-47  Score=391.16  Aligned_cols=259  Identities=29%  Similarity=0.385  Sum_probs=208.0

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCc----
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEV----  467 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----  467 (684)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++.   .+....+.+.+|+++|++++||||+++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999996 4799999998764   345566789999999999999999999999987653    


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .||||||+++++|.+++...+   ++++..++.++.||+.||+|||+++   |+||||||+||||+.++..+|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            789999999999999998765   3999999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCC--ceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh
Q 043157          548 SMAVDQ--THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF  625 (684)
Q Consensus       548 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  625 (684)
                      ......  ........||+.|+|||++.+..++.++||||||+++|||+||+.||...+..+.      +.......   
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~---  230 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVRED---  230 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCC---
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcC---
Confidence            654322  2234456799999999999999999999999999999999999999985543221      11111111   


Q ss_pred             hhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhH
Q 043157          626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRP-TMREVTSELAGIK  673 (684)
Q Consensus       626 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-t~~evl~~L~~i~  673 (684)
                          +........+.+.++.+|+.+||+.||++|| |++|+++.|.+++
T Consensus       231 ----~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         231 ----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ----CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                0111222345677899999999999999999 8999999999886

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-47  Score=400.13  Aligned_cols=248  Identities=25%  Similarity=0.306  Sum_probs=211.2

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||+++. .+|+.||||+++..   .....+++.+|+.+|++++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5699999999999999999996 47999999987642   2345678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++.+...   +++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        85 ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999987653   899999999999999999999999   999999999999999999999999999865433


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .. ......||+.|+|||++.+..++.++|||||||+||||++|++||...+..+.   ..            .+...  
T Consensus       159 ~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~------------~i~~~--  220 (337)
T d1o6la_         159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FE------------LILME--  220 (337)
T ss_dssp             TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH------------HHHHC--
T ss_pred             Cc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH---HH------------HHhcC--
Confidence            32 34456799999999999999999999999999999999999999986553221   00            01111  


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPT-----MREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt-----~~evl~~  668 (684)
                      ....+...+.++.+|+.+||+.||++||+     ++|++++
T Consensus       221 ~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         221 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            11234556778999999999999999995     7888875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=393.01  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=201.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC--CC--cEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP--DG--KIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~--~g--~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      ++|++.+.||+|+||+||+|++.  ++  ..||||+++.   ...+..++|.+|+++|++++||||+++++++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            45899999999999999999853  22  3789998764   234556789999999999999999999999965 5678


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+++|+|.+++.....  ++++..+++++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999998887543  3999999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCce--eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          550 AVDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       550 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      ......  ......|+..|+|||++.+..++.++||||||+++|||+| |+.||......+..               ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---------------~~  226 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---------------HK  226 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---------------HH
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH---------------HH
Confidence            544332  2334457889999999999999999999999999999998 89999755433211               11


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGI  672 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i  672 (684)
                      +.......+.+...+.++.+|+.+||+.||++|||++||++.|++.
T Consensus       227 i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1111122233456677899999999999999999999999998865

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-47  Score=394.61  Aligned_cols=258  Identities=29%  Similarity=0.457  Sum_probs=209.5

Q ss_pred             CceeceeCcEEEEEEEeCCC----cEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec-CcceEEEEec
Q 043157          402 NRILGQGGQGTVYKGMLPDG----KIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCLET-EVPLLVYEFI  475 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E~~  475 (684)
                      .++||+|+||+||+|.+.++    ..||||+++. .+....++|.+|+++|++++||||+++++++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999996532    2689998864 5666778999999999999999999999998764 5789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      ++|+|.++++....  .+++..+++++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999986544  3788999999999999999999999   999999999999999999999999999876533222


Q ss_pred             ---eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          556 ---MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       556 ---~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                         ......||+.|+|||.+....++.++||||||++||||+||+.||.......  .+...+            . ...
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i------------~-~g~  251 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL------------L-QGR  251 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH------------H-TTC
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH------------H-cCC
Confidence               2233468999999999999999999999999999999999888876432111  111111            1 111


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCC
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGAS  679 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~  679 (684)
                      ....+...+.++.+|+.+||+.||++||+|+||+++|++|+++...+
T Consensus       252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence            11223455678999999999999999999999999999998765443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-47  Score=397.46  Aligned_cols=259  Identities=26%  Similarity=0.436  Sum_probs=209.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCc--EEEEEeccc-cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGK--IVAVKKSKV-IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|++.++||+|+||+||+|.++ ++.  .||||+++. ...+..+.|.+|+++|+++ +|||||++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56889999999999999999975 444  578888754 3445667899999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcE
Q 043157          472 YEFIPNGTLFQYIHDQN-------------EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA  538 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~  538 (684)
                      |||+++|+|.++|+...             ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            99999999999997641             2345999999999999999999999999   9999999999999999999


Q ss_pred             EEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCC-CCCCCCChhhhhhHHHHHHH
Q 043157          539 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGE-KPIRFTTLEEDKSLAAYFLF  617 (684)
Q Consensus       539 kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~-~P~~~~~~~~~~~l~~~~~~  617 (684)
                      ||+|||+++.......  .....||..|+|||.+.+..++.++||||||+++|||++|. +||...+..+          
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~----------  234 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----------  234 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------
T ss_pred             EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH----------
Confidence            9999999976542222  22345899999999999999999999999999999999976 5665433221          


Q ss_pred             HhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhc
Q 043157          618 AMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWN  676 (684)
Q Consensus       618 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~  676 (684)
                            +.+.+......+.+...+.++.+|+.+||+.||++||||+||+++|++|....
T Consensus       235 ------~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         235 ------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             ------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ------HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                  11111122223344567789999999999999999999999999999988643

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=395.53  Aligned_cols=266  Identities=24%  Similarity=0.426  Sum_probs=220.0

Q ss_pred             HHHHhcCCCcCceeceeCcEEEEEEEe------CCCcEEEEEeccc-cChhHHHHHHHHHHHHhhc-CCCcccceeeeee
Q 043157          392 LERATDNFNLNRILGQGGQGTVYKGML------PDGKIVAVKKSKV-IDESKVEEFINEMVILSQI-NHRNVVKLLGCCL  463 (684)
Q Consensus       392 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  463 (684)
                      ++...++|++.++||+|+||+||+|++      .+++.||||+++. .......+|.+|+.+++++ +|||||++++++.
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            334456899999999999999999985      2467899999875 4455667899999999999 6999999999999


Q ss_pred             ecCcceEEEEecCCCCHHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 043157          464 ETEVPLLVYEFIPNGTLFQYIHDQNE---------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKST  528 (684)
Q Consensus       464 ~~~~~~lv~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~  528 (684)
                      +....++||||+++|+|.++++....               ...+++..++.++.||++||+|||+++   |+||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence            99999999999999999999986532               235899999999999999999999999   999999999


Q ss_pred             CEEECCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChh
Q 043157          529 NILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLE  606 (684)
Q Consensus       529 NILl~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~  606 (684)
                      |||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+| |++||......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987664433 33445678999999999999999999999999999999999 55555433221


Q ss_pred             hhhhHHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          607 EDKSLAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       607 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                      +               .+.+++........+...+.++.+|+.+||+.||++|||++||+++|+++.+.
T Consensus       255 ~---------------~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         255 S---------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             H---------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H---------------HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            1               11223333333344456678899999999999999999999999999876553

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.6e-47  Score=393.99  Aligned_cols=245  Identities=26%  Similarity=0.369  Sum_probs=208.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||+++.+ +|+.||||+++..   .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46999999999999999999964 6999999987642   2344678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+++|+|.+++.....   +++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999999987653   889999999999999999999999   999999999999999999999999999876432


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                          .....||+.|||||++.+..++.++|||||||+||||+||+.||...+..+..               ..+.... 
T Consensus       158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---------------~~i~~~~-  217 (316)
T d1fota_         158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY---------------EKILNAE-  217 (316)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------------HHHHHCC-
T ss_pred             ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH---------------HHHHcCC-
Confidence                23457999999999999999999999999999999999999999865432210               1111111 


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                       ...+...+.++.+++.+||+.||++||     |++|++++
T Consensus       218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence             123345667899999999999999996     89999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-47  Score=392.83  Aligned_cols=261  Identities=27%  Similarity=0.446  Sum_probs=213.2

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeCC--------CcEEEEEeccc-cChhHHHHHHHHHHHHhhc-CCCcccceeeeeeec
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLPD--------GKIVAVKKSKV-IDESKVEEFINEMVILSQI-NHRNVVKLLGCCLET  465 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~~--------g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~  465 (684)
                      .++|++.+.||+|+||+||+|+...        +..||||+++. .......++.+|+..+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4578999999999999999998532        24799999865 3345568899999999888 899999999999999


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL  532 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl  532 (684)
                      ...++||||+++|+|.++|.....             ...+++..++.++.||+.||+|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999986532             235899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeccCCccccccCCc-eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHh-CCCCCCCCChhhhhh
Q 043157          533 DDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLT-GEKPIRFTTLEEDKS  610 (684)
Q Consensus       533 ~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-G~~P~~~~~~~~~~~  610 (684)
                      +.++.+||+|||+++....... .......+++.|+|||.+.+..++.|+||||||+++|||++ |++||.......   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence            9999999999999987654332 23344568999999999999999999999999999999998 688887544322   


Q ss_pred             HHHHHHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 043157          611 LAAYFLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAW  675 (684)
Q Consensus       611 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~  675 (684)
                                   +.+.+........+...+.++.+|+.+||+.||++|||+.||++.|++|.+.
T Consensus       246 -------------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         246 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             -------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence                         1112222223344456678899999999999999999999999999999764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-46  Score=383.43  Aligned_cols=249  Identities=27%  Similarity=0.400  Sum_probs=207.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC---------hhHHHHHHHHHHHHhhcC-CCcccceeeeeeec
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID---------ESKVEEFINEMVILSQIN-HRNVVKLLGCCLET  465 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~  465 (684)
                      ++|++.+.||+|+||+||+++. .+++.||||++....         +...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5799999999999999999996 478999999875422         123456889999999997 99999999999999


Q ss_pred             CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCC
Q 043157          466 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA  545 (684)
Q Consensus       466 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl  545 (684)
                      +..+|||||+++|+|.++|+...   ++++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999998764   3999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCceeeecccccCCCCCcccccc------CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM  619 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~  619 (684)
                      ++......  ......||+.|+|||++.+      ..++.++||||+|++||||++|+.||......+..          
T Consensus       157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~----------  224 (277)
T d1phka_         157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML----------  224 (277)
T ss_dssp             CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------
T ss_pred             eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH----------
Confidence            98764332  3344679999999999853      45788999999999999999999999865432211          


Q ss_pred             hhhhhhhhhhhh--hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          620 KEERLFEILDAR--VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       620 ~~~~~~~~~d~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           ..+....  .........++++.+|+.+||+.||++|||++|++++
T Consensus       225 -----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         225 -----RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             -----HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -----HHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                 0111111  1112224567789999999999999999999999765

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-47  Score=393.16  Aligned_cols=265  Identities=26%  Similarity=0.410  Sum_probs=217.6

Q ss_pred             HHHHHhcCCCcCceeceeCcEEEEEEEeC------CCcEEEEEeccc-cChhHHHHHHHHHHHHhhcCCCcccceeeeee
Q 043157          391 ELERATDNFNLNRILGQGGQGTVYKGMLP------DGKIVAVKKSKV-IDESKVEEFINEMVILSQINHRNVVKLLGCCL  463 (684)
Q Consensus       391 e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  463 (684)
                      +++...++|++.++||+|+||+||+|.+.      +++.||||+++. ........|.+|++++++++||||+++++++.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            44455578999999999999999999863      357899999865 34455677999999999999999999999999


Q ss_pred             ecCcceEEEEecCCCCHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 043157          464 ETEVPLLVYEFIPNGTLFQYIHDQN-------EDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY  536 (684)
Q Consensus       464 ~~~~~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~  536 (684)
                      ..+..++||||+++|+|.++++...       ....+++..+.+++.|+++||.|||+++   |+||||||+||||++++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence            9999999999999999999987532       2234799999999999999999999998   99999999999999999


Q ss_pred             cEEEeccCCccccccCCcee-eecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCC-CCCCCCChhhhhhHHHH
Q 043157          537 RAKVSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGE-KPIRFTTLEEDKSLAAY  614 (684)
Q Consensus       537 ~~kl~DFgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~-~P~~~~~~~~~~~l~~~  614 (684)
                      ++||+|||+++......... .....||+.|+|||.+.+..++.++||||||++||||+||. +||...+..+.      
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~------  244 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------  244 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH------
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence            99999999998765433322 33345899999999999999999999999999999999985 67754432221      


Q ss_pred             HHHHhhhhhhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 043157          615 FLFAMKEERLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKA  674 (684)
Q Consensus       615 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~  674 (684)
                                .+.+........+...+..+.+|+.+||+.||++|||++||+++|++...
T Consensus       245 ----------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         245 ----------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             ----------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ----------HHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                      11111111223345667789999999999999999999999999987643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-46  Score=394.76  Aligned_cols=245  Identities=22%  Similarity=0.300  Sum_probs=208.6

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc---cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV---IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  472 (684)
                      ++|++.+.||+|+||+||++.++ +|+.||||++..   .+....+.+.+|+++|++++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999964 799999998753   22344678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccC
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~  552 (684)
                      ||+.+|+|.+++.+.+.   +++..++.++.||+.||.|||+++   |+||||||+||||+.++++||+|||+++.....
T Consensus       121 e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999987653   999999999999999999999999   999999999999999999999999999876432


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                          .....||+.|||||++.+..++.++|||||||+||||+||+.||........   .            ..+.... 
T Consensus       195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~------------~~i~~~~-  254 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---Y------------EKIVSGK-  254 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H------------HHHHHCC-
T ss_pred             ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH---H------------HHHhcCC-
Confidence                2345699999999999999999999999999999999999999975442211   0            0111111 


Q ss_pred             hccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          633 MKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       633 ~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                       ...+...+.++.+|+.+||+.||++|+     |++|++++
T Consensus       255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence             122345677899999999999999994     89999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-46  Score=386.67  Aligned_cols=271  Identities=22%  Similarity=0.305  Sum_probs=202.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC----cceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETE----VPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lv~  472 (684)
                      ..|.+.++||+|+||+||+|++ +|+.||||+++.... .......|+..+.+++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            3577889999999999999987 688999998864322 2222334555556789999999999998765    468999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA-----SIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      ||+++|+|.++|++.    .++|..+++++.|++.||+|||+..     ..+|+||||||+||||++++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            999999999999875    3899999999999999999999741     1239999999999999999999999999998


Q ss_pred             ccccCCce---eeecccccCCCCCccccccCC------CCCccchhhhHHHHHHHHhCCCCCCCCChhhhh--------h
Q 043157          548 SMAVDQTH---MTTQVHGTFGYLDPEYFRSSQ------FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK--------S  610 (684)
Q Consensus       548 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~--------~  610 (684)
                      ........   ......||+.|+|||++....      ++.|+||||||++||||+||..|+.........        .
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            76544332   234467999999999987643      577999999999999999999887543221100        0


Q ss_pred             HHHHHHHHhhhhhhhhhhhhhhhcc-CChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcC
Q 043157          611 LAAYFLFAMKEERLFEILDARVMKE-SGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNG  677 (684)
Q Consensus       611 l~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~  677 (684)
                      ..........    .+.+++..... ...+.+..+.+|+.+||+.||++|||+.||+++|++|...++
T Consensus       237 ~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         237 SVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             CHHHHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            0000001111    11111111111 123456779999999999999999999999999999997654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-46  Score=389.55  Aligned_cols=250  Identities=24%  Similarity=0.297  Sum_probs=207.9

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      .++|++.+.||+|+||+||+|... +++.||||.++.... +...+.+|+++|++++||||+++++++.+.+..||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467999999999999999999965 688999999876443 346688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC--CCcEEEeccCCccccccC
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD--KYRAKVSDFGASRSMAVD  552 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DFgl~~~~~~~  552 (684)
                      +++|+|.+++.+.+.  .+++..++.++.||++||+|||+++   |+||||||+|||++.  ...+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999986542  4899999999999999999999999   999999999999984  458999999999876433


Q ss_pred             CceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhhh
Q 043157          553 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDARV  632 (684)
Q Consensus       553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~  632 (684)
                      .  ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+..               ..+.....
T Consensus       158 ~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~---------------~~i~~~~~  220 (321)
T d1tkia_         158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---------------ENIMNAEY  220 (321)
T ss_dssp             C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------------HHHHHTCC
T ss_pred             C--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHHhCCC
Confidence            3  233446899999999999999999999999999999999999999865432210               01111100


Q ss_pred             --hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          633 --MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       633 --~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        ........+.++.+|+.+||+.||++|||++|++++
T Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              001112346678999999999999999999999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.9e-46  Score=393.71  Aligned_cols=249  Identities=21%  Similarity=0.304  Sum_probs=202.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHH---HHHHHHHhhcCCCcccceeeeeeecCcce
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEF---INEMVILSQINHRNVVKLLGCCLETEVPL  469 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~---~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  469 (684)
                      ++|++.++||+|+||+||+|+.. +|+.||||++...   .......+   .+|+.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999965 6999999987531   11122333   34577777888999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      +||||+++|+|.++|.+...   +++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        84 ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999987643   899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEIL  628 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  628 (684)
                      ....   .....||+.|+|||++.. ..++.++|||||||+||||+||+.||......+...+.    .        ...
T Consensus       158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~--------~~~  222 (364)
T d1omwa3         158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----R--------MTL  222 (364)
T ss_dssp             SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----H--------HSS
T ss_pred             CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----H--------hcc
Confidence            5332   334569999999999865 56899999999999999999999999865432211100    0        000


Q ss_pred             hhhhhccCChhHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 043157          629 DARVMKESGGDEIITFAKVAKRCLNLNGKKRPT-----MREVTSE  668 (684)
Q Consensus       629 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt-----~~evl~~  668 (684)
                      .  .....+...+.++.+||.+||+.||++|||     ++|++++
T Consensus       223 ~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         223 T--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             S--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             c--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            0  112233456778999999999999999999     6888764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=390.06  Aligned_cols=247  Identities=25%  Similarity=0.343  Sum_probs=206.4

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEecccc---ChhHHHHHHHHHHHHh-hcCCCcccceeeeeeecCcceEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVI---DESKVEEFINEMVILS-QINHRNVVKLLGCCLETEVPLLV  471 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~lv  471 (684)
                      ++|++.+.||+|+||+||+|+.. +++.||||+++..   .....+.+..|+.++. .++||||+++++++.+.+..+||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999965 7999999988642   2334566777777765 68999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccccc
Q 043157          472 YEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV  551 (684)
Q Consensus       472 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~  551 (684)
                      |||+++|+|.++++....   +++..++.++.||+.||+|||+++   |+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999987653   899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhhhhhhh
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFEILDAR  631 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  631 (684)
                      ... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+.   ..    .+.        .. 
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~----~i~--------~~-  218 (320)
T d1xjda_         156 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FH----SIR--------MD-  218 (320)
T ss_dssp             TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHH--------HC-
T ss_pred             ccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH---HH----HHH--------cC-
Confidence            333 33445799999999999999999999999999999999999999986543321   10    010        01 


Q ss_pred             hhccCChhHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 043157          632 VMKESGGDEIITFAKVAKRCLNLNGKKRPTMR-EVTS  667 (684)
Q Consensus       632 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~-evl~  667 (684)
                       ....+...+.++.+|+.+||+.||++|||+. |+++
T Consensus       219 -~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 -NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence             1123345677899999999999999999996 7764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-46  Score=385.22  Aligned_cols=257  Identities=23%  Similarity=0.262  Sum_probs=197.0

Q ss_pred             CceeceeCcEEEEEEEeC-CCcEEEEEeccccChh-----HHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEec
Q 043157          402 NRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDES-----KVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEFI  475 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~  475 (684)
                      .++||+|+||+||+|... +|+.||||+++.....     ..+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999964 6899999988653322     2356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCce
Q 043157          476 PNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH  555 (684)
Q Consensus       476 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~~  555 (684)
                      .++++..++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             cchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            888776665433   24889999999999999999999999   99999999999999999999999999987554332 


Q ss_pred             eeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh---hhhhhhhhh-
Q 043157          556 MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE---ERLFEILDA-  630 (684)
Q Consensus       556 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d~-  630 (684)
                      ......||+.|+|||++.. ..++.++|||||||++|||+||++||......+.  +...+ .....   ..+...... 
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l~~i~-~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIF-ETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-HHHCCCCTTTSSSTTSST
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--HHHHH-HhcCCCChhhccchhccc
Confidence            2334568999999999865 4579999999999999999999999986553322  11111 11110   000000000 


Q ss_pred             ----------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          631 ----------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       631 ----------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                                ..........+.++.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence                      00001112346789999999999999999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=380.93  Aligned_cols=268  Identities=23%  Similarity=0.339  Sum_probs=204.3

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|++.++||+|+||+||+|.. .+++.||||+++...  +...+++.+|+++|++++|||||++++++.+....++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999996 579999999886532  2335789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      |+.+ ++.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9975 4555554432 224999999999999999999999999   9999999999999999999999999998764333


Q ss_pred             ceeeecccccCCCCCccccccCC-CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh-hhhhhhhhhh-
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK-EERLFEILDA-  630 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~-  630 (684)
                      . ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..+  .+......... .+........ 
T Consensus       157 ~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         157 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             B-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             c-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhccccccc
Confidence            2 233446999999999877655 5789999999999999999999998654322  12211111111 0000000000 


Q ss_pred             -hhh-----------ccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 043157          631 -RVM-----------KESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGI  672 (684)
Q Consensus       631 -~~~-----------~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i  672 (684)
                       ...           .......+.++.+|+.+||+.||++|||++|++++  ++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence             000           00112345778999999999999999999999986  4444

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.7e-45  Score=378.50  Aligned_cols=263  Identities=20%  Similarity=0.293  Sum_probs=203.9

Q ss_pred             cCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccC--hhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID--ESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.++||+|+||+||+|++++|+.||||+++...  ....+.+.+|+.+|++++||||+++++++.+.+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5799999999999999999999999999999986533  33367899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCCc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT  554 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~~  554 (684)
                      +.++.+..+.....   .+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            98776666655443   4999999999999999999999999   99999999999999999999999999987543322


Q ss_pred             eeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--hhhhhhhh---
Q 043157          555 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--EERLFEIL---  628 (684)
Q Consensus       555 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~---  628 (684)
                       ......+++.|+|||.+.. ..++.++||||||+++|||++|+.||......+  .+...+...-.  ........   
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCChhhccchhhhh
Confidence             2333458999999999865 456899999999999999999999998654322  12111111100  00000000   


Q ss_pred             ---------hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          629 ---------DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       629 ---------d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                               .+..........+.++.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     0001112223456789999999999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=388.32  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=199.2

Q ss_pred             cCCCcC-ceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhc-CCCcccceeeeeee----cCcce
Q 043157          397 DNFNLN-RILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQI-NHRNVVKLLGCCLE----TEVPL  469 (684)
Q Consensus       397 ~~~~~~-~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----~~~~~  469 (684)
                      ++|.+. ++||+|+||+||+|.. .+++.||||+++.     ...+.+|++++.++ +|||||++++++.+    +...+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            578876 4699999999999996 5789999999863     24567899987655 89999999999875    45689


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCcEEEeccCCc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGAS  546 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgl~  546 (684)
                      |||||+++|+|.++|.+... ..+++..++.++.||+.||+|||+++   |+||||||+|||++.   .+.+||+|||++
T Consensus        86 ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            99999999999999986532 35999999999999999999999999   999999999999985   567999999999


Q ss_pred             cccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE  626 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~  626 (684)
                      +.......  .....||+.|+|||++.+..++.++|||||||+||||+||+.||......+....   .........   
T Consensus       162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~~~---  233 (335)
T d2ozaa1         162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQ---  233 (335)
T ss_dssp             EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS---
T ss_pred             eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHhcCC---
Confidence            87654332  3445699999999999999999999999999999999999999975432211000   000000000   


Q ss_pred             hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                         ...........+.++.+|+.+||+.||++|||+.|++++
T Consensus       234 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         234 ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ---SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               000001113456789999999999999999999999885

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-45  Score=377.88  Aligned_cols=269  Identities=24%  Similarity=0.333  Sum_probs=203.7

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CC-CcEEEEEecccc--ChhHHHHHHHHHHHHhhc---CCCcccceeeeeee----
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PD-GKIVAVKKSKVI--DESKVEEFINEMVILSQI---NHRNVVKLLGCCLE----  464 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~-g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~----  464 (684)
                      .++|++.++||+|+||+||+|.+ ++ ++.||||+++..  .......+.+|+.+|+.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            36899999999999999999996 34 678999987542  222334566777777666   79999999999863    


Q ss_pred             -cCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEecc
Q 043157          465 -TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF  543 (684)
Q Consensus       465 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF  543 (684)
                       ....+++|||++++++.........  .+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             3467899999988777655544333  4899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--h
Q 043157          544 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK--E  621 (684)
Q Consensus       544 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~--~  621 (684)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.  +.........  .
T Consensus       161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~  236 (305)
T d1blxa_         161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGE  236 (305)
T ss_dssp             CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCG
T ss_pred             hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCch
Confidence            9987654322  33456799999999999999999999999999999999999999986654332  1111111100  0


Q ss_pred             hhhhh----------hhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhH
Q 043157          622 ERLFE----------ILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGIK  673 (684)
Q Consensus       622 ~~~~~----------~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i~  673 (684)
                      .....          ..............+..+.+|+.+||+.||++|||++|++++  |+.|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence            00000          000011112234456788999999999999999999999886  45443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=376.22  Aligned_cols=240  Identities=25%  Similarity=0.424  Sum_probs=198.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccC------hhHHHHHHHHHHHHhhcC--CCcccceeeeeeecCc
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVID------ESKVEEFINEMVILSQIN--HRNVVKLLGCCLETEV  467 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~  467 (684)
                      ++|++.++||+|+||+||+|... +|+.||||++....      .....++.+|+.+|++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999964 78999999875321      112244678999999996  9999999999999999


Q ss_pred             ceEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCcEEEeccCC
Q 043157          468 PLLVYEFIPN-GTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGA  545 (684)
Q Consensus       468 ~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgl  545 (684)
                      .++||||+.+ +++.+++....   .+++..++.++.||++||+|||+++   |+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 68888887654   3999999999999999999999999   999999999999985 57999999999


Q ss_pred             ccccccCCceeeecccccCCCCCccccccCCC-CCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhh
Q 043157          546 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERL  624 (684)
Q Consensus       546 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~  624 (684)
                      ++.....   ..+...||+.|+|||++.+..+ +.++|||||||+||||+||+.||....     .              
T Consensus       158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~--------------  215 (273)
T d1xwsa_         158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E--------------  215 (273)
T ss_dssp             CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H--------------
T ss_pred             ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H--------------
Confidence            9765432   2345679999999999987765 567999999999999999999996321     0              


Q ss_pred             hhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          625 FEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       625 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                        +...  ....+...+.++.+|+.+||+.||++|||++|++++
T Consensus       216 --i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         216 --IIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             --HHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --Hhhc--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              0000  011234456789999999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=375.00  Aligned_cols=266  Identities=20%  Similarity=0.279  Sum_probs=201.8

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc-ChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC----cce
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI-DESKVEEFINEMVILSQINHRNVVKLLGCCLETE----VPL  469 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~  469 (684)
                      .++|++.++||+|+||+||+|.. .+|+.||||++... .....+++++|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35799999999999999999985 57999999998653 3455778999999999999999999999997654    235


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcccc
Q 043157          470 LVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM  549 (684)
Q Consensus       470 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~  549 (684)
                      ++++++.+|+|.+++...    .+++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            666777899999999764    3899999999999999999999999   999999999999999999999999999865


Q ss_pred             ccCCce--eeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhh---
Q 043157          550 AVDQTH--MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEER---  623 (684)
Q Consensus       550 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~---  623 (684)
                      ......  ......||+.|+|||++.. ..++.++||||+|+++|||++|+.||......+................   
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            433222  2344568999999999854 5678999999999999999999999986654332211111100000000   


Q ss_pred             -----hhhhhhhh------hhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          624 -----LFEILDAR------VMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       624 -----~~~~~d~~------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                           ........      .........+.++.+|+.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 00000000      0001112345678999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-43  Score=363.85  Aligned_cols=266  Identities=20%  Similarity=0.270  Sum_probs=204.8

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccc-eeeeeeecCcceEEEEe
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVK-LLGCCLETEVPLLVYEF  474 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~~~~~~lv~E~  474 (684)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||.+....  ..+++..|++++++++|+|++. +..+..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5799999999999999999996 468999999866532  2346788999999998776555 45556677788899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCcEEEeccCCcccccc
Q 043157          475 IPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGASRSMAV  551 (684)
Q Consensus       475 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgl~~~~~~  551 (684)
                      + +++|.+.+.....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+++....
T Consensus        85 ~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 L-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             C-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             c-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9 5677777765443  4899999999999999999999999   999999999999863   55799999999987654


Q ss_pred             CCce------eeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh
Q 043157          552 DQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF  625 (684)
Q Consensus       552 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  625 (684)
                      ....      ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...............    ....+ 
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~----~~~~~-  233 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI----SEKKM-  233 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH----HHHHH-
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh----hcccC-
Confidence            3322      234557999999999999999999999999999999999999999865443322111100    00000 


Q ss_pred             hhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCC
Q 043157          626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGAS  679 (684)
Q Consensus       626 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~  679 (684)
                          ...........+.++.+|+.+||+.||++||+++++.+.|+++..+.+..
T Consensus       234 ----~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~  283 (299)
T d1ckia_         234 ----STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  283 (299)
T ss_dssp             ----HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             ----CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence                00011122345678999999999999999999999999999887655443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.8e-43  Score=360.58  Aligned_cols=267  Identities=16%  Similarity=0.173  Sum_probs=212.9

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCC-CcccceeeeeeecCcceEEEE
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINH-RNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lv~E  473 (684)
                      .++|++.++||+|+||+||+|++. +|+.||||.+....  ..+++.+|++.++.++| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            367999999999999999999965 68999999875432  23457789999999965 899999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-----CCcEEEeccCCccc
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-----KYRAKVSDFGASRS  548 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DFgl~~~  548 (684)
                      |+ +++|.++++....  .+++..+..++.|++.||+|||+++   |+||||||+||||+.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 7899999987544  4899999999999999999999999   999999999999974     57899999999987


Q ss_pred             cccCCc------eeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhh
Q 043157          549 MAVDQT------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEE  622 (684)
Q Consensus       549 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~  622 (684)
                      ......      .......||+.|||||++.+..++.++||||||+++|||+||+.||....................  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~--  233 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--  233 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH--
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC--
Confidence            643322      123345799999999999999999999999999999999999999986544332211111111000  


Q ss_pred             hhhhhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhcCCC
Q 043157          623 RLFEILDARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSELAGIKAWNGAS  679 (684)
Q Consensus       623 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~  679 (684)
                             .....+.....+.++.+++..|++.+|++||+++.+.+.|+++..+.+..
T Consensus       234 -------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~  283 (293)
T d1csna_         234 -------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  283 (293)
T ss_dssp             -------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             -------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence                   00111122345678999999999999999999999999998876655443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=372.57  Aligned_cols=264  Identities=21%  Similarity=0.298  Sum_probs=201.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC------
Q 043157          396 TDNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETE------  466 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------  466 (684)
                      .++|++.++||+|+||+||+|... +|+.||||+++.  .+....+.+.+|+++|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467999999999999999999964 699999999864  34556778999999999999999999999998665      


Q ss_pred             cceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCc
Q 043157          467 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS  546 (684)
Q Consensus       467 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~  546 (684)
                      ..++||||+ +.+|..+++..    .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            468999999 56788777654    3999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh------
Q 043157          547 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM------  619 (684)
Q Consensus       547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~------  619 (684)
                      +.....    .+...||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.....  ........      
T Consensus       169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL--KEIMKVTGTPPAEF  242 (346)
T ss_dssp             EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHH
T ss_pred             eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH--HHHHhccCCCcHHH
Confidence            875432    234568999999999876 45689999999999999999999999866433221  11111000      


Q ss_pred             ----hhhhhhhh---h---hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhH
Q 043157          620 ----KEERLFEI---L---DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGIK  673 (684)
Q Consensus       620 ----~~~~~~~~---~---d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i~  673 (684)
                          ........   +   ............+.++.+|+.+||+.||++|||++|++++  |+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                00000000   0   0001112223456788999999999999999999999987  55554

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=370.33  Aligned_cols=267  Identities=22%  Similarity=0.271  Sum_probs=198.6

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEecccc--ChhHHHHHHHHHHHHhhcCCCcccceeeeeeec-------
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVI--DESKVEEFINEMVILSQINHRNVVKLLGCCLET-------  465 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------  465 (684)
                      .++|++.+.||+|+||+||+|++ ++|+.||||++...  .+...+++.+|+++|++++||||+++++++...       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36899999999999999999996 47999999987542  334457789999999999999999999998653       


Q ss_pred             -CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccC
Q 043157          466 -EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG  544 (684)
Q Consensus       466 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg  544 (684)
                       ...++||||++++++..+.....   .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence             35789999998776665544332   3899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCc---eeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh
Q 043157          545 ASRSMAVDQT---HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMK  620 (684)
Q Consensus       545 l~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~  620 (684)
                      +++.......   .......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+.............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9976553222   122334689999999998764 689999999999999999999999986554333222211111111


Q ss_pred             hhhhhhh--------hhhhhhccCC-------hhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          621 EERLFEI--------LDARVMKESG-------GDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       621 ~~~~~~~--------~d~~~~~~~~-------~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .......        +.........       ...+.++.+|+.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            1100000        0000000000       1124467889999999999999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-43  Score=372.12  Aligned_cols=266  Identities=24%  Similarity=0.299  Sum_probs=199.7

Q ss_pred             CCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCcccceeeeeeecC------cceE
Q 043157          398 NFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVVKLLGCCLETE------VPLL  470 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~l  470 (684)
                      +|+..++||+|+||+||+|++. +|+.||||++.....    ...+|+++|++++||||+++++++....      ..+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888999999999999999975 699999998865322    2347999999999999999999986432      3689


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-cEEEeccCCcccc
Q 043157          471 VYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSM  549 (684)
Q Consensus       471 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgl~~~~  549 (684)
                      ||||++++.+..+.+.......+++..++.++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987654444443333445999999999999999999999999   99999999999999765 8999999999876


Q ss_pred             ccCCceeeecccccCCCCCcccccc-CCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh--hhhhhhh
Q 043157          550 AVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAM--KEERLFE  626 (684)
Q Consensus       550 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~--~~~~~~~  626 (684)
                      .....  .....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.  +...+...-  ....+.+
T Consensus       174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHH
T ss_pred             cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhhh
Confidence            54332  234568999999998764 5789999999999999999999999986653321  221111100  0000000


Q ss_pred             hh------------hhhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhHh
Q 043157          627 IL------------DARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE--LAGIKA  674 (684)
Q Consensus       627 ~~------------d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~--L~~i~~  674 (684)
                      ..            ............+.++.+|+.+||+.||++|||++|++++  ++.++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            00            0001111223456789999999999999999999999975  555543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=359.34  Aligned_cols=263  Identities=21%  Similarity=0.313  Sum_probs=207.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeecCcceEEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLETEVPLLVYE  473 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  473 (684)
                      ++|++.++||+|+||+||+|++ .+++.||||+++.  ......+++.+|+.+|++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999996 4789999998754  334567889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCccccccCC
Q 043157          474 FIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ  553 (684)
Q Consensus       474 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~~~~~~~  553 (684)
                      ++.+++|..++...+   .+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988887654   3899999999999999999999999   9999999999999999999999999998765433


Q ss_pred             ceeeecccccCCCCCccccccCC-CCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhh--hhh----hh
Q 043157          554 THMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKE--ERL----FE  626 (684)
Q Consensus       554 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~--~~~----~~  626 (684)
                      . ......+++.|+|||.+.... ++.++|||||||++|||++|+.||.......+ .+.. +......  ...    ..
T Consensus       156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKR-IFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHH-HHHHHCCCCTTTCTTGGG
T ss_pred             c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-HHHH-HHhhcCCCChhhhhhhhh
Confidence            3 223344778899999987654 68999999999999999999999754332221 1111 1111110  000    00


Q ss_pred             hhh---------hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 ILD---------ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 ~~d---------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      ..+         ...........+..+.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000         001111223456789999999999999999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-43  Score=367.48  Aligned_cols=253  Identities=27%  Similarity=0.351  Sum_probs=207.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC----CCcEEEEEecccc----ChhHHHHHHHHHHHHhhcCC-CcccceeeeeeecCc
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP----DGKIVAVKKSKVI----DESKVEEFINEMVILSQINH-RNVVKLLGCCLETEV  467 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~  467 (684)
                      ++|++.++||+|+||+||+|...    +|+.||||.++..    +....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999842    4789999987532    23345678899999999976 899999999999999


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .+++|||+.+|+|.+++.....   +++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999987754   788999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCceeeecccccCCCCCccccccC--CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF  625 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~  625 (684)
                      ..............|++.|++||.+...  .++.++|||||||+||||++|+.||......+.....   ..        
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~~--------  246 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SR--------  246 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HH--------
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HH--------
Confidence            7765555555566799999999998654  4688999999999999999999999765433221110   00        


Q ss_pred             hhhhhhhhccCChhHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043157          626 EILDARVMKESGGDEIITFAKVAKRCLNLNGKKRP-----TMREVTSE  668 (684)
Q Consensus       626 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----t~~evl~~  668 (684)
                      ...  ......+...+.++.+|+.+||+.||++||     |++|++++
T Consensus       247 ~~~--~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         247 RIL--KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             HHH--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             hcc--cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            000  111223456778999999999999999999     47888864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.7e-42  Score=360.05  Aligned_cols=256  Identities=23%  Similarity=0.320  Sum_probs=198.5

Q ss_pred             cCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcC-CCcccceeeeeeec--CcceEEE
Q 043157          397 DNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVVKLLGCCLET--EVPLLVY  472 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lv~  472 (684)
                      ++|++.++||+|+||+||+|+. .+++.||||+++...   .+++.+|+++|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999996 478999999986533   467889999999995 99999999999744  4688999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-cEEEeccCCcccccc
Q 043157          473 EFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAV  551 (684)
Q Consensus       473 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgl~~~~~~  551 (684)
                      ||+++++|.++.+      .+++..++.++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            9999999876532      3899999999999999999999999   99999999999998654 699999999987653


Q ss_pred             CCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhhh----
Q 043157          552 DQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLFE----  626 (684)
Q Consensus       552 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~~----  626 (684)
                      ...  .....+|+.|+|||.+.+. .++.++||||||++++||++|+.||........... .. ...........    
T Consensus       183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~-~i-~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV-RI-AKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH-HH-HHHHCHHHHHHHHHH
T ss_pred             CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH-HH-HHHHCCchhhhhhhh
Confidence            332  3445689999999998765 579999999999999999999999976544322111 11 11111000000    


Q ss_pred             -----------hhh--------hhhhccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          627 -----------ILD--------ARVMKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       627 -----------~~d--------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                                 ...        ...........+.++.+|+.+||+.||++|||++|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       000        000111113356789999999999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-41  Score=360.87  Aligned_cols=261  Identities=21%  Similarity=0.300  Sum_probs=193.0

Q ss_pred             cCCCcCceeceeCcEEEEEEEeC-CCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec------Cc
Q 043157          397 DNFNLNRILGQGGQGTVYKGMLP-DGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLET------EV  467 (684)
Q Consensus       397 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~  467 (684)
                      ++|++.++||+|+||+||+|.+. +|+.||||++..  .+....+++.+|+.+|++++||||+++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999965 699999998864  3456667899999999999999999999999643      56


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .++||||+.++ |.+.+..     .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            79999999654 5555542     2899999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH-----Hhh--
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLF-----AMK--  620 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~-----~~~--  620 (684)
                      .....  .......+|+.|+|||++.+..++.++||||+|++++||++|+.||...+.............     .+.  
T Consensus       168 ~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             ccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            65432  233445689999999999999999999999999999999999999986553222111100000     000  


Q ss_pred             hhhhh---------------hhhhhhhhc---cCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          621 EERLF---------------EILDARVMK---ESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       621 ~~~~~---------------~~~d~~~~~---~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                      .....               .........   ......+.++.+|+.+||+.||++|||++|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000               000000000   0113457789999999999999999999999876

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-42  Score=361.88  Aligned_cols=261  Identities=22%  Similarity=0.284  Sum_probs=199.1

Q ss_pred             hcCCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccc--cChhHHHHHHHHHHHHhhcCCCcccceeeeeeec-----Cc
Q 043157          396 TDNFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKV--IDESKVEEFINEMVILSQINHRNVVKLLGCCLET-----EV  467 (684)
Q Consensus       396 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~  467 (684)
                      .++|++.++||+|+||+||+|.. .+|+.||||+++.  .+....+++.+|+++|++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999995 5799999999864  3445667899999999999999999999998643     34


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      .+++|+++.+|+|.++++..    .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            57778888999999999654    3999999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCCceeeecccccCCCCCccccccC-CCCCccchhhhHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhhhhhh-
Q 043157          548 SMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDKSLAAYFLFAMKEERLF-  625 (684)
Q Consensus       548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~~l~~~~~~~~~~~~~~-  625 (684)
                      ....    ......|++.|+|||.+.+. .++.++||||||+++|+|++|+.||...+............ ........ 
T Consensus       170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~-~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV-GTPGAELLK  244 (348)
T ss_dssp             CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCHHHHT
T ss_pred             ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-CCCChHHhh
Confidence            5432    22345689999999987665 46889999999999999999999998665432221111000 00000000 


Q ss_pred             --------hhhhhhh------hccCChhHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043157          626 --------EILDARV------MKESGGDEIITFAKVAKRCLNLNGKKRPTMREVTSE  668 (684)
Q Consensus       626 --------~~~d~~~------~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~evl~~  668 (684)
                              .......      ........+.++.+|+.+||+.||++|||++|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                    0000000      000112345678999999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.3e-37  Score=325.74  Aligned_cols=262  Identities=21%  Similarity=0.231  Sum_probs=192.7

Q ss_pred             CCCcCceeceeCcEEEEEEEe-CCCcEEEEEeccccChhHHHHHHHHHHHHhhcC-----------CCcccceeeeeeec
Q 043157          398 NFNLNRILGQGGQGTVYKGML-PDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-----------HRNVVKLLGCCLET  465 (684)
Q Consensus       398 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~~  465 (684)
                      +|++.++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+++++.++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            599999999999999999996 47999999998743 334567888999998875           57899999988654


Q ss_pred             --CcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCC------
Q 043157          466 --EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKY------  536 (684)
Q Consensus       466 --~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiH~Dlkp~NILl~~~~------  536 (684)
                        ...+++|++...+..............+++..++.++.||+.||+|||+ .+   |+||||||+||||+.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence              3456677776665544444444444568999999999999999999998 77   99999999999997654      


Q ss_pred             cEEEeccCCccccccCCceeeecccccCCCCCccccccCCCCCccchhhhHHHHHHHHhCCCCCCCCChhhhh----hHH
Q 043157          537 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLAELLTGEKPIRFTTLEEDK----SLA  612 (684)
Q Consensus       537 ~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltG~~P~~~~~~~~~~----~l~  612 (684)
                      .+|++|||.+......    .....||+.|+|||++....++.++||||+|++++||++|+.||.........    .+.
T Consensus       170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            4999999998754322    23456899999999999999999999999999999999999999754322111    111


Q ss_pred             HHHHHHhhh--hhh-------hhhhhh-------------------hhhccCChhHHHHHHHHHHHhhccCCCCCCCHHH
Q 043157          613 AYFLFAMKE--ERL-------FEILDA-------------------RVMKESGGDEIITFAKVAKRCLNLNGKKRPTMRE  664 (684)
Q Consensus       613 ~~~~~~~~~--~~~-------~~~~d~-------------------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPt~~e  664 (684)
                      ..+ .....  ...       ....+.                   ..........+.++.+|+.+||+.||++|||++|
T Consensus       246 ~~~-~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         246 QII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHH-HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            111 11000  000       000000                   0011234567889999999999999999999999


Q ss_pred             HHHH
Q 043157          665 VTSE  668 (684)
Q Consensus       665 vl~~  668 (684)
                      ++++
T Consensus       325 ~L~H  328 (362)
T d1q8ya_         325 LVNH  328 (362)
T ss_dssp             HHTC
T ss_pred             HhcC
Confidence            9875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=6.8e-23  Score=196.72  Aligned_cols=165  Identities=17%  Similarity=0.193  Sum_probs=122.0

Q ss_pred             CcCceeceeCcEEEEEEEeCCCcEEEEEeccccC------------------hhHHHHHHHHHHHHhhcCCCcccceeee
Q 043157          400 NLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVID------------------ESKVEEFINEMVILSQINHRNVVKLLGC  461 (684)
Q Consensus       400 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~HpnIv~l~~~  461 (684)
                      .+.++||+|+||+||+|...+|+.||||.++...                  ........+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4678999999999999998899999999754210                  1112345678999999999999988765


Q ss_pred             eeecCcceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCcEEEe
Q 043157          462 CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS  541 (684)
Q Consensus       462 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~  541 (684)
                      .    ..+++|||+++..+.+          +++.....++.|++++|+|||+++   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            3    3479999998765422          344456689999999999999999   9999999999999976 58999


Q ss_pred             ccCCccccccCCceeeecccccCCCCCc--c---ccccCCCCCccchhhhHHHHH
Q 043157          542 DFGASRSMAVDQTHMTTQVHGTFGYLDP--E---YFRSSQFTDKSDVYSFGVVLA  591 (684)
Q Consensus       542 DFgl~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~ksDv~SlGvil~  591 (684)
                      |||++.....+....         |+..  +   .+....|+.++|+||+.--++
T Consensus       145 DFG~a~~~~~~~~~~---------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         145 DFPQSVEVGEEGWRE---------ILERDVRNIITYFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCTTCEETTSTTHHH---------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred             ECCCcccCCCCCcHH---------HHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence            999987654322210         1111  0   012356788999999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=2.4e-07  Score=91.03  Aligned_cols=150  Identities=16%  Similarity=0.136  Sum_probs=104.2

Q ss_pred             HHHHHHHhcCCCcCceeceeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcC-CCcccceeeeeeecCc
Q 043157          389 SKELERATDNFNLNRILGQGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQIN-HRNVVKLLGCCLETEV  467 (684)
Q Consensus       389 ~~e~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~  467 (684)
                      ..++.....+|+..+..+.++...||+... +++.+.+|+...........+.+|...++.+. +--+.+++.+..+.+.
T Consensus         6 ~~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           6 SPELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             CHHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             CHHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            467777777888777766566689999865 45556778766544444456778888888774 4446778888888888


Q ss_pred             ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 043157          468 PLLVYEFIPNGTLFQYIHDQNEDFPITWEMRLRIAIEVSGALSYLHSAA-------------------------------  516 (684)
Q Consensus       468 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-------------------------------  516 (684)
                      .++||+++++.++.+......     .   ...++.++++.|+.||+..                               
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             eEEEEEecccccccccccccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            999999999988765543211     1   1234455555555555321                               


Q ss_pred             -------------------------CCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          517 -------------------------SIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       517 -------------------------~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                                               ...++|+|+.|.|||++++..+-|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                     1127899999999999987666799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.72  E-value=3.1e-05  Score=74.95  Aligned_cols=74  Identities=18%  Similarity=0.144  Sum_probs=53.6

Q ss_pred             eeceeC-cEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCC--CcccceeeeeeecCcceEEEEecCCCCH
Q 043157          404 ILGQGG-QGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGTL  480 (684)
Q Consensus       404 ~LG~G~-~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lv~E~~~~gsL  480 (684)
                      .+..|. .+.||+...+++..+.+|.......   ..+..|...++.+..  -.+.+++.+..+.+..++||+++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            334444 4689999988888888897654332   346678888877743  3356788888888889999999987655

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.54  E-value=0.00016  Score=74.74  Aligned_cols=76  Identities=16%  Similarity=0.203  Sum_probs=48.7

Q ss_pred             CceeceeCcEEEEEEEeCC-CcEEEEEeccc----cC---hhHHHHHHHHHHHHhhcC-C--CcccceeeeeeecCcceE
Q 043157          402 NRILGQGGQGTVYKGMLPD-GKIVAVKKSKV----ID---ESKVEEFINEMVILSQIN-H--RNVVKLLGCCLETEVPLL  470 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~----~~---~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~~~~~l  470 (684)
                      .+.||.|..-.||+....+ ++.++||....    ..   +...++...|.+.|+.+. +  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4568999999999998654 67889995432    11   112344567888887773 3  334555543  5567789


Q ss_pred             EEEecCCCC
Q 043157          471 VYEFIPNGT  479 (684)
Q Consensus       471 v~E~~~~gs  479 (684)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.21  E-value=0.0083  Score=59.62  Aligned_cols=136  Identities=14%  Similarity=0.129  Sum_probs=76.0

Q ss_pred             cEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCccc--cee-----eeeeecCcceEEEEecCCCCHH-
Q 043157          410 QGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV--KLL-----GCCLETEVPLLVYEFIPNGTLF-  481 (684)
Q Consensus       410 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv--~l~-----~~~~~~~~~~lv~E~~~~gsL~-  481 (684)
                      .=.||+...++|+.+++|..+... ...+++..|...+..|...++.  ..+     ......+..+.++++++|..+. 
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            458999999999999999876432 1345677788888887533222  111     1122345567889988763221 


Q ss_pred             -------------HHHhhc------CCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----CCCCC
Q 043157          482 -------------QYIHDQ------NEDFPITWE-------------------MRLRIAIEVSGALSYLHS----AASIP  519 (684)
Q Consensus       482 -------------~~l~~~------~~~~~l~~~-------------------~~~~i~~qia~aL~yLH~----~~~~~  519 (684)
                                   ..+|..      .....+++.                   .+..+...+.+.++.+..    .....
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                         111110      001111211                   111122222333333332    22344


Q ss_pred             eEecCCCCCCEEECCCCcEEEeccCCccc
Q 043157          520 IYHRDIKSTNILLDDKYRAKVSDFGASRS  548 (684)
Q Consensus       520 iiH~Dlkp~NILl~~~~~~kl~DFgl~~~  548 (684)
                      ++|+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  45899997653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.14  E-value=0.0057  Score=62.66  Aligned_cols=73  Identities=21%  Similarity=0.248  Sum_probs=47.8

Q ss_pred             CceeceeCcEEEEEEEeCCC--------cEEEEEeccccChhHHHHHHHHHHHHhhcCCCcc-cceeeeeeecCcceEEE
Q 043157          402 NRILGQGGQGTVYKGMLPDG--------KIVAVKKSKVIDESKVEEFINEMVILSQINHRNV-VKLLGCCLETEVPLLVY  472 (684)
Q Consensus       402 ~~~LG~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~  472 (684)
                      .+.|+.|-.=.+|+...+++        +.|.+++... ... .....+|..+++.+.-.++ .++++++.    -.+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            45688788889999886543        4566665432 222 2345689999988843344 46777764    36899


Q ss_pred             EecCCCCH
Q 043157          473 EFIPNGTL  480 (684)
Q Consensus       473 E~~~~gsL  480 (684)
                      ||+++.+|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.81  E-value=0.011  Score=58.12  Aligned_cols=158  Identities=10%  Similarity=0.058  Sum_probs=82.3

Q ss_pred             CCHHHHHHHhcCCCcCceec-----eeCcEEEEEEEeCCCcEEEEEeccccChhHHHHHHHHHHHHhhcCCCccc--cee
Q 043157          387 FTSKELERATDNFNLNRILG-----QGGQGTVYKGMLPDGKIVAVKKSKVIDESKVEEFINEMVILSQINHRNVV--KLL  459 (684)
Q Consensus       387 ~~~~e~~~~~~~~~~~~~LG-----~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv--~l~  459 (684)
                      ++.+|++....+|.+++...     .|---+.|+.+.++|+ +++|+....  ...+++..|++++..|...++.  ..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence            46778888888898866543     5555778999887765 788876532  1223445567777776432221  111


Q ss_pred             e------eeeecCcceEEEEecCCCCHH--------------HHHhhcCCC------CCCCH------------------
Q 043157          460 G------CCLETEVPLLVYEFIPNGTLF--------------QYIHDQNED------FPITW------------------  495 (684)
Q Consensus       460 ~------~~~~~~~~~lv~E~~~~gsL~--------------~~l~~~~~~------~~l~~------------------  495 (684)
                      .      +.........++.++.+....              ..++.....      .....                  
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      111233445666666543221              111110000      00000                  


Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCcEEEeccCCcc
Q 043157          496 EMRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASR  547 (684)
Q Consensus       496 ~~~~~i~~qia~aL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl~~  547 (684)
                      ......+..+...+.-.+.. -+..++|+|+.+.||+++++...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            01111222222333333221 12348999999999999988777899999764

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.10  E-value=0.005  Score=41.16  Aligned_cols=14  Identities=36%  Similarity=0.899  Sum_probs=12.3

Q ss_pred             CCccccCCCCCCCCC
Q 043157          258 TSGHNCSKCPDGYNY  272 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g  272 (684)
                      .++|.| .|+.||.+
T Consensus        23 ~Gsy~C-~C~~Gy~~   36 (43)
T d1emoa1          23 DGSYRC-ECPFGYIL   36 (43)
T ss_dssp             SSCCCC-CCCTTEEE
T ss_pred             CCCeEe-ECCCCccc
Confidence            567999 99999986

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.09  E-value=0.014  Score=38.93  Aligned_cols=30  Identities=7%  Similarity=-0.142  Sum_probs=24.1

Q ss_pred             CcCcccccc--ccccCcceeecccccceeeeEEEeeccc
Q 043157          286 CSPKRSRDS--FFSKKTRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       286 c~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      |.|||||..  +..  ..+|.|++|+     |.|.|++.
T Consensus         2 CvDidEC~~~~~~~--~~~C~Nt~Gs-----y~C~C~~G   33 (43)
T d1emoa1           2 AVDMDECKEPDVCK--HGQCINTDGS-----YRCECPFG   33 (43)
T ss_dssp             CCCCCSSSSTTSCS--SSCCCCCSSC-----CCCCCCTT
T ss_pred             CcceeccCCcCCCC--CCEeECCCCC-----eEeECCCC
Confidence            789999982  222  5789999999     99999973

>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.84  E-value=0.027  Score=37.60  Aligned_cols=28  Identities=0%  Similarity=-0.191  Sum_probs=22.1

Q ss_pred             cCccccc----cccccCcceeecccccceeeeEEEeeccc
Q 043157          287 SPKRSRD----SFFSKKTRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       287 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      +|||||.    .| .  +++|.|++|+     |.|.|+..
T Consensus         1 TDidEC~~~~~~C-~--~~~C~Nt~Gs-----y~C~C~~G   32 (44)
T d1lmja1           1 TDIDECRISPDLC-G--RGQCVNTPGD-----FECKCDEG   32 (44)
T ss_dssp             CCCCTTTTCSSTT-T--TSCEEEETTE-----EEECCCSS
T ss_pred             CcccccCCCCCCC-C--CCEeEcCCCC-----eEEeCCCC
Confidence            3678887    24 2  5789999999     99999983

>d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.59  E-value=0.021  Score=38.03  Aligned_cols=28  Identities=4%  Similarity=-0.160  Sum_probs=22.6

Q ss_pred             cCccccc----cccccCcceeecccccceeeeEEEeeccc
Q 043157          287 SPKRSRD----SFFSKKTRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       287 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      +|||||.    .|.   .+.|.|++|+     |.|.|+..
T Consensus         1 qDinEC~~~~~~c~---~~~C~Nt~Gs-----y~C~C~~G   32 (43)
T d1uzka2           1 EDIDECQELPGLCQ---GGKCINTFGS-----FQCRCPTG   32 (43)
T ss_dssp             EECCHHHHCGGGGB---TSEEEECSSC-----EEEECCTT
T ss_pred             CCcccccCCCCCcC---CCEEECCCCC-----eEeECCCC
Confidence            5788987    242   5799999999     99999873

>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.67  E-value=0.046  Score=36.27  Aligned_cols=31  Identities=6%  Similarity=-0.210  Sum_probs=21.9

Q ss_pred             cCccccccccccCcceeecccccceeeeEEEeeccc
Q 043157          287 SPKRSRDSFFSKKTRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      +|||||..-..-..+.|.|++|+     |.|.|+..
T Consensus         1 TDidEC~~~~~~c~~~C~Nt~G~-----y~C~C~~G   31 (43)
T d1uzka1           1 TDVNECLDPTTCISGNCVNTPGS-----YICDCPPD   31 (43)
T ss_dssp             CCCCGGGSTTSSBTSEEEEETTE-----EEEECCTT
T ss_pred             CCccccCCCCcCcCCEeECCCCC-----EEEecCCC
Confidence            36788872000016799999999     99999873

>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Thrombomodulin, different EGF-like domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.40  E-value=0.039  Score=35.83  Aligned_cols=27  Identities=4%  Similarity=-0.156  Sum_probs=21.3

Q ss_pred             Cccccc---cccccCcceeecccccceeeeEEEeecccc
Q 043157          288 PKRSRD---SFFSKKTRIIFGNISSFIIYRYAISILRLS  323 (684)
Q Consensus       288 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (684)
                      |||||.   +|    ..+|.|+.|+     |.|.|++..
T Consensus         1 DidEC~~~~~C----~~~C~N~~Gs-----y~C~C~~Gy   30 (40)
T d1dx5i3           1 DIDECENGGFC----SGVCHNLPGT-----FECICGPDS   30 (40)
T ss_dssp             ECCHHHHCSSC----SSEEEECSSS-----EEEEECSSS
T ss_pred             CccccCCCcCc----cCEeeCCCCC-----eEeECCCCC
Confidence            466766   35    5699999999     999999843

>d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-like domain of nidogen-1
domain: EGF-like domain of nidogen-1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=91.29  E-value=0.013  Score=38.36  Aligned_cols=19  Identities=26%  Similarity=0.686  Sum_probs=15.3

Q ss_pred             cCCCcccCCCCccccCCCCCCCCC
Q 043157          249 SSGDLICNTTSGHNCSKCPDGYNY  272 (684)
Q Consensus       249 ~c~~~~~~~~~gy~C~~C~~G~~g  272 (684)
                      +|.+.    .++|.| .|+.||.|
T Consensus        14 ~C~Nt----~Gsy~C-~C~~Gy~G   32 (40)
T d1gl4a2          14 ECRDY----ATGFCC-RCVANYTG   32 (40)
T ss_dssp             EEEEC----SSCEEE-EECTTEEE
T ss_pred             EeecC----CCCeEe-ECCCCCcC
Confidence            35555    568999 99999999

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.19  E-value=0.076  Score=34.95  Aligned_cols=28  Identities=7%  Similarity=0.048  Sum_probs=22.6

Q ss_pred             cCccccc----cccccCcceeecccccceeeeEEEeecc
Q 043157          287 SPKRSRD----SFFSKKTRIIFGNISSFIIYRYAISILR  321 (684)
Q Consensus       287 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (684)
                      +|||||.    +|..  .++|++..++     |.|.|++
T Consensus         1 qDideC~~~~~pC~n--~g~C~n~~g~-----y~C~C~~   32 (42)
T d2vj3a1           1 QDVDECSLGANPCEH--AGKCINTLGS-----FECQCLQ   32 (42)
T ss_dssp             CCCCTTTSSSCSSST--TCEEEECSSS-----EEEECCT
T ss_pred             CCCccccCCCCCCCC--CcEeECCCCC-----EEeECCC
Confidence            4677776    4644  6899999999     9999987

>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.74  E-value=0.037  Score=36.54  Aligned_cols=27  Identities=7%  Similarity=-0.109  Sum_probs=21.3

Q ss_pred             Cccccc----cccccCcceeecccccceeeeEEEeeccc
Q 043157          288 PKRSRD----SFFSKKTRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       288 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      |||||.    .| .  +++|.|+.|+     |.|.|++.
T Consensus         1 DidEC~~~~~~C-~--~~~C~Nt~Gs-----y~C~C~~G   31 (42)
T d1lmja2           1 DIDECQRDPLLC-R--GGVCHNTEGS-----YRCECPPG   31 (42)
T ss_dssp             ECCHHHHCSSTT-T--TSEEEEETTE-----EEEESCTT
T ss_pred             CccccCCCCCCC-C--CCEeECCCCC-----eEEeCCCC
Confidence            577776    24 2  5799999999     99999883

>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.45  E-value=0.051  Score=35.60  Aligned_cols=18  Identities=28%  Similarity=0.881  Sum_probs=14.4

Q ss_pred             CCCcccCCCCccccCCCCCCCCC
Q 043157          250 SGDLICNTTSGHNCSKCPDGYNY  272 (684)
Q Consensus       250 c~~~~~~~~~gy~C~~C~~G~~g  272 (684)
                      |.+.    .++|+| .|+.||.-
T Consensus        14 C~n~----~Gsy~C-~C~~Gy~L   31 (41)
T d1i0ua2          14 CVNL----EGGYKC-QCEEGFQL   31 (41)
T ss_dssp             EECS----SSCCEE-CCCTTEEE
T ss_pred             eECC----CCCEEe-ECCCCCeE
Confidence            6555    678999 99999874

>d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: E-selectin, EGF-domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.61  E-value=0.038  Score=36.02  Aligned_cols=30  Identities=20%  Similarity=0.396  Sum_probs=19.2

Q ss_pred             ccccCCcccccccCCCcccCCCCccccCCCCCCCCC
Q 043157          237 VCNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNY  272 (684)
Q Consensus       237 aC~~~~~C~~~~~c~~~~~~~~~gy~C~~C~~G~~g  272 (684)
                      +|.++ .|.....|.+.    ..+|.| .|+.||.|
T Consensus         3 ~C~~~-pC~ngg~C~~~----~~~y~C-~C~~g~~G   32 (40)
T d1g1sa2           3 SCQDM-SCSKQGECLET----IGNYTC-SCYPGFYG   32 (40)
T ss_dssp             CCCTT-GGGGSEEEEEC----SSSEEE-EECTTEES
T ss_pred             cccCC-cCCCCcEEECC----CCCeEE-eCCCCccC
Confidence            34443 34333345544    568999 99999998

>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.55  E-value=0.053  Score=36.09  Aligned_cols=18  Identities=28%  Similarity=0.754  Sum_probs=14.8

Q ss_pred             CCCcccCCCCccccCCCCCCCCC
Q 043157          250 SGDLICNTTSGHNCSKCPDGYNY  272 (684)
Q Consensus       250 c~~~~~~~~~gy~C~~C~~G~~g  272 (684)
                      |.|.    .++|.| .|+.||++
T Consensus        18 C~Nt----~Gsy~C-~C~~Gy~~   35 (44)
T d1lmja1          18 CVNT----PGDFEC-KCDEGYES   35 (44)
T ss_dssp             EEEE----TTEEEE-CCCSSEEE
T ss_pred             eEcC----CCCeEE-eCCCCCcc
Confidence            5555    678999 99999987

>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.98  E-value=0.083  Score=34.11  Aligned_cols=24  Identities=25%  Similarity=0.466  Sum_probs=17.4

Q ss_pred             ccccccCCCcccCCCCccccCCCCCCCCC
Q 043157          244 CLIQLSSGDLICNTTSGHNCSKCPDGYNY  272 (684)
Q Consensus       244 C~~~~~c~~~~~~~~~gy~C~~C~~G~~g  272 (684)
                      |.....|.+.    ..+|.| .|+.||.|
T Consensus         8 C~ngg~C~~~----~~~y~C-~C~~G~~G   31 (39)
T d1xkba1           8 CQNQGKCKDG----LGEYTC-TCLEGFEG   31 (39)
T ss_dssp             CCSSCEECCC----SSSCCE-ECCTTEET
T ss_pred             CCCCcEEECC----CCCEEE-ECCCCCCc
Confidence            4333446555    668999 99999998

>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Complement protease C1R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.56  E-value=0.25  Score=34.12  Aligned_cols=18  Identities=11%  Similarity=0.060  Sum_probs=15.6

Q ss_pred             cceeecccccceeeeEEEeeccc
Q 043157          300 TRIIFGNISSFIIYRYAISILRL  322 (684)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~  322 (684)
                      ..+|.|++|+     |.|.|+..
T Consensus        23 ~~~C~Nt~Gs-----Y~C~C~~G   40 (53)
T d1apqa_          23 QHLCHNYVGG-----YFCSCRPG   40 (53)
T ss_dssp             SSEEEEETTE-----EEEECSTT
T ss_pred             cCEeEcCCCC-----eEeECCCC
Confidence            3589999999     99999973

>d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: E-selectin, EGF-domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.53  E-value=0.051  Score=35.18  Aligned_cols=30  Identities=20%  Similarity=0.503  Sum_probs=20.0

Q ss_pred             ccccCCcccccccCCCcccCCCCccccCCCCCCCCC
Q 043157          237 VCNKDDRCLIQLSSGDLICNTTSGHNCSKCPDGYNY  272 (684)
Q Consensus       237 aC~~~~~C~~~~~c~~~~~~~~~gy~C~~C~~G~~g  272 (684)
                      +|.++ .|.....|.+.    ..+|.| .|+.||.|
T Consensus         3 ~C~~~-pC~ngg~C~~~----~~~~~C-~C~~g~~G   32 (39)
T d1g1ta2           3 ACTNT-SCSGHGECVET----INNYTC-KCDPGFSG   32 (39)
T ss_dssp             CCCTT-GGGGSEEEEEE----TTEEEE-EECTTEES
T ss_pred             cccCC-cCCCCcEEECC----CCCEEE-eCCCCCcC
Confidence            44443 34444445554    668999 99999998

>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.20  E-value=0.099  Score=33.72  Aligned_cols=14  Identities=29%  Similarity=0.729  Sum_probs=12.8

Q ss_pred             CCccccCCCCCCCCC
Q 043157          258 TSGHNCSKCPDGYNY  272 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g  272 (684)
                      ..+|.| .|+.||.|
T Consensus        21 ~~~y~C-~C~~g~~G   34 (39)
T d1edmb_          21 INSYEC-WCPFGFEG   34 (39)
T ss_dssp             TTEEEE-ECCTTCCS
T ss_pred             CCCEEE-ECCCCCCC
Confidence            668999 99999998

>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.41  E-value=0.094  Score=32.95  Aligned_cols=24  Identities=29%  Similarity=0.664  Sum_probs=16.9

Q ss_pred             ccccccCCCcccCCCCccccCCCCCCCCC
Q 043157          244 CLIQLSSGDLICNTTSGHNCSKCPDGYNY  272 (684)
Q Consensus       244 C~~~~~c~~~~~~~~~gy~C~~C~~G~~g  272 (684)
                      |....+|.+.    ..+|.| .|+.||.|
T Consensus         8 C~ngg~C~~~----~~~y~C-~C~~g~~G   31 (35)
T d2vj3a3           8 CLHNGRCLDK----INEFQC-ECPTGFTG   31 (35)
T ss_dssp             STTTCEEEEC----SSCEEE-ECCTTEES
T ss_pred             CCCCcEEECC----CCCeEE-ECCCCCCC
Confidence            3333345554    568999 99999998

>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Thrombomodulin, different EGF-like domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.37  E-value=0.078  Score=34.35  Aligned_cols=18  Identities=17%  Similarity=0.401  Sum_probs=15.1

Q ss_pred             CCCcccCCCCccccCCCCCCCCC
Q 043157          250 SGDLICNTTSGHNCSKCPDGYNY  272 (684)
Q Consensus       250 c~~~~~~~~~gy~C~~C~~G~~g  272 (684)
                      |.+.    .++|+| .|+.||..
T Consensus        15 C~N~----~Gsy~C-~C~~Gy~l   32 (40)
T d1dx5i3          15 CHNL----PGTFEC-ICGPDSAL   32 (40)
T ss_dssp             EEEC----SSSEEE-EECSSSSC
T ss_pred             eeCC----CCCeEe-ECCCCCee
Confidence            6655    678999 99999987

>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.88  E-value=0.1  Score=33.64  Aligned_cols=14  Identities=29%  Similarity=0.683  Sum_probs=12.8

Q ss_pred             CCccccCCCCCCCCC
Q 043157          258 TSGHNCSKCPDGYNY  272 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g  272 (684)
                      ..+|.| .|+.||.|
T Consensus        19 ~~~y~C-~C~~G~~G   32 (39)
T d2vj3a2          19 IGEFQC-ICMPGYEG   32 (39)
T ss_dssp             SSCEEE-ECCTTEES
T ss_pred             CCCEEE-eCCCCCcc
Confidence            668999 99999998

>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=83.60  E-value=0.098  Score=33.32  Aligned_cols=14  Identities=14%  Similarity=0.323  Sum_probs=12.8

Q ss_pred             CCccccCCCCCCCCC
Q 043157          258 TSGHNCSKCPDGYNY  272 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g  272 (684)
                      ..+|.| .|+.||.|
T Consensus        20 ~~~y~C-~C~~g~~G   33 (37)
T d2c4fl1          20 LQSYIC-FCLPAFEG   33 (37)
T ss_dssp             TTEEEE-ECCTTEES
T ss_pred             CCCeEE-ECCCCCcC
Confidence            668999 99999998

>d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Plasminogen activator (tissue-type), t-PA
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.60  E-value=0.22  Score=32.39  Aligned_cols=14  Identities=36%  Similarity=0.952  Sum_probs=12.6

Q ss_pred             CCccccCCCCCCCCC
Q 043157          258 TSGHNCSKCPDGYNY  272 (684)
Q Consensus       258 ~~gy~C~~C~~G~~g  272 (684)
                      ..+|.| .|+.||.|
T Consensus        18 ~~~y~C-~C~~g~~G   31 (41)
T d1tpga1          18 FSDFVC-QCPEGFAG   31 (41)
T ss_dssp             SSCEEE-ECCTTCBS
T ss_pred             CCCeEE-CCCCCCCC
Confidence            558999 99999998

>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Complement protease C1R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.52  E-value=0.15  Score=35.30  Aligned_cols=19  Identities=26%  Similarity=0.655  Sum_probs=15.1

Q ss_pred             cCCCcccCCCCccccCCCCCCCCC
Q 043157          249 SSGDLICNTTSGHNCSKCPDGYNY  272 (684)
Q Consensus       249 ~c~~~~~~~~~gy~C~~C~~G~~g  272 (684)
                      .|.|.    .+||+| .|+.||..
T Consensus        25 ~C~Nt----~GsY~C-~C~~Gy~l   43 (53)
T d1apqa_          25 LCHNY----VGGYFC-SCRPGYEL   43 (53)
T ss_dssp             EEEEE----TTEEEE-ECSTTCEE
T ss_pred             EeEcC----CCCeEe-ECCCCCeE
Confidence            36655    678999 99999974

>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.61  E-value=0.16  Score=33.54  Aligned_cols=19  Identities=16%  Similarity=0.544  Sum_probs=15.0

Q ss_pred             cCCCcccCCCCccccCCCCCCCCC
Q 043157          249 SSGDLICNTTSGHNCSKCPDGYNY  272 (684)
Q Consensus       249 ~c~~~~~~~~~gy~C~~C~~G~~g  272 (684)
                      .|.+.    .+||.| .|+.||+.
T Consensus        16 ~C~Nt----~G~y~C-~C~~Gy~l   34 (43)
T d1uzka1          16 NCVNT----PGSYIC-DCPPDFEL   34 (43)
T ss_dssp             EEEEE----TTEEEE-ECCTTCEE
T ss_pred             EeECC----CCCEEE-ecCCCCEE
Confidence            35555    678999 99999976